trn,registry,date_registration,date_enrollement,retrospective_registration,recruitment_status,phase,study_type,countries,public_title,target_enrollment,web_address,euctr_country
IRCT20180223038837N1,IRCT,2018-12-08,2018-10-23,TRUE,Recruiting,Not Applicable,Interventional,Iran,Comparative study of radiofrequency ablation & foam sclerotherapy for treatment patients suffering from varicose veins,60,http://en.irct.ir/trial/32039,NA
NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,TRUE,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),500,https://clinicaltrials.gov/show/NCT04246242,NA
ChiCTR2000029953,ChiCTR,2020-02-17,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=49217,NA
ChiCTR2000029949,ChiCTR,2020-02-16,2020-02-16,FALSE,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49181,NA
ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49599,NA
ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49596,NA
ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,TRUE,Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49612,NA
ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,TRUE,Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49607,NA
ChiCTR2000029907,ChiCTR,2020-02-16,2020-02-16,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,1000,http://www.chictr.org.cn/showproj.aspx?proj=49587,NA
ChiCTR2000029905,ChiCTR,2020-02-16,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,271,http://www.chictr.org.cn/showproj.aspx?proj=49595,NA
ChiCTR2000029896,ChiCTR,2020-02-16,2020-01-31,TRUE,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49432,NA
ChiCTR2000029883,ChiCTR,2020-02-16,2020-02-17,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,200,http://www.chictr.org.cn/showproj.aspx?proj=49549,NA
ChiCTR2000029870,ChiCTR,2020-02-15,2020-02-15,FALSE,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=49563,NA
ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,TRUE,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",300,http://www.chictr.org.cn/showproj.aspx?proj=49486,NA
ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,FALSE,Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",520,http://www.chictr.org.cn/showproj.aspx?proj=49514,NA
ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",180,http://www.chictr.org.cn/showproj.aspx?proj=49543,NA
ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",20,http://www.chictr.org.cn/showproj.aspx?proj=49532,NA
ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,FALSE,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49533,NA
ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49530,NA
ChiCTR2000029839,ChiCTR,2020-02-15,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49439,NA
ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,FALSE,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,400,http://www.chictr.org.cn/showproj.aspx?proj=49306,NA
ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,TRUE,Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,80,http://www.chictr.org.cn/showproj.aspx?proj=49490,NA
ChiCTR2000029815,ChiCTR,2020-02-14,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),800,http://www.chictr.org.cn/showproj.aspx?proj=49346,NA
ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=49387,NA
ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),72,http://www.chictr.org.cn/showproj.aspx?proj=49425,NA
ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49355,NA
ChiCTR2000029810,ChiCTR,2020-02-14,2020-02-16,FALSE,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,10000,http://www.chictr.org.cn/showproj.aspx?proj=49407,NA
ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,TRUE,Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49161,NA
ChiCTR2000029805,ChiCTR,2020-02-14,2020-02-12,TRUE,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49188,NA
ChiCTR2000029804,ChiCTR,2020-02-14,2020-02-12,TRUE,Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49178,NA
ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49453,NA
ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,FALSE,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49348,NA
ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=49452,NA
ChiCTR2000029782,ChiCTR,2020-02-13,2020-01-30,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),27,http://www.chictr.org.cn/showproj.aspx?proj=49445,NA
ChiCTR2000029779,ChiCTR,2020-02-13,2020-02-14,FALSE,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,0,http://www.chictr.org.cn/showproj.aspx?proj=49378,NA
ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),600,http://www.chictr.org.cn/showproj.aspx?proj=49422,NA
ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,TRUE,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",160,http://www.chictr.org.cn/showproj.aspx?proj=49380,NA
ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=49342,NA
ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,FALSE,Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49415,NA
ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,TRUE,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",60,http://www.chictr.org.cn/showproj.aspx?proj=49131,NA
ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,TRUE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",188,http://www.chictr.org.cn/showproj.aspx?proj=49409,NA
ChiCTR2000029764,ChiCTR,2020-02-13,2020-02-16,FALSE,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,100,http://www.chictr.org.cn/showproj.aspx?proj=49388,NA
ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,FALSE,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",408,http://www.chictr.org.cn/showproj.aspx?proj=49408,NA
ChiCTR2000029758,ChiCTR,2020-02-12,2020-02-03,TRUE,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,100,http://www.chictr.org.cn/showproj.aspx?proj=49295,NA
ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),238,http://www.chictr.org.cn/showproj.aspx?proj=49222,NA
ChiCTR2000029754,ChiCTR,2020-02-12,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,1500,http://www.chictr.org.cn/showproj.aspx?proj=49370,NA
ChiCTR2000029751,ChiCTR,2020-02-12,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),350,http://www.chictr.org.cn/showproj.aspx?proj=49354,NA
ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,FALSE,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49287,NA
ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",90,http://www.chictr.org.cn/showproj.aspx?proj=49297,NA
ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,FALSE,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",112,http://www.chictr.org.cn/showproj.aspx?proj=49263,NA
ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,FALSE,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",440,http://www.chictr.org.cn/showproj.aspx?proj=49283,NA
ChiCTR2000029735,ChiCTR,2020-02-10,2020-01-26,TRUE,Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=49279,NA
ChiCTR2000029734,ChiCTR,2020-02-10,2020-02-08,TRUE,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=48868,NA
ChiCTR2000029732,ChiCTR,2020-02-10,2020-02-10,FALSE,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),156,http://www.chictr.org.cn/showproj.aspx?proj=49302,NA
ChiCTR2000029695,ChiCTR,2020-02-10,2020-03-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,300,http://www.chictr.org.cn/showproj.aspx?proj=49219,NA
ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49086,NA
ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,FALSE,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",192,http://www.chictr.org.cn/showproj.aspx?proj=49187,NA
ChiCTR2000029637,ChiCTR,2020-02-08,2020-02-07,TRUE,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49127,NA
ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,FALSE,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,40,http://www.chictr.org.cn/showproj.aspx?proj=49215,NA
ChiCTR2000029628,ChiCTR,2020-02-07,2020-02-07,FALSE,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=49155,NA
ChiCTR2000029626,ChiCTR,2020-02-07,2020-02-17,FALSE,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49170,NA
ChiCTR2000029625,ChiCTR,2020-02-07,2020-02-17,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=49177,NA
ChiCTR2000029624,ChiCTR,2020-02-07,2020-02-08,FALSE,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=49132,NA
ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,FALSE,Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),380,http://www.chictr.org.cn/showproj.aspx?proj=49165,NA
ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,FALSE,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",205,http://www.chictr.org.cn/showproj.aspx?proj=49145,NA
ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),63,http://www.chictr.org.cn/showproj.aspx?proj=49146,NA
ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,FALSE,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49075,NA
ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,600,http://www.chictr.org.cn/showproj.aspx?proj=48985,NA
ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,400,http://www.chictr.org.cn/showproj.aspx?proj=48988,NA
ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=49042,NA
ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,FALSE,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",1000,http://www.chictr.org.cn/showproj.aspx?proj=49080,NA
ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,TRUE,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=48880,NA
ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,TRUE,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,200,http://www.chictr.org.cn/showproj.aspx?proj=48792,NA
ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",30,http://www.chictr.org.cn/showproj.aspx?proj=49015,NA
ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",30,http://www.chictr.org.cn/showproj.aspx?proj=49013,NA
ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,FALSE,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=48968,NA
ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=48992,NA
ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",328,http://www.chictr.org.cn/showproj.aspx?proj=48991,NA
ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,FALSE,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",140,http://www.chictr.org.cn/showproj.aspx?proj=48860,NA
ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,FALSE,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",100,http://www.chictr.org.cn/showproj.aspx?proj=48861,NA
ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",90,http://www.chictr.org.cn/showproj.aspx?proj=48971,NA
ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=48931,NA
ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,FALSE,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,200,http://www.chictr.org.cn/showproj.aspx?proj=48965,NA
ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=48919,NA
ChiCTR2000029462,ChiCTR,2020-02-02,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=48922,NA
ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,FALSE,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48927,NA
ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,100,http://www.chictr.org.cn/showproj.aspx?proj=48930,NA
ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,FALSE,Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,100,http://www.chictr.org.cn/showproj.aspx?proj=48929,NA
ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=48904,NA
ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,FALSE,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48911,NA
ChiCTR2000029437,ChiCTR,2020-02-01,2020-02-03,FALSE,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=48913,NA
ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=48884,NA
ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,120,http://www.chictr.org.cn/showproj.aspx?proj=48827,NA
ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,FALSE,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),72,http://www.chictr.org.cn/showproj.aspx?proj=48881,NA
ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),45,http://www.chictr.org.cn/showproj.aspx?proj=48907,NA
ChiCTR2000029430,ChiCTR,2020-02-01,2020-02-03,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),600,http://www.chictr.org.cn/showproj.aspx?proj=48902,NA
ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,FALSE,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,42,http://www.chictr.org.cn/showproj.aspx?proj=48886,NA
ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=48824,NA
ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,TRUE,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=48768,NA
IRCT20190809044488N1,IRCT,2020-01-13,2019-09-07,TRUE,Recruiting,Phase 3,Interventional,Iran,"Effects of using Forced Hot air system on physiological parameters, waking time and arterial blood gases in patients undergoing coronary artery bypass grafting surgery",102,http://en.irct.ir/trial/41571,NA
ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50025,NA
ChiCTR2000030185,ChiCTR,2020-02-24,2020-02-24,FALSE,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=50058,NA
ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,FALSE,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50059,NA
ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,TRUE,Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,60,http://www.chictr.org.cn/showproj.aspx?proj=49229,NA
ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,TRUE,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),16,http://www.chictr.org.cn/showproj.aspx?proj=50017,NA
ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=49567,NA
ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",20,http://www.chictr.org.cn/showproj.aspx?proj=49696,NA
ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49947,NA
ChiCTR2000030164,ChiCTR,2020-02-24,2020-02-24,FALSE,Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,10,http://www.chictr.org.cn/showproj.aspx?proj=49983,NA
ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,FALSE,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50004,NA
ChiCTR2000030137,ChiCTR,2020-02-24,2020-02-24,FALSE,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),130,http://www.chictr.org.cn/showproj.aspx?proj=50007,NA
ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),130,http://www.chictr.org.cn/showproj.aspx?proj=50005,NA
ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49594,NA
ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,TRUE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",348,http://www.chictr.org.cn/showproj.aspx?proj=49762,NA
ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),16,http://www.chictr.org.cn/showproj.aspx?proj=49901,NA
ChiCTR2000030115,ChiCTR,2020-02-23,2020-02-27,FALSE,Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,50,http://www.chictr.org.cn/showproj.aspx?proj=49964,NA
ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,TRUE,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988,NA
ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,FALSE,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),180,http://www.chictr.org.cn/showproj.aspx?proj=49747,NA
ChiCTR2000030096,ChiCTR,2020-02-23,2020-02-17,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49794,NA
ChiCTR2000030094,ChiCTR,2020-02-23,2020-03-01,FALSE,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",200,http://www.chictr.org.cn/showproj.aspx?proj=49970,NA
ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49932,NA
ChiCTR2000030092,ChiCTR,2020-02-23,2020-02-12,TRUE,Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,800,http://www.chictr.org.cn/showproj.aspx?proj=49880,NA
ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,FALSE,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,400,http://www.chictr.org.cn/showproj.aspx?proj=49910,NA
ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,FALSE,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49889,NA
ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49902,NA
ChiCTR2000030087,ChiCTR,2020-02-22,2020-02-12,TRUE,Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),800,http://www.chictr.org.cn/showproj.aspx?proj=49919,NA
ChiCTR2000030086,ChiCTR,2020-02-22,2020-02-24,FALSE,Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,210,http://www.chictr.org.cn/showproj.aspx?proj=49934,NA
ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,FALSE,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,180,http://www.chictr.org.cn/showproj.aspx?proj=49952,NA
ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,FALSE,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",200,http://www.chictr.org.cn/showproj.aspx?proj=49831,NA
ChiCTR2000030056,ChiCTR,2020-02-22,2020-02-23,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,100,http://www.chictr.org.cn/showproj.aspx?proj=49904,NA
ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49869,NA
ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,TRUE,Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=49861,NA
ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,FALSE,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",300,http://www.chictr.org.cn/showproj.aspx?proj=49866,NA
ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=49891,NA
ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=49544,NA
ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,TRUE,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",132,http://www.chictr.org.cn/showproj.aspx?proj=49647,NA
ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),828,http://www.chictr.org.cn/showproj.aspx?proj=49703,NA
ChiCTR2000030032,ChiCTR,2020-02-21,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,20,http://www.chictr.org.cn/showproj.aspx?proj=49816,NA
ChiCTR2000030030,ChiCTR,2020-02-20,2020-02-20,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),2000,http://www.chictr.org.cn/showproj.aspx?proj=49841,NA
ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,TRUE,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49824,NA
ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,FALSE,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=49852,NA
ChiCTR2000030021,ChiCTR,2020-02-20,2020-02-20,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,10,http://www.chictr.org.cn/showproj.aspx?proj=49690,NA
ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,TRUE,Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49812,NA
ChiCTR2000030019,ChiCTR,2020-02-20,2020-02-28,FALSE,Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",600,http://www.chictr.org.cn/showproj.aspx?proj=49768,NA
ChiCTR2000030017,ChiCTR,2020-02-20,2020-02-17,TRUE,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49798,NA
ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,TRUE,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49799,NA
ChiCTR2000030015,ChiCTR,2020-02-20,2020-02-19,TRUE,Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,300,http://www.chictr.org.cn/showproj.aspx?proj=49800,NA
ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,FALSE,Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49718,NA
ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49777,NA
ChiCTR2000030008,ChiCTR,2020-02-19,2020-02-12,TRUE,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,100,http://www.chictr.org.cn/showproj.aspx?proj=49426,NA
ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,TRUE,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49619,NA
ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,FALSE,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49737,NA
ChiCTR2000030004,ChiCTR,2020-02-19,2020-02-20,FALSE,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,150000,http://www.chictr.org.cn/showproj.aspx?proj=49783,NA
ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,FALSE,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),480,http://www.chictr.org.cn/showproj.aspx?proj=49770,NA
ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,TRUE,Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49738,NA
ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,TRUE,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",240,http://www.chictr.org.cn/showproj.aspx?proj=49723,NA
ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,TRUE,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",50,http://www.chictr.org.cn/showproj.aspx?proj=49748,NA
ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49717,NA
ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,FALSE,Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=49510,NA
ChiCTR2000029995,ChiCTR,2020-02-19,2020-02-20,FALSE,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,200,http://www.chictr.org.cn/showproj.aspx?proj=49418,NA
ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,FALSE,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,200,http://www.chictr.org.cn/showproj.aspx?proj=49309,NA
ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,TRUE,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49574,NA
ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49674,NA
ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,FALSE,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=49720,NA
ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,TRUE,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=49218,NA
ChiCTR2000029985,ChiCTR,2020-02-18,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),1853,http://www.chictr.org.cn/showproj.aspx?proj=49711,NA
ChiCTR2000029981,ChiCTR,2020-02-18,2020-02-18,FALSE,Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,60,http://www.chictr.org.cn/showproj.aspx?proj=49692,NA
ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,FALSE,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),186,http://www.chictr.org.cn/showproj.aspx?proj=49702,NA
ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,TRUE,Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",300,http://www.chictr.org.cn/showproj.aspx?proj=49321,NA
ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,FALSE,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49664,NA
ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,100,http://www.chictr.org.cn/showproj.aspx?proj=49639,NA
ChiCTR2000029959,ChiCTR,2020-02-17,2020-01-25,TRUE,Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,30,http://www.chictr.org.cn/showproj.aspx?proj=49636,NA
ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,FALSE,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=49618,NA
ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,FALSE,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",300,http://www.chictr.org.cn/showproj.aspx?proj=49402,NA
ChiCTR2000029866,ChiCTR,2020-02-15,2020-02-17,FALSE,Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,120,http://www.chictr.org.cn/showproj.aspx?proj=49519,NA
ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,FALSE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",68,http://www.chictr.org.cn/showproj.aspx?proj=49534,NA
ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",320,http://www.chictr.org.cn/showproj.aspx?proj=49428,NA
ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,FALSE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49138,NA
ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,FALSE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=49220,NA
ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,FALSE,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),78,http://www.chictr.org.cn/showproj.aspx?proj=49317,NA
ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=50380,NA
ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,FALSE,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50273,NA
ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,80,http://www.chictr.org.cn/showproj.aspx?proj=50268,NA
ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",30,http://www.chictr.org.cn/showproj.aspx?proj=50174,NA
ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,60,http://www.chictr.org.cn/showproj.aspx?proj=50286,NA
ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,FALSE,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50341,NA
ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",340,http://www.chictr.org.cn/showproj.aspx?proj=50173,NA
ChiCTR2000030391,ChiCTR,2020-03-01,2020-03-01,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,100,http://www.chictr.org.cn/showproj.aspx?proj=30796,NA
ChiCTR2000030390,ChiCTR,2020-03-01,2020-01-01,TRUE,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,3000,http://www.chictr.org.cn/showproj.aspx?proj=50224,NA
ChiCTR2000030389,ChiCTR,2020-03-01,2020-02-29,TRUE,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50278,NA
ChiCTR2000030387,ChiCTR,2020-03-01,2020-03-01,FALSE,Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),130,http://www.chictr.org.cn/showproj.aspx?proj=50329,NA
ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=50323,NA
ChiCTR2000030382,ChiCTR,2020-02-17,2020-03-01,FALSE,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,50,http://www.chictr.org.cn/showproj.aspx?proj=50325,NA
ChiCTR2000030363,ChiCTR,2020-02-29,2020-02-23,TRUE,Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",120,http://www.chictr.org.cn/showproj.aspx?proj=49984,NA
ChiCTR2000030334,ChiCTR,2020-02-28,2020-02-19,TRUE,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),25,http://www.chictr.org.cn/showproj.aspx?proj=49491,NA
ChiCTR2000030333,ChiCTR,2020-02-28,2020-03-04,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label controlled trial for the efficacy and safety of Pirfenidone in patients with severe and critical novel coronavirus pneumonia (COVID-19)",292,http://www.chictr.org.cn/showproj.aspx?proj=48801,NA
ChiCTR2000030327,ChiCTR,2020-02-28,2020-01-21,TRUE,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50214,NA
ChiCTR2000030325,ChiCTR,2020-02-28,2020-02-28,FALSE,Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,500,http://www.chictr.org.cn/showproj.aspx?proj=50227,NA
ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50231,NA
ChiCTR2000030322,ChiCTR,2020-02-28,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,210,http://www.chictr.org.cn/showproj.aspx?proj=50240,NA
ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,300,http://www.chictr.org.cn/showproj.aspx?proj=50247,NA
ChiCTR2000030315,ChiCTR,2020-02-28,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50255,NA
ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50248,NA
ChiCTR2000030305,ChiCTR,2020-02-28,2020-03-09,FALSE,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50223,NA
ChiCTR2000030293,ChiCTR,2020-02-27,2020-03-01,FALSE,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,300,http://www.chictr.org.cn/showproj.aspx?proj=50195,NA
ChiCTR2000030290,ChiCTR,2020-02-27,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,2000,http://www.chictr.org.cn/showproj.aspx?proj=50175,NA
ChiCTR2000030283,ChiCTR,2020-02-27,2020-02-27,FALSE,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50119,NA
ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=49691,NA
ChiCTR2000030264,ChiCTR,2020-02-26,2020-02-28,FALSE,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=50161,NA
ChiCTR2000030263,ChiCTR,2020-02-26,2020-02-20,TRUE,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,200,http://www.chictr.org.cn/showproj.aspx?proj=50140,NA
ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),26,http://www.chictr.org.cn/showproj.aspx?proj=49963,NA
ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,20,http://www.chictr.org.cn/showproj.aspx?proj=50130,NA
ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",60,http://www.chictr.org.cn/showproj.aspx?proj=49887,NA
ChiCTR2000030257,ChiCTR,2020-02-26,2020-03-09,FALSE,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,100,http://www.chictr.org.cn/showproj.aspx?proj=50006,NA
ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,FALSE,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,300,http://www.chictr.org.cn/showproj.aspx?proj=50089,NA
ChiCTR2000030253,ChiCTR,2020-02-26,2020-02-27,FALSE,Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,30,http://www.chictr.org.cn/showproj.aspx?proj=50143,NA
ChiCTR2000030226,ChiCTR,2020-02-26,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",40,http://www.chictr.org.cn/showproj.aspx?proj=49855,NA
ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,TRUE,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),186,http://www.chictr.org.cn/showproj.aspx?proj=49945,NA
ChiCTR2000030223,ChiCTR,2020-02-26,2020-02-20,TRUE,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,5000,http://www.chictr.org.cn/showproj.aspx?proj=50026,NA
ChiCTR2000030222,ChiCTR,2020-02-25,2020-02-21,TRUE,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of participants                                        Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People,658,http://www.chictr.org.cn/showproj.aspx?proj=50048,NA
ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,TRUE,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50110,NA
ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,TRUE,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50115,NA
ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),120,http://www.chictr.org.cn/showproj.aspx?proj=50107,NA
ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,TRUE,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=49883,NA
ChiCTR2000030162,ChiCTR,2020-02-24,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                     Study for the water extract of soybean in the treatment of patients with novel coronavirus pneumonia (COVID-19),Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49570,NA
ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,TRUE,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=49914,NA
ChiCTR2000030042,ChiCTR,2020-02-21,2020-02-21,FALSE,Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                                                A Medical Records Based Study for Construction and Analysis of Diagnosis Predictive&,240,http://www.chictr.org.cn/showproj.aspx?proj=49899,NA
ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,FALSE,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",100,http://www.chictr.org.cn/showproj.aspx?proj=49797,NA
ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,FALSE,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,450,http://www.chictr.org.cn/showproj.aspx?proj=49796,NA
ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,FALSE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",72,http://www.chictr.org.cn/showproj.aspx?proj=49666,NA
ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,FALSE,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=49592,NA
ChiCTR2000029952,ChiCTR,2020-02-17,2020-02-17,FALSE,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                         Medical records based study for epidemiological and clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Chongqing,0,http://www.chictr.org.cn/showproj.aspx?proj=49630,NA
ChiCTR2000029900,ChiCTR,2020-02-16,2020-02-17,FALSE,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,200,http://www.chictr.org.cn/showproj.aspx?proj=49377,NA
ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,FALSE,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=49536,NA
ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,FALSE,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",100,http://www.chictr.org.cn/showproj.aspx?proj=49482,NA
ChiCTR2000029829,ChiCTR,2020-02-15,2020-02-15,FALSE,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                 Medical records based study for Heart-type fatty acid-binding protein on prognosis of novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49520,NA
ChiCTR2000029762,ChiCTR,2020-02-12,2020-02-12,FALSE,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                                                                              Clinical study for the effect and,60,http://www.chictr.org.cn/showproj.aspx?proj=49404,NA
ChiCTR2000029761,ChiCTR,2020-02-12,2020-02-13,FALSE,Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                Clinical study on the safety and effectiveness of Hydroxychloroquine Sulfate tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19),240,http://www.chictr.org.cn/showproj.aspx?proj=49400,NA
ChiCTR2000029760,ChiCTR,2020-02-12,2020-02-12,FALSE,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                              A study for the efficacy of hydroxychloroquine for mild and moderate COVID-19 infectious diseases,240,http://www.chictr.org.cn/showproj.aspx?proj=49369,NA
ChiCTR2000029759,ChiCTR,2020-02-12,2020-02-15,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Retracted due to lack of patient                               A multicenter, randomized, open label, controlled trial for the efficacy and safety of ASC09/ Ritonavir compound tablets and Lopinavir/ Ritonavir (Kaletra) and Arbidol tablets in the treatm",60,http://www.chictr.org.cn/showproj.aspx?proj=49352,NA
ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,FALSE,Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",120,http://www.chictr.org.cn/showproj.aspx?proj=49301,NA
ChiCTR2000029728,ChiCTR,2020-02-10,2020-02-15,FALSE,Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=49250,NA
ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,TRUE,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",108,http://www.chictr.org.cn/showproj.aspx?proj=48782,NA
ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,FALSE,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,48,http://www.chictr.org.cn/showproj.aspx?proj=48777,NA
ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,30,http://www.chictr.org.cn/showproj.aspx?proj=50727,NA
ChiCTR2000030593,ChiCTR,2020-03-08,2020-03-10,FALSE,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",150,http://www.chictr.org.cn/showproj.aspx?proj=50228,NA
ChiCTR2000030581,ChiCTR,2020-03-08,2020-02-02,TRUE,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,192,http://www.chictr.org.cn/showproj.aspx?proj=50394,NA
ChiCTR2000030579,ChiCTR,2020-03-08,2020-02-15,TRUE,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50692,NA
ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,TRUE,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50690,NA
ChiCTR2000030574,ChiCTR,2020-03-07,2020-03-08,FALSE,Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=49953,NA
ChiCTR2000030564,ChiCTR,2020-03-07,2020-03-15,FALSE,Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50653,NA
ChiCTR2000030559,ChiCTR,2020-03-07,2020-03-07,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),12,http://www.chictr.org.cn/showproj.aspx?proj=50583,NA
ChiCTR2000030557,ChiCTR,2020-03-07,2020-03-10,FALSE,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",1030,http://www.chictr.org.cn/showproj.aspx?proj=50667,NA
ChiCTR2000030556,ChiCTR,2020-03-07,2020-03-15,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50672,NA
ChiCTR2000030552,ChiCTR,2020-03-07,2020-03-08,FALSE,Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),70,http://www.chictr.org.cn/showproj.aspx?proj=49708,NA
ChiCTR2000030544,ChiCTR,2020-03-06,2020-02-24,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),1500,http://www.chictr.org.cn/showproj.aspx?proj=50134,NA
ChiCTR2000030543,ChiCTR,2020-03-06,2020-02-14,TRUE,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),35,http://www.chictr.org.cn/showproj.aspx?proj=50541,NA
ChiCTR2000030542,ChiCTR,2020-03-06,2020-03-09,FALSE,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",600,http://www.chictr.org.cn/showproj.aspx?proj=50608,NA
ChiCTR2000030541,ChiCTR,2020-03-06,2020-03-06,FALSE,Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,1300,http://www.chictr.org.cn/showproj.aspx?proj=50623,NA
ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,FALSE,Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658,NA
ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,TRUE,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,100,http://www.chictr.org.cn/showproj.aspx?proj=49790,NA
ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,TRUE,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=50586,NA
ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,TRUE,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,60,http://www.chictr.org.cn/showproj.aspx?proj=49632,NA
ChiCTR2000030493,ChiCTR,2020-03-04,2020-03-04,FALSE,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",1300,http://www.chictr.org.cn/showproj.aspx?proj=50547,NA
ChiCTR2000030492,ChiCTR,2020-03-04,2020-03-04,FALSE,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,200,http://www.chictr.org.cn/showproj.aspx?proj=50549,NA
ChiCTR2000030491,ChiCTR,2020-03-04,2020-03-03,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,100,http://www.chictr.org.cn/showproj.aspx?proj=50552,NA
ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50487,NA
ChiCTR2000030489,ChiCTR,2020-03-04,2020-02-01,TRUE,Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,1000,http://www.chictr.org.cn/showproj.aspx?proj=50490,NA
ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,FALSE,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",10,http://www.chictr.org.cn/showproj.aspx?proj=50507,NA
ChiCTR2000030485,ChiCTR,2020-03-03,2020-03-03,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,90,http://www.chictr.org.cn/showproj.aspx?proj=50459,NA
ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,TRUE,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=50263,NA
ChiCTR2000030482,ChiCTR,2020-03-03,2020-03-06,FALSE,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",8000,http://www.chictr.org.cn/showproj.aspx?proj=50353,NA
ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,TRUE,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=50453,NA
ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,FALSE,Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",328,http://www.chictr.org.cn/showproj.aspx?proj=50470,NA
ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50450,NA
ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,FALSE,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),19,http://www.chictr.org.cn/showproj.aspx?proj=50458,NA
ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),19,http://www.chictr.org.cn/showproj.aspx?proj=50452,NA
ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,TRUE,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=49753,NA
ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,FALSE,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),394,http://www.chictr.org.cn/showproj.aspx?proj=50421,NA
ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,TRUE,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),96,http://www.chictr.org.cn/showproj.aspx?proj=50082,NA
ChiCTR2000030468,ChiCTR,2020-03-02,2020-02-28,TRUE,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,950,http://www.chictr.org.cn/showproj.aspx?proj=50390,NA
ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,60,http://www.chictr.org.cn/showproj.aspx?proj=50378,NA
ChiCTR2000030465,ChiCTR,2020-03-02,2020-03-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                        Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19),70,http://www.chictr.org.cn/showproj.aspx?proj=50388,NA
ChiCTR2000030464,ChiCTR,2020-03-02,2020-03-03,FALSE,Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50382,NA
ChiCTR2000030453,ChiCTR,2020-03-02,2020-03-02,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50381,NA
ChiCTR2000030436,ChiCTR,2020-03-01,2020-03-06,FALSE,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50297,NA
ChiCTR2000030312,ChiCTR,2020-02-28,2020-02-29,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Cancelled, due to modify the protocol                                          A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment&",24,http://www.chictr.org.cn/showproj.aspx?proj=50258,NA
ChiCTR2000030304,ChiCTR,2020-02-28,2020-03-10,FALSE,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=49653,NA
ChiCTR2000030163,ChiCTR,2020-02-24,2020-02-25,FALSE,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),256,http://www.chictr.org.cn/showproj.aspx?proj=50031,NA
ChiCTR2000030014,ChiCTR,2020-02-20,2020-02-19,TRUE,Not Recruiting,Not Applicable,Interventional,China,Cancelled due to lack of patient                               Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients,300,http://www.chictr.org.cn/showproj.aspx?proj=49802,NA
ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,FALSE,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49435,NA
ChiCTR2000029958,ChiCTR,2020-02-17,2020-02-17,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,260,http://www.chictr.org.cn/showproj.aspx?proj=49635,NA
ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,FALSE,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=49081,NA
ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,TRUE,Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",70,http://www.chictr.org.cn/showproj.aspx?proj=49088,NA
ChiCTR2000029579,ChiCTR,2020-02-05,2020-01-31,TRUE,Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,200,http://www.chictr.org.cn/showproj.aspx?proj=49045,NA
ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,TRUE,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=48775,NA
ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,TRUE,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=49014,NA
ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,TRUE,Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",160,http://www.chictr.org.cn/showproj.aspx?proj=48684,NA
ChiCTR2000030902,ChiCTR,2020-03-16,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,1000,http://www.chictr.org.cn/showproj.aspx?proj=51130,NA
ChiCTR2000030901,ChiCTR,2020-03-16,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,100,http://www.chictr.org.cn/showproj.aspx?proj=51064,NA
ChiCTR2000030898,ChiCTR,2020-03-16,2020-01-27,TRUE,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=50780,NA
ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,TRUE,Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50462,NA
ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),24,http://www.chictr.org.cn/showproj.aspx?proj=51028,NA
ChiCTR2000030895,ChiCTR,2020-03-16,2020-03-14,TRUE,Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,1000,http://www.chictr.org.cn/showproj.aspx?proj=51034,NA
ChiCTR2000030894,ChiCTR,2020-03-16,2020-03-01,TRUE,Recruiting,Phase 4,Interventional,China,"Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial",150,http://www.chictr.org.cn/showproj.aspx?proj=51126,NA
ChiCTR2000030893,ChiCTR,2020-03-16,2020-03-19,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,50,http://www.chictr.org.cn/showproj.aspx?proj=51073,NA
ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,TRUE,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,40,http://www.chictr.org.cn/showproj.aspx?proj=51118,NA
ChiCTR2000030883,ChiCTR,2020-03-16,2020-02-18,TRUE,Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50960,NA
ChiCTR2000030866,ChiCTR,2020-03-16,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",30,http://www.chictr.org.cn/showproj.aspx?proj=50299,NA
ChiCTR2000030865,ChiCTR,2020-03-16,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,200,http://www.chictr.org.cn/showproj.aspx?proj=49933,NA
ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50662,NA
ChiCTR2000030863,ChiCTR,2020-03-16,2020-01-22,TRUE,Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,5000,http://www.chictr.org.cn/showproj.aspx?proj=50767,NA
ChiCTR2000030862,ChiCTR,2020-03-16,2020-01-24,TRUE,Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,150,http://www.chictr.org.cn/showproj.aspx?proj=51107,NA
ChiCTR2000030861,ChiCTR,2020-03-16,2019-02-27,TRUE,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,90,http://www.chictr.org.cn/showproj.aspx?proj=51103,NA
ChiCTR2000030860,ChiCTR,2020-03-16,2020-03-16,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,100,http://www.chictr.org.cn/showproj.aspx?proj=51102,NA
ChiCTR2000030859,ChiCTR,2020-03-16,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,1305,http://www.chictr.org.cn/showproj.aspx?proj=51025,NA
ChiCTR2000030858,ChiCTR,2020-03-16,2020-02-06,TRUE,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",483,http://www.chictr.org.cn/showproj.aspx?proj=51097,NA
ChiCTR2000030857,ChiCTR,2020-03-16,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=51040,NA
ChiCTR2000030856,ChiCTR,2020-03-16,2020-02-15,TRUE,Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,600,http://www.chictr.org.cn/showproj.aspx?proj=51091,NA
ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,TRUE,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51090,NA
ChiCTR2000030854,ChiCTR,2020-03-16,2020-01-22,TRUE,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",237,http://www.chictr.org.cn/showproj.aspx?proj=51083,NA
ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51081,NA
ChiCTR2000030852,ChiCTR,2020-03-16,2020-01-27,TRUE,Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51077,NA
ChiCTR2000030850,ChiCTR,2020-03-15,2020-03-15,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,226,http://www.chictr.org.cn/showproj.aspx?proj=51056,NA
ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,81,http://www.chictr.org.cn/showproj.aspx?proj=51086,NA
ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,TRUE,Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=51072,NA
ChiCTR2000030839,ChiCTR,2020-03-15,2020-03-01,TRUE,Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,100,http://www.chictr.org.cn/showproj.aspx?proj=50904,NA
ChiCTR2000030838,ChiCTR,2020-03-15,2020-01-20,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,1000,http://www.chictr.org.cn/showproj.aspx?proj=51071,NA
ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,TRUE,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,300,http://www.chictr.org.cn/showproj.aspx?proj=51054,NA
ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=51050,NA
ChiCTR2000030834,ChiCTR,2020-03-15,2020-03-16,FALSE,Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,500,http://www.chictr.org.cn/showproj.aspx?proj=51047,NA
ChiCTR2000030833,ChiCTR,2020-03-15,2020-03-22,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,400,http://www.chictr.org.cn/showproj.aspx?proj=51035,NA
ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),800,http://www.chictr.org.cn/showproj.aspx?proj=51044,NA
ChiCTR2000030831,ChiCTR,2020-03-15,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,75,http://www.chictr.org.cn/showproj.aspx?proj=51036,NA
ChiCTR2000030830,ChiCTR,2020-03-15,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,150,http://www.chictr.org.cn/showproj.aspx?proj=51009,NA
ChiCTR2000030819,ChiCTR,2020-03-15,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",600,http://www.chictr.org.cn/showproj.aspx?proj=51039,NA
ChiCTR2000030818,ChiCTR,2020-03-15,2020-01-31,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=51037,NA
ChiCTR2000030816,ChiCTR,2020-03-15,2020-02-24,TRUE,Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,200,http://www.chictr.org.cn/showproj.aspx?proj=51048,NA
ChiCTR2000030814,ChiCTR,2020-03-15,2020-02-20,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,100,http://www.chictr.org.cn/showproj.aspx?proj=51042,NA
ChiCTR2000030812,ChiCTR,2020-03-15,2020-01-31,TRUE,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,50,http://www.chictr.org.cn/showproj.aspx?proj=50947,NA
ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,TRUE,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986,NA
ChiCTR2000030809,ChiCTR,2020-03-15,2020-02-22,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,1000,http://www.chictr.org.cn/showproj.aspx?proj=51015,NA
ChiCTR2000030807,ChiCTR,2020-03-15,2020-02-15,TRUE,Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51019,NA
ChiCTR2000030806,ChiCTR,2020-03-15,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=51029,NA
ChiCTR2000030805,ChiCTR,2020-03-15,2020-02-15,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51026,NA
ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,TRUE,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,128,http://www.chictr.org.cn/showproj.aspx?proj=51018,NA
ChiCTR2000030803,ChiCTR,2020-03-15,2020-01-31,TRUE,Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=51007,NA
ChiCTR2000030802,ChiCTR,2020-03-15,2020-01-27,TRUE,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),2000,http://www.chictr.org.cn/showproj.aspx?proj=51004,NA
ChiCTR2000030801,ChiCTR,2020-03-15,2020-01-23,TRUE,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,100,http://www.chictr.org.cn/showproj.aspx?proj=50998,NA
ChiCTR2000030800,ChiCTR,2020-03-15,2020-02-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                Study on levels of inflammatory factors in peripheral blood of patients with novel coronavirus pneumonia (COVID-19) and their diagnostic and prognostic value,22,http://www.chictr.org.cn/showproj.aspx?proj=50997,NA
ChiCTR2000030799,ChiCTR,2020-03-15,2020-01-20,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=50995,NA
ChiCTR2000030798,ChiCTR,2020-03-15,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50994,NA
ChiCTR2000030797,ChiCTR,2020-03-15,2020-03-07,TRUE,Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,100,http://www.chictr.org.cn/showproj.aspx?proj=50988,NA
ChiCTR2000030796,ChiCTR,2020-03-15,2020-01-29,TRUE,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=50991,NA
ChiCTR2000030795,ChiCTR,2020-03-15,2020-03-20,FALSE,Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=50982,NA
ChiCTR2000030784,ChiCTR,2020-03-14,2020-01-17,TRUE,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,150,http://www.chictr.org.cn/showproj.aspx?proj=50307,NA
ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,FALSE,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50973,NA
ChiCTR2000030778,ChiCTR,2020-03-14,2020-01-20,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,40,http://www.chictr.org.cn/showproj.aspx?proj=50987,NA
ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,TRUE,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50934,NA
ChiCTR2000030768,ChiCTR,2020-03-14,2020-02-01,TRUE,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),450,http://www.chictr.org.cn/showproj.aspx?proj=50968,NA
ChiCTR2000030764,ChiCTR,2020-03-13,2020-03-07,TRUE,Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",2800,http://www.chictr.org.cn/showproj.aspx?proj=50852,NA
ChiCTR2000030763,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50921,NA
ChiCTR2000030762,ChiCTR,2020-03-13,2019-12-01,TRUE,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',100,http://www.chictr.org.cn/showproj.aspx?proj=50950,NA
ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,FALSE,Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,20,http://www.chictr.org.cn/showproj.aspx?proj=50956,NA
ChiCTR2000030760,ChiCTR,2020-03-13,2020-03-13,FALSE,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",74,http://www.chictr.org.cn/showproj.aspx?proj=50955,NA
ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),70,http://www.chictr.org.cn/showproj.aspx?proj=49284,NA
ChiCTR2000030758,ChiCTR,2020-03-13,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50590,NA
ChiCTR2000030757,ChiCTR,2020-03-13,2020-03-13,FALSE,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,100,http://www.chictr.org.cn/showproj.aspx?proj=50648,NA
ChiCTR2000030756,ChiCTR,2020-03-13,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50705,NA
ChiCTR2000030755,ChiCTR,2020-03-13,2020-03-15,FALSE,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",400,http://www.chictr.org.cn/showproj.aspx?proj=50945,NA
ChiCTR2000030754,ChiCTR,2020-03-13,2020-03-11,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50824,NA
ChiCTR2000030753,ChiCTR,2020-03-13,2020-02-01,TRUE,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50901,NA
ChiCTR2000030752,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=50925,NA
ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,TRUE,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50941,NA
ChiCTR2000030747,ChiCTR,2020-03-13,2020-02-22,TRUE,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),1500,http://www.chictr.org.cn/showproj.aspx?proj=50000,NA
ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50910,NA
ChiCTR2000030742,ChiCTR,2020-03-13,2020-03-15,FALSE,Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",200,http://www.chictr.org.cn/showproj.aspx?proj=50857,NA
ChiCTR2000030741,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=50907,NA
ChiCTR2000030740,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,100,http://www.chictr.org.cn/showproj.aspx?proj=50900,NA
ChiCTR2000030739,ChiCTR,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,100,http://www.chictr.org.cn/showproj.aspx?proj=50896,NA
ChiCTR2000030722,ChiCTR,2020-03-12,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50338,NA
ChiCTR2000030721,ChiCTR,2020-03-12,2020-03-16,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50759,NA
ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,TRUE,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,120,http://www.chictr.org.cn/showproj.aspx?proj=50793,NA
ChiCTR2000030719,ChiCTR,2020-03-11,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,1071,http://www.chictr.org.cn/showproj.aspx?proj=50867,NA
ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,TRUE,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=50843,NA
ChiCTR2000030717,ChiCTR,2020-03-11,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,260,http://www.chictr.org.cn/showproj.aspx?proj=50860,NA
ChiCTR2000030716,ChiCTR,2020-03-11,2020-03-05,TRUE,Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,150,http://www.chictr.org.cn/showproj.aspx?proj=50850,NA
ChiCTR2000030708,ChiCTR,2020-03-11,2020-03-10,TRUE,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,1000,http://www.chictr.org.cn/showproj.aspx?proj=50083,NA
ChiCTR2000030707,ChiCTR,2020-03-11,2020-03-20,FALSE,Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,78,http://www.chictr.org.cn/showproj.aspx?proj=50160,NA
ChiCTR2000030706,ChiCTR,2020-03-11,2020-02-09,TRUE,Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                       Application of cas13a-mediated RNA detection in the assay of novel coronavirus nucleic acid (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=50001,NA
ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",40,http://www.chictr.org.cn/showproj.aspx?proj=50251,NA
ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,TRUE,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,50,http://www.chictr.org.cn/showproj.aspx?proj=50537,NA
ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=50795,NA
ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,60,http://www.chictr.org.cn/showproj.aspx?proj=50786,NA
ChiCTR2000030697,ChiCTR,2020-03-10,2020-03-10,FALSE,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",1500,http://www.chictr.org.cn/showproj.aspx?proj=50781,NA
ChiCTR2000030690,ChiCTR,2020-03-10,2020-02-10,TRUE,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50261,NA
ChiCTR2000030687,ChiCTR,2020-03-09,2020-02-01,TRUE,Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,120,http://www.chictr.org.cn/showproj.aspx?proj=50572,NA
ChiCTR2000030686,ChiCTR,2020-03-09,2020-03-03,TRUE,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,300,http://www.chictr.org.cn/showproj.aspx?proj=50714,NA
ChiCTR2000030683,ChiCTR,2020-03-09,2020-03-09,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,234,http://www.chictr.org.cn/showproj.aspx?proj=50633,NA
ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,240,http://www.chictr.org.cn/showproj.aspx?proj=50763,NA
ChiCTR2000030679,ChiCTR,2020-03-09,2020-01-28,TRUE,Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,500,http://www.chictr.org.cn/showproj.aspx?proj=50730,NA
ChiCTR2000030619,ChiCTR,2020-03-08,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=50656,NA
ChiCTR2000030606,ChiCTR,2020-03-08,2020-03-09,FALSE,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50713,NA
ChiCTR2000030597,ChiCTR,2020-03-08,2020-03-09,FALSE,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=50702,NA
ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,TRUE,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50693,NA
ChiCTR2000030558,ChiCTR,2020-03-07,2020-03-07,FALSE,No Status Given,Not Applicable,Epidemiological research,China,Cancelled by the investigator             Epidemiological research of novel coronavirus pneumonia (COVID-19) suspected cases based on virus nucleic acid test combined with low-dose chest CT screening in primary hospital,264,http://www.chictr.org.cn/showproj.aspx?proj=50678,NA
ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,TRUE,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",300,http://www.chictr.org.cn/showproj.aspx?proj=50126,NA
ChiCTR2000030528,ChiCTR,2020-03-06,2020-03-06,FALSE,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50641,NA
ChiCTR2000030509,ChiCTR,2020-03-05,2020-03-13,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator           Clinical Study of NK Cells in the Treatment of Novel Coronavirus Pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49956,NA
ChiCTR2000030483,ChiCTR,2020-03-03,2020-03-01,TRUE,Not Recruiting,Phase 1,Interventional,China,"Cancelled by the investigator         A multicentre, randomized, controlled trial for the Ba-Duan-Jin in the adjunctive treatment of patients with common type novel coronavirus pneumonia (COVID-19)",16,http://www.chictr.org.cn/showproj.aspx?proj=50495,NA
ChiCTR2000030478,ChiCTR,2020-03-03,2020-02-26,TRUE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                                    Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=50460,NA
ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,FALSE,Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=50455,NA
ChiCTR2000030466,ChiCTR,2020-03-02,2020-02-26,TRUE,No Status Given,Not Applicable,Observational,China,Cancelled due to lack of patients                                       Investigation on Mental Health Status and Psychological Intervention of Hospitalized Patients with Novel Coronavirus Pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50387,NA
ChiCTR2000030417,ChiCTR,2020-03-01,2020-03-01,FALSE,No Status Given,Not Applicable,Interventional,China,Cancelled by the investigator                               Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=50279,NA
ChiCTR2000030381,ChiCTR,2020-02-29,2020-02-29,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Cancelled by investigator           A randomized, open-label, controlled and single-center trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient",40,http://www.chictr.org.cn/showproj.aspx?proj=50290,NA
ChiCTR2000030329,ChiCTR,2020-02-28,2020-03-05,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                          Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19),90,http://www.chictr.org.cn/showproj.aspx?proj=49779,NA
ChiCTR2000030306,ChiCTR,2020-02-28,2020-03-19,FALSE,No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Mechanism of novel coronavirus pneumonia (COVID-19) virus with silent latent immune system induced by envelope protein and vaccine development,15,http://www.chictr.org.cn/showproj.aspx?proj=50222,NA
ChiCTR2000030221,ChiCTR,2020-02-25,2020-01-31,TRUE,Recruiting,Not Applicable,Health services research,No Country Given,Cancelled by the investigator               Study for sleep status of medical staffs of hospitals administrating suspected cases of Novel Coronavirus Pneumonia (COVID-19),960,http://www.chictr.org.cn/showproj.aspx?proj=50071,NA
ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,FALSE,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50057,NA
ChiCTR2000030135,ChiCTR,2020-02-24,2020-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                  A randomized controlled trial for high-dose Vitamin C in the treatment of severe and critical novel coronavirus pneumonia (COVID-19) patients,39,http://www.chictr.org.cn/showproj.aspx?proj=50002,NA
ChiCTR2000030114,ChiCTR,2020-02-23,2020-02-24,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",150,http://www.chictr.org.cn/showproj.aspx?proj=49987,NA
ChiCTR2000030085,ChiCTR,2020-02-22,2020-02-22,FALSE,No Status Given,Not Applicable,Diagnostic test,China,Cancelled by the investigator               Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients,400,http://www.chictr.org.cn/showproj.aspx?proj=49948,NA
ChiCTR2000030082,ChiCTR,2020-02-22,2020-02-23,FALSE,No Status Given,Phase 4,Interventional,China,Cancelled by the investigator             Randomized controlled trial for the efficacy of dihydroartemisinine piperaquine in the treatment of mild/common novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49915,NA
ChiCTR2000030055,ChiCTR,2020-02-22,2020-02-10,TRUE,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),460,http://www.chictr.org.cn/showproj.aspx?proj=49864,NA
ChiCTR2000030031,ChiCTR,2020-02-21,2020-02-20,TRUE,No Status Given,Phase 4,Interventional,China,"Cancelled by the investigator                              A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV",120,http://www.chictr.org.cn/showproj.aspx?proj=49806,NA
ChiCTR2000030005,ChiCTR,2020-02-19,2020-02-21,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,200,http://www.chictr.org.cn/showproj.aspx?proj=49669,NA
ChiCTR2000029984,ChiCTR,2020-02-18,2020-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator              Study on the effect of human placenta biological preparation on the defense of immune function against novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49712,NA
ChiCTR2000029957,ChiCTR,2020-02-17,2020-02-24,FALSE,Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                         An observational study of high-dose Vitamin C in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),66,http://www.chictr.org.cn/showproj.aspx?proj=49633,NA
ChiCTR2000029895,ChiCTR,2020-02-16,2020-02-16,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,Cancelled by investigator                Single arm study for the efficacy and safety of GD31 in patients with novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=49569,NA
ChiCTR2000029837,ChiCTR,2020-02-15,2020-02-17,FALSE,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator          A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)",120,http://www.chictr.org.cn/showproj.aspx?proj=49495,NA
ChiCTR2000029826,ChiCTR,2020-02-14,2020-02-17,FALSE,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator            A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in serious/critically ill patients with novel coronavirus pneumonia (COVID-19)",45,http://www.chictr.org.cn/showproj.aspx?proj=49481,NA
ChiCTR2000029820,ChiCTR,2020-02-14,2020-02-01,TRUE,No Status Given,Not Applicable,Observational,China,Cancelled by investigator                                      A cox regression analysis of prognosis of novel coronavirus pneumonia (COVID-19),410,http://www.chictr.org.cn/showproj.aspx?proj=49492,NA
ChiCTR2000029818,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator            Clinical Study for Umbilical Cord Blood Plasma in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49382,NA
ChiCTR2000029817,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                    Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49384,NA
ChiCTR2000029816,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                      Clinical Study for Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49389,NA
ChiCTR2000029812,ChiCTR,2020-02-14,2020-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator               Clinical Study for Umbilical Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49374,NA
ChiCTR2000029770,ChiCTR,2020-02-13,2020-02-13,FALSE,Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",500,http://www.chictr.org.cn/showproj.aspx?proj=49412,NA
ChiCTR2000029592,ChiCTR,2020-02-05,2020-02-07,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,1000,http://www.chictr.org.cn/showproj.aspx?proj=49069,NA
ChiCTR2000031163,ChiCTR,2020-03-23,2020-02-16,TRUE,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=51390,NA
ChiCTR2000031150,ChiCTR,2020-03-23,2020-04-01,FALSE,Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,150,http://www.chictr.org.cn/showproj.aspx?proj=51021,NA
ChiCTR2000031140,ChiCTR,2020-03-22,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,300,http://www.chictr.org.cn/showproj.aspx?proj=50605,NA
ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,TRUE,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=51404,NA
ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,TRUE,Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=51416,NA
ChiCTR2000031115,ChiCTR,2020-03-22,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=51032,NA
ChiCTR2000031104,ChiCTR,2020-03-22,2020-02-05,TRUE,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51185,NA
ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,FALSE,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=51148,NA
ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,TRUE,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=51136,NA
ChiCTR2000031088,ChiCTR,2020-03-22,2020-02-09,TRUE,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),314,http://www.chictr.org.cn/showproj.aspx?proj=51132,NA
ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,TRUE,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,320,http://www.chictr.org.cn/showproj.aspx?proj=50984,NA
ChiCTR2000031014,ChiCTR,2020-03-21,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,100,http://www.chictr.org.cn/showproj.aspx?proj=51348,NA
ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,TRUE,Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,60,http://www.chictr.org.cn/showproj.aspx?proj=51349,NA
ChiCTR2000030993,ChiCTR,2020-03-20,2020-03-12,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,300,http://www.chictr.org.cn/showproj.aspx?proj=51342,NA
ChiCTR2000030992,ChiCTR,2020-03-20,2020-03-10,TRUE,Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=51338,NA
ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,FALSE,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,76,http://www.chictr.org.cn/showproj.aspx?proj=51331,NA
ChiCTR2000030987,ChiCTR,2020-03-20,2020-03-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,China,A Randomized Controlled Trial for Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51329,NA
ChiCTR2000030986,ChiCTR,2020-03-20,2020-03-20,FALSE,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,200,http://www.chictr.org.cn/showproj.aspx?proj=51316,NA
ChiCTR2000030985,ChiCTR,2020-03-20,2020-03-04,TRUE,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",1300,http://www.chictr.org.cn/showproj.aspx?proj=51311,NA
ChiCTR2000030961,ChiCTR,2020-03-20,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",2000,http://www.chictr.org.cn/showproj.aspx?proj=51291,NA
ChiCTR2000030952,ChiCTR,2020-03-19,2020-01-18,TRUE,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,93,http://www.chictr.org.cn/showproj.aspx?proj=51278,NA
ChiCTR2000030951,ChiCTR,2020-03-19,2020-03-20,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,2500,http://www.chictr.org.cn/showproj.aspx?proj=51283,NA
ChiCTR2000030950,ChiCTR,2020-03-19,2020-02-10,TRUE,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,50,http://www.chictr.org.cn/showproj.aspx?proj=51272,NA
ChiCTR2000030947,ChiCTR,2020-03-19,2020-02-11,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),34,http://www.chictr.org.cn/showproj.aspx?proj=51267,NA
ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,TRUE,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=51265,NA
ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,FALSE,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50199,NA
ChiCTR2000030943,ChiCTR,2020-03-18,2020-03-31,FALSE,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,200,http://www.chictr.org.cn/showproj.aspx?proj=50898,NA
ChiCTR2000030942,ChiCTR,2020-03-18,2020-01-20,TRUE,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,191,http://www.chictr.org.cn/showproj.aspx?proj=50981,NA
ChiCTR2000030941,ChiCTR,2020-03-18,2020-01-28,TRUE,Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",200,http://www.chictr.org.cn/showproj.aspx?proj=51000,NA
ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,TRUE,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=51059,NA
ChiCTR2000030934,ChiCTR,2020-03-18,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),90,http://www.chictr.org.cn/showproj.aspx?proj=51160,NA
ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,FALSE,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,108,http://www.chictr.org.cn/showproj.aspx?proj=51184,NA
ChiCTR2000030932,ChiCTR,2020-03-18,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51230,NA
ChiCTR2000030931,ChiCTR,2020-03-18,2020-03-23,FALSE,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=51212,NA
ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=50696,NA
ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,TRUE,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",30,http://www.chictr.org.cn/showproj.aspx?proj=51141,NA
ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,TRUE,Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",100,http://www.chictr.org.cn/showproj.aspx?proj=50476,NA
ChiCTR2000030919,ChiCTR,2020-03-17,2020-03-20,FALSE,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=51149,NA
ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,TRUE,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),108,http://www.chictr.org.cn/showproj.aspx?proj=51154,NA
ChiCTR2000030771,ChiCTR,2020-03-14,2020-03-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,30,http://www.chictr.org.cn/showproj.aspx?proj=50961,NA
ChiCTR2000030765,ChiCTR,2020-03-13,2019-12-01,TRUE,Not Recruiting,Not Applicable,Epidemiological research,China,Cancelled by the investigator                 Clinical guidance of diagnose and treatment for novel coronavirus pneumonia (COVID-19) based on ''Shi-Du-Yi'',Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50964,NA
ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,40,http://www.chictr.org.cn/showproj.aspx?proj=50660,NA
ChiCTR2000030519,ChiCTR,2020-03-05,2020-03-06,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=50604,NA
ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,TRUE,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusâ€“infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",240,http://www.chictr.org.cn/showproj.aspx?proj=50137,NA
ChiCTR2000030224,ChiCTR,2020-02-26,2020-02-26,FALSE,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                Clinical study of mesenchymal stem cells in treating severe novel coronavirus pneumonia (COVID-19),32,http://www.chictr.org.cn/showproj.aspx?proj=49968,NA
ChiCTR2000030168,ChiCTR,2020-02-24,2020-02-29,FALSE,Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                   A real world study for Compound Houttuyniae Mixture for prevention of novel coronavirus pneumonia (COVID-19),2000,http://www.chictr.org.cn/showproj.aspx?proj=49433,NA
ChiCTR2000030095,ChiCTR,2020-02-23,2020-02-23,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,94,http://www.chictr.org.cn/showproj.aspx?proj=49845,NA
ChiCTR2000029955,ChiCTR,2020-02-17,2020-03-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,80,http://www.chictr.org.cn/showproj.aspx?proj=49531,NA
ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,TRUE,Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",360,http://www.chictr.org.cn/showproj.aspx?proj=49524,NA
ChiCTR2000029830,ChiCTR,2020-02-15,2020-02-14,TRUE,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",400,http://www.chictr.org.cn/showproj.aspx?proj=49511,NA
ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,FALSE,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=49074,NA
ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,FALSE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",480,http://www.chictr.org.cn/showproj.aspx?proj=49065,NA
ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",90,http://www.chictr.org.cn/showproj.aspx?proj=48809,NA
EUCTR2020-000890-25,EudraCT,2020-03-10,2020-05-03,FALSE,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,FR
JPRN-UMIN000039686,UMIN-CTR,2020-03-06,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,NA
ChiCTR2000031366,ChiCTR,2020-03-29,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,5000,http://www.chictr.org.cn/showproj.aspx?proj=51692,NA
ChiCTR2000031365,ChiCTR,2020-03-29,2020-01-17,TRUE,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,0,http://www.chictr.org.cn/showproj.aspx?proj=51694,NA
ChiCTR2000031361,ChiCTR,2020-03-28,2020-03-31,FALSE,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),2000,http://www.chictr.org.cn/showproj.aspx?proj=51385,NA
ChiCTR2000031356,ChiCTR,2020-03-28,2020-04-12,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),600,http://www.chictr.org.cn/showproj.aspx?proj=51499,NA
ChiCTR2000031337,ChiCTR,2020-03-28,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",400,http://www.chictr.org.cn/showproj.aspx?proj=51170,NA
ChiCTR2000031336,ChiCTR,2020-03-28,2020-04-12,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=51517,NA
ChiCTR2000031330,ChiCTR,2020-03-27,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,160,http://www.chictr.org.cn/showproj.aspx?proj=51504,NA
ChiCTR2000031329,ChiCTR,2020-03-27,2020-03-11,TRUE,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",120,http://www.chictr.org.cn/showproj.aspx?proj=51667,NA
ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,TRUE,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,60,http://www.chictr.org.cn/showproj.aspx?proj=51425,NA
ChiCTR2000031324,ChiCTR,2020-03-27,2020-04-10,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=51668,NA
ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,20,http://www.chictr.org.cn/showproj.aspx?proj=51647,NA
ChiCTR2000031301,ChiCTR,2020-03-27,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,100,http://www.chictr.org.cn/showproj.aspx?proj=51603,NA
ChiCTR2000031296,ChiCTR,2020-03-27,2020-01-14,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,200,http://www.chictr.org.cn/showproj.aspx?proj=51584,NA
ChiCTR2000031293,ChiCTR,2020-03-27,2020-03-16,TRUE,Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,240,http://www.chictr.org.cn/showproj.aspx?proj=51629,NA
ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,TRUE,Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,110,http://www.chictr.org.cn/showproj.aspx?proj=51455,NA
ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),80,http://www.chictr.org.cn/showproj.aspx?proj=51194,NA
ChiCTR2000031252,ChiCTR,2020-03-25,2020-02-10,TRUE,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,60,http://www.chictr.org.cn/showproj.aspx?proj=51559,NA
ChiCTR2000031247,ChiCTR,2020-03-25,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=51540,NA
ChiCTR2000031246,ChiCTR,2020-03-25,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),68,http://www.chictr.org.cn/showproj.aspx?proj=51535,NA
ChiCTR2000031245,ChiCTR,2020-03-25,2020-01-25,TRUE,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,2000,http://www.chictr.org.cn/showproj.aspx?proj=51518,NA
ChiCTR2000031244,ChiCTR,2020-03-25,2020-03-25,FALSE,Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,200,http://www.chictr.org.cn/showproj.aspx?proj=51486,NA
ChiCTR2000031227,ChiCTR,2020-03-25,2020-03-26,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",40,http://www.chictr.org.cn/showproj.aspx?proj=51473,NA
ChiCTR2000031214,ChiCTR,2020-03-24,2020-03-31,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,60,http://www.chictr.org.cn/showproj.aspx?proj=51509,NA
ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,TRUE,Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",300,http://www.chictr.org.cn/showproj.aspx?proj=49420,NA
ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,TRUE,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),28,http://www.chictr.org.cn/showproj.aspx?proj=51030,NA
ChiCTR2000031198,ChiCTR,2020-03-23,2020-04-01,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51488,NA
ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,TRUE,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,90,http://www.chictr.org.cn/showproj.aspx?proj=51112,NA
ChiCTR2000031187,ChiCTR,2020-03-23,2020-03-23,FALSE,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),1292,http://www.chictr.org.cn/showproj.aspx?proj=51442,NA
ChiCTR2000031176,ChiCTR,2020-03-23,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,100,http://www.chictr.org.cn/showproj.aspx?proj=51443,NA
ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,FALSE,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),204,http://www.chictr.org.cn/showproj.aspx?proj=51317,NA
ChiCTR2000030962,ChiCTR,2020-03-20,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",60,http://www.chictr.org.cn/showproj.aspx?proj=51254,NA
ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),76,http://www.chictr.org.cn/showproj.aspx?proj=51061,NA
ChiCTR2000030938,ChiCTR,2020-03-18,2020-02-28,TRUE,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=51239,NA
ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,FALSE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",144,http://www.chictr.org.cn/showproj.aspx?proj=51240,NA
ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,TRUE,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),2840,http://www.chictr.org.cn/showproj.aspx?proj=51100,NA
ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,TRUE,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=51139,NA
ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,TRUE,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=50778,NA
ChiCTR2000030330,ChiCTR,2020-02-28,2020-02-28,FALSE,No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Clinical research of 6-minute walk training on motor function of novel coronavirus pneumonia (COVID-19),10,http://www.chictr.org.cn/showproj.aspx?proj=50274,NA
ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,FALSE,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,204,http://www.chictr.org.cn/showproj.aspx?proj=50202,NA
ChiCTR2000030256,ChiCTR,2020-02-26,2020-02-01,TRUE,Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",1000,http://www.chictr.org.cn/showproj.aspx?proj=50078,NA
ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,TRUE,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50066,NA
ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=49840,NA
ChiCTR2000029982,ChiCTR,2020-02-18,2020-03-26,FALSE,Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,150,http://www.chictr.org.cn/showproj.aspx?proj=49724,NA
EUCTR2020-000919-69,EudraCT,2020-03-17,2020-03-17,FALSE,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-GuÃ©rin,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,NL
EUCTR2020-001023-14,EudraCT,2020-03-17,2020-03-17,FALSE,Authorised,Phase 2,Interventional,United Kingdom,a trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients with COVID-19,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001023-14,GB
NCT04331860,ClinicalTrials.gov,2020-03-30,2020-03-30,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Public Image Registry,500000,https://clinicaltrials.gov/show/NCT04331860,NA
ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,TRUE,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),192,http://www.chictr.org.cn/showproj.aspx?proj=51119,NA
ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50474,NA
ChiCTR2000031627,ChiCTR,2020-04-05,2020-04-20,FALSE,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,60,http://www.chictr.org.cn/showproj.aspx?proj=51865,NA
ChiCTR2000031589,ChiCTR,2020-04-05,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),462,http://www.chictr.org.cn/showproj.aspx?proj=51969,NA
ChiCTR2000031587,ChiCTR,2020-04-04,2020-01-27,TRUE,Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",2000,http://www.chictr.org.cn/showproj.aspx?proj=51952,NA
ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,TRUE,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51684,NA
ChiCTR2000031538,ChiCTR,2020-04-03,2020-04-03,FALSE,Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,123,http://www.chictr.org.cn/showproj.aspx?proj=51938,NA
ChiCTR2000031533,ChiCTR,2020-04-03,2020-04-10,FALSE,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,7000,http://www.chictr.org.cn/showproj.aspx?proj=51835,NA
ChiCTR2000031504,ChiCTR,2020-04-03,2019-12-01,TRUE,Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,2000,http://www.chictr.org.cn/showproj.aspx?proj=51781,NA
ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=51911,NA
ChiCTR2000031500,ChiCTR,2020-04-02,2020-03-05,TRUE,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),58,http://www.chictr.org.cn/showproj.aspx?proj=51897,NA
ChiCTR2000031499,ChiCTR,2020-04-02,2020-02-10,TRUE,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,55,http://www.chictr.org.cn/showproj.aspx?proj=51915,NA
ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,TRUE,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),36,http://www.chictr.org.cn/showproj.aspx?proj=51904,NA
ChiCTR2000031465,ChiCTR,2020-04-02,2020-03-25,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,200,http://www.chictr.org.cn/showproj.aspx?proj=51538,NA
ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),56,http://www.chictr.org.cn/showproj.aspx?proj=51693,NA
ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,FALSE,Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",80,http://www.chictr.org.cn/showproj.aspx?proj=51859,NA
ChiCTR2000031439,ChiCTR,2020-04-01,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51837,NA
ChiCTR2000031438,ChiCTR,2020-04-01,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,820,http://www.chictr.org.cn/showproj.aspx?proj=51815,NA
ChiCTR2000031432,ChiCTR,2020-03-31,2020-05-01,FALSE,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,15,http://www.chictr.org.cn/showproj.aspx?proj=51646,NA
ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,TRUE,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,200,http://www.chictr.org.cn/showproj.aspx?proj=49254,NA
ChiCTR2000031429,ChiCTR,2020-03-31,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",2000,http://www.chictr.org.cn/showproj.aspx?proj=51816,NA
ChiCTR2000031428,ChiCTR,2020-03-31,2020-02-05,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=51813,NA
ChiCTR2000031427,ChiCTR,2020-03-31,2020-03-25,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,200,http://www.chictr.org.cn/showproj.aspx?proj=51809,NA
ChiCTR2000031376,ChiCTR,2020-03-29,2020-03-28,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,600,http://www.chictr.org.cn/showproj.aspx?proj=51724,NA
ChiCTR2000031199,ChiCTR,2020-03-23,2020-02-04,TRUE,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=51478,NA
EUCTR2020-000936-23,EudraCT,2020-03-09,2020-09-03,FALSE,Authorised,Phase 3,Interventional,"United Kingdom, Belgium, Netherlands, Luxembourg, Spain, France, Germany","Multi-centre, adaptive, randomized trial of the safety and efficacy of treatments of COVID-19 in hospitalized adults - DisCoVeRy",3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23,FR
EUCTR2020-001386-37,EudraCT,2020-04-02,2020-03-27,TRUE,Authorised,Phase 2,Interventional,Italy,Efficacy of Tocilizumab - COVID-19,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001386-37,IT
ACTRN12620000443998,ANZCTR,2020-04-06,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,58,https://anzctr.org.au/ACTRN12620000443998.aspx,NA
ACTRN12620000444987,ANZCTR,2020-04-06,2020-07-04,FALSE,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),100000,https://anzctr.org.au/ACTRN12620000444987.aspx,NA
ACTRN12620000438954,ANZCTR,2020-04-06,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU â€“ comparison of management strategies on survival and time on ventilation.,60,https://anzctr.org.au/ACTRN12620000438954.aspx,NA
ACTRN12620000449932,ANZCTR,2020-04-06,2020-10-04,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,200,https://anzctr.org.au/ACTRN12620000449932.aspx,NA
ChiCTR2000031860,ChiCTR,2020-04-12,2020-04-27,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,150,http://www.chictr.org.cn/showproj.aspx?proj=52198,NA
ChiCTR2000031836,ChiCTR,2020-04-11,2020-01-23,TRUE,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,45,http://www.chictr.org.cn/showproj.aspx?proj=52213,NA
ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),120,http://www.chictr.org.cn/showproj.aspx?proj=52216,NA
ChiCTR2000031794,ChiCTR,2020-04-10,2020-04-08,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),130,http://www.chictr.org.cn/showproj.aspx?proj=52193,NA
ChiCTR2000031783,ChiCTR,2020-04-10,2020-03-24,TRUE,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,883,http://www.chictr.org.cn/showproj.aspx?proj=51832,NA
ChiCTR2000031782,ChiCTR,2020-04-10,2020-04-13,FALSE,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),550,http://www.chictr.org.cn/showproj.aspx?proj=51934,NA
ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,TRUE,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",500,http://www.chictr.org.cn/showproj.aspx?proj=52006,NA
ChiCTR2000031779,ChiCTR,2020-04-10,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,50,http://www.chictr.org.cn/showproj.aspx?proj=52051,NA
ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,TRUE,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),105,http://www.chictr.org.cn/showproj.aspx?proj=52165,NA
ChiCTR2000031770,ChiCTR,2020-04-09,2020-01-22,TRUE,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,119,http://www.chictr.org.cn/showproj.aspx?proj=52148,NA
ChiCTR2000031752,ChiCTR,2020-04-09,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),75,http://www.chictr.org.cn/showproj.aspx?proj=52135,NA
ChiCTR2000031751,ChiCTR,2020-04-08,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,60,http://www.chictr.org.cn/showproj.aspx?proj=52130,NA
ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=50613,NA
ChiCTR2000031705,ChiCTR,2020-04-07,2020-03-10,TRUE,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=51793,NA
ChiCTR2000031700,ChiCTR,2020-04-07,2020-04-21,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,600,http://www.chictr.org.cn/showproj.aspx?proj=52052,NA
ChiCTR2000031699,ChiCTR,2020-04-07,2020-02-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,33,http://www.chictr.org.cn/showproj.aspx?proj=51924,NA
ChiCTR2000031675,ChiCTR,2020-04-06,2020-04-06,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),2000,http://www.chictr.org.cn/showproj.aspx?proj=52037,NA
ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,120,http://www.chictr.org.cn/showproj.aspx?proj=50928,NA
ChiCTR2000030494,ChiCTR,2020-03-05,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),600,http://www.chictr.org.cn/showproj.aspx?proj=50077,NA
ChiCTR2000030331,ChiCTR,2020-02-28,2020-02-01,TRUE,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,498,http://www.chictr.org.cn/showproj.aspx?proj=50271,NA
ChiCTR2000030328,ChiCTR,2020-02-28,2020-03-02,FALSE,Not Recruiting,Phase 4,Interventional,China,Cancelled by the investigator                            Clinical application of inhaled acetylcysteine solution in the treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50241,NA
EUCTR2020-001301-23,EudraCT,2020-03-26,2020-10-04,FALSE,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,FR
EUCTR2020-001188-96,EudraCT,2020-03-24,2020-07-04,FALSE,Authorised,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 infection (COVID-19) in exposed healthcare workers: a randomized double-blind placebo-controlled clinical trial,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001188-96,FR
EUCTR2020-001373-70,EudraCT,2020-03-29,2020-01-04,TRUE,Authorised,"Human pharmacology (Phase I): 
Therapeutic exploratory (Phase II): yes
Therapeutic confirmatory - (Phase III): 
Therapeutic use (Phase IV): no
",Interventional,France,"Study comparing the efficacy of a chloroquine analog (GNS561), anti PD-1 (nivolumab) and anti-interleukine-6 receptor (tocilizumab) versus standard of care in advanced or metastatic cancer patients with SARS-CoV-2 (COVID-19) infection",273,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001373-70,FR
EUCTR2020-001381-11,EudraCT,2020-03-29,2020-08-04,FALSE,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,FR
EUCTR2020-001457-43,EudraCT,2020-04-02,2020-10-04,FALSE,Authorised,Phase 3,Interventional,France,Dexamethasone and oxygen support strategies in ICU patients with Covid-19 pneumonia,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001457-43,FR
EUCTR2020-001442-19,EudraCT,2020-04-03,2020-02-04,TRUE,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,ES
EUCTR2020-001385-11,EudraCT,2020-04-03,2020-03-28,TRUE,Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,ES
EUCTR2020-001409-21,EudraCT,2020-04-03,2020-01-04,TRUE,Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,ES
EUCTR2020-001492-33,EudraCT,2020-04-01,2020-10-04,FALSE,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,FR
EUCTR2020-001194-69,EudraCT,2020-04-07,2020-03-30,TRUE,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,ES
EUCTR2020-001565-37,EudraCT,2020-04-07,2020-03-04,TRUE,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,ES
EUCTR2020-001421-31,EudraCT,2020-04-07,2020-06-04,FALSE,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,ES
EUCTR2020-001606-33,EudraCT,2020-04-07,2020-07-04,FALSE,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,ES
EUCTR2020-001039-29,EudraCT,2020-03-31,2020-01-04,TRUE,Authorised,Phase 2,Interventional,Greece,MANAGEMENT OF NOVEL SARS CORONAVIRUS,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001039-29,GR
NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,10,https://clinicaltrials.gov/show/NCT04337216,NA
NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,TRUE,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,1450,https://clinicaltrials.gov/show/NCT04343677,NA
ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group EasybreatheÂ® snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,100,https://anzctr.org.au/ACTRN12620000472976.aspx,NA
ACTRN12620000479909,ANZCTR,2020-04-16,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,"Australia, United States, Italy, Spain, China, Germany",Mental health and wellbeing on general population during the COVID-19 outbreak,3000,https://anzctr.org.au/ACTRN12620000479909.aspx,NA
ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of NasodineÂ® Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,20,https://anzctr.org.au/ACTRN12620000470998.aspx,NA
ACTRN12620000480987,ANZCTR,2020-04-16,2020-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),507,https://anzctr.org.au/ACTRN12620000480987.aspx,NA
ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,TRUE,Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=52477,NA
ChiCTR2000032095,ChiCTR,2020-04-19,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",130,http://www.chictr.org.cn/showproj.aspx?proj=52565,NA
ChiCTR2000032040,ChiCTR,2020-04-18,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=52529,NA
ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,TRUE,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),8,http://www.chictr.org.cn/showproj.aspx?proj=52483,NA
ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,FALSE,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),45,http://www.chictr.org.cn/showproj.aspx?proj=52142,NA
ChiCTR2000032010,ChiCTR,2020-04-17,2020-05-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,3000,http://www.chictr.org.cn/showproj.aspx?proj=52479,NA
ChiCTR2000032009,ChiCTR,2020-04-17,2020-02-08,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,30,http://www.chictr.org.cn/showproj.aspx?proj=52490,NA
ChiCTR2000031982,ChiCTR,2020-04-16,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,240,http://www.chictr.org.cn/showproj.aspx?proj=52341,NA
ChiCTR2000031954,ChiCTR,2020-04-16,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=52365,NA
ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,FALSE,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414,NA
ChiCTR2000031930,ChiCTR,2020-04-15,2020-01-31,TRUE,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),9,http://www.chictr.org.cn/showproj.aspx?proj=51602,NA
ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,TRUE,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=52106,NA
ChiCTR2000031712,ChiCTR,2020-04-07,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,60,http://www.chictr.org.cn/showproj.aspx?proj=51650,NA
ChiCTR2000030300,ChiCTR,2020-02-28,2020-02-20,TRUE,Recruiting,Phase 1,Interventional,China,Cancelled by the investigator             Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high risk novel coronavirus pneumonia (COVID-19) patients,9,http://www.chictr.org.cn/showproj.aspx?proj=50022,NA
ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,FALSE,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=49631,NA
ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,FALSE,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",240,http://www.chictr.org.cn/showproj.aspx?proj=48889,NA
ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,FALSE,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",240,http://www.chictr.org.cn/showproj.aspx?proj=48898,NA
EUCTR2020-001303-16,EudraCT,2020-03-29,2020-11-04,FALSE,Authorised,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on Survival in Elderly Hospitalized Patients with VIDOC-19 : A Randomized, Multi-Centre, Adaptive, Blinded Study",1600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001303-16,FR
EUCTR2020-001156-18,EudraCT,2020-04-03,2020-03-27,TRUE,Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,ES
EUCTR2019-002688-89,EudraCT,2019-07-26,2019-10-12,FALSE,Authorised,Phase 1/Phase 2,Interventional,Spain,"Clinical study to assess the safety and preliminary efficacy of HCR040, a drug based on mesenchymal stem cells, in patients with acute respiratory distress syndrome. (included patients COVID-19)",26,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002688-89,ES
EUCTR2020-001160-28,EudraCT,2020-04-13,2020-09-04,FALSE,Authorised,Phase 2,Interventional,Spain,Tocilizumab plus Pembrolizumab in COVID-19,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001160-28,ES
EUCTR2020-001262-11,EudraCT,2020-04-13,2020-09-04,FALSE,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,ES
EUCTR2020-001290-74,EudraCT,2020-04-13,2020-11-04,FALSE,Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,ES
EUCTR2020-001321-31,EudraCT,2020-04-13,2020-11-04,FALSE,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,ES
EUCTR2020-001437-12,EudraCT,2020-04-13,2020-09-04,FALSE,Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,ES
EUCTR2020-001587-29,EudraCT,2020-04-13,2020-08-04,FALSE,Authorised,Phase 4,Interventional,Spain,Preventing SARS-CoV-2 virus infection and severity of COVID-19 diseases during pregnancy with hydroxychloroquine,714,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001587-29,ES
EUCTR2020-001689-12,EudraCT,2020-04-13,2020-11-04,FALSE,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,ES
EUCTR2020-001331-26,EudraCT,2020-04-14,2020-04-14,FALSE,Authorised,Phase 3,Interventional,United Kingdom,Preventative Drug Treatment for COVID-19 Infectious Disease,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001331-26,GB
EUCTR2020-001379-34,EudraCT,2020-04-14,2020-04-14,FALSE,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,ES
EUCTR2020-001682-36,EudraCT,2020-04-14,2020-04-13,TRUE,Authorised,Phase 2,Interventional,Spain,Treatment of COVID-19 with allogeneic mesenchymal cells (MSVÂ®).,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001682-36,ES
EUCTR2020-001511-25,EudraCT,2020-04-15,2020-04-14,TRUE,Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,ES
EUCTR2020-001448-24,EudraCT,2020-04-17,2020-04-15,TRUE,Authorised,Phase 3,Interventional,"Ghana, South Africa, United Kingdom, India, Nigeria",Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001448-24,GB
EUCTR2020-001570-30,EudraCT,2020-04-06,2020-09-04,FALSE,Authorised,Phase 3,Interventional,France,ICAR (IgIV in Covid-related ARds),126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001570-30,FR
EUCTR2020-001254-22,EudraCT,2020-03-24,2020-03-24,FALSE,Authorised,Phase 4,Interventional,Belgium,Sargramostim in patients with acute hypoxic respiratory failure due to COVID-19,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001254-22,BE
IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,45,http://en.irct.ir/trial/46424,NA
IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,50,http://en.irct.ir/trial/46536,NA
IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,30,http://en.irct.ir/trial/46538,NA
IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon ÃŸ in treatment  of COVID-19,30,http://en.irct.ir/trial/46545,NA
IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,150,http://en.irct.ir/trial/46554,NA
IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),20,http://en.irct.ir/trial/46561,NA
IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,50,http://en.irct.ir/trial/46567,NA
IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,40,http://en.irct.ir/trial/46573,NA
IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,TRUE,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,125,http://en.irct.ir/trial/46576,NA
IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,310,http://en.irct.ir/trial/46603,NA
IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,62,http://en.irct.ir/trial/46609,NA
IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,10,http://en.irct.ir/trial/46623,NA
IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,30,http://en.irct.ir/trial/46624,NA
IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,TRUE,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,60,http://en.irct.ir/trial/46629,NA
IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,60,http://en.irct.ir/trial/46637,NA
IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,TRUE,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,40,http://en.irct.ir/trial/46665,NA
IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,FALSE,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,10,http://en.irct.ir/trial/46668,NA
IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,374,http://en.irct.ir/trial/46678,NA
IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,TRUE,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,40,http://en.irct.ir/trial/46681,NA
IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,200,http://en.irct.ir/trial/46690,NA
IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,200,http://en.irct.ir/trial/46693,NA
IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/46697,NA
IRCT20200324046852N1,IRCT,2020-04-05,2020-04-01,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of efficacy of oral Levamisole and  Formoterol+Budesonide inhaler with standard treatment of Corona infection.,30,http://en.irct.ir/trial/46706,NA
IRCT20200324046851N1,IRCT,2020-04-03,2020-03-29,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of nano curcumin supplementation on the reduction of inflammation and mortality in patients with coronavirus 2019 admitted to ICU ward of imam Reza hospital in Tabriz,86,http://en.irct.ir/trial/46712,NA
IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,TRUE,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,30,http://en.irct.ir/trial/46720,NA
IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,60,http://en.irct.ir/trial/46736,NA
IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,TRUE,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,200,http://en.irct.ir/trial/46759,NA
IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,80,http://en.irct.ir/trial/46775,NA
IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,40,http://en.irct.ir/trial/46786,NA
IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,TRUE,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,5,http://en.irct.ir/trial/46789,NA
IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,60,http://en.irct.ir/trial/46803,NA
IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,60,http://en.irct.ir/trial/46804,NA
IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",105,http://en.irct.ir/trial/46810,NA
IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,100,http://en.irct.ir/trial/46824,NA
IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,10,http://en.irct.ir/trial/46837,NA
IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,TRUE,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,60,http://en.irct.ir/trial/46838,NA
JPRN-UMIN000039986,UMIN-CTR,2020-03-31,2020-03-28,TRUE,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,NA
JPRN-UMIN000040185,UMIN-CTR,2020-04-17,2020-04-17,FALSE,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,600,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,NA
JPRN-UMIN000040188,UMIN-CTR,2020-04-17,2020-04-17,FALSE,Not Recruiting,Not Applicable,Other,"Japan, North America",Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045825,NA
ACTRN12620000492954,ANZCTR,2020-04-20,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,20,https://anzctr.org.au/ACTRN12620000492954.aspx,NA
ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",34,https://anzctr.org.au/ACTRN12620000482965.aspx,NA
ACTRN12620000498998,ANZCTR,2020-04-20,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,France,Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic,700,https://anzctr.org.au/ACTRN12620000498998.aspx,NA
ACTRN12620000493943,ANZCTR,2020-04-20,2020-07-04,FALSE,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,50,https://anzctr.org.au/ACTRN12620000493943.aspx,NA
ChiCTR2000032412,ChiCTR,2020-04-27,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for the effectiveness and safety of Xi-Yan-Ping injection combined with conventional protocol in the treatment of common type novel coronavirus pneumonia (COVID-19),426,http://www.chictr.org.cn/showproj.aspx?proj=52988,NA
ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,TRUE,Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",120,http://www.chictr.org.cn/showproj.aspx?proj=52958,NA
ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,TRUE,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",200,http://www.chictr.org.cn/showproj.aspx?proj=52942,NA
ChiCTR2000032368,ChiCTR,2020-04-26,2020-04-15,TRUE,Not Recruiting,Not Applicable,Health services research,China,Investigation on the mental health status and intervention of the medical staff of the national rescue medical team in hubei province during the pandemic of novel coronavirus pneumonia (COVID-19),116,http://www.chictr.org.cn/showproj.aspx?proj=52933,NA
ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,TRUE,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,186,http://www.chictr.org.cn/showproj.aspx?proj=52972,NA
ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,TRUE,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",120,http://www.chictr.org.cn/showproj.aspx?proj=52692,NA
ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,TRUE,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,242,http://www.chictr.org.cn/showproj.aspx?proj=52867,NA
ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=52916,NA
ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",350,http://www.chictr.org.cn/showproj.aspx?proj=52824,NA
ChiCTR2000032239,ChiCTR,2020-04-23,2020-01-29,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for epidemiological characteristics of 88 patients with new coronavirus pneumonia (COVID-19) and its impact on severe disease,88,http://www.chictr.org.cn/showproj.aspx?proj=52507,NA
ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,TRUE,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",200,http://www.chictr.org.cn/showproj.aspx?proj=52699,NA
ChiCTR2000032233,ChiCTR,2020-04-23,2020-04-23,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical study for the potential impact of novel coronavirus pneumonia (COVID-19) on endocrine system,28,http://www.chictr.org.cn/showproj.aspx?proj=52796,NA
ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,200,http://www.chictr.org.cn/showproj.aspx?proj=52781,NA
ChiCTR2000032213,ChiCTR,2020-04-23,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for the impact of wearing medical masks on oxygen saturation in adult surgical patients after general anaesthesia during novel coronavirus pneumonia (COVID-19) pandemic,151,http://www.chictr.org.cn/showproj.aspx?proj=52788,NA
ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",200,http://www.chictr.org.cn/showproj.aspx?proj=52662,NA
ChiCTR2000032162,ChiCTR,2020-04-21,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for ECMO in the rescue therapy of extremely critical novel coronavirus pneumonia (COVID-19) patients,80,http://www.chictr.org.cn/showproj.aspx?proj=52694,NA
ChiCTR2000032161,ChiCTR,2020-04-21,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,A retrospective study for evolution and clinical outcomes study of novel coronavirus pneumonia (COVID-19) patients,2000,http://www.chictr.org.cn/showproj.aspx?proj=52561,NA
ISRCTN18348009,ISRCTN,2020-04-15,2020-04-16,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,80,http://isrctn.com/ISRCTN18348009,NA
ISRCTN51255782,ISRCTN,2020-04-14,2020-04-14,FALSE,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,2170,http://isrctn.com/ISRCTN51255782,NA
ISRCTN80453162,ISRCTN,2020-04-14,2020-09-04,FALSE,Recruiting,Not Applicable,Observational,"French Southern Territories, Nepal, Saudi Arabia, United Kingdom, Yemen, Azerbaijan, Curacao, Korea, South, Virgin Islands, U.S., Gabon, Guatemala, Cote d'Ivoire, Poland, Venezuela, Armenia, Austria, China, Romania, Denmark, Malawi, Martinique, Swaziland, United States, Ethiopia, Guam, Belgium, Burkina Faso, Democratic Republic of Congo, Cameroon, Gibraltar, Mongolia, Timor-Leste, Botswana, Myanmar, Panama, Turkmenistan, Cyprus, Holy See (Vatican City State), New Zealand, Netherlands, Saint Pierre and Miquelon, Nauru, Madagascar, San Marino, Liechtenstein, American Samoa, Tajikistan, Slovenia, Singapore, Slovakia, Colombia, Netherlands Antilles, Andorra, Togo, Spain, Burundi, Uganda, Bouvet Island, Guinea-Bissau, Sri Lanka, Moldova, Georgia, Aruba, Angola, Bhutan, Norway, British Indian Ocean Territory, Turkey, Djibouti, Finland, Paraguay, Chad, Costa Rica, Pitcairn, Mozambique, Afghanistan, Luxembourg, Laos, Ecuador, Sudan, Uruguay, Central African Republic, Lebanon, Bulgaria, Switzerland, Cayman Islands, Nicaragua, Guadeloupe, Namibia, Saint Helena, South Sudan, Croatia, Brazil, Mali, Svalbard and Jan Mayen, El Salvador, Nigeria, Sierra Leone, Chile, Bahrain, Suriname, Albania, Mauritius, Kuwait, Bermuda, Kiribati, Christmas Island, Antarctica, Jamaica, Saint Kitts and Nevis, Palestinian Territory, Barbados, India, Tonga, Haiti, United States Minor Outlying Islands, Guyana, Kosovo, Kyrgyzstan, Zambia, Cambodia, Algeria, Falkland Islands, Japan, Antigua and Barbuda, Maldives, Rwanda, France, Saint Vincent and the Grenadines, Belize, Lithuania, Bonaire Saint Eustatius and Saba, Heard Island and Mcdonald Islands, Dominican Republic, Honduras, Fiji, Greece, Mayotte, Micronesia, Federated States of, Czech Republic, Taiwan, Puerto Rico, Montenegro, United Arab Emirates, Kazakhstan, Seychelles, Uzbekistan, Turks and Caicos Islands, Argentina, Hungary, Virgin Islands, British, Iceland, Wallis and Futuna, Democratic Republic of Congo, Solomon Islands, Papua New Guinea, Italy, Mexico, Guernsey, Malta, Syria, Vanuatu, Monaco, Montserrat, Liberia, Malaysia, Philippines, Kenya, Palau, Senegal, Australia, Portugal, Eritrea, Samoa, Comoros, Thailand, Estonia, Serbia, Bahamas, Cocos (Keeling) Islands, Isle of Man, Niue, Cook Islands, Tokelau, Cuba, Faroe Islands, Sweden, Russian Federation, Tanzania, Jordan, Benin, Macedonia, Canada, Pakistan, Morocco, Saint Lucia, Bolivia, Egypt, Vietnam, Lesotho, Macao, Niger, Sao Tome and Principe, Bosnia and Herzegovina, Libya, Mauritania, Hong Kong, Ireland, Indonesia, French Polynesia, Gambia, Anguilla, Bangladesh, Belarus, Sint Maarten (Dutch part), Saint Martin (French part), Northern Mariana Islands, Iraq, Somalia, Germany, Tuvalu, Equatorial Guinea, South Africa, Trinidad and Tobago, Marshall Islands, Cape Verde, Dominica, Grenada, Ukraine, Western Sahara, Oman, Jersey, Latvia, New Caledonia, Ghana, Korea, North, Iran, Qatar, Peru, Greenland, Tunisia, Reunion, Israel, Norfolk Island, French Guiana, Brunei, Zimbabwe, Guinea, Saint Barthelemy, South Georgia and the South Sandwich Is","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",200,http://isrctn.com/ISRCTN80453162,NA
EUCTR2020-001329-30,EudraCT,2020-04-03,2020-09-04,FALSE,Authorised,Phase 4,Interventional,"China, United States, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,AT
EUCTR2020-001527-14,EudraCT,2020-04-06,2020-04-21,FALSE,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,NL
EUCTR2020-001366-11,EudraCT,2020-04-20,2020-09-04,FALSE,Authorised,Phase 3,Interventional,"Argentina, South Africa, Indonesia, Peru, Canada, Italy, Thailand, Spain, Brazil, Norway, Iran, Germany, Switzerland",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11,IT
EUCTR2020-001255-40,EudraCT,2020-04-20,2020-04-16,TRUE,Authorised,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE storm caused by infection with COVID-19.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001255-40,ES
EUCTR2020-001531-27,EudraCT,2020-04-20,2020-04-18,TRUE,Authorised,Phase 2,Interventional,Spain,Clinical trial of Sarilumab in adults hospitalized with COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001531-27,ES
EUCTR2020-001459-42,EudraCT,2020-04-14,2020-04-22,FALSE,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,DK
EUCTR2020-001500-41,EudraCT,2020-04-04,2020-03-04,TRUE,Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,BE
NCT04372069,ClinicalTrials.gov,2020-04-29,2020-04-09,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,London Ambulance Service Experience of COVID-19,40,https://clinicaltrials.gov/show/NCT04372069,NA
ACTRN12620000512921,ANZCTR,2020-04-27,2020-04-29,FALSE,Not Recruiting,Not Applicable,Observational,Australia,SARS-CoV2 in children presenting to hospital: A repeating point prevalence study during the COVID-19 pandemic in South East Queensland,400,https://anzctr.org.au/ACTRN12620000512921.aspx,NA
ACTRN12620000527965,ANZCTR,2020-04-29,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia.,1000,https://anzctr.org.au/ACTRN12620000527965.aspx,NA
ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,TRUE,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,100,http://www.chictr.org.cn/showproj.aspx?proj=53190,NA
ChiCTR2000032574,ChiCTR,2020-05-03,2020-01-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR,248,http://www.chictr.org.cn/showproj.aspx?proj=53122,NA
ChiCTR2000032527,ChiCTR,2020-05-01,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,China,"Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study",8500,http://www.chictr.org.cn/showproj.aspx?proj=53196,NA
ChiCTR2000032514,ChiCTR,2020-05-01,2020-05-05,FALSE,Not Recruiting,Not Applicable,Basic Science,China,Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19),13,http://www.chictr.org.cn/showproj.aspx?proj=53181,NA
ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,TRUE,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394,NA
ChiCTR2000032480,ChiCTR,2020-04-29,2020-04-29,FALSE,Not Recruiting,Not Applicable,Observational,China,Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19)  convalescence,1000,http://www.chictr.org.cn/showproj.aspx?proj=52698,NA
ChiCTR2000032478,ChiCTR,2020-04-29,2020-02-03,TRUE,Recruiting,Not Applicable,Observational,China,TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control,3000,http://www.chictr.org.cn/showproj.aspx?proj=52777,NA
ChiCTR2000032476,ChiCTR,2020-04-29,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,China,Analysis of clinical features of novel coronavirus  pneumonia (COVID-19): a medical records based study,500,http://www.chictr.org.cn/showproj.aspx?proj=53094,NA
ChiCTR2000032461,ChiCTR,2020-04-29,2020-05-06,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19),500,http://www.chictr.org.cn/showproj.aspx?proj=52482,NA
ChiCTR2000032460,ChiCTR,2020-04-29,2020-01-20,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19),76,http://www.chictr.org.cn/showproj.aspx?proj=52875,NA
ChiCTR2000032458,ChiCTR,2020-04-29,2020-02-29,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence,25,http://www.chictr.org.cn/showproj.aspx?proj=52779,NA
ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=53048,NA
ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,TRUE,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,140,http://www.chictr.org.cn/showproj.aspx?proj=53050,NA
ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,FALSE,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=52506,NA
ChiCTR2000031896,ChiCTR,2020-04-14,2020-02-05,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,923,http://www.chictr.org.cn/showproj.aspx?proj=52332,NA
ChiCTR2000031327,ChiCTR,2020-03-27,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,120,http://www.chictr.org.cn/showproj.aspx?proj=51669,NA
ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,FALSE,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),1000,http://www.chictr.org.cn/showproj.aspx?proj=51437,NA
EUCTR2020-001723-13,EudraCT,2020-04-08,2020-04-17,FALSE,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,FR
EUCTR2020-001823-15,EudraCT,2020-04-15,2020-04-28,FALSE,Authorised,Phase 4,Interventional,France,Evaluation of the concentration-effect relationship of enoxaparin for thromboembolic prevention in COVID-19 resuscitation patients. COV-ENOX study,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001823-15,FR
EUCTR2020-001678-31,EudraCT,2020-04-17,2020-04-28,FALSE,Authorised,Phase 3,Interventional,France,"Randomized controlled trial evaluating the efficacy of vaccination with Bacillus Calmette and GuÃ©rin (BCG) in the Prevention of COVID-19 via the strengthening of innate immunity in Health Care Workers.â€
COVID-BCG",1120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001678-31,FR
EUCTR2020-001364-29,EudraCT,2020-04-27,2020-04-20,TRUE,Authorised,Phase 1/Phase 2,Interventional,Spain,"Study with stem cells from allogenic adipose tissue, in patients with coronavirus severe pneumonia",26,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001364-29,ES
EUCTR2020-001717-20,EudraCT,2020-04-27,2020-04-20,TRUE,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,ES
EUCTR2020-000982-18,EudraCT,2020-03-24,2020-03-26,FALSE,Authorised,Phase 3,Interventional,Norway,A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19).,443,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18,NO
ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),2000,https://anzctr.org.au/ACTRN12620000524998.aspx,NA
ChiCTR2000032770,ChiCTR,2020-05-10,2020-01-29,TRUE,Not Recruiting,Not Applicable,Observational,China,Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study,52,http://www.chictr.org.cn/showproj.aspx?proj=53228,NA
ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",342,http://www.chictr.org.cn/showproj.aspx?proj=53368,NA
ChiCTR2000032768,ChiCTR,2020-05-09,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Correlation between novel coronavirus pneumonia (COVID-19) and mental health of breast cancer patients: a cross-sectional study in Hunan Province,309,http://www.chictr.org.cn/showproj.aspx?proj=53460,NA
ChiCTR2000032767,ChiCTR,2020-05-09,2020-05-09,FALSE,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the treatment of Novel Coronavirus Pneumonia (COVID-19),782,http://www.chictr.org.cn/showproj.aspx?proj=53476,NA
ChiCTR2000032743,ChiCTR,2020-05-09,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,China,The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the novel coronavirus pneumonia (COVID-19) pandemic: a before and after study,151,http://www.chictr.org.cn/showproj.aspx?proj=53431,NA
ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,60,http://www.chictr.org.cn/showproj.aspx?proj=53458,NA
ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,TRUE,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),40,http://www.chictr.org.cn/showproj.aspx?proj=53322,NA
ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,TRUE,Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,12,http://www.chictr.org.cn/showproj.aspx?proj=53389,NA
ChiCTR2000032686,ChiCTR,2020-05-06,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for the application of novel coronavirus pneumonia (COVID-19) intestinal tract toxicity in diagnosis and its prognostic effect,390,http://www.chictr.org.cn/showproj.aspx?proj=53153,NA
ChiCTR2000032666,ChiCTR,2020-05-05,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,China,Follow-up study of pregnancy outcomes  of novel coronavirus pneumonia (COVID-19) complicated in the first and second trimester,6,http://www.chictr.org.cn/showproj.aspx?proj=53285,NA
ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=52671,NA
EUCTR2020-001700-42,EudraCT,2020-04-11,2020-06-05,FALSE,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,FR
EUCTR2020-001766-11,EudraCT,2020-04-15,2020-04-29,FALSE,Authorised,Phase 2,Interventional,France,Losartan and spironolactone treatment for COVID-19 patients with acute respiratory failure in intensive care unit,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001766-11,FR
EUCTR2020-001370-30,EudraCT,2020-04-15,2020-04-28,FALSE,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30,GB
EUCTR2020-001709-21,EudraCT,2020-04-16,2020-04-29,FALSE,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,FR
EUCTR2020-001768-27,EudraCT,2020-04-16,2020-04-27,FALSE,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,FR
EUCTR2020-001598-66,EudraCT,2020-04-16,2020-04-05,TRUE,Authorised,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome â€“ 1,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,FR
EUCTR2020-001909-22,EudraCT,2020-04-16,2020-04-29,FALSE,Authorised,Phase 3,Interventional,France,EFFICACY OF INTRAVENOUS ALMITRINE IN REDUCING THE NEED FOR MECHANICAL VENTILATION IN PATIENTS WITH HYPOXEMIC ACUTE RESPIRATORY FAILURE DUE TO COVID-19-RELATED PNEUMONIA:  A RANDOMIZED CONTROLLED DOUBLE-BLIND STUDYFROM THE SKIP-ICU CONSORTIUM,212,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001909-22,FR
EUCTR2020-001449-38,EudraCT,2020-04-17,2020-04-29,FALSE,Authorised,Phase 3,Interventional,United Kingdom,A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaRe,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001449-38,GB
EUCTR2020-001786-36,EudraCT,2020-04-15,2020-06-05,FALSE,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, Italy, United States, Spain, France",Study of investigational medicinal product of CYT107 in patients with COVID-19 infection who have low number of lymphocytes in their blood (ILIAD 7 trial),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001786-36,GB
EUCTR2020-001721-31,EudraCT,2020-04-27,2020-01-05,TRUE,Authorised,Phase 2,Interventional,United Kingdom,Sinus-Wash Pilot Study,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001721-31,GB
EUCTR2020-001783-28,EudraCT,2020-04-29,2020-06-05,FALSE,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,HU
EUCTR2020-001882-36,EudraCT,2020-04-30,2020-07-05,FALSE,Authorised,Phase 2,Interventional,Greece,CLARITHROMYCIN IN COVID-19,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001882-36,GR
EUCTR2020-001206-35,EudraCT,2020-03-26,2020-04-14,FALSE,Authorised,Phase 4,Interventional,Austria,Discontinuation of ACE inhibitors in patients with COVID-19 infection,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35,AT
EUCTR2020-001696-32,EudraCT,2020-05-08,2020-08-05,FALSE,Authorised,Phase 2,Interventional,Spain,Efficacy and safety study of IVIG in hospitalized subjects with COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001696-32,ES
NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,FALSE,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",30,https://clinicaltrials.gov/show/NCT04380948,NA
ISRCTN87832712,ISRCTN,2020-05-05,2020-10-05,FALSE,Recruiting,Not Applicable,Observational,Italy,Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients,20,http://isrctn.com/ISRCTN87832712,NA
ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,FALSE,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,25,http://www.chictr.org.cn/showproj.aspx?proj=53790,NA
ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,TRUE,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",200,http://www.chictr.org.cn/showproj.aspx?proj=53274,NA
ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,TRUE,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,240,http://www.chictr.org.cn/showproj.aspx?proj=53658,NA
ChiCTR2000032895,ChiCTR,2020-05-15,2020-01-18,TRUE,Recruiting,Not Applicable,Observational,China,"Epidemiological, clinical and prognosticated features of novel coronavirus pneumonia (COVID-19) in Zhuhai",100,http://www.chictr.org.cn/showproj.aspx?proj=51841,NA
ChiCTR2000032884,ChiCTR,2020-05-14,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,China,The duration and influencing factors of medical staff wearing disposable protective equipment in the isolation area during novel coronavirus pneumonia (COVID-19): an epidemiological study,176,http://www.chictr.org.cn/showproj.aspx?proj=53473,NA
ChiCTR2000032842,ChiCTR,2020-05-13,2020-05-25,FALSE,Not Recruiting,Not Applicable,Diagnostic test,No Country Given,Rapid Detection 2019-nCOV via Surface Plasamon Resonance,200,http://www.chictr.org.cn/showproj.aspx?proj=53621,NA
ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,TRUE,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136,NA
ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,FALSE,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",100,http://www.chictr.org.cn/showproj.aspx?proj=49224,NA
ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,FALSE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",400,http://www.chictr.org.cn/showproj.aspx?proj=49051,NA
IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,40,http://en.irct.ir/trial/46533,NA
IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,TRUE,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,85,http://en.irct.ir/trial/46550,NA
IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,80,http://en.irct.ir/trial/46551,NA
IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,100,http://en.irct.ir/trial/46639,NA
IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,120,http://en.irct.ir/trial/46660,NA
IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,62,http://en.irct.ir/trial/46713,NA
IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,60,http://en.irct.ir/trial/46715,NA
IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,100,http://en.irct.ir/trial/46731,NA
IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,70,http://en.irct.ir/trial/46741,NA
IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,120,http://en.irct.ir/trial/46762,NA
IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,68,http://en.irct.ir/trial/46782,NA
IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,FALSE,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with â€œSofosbuvir standard of care therapeutic regimenVelpatasvirâ€ to â€œstandard of caretherapeutic regimenâ€ in patients with COVID-19,80,http://en.irct.ir/trial/46790,NA
IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,FALSE,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,50,http://en.irct.ir/trial/46811,NA
IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,40,http://en.irct.ir/trial/46814,NA
IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,100,http://en.irct.ir/trial/46849,NA
IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/46850,NA
IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,TRUE,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with â€œSofosbuvir-Daclatasvirâ€, â€œLithiumâ€,and â€œTrifluoprazineâ€ to â€œstandard of care in three groups of patients with COVID-19",80,http://en.irct.ir/trial/46853,NA
IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,40,http://en.irct.ir/trial/46868,NA
IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,TRUE,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",110,http://en.irct.ir/trial/46879,NA
IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,48,http://en.irct.ir/trial/46885,NA
IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,FALSE,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,50,http://en.irct.ir/trial/46887,NA
IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,40,http://en.irct.ir/trial/46893,NA
IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,60,http://en.irct.ir/trial/46903,NA
IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,60,http://en.irct.ir/trial/46907,NA
IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),130,http://en.irct.ir/trial/46913,NA
IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,60,http://en.irct.ir/trial/46926,NA
IRCT20200405046953N1,IRCT,2020-04-06,2020-04-08,FALSE,Recruiting,Phase 3,Interventional,Iran,Comparison of therapies for COVID-19,3000,http://en.irct.ir/trial/46930,NA
IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,FALSE,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,12,http://en.irct.ir/trial/46931,NA
IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,FALSE,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,500,http://en.irct.ir/trial/46932,NA
IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,TRUE,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",40,http://en.irct.ir/trial/46940,NA
IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,84,http://en.irct.ir/trial/46942,NA
IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,60,http://en.irct.ir/trial/46946,NA
IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,40,http://en.irct.ir/trial/46958,NA
IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,15,http://en.irct.ir/trial/46961,NA
IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,FALSE,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,906,http://en.irct.ir/trial/46968,NA
IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,60,http://en.irct.ir/trial/46969,NA
IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,TRUE,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,60,http://en.irct.ir/trial/46973,NA
IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,140,http://en.irct.ir/trial/46974,NA
IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,40,http://en.irct.ir/trial/46977,NA
IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,40,http://en.irct.ir/trial/46978,NA
IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,70,http://en.irct.ir/trial/47006,NA
IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,30,http://en.irct.ir/trial/47013,NA
IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,FALSE,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,100,http://en.irct.ir/trial/47014,NA
IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,10,http://en.irct.ir/trial/47015,NA
IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,60,http://en.irct.ir/trial/47018,NA
IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,10,http://en.irct.ir/trial/47021,NA
IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,100,http://en.irct.ir/trial/47022,NA
IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,50,http://en.irct.ir/trial/47034,NA
IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,TRUE,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,101,http://en.irct.ir/trial/47052,NA
IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,60,http://en.irct.ir/trial/47061,NA
IRCT20200217046526N2,IRCT,2020-04-13,2020-04-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,60,http://en.irct.ir/trial/47073,NA
IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,110,http://en.irct.ir/trial/47078,NA
IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,200,http://en.irct.ir/trial/47087,NA
IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,40,http://en.irct.ir/trial/47088,NA
IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,1000,http://en.irct.ir/trial/47090,NA
IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,82,http://en.irct.ir/trial/47099,NA
IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,30,http://en.irct.ir/trial/47115,NA
IRCT20170207032444N3,IRCT,2020-04-17,2020-04-15,TRUE,Recruiting,Phase 3,Interventional,Iran,Thalidomide in COVID19,60,http://en.irct.ir/trial/47119,NA
IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,60,http://en.irct.ir/trial/47139,NA
IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,FALSE,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,40,http://en.irct.ir/trial/47141,NA
IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,60,http://en.irct.ir/trial/47142,NA
IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,76,http://en.irct.ir/trial/47146,NA
IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,80,http://en.irct.ir/trial/47149,NA
IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,TRUE,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,60,http://en.irct.ir/trial/47152,NA
IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,20,http://en.irct.ir/trial/47156,NA
IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,TRUE,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",60,http://en.irct.ir/trial/47160,NA
IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,50,http://en.irct.ir/trial/47169,NA
IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,FALSE,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,15,http://en.irct.ir/trial/47212,NA
IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,TRUE,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,20,http://en.irct.ir/trial/47219,NA
IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,100,http://en.irct.ir/trial/47234,NA
IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,110,http://en.irct.ir/trial/47244,NA
IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,66,http://en.irct.ir/trial/47251,NA
IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,70,http://en.irct.ir/trial/47264,NA
IRCT20200419047128N1,IRCT,2020-04-22,2020-05-04,FALSE,Recruiting,Phase 3,Interventional,Iran,Tranilast in COVID19,60,http://en.irct.ir/trial/47265,NA
IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,TRUE,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,10,http://en.irct.ir/trial/47266,NA
IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",80,http://en.irct.ir/trial/47268,NA
IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,6,http://en.irct.ir/trial/47275,NA
IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,70,http://en.irct.ir/trial/47300,NA
IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,100,http://en.irct.ir/trial/47318,NA
IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,84,http://en.irct.ir/trial/47334,NA
IRCT20190618043923N4,IRCT,2020-05-04,2020-04-25,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Ozone Autohemotherapy in Covid19,20,http://en.irct.ir/trial/47363,NA
IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,FALSE,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,86,http://en.irct.ir/trial/47387,NA
IRCT20200419047128N2,IRCT,2020-04-24,2020-04-29,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Quercetin in COVID19,60,http://en.irct.ir/trial/47396,NA
IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,TRUE,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",80,http://en.irct.ir/trial/47401,NA
IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),60,http://en.irct.ir/trial/47437,NA
IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,40,http://en.irct.ir/trial/47468,NA
IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),80,http://en.irct.ir/trial/47475,NA
IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,46,http://en.irct.ir/trial/47495,NA
IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,FALSE,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,100,http://en.irct.ir/trial/47501,NA
IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,30,http://en.irct.ir/trial/47508,NA
IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),80,http://en.irct.ir/trial/47516,NA
IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,60,http://en.irct.ir/trial/47520,NA
IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,48,http://en.irct.ir/trial/47572,NA
IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,FALSE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47576,NA
IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,FALSE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47577,NA
IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,FALSE,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",40,http://en.irct.ir/trial/47578,NA
IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,60,http://en.irct.ir/trial/47594,NA
IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,120,http://en.irct.ir/trial/47629,NA
IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,152,http://en.irct.ir/trial/47639,NA
IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,50,http://en.irct.ir/trial/47641,NA
IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,FALSE,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,40,http://en.irct.ir/trial/47682,NA
IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,68,http://en.irct.ir/trial/47684,NA
IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,FALSE,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,88,http://en.irct.ir/trial/47934,NA
IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,124,http://en.irct.ir/trial/47953,NA
IRCT20200509047366N1,IRCT,2020-05-12,2020-05-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Radiotherapy in COVID-19,5,http://en.irct.ir/trial/48020,NA
IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,FALSE,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",81,http://en.irct.ir/trial/48043,NA
KCT0005005,CRiS,2020-05-11,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,South Korea,Psychiatric Consultation for COVID-19 Patients,54,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16339,NA
KCT0005003,CRiS,2020-05-11,2020-05-25,FALSE,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,NA
JPRN-jRCT2031190264,jRCT,2020-03-24,2020-03-26,FALSE,Not Recruiting,Phase 3,Interventional,"United States, Japan, South Korea","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",100,https://jrct.niph.go.jp/latest-detail/jRCT2031190264,NA
JPRN-UMIN000040193,UMIN-CTR,2020-04-18,2020-04-30,FALSE,Not Recruiting,Not Applicable,Observational,Japan,"Evaluating the social function of people with dementia under the COVID-19 epidemic 
by the Japanese version of the social functioning in dementia scale",300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045831,NA
JPRN-UMIN000040286,UMIN-CTR,2020-05-11,2020-05-12,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,NA
JPRN-UMIN000040295,UMIN-CTR,2020-05-02,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on diagnosis and treatment of COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045974,NA
JPRN-UMIN000040335,UMIN-CTR,2020-05-08,2020-05-08,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Impacts of COVID-19 prevention life in community-dwelling older adults and support measures,346,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045960,NA
JPRN-UMIN000040401,UMIN-CTR,2020-05-15,2020-05-15,FALSE,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,NA
ACTRN12620000575932,ANZCTR,2020-05-18,2020-03-05,TRUE,Recruiting,Not Applicable,Observational,Australia,Prevalence of the loss of smell in patients with COVID-19: The SMELLY Study,100,https://anzctr.org.au/ACTRN12620000575932.aspx,NA
ISRCTN85216856,ISRCTN,2020-05-11,2020-10-05,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,200,http://isrctn.com/ISRCTN85216856,NA
ChiCTR2000033200,ChiCTR,2020-05-23,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,The real-world study for the change of early breast cancer diagnosis and treatment mode under the pandemic of Coronavirus Disease 2019 (COVID-19),10000,http://www.chictr.org.cn/showproj.aspx?proj=54056,NA
ChiCTR2000033198,ChiCTR,2020-05-23,2020-05-25,FALSE,Recruiting,Not Applicable,Observational,China,Status of management of surgery in Beijing during COVID-19,500,http://www.chictr.org.cn/showproj.aspx?proj=54015,NA
ChiCTR2000033197,ChiCTR,2020-05-23,2020-05-13,TRUE,Not Recruiting,Not Applicable,Observational,China,Investigation of Mental Status for in-patients with gastrointestinal malignancy  during the COVID-19 Pandemic,65,http://www.chictr.org.cn/showproj.aspx?proj=53451,NA
ChiCTR2000033190,ChiCTR,2020-05-23,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,China,The research Of novel coronavirus pneumonia (COVID-19) patients' immune status and severity of disease,60,http://www.chictr.org.cn/showproj.aspx?proj=54062,NA
ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=53925,NA
ChiCTR2000033108,ChiCTR,2020-05-21,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,China,"Associations between suboptimal health status  and TraditChinese Medicine constitution of medical staff fighting the disease, recovered COVID-19 patients and the general public under the outbreak of novel coronavirus pneumonia: an epidemiological study",600,http://www.chictr.org.cn/showproj.aspx?proj=54000,NA
ChiCTR2000033107,ChiCTR,2020-05-21,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) patients with pre-existing HBV infection,72,http://www.chictr.org.cn/showproj.aspx?proj=54010,NA
ChiCTR2000033104,ChiCTR,2020-05-21,2020-03-07,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study for rapid detection of novel coronavirus pneumonia (COVID-19) nucleic acid,670,http://www.chictr.org.cn/showproj.aspx?proj=53845,NA
ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,TRUE,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=53529,NA
ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,TRUE,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,6,http://www.chictr.org.cn/showproj.aspx?proj=53859,NA
ChiCTR2000033055,ChiCTR,2020-05-19,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) and Symptomatic Venous Thromboembolism: a Multicenter Retrospective Study,300,http://www.chictr.org.cn/showproj.aspx?proj=53860,NA
ChiCTR2000033054,ChiCTR,2020-05-19,2020-05-19,FALSE,Recruiting,Not Applicable,Observational,No Country Given,The investigation of psychosocial stress status in juveniles during the pandemic of the novel coronavirus pneumonia (COVID-19),800,http://www.chictr.org.cn/showproj.aspx?proj=53894,NA
ChiCTR2000033053,ChiCTR,2020-05-19,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Efficacy of Early Prone Positioning in Non-Mechanical Ventilation novel coronavirus pneumonia (COVID-19) Patients with Severe Hypoxia- a single-center prospective cohort study,60,http://www.chictr.org.cn/showproj.aspx?proj=53886,NA
ChiCTR2000033052,ChiCTR,2020-05-19,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Acute Care Surgery during novel coronavirus pneumonia (COVID-19) pandemic in Spain,400,http://www.chictr.org.cn/showproj.aspx?proj=53892,NA
ChiCTR2000033050,ChiCTR,2020-05-18,2020-05-04,TRUE,Recruiting,Not Applicable,Observational,China,Effect of high dose intravenous vitamin C on moderate novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,110,http://www.chictr.org.cn/showproj.aspx?proj=53590,NA
ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,FALSE,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,160,http://www.chictr.org.cn/showproj.aspx?proj=53840,NA
EUCTR2020-001805-21,EudraCT,2020-05-07,2020-05-15,FALSE,Authorised,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in treatment of Novel Coronavirus (COVID-19),120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001805-21,GB
EUCTR2020-001886-35,EudraCT,2020-05-11,2020-05-15,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A Clinical Trial of Nebulized Bovactant (Alveofact Â®) for the Treatment of Moderate to Severe COVID-19,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001886-35,GB
EUCTR2020-001614-38,EudraCT,2020-04-06,2020-04-22,FALSE,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,BE
NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,300,https://clinicaltrials.gov/show/NCT04404634,NA
ACTRN12620000602921,ANZCTR,2020-05-25,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Post-Intensive Care Nutrition Status in Patients with COVID-19,200,https://anzctr.org.au/ACTRN12620000602921.aspx,NA
ACTRN12620000617965,ANZCTR,2020-05-27,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Australia,Multi-site audit of COVID-19 airway interventions,100,https://anzctr.org.au/ACTRN12620000617965.aspx,NA
ACTRN12620000593932,ANZCTR,2020-05-22,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Has the threat of SARS COVID-19 increased influenza vaccination rates in pregnant women?,100,https://anzctr.org.au/ACTRN12620000593932.aspx,NA
ACTRN12620000609954,ANZCTR,2020-05-25,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Australia,Covid-19 Biobank of clinical samples and data for use in research to help understand the immune characteristics of people who are diagnosed with COVID19.,250,https://anzctr.org.au/ACTRN12620000609954.aspx,NA
ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,300,http://www.chictr.org.cn/showproj.aspx?proj=54482,NA
ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,TRUE,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,30,http://www.chictr.org.cn/showproj.aspx?proj=54408,NA
ChiCTR2000033364,ChiCTR,2020-05-29,2020-05-21,TRUE,Recruiting,Not Applicable,Observational,China,A correlation study between food intake and risk factors of PTSD after the COVID-19 of shift medical staff,300,http://www.chictr.org.cn/showproj.aspx?proj=54280,NA
ChiCTR2000033347,ChiCTR,2020-05-28,2020-01-29,TRUE,Not Recruiting,Not Applicable,Observational,China,Epidemiological and Clinical Characteristics of 20 Re-positive novel coronavirus pneumonia (COVID-19) Patients,20,http://www.chictr.org.cn/showproj.aspx?proj=53976,NA
ChiCTR2000033346,ChiCTR,2020-05-28,2020-02-29,TRUE,Not Recruiting,Not Applicable,Observational,China,Erythrocyte Sedimentation Rate in novel coronavirus pneumonia (COVID-19) patients,80,http://www.chictr.org.cn/showproj.aspx?proj=54388,NA
ChiCTR2000033345,ChiCTR,2020-05-28,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,China,Study for the effect of Traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-1) in the high risk area,10000,http://www.chictr.org.cn/showproj.aspx?proj=54282,NA
ChiCTR2000033342,ChiCTR,2020-05-28,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,China,The comprehensive evaluation of therapeutic drugs for pediatric novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=54371,NA
ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,TRUE,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,24,http://www.chictr.org.cn/showproj.aspx?proj=54346,NA
ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,TRUE,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=54321,NA
ChiCTR2000033319,ChiCTR,2020-05-27,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,China,"A follow up research of exercise, cardiopulmonary and quality of Life for patients of novel coronavirus pneumonia (COVID-19)",85,http://www.chictr.org.cn/showproj.aspx?proj=54327,NA
ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,TRUE,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,104,http://www.chictr.org.cn/showproj.aspx?proj=54326,NA
ChiCTR2000033317,ChiCTR,2020-05-27,2020-05-25,TRUE,Not Recruiting,Not Applicable,Observational,China,Psychiatric admissions during the COVID-19 pandemic,10000,http://www.chictr.org.cn/showproj.aspx?proj=54295,NA
ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",60,http://www.chictr.org.cn/showproj.aspx?proj=54176,NA
ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,150,http://www.chictr.org.cn/showproj.aspx?proj=49590,NA
ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,TRUE,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,120,http://www.chictr.org.cn/showproj.aspx?proj=54185,NA
ChiCTR2000031539,ChiCTR,2020-04-03,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),180,http://www.chictr.org.cn/showproj.aspx?proj=51893,NA
ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,TRUE,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773,NA
ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,TRUE,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,300,http://isrctn.com/ISRCTN15254871,NA
EUCTR2020-001573-78,EudraCT,2020-04-14,2020-06-05,FALSE,Authorised,Phase 2,Interventional,"France, United States",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78,FR
EUCTR2020-001754-21,EudraCT,2020-04-17,2020-05-19,FALSE,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21,FR
EUCTR2020-001963-10,EudraCT,2020-04-20,2020-12-05,FALSE,Authorised,Phase 3,Interventional,France,"Interleukin-1 (IL-1) and Interferon gamma (IFNg) inhibition during COVID 19 inflammation: Randomized, controlled study assessing efficacy and safety of Anakinra and Ruxolitinib",54,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001963-10,FR
EUCTR2020-001536-98,EudraCT,2020-04-20,2020-04-18,TRUE,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,ES
EUCTR2020-001497-30,EudraCT,2020-04-28,2020-12-05,FALSE,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",ravulizumab for the treatment of patients with Coronavirus Disease 2019,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,FR
EUCTR2020-001684-89,EudraCT,2020-04-17,2020-05-05,FALSE,Authorised,Phase 2,Interventional,United Kingdom,"A clinical trial to gather information on the safety and effectiveness of drugs in patients with the COVID-19 infection, that could be used in larger trials.",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001684-89,GB
EUCTR2020-001296-33,EudraCT,2020-04-03,2020-06-05,FALSE,Authorised,Phase 2,Interventional,Denmark,"Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in patients with COVID-19 induced respiratory failure â€“ a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial",80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001296-33,DK
EUCTR2020-001759-42,EudraCT,2020-05-13,2020-05-20,FALSE,Authorised,Phase 2,Interventional,"Chile, Argentina, Sweden, South Africa, United Kingdom, Belgium, Netherlands, Canada, United States, Mexico, Spain, Brazil, Japan, Poland, France",Investigating otilimab in patients with severe coronavirus related lung disease.,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001759-42,GB
ACTRN12620000635965,ANZCTR,2020-05-29,2020-05-06,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",50,https://anzctr.org.au/ACTRN12620000635965.aspx,NA
ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,FALSE,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,60,http://www.chictr.org.cn/showproj.aspx?proj=54707,NA
ChiCTR2000033609,ChiCTR,2020-06-07,2020-05-07,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for nano short peptide nutrition intervention on the prognosis of patients with novel coronavirus pneumonia (COVID-19),206,http://www.chictr.org.cn/showproj.aspx?proj=54788,NA
ChiCTR2000033580,ChiCTR,2020-06-06,2020-01-25,TRUE,Not Recruiting,Not Applicable,Observational,China,"Analysis of Characteristics of recurrent positive RT-PCR findings of recovered patients from novel coronavirus pneumonia (COVID-19) in Wuhan, China: a medical records based study",758,http://www.chictr.org.cn/showproj.aspx?proj=54787,NA
ChiCTR2000033517,ChiCTR,2020-06-03,2020-06-05,FALSE,Not Recruiting,Not Applicable,Observational,China,Effectiveness of day care service on improving the physical and psychological well-being of people with dementia and easing the caregiving burden in COVID-19 pandemic,150,http://www.chictr.org.cn/showproj.aspx?proj=54668,NA
ChiCTR2000033514,ChiCTR,2020-06-03,2020-02-17,TRUE,Recruiting,Not Applicable,Observational,China,"A Survey Among Collage Students for Changes and impact factors of Lifestyle, Psychology and Weight During Keep Stay at Home for four months in the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",14000,http://www.chictr.org.cn/showproj.aspx?proj=54579,NA
ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,TRUE,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,9,http://www.chictr.org.cn/showproj.aspx?proj=54278,NA
ISRCTN15571919,ISRCTN,2020-05-28,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,"India, Bangladesh, Pakistan","Investigating the impact of COVID-19 and its response, on people with severe mental illness in South Asia",2000,http://isrctn.com/ISRCTN15571919,NA
ISRCTN77353041,ISRCTN,2020-04-07,2020-08-04,FALSE,Not Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,2000,http://isrctn.com/ISRCTN77353041,NA
EUCTR2020-001597-30,EudraCT,2020-04-09,2020-05-29,FALSE,Authorised,Phase 2,Interventional,"Italy, Ireland, United States, United Kingdom",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30,GB
EUCTR2020-002111-22,EudraCT,2020-04-29,2020-06-26,FALSE,Authorised,Phase 3,Interventional,Poland,Study evaluating the impact of BCG vaccination on the incidence and course of SARS-CoV-2 infection among health care workers in Poland during the COVID-19 pandemic,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002111-22,PL
EUCTR2020-001849-39,EudraCT,2020-04-28,2020-05-18,FALSE,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39,SE
EUCTR2020-001951-42,EudraCT,2020-04-29,2020-08-05,FALSE,Authorised,Phase 3,Interventional,"Spain, Canada, Italy, Poland",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42,PL
ChiCTR2000033872,ChiCTR,2020-06-15,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Serum protein marker in patients with novel coronavirus pneumonia (COVID-19),350,http://www.chictr.org.cn/showproj.aspx?proj=54781,NA
ChiCTR2000033830,ChiCTR,2020-06-14,2020-06-12,TRUE,Not Recruiting,Not Applicable,Observational,China,Development and Application of a Low-Cost Ear-Contactless Stethoscope Powered by Raspberry Pi and Python,12,http://www.chictr.org.cn/showproj.aspx?proj=54971,NA
ChiCTR2000033798,ChiCTR,2020-06-12,2020-06-12,FALSE,Not Recruiting,Not Applicable,Observational,China,The efficacy and safety of convalescent plasma therapy in novel coronavirus pneumonia (COVID-19): A medical records based retrospective cohort study,150,http://www.chictr.org.cn/showproj.aspx?proj=55194,NA
ChiCTR2000033782,ChiCTR,2020-06-12,2020-06-18,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study of novel coronavirus pneumonia (COVID-19) patients,1400,http://www.chictr.org.cn/showproj.aspx?proj=55039,NA
ChiCTR2000033781,ChiCTR,2020-06-12,2020-06-18,FALSE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for predictors of novel coronavirus pneumonia (COVID-19) elderly patients,114,http://www.chictr.org.cn/showproj.aspx?proj=55054,NA
ChiCTR2000033780,ChiCTR,2020-06-12,2020-06-11,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for analysis of Tongue Features of novel coronavirus pneumonia (COVID-19) Patients,500,http://www.chictr.org.cn/showproj.aspx?proj=55027,NA
ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,TRUE,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=55097,NA
ChiCTR2000033745,ChiCTR,2020-06-11,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,China,"Clinical study on the effect of Clarenicol oral liquid on the relief of pharyngeal symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible populations",240,http://www.chictr.org.cn/showproj.aspx?proj=55100,NA
ChiCTR2000033723,ChiCTR,2020-06-10,2020-06-09,TRUE,Not Recruiting,Not Applicable,Observational,China,A study for long-term prognosis in hospitalized novel coronavirus pneumonia (COVID-19) patients,2500,http://www.chictr.org.cn/showproj.aspx?proj=54977,NA
ChiCTR2000033720,ChiCTR,2020-06-10,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,China,"Clinical observation of the relieving effect of Clarenicol oral liquid on the throat symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible people",240,http://www.chictr.org.cn/showproj.aspx?proj=55040,NA
ChiCTR2000033719,ChiCTR,2020-06-10,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Hip Fracture in elderly people during COVID-19 State of Alarm in Spain: reports from a specialized Center,206,http://www.chictr.org.cn/showproj.aspx?proj=55044,NA
ChiCTR2000033705,ChiCTR,2020-06-10,2020-02-27,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the preliminary efficacy of Tocilizumab in the treatment of the patients with novel coronavirus pneumonia (COVID-19),61,http://www.chictr.org.cn/showproj.aspx?proj=54989,NA
EUCTR2020-001571-32,EudraCT,2020-04-07,2020-04-15,FALSE,Authorised,Phase 2,Interventional,France,Low dose of IL-2 In Acute respiratory DistrEss syndrome related to COVID-19,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001571-32,FR
EUCTR2020-001363-85,EudraCT,2020-04-17,2020-04-23,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,DK
EUCTR2020-001411-25,EudraCT,2020-04-06,2020-04-24,FALSE,Authorised,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, United States, Israel, Spain, Italy, Austria, France, India, Germany, Malaysia",Low Dose Oral Selinexor in Patients with Severe COVID-19 Infection,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,GB
EUCTR2020-001937-11,EudraCT,2020-06-08,2020-04-30,TRUE,Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11,GB
IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),70,http://en.irct.ir/trial/46463,NA
IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,TRUE,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,94,http://en.irct.ir/trial/46519,NA
IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,80,http://en.irct.ir/trial/46718,NA
IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,70,http://en.irct.ir/trial/46721,NA
IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,70,http://en.irct.ir/trial/46728,NA
IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,FALSE,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,100,http://en.irct.ir/trial/46732,NA
IRCT20200401046909N1,IRCT,2020-04-09,2020-04-15,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the  efficacy of oral 25-hydroxyvitamin D3 on COVID-19,260,http://en.irct.ir/trial/46875,NA
IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,68,http://en.irct.ir/trial/46904,NA
IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,TRUE,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,30,http://en.irct.ir/trial/46963,NA
IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,TRUE,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,60,http://en.irct.ir/trial/46975,NA
IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,60,http://en.irct.ir/trial/46983,NA
IRCT20200401046909N2,IRCT,2020-04-11,2020-04-14,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of oral 25-hydroxyvitamin D3 on COVID-19,540,http://en.irct.ir/trial/47010,NA
IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,6,http://en.irct.ir/trial/47030,NA
IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,150,http://en.irct.ir/trial/47044,NA
IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,60,http://en.irct.ir/trial/47062,NA
IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,TRUE,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,74,http://en.irct.ir/trial/47091,NA
IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,FALSE,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,30,http://en.irct.ir/trial/47188,NA
IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,30,http://en.irct.ir/trial/47197,NA
IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,100,http://en.irct.ir/trial/47200,NA
IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,100,http://en.irct.ir/trial/47209,NA
IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,500,http://en.irct.ir/trial/47279,NA
IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,FALSE,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",62,http://en.irct.ir/trial/47335,NA
IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,60,http://en.irct.ir/trial/47504,NA
IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,50,http://en.irct.ir/trial/47559,NA
IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,TRUE,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,40,http://en.irct.ir/trial/47609,NA
IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,FALSE,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,40,http://en.irct.ir/trial/47645,NA
IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,68,http://en.irct.ir/trial/47665,NA
IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,30,http://en.irct.ir/trial/47666,NA
IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,10,http://en.irct.ir/trial/47692,NA
IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,300,http://en.irct.ir/trial/47704,NA
IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,100,http://en.irct.ir/trial/47707,NA
IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,120,http://en.irct.ir/trial/47722,NA
IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,FALSE,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,10,http://en.irct.ir/trial/47735,NA
IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,80,http://en.irct.ir/trial/47935,NA
IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,90,http://en.irct.ir/trial/47964,NA
IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,TRUE,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,60,http://en.irct.ir/trial/47974,NA
IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",60,http://en.irct.ir/trial/47979,NA
IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,FALSE,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,130000,http://en.irct.ir/trial/47989,NA
IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,60,http://en.irct.ir/trial/47990,NA
IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,60,http://en.irct.ir/trial/48001,NA
IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,100,http://en.irct.ir/trial/48018,NA
IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,80,http://en.irct.ir/trial/48019,NA
IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,100,http://en.irct.ir/trial/48024,NA
IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,FALSE,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,92,http://en.irct.ir/trial/48039,NA
IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,FALSE,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,40,http://en.irct.ir/trial/48058,NA
IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,72,http://en.irct.ir/trial/48061,NA
IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,FALSE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,100,http://en.irct.ir/trial/48066,NA
IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,TRUE,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,40,http://en.irct.ir/trial/48096,NA
IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,30,http://en.irct.ir/trial/48102,NA
IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,84,http://en.irct.ir/trial/48114,NA
IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,TRUE,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",60,http://en.irct.ir/trial/48116,NA
IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,60,http://en.irct.ir/trial/48126,NA
IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,50,http://en.irct.ir/trial/48141,NA
IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,48,http://en.irct.ir/trial/48153,NA
IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,50,http://en.irct.ir/trial/48176,NA
IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,TRUE,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,15,http://en.irct.ir/trial/48185,NA
IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,20,http://en.irct.ir/trial/48187,NA
IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,50,http://en.irct.ir/trial/48213,NA
IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,70,http://en.irct.ir/trial/48218,NA
IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,108,http://en.irct.ir/trial/48226,NA
IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,60,http://en.irct.ir/trial/48262,NA
IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,80,http://en.irct.ir/trial/48289,NA
IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,60,http://en.irct.ir/trial/48292,NA
IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,30,http://en.irct.ir/trial/48312,NA
IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,76,http://en.irct.ir/trial/48329,NA
IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,74,http://en.irct.ir/trial/48403,NA
IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",60,http://en.irct.ir/trial/48444,NA
IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,50,http://en.irct.ir/trial/48495,NA
IRCT20160118026097N3,IRCT,2020-05-31,2020-03-20,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of interferon on the treatment of covid19 patients,60,http://en.irct.ir/trial/48517,NA
IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,60,http://en.irct.ir/trial/48534,NA
IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,80,http://en.irct.ir/trial/48644,NA
IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,FALSE,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,30,http://en.irct.ir/trial/48702,NA
IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,FALSE,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",60,http://en.irct.ir/trial/48749,NA
KCT0005105,CRiS,2020-06-10,2020-04-08,TRUE,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults with Mild COVID-19,141,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,NA
JPRN-jRCTs031190227,jRCT,2020-02-27,2020-01-04,TRUE,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,NA
JPRN-jRCTs032200044,jRCT,2020-06-03,2020-03-06,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,NA
JPRN-UMIN000039997,UMIN-CTR,2020-04-01,2020-04-01,FALSE,Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",3700,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,NA
JPRN-UMIN000040219,UMIN-CTR,2020-04-22,2020-04-23,FALSE,Not Recruiting,Not Applicable,Observational,Japan,A prospective cohort study to follow the health status of medical staff engage in COVID-19,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045877,NA
JPRN-UMIN000040341,UMIN-CTR,2020-05-09,2020-05-09,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,NA
JPRN-UMIN000040353,UMIN-CTR,2020-05-11,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046029,NA
JPRN-UMIN000040407,UMIN-CTR,2020-05-15,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,NA
JPRN-UMIN000040451,UMIN-CTR,2020-05-20,2020-05-22,FALSE,Not Recruiting,Not Applicable,Other,"Japan,North America,Europe",COVID 19 - What Families Think and Do? A Survey for Families Visiting the Pediatric Emergency Department,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046169,NA
JPRN-UMIN000040476,UMIN-CTR,2020-05-21,2020-05-21,FALSE,Recruiting,Not Applicable,Observational,Japan,Clinical record investigation about ADHD children before and after the emergency declaration because of COVID19,10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046085,NA
JPRN-UMIN000040479,UMIN-CTR,2020-05-22,2020-05-22,FALSE,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,NA
JPRN-UMIN000040516,UMIN-CTR,2020-05-26,2023-03-31,FALSE,Recruiting,Not Applicable,Observational,Japan,Usefulness of PCR testing for COVID-19 before gastrointestinal endoscopy and hospitalization,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046253,NA
JPRN-UMIN000040520,UMIN-CTR,2020-05-26,2020-05-13,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046256,NA
JPRN-UMIN000040563,UMIN-CTR,2020-05-28,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on cytokine removal effect of continuous hemodiafiltration in COVID-19,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046299,NA
JPRN-UMIN000040614,UMIN-CTR,2020-06-01,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,Japan,A retrospective study on the therapeutic effect of tocilizumab on COVID-19,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046354,NA
JPRN-UMIN000040616,UMIN-CTR,2020-06-01,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,Japan,Retrospective study on clinical and pathological aspects of COVID-19,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046355,NA
JPRN-UMIN000040617,UMIN-CTR,2020-06-01,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,Japan,A retrospective study on serum markers in the diagnosis and differentiation of COVID-19,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046356,NA
JPRN-UMIN000040694,UMIN-CTR,2020-06-09,2020-06-10,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,NA
ACTRN12620000500954,ANZCTR,2020-04-22,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,20,https://anzctr.org.au/ACTRN12620000500954.aspx,NA
ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,40,https://anzctr.org.au/ACTRN12620000676910.aspx,NA
ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,100,http://isrctn.com/ISRCTN94091479,NA
ISRCTN33578935,ISRCTN,2020-06-02,2020-01-06,TRUE,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,64,http://isrctn.com/ISRCTN33578935,NA
ISRCTN21363594,ISRCTN,2020-05-18,2020-01-05,TRUE,Recruiting,Not Applicable,Interventional,"United Arab Emirates, Oman, Saudi Arabia",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),80,http://isrctn.com/ISRCTN21363594,NA
ISRCTN40092247,ISRCTN,2020-04-01,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,500,http://isrctn.com/ISRCTN40092247,NA
ChiCTR2000033980,ChiCTR,2020-06-19,2020-06-10,TRUE,Not Recruiting,Not Applicable,Observational,China,"A follow-up study of novel coronavirus pneumonia (COVID-19) patients in Wanzhou District, Chongqing",67,http://www.chictr.org.cn/showproj.aspx?proj=55355,NA
ChiCTR2000033960,ChiCTR,2020-06-19,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,China,A multicenter clinical study: transmission of COVID-19 and impact on health and developmental outcomes among newborns of mothers with confirmed/suspected COVID-19,90,http://www.chictr.org.cn/showproj.aspx?proj=55376,NA
ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,TRUE,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures â€“ an online survey,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291,NA
ChiCTR2000033919,ChiCTR,2020-06-17,2020-06-16,TRUE,Recruiting,Not Applicable,Observational,China,A medical records based study for the influence of novel coronavirus pneumonia (COVID-19) on the symptoms of patients with achalasia,286,http://www.chictr.org.cn/showproj.aspx?proj=55301,NA
ChiCTR2000033899,ChiCTR,2020-06-16,2020-06-04,TRUE,Not Recruiting,Not Applicable,Health services research,Pakistan,Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country,64,http://www.chictr.org.cn/showproj.aspx?proj=55295,NA
ChiCTR2000031707,ChiCTR,2020-04-07,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,47,http://www.chictr.org.cn/showproj.aspx?proj=52079,NA
EUCTR2020-001636-95,EudraCT,2020-05-04,2020-05-20,FALSE,Authorised,Phase 2,Interventional,United Kingdom,Does subcutaneously(SC) administered of anakinra achieve good penetration in blood and result in reduce inflammation in patients with SARS-CoV-19?,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001636-95,GB
EUCTR2020-001481-11,EudraCT,2020-04-16,2020-04-22,FALSE,Authorised,Phase 2,Interventional,Germany,Treatment with Ruxolitinib in Covid-19 patients with severe symptoms,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001481-11,DE
EUCTR2020-001889-10,EudraCT,2020-05-15,2020-02-06,TRUE,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10,GB
EUCTR2020-002120-37,EudraCT,2020-06-08,2020-06-16,FALSE,Authorised,Phase 2/Phase 3,Interventional,"United Kingdom, Netherlands, United States, Italy, Spain, France, Germany","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37,GB
EUCTR2020-001497-30,EudraCT,2020-04-27,2020-07-05,FALSE,Authorised,Phase 3,Interventional,"United Kingdom, Italy, United States, Spain, France, Germany",ravulizumab for the treatment of patients with Coronavirus Disease 2019,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,GB
ACTRN12620000688987,ANZCTR,2020-06-19,2020-02-06,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShieldÂ® N-95 masks
",80,https://anzctr.org.au/ACTRN12620000688987.aspx,NA
ACTRN12620000692932,ANZCTR,2020-06-22,2020-06-24,FALSE,Not Recruiting,Not Applicable,Observational,United States,Atrial Fibrillation in Patients with an Implantable Cardiac Device during the COVID-19 Pandemic,10000,https://anzctr.org.au/ACTRN12620000692932.aspx,NA
ISRCTN15475176,ISRCTN,2020-06-10,2020-05-24,TRUE,Recruiting,Not Applicable,Observational,Saudi Arabia,A Saudi Arabia based study into the impact of coronavirus infection on the nervous system,1000,http://isrctn.com/ISRCTN15475176,NA
ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,FALSE,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),340,http://www.chictr.org.cn/showproj.aspx?proj=55154,NA
ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,FALSE,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",168,http://www.chictr.org.cn/showproj.aspx?proj=55524,NA
ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,TRUE,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,25,http://www.chictr.org.cn/showproj.aspx?proj=55582,NA
ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,FALSE,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",120,http://www.chictr.org.cn/showproj.aspx?proj=49104,NA
EUCTR2020-001767-86,EudraCT,2020-04-15,2020-06-25,FALSE,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86,IE
EUCTR2020-002060-31,EudraCT,2020-05-26,2020-06-22,FALSE,Authorised,Phase 3,Interventional,Czech Republic,An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002060-31,CZ
EUCTR2020-001777-71,EudraCT,2020-04-30,2020-06-05,FALSE,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,GB
EUCTR2020-001435-27,EudraCT,2020-04-01,2020-10-04,FALSE,Authorised,Phase 3,Interventional,France,"Home treatment of elderly patients with symptomatic SARS-CoV-2 infection (COVID-19) : a multiarm, multi-stage (MAMS) randomized trial to assess the efficacy and safety
of several experimental treatments to reduce the risk of hospitalization or death
(COVERAGE trial)",845,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001435-27,FR
ACTRN12620000702910,ANZCTR,2020-06-26,2020-06-29,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Fit testing of N95 filtering facepieces for anaesthetists and nurses treating COVID-19 patients,60,https://anzctr.org.au/ACTRN12620000702910.aspx,NA
ISRCTN12394803,ISRCTN,2020-06-22,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,"Nepal, Greece, United Kingdom, Netherlands, Taiwan, Gambia, Italy, Spain, Latvia, Austria, France, Slovenia, Germany, Switzerland","DIAMONDS-SEARCH study: Designing new tests that can diagnose the causes of fever, including COVID-19",5000,http://isrctn.com/ISRCTN12394803,NA
ChiCTR2000034359,ChiCTR,2020-07-03,2020-10-01,FALSE,Not Recruiting,Not Applicable,Health services research,China,Novel coronavirus pneumonia (COVID-19) Prevention and Control Strategy - Development of multi-layer Network Early Warning System,6000,http://www.chictr.org.cn/showproj.aspx?proj=56012,NA
ChiCTR2000034346,ChiCTR,2020-07-02,2020-04-10,TRUE,Not Recruiting,Not Applicable,Health services research,China,Survey for Surgery status of a designated Hospital for COVID-19 management in Guangzhou,3239,http://www.chictr.org.cn/showproj.aspx?proj=55654,NA
ChiCTR2000034287,ChiCTR,2020-07-01,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Qualitative Study on Self-protection Experience of Medical Staff in the Isolation Area of Novel Coronavirus Pneumonia (COVID-19),11,http://www.chictr.org.cn/showproj.aspx?proj=55339,NA
ChiCTR2000033105,ChiCTR,2020-05-21,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,China,Follow up study of convalescent patients of novel coronavirus pneumonia (COVID-19),400,http://www.chictr.org.cn/showproj.aspx?proj=52816,NA
EUCTR2020-001271-33,EudraCT,2020-03-24,2020-03-31,FALSE,Not Recruiting,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 Ã  risque dâ€™aggravation secondaire : Ã©tude prospective multicentrique randomisÃ©e en double aveugle,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,FR
EUCTR2020-001258-23,EudraCT,2020-04-20,2020-04-20,FALSE,Authorised,Phase 2,Interventional,Italy,COLCHICINE TO COUNTERACT INFLAMMATORY RESPONSE IN COVID-19 PNEUMONIA,310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001258-23,IT
EUCTR2020-002230-32,EudraCT,2020-06-11,2020-06-23,FALSE,Authorised,Phase 2,Interventional,United Kingdom,Investigating potential new therapies for COVID-19.,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002230-32,GB
EUCTR2020-002448-21,EudraCT,2020-05-20,2020-05-26,FALSE,Authorised,Phase 4,Interventional,Greece,BCG VACCINATION TO PREVENT COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002448-21,GR
EUCTR2020-001740-26,EudraCT,2020-04-24,2020-05-05,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A study of an antibiotic called Azithromycin for those who come to hospital with COVID-19 symptoms who are not admitted to hospital (otherwise known as Ambulatory COVID-19) â€“ ATOMIC2,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001740-26,GB
EUCTR2020-001366-11,EudraCT,2020-04-17,2020-05-15,FALSE,Authorised,Phase 4,Interventional,"Australia, Ireland, Portugal, Canada, Norway, Italy, Spain, Latvia, France, India, Lithuania, Romania",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11,IE
ISRCTN18077365,ISRCTN,2020-07-02,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,Italy,Can the COVID-19 virus be detected in the smoke generated in minimally invasive surgery in patients with confirmed coronavirus infection?,20,http://isrctn.com/ISRCTN18077365,NA
ChiCTR2000034588,ChiCTR,2020-07-11,2020-02-16,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,An observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: is there a â€œlockdownâ€ effect?,207,http://www.chictr.org.cn/showproj.aspx?proj=56245,NA
ChiCTR2000034563,ChiCTR,2020-07-10,2020-02-16,TRUE,Recruiting,Not Applicable,Observational,China,Follow-up study on the recovery period of novel coronavirus pneumonia (COVID-19) patients,50,http://www.chictr.org.cn/showproj.aspx?proj=51931,NA
ChiCTR2000034537,ChiCTR,2020-07-09,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,China,Psychological Preparedness towards Novel Coronavirus (COVID-19) among Old Age Home Staff - an online survey,500,http://www.chictr.org.cn/showproj.aspx?proj=56285,NA
ChiCTR2000034522,ChiCTR,2020-07-08,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,China,Hidden COVID-19 infection in Hong Kong,3000,http://www.chictr.org.cn/showproj.aspx?proj=53548,NA
ChiCTR2000034519,ChiCTR,2020-07-08,2020-07-30,FALSE,Not Recruiting,Not Applicable,Observational,China,Exercise with a face mask might be dangerous during the period of COVID 2019: an optical coherence tomography angiography study in healthy young adults.,30,http://www.chictr.org.cn/showproj.aspx?proj=56079,NA
ChiCTR2000031928,ChiCTR,2020-04-14,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,China,"Cancelled by the investigator                  Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",3000,http://www.chictr.org.cn/showproj.aspx?proj=52353,NA
IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,FALSE,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with coronavirus disease-2019 (COVID-19) referring to Sina and Imam-Khomeini Hospitals in 2020,60,http://en.irct.ir/trial/46531,NA
IRCT20200416047099N2,IRCT,2020-07-04,2020-06-21,TRUE,Recruiting,Phase 2,Interventional,Iran,Plasma exchange in COVID-19 patients,10,http://en.irct.ir/trial/47357,NA
IRCT20200428047229N1,IRCT,2020-06-27,2020-03-29,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Medical Beer on COVID-19,60,http://en.irct.ir/trial/47530,NA
IRCT20200428047232N1,IRCT,2020-07-05,2020-05-09,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Thalidomide in Covid 19 pneumonia,60,http://en.irct.ir/trial/47637,NA
IRCT20200504047298N2,IRCT,2020-06-15,2020-07-10,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Opuntia Cactus extract in patients with Covid-19,48,http://en.irct.ir/trial/47675,NA
IRCT20171105037262N4,IRCT,2020-06-18,2020-04-29,TRUE,Recruiting,Phase 3,Interventional,Iran,Adalimumab effect on COVID-19,100,http://en.irct.ir/trial/47696,NA
IRCT20200508047345N1,IRCT,2020-06-14,2020-06-21,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Combined effects of Extracts on  Covid-19,100,http://en.irct.ir/trial/47987,NA
IRCT20200511047396N1,IRCT,2020-05-16,2020-06-30,FALSE,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients,50,http://en.irct.ir/trial/48048,NA
IRCT20180425039414N3,IRCT,2020-06-17,2020-04-20,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19),80,http://en.irct.ir/trial/48083,NA
IRCT20200510047385N1,IRCT,2020-07-07,2020-06-30,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of SVF and exosome in covid-19 patients with acute respiratory distress syndrome,60,http://en.irct.ir/trial/48099,NA
IRCT20200513047426N1,IRCT,2020-06-27,2020-06-21,TRUE,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of oral hydroxy-chloroquine in close contacts of COVID-19 patients,500,http://en.irct.ir/trial/48236,NA
IRCT20110726007117N11,IRCT,2020-07-05,2020-06-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D supplementation in novel corona virus 2019,210,http://en.irct.ir/trial/48287,NA
IRCT20200112046089N1,IRCT,2020-06-25,2020-06-14,TRUE,Recruiting,Phase 3,Interventional,Iran,Resveratrol in COVID19,50,http://en.irct.ir/trial/48330,NA
IRCT20200330046899N1,IRCT,2020-06-17,2020-04-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Effectiveness of herbal capsule in  COVID-19,50,http://en.irct.ir/trial/48365,NA
IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,TRUE,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,100,http://en.irct.ir/trial/48493,NA
IRCT20200317046797N6,IRCT,2020-06-18,2020-06-21,FALSE,Recruiting,Phase 3,Interventional,Iran,Edaravone in COVID-19,30,http://en.irct.ir/trial/48500,NA
IRCT20200504047298N1,IRCT,2020-06-14,2020-06-14,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atazanavir/Ritonavirin treatment of COViD-19,100,http://en.irct.ir/trial/48640,NA
IRCT20200505047305N1,IRCT,2020-06-30,2020-06-06,TRUE,Recruiting,Not Applicable,Interventional,Iran,Grief counseling in family members of the COVID-19 victims,120,http://en.irct.ir/trial/48683,NA
IRCT20150107020592N29,IRCT,2020-06-21,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Blood Purification Techniques on  COVID-19 Pneumonia,12,http://en.irct.ir/trial/48695,NA
IRCT20200607047675N1,IRCT,2020-06-15,2020-06-19,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19),100,http://en.irct.ir/trial/48700,NA
IRCT20200608047686N1,IRCT,2020-06-30,2020-05-31,TRUE,Not Recruiting,Phase 2,Interventional,Iran,The role of metronidazole in COVID-19,30,http://en.irct.ir/trial/48717,NA
IRCT20150107020592N26,IRCT,2020-06-15,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS),20,http://en.irct.ir/trial/48746,NA
IRCT20200609047707N1,IRCT,2020-06-24,2020-07-09,FALSE,Recruiting,Phase 3,Interventional,Iran,Effective of Elman tablet on COVID-19 infection severity,90,http://en.irct.ir/trial/48764,NA
IRCT20200611047735N1,IRCT,2020-06-19,2020-07-05,FALSE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of nano micelles containing curcumin (Sina Ccurcumin) as a therapeutic supplement in patients with COVID-19,40,http://en.irct.ir/trial/48843,NA
IRCT20150107020592N27,IRCT,2020-06-15,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of pentaglobin in the treatment of critically ill patients with COVID-19,60,http://en.irct.ir/trial/48907,NA
IRCT20200515047456N1,IRCT,2020-06-28,2020-06-17,TRUE,Recruiting,Phase 3,Interventional,Iran,The role of anticoagulant and thrombolitic in treatment of COVID patients,15,http://en.irct.ir/trial/48929,NA
IRCT20200611047727N1,IRCT,2020-06-24,2020-07-22,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of Inspiratory muscle training in patients with COVID-19,40,http://en.irct.ir/trial/48941,NA
IRCT20150107020592N28,IRCT,2020-06-18,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of borage based solutions in cytokine's levels in covid-19 ARDS patients,50,http://en.irct.ir/trial/48972,NA
IRCT20150107020592N30,IRCT,2020-07-10,2020-03-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Prophylactic  Favipiravir  for Healthcare Workers in COVID-19 Pandemic,30,http://en.irct.ir/trial/48992,NA
IRCT20150725023332N3,IRCT,2020-06-27,2020-04-20,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of Bromelain and Montelukast  in Covid-19 patients,60,http://en.irct.ir/trial/49112,NA
IRCT20180712040446N2,IRCT,2020-07-01,2020-06-30,TRUE,Recruiting,Phase 3,Interventional,Iran,Investigating the effect of  sweet almond on symptoms of COVID 19,60,http://en.irct.ir/trial/49120,NA
IRCT20190121042444N3,IRCT,2020-07-04,2020-02-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients,78,http://en.irct.ir/trial/49132,NA
IRCT20111224008507N3,IRCT,2020-06-27,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in the treatment of coronavirus infection,60,http://en.irct.ir/trial/49174,NA
IRCT20180519039711N6,IRCT,2020-06-29,2020-07-19,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of mandala staining on anxiety in patients with COVID-19,60,http://en.irct.ir/trial/49186,NA
IRCT20200426047206N2,IRCT,2020-07-06,2020-07-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia,30,http://en.irct.ir/trial/49385,NA
EUCTR2020-001413-20,EudraCT,2020-04-13,2020-07-04,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Efficacy and safety of siltuximab vs. corticosteroids in hospitalized patients with COVID-19 pneumonia,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001413-20,ES
EUCTR2020-001270-29,EudraCT,2020-03-30,2020-02-04,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,"Denmark, Hungary, United Kingdom, Czech Republic, France, Germany",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,GB
EUCTR2020-001198-55,EudraCT,2020-03-21,2020-03-04,TRUE,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,DK
EUCTR2020-001750-22,EudraCT,2020-07-07,2020-09-07,FALSE,Authorised,Phase 2,Interventional,United Kingdom,Multi-arm trial of Inflammatory Signal Inhibitors for COVID-19 (MATIS),186,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001750-22,GB
JPRN-jRCTs031190226,jRCT,2020-02-27,2020-03-14,FALSE,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,100,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,NA
JPRN-jRCTs041200025,jRCT,2020-07-01,2020-01-07,TRUE,Recruiting,Phase 2,Interventional,Japan,Phase II trial of combination therapy with favipiravir and corticosteroids for COVID-19,69,https://jrct.niph.go.jp/latest-detail/jRCTs041200025,NA
JPRN-UMIN000040409,UMIN-CTR,2020-07-01,2020-06-20,TRUE,Not Recruiting,Not Applicable,Observational,"Japan,South America,Europe","Study of International Clinical Data Collection, Doctor to Doctor Telemedicine, education, and AI platform against deterioration of COVID-19",1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046113,NA
JPRN-UMIN000040733,UMIN-CTR,2020-06-22,2020-06-22,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,A study on the prevalence of infection in dental institutions by measuring the antibody titer to COVID-19 of the staff members of Kanagawa Dental College Medical Center,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461,NA
JPRN-UMIN000040816,UMIN-CTR,2020-06-17,2020-06-18,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Relationship between age and viral load in novel coronavirus patients,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046573,NA
JPRN-UMIN000040838,UMIN-CTR,2020-07-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,A seroprevalence study of COVID-19 in IBD patients,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628,NA
NCT04471662,ClinicalTrials.gov,2020-07-13,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients,50,https://clinicaltrials.gov/show/NCT04471662,NA
ACTRN12620000734965,ANZCTR,2020-07-13,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,"United States, Canada, Australia, Ireland",Lung ultrasound to predict invasive ventilation of patients with COVID-19 lung disease,1000,https://anzctr.org.au/ACTRN12620000734965.aspx,NA
ACTRN12620000740998,ANZCTR,2020-07-16,2020-07-16,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,A Study of Lying Face Down to Help Improve Oxygen Levels of Adults Not Needing Ventilators in Intensive Care with COVID-19,20,https://anzctr.org.au/ACTRN12620000740998.aspx,NA
ACTRN12620000731998,ANZCTR,2020-07-13,2020-01-09,TRUE,Not Recruiting,Phase 1,Interventional,Australia,Will treating the overwhelming patient response with medications affect COVID-19 mortality?,36,https://anzctr.org.au/ACTRN12620000731998.aspx,NA
ACTRN12620000737932,ANZCTR,2020-07-14,2020-05-22,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Nasal washout and gargling for healthcare staff in Care Homes during the COVID-19 pandemic: The Good-NIGHT COVID pilot study,300,https://anzctr.org.au/ACTRN12620000737932.aspx,NA
ISRCTN55886926,ISRCTN,2020-06-01,2021-05-17,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Investigation of COVID-19 symptoms and potential immunity in the general population,90000,http://isrctn.com/ISRCTN55886926,NA
ChiCTR2000034798,ChiCTR,2020-07-19,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Clinical features and prognostic factors for patients admitted for COVID-19 pneumonia,309,http://www.chictr.org.cn/showproj.aspx?proj=55616,NA
ChiCTR2000034795,ChiCTR,2020-07-19,2020-01-28,TRUE,Not Recruiting,Not Applicable,Interventional,China,The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial,42,http://www.chictr.org.cn/showproj.aspx?proj=56756,NA
ChiCTR2000034794,ChiCTR,2020-07-19,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,China,"Sancai granule improves lung and kidney function for patient with novel coronavirus pneumonia (COVID-19) in the recovery period: a randomized, parallel controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=56771,NA
ChiCTR2000034784,ChiCTR,2020-07-19,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Management of acute respiratory failure due to Sars CoV2 with non invasive ventilatory support: a medical records based study,104,http://www.chictr.org.cn/showproj.aspx?proj=55391,NA
ChiCTR2000034781,ChiCTR,2020-07-18,2020-06-16,TRUE,Recruiting,Not Applicable,Observational,China,A follow-up study of long-term prognosis in patients with severe novel coronavirus pneumonia (COVID-19),280,http://www.chictr.org.cn/showproj.aspx?proj=56642,NA
ChiCTR2000034680,ChiCTR,2020-07-14,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): a research protocol,200,http://www.chictr.org.cn/showproj.aspx?proj=56364,NA
EUCTR2020-001504-42,EudraCT,2020-04-20,2020-07-15,FALSE,Authorised,Phase 2,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42,FR
EUCTR2020-001747-21,EudraCT,2020-05-22,2020-06-07,FALSE,Authorised,Phase 4,Interventional,Portugal,Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19),160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001747-21,PT
EUCTR2020-002106-68,EudraCT,2020-07-07,2020-07-16,FALSE,Authorised,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early antivirals,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68,GB
EUCTR2020-001808-42,EudraCT,2020-07-10,2020-06-17,TRUE,Authorised,Phase 2,Interventional,Spain,"PHASE II CLINICAL TRIAL, SINGLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TO EXPLORE THE EFFECTIVENESS AND SAFETY OF MELATONIN  IN PATIENTS WITH COVID-19 ENTERED INTO THE INTENSIVE CARE UNIT",18,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001808-42,ES
EUCTR2020-002193-27,EudraCT,2020-07-14,2020-06-15,TRUE,Authorised,Phase 2,Interventional,Spain,"Double-blind, randomized, controlled, clinical trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19",20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002193-27,ES
ChiCTR2000034852,ChiCTR,2020-07-22,2020-07-15,TRUE,Recruiting,Not Applicable,Observational,China,Management of endotracheal intubation in critically ill patients with novel coronavirus pneumonia (COVID-19) and clinical characteristics: a medical records based study,14,http://www.chictr.org.cn/showproj.aspx?proj=56528,NA
ChiCTR2000034433,ChiCTR,2020-07-05,2020-05-27,TRUE,Not Recruiting,Not Applicable,Observational,China,The experiences of nurses hospitalized with novel coronavirus pneumonia (COVID-19) in China: a qualitative study Summary,15,http://www.chictr.org.cn/showproj.aspx?proj=56104,NA
EUCTR2020-001445-39,EudraCT,2020-04-03,2020-03-31,TRUE,Not Recruiting,Phase 2,Interventional,Spain,CLINICAL TRIAL TO EVALUATE METHYLPREDNISOLONE PULSES AND TACROLIMUS IN HOSPITALIZED PATIENTS WITH SEVERE PNEUMONIA SECONDARY TO COVID-19 (TACROVID),84,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001445-39,ES
EUCTR2020-001765-37,EudraCT,2020-04-13,2020-11-04,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,ES
EUCTR2020-001707-16,EudraCT,2020-07-22,2020-06-25,TRUE,Authorised,Phase 3,Interventional,Spain,"PHASE III RANDOMIZED, UNICENTRIC OPEN, CONTROLLED CLINICAL TRIAL TO DEMONSTRATE THE EFFECTIVENESS OF TOCILIZUMAB AGAINST SYSTEMIC CORTICOTHERAPY IN PATIENTS ENTERED BY COVID-19 WITH BILATERAL PNEUMONIA AND BAD EVOLUTION",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001707-16,ES
EUCTR2020-001890-56,EudraCT,2020-07-22,2020-10-06,FALSE,Authorised,Phase 4,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of gammaglobulins in COVID-19 treatment,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001890-56,ES
EUCTR2020-001794-77,EudraCT,2020-07-22,2020-10-06,FALSE,Authorised,Phase 2,Interventional,Spain,Randomised clinical trial to test if silibinin administration can prevent the respiratory failure secondary to the COVID19 lung infection in oncologic patients.,92,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001794-77,ES
EUCTR2020-001929-31,EudraCT,2020-07-22,2020-06-16,TRUE,Authorised,Phase 4,Interventional,Spain,Controlled trial on the usefulness of pioglitazone treatment in patients with type 2 diabetes mellitus and COVID-19.,76,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001929-31,ES
EUCTR2020-002186-34,EudraCT,2020-07-22,2020-03-06,TRUE,Authorised,Phase 4,Interventional,Spain,Efficacy of the early use of corticotherapy in CoV-2 infection to prevent the progression of acute respiratory distress syndrome (ARDS),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002186-34,ES
EUCTR2020-002310-41,EudraCT,2020-07-22,2020-06-15,TRUE,Authorised,Phase 2,Interventional,Spain,â€œMADRID-COVIDâ€,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002310-41,ES
EUCTR2020-002166-13,EudraCT,2020-07-22,2020-09-07,FALSE,Authorised,Phase 2,Interventional,Spain,Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients with SARS-CoV-2 (COVID-19) Infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002166-13,ES
EUCTR2020-002449-41,EudraCT,2020-07-22,2020-06-15,TRUE,Authorised,Phase 3,Interventional,Spain,"Pilot trial on early treatment with hydroxychloroquine in patients with
COVID-19 who do not have hospital admission at diagnosis.",340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41,ES
EUCTR2020-001904-41,EudraCT,2020-04-30,2020-05-20,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A study comparing favipiravir versus standard of care management as an early treatment arm in COVID-19 patients,302,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001904-41,GB
EUCTR2020-002668-29,EudraCT,2020-06-10,2020-06-25,FALSE,Authorised,Phase 2,Interventional,United Kingdom,plasma exchange in severe COVID-19 infection,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29,GB
EUCTR2020-002632-75,EudraCT,2020-06-01,2020-08-07,FALSE,Authorised,Phase 2,Interventional,United Kingdom,"Trial to be conducted in more sites, with drug known to both patient and Investigator, in which patients will be assigned randomly to receive the drug or not in order to assess the efficacy and tolerability of the drug (porcine surfactant, CurosurfÂ®) in hospitalized patients with SARS-COV-19 (COVID-19 INFECTION) acute respiratory distress syndrome",85,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002632-75,GB
ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,FALSE,No Status Given,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,160,https://anzctr.org.au/ACTRN12620000588998.aspx,NA
ACTRN12620000566932,ANZCTR,2020-05-14,2020-05-10,TRUE,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,400,https://anzctr.org.au/ACTRN12620000566932.aspx,NA
ACTRN12620000674932,ANZCTR,2020-06-12,2020-07-13,FALSE,Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants.",120,https://anzctr.org.au/ACTRN12620000674932.aspx,NA
ACTRN12620000778987,ANZCTR,2020-07-30,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Persistent lung and arterial inflammation following COVID-19 pneumonia,30,https://anzctr.org.au/ACTRN12620000778987.aspx,NA
ISRCTN89573163,ISRCTN,2020-07-15,2020-08-24,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,BEAT-CORONA: Building evidence to advance treatments for COVID-19,10000,http://isrctn.com/ISRCTN89573163,NA
ISRCTN14326006,ISRCTN,2020-04-14,2020-04-13,TRUE,Recruiting,Phase 3,Interventional,Canada,Does taking hydroxychloroquine before and during exposure to patients protect frontline healthcare workers from coronavirus?,988,http://isrctn.com/ISRCTN14326006,NA
ChiCTR2000035060,ChiCTR,2020-07-29,2020-07-20,TRUE,Not Recruiting,Not Applicable,Observational,China,Comprehensive mental and physical health assessment and intervention studies for novel coronavirus pneumonia (COVID-19) patients,2000,http://www.chictr.org.cn/showproj.aspx?proj=57232,NA
ChiCTR2000029865,ChiCTR,2020-02-15,2020-02-20,FALSE,Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,1200,http://www.chictr.org.cn/showproj.aspx?proj=49545,NA
EUCTR2020-002494-10,EudraCT,2020-06-08,2020-07-17,FALSE,Authorised,Phase 4,Interventional,United Kingdom,PERSONAL-COVIDBP,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10,GB
EUCTR2020-002476-13,EudraCT,2020-06-29,2020-07-24,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19.,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13,GB
EUCTR2020-002952-18,EudraCT,2020-07-09,2020-07-21,FALSE,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,DEFEAT-COVID Study,178,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002952-18,GB
ACTRN12620000787987,ANZCTR,2020-08-04,2020-09-30,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Anxiety and Depression Arising from COVID-19-Related Financial Stress,206,https://anzctr.org.au/ACTRN12620000787987.aspx,NA
ChiCTR2000035362,ChiCTR,2020-08-09,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,China,Psychological health condition and effect of psychological couseling of infertile couples receiving ART during novel coronavirus pneumonia (COVID-19) pandemic,300,http://www.chictr.org.cn/showproj.aspx?proj=57875,NA
ChiCTR2000035342,ChiCTR,2020-08-09,2020-03-01,TRUE,Recruiting,Not Applicable,Diagnostic test,China,Ultrafast Screening of novel coronavirus pneumonia (COVID-19) by Machine Learning Analysis of Exhaled NO,250,http://www.chictr.org.cn/showproj.aspx?proj=57431,NA
ChiCTR2000035213,ChiCTR,2020-08-03,2020-08-10,FALSE,Not Recruiting,Not Applicable,Health services research,No Country Given,"Evaluation of Knowledge, Attitude and Practice (KAP) of Pharmacists towards novel coronavirus pneumonia (COVID-19): A Cross-Sectional Study",480,http://www.chictr.org.cn/showproj.aspx?proj=57283,NA
ChiCTR2000031734,ChiCTR,2020-04-08,2020-03-19,TRUE,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel Coronavirus Pneumonia (COVID-19): a randomized, open-label, controlled trial",40,http://www.chictr.org.cn/showproj.aspx?proj=52103,NA
ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,TRUE,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",60,http://www.chictr.org.cn/showproj.aspx?proj=49918,NA
ISRCTN17072692,ISRCTN,2020-06-04,2020-06-16,FALSE,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,320,http://isrctn.com/ISRCTN17072692,NA
EUCTR2020-001417-21,EudraCT,2020-04-01,2020-12-04,FALSE,Not Recruiting,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,BE
EUCTR2020-001770-30,EudraCT,2020-04-15,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,BE
EUCTR2020-002574-27,EudraCT,2020-06-15,2020-07-08,FALSE,Authorised,Phase 1/Phase 2,Interventional,France,A study to evaluate the safety and efficacy of XAV-19 in patients with COVID-19 induced moderate pneumonia,368,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002574-27,FR
JPRN-UMIN000040656,UMIN-CTR,2020-08-01,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046390,NA
JPRN-UMIN000041073,UMIN-CTR,2020-07-12,2015-01-01,TRUE,Recruiting,Not Applicable,Observational,Japan,A study of changes in emergency department patient dynamics during the COVID-19 outbreak,100000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046864,NA
JPRN-UMIN000041102,UMIN-CTR,2020-07-14,2020-02-13,TRUE,Recruiting,Not Applicable,Observational,Japan,Reserch on patients with COVID-19 at Osaka Saiseikai Nakatsu Hospital,1200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045985,NA
JPRN-UMIN000041160,UMIN-CTR,2020-08-01,2020-08-27,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study,42,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000,NA
JPRN-UMIN000041186,UMIN-CTR,2020-07-23,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Japan,Survey of Coronavirus disease 2019(COVID-19),2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047028,NA
JPRN-UMIN000041301,UMIN-CTR,2020-08-04,2020-07-04,TRUE,Recruiting,Not Applicable,Observational,Japan,An observational study of the treatment of patients with mild and moderate COVID-19 (including suspected patients),1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047163,NA
ACTRN12620000786998,ANZCTR,2020-08-04,2020-08-24,FALSE,Not Recruiting,Not Applicable,Interventional,New Zealand,A Digital Companion for Loneliness During the COVID-19 Pandemic: A Feasibility Study,30,https://anzctr.org.au/ACTRN12620000786998.aspx,NA
ACTRN12620000795998,ANZCTR,2020-08-07,2020-05-31,TRUE,Not Recruiting,Not Applicable,Interventional,Bangladesh,COVID-19 Health and wellbeing Trial in Bangladesh,2402,https://anzctr.org.au/ACTRN12620000795998.aspx,NA
ACTRN12620000799954,ANZCTR,2020-08-10,2020-08-25,FALSE,Not Recruiting,Not Applicable,Observational,"Argentina, Australia, Ireland, South Africa, Hong Kong, United States, Italy, Brazil, Spain, Japan, Germany",Long-term Impact in Intensive Care Survivors of Coronavirus disease-19 (COVID-19),200,https://anzctr.org.au/ACTRN12620000799954.aspx,NA
ACTRN12620000808943,ANZCTR,2020-08-11,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Australia,A Patient Perspective Survey on Masking or De-Masking the Medical Staff amid COVID-19 Pandemic,600,https://anzctr.org.au/ACTRN12620000808943.aspx,NA
ACTRN12620000811909,ANZCTR,2020-08-13,2020-09-30,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Mood Training Program on Anxiety and Depression Arising from COVID-19-Related Stress,240,https://anzctr.org.au/ACTRN12620000811909.aspx,NA
ChiCTR2000035691,ChiCTR,2020-08-16,2020-08-20,FALSE,Not Recruiting,Phase 1,Prevention,China,"A randomized, double-blind, placebo-controlled phase I clinical trial for evaluation of the safety and tolerability of recombinant novel coronavirus vaccines (CHO cells) in healthy people aged 60 years and above",50,http://www.chictr.org.cn/showproj.aspx?proj=58207,NA
ChiCTR2000035046,ChiCTR,2020-07-29,2020-02-04,TRUE,Recruiting,Not Applicable,Observational,China,Efficacy and outcomes of Lian-Hua Qing-Wen capsule in the treatment of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,147,http://www.chictr.org.cn/showproj.aspx?proj=57179,NA
ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),288,http://www.chictr.org.cn/showproj.aspx?proj=53003,NA
ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,TRUE,No Status Given,Not Applicable,Interventional,China,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,110,http://www.chictr.org.cn/showproj.aspx?proj=49502,NA
ISRCTN17717312,ISRCTN,2020-07-23,2020-07-30,FALSE,Recruiting,Not Applicable,Observational,"French Southern Territories, Nepal, Saudi Arabia, Yemen, Azerbaijan, Curacao, Korea, South, Virgin Islands, U.S., Gabon, Guatemala, Cote d'Ivoire, Austria, Armenia, China, Poland, Venezuela, Romania, Denmark, Malawi, Belgium, Burkina Faso, Democratic Republic of Congo, Ethiopia, Guam, Martinique, Swaziland, United States, Cameroon, Gibraltar, Mongolia, Timor-Leste, Botswana, Myanmar, Panama, Turkmenistan, Cyprus, Holy See (Vatican City State), New Zealand, Netherlands, Saint Pierre and Miquelon, Nauru, Madagascar, San Marino, Liechtenstein, American Samoa, Tajikistan, Slovenia, Singapore, Slovakia, Colombia, Netherlands Antilles, Andorra, Burundi, Spain, Togo, Uganda, Bouvet Island, Guinea-Bissau, Sri Lanka, Moldova, Georgia, Aruba, Angola, Bhutan, British Indian Ocean Territory, Norway, Turkey, Djibouti, Finland, Paraguay, Chad, Costa Rica, Pitcairn, Afghanistan, Mozambique, Luxembourg, Laos, Ecuador, Sudan, Uruguay, Central African Republic, Lebanon, Bulgaria, Cayman Islands, Switzerland, Croatia, Guadeloupe, Namibia, Nicaragua, Saint Helena, South Sudan, Brazil, Mali, Svalbard and Jan Mayen, El Salvador, Nigeria, Sierra Leone, Chile, Bahrain, Suriname, Albania, Mauritius, Kuwait, Bermuda, Christmas Island, Kiribati, Antarctica, Barbados, Jamaica, Palestinian Territory, Saint Kitts and Nevis, India, Tonga, Haiti, United States Minor Outlying Islands, Guyana, Kosovo, Kyrgyzstan, Zambia, Cambodia, Algeria, Falkland Islands, Antigua and Barbuda, Japan, Maldives, Aland Islands, Belize, France, Rwanda, Lithuania, Saint Vincent and the Grenadines, Bonaire Saint Eustatius and Saba, Heard Island and Mcdonald Islands, Dominican Republic, Honduras, Fiji, Greece, Mayotte, Micronesia, Federated States of, Czech Republic, Taiwan, Puerto Rico, Montenegro, United Arab Emirates, Kazakhstan, Seychelles, Uzbekistan, Turks and Caicos Islands, Argentina, Hungary, Virgin Islands, British, Iceland, Democratic Republic of Congo, Wallis and Futuna, Solomon Islands, Papua New Guinea, Italy, Mexico, Guernsey, Malta, Syria, Vanuatu, Monaco, Montserrat, Liberia, Malaysia, Philippines, Kenya, Palau, Senegal, Australia, Portugal, Eritrea, Samoa, Comoros, Cocos (Keeling) Islands, Bahamas, Cook Islands, Estonia, Serbia, Isle of Man, Niue, Thailand, Cuba, Tokelau, Faroe Islands, Sweden, Russian Federation, Tanzania, Benin, Jordan, Macedonia, Canada, Pakistan, Morocco, Saint Lucia, Bolivia, Egypt, Vietnam, Lesotho, Macao, Niger, Sao Tome and Principe, Bosnia and Herzegovina, Libya, Mauritania, Hong Kong, Ireland, Indonesia, French Polynesia, Anguilla, Bangladesh, Belarus, Gambia, Sint Maarten (Dutch part), Saint Martin (French part), Northern Mariana Islands, Iraq, Somalia, Germany, Tuvalu, Equatorial Guinea, South Africa, Trinidad and Tobago, Marshall Islands, Cape Verde, Dominica, Grenada, Ukraine, Western Sahara, Oman, Jersey, Latvia, New Caledonia, Ghana, Korea, North, Iran, Qatar, Peru, Greenland, Tunisia, Reunion, Brunei, Israel, French Guiana, Norfolk Island, Zimbabwe, Guinea, Saint Barthelemy, South Georgia and the South Sandwich Is",CORONATION: Coronavirus (COVID-19) multinational observational registry,10000,http://isrctn.com/ISRCTN17717312,NA
ISRCTN60069084,ISRCTN,2020-07-19,2020-01-09,TRUE,Recruiting,Phase 3/Phase 4,Interventional,"Oman, Saudi Arabia",Effect of N-acetylcysteine on COVID-19 treatment,1180,http://isrctn.com/ISRCTN60069084,NA
ISRCTN14025343,ISRCTN,2020-07-02,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,"Chile, Colombia, Italy, Brazil, Spain",Lifestyle modification of adolescents from different countries during confinement by Covid-19,500,http://isrctn.com/ISRCTN14025343,NA
ISRCTN60400862,ISRCTN,2020-06-22,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,"Evaluation of a COVID-19 antibody test: What is the performance of the Panbioâ„¢ COVID-19 IgG/IgM rapid test device in fingerstick blood, venous whole blood, serum and plasma in adult participants?",206,http://isrctn.com/ISRCTN60400862,NA
ISRCTN13694948,ISRCTN,2020-04-01,2020-02-04,TRUE,Recruiting,Not Applicable,Observational,"French Southern Territories, Sweden, United Kingdom, Norway, Turkey, Finland, Austria, France, Lithuania, Denmark, Ireland, Greece, Belgium, United States, Czech Republic, Luxembourg, Germany, Lebanon, Bulgaria, Switzerland, Cyprus, Croatia, New Zealand, South Africa, Netherlands, Italy, Brazil, Liechtenstein, Malta, Slovenia, Australia, Portugal, Slovakia, Israel, Spain, Isle of Man",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,400,http://isrctn.com/ISRCTN13694948,NA
IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,100,http://en.irct.ir/trial/46897,NA
IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,125,http://en.irct.ir/trial/47012,NA
IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,60,http://en.irct.ir/trial/47016,NA
IRCT20200414047076N1,IRCT,2020-08-01,2020-04-18,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers,160,http://en.irct.ir/trial/47286,NA
IRCT20170922036314N4,IRCT,2020-06-22,2020-07-10,FALSE,Recruiting,Not Applicable,Interventional,Iran,"The effects of self-care cellphone application on stress, anxiety and depression among admitted patients with COVID-19",112,http://en.irct.ir/trial/47383,NA
IRCT20200503047281N1,IRCT,2020-07-25,2020-09-22,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of Convalescent Plasma Therapy for COVID-19 Patients,40,http://en.irct.ir/trial/47632,NA
IRCT20200505047318N1,IRCT,2020-08-06,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of finasterid on COVID-19 treatment,80,http://en.irct.ir/trial/48007,NA
IRCT20110907007511N4,IRCT,2020-07-25,2020-05-16,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Lavender syrup on COVID-19,30,http://en.irct.ir/trial/48013,NA
IRCT20200511047399N1,IRCT,2020-07-23,2020-02-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of omega-3 on diabetic patients with Covid-19,30,http://en.irct.ir/trial/48045,NA
IRCT20200522047545N1,IRCT,2020-08-05,2020-07-31,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19",200,http://en.irct.ir/trial/48351,NA
IRCT20200522047542N1,IRCT,2020-08-04,2020-07-18,TRUE,Recruiting,Phase 1,Interventional,Iran,Effect of Corton on olfactory dysfunction in COVID-19 patients,70,http://en.irct.ir/trial/48379,NA
IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,100,http://en.irct.ir/trial/48394,NA
IRCT20200525047570N1,IRCT,2020-07-30,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,Iran,"A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine storm",60,http://en.irct.ir/trial/48583,NA
IRCT20200607047682N1,IRCT,2020-07-27,2020-06-09,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial of Annual SZ drug in Covid-19,60,http://en.irct.ir/trial/48727,NA
IRCT20190602043787N3,IRCT,2020-07-20,2020-07-22,FALSE,Recruiting,Phase 3,Interventional,Iran,Ivermectin effect in the treatment of patients with covid-19,40,http://en.irct.ir/trial/49180,NA
IRCT20190624043993N3,IRCT,2020-07-23,2020-08-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The evaluation of isotretinoineffects on treatment of COVID-19 infections,50,http://en.irct.ir/trial/49257,NA
IRCT20190624043993N2,IRCT,2020-07-12,2020-08-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of ivermectin effects on Covid-19,50,http://en.irct.ir/trial/49280,NA
IRCT20200105046009N4,IRCT,2020-07-18,2020-06-30,TRUE,Recruiting,Phase 3,Interventional,Iran,management of the  pulmonary diseases based on Persian medicine in patients infected with COVID-19,80,http://en.irct.ir/trial/49365,NA
IRCT20200506047323N3,IRCT,2020-07-22,2020-07-25,FALSE,Recruiting,Phase 3,Interventional,Iran,The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19,60,http://en.irct.ir/trial/49463,NA
IRCT20200705048013N1,IRCT,2020-07-19,2020-02-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of Pentoxifylline in patients with Covid-19,150,http://en.irct.ir/trial/49525,NA
IRCT20190406043175N3,IRCT,2020-07-12,2020-08-22,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of diet based on traditional medicine on COVID-19,80,http://en.irct.ir/trial/49530,NA
IRCT20170117032025N7,IRCT,2020-07-12,2020-07-11,TRUE,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Mouthwashes in Early Reducing the mouth Viral Load Among COVID-19 Patients,60,http://en.irct.ir/trial/49534,NA
IRCT20190415043279N6,IRCT,2020-07-24,2020-07-10,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Afsantin on COVID 19,80,http://en.irct.ir/trial/49544,NA
IRCT20200426047206N3,IRCT,2020-07-21,2020-07-22,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19,48,http://en.irct.ir/trial/49579,NA
IRCT20200408046990N3,IRCT,2020-07-16,2020-07-21,FALSE,Recruiting,Phase 2,Interventional,Iran,"Evaluation of atorvastatin tablet as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem Hospital, Mashhad",40,http://en.irct.ir/trial/49629,NA
IRCT20151227025726N20,IRCT,2020-07-26,2020-07-09,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients,80,http://en.irct.ir/trial/49638,NA
IRCT20101020004976N6,IRCT,2020-07-18,2020-05-14,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of  LactocareÂ® synbiotic on the prevention of COVID-19 infection in the staff of emergency department,80,http://en.irct.ir/trial/49670,NA
IRCT20180513039641N2,IRCT,2020-07-27,2020-07-26,TRUE,Recruiting,Phase 3,Interventional,Iran,Determination of dandelion capsule on patient with Covid-19 virus,80,http://en.irct.ir/trial/49803,NA
IRCT20200506047323N4,IRCT,2020-08-01,2020-08-10,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Desferal in COVID-19,60,http://en.irct.ir/trial/49881,NA
IRCT20200723048178N1,IRCT,2020-07-28,2020-07-28,FALSE,Recruiting,Not Applicable,Interventional,Pakistan,nimesulide in COVID-19 infection,60,http://en.irct.ir/trial/49901,NA
IRCT20160131026298N4,IRCT,2020-08-04,2020-04-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individuals,60,http://en.irct.ir/trial/49925,NA
KCT0005307,CRiS,2020-08-11,2020-09-30,FALSE,Recruiting,Phase 2,Interventional,South Korea,AN OPEN LABEL PHYSICIAN INITIATED 28 DAY PHASE 2A STUDY OF IFENPRODIL ON LUNG FUNCTION IN CONFIRMED COVID-19 INFECTED PATIENTS WITH SEVERE PNEUMONIA,40,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062,NA
KCT0005226,CRiS,2020-07-13,2020-03-23,TRUE,Not Recruiting,Not Applicable,Observational,South Korea,Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea,293,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16997,NA
EUCTR2020-001333-13,EudraCT,2020-04-02,2020-09-04,FALSE,Not Recruiting,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,FR
EUCTR2020-001739-28,EudraCT,2020-04-10,2020-05-20,FALSE,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28,BE
ISRCTN15634328,ISRCTN,2020-08-13,2020-02-06,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"
                Coronavirus (COVID-19) antibody response in healthcare staff: What proportion of healthcare staff have COVID-19 antibodies? How long do the antibodies last? Do the antibodies protect against recurring infection?

",2000,http://isrctn.com/ISRCTN15634328,NA
ISRCTN20867558,ISRCTN,2020-05-04,2020-08-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Survive and Thrive: exploring the wellbeing of doctors in a post-COVID-19 era,350,http://isrctn.com/ISRCTN20867558,NA
ChiCTR2000035907,ChiCTR,2020-08-19,2020-01-31,TRUE,Not Recruiting,Not Applicable,Observational,China,The Efficacy of Early Prone or Lateral Positioning in Severe COVID-19 Patients: a Single-Center Prospective Cohort Study,197,http://www.chictr.org.cn/showproj.aspx?proj=57893,NA
EUCTR2017-000632-34,EudraCT,2017-02-14,2017-04-25,FALSE,Authorised,Phase 4,Interventional,"Denmark, Iceland, United Kingdom, Netherlands, Norway, Finland, Switzerland","Oxygen supplementation in patients with acute pulmonary failure admitted to the intensive care unit: A clinical trial of two seperate levels of oxygen supplementation during treatment in the intensive care unit

Addendum: Trial extension including only COVID-19 patients
",3708,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000632-34,DK
NCT04525118,ClinicalTrials.gov,2020-07-29,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform,100000,https://clinicaltrials.gov/show/NCT04525118,NA
ACTRN12620000840987,ANZCTR,2020-08-26,2020-05-05,TRUE,Recruiting,Phase 1,Interventional,Australia,Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia,10,https://anzctr.org.au/ACTRN12620000840987.aspx,NA
ACTRN12620000854932,ANZCTR,2020-08-27,2020-08-18,TRUE,Recruiting,Not Applicable,Observational,Australia,"ADAPT-C Sub-Study: Community-based cohort of people tested for COVID-19
",150,https://anzctr.org.au/ACTRN12620000854932.aspx,NA
ACTRN12620000843954,ANZCTR,2020-08-26,2020-01-09,TRUE,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. Arm 1 : Prevention in patients not infected with COVID-19.",1914,https://anzctr.org.au/ACTRN12620000843954.aspx,NA
ACTRN12620000842965,ANZCTR,2020-08-26,2020-01-09,TRUE,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 2 : Post-exposure prevention in patients recently exposed to COVID-19",170,https://anzctr.org.au/ACTRN12620000842965.aspx,NA
ACTRN12620000841976,ANZCTR,2020-08-26,2020-01-09,TRUE,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 3: treatment among cancer patients with moderate COVID-19 infection.",126,https://anzctr.org.au/ACTRN12620000841976.aspx,NA
ACTRN12620000844943,ANZCTR,2020-08-26,2020-01-09,TRUE,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer
Arm 4: treatment among cancer patients with severe COVID-19 infection.",72,https://anzctr.org.au/ACTRN12620000844943.aspx,NA
ISRCTN93266696,ISRCTN,2020-06-11,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Studying the immune response and long-term morbidity of COVID-19 infection in pregnancy,200,http://isrctn.com/ISRCTN93266696,NA
ChiCTR2000035985,ChiCTR,2020-08-21,2020-10-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,A clinical study based on novel Coronavirus intelligent robot for nasopharyngeal swab sampling,550,http://www.chictr.org.cn/showproj.aspx?proj=59191,NA
ChiCTR2000035633,ChiCTR,2020-08-15,2020-11-13,FALSE,Not Recruiting,Not Applicable,Interventional,China,"Clinical study of safety, tolerance, and pharmacokinetics of nebulizer (INF-K + anti-inflammatory factor TFF2) in healthy volunteers and exploration of PK/PD fitting modeling in clinical trials of Novel Coronavirus Pneumonia (COVID-19) patients",32,http://www.chictr.org.cn/showproj.aspx?proj=57741,NA
ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",160,http://www.chictr.org.cn/showproj.aspx?proj=52679,NA
EUCTR2020-001408-41,EudraCT,2020-04-07,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,DE
EUCTR2020-001888-90,EudraCT,2020-04-16,2020-04-30,FALSE,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for healthcare workers against COVID-19,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001888-90,DK
ACTRN12620000876998,ANZCTR,2020-09-03,2020-08-14,TRUE,Recruiting,Not Applicable,Interventional,Australia,The Building Educatorsâ€™ Skills in Adolescent Mental Health (BEAM) study: A cluster randomised-controlled trial of an adolescent mental health training program for secondary school Educators,234,https://anzctr.org.au/ACTRN12620000876998.aspx,NA
ACTRN12620000869976,ANZCTR,2020-08-31,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Management of early breast cancer during the COVID-19 pandemic: Single institution experience,150,https://anzctr.org.au/ACTRN12620000869976.aspx,NA
ISRCTN89159899,ISRCTN,2020-08-21,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of a rapid COVID-19 test (FASTER),400,http://isrctn.com/ISRCTN89159899,NA
ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,100,http://isrctn.com/ISRCTN99248812,NA
EUCTR2020-002394-94,EudraCT,2020-06-04,2020-06-22,FALSE,Authorised,Phase 2,Interventional,Belgium,"Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild or
moderate corona virus disease (COVID-19)",6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002394-94,BE
EUCTR2020-001644-25,EudraCT,2020-05-08,2020-10-06,FALSE,Authorised,Phase 2,Interventional,"Chile, Argentina, Sweden, Russian Federation, South Africa, Peru, Italy, Mexico, Spain, Turkey, Brazil, Japan, France, Germany","A Phase 2, Open-Label, Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19",177,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25,DE
EUCTR2020-001673-75,EudraCT,2020-06-04,2020-02-07,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Belgium, Italy, Brazil, Spain, Mexico, France, Germany","Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress.

",1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,GB
KCT0005344,CRiS,2020-08-24,2020-06-18,TRUE,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,60,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17363,NA
JPRN-JapicCTI-205238,JapicCTI,2020-03-27,2020-03-31,FALSE,Not Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,NA
JPRN-JapicCTI-205416,JapicCTI,2020-08-19,2020-01-09,TRUE,Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19),6,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416,NA
JPRN-jRCT1032200025,jRCT,2020-05-01,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Japan,new SARS-CoV-2 detection system (COVID-19),50,https://jrct.niph.go.jp/latest-detail/jRCT1032200025,NA
JPRN-jRCTs041190120,jRCT,2020-03-02,2020-02-03,TRUE,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,NA
JPRN-UMIN000040453,UMIN-CTR,2020-05-25,2020-05-25,FALSE,Recruiting,Not Applicable,Observational,Japan,Corona virus disease 2019 (COVID-19) antibody seroprevalence of the medical staff in the hospital with cluster of COVID-19.,2500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046159,NA
JPRN-UMIN000040837,UMIN-CTR,2020-06-24,2020-05-27,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,A Randomized Controlled trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression in the Covid-19 Pandemic,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623,NA
JPRN-UMIN000041402,UMIN-CTR,2020-09-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Investigation for clinical utility of diagnostic reagents for COVID-19,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047146,NA
JPRN-UMIN000041430,UMIN-CTR,2020-08-16,2020-07-30,TRUE,Recruiting,Not Applicable,Other,Asia(except Japan),Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-Analysis,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046347,NA
JPRN-UMIN000041450,UMIN-CTR,2020-08-20,2020-05-12,TRUE,Recruiting,Not Applicable,Observational,Japan,Epidemiological survey of COVID-19 patients in Japan,10000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047316,NA
JPRN-UMIN000041557,UMIN-CTR,2020-09-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Study to establish effective measures for COVID-19 in psychiatric medical institutes,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047450,NA
IRCT20200402046917N1,IRCT,2020-08-31,2020-08-22,TRUE,Recruiting,Not Applicable,Interventional,Iran,therapeutic effect of Rosa Damascena extract in treatment of COVID-19,20,http://en.irct.ir/trial/46938,NA
IRCT20170128032241N3,IRCT,2020-08-17,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation the Efficacy of CURCUDEN 35 in Patients with COVID-19,20,http://en.irct.ir/trial/47031,NA
IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,64,http://en.irct.ir/trial/47058,NA
IRCT20200418047119N1,IRCT,2020-09-01,2020-08-31,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of curcumin in treatment of respiratory syndrome of corona,42,http://en.irct.ir/trial/47231,NA
IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,90,http://en.irct.ir/trial/47319,NA
IRCT20200514047445N1,IRCT,2020-08-10,2020-08-05,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in improving patients with covid -19,60,http://en.irct.ir/trial/48275,NA
IRCT20190131042569N5,IRCT,2020-08-23,2020-06-29,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of nebulizing Peppermint extract and Rose extract on percentage of blood oxygen saturation in patients with COVID-19,60,http://en.irct.ir/trial/48311,NA
IRCT20200527047581N1,IRCT,2020-08-23,2020-06-05,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of  oral health care and mouth rinse in treatment of Covid-19,200,http://en.irct.ir/trial/48447,NA
IRCT20200616047792N1,IRCT,2020-08-03,2020-08-18,FALSE,Recruiting,Not Applicable,Interventional,Iran,A study of therapeutic effect of blood ozone therapy of severe Covid-19 patients,60,http://en.irct.ir/trial/48978,NA
IRCT20200616047799N1,IRCT,2020-08-23,2020-06-30,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Photobiomodulation anti-inflammatory effect in COVID-19,40,http://en.irct.ir/trial/49012,NA
IRCT20090304001739N3,IRCT,2020-09-01,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of slow release mucoadhesive paste ofâ€ MUCODENTOL â€œ in oral vestibule on symptoms of COVID-19 disease  in hospital staff,1600,http://en.irct.ir/trial/49065,NA
IRCT20200623047897N1,IRCT,2020-08-16,2020-05-21,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of N-acetylcysteine in patients with COVID-19,60,http://en.irct.ir/trial/49277,NA
IRCT20200630047962N1,IRCT,2020-08-21,2020-08-07,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effect of progressive muscle relaxation on covid-19 anxiety in pregnant women,126,http://en.irct.ir/trial/49309,NA
IRCT20200705048011N1,IRCT,2020-08-16,2020-08-22,FALSE,Recruiting,Not Applicable,Interventional,Iran,Garlic and cinnamon on the treatment of patients with corona,45,http://en.irct.ir/trial/49481,NA
IRCT20190312043030N2,IRCT,2020-08-19,2020-06-29,TRUE,Recruiting,Phase 3,Interventional,Iran,"The effect of selenium, vitamin C and methylprednisolone combination on mortality and morbidity of Covid-19 patients.",40,http://en.irct.ir/trial/49508,NA
IRCT20170716035126N4,IRCT,2020-08-26,2020-07-10,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The efficacy of methylprednisolone mini pulse on the treatment of COVID-19 patients admitted to intensive care unit,60,http://en.irct.ir/trial/49519,NA
IRCT20200711048076N1,IRCT,2020-09-05,2020-05-21,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of mucodentol on covid-19 symptoms,600,http://en.irct.ir/trial/49555,NA
IRCT20200509047364N2,IRCT,2020-08-17,2020-06-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Famotidine and COVID-19,20,http://en.irct.ir/trial/49657,NA
IRCT20200718048129N1,IRCT,2020-08-11,2020-08-22,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Hydroxychloroquine and Clarithromycin in dyspnea and caugh caused by COVID-19 in recovery phase,45,http://en.irct.ir/trial/49729,NA
IRCT20200725048199N1,IRCT,2020-08-11,2020-08-10,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Shalomin on the treatment and improvement of symptoms in patients with Covid 19,146,http://en.irct.ir/trial/49853,NA
IRCT20160808029264N9,IRCT,2020-08-15,2020-09-20,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of chest physiotherapy in COVID-19 patients with respiratory infection,44,http://en.irct.ir/trial/49890,NA
IRCT20190831044653N5,IRCT,2020-08-24,2020-08-20,TRUE,Recruiting,Phase 2,Interventional,Iran,?The effect of Atorvastatin therapy in COVID-19,160,http://en.irct.ir/trial/49893,NA
IRCT20200730048253N1,IRCT,2020-08-08,2020-08-22,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluating the effectiveness of intravenous ozonized saline in COVID-19 disease,60,http://en.irct.ir/trial/50031,NA
IRCT20091012002582N22,IRCT,2020-08-08,2020-08-22,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of hemoperfusion on short term outcome of critical ill COVID-19,160,http://en.irct.ir/trial/50079,NA
IRCT20101219005416N3,IRCT,2020-08-26,2020-08-10,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of traditional medicine protocol included Astraglus gossypinus  with  Ferula assa capsule on improvement of  COVID-19 outpatients symptoms,120,http://en.irct.ir/trial/50101,NA
IRCT20200806048318N1,IRCT,2020-08-20,2020-09-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal tea on improving respiratory symptoms in patients with Covid-19,80,http://en.irct.ir/trial/50227,NA
IRCT20200506047323N5,IRCT,2020-08-14,2020-08-22,FALSE,Recruiting,Phase 3,Interventional,Iran,Melatonin in COVID-19,60,http://en.irct.ir/trial/50239,NA
IRCT20090701002113N2,IRCT,2020-08-25,2020-08-15,TRUE,Recruiting,Phase 3,Interventional,Iran,Methylene Blue in COVID-19,260,http://en.irct.ir/trial/50275,NA
IRCT20180922041089N4,IRCT,2020-08-23,2020-04-19,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of oral Ivermectin on patients with COVID-19,130,http://en.irct.ir/trial/50305,NA
IRCT20161108030776N3,IRCT,2020-08-26,2020-09-05,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of donkey milk on the new corona virus infection,110,http://en.irct.ir/trial/50341,NA
ACTRN12620000421932,ANZCTR,2020-03-30,2020-05-03,FALSE,Recruiting,Not Applicable,Observational,"Sweden, Saudi Arabia, United Kingdom, Canada, Morocco, Vietnam, Egypt, Japan, Turkey, Austria, Poland, Hong Kong, Ireland, Indonesia, United Arab Emirates, Belgium, United States, Luxembourg, Germany, Lebanon, Switzerland, Argentina, Croatia, South Africa, Netherlands, South Korea, Italy, Brazil, Ukraine, Mexico, China, Philippines, Singapore, Chile, Kenya, Tunisia, Australia, Qatar, Colombia, Kuwait, Thailand, Estonia, Spain, Zimbabwe, India",COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD),10000,https://anzctr.org.au/ACTRN12620000421932.aspx,NA
ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-23,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,1,https://anzctr.org.au/ACTRN12620000477921.aspx,NA
ACTRN12620000454976,ANZCTR,2020-04-08,2020-02-07,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,160,https://anzctr.org.au/ACTRN12620000454976.aspx,NA
ACTRN12620000487910,ANZCTR,2020-04-20,2020-07-04,FALSE,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,500,https://anzctr.org.au/ACTRN12620000487910.aspx,NA
ACTRN12620000517976,ANZCTR,2020-04-27,2020-09-07,FALSE,Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),206,https://anzctr.org.au/ACTRN12620000517976.aspx,NA
ACTRN12620000580976,ANZCTR,2020-05-19,2020-10-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (â€œTROCARâ€),150,https://anzctr.org.au/ACTRN12620000580976.aspx,NA
ACTRN12620000590965,ANZCTR,2020-05-21,2020-05-26,FALSE,Recruiting,Not Applicable,Observational,Australia,Psychological impact of COVID-19 pandemic on perioperative staff at the Royal Melbourne Hospital â€“ a longitudinal study,90,https://anzctr.org.au/ACTRN12620000590965.aspx,NA
ACTRN12620000698976,ANZCTR,2020-06-23,2020-10-06,FALSE,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,40,https://anzctr.org.au/ACTRN12620000698976.aspx,NA
ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,FALSE,No Status Given,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus Calmetteâ€“GuÃ©rin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",3468,https://anzctr.org.au/ACTRN12620000707965.aspx,NA
ACTRN12620000817943,ANZCTR,2020-08-14,2020-08-22,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of COVID-19 Vaccine in Healthy Adults",280,https://anzctr.org.au/ACTRN12620000817943.aspx,NA
ACTRN12620000860965,ANZCTR,2020-08-28,2020-01-09,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,A research study to determine the effect of a smartphone application (app) on management of patients with heart failure in isolation due to COVID-19,400,https://anzctr.org.au/ACTRN12620000860965.aspx,NA
ChiCTR2000034825,ChiCTR,2020-07-21,2020-07-20,TRUE,Not Recruiting,Phase 1,Interventional,China,A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China,144,http://www.chictr.org.cn/showproj.aspx?proj=56834,NA
ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),150,http://www.chictr.org.cn/showproj.aspx?proj=51940,NA
EUCTR2020-002503-19,EudraCT,2020-07-30,2020-11-09,FALSE,Authorised,Phase 3,Interventional,"Spain, Netherlands, Australia, United Kingdom",Tuberculosis vaccination to Reduce the impact of Coronavirus infection in healthcare workers following contact of Coronavirus,7244,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002503-19,GB
ACTRN12620000474954,ANZCTR,2020-04-15,2020-04-28,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,100,https://anzctr.org.au/ACTRN12620000474954.aspx,NA
ACTRN12620000571976,ANZCTR,2020-05-15,2020-04-06,TRUE,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",75,https://anzctr.org.au/ACTRN12620000571976.aspx,NA
ACTRN12620000909921,ANZCTR,2020-09-14,2020-09-28,FALSE,Not Recruiting,Not Applicable,Observational,New Zealand,The March 15 Study: Examining the impacts and recovery from the March 15 2019 Christchurch Mosque attacks in people most directly exposed and their adult family members,600,https://anzctr.org.au/ACTRN12620000909921.aspx,NA
ACTRN12620000921987,ANZCTR,2020-09-17,2020-09-23,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Sources of a Resilient Mindset in Health Professionals During COVID-19: The SOAR Study,20,https://anzctr.org.au/ACTRN12620000921987.aspx,NA
ACTRN12620000857909,ANZCTR,2020-08-28,2020-03-27,TRUE,Not Recruiting,Not Applicable,Observational,Australia,The impact of work loss during the COVID-19 pandemic on health and employment.,1829,https://anzctr.org.au/ACTRN12620000857909.aspx,NA
ACTRN12620000922976,ANZCTR,2020-09-17,2020-05-29,TRUE,Not Recruiting,Not Applicable,Observational,Australia,DETECT Schools Study: Understanding the impact of COVID-19 in Western Australian Schools,30000,https://anzctr.org.au/ACTRN12620000922976.aspx,NA
ISRCTN44152751,ISRCTN,2020-05-04,2020-11-05,FALSE,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,116750,http://isrctn.com/ISRCTN44152751,NA
ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364,NA
EUCTR2020-002314-40,EudraCT,2020-07-15,2020-09-14,FALSE,Authorised,Phase 2,Interventional,Austria,A Pilot study to investigate the cardiac effect and pharmacokinetics of potential combination treatments for COVID-19,16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002314-40,AT
EUCTR2020-001860-27,EudraCT,2020-04-17,2020-12-05,FALSE,Authorised,Phase 1/Phase 2,Interventional,United Kingdom,AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment. A randomised Phase I/II study to determine the safety and effectiveness of multiple drugs for the treatment of COVID-19,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001860-27,GB
EUCTR2020-001466-11,EudraCT,2020-04-14,2020-04-15,FALSE,Authorised,Phase 2,Interventional,Greece,Prevention of severe respiratory failure in Covid-19,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001466-11,GR
EUCTR2020-001643-13,EudraCT,2020-04-29,2020-05-15,FALSE,Authorised,Phase 3,Interventional,United Kingdom,A randomised double-blind placebo-controlled trial of Brensocatib (INS1007) in patients with severe COVID-19,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001643-13,GB
ACTRN12620000878976,ANZCTR,2020-09-03,2020-09-17,FALSE,Not Recruiting,Not Applicable,Observational,Australia,A Collaborative Maternity and Newborn Dashboard for the COVID-19 Pandemic,180000,https://anzctr.org.au/ACTRN12620000878976.aspx,NA
ISRCTN10373531,ISRCTN,2020-09-15,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,The ability of the steep ramp test to measure and monitor aerobic capacity,50,http://isrctn.com/ISRCTN10373531,NA
ISRCTN51232965,ISRCTN,2020-09-14,2020-07-13,TRUE,Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety and immune response of a vaccine against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) when given to healthy adult participants",216,http://isrctn.com/ISRCTN51232965,NA
ISRCTN10378358,ISRCTN,2020-07-08,2020-01-11,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"Reducing the risk of COVID-19 spread in hospitals, by stopping droplets from spreading",400,http://isrctn.com/ISRCTN10378358,NA
ChiCTR2000036982,ChiCTR,2020-08-26,2020-06-22,TRUE,Recruiting,Not Applicable,Observational,Italy,Long term follow up of patients with COVID 19,250,http://www.chictr.org.cn/showproj.aspx?proj=59893,NA
ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,TRUE,No Status Given,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",20,http://www.chictr.org.cn/showproj.aspx?proj=50254,NA
ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,FALSE,Not Recruiting,Not Applicable,Interventional,China,Withdraw       Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,30,http://www.chictr.org.cn/showproj.aspx?proj=41760,NA
ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,FALSE,Not Recruiting,Not Applicable,Interventional,China,Withdraw           Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,30,http://www.chictr.org.cn/showproj.aspx?proj=49062,NA
EUCTR2020-001281-11,EudraCT,2020-03-26,2020-03-30,FALSE,Not Recruiting,Phase 4,Interventional,France,Evaluation of the concentration/viral effect relationship of hydroxychloroquine in COVID-19 patients in the intensive care unit..,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001281-11,FR
EUCTR2020-001530-35,EudraCT,2020-04-13,2020-09-04,FALSE,Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,ES
EUCTR2020-001634-36,EudraCT,2020-04-13,2020-09-04,FALSE,Authorised,Phase 2,Interventional,Spain,Randomized open pilot study to evaluate the efficacy of subcutaneous sarilumab in patients with moderate-severe COVID-19 infection.,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001634-36,ES
EUCTR2020-001622-64,EudraCT,2020-04-20,2020-04-19,TRUE,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,ES
EUCTR2020-001722-66,EudraCT,2020-04-27,2020-04-23,TRUE,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,ES
EUCTR2020-001505-22,EudraCT,2020-04-27,2020-04-23,TRUE,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,ES
EUCTR2020-001541-39,EudraCT,2020-04-27,2020-04-24,TRUE,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,ES
EUCTR2020-001618-39,EudraCT,2020-04-27,2020-04-24,TRUE,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,ES
EUCTR2020-000705-86,EudraCT,2020-05-05,2020-04-26,TRUE,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,ES
EUCTR2020-001825-29,EudraCT,2020-05-05,2020-04-28,TRUE,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,ES
EUCTR2020-001697-30,EudraCT,2020-05-07,2020-04-23,TRUE,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,ES
EUCTR2020-001376-15,EudraCT,2020-04-06,2020-05-13,FALSE,Not Recruiting,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15,DE
EUCTR2020-002728-35,EudraCT,2020-08-13,2020-09-17,FALSE,Authorised,Phase 3,Interventional,Hungary,Clinical trial of Favipiravir treatment of patients with COVID-19,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002728-35,HU
EUCTR2020-001640-26,EudraCT,2020-04-09,2020-04-17,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A clinical trial of nebulised recombinant tissue plasminogen activator (rtPA) in patients with COVID-19 Acute Respiratory Distress Syndrome to decrease the duration of ventilatory support and mortality: A pilot study (the PACA trial),36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001640-26,GB
EUCTR2020-003470-47,EudraCT,2020-09-26,2020-08-27,TRUE,Authorised,Phase 4,Interventional,Netherlands,Investigation IN VULNERABLE ELDERLY to evaluate the reduction of respiratory infections during the coronapandemie by training of the immuunsystem through a BCG vaccination,5200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003470-47,NL
EUCTR2020-001686-36,EudraCT,2020-04-14,2020-04-23,FALSE,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,FR
ACTRN12620000834954,ANZCTR,2020-08-24,2020-09-16,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants",24,https://anzctr.org.au/ACTRN12620000834954.aspx,NA
ACTRN12620000977976,ANZCTR,2020-09-30,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,Australia,National Asthma Treatment Survey in Australian adults,8000,https://anzctr.org.au/ACTRN12620000977976.aspx,NA
JPRN-UMIN000041458,UMIN-CTR,2020-10-01,2020-07-01,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,Research on the maintenance and improvement of physical and mental functions of elderly people under the self-restraint caused by COVID-19 by using a remote system to connect their homes,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327,NA
EUCTR2020-001367-88,EudraCT,2020-04-01,2020-04-14,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Efficacy and safety of novel treatment options for adults with COVID-19 pneumonia,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001367-88,DK
EUCTR2020-001395-15,EudraCT,2020-03-30,2020-06-04,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Low dose hydrocortisone in patients with COVID-19 and severe oxygen deficiency â€“ the COVID STEROID trial,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001395-15,DK
EUCTR2020-002542-16,EudraCT,2020-09-17,2020-09-30,FALSE,Authorised,Phase 3,Interventional,"Denmark, Argentina, Portugal, Greece, United Kingdom, Belgium, Peru, Thailand, United States, Spain, Israel, Mexico, Japan, Poland, France, Germany, Nigeria",Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC),500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002542-16,GB
EUCTR2020-001807-18,EudraCT,2020-04-29,2020-05-18,FALSE,Authorised,Phase 2,Interventional,"Argentina, Moldova, Republic of, South Africa, United Kingdom, Ukraine, United States, Brazil, Finland, Poland, Romania",TD-0903 for acute lung injury associated with COVID-19,222,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001807-18,GB
EUCTR2020-001327-13,EudraCT,2020-03-30,2020-04-21,FALSE,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,AT
EUCTR2020-002110-41,EudraCT,2020-05-29,2020-06-18,FALSE,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,A clinical study in a community setting to see whether use of camostat reduces the worsening of COVID-19.,389,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002110-41,GB
IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,30,http://en.irct.ir/trial/46564,NA
IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,324,http://en.irct.ir/trial/46783,NA
IRCT20190810044500N7,IRCT,2020-09-19,2020-04-08,TRUE,Recruiting,Phase 2,Interventional,Iran,Evaluation of Levamisole efficacy in treatment of Covid-19,50,http://en.irct.ir/trial/46826,NA
IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",60,http://en.irct.ir/trial/46828,NA
IRCT20190717044241N2,IRCT,2020-04-22,2020-04-20,TRUE,Recruiting,Phase 1,Interventional,Iran,Cell therapy in patients with COVID-19,5,http://en.irct.ir/trial/47110,NA
IRCT20081019001369N7,IRCT,2020-09-27,2020-10-22,FALSE,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate against COVID-19,30,http://en.irct.ir/trial/47441,NA
IRCT20200504047295N1,IRCT,2020-09-16,2020-08-10,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of Shallomin syrup on patients affected by COVID-19,90,http://en.irct.ir/trial/47661,NA
IRCT20160118026097N4,IRCT,2020-09-13,2020-03-29,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of dexamethasone in the treatment of high-risk covid19 patients,60,http://en.irct.ir/trial/48310,NA
IRCT20160118026097N5,IRCT,2020-09-19,2020-03-29,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of plasmapheresis in the treatment of high-risk covid patients in Qom province,60,http://en.irct.ir/trial/48401,NA
IRCT20190226042851N1,IRCT,2020-10-05,2020-08-22,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of nano-based inhalation solution to relieve shortness of breath in COVID-19 patients,40,http://en.irct.ir/trial/48462,NA
IRCT20180624040213N2,IRCT,2020-09-14,2020-07-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Montelukast in COVID-19,114,http://en.irct.ir/trial/49420,NA
IRCT20200504047298N3,IRCT,2020-09-09,2020-08-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Diphenhydramine Compound in Covid-19,120,http://en.irct.ir/trial/49696,NA
IRCT20191228045924N1,IRCT,2020-09-20,2020-04-19,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of methylene blue on treatment of COVID-19 patients,80,http://en.irct.ir/trial/49767,NA
IRCT20200802048266N1,IRCT,2020-09-22,2020-11-19,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of MMR vaccine in preventing Covid disease 19,323,http://en.irct.ir/trial/50035,NA
IRCT20131112015390N5,IRCT,2020-09-26,2020-05-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19",110,http://en.irct.ir/trial/50268,NA
IRCT20200317046797N7,IRCT,2020-09-14,2020-04-20,TRUE,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease,3500,http://en.irct.ir/trial/50556,NA
IRCT20200831048568N1,IRCT,2020-09-11,2020-09-10,TRUE,Recruiting,Phase 3,Interventional,Iran,Efficacy of sofosbuvir and daclatasvir in ambulatory patients with coronavirus disease,2000,http://en.irct.ir/trial/50601,NA
IRCT20181203041832N1,IRCT,2020-10-05,2020-09-22,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effectiveness of online mindfulness training on mental health and quality of work life of nurses fighting on the frontlines against COVID-19,36,http://en.irct.ir/trial/50750,NA
IRCT20200902048598N1,IRCT,2020-09-28,2020-09-22,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of education in the prevention of covid-19,200,http://en.irct.ir/trial/50796,NA
IRCT20140911019125N8,IRCT,2020-09-26,2020-09-10,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of corona disease,120,http://en.irct.ir/trial/50848,NA
IRCT20200913048701N1,IRCT,2020-09-22,2020-09-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of effects of eucalyptus tablets on the process of covid 19 disease,50,http://en.irct.ir/trial/50912,NA
IRCT20200907048644N1,IRCT,2020-10-04,2020-09-22,TRUE,Recruiting,Phase 1,Interventional,Iran,Celecoxib effects on  COVID-19 patients,60,http://en.irct.ir/trial/50932,NA
IRCT20200913048708N1,IRCT,2020-10-01,2020-10-31,FALSE,Not Recruiting,Phase 2,Interventional,Iran,Efficacy and safety of Chlorpromazine  in the treatment of COVID-19 patients,60,http://en.irct.ir/trial/50959,NA
IRCT20131115015405N4,IRCT,2020-10-03,2020-07-22,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of fluvoxamine on cytokine in COVID-19 patients,40,http://en.irct.ir/trial/50977,NA
IRCT20131125015536N13,IRCT,2020-10-03,2020-05-21,TRUE,Recruiting,Not Applicable,Interventional,Iran,Assessment of the effect of nanocurcumin supplement in patients with COVID-19,48,http://en.irct.ir/trial/51310,NA
IRCT20201001048893N1,IRCT,2020-10-03,2020-03-10,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of Online Psycho-educational Interventions on Psychological Health of Patients with COVID-19,50,http://en.irct.ir/trial/51328,NA
ISRCTN32891583,ISRCTN,2020-10-02,2020-10-15,FALSE,Recruiting,Not Applicable,Observational,Indonesia,Investigating the COVID-19 mucosal immunity of children in Indonesia,100,http://isrctn.com/ISRCTN32891583,NA
ISRCTN59449699,ISRCTN,2020-08-07,2020-09-28,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Visualising blood vessel disease in the eye in COVID-19,30,http://isrctn.com/ISRCTN59449699,NA
ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,FALSE,Not Recruiting,Not Applicable,Interventional,China,Canceled by the investigator                                       Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=44213,NA
EUCTR2020-001610-38,EudraCT,2020-04-07,2020-09-16,FALSE,Authorised,Phase 4,Interventional,Denmark,Irbesartan and Oseltamivir treatment of COVID-19 infection.,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001610-38,DK
EUCTR2020-001498-63,EudraCT,2020-06-09,2020-01-10,TRUE,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, United States, Brazil, France","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,GB
ISRCTN18428598,ISRCTN,2020-10-08,2020-01-01,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Does the Flexible Phonics programme lead to improved reading outcomes for children in Reception when taught in addition to existing phonics programmes/practice?,2875,http://isrctn.com/ISRCTN18428598,NA
ISRCTN43900695,ISRCTN,2020-04-08,2020-08-17,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,60,http://isrctn.com/ISRCTN43900695,NA
EUCTR2020-004928-42,EudraCT,2020-10-12,2020-12-10,FALSE,Authorised,Phase 3,Interventional,Hungary,Clinical trail of remdesivir in Covid-19 patinets,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004928-42,HU
EUCTR2020-001473-79,EudraCT,2020-04-24,2020-07-05,FALSE,Authorised,Phase 3,Interventional,"Spain, Italy, United States, United Kingdom",Dapagliflozin in Respiratory failure in patients with COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001473-79,GB
EUCTR2020-002211-21,EudraCT,2020-07-07,2020-07-31,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A Phase II clinical trial to assess how safe and how effective AZD1656 is in treating COVID-19 in diabetic patients compared to placebo.,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002211-21,GB
EUCTR2020-001803-17,EudraCT,2020-06-05,2020-07-14,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Spain, Italy, United States, United Kingdom",Phase 2/3 study of Remdesivir in patients from birth to <18 years old with COVID-19,52,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001803-17,GB
ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,1000,http://isrctn.com/ISRCTN14966673,NA
EUCTR2020-001010-38,EudraCT,2020-03-16,2020-03-23,FALSE,Not Recruiting,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,NO
EUCTR2020-001455-40,EudraCT,2020-04-01,2020-01-04,TRUE,Not Recruiting,Phase 2,Interventional,Greece,A study using colchicine for preventing the complications from Covid-19,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001455-40,GR
EUCTR2020-002295-13,EudraCT,2020-05-22,2020-10-15,FALSE,Authorised,Phase 2,Interventional,France,"Evaluation of the efficacy, safety and tolerability of alisporivir for the treatment of hospitalised patients with infections due to SARS-CoV-2 (COVID-19). 
",100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002295-13,FR
EUCTR2020-001734-36,EudraCT,2020-04-15,2020-04-20,FALSE,Not Recruiting,Phase 3,Interventional,France,Efficacy and safety of ANAkinra during Adult Â« COVID-19 Â» with Aggravating respiratory symptoms: a multicenter open-label controlled randomized trial,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001734-36,FR
EUCTR2020-001867-94,EudraCT,2020-04-20,2020-10-15,FALSE,Authorised,Phase 3,Interventional,France,Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectÃ©s par le SARS-CoV2 (COVID-19) non hospitalisÃ©s,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001867-94,FR
EUCTR2020-001745-40,EudraCT,2020-06-24,2020-04-23,TRUE,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40,IT
EUCTR2020-001732-10,EudraCT,2020-04-27,2020-05-28,FALSE,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10,DE
ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,FALSE,No Status Given,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,70,https://anzctr.org.au/ACTRN12620000457943.aspx,NA
ACTRN12620000557932,ANZCTR,2020-05-11,2020-07-09,FALSE,Recruiting,Not Applicable,Interventional,"Turkey, Australia","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",200,https://anzctr.org.au/ACTRN12620000557932.aspx,NA
ACTRN12620001114932,ANZCTR,2020-10-28,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Morbidity Post COVID-19 - Investigation and call to action,200,https://anzctr.org.au/ACTRN12620001114932.aspx,NA
ISRCTN13447477,ISRCTN,2020-05-22,2020-04-11,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,22,http://isrctn.com/ISRCTN13447477,NA
EUCTR2020-003486-19,EudraCT,2020-08-14,2020-08-10,TRUE,Authorised,Phase 2,Interventional,United Kingdom,SFX-01 treatment for Acute Respiratory Infections (STAR-Covid19),300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19,GB
EUCTR2020-001162-12,EudraCT,2020-03-20,2020-03-26,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Canada, Italy, Israel, Spain, Japan, France, Germany",Sarilumab COVID-19,460,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001162-12,FR
EUCTR2020-003689-37,EudraCT,2020-10-01,2020-10-27,FALSE,Authorised,Phase 2,Interventional,France,"REmimazolam infusion in the context of Hypnotic Shortage in the Critical care Unit during the pandemic of COVID-19. The non-randomized, non-controlled, pilot, open, mono-centric REHSCU study.",30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003689-37,FR
EUCTR2020-002677-95,EudraCT,2020-08-10,2020-08-25,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, United Kingdom, United States, Brazil, Mexico, Italy",A clinical trial using opaganib in adult patients hospitalised with severe pneumonia due to COVID-19,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002677-95,IT
EUCTR2020-001662-11,EudraCT,2020-04-15,2020-05-05,FALSE,Not Recruiting,Phase 3,Interventional,"United Kingdom, United States, Italy, Spain, France, Germany","Phase 3 randomized, double-blind, placebo-controlled, multi-center study to assess the efficacy and safety of ruxolitinib in patients with COVID-19 associated cytokine storm (RUXCOVID)",402,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001662-11,DE
EUCTR2020-001689-12,EudraCT,2020-10-19,2020-10-23,FALSE,Authorised,Phase 3,Interventional,"South Africa, Greece, United Kingdom, Canada, United States, Brazil, Spain",COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),6000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,GR
EUCTR2020-004123-16,EudraCT,2020-09-11,2020-09-23,FALSE,Authorised,Phase 3,Interventional,United Kingdom,Study to evaluate the efficacy and safety of a SARS-CoV-2 rS vaccine with Matrix-M1â„¢ Adjuvant in Adult Participants 18-84 Years of Age in the United Kingdom,15000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004123-16,GB
JPRN-UMIN000042034,UMIN-CTR,2020-10-07,2020-09-09,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,About preventive measures against covid-19 infection in sports,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574,NA
JPRN-UMIN000042052,UMIN-CTR,2020-10-30,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Asia(except Japan),Orthopaedic Surgery in The Pandemic Era,35,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047986,NA
JPRN-UMIN000042061,UMIN-CTR,2020-10-09,2020-09-25,TRUE,Not Recruiting,Not Applicable,Observational,Japan,&quot;Study of resistance to COVID-19 of medical staff&quot; -(Pilot Study)-,165,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047878,NA
JPRN-UMIN000042106,UMIN-CTR,2020-10-15,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Japan,The impact of COVID19 pandemic-related activity restriction on the outcomes of chronic obstructive lung disease,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048052,NA
JPRN-UMIN000042142,UMIN-CTR,2020-10-17,2020-05-19,TRUE,Not Recruiting,Not Applicable,Other,Japan,cohort survey of healthcare workers with COVID-19 infection,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047872,NA
JPRN-UMIN000042211,UMIN-CTR,2020-10-23,2020-08-15,TRUE,Not Recruiting,Not Applicable,Observational,Japan,The impact of COVID-19 pandemic on colorectal cancer therapy,123,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048176,NA
ACTRN12620001029987,ANZCTR,2020-10-09,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian Emergency Department with suspected COVID-19.,300,https://anzctr.org.au/ACTRN12620001029987.aspx,NA
ISRCTN13539303,ISRCTN,2020-10-30,2020-08-06,TRUE,Recruiting,Not Applicable,Observational,"French Southern Territories, Nepal, Saudi Arabia, United Kingdom, Yemen, Azerbaijan, Curacao, Korea, South, Virgin Islands, U.S., Gabon, Guatemala, Cote d'Ivoire, Austria, Armenia, China, Poland, Venezuela, Romania, Denmark, Malawi, Belgium, Burkina Faso, Democratic Republic of Congo, Ethiopia, Guam, Martinique, Swaziland, United States, Cameroon, Gibraltar, Mongolia, Timor-Leste, Botswana, Myanmar, Panama, Turkmenistan, Cyprus, Holy See (Vatican City State), New Zealand, Netherlands, Saint Pierre and Miquelon, Nauru, Madagascar, San Marino, Liechtenstein, American Samoa, Tajikistan, Slovenia, Singapore, Slovakia, Colombia, Netherlands Antilles, Andorra, Burundi, Spain, Togo, Uganda, Bouvet Island, Guinea-Bissau, Sri Lanka, Moldova, Georgia, Aruba, Angola, Bhutan, British Indian Ocean Territory, Norway, Turkey, Djibouti, Finland, Paraguay, Chad, Costa Rica, Pitcairn, Afghanistan, Mozambique, Luxembourg, Laos, Ecuador, Sudan, Uruguay, Central African Republic, Lebanon, Bulgaria, Cayman Islands, Switzerland, Croatia, Guadeloupe, Namibia, Nicaragua, Saint Helena, South Sudan, Brazil, Mali, Svalbard and Jan Mayen, El Salvador, Nigeria, Sierra Leone, Chile, Bahrain, Suriname, Albania, Mauritius, Kuwait, Bermuda, Christmas Island, Kiribati, Antarctica, Barbados, Jamaica, Palestinian Territory, Saint Kitts and Nevis, India, Tonga, Haiti, United States Minor Outlying Islands, Guyana, Kosovo, Kyrgyzstan, Zambia, Cambodia, Algeria, Falkland Islands, Antigua and Barbuda, Japan, Maldives, Aland Islands, Belize, France, Rwanda, Lithuania, Saint Vincent and the Grenadines, Bonaire Saint Eustatius and Saba, Heard Island and Mcdonald Islands, Dominican Republic, Honduras, Fiji, Greece, Mayotte, Micronesia, Federated States of, Czech Republic, Taiwan, Puerto Rico, Montenegro, United Arab Emirates, Kazakhstan, Seychelles, Uzbekistan, Turks and Caicos Islands, Argentina, Hungary, Virgin Islands, British, Iceland, Democratic Republic of Congo, Wallis and Futuna, Solomon Islands, Papua New Guinea, Italy, Mexico, Guernsey, Malta, Syria, Vanuatu, Monaco, Montserrat, Liberia, Malaysia, Philippines, Kenya, Palau, Senegal, Australia, Portugal, Eritrea, Samoa, Comoros, Cook Islands, Bahamas, Cocos (Keeling) Islands, Estonia, Serbia, Isle of Man, Niue, Thailand, Cuba, Tokelau, Faroe Islands, Sweden, Russian Federation, Tanzania, Benin, Jordan, Macedonia, Canada, Pakistan, Morocco, Saint Lucia, Bolivia, Egypt, Vietnam, Lesotho, Macao, Niger, Sao Tome and Principe, Bosnia and Herzegovina, Libya, Mauritania, Hong Kong, Ireland, Indonesia, French Polynesia, Anguilla, Bangladesh, Belarus, Gambia, Sint Maarten (Dutch part), Saint Martin (French part), Northern Mariana Islands, Iraq, Somalia, Germany, Tuvalu, Equatorial Guinea, South Africa, Trinidad and Tobago, Marshall Islands, Cape Verde, Dominica, Grenada, Ukraine, Western Sahara, Oman, Jersey, Latvia, New Caledonia, Ghana, Korea, North, Iran, Qatar, Peru, Greenland, Tunisia, Reunion, Brunei, Israel, French Guiana, Norfolk Island, Zimbabwe, Guinea, Saint Barthelemy, South Georgia and the South Sandwich Is",An international registry of coronavirus exposure in pregnancy,25000,http://isrctn.com/ISRCTN13539303,NA
ISRCTN13455972,ISRCTN,2020-08-04,2020-04-08,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of coronavirus self-isolation interventions,10000,http://isrctn.com/ISRCTN13455972,NA
ChiCTR2000038740,ChiCTR,2020-09-30,2020-08-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Study on Traditional Chinese Medicine Intervention Program for the Sequela of novel coronavirus pneumonia (COVID-19),200,http://www.chictr.org.cn/showproj.aspx?proj=62250,NA
ChiCTR2000038739,ChiCTR,2020-09-30,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Analysis on the Distribution of TCM Syndromes in convalescent novel coronavirus pneumonia (COVID-19) patients,800,http://www.chictr.org.cn/showproj.aspx?proj=62287,NA
ChiCTR2000037782,ChiCTR,2020-09-01,2020-09-01,FALSE,Not Recruiting,Phase 1,Interventional,China,A Phase I Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),60,http://www.chictr.org.cn/showproj.aspx?proj=55421,NA
ChiCTR2000037524,ChiCTR,2020-08-29,2020-08-29,FALSE,Not Recruiting,Not Applicable,Interventional,China,Effects of an online mindfulness-based intervention on quality of life and psychological symptoms in novel coronavirus pneumonia (COVID-19) patients in China: a randomized controlled trial,1600,http://www.chictr.org.cn/showproj.aspx?proj=60034,NA
ChiCTR2000037518,ChiCTR,2020-08-28,2020-08-28,FALSE,Not Recruiting,Phase 1,Interventional,China,"Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)",168,http://www.chictr.org.cn/showproj.aspx?proj=60581,NA
ChiCTR2000037342,ChiCTR,2020-08-28,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based research on the establishment of a precise treatment system for novel coronavirus pneumonia (COVID-19) from the perspective of ''damp-and-heat epidemic'',300,http://www.chictr.org.cn/showproj.aspx?proj=60400,NA
ChiCTR2000037078,ChiCTR,2020-08-26,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,China,The technical specification of precise drug therapy and the systematic study of novel Coronavirus inactivation procedure for biological samples,200,http://www.chictr.org.cn/showproj.aspx?proj=60149,NA
ChiCTR2000036871,ChiCTR,2020-08-25,2020-09-01,FALSE,Not Recruiting,Phase 4,Interventional,Pakistan,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.",300,http://www.chictr.org.cn/showproj.aspx?proj=55984,NA
ChiCTR2000036849,ChiCTR,2020-08-25,2020-10-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Establishment of imaging diagnostic models for novel coronavirus pneumonia (COVID-19) and related brain injury based on artificial intelligence,2000,http://www.chictr.org.cn/showproj.aspx?proj=59903,NA
ChiCTR2000036661,ChiCTR,2020-08-24,2020-10-30,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Application of IL-18/IL-18BP in diagnosis and treatment of novel coronavirus pneumonia (COVID-19),30,http://www.chictr.org.cn/showproj.aspx?proj=59797,NA
ChiCTR2000036333,ChiCTR,2020-08-22,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Using Mindfulness to Reduce Anxiety and Depression of Patient with Fever Undergoing Screening in an Isolation Ward During novel coronavirus pneumonia (COVID-19) pandemic,51,http://www.chictr.org.cn/showproj.aspx?proj=57115,NA
ChiCTR2000036217,ChiCTR,2020-08-21,2020-10-01,FALSE,Not Recruiting,Not Applicable,Diagnostic test,China,Multi-center study on intelligent accurate diagnosis and critical illness prediction of novel coronavirus pneumonia (COVID-19) with multimodal imaging,1000,http://www.chictr.org.cn/showproj.aspx?proj=59358,NA
IRCT20100623004251N13,IRCT,2020-04-04,2019-10-23,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Comparison of the Effect of Types of Orthosis and Back School Program on Physical Fitness and Respiratory Capacity of Elderly with Thoracic Kyphosis,60,http://en.irct.ir/trial/42393,NA
IRCT20200324046850N5,IRCT,2020-04-04,2020-10-17,FALSE,Recruiting,Phase 2,Interventional,Iran,Effectiveness of vitamin C on the improvement process of patients with COVID-19,400,http://en.irct.ir/trial/46751,NA
IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,357,http://en.irct.ir/trial/47163,NA
IRCT20200328046885N1,IRCT,2020-10-12,2020-07-19,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the effectiveness of two treatment regimens in patients with COVID-19,300,http://en.irct.ir/trial/47565,NA
IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,120,http://en.irct.ir/trial/48049,NA
IRCT20200531047619N1,IRCT,2020-10-18,2020-08-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tofacitinib in covid-19 patients,10,http://en.irct.ir/trial/48766,NA
IRCT20200802048267N1,IRCT,2020-10-20,2020-08-22,TRUE,Recruiting,Phase 2,Interventional,Iran,Propolis supplementation AND Coronavirus,80,http://en.irct.ir/trial/50162,NA
IRCT20200816048422N1,IRCT,2020-10-16,2020-06-25,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19),70,http://en.irct.ir/trial/50363,NA
IRCT20150808023559N23,IRCT,2020-10-11,2020-09-20,TRUE,Recruiting,Phase 2,Interventional,Iran,Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19,100,http://en.irct.ir/trial/50405,NA
IRCT20200825048514N1,IRCT,2020-10-10,2020-05-04,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of ÃŸ-interferon and methylprednisolone in COVID-19,60,http://en.irct.ir/trial/50543,NA
IRCT20200328046886N2,IRCT,2020-10-12,2020-08-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19,120,http://en.irct.ir/trial/50980,NA
IRCT20080901001165N63,IRCT,2020-10-22,2020-07-22,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Myrtus nasal spray in controlling the symptoms of patients with mild  COVID-19,100,http://en.irct.ir/trial/51157,NA
IRCT20100228003449N31,IRCT,2020-10-08,2020-09-26,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Corticosteroids in COVID-19,119,http://en.irct.ir/trial/51163,NA
IRCT20200923048815N1,IRCT,2020-10-15,2020-10-22,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of synbiotic on inflammatory markers and clinical manifestations in patients with C0VID-19,80,http://en.irct.ir/trial/51166,NA
IRCT20200922048804N1,IRCT,2020-10-06,2020-08-05,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Melatonin in COVID-19,20,http://en.irct.ir/trial/51177,NA
IRCT20200404046937N5,IRCT,2020-10-14,2020-09-27,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of remdesivir in COVID-19,50,http://en.irct.ir/trial/51178,NA
IRCT20200928048867N1,IRCT,2020-10-22,2020-10-01,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors,10,http://en.irct.ir/trial/51319,NA
IRCT20201003048904N1,IRCT,2020-10-11,2020-10-11,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of Blood Transfusion in Covid-19,40,http://en.irct.ir/trial/51364,NA
IRCT20201003048905N1,IRCT,2020-10-07,2020-05-23,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of spiritual care based on Ghalbe Salim on anxiety related to COVID-19 (corona phobia),14,http://en.irct.ir/trial/51394,NA
IRCT20201004048922N1,IRCT,2020-10-10,2020-10-11,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial,75,http://en.irct.ir/trial/51443,NA
IRCT20201005048936N1,IRCT,2020-10-26,2020-10-31,FALSE,Recruiting,Phase 3,Interventional,Iran,The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19,126,http://en.irct.ir/trial/51499,NA
IRCT20181208041886N1,IRCT,2020-10-18,2020-10-22,FALSE,Recruiting,Not Applicable,Interventional,Iran,Levamizole in treatment of COVID19.,60,http://en.irct.ir/trial/51501,NA
IRCT20200128046294N3,IRCT,2020-10-22,2020-10-24,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Safety of Sofosbuvir /Daclatasvir in outpatients with COVID-19,50,http://en.irct.ir/trial/51585,NA
IRCT20200930048892N1,IRCT,2020-10-18,2020-10-20,FALSE,Recruiting,Not Applicable,Interventional,Iran,evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients,70,http://en.irct.ir/trial/51595,NA
EUCTR2020-001275-32,EudraCT,2020-03-24,2020-03-04,TRUE,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 treatment of serious COVID-19 disease with threatening respiratory failure,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001275-32,DK
EUCTR2020-002122-82,EudraCT,2020-05-07,2020-12-06,FALSE,Authorised,Phase 2,Interventional,Germany,Clinical study for the Evaluation of efficacy and safety of a Treatment with Plasma gained from patients who recovered from COVID-19 infection and given to patients who are currently suffering from a severe COVID-19 infection,58,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002122-82,DE
ACTRN12620001193965,ANZCTR,2020-11-10,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Australia,"The adequacy of user seal checking for N95 respirators compared to formal fit testing, a multicentred observational study",150,https://anzctr.org.au/ACTRN12620001193965.aspx,NA
ISRCTN25647404,ISRCTN,2020-11-09,2020-09-20,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Measurement of the effect of mouthwash against COVID-19,104,http://isrctn.com/ISRCTN25647404,NA
ISRCTN63911163,ISRCTN,2020-11-05,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Analysis of the immunological response to coronavirus infection,600,http://isrctn.com/ISRCTN63911163,NA
ISRCTN11188345,ISRCTN,2020-05-15,2020-07-05,FALSE,Recruiting,Phase 4,Interventional,United Kingdom,A therapeutic study in pre-ICU patients admitted with coronavirus using repurposed drugs,375,http://isrctn.com/ISRCTN11188345,NA
EUCTR2020-001891-14,EudraCT,2020-05-05,2020-04-05,TRUE,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,ES
EUCTR2020-002032-69,EudraCT,2020-05-05,2020-04-05,TRUE,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,ES
EUCTR2020-001827-15,EudraCT,2020-05-05,2020-04-30,TRUE,Authorised,Phase 3,Interventional,Spain,"EARLY TREATMENT OF PNEUMONIA COVID-19 WITH GLUCOCORTICOIDS.
RANDOMIZED CONTROLLED CLINICAL TRIAL",72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001827-15,ES
EUCTR2020-001603-16,EudraCT,2020-05-08,2020-06-05,FALSE,Authorised,Phase 3,Interventional,Spain,Ensayo clÃ­nico aleatorizado para investigar la eficacia de la administraciÃ³n anticipada de la colchicina en pacientes mayores de 70 aÃ±os y de alto riesgo en tener complicaciones pulmonares como neumonÃ­a asociada al coronavirus.,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,ES
EUCTR2020-001994-66,EudraCT,2020-05-08,2020-06-05,FALSE,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,ES
EUCTR2020-001934-37,EudraCT,2020-05-08,2020-07-05,FALSE,Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,ES
EUCTR2020-001474-29,EudraCT,2020-05-08,2020-07-05,FALSE,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,ES
EUCTR2020-001953-36,EudraCT,2020-05-08,2020-08-05,FALSE,Authorised,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Patients with Coronavirus Disease (COVID-19),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001953-36,ES
EUCTR2020-001512-26,EudraCT,2020-04-01,2020-04-22,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Hydroxychloroquine for the treatment of mild COVID-19 disease,2700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001512-26,DE
EUCTR2020-001903-17,EudraCT,2020-05-15,2020-10-06,FALSE,Authorised,Phase 3,Interventional,Spain,Effects of Tocilizumab  and its combination with Vitamin D to treat the increased defensive response in COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001903-17,ES
EUCTR2020-002114-40,EudraCT,2020-06-17,2020-07-30,FALSE,Authorised,Phase 3,Interventional,France,Nintedanib for the treatment of pulmonary fibrosis induced by Covid-19,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002114-40,FR
EUCTR2020-001852-16,EudraCT,2020-07-14,2020-07-14,FALSE,Authorised,Phase 2,Interventional,Netherlands,Iodine treatment Coronavirus infection,224,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001852-16,NL
EUCTR2020-002056-20,EudraCT,2020-06-15,2020-10-14,FALSE,Authorised,Phase 2,Interventional,France,"X06 to rescue acute respiratory distress syndrome 
during Covid-19 pneumonia  : FX-COVID
",50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002056-20,FR
EUCTR2020-004144-28,EudraCT,2020-10-15,2020-10-23,FALSE,Authorised,Phase 2,Interventional,United Kingdom,PROphylaxis for paTiEnts at risk of COVID-19 infecTion - PROTECT,1500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004144-28,GB
EUCTR2020-002497-27,EudraCT,2020-10-22,2020-10-27,FALSE,Authorised,Phase 4,Interventional,Czech Republic,"A randomized, open-label, phase IV monocentric study evaluating the clinical effect of oral immunomodulatory therapy with IMUNORÂ® in patients with moderate COVID-19 disease",30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002497-27,CZ
EUCTR2020-001736-95,EudraCT,2020-04-23,2020-04-28,FALSE,Authorised,Phase 2,Interventional,United Kingdom,A Phase 2 Study for the Treatment of COVID 19 in Hospitalised Patients,1800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001736-95,GB
EUCTR2020-002293-28,EudraCT,2020-05-13,2020-05-29,FALSE,Authorised,Phase 2,Interventional,Sweden,"Treatment with Omega-3 polyunsaturated fatty acids in COVID-19 patients.

A single-blind, randomized, placebo-controlled feasibility study.",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002293-28,SE
EUCTR2020-001072-15,EudraCT,2020-03-19,2020-03-26,FALSE,Authorised,Phase 2,Interventional,United Kingdom,"A phase I/II to determine efficacy, safety and immunogenicity of a candidate COVID-19 vaccine",1112,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001072-15,GB
EUCTR2020-002225-29,EudraCT,2020-04-30,2020-12-11,FALSE,Authorised,Phase 2,Interventional,France,Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections.,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002225-29,FR
ACTRN12620000554965,ANZCTR,2020-05-11,2020-05-14,FALSE,Recruiting,Not Applicable,Observational,Australia,"ADAPT - COVID-19 Study - A prospective, observational cohort study at St Vincentâ€™s Hospital Sydney",300,https://anzctr.org.au/ACTRN12620000554965.aspx,NA
ISRCTN16842454,ISRCTN,2020-11-10,2020-05-19,TRUE,Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and safety of plasma convalescent therapy in patients with COVID-19,5,http://isrctn.com/ISRCTN16842454,NA
EUCTR2020-001467-82,EudraCT,2020-04-28,2020-10-23,FALSE,Authorised,Phase 2,Interventional,Netherlands,Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001467-82,NL
EUCTR2020-004743-83,EudraCT,2020-10-26,2020-09-11,TRUE,Authorised,Phase 3,Interventional,"Moldova, Republic of, Russian Federation, United Kingdom, Canada, Turkey, Poland, France, Romania, Belgium, Germany, Argentina, South Africa, Netherlands, Ukraine, Italy, Mexico, Brazil, Chile, Peru, Portugal, Colombia, United States, Israel, Serbia, Spain, India",A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004743-83,GB
EUCTR2020-004356-16,EudraCT,2020-10-12,2020-11-18,FALSE,Authorised,Phase 3,Interventional,"United Kingdom, Belgium, United States, Spain, France","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection",5000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004356-16,GB
ACTRN12620001265965,ANZCTR,2020-11-25,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Epidemiology and clinical features in patients with COVID-19 in Mexican Southeast: A retrospective analysis,1000,https://anzctr.org.au/ACTRN12620001265965.aspx,NA
ACTRN12620001279910,ANZCTR,2020-11-26,2021-01-02,FALSE,Not Recruiting,Not Applicable,Observational,Australia,"Investigating the safety, satisfaction and efficacy of pulmonary tele rehabilitation for people with respiratory conditions, including patients recovering from COVID-19.


",100,https://anzctr.org.au/ACTRN12620001279910.aspx,NA
ACTRN12620001269921,ANZCTR,2020-11-25,2020-11-27,FALSE,Not Recruiting,Not Applicable,Observational,Australia,The Loddon Mallee Healthcare Worker COVID-19 Study,4000,https://anzctr.org.au/ACTRN12620001269921.aspx,NA
ISRCTN63459073,ISRCTN,2020-11-19,2019-01-04,TRUE,Recruiting,Not Applicable,Observational,Portugal,"COVID-19 pandemic effects on depression, anxiety and help-seeking attitudes in college students",500,http://isrctn.com/ISRCTN63459073,NA
ISRCTN68675756,ISRCTN,2020-07-01,2020-10-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Psychological intervention to improve the mental health of patients with COVID-19,93,http://isrctn.com/ISRCTN68675756,NA
ISRCTN55218215,ISRCTN,2019-07-05,2019-01-02,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Trial of financial incentives for preventing postpartum return to smoking,900,http://isrctn.com/ISRCTN55218215,NA
EUCTR2020-001553-48,EudraCT,2020-04-03,2020-04-13,FALSE,Not Recruiting,Phase 2,Interventional,France,CorticoÃ¯des au cours de la pneumonie virale Covid-19 liÃ©e Ã  lâ€™infection par le SARS-Cov-2,304,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001553-48,FR
EUCTR2020-001357-52,EudraCT,2020-05-14,2020-05-13,TRUE,Authorised,Phase 4,Interventional,Spain,Effect of the administration of Hydroxychloroquine as prevention of COVID-19 infection in patients with biological treatment or with JAK inhibitors,800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001357-52,ES
EUCTR2020-001319-26,EudraCT,2020-05-14,2020-05-14,FALSE,Authorised,Phase 3,Interventional,Spain,Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive.,1080,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001319-26,ES
EUCTR2020-001995-13,EudraCT,2020-05-21,2020-05-15,TRUE,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13,ES
EUCTR2020-002274-28,EudraCT,2020-05-21,2020-05-19,TRUE,Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28,ES
EUCTR2020-001704-42,EudraCT,2020-05-21,2020-05-15,TRUE,Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42,ES
EUCTR2020-002287-31,EudraCT,2020-05-25,2020-05-22,TRUE,Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31,ES
EUCTR2020-002037-15,EudraCT,2020-05-26,2020-05-25,TRUE,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15,ES
EUCTR2020-001960-28,EudraCT,2020-05-26,2020-05-25,TRUE,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28,ES
EUCTR2020-001841-38,EudraCT,2020-05-26,2020-05-25,TRUE,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38,ES
EUCTR2020-002456-21,EudraCT,2020-05-26,2020-05-28,FALSE,Not Recruiting,Phase 4,Interventional,Netherlands,Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002456-21,NL
EUCTR2020-001605-23,EudraCT,2020-05-31,2020-05-29,TRUE,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23,ES
EUCTR2020-002312-43,EudraCT,2020-05-31,2020-05-28,TRUE,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43,ES
EUCTR2020-001671-32,EudraCT,2020-05-31,2020-05-28,TRUE,Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32,ES
EUCTR2020-002009-25,EudraCT,2020-06-04,2020-01-10,TRUE,Authorised,Phase 2,Interventional,Czech Republic,The efficacy and safety of Eftilagimod Alpha Treatment in COVID-19 disease (EAT COVID trial),104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002009-25,CZ
EUCTR2020-001971-33,EudraCT,2020-07-22,2020-02-06,TRUE,Authorised,Phase 3,Interventional,Spain,"Pragmatic study ""CORIVER"": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID19)",45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001971-33,ES
EUCTR2020-002567-57,EudraCT,2020-10-22,2020-11-23,FALSE,Authorised,Phase 4,Interventional,United Kingdom,To determine whether administration of almitrine bismesylate can ameliorate hypoxaemia in Covid-19 and augment effectiveness of supplementary oxygen therapy and respiratory support.,112,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002567-57,GB
EUCTR2020-004682-39,EudraCT,2020-11-13,2020-11-16,FALSE,Authorised,Phase 4,Interventional,Czech Republic,"Pilot, open-label, monocentric study evaluating safety and clinical effect of application of NORMOSANGÂ® in patients with COVID-19 disease",8,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004682-39,CZ
EUCTR2020-001689-12,EudraCT,2020-10-15,2020-11-20,FALSE,Authorised,Phase 3,Interventional,"South Africa, Greece, United Kingdom, Canada, United States, Brazil, Spain",COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),6000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,GB
EUCTR2020-001113-21,EudraCT,2020-03-19,2020-03-17,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Nepal, Vietnam, Indonesia, United Kingdom",RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY),20000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001113-21,GB
EUCTR2020-001784-88,EudraCT,2020-04-17,2020-04-29,FALSE,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,FI
ChiCTR2000038537,ChiCTR,2020-09-23,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Iraq,Large vessel thrombosis in patients with COVID-19,7,http://www.chictr.org.cn/showproj.aspx?proj=60821,NA
ChiCTR2000038134,ChiCTR,2020-09-11,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,China,Half-year follow-up of novel coronavirus pneumonia (COVID-19) rehabilitated patients in Chongqing Municipality,40,http://www.chictr.org.cn/showproj.aspx?proj=61155,NA
ChiCTR2000034796,ChiCTR,2020-07-19,2020-01-18,TRUE,Recruiting,Not Applicable,Observational,China,the efficacy and safety of heparin in the treatment of novel coronavirus pneumonia (COVID-19): a retrospective single center clinical trial,160,http://www.chictr.org.cn/showproj.aspx?proj=55775,NA
IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,64,http://en.irct.ir/trial/46733,NA
IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",80,http://en.irct.ir/trial/47019,NA
IRCT20200415047080N2,IRCT,2020-11-07,2020-04-04,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of TAC cocktail in critically ill patients with Covid 19 induced pneumonia,30,http://en.irct.ir/trial/47186,NA
IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus (COVID-19),100,http://en.irct.ir/trial/47529,NA
IRCT20200415047080N1,IRCT,2020-11-02,2020-09-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Tissue plasminogen activator (TPA) for treatment of ARDS induced by Covid-19,30,http://en.irct.ir/trial/47982,NA
IRCT20200608047686N2,IRCT,2020-11-19,2020-10-17,TRUE,Recruiting,Phase 2,Interventional,Iran,The role of hemoperfusion in COVID-19,40,http://en.irct.ir/trial/48933,NA
IRCT20151227025726N24,IRCT,2020-11-25,2020-07-10,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of bromhexine administration in COVID-19,100,http://en.irct.ir/trial/49043,NA
IRCT20200624047908N1,IRCT,2020-07-05,2020-07-13,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of sofosbuvir/daclatasvir  in COVID-19 patients,1000,http://en.irct.ir/trial/49198,NA
IRCT20150623022884N3,IRCT,2020-11-18,2020-04-08,TRUE,Not Recruiting,Phase 2,Interventional,Iran,MAB98 for treatment of Covid-19,120,http://en.irct.ir/trial/49249,NA
IRCT20130428013151N2,IRCT,2020-10-28,2020-04-25,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of mucodentol on people with coronavirus,200,http://en.irct.ir/trial/49356,NA
IRCT20200506047323N6,IRCT,2020-11-17,2020-11-15,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Ivermectin in treatment of COVID-19,120,http://en.irct.ir/trial/49501,NA
IRCT20160131026298N6,IRCT,2020-09-08,2020-11-05,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Nigel-7 capsule and black seed mixture on corona,80,http://en.irct.ir/trial/50246,NA
IRCT20160919029870N3,IRCT,2020-11-24,2020-03-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of selenium in patients with Covid-19,80,http://en.irct.ir/trial/50425,NA
IRCT20200711048077N1,IRCT,2020-11-16,2020-11-21,FALSE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of respiratory Tele-rehabilitation in patient with COVID-19,60,http://en.irct.ir/trial/50721,NA
IRCT20200408046987N2,IRCT,2020-11-07,2020-10-16,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19,150,http://en.irct.ir/trial/51007,NA
IRCT20200921048786N1,IRCT,2020-11-11,2020-09-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of interferon beta-1b in the treatment of COVID-19,82,http://en.irct.ir/trial/51086,NA
IRCT20151227025726N23,IRCT,2020-11-10,2020-08-06,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19,60,http://en.irct.ir/trial/51473,NA
IRCT20181030041504N1,IRCT,2020-11-08,2020-10-07,TRUE,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation of the combined effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19",100,http://en.irct.ir/trial/51482,NA
IRCT20200428047229N3,IRCT,2020-11-25,2020-09-08,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of cupping on respiratory symptoms of COVID-19,72,http://en.irct.ir/trial/51516,NA
IRCT20201012049010N1,IRCT,2020-11-12,2020-07-22,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of balloon-blowing on dyspnea and oxygenation in non-critical adult covid-19 patients.,90,http://en.irct.ir/trial/51591,NA
IRCT20200426047206N4,IRCT,2020-11-01,2020-10-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Melatonin in treatment of COVID-19,60,http://en.irct.ir/trial/51687,NA
IRCT20150825023753N17,IRCT,2020-11-01,2020-04-13,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital,18,http://en.irct.ir/trial/51709,NA
IRCT20201015049030N1,IRCT,2020-11-07,2020-09-11,TRUE,Recruiting,Phase 2,Interventional,Iran,Effect of  Dexamethasone on treatment of COVID-19,200,http://en.irct.ir/trial/51736,NA
IRCT20201020049088N1,IRCT,2020-11-15,2020-11-05,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effects of aromatherapy on the anxiety and sleep quality of the patients with COVID-19,60,http://en.irct.ir/trial/51748,NA
IRCT20201016049048N1,IRCT,2020-11-04,2020-11-07,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of Iranian Borage on the management of Covid-19 symptoms,60,http://en.irct.ir/trial/51767,NA
IRCT20201015049036N1,IRCT,2020-11-27,2020-09-12,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Efficacy of Date Palm Leaf Extract (Phoenix dactylifera) in Patients with COVID-19 Hospitalized in Ganjavian Hospital in Dezful,100,http://en.irct.ir/trial/51772,NA
IRCT20181208041886N2,IRCT,2020-10-29,2020-11-21,FALSE,Recruiting,Not Applicable,Interventional,Iran,Aftogel and COVID-19 PCR test,60,http://en.irct.ir/trial/51774,NA
IRCT20200720048139N1,IRCT,2020-11-09,2020-11-21,FALSE,Recruiting,Phase 2,Interventional,Iran,Investigating effect of Spirulina dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units,138,http://en.irct.ir/trial/51784,NA
IRCT20200927048848N2,IRCT,2020-11-04,2020-10-31,TRUE,Recruiting,Phase 3,Interventional,Iran,squalene and COVID-19,15,http://en.irct.ir/trial/51922,NA
IRCT20170809035597N2,IRCT,2020-11-16,2020-08-17,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of  pentoxifylline in treatment and recovery of patients with COVID-19,86,http://en.irct.ir/trial/51927,NA
IRCT20191211045691N2,IRCT,2020-11-02,2020-09-14,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Doxycycline in combination with standard treatment in Covid-19 patients,60,http://en.irct.ir/trial/51951,NA
IRCT20190713044192N2,IRCT,2020-11-21,2020-11-21,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of the online child birth preparation classes on pregnant women during COVID_19  pandemic,100,http://en.irct.ir/trial/52153,NA
IRCT20170315033086N7,IRCT,2020-11-12,2020-11-21,FALSE,Recruiting,Phase 2,Interventional,Iran,An Investigation of the impact of Faramir on the clinical symptoms in patients with COVID-19,128,http://en.irct.ir/trial/52223,NA
IRCT20190804044429N4,IRCT,2020-11-25,2020-11-10,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,pentoxifyliine in COVID-19,60,http://en.irct.ir/trial/52284,NA
JPRN-UMIN000042248,UMIN-CTR,2020-11-11,2020-07-10,TRUE,Recruiting,Not Applicable,Observational,Japan,The relationship between COVID-19 Infection and new onset and prognosis of vasospastic angina: Multi-center prospective study,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048215,NA
JPRN-UMIN000042453,UMIN-CTR,2020-11-16,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Asia(except Japan),"Does emergency Orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia",14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048463,NA
JPRN-UMIN000042489,UMIN-CTR,2020-11-18,2020-04-08,TRUE,Not Recruiting,Not Applicable,Observational,Europe,Antiinflammatory and anticoagulative agents in COVID-19 pneumonia treatment,157,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048499,NA
KCT0005634,CRiS,2020-11-27,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,South Korea,EFFECTIVENESS OF COVID-19 SCREENING IN PATIENTS BEFORE SURGERY,1500,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18110,NA
ACTRN12620000788976,ANZCTR,2020-08-05,2021-04-01,FALSE,Recruiting,Phase 1,Interventional,Australia,Safety and efficacy of intranasal delivery of BromAcÂ® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients,40,https://anzctr.org.au/ACTRN12620000788976.aspx,NA
ISRCTN11946807,ISRCTN,2020-11-23,2020-11-13,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Characterisation of COVID-19 long-term immunity,250,http://isrctn.com/ISRCTN11946807,NA
ISRCTN93382525,ISRCTN,2020-08-03,2020-12-10,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,STAR (Study of Trauma And Recovery): a trial of trauma-focused psychological therapy for psychosis,300,http://isrctn.com/ISRCTN93382525,NA
ISRCTN14241621,ISRCTN,2020-07-21,2020-03-30,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,Trial of inhaled anti-viral (SNG001) for SARS-CoV-2 (COVID-19) infection,220,http://isrctn.com/ISRCTN14241621,NA
ISRCTN17898730,ISRCTN,2020-04-23,2020-07-04,FALSE,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,150,http://isrctn.com/ISRCTN17898730,NA
EUCTR2020-001654-21,EudraCT,2020-05-05,2020-09-16,FALSE,Authorised,Phase 2,Interventional,Germany,"Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumonia 
",238,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001654-21,DE
EUCTR2020-000936-23,EudraCT,2020-07-03,2020-11-08,FALSE,Authorised,Phase 3,Interventional,"France, Portugal, Austria",Safety and efficacy of treatments of COVID-19 in hospitalized adults (Discovery),3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23,PT
EUCTR2020-001228-32,EudraCT,2020-04-21,2020-04-05,TRUE,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,12390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001228-32,GB
EUCTR2020-003643-29,EudraCT,2020-10-05,2020-10-11,FALSE,Authorised,Phase 3,Interventional,"South Africa, United Kingdom, United States, Italy, Spain, France, Germany",A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S vaccine for the Prevention of COVID-19 disease in Adults Aged 18 Years and Older,30000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003643-29,GB
ChiCTR2000038609,ChiCTR,2020-09-26,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,China,Follow-up Study on Pulmonary Function and Lung Radiographic Changes in Rehabilitating COVID-19 Patients After Discharge,300,http://www.chictr.org.cn/showproj.aspx?proj=62070,NA
ChiCTR2000038256,ChiCTR,2020-09-15,2020-09-07,TRUE,Recruiting,Not Applicable,Interventional,China,Motion Modelling for Sedentary Behavior during the novel coronavirus pneumonia (COVID-19) pandemic: 10-min High Intensity Interval Training (HIIT) with Music Therapy (MT),118,http://www.chictr.org.cn/showproj.aspx?proj=61345,NA
ChiCTR2000038255,ChiCTR,2020-09-15,2020-05-25,TRUE,Recruiting,Not Applicable,Interventional,China,Establishment of psychological assistance system for the bereaved during the COVID-19 pandemic,300,http://www.chictr.org.cn/showproj.aspx?proj=61390,NA
ChiCTR2000030782,ChiCTR,2020-03-14,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,No Country Given,"Canceled by the investigator                                    The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",20,http://www.chictr.org.cn/showproj.aspx?proj=50976,NA
NCT00571389,ClinicalTrials.gov,2007-12-10,2007-11-01,TRUE,Recruiting,Not Applicable,Observational,United States,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,1000,https://clinicaltrials.gov/show/NCT00571389,NA
NCT02765191,ClinicalTrials.gov,2016-05-02,2016-04-01,TRUE,Recruiting,Not Applicable,Interventional,Sweden,MR-Evaluation of Renal Function In Septic Patients,20,https://clinicaltrials.gov/show/NCT02765191,NA
NCT03042143,ClinicalTrials.gov,2017-02-01,2019-01-07,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),75,https://clinicaltrials.gov/show/NCT03042143,NA
NCT03226886,ClinicalTrials.gov,2017-07-06,2012-02-05,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,TRACERx Renal CAPTURE Sub-study,360,https://clinicaltrials.gov/show/NCT03226886,NA
NCT03331445,ClinicalTrials.gov,2017-10-25,2017-10-24,TRUE,Recruiting,Phase 2,Interventional,Canada,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,20,https://clinicaltrials.gov/show/NCT03331445,NA
NCT03907891,ClinicalTrials.gov,2019-04-03,2019-08-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,225,https://clinicaltrials.gov/show/NCT03907891,NA
NCT04148430,ClinicalTrials.gov,2019-10-30,2019-10-30,FALSE,Recruiting,Phase 2,Interventional,United States,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,90,https://clinicaltrials.gov/show/NCT04148430,NA
NCT04177927,ClinicalTrials.gov,2019-11-20,2019-07-01,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Endtidalcarbondioxide Monitoring,60,https://clinicaltrials.gov/show/NCT04177927,NA
NCT04233268,ClinicalTrials.gov,2020-01-15,2020-04-06,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,250,https://clinicaltrials.gov/show/NCT04233268,NA
NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,80,https://clinicaltrials.gov/show/NCT04244591,NA
NCT04245631,ClinicalTrials.gov,2020-01-26,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",50,https://clinicaltrials.gov/show/NCT04245631,NA
NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,FALSE,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,0,https://clinicaltrials.gov/show/NCT04251767,NA
NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,TRUE,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,150,https://clinicaltrials.gov/show/NCT04251871,NA
NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,FALSE,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,20,https://clinicaltrials.gov/show/NCT04252118,NA
NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,FALSE,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04252274,NA
NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,FALSE,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,308,https://clinicaltrials.gov/show/NCT04252664,NA
NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,TRUE,Not Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,86,https://clinicaltrials.gov/show/NCT04252885,NA
NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,TRUE,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",100,https://clinicaltrials.gov/show/NCT04254874,NA
NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,TRUE,Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",400,https://clinicaltrials.gov/show/NCT04255017,NA
NCT04255940,ClinicalTrials.gov,2020-02-03,2020-01-20,TRUE,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,12000,https://clinicaltrials.gov/show/NCT04255940,NA
NCT04256395,ClinicalTrials.gov,2020-02-01,2020-02-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,102456,https://clinicaltrials.gov/show/NCT04256395,NA
NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,FALSE,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,237,https://clinicaltrials.gov/show/NCT04257656,NA
NCT04259892,ClinicalTrials.gov,2020-02-05,2020-02-04,TRUE,Recruiting,Not Applicable,Observational,"France, French Guiana",Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,345,https://clinicaltrials.gov/show/NCT04259892,NA
NCT04260308,ClinicalTrials.gov,2020-02-03,2020-02-03,FALSE,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,30000,https://clinicaltrials.gov/show/NCT04260308,NA
NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,380,https://clinicaltrials.gov/show/NCT04260594,NA
NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,TRUE,Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",60,https://clinicaltrials.gov/show/NCT04261270,NA
NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,80,https://clinicaltrials.gov/show/NCT04261426,NA
NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,FALSE,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04261517,NA
NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,160,https://clinicaltrials.gov/show/NCT04261907,NA
NCT04262921,ClinicalTrials.gov,2020-02-06,2020-02-08,FALSE,Recruiting,Not Applicable,Observational,France,French COVID Cohort,5000,https://clinicaltrials.gov/show/NCT04262921,NA
NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,TRUE,Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,100,https://clinicaltrials.gov/show/NCT04263402,NA
NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,FALSE,Not Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,56,https://clinicaltrials.gov/show/NCT04264533,NA
NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,FALSE,Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,10,https://clinicaltrials.gov/show/NCT04264858,NA
NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,120,https://clinicaltrials.gov/show/NCT04268537,NA
NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,TRUE,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,16,https://clinicaltrials.gov/show/NCT04269525,NA
NCT04270383,ClinicalTrials.gov,2020-02-11,2020-02-15,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,500,https://clinicaltrials.gov/show/NCT04270383,NA
NCT04272710,ClinicalTrials.gov,2020-02-12,2020-01-25,TRUE,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,0,https://clinicaltrials.gov/show/NCT04272710,NA
NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,TRUE,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,86,https://clinicaltrials.gov/show/NCT04273321,NA
NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,100,https://clinicaltrials.gov/show/NCT04273529,NA
NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,40,https://clinicaltrials.gov/show/NCT04273581,NA
NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,48,https://clinicaltrials.gov/show/NCT04273646,NA
NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,FALSE,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),18,https://clinicaltrials.gov/show/NCT04273763,NA
NCT04274322,ClinicalTrials.gov,2020-02-16,2020-02-19,FALSE,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,117,https://clinicaltrials.gov/show/NCT04274322,NA
NCT04275388,ClinicalTrials.gov,2020-02-17,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,426,https://clinicaltrials.gov/show/NCT04275388,NA
NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,FALSE,Not Recruiting,Phase 2,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,27,https://clinicaltrials.gov/show/NCT04275414,NA
NCT04275947,ClinicalTrials.gov,2020-02-17,2020-02-14,TRUE,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),450,https://clinicaltrials.gov/show/NCT04275947,NA
NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,TRUE,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",127,https://clinicaltrials.gov/show/NCT04276688,NA
NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,100,https://clinicaltrials.gov/show/NCT04276896,NA
NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,TRUE,Not Recruiting,Phase 1,Interventional,China,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,24,https://clinicaltrials.gov/show/NCT04276987,NA
NCT04278404,ClinicalTrials.gov,2020-02-18,2020-03-05,FALSE,Recruiting,Not Applicable,Observational,"Canada, United States","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",5000,https://clinicaltrials.gov/show/NCT04278404,NA
NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,300,https://clinicaltrials.gov/show/NCT04278963,NA
NCT04279197,ClinicalTrials.gov,2020-02-15,2020-04-23,FALSE,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,160,https://clinicaltrials.gov/show/NCT04279197,NA
NCT04279782,ClinicalTrials.gov,2020-02-15,2020-01-20,TRUE,Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,100,https://clinicaltrials.gov/show/NCT04279782,NA
NCT04279795,ClinicalTrials.gov,2020-02-19,2020-01-20,TRUE,Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,20,https://clinicaltrials.gov/show/NCT04279795,NA
NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,FALSE,Not Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,0,https://clinicaltrials.gov/show/NCT04280588,NA
NCT04280913,ClinicalTrials.gov,2020-02-20,2020-02-22,FALSE,Not Recruiting,Not Applicable,Observational,China,Clinical Outcomes of Patients With COVID19,0,https://clinicaltrials.gov/show/NCT04280913,NA
NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,230,https://clinicaltrials.gov/show/NCT04281693,NA
NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,TRUE,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,294,https://clinicaltrials.gov/show/NCT04282902,NA
NCT04283396,ClinicalTrials.gov,2020-02-13,2020-02-21,FALSE,Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),2000,https://clinicaltrials.gov/show/NCT04283396,NA
NCT04284046,ClinicalTrials.gov,2020-02-22,2020-01-31,TRUE,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,39,https://clinicaltrials.gov/show/NCT04284046,NA
NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04285190,NA
NCT04285801,ClinicalTrials.gov,2020-02-24,2020-02-14,TRUE,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,8,https://clinicaltrials.gov/show/NCT04285801,NA
NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,TRUE,Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,520,https://clinicaltrials.gov/show/NCT04286503,NA
NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04287686,NA
NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,FALSE,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),100,https://clinicaltrials.gov/show/NCT04288102,NA
NCT04288713,ClinicalTrials.gov,2020-02-27,2019-10-01,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Not Available,https://clinicaltrials.gov/show/NCT04288713,NA
NCT04290858,ClinicalTrials.gov,2020-02-27,2020-03-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,0,https://clinicaltrials.gov/show/NCT04290858,NA
NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,0,https://clinicaltrials.gov/show/NCT04290871,NA
NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,550,https://clinicaltrials.gov/show/NCT04291053,NA
NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,TRUE,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,11,https://clinicaltrials.gov/show/NCT04291729,NA
NCT04292327,ClinicalTrials.gov,2020-02-23,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,400,https://clinicaltrials.gov/show/NCT04292327,NA
NCT04292340,ClinicalTrials.gov,2020-02-25,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,15,https://clinicaltrials.gov/show/NCT04292340,NA
NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,FALSE,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, Singapore, United States, Italy, Spain, Japan, China, France, Germany, South Korea, Switzerland",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19),4891,https://clinicaltrials.gov/show/NCT04292899,NA
NCT04292964,ClinicalTrials.gov,2020-03-01,2020-03-01,FALSE,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,201,https://clinicaltrials.gov/show/NCT04292964,NA
NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,0,https://clinicaltrials.gov/show/NCT04293692,NA
NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2ÃŸ in the Treatment of Novel Coronavirus Patients,328,https://clinicaltrials.gov/show/NCT04293887,NA
NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),80,https://clinicaltrials.gov/show/NCT04295551,NA
NCT04298060,ClinicalTrials.gov,2020-02-28,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),280,https://clinicaltrials.gov/show/NCT04298060,NA
NCT04298814,ClinicalTrials.gov,2020-02-26,2020-08-07,FALSE,Not Recruiting,Not Applicable,Observational,China,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04298814,NA
NCT04299152,ClinicalTrials.gov,2020-02-28,2020-11-10,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,20,https://clinicaltrials.gov/show/NCT04299152,NA
NCT04299711,ClinicalTrials.gov,2020-03-04,2020-10-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,3428,https://clinicaltrials.gov/show/NCT04299711,NA
NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,TRUE,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,100,https://clinicaltrials.gov/show/NCT04299724,NA
NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,24,https://clinicaltrials.gov/show/NCT04302519,NA
NCT04302688,ClinicalTrials.gov,2020-03-07,2019-12-10,TRUE,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,669,https://clinicaltrials.gov/show/NCT04302688,NA
NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,2300,https://clinicaltrials.gov/show/NCT04304053,NA
NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,TRUE,Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,10,https://clinicaltrials.gov/show/NCT04304313,NA
NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,FALSE,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,140,https://clinicaltrials.gov/show/NCT04305106,NA
NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,FALSE,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,70,https://clinicaltrials.gov/show/NCT04305457,NA
NCT04305574,ClinicalTrials.gov,2020-03-08,2020-03-07,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,1145,https://clinicaltrials.gov/show/NCT04305574,NA
NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,FALSE,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,19491,https://clinicaltrials.gov/show/NCT04306055,NA
NCT04306497,ClinicalTrials.gov,2020-03-01,2020-01-22,TRUE,Not Recruiting,Not Applicable,Observational,China,TCM Differentiation and Treatment Protocol of COVID-19,340,https://clinicaltrials.gov/show/NCT04306497,NA
NCT04306705,ClinicalTrials.gov,2020-03-08,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,120,https://clinicaltrials.gov/show/NCT04306705,NA
NCT04307459,ClinicalTrials.gov,2020-03-10,2020-03-19,FALSE,Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and COVID-19 in Real Life,50,https://clinicaltrials.gov/show/NCT04307459,NA
NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,FALSE,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),65,https://clinicaltrials.gov/show/NCT04307693,NA
NCT04308187,ClinicalTrials.gov,2020-03-12,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,50000,https://clinicaltrials.gov/show/NCT04308187,NA
NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,FALSE,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04308317,NA
NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,TRUE,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,150,https://clinicaltrials.gov/show/NCT04310228,NA
NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,116,https://clinicaltrials.gov/show/NCT04310865,NA
NCT04311398,ClinicalTrials.gov,2020-03-14,2020-05-13,FALSE,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,100,https://clinicaltrials.gov/show/NCT04311398,NA
NCT04312100,ClinicalTrials.gov,2020-03-13,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04312100,NA
NCT04312464,ClinicalTrials.gov,2020-03-04,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,500,https://clinicaltrials.gov/show/NCT04312464,NA
NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,FALSE,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,108,https://clinicaltrials.gov/show/NCT04313127,NA
NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,FALSE,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,5,https://clinicaltrials.gov/show/NCT04313322,NA
NCT04313946,ClinicalTrials.gov,2020-03-17,2020-03-18,FALSE,Recruiting,Not Applicable,Observational,"United Kingdom, Italy, Romania",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,200,https://clinicaltrials.gov/show/NCT04313946,NA
NCT04314232,ClinicalTrials.gov,2020-03-17,2020-03-18,FALSE,Recruiting,Not Applicable,Observational,Norway,Mechanisms for Covid-19 Disease Complications,200,https://clinicaltrials.gov/show/NCT04314232,NA
NCT04314271,ClinicalTrials.gov,2020-03-16,2020-03-20,FALSE,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,80,https://clinicaltrials.gov/show/NCT04314271,NA
NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,1912,https://clinicaltrials.gov/show/NCT04315298,NA
NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,TRUE,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,38,https://clinicaltrials.gov/show/NCT04315480,NA
NCT04315870,ClinicalTrials.gov,2020-03-18,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,20,https://clinicaltrials.gov/show/NCT04315870,NA
NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,FALSE,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),500,https://clinicaltrials.gov/show/NCT04315896,NA
NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,NestaCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,90,https://clinicaltrials.gov/show/NCT04315987,NA
NCT04316299,ClinicalTrials.gov,2020-03-17,2020-02-26,TRUE,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,287,https://clinicaltrials.gov/show/NCT04316299,NA
NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,FALSE,Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,53,https://clinicaltrials.gov/show/NCT04316377,NA
NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag â„¢ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,200,https://clinicaltrials.gov/show/NCT04316728,NA
NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,FALSE,Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),400,https://clinicaltrials.gov/show/NCT04318015,NA
NCT04318301,ClinicalTrials.gov,2020-03-20,2020-03-21,FALSE,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,275,https://clinicaltrials.gov/show/NCT04318301,NA
NCT04318366,ClinicalTrials.gov,2020-03-19,2020-03-19,FALSE,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",1000,https://clinicaltrials.gov/show/NCT04318366,NA
NCT04318418,ClinicalTrials.gov,2020-03-19,2020-03-23,FALSE,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",3400,https://clinicaltrials.gov/show/NCT04318418,NA
NCT04318431,ClinicalTrials.gov,2020-03-20,2020-04-14,FALSE,Not Recruiting,Not Applicable,Interventional,France,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,605,https://clinicaltrials.gov/show/NCT04318431,NA
NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),1600,https://clinicaltrials.gov/show/NCT04318444,NA
NCT04319016,ClinicalTrials.gov,2020-03-20,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,200,https://clinicaltrials.gov/show/NCT04319016,NA
NCT04319172,ClinicalTrials.gov,2020-03-20,2020-03-12,TRUE,Recruiting,Not Applicable,Observational,Spain,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,50,https://clinicaltrials.gov/show/NCT04319172,NA
NCT04319211,ClinicalTrials.gov,2020-03-20,2020-03-25,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",200,https://clinicaltrials.gov/show/NCT04319211,NA
NCT04319315,ClinicalTrials.gov,2020-03-16,2020-03-11,TRUE,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,400,https://clinicaltrials.gov/show/NCT04319315,NA
NCT04319731,ClinicalTrials.gov,2020-03-22,2020-03-20,TRUE,Recruiting,Phase 1,Interventional,United States,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,10,https://clinicaltrials.gov/show/NCT04319731,NA
NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,150,https://clinicaltrials.gov/show/NCT04319900,NA
NCT04320017,ClinicalTrials.gov,2020-03-20,2020-03-20,FALSE,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,500,https://clinicaltrials.gov/show/NCT04320017,NA
NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,FALSE,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),216,https://clinicaltrials.gov/show/NCT04320056,NA
NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,TRUE,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,2944,https://clinicaltrials.gov/show/NCT04320238,NA
NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",200,https://clinicaltrials.gov/show/NCT04320277,NA
NCT04320472,ClinicalTrials.gov,2020-03-22,2020-03-23,FALSE,Not Recruiting,Not Applicable,Observational,"Colombia, United States, Brazil, Egypt, Mexico, Spain, France",Acute Encephalopathy in Critically Ill Patients With COVID-19,250,https://clinicaltrials.gov/show/NCT04320472,NA
NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,FALSE,Not Recruiting,Phase 3,Interventional,"Denmark, United Kingdom, Netherlands, Canada, United States, Italy, Spain, France, Germany",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,450,https://clinicaltrials.gov/show/NCT04320615,NA
NCT04320732,ClinicalTrials.gov,2020-03-23,2020-03-27,FALSE,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,250000,https://clinicaltrials.gov/show/NCT04320732,NA
NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,TRUE,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,5,https://clinicaltrials.gov/show/NCT04320953,NA
NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,FALSE,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174,NA
NCT04321265,ClinicalTrials.gov,2020-03-19,2020-03-19,FALSE,Recruiting,Not Applicable,Observational,"Denmark, France, Germany, Norway",Outcomes and Prognostic Factors in COVID-19,4000,https://clinicaltrials.gov/show/NCT04321265,NA
NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,533,https://clinicaltrials.gov/show/NCT04321369,NA
NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,49,https://clinicaltrials.gov/show/NCT04321421,NA
NCT04321616,ClinicalTrials.gov,2020-03-23,2020-03-28,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Norway,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,700,https://clinicaltrials.gov/show/NCT04321616,NA
NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,FALSE,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,7576,https://clinicaltrials.gov/show/NCT04321928,NA
NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,FALSE,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,800,https://clinicaltrials.gov/show/NCT04321993,NA
NCT04322188,ClinicalTrials.gov,2020-03-24,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,Italy,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,220,https://clinicaltrials.gov/show/NCT04322188,NA
NCT04322279,ClinicalTrials.gov,2020-03-24,2020-03-09,TRUE,Recruiting,Not Applicable,Observational,"France, French Guiana",Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,300,https://clinicaltrials.gov/show/NCT04322279,NA
NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,120,https://clinicaltrials.gov/show/NCT04322344,NA
NCT04322487,ClinicalTrials.gov,2020-03-23,2020-04-08,FALSE,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",100,https://clinicaltrials.gov/show/NCT04322487,NA
NCT04322513,ClinicalTrials.gov,2020-03-23,2020-03-24,FALSE,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,110,https://clinicaltrials.gov/show/NCT04322513,NA
NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,310,https://clinicaltrials.gov/show/NCT04322565,NA
NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,FALSE,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04322773,NA
NCT04322786,ClinicalTrials.gov,2020-03-23,1998-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",1302508,https://clinicaltrials.gov/show/NCT04322786,NA
NCT04323228,ClinicalTrials.gov,2020-03-23,2020-09-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,40,https://clinicaltrials.gov/show/NCT04323228,NA
NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,TRUE,Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,50,https://clinicaltrials.gov/show/NCT04323332,NA
NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,FALSE,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,1000,https://clinicaltrials.gov/show/NCT04323345,NA
NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,TRUE,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,500,https://clinicaltrials.gov/show/NCT04323514,NA
NCT04323592,ClinicalTrials.gov,2020-03-19,2020-03-23,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,173,https://clinicaltrials.gov/show/NCT04323592,NA
NCT04323631,ClinicalTrials.gov,2020-03-25,2020-04-30,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,0,https://clinicaltrials.gov/show/NCT04323631,NA
NCT04323644,ClinicalTrials.gov,2020-03-25,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),1000,https://clinicaltrials.gov/show/NCT04323644,NA
NCT04323761,ClinicalTrials.gov,2020-03-24,2020-09-15,FALSE,Not Recruiting,Not Applicable,Expanded Access,"United Kingdom, Canada, Austria, Poland, France, Lithuania, Romania, Denmark, Ireland, Greece, Belgium, Germany, Switzerland, Cyprus, Hungary, Iceland, Netherlands, Italy, Slovenia, Australia, Portugal, Slovakia, United States, Estonia, Israel, Spain, Czech Republic",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Not Available,https://clinicaltrials.gov/show/NCT04323761,NA
NCT04323787,ClinicalTrials.gov,2020-03-24,2020-03-30,FALSE,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,50000,https://clinicaltrials.gov/show/NCT04323787,NA
NCT04323839,ClinicalTrials.gov,2020-03-24,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),2000,https://clinicaltrials.gov/show/NCT04323839,NA
NCT04323878,ClinicalTrials.gov,2020-03-25,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,3000,https://clinicaltrials.gov/show/NCT04323878,NA
NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,FALSE,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,1000,https://clinicaltrials.gov/show/NCT04324047,NA
NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,239,https://clinicaltrials.gov/show/NCT04324073,NA
NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,FALSE,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,600,https://clinicaltrials.gov/show/NCT04324190,NA
NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,TRUE,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,4,https://clinicaltrials.gov/show/NCT04324489,NA
NCT04324684,ClinicalTrials.gov,2020-03-25,2020-03-31,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for COVID-19 Pneumonia,198,https://clinicaltrials.gov/show/NCT04324684,NA
NCT04324866,ClinicalTrials.gov,2020-03-24,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,300,https://clinicaltrials.gov/show/NCT04324866,NA
NCT04324996,ClinicalTrials.gov,2020-03-25,2020-02-21,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,90,https://clinicaltrials.gov/show/NCT04324996,NA
NCT04325412,ClinicalTrials.gov,2020-03-25,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,1000,https://clinicaltrials.gov/show/NCT04325412,NA
NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,0,https://clinicaltrials.gov/show/NCT04325672,NA
NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,FALSE,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,200,https://clinicaltrials.gov/show/NCT04325867,NA
NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,FALSE,Not Recruiting,Phase 3,Interventional,"France, Monaco",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,259,https://clinicaltrials.gov/show/NCT04325893,NA
NCT04325919,ClinicalTrials.gov,2020-03-24,2020-02-24,TRUE,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,170,https://clinicaltrials.gov/show/NCT04325919,NA
NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,TRUE,Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,10,https://clinicaltrials.gov/show/NCT04326036,NA
NCT04326075,ClinicalTrials.gov,2020-03-26,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure.,900,https://clinicaltrials.gov/show/NCT04326075,NA
NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,240,https://clinicaltrials.gov/show/NCT04326114,NA
NCT04326309,ClinicalTrials.gov,2020-03-26,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,1000,https://clinicaltrials.gov/show/NCT04326309,NA
NCT04326387,ClinicalTrials.gov,2020-03-26,2020-04-06,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,200,https://clinicaltrials.gov/show/NCT04326387,NA
NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,FALSE,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,300,https://clinicaltrials.gov/show/NCT04326426,NA
NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,FALSE,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,30,https://clinicaltrials.gov/show/NCT04326452,NA
NCT04326725,ClinicalTrials.gov,2020-03-26,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,80,https://clinicaltrials.gov/show/NCT04326725,NA
NCT04327180,ClinicalTrials.gov,2020-03-25,2020-03-30,FALSE,Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,500,https://clinicaltrials.gov/show/NCT04327180,NA
NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,FALSE,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,30,https://clinicaltrials.gov/show/NCT04327349,NA
NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,299,https://clinicaltrials.gov/show/NCT04327401,NA
NCT04327479,ClinicalTrials.gov,2020-03-26,2020-03-26,FALSE,Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,728,https://clinicaltrials.gov/show/NCT04327479,NA
NCT04327531,ClinicalTrials.gov,2020-03-27,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",200,https://clinicaltrials.gov/show/NCT04327531,NA
NCT04327674,ClinicalTrials.gov,2020-03-27,2020-03-14,TRUE,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,375,https://clinicaltrials.gov/show/NCT04327674,NA
NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,FALSE,Recruiting,Not Applicable,Interventional,"French Guiana, Guadeloupe, New Caledonia",Household Transmission Investigation Study for COVID-19 in Tropical Regions,1300,https://clinicaltrials.gov/show/NCT04328129,NA
NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,FALSE,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,75,https://clinicaltrials.gov/show/NCT04328272,NA
NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,FALSE,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,1200,https://clinicaltrials.gov/show/NCT04328285,NA
NCT04328454,ClinicalTrials.gov,2020-03-27,2020-01-30,TRUE,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,120,https://clinicaltrials.gov/show/NCT04328454,NA
NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,FALSE,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,1500,https://clinicaltrials.gov/show/NCT04328467,NA
NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),829,https://clinicaltrials.gov/show/NCT04328961,NA
NCT04329507,ClinicalTrials.gov,2020-03-26,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),200,https://clinicaltrials.gov/show/NCT04329507,NA
NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,101,https://clinicaltrials.gov/show/NCT04329533,NA
NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,FALSE,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,400,https://clinicaltrials.gov/show/NCT04329572,NA
NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,FALSE,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,148,https://clinicaltrials.gov/show/NCT04329611,NA
NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,FALSE,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04329650,NA
NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,85,https://clinicaltrials.gov/show/NCT04329832,NA
NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),2486,https://clinicaltrials.gov/show/NCT04330144,NA
NCT04330261,ClinicalTrials.gov,2020-03-30,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,12500,https://clinicaltrials.gov/show/NCT04330261,NA
NCT04330300,ClinicalTrials.gov,2020-03-30,2020-04-30,FALSE,Not Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,2414,https://clinicaltrials.gov/show/NCT04330300,NA
NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",800,https://clinicaltrials.gov/show/NCT04330495,NA
NCT04330521,ClinicalTrials.gov,2020-03-30,2020-04-08,FALSE,Recruiting,Not Applicable,Observational,United States,Impact of the Coronavirus (COVID-19) on Patients With Cancer,50,https://clinicaltrials.gov/show/NCT04330521,NA
NCT04330599,ClinicalTrials.gov,2020-03-31,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,12000,https://clinicaltrials.gov/show/NCT04330599,NA
NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,30,https://clinicaltrials.gov/show/NCT04331470,NA
NCT04331509,ClinicalTrials.gov,2020-03-31,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,"United States, United Kingdom",COVID-19 Symptom Tracker,10000000,https://clinicaltrials.gov/show/NCT04331509,NA
NCT04331574,ClinicalTrials.gov,2020-03-30,2020-03-10,TRUE,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,2000,https://clinicaltrials.gov/show/NCT04331574,NA
NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,9,https://clinicaltrials.gov/show/NCT04331613,NA
NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,TRUE,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),228,https://clinicaltrials.gov/show/NCT04331808,NA
NCT04332016,ClinicalTrials.gov,2020-03-30,2020-04-02,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,2000,https://clinicaltrials.gov/show/NCT04332016,NA
NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,10,https://clinicaltrials.gov/show/NCT04332380,NA
NCT04332666,ClinicalTrials.gov,2020-03-27,2020-09-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",60,https://clinicaltrials.gov/show/NCT04332666,NA
NCT04332835,ClinicalTrials.gov,2020-03-31,2020-08-08,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",92,https://clinicaltrials.gov/show/NCT04332835,NA
NCT04332913,ClinicalTrials.gov,2020-03-26,2020-04-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,30,https://clinicaltrials.gov/show/NCT04332913,NA
NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,115,https://clinicaltrials.gov/show/NCT04333251,NA
NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,3170,https://clinicaltrials.gov/show/NCT04333407,NA
NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,50,https://clinicaltrials.gov/show/NCT04333550,NA
NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,FALSE,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,210,https://clinicaltrials.gov/show/NCT04333589,NA
NCT04333628,ClinicalTrials.gov,2020-04-01,2020-06-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Israel,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,5,https://clinicaltrials.gov/show/NCT04333628,NA
NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,FALSE,Not Recruiting,Phase 1,Interventional,"Netherlands, France, United States, Belgium",Hydroxychloroquine in Outpatient Adults With COVID-19,8,https://clinicaltrials.gov/show/NCT04333654,NA
NCT04333693,ClinicalTrials.gov,2020-03-31,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,50,https://clinicaltrials.gov/show/NCT04333693,NA
NCT04333849,ClinicalTrials.gov,2020-04-01,2020-03-25,TRUE,Not Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,132,https://clinicaltrials.gov/show/NCT04333849,NA
NCT04333862,ClinicalTrials.gov,2020-04-01,2020-03-19,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,500,https://clinicaltrials.gov/show/NCT04333862,NA
NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04334005,NA
NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,FALSE,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,750,https://clinicaltrials.gov/show/NCT04334265,NA
NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,FALSE,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,1550,https://clinicaltrials.gov/show/NCT04334382,NA
NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,FALSE,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,230,https://clinicaltrials.gov/show/NCT04334629,NA
NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,FALSE,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,194,https://clinicaltrials.gov/show/NCT04334850,NA
NCT04334876,ClinicalTrials.gov,2020-04-02,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,340,https://clinicaltrials.gov/show/NCT04334876,NA
NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,TRUE,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,13,https://clinicaltrials.gov/show/NCT04334967,NA
NCT04335019,ClinicalTrials.gov,2020-04-02,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,300,https://clinicaltrials.gov/show/NCT04335019,NA
NCT04335032,ClinicalTrials.gov,2020-04-01,2020-11-09,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),284,https://clinicaltrials.gov/show/NCT04335032,NA
NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,FALSE,Not Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),5,https://clinicaltrials.gov/show/NCT04335071,NA
NCT04335162,ClinicalTrials.gov,2020-04-03,2020-02-28,TRUE,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),100,https://clinicaltrials.gov/show/NCT04335162,NA
NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,172,https://clinicaltrials.gov/show/NCT04335279,NA
NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-09,FALSE,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,24,https://clinicaltrials.gov/show/NCT04335305,NA
NCT04335630,ClinicalTrials.gov,2020-04-02,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,500,https://clinicaltrials.gov/show/NCT04335630,NA
NCT04335747,ClinicalTrials.gov,2020-04-03,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,333,https://clinicaltrials.gov/show/NCT04335747,NA
NCT04335773,ClinicalTrials.gov,2020-04-03,2020-04-03,FALSE,Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",350,https://clinicaltrials.gov/show/NCT04335773,NA
NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,FALSE,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,651,https://clinicaltrials.gov/show/NCT04335786,NA
NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,68,https://clinicaltrials.gov/show/NCT04335851,NA
NCT04336345,ClinicalTrials.gov,2020-04-02,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,150,https://clinicaltrials.gov/show/NCT04336345,NA
NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,TRUE,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,100,https://clinicaltrials.gov/show/NCT04336462,NA
NCT04336657,ClinicalTrials.gov,2020-04-03,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,100,https://clinicaltrials.gov/show/NCT04336657,NA
NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,440,https://clinicaltrials.gov/show/NCT04336748,NA
NCT04336774,ClinicalTrials.gov,2020-04-03,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,0,https://clinicaltrials.gov/show/NCT04336774,NA
NCT04336787,ClinicalTrials.gov,2020-04-03,2020-04-12,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",100,https://clinicaltrials.gov/show/NCT04336787,NA
NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,TRUE,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,100,https://clinicaltrials.gov/show/NCT04336904,NA
NCT04336956,ClinicalTrials.gov,2020-03-30,2020-04-07,FALSE,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,250,https://clinicaltrials.gov/show/NCT04336956,NA
NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,FALSE,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,50,https://clinicaltrials.gov/show/NCT04337008,NA
NCT04337047,ClinicalTrials.gov,2020-04-03,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,France,Distress in Crisis Situations During COVID-19,2000,https://clinicaltrials.gov/show/NCT04337047,NA
NCT04337151,ClinicalTrials.gov,2020-04-03,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,100,https://clinicaltrials.gov/show/NCT04337151,NA
NCT04337190,ClinicalTrials.gov,2020-04-03,2020-04-03,FALSE,Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),100,https://clinicaltrials.gov/show/NCT04337190,NA
NCT04337320,ClinicalTrials.gov,2020-04-05,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",40,https://clinicaltrials.gov/show/NCT04337320,NA
NCT04337346,ClinicalTrials.gov,2020-04-05,2020-04-05,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,80,https://clinicaltrials.gov/show/NCT04337346,NA
NCT04337489,ClinicalTrials.gov,2020-04-01,2020-07-28,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),200,https://clinicaltrials.gov/show/NCT04337489,NA
NCT04337502,ClinicalTrials.gov,2020-04-06,2019-12-23,TRUE,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,300,https://clinicaltrials.gov/show/NCT04337502,NA
NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,FALSE,Not Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,6000,https://clinicaltrials.gov/show/NCT04337541,NA
NCT04337762,ClinicalTrials.gov,2020-04-06,2020-04-06,FALSE,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,100000,https://clinicaltrials.gov/show/NCT04337762,NA
NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,200,https://clinicaltrials.gov/show/NCT04337788,NA
NCT04338100,ClinicalTrials.gov,2020-03-31,2020-04-06,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04338100,NA
NCT04338347,ClinicalTrials.gov,2020-03-31,2019-01-10,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,Not Available,https://clinicaltrials.gov/show/NCT04338347,NA
NCT04338360,ClinicalTrials.gov,2020-04-03,2019-01-10,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04338360,NA
NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-16,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,50,https://clinicaltrials.gov/show/NCT04338568,NA
NCT04338672,ClinicalTrials.gov,2020-04-04,2020-04-05,FALSE,Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,10000,https://clinicaltrials.gov/show/NCT04338672,NA
NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-22,FALSE,Recruiting,Phase 3,Interventional,Pakistan,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",500,https://clinicaltrials.gov/show/NCT04338698,NA
NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,96,https://clinicaltrials.gov/show/NCT04338802,NA
NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,334,https://clinicaltrials.gov/show/NCT04338906,NA
NCT04338932,ClinicalTrials.gov,2020-04-07,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 and Deep Venous Thrombosis,12,https://clinicaltrials.gov/show/NCT04338932,NA
NCT04338945,ClinicalTrials.gov,2020-04-07,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,800,https://clinicaltrials.gov/show/NCT04338945,NA
NCT04339322,ClinicalTrials.gov,2020-04-07,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,200,https://clinicaltrials.gov/show/NCT04339322,NA
NCT04339387,ClinicalTrials.gov,2020-04-06,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,1326,https://clinicaltrials.gov/show/NCT04339387,NA
NCT04339608,ClinicalTrials.gov,2020-04-07,2020-04-02,TRUE,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,10000,https://clinicaltrials.gov/show/NCT04339608,NA
NCT04339634,ClinicalTrials.gov,2020-04-07,2020-04-07,FALSE,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,12123,https://clinicaltrials.gov/show/NCT04339634,NA
NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04339660,NA
NCT04339686,ClinicalTrials.gov,2020-04-08,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,France,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,56000,https://clinicaltrials.gov/show/NCT04339686,NA
NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,FALSE,Not Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,3,https://clinicaltrials.gov/show/NCT04339816,NA
NCT04339998,ClinicalTrials.gov,2020-04-06,2020-04-15,FALSE,Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),500,https://clinicaltrials.gov/show/NCT04339998,NA
NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,FALSE,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,10,https://clinicaltrials.gov/show/NCT04340050,NA
NCT04340219,ClinicalTrials.gov,2020-03-31,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",394,https://clinicaltrials.gov/show/NCT04340219,NA
NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,TRUE,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,10,https://clinicaltrials.gov/show/NCT04340414,NA
NCT04340466,ClinicalTrials.gov,2020-04-07,2020-04-03,TRUE,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,220,https://clinicaltrials.gov/show/NCT04340466,NA
NCT04340479,ClinicalTrials.gov,2020-04-06,2020-07-30,FALSE,Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,20,https://clinicaltrials.gov/show/NCT04340479,NA
NCT04340921,ClinicalTrials.gov,2020-04-03,2020-05-14,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,140,https://clinicaltrials.gov/show/NCT04340921,NA
NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,TRUE,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,84,https://clinicaltrials.gov/show/NCT04341038,NA
NCT04341103,ClinicalTrials.gov,2020-03-16,2020-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,500,https://clinicaltrials.gov/show/NCT04341103,NA
NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,FALSE,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,550,https://clinicaltrials.gov/show/NCT04341142,NA
NCT04341168,ClinicalTrials.gov,2020-04-03,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",160,https://clinicaltrials.gov/show/NCT04341168,NA
NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,TRUE,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,1000,https://clinicaltrials.gov/show/NCT04341207,NA
NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,FALSE,Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),508,https://clinicaltrials.gov/show/NCT04341389,NA
NCT04341480,ClinicalTrials.gov,2020-04-07,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,305,https://clinicaltrials.gov/show/NCT04341480,NA
NCT04341506,ClinicalTrials.gov,2020-04-07,2020-09-08,FALSE,Recruiting,Not Applicable,Observational,United States,Non-contact ECG Sensor System for COVID19,100,https://clinicaltrials.gov/show/NCT04341506,NA
NCT04341519,ClinicalTrials.gov,2020-04-07,2020-04-06,TRUE,Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",1464,https://clinicaltrials.gov/show/NCT04341519,NA
NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,0,https://clinicaltrials.gov/show/NCT04341610,NA
NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,FALSE,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04341675,NA
NCT04341766,ClinicalTrials.gov,2020-04-01,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,106,https://clinicaltrials.gov/show/NCT04341766,NA
NCT04341792,ClinicalTrials.gov,2020-04-07,2020-04-11,FALSE,Recruiting,Not Applicable,Observational,France,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,1000,https://clinicaltrials.gov/show/NCT04341792,NA
NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",27,https://clinicaltrials.gov/show/NCT04341870,NA
NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,670,https://clinicaltrials.gov/show/NCT04341922,NA
NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,0,https://clinicaltrials.gov/show/NCT04342156,NA
NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-04,TRUE,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,400,https://clinicaltrials.gov/show/NCT04342169,NA
NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),426,https://clinicaltrials.gov/show/NCT04342182,NA
NCT04342195,ClinicalTrials.gov,2020-04-08,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,50,https://clinicaltrials.gov/show/NCT04342195,NA
NCT04342208,ClinicalTrials.gov,2020-04-07,2020-04-10,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,500,https://clinicaltrials.gov/show/NCT04342208,NA
NCT04342637,ClinicalTrials.gov,2020-04-07,2020-04-10,FALSE,Not Recruiting,Not Applicable,Observational,"Egypt, Iran, United States",COVID-19 Endoscopy Survey,163,https://clinicaltrials.gov/show/NCT04342637,NA
NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,152,https://clinicaltrials.gov/show/NCT04342650,NA
NCT04342702,ClinicalTrials.gov,2020-04-04,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,504,https://clinicaltrials.gov/show/NCT04342702,NA
NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,95,https://clinicaltrials.gov/show/NCT04342897,NA
NCT04343001,ClinicalTrials.gov,2020-04-08,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,0,https://clinicaltrials.gov/show/NCT04343001,NA
NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,FALSE,Not Recruiting,Phase 1,Interventional,Iraq,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,16,https://clinicaltrials.gov/show/NCT04343092,NA
NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,FALSE,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (OptivoÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",92,https://clinicaltrials.gov/show/NCT04343144,NA
NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,48,https://clinicaltrials.gov/show/NCT04343183,NA
NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,FALSE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,48,https://clinicaltrials.gov/show/NCT04343261,NA
NCT04343339,ClinicalTrials.gov,2020-04-08,2020-04-08,FALSE,Not Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,100,https://clinicaltrials.gov/show/NCT04343339,NA
NCT04343404,ClinicalTrials.gov,2020-04-08,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,100,https://clinicaltrials.gov/show/NCT04343404,NA
NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,86,https://clinicaltrials.gov/show/NCT04343651,NA
NCT04343690,ClinicalTrials.gov,2020-04-09,2020-03-27,TRUE,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),0,https://clinicaltrials.gov/show/NCT04343690,NA
NCT04343742,ClinicalTrials.gov,2020-04-07,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,20,https://clinicaltrials.gov/show/NCT04343742,NA
NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,FALSE,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",60,https://clinicaltrials.gov/show/NCT04343768,NA
NCT04343781,ClinicalTrials.gov,2020-04-09,2020-03-22,TRUE,Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,353,https://clinicaltrials.gov/show/NCT04343781,NA
NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,Using BiovitalsÂ® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,200,https://clinicaltrials.gov/show/NCT04343794,NA
NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,436,https://clinicaltrials.gov/show/NCT04343963,NA
NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,TRUE,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,25,https://clinicaltrials.gov/show/NCT04344106,NA
NCT04344145,ClinicalTrials.gov,2020-04-09,2020-04-16,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,693,https://clinicaltrials.gov/show/NCT04344145,NA
NCT04344171,ClinicalTrials.gov,2020-04-10,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,"Germany, Romania",CovidDB: The Covid-19 Inpatient Database,5000,https://clinicaltrials.gov/show/NCT04344171,NA
NCT04344197,ClinicalTrials.gov,2020-04-09,2020-04-02,TRUE,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",1200,https://clinicaltrials.gov/show/NCT04344197,NA
NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,149,https://clinicaltrials.gov/show/NCT04344210,NA
NCT04344249,ClinicalTrials.gov,2020-04-08,2020-04-10,FALSE,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,850,https://clinicaltrials.gov/show/NCT04344249,NA
NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,11,https://clinicaltrials.gov/show/NCT04344288,NA
NCT04344327,ClinicalTrials.gov,2020-04-09,2020-04-10,FALSE,Not Recruiting,Not Applicable,Observational,France,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,2878,https://clinicaltrials.gov/show/NCT04344327,NA
NCT04344379,ClinicalTrials.gov,2020-03-27,2020-04-17,FALSE,Not Recruiting,Phase 3,Interventional,France,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,122,https://clinicaltrials.gov/show/NCT04344379,NA
NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,FALSE,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04344431,NA
NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-13,FALSE,Not Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,600,https://clinicaltrials.gov/show/NCT04344444,NA
NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",80,https://clinicaltrials.gov/show/NCT04344457,NA
NCT04344509,ClinicalTrials.gov,2020-04-10,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,10000,https://clinicaltrials.gov/show/NCT04344509,NA
NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,FALSE,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,164,https://clinicaltrials.gov/show/NCT04344600,NA
NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,FALSE,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",808,https://clinicaltrials.gov/show/NCT04344756,NA
NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (AvastinÂ®/ZeribevÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",130,https://clinicaltrials.gov/show/NCT04344782,NA
NCT04344912,ClinicalTrials.gov,2020-04-10,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,France,Impact of COVID19 Outbreak in Cardiac Acute Care,500,https://clinicaltrials.gov/show/NCT04344912,NA
NCT04344938,ClinicalTrials.gov,2020-04-10,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,874,https://clinicaltrials.gov/show/NCT04344938,NA
NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,FALSE,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",60,https://clinicaltrials.gov/show/NCT04344951,NA
NCT04344964,ClinicalTrials.gov,2020-04-10,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,186,https://clinicaltrials.gov/show/NCT04344964,NA
NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,TRUE,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,10,https://clinicaltrials.gov/show/NCT04345276,NA
NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,FALSE,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,1100,https://clinicaltrials.gov/show/NCT04345289,NA
NCT04345315,ClinicalTrials.gov,2020-04-10,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",500,https://clinicaltrials.gov/show/NCT04345315,NA
NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,60,https://clinicaltrials.gov/show/NCT04345406,NA
NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,310,https://clinicaltrials.gov/show/NCT04345445,NA
NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,18,https://clinicaltrials.gov/show/NCT04345549,NA
NCT04345640,ClinicalTrials.gov,2020-04-10,2020-04-10,FALSE,Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,1000,https://clinicaltrials.gov/show/NCT04345640,NA
NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,TRUE,Not Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,17,https://clinicaltrials.gov/show/NCT04345692,NA
NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),7,https://clinicaltrials.gov/show/NCT04345861,NA
NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,FALSE,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,60,https://clinicaltrials.gov/show/NCT04345887,NA
NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-15,FALSE,Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",120,https://clinicaltrials.gov/show/NCT04345991,NA
NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,TRUE,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,200,https://clinicaltrials.gov/show/NCT04346017,NA
NCT04346043,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,100,https://clinicaltrials.gov/show/NCT04346043,NA
NCT04346056,ClinicalTrials.gov,2020-04-13,2020-04-14,FALSE,Recruiting,Not Applicable,Observational,Egypt,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,500,https://clinicaltrials.gov/show/NCT04346056,NA
NCT04346082,ClinicalTrials.gov,2020-04-07,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,30,https://clinicaltrials.gov/show/NCT04346082,NA
NCT04346121,ClinicalTrials.gov,2020-04-10,2020-04-28,FALSE,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,132,https://clinicaltrials.gov/show/NCT04346121,NA
NCT04346160,ClinicalTrials.gov,2020-04-10,2020-04-14,FALSE,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",25,https://clinicaltrials.gov/show/NCT04346160,NA
NCT04346186,ClinicalTrials.gov,2020-04-11,2020-04-15,FALSE,Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,30000,https://clinicaltrials.gov/show/NCT04346186,NA
NCT04346212,ClinicalTrials.gov,2020-04-10,2020-04-14,FALSE,Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04346212,NA
NCT04346264,ClinicalTrials.gov,2020-04-13,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,5500,https://clinicaltrials.gov/show/NCT04346264,NA
NCT04346342,ClinicalTrials.gov,2020-04-09,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),1122,https://clinicaltrials.gov/show/NCT04346342,NA
NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,TRUE,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,126,https://clinicaltrials.gov/show/NCT04346355,NA
NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),20,https://clinicaltrials.gov/show/NCT04346368,NA
NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,12,https://clinicaltrials.gov/show/NCT04346420,NA
NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,FALSE,Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,29,https://clinicaltrials.gov/show/NCT04346446,NA
NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,FALSE,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,10,https://clinicaltrials.gov/show/NCT04346589,NA
NCT04346602,ClinicalTrials.gov,2020-04-06,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,132,https://clinicaltrials.gov/show/NCT04346602,NA
NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,FALSE,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",120,https://clinicaltrials.gov/show/NCT04346797,NA
NCT04346810,ClinicalTrials.gov,2020-04-08,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,100,https://clinicaltrials.gov/show/NCT04346810,NA
NCT04346953,ClinicalTrials.gov,2020-04-13,2020-08-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),128,https://clinicaltrials.gov/show/NCT04346953,NA
NCT04347070,ClinicalTrials.gov,2020-04-10,2017-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,150,https://clinicaltrials.gov/show/NCT04347070,NA
NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,FALSE,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,138,https://clinicaltrials.gov/show/NCT04347226,NA
NCT04347278,ClinicalTrials.gov,2020-04-03,2020-04-22,FALSE,Recruiting,Not Applicable,Observational,Spain,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,1000,https://clinicaltrials.gov/show/NCT04347278,NA
NCT04347369,ClinicalTrials.gov,2020-03-18,2020-01-17,TRUE,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,1000,https://clinicaltrials.gov/show/NCT04347369,NA
NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,313,https://clinicaltrials.gov/show/NCT04347382,NA
NCT04347460,ClinicalTrials.gov,2020-04-08,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,20,https://clinicaltrials.gov/show/NCT04347460,NA
NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,0,https://clinicaltrials.gov/show/NCT04347512,NA
NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,FALSE,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,575,https://clinicaltrials.gov/show/NCT04347681,NA
NCT04347694,ClinicalTrials.gov,2020-04-12,2020-04-11,TRUE,Recruiting,Not Applicable,Observational,Austria,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,400,https://clinicaltrials.gov/show/NCT04347694,NA
NCT04347798,ClinicalTrials.gov,2020-04-13,2020-09-01,FALSE,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,500,https://clinicaltrials.gov/show/NCT04347798,NA
NCT04347850,ClinicalTrials.gov,2020-04-09,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),500,https://clinicaltrials.gov/show/NCT04347850,NA
NCT04347876,ClinicalTrials.gov,2020-04-14,2020-04-11,TRUE,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,100,https://clinicaltrials.gov/show/NCT04347876,NA
NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,0,https://clinicaltrials.gov/show/NCT04347889,NA
NCT04347928,ClinicalTrials.gov,2020-04-08,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,France,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,15,https://clinicaltrials.gov/show/NCT04347928,NA
NCT04347941,ClinicalTrials.gov,2020-04-08,2020-07-11,FALSE,Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,200,https://clinicaltrials.gov/show/NCT04347941,NA
NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,TRUE,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,122,https://clinicaltrials.gov/show/NCT04347980,NA
NCT04348227,ClinicalTrials.gov,2020-04-10,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,120,https://clinicaltrials.gov/show/NCT04348227,NA
NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,FALSE,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,1800,https://clinicaltrials.gov/show/NCT04348370,NA
NCT04348396,ClinicalTrials.gov,2020-04-10,2020-04-03,TRUE,Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,300,https://clinicaltrials.gov/show/NCT04348396,NA
NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,50,https://clinicaltrials.gov/show/NCT04348409,NA
NCT04348448,ClinicalTrials.gov,2020-04-13,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",100,https://clinicaltrials.gov/show/NCT04348448,NA
NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,200,https://clinicaltrials.gov/show/NCT04348474,NA
NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,FALSE,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04348513,NA
NCT04348552,ClinicalTrials.gov,2020-04-13,2020-04-28,FALSE,Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,1000,https://clinicaltrials.gov/show/NCT04348552,NA
NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,TRUE,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,94,https://clinicaltrials.gov/show/NCT04348695,NA
NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,20,https://clinicaltrials.gov/show/NCT04348877,NA
NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,FALSE,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,927,https://clinicaltrials.gov/show/NCT04348929,NA
NCT04348942,ClinicalTrials.gov,2020-04-13,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,United States,"A COVID-19 Symptom, Exposure and Immune Response Registry",10000,https://clinicaltrials.gov/show/NCT04348942,NA
NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,FALSE,Recruiting,Phase 2,Interventional,"United Kingdom, United States, Israel, Spain, Austria, France",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,230,https://clinicaltrials.gov/show/NCT04349098,NA
NCT04349202,ClinicalTrials.gov,2020-04-13,2020-04-10,TRUE,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,56000,https://clinicaltrials.gov/show/NCT04349202,NA
NCT04349228,ClinicalTrials.gov,2020-04-14,2020-04-28,FALSE,Not Recruiting,Phase 3,Interventional,Tunisia,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,0,https://clinicaltrials.gov/show/NCT04349228,NA
NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04349241,NA
NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,1800,https://clinicaltrials.gov/show/NCT04349410,NA
NCT04349540,ClinicalTrials.gov,2020-04-14,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,40,https://clinicaltrials.gov/show/NCT04349540,NA
NCT04349982,ClinicalTrials.gov,2020-04-10,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04349982,NA
NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04350086,NA
NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,TRUE,Not Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04350281,NA
NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,TRUE,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,0,https://clinicaltrials.gov/show/NCT04350450,NA
NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-17,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,0,https://clinicaltrials.gov/show/NCT04350476,NA
NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,FALSE,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04350671,NA
NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,FALSE,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04350684,NA
NCT04350710,ClinicalTrials.gov,2020-04-09,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,France,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,50,https://clinicaltrials.gov/show/NCT04350710,NA
NCT04350723,ClinicalTrials.gov,2020-04-14,2020-06-10,FALSE,Recruiting,Not Applicable,Interventional,"Canada, Saudi Arabia",Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,350,https://clinicaltrials.gov/show/NCT04350723,NA
NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,FALSE,Not Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",54,https://clinicaltrials.gov/show/NCT04350736,NA
NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,900,https://clinicaltrials.gov/show/NCT04350931,NA
NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,90,https://clinicaltrials.gov/show/NCT04351295,NA
NCT04351529,ClinicalTrials.gov,2020-04-16,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,1000,https://clinicaltrials.gov/show/NCT04351529,NA
NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,32,https://clinicaltrials.gov/show/NCT04351542,NA
NCT04351568,ClinicalTrials.gov,2020-04-14,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,874,https://clinicaltrials.gov/show/NCT04351568,NA
NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,TRUE,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,20,https://clinicaltrials.gov/show/NCT04351620,NA
NCT04351646,ClinicalTrials.gov,2020-04-07,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),500,https://clinicaltrials.gov/show/NCT04351646,NA
NCT04351659,ClinicalTrials.gov,2020-04-16,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,8,https://clinicaltrials.gov/show/NCT04351659,NA
NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,804,https://clinicaltrials.gov/show/NCT04351763,NA
NCT04351789,ClinicalTrials.gov,2020-04-11,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,66,https://clinicaltrials.gov/show/NCT04351789,NA
NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,FALSE,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,20,https://clinicaltrials.gov/show/NCT04351906,NA
NCT04351919,ClinicalTrials.gov,2020-04-15,2020-05-05,FALSE,Not Recruiting,Phase 4,Interventional,Tunisia,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),0,https://clinicaltrials.gov/show/NCT04351919,NA
NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,42,https://clinicaltrials.gov/show/NCT04352465,NA
NCT04352491,ClinicalTrials.gov,2020-04-14,2020-04-24,FALSE,Not Recruiting,Not Applicable,Observational,India,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,347,https://clinicaltrials.gov/show/NCT04352491,NA
NCT04352582,ClinicalTrials.gov,2020-04-13,2020-04-14,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Vaccination Attitudes,1194,https://clinicaltrials.gov/show/NCT04352582,NA
NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),744,https://clinicaltrials.gov/show/NCT04352608,NA
NCT04352699,ClinicalTrials.gov,2020-04-14,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,120,https://clinicaltrials.gov/show/NCT04352699,NA
NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,2000,https://clinicaltrials.gov/show/NCT04352751,NA
NCT04352764,ClinicalTrials.gov,2020-04-16,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,United States,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,5000,https://clinicaltrials.gov/show/NCT04352764,NA
NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,TRUE,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,20,https://clinicaltrials.gov/show/NCT04352803,NA
NCT04352842,ClinicalTrials.gov,2020-04-16,2020-01-21,TRUE,Not Recruiting,Not Applicable,Observational,China,Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19),51,https://clinicaltrials.gov/show/NCT04352842,NA
NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,FALSE,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),1000,https://clinicaltrials.gov/show/NCT04352933,NA
NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,FALSE,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,374,https://clinicaltrials.gov/show/NCT04352946,NA
NCT04352985,ClinicalTrials.gov,2020-04-15,2020-05-01,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Not Available,https://clinicaltrials.gov/show/NCT04352985,NA
NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,450,https://clinicaltrials.gov/show/NCT04353128,NA
NCT04353141,ClinicalTrials.gov,2020-04-16,2020-04-28,FALSE,Recruiting,Not Applicable,Observational,"United Kingdom, Italy, Belgium",International Lung UltraSound Analysis (ILUSA) Study,1850,https://clinicaltrials.gov/show/NCT04353141,NA
NCT04353206,ClinicalTrials.gov,2020-04-16,2020-06-27,FALSE,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,60,https://clinicaltrials.gov/show/NCT04353206,NA
NCT04353245,ClinicalTrials.gov,2020-04-15,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,130,https://clinicaltrials.gov/show/NCT04353245,NA
NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,58,https://clinicaltrials.gov/show/NCT04353271,NA
NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,FALSE,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,114,https://clinicaltrials.gov/show/NCT04353284,NA
NCT04353323,ClinicalTrials.gov,2020-04-15,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID 19-Caregivers IGg Seroconversion,130,https://clinicaltrials.gov/show/NCT04353323,NA
NCT04353401,ClinicalTrials.gov,2020-04-15,2020-08-03,FALSE,Recruiting,Not Applicable,Observational,United States,WGS Analysis of COVID-19 Positive Patients,5000,https://clinicaltrials.gov/show/NCT04353401,NA
NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,4000,https://clinicaltrials.gov/show/NCT04353518,NA
NCT04353609,ClinicalTrials.gov,2020-04-15,2020-04-18,FALSE,Recruiting,Not Applicable,Observational,France,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",13770,https://clinicaltrials.gov/show/NCT04353609,NA
NCT04354389,ClinicalTrials.gov,2020-04-15,2020-07-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,0,https://clinicaltrials.gov/show/NCT04354389,NA
NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,300,https://clinicaltrials.gov/show/NCT04354428,NA
NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,0,https://clinicaltrials.gov/show/NCT04354441,NA
NCT04354558,ClinicalTrials.gov,2020-04-06,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,France,French Single Centre Experience of Critically Ill Patients With Covid 19,200,https://clinicaltrials.gov/show/NCT04354558,NA
NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,200,https://clinicaltrials.gov/show/NCT04354597,NA
NCT04354701,ClinicalTrials.gov,2020-04-16,2020-03-17,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 and Cancer Consortium Registry,10000,https://clinicaltrials.gov/show/NCT04354701,NA
NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,0,https://clinicaltrials.gov/show/NCT04354714,NA
NCT04354753,ClinicalTrials.gov,2020-04-17,2020-03-28,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,AiM COVID for Covid 19 Tracking and Prediction,80,https://clinicaltrials.gov/show/NCT04354753,NA
NCT04354779,ClinicalTrials.gov,2020-04-17,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,Austria,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,3301,https://clinicaltrials.gov/show/NCT04354779,NA
NCT04354792,ClinicalTrials.gov,2020-04-16,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Asymptomatic COVID-19 Infection Among Healthcare Workers,500,https://clinicaltrials.gov/show/NCT04354792,NA
NCT04354805,ClinicalTrials.gov,2020-04-17,2020-08-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,100,https://clinicaltrials.gov/show/NCT04354805,NA
NCT04354818,ClinicalTrials.gov,2020-04-16,2020-05-11,FALSE,Recruiting,Not Applicable,Observational,Australia,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),1000,https://clinicaltrials.gov/show/NCT04354818,NA
NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,TRUE,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,90,https://clinicaltrials.gov/show/NCT04355026,NA
NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,TRUE,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",250,https://clinicaltrials.gov/show/NCT04355052,NA
NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,TRUE,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,20,https://clinicaltrials.gov/show/NCT04355247,NA
NCT04355338,ClinicalTrials.gov,2020-04-17,2020-10-25,FALSE,Recruiting,Not Applicable,Observational,Brazil,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),4100,https://clinicaltrials.gov/show/NCT04355338,NA
NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,FALSE,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),400,https://clinicaltrials.gov/show/NCT04355351,NA
NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,FALSE,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),230,https://clinicaltrials.gov/show/NCT04355429,NA
NCT04355442,ClinicalTrials.gov,2020-04-16,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Evolution of Facial Trauma During COVID Containment Measures,300,https://clinicaltrials.gov/show/NCT04355442,NA
NCT04355481,ClinicalTrials.gov,2020-04-17,2020-04-17,FALSE,Recruiting,Not Applicable,Observational,France,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,150,https://clinicaltrials.gov/show/NCT04355481,NA
NCT04355507,ClinicalTrials.gov,2020-04-17,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Computed Tomography for COVID-19 Diagnosis,10000,https://clinicaltrials.gov/show/NCT04355507,NA
NCT04355611,ClinicalTrials.gov,2020-04-17,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,France,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,2000,https://clinicaltrials.gov/show/NCT04355611,NA
NCT04355624,ClinicalTrials.gov,2020-04-17,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,France,Kidney Involvement in COVID-19 Disease (COVKID),80,https://clinicaltrials.gov/show/NCT04355624,NA
NCT04355715,ClinicalTrials.gov,2020-04-17,2019-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,200,https://clinicaltrials.gov/show/NCT04355715,NA
NCT04355741,ClinicalTrials.gov,2020-04-15,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Portugal,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",115,https://clinicaltrials.gov/show/NCT04355741,NA
NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,TRUE,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,40,https://clinicaltrials.gov/show/NCT04355754,NA
NCT04355871,ClinicalTrials.gov,2020-04-19,2020-03-18,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,4035,https://clinicaltrials.gov/show/NCT04355871,NA
NCT04355884,ClinicalTrials.gov,2020-04-19,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Hong Kong,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,100,https://clinicaltrials.gov/show/NCT04355884,NA
NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,FALSE,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04355897,NA
NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,FALSE,Recruiting,Phase 4,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,400,https://clinicaltrials.gov/show/NCT04355936,NA
NCT04356365,ClinicalTrials.gov,2020-04-21,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Norway,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),10084,https://clinicaltrials.gov/show/NCT04356365,NA
NCT04356417,ClinicalTrials.gov,2020-04-17,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,6000000,https://clinicaltrials.gov/show/NCT04356417,NA
NCT04356443,ClinicalTrials.gov,2020-04-16,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,United States,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,500,https://clinicaltrials.gov/show/NCT04356443,NA
NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,90,https://clinicaltrials.gov/show/NCT04356482,NA
NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,15,https://clinicaltrials.gov/show/NCT04356508,NA
NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,FALSE,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,40,https://clinicaltrials.gov/show/NCT04356534,NA
NCT04356560,ClinicalTrials.gov,2020-04-13,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,300,https://clinicaltrials.gov/show/NCT04356560,NA
NCT04356586,ClinicalTrials.gov,2020-04-17,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,287,https://clinicaltrials.gov/show/NCT04356586,NA
NCT04356885,ClinicalTrials.gov,2020-04-19,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 and Psychotic Symptoms in France,600,https://clinicaltrials.gov/show/NCT04356885,NA
NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,FALSE,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,243,https://clinicaltrials.gov/show/NCT04356937,NA
NCT04357028,ClinicalTrials.gov,2020-04-19,2020-07-13,FALSE,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,200,https://clinicaltrials.gov/show/NCT04357028,NA
NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,TRUE,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,10,https://clinicaltrials.gov/show/NCT04357106,NA
NCT04357275,ClinicalTrials.gov,2020-04-15,2020-03-13,TRUE,Recruiting,Not Applicable,Observational,Switzerland,The RIsk Stratification in COVID-19 Patients in the ICU Registry,10000,https://clinicaltrials.gov/show/NCT04357275,NA
NCT04357314,ClinicalTrials.gov,2020-04-19,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,6332,https://clinicaltrials.gov/show/NCT04357314,NA
NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),122,https://clinicaltrials.gov/show/NCT04357327,NA
NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04357340,NA
NCT04357418,ClinicalTrials.gov,2020-04-16,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,187,https://clinicaltrials.gov/show/NCT04357418,NA
NCT04357431,ClinicalTrials.gov,2020-04-21,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Among Egyptian Health Care Providers,565,https://clinicaltrials.gov/show/NCT04357431,NA
NCT04357535,ClinicalTrials.gov,2020-04-19,2020-05-10,FALSE,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,314,https://clinicaltrials.gov/show/NCT04357535,NA
NCT04357613,ClinicalTrials.gov,2020-04-20,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,99,https://clinicaltrials.gov/show/NCT04357613,NA
NCT04357639,ClinicalTrials.gov,2020-04-20,2020-05-28,FALSE,Recruiting,Not Applicable,Observational,France,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),1040,https://clinicaltrials.gov/show/NCT04357639,NA
NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,20,https://clinicaltrials.gov/show/NCT04357782,NA
NCT04357834,ClinicalTrials.gov,2020-04-17,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,Switzerland,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,100,https://clinicaltrials.gov/show/NCT04357834,NA
NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,120,https://clinicaltrials.gov/show/NCT04357860,NA
NCT04357977,ClinicalTrials.gov,2020-04-20,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,300,https://clinicaltrials.gov/show/NCT04357977,NA
NCT04357990,ClinicalTrials.gov,2020-04-20,2020-09-04,FALSE,Recruiting,Not Applicable,Interventional,Iceland,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,128,https://clinicaltrials.gov/show/NCT04357990,NA
NCT04358042,ClinicalTrials.gov,2020-04-08,2020-04-24,FALSE,Recruiting,Not Applicable,Observational,France,PSYCHIATRIC Disorders and Covid-19,250,https://clinicaltrials.gov/show/NCT04358042,NA
NCT04358380,ClinicalTrials.gov,2020-04-18,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Argentina,Liver Injury in Patients With COVID-19,320,https://clinicaltrials.gov/show/NCT04358380,NA
NCT04358510,ClinicalTrials.gov,2020-04-20,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Mortality Prediction Model,114,https://clinicaltrials.gov/show/NCT04358510,NA
NCT04358536,ClinicalTrials.gov,2020-04-20,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,230,https://clinicaltrials.gov/show/NCT04358536,NA
NCT04358588,ClinicalTrials.gov,2020-04-21,2014-02-01,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04358588,NA
NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,12,https://clinicaltrials.gov/show/NCT04358614,NA
NCT04358627,ClinicalTrials.gov,2020-04-15,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,80,https://clinicaltrials.gov/show/NCT04358627,NA
NCT04358640,ClinicalTrials.gov,2020-04-21,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,France,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,2000,https://clinicaltrials.gov/show/NCT04358640,NA
NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",480,https://clinicaltrials.gov/show/NCT04358809,NA
NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,0,https://clinicaltrials.gov/show/NCT04358835,NA
NCT04359121,ClinicalTrials.gov,2020-04-21,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Austria,COVID-19 and the Developement of Phobic Fears of Disease,600,https://clinicaltrials.gov/show/NCT04359121,NA
NCT04359212,ClinicalTrials.gov,2020-04-21,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,90,https://clinicaltrials.gov/show/NCT04359212,NA
NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,TRUE,Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,20,https://clinicaltrials.gov/show/NCT04359251,NA
NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,392,https://clinicaltrials.gov/show/NCT04359264,NA
NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,FALSE,Not Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,77,https://clinicaltrials.gov/show/NCT04359277,NA
NCT04359290,ClinicalTrials.gov,2020-04-15,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,15,https://clinicaltrials.gov/show/NCT04359290,NA
NCT04359303,ClinicalTrials.gov,2020-04-09,2020-07-01,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,50,https://clinicaltrials.gov/show/NCT04359303,NA
NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,FALSE,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04359316,NA
NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,TRUE,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,110,https://clinicaltrials.gov/show/NCT04359329,NA
NCT04359407,ClinicalTrials.gov,2020-04-20,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,Switzerland,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,16,https://clinicaltrials.gov/show/NCT04359407,NA
NCT04359459,ClinicalTrials.gov,2020-04-20,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,150,https://clinicaltrials.gov/show/NCT04359459,NA
NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,FALSE,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,200,https://clinicaltrials.gov/show/NCT04359537,NA
NCT04359602,ClinicalTrials.gov,2020-04-21,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 Recovered Volunteer Research Participant Pool Registry,10000,https://clinicaltrials.gov/show/NCT04359602,NA
NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,FALSE,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04359615,NA
NCT04359654,ClinicalTrials.gov,2020-04-21,2020-06-16,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,50,https://clinicaltrials.gov/show/NCT04359654,NA
NCT04359667,ClinicalTrials.gov,2020-04-16,2020-06-16,FALSE,Recruiting,Not Applicable,Observational,Croatia,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,30,https://clinicaltrials.gov/show/NCT04359667,NA
NCT04359693,ClinicalTrials.gov,2020-04-21,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,1576,https://clinicaltrials.gov/show/NCT04359693,NA
NCT04359706,ClinicalTrials.gov,2020-04-21,2020-05-08,FALSE,Recruiting,Not Applicable,Observational,France,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,30,https://clinicaltrials.gov/show/NCT04359706,NA
NCT04359849,ClinicalTrials.gov,2020-04-20,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Sequencing and Tracking of Phylogeny in COVID-19 Study,500,https://clinicaltrials.gov/show/NCT04359849,NA
NCT04359862,ClinicalTrials.gov,2020-04-21,2020-04-16,TRUE,Recruiting,Phase 4,Interventional,Spain,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,50,https://clinicaltrials.gov/show/NCT04359862,NA
NCT04359927,ClinicalTrials.gov,2020-04-21,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Spain,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,10000,https://clinicaltrials.gov/show/NCT04359927,NA
NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-25,FALSE,Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",1600,https://clinicaltrials.gov/show/NCT04359953,NA
NCT04359992,ClinicalTrials.gov,2020-04-16,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Study of Hemostasis in Case of Severe COVID-19,50,https://clinicaltrials.gov/show/NCT04359992,NA
NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,100,https://clinicaltrials.gov/show/NCT04360122,NA
NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04360356,NA
NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,FALSE,Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04360551,NA
NCT04360707,ClinicalTrials.gov,2020-04-22,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,France,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,300,https://clinicaltrials.gov/show/NCT04360707,NA
NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,FALSE,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,0,https://clinicaltrials.gov/show/NCT04360759,NA
NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,TRUE,Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",3600,https://clinicaltrials.gov/show/NCT04360811,NA
NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,FALSE,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,170,https://clinicaltrials.gov/show/NCT04360824,NA
NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,FALSE,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,10,https://clinicaltrials.gov/show/NCT04360837,NA
NCT04360850,ClinicalTrials.gov,2020-04-21,2020-04-24,FALSE,Recruiting,Not Applicable,Observational,United States,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,10000,https://clinicaltrials.gov/show/NCT04360850,NA
NCT04360863,ClinicalTrials.gov,2020-04-22,2020-04-24,FALSE,Recruiting,Not Applicable,Observational,Hong Kong,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,150,https://clinicaltrials.gov/show/NCT04360863,NA
NCT04360876,ClinicalTrials.gov,2020-04-22,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,0,https://clinicaltrials.gov/show/NCT04360876,NA
NCT04360954,ClinicalTrials.gov,2020-04-20,2020-04-23,FALSE,Not Recruiting,Not Applicable,Observational,United States,Evaluation of Antibody Tests for COVID-19,461,https://clinicaltrials.gov/show/NCT04360954,NA
NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,TRUE,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,80,https://clinicaltrials.gov/show/NCT04360980,NA
NCT04361019,ClinicalTrials.gov,2020-04-22,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Spain,Physical Activity in University Students Around COVID-19 Confinement,25000,https://clinicaltrials.gov/show/NCT04361019,NA
NCT04361032,ClinicalTrials.gov,2020-04-22,2020-09-04,FALSE,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",260,https://clinicaltrials.gov/show/NCT04361032,NA
NCT04361123,ClinicalTrials.gov,2020-04-22,2020-05-06,FALSE,Recruiting,Not Applicable,Observational,United States,Atrium COVID-19 Syndromic and Serologic Surveillance,450000,https://clinicaltrials.gov/show/NCT04361123,NA
NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,FALSE,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04361214,NA
NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,FALSE,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,220,https://clinicaltrials.gov/show/NCT04361253,NA
NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04361318,NA
NCT04361422,ClinicalTrials.gov,2020-04-21,2020-12-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,300,https://clinicaltrials.gov/show/NCT04361422,NA
NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,50,https://clinicaltrials.gov/show/NCT04361435,NA
NCT04361461,ClinicalTrials.gov,2020-04-22,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),0,https://clinicaltrials.gov/show/NCT04361461,NA
NCT04361500,ClinicalTrials.gov,2020-04-22,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Germany,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,100,https://clinicaltrials.gov/show/NCT04361500,NA
NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,TRUE,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,40,https://clinicaltrials.gov/show/NCT04361526,NA
NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,FALSE,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),0,https://clinicaltrials.gov/show/NCT04361552,NA
NCT04361565,ClinicalTrials.gov,2020-04-22,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,France,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04361565,NA
NCT04361591,ClinicalTrials.gov,2020-04-22,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Spain,COVID-19 in Liver Transplant Recipients,200,https://clinicaltrials.gov/show/NCT04361591,NA
NCT04361604,ClinicalTrials.gov,2020-04-20,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,270,https://clinicaltrials.gov/show/NCT04361604,NA
NCT04361643,ClinicalTrials.gov,2020-04-23,2020-10-27,FALSE,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,120,https://clinicaltrials.gov/show/NCT04361643,NA
NCT04361786,ClinicalTrials.gov,2020-04-17,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,10,https://clinicaltrials.gov/show/NCT04361786,NA
NCT04361903,ClinicalTrials.gov,2020-04-14,2020-04-25,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,13,https://clinicaltrials.gov/show/NCT04361903,NA
NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),37,https://clinicaltrials.gov/show/NCT04361916,NA
NCT04361981,ClinicalTrials.gov,2020-04-23,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,50,https://clinicaltrials.gov/show/NCT04361981,NA
NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-18,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,24,https://clinicaltrials.gov/show/NCT04362059,NA
NCT04362111,ClinicalTrials.gov,2020-04-21,2020-07-29,FALSE,Recruiting,Phase 3,Interventional,United States,Early Treatment of Cytokine Storm Syndrome in Covid-19,30,https://clinicaltrials.gov/show/NCT04362111,NA
NCT04362124,ClinicalTrials.gov,2020-04-21,2020-08-01,FALSE,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,0,https://clinicaltrials.gov/show/NCT04362124,NA
NCT04362150,ClinicalTrials.gov,2020-04-23,2020-04-21,TRUE,Not Recruiting,Not Applicable,Observational,United States,Long-term Impact of Infection With Novel Coronavirus (COVID-19),800,https://clinicaltrials.gov/show/NCT04362150,NA
NCT04362267,ClinicalTrials.gov,2020-04-23,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,France,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,150,https://clinicaltrials.gov/show/NCT04362267,NA
NCT04362319,ClinicalTrials.gov,2020-04-23,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Malaysia,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,85,https://clinicaltrials.gov/show/NCT04362319,NA
NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,TRUE,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",25,https://clinicaltrials.gov/show/NCT04362332,NA
NCT04362345,ClinicalTrials.gov,2020-04-20,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,France,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04362345,NA
NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,120,https://clinicaltrials.gov/show/NCT04362358,NA
NCT04362930,ClinicalTrials.gov,2020-04-24,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),2000,https://clinicaltrials.gov/show/NCT04362930,NA
NCT04362943,ClinicalTrials.gov,2020-04-22,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Spain,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,576,https://clinicaltrials.gov/show/NCT04362943,NA
NCT04362969,ClinicalTrials.gov,2020-04-23,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Ecuador,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",300,https://clinicaltrials.gov/show/NCT04362969,NA
NCT04363008,ClinicalTrials.gov,2020-04-21,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Canada,COVID 19 Biomarkers,150,https://clinicaltrials.gov/show/NCT04363008,NA
NCT04363047,ClinicalTrials.gov,2020-04-20,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",125,https://clinicaltrials.gov/show/NCT04363047,NA
NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,104,https://clinicaltrials.gov/show/NCT04363060,NA
NCT04363099,ClinicalTrials.gov,2020-04-23,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,France,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,1000,https://clinicaltrials.gov/show/NCT04363099,NA
NCT04363177,ClinicalTrials.gov,2020-04-21,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,"China, Sweden, Hong Kong",Global Mental Health of Urban Mothers,200,https://clinicaltrials.gov/show/NCT04363177,NA
NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),300,https://clinicaltrials.gov/show/NCT04363203,NA
NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,66,https://clinicaltrials.gov/show/NCT04363216,NA
NCT04363229,ClinicalTrials.gov,2020-04-23,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,250,https://clinicaltrials.gov/show/NCT04363229,NA
NCT04363268,ClinicalTrials.gov,2020-04-23,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,United States,ACCESS A Master Digital Surveillance Protocol for COVID-19,1000000,https://clinicaltrials.gov/show/NCT04363268,NA
NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-31,FALSE,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,500,https://clinicaltrials.gov/show/NCT04363385,NA
NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,FALSE,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,70,https://clinicaltrials.gov/show/NCT04363437,NA
NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,FALSE,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),1700,https://clinicaltrials.gov/show/NCT04363450,NA
NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-24,FALSE,Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,50,https://clinicaltrials.gov/show/NCT04363528,NA
NCT04363541,ClinicalTrials.gov,2020-04-23,2020-08-27,FALSE,Recruiting,Not Applicable,Interventional,Mexico,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,274,https://clinicaltrials.gov/show/NCT04363541,NA
NCT04363671,ClinicalTrials.gov,2020-04-21,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),30,https://clinicaltrials.gov/show/NCT04363671,NA
NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04363736,NA
NCT04363788,ClinicalTrials.gov,2020-04-23,2020-02-28,TRUE,Not Recruiting,Not Applicable,Observational,Poland,Needle Stick Injuries in Emergency Medical Service Practice,300,https://clinicaltrials.gov/show/NCT04363788,NA
NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,FALSE,Recruiting,Phase 3,Interventional,Dominican Republic,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04363814,NA
NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",1080,https://clinicaltrials.gov/show/NCT04363840,NA
NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04363853,NA
NCT04363866,ClinicalTrials.gov,2020-04-24,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),0,https://clinicaltrials.gov/show/NCT04363866,NA
NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,50,https://clinicaltrials.gov/show/NCT04364594,NA
NCT04364698,ClinicalTrials.gov,2020-04-24,2020-05-07,FALSE,Recruiting,Not Applicable,Observational,France,Observational Cohort of COVID-19 Patients at Raymond-Poincare,500,https://clinicaltrials.gov/show/NCT04364698,NA
NCT04364711,ClinicalTrials.gov,2020-04-20,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,2000,https://clinicaltrials.gov/show/NCT04364711,NA
NCT04364815,ClinicalTrials.gov,2020-04-22,2020-12-01,FALSE,Not Recruiting,Phase 3,Interventional,Philippines,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,0,https://clinicaltrials.gov/show/NCT04364815,NA
NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-09,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,700,https://clinicaltrials.gov/show/NCT04364893,NA
NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,TRUE,Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,0,https://clinicaltrials.gov/show/NCT04365231,NA
NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,TRUE,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,128,https://clinicaltrials.gov/show/NCT04365309,NA
NCT04365322,ClinicalTrials.gov,2020-04-25,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,France,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),160,https://clinicaltrials.gov/show/NCT04365322,NA
NCT04365348,ClinicalTrials.gov,2020-04-25,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,300,https://clinicaltrials.gov/show/NCT04365348,NA
NCT04365361,ClinicalTrials.gov,2020-04-25,2020-04-26,FALSE,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of the COVID-19 on Students.,300,https://clinicaltrials.gov/show/NCT04365361,NA
NCT04365517,ClinicalTrials.gov,2020-04-14,2020-12-29,FALSE,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,170,https://clinicaltrials.gov/show/NCT04365517,NA
NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,TRUE,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,90,https://clinicaltrials.gov/show/NCT04365608,NA
NCT04365634,ClinicalTrials.gov,2020-04-25,2020-02-02,TRUE,Not Recruiting,Not Applicable,Observational,China,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,306,https://clinicaltrials.gov/show/NCT04365634,NA
NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,270,https://clinicaltrials.gov/show/NCT04365738,NA
NCT04365816,ClinicalTrials.gov,2020-04-24,2020-04-30,FALSE,Not Recruiting,Not Applicable,Observational,France,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,403,https://clinicaltrials.gov/show/NCT04365816,NA
NCT04365881,ClinicalTrials.gov,2020-04-26,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Norway,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,10084,https://clinicaltrials.gov/show/NCT04365881,NA
NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,TRUE,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,20,https://clinicaltrials.gov/show/NCT04365972,NA
NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,FALSE,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,500,https://clinicaltrials.gov/show/NCT04365985,NA
NCT04366024,ClinicalTrials.gov,2020-04-21,2020-01-17,TRUE,Recruiting,Not Applicable,Observational,China,A Novel Nomogram to Predict Severity of COVID-19,1000,https://clinicaltrials.gov/show/NCT04366024,NA
NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,60,https://clinicaltrials.gov/show/NCT04366063,NA
NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,TRUE,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,152,https://clinicaltrials.gov/show/NCT04366089,NA
NCT04366167,ClinicalTrials.gov,2020-04-24,2020-04-18,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04366167,NA
NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,TRUE,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,314,https://clinicaltrials.gov/show/NCT04366180,NA
NCT04366206,ClinicalTrials.gov,2020-04-19,2020-03-14,TRUE,Recruiting,Not Applicable,Observational,France,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,143,https://clinicaltrials.gov/show/NCT04366206,NA
NCT04366219,ClinicalTrials.gov,2020-04-27,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",2000,https://clinicaltrials.gov/show/NCT04366219,NA
NCT04366232,ClinicalTrials.gov,2020-04-27,2020-08-19,FALSE,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),2,https://clinicaltrials.gov/show/NCT04366232,NA
NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,72,https://clinicaltrials.gov/show/NCT04366245,NA
NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,FALSE,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,106,https://clinicaltrials.gov/show/NCT04366271,NA
NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,TRUE,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,41,https://clinicaltrials.gov/show/NCT04366297,NA
NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,26,https://clinicaltrials.gov/show/NCT04366323,NA
NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,FALSE,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,40,https://clinicaltrials.gov/show/NCT04366739,NA
NCT04366752,ClinicalTrials.gov,2020-04-27,2020-04-22,TRUE,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,100,https://clinicaltrials.gov/show/NCT04366752,NA
NCT04366765,ClinicalTrials.gov,2020-04-06,2020-03-19,TRUE,Recruiting,Not Applicable,Observational,Switzerland,COVID-19 Survival - The COVIVA Study,1500,https://clinicaltrials.gov/show/NCT04366765,NA
NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,120,https://clinicaltrials.gov/show/NCT04366817,NA
NCT04366856,ClinicalTrials.gov,2020-04-26,2020-06-26,FALSE,Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),500,https://clinicaltrials.gov/show/NCT04366856,NA
NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,TRUE,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,45,https://clinicaltrials.gov/show/NCT04366882,NA
NCT04366921,ClinicalTrials.gov,2020-04-17,2020-04-10,TRUE,Recruiting,Not Applicable,Observational,"Sweden, Russian Federation, United Kingdom, Poland, Austria, France, Lithuania, Denmark, Greece, Belgium, Germany, Switzerland, Hungary, Netherlands, Italy, Portugal, Israel, Spain, Czech Republic",European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,150,https://clinicaltrials.gov/show/NCT04366921,NA
NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,TRUE,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,60,https://clinicaltrials.gov/show/NCT04366947,NA
NCT04366986,ClinicalTrials.gov,2020-04-23,2020-06-23,FALSE,Recruiting,Not Applicable,Observational,United States,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,25000,https://clinicaltrials.gov/show/NCT04366986,NA
NCT04367064,ClinicalTrials.gov,2020-04-26,2020-04-25,TRUE,Recruiting,Not Applicable,Observational,India,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),1000,https://clinicaltrials.gov/show/NCT04367064,NA
NCT04367168,ClinicalTrials.gov,2020-04-24,2020-05-27,FALSE,Recruiting,Phase 2,Interventional,Mexico,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,174,https://clinicaltrials.gov/show/NCT04367168,NA
NCT04367207,ClinicalTrials.gov,2020-04-27,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,South Africa,African Covid-19 Critical Care Outcomes Study,2000,https://clinicaltrials.gov/show/NCT04367207,NA
NCT04367337,ClinicalTrials.gov,2020-04-28,2020-03-25,TRUE,Not Recruiting,Not Applicable,Observational,"Switzerland, Australia, Portugal, Canada, Gambia, Italy, Israel, Poland, China, France, Germany, Malaysia, Singapore, Romania",Health Behavior Change During COVID-19 Pandemic,6079,https://clinicaltrials.gov/show/NCT04367337,NA
NCT04367350,ClinicalTrials.gov,2020-04-28,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,500,https://clinicaltrials.gov/show/NCT04367350,NA
NCT04367363,ClinicalTrials.gov,2020-04-17,2020-03-17,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Social Media and COVID-19,151,https://clinicaltrials.gov/show/NCT04367363,NA
NCT04367402,ClinicalTrials.gov,2020-04-17,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Italy,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",600,https://clinicaltrials.gov/show/NCT04367402,NA
NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,TRUE,Not Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,130,https://clinicaltrials.gov/show/NCT04367545,NA
NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,TRUE,Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,99,https://clinicaltrials.gov/show/NCT04367662,NA
NCT04367714,ClinicalTrials.gov,2020-04-27,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Denmark,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,300,https://clinicaltrials.gov/show/NCT04367714,NA
NCT04367792,ClinicalTrials.gov,2020-04-27,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Cardiac Injury in COVID-19: a Pathology Study,60,https://clinicaltrials.gov/show/NCT04367792,NA
NCT04367805,ClinicalTrials.gov,2020-04-27,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients With Hepatocellular Carcinoma,50,https://clinicaltrials.gov/show/NCT04367805,NA
NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,FALSE,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04367831,NA
NCT04367896,ClinicalTrials.gov,2020-04-27,2020-03-24,TRUE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,1819,https://clinicaltrials.gov/show/NCT04367896,NA
NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",400,https://clinicaltrials.gov/show/NCT04368013,NA
NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,FALSE,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,40,https://clinicaltrials.gov/show/NCT04368260,NA
NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,Telemedicine for Follow-up of Systemic Lupus Erythematosus,150,https://clinicaltrials.gov/show/NCT04368299,NA
NCT04368351,ClinicalTrials.gov,2020-04-27,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Bacteriotherapy in the Treatment of COVID-19,70,https://clinicaltrials.gov/show/NCT04368351,NA
NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,TRUE,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,5,https://clinicaltrials.gov/show/NCT04368377,NA
NCT04368390,ClinicalTrials.gov,2020-04-28,2020-04-03,TRUE,Recruiting,Not Applicable,Observational,France,Neuroradiolological Analysis of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04368390,NA
NCT04368637,ClinicalTrials.gov,2020-04-26,2020-05-03,FALSE,Recruiting,Not Applicable,Observational,Jordan,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,50,https://clinicaltrials.gov/show/NCT04368637,NA
NCT04368793,ClinicalTrials.gov,2020-04-23,2020-04-06,TRUE,Recruiting,Not Applicable,Observational,China,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,200,https://clinicaltrials.gov/show/NCT04368793,NA
NCT04368832,ClinicalTrials.gov,2020-04-22,2020-04-25,FALSE,Not Recruiting,Not Applicable,Observational,France,imPROving prenaTal carE During ConfinemenT,108,https://clinicaltrials.gov/show/NCT04368832,NA
NCT04368871,ClinicalTrials.gov,2020-04-29,2020-04-28,TRUE,Recruiting,Not Applicable,Observational,India,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,200,https://clinicaltrials.gov/show/NCT04368871,NA
NCT04368884,ClinicalTrials.gov,2020-04-29,2020-04-22,TRUE,Recruiting,Not Applicable,Observational,India,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,1000,https://clinicaltrials.gov/show/NCT04368884,NA
NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,60,https://clinicaltrials.gov/show/NCT04368923,NA
NCT04368975,ClinicalTrials.gov,2020-04-27,2020-03-12,TRUE,Recruiting,Not Applicable,Observational,Spain,ARDS Caused by COVID-19,500,https://clinicaltrials.gov/show/NCT04368975,NA
NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Australia, United States",Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,1419,https://clinicaltrials.gov/show/NCT04368988,NA
NCT04369300,ClinicalTrials.gov,2020-04-28,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,India,Anxiety And Depression During COVID-19 IN INDIA,1000,https://clinicaltrials.gov/show/NCT04369300,NA
NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,FALSE,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",200,https://clinicaltrials.gov/show/NCT04369365,NA
NCT04369378,ClinicalTrials.gov,2020-04-24,2020-08-19,FALSE,Recruiting,Not Applicable,Interventional,United States,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04369378,NA
NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,TRUE,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,115,https://clinicaltrials.gov/show/NCT04369456,NA
NCT04369690,ClinicalTrials.gov,2020-04-20,2020-04-03,TRUE,Recruiting,Not Applicable,Observational,Canada,"The Psychological, Social, and Economic Impacts of COVID-19",1000,https://clinicaltrials.gov/show/NCT04369690,NA
NCT04369794,ClinicalTrials.gov,2020-04-27,2020-08-10,FALSE,Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",1000,https://clinicaltrials.gov/show/NCT04369794,NA
NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,TRUE,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),100,https://clinicaltrials.gov/show/NCT04369820,NA
NCT04369859,ClinicalTrials.gov,2020-04-29,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,France,Obstetric and Perinatal Outcomes of Women With COVID-19,1300,https://clinicaltrials.gov/show/NCT04369859,NA
NCT04369989,ClinicalTrials.gov,2020-04-28,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,United States,Observational Study of COVID-19 Treatment Efficacy,1000,https://clinicaltrials.gov/show/NCT04369989,NA
NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,374,https://clinicaltrials.gov/show/NCT04370015,NA
NCT04370171,ClinicalTrials.gov,2020-04-27,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,France,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,610,https://clinicaltrials.gov/show/NCT04370171,NA
NCT04370197,ClinicalTrials.gov,2020-04-29,2020-03-03,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 Epidemic on Acute Stroke Management,300,https://clinicaltrials.gov/show/NCT04370197,NA
NCT04370210,ClinicalTrials.gov,2020-04-29,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,France,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,247,https://clinicaltrials.gov/show/NCT04370210,NA
NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,208,https://clinicaltrials.gov/show/NCT04370223,NA
NCT04370275,ClinicalTrials.gov,2020-04-29,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,Italy,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,235,https://clinicaltrials.gov/show/NCT04370275,NA
NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,TRUE,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04370288,NA
NCT04370678,ClinicalTrials.gov,2020-04-24,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,79,https://clinicaltrials.gov/show/NCT04370678,NA
NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,456517,https://clinicaltrials.gov/show/NCT04370886,NA
NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,FALSE,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,250,https://clinicaltrials.gov/show/NCT04370938,NA
NCT04371107,ClinicalTrials.gov,2020-04-27,2020-04-29,FALSE,Not Recruiting,Phase 3,Interventional,France,Proactive Care of Ambulatory COVID19 Patients,64,https://clinicaltrials.gov/show/NCT04371107,NA
NCT04371250,ClinicalTrials.gov,2020-04-22,2020-04-30,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,800,https://clinicaltrials.gov/show/NCT04371250,NA
NCT04371302,ClinicalTrials.gov,2020-04-29,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,145,https://clinicaltrials.gov/show/NCT04371302,NA
NCT04371315,ClinicalTrials.gov,2020-04-24,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,United States,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",400,https://clinicaltrials.gov/show/NCT04371315,NA
NCT04371328,ClinicalTrials.gov,2020-04-29,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,France,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,1860,https://clinicaltrials.gov/show/NCT04371328,NA
NCT04371406,ClinicalTrials.gov,2020-04-29,2020-04-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04371406,NA
NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,15475,https://clinicaltrials.gov/show/NCT04371419,NA
NCT04371471,ClinicalTrials.gov,2020-04-30,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Covid-19 Pandemic Triage Score,50,https://clinicaltrials.gov/show/NCT04371471,NA
NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,TRUE,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,115,https://clinicaltrials.gov/show/NCT04371510,NA
NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,1100,https://clinicaltrials.gov/show/NCT04371523,NA
NCT04371562,ClinicalTrials.gov,2020-04-30,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Predicting Death and ICU Admission in COVID-19 Patients in ED,300,https://clinicaltrials.gov/show/NCT04371562,NA
NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,TRUE,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,60,https://clinicaltrials.gov/show/NCT04371601,NA
NCT04371679,ClinicalTrials.gov,2020-04-30,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04371679,NA
NCT04371744,ClinicalTrials.gov,2020-04-30,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,France,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,100,https://clinicaltrials.gov/show/NCT04371744,NA
NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,FALSE,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,56,https://clinicaltrials.gov/show/NCT04371822,NA
NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,0,https://clinicaltrials.gov/show/NCT04371926,NA
NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),330,https://clinicaltrials.gov/show/NCT04371952,NA
NCT04371965,ClinicalTrials.gov,2020-04-29,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",24,https://clinicaltrials.gov/show/NCT04371965,NA
NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-08,FALSE,Recruiting,Phase 1,Interventional,United States,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),100,https://clinicaltrials.gov/show/NCT04372004,NA
NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,FALSE,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,1,https://clinicaltrials.gov/show/NCT04372017,NA
NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,10000,https://clinicaltrials.gov/show/NCT04372030,NA
NCT04372043,ClinicalTrials.gov,2020-04-29,2020-04-30,FALSE,Not Recruiting,Not Applicable,Observational,Lebanon,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,1200,https://clinicaltrials.gov/show/NCT04372043,NA
NCT04372199,ClinicalTrials.gov,2020-04-29,2020-04-29,FALSE,Recruiting,Not Applicable,Observational,Italy,SEVERITY SCORE FOR COVID-19 PNEUMONIA,248,https://clinicaltrials.gov/show/NCT04372199,NA
NCT04372368,ClinicalTrials.gov,2020-04-29,2019-06-19,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,Convalescent Plasma for the Treatment of Patients With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04372368,NA
NCT04372576,ClinicalTrials.gov,2020-04-29,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Hungary,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04372576,NA
NCT04372693,ClinicalTrials.gov,2020-04-27,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,180,https://clinicaltrials.gov/show/NCT04372693,NA
NCT04372979,ClinicalTrials.gov,2020-04-24,2020-09-14,FALSE,Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,80,https://clinicaltrials.gov/show/NCT04372979,NA
NCT04373109,ClinicalTrials.gov,2020-04-16,2020-04-16,FALSE,Not Recruiting,Not Applicable,Observational,Switzerland,Stroke Rehabilitation Outcome During COVID-19 Lockdown,36,https://clinicaltrials.gov/show/NCT04373109,NA
NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",2500,https://clinicaltrials.gov/show/NCT04373135,NA
NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,209,https://clinicaltrials.gov/show/NCT04373161,NA
NCT04373213,ClinicalTrials.gov,2020-04-30,2020-05-05,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,30,https://clinicaltrials.gov/show/NCT04373213,NA
NCT04373382,ClinicalTrials.gov,2020-04-30,2020-07-27,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,882,https://clinicaltrials.gov/show/NCT04373382,NA
NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,FALSE,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,602,https://clinicaltrials.gov/show/NCT04373707,NA
NCT04373798,ClinicalTrials.gov,2020-05-01,2020-05-04,FALSE,Recruiting,Not Applicable,Observational,Denmark,C-reactive Protein Levels Among Individuals With COVID-19,3000,https://clinicaltrials.gov/show/NCT04373798,NA
NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,TRUE,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,50,https://clinicaltrials.gov/show/NCT04373824,NA
NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,240,https://clinicaltrials.gov/show/NCT04374019,NA
NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,120,https://clinicaltrials.gov/show/NCT04374032,NA
NCT04374058,ClinicalTrials.gov,2020-05-01,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Less Frequency Hemodialysis and COVID-19,50,https://clinicaltrials.gov/show/NCT04374058,NA
NCT04374071,ClinicalTrials.gov,2020-04-30,2020-03-12,TRUE,Not Recruiting,Not Applicable,Observational,United States,Early Short Course Corticosteroids in COVID-19,250,https://clinicaltrials.gov/show/NCT04374071,NA
NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,FALSE,Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04374084,NA
NCT04374097,ClinicalTrials.gov,2020-05-02,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Norway,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,1778,https://clinicaltrials.gov/show/NCT04374097,NA
NCT04374110,ClinicalTrials.gov,2020-04-22,2020-05-05,FALSE,Recruiting,Not Applicable,Observational,Poland,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04374110,NA
NCT04374123,ClinicalTrials.gov,2020-04-20,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Ecuador,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,111,https://clinicaltrials.gov/show/NCT04374123,NA
NCT04374422,ClinicalTrials.gov,2020-04-29,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 Pandemic and Female Sexual Behavior,58,https://clinicaltrials.gov/show/NCT04374422,NA
NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,FALSE,Not Recruiting,Phase 2,Interventional,India,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,100,https://clinicaltrials.gov/show/NCT04374487,NA
NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,TRUE,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,116,https://clinicaltrials.gov/show/NCT04374539,NA
NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,FALSE,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,0,https://clinicaltrials.gov/show/NCT04374552,NA
NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,FALSE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,29,https://clinicaltrials.gov/show/NCT04374565,NA
NCT04374591,ClinicalTrials.gov,2020-05-02,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,Egypt,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,180,https://clinicaltrials.gov/show/NCT04374591,NA
NCT04374617,ClinicalTrials.gov,2020-05-02,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,230,https://clinicaltrials.gov/show/NCT04374617,NA
NCT04374643,ClinicalTrials.gov,2020-04-30,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,500,https://clinicaltrials.gov/show/NCT04374643,NA
NCT04374695,ClinicalTrials.gov,2020-05-03,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",700,https://clinicaltrials.gov/show/NCT04374695,NA
NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,FALSE,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,328,https://clinicaltrials.gov/show/NCT04374786,NA
NCT04374838,ClinicalTrials.gov,2020-05-01,2020-05-15,FALSE,Recruiting,Not Applicable,Observational,Egypt,Effect of COVID-19 Pandemic on Pediatric Cancer Care,20,https://clinicaltrials.gov/show/NCT04374838,NA
NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,TRUE,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,58,https://clinicaltrials.gov/show/NCT04374903,NA
NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,FALSE,Not Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,58,https://clinicaltrials.gov/show/NCT04375098,NA
NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,20,https://clinicaltrials.gov/show/NCT04375124,NA
NCT04375176,ClinicalTrials.gov,2020-05-03,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,Italy,Monocytes and NK Cells Activity in Covid-19 Patients,150,https://clinicaltrials.gov/show/NCT04375176,NA
NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,TRUE,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,308,https://clinicaltrials.gov/show/NCT04375202,NA
NCT04375501,ClinicalTrials.gov,2020-05-04,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,442,https://clinicaltrials.gov/show/NCT04375501,NA
NCT04375644,ClinicalTrials.gov,2020-05-04,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),1800,https://clinicaltrials.gov/show/NCT04375644,NA
NCT04375670,ClinicalTrials.gov,2020-04-28,2020-05-11,FALSE,Recruiting,Not Applicable,Observational,France,COVID19-FOIE National Observatory,1000,https://clinicaltrials.gov/show/NCT04375670,NA
NCT04375709,ClinicalTrials.gov,2020-05-04,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,60,https://clinicaltrials.gov/show/NCT04375709,NA
NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,20,https://clinicaltrials.gov/show/NCT04375735,NA
NCT04375748,ClinicalTrials.gov,2020-04-21,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,"France, Mayotte, RÃ©union, Martinique",Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,400,https://clinicaltrials.gov/show/NCT04375748,NA
NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),10,https://clinicaltrials.gov/show/NCT04375774,NA
NCT04376034,ClinicalTrials.gov,2020-04-19,2020-04-16,TRUE,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,240,https://clinicaltrials.gov/show/NCT04376034,NA
NCT04376398,ClinicalTrials.gov,2020-05-04,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,200,https://clinicaltrials.gov/show/NCT04376398,NA
NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,FALSE,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,450,https://clinicaltrials.gov/show/NCT04376476,NA
NCT04376580,ClinicalTrials.gov,2020-04-30,2020-04-30,FALSE,Recruiting,Not Applicable,Observational,Argentina,Use of the Nasal Cannula During COVID-19,100,https://clinicaltrials.gov/show/NCT04376580,NA
NCT04376710,ClinicalTrials.gov,2020-05-04,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Surgical Telemedicine in the COVID-19 Pandemic Era,180,https://clinicaltrials.gov/show/NCT04376710,NA
NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-20,FALSE,Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,15,https://clinicaltrials.gov/show/NCT04376788,NA
NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,40,https://clinicaltrials.gov/show/NCT04376814,NA
NCT04376840,ClinicalTrials.gov,2020-05-04,2020-05-28,FALSE,Recruiting,Not Applicable,Interventional,France,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,270,https://clinicaltrials.gov/show/NCT04376840,NA
NCT04376853,ClinicalTrials.gov,2020-04-20,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Germany,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,50,https://clinicaltrials.gov/show/NCT04376853,NA
NCT04376905,ClinicalTrials.gov,2020-04-16,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),30,https://clinicaltrials.gov/show/NCT04376905,NA
NCT04376944,ClinicalTrials.gov,2020-05-04,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,300,https://clinicaltrials.gov/show/NCT04376944,NA
NCT04376996,ClinicalTrials.gov,2020-05-04,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Slovenia,Slovenian National COVID-19 Prevalence Study,3000,https://clinicaltrials.gov/show/NCT04376996,NA
NCT04377035,ClinicalTrials.gov,2020-05-01,2020-03-31,TRUE,Recruiting,Not Applicable,Observational,Denmark,The Role of Ultrasound in COVID-19,1000,https://clinicaltrials.gov/show/NCT04377035,NA
NCT04377074,ClinicalTrials.gov,2020-05-04,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Norway,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,2880,https://clinicaltrials.gov/show/NCT04377074,NA
NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,FALSE,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,2000,https://clinicaltrials.gov/show/NCT04377308,NA
NCT04377412,ClinicalTrials.gov,2020-05-02,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,"Sweden, Australia, Hong Kong, Poland, Albania, Taiwan, United States, Israel, Italy, Norway, Spain, Lebanon, France, Germany, Czech Republic",Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,8500,https://clinicaltrials.gov/show/NCT04377412,NA
NCT04377425,ClinicalTrials.gov,2020-04-29,2020-05-07,FALSE,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,0,https://clinicaltrials.gov/show/NCT04377425,NA
NCT04377464,ClinicalTrials.gov,2020-05-04,2020-05-05,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - Quality of Life After Infection,200,https://clinicaltrials.gov/show/NCT04377464,NA
NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,FALSE,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),30,https://clinicaltrials.gov/show/NCT04377477,NA
NCT04377490,ClinicalTrials.gov,2020-05-05,2020-05-04,TRUE,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,100,https://clinicaltrials.gov/show/NCT04377490,NA
NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04377503,NA
NCT04377581,ClinicalTrials.gov,2020-04-30,2020-04-09,TRUE,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",18251,https://clinicaltrials.gov/show/NCT04377581,NA
NCT04377607,ClinicalTrials.gov,2020-05-04,2020-11-01,FALSE,Recruiting,Not Applicable,Observational,Turkey,Haemoglobin Concentration on COVID-19,200,https://clinicaltrials.gov/show/NCT04377607,NA
NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,FALSE,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,660,https://clinicaltrials.gov/show/NCT04377646,NA
NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,9,https://clinicaltrials.gov/show/NCT04377659,NA
NCT04377724,ClinicalTrials.gov,2020-05-05,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Spread and Course of COVID-19 Infections,3000,https://clinicaltrials.gov/show/NCT04377724,NA
NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,0,https://clinicaltrials.gov/show/NCT04377737,NA
NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,TRUE,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,500,https://clinicaltrials.gov/show/NCT04377750,NA
NCT04377776,ClinicalTrials.gov,2020-05-05,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",644,https://clinicaltrials.gov/show/NCT04377776,NA
NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,FALSE,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,400,https://clinicaltrials.gov/show/NCT04377802,NA
NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04377997,NA
NCT04378244,ClinicalTrials.gov,2020-05-04,2021-01-12,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,18,https://clinicaltrials.gov/show/NCT04378244,NA
NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04378257,NA
NCT04378582,ClinicalTrials.gov,2020-05-05,2020-05-07,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,1589,https://clinicaltrials.gov/show/NCT04378582,NA
NCT04378595,ClinicalTrials.gov,2020-05-05,2020-04-10,TRUE,Recruiting,Not Applicable,Observational,United States,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,1000,https://clinicaltrials.gov/show/NCT04378595,NA
NCT04378686,ClinicalTrials.gov,2020-05-05,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,Belgium,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,500,https://clinicaltrials.gov/show/NCT04378686,NA
NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,TRUE,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),90,https://clinicaltrials.gov/show/NCT04378712,NA
NCT04378738,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,Turkey,Social Media and Covid19 Pandemic,212,https://clinicaltrials.gov/show/NCT04378738,NA
NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,53,https://clinicaltrials.gov/show/NCT04378803,NA
NCT04378829,ClinicalTrials.gov,2020-05-03,2020-09-12,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",40,https://clinicaltrials.gov/show/NCT04378829,NA
NCT04378842,ClinicalTrials.gov,2020-05-05,2020-05-18,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 and ICU-acquired MDR Bacteria,690,https://clinicaltrials.gov/show/NCT04378842,NA
NCT04378881,ClinicalTrials.gov,2020-05-05,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,100,https://clinicaltrials.gov/show/NCT04378881,NA
NCT04379063,ClinicalTrials.gov,2020-05-05,2020-05-13,FALSE,Not Recruiting,Not Applicable,Observational,Canada,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,342,https://clinicaltrials.gov/show/NCT04379063,NA
NCT04379232,ClinicalTrials.gov,2020-05-04,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,France,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,112,https://clinicaltrials.gov/show/NCT04379232,NA
NCT04379245,ClinicalTrials.gov,2020-05-04,2020-04-30,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,4200,https://clinicaltrials.gov/show/NCT04379245,NA
NCT04379284,ClinicalTrials.gov,2020-05-04,2020-05-08,FALSE,Recruiting,Not Applicable,Observational,United States,Risks of COVID19 in the Pregnant Population,100,https://clinicaltrials.gov/show/NCT04379284,NA
NCT04379310,ClinicalTrials.gov,2020-05-04,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),54,https://clinicaltrials.gov/show/NCT04379310,NA
NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,FALSE,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04379336,NA
NCT04379375,ClinicalTrials.gov,2020-05-04,2020-07-27,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,45,https://clinicaltrials.gov/show/NCT04379375,NA
NCT04379440,ClinicalTrials.gov,2020-05-03,2020-04-25,TRUE,Recruiting,Not Applicable,Observational,Italy,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),1500,https://clinicaltrials.gov/show/NCT04379440,NA
NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,10,https://clinicaltrials.gov/show/NCT04379453,NA
NCT04379466,ClinicalTrials.gov,2020-05-04,2020-05-05,FALSE,Recruiting,Not Applicable,Observational,France,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,60,https://clinicaltrials.gov/show/NCT04379466,NA
NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),562,https://clinicaltrials.gov/show/NCT04379479,NA
NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,0,https://clinicaltrials.gov/show/NCT04379492,NA
NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,TRUE,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,230,https://clinicaltrials.gov/show/NCT04379531,NA
NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,TRUE,Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,60,https://clinicaltrials.gov/show/NCT04380376,NA
NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),372,https://clinicaltrials.gov/show/NCT04380519,NA
NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Canada, Mongolia",Tableted COVID-19 Therapeutic Vaccine,20,https://clinicaltrials.gov/show/NCT04380532,NA
NCT04380662,ClinicalTrials.gov,2020-05-07,2020-06-30,FALSE,Not Recruiting,Not Applicable,Observational,France,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,800,https://clinicaltrials.gov/show/NCT04380662,NA
NCT04380714,ClinicalTrials.gov,2020-05-07,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,700,https://clinicaltrials.gov/show/NCT04380714,NA
NCT04380727,ClinicalTrials.gov,2020-04-28,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,France,Almitrine and COVID-19 Related Hypoxemia,17,https://clinicaltrials.gov/show/NCT04380727,NA
NCT04380766,ClinicalTrials.gov,2020-04-21,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Covid-19 Pandemic and Pancreatic Surgery in Italy,730,https://clinicaltrials.gov/show/NCT04380766,NA
NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,FALSE,Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,106,https://clinicaltrials.gov/show/NCT04380818,NA
NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-18,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,60,https://clinicaltrials.gov/show/NCT04380935,NA
NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,170,https://clinicaltrials.gov/show/NCT04381000,NA
NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04381052,NA
NCT04381286,ClinicalTrials.gov,2020-04-23,2019-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Transpulmonary Driving Pressure in ARDS COVID19 Patients,40,https://clinicaltrials.gov/show/NCT04381286,NA
NCT04381312,ClinicalTrials.gov,2020-04-10,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,France,Direct and Indirect Impact of COVID-19 In Older Populations,1000,https://clinicaltrials.gov/show/NCT04381312,NA
NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,92,https://clinicaltrials.gov/show/NCT04381338,NA
NCT04381351,ClinicalTrials.gov,2020-05-07,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Germany,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,50,https://clinicaltrials.gov/show/NCT04381351,NA
NCT04381819,ClinicalTrials.gov,2020-05-04,2020-03-02,TRUE,Recruiting,Not Applicable,Observational,Norway,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",1000,https://clinicaltrials.gov/show/NCT04381819,NA
NCT04381845,ClinicalTrials.gov,2020-05-06,2020-12-10,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Immunity and Infections in the Psychiatric Population,200,https://clinicaltrials.gov/show/NCT04381845,NA
NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,FALSE,Not Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,196,https://clinicaltrials.gov/show/NCT04381858,NA
NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,110,https://clinicaltrials.gov/show/NCT04381871,NA
NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,FALSE,Not Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,45,https://clinicaltrials.gov/show/NCT04381884,NA
NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,FALSE,Not Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,46,https://clinicaltrials.gov/show/NCT04382066,NA
NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,32,https://clinicaltrials.gov/show/NCT04382092,NA
NCT04382131,ClinicalTrials.gov,2020-05-08,2020-06-23,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),405,https://clinicaltrials.gov/show/NCT04382131,NA
NCT04382196,ClinicalTrials.gov,2020-05-08,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 on Mental Health of Health Care Workers,497,https://clinicaltrials.gov/show/NCT04382196,NA
NCT04382469,ClinicalTrials.gov,2020-05-05,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,48,https://clinicaltrials.gov/show/NCT04382469,NA
NCT04382508,ClinicalTrials.gov,2020-05-06,2020-03-22,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,1500,https://clinicaltrials.gov/show/NCT04382508,NA
NCT04382534,ClinicalTrials.gov,2020-04-26,2020-03-10,TRUE,Recruiting,Not Applicable,Observational,China,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,300,https://clinicaltrials.gov/show/NCT04382534,NA
NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,40,https://clinicaltrials.gov/show/NCT04382547,NA
NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,TRUE,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,80,https://clinicaltrials.gov/show/NCT04382729,NA
NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,40,https://clinicaltrials.gov/show/NCT04382768,NA
NCT04382781,ClinicalTrials.gov,2020-05-06,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Immunosupressive Treatment in COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04382781,NA
NCT04382794,ClinicalTrials.gov,2020-05-08,2020-05-14,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,338,https://clinicaltrials.gov/show/NCT04382794,NA
NCT04383470,ClinicalTrials.gov,2020-04-27,2020-04-26,TRUE,Recruiting,Not Applicable,Observational,Greece,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,100000,https://clinicaltrials.gov/show/NCT04383470,NA
NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,333,https://clinicaltrials.gov/show/NCT04383535,NA
NCT04383548,ClinicalTrials.gov,2020-04-17,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,100,https://clinicaltrials.gov/show/NCT04383548,NA
NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-22,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),422,https://clinicaltrials.gov/show/NCT04383574,NA
NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,300,https://clinicaltrials.gov/show/NCT04383587,NA
NCT04383626,ClinicalTrials.gov,2020-05-10,2020-03-02,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Fear Among Dentists During COVID-19 Pandemic,216,https://clinicaltrials.gov/show/NCT04383626,NA
NCT04383652,ClinicalTrials.gov,2020-05-07,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,Australia,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,200,https://clinicaltrials.gov/show/NCT04383652,NA
NCT04383717,ClinicalTrials.gov,2020-05-04,2020-05-05,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,60,https://clinicaltrials.gov/show/NCT04383717,NA
NCT04383886,ClinicalTrials.gov,2020-05-08,2020-04-18,TRUE,Recruiting,Not Applicable,Observational,France,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04383886,NA
NCT04384029,ClinicalTrials.gov,2020-04-20,2020-03-24,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,The Geneva Covid-19 CVD Study,7000,https://clinicaltrials.gov/show/NCT04384029,NA
NCT04384250,ClinicalTrials.gov,2020-05-10,2020-05-10,FALSE,Recruiting,Not Applicable,Observational,Egypt,Genetic Basis of COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04384250,NA
NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,33,https://clinicaltrials.gov/show/NCT04384380,NA
NCT04384406,ClinicalTrials.gov,2020-05-10,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,467,https://clinicaltrials.gov/show/NCT04384406,NA
NCT04384419,ClinicalTrials.gov,2020-05-05,2020-05-29,FALSE,Recruiting,Not Applicable,Observational,France,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",1000,https://clinicaltrials.gov/show/NCT04384419,NA
NCT04384458,ClinicalTrials.gov,2020-05-08,2020-07-20,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,400,https://clinicaltrials.gov/show/NCT04384458,NA
NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,50,https://clinicaltrials.gov/show/NCT04384497,NA
NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-20,FALSE,Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,1120,https://clinicaltrials.gov/show/NCT04384549,NA
NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),100,https://clinicaltrials.gov/show/NCT04384588,NA
NCT04384614,ClinicalTrials.gov,2020-05-09,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Tunisia,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,0,https://clinicaltrials.gov/show/NCT04384614,NA
NCT04384705,ClinicalTrials.gov,2020-05-06,2020-06-17,FALSE,Recruiting,Not Applicable,Observational,France,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,500,https://clinicaltrials.gov/show/NCT04384705,NA
NCT04384887,ClinicalTrials.gov,2020-05-11,2020-04-25,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",100,https://clinicaltrials.gov/show/NCT04384887,NA
NCT04384926,ClinicalTrials.gov,2020-05-11,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Spain,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,1000,https://clinicaltrials.gov/show/NCT04384926,NA
NCT04385004,ClinicalTrials.gov,2020-05-08,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,France,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",320,https://clinicaltrials.gov/show/NCT04385004,NA
NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,FALSE,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,40,https://clinicaltrials.gov/show/NCT04385017,NA
NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,400,https://clinicaltrials.gov/show/NCT04385043,NA
NCT04385069,ClinicalTrials.gov,2020-04-20,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,500,https://clinicaltrials.gov/show/NCT04385069,NA
NCT04385108,ClinicalTrials.gov,2020-05-05,2020-03-04,TRUE,Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,170,https://clinicaltrials.gov/show/NCT04385108,NA
NCT04385121,ClinicalTrials.gov,2020-04-16,2020-04-16,FALSE,Recruiting,Not Applicable,Observational,France,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,60,https://clinicaltrials.gov/show/NCT04385121,NA
NCT04385147,ClinicalTrials.gov,2020-05-11,2020-05-18,FALSE,Not Recruiting,Not Applicable,Observational,"Peru, United States, Egypt, Germany, Singapore",Advanced Endoscopy During COVID-19,670,https://clinicaltrials.gov/show/NCT04385147,NA
NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,FALSE,Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,60,https://clinicaltrials.gov/show/NCT04385186,NA
NCT04385212,ClinicalTrials.gov,2020-04-29,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Outcomes in Hospitalized Older Patients With COVID-19,230,https://clinicaltrials.gov/show/NCT04385212,NA
NCT04385251,ClinicalTrials.gov,2020-05-08,2020-06-18,FALSE,Recruiting,Not Applicable,Observational,"Denmark, Argentina, United States, United Kingdom",International SARS-CoV-2 (COVID-19) Infection Observational Study,10000,https://clinicaltrials.gov/show/NCT04385251,NA
NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,FALSE,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",30,https://clinicaltrials.gov/show/NCT04385576,NA
NCT04385810,ClinicalTrials.gov,2020-04-29,2020-04-27,TRUE,Not Recruiting,Not Applicable,Interventional,France,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,23,https://clinicaltrials.gov/show/NCT04385810,NA
NCT04385823,ClinicalTrials.gov,2020-05-11,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,62,https://clinicaltrials.gov/show/NCT04385823,NA
NCT04385914,ClinicalTrials.gov,2020-05-11,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,200,https://clinicaltrials.gov/show/NCT04385914,NA
NCT04386083,ClinicalTrials.gov,2020-05-04,2020-06-10,FALSE,Recruiting,Not Applicable,Observational,Philippines,Neurologic Manifestations of COVID-19,1342,https://clinicaltrials.gov/show/NCT04386083,NA
NCT04386109,ClinicalTrials.gov,2020-04-15,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Neonatal Complications of Coronavirus Disease (COVID-19),500,https://clinicaltrials.gov/show/NCT04386109,NA
NCT04386265,ClinicalTrials.gov,2020-05-11,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,"United States, Poland",Compassionate Use of Hyperbaric Oxygen Therapy,100,https://clinicaltrials.gov/show/NCT04386265,NA
NCT04386369,ClinicalTrials.gov,2020-04-14,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,17,https://clinicaltrials.gov/show/NCT04386369,NA
NCT04386395,ClinicalTrials.gov,2020-05-06,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,France,Immune Changes in Severe COVID-19 Pulmonary Infections,15,https://clinicaltrials.gov/show/NCT04386395,NA
NCT04386460,ClinicalTrials.gov,2020-05-12,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,100,https://clinicaltrials.gov/show/NCT04386460,NA
NCT04386512,ClinicalTrials.gov,2020-05-12,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),89,https://clinicaltrials.gov/show/NCT04386512,NA
NCT04386668,ClinicalTrials.gov,2020-05-12,2020-05-26,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,80,https://clinicaltrials.gov/show/NCT04386668,NA
NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04386694,NA
NCT04386759,ClinicalTrials.gov,2020-04-30,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Healthcare Workers,6000,https://clinicaltrials.gov/show/NCT04386759,NA
NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,1500,https://clinicaltrials.gov/show/NCT04386850,NA
NCT04387214,ClinicalTrials.gov,2020-05-12,2020-04-13,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Pandemic and Academic Performance of Veterinary Students,1426,https://clinicaltrials.gov/show/NCT04387214,NA
NCT04387253,ClinicalTrials.gov,2020-05-12,2020-05-23,FALSE,Recruiting,Not Applicable,Interventional,France,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,80,https://clinicaltrials.gov/show/NCT04387253,NA
NCT04387279,ClinicalTrials.gov,2020-05-12,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,South Korea,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,800,https://clinicaltrials.gov/show/NCT04387279,NA
NCT04387292,ClinicalTrials.gov,2020-05-12,2020-09-07,FALSE,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,100,https://clinicaltrials.gov/show/NCT04387292,NA
NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,FALSE,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,59,https://clinicaltrials.gov/show/NCT04387409,NA
NCT04387643,ClinicalTrials.gov,2020-05-13,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,India,Protecting Health Care Workers During the COVID-19 Outbreak,52,https://clinicaltrials.gov/show/NCT04387643,NA
NCT04387786,ClinicalTrials.gov,2020-05-11,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,United States,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),5,https://clinicaltrials.gov/show/NCT04387786,NA
NCT04387799,ClinicalTrials.gov,2020-05-13,2020-05-13,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Determinants of COVID-19 Pneumonia (MC-19),520,https://clinicaltrials.gov/show/NCT04387799,NA
NCT04387890,ClinicalTrials.gov,2020-05-13,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,50,https://clinicaltrials.gov/show/NCT04387890,NA
NCT04387929,ClinicalTrials.gov,2020-05-13,2020-05-04,TRUE,Recruiting,Not Applicable,Observational,Italy,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,6000,https://clinicaltrials.gov/show/NCT04387929,NA
NCT04388410,ClinicalTrials.gov,2020-05-12,2020-08-25,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,410,https://clinicaltrials.gov/show/NCT04388410,NA
NCT04388436,ClinicalTrials.gov,2020-05-11,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Post Covid-19 Cardiopulmonary and Immunological Changes,100,https://clinicaltrials.gov/show/NCT04388436,NA
NCT04388579,ClinicalTrials.gov,2020-05-12,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Portugal,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,100,https://clinicaltrials.gov/show/NCT04388579,NA
NCT04388631,ClinicalTrials.gov,2020-05-12,2020-05-10,TRUE,Recruiting,Not Applicable,Observational,China,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,200,https://clinicaltrials.gov/show/NCT04388631,NA
NCT04388644,ClinicalTrials.gov,2020-05-12,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,Taiwan,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,300,https://clinicaltrials.gov/show/NCT04388644,NA
NCT04388657,ClinicalTrials.gov,2020-05-13,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,France,"COVID-19, bLOod Coagulation and Thrombosis",100,https://clinicaltrials.gov/show/NCT04388657,NA
NCT04388670,ClinicalTrials.gov,2020-05-12,2020-02-22,TRUE,Recruiting,Not Applicable,Observational,Italy,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,1500,https://clinicaltrials.gov/show/NCT04388670,NA
NCT04389320,ClinicalTrials.gov,2020-05-11,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Antimalarial and Covid 19 in Rheumatoid Arthritis,60,https://clinicaltrials.gov/show/NCT04389320,NA
NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,TRUE,Not Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,40,https://clinicaltrials.gov/show/NCT04389333,NA
NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,TRUE,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",50,https://clinicaltrials.gov/show/NCT04389372,NA
NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,TRUE,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),60,https://clinicaltrials.gov/show/NCT04389385,NA
NCT04389411,ClinicalTrials.gov,2020-05-13,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,600,https://clinicaltrials.gov/show/NCT04389411,NA
NCT04389450,ClinicalTrials.gov,2020-05-14,2020-10-01,FALSE,Recruiting,Phase 2,Interventional,"United States, Israel","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",140,https://clinicaltrials.gov/show/NCT04389450,NA
NCT04389463,ClinicalTrials.gov,2020-05-14,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,France,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,350,https://clinicaltrials.gov/show/NCT04389463,NA
NCT04389476,ClinicalTrials.gov,2020-05-14,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,2500,https://clinicaltrials.gov/show/NCT04389476,NA
NCT04389489,ClinicalTrials.gov,2020-05-14,2020-05-14,FALSE,Recruiting,Not Applicable,Observational,Turkey,Postpartum Sexual Function in Pregnant Women With COVID-19,140,https://clinicaltrials.gov/show/NCT04389489,NA
NCT04389515,ClinicalTrials.gov,2020-05-14,2020-05-14,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",75,https://clinicaltrials.gov/show/NCT04389515,NA
NCT04389554,ClinicalTrials.gov,2020-05-14,2020-05-14,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,D-dimer Levels in Pregnant With COVID-19,300,https://clinicaltrials.gov/show/NCT04389554,NA
NCT04389567,ClinicalTrials.gov,2020-05-13,2020-05-12,TRUE,Not Recruiting,Not Applicable,Observational,United States,Famotidine Outpatient COVID-19 Treatment Study,10,https://clinicaltrials.gov/show/NCT04389567,NA
NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,160,https://clinicaltrials.gov/show/NCT04389580,NA
NCT04389645,ClinicalTrials.gov,2020-05-13,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,Israel,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,52,https://clinicaltrials.gov/show/NCT04389645,NA
NCT04389658,ClinicalTrials.gov,2020-05-14,2020-05-07,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),1526,https://clinicaltrials.gov/show/NCT04389658,NA
NCT04389684,ClinicalTrials.gov,2020-05-14,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,France,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,120,https://clinicaltrials.gov/show/NCT04389684,NA
NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,200,https://clinicaltrials.gov/show/NCT04389801,NA
NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,TRUE,Not Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,15,https://clinicaltrials.gov/show/NCT04389944,NA
NCT04389996,ClinicalTrials.gov,2020-05-12,2020-05-14,FALSE,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,5000,https://clinicaltrials.gov/show/NCT04389996,NA
NCT04390022,ClinicalTrials.gov,2020-05-07,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,24,https://clinicaltrials.gov/show/NCT04390022,NA
NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,116,https://clinicaltrials.gov/show/NCT04390061,NA
NCT04390074,ClinicalTrials.gov,2020-05-14,2020-05-27,FALSE,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,9905,https://clinicaltrials.gov/show/NCT04390074,NA
NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),10,https://clinicaltrials.gov/show/NCT04390178,NA
NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,5,https://clinicaltrials.gov/show/NCT04390412,NA
NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,FALSE,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),1167,https://clinicaltrials.gov/show/NCT04390464,NA
NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,197,https://clinicaltrials.gov/show/NCT04390516,NA
NCT04390555,ClinicalTrials.gov,2020-05-06,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Switzerland,The Global PCHF-COVICAV Registry,1500,https://clinicaltrials.gov/show/NCT04390555,NA
NCT04390594,ClinicalTrials.gov,2020-05-14,2020-08-13,FALSE,Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,186,https://clinicaltrials.gov/show/NCT04390594,NA
NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),231,https://clinicaltrials.gov/show/NCT04391101,NA
NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,TRUE,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,108,https://clinicaltrials.gov/show/NCT04391127,NA
NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,FALSE,Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,248,https://clinicaltrials.gov/show/NCT04391140,NA
NCT04391400,ClinicalTrials.gov,2020-05-14,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",500,https://clinicaltrials.gov/show/NCT04391400,NA
NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,TRUE,Not Recruiting,Phase 2,Interventional,United States,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,10,https://clinicaltrials.gov/show/NCT04391712,NA
NCT04391829,ClinicalTrials.gov,2020-05-13,2020-08-31,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,20,https://clinicaltrials.gov/show/NCT04391829,NA
NCT04391881,ClinicalTrials.gov,2020-05-14,2020-05-30,FALSE,Recruiting,Not Applicable,Observational,Egypt,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,500,https://clinicaltrials.gov/show/NCT04391881,NA
NCT04391946,ClinicalTrials.gov,2020-05-13,2020-03-14,TRUE,Recruiting,Not Applicable,Observational,France,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,50,https://clinicaltrials.gov/show/NCT04391946,NA
NCT04392089,ClinicalTrials.gov,2020-05-14,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Denmark,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,20,https://clinicaltrials.gov/show/NCT04392089,NA
NCT04392115,ClinicalTrials.gov,2020-05-15,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The PREPARE for COVID Trial,372,https://clinicaltrials.gov/show/NCT04392115,NA
NCT04392128,ClinicalTrials.gov,2020-05-15,2020-09-02,FALSE,Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),0,https://clinicaltrials.gov/show/NCT04392128,NA
NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,TRUE,Not Recruiting,Phase 1,Interventional,"United States, United Kingdom","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",130,https://clinicaltrials.gov/show/NCT04392219,NA
NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,TRUE,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,100,https://clinicaltrials.gov/show/NCT04392232,NA
NCT04392245,ClinicalTrials.gov,2020-05-15,2020-04-15,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Proctologic Practice and Covid-19,1050,https://clinicaltrials.gov/show/NCT04392245,NA
NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,TRUE,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,500,https://clinicaltrials.gov/show/NCT04392323,NA
NCT04392388,ClinicalTrials.gov,2020-05-15,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,France,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",110000,https://clinicaltrials.gov/show/NCT04392388,NA
NCT04392401,ClinicalTrials.gov,2020-05-13,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,200,https://clinicaltrials.gov/show/NCT04392401,NA
NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,60,https://clinicaltrials.gov/show/NCT04392414,NA
NCT04392427,ClinicalTrials.gov,2020-05-12,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04392427,NA
NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,100,https://clinicaltrials.gov/show/NCT04392713,NA
NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,75,https://clinicaltrials.gov/show/NCT04392869,NA
NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,FALSE,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,520,https://clinicaltrials.gov/show/NCT04392973,NA
NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"United Kingdom, Belgium, Italy, Brazil, Mexico, Spain, France, Germany",ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,1034,https://clinicaltrials.gov/show/NCT04393038,NA
NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,126,https://clinicaltrials.gov/show/NCT04393051,NA
NCT04393077,ClinicalTrials.gov,2020-05-11,2020-05-10,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,80,https://clinicaltrials.gov/show/NCT04393077,NA
NCT04393233,ClinicalTrials.gov,2020-04-22,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,France,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,300,https://clinicaltrials.gov/show/NCT04393233,NA
NCT04393324,ClinicalTrials.gov,2020-05-17,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,Spain,The Critical Care Response to the COVID-19 Pandemic in Madrid,2500,https://clinicaltrials.gov/show/NCT04393324,NA
NCT04393402,ClinicalTrials.gov,2020-05-15,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,France,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),14,https://clinicaltrials.gov/show/NCT04393402,NA
NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,100,https://clinicaltrials.gov/show/NCT04393415,NA
NCT04393428,ClinicalTrials.gov,2020-05-14,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04393428,NA
NCT04393558,ClinicalTrials.gov,2020-05-16,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,United States,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,100,https://clinicaltrials.gov/show/NCT04393558,NA
NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,394,https://clinicaltrials.gov/show/NCT04393636,NA
NCT04393649,ClinicalTrials.gov,2020-05-13,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Canada,First Level Socio-geriatric Evaluation: ESOGER Databank,20000,https://clinicaltrials.gov/show/NCT04393649,NA
NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,1,https://clinicaltrials.gov/show/NCT04393727,NA
NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,TRUE,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,40,https://clinicaltrials.gov/show/NCT04393792,NA
NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-05,TRUE,Not Recruiting,Phase 3,Interventional,Spain,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,560,https://clinicaltrials.gov/show/NCT04393818,NA
NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,48,https://clinicaltrials.gov/show/NCT04393948,NA
NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,TRUE,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,600,https://clinicaltrials.gov/show/NCT04393961,NA
NCT04393974,ClinicalTrials.gov,2020-05-18,2020-03-24,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Cancer Patients,1000,https://clinicaltrials.gov/show/NCT04393974,NA
NCT04394000,ClinicalTrials.gov,2020-05-16,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,72,https://clinicaltrials.gov/show/NCT04394000,NA
NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,34,https://clinicaltrials.gov/show/NCT04394039,NA
NCT04394078,ClinicalTrials.gov,2020-05-18,2020-05-06,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Depression and Quality of Life,543,https://clinicaltrials.gov/show/NCT04394078,NA
NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,FALSE,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,605,https://clinicaltrials.gov/show/NCT04394117,NA
NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,Spain,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,102,https://clinicaltrials.gov/show/NCT04394169,NA
NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,TRUE,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,15,https://clinicaltrials.gov/show/NCT04394182,NA
NCT04394208,ClinicalTrials.gov,2020-05-15,2020-08-16,FALSE,Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04394208,NA
NCT04394390,ClinicalTrials.gov,2020-05-18,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,100,https://clinicaltrials.gov/show/NCT04394390,NA
NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,FALSE,Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,204,https://clinicaltrials.gov/show/NCT04394416,NA
NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,TRUE,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04394442,NA
NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-30,FALSE,Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,236,https://clinicaltrials.gov/show/NCT04394455,NA
NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,10,https://clinicaltrials.gov/show/NCT04394793,NA
NCT04395170,ClinicalTrials.gov,2020-05-15,2020-09-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,75,https://clinicaltrials.gov/show/NCT04395170,NA
NCT04395300,ClinicalTrials.gov,2020-05-19,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Sleep Quality in Healthcare Personnel During COVID-19,143,https://clinicaltrials.gov/show/NCT04395300,NA
NCT04395391,ClinicalTrials.gov,2020-05-19,2020-05-18,TRUE,Not Recruiting,Not Applicable,Observational,United States,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,30,https://clinicaltrials.gov/show/NCT04395391,NA
NCT04395482,ClinicalTrials.gov,2020-05-18,2020-05-07,TRUE,Recruiting,Not Applicable,Observational,"San Marino, Italy",Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,500,https://clinicaltrials.gov/show/NCT04395482,NA
NCT04395664,ClinicalTrials.gov,2020-05-19,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Arrhythmias in Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04395664,NA
NCT04395742,ClinicalTrials.gov,2020-05-14,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",93,https://clinicaltrials.gov/show/NCT04395742,NA
NCT04395755,ClinicalTrials.gov,2020-05-19,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,503,https://clinicaltrials.gov/show/NCT04395755,NA
NCT04395768,ClinicalTrials.gov,2020-05-18,2020-09-09,FALSE,Recruiting,Phase 2,Interventional,Australia,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,200,https://clinicaltrials.gov/show/NCT04395768,NA
NCT04395781,ClinicalTrials.gov,2020-05-18,2020-05-18,FALSE,Recruiting,Not Applicable,Observational,"Indonesia, Pakistan, Japan, China, India, Malaysia, Singapore",Pediatric Acute and Critical Care COVID-19 Registry of Asia,2000,https://clinicaltrials.gov/show/NCT04395781,NA
NCT04395794,ClinicalTrials.gov,2020-05-19,2020-05-07,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,SARS-CoV-2 Disguise Study,900,https://clinicaltrials.gov/show/NCT04395794,NA
NCT04395833,ClinicalTrials.gov,2020-05-15,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,France,National Survey on the Lockdown of Children With Disabilities,2500,https://clinicaltrials.gov/show/NCT04395833,NA
NCT04395859,ClinicalTrials.gov,2020-05-18,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,France,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,1500,https://clinicaltrials.gov/show/NCT04395859,NA
NCT04395872,ClinicalTrials.gov,2020-05-08,2020-05-28,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Psychiatric Consultation for COVID-19 Patients,54,https://clinicaltrials.gov/show/NCT04395872,NA
NCT04395885,ClinicalTrials.gov,2020-05-19,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Sexual Function During COVID 19 Pandemic,306,https://clinicaltrials.gov/show/NCT04395885,NA
NCT04396067,ClinicalTrials.gov,2020-05-18,2020-10-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,360,https://clinicaltrials.gov/show/NCT04396067,NA
NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-26,FALSE,Recruiting,Phase 2,Interventional,"Moldova, Republic of, South Africa, Belgium, Ukraine, United States, Brazil, Romania",Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),190,https://clinicaltrials.gov/show/NCT04396106,NA
NCT04396197,ClinicalTrials.gov,2020-05-17,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,92,https://clinicaltrials.gov/show/NCT04396197,NA
NCT04396210,ClinicalTrials.gov,2020-05-18,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,389,https://clinicaltrials.gov/show/NCT04396210,NA
NCT04396353,ClinicalTrials.gov,2020-05-18,2020-06-04,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,1574,https://clinicaltrials.gov/show/NCT04396353,NA
NCT04396600,ClinicalTrials.gov,2020-04-23,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,United States,The Professional Peer Resilience Initiative,1200,https://clinicaltrials.gov/show/NCT04396600,NA
NCT04397172,ClinicalTrials.gov,2020-05-20,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,50,https://clinicaltrials.gov/show/NCT04397172,NA
NCT04397237,ClinicalTrials.gov,2020-05-19,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,3600,https://clinicaltrials.gov/show/NCT04397237,NA
NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,336,https://clinicaltrials.gov/show/NCT04397328,NA
NCT04397380,ClinicalTrials.gov,2020-05-16,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,100,https://clinicaltrials.gov/show/NCT04397380,NA
NCT04397471,ClinicalTrials.gov,2020-05-13,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,10,https://clinicaltrials.gov/show/NCT04397471,NA
NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),50,https://clinicaltrials.gov/show/NCT04397497,NA
NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,TRUE,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,206,https://clinicaltrials.gov/show/NCT04397562,NA
NCT04397588,ClinicalTrials.gov,2020-05-19,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,France,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,300,https://clinicaltrials.gov/show/NCT04397588,NA
NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,TRUE,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,68,https://clinicaltrials.gov/show/NCT04397666,NA
NCT04397692,ClinicalTrials.gov,2020-05-19,2020-06-13,FALSE,Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),20,https://clinicaltrials.gov/show/NCT04397692,NA
NCT04397822,ClinicalTrials.gov,2020-05-19,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,110,https://clinicaltrials.gov/show/NCT04397822,NA
NCT04397835,ClinicalTrials.gov,2020-04-21,2020-04-17,TRUE,Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,800,https://clinicaltrials.gov/show/NCT04397835,NA
NCT04397848,ClinicalTrials.gov,2020-05-19,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,Canada,Mental Health Outcomes in Healthcare Workers During COVID-19,3852,https://clinicaltrials.gov/show/NCT04397848,NA
NCT04398043,ClinicalTrials.gov,2020-05-19,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,SARS-CoV 2 in Personal Protective Equipment,16,https://clinicaltrials.gov/show/NCT04398043,NA
NCT04398147,ClinicalTrials.gov,2020-05-18,2020-08-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,696,https://clinicaltrials.gov/show/NCT04398147,NA
NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04398277,NA
NCT04398290,ClinicalTrials.gov,2020-05-20,2020-12-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,0,https://clinicaltrials.gov/show/NCT04398290,NA
NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,70,https://clinicaltrials.gov/show/NCT04398303,NA
NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,240,https://clinicaltrials.gov/show/NCT04399005,NA
NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),2000,https://clinicaltrials.gov/show/NCT04399109,NA
NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,FALSE,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,20,https://clinicaltrials.gov/show/NCT04399317,NA
NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,100,https://clinicaltrials.gov/show/NCT04399681,NA
NCT04399733,ClinicalTrials.gov,2020-05-21,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,EMPOWER - BAME vs COVID,12800,https://clinicaltrials.gov/show/NCT04399733,NA
NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,TRUE,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,30,https://clinicaltrials.gov/show/NCT04399746,NA
NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,13,https://clinicaltrials.gov/show/NCT04399798,NA
NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,FALSE,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",842,https://clinicaltrials.gov/show/NCT04399967,NA
NCT04400006,ClinicalTrials.gov,2020-05-21,2020-05-06,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Ozone Therapy in the Prevention of COVID-19 Infection,71,https://clinicaltrials.gov/show/NCT04400006,NA
NCT04400019,ClinicalTrials.gov,2020-05-20,2020-09-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),1930,https://clinicaltrials.gov/show/NCT04400019,NA
NCT04400448,ClinicalTrials.gov,2020-05-14,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Acceptance of Telemedicine During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04400448,NA
NCT04400812,ClinicalTrials.gov,2020-05-20,2020-05-19,TRUE,Recruiting,Not Applicable,Observational,Egypt,Attitude and Perception Towards COVID-19 Pandemic,5000,https://clinicaltrials.gov/show/NCT04400812,NA
NCT04400877,ClinicalTrials.gov,2020-05-22,2020-06-08,FALSE,Not Recruiting,Not Applicable,Observational,Sweden,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,7795,https://clinicaltrials.gov/show/NCT04400877,NA
NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-02,FALSE,Recruiting,Phase 2,Interventional,Singapore,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,30,https://clinicaltrials.gov/show/NCT04400929,NA
NCT04401033,ClinicalTrials.gov,2020-05-21,2020-05-11,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),450,https://clinicaltrials.gov/show/NCT04401033,NA
NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,France,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,4000,https://clinicaltrials.gov/show/NCT04401046,NA
NCT04401072,ClinicalTrials.gov,2020-05-22,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,Egypt,Attitude of Egyptian Population Toward COVID 19 in Ramadan,500,https://clinicaltrials.gov/show/NCT04401072,NA
NCT04401085,ClinicalTrials.gov,2020-05-21,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,Czech Republic,COVID-19: Herd Immunity Study in the Czech Republic,27000,https://clinicaltrials.gov/show/NCT04401085,NA
NCT04401098,ClinicalTrials.gov,2020-05-22,2020-05-02,TRUE,Recruiting,Not Applicable,Observational,Egypt,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,700,https://clinicaltrials.gov/show/NCT04401098,NA
NCT04401111,ClinicalTrials.gov,2020-05-22,2020-06-16,FALSE,Recruiting,Not Applicable,Observational,France,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),150,https://clinicaltrials.gov/show/NCT04401111,NA
NCT04401124,ClinicalTrials.gov,2020-05-22,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Status of Management of Surgery in Beijing During COVID-19,500,https://clinicaltrials.gov/show/NCT04401124,NA
NCT04401163,ClinicalTrials.gov,2020-05-12,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,180,https://clinicaltrials.gov/show/NCT04401163,NA
NCT04401228,ClinicalTrials.gov,2020-05-21,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Predictive Models for Intensive Care Admission and Death of COVID-19,60,https://clinicaltrials.gov/show/NCT04401228,NA
NCT04401241,ClinicalTrials.gov,2020-05-18,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Monaco,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,257,https://clinicaltrials.gov/show/NCT04401241,NA
NCT04401254,ClinicalTrials.gov,2020-05-07,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,Australia,Recovery of Patients From COVID-19 After Critical Illness,300,https://clinicaltrials.gov/show/NCT04401254,NA
NCT04401527,ClinicalTrials.gov,2020-05-21,2020-07-22,FALSE,Not Recruiting,Phase 2,Interventional,United States,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,0,https://clinicaltrials.gov/show/NCT04401527,NA
NCT04401540,ClinicalTrials.gov,2020-05-22,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Characteristics of Neonatal Covid-19 in Turkey,90,https://clinicaltrials.gov/show/NCT04401540,NA
NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,250,https://clinicaltrials.gov/show/NCT04401644,NA
NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-28,FALSE,Recruiting,Phase 1/Phase 2,Interventional,"United States, Brazil",A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,66,https://clinicaltrials.gov/show/NCT04402060,NA
NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,50,https://clinicaltrials.gov/show/NCT04402203,NA
NCT04402229,ClinicalTrials.gov,2020-05-21,2020-05-12,TRUE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of the Covid-19 Pandemic on Student Nurses,2000,https://clinicaltrials.gov/show/NCT04402229,NA
NCT04402814,ClinicalTrials.gov,2020-05-22,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,United States,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,90,https://clinicaltrials.gov/show/NCT04402814,NA
NCT04402827,ClinicalTrials.gov,2020-05-23,2020-08-01,FALSE,Recruiting,Not Applicable,Observational,Spain,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,60,https://clinicaltrials.gov/show/NCT04402827,NA
NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,TRUE,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),5,https://clinicaltrials.gov/show/NCT04402840,NA
NCT04402879,ClinicalTrials.gov,2020-05-22,2020-11-10,FALSE,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,596,https://clinicaltrials.gov/show/NCT04402879,NA
NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,60,https://clinicaltrials.gov/show/NCT04402892,NA
NCT04403009,ClinicalTrials.gov,2020-04-21,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04403009,NA
NCT04403035,ClinicalTrials.gov,2020-05-21,2020-05-10,TRUE,Recruiting,Not Applicable,Observational,United States,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,100,https://clinicaltrials.gov/show/NCT04403035,NA
NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,TRUE,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,70,https://clinicaltrials.gov/show/NCT04403243,NA
NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,TRUE,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",35,https://clinicaltrials.gov/show/NCT04403269,NA
NCT04403438,ClinicalTrials.gov,2020-05-23,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Familial Mediterranean Fever and BehÃ§et: Analysis Before and After Covid19 Pandemic,45,https://clinicaltrials.gov/show/NCT04403438,NA
NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,FALSE,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,20,https://clinicaltrials.gov/show/NCT04403477,NA
NCT04403581,ClinicalTrials.gov,2020-05-19,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",384,https://clinicaltrials.gov/show/NCT04403581,NA
NCT04403607,ClinicalTrials.gov,2020-05-20,2020-05-22,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Cardiac Imaging in SARS-CoV-2 (COVID-19),180,https://clinicaltrials.gov/show/NCT04403607,NA
NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04403646,NA
NCT04403672,ClinicalTrials.gov,2020-05-24,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Bangladesh,Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,120,https://clinicaltrials.gov/show/NCT04403672,NA
NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,129,https://clinicaltrials.gov/show/NCT04403685,NA
NCT04403828,ClinicalTrials.gov,2020-05-24,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,323,https://clinicaltrials.gov/show/NCT04403828,NA
NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,200,https://clinicaltrials.gov/show/NCT04403906,NA
NCT04404179,ClinicalTrials.gov,2020-05-24,2020-03-27,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Setting up a COVID-19 Care Facility at a Prison in Pakistan,69,https://clinicaltrials.gov/show/NCT04404179,NA
NCT04404608,ClinicalTrials.gov,2020-05-23,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Etiology of Lymphopenia in Covid19 Infection,90,https://clinicaltrials.gov/show/NCT04404608,NA
NCT04405232,ClinicalTrials.gov,2020-05-26,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,5000,https://clinicaltrials.gov/show/NCT04405232,NA
NCT04405271,ClinicalTrials.gov,2020-05-26,2020-07-31,FALSE,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),1378,https://clinicaltrials.gov/show/NCT04405271,NA
NCT04405284,ClinicalTrials.gov,2020-05-26,2020-06-04,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down.,425,https://clinicaltrials.gov/show/NCT04405284,NA
NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,TRUE,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,80,https://clinicaltrials.gov/show/NCT04405310,NA
NCT04405362,ClinicalTrials.gov,2020-05-18,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,753,https://clinicaltrials.gov/show/NCT04405362,NA
NCT04405466,ClinicalTrials.gov,2020-05-19,2020-04-22,TRUE,Recruiting,Not Applicable,Observational,Germany,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,500,https://clinicaltrials.gov/show/NCT04405466,NA
NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",1210,https://clinicaltrials.gov/show/NCT04405492,NA
NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,TRUE,Not Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,51,https://clinicaltrials.gov/show/NCT04405544,NA
NCT04405726,ClinicalTrials.gov,2020-05-25,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,France,Prognostic Factors of COVID19,500,https://clinicaltrials.gov/show/NCT04405726,NA
NCT04405869,ClinicalTrials.gov,2020-05-25,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,France,Thromboembolic Events in Severe COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04405869,NA
NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,FALSE,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",200,https://clinicaltrials.gov/show/NCT04405921,NA
NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,2000,https://clinicaltrials.gov/show/NCT04405934,NA
NCT04405973,ClinicalTrials.gov,2020-05-25,2020-05-19,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,133,https://clinicaltrials.gov/show/NCT04405973,NA
NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,TRUE,Not Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,50,https://clinicaltrials.gov/show/NCT04405999,NA
NCT04406090,ClinicalTrials.gov,2020-05-26,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Endovascular Thrombectomy in COVID-19 Infected Patients,50,https://clinicaltrials.gov/show/NCT04406090,NA
NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04406181,NA
NCT04406233,ClinicalTrials.gov,2020-05-23,2020-05-23,FALSE,Recruiting,Not Applicable,Observational,Brazil,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,176,https://clinicaltrials.gov/show/NCT04406233,NA
NCT04406324,ClinicalTrials.gov,2020-05-13,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19: Respiratory and Sleep Follow-up,400,https://clinicaltrials.gov/show/NCT04406324,NA
NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,TRUE,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,50,https://clinicaltrials.gov/show/NCT04406493,NA
NCT04406571,ClinicalTrials.gov,2020-05-27,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,700,https://clinicaltrials.gov/show/NCT04406571,NA
NCT04406844,ClinicalTrials.gov,2020-05-25,2020-05-09,TRUE,Recruiting,Not Applicable,Observational,India,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,150,https://clinicaltrials.gov/show/NCT04406844,NA
NCT04407117,ClinicalTrials.gov,2020-05-27,2017-03-23,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Appendicitis During the National Lockdown During the COVID-19 Pandemic,6000000,https://clinicaltrials.gov/show/NCT04407117,NA
NCT04407156,ClinicalTrials.gov,2020-05-06,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,724,https://clinicaltrials.gov/show/NCT04407156,NA
NCT04407169,ClinicalTrials.gov,2020-04-14,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,617,https://clinicaltrials.gov/show/NCT04407169,NA
NCT04407195,ClinicalTrials.gov,2020-05-27,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 and Mental Health,2000,https://clinicaltrials.gov/show/NCT04407195,NA
NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,TRUE,Not Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,10,https://clinicaltrials.gov/show/NCT04407208,NA
NCT04407221,ClinicalTrials.gov,2020-05-03,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 Research in Organ Transplant Recipients,1100,https://clinicaltrials.gov/show/NCT04407221,NA
NCT04407299,ClinicalTrials.gov,2020-05-23,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Impact on Rheumatic Patients,360,https://clinicaltrials.gov/show/NCT04407299,NA
NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,FALSE,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,100,https://clinicaltrials.gov/show/NCT04407390,NA
NCT04407429,ClinicalTrials.gov,2020-05-27,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,Austria,Vienna Versus SARS-CoV-2 Virus Study,12000,https://clinicaltrials.gov/show/NCT04407429,NA
NCT04407468,ClinicalTrials.gov,2020-05-27,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,827,https://clinicaltrials.gov/show/NCT04407468,NA
NCT04407494,ClinicalTrials.gov,2020-05-27,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),809,https://clinicaltrials.gov/show/NCT04407494,NA
NCT04407559,ClinicalTrials.gov,2020-05-27,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-SErology in Rheumatoid Arthritis (COVID-19),216,https://clinicaltrials.gov/show/NCT04407559,NA
NCT04407572,ClinicalTrials.gov,2020-05-27,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,44,https://clinicaltrials.gov/show/NCT04407572,NA
NCT04407585,ClinicalTrials.gov,2020-05-27,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Testing the Accuracy of a Digital Test to Diagnose Covid-19,1000000,https://clinicaltrials.gov/show/NCT04407585,NA
NCT04407598,ClinicalTrials.gov,2020-05-27,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,COPD in the Time of COVID-19,160,https://clinicaltrials.gov/show/NCT04407598,NA
NCT04407663,ClinicalTrials.gov,2020-05-27,2020-03-03,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",138,https://clinicaltrials.gov/show/NCT04407663,NA
NCT04407923,ClinicalTrials.gov,2020-05-28,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,France,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,150,https://clinicaltrials.gov/show/NCT04407923,NA
NCT04408014,ClinicalTrials.gov,2020-05-22,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of SÃ£o Paulo,18901,https://clinicaltrials.gov/show/NCT04408014,NA
NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,2000,https://clinicaltrials.gov/show/NCT04408066,NA
NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,FALSE,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,2000,https://clinicaltrials.gov/show/NCT04408131,NA
NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,TRUE,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04408209,NA
NCT04408222,ClinicalTrials.gov,2020-05-25,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,United States,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,29,https://clinicaltrials.gov/show/NCT04408222,NA
NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,300,https://clinicaltrials.gov/show/NCT04408235,NA
NCT04408326,ClinicalTrials.gov,2020-05-27,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,50,https://clinicaltrials.gov/show/NCT04408326,NA
NCT04408339,ClinicalTrials.gov,2020-05-19,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,500,https://clinicaltrials.gov/show/NCT04408339,NA
NCT04408378,ClinicalTrials.gov,2020-05-27,2020-06-05,FALSE,Recruiting,Not Applicable,Observational,Turkey,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,156,https://clinicaltrials.gov/show/NCT04408378,NA
NCT04408391,ClinicalTrials.gov,2020-05-26,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,France,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,0,https://clinicaltrials.gov/show/NCT04408391,NA
NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,TRUE,Not Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,325,https://clinicaltrials.gov/show/NCT04408456,NA
NCT04409184,ClinicalTrials.gov,2020-05-28,2020-08-14,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,0,https://clinicaltrials.gov/show/NCT04409184,NA
NCT04409197,ClinicalTrials.gov,2020-05-18,2020-05-08,TRUE,Not Recruiting,Not Applicable,Observational,France,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",4789,https://clinicaltrials.gov/show/NCT04409197,NA
NCT04409249,ClinicalTrials.gov,2020-05-28,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Prognosis in Pregnant With COVID-19,155,https://clinicaltrials.gov/show/NCT04409249,NA
NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,55,https://clinicaltrials.gov/show/NCT04409522,NA
NCT04409535,ClinicalTrials.gov,2020-05-11,2020-05-07,TRUE,Not Recruiting,Not Applicable,Observational,United States,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,500,https://clinicaltrials.gov/show/NCT04409535,NA
NCT04409574,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,31,https://clinicaltrials.gov/show/NCT04409574,NA
NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04409886,NA
NCT04409899,ClinicalTrials.gov,2020-05-26,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Spain,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,300,https://clinicaltrials.gov/show/NCT04409899,NA
NCT04409951,ClinicalTrials.gov,2020-05-22,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Pharmacy Education During Covid-19 Outbreak,100,https://clinicaltrials.gov/show/NCT04409951,NA
NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,45,https://clinicaltrials.gov/show/NCT04410016,NA
NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,FALSE,Not Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04410159,NA
NCT04410263,ClinicalTrials.gov,2020-05-18,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,300,https://clinicaltrials.gov/show/NCT04410263,NA
NCT04410328,ClinicalTrials.gov,2020-05-28,2020-10-21,FALSE,Recruiting,Phase 3,Interventional,United States,Aggrenox To Treat Acute Covid-19,132,https://clinicaltrials.gov/show/NCT04410328,NA
NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,FALSE,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),506517,https://clinicaltrials.gov/show/NCT04410458,NA
NCT04410471,ClinicalTrials.gov,2020-05-29,2020-05-29,FALSE,Recruiting,Not Applicable,Observational,Spain,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,300,https://clinicaltrials.gov/show/NCT04410471,NA
NCT04410484,ClinicalTrials.gov,2020-05-29,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,1500,https://clinicaltrials.gov/show/NCT04410484,NA
NCT04410510,ClinicalTrials.gov,2020-05-27,2020-09-30,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Colombia,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,100,https://clinicaltrials.gov/show/NCT04410510,NA
NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-15,FALSE,Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,25,https://clinicaltrials.gov/show/NCT04410536,NA
NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,TRUE,Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,560,https://clinicaltrials.gov/show/NCT04410692,NA
NCT04410835,ClinicalTrials.gov,2020-05-14,2020-04-28,TRUE,Recruiting,Not Applicable,Observational,Austria,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,1000,https://clinicaltrials.gov/show/NCT04410835,NA
NCT04410939,ClinicalTrials.gov,2020-05-22,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 PCR Test Results in Asymptomatic Pregnants,179,https://clinicaltrials.gov/show/NCT04410939,NA
NCT04411459,ClinicalTrials.gov,2020-05-29,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,470,https://clinicaltrials.gov/show/NCT04411459,NA
NCT04411563,ClinicalTrials.gov,2020-05-25,2020-05-21,TRUE,Recruiting,Not Applicable,Observational,Turkey,Epigenetic Tools as Prognostic Predictors in Covid19,105,https://clinicaltrials.gov/show/NCT04411563,NA
NCT04411576,ClinicalTrials.gov,2020-05-26,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,Sweden,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,40000,https://clinicaltrials.gov/show/NCT04411576,NA
NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,TRUE,Not Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,24,https://clinicaltrials.gov/show/NCT04411628,NA
NCT04411784,ClinicalTrials.gov,2020-05-29,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",200,https://clinicaltrials.gov/show/NCT04411784,NA
NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-04,FALSE,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,100,https://clinicaltrials.gov/show/NCT04412018,NA
NCT04412031,ClinicalTrials.gov,2020-05-29,2019-11-11,TRUE,Not Recruiting,Not Applicable,Observational,France,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,802,https://clinicaltrials.gov/show/NCT04412031,NA
NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04412239,NA
NCT04412252,ClinicalTrials.gov,2020-05-30,2020-07-06,FALSE,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,0,https://clinicaltrials.gov/show/NCT04412252,NA
NCT04412278,ClinicalTrials.gov,2020-05-30,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,392,https://clinicaltrials.gov/show/NCT04412278,NA
NCT04412304,ClinicalTrials.gov,2020-05-30,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,166,https://clinicaltrials.gov/show/NCT04412304,NA
NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-23,TRUE,Not Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,241,https://clinicaltrials.gov/show/NCT04412343,NA
NCT04412382,ClinicalTrials.gov,2020-05-26,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Covid-19: Possible Role of Neutrophil Extracellular Traps,100,https://clinicaltrials.gov/show/NCT04412382,NA
NCT04412460,ClinicalTrials.gov,2020-05-20,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Echocardiography in Patients With Covid-19,500,https://clinicaltrials.gov/show/NCT04412460,NA
NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,100,https://clinicaltrials.gov/show/NCT04412486,NA
NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,942,https://clinicaltrials.gov/show/NCT04412538,NA
NCT04412655,ClinicalTrials.gov,2020-06-01,2020-05-05,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,6609,https://clinicaltrials.gov/show/NCT04412655,NA
NCT04412746,ClinicalTrials.gov,2020-06-01,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Algeria,Covid-19 and Diabetes in West of Algeria,100,https://clinicaltrials.gov/show/NCT04412746,NA
NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-12,FALSE,Recruiting,Phase 3,Interventional,United States,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,300,https://clinicaltrials.gov/show/NCT04412772,NA
NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,28,https://clinicaltrials.gov/show/NCT04413006,NA
NCT04413045,ClinicalTrials.gov,2020-06-01,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,"Novel COVID-19, A National Analysis",61,https://clinicaltrials.gov/show/NCT04413045,NA
NCT04413058,ClinicalTrials.gov,2020-05-27,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Menstrual Cycle Characteristics of Healthcare Professionals,260,https://clinicaltrials.gov/show/NCT04413058,NA
NCT04413071,ClinicalTrials.gov,2020-05-23,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Cardiac COVID-19 Health Care Workers,142,https://clinicaltrials.gov/show/NCT04413071,NA
NCT04413435,ClinicalTrials.gov,2020-05-25,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,Turkey,Clinical Characteristics of Critically Ill Patients With COVID-19,105,https://clinicaltrials.gov/show/NCT04413435,NA
NCT04413747,ClinicalTrials.gov,2020-05-29,2020-08-15,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID-19,1000,https://clinicaltrials.gov/show/NCT04413747,NA
NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,120,https://clinicaltrials.gov/show/NCT04413838,NA
NCT04413877,ClinicalTrials.gov,2020-05-25,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),600,https://clinicaltrials.gov/show/NCT04413877,NA
NCT04413955,ClinicalTrials.gov,2020-05-19,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United States,Registry of SeraphÂ®-100 MicrobindÂ® Affinity Blood Filter for COVID-19 Under EUA,100,https://clinicaltrials.gov/show/NCT04413955,NA
NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,FALSE,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",600,https://clinicaltrials.gov/show/NCT04413968,NA
NCT04414059,ClinicalTrials.gov,2020-06-01,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,155,https://clinicaltrials.gov/show/NCT04414059,NA
NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,100,https://clinicaltrials.gov/show/NCT04414098,NA
NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,200,https://clinicaltrials.gov/show/NCT04414371,NA
NCT04414657,ClinicalTrials.gov,2020-06-02,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,Switzerland,USZ BioResource COVID,500,https://clinicaltrials.gov/show/NCT04414657,NA
NCT04414904,ClinicalTrials.gov,2020-05-29,2020-06-10,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Determining the Reproductive Health of Men Post-COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04414904,NA
NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,186,https://clinicaltrials.gov/show/NCT04415073,NA
NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,FALSE,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,120,https://clinicaltrials.gov/show/NCT04415086,NA
NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,20,https://clinicaltrials.gov/show/NCT04415879,NA
NCT04416009,ClinicalTrials.gov,2020-06-01,2020-07-05,FALSE,Recruiting,Not Applicable,Observational,Turkey,Extracellular Water in Covid 19 Pneumonia,52,https://clinicaltrials.gov/show/NCT04416009,NA
NCT04416061,ClinicalTrials.gov,2020-06-01,2020-05-25,TRUE,Not Recruiting,Not Applicable,Observational,Hong Kong,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,2500,https://clinicaltrials.gov/show/NCT04416061,NA
NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04416113,NA
NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,TRUE,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,10,https://clinicaltrials.gov/show/NCT04416139,NA
NCT04416256,ClinicalTrials.gov,2020-05-29,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 Pandemic and Worldwide Organ Procurement,230000,https://clinicaltrials.gov/show/NCT04416256,NA
NCT04416334,ClinicalTrials.gov,2020-06-03,2020-08-19,FALSE,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,954,https://clinicaltrials.gov/show/NCT04416334,NA
NCT04416347,ClinicalTrials.gov,2020-05-06,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,COVID19 Clinical Predictors and Outcome,800,https://clinicaltrials.gov/show/NCT04416347,NA
NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,TRUE,Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,40,https://clinicaltrials.gov/show/NCT04416360,NA
NCT04416373,ClinicalTrials.gov,2020-05-29,2020-03-22,TRUE,Recruiting,Not Applicable,Observational,Portugal,COVID-19 and Pregnancy Outcomes,300,https://clinicaltrials.gov/show/NCT04416373,NA
NCT04416438,ClinicalTrials.gov,2020-06-03,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,50,https://clinicaltrials.gov/show/NCT04416438,NA
NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,TRUE,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,2014,https://clinicaltrials.gov/show/NCT04417335,NA
NCT04417374,ClinicalTrials.gov,2020-06-03,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",94,https://clinicaltrials.gov/show/NCT04417374,NA
NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,84,https://clinicaltrials.gov/show/NCT04418128,NA
NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,FALSE,Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,300,https://clinicaltrials.gov/show/NCT04418206,NA
NCT04418245,ClinicalTrials.gov,2020-06-04,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,"France, Martinique",CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,1000,https://clinicaltrials.gov/show/NCT04418245,NA
NCT04418375,ClinicalTrials.gov,2020-06-02,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,France,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),4000,https://clinicaltrials.gov/show/NCT04418375,NA
NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-24,FALSE,Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,1200,https://clinicaltrials.gov/show/NCT04418518,NA
NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,10,https://clinicaltrials.gov/show/NCT04418531,NA
NCT04418544,ClinicalTrials.gov,2020-06-01,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United States,Vocal Feature Analysis Algorithm for COVID-19 Detection,400,https://clinicaltrials.gov/show/NCT04418544,NA
NCT04418609,ClinicalTrials.gov,2020-05-28,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Neuro-COVID-19: Neurological Complications of COVID-19,30,https://clinicaltrials.gov/show/NCT04418609,NA
NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,11120,https://clinicaltrials.gov/show/NCT04418947,NA
NCT04419064,ClinicalTrials.gov,2020-06-02,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Confirmation of Ventilation and Intubation by Determination With Ultrasonography,118,https://clinicaltrials.gov/show/NCT04419064,NA
NCT04419545,ClinicalTrials.gov,2020-06-04,2020-03-24,TRUE,Recruiting,Not Applicable,Observational,Italy,Covid Radiographic Images Data-set for A.I,2500,https://clinicaltrials.gov/show/NCT04419545,NA
NCT04419571,ClinicalTrials.gov,2020-06-04,2020-03-23,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,94,https://clinicaltrials.gov/show/NCT04419571,NA
NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,300,https://clinicaltrials.gov/show/NCT04420260,NA
NCT04420286,ClinicalTrials.gov,2020-06-05,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,France,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,9000,https://clinicaltrials.gov/show/NCT04420286,NA
NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,TRUE,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,120,https://clinicaltrials.gov/show/NCT04420299,NA
NCT04420312,ClinicalTrials.gov,2020-06-05,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,1024,https://clinicaltrials.gov/show/NCT04420312,NA
NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,FALSE,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",800,https://clinicaltrials.gov/show/NCT04420338,NA
NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,41,https://clinicaltrials.gov/show/NCT04420390,NA
NCT04420416,ClinicalTrials.gov,2020-06-04,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,Mental Health and Academic Performance in COVID-19,720,https://clinicaltrials.gov/show/NCT04420416,NA
NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,21,https://clinicaltrials.gov/show/NCT04420806,NA
NCT04420988,ClinicalTrials.gov,2020-05-06,2020-10-14,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,Not Available,https://clinicaltrials.gov/show/NCT04420988,NA
NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,FALSE,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,500,https://clinicaltrials.gov/show/NCT04421391,NA
NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,150,https://clinicaltrials.gov/show/NCT04421534,NA
NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,TRUE,Not Recruiting,Phase 3,Interventional,"Canada, United States",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),70,https://clinicaltrials.gov/show/NCT04421664,NA
NCT04422340,ClinicalTrials.gov,2020-06-08,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Senior-COVID-Rea Multicentric Survey,185,https://clinicaltrials.gov/show/NCT04422340,NA
NCT04422379,ClinicalTrials.gov,2020-06-07,2020-06-07,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,314,https://clinicaltrials.gov/show/NCT04422379,NA
NCT04422418,ClinicalTrials.gov,2020-06-03,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,United Arab Emirates,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,200,https://clinicaltrials.gov/show/NCT04422418,NA
NCT04422444,ClinicalTrials.gov,2020-06-04,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Post Intensive Care Syndrome in COVID19 Patients,100,https://clinicaltrials.gov/show/NCT04422444,NA
NCT04422470,ClinicalTrials.gov,2020-06-08,2020-06-22,FALSE,Recruiting,Not Applicable,Observational,Russian Federation,Registry of Patients With Hematologic Disease and COVID-19 in Russia,200,https://clinicaltrials.gov/show/NCT04422470,NA
NCT04422522,ClinicalTrials.gov,2020-06-07,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Fibromyalgia During the COVID-19 Pandemic,45,https://clinicaltrials.gov/show/NCT04422522,NA
NCT04422535,ClinicalTrials.gov,2020-06-03,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Spain,Effects on the Qt Interval of COVID-19 Coronavirus Infection,80,https://clinicaltrials.gov/show/NCT04422535,NA
NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,340,https://clinicaltrials.gov/show/NCT04422561,NA
NCT04422574,ClinicalTrials.gov,2020-06-08,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID 19 Serology in Pulmonologists,97,https://clinicaltrials.gov/show/NCT04422574,NA
NCT04422587,ClinicalTrials.gov,2020-06-05,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,1860,https://clinicaltrials.gov/show/NCT04422587,NA
NCT04422626,ClinicalTrials.gov,2020-06-06,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,42,https://clinicaltrials.gov/show/NCT04422626,NA
NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,30,https://clinicaltrials.gov/show/NCT04422678,NA
NCT04422977,ClinicalTrials.gov,2020-06-05,2020-06-08,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Serological Study of the Exposure of Personnel to Sars-cov-2,900,https://clinicaltrials.gov/show/NCT04422977,NA
NCT04423003,ClinicalTrials.gov,2020-06-08,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Endoscopic Interventions in Patients With COVID-19,10,https://clinicaltrials.gov/show/NCT04423003,NA
NCT04423042,ClinicalTrials.gov,2020-06-05,2020-07-30,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,30,https://clinicaltrials.gov/show/NCT04423042,NA
NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04423289,NA
NCT04423315,ClinicalTrials.gov,2020-06-05,2020-06-08,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,70,https://clinicaltrials.gov/show/NCT04423315,NA
NCT04423640,ClinicalTrials.gov,2020-05-27,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Mexico,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04423640,NA
NCT04423692,ClinicalTrials.gov,2020-06-07,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Knowledge About Covid-19 Infection in Pregnant Women,30,https://clinicaltrials.gov/show/NCT04423692,NA
NCT04423770,ClinicalTrials.gov,2020-06-08,2020-06-08,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Related Health and Infection Control Practices Among Dentists,4000,https://clinicaltrials.gov/show/NCT04423770,NA
NCT04423861,ClinicalTrials.gov,2020-06-08,2020-12-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,380,https://clinicaltrials.gov/show/NCT04423861,NA
NCT04423978,ClinicalTrials.gov,2020-06-08,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Implications of Covid-19 on the Lifestyle Changes,1826,https://clinicaltrials.gov/show/NCT04423978,NA
NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991,NA
NCT04424056,ClinicalTrials.gov,2020-06-08,2020-09-01,FALSE,Not Recruiting,Phase 3,Interventional,France,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",216,https://clinicaltrials.gov/show/NCT04424056,NA
NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,TRUE,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,80,https://clinicaltrials.gov/show/NCT04424134,NA
NCT04424771,ClinicalTrials.gov,2020-06-07,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,800,https://clinicaltrials.gov/show/NCT04424771,NA
NCT04424836,ClinicalTrials.gov,2020-06-07,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,HFNC Treatment in COVID-19 Pneumonia,43,https://clinicaltrials.gov/show/NCT04424836,NA
NCT04424849,ClinicalTrials.gov,2020-06-08,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Turkey,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04424849,NA
NCT04424940,ClinicalTrials.gov,2020-05-20,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Democratic Republic of Congo,COVID-19 Lessons Learned: the Outcome of TOMEKAÂ® Project is to Teach,800,https://clinicaltrials.gov/show/NCT04424940,NA
NCT04425044,ClinicalTrials.gov,2020-06-09,2020-04-12,TRUE,Not Recruiting,Not Applicable,Observational,India,AiM Covid Self Monitoring,1000,https://clinicaltrials.gov/show/NCT04425044,NA
NCT04425213,ClinicalTrials.gov,2020-05-28,2020-05-12,TRUE,Not Recruiting,Not Applicable,Observational,France,Obesity and Mortality of Critically Ill Patients With COVID-19,250,https://clinicaltrials.gov/show/NCT04425213,NA
NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-24,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04425317,NA
NCT04425382,ClinicalTrials.gov,2020-05-21,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Qatar,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,200,https://clinicaltrials.gov/show/NCT04425382,NA
NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,"China, Germany, Romania","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",256,https://clinicaltrials.gov/show/NCT04425460,NA
NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,60,https://clinicaltrials.gov/show/NCT04425499,NA
NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,100,https://clinicaltrials.gov/show/NCT04425707,NA
NCT04425720,ClinicalTrials.gov,2020-06-02,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,300,https://clinicaltrials.gov/show/NCT04425720,NA
NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),0,https://clinicaltrials.gov/show/NCT04425733,NA
NCT04425759,ClinicalTrials.gov,2020-06-08,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,Spain,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),2400,https://clinicaltrials.gov/show/NCT04425759,NA
NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),342,https://clinicaltrials.gov/show/NCT04425772,NA
NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,236,https://clinicaltrials.gov/show/NCT04425837,NA
NCT04425850,ClinicalTrials.gov,2020-06-08,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,229,https://clinicaltrials.gov/show/NCT04425850,NA
NCT04425863,ClinicalTrials.gov,2020-06-08,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19",167,https://clinicaltrials.gov/show/NCT04425863,NA
NCT04425889,ClinicalTrials.gov,2020-06-06,2020-05-05,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,COVID-19 Antibodies Among Healthcare Workers,156,https://clinicaltrials.gov/show/NCT04425889,NA
NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut BergoniÃ© in the Context of the COVID-19 Pandemic,550,https://clinicaltrials.gov/show/NCT04426006,NA
NCT04426084,ClinicalTrials.gov,2020-06-09,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,22784,https://clinicaltrials.gov/show/NCT04426084,NA
NCT04426253,ClinicalTrials.gov,2020-06-09,2020-06-05,TRUE,Not Recruiting,Not Applicable,Observational,Hungary,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",1000,https://clinicaltrials.gov/show/NCT04426253,NA
NCT04426266,ClinicalTrials.gov,2020-06-08,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Hungary,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,441,https://clinicaltrials.gov/show/NCT04426266,NA
NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,TRUE,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,3500,https://clinicaltrials.gov/show/NCT04426292,NA
NCT04426344,ClinicalTrials.gov,2020-06-03,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04426344,NA
NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,TRUE,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,300,https://clinicaltrials.gov/show/NCT04427098,NA
NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,TRUE,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04427137,NA
NCT04427176,ClinicalTrials.gov,2020-06-10,2020-04-29,TRUE,Not Recruiting,Not Applicable,Observational,France,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,15,https://clinicaltrials.gov/show/NCT04427176,NA
NCT04427267,ClinicalTrials.gov,2020-06-10,2020-06-03,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,6,https://clinicaltrials.gov/show/NCT04427267,NA
NCT04427280,ClinicalTrials.gov,2020-05-21,2020-05-26,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),60,https://clinicaltrials.gov/show/NCT04427280,NA
NCT04427345,ClinicalTrials.gov,2020-06-04,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Predictive Factors COVID-19 Patients,1000,https://clinicaltrials.gov/show/NCT04427345,NA
NCT04427358,ClinicalTrials.gov,2020-06-10,2020-05-07,TRUE,Not Recruiting,Not Applicable,Observational,France,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,100,https://clinicaltrials.gov/show/NCT04427358,NA
NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,20,https://clinicaltrials.gov/show/NCT04427631,NA
NCT04427735,ClinicalTrials.gov,2020-06-09,2019-01-24,TRUE,Recruiting,Not Applicable,Observational,China,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,200,https://clinicaltrials.gov/show/NCT04427735,NA
NCT04427813,ClinicalTrials.gov,2020-06-09,2020-06-11,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Sexual Health and Problems During the Covid -19 Infection,400,https://clinicaltrials.gov/show/NCT04427813,NA
NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,200,https://clinicaltrials.gov/show/NCT04427865,NA
NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,5,https://clinicaltrials.gov/show/NCT04427878,NA
NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,32,https://clinicaltrials.gov/show/NCT04428073,NA
NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,TRUE,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,186,https://clinicaltrials.gov/show/NCT04428099,NA
NCT04429334,ClinicalTrials.gov,2020-05-29,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",60,https://clinicaltrials.gov/show/NCT04429334,NA
NCT04429477,ClinicalTrials.gov,2020-06-09,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Cerebral Compliance Impairment in COVID-19,50,https://clinicaltrials.gov/show/NCT04429477,NA
NCT04429594,ClinicalTrials.gov,2020-06-10,2020-07-28,FALSE,Recruiting,Not Applicable,Interventional,France,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),1000,https://clinicaltrials.gov/show/NCT04429594,NA
NCT04429620,ClinicalTrials.gov,2020-06-10,2020-05-30,TRUE,Recruiting,Not Applicable,Observational,Hungary,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,100,https://clinicaltrials.gov/show/NCT04429620,NA
NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,TRUE,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,100,https://clinicaltrials.gov/show/NCT04429711,NA
NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04429763,NA
NCT04429815,ClinicalTrials.gov,2020-06-11,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,489,https://clinicaltrials.gov/show/NCT04429815,NA
NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,45,https://clinicaltrials.gov/show/NCT04429828,NA
NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,TRUE,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,700,https://clinicaltrials.gov/show/NCT04429867,NA
NCT04430062,ClinicalTrials.gov,2020-06-11,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,14,https://clinicaltrials.gov/show/NCT04430062,NA
NCT04430322,ClinicalTrials.gov,2020-06-11,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,330,https://clinicaltrials.gov/show/NCT04430322,NA
NCT04430374,ClinicalTrials.gov,2020-06-11,2020-06-02,TRUE,Recruiting,Not Applicable,Observational,Qatar,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,100,https://clinicaltrials.gov/show/NCT04430374,NA
NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,TRUE,Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,72,https://clinicaltrials.gov/show/NCT04430608,NA
NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,FALSE,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,403535,https://clinicaltrials.gov/show/NCT04431180,NA
NCT04431310,ClinicalTrials.gov,2020-05-11,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,Denmark,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,300,https://clinicaltrials.gov/show/NCT04431310,NA
NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,FALSE,Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,64,https://clinicaltrials.gov/show/NCT04431466,NA
NCT04431869,ClinicalTrials.gov,2020-06-11,2020-08-18,FALSE,Recruiting,Not Applicable,Observational,United States,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,200,https://clinicaltrials.gov/show/NCT04431869,NA
NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04432051,NA
NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,36,https://clinicaltrials.gov/show/NCT04432103,NA
NCT04432766,ClinicalTrials.gov,2020-06-12,2020-10-20,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,174,https://clinicaltrials.gov/show/NCT04432766,NA
NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,FALSE,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,160,https://clinicaltrials.gov/show/NCT04432805,NA
NCT04432948,ClinicalTrials.gov,2020-06-14,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,Greece,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,200,https://clinicaltrials.gov/show/NCT04432948,NA
NCT04432961,ClinicalTrials.gov,2020-06-15,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),200,https://clinicaltrials.gov/show/NCT04432961,NA
NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,TRUE,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04432987,NA
NCT04433000,ClinicalTrials.gov,2020-06-12,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,34,https://clinicaltrials.gov/show/NCT04433000,NA
NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,300,https://clinicaltrials.gov/show/NCT04433013,NA
NCT04433026,ClinicalTrials.gov,2020-06-14,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",90,https://clinicaltrials.gov/show/NCT04433026,NA
NCT04433039,ClinicalTrials.gov,2020-06-14,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,130,https://clinicaltrials.gov/show/NCT04433039,NA
NCT04433260,ClinicalTrials.gov,2020-06-09,2020-07-25,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,COVID19 and Physical and Emotional Wellbeing of HCP,1050,https://clinicaltrials.gov/show/NCT04433260,NA
NCT04433286,ClinicalTrials.gov,2020-06-10,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,1000,https://clinicaltrials.gov/show/NCT04433286,NA
NCT04433312,ClinicalTrials.gov,2020-06-10,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,10000,https://clinicaltrials.gov/show/NCT04433312,NA
NCT04433325,ClinicalTrials.gov,2020-06-12,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,150,https://clinicaltrials.gov/show/NCT04433325,NA
NCT04433754,ClinicalTrials.gov,2020-06-12,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,500,https://clinicaltrials.gov/show/NCT04433754,NA
NCT04433871,ClinicalTrials.gov,2020-04-24,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 in Pediatric Oncology and Hematology Centers in France,300,https://clinicaltrials.gov/show/NCT04433871,NA
NCT04433988,ClinicalTrials.gov,2020-06-13,2020-12-13,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,200,https://clinicaltrials.gov/show/NCT04433988,NA
NCT04434014,ClinicalTrials.gov,2020-06-06,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,Egypt,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,300,https://clinicaltrials.gov/show/NCT04434014,NA
NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,TRUE,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,30,https://clinicaltrials.gov/show/NCT04434131,NA
NCT04434144,ClinicalTrials.gov,2020-06-09,2020-05-02,TRUE,Not Recruiting,Not Applicable,Observational,Bangladesh,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,116,https://clinicaltrials.gov/show/NCT04434144,NA
NCT04434157,ClinicalTrials.gov,2020-06-12,2020-03-28,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,221,https://clinicaltrials.gov/show/NCT04434157,NA
NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,330,https://clinicaltrials.gov/show/NCT04434248,NA
NCT04434417,ClinicalTrials.gov,2020-06-09,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,1000,https://clinicaltrials.gov/show/NCT04434417,NA
NCT04435015,ClinicalTrials.gov,2020-06-16,2021-02-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,200,https://clinicaltrials.gov/show/NCT04435015,NA
NCT04435028,ClinicalTrials.gov,2020-06-15,2019-01-14,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,111,https://clinicaltrials.gov/show/NCT04435028,NA
NCT04435041,ClinicalTrials.gov,2020-06-16,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Remote-by-Default Care in the COVID-19 Pandemic,1,https://clinicaltrials.gov/show/NCT04435041,NA
NCT04435080,ClinicalTrials.gov,2020-06-15,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,35,https://clinicaltrials.gov/show/NCT04435080,NA
NCT04435106,ClinicalTrials.gov,2020-05-26,2020-04-03,TRUE,Not Recruiting,Not Applicable,Observational,Israel,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),23,https://clinicaltrials.gov/show/NCT04435106,NA
NCT04435119,ClinicalTrials.gov,2020-06-12,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Covid-19 and Vitamin D in Nursing-home,96,https://clinicaltrials.gov/show/NCT04435119,NA
NCT04435223,ClinicalTrials.gov,2020-06-16,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,France,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,62,https://clinicaltrials.gov/show/NCT04435223,NA
NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,TRUE,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,200,https://clinicaltrials.gov/show/NCT04435314,NA
NCT04435327,ClinicalTrials.gov,2020-06-12,2020-08-17,FALSE,Recruiting,Not Applicable,Observational,Italy,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),300,https://clinicaltrials.gov/show/NCT04435327,NA
NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,TRUE,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,200,https://clinicaltrials.gov/show/NCT04435353,NA
NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,TRUE,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),78,https://clinicaltrials.gov/show/NCT04435717,NA
NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,1,https://clinicaltrials.gov/show/NCT04435808,NA
NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",38,https://clinicaltrials.gov/show/NCT04436471,NA
NCT04437121,ClinicalTrials.gov,2020-06-15,2020-04-30,TRUE,Not Recruiting,Not Applicable,Observational,Greece,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,397,https://clinicaltrials.gov/show/NCT04437121,NA
NCT04437693,ClinicalTrials.gov,2020-06-17,2020-08-31,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04437693,NA
NCT04437706,ClinicalTrials.gov,2020-06-17,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,United States,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,200,https://clinicaltrials.gov/show/NCT04437706,NA
NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-29,FALSE,Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",100,https://clinicaltrials.gov/show/NCT04437719,NA
NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,TRUE,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04437823,NA
NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",38,https://clinicaltrials.gov/show/NCT04437875,NA
NCT04437901,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,"United Kingdom, Belgium, Netherlands, Italy, Spain",COVIDAR - Arrhythmias in COVID-19,10000,https://clinicaltrials.gov/show/NCT04437901,NA
NCT04438057,ClinicalTrials.gov,2020-06-17,2020-08-12,FALSE,Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,150,https://clinicaltrials.gov/show/NCT04438057,NA
NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,TRUE,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,400,https://clinicaltrials.gov/show/NCT04438070,NA
NCT04438629,ClinicalTrials.gov,2020-06-16,2020-03-26,TRUE,Recruiting,Not Applicable,Observational,Italy,Evaluation of Immune Response in COVID-19 Patients,80,https://clinicaltrials.gov/show/NCT04438629,NA
NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,67,https://clinicaltrials.gov/show/NCT04438694,NA
NCT04438837,ClinicalTrials.gov,2020-06-18,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,582,https://clinicaltrials.gov/show/NCT04438837,NA
NCT04438941,ClinicalTrials.gov,2020-06-17,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,France,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,100,https://clinicaltrials.gov/show/NCT04438941,NA
NCT04438954,ClinicalTrials.gov,2020-06-17,2020-05-05,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",30,https://clinicaltrials.gov/show/NCT04438954,NA
NCT04438993,ClinicalTrials.gov,2020-06-18,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,The COVID-19 Disease and CARdiac Events Study,100,https://clinicaltrials.gov/show/NCT04438993,NA
NCT04439006,ClinicalTrials.gov,2020-06-17,2020-07-22,FALSE,Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,72,https://clinicaltrials.gov/show/NCT04439006,NA
NCT04440098,ClinicalTrials.gov,2020-06-18,2020-04-22,TRUE,Not Recruiting,Not Applicable,Observational,United States,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,1008,https://clinicaltrials.gov/show/NCT04440098,NA
NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,FALSE,Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,200,https://clinicaltrials.gov/show/NCT04441385,NA
NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04441398,NA
NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,TRUE,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,49,https://clinicaltrials.gov/show/NCT04441424,NA
NCT04441489,ClinicalTrials.gov,2020-06-16,2020-03-27,TRUE,Not Recruiting,Not Applicable,Observational,Monaco,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,13,https://clinicaltrials.gov/show/NCT04441489,NA
NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,24,https://clinicaltrials.gov/show/NCT04441632,NA
NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,TRUE,Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",1800,https://clinicaltrials.gov/show/NCT04441684,NA
NCT04441814,ClinicalTrials.gov,2020-06-18,2019-07-23,TRUE,Recruiting,Not Applicable,Observational,Italy,FOUND - Ancillary Study to Smile Protocol NCT03654105,960,https://clinicaltrials.gov/show/NCT04441814,NA
NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,TRUE,Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",40,https://clinicaltrials.gov/show/NCT04441918,NA
NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,TRUE,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,1000,https://clinicaltrials.gov/show/NCT04442152,NA
NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,TRUE,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,50,https://clinicaltrials.gov/show/NCT04442191,NA
NCT04442204,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,4000,https://clinicaltrials.gov/show/NCT04442204,NA
NCT04442217,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,4000,https://clinicaltrials.gov/show/NCT04442217,NA
NCT04442243,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,889,https://clinicaltrials.gov/show/NCT04442243,NA
NCT04442282,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,5041,https://clinicaltrials.gov/show/NCT04442282,NA
NCT04442308,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Stress After the Covid-19 Pandemic,1440,https://clinicaltrials.gov/show/NCT04442308,NA
NCT04442360,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,4000,https://clinicaltrials.gov/show/NCT04442360,NA
NCT04442386,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,1500,https://clinicaltrials.gov/show/NCT04442386,NA
NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,60,https://clinicaltrials.gov/show/NCT04442958,NA
NCT04443140,ClinicalTrials.gov,2020-06-21,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,131,https://clinicaltrials.gov/show/NCT04443140,NA
NCT04443179,ClinicalTrials.gov,2020-06-19,2013-04-05,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Brain Imaging in Babies Study,790,https://clinicaltrials.gov/show/NCT04443179,NA
NCT04443270,ClinicalTrials.gov,2020-06-17,2020-07-27,FALSE,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04443270,NA
NCT04443361,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Insomnia After the COVID-19 Pandemic,5000,https://clinicaltrials.gov/show/NCT04443361,NA
NCT04443673,ClinicalTrials.gov,2020-06-18,2020-08-20,FALSE,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,82,https://clinicaltrials.gov/show/NCT04443673,NA
NCT04443699,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors of Mental Well-being During the COVID-19 Pandemic,4000,https://clinicaltrials.gov/show/NCT04443699,NA
NCT04443712,ClinicalTrials.gov,2020-06-16,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Egypt,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),1900,https://clinicaltrials.gov/show/NCT04443712,NA
NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04443725,NA
NCT04443764,ClinicalTrials.gov,2020-06-19,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,287,https://clinicaltrials.gov/show/NCT04443764,NA
NCT04443868,ClinicalTrials.gov,2020-06-20,2021-01-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04443868,NA
NCT04444115,ClinicalTrials.gov,2020-06-20,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,10084,https://clinicaltrials.gov/show/NCT04444115,NA
NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,TRUE,Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,20,https://clinicaltrials.gov/show/NCT04444271,NA
NCT04444310,ClinicalTrials.gov,2020-06-19,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Antibody Responses in Contacts of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04444310,NA
NCT04444336,ClinicalTrials.gov,2020-06-21,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,4000,https://clinicaltrials.gov/show/NCT04444336,NA
NCT04444531,ClinicalTrials.gov,2020-06-22,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,18,https://clinicaltrials.gov/show/NCT04444531,NA
NCT04444557,ClinicalTrials.gov,2020-06-21,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,97,https://clinicaltrials.gov/show/NCT04444557,NA
NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,TRUE,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04444596,NA
NCT04444609,ClinicalTrials.gov,2020-06-16,2020-06-18,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,230,https://clinicaltrials.gov/show/NCT04444609,NA
NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-24,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,2130,https://clinicaltrials.gov/show/NCT04444674,NA
NCT04444687,ClinicalTrials.gov,2020-06-15,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,20,https://clinicaltrials.gov/show/NCT04444687,NA
NCT04444713,ClinicalTrials.gov,2020-06-20,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,10084,https://clinicaltrials.gov/show/NCT04444713,NA
NCT04445207,ClinicalTrials.gov,2020-06-20,2020-06-22,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04445207,NA
NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,TRUE,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,40,https://clinicaltrials.gov/show/NCT04445246,NA
NCT04445259,ClinicalTrials.gov,2020-05-27,2020-06-20,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,300,https://clinicaltrials.gov/show/NCT04445259,NA
NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04445311,NA
NCT04445324,ClinicalTrials.gov,2020-06-22,2020-08-25,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,30,https://clinicaltrials.gov/show/NCT04445324,NA
NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,10,https://clinicaltrials.gov/show/NCT04445337,NA
NCT04445376,ClinicalTrials.gov,2020-06-22,2020-07-03,FALSE,Not Recruiting,Not Applicable,Interventional,Pakistan,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,20,https://clinicaltrials.gov/show/NCT04445376,NA
NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,TRUE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",210,https://clinicaltrials.gov/show/NCT04445389,NA
NCT04445402,ClinicalTrials.gov,2020-06-22,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,United States,Pediatrics HOT COVID-19 Database in NY Tristate,1500,https://clinicaltrials.gov/show/NCT04445402,NA
NCT04445415,ClinicalTrials.gov,2020-06-18,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,250,https://clinicaltrials.gov/show/NCT04445415,NA
NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,20,https://clinicaltrials.gov/show/NCT04445454,NA
NCT04445467,ClinicalTrials.gov,2020-06-22,2020-08-01,FALSE,Recruiting,Phase 2,Interventional,Australia,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,190,https://clinicaltrials.gov/show/NCT04445467,NA
NCT04445506,ClinicalTrials.gov,2020-06-19,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Short Term Corticosteroids in SARS-CoV2 Patients,50,https://clinicaltrials.gov/show/NCT04445506,NA
NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,TRUE,Recruiting,Not Applicable,Interventional,Belgium,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,90,https://clinicaltrials.gov/show/NCT04445597,NA
NCT04445610,ClinicalTrials.gov,2020-06-23,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,60,https://clinicaltrials.gov/show/NCT04445610,NA
NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,FALSE,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,128,https://clinicaltrials.gov/show/NCT04445623,NA
NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,FALSE,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,100,https://clinicaltrials.gov/show/NCT04445935,NA
NCT04445961,ClinicalTrials.gov,2020-06-22,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,117,https://clinicaltrials.gov/show/NCT04445961,NA
NCT04446065,ClinicalTrials.gov,2020-06-23,2020-09-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PrevifenonÂ® as Chemoprophylaxis of COVID-19 in Health Workers,524,https://clinicaltrials.gov/show/NCT04446065,NA
NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,FALSE,Not Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,4257,https://clinicaltrials.gov/show/NCT04446104,NA
NCT04446286,ClinicalTrials.gov,2020-06-23,2020-06-18,TRUE,Recruiting,Not Applicable,Observational,France,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,50,https://clinicaltrials.gov/show/NCT04446286,NA
NCT04446338,ClinicalTrials.gov,2020-06-22,2020-05-13,TRUE,Recruiting,Not Applicable,Observational,Germany,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,300,https://clinicaltrials.gov/show/NCT04446338,NA
NCT04446377,ClinicalTrials.gov,2020-06-23,2020-07-15,FALSE,Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,142,https://clinicaltrials.gov/show/NCT04446377,NA
NCT04447131,ClinicalTrials.gov,2020-06-17,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Brazil,Effect of COVID-19 on Platelet Aggregation,200,https://clinicaltrials.gov/show/NCT04447131,NA
NCT04447144,ClinicalTrials.gov,2020-06-23,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",200,https://clinicaltrials.gov/show/NCT04447144,NA
NCT04447222,ClinicalTrials.gov,2020-06-11,2020-05-12,TRUE,Recruiting,Not Applicable,Observational,United States,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,1242,https://clinicaltrials.gov/show/NCT04447222,NA
NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-23,FALSE,Recruiting,Phase 2,Interventional,Brazil,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,176,https://clinicaltrials.gov/show/NCT04447235,NA
NCT04447495,ClinicalTrials.gov,2020-06-23,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Self-sampling for the Study of COVID-19,500,https://clinicaltrials.gov/show/NCT04447495,NA
NCT04447638,ClinicalTrials.gov,2020-06-24,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Percutaneous Tracheostomy With COVID-19,24,https://clinicaltrials.gov/show/NCT04447638,NA
NCT04447781,ClinicalTrials.gov,2020-06-16,2020-07-15,FALSE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",160,https://clinicaltrials.gov/show/NCT04447781,NA
NCT04448119,ClinicalTrials.gov,2020-06-24,2020-10-16,FALSE,Recruiting,Phase 2,Interventional,Canada,Control of COVID-19 Outbreaks in Long Term Care,760,https://clinicaltrials.gov/show/NCT04448119,NA
NCT04448405,ClinicalTrials.gov,2020-06-19,2020-06-18,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 Lockdown and Deviant Sexual Fantasies,100,https://clinicaltrials.gov/show/NCT04448405,NA
NCT04448717,ClinicalTrials.gov,2020-06-18,2020-06-16,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,8000,https://clinicaltrials.gov/show/NCT04448717,NA
NCT04448743,ClinicalTrials.gov,2020-06-22,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Role of Microparticles in Covid-19 Infection,175,https://clinicaltrials.gov/show/NCT04448743,NA
NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-26,FALSE,Not Recruiting,Not Applicable,Interventional,France,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),2006,https://clinicaltrials.gov/show/NCT04448769,NA
NCT04448782,ClinicalTrials.gov,2020-06-17,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,32,https://clinicaltrials.gov/show/NCT04448782,NA
NCT04449042,ClinicalTrials.gov,2020-06-22,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,United States,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,15000,https://clinicaltrials.gov/show/NCT04449042,NA
NCT04449081,ClinicalTrials.gov,2020-06-25,2020-04-25,TRUE,Not Recruiting,Not Applicable,Observational,Malaysia,"Knowledge, Attitude and Practice of Dental Students About COVID-19",215,https://clinicaltrials.gov/show/NCT04449081,NA
NCT04449094,ClinicalTrials.gov,2020-06-25,2020-02-28,TRUE,Not Recruiting,Not Applicable,Observational,France,Emergence of the COVID 19 Epidemic in the City of Nice,200,https://clinicaltrials.gov/show/NCT04449094,NA
NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-18,FALSE,Recruiting,Phase 1,Interventional,"Germany, Belgium","A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",284,https://clinicaltrials.gov/show/NCT04449276,NA
NCT04449627,ClinicalTrials.gov,2020-06-11,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,125,https://clinicaltrials.gov/show/NCT04449627,NA
NCT04449718,ClinicalTrials.gov,2020-06-16,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Vitamin D Supplementation in Patients With COVID-19,240,https://clinicaltrials.gov/show/NCT04449718,NA
NCT04449783,ClinicalTrials.gov,2020-06-23,2020-06-25,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,150,https://clinicaltrials.gov/show/NCT04449783,NA
NCT04449965,ClinicalTrials.gov,2020-06-24,2020-07-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Povidone-Iodine Rinses in the Management of COVID-19,81,https://clinicaltrials.gov/show/NCT04449965,NA
NCT04449978,ClinicalTrials.gov,2020-06-23,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,Canada,TARGet Kids! COVID-19 Study of Children and Families,1082,https://clinicaltrials.gov/show/NCT04449978,NA
NCT04450004,ClinicalTrials.gov,2020-06-18,2020-07-10,FALSE,Not Recruiting,Phase 1,Interventional,Canada,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",180,https://clinicaltrials.gov/show/NCT04450004,NA
NCT04450277,ClinicalTrials.gov,2020-06-25,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,15,https://clinicaltrials.gov/show/NCT04450277,NA
NCT04451239,ClinicalTrials.gov,2020-06-28,2020-06-30,FALSE,Not Recruiting,Not Applicable,Interventional,Kuwait,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,12,https://clinicaltrials.gov/show/NCT04451239,NA
NCT04451317,ClinicalTrials.gov,2020-06-26,2020-06-12,TRUE,Recruiting,Not Applicable,Observational,France,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,600,https://clinicaltrials.gov/show/NCT04451317,NA
NCT04451577,ClinicalTrials.gov,2020-06-25,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Italy,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",5000,https://clinicaltrials.gov/show/NCT04451577,NA
NCT04451694,ClinicalTrials.gov,2020-06-15,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,800,https://clinicaltrials.gov/show/NCT04451694,NA
NCT04451889,ClinicalTrials.gov,2020-06-29,2020-08-01,FALSE,Recruiting,Not Applicable,Interventional,Russian Federation,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,15,https://clinicaltrials.gov/show/NCT04451889,NA
NCT04451902,ClinicalTrials.gov,2020-06-23,2020-06-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,80,https://clinicaltrials.gov/show/NCT04451902,NA
NCT04452422,ClinicalTrials.gov,2020-06-23,2020-06-23,FALSE,Recruiting,Not Applicable,Observational,France,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,30,https://clinicaltrials.gov/show/NCT04452422,NA
NCT04452474,ClinicalTrials.gov,2020-06-25,2020-06-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,376,https://clinicaltrials.gov/show/NCT04452474,NA
NCT04452487,ClinicalTrials.gov,2020-06-23,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,France,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),2500,https://clinicaltrials.gov/show/NCT04452487,NA
NCT04452565,ClinicalTrials.gov,2020-06-26,2020-10-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",525,https://clinicaltrials.gov/show/NCT04452565,NA
NCT04452604,ClinicalTrials.gov,2020-06-18,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,30,https://clinicaltrials.gov/show/NCT04452604,NA
NCT04452617,ClinicalTrials.gov,2020-06-26,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,France,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,40,https://clinicaltrials.gov/show/NCT04452617,NA
NCT04452630,ClinicalTrials.gov,2020-06-26,2020-06-23,TRUE,Recruiting,Not Applicable,Observational,France,Cardiovascular Consequences After COVID-19,200,https://clinicaltrials.gov/show/NCT04452630,NA
NCT04452643,ClinicalTrials.gov,2020-06-26,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,Mexico,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,0,https://clinicaltrials.gov/show/NCT04452643,NA
NCT04452682,ClinicalTrials.gov,2020-06-21,2020-05-25,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,998,https://clinicaltrials.gov/show/NCT04452682,NA
NCT04452708,ClinicalTrials.gov,2020-06-29,2020-06-11,TRUE,Recruiting,Not Applicable,Observational,Hong Kong,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,15,https://clinicaltrials.gov/show/NCT04452708,NA
NCT04452773,ClinicalTrials.gov,2020-06-25,2020-07-14,FALSE,Recruiting,Not Applicable,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Food Supplement ManremycÂ® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,315,https://clinicaltrials.gov/show/NCT04452773,NA
NCT04452799,ClinicalTrials.gov,2020-06-29,2020-07-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Hesperidin and Diosmin for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04452799,NA
NCT04452812,ClinicalTrials.gov,2020-06-29,2020-07-06,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,15,https://clinicaltrials.gov/show/NCT04452812,NA
NCT04452942,ClinicalTrials.gov,2020-06-27,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),30,https://clinicaltrials.gov/show/NCT04452942,NA
NCT04453280,ClinicalTrials.gov,2020-06-30,2020-05-18,TRUE,Not Recruiting,Not Applicable,Observational,Czech Republic,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),695,https://clinicaltrials.gov/show/NCT04453280,NA
NCT04453475,ClinicalTrials.gov,2020-06-29,2020-07-01,FALSE,Recruiting,Not Applicable,Interventional,Germany,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,1230,https://clinicaltrials.gov/show/NCT04453475,NA
NCT04453488,ClinicalTrials.gov,2020-06-30,2020-07-30,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,315,https://clinicaltrials.gov/show/NCT04453488,NA
NCT04453501,ClinicalTrials.gov,2020-06-25,2020-03-02,TRUE,Not Recruiting,Not Applicable,Observational,France,Anti Infective Agents Impact in COVID-19 Pneumonia,132,https://clinicaltrials.gov/show/NCT04453501,NA
NCT04453514,ClinicalTrials.gov,2020-06-30,2020-07-21,FALSE,Recruiting,Not Applicable,Interventional,United States,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,200,https://clinicaltrials.gov/show/NCT04453514,NA
NCT04453527,ClinicalTrials.gov,2020-06-25,2020-05-28,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,100,https://clinicaltrials.gov/show/NCT04453527,NA
NCT04453540,ClinicalTrials.gov,2020-06-30,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,150,https://clinicaltrials.gov/show/NCT04453540,NA
NCT04453553,ClinicalTrials.gov,2020-06-29,2020-07-02,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,CICERO- A Care Home Study of COVID-19,50,https://clinicaltrials.gov/show/NCT04453553,NA
NCT04453579,ClinicalTrials.gov,2020-06-29,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",116,https://clinicaltrials.gov/show/NCT04453579,NA
NCT04453670,ClinicalTrials.gov,2020-05-15,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,France,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,7,https://clinicaltrials.gov/show/NCT04453670,NA
NCT04453748,ClinicalTrials.gov,2020-05-21,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,Poland,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",200,https://clinicaltrials.gov/show/NCT04453748,NA
NCT04454307,ClinicalTrials.gov,2020-06-29,2020-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,100,https://clinicaltrials.gov/show/NCT04454307,NA
NCT04454333,ClinicalTrials.gov,2020-06-30,2020-06-03,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 in Pain Perspective,466,https://clinicaltrials.gov/show/NCT04454333,NA
NCT04454372,ClinicalTrials.gov,2020-06-29,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),187,https://clinicaltrials.gov/show/NCT04454372,NA
NCT04454606,ClinicalTrials.gov,2020-06-26,2020-05-01,TRUE,Not Recruiting,Not Applicable,Interventional,Thailand,The New Silicone N99 Half-Piece Respirator,43,https://clinicaltrials.gov/show/NCT04454606,NA
NCT04455243,ClinicalTrials.gov,2020-07-01,2020-08-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,1180,https://clinicaltrials.gov/show/NCT04455243,NA
NCT04455308,ClinicalTrials.gov,2020-06-30,2020-07-21,FALSE,Not Recruiting,Not Applicable,Interventional,France,COVID-19 and Chilblains,269,https://clinicaltrials.gov/show/NCT04455308,NA
NCT04455347,ClinicalTrials.gov,2020-07-01,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,France,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,80,https://clinicaltrials.gov/show/NCT04455347,NA
NCT04455360,ClinicalTrials.gov,2020-06-26,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,26,https://clinicaltrials.gov/show/NCT04455360,NA
NCT04455451,ClinicalTrials.gov,2020-07-01,2020-08-06,FALSE,Recruiting,Not Applicable,Observational,Germany,Intensive Care Therapy of Covid-19 Disease in Germany,2000,https://clinicaltrials.gov/show/NCT04455451,NA
NCT04456010,ClinicalTrials.gov,2020-06-15,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 in ART: Perception and Experience,600,https://clinicaltrials.gov/show/NCT04456010,NA
NCT04456049,ClinicalTrials.gov,2020-07-01,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Switzerland,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,90,https://clinicaltrials.gov/show/NCT04456049,NA
NCT04456075,ClinicalTrials.gov,2020-06-29,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Germany,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,100,https://clinicaltrials.gov/show/NCT04456075,NA
NCT04456101,ClinicalTrials.gov,2020-06-30,2020-06-19,TRUE,Recruiting,Not Applicable,Observational,China,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",240,https://clinicaltrials.gov/show/NCT04456101,NA
NCT04456361,ClinicalTrials.gov,2020-06-23,2020-04-16,TRUE,Not Recruiting,Phase 1,Interventional,Mexico,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,9,https://clinicaltrials.gov/show/NCT04456361,NA
NCT04456426,ClinicalTrials.gov,2020-05-29,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",250,https://clinicaltrials.gov/show/NCT04456426,NA
NCT04456556,ClinicalTrials.gov,2020-06-30,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),5,https://clinicaltrials.gov/show/NCT04456556,NA
NCT04456933,ClinicalTrials.gov,2020-06-30,2020-06-29,TRUE,Recruiting,Not Applicable,Observational,Spain,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,148,https://clinicaltrials.gov/show/NCT04456933,NA
NCT04457349,ClinicalTrials.gov,2020-06-30,2020-07-25,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,10,https://clinicaltrials.gov/show/NCT04457349,NA
NCT04457388,ClinicalTrials.gov,2020-06-30,2020-03-25,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Tele-Yoga Therapy for Chronic Pain,18,https://clinicaltrials.gov/show/NCT04457388,NA
NCT04457505,ClinicalTrials.gov,2020-07-01,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,Spain,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,5000,https://clinicaltrials.gov/show/NCT04457505,NA
NCT04457570,ClinicalTrials.gov,2020-07-02,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,France,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,600,https://clinicaltrials.gov/show/NCT04457570,NA
NCT04457609,ClinicalTrials.gov,2020-05-27,2020-07-01,FALSE,Recruiting,Phase 1,Interventional,Indonesia,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04457609,NA
NCT04457726,ClinicalTrials.gov,2020-07-02,2020-07-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Singapore,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,18,https://clinicaltrials.gov/show/NCT04457726,NA
NCT04458246,ClinicalTrials.gov,2020-07-01,2020-07-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,140,https://clinicaltrials.gov/show/NCT04458246,NA
NCT04458948,ClinicalTrials.gov,2020-06-09,2020-03-24,TRUE,Not Recruiting,Phase 2,Interventional,United States,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,10000,https://clinicaltrials.gov/show/NCT04458948,NA
NCT04459312,ClinicalTrials.gov,2020-07-03,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Germany,National Covid-19 Surveillance Physicians,600,https://clinicaltrials.gov/show/NCT04459312,NA
NCT04459325,ClinicalTrials.gov,2020-07-03,2020-06-01,TRUE,Not Recruiting,Phase 3,Interventional,Russian Federation,TigeraseÂ® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04459325,NA
NCT04459351,ClinicalTrials.gov,2020-06-18,2020-06-19,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,500,https://clinicaltrials.gov/show/NCT04459351,NA
NCT04459390,ClinicalTrials.gov,2020-07-05,2020-07-20,FALSE,Recruiting,Not Applicable,Observational,Egypt,Association of Comorbidities With COVID19,100,https://clinicaltrials.gov/show/NCT04459390,NA
NCT04459455,ClinicalTrials.gov,2020-06-29,2020-08-19,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",500,https://clinicaltrials.gov/show/NCT04459455,NA
NCT04459520,ClinicalTrials.gov,2020-07-05,2020-07-23,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,1400,https://clinicaltrials.gov/show/NCT04459520,NA
NCT04459533,ClinicalTrials.gov,2020-06-22,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Sparing in Neuromuscular Blockade in COVID 19 ICU,250,https://clinicaltrials.gov/show/NCT04459533,NA
NCT04459637,ClinicalTrials.gov,2020-06-25,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,China,COVID-19 Surveillance Based on Smart Wearable Device,200,https://clinicaltrials.gov/show/NCT04459637,NA
NCT04459689,ClinicalTrials.gov,2020-07-02,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 in PID Survey,200,https://clinicaltrials.gov/show/NCT04459689,NA
NCT04459975,ClinicalTrials.gov,2020-06-12,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,200,https://clinicaltrials.gov/show/NCT04459975,NA
NCT04460105,ClinicalTrials.gov,2020-06-30,2020-10-31,FALSE,Not Recruiting,Phase 1,Interventional,United States,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04460105,NA
NCT04460170,ClinicalTrials.gov,2020-06-29,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 Follow up Intensive Care Studies,100,https://clinicaltrials.gov/show/NCT04460170,NA
NCT04460196,ClinicalTrials.gov,2020-07-06,2020-07-08,FALSE,Not Recruiting,Not Applicable,Observational,France,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,900,https://clinicaltrials.gov/show/NCT04460196,NA
NCT04460274,ClinicalTrials.gov,2020-07-03,2019-12-31,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Forecast Number of Covid-19 Cases Worldwide,7882471,https://clinicaltrials.gov/show/NCT04460274,NA
NCT04460469,ClinicalTrials.gov,2020-07-04,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,1500,https://clinicaltrials.gov/show/NCT04460469,NA
NCT04460534,ClinicalTrials.gov,2020-07-02,2020-05-07,TRUE,Recruiting,Not Applicable,Interventional,France,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),100,https://clinicaltrials.gov/show/NCT04460534,NA
NCT04460547,ClinicalTrials.gov,2020-07-03,2020-07-25,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04460547,NA
NCT04460599,ClinicalTrials.gov,2020-07-06,2020-03-08,TRUE,Recruiting,Not Applicable,Observational,France,Neurological Features During COVID19,30,https://clinicaltrials.gov/show/NCT04460599,NA
NCT04460664,ClinicalTrials.gov,2020-06-30,2020-08-14,FALSE,Recruiting,Not Applicable,Observational,United States,Coagulation Changes Associated With COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04460664,NA
NCT04460677,ClinicalTrials.gov,2020-07-06,2020-08-12,FALSE,Recruiting,Not Applicable,Interventional,United States,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,80,https://clinicaltrials.gov/show/NCT04460677,NA
NCT04460690,ClinicalTrials.gov,2020-07-06,2020-07-13,FALSE,Recruiting,Not Applicable,Interventional,United States,"Rapid, Onsite COVID-19 Detection",10000,https://clinicaltrials.gov/show/NCT04460690,NA
NCT04460703,ClinicalTrials.gov,2020-07-02,2020-07-03,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"COVID-19 Vaccine Messaging, Part 1",4000,https://clinicaltrials.gov/show/NCT04460703,NA
NCT04461340,ClinicalTrials.gov,2020-07-04,2020-08-15,FALSE,Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Sirolimus in COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04461340,NA
NCT04461379,ClinicalTrials.gov,2020-07-02,2020-07-21,FALSE,Not Recruiting,Phase 3,Interventional,Mexico,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",908,https://clinicaltrials.gov/show/NCT04461379,NA
NCT04461925,ClinicalTrials.gov,2020-07-01,2020-05-02,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Ukraine,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,30,https://clinicaltrials.gov/show/NCT04461925,NA
NCT04462120,ClinicalTrials.gov,2020-06-19,2020-06-16,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,100,https://clinicaltrials.gov/show/NCT04462120,NA
NCT04462393,ClinicalTrials.gov,2020-07-06,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,1563,https://clinicaltrials.gov/show/NCT04462393,NA
NCT04462848,ClinicalTrials.gov,2020-06-30,2020-08-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,30,https://clinicaltrials.gov/show/NCT04462848,NA
NCT04463264,ClinicalTrials.gov,2020-06-26,2020-06-26,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),135,https://clinicaltrials.gov/show/NCT04463264,NA
NCT04463420,ClinicalTrials.gov,2020-07-04,2020-08-15,FALSE,Recruiting,Not Applicable,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,224,https://clinicaltrials.gov/show/NCT04463420,NA
NCT04463433,ClinicalTrials.gov,2020-04-12,2020-02-01,TRUE,Recruiting,Not Applicable,Interventional,China,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,300,https://clinicaltrials.gov/show/NCT04463433,NA
NCT04463472,ClinicalTrials.gov,2020-07-08,2020-06-29,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0301-COVID19),30,https://clinicaltrials.gov/show/NCT04463472,NA
NCT04463706,ClinicalTrials.gov,2020-07-06,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Spain,COVID19 Severity Prediction and Health Services Research Evaluation,20000,https://clinicaltrials.gov/show/NCT04463706,NA
NCT04463758,ClinicalTrials.gov,2020-07-08,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,3060,https://clinicaltrials.gov/show/NCT04463758,NA
NCT04464460,ClinicalTrials.gov,2020-07-08,2020-09-25,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",0,https://clinicaltrials.gov/show/NCT04464460,NA
NCT04464486,ClinicalTrials.gov,2020-06-26,2020-04-21,TRUE,Recruiting,Not Applicable,Interventional,United States,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,300,https://clinicaltrials.gov/show/NCT04464486,NA
NCT04465058,ClinicalTrials.gov,2020-07-08,2020-07-08,FALSE,Recruiting,Not Applicable,Observational,Egypt,Characteristics of Critically Ill COVID 19 Patients,50,https://clinicaltrials.gov/show/NCT04465058,NA
NCT04465656,ClinicalTrials.gov,2020-06-30,2020-07-07,FALSE,Recruiting,Not Applicable,Observational,France,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,250,https://clinicaltrials.gov/show/NCT04465656,NA
NCT04465695,ClinicalTrials.gov,2020-07-09,2020-07-14,FALSE,Recruiting,Phase 2,Interventional,China,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,81,https://clinicaltrials.gov/show/NCT04465695,NA
NCT04465981,ClinicalTrials.gov,2020-07-07,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,United States,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,80,https://clinicaltrials.gov/show/NCT04465981,NA
NCT04466280,ClinicalTrials.gov,2020-07-09,2020-07-15,FALSE,Recruiting,Not Applicable,Interventional,Iran,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",180,https://clinicaltrials.gov/show/NCT04466280,NA
NCT04466306,ClinicalTrials.gov,2020-06-24,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,"United Kingdom, Canada, United States, Israel, Serbia, Spain, Japan",Pediatric Acute Kidney Injury in COVID-19,250,https://clinicaltrials.gov/show/NCT04466306,NA
NCT04466462,ClinicalTrials.gov,2020-07-08,2020-05-26,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,1000,https://clinicaltrials.gov/show/NCT04466462,NA
NCT04466540,ClinicalTrials.gov,2020-07-03,2020-05-12,TRUE,Recruiting,Phase 4,Interventional,Brazil,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),1300,https://clinicaltrials.gov/show/NCT04466540,NA
NCT04466605,ClinicalTrials.gov,2020-07-09,2020-03-30,TRUE,Not Recruiting,Not Applicable,Interventional,India,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,64,https://clinicaltrials.gov/show/NCT04466605,NA
NCT04466644,ClinicalTrials.gov,2020-07-09,2020-06-08,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),340,https://clinicaltrials.gov/show/NCT04466644,NA
NCT04466657,ClinicalTrials.gov,2020-07-09,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Nigeria,Antioxidant Therapy for COVID-19 Study,90,https://clinicaltrials.gov/show/NCT04466657,NA
NCT04467008,ClinicalTrials.gov,2020-07-09,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Covid-19 Rapid Diagnostic Tests on Blood Drop,113,https://clinicaltrials.gov/show/NCT04467008,NA
NCT04467047,ClinicalTrials.gov,2020-07-07,2020-07-25,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,10,https://clinicaltrials.gov/show/NCT04467047,NA
NCT04467151,ClinicalTrials.gov,2020-07-09,2020-10-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",0,https://clinicaltrials.gov/show/NCT04467151,NA
NCT04467918,ClinicalTrials.gov,2020-07-03,2020-07-06,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,100,https://clinicaltrials.gov/show/NCT04467918,NA
NCT04468035,ClinicalTrials.gov,2020-07-10,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,France,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,30,https://clinicaltrials.gov/show/NCT04468035,NA
NCT04468139,ClinicalTrials.gov,2020-07-05,2020-06-20,TRUE,Recruiting,Phase 4,Interventional,Saudi Arabia,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",60,https://clinicaltrials.gov/show/NCT04468139,NA
NCT04468217,ClinicalTrials.gov,2020-07-09,2020-06-02,TRUE,Recruiting,Not Applicable,Observational,Chile,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,150,https://clinicaltrials.gov/show/NCT04468217,NA
NCT04468256,ClinicalTrials.gov,2020-07-09,2020-07-26,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,The Heart Hive COVID-19 Study,1000,https://clinicaltrials.gov/show/NCT04468256,NA
NCT04468308,ClinicalTrials.gov,2020-06-22,2020-09-08,FALSE,Recruiting,Not Applicable,Observational,Austria,VRQOL in Cataract Patients During the COVID-19 Pandemic,116,https://clinicaltrials.gov/show/NCT04468308,NA
NCT04468412,ClinicalTrials.gov,2020-07-09,2020-07-14,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Influence of COVID-19 on Vascular Endothelial Function,203,https://clinicaltrials.gov/show/NCT04468412,NA
NCT04468646,ClinicalTrials.gov,2020-07-07,2020-06-15,TRUE,Recruiting,Phase 3,Interventional,Pakistan,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,100,https://clinicaltrials.gov/show/NCT04468646,NA
NCT04468802,ClinicalTrials.gov,2020-07-09,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,32,https://clinicaltrials.gov/show/NCT04468802,NA
NCT04469153,ClinicalTrials.gov,2020-06-29,2020-06-29,FALSE,Recruiting,Not Applicable,Observational,France,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,57,https://clinicaltrials.gov/show/NCT04469153,NA
NCT04469621,ClinicalTrials.gov,2020-06-28,2020-07-17,FALSE,Not Recruiting,Phase 1,Interventional,"Chile, Argentina, Russian Federation, Mexico, Brazil",A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,68,https://clinicaltrials.gov/show/NCT04469621,NA
NCT04469647,ClinicalTrials.gov,2020-07-13,2020-07-19,FALSE,Recruiting,Not Applicable,Observational,Saudi Arabia,COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH,1200,https://clinicaltrials.gov/show/NCT04469647,NA
NCT04469660,ClinicalTrials.gov,2020-07-13,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,India,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,1300,https://clinicaltrials.gov/show/NCT04469660,NA
NCT04470297,ClinicalTrials.gov,2020-07-12,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,100,https://clinicaltrials.gov/show/NCT04470297,NA
NCT04470323,ClinicalTrials.gov,2020-07-12,2020-07-22,FALSE,Recruiting,Not Applicable,Observational,Egypt,Functional Exhaustion of T Cells in COVID19 Patients,100,https://clinicaltrials.gov/show/NCT04470323,NA
NCT04470414,ClinicalTrials.gov,2020-07-12,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 IgG Antibodies in the Serum of Recovered Patients,100,https://clinicaltrials.gov/show/NCT04470414,NA
NCT04470531,ClinicalTrials.gov,2020-07-11,2020-07-12,FALSE,Recruiting,Phase 2,Interventional,Bangladesh,Role of Co-trimoxazole in Severe COVID-19 Patients,94,https://clinicaltrials.gov/show/NCT04470531,NA
NCT04470557,ClinicalTrials.gov,2020-07-11,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Relation Between Lab Finding and COVID-19 Severity,100,https://clinicaltrials.gov/show/NCT04470557,NA
NCT04470583,ClinicalTrials.gov,2020-07-13,2020-10-09,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating Clinical Parameters of COVID-19 in Pregnancy,116,https://clinicaltrials.gov/show/NCT04470583,NA
NCT04470609,ClinicalTrials.gov,2020-07-13,2020-07-10,TRUE,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ?60 Years,471,https://clinicaltrials.gov/show/NCT04470609,NA
NCT04470739,ClinicalTrials.gov,2020-07-12,2020-05-30,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,20,https://clinicaltrials.gov/show/NCT04470739,NA
NCT04471649,ClinicalTrials.gov,2020-07-07,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,Egypt,Hydroxy Chloroquine and Covid in RA Patients,80,https://clinicaltrials.gov/show/NCT04471649,NA
NCT04471701,ClinicalTrials.gov,2020-07-14,2020-04-13,TRUE,Recruiting,Not Applicable,Observational,Italy,Italian Web-based Cross-sectional Survey on COVID-19,200000,https://clinicaltrials.gov/show/NCT04471701,NA
NCT04471831,ClinicalTrials.gov,2020-07-07,2020-07-13,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",30,https://clinicaltrials.gov/show/NCT04471831,NA
NCT04472052,ClinicalTrials.gov,2020-07-10,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Frequency of Perforated Appendicitis in Times of COVID-19,143,https://clinicaltrials.gov/show/NCT04472052,NA
NCT04472078,ClinicalTrials.gov,2020-07-12,2020-06-10,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",873,https://clinicaltrials.gov/show/NCT04472078,NA
NCT04472494,ClinicalTrials.gov,2020-07-14,2020-08-24,FALSE,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,129,https://clinicaltrials.gov/show/NCT04472494,NA
NCT04472572,ClinicalTrials.gov,2020-07-14,2020-12-25,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for Treatment of COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04472572,NA
NCT04472793,ClinicalTrials.gov,2020-06-03,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,United States,Repeated Employee Testing for Understanding Our Recovery to Normal,200,https://clinicaltrials.gov/show/NCT04472793,NA
NCT04473053,ClinicalTrials.gov,2020-07-09,2020-07-03,TRUE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Rapid Experimental Medicine for COVID-19,60,https://clinicaltrials.gov/show/NCT04473053,NA
NCT04473105,ClinicalTrials.gov,2020-05-20,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,500,https://clinicaltrials.gov/show/NCT04473105,NA
NCT04473118,ClinicalTrials.gov,2020-07-15,2020-07-11,TRUE,Recruiting,Not Applicable,Observational,Qatar,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,25000,https://clinicaltrials.gov/show/NCT04473118,NA
NCT04473131,ClinicalTrials.gov,2020-07-15,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,Qatar,Immune Profiling of COVID19-patients Admitted to ICU,300,https://clinicaltrials.gov/show/NCT04473131,NA
NCT04473170,ClinicalTrials.gov,2020-07-14,2020-04-04,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United Arab Emirates,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,146,https://clinicaltrials.gov/show/NCT04473170,NA
NCT04473183,ClinicalTrials.gov,2020-07-14,2020-07-21,FALSE,Recruiting,Not Applicable,Observational,United States,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,3000,https://clinicaltrials.gov/show/NCT04473183,NA
NCT04473248,ClinicalTrials.gov,2020-07-14,2020-06-28,TRUE,Not Recruiting,Not Applicable,Interventional,Canada,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,27,https://clinicaltrials.gov/show/NCT04473248,NA
NCT04473352,ClinicalTrials.gov,2020-06-18,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Detection Tests in Different Body Fluids,80,https://clinicaltrials.gov/show/NCT04473352,NA
NCT04473599,ClinicalTrials.gov,2020-07-13,2020-04-17,TRUE,Recruiting,Not Applicable,Interventional,United States,Stay Well at Home: a Text-messaging Study Social Distancing,200,https://clinicaltrials.gov/show/NCT04473599,NA
NCT04474067,ClinicalTrials.gov,2020-07-15,2020-06-28,TRUE,Recruiting,Not Applicable,Observational,Israel,COVID-19 - Cytokine Storm,300,https://clinicaltrials.gov/show/NCT04474067,NA
NCT04474080,ClinicalTrials.gov,2020-07-08,2021-01-15,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,1080,https://clinicaltrials.gov/show/NCT04474080,NA
NCT04474249,ClinicalTrials.gov,2020-06-29,2020-06-25,TRUE,Recruiting,Not Applicable,Observational,Sweden,Follow-up of Critical COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04474249,NA
NCT04474288,ClinicalTrials.gov,2020-07-15,2020-07-16,FALSE,Recruiting,Not Applicable,Observational,United States,The COVID-19 PUI Reality Check (CPRC) Study,400,https://clinicaltrials.gov/show/NCT04474288,NA
NCT04474301,ClinicalTrials.gov,2020-07-14,2020-06-11,TRUE,Recruiting,Not Applicable,Observational,United States,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,1152,https://clinicaltrials.gov/show/NCT04474301,NA
NCT04474340,ClinicalTrials.gov,2020-07-15,2020-05-21,TRUE,Recruiting,Phase 1,Interventional,Kuwait,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,300,https://clinicaltrials.gov/show/NCT04474340,NA
NCT04474444,ClinicalTrials.gov,2020-07-12,2019-03-23,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),55000,https://clinicaltrials.gov/show/NCT04474444,NA
NCT04475068,ClinicalTrials.gov,2020-07-14,2020-07-17,FALSE,Recruiting,Not Applicable,Observational,Peru,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,12,https://clinicaltrials.gov/show/NCT04475068,NA
NCT04475081,ClinicalTrials.gov,2020-07-14,2020-08-17,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,60,https://clinicaltrials.gov/show/NCT04475081,NA
NCT04475185,ClinicalTrials.gov,2020-07-15,2020-07-20,FALSE,Recruiting,Not Applicable,Interventional,France,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,117,https://clinicaltrials.gov/show/NCT04475185,NA
NCT04475211,ClinicalTrials.gov,2020-07-10,2020-08-10,FALSE,Recruiting,Not Applicable,Observational,France,LILLE COVID RESEARCH NETWORK (Covid-19),1000,https://clinicaltrials.gov/show/NCT04475211,NA
NCT04475471,ClinicalTrials.gov,2020-07-01,2020-06-11,TRUE,Recruiting,Not Applicable,Observational,"Argentina, Ghana, Sudan, Iran, India, Bosnia and Herzegovina",WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,5200,https://clinicaltrials.gov/show/NCT04475471,NA
NCT04475484,ClinicalTrials.gov,2020-07-06,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,France,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,30000,https://clinicaltrials.gov/show/NCT04475484,NA
NCT04475562,ClinicalTrials.gov,2020-07-15,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19?,219,https://clinicaltrials.gov/show/NCT04475562,NA
NCT04475575,ClinicalTrials.gov,2020-07-15,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19 Antibodies?,222,https://clinicaltrials.gov/show/NCT04475575,NA
NCT04475601,ClinicalTrials.gov,2020-06-08,2020-07-15,FALSE,Recruiting,Phase 2,Interventional,Sweden,Enzalutamide Treatment in COVID-19,500,https://clinicaltrials.gov/show/NCT04475601,NA
NCT04476589,ClinicalTrials.gov,2020-07-16,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,United States,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,100,https://clinicaltrials.gov/show/NCT04476589,NA
NCT04476602,ClinicalTrials.gov,2020-07-16,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,United States,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,500,https://clinicaltrials.gov/show/NCT04476602,NA
NCT04476823,ClinicalTrials.gov,2020-07-16,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,France,European Pathology Laboratories and COVID-19,71,https://clinicaltrials.gov/show/NCT04476823,NA
NCT04476927,ClinicalTrials.gov,2020-06-16,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,300,https://clinicaltrials.gov/show/NCT04476927,NA
NCT04476940,ClinicalTrials.gov,2020-07-13,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Breastfeeding Guideline for African-Americans,200,https://clinicaltrials.gov/show/NCT04476940,NA
NCT04477083,ClinicalTrials.gov,2020-07-14,2020-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,Egypt,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",40,https://clinicaltrials.gov/show/NCT04477083,NA
NCT04477473,ClinicalTrials.gov,2020-07-17,2020-06-30,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,100,https://clinicaltrials.gov/show/NCT04477473,NA
NCT04477642,ClinicalTrials.gov,2020-04-22,2020-08-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Abatacept for Patients With COVID-19 and Respiratory Distress,0,https://clinicaltrials.gov/show/NCT04477642,NA
NCT04477889,ClinicalTrials.gov,2020-07-17,2020-06-20,TRUE,Recruiting,Not Applicable,Observational,United States,Methodist Health System COVID-19 Patient Registry,500,https://clinicaltrials.gov/show/NCT04477889,NA
NCT04478071,ClinicalTrials.gov,2020-07-15,2020-08-22,FALSE,Recruiting,Phase 2,Interventional,United States,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),300,https://clinicaltrials.gov/show/NCT04478071,NA
NCT04478539,ClinicalTrials.gov,2020-07-14,2020-06-01,TRUE,Recruiting,Not Applicable,Interventional,North Macedonia,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,35,https://clinicaltrials.gov/show/NCT04478539,NA
NCT04479124,ClinicalTrials.gov,2020-07-19,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,2000,https://clinicaltrials.gov/show/NCT04479124,NA
NCT04479137,ClinicalTrials.gov,2020-07-18,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,5000,https://clinicaltrials.gov/show/NCT04479137,NA
NCT04479163,ClinicalTrials.gov,2020-06-29,2020-06-04,TRUE,Not Recruiting,Not Applicable,Interventional,Argentina,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,165,https://clinicaltrials.gov/show/NCT04479163,NA
NCT04479202,ClinicalTrials.gov,2020-05-13,2020-02-08,TRUE,Not Recruiting,Phase 4,Interventional,China,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,76,https://clinicaltrials.gov/show/NCT04479202,NA
NCT04479280,ClinicalTrials.gov,2020-07-19,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,70,https://clinicaltrials.gov/show/NCT04479280,NA
NCT04479293,ClinicalTrials.gov,2020-07-19,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Post COVID-19 Functional Status in Egypt,400,https://clinicaltrials.gov/show/NCT04479293,NA
NCT04479332,ClinicalTrials.gov,2020-07-16,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),334,https://clinicaltrials.gov/show/NCT04479332,NA
NCT04479345,ClinicalTrials.gov,2020-07-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",100,https://clinicaltrials.gov/show/NCT04479345,NA
NCT04479358,ClinicalTrials.gov,2020-07-13,2020-09-10,FALSE,Recruiting,Phase 2,Interventional,United States,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,332,https://clinicaltrials.gov/show/NCT04479358,NA
NCT04479540,ClinicalTrials.gov,2020-07-06,2020-05-26,TRUE,Recruiting,Not Applicable,Interventional,France,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,120,https://clinicaltrials.gov/show/NCT04479540,NA
NCT04479982,ClinicalTrials.gov,2020-07-17,2020-09-24,FALSE,Recruiting,Not Applicable,Observational,Egypt,Microbial Infection and AMR in Hospitalized Patients With Covid 19,70,https://clinicaltrials.gov/show/NCT04479982,NA
NCT04480034,ClinicalTrials.gov,2020-07-15,2020-07-15,FALSE,Recruiting,Not Applicable,Observational,Italy,Obesity Surgery During 2020 Italian Pandemic,1600,https://clinicaltrials.gov/show/NCT04480034,NA
NCT04480060,ClinicalTrials.gov,2020-07-18,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,100000,https://clinicaltrials.gov/show/NCT04480060,NA
NCT04480333,ClinicalTrials.gov,2020-07-13,2020-09-15,FALSE,Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",45,https://clinicaltrials.gov/show/NCT04480333,NA
NCT04480398,ClinicalTrials.gov,2020-07-18,2020-05-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,91,https://clinicaltrials.gov/show/NCT04480398,NA
NCT04480515,ClinicalTrials.gov,2020-07-17,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Does COVID-19 Pandemic Reduce In-hospital Mortality?,5000,https://clinicaltrials.gov/show/NCT04480515,NA
NCT04480580,ClinicalTrials.gov,2020-07-20,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,100,https://clinicaltrials.gov/show/NCT04480580,NA
NCT04480593,ClinicalTrials.gov,2020-07-12,2020-06-02,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,120,https://clinicaltrials.gov/show/NCT04480593,NA
NCT04480606,ClinicalTrials.gov,2020-07-16,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,88,https://clinicaltrials.gov/show/NCT04480606,NA
NCT04480632,ClinicalTrials.gov,2020-07-17,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,Colombia,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,44,https://clinicaltrials.gov/show/NCT04480632,NA
NCT04481360,ClinicalTrials.gov,2020-07-11,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,100,https://clinicaltrials.gov/show/NCT04481360,NA
NCT04481633,ClinicalTrials.gov,2020-07-21,2020-09-09,FALSE,Recruiting,Not Applicable,Interventional,France,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,800,https://clinicaltrials.gov/show/NCT04481633,NA
NCT04481646,ClinicalTrials.gov,2020-07-21,2020-06-12,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,630,https://clinicaltrials.gov/show/NCT04481646,NA
NCT04482205,ClinicalTrials.gov,2020-07-21,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,840,https://clinicaltrials.gov/show/NCT04482205,NA
NCT04482634,ClinicalTrials.gov,2020-07-21,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation Versus Home Exercise Program in COVID-19,122,https://clinicaltrials.gov/show/NCT04482634,NA
NCT04482673,ClinicalTrials.gov,2020-07-01,2020-07-31,FALSE,Recruiting,Phase 4,Interventional,United States,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04482673,NA
NCT04483622,ClinicalTrials.gov,2020-07-21,2020-06-12,TRUE,Recruiting,Not Applicable,Observational,Egypt,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,30,https://clinicaltrials.gov/show/NCT04483622,NA
NCT04483752,ClinicalTrials.gov,2020-07-21,2020-06-08,TRUE,Recruiting,Not Applicable,Interventional,France,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,100,https://clinicaltrials.gov/show/NCT04483752,NA
NCT04483830,ClinicalTrials.gov,2020-07-22,2020-06-05,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Mexico,Suloexide in the Treatment of Early Stages of COVID-19,243,https://clinicaltrials.gov/show/NCT04483830,NA
NCT04483908,ClinicalTrials.gov,2020-07-22,2020-04-10,TRUE,Recruiting,Not Applicable,Observational,Switzerland,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,550,https://clinicaltrials.gov/show/NCT04483908,NA
NCT04484207,ClinicalTrials.gov,2020-07-21,2020-07-06,TRUE,Recruiting,Not Applicable,Interventional,United States,Addressing COVID-19 Mental Health Problems Among US Veterans,200,https://clinicaltrials.gov/show/NCT04484207,NA
NCT04484493,ClinicalTrials.gov,2020-07-22,2020-08-08,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Corticosteroid Nasal Spray in COVID-19 Anosmia,100,https://clinicaltrials.gov/show/NCT04484493,NA
NCT04484545,ClinicalTrials.gov,2020-07-22,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,250,https://clinicaltrials.gov/show/NCT04484545,NA
NCT04484597,ClinicalTrials.gov,2020-07-14,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Egypt,Predictors of COVID-19 Infection and Disease Progression,100,https://clinicaltrials.gov/show/NCT04484597,NA
NCT04485169,ClinicalTrials.gov,2020-07-21,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Pakistan,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,280,https://clinicaltrials.gov/show/NCT04485169,NA
NCT04485351,ClinicalTrials.gov,2020-07-02,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,France,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,700,https://clinicaltrials.gov/show/NCT04485351,NA
NCT04485364,ClinicalTrials.gov,2020-07-23,2020-04-14,TRUE,Not Recruiting,Not Applicable,Observational,France,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04485364,NA
NCT04485429,ClinicalTrials.gov,2020-07-20,2020-07-20,FALSE,Recruiting,Phase 3,Interventional,Brazil,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,268,https://clinicaltrials.gov/show/NCT04485429,NA
NCT04486404,ClinicalTrials.gov,2020-07-23,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,"Chile, Argentina, Colombia, Spain, Ecuador","Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",2500,https://clinicaltrials.gov/show/NCT04486404,NA
NCT04486417,ClinicalTrials.gov,2020-07-22,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,20,https://clinicaltrials.gov/show/NCT04486417,NA
NCT04486729,ClinicalTrials.gov,2020-07-21,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Argentina,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,15,https://clinicaltrials.gov/show/NCT04486729,NA
NCT04487119,ClinicalTrials.gov,2020-07-24,2020-08-12,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Hematology and Clinical Picture in Pediatric COVID-19 Infection,29,https://clinicaltrials.gov/show/NCT04487119,NA
NCT04487171,ClinicalTrials.gov,2020-07-24,2020-07-21,TRUE,Recruiting,Not Applicable,Interventional,France,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,248,https://clinicaltrials.gov/show/NCT04487171,NA
NCT04487444,ClinicalTrials.gov,2020-07-22,2020-09-10,FALSE,Recruiting,Phase 2,Interventional,United States,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04487444,NA
NCT04487574,ClinicalTrials.gov,2020-07-22,2020-07-25,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,118,https://clinicaltrials.gov/show/NCT04487574,NA
NCT04487639,ClinicalTrials.gov,2020-07-21,2020-07-10,TRUE,Recruiting,Not Applicable,Interventional,France,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,250,https://clinicaltrials.gov/show/NCT04487639,NA
NCT04487665,ClinicalTrials.gov,2020-07-21,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,50,https://clinicaltrials.gov/show/NCT04487665,NA
NCT04487886,ClinicalTrials.gov,2020-07-23,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),80,https://clinicaltrials.gov/show/NCT04487886,NA
NCT04487951,ClinicalTrials.gov,2020-07-24,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04487951,NA
NCT04487964,ClinicalTrials.gov,2020-07-24,2020-01-01,TRUE,Recruiting,Not Applicable,Interventional,Egypt,Complementary Intervention for COVID-19,70,https://clinicaltrials.gov/show/NCT04487964,NA
NCT04487977,ClinicalTrials.gov,2020-07-23,2020-04-22,TRUE,Recruiting,Not Applicable,Observational,Spain,Survey on COVID-19 Airway Management,5000,https://clinicaltrials.gov/show/NCT04487977,NA
NCT04488471,ClinicalTrials.gov,2020-07-24,2020-06-30,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,232,https://clinicaltrials.gov/show/NCT04488471,NA
NCT04488484,ClinicalTrials.gov,2020-07-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,450,https://clinicaltrials.gov/show/NCT04488484,NA
NCT04488510,ClinicalTrials.gov,2020-07-23,2020-05-06,TRUE,Not Recruiting,Not Applicable,Observational,France,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,150,https://clinicaltrials.gov/show/NCT04488510,NA
NCT04488549,ClinicalTrials.gov,2020-07-23,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),1051,https://clinicaltrials.gov/show/NCT04488549,NA
NCT04488562,ClinicalTrials.gov,2020-06-02,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,150,https://clinicaltrials.gov/show/NCT04488562,NA
NCT04488588,ClinicalTrials.gov,2020-07-24,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,1064,https://clinicaltrials.gov/show/NCT04488588,NA
NCT04489628,ClinicalTrials.gov,2020-07-24,2020-08-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Tele-health Enabled Clinical Trial for COVID-19,110,https://clinicaltrials.gov/show/NCT04489628,NA
NCT04490278,ClinicalTrials.gov,2020-07-23,2020-09-29,FALSE,Recruiting,Not Applicable,Interventional,United States,CoV-PICS: A Virtual Post-ICU Clinic,80,https://clinicaltrials.gov/show/NCT04490278,NA
NCT04490772,ClinicalTrials.gov,2020-07-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,200,https://clinicaltrials.gov/show/NCT04490772,NA
NCT04490811,ClinicalTrials.gov,2020-06-20,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,France,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,800,https://clinicaltrials.gov/show/NCT04490811,NA
NCT04490837,ClinicalTrials.gov,2020-05-15,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),3500,https://clinicaltrials.gov/show/NCT04490837,NA
NCT04490850,ClinicalTrials.gov,2020-07-28,2020-07-15,TRUE,Recruiting,Not Applicable,Interventional,French Guiana,COVID-19 Seroprevalence Study in French Guiana,1500,https://clinicaltrials.gov/show/NCT04490850,NA
NCT04491201,ClinicalTrials.gov,2020-07-27,2020-07-27,FALSE,Recruiting,Not Applicable,Observational,China,National Survey of the Impact of COVID-19 Pandemics,6000,https://clinicaltrials.gov/show/NCT04491201,NA
NCT04491227,ClinicalTrials.gov,2020-07-24,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,"Chile, United Kingdom, Canada, United States, Bolivia, India",Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,2000,https://clinicaltrials.gov/show/NCT04491227,NA
NCT04491240,ClinicalTrials.gov,2020-07-27,2020-07-20,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,30,https://clinicaltrials.gov/show/NCT04491240,NA
NCT04491292,ClinicalTrials.gov,2020-07-28,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,United States,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,20000,https://clinicaltrials.gov/show/NCT04491292,NA
NCT04491318,ClinicalTrials.gov,2020-07-27,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Spain,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,27,https://clinicaltrials.gov/show/NCT04491318,NA
NCT04491994,ClinicalTrials.gov,2020-07-28,2020-04-10,TRUE,Not Recruiting,Phase 3,Interventional,Pakistan,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,540,https://clinicaltrials.gov/show/NCT04491994,NA
NCT04492189,ClinicalTrials.gov,2020-04-19,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Containment Measures and Eating Disorders,40,https://clinicaltrials.gov/show/NCT04492189,NA
NCT04492202,ClinicalTrials.gov,2020-07-28,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals",200,https://clinicaltrials.gov/show/NCT04492202,NA
NCT04492228,ClinicalTrials.gov,2020-07-25,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,Italy,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,100,https://clinicaltrials.gov/show/NCT04492228,NA
NCT04492267,ClinicalTrials.gov,2020-07-23,2020-07-07,TRUE,Recruiting,Not Applicable,Observational,France,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,700,https://clinicaltrials.gov/show/NCT04492267,NA
NCT04492358,ClinicalTrials.gov,2020-07-28,2020-10-22,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Spain,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",144,https://clinicaltrials.gov/show/NCT04492358,NA
NCT04492371,ClinicalTrials.gov,2020-07-28,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,"Greece, Belgium, Netherlands, United Kingdom, Italy, Austria, Germany, Czech Republic",COVID-19 Infection and Multiple Myeloma,500,https://clinicaltrials.gov/show/NCT04492371,NA
NCT04492501,ClinicalTrials.gov,2020-07-28,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Pakistan,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,600,https://clinicaltrials.gov/show/NCT04492501,NA
NCT04492514,ClinicalTrials.gov,2020-07-28,2020-05-20,TRUE,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,60,https://clinicaltrials.gov/show/NCT04492514,NA
NCT04492865,ClinicalTrials.gov,2020-07-25,2020-07-30,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,MSCT Chest in Suspected COVID-19 Patients,150,https://clinicaltrials.gov/show/NCT04492865,NA
NCT04492891,ClinicalTrials.gov,2020-07-20,2020-11-23,FALSE,Recruiting,Phase 2,Interventional,United States,Cyclosporine For The Treatment Of COVID-19(+),75,https://clinicaltrials.gov/show/NCT04492891,NA
NCT04492904,ClinicalTrials.gov,2020-07-27,2020-07-23,TRUE,Recruiting,Not Applicable,Observational,Singapore,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,5000,https://clinicaltrials.gov/show/NCT04492904,NA
NCT04492943,ClinicalTrials.gov,2020-04-24,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,United States,To Observe Whether Isoflurane Can Treat COVID-19 Patients,35,https://clinicaltrials.gov/show/NCT04492943,NA
NCT04493242,ClinicalTrials.gov,2020-07-29,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Extracellular Vesicle Infusion Therapy for Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04493242,NA
NCT04493268,ClinicalTrials.gov,2020-07-28,2020-03-07,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,HYPONATREMIA IN COVID-19 PATIENTS,250,https://clinicaltrials.gov/show/NCT04493268,NA
NCT04493294,ClinicalTrials.gov,2020-07-29,2020-11-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,500,https://clinicaltrials.gov/show/NCT04493294,NA
NCT04493307,ClinicalTrials.gov,2020-06-25,2020-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04493307,NA
NCT04493359,ClinicalTrials.gov,2020-07-29,2020-07-25,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,240,https://clinicaltrials.gov/show/NCT04493359,NA
NCT04494204,ClinicalTrials.gov,2020-07-28,2020-08-07,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04494204,NA
NCT04494399,ClinicalTrials.gov,2020-07-28,2020-07-29,FALSE,Recruiting,Phase 2,Interventional,Hong Kong,IFN Beta-1b and Ribavirin for Covid-19,96,https://clinicaltrials.gov/show/NCT04494399,NA
NCT04494724,ClinicalTrials.gov,2020-07-21,2020-07-13,TRUE,Recruiting,Phase 2,Interventional,United States,Clazakizumab vs. Placebo - COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04494724,NA
NCT04494867,ClinicalTrials.gov,2020-07-29,2020-08-19,FALSE,Recruiting,Not Applicable,Interventional,United States,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,20,https://clinicaltrials.gov/show/NCT04494867,NA
NCT04495543,ClinicalTrials.gov,2020-07-23,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',75,https://clinicaltrials.gov/show/NCT04495543,NA
NCT04495842,ClinicalTrials.gov,2020-07-30,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,United States,The Effect of Aromatherapy on COVID-19-induced Anxiety,65,https://clinicaltrials.gov/show/NCT04495842,NA
NCT04496141,ClinicalTrials.gov,2020-07-30,2020-07-27,TRUE,Not Recruiting,Not Applicable,Observational,Hong Kong,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,70,https://clinicaltrials.gov/show/NCT04496141,NA
NCT04496869,ClinicalTrials.gov,2020-06-15,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,600,https://clinicaltrials.gov/show/NCT04496869,NA
NCT04497194,ClinicalTrials.gov,2020-05-18,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Registry of COVID-19 Patients at AOUI Verona,500,https://clinicaltrials.gov/show/NCT04497194,NA
NCT04497246,ClinicalTrials.gov,2020-08-03,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Belgium,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",5000,https://clinicaltrials.gov/show/NCT04497246,NA
NCT04497272,ClinicalTrials.gov,2020-08-03,2020-08-07,FALSE,Recruiting,Not Applicable,Interventional,France,Assesment of the Metabolomic Signature in COVID-19 Patients,150,https://clinicaltrials.gov/show/NCT04497272,NA
NCT04497311,ClinicalTrials.gov,2020-07-31,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,Mexico,Tomographic Findings in COVID-19 and Influenza,100,https://clinicaltrials.gov/show/NCT04497311,NA
NCT04497389,ClinicalTrials.gov,2020-06-09,2020-10-28,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04497389,NA
NCT04497402,ClinicalTrials.gov,2020-07-31,2020-09-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Sex-Informed Data in the COVID-19 Pandemic.,88,https://clinicaltrials.gov/show/NCT04497402,NA
NCT04497415,ClinicalTrials.gov,2020-08-02,2020-10-21,FALSE,Recruiting,Not Applicable,Interventional,United States,The COVID-19 and Healthcare Workers: An Active Intervention,1200,https://clinicaltrials.gov/show/NCT04497415,NA
NCT04497441,ClinicalTrials.gov,2020-08-01,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,Saudi Arabia,Netizens' Perception of COVID-19 Information & Information Sources.,385,https://clinicaltrials.gov/show/NCT04497441,NA
NCT04497454,ClinicalTrials.gov,2020-07-31,2020-05-08,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),128,https://clinicaltrials.gov/show/NCT04497454,NA
NCT04497467,ClinicalTrials.gov,2020-08-02,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,Taiwan,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,1200000,https://clinicaltrials.gov/show/NCT04497467,NA
NCT04497519,ClinicalTrials.gov,2020-07-27,2020-09-15,FALSE,Not Recruiting,Phase 1,Interventional,Netherlands,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,12,https://clinicaltrials.gov/show/NCT04497519,NA
NCT04497610,ClinicalTrials.gov,2020-08-02,2020-08-04,FALSE,Not Recruiting,Not Applicable,Observational,Costa Rica,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,1000,https://clinicaltrials.gov/show/NCT04497610,NA
NCT04497623,ClinicalTrials.gov,2020-07-27,2020-07-28,FALSE,Not Recruiting,Not Applicable,Interventional,Colombia,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",5,https://clinicaltrials.gov/show/NCT04497623,NA
NCT04497779,ClinicalTrials.gov,2020-06-29,2020-07-13,FALSE,Recruiting,Not Applicable,Observational,United States,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,800,https://clinicaltrials.gov/show/NCT04497779,NA
NCT04497818,ClinicalTrials.gov,2020-08-01,2020-06-16,TRUE,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Correlation Fear of COVID-19 & Dental Treatment Anxiety,385,https://clinicaltrials.gov/show/NCT04497818,NA
NCT04498065,ClinicalTrials.gov,2020-08-03,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,MYocardial DOmmages Related to COVID-19,200,https://clinicaltrials.gov/show/NCT04498065,NA
NCT04498091,ClinicalTrials.gov,2020-08-03,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,France,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,35,https://clinicaltrials.gov/show/NCT04498091,NA
NCT04498299,ClinicalTrials.gov,2020-07-31,2020-09-01,FALSE,Recruiting,Not Applicable,Observational,Mexico,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,30,https://clinicaltrials.gov/show/NCT04498299,NA
NCT04498507,ClinicalTrials.gov,2020-08-01,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Psychosocial Outcomes in Families of COVID-19 ICU Patients,39,https://clinicaltrials.gov/show/NCT04498507,NA
NCT04498936,ClinicalTrials.gov,2020-04-14,2020-07-15,FALSE,Not Recruiting,Phase 4,Interventional,Egypt,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,240,https://clinicaltrials.gov/show/NCT04498936,NA
NCT04499300,ClinicalTrials.gov,2020-08-03,2020-06-09,TRUE,Recruiting,Not Applicable,Observational,Belgium,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,50,https://clinicaltrials.gov/show/NCT04499300,NA
NCT04499313,ClinicalTrials.gov,2020-07-27,2020-08-02,FALSE,Recruiting,Phase 3,Interventional,Bangladesh,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,60,https://clinicaltrials.gov/show/NCT04499313,NA
NCT04500067,ClinicalTrials.gov,2020-07-15,2020-05-07,TRUE,Not Recruiting,Phase 3,Interventional,Ukraine,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",76,https://clinicaltrials.gov/show/NCT04500067,NA
NCT04500132,ClinicalTrials.gov,2020-08-04,2020-05-28,TRUE,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,60,https://clinicaltrials.gov/show/NCT04500132,NA
NCT04500366,ClinicalTrials.gov,2020-07-31,2020-08-26,FALSE,Recruiting,Not Applicable,Interventional,Canada,GERAS Frailty Rehabilitation at Home During COVID-19,70,https://clinicaltrials.gov/show/NCT04500366,NA
NCT04500418,ClinicalTrials.gov,2020-08-04,2020-08-25,FALSE,Recruiting,Phase 2,Interventional,Germany,CharitÃ© Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,183,https://clinicaltrials.gov/show/NCT04500418,NA
NCT04500600,ClinicalTrials.gov,2020-07-24,2020-06-11,TRUE,Recruiting,Not Applicable,Observational,United States,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,50000,https://clinicaltrials.gov/show/NCT04500600,NA
NCT04500652,ClinicalTrials.gov,2020-07-24,2020-06-27,TRUE,Recruiting,Not Applicable,Observational,Turkey,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,310,https://clinicaltrials.gov/show/NCT04500652,NA
NCT04501172,ClinicalTrials.gov,2020-07-25,2020-06-25,TRUE,Not Recruiting,Not Applicable,Observational,Greece,Impact of Spectacles on Compliance to Mask-wearing Directives,1214,https://clinicaltrials.gov/show/NCT04501172,NA
NCT04501783,ClinicalTrials.gov,2020-08-05,2020-05-20,TRUE,Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,168,https://clinicaltrials.gov/show/NCT04501783,NA
NCT04501822,ClinicalTrials.gov,2020-07-28,2020-07-19,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,380,https://clinicaltrials.gov/show/NCT04501822,NA
NCT04501965,ClinicalTrials.gov,2020-08-03,2020-06-01,TRUE,Recruiting,Phase 2,Interventional,Guinea,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,231,https://clinicaltrials.gov/show/NCT04501965,NA
NCT04501991,ClinicalTrials.gov,2020-08-05,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,114,https://clinicaltrials.gov/show/NCT04501991,NA
NCT04502056,ClinicalTrials.gov,2020-08-02,2020-07-31,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Covid-19 Messaging to Underserved Communities - 2nd Experiment,20000,https://clinicaltrials.gov/show/NCT04502056,NA
NCT04502069,ClinicalTrials.gov,2020-07-10,2020-08-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,0,https://clinicaltrials.gov/show/NCT04502069,NA
NCT04502108,ClinicalTrials.gov,2020-08-05,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Behavior During and After COVID-19 Crisis,1000,https://clinicaltrials.gov/show/NCT04502108,NA
NCT04502342,ClinicalTrials.gov,2020-08-04,2020-06-01,TRUE,Recruiting,Phase 2,Interventional,Guinea,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",30,https://clinicaltrials.gov/show/NCT04502342,NA
NCT04502472,ClinicalTrials.gov,2020-08-04,2020-06-06,TRUE,Recruiting,Phase 2/Phase 3,Interventional,United States,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,200,https://clinicaltrials.gov/show/NCT04502472,NA
NCT04502667,ClinicalTrials.gov,2020-08-04,2020-07-15,TRUE,Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,40,https://clinicaltrials.gov/show/NCT04502667,NA
NCT04503057,ClinicalTrials.gov,2020-08-03,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Sweden,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),300,https://clinicaltrials.gov/show/NCT04503057,NA
NCT04503434,ClinicalTrials.gov,2020-06-11,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,517,https://clinicaltrials.gov/show/NCT04503434,NA
NCT04503447,ClinicalTrials.gov,2020-08-04,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 Seroprevalence Study in ITM Staff,330,https://clinicaltrials.gov/show/NCT04503447,NA
NCT04503525,ClinicalTrials.gov,2020-08-04,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,France,Nutritional Assessment of Hospitalized Patients With COVID-19,50,https://clinicaltrials.gov/show/NCT04503525,NA
NCT04504877,ClinicalTrials.gov,2020-08-04,2020-06-16,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,120,https://clinicaltrials.gov/show/NCT04504877,NA
NCT04505098,ClinicalTrials.gov,2020-08-05,2020-08-07,FALSE,Recruiting,Phase 4,Interventional,United States,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,16500,https://clinicaltrials.gov/show/NCT04505098,NA
NCT04505605,ClinicalTrials.gov,2020-07-31,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,France,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04505605,NA
NCT04505631,ClinicalTrials.gov,2020-08-03,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,France,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04505631,NA
NCT04505709,ClinicalTrials.gov,2020-08-07,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,Spain,"Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",1000,https://clinicaltrials.gov/show/NCT04505709,NA
NCT04506229,ClinicalTrials.gov,2020-08-07,2020-08-20,FALSE,Recruiting,Not Applicable,Observational,United States,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,60,https://clinicaltrials.gov/show/NCT04506229,NA
NCT04506515,ClinicalTrials.gov,2020-08-03,2020-04-09,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,3000,https://clinicaltrials.gov/show/NCT04506515,NA
NCT04506632,ClinicalTrials.gov,2020-07-21,2020-06-02,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Burden for STaff Working in the NHS,100,https://clinicaltrials.gov/show/NCT04506632,NA
NCT04507282,ClinicalTrials.gov,2020-08-07,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Eosinophil and Anticoagulation in COVID-19 Patients,80,https://clinicaltrials.gov/show/NCT04507282,NA
NCT04507867,ClinicalTrials.gov,2020-08-06,2020-08-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,240,https://clinicaltrials.gov/show/NCT04507867,NA
NCT04508439,ClinicalTrials.gov,2020-08-05,2020-06-20,TRUE,Recruiting,Not Applicable,Interventional,Mexico,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,130,https://clinicaltrials.gov/show/NCT04508439,NA
NCT04508712,ClinicalTrials.gov,2020-08-08,2020-08-10,FALSE,Recruiting,Not Applicable,Observational,China,Long-term Outcomes in Patients With COVID-19,900,https://clinicaltrials.gov/show/NCT04508712,NA
NCT04508868,ClinicalTrials.gov,2020-08-10,2020-08-17,FALSE,Recruiting,Not Applicable,Interventional,Sweden,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,154,https://clinicaltrials.gov/show/NCT04508868,NA
NCT04508920,ClinicalTrials.gov,2020-08-07,2019-05-15,TRUE,Recruiting,Not Applicable,Observational,Mexico,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,76,https://clinicaltrials.gov/show/NCT04508920,NA
NCT04508933,ClinicalTrials.gov,2020-08-08,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",10,https://clinicaltrials.gov/show/NCT04508933,NA
NCT04508959,ClinicalTrials.gov,2020-08-10,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Canada,The McMaster Multi-Regional COVID-19 Hospital Case Registry,1500,https://clinicaltrials.gov/show/NCT04508959,NA
NCT04508972,ClinicalTrials.gov,2020-08-10,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Canada,The VOICE-COVID-19,200,https://clinicaltrials.gov/show/NCT04508972,NA
NCT04508985,ClinicalTrials.gov,2020-08-10,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The McGill RAAS-COVID-19 Trial,40,https://clinicaltrials.gov/show/NCT04508985,NA
NCT04509713,ClinicalTrials.gov,2020-08-06,2020-07-02,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Canine COVID-19 Detection,16250,https://clinicaltrials.gov/show/NCT04509713,NA
NCT04509986,ClinicalTrials.gov,2020-08-11,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,GlobalSurg-CovidSurg Week,1000,https://clinicaltrials.gov/show/NCT04509986,NA
NCT04510012,ClinicalTrials.gov,2020-08-10,2020-03-05,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Characterizing the Immune Response and Neuronal Damage in COVID-19,150,https://clinicaltrials.gov/show/NCT04510012,NA
NCT04510025,ClinicalTrials.gov,2020-07-14,2020-05-13,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Capturing MultiORgan Effects of COVID-19,616,https://clinicaltrials.gov/show/NCT04510025,NA
NCT04510233,ClinicalTrials.gov,2020-08-10,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Ivermectin Nasal Spray for COVID19 Patients,60,https://clinicaltrials.gov/show/NCT04510233,NA
NCT04510402,ClinicalTrials.gov,2020-08-10,2020-08-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,50,https://clinicaltrials.gov/show/NCT04510402,NA
NCT04510441,ClinicalTrials.gov,2020-08-07,2020-05-26,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,2000,https://clinicaltrials.gov/show/NCT04510441,NA
NCT04510467,ClinicalTrials.gov,2020-08-11,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,1313,https://clinicaltrials.gov/show/NCT04510467,NA
NCT04510493,ClinicalTrials.gov,2020-08-11,2020-10-23,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,116,https://clinicaltrials.gov/show/NCT04510493,NA
NCT04510519,ClinicalTrials.gov,2020-08-07,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,50,https://clinicaltrials.gov/show/NCT04510519,NA
NCT04510623,ClinicalTrials.gov,2020-08-11,2020-03-17,TRUE,Recruiting,Not Applicable,Observational,Canada,Host Response Mediators in Coronavirus (COVID-19) Infection,500,https://clinicaltrials.gov/show/NCT04510623,NA
NCT04510662,ClinicalTrials.gov,2020-08-11,2020-08-01,TRUE,Recruiting,Phase 2,Interventional,Mexico,Telmisartan in Respiratory Failure Due to COVID-19,60,https://clinicaltrials.gov/show/NCT04510662,NA
NCT04511429,ClinicalTrials.gov,2020-07-24,2020-06-30,TRUE,Recruiting,Not Applicable,Observational,Brazil,COVID-19 in Immunosuppressed Children,200,https://clinicaltrials.gov/show/NCT04511429,NA
NCT04511780,ClinicalTrials.gov,2020-08-12,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID-19 Outbreak on Caregivers,5000,https://clinicaltrials.gov/show/NCT04511780,NA
NCT04511962,ClinicalTrials.gov,2020-08-05,2020-08-12,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,"Feasibility, of Tele-rehabilitation Following COVID-19",40,https://clinicaltrials.gov/show/NCT04511962,NA
NCT04512027,ClinicalTrials.gov,2020-08-11,2020-09-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,10,https://clinicaltrials.gov/show/NCT04512027,NA
NCT04512118,ClinicalTrials.gov,2020-08-12,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,France,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,22,https://clinicaltrials.gov/show/NCT04512118,NA
NCT04513158,ClinicalTrials.gov,2020-08-06,2020-08-14,FALSE,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,100,https://clinicaltrials.gov/show/NCT04513158,NA
NCT04513184,ClinicalTrials.gov,2020-08-12,2020-07-14,TRUE,Recruiting,Phase 2,Interventional,Mexico,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04513184,NA
NCT04513210,ClinicalTrials.gov,2020-08-11,2020-10-10,FALSE,Recruiting,Not Applicable,Observational,Poland,Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection,300,https://clinicaltrials.gov/show/NCT04513210,NA
NCT04513314,ClinicalTrials.gov,2020-08-12,2021-11-01,FALSE,Not Recruiting,Phase 4,Interventional,United States,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,20,https://clinicaltrials.gov/show/NCT04513314,NA
NCT04513470,ClinicalTrials.gov,2020-08-10,2020-08-01,TRUE,Not Recruiting,Phase 1,Interventional,Israel,Allocetra-OTS in COVID-19,5,https://clinicaltrials.gov/show/NCT04513470,NA
NCT04513496,ClinicalTrials.gov,2020-08-04,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Telemedicine in HIV Care in Buenos Aires,4000,https://clinicaltrials.gov/show/NCT04513496,NA
NCT04513847,ClinicalTrials.gov,2020-08-12,2020-08-13,FALSE,Not Recruiting,Not Applicable,Observational,Canada,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,661,https://clinicaltrials.gov/show/NCT04513847,NA
NCT04513990,ClinicalTrials.gov,2020-06-05,2020-04-09,TRUE,Recruiting,Not Applicable,Interventional,United States,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),1500,https://clinicaltrials.gov/show/NCT04513990,NA
NCT04514003,ClinicalTrials.gov,2020-08-13,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Norway,The Corona and COVID-19 Study in Telemark and Agder,5000,https://clinicaltrials.gov/show/NCT04514003,NA
NCT04514302,ClinicalTrials.gov,2020-08-12,2020-10-20,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,51,https://clinicaltrials.gov/show/NCT04514302,NA
NCT04514627,ClinicalTrials.gov,2020-07-08,2020-07-13,FALSE,Recruiting,Not Applicable,Interventional,United States,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,100,https://clinicaltrials.gov/show/NCT04514627,NA
NCT04514705,ClinicalTrials.gov,2020-08-11,2020-08-11,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Characteristics in Post Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04514705,NA
NCT04515108,ClinicalTrials.gov,2020-08-14,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,108,https://clinicaltrials.gov/show/NCT04515108,NA
NCT04515199,ClinicalTrials.gov,2020-08-07,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Home Management of Adult Egyptian Mild COVID-19 Cases,400,https://clinicaltrials.gov/show/NCT04515199,NA
NCT04515225,ClinicalTrials.gov,2020-08-13,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Prevalence in HIV-infected Patients,500,https://clinicaltrials.gov/show/NCT04515225,NA
NCT04516486,ClinicalTrials.gov,2020-06-23,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,France,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,180,https://clinicaltrials.gov/show/NCT04516486,NA
NCT04516512,ClinicalTrials.gov,2020-08-17,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Assessment of SARS-CoV-2 Seroprevalence in Detention,2500,https://clinicaltrials.gov/show/NCT04516512,NA
NCT04516564,ClinicalTrials.gov,2020-08-13,2020-09-01,FALSE,Recruiting,Phase 1,Interventional,New Zealand,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",32,https://clinicaltrials.gov/show/NCT04516564,NA
NCT04516668,ClinicalTrials.gov,2020-08-17,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,250,https://clinicaltrials.gov/show/NCT04516668,NA
NCT04516811,ClinicalTrials.gov,2020-08-12,2020-09-21,FALSE,Recruiting,Phase 3,Interventional,South Africa,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,600,https://clinicaltrials.gov/show/NCT04516811,NA
NCT04516824,ClinicalTrials.gov,2020-08-16,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,2160,https://clinicaltrials.gov/show/NCT04516824,NA
NCT04516837,ClinicalTrials.gov,2020-08-16,2020-08-31,FALSE,Recruiting,Phase 2,Interventional,China,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),120,https://clinicaltrials.gov/show/NCT04516837,NA
NCT04516850,ClinicalTrials.gov,2020-08-16,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Switzerland,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,500,https://clinicaltrials.gov/show/NCT04516850,NA
NCT04516915,ClinicalTrials.gov,2020-08-10,2020-06-15,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in the Treatment of COVID-19,120,https://clinicaltrials.gov/show/NCT04516915,NA
NCT04516941,ClinicalTrials.gov,2020-08-05,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,Switzerland,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,420,https://clinicaltrials.gov/show/NCT04516941,NA
NCT04516954,ClinicalTrials.gov,2020-08-17,2020-08-01,TRUE,Recruiting,Phase 1,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04516954,NA
NCT04517123,ClinicalTrials.gov,2020-08-14,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,United States,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",100,https://clinicaltrials.gov/show/NCT04517123,NA
NCT04517682,ClinicalTrials.gov,2020-05-19,2020-05-21,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 and SARS-CoV-2 Detection in Saliva,300,https://clinicaltrials.gov/show/NCT04517682,NA
NCT04517695,ClinicalTrials.gov,2020-08-14,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,United States,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,30,https://clinicaltrials.gov/show/NCT04517695,NA
NCT04518514,ClinicalTrials.gov,2020-07-28,2020-04-20,TRUE,Recruiting,Not Applicable,Interventional,Germany,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),100,https://clinicaltrials.gov/show/NCT04518514,NA
NCT04518735,ClinicalTrials.gov,2020-08-18,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),1707,https://clinicaltrials.gov/show/NCT04518735,NA
NCT04518969,ClinicalTrials.gov,2020-04-25,2020-05-03,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,24,https://clinicaltrials.gov/show/NCT04518969,NA
NCT04519034,ClinicalTrials.gov,2020-08-03,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,27000,https://clinicaltrials.gov/show/NCT04519034,NA
NCT04519125,ClinicalTrials.gov,2020-08-18,2020-08-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,950,https://clinicaltrials.gov/show/NCT04519125,NA
NCT04519216,ClinicalTrials.gov,2020-08-12,2020-07-31,TRUE,Recruiting,Not Applicable,Interventional,United States,Breastfeeding Education in the Time of COVID-19,39,https://clinicaltrials.gov/show/NCT04519216,NA
NCT04519307,ClinicalTrials.gov,2020-08-18,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Newborns Presenting With Suspected COVID 19,72,https://clinicaltrials.gov/show/NCT04519307,NA
NCT04519320,ClinicalTrials.gov,2020-08-18,2020-05-18,TRUE,Recruiting,Not Applicable,Interventional,France,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,140,https://clinicaltrials.gov/show/NCT04519320,NA
NCT04519385,ClinicalTrials.gov,2020-08-17,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,69,https://clinicaltrials.gov/show/NCT04519385,NA
NCT04519398,ClinicalTrials.gov,2020-08-18,2020-08-18,FALSE,Recruiting,Not Applicable,Observational,Romania,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,60,https://clinicaltrials.gov/show/NCT04519398,NA
NCT04519424,ClinicalTrials.gov,2020-08-18,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,CSL324 in COVID-19,0,https://clinicaltrials.gov/show/NCT04519424,NA
NCT04520620,ClinicalTrials.gov,2020-07-22,2020-05-02,TRUE,Not Recruiting,Phase 4,Interventional,France,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,0,https://clinicaltrials.gov/show/NCT04520620,NA
NCT04520880,ClinicalTrials.gov,2020-07-21,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,158,https://clinicaltrials.gov/show/NCT04520880,NA
NCT04521010,ClinicalTrials.gov,2020-08-13,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Poland,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,700,https://clinicaltrials.gov/show/NCT04521010,NA
NCT04521036,ClinicalTrials.gov,2020-08-18,2020-12-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients (CPCP),44,https://clinicaltrials.gov/show/NCT04521036,NA
NCT04521296,ClinicalTrials.gov,2020-07-07,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,90,https://clinicaltrials.gov/show/NCT04521296,NA
NCT04521322,ClinicalTrials.gov,2020-08-19,2020-07-24,TRUE,Recruiting,Phase 4,Interventional,Argentina,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,400,https://clinicaltrials.gov/show/NCT04521322,NA
NCT04521400,ClinicalTrials.gov,2020-08-18,2020-08-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",100,https://clinicaltrials.gov/show/NCT04521400,NA
NCT04522037,ClinicalTrials.gov,2020-07-06,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,France,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,200,https://clinicaltrials.gov/show/NCT04522037,NA
NCT04522076,ClinicalTrials.gov,2020-08-18,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,1124,https://clinicaltrials.gov/show/NCT04522076,NA
NCT04522128,ClinicalTrials.gov,2020-05-12,2020-05-22,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,969,https://clinicaltrials.gov/show/NCT04522128,NA
NCT04522466,ClinicalTrials.gov,2020-08-19,2020-04-03,TRUE,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,7,https://clinicaltrials.gov/show/NCT04522466,NA
NCT04522817,ClinicalTrials.gov,2020-08-20,2020-10-05,FALSE,Recruiting,Phase 1,Interventional,United States,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,12,https://clinicaltrials.gov/show/NCT04522817,NA
NCT04523012,ClinicalTrials.gov,2020-08-20,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 and HIV Patients,2200,https://clinicaltrials.gov/show/NCT04523012,NA
NCT04523051,ClinicalTrials.gov,2020-08-20,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Rehabilitation After Admission in Intensive Care Unit for COVID-19,40,https://clinicaltrials.gov/show/NCT04523051,NA
NCT04523831,ClinicalTrials.gov,2020-08-19,2020-06-01,TRUE,Not Recruiting,Phase 3,Interventional,Bangladesh,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,400,https://clinicaltrials.gov/show/NCT04523831,NA
NCT04524052,ClinicalTrials.gov,2020-08-19,2020-08-01,TRUE,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",32,https://clinicaltrials.gov/show/NCT04524052,NA
NCT04524156,ClinicalTrials.gov,2020-04-30,2020-10-04,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,100,https://clinicaltrials.gov/show/NCT04524156,NA
NCT04524234,ClinicalTrials.gov,2020-08-21,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Cardiac Dysfunction in Critically Ill Patients Infected With COVID-19,133,https://clinicaltrials.gov/show/NCT04524234,NA
NCT04524520,ClinicalTrials.gov,2020-08-19,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",30,https://clinicaltrials.gov/show/NCT04524520,NA
NCT04524754,ClinicalTrials.gov,2020-08-21,2020-07-11,TRUE,Recruiting,Not Applicable,Observational,Egypt,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,218,https://clinicaltrials.gov/show/NCT04524754,NA
NCT04525287,ClinicalTrials.gov,2020-08-20,2020-02-20,TRUE,Recruiting,Not Applicable,Observational,China,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,1000,https://clinicaltrials.gov/show/NCT04525287,NA
NCT04525378,ClinicalTrials.gov,2020-07-31,2020-07-01,TRUE,Recruiting,Phase 1,Interventional,Brazil,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,20,https://clinicaltrials.gov/show/NCT04525378,NA
NCT04525404,ClinicalTrials.gov,2020-08-17,2020-11-12,FALSE,Recruiting,Not Applicable,Observational,Canada,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,228,https://clinicaltrials.gov/show/NCT04525404,NA
NCT04525716,ClinicalTrials.gov,2020-08-21,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Sweden,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,2000,https://clinicaltrials.gov/show/NCT04525716,NA
NCT04525742,ClinicalTrials.gov,2020-06-28,2020-07-05,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 Pandemic and Parents of Disabled Children,309,https://clinicaltrials.gov/show/NCT04525742,NA
NCT04526054,ClinicalTrials.gov,2020-08-03,2020-09-03,FALSE,Recruiting,Not Applicable,Interventional,France,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04526054,NA
NCT04526405,ClinicalTrials.gov,2020-08-06,2020-07-14,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,63,https://clinicaltrials.gov/show/NCT04526405,NA
NCT04526769,ClinicalTrials.gov,2020-08-21,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Detecting SARS-CoV-2 in Tears,30,https://clinicaltrials.gov/show/NCT04526769,NA
NCT04526821,ClinicalTrials.gov,2020-08-21,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,Peru,Lactoferrin for Prevention of COVID-19 in Health Care Workers,336,https://clinicaltrials.gov/show/NCT04526821,NA
NCT04527133,ClinicalTrials.gov,2020-08-24,2020-06-11,TRUE,Not Recruiting,Not Applicable,Interventional,Russian Federation,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,30,https://clinicaltrials.gov/show/NCT04527133,NA
NCT04527198,ClinicalTrials.gov,2020-06-02,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,40,https://clinicaltrials.gov/show/NCT04527198,NA
NCT04527211,ClinicalTrials.gov,2020-08-24,2020-09-07,FALSE,Not Recruiting,Phase 3,Interventional,Colombia,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,550,https://clinicaltrials.gov/show/NCT04527211,NA
NCT04527458,ClinicalTrials.gov,2020-08-24,2020-02-24,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Case Fatalities in Hospitalised COVID-19 Patients in the UK,70000,https://clinicaltrials.gov/show/NCT04527458,NA
NCT04527497,ClinicalTrials.gov,2020-08-20,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,Germany,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,50,https://clinicaltrials.gov/show/NCT04527497,NA
NCT04527601,ClinicalTrials.gov,2020-08-25,2020-08-21,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,885,https://clinicaltrials.gov/show/NCT04527601,NA
NCT04527614,ClinicalTrials.gov,2020-08-18,2020-09-24,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,2000,https://clinicaltrials.gov/show/NCT04527614,NA
NCT04528771,ClinicalTrials.gov,2020-08-25,2020-10-31,FALSE,Not Recruiting,Phase 1,Interventional,United States,S-Nitrosylation Therapy of COVID-19,21,https://clinicaltrials.gov/show/NCT04528771,NA
NCT04528927,ClinicalTrials.gov,2020-05-06,2020-05-15,FALSE,Not Recruiting,Phase 3,Interventional,Tunisia,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",0,https://clinicaltrials.gov/show/NCT04528927,NA
NCT04529408,ClinicalTrials.gov,2020-08-26,2020-08-26,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,60,https://clinicaltrials.gov/show/NCT04529408,NA
NCT04529447,ClinicalTrials.gov,2020-08-26,2020-06-10,TRUE,Not Recruiting,Not Applicable,Observational,South Korea,Response of Korean Medicine Hospital to COVID-19,485,https://clinicaltrials.gov/show/NCT04529447,NA
NCT04529460,ClinicalTrials.gov,2020-08-26,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Healthy Volunteer COVID-19 Antibody Testing Study,200,https://clinicaltrials.gov/show/NCT04529460,NA
NCT04530370,ClinicalTrials.gov,2020-08-26,2020-05-29,TRUE,Recruiting,Phase 1,Interventional,Egypt,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,30,https://clinicaltrials.gov/show/NCT04530370,NA
NCT04530422,ClinicalTrials.gov,2020-08-26,2020-04-15,TRUE,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,250,https://clinicaltrials.gov/show/NCT04530422,NA
NCT04530461,ClinicalTrials.gov,2020-08-26,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Tunisia,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,200,https://clinicaltrials.gov/show/NCT04530461,NA
NCT04530578,ClinicalTrials.gov,2020-08-17,2020-06-01,TRUE,Recruiting,Phase 4,Interventional,Argentina,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,200,https://clinicaltrials.gov/show/NCT04530578,NA
NCT04530604,ClinicalTrials.gov,2020-08-25,2020-10-01,FALSE,Recruiting,Phase 1,Interventional,United States,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),12,https://clinicaltrials.gov/show/NCT04530604,NA
NCT04531111,ClinicalTrials.gov,2020-08-25,2020-07-07,TRUE,Recruiting,Not Applicable,Observational,Egypt,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,150,https://clinicaltrials.gov/show/NCT04531111,NA
NCT04531202,ClinicalTrials.gov,2020-08-26,2020-03-02,TRUE,Recruiting,Not Applicable,Observational,Brazil,CORE Study COVID-19,2000,https://clinicaltrials.gov/show/NCT04531202,NA
NCT04531501,ClinicalTrials.gov,2020-08-26,2020-06-29,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Saliva Test Research Study,400,https://clinicaltrials.gov/show/NCT04531501,NA
NCT04531618,ClinicalTrials.gov,2020-08-19,2020-08-13,TRUE,Recruiting,Not Applicable,Interventional,United States,Mother-infant Bonding During COVID-19,280,https://clinicaltrials.gov/show/NCT04531618,NA
NCT04531735,ClinicalTrials.gov,2020-08-19,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,28,https://clinicaltrials.gov/show/NCT04531735,NA
NCT04531774,ClinicalTrials.gov,2020-08-26,2020-08-28,FALSE,Recruiting,Not Applicable,Interventional,Switzerland,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,160,https://clinicaltrials.gov/show/NCT04531774,NA
NCT04532554,ClinicalTrials.gov,2020-08-24,2020-10-26,FALSE,Not Recruiting,Phase 4,Interventional,Egypt,Growth Hormone in Obese Cases With Covid-19,0,https://clinicaltrials.gov/show/NCT04532554,NA
NCT04532632,ClinicalTrials.gov,2020-08-28,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Taste and Smell Impairment in Critically Ill COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04532632,NA
NCT04532931,ClinicalTrials.gov,2020-08-26,2020-09-03,FALSE,Recruiting,Phase 2,Interventional,South Africa,COVID-19 Treatment in South Africa,250,https://clinicaltrials.gov/show/NCT04532931,NA
NCT04533399,ClinicalTrials.gov,2020-08-28,2020-08-17,TRUE,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,4400,https://clinicaltrials.gov/show/NCT04533399,NA
NCT04534400,ClinicalTrials.gov,2020-08-26,2020-09-01,FALSE,Recruiting,Not Applicable,Observational,France,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,1000,https://clinicaltrials.gov/show/NCT04534400,NA
NCT04534478,ClinicalTrials.gov,2020-08-31,2020-09-07,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,120,https://clinicaltrials.gov/show/NCT04534478,NA
NCT04534569,ClinicalTrials.gov,2020-08-30,2020-09-04,FALSE,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),40,https://clinicaltrials.gov/show/NCT04534569,NA
NCT04534608,ClinicalTrials.gov,2020-08-31,2020-05-11,TRUE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Child Health Investigation of Latent Disease in Hamburg,6000,https://clinicaltrials.gov/show/NCT04534608,NA
NCT04534621,ClinicalTrials.gov,2020-08-25,2020-08-26,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,948,https://clinicaltrials.gov/show/NCT04534621,NA
NCT04534673,ClinicalTrials.gov,2020-04-20,2020-08-05,FALSE,Recruiting,Phase 2,Interventional,Israel,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04534673,NA
NCT04534712,ClinicalTrials.gov,2020-08-30,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,100,https://clinicaltrials.gov/show/NCT04534712,NA
NCT04534725,ClinicalTrials.gov,2020-08-30,2020-11-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,2282,https://clinicaltrials.gov/show/NCT04534725,NA
NCT04535063,ClinicalTrials.gov,2020-08-29,2020-04-18,TRUE,Recruiting,Phase 3,Interventional,Argentina,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04535063,NA
NCT04535154,ClinicalTrials.gov,2020-08-29,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Norway,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,264,https://clinicaltrials.gov/show/NCT04535154,NA
NCT04535297,ClinicalTrials.gov,2020-08-31,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,Israel,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,198,https://clinicaltrials.gov/show/NCT04535297,NA
NCT04535700,ClinicalTrials.gov,2020-08-27,2020-09-18,FALSE,Recruiting,Phase 4,Interventional,Spain,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,76,https://clinicaltrials.gov/show/NCT04535700,NA
NCT04535791,ClinicalTrials.gov,2020-07-30,2020-07-15,TRUE,Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,400,https://clinicaltrials.gov/show/NCT04535791,NA
NCT04536051,ClinicalTrials.gov,2020-09-01,2020-06-02,TRUE,Recruiting,Phase 3,Interventional,Brazil,A Study of a Candidate COVID-19 Vaccine (COV003),10300,https://clinicaltrials.gov/show/NCT04536051,NA
NCT04536090,ClinicalTrials.gov,2020-08-31,2020-11-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,150,https://clinicaltrials.gov/show/NCT04536090,NA
NCT04536285,ClinicalTrials.gov,2020-08-27,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,36,https://clinicaltrials.gov/show/NCT04536285,NA
NCT04536363,ClinicalTrials.gov,2020-08-29,2020-10-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Cri Analog PG1 Effectiveness and Safety in Covid-19,284,https://clinicaltrials.gov/show/NCT04536363,NA
NCT04536441,ClinicalTrials.gov,2020-08-26,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Malaysia,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,161,https://clinicaltrials.gov/show/NCT04536441,NA
NCT04537117,ClinicalTrials.gov,2020-09-02,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",202,https://clinicaltrials.gov/show/NCT04537117,NA
NCT04537130,ClinicalTrials.gov,2020-09-02,2020-12-01,FALSE,Not Recruiting,Phase 1,Interventional,Spain,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,40,https://clinicaltrials.gov/show/NCT04537130,NA
NCT04537338,ClinicalTrials.gov,2020-08-27,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,2000,https://clinicaltrials.gov/show/NCT04537338,NA
NCT04537559,ClinicalTrials.gov,2020-08-27,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Impact of COVID-19 Outbreak on Non-COVID-19 Patients,40000,https://clinicaltrials.gov/show/NCT04537559,NA
NCT04537572,ClinicalTrials.gov,2020-09-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,300,https://clinicaltrials.gov/show/NCT04537572,NA
NCT04537585,ClinicalTrials.gov,2020-08-29,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Democratic Republic of Congo,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",2000,https://clinicaltrials.gov/show/NCT04537585,NA
NCT04537858,ClinicalTrials.gov,2020-08-29,2020-06-18,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,50,https://clinicaltrials.gov/show/NCT04537858,NA
NCT04538469,ClinicalTrials.gov,2020-09-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",1000,https://clinicaltrials.gov/show/NCT04538469,NA
NCT04538586,ClinicalTrials.gov,2020-09-03,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,France,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",1000,https://clinicaltrials.gov/show/NCT04538586,NA
NCT04539834,ClinicalTrials.gov,2020-09-01,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Electrolyte State in Patients With COVID-19,52,https://clinicaltrials.gov/show/NCT04539834,NA
NCT04540029,ClinicalTrials.gov,2020-09-02,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,Italy,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,600,https://clinicaltrials.gov/show/NCT04540029,NA
NCT04540185,ClinicalTrials.gov,2020-09-04,2020-11-01,FALSE,Recruiting,Phase 3,Interventional,"New Zealand, United States",A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,3600,https://clinicaltrials.gov/show/NCT04540185,NA
NCT04540484,ClinicalTrials.gov,2020-09-03,2020-08-26,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,900,https://clinicaltrials.gov/show/NCT04540484,NA
NCT04540926,ClinicalTrials.gov,2020-09-02,2020-09-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04540926,NA
NCT04540939,ClinicalTrials.gov,2020-09-04,2020-10-19,FALSE,Recruiting,Not Applicable,Interventional,United States,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,60,https://clinicaltrials.gov/show/NCT04540939,NA
NCT04541472,ClinicalTrials.gov,2020-09-07,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),1000,https://clinicaltrials.gov/show/NCT04541472,NA
NCT04541485,ClinicalTrials.gov,2020-09-07,2020-10-06,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",40,https://clinicaltrials.gov/show/NCT04541485,NA
NCT04542044,ClinicalTrials.gov,2020-09-02,2020-04-02,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,40,https://clinicaltrials.gov/show/NCT04542044,NA
NCT04542083,ClinicalTrials.gov,2020-09-04,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,France,"Covid-19, Acute Myocardial Infarctions and Strokes in France",4000,https://clinicaltrials.gov/show/NCT04542083,NA
NCT04542122,ClinicalTrials.gov,2020-08-31,2020-09-03,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04542122,NA
NCT04542330,ClinicalTrials.gov,2020-09-07,2020-09-15,FALSE,Recruiting,Phase 3,Interventional,Denmark,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,1900,https://clinicaltrials.gov/show/NCT04542330,NA
NCT04542408,ClinicalTrials.gov,2020-09-06,2020-11-12,FALSE,Recruiting,Phase 3,Interventional,Germany,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,172,https://clinicaltrials.gov/show/NCT04542408,NA
NCT04542421,ClinicalTrials.gov,2020-09-04,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,90,https://clinicaltrials.gov/show/NCT04542421,NA
NCT04542447,ClinicalTrials.gov,2020-09-06,2020-09-01,TRUE,Recruiting,Phase 1,Interventional,India,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,10,https://clinicaltrials.gov/show/NCT04542447,NA
NCT04542694,ClinicalTrials.gov,2020-09-04,2020-05-21,TRUE,Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04542694,NA
NCT04542876,ClinicalTrials.gov,2020-09-08,2020-05-01,TRUE,Not Recruiting,Not Applicable,Interventional,India,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,46,https://clinicaltrials.gov/show/NCT04542876,NA
NCT04542954,ClinicalTrials.gov,2020-09-07,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Kuwait,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,104,https://clinicaltrials.gov/show/NCT04542954,NA
NCT04542980,ClinicalTrials.gov,2020-04-13,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,200,https://clinicaltrials.gov/show/NCT04542980,NA
NCT04543006,ClinicalTrials.gov,2020-09-08,2020-09-08,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,170,https://clinicaltrials.gov/show/NCT04543006,NA
NCT04544072,ClinicalTrials.gov,2020-08-15,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,400,https://clinicaltrials.gov/show/NCT04544072,NA
NCT04544150,ClinicalTrials.gov,2020-09-08,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Gastrointestinal Manifestations Among Patients With COVID19,220,https://clinicaltrials.gov/show/NCT04544150,NA
NCT04544605,ClinicalTrials.gov,2020-09-03,2020-09-07,FALSE,Recruiting,Not Applicable,Observational,China,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,150,https://clinicaltrials.gov/show/NCT04544605,NA
NCT04544878,ClinicalTrials.gov,2020-09-03,2020-03-26,TRUE,Recruiting,Not Applicable,Observational,France,Pediatric Intensive Care and COVID-19,100,https://clinicaltrials.gov/show/NCT04544878,NA
NCT04544891,ClinicalTrials.gov,2020-09-09,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,France,TREM-1 Pathway Activation in COVID-19,1000,https://clinicaltrials.gov/show/NCT04544891,NA
NCT04546191,ClinicalTrials.gov,2020-09-10,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Iceland,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,1580,https://clinicaltrials.gov/show/NCT04546191,NA
NCT04546737,ClinicalTrials.gov,2020-09-10,2020-09-08,TRUE,Recruiting,Not Applicable,Interventional,France,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",20,https://clinicaltrials.gov/show/NCT04546737,NA
NCT04546841,ClinicalTrials.gov,2020-08-26,2020-11-27,FALSE,Recruiting,Phase 1,Interventional,Germany,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,36,https://clinicaltrials.gov/show/NCT04546841,NA
NCT04547114,ClinicalTrials.gov,2020-09-11,2020-09-14,FALSE,Recruiting,Not Applicable,Observational,Germany,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,200,https://clinicaltrials.gov/show/NCT04547114,NA
NCT04547283,ClinicalTrials.gov,2020-09-09,2020-06-14,TRUE,Recruiting,Not Applicable,Interventional,United States,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04547283,NA
NCT04547634,ClinicalTrials.gov,2020-08-17,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Oncology Patients,30,https://clinicaltrials.gov/show/NCT04547634,NA
NCT04548492,ClinicalTrials.gov,2020-09-11,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,175,https://clinicaltrials.gov/show/NCT04548492,NA
NCT04548531,ClinicalTrials.gov,2020-09-09,2020-09-10,FALSE,Recruiting,Not Applicable,Interventional,United States,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,800,https://clinicaltrials.gov/show/NCT04548531,NA
NCT04548544,ClinicalTrials.gov,2020-09-11,2019-10-18,TRUE,Not Recruiting,Not Applicable,Interventional,United States,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,21,https://clinicaltrials.gov/show/NCT04548544,NA
NCT04548557,ClinicalTrials.gov,2020-09-07,2020-09-15,FALSE,Not Recruiting,Phase 3,Interventional,Pakistan,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,60,https://clinicaltrials.gov/show/NCT04548557,NA
NCT04548908,ClinicalTrials.gov,2020-09-07,2020-08-03,TRUE,Recruiting,Not Applicable,Observational,France,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,1300,https://clinicaltrials.gov/show/NCT04548908,NA
NCT04549337,ClinicalTrials.gov,2020-09-09,2020-09-25,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,10,https://clinicaltrials.gov/show/NCT04549337,NA
NCT04549350,ClinicalTrials.gov,2020-09-08,2020-05-19,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Sleep Quality Among HCWs,217,https://clinicaltrials.gov/show/NCT04549350,NA
NCT04549376,ClinicalTrials.gov,2020-09-11,2020-07-01,TRUE,Recruiting,Phase 2,Interventional,Bangladesh,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,200,https://clinicaltrials.gov/show/NCT04549376,NA
NCT04549636,ClinicalTrials.gov,2020-08-28,2020-09-18,FALSE,Recruiting,Not Applicable,Observational,Canada,COVID-19 Related Lung Ventilation and Perfusion Injury,92,https://clinicaltrials.gov/show/NCT04549636,NA
NCT04549831,ClinicalTrials.gov,2020-09-11,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,Italy,Genetic Bases of COVID-19 Clinical Variability,2000,https://clinicaltrials.gov/show/NCT04549831,NA
NCT04550312,ClinicalTrials.gov,2020-09-13,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,China,The Impact of Lifestyle Changes on Non-COVID Deaths,80000,https://clinicaltrials.gov/show/NCT04550312,NA
NCT04551274,ClinicalTrials.gov,2020-09-01,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Music Therapy in Frontline Healthcare Workers,20,https://clinicaltrials.gov/show/NCT04551274,NA
NCT04551690,ClinicalTrials.gov,2020-07-28,2020-04-15,TRUE,Not Recruiting,Not Applicable,Observational,Chile,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),720,https://clinicaltrials.gov/show/NCT04551690,NA
NCT04551755,ClinicalTrials.gov,2020-09-03,2020-09-01,TRUE,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,188,https://clinicaltrials.gov/show/NCT04551755,NA
NCT04551781,ClinicalTrials.gov,2020-09-13,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,450,https://clinicaltrials.gov/show/NCT04551781,NA
NCT04552340,ClinicalTrials.gov,2020-09-08,2020-03-16,TRUE,Recruiting,Not Applicable,Observational,Italy,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",1500,https://clinicaltrials.gov/show/NCT04552340,NA
NCT04552483,ClinicalTrials.gov,2020-09-09,2020-06-08,TRUE,Not Recruiting,Phase 2,Interventional,Brazil,Effects of Early Use of Nitazoxanide in Patients With COVID-19,392,https://clinicaltrials.gov/show/NCT04552483,NA
NCT04552951,ClinicalTrials.gov,2020-05-21,2020-04-04,TRUE,Recruiting,Phase 4,Interventional,Spain,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,80,https://clinicaltrials.gov/show/NCT04552951,NA
NCT04553575,ClinicalTrials.gov,2020-09-15,2020-09-25,FALSE,Recruiting,Not Applicable,Observational,France,CoViD-19 Patient in Reims University Hospital in March to April 2020,499,https://clinicaltrials.gov/show/NCT04553575,NA
NCT04553705,ClinicalTrials.gov,2020-09-15,2020-09-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",200,https://clinicaltrials.gov/show/NCT04553705,NA
NCT04554251,ClinicalTrials.gov,2020-09-06,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Global Impact of COVID-19 on Pulmonology Special Units,100,https://clinicaltrials.gov/show/NCT04554251,NA
NCT04554264,ClinicalTrials.gov,2020-09-02,2020-09-01,TRUE,Recruiting,Not Applicable,Interventional,France,Complicated Grief in ICU in the Aftermath of COVID-19,160,https://clinicaltrials.gov/show/NCT04554264,NA
NCT04554433,ClinicalTrials.gov,2020-09-17,2020-12-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,80,https://clinicaltrials.gov/show/NCT04554433,NA
NCT04554979,ClinicalTrials.gov,2020-09-12,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,199,https://clinicaltrials.gov/show/NCT04554979,NA
NCT04554992,ClinicalTrials.gov,2020-08-26,2020-03-20,TRUE,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),350,https://clinicaltrials.gov/show/NCT04554992,NA
NCT04555005,ClinicalTrials.gov,2020-06-11,2020-03-10,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,1000,https://clinicaltrials.gov/show/NCT04555005,NA
NCT04555109,ClinicalTrials.gov,2020-09-17,2020-06-30,TRUE,Recruiting,Not Applicable,Observational,Canada,Convalescent Plasma for COVID-19 Research Donor Study,1000,https://clinicaltrials.gov/show/NCT04555109,NA
NCT04555148,ClinicalTrials.gov,2020-09-16,2020-09-20,FALSE,Recruiting,Phase 2,Interventional,South Korea,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),60,https://clinicaltrials.gov/show/NCT04555148,NA
NCT04555954,ClinicalTrials.gov,2020-09-14,2020-04-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Determining the Physical Activity Level of Healthy Adults During Pandemic,205,https://clinicaltrials.gov/show/NCT04555954,NA
NCT04556565,ClinicalTrials.gov,2020-09-10,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,Spain,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,16000,https://clinicaltrials.gov/show/NCT04556565,NA
NCT04556604,ClinicalTrials.gov,2020-09-18,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Surgical Consent During the COVID-19 Pandemic,45,https://clinicaltrials.gov/show/NCT04556604,NA
NCT04556630,ClinicalTrials.gov,2020-09-18,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,360,https://clinicaltrials.gov/show/NCT04556630,NA
NCT04556864,ClinicalTrials.gov,2020-09-12,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,67,https://clinicaltrials.gov/show/NCT04556864,NA
NCT04557605,ClinicalTrials.gov,2020-09-09,2020-09-14,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Effects of a Face Mask on Oxygenation During Exercise,14,https://clinicaltrials.gov/show/NCT04557605,NA
NCT04558021,ClinicalTrials.gov,2020-09-18,2020-10-08,FALSE,Recruiting,Phase 3,Interventional,Turkey,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,200,https://clinicaltrials.gov/show/NCT04558021,NA
NCT04558307,ClinicalTrials.gov,2020-09-18,2020-06-03,TRUE,Recruiting,Not Applicable,Observational,United States,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,1000,https://clinicaltrials.gov/show/NCT04558307,NA
NCT04558411,ClinicalTrials.gov,2020-09-20,2020-09-12,TRUE,Recruiting,Not Applicable,Interventional,United States,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",150,https://clinicaltrials.gov/show/NCT04558411,NA
NCT04558424,ClinicalTrials.gov,2020-09-21,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,Bangladesh,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",50,https://clinicaltrials.gov/show/NCT04558424,NA
NCT04558437,ClinicalTrials.gov,2020-06-10,2020-06-12,FALSE,Recruiting,Not Applicable,Observational,France,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",20000,https://clinicaltrials.gov/show/NCT04558437,NA
NCT04558450,ClinicalTrials.gov,2020-08-31,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),360,https://clinicaltrials.gov/show/NCT04558450,NA
NCT04558463,ClinicalTrials.gov,2020-09-03,2020-04-16,TRUE,Recruiting,Phase 3,Interventional,Indonesia,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,100,https://clinicaltrials.gov/show/NCT04558463,NA
NCT04558645,ClinicalTrials.gov,2020-09-18,2020-09-18,FALSE,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Physical Activity and Quality of Life of Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04558645,NA
NCT04558996,ClinicalTrials.gov,2020-09-18,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Spanish Registry of Pregnant Women With COVID-19,3000,https://clinicaltrials.gov/show/NCT04558996,NA
NCT04559009,ClinicalTrials.gov,2020-09-21,2020-10-15,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,100,https://clinicaltrials.gov/show/NCT04559009,NA
NCT04559035,ClinicalTrials.gov,2020-09-21,2020-09-24,FALSE,Recruiting,Not Applicable,Interventional,United States,Nasal Irrigation to Reduce COVID-19 Morbidity,200,https://clinicaltrials.gov/show/NCT04559035,NA
NCT04559074,ClinicalTrials.gov,2020-08-26,2020-10-23,FALSE,Recruiting,Phase 4,Interventional,United Kingdom,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04559074,NA
NCT04560231,ClinicalTrials.gov,2020-07-11,2020-06-01,TRUE,Recruiting,Phase 1,Interventional,Pakistan,Remdesivir in COVID-19 Lahore General Hospital,30,https://clinicaltrials.gov/show/NCT04560231,NA
NCT04560413,ClinicalTrials.gov,2020-09-20,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",77,https://clinicaltrials.gov/show/NCT04560413,NA
NCT04560530,ClinicalTrials.gov,2020-09-22,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Saudi Arabia,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,76,https://clinicaltrials.gov/show/NCT04560530,NA
NCT04560881,ClinicalTrials.gov,2020-09-16,2020-09-16,FALSE,Not Recruiting,Phase 3,Interventional,Argentina,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",3000,https://clinicaltrials.gov/show/NCT04560881,NA
NCT04561024,ClinicalTrials.gov,2020-09-22,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Hong Kong,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,4000,https://clinicaltrials.gov/show/NCT04561024,NA
NCT04561063,ClinicalTrials.gov,2020-09-21,2020-12-01,FALSE,Not Recruiting,Phase 2,Interventional,South Africa,COVID-19 Prophylaxis South Africa (COVER HCW),1950,https://clinicaltrials.gov/show/NCT04561063,NA
NCT04561076,ClinicalTrials.gov,2020-09-07,2020-12-09,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,24,https://clinicaltrials.gov/show/NCT04561076,NA
NCT04561141,ClinicalTrials.gov,2020-09-22,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Post Covid Syndrome: Clinical Pattern and Functional Assessment,85,https://clinicaltrials.gov/show/NCT04561141,NA
NCT04561154,ClinicalTrials.gov,2020-09-09,2020-06-11,TRUE,Recruiting,Not Applicable,Interventional,France,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,134,https://clinicaltrials.gov/show/NCT04561154,NA
NCT04561193,ClinicalTrials.gov,2020-09-22,2020-05-30,TRUE,Recruiting,Not Applicable,Observational,United States,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),200,https://clinicaltrials.gov/show/NCT04561193,NA
NCT04561219,ClinicalTrials.gov,2020-09-22,2020-04-19,TRUE,Not Recruiting,Phase 2,Interventional,Brazil,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,500,https://clinicaltrials.gov/show/NCT04561219,NA
NCT04562246,ClinicalTrials.gov,2020-09-22,2020-08-14,TRUE,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 IgG and IgM Serologic Assays,500,https://clinicaltrials.gov/show/NCT04562246,NA
NCT04562285,ClinicalTrials.gov,2020-09-22,2020-06-23,TRUE,Recruiting,Not Applicable,Observational,United States,Sustained Immunity to SARS-CoV-2,500,https://clinicaltrials.gov/show/NCT04562285,NA
NCT04563156,ClinicalTrials.gov,2020-09-23,2020-06-23,TRUE,Recruiting,Not Applicable,Observational,Brazil,Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection,100,https://clinicaltrials.gov/show/NCT04563156,NA
NCT04563208,ClinicalTrials.gov,2020-09-21,2020-12-01,FALSE,Not Recruiting,Phase 2,Interventional,South Africa,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,40,https://clinicaltrials.gov/show/NCT04563208,NA
NCT04563442,ClinicalTrials.gov,2020-09-23,2020-10-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Comorbidities And Complications Associated With Covid-19 Infection,200,https://clinicaltrials.gov/show/NCT04563442,NA
NCT04563650,ClinicalTrials.gov,2020-09-18,2020-09-18,FALSE,Recruiting,Not Applicable,Interventional,France,COVID-19 Serology and Immunosenescence,330,https://clinicaltrials.gov/show/NCT04563650,NA
NCT04563676,ClinicalTrials.gov,2020-09-23,2020-09-22,TRUE,Recruiting,Not Applicable,Interventional,France,Physiopathology and Sequelae of COVID-19 Infection,400,https://clinicaltrials.gov/show/NCT04563676,NA
NCT04563689,ClinicalTrials.gov,2020-09-22,2020-06-18,TRUE,Not Recruiting,Not Applicable,Interventional,Colombia,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,23,https://clinicaltrials.gov/show/NCT04563689,NA
NCT04564040,ClinicalTrials.gov,2020-08-27,2020-10-12,FALSE,Recruiting,Phase 1,Interventional,Germany,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,40,https://clinicaltrials.gov/show/NCT04564040,NA
NCT04565106,ClinicalTrials.gov,2020-09-24,2020-04-15,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Automatic Oxygen Titration With O2maticÂ® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,16,https://clinicaltrials.gov/show/NCT04565106,NA
NCT04565509,ClinicalTrials.gov,2020-09-24,2020-11-20,FALSE,Recruiting,Not Applicable,Interventional,United States,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,2500,https://clinicaltrials.gov/show/NCT04565509,NA
NCT04565782,ClinicalTrials.gov,2020-09-22,2020-09-15,TRUE,Recruiting,Not Applicable,Observational,Egypt,Corona Virus Infection Among Liver Transplant Recipients,150,https://clinicaltrials.gov/show/NCT04565782,NA
NCT04566276,ClinicalTrials.gov,2020-09-15,2021-01-01,FALSE,Not Recruiting,Phase 1,Interventional,Thailand,ChulaCov19 mRNA Vaccine in Healthy Adults,96,https://clinicaltrials.gov/show/NCT04566276,NA
NCT04566770,ClinicalTrials.gov,2020-09-22,2020-09-24,FALSE,Recruiting,Phase 2,Interventional,China,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),481,https://clinicaltrials.gov/show/NCT04566770,NA
NCT04566965,ClinicalTrials.gov,2020-09-24,2020-08-18,TRUE,Recruiting,Not Applicable,Observational,United States,Serology to Covid for Recording Exposures and Evaluating Needs,230,https://clinicaltrials.gov/show/NCT04566965,NA
NCT04567173,ClinicalTrials.gov,2020-09-24,2020-09-21,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Philippines,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,136,https://clinicaltrials.gov/show/NCT04567173,NA
NCT04567576,ClinicalTrials.gov,2020-09-24,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Factors for COVID-19 in Rheumatology,150,https://clinicaltrials.gov/show/NCT04567576,NA
NCT04567810,ClinicalTrials.gov,2020-09-18,2020-09-18,FALSE,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",48,https://clinicaltrials.gov/show/NCT04567810,NA
NCT04567927,ClinicalTrials.gov,2020-09-18,2020-03-03,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04567927,NA
NCT04567953,ClinicalTrials.gov,2020-09-25,2020-07-28,TRUE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Tests With Saliva Specimens,2000,https://clinicaltrials.gov/show/NCT04567953,NA
NCT04567979,ClinicalTrials.gov,2020-09-25,2020-06-11,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,149,https://clinicaltrials.gov/show/NCT04567979,NA
NCT04568005,ClinicalTrials.gov,2020-09-25,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04568005,NA
NCT04568018,ClinicalTrials.gov,2020-09-18,2020-07-03,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,120,https://clinicaltrials.gov/show/NCT04568018,NA
NCT04568096,ClinicalTrials.gov,2020-09-26,2020-11-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,160,https://clinicaltrials.gov/show/NCT04568096,NA
NCT04568135,ClinicalTrials.gov,2020-09-18,2020-10-31,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,1000,https://clinicaltrials.gov/show/NCT04568135,NA
NCT04568148,ClinicalTrials.gov,2020-04-15,2020-04-15,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Biorepository,50,https://clinicaltrials.gov/show/NCT04568148,NA
NCT04568356,ClinicalTrials.gov,2020-09-27,2020-04-24,TRUE,Not Recruiting,Not Applicable,Interventional,United States,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,200,https://clinicaltrials.gov/show/NCT04568356,NA
NCT04568421,ClinicalTrials.gov,2020-09-23,2020-08-18,TRUE,Recruiting,Not Applicable,Observational,Argentina,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,3000,https://clinicaltrials.gov/show/NCT04568421,NA
NCT04568525,ClinicalTrials.gov,2020-09-23,2020-07-01,TRUE,Not Recruiting,Not Applicable,Interventional,Kyrgyzstan,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,195,https://clinicaltrials.gov/show/NCT04568525,NA
NCT04568655,ClinicalTrials.gov,2020-09-28,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,The Noninvasive Ventilation to COVID-19 Patients,23,https://clinicaltrials.gov/show/NCT04568655,NA
NCT04568876,ClinicalTrials.gov,2020-09-24,2020-10-23,FALSE,Recruiting,Phase 4,Interventional,Italy,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04568876,NA
NCT04569188,ClinicalTrials.gov,2020-09-04,2020-05-15,TRUE,Not Recruiting,Phase 2,Interventional,Italy,Convalescent Plasma in COVID-19 Elderly Patients,21,https://clinicaltrials.gov/show/NCT04569188,NA
NCT04569266,ClinicalTrials.gov,2020-09-10,2020-08-07,TRUE,Recruiting,Not Applicable,Interventional,France,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,200,https://clinicaltrials.gov/show/NCT04569266,NA
NCT04569292,ClinicalTrials.gov,2020-09-16,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Italy,COVID-19 Infection in Cancer Pantients,150,https://clinicaltrials.gov/show/NCT04569292,NA
NCT04569344,ClinicalTrials.gov,2020-09-25,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 and Venous Thromboembolism Risk,40000,https://clinicaltrials.gov/show/NCT04569344,NA
NCT04569383,ClinicalTrials.gov,2020-09-21,2020-10-05,FALSE,Recruiting,Phase 1,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",30,https://clinicaltrials.gov/show/NCT04569383,NA
NCT04569825,ClinicalTrials.gov,2020-09-29,2020-08-01,TRUE,Recruiting,Phase 1,Interventional,Iraq,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,250,https://clinicaltrials.gov/show/NCT04569825,NA
NCT04569851,ClinicalTrials.gov,2020-04-11,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019),100000,https://clinicaltrials.gov/show/NCT04569851,NA
NCT04570449,ClinicalTrials.gov,2020-09-29,2020-09-01,TRUE,Not Recruiting,Phase 1,Interventional,United States,Pilot Randomized Controlled Trial: Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),40,https://clinicaltrials.gov/show/NCT04570449,NA
NCT04570462,ClinicalTrials.gov,2020-07-21,2020-05-18,TRUE,Recruiting,Not Applicable,Interventional,United States,Mild Hypothermia for COVID-19 ARDS,20,https://clinicaltrials.gov/show/NCT04570462,NA
NCT04570982,ClinicalTrials.gov,2020-07-24,2020-07-30,FALSE,Recruiting,Not Applicable,Observational,Nepal,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,200,https://clinicaltrials.gov/show/NCT04570982,NA
NCT04572399,ClinicalTrials.gov,2020-09-28,2020-10-30,FALSE,Recruiting,Not Applicable,Interventional,United States,UVA Light Device to Treat COVID-19,5,https://clinicaltrials.gov/show/NCT04572399,NA
NCT04572438,ClinicalTrials.gov,2020-09-29,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,2500,https://clinicaltrials.gov/show/NCT04572438,NA
NCT04573153,ClinicalTrials.gov,2020-09-30,2020-09-21,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Turkey,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,400,https://clinicaltrials.gov/show/NCT04573153,NA
NCT04573270,ClinicalTrials.gov,2020-09-23,2020-04-24,TRUE,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stem Cells for the Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04573270,NA
NCT04573322,ClinicalTrials.gov,2020-09-29,2020-09-10,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Romania,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,224,https://clinicaltrials.gov/show/NCT04573322,NA
NCT04573335,ClinicalTrials.gov,2020-09-29,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Diabetes Outcomes in COVID-19 Pandemic,1282,https://clinicaltrials.gov/show/NCT04573335,NA
NCT04573348,ClinicalTrials.gov,2020-09-30,2020-10-14,FALSE,Recruiting,Not Applicable,Observational,Israel,T Cells Response to SARS COV 2 Peptides,400,https://clinicaltrials.gov/show/NCT04573348,NA
NCT04573361,ClinicalTrials.gov,2020-09-29,2020-05-02,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,723,https://clinicaltrials.gov/show/NCT04573361,NA
NCT04573634,ClinicalTrials.gov,2020-09-30,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,United States,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,960,https://clinicaltrials.gov/show/NCT04573634,NA
NCT04573855,ClinicalTrials.gov,2020-09-30,2020-12-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,41,https://clinicaltrials.gov/show/NCT04573855,NA
NCT04573868,ClinicalTrials.gov,2020-09-30,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Spain,"National Study ""AEC COVID-19""",1000,https://clinicaltrials.gov/show/NCT04573868,NA
NCT04574050,ClinicalTrials.gov,2020-09-28,2020-12-03,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,SELF-BREATHE RCT for Chronic Breathlessness,40,https://clinicaltrials.gov/show/NCT04574050,NA
NCT04574765,ClinicalTrials.gov,2020-09-28,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Canada,A Research Platform to Screen Healthcare Workers,100000,https://clinicaltrials.gov/show/NCT04574765,NA
NCT04574869,ClinicalTrials.gov,2020-09-16,2020-10-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,42,https://clinicaltrials.gov/show/NCT04574869,NA
NCT04575168,ClinicalTrials.gov,2020-10-01,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,United States,Clinical Study Spartan COVID-19 V2 System,100,https://clinicaltrials.gov/show/NCT04575168,NA
NCT04575545,ClinicalTrials.gov,2020-10-02,2020-10-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,600,https://clinicaltrials.gov/show/NCT04575545,NA
NCT04575558,ClinicalTrials.gov,2020-05-18,2020-06-30,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,0,https://clinicaltrials.gov/show/NCT04575558,NA
NCT04575571,ClinicalTrials.gov,2020-09-24,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Canada,MAVIPAN: My Life and the COVID-19 Pandemic,5000,https://clinicaltrials.gov/show/NCT04575571,NA
NCT04576299,ClinicalTrials.gov,2020-09-28,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,"Chile, Ecuador, Spain, Colombia",Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,800,https://clinicaltrials.gov/show/NCT04576299,NA
NCT04577105,ClinicalTrials.gov,2020-10-02,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Risk Factors and Computed Tomography Findings in COVID-19.,233,https://clinicaltrials.gov/show/NCT04577105,NA
NCT04577235,ClinicalTrials.gov,2020-09-29,2020-06-05,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,29,https://clinicaltrials.gov/show/NCT04577235,NA
NCT04577378,ClinicalTrials.gov,2020-04-13,2020-10-20,FALSE,Not Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,45,https://clinicaltrials.gov/show/NCT04577378,NA
NCT04578197,ClinicalTrials.gov,2020-09-02,2020-08-18,TRUE,Recruiting,Not Applicable,Observational,Sweden,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,100,https://clinicaltrials.gov/show/NCT04578197,NA
NCT04578210,ClinicalTrials.gov,2020-10-01,2020-09-04,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Spain,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,58,https://clinicaltrials.gov/show/NCT04578210,NA
NCT04578236,ClinicalTrials.gov,2020-10-04,2020-11-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",360,https://clinicaltrials.gov/show/NCT04578236,NA
NCT04579289,ClinicalTrials.gov,2020-10-01,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,230,https://clinicaltrials.gov/show/NCT04579289,NA
NCT04579471,ClinicalTrials.gov,2020-10-06,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,2000,https://clinicaltrials.gov/show/NCT04579471,NA
NCT04579549,ClinicalTrials.gov,2020-10-06,2020-09-29,TRUE,Recruiting,Not Applicable,Interventional,United States,Repeat Testing for SARS-CoV-2,10000,https://clinicaltrials.gov/show/NCT04579549,NA
NCT04579562,ClinicalTrials.gov,2020-10-06,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Regional COVID Epidemiology in England (RECEDE),5000,https://clinicaltrials.gov/show/NCT04579562,NA
NCT04579627,ClinicalTrials.gov,2020-10-06,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,"Facial Hair, PPE and COVID-19",358,https://clinicaltrials.gov/show/NCT04579627,NA
NCT04581018,ClinicalTrials.gov,2020-08-11,2020-08-13,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04581018,NA
NCT04581044,ClinicalTrials.gov,2020-10-06,2020-09-17,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Impact of COVID-19 on Psoriasis Practice,197,https://clinicaltrials.gov/show/NCT04581044,NA
NCT04581070,ClinicalTrials.gov,2020-05-29,2020-04-29,TRUE,Not Recruiting,Not Applicable,Observational,Ireland,"The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic""",4,https://clinicaltrials.gov/show/NCT04581070,NA
NCT04581096,ClinicalTrials.gov,2020-10-07,2020-10-02,TRUE,Recruiting,Not Applicable,Observational,Spain,Mapping COVID-19 Spread in a Tertiary Hospital,3000,https://clinicaltrials.gov/show/NCT04581096,NA
NCT04581135,ClinicalTrials.gov,2020-09-17,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,500,https://clinicaltrials.gov/show/NCT04581135,NA
NCT04581148,ClinicalTrials.gov,2020-10-03,2020-10-05,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),2000,https://clinicaltrials.gov/show/NCT04581148,NA
NCT04581161,ClinicalTrials.gov,2020-08-19,2020-08-28,FALSE,Recruiting,Not Applicable,Interventional,United States,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04581161,NA
NCT04581291,ClinicalTrials.gov,2020-10-04,2020-01-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,30,https://clinicaltrials.gov/show/NCT04581291,NA
NCT04581889,ClinicalTrials.gov,2020-10-07,2020-07-02,TRUE,Recruiting,Not Applicable,Observational,Germany,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in TÃ¼bingen Children,2380,https://clinicaltrials.gov/show/NCT04581889,NA
NCT04582214,ClinicalTrials.gov,2020-10-06,2020-09-28,TRUE,Recruiting,Not Applicable,Interventional,United States,Oscillation and Lung Expansion Therapy in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04582214,NA
NCT04582318,ClinicalTrials.gov,2020-10-07,2020-11-08,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",48,https://clinicaltrials.gov/show/NCT04582318,NA
NCT04583228,ClinicalTrials.gov,2020-09-25,2020-11-30,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",40,https://clinicaltrials.gov/show/NCT04583228,NA
NCT04583293,ClinicalTrials.gov,2020-10-06,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Acute kIDnEy Injury in coviD-19,220,https://clinicaltrials.gov/show/NCT04583293,NA
NCT04583306,ClinicalTrials.gov,2020-10-09,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Italy,The Salivary Raman COVID-19 Fingerprint,120,https://clinicaltrials.gov/show/NCT04583306,NA
NCT04583319,ClinicalTrials.gov,2020-09-30,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",160,https://clinicaltrials.gov/show/NCT04583319,NA
NCT04583449,ClinicalTrials.gov,2020-10-02,2020-08-19,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,250,https://clinicaltrials.gov/show/NCT04583449,NA
NCT04583566,ClinicalTrials.gov,2020-10-07,2020-10-04,TRUE,Recruiting,Not Applicable,Observational,Egypt,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",40,https://clinicaltrials.gov/show/NCT04583566,NA
NCT04583865,ClinicalTrials.gov,2020-10-07,2020-10-07,FALSE,Not Recruiting,Not Applicable,Observational,France,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,400,https://clinicaltrials.gov/show/NCT04583865,NA
NCT04584411,ClinicalTrials.gov,2020-09-09,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,50,https://clinicaltrials.gov/show/NCT04584411,NA
NCT04584424,ClinicalTrials.gov,2020-09-22,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,Ethiopia,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,6390,https://clinicaltrials.gov/show/NCT04584424,NA
NCT04584580,ClinicalTrials.gov,2020-10-06,2020-08-01,TRUE,Recruiting,Phase 4,Interventional,Egypt,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04584580,NA
NCT04584593,ClinicalTrials.gov,2020-10-12,2020-10-02,TRUE,Recruiting,Not Applicable,Interventional,France,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,50,https://clinicaltrials.gov/show/NCT04584593,NA
NCT04584606,ClinicalTrials.gov,2020-10-06,2020-06-27,TRUE,Recruiting,Not Applicable,Observational,Egypt,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04584606,NA
NCT04584671,ClinicalTrials.gov,2020-10-07,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,Canada,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,200,https://clinicaltrials.gov/show/NCT04584671,NA
NCT04586114,ClinicalTrials.gov,2020-10-08,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,200,https://clinicaltrials.gov/show/NCT04586114,NA
NCT04586140,ClinicalTrials.gov,2020-10-12,2020-11-09,FALSE,Not Recruiting,Not Applicable,Observational,France,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,30,https://clinicaltrials.gov/show/NCT04586140,NA
NCT04586153,ClinicalTrials.gov,2020-10-12,2020-12-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Assess the Effect of Meplazumab on COVID-19,456,https://clinicaltrials.gov/show/NCT04586153,NA
NCT04586413,ClinicalTrials.gov,2020-10-07,2020-10-07,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),100,https://clinicaltrials.gov/show/NCT04586413,NA
NCT04587245,ClinicalTrials.gov,2020-10-07,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,United States,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,100,https://clinicaltrials.gov/show/NCT04587245,NA
NCT04587258,ClinicalTrials.gov,2020-10-08,2020-08-28,TRUE,Recruiting,Not Applicable,Observational,United States,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,100,https://clinicaltrials.gov/show/NCT04587258,NA
NCT04587323,ClinicalTrials.gov,2020-09-22,2020-05-22,TRUE,Recruiting,Not Applicable,Observational,United States,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,100,https://clinicaltrials.gov/show/NCT04587323,NA
NCT04587375,ClinicalTrials.gov,2020-06-18,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Diagnosis of Endocrine Dysfunctions in Covid-19,50,https://clinicaltrials.gov/show/NCT04587375,NA
NCT04587414,ClinicalTrials.gov,2020-09-08,2019-03-06,TRUE,Not Recruiting,Not Applicable,Interventional,Finland,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,122,https://clinicaltrials.gov/show/NCT04587414,NA
NCT04587921,ClinicalTrials.gov,2020-08-18,2020-06-22,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,90,https://clinicaltrials.gov/show/NCT04587921,NA
NCT04588909,ClinicalTrials.gov,2020-10-14,2020-03-23,TRUE,Not Recruiting,Not Applicable,Observational,India,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,100,https://clinicaltrials.gov/show/NCT04588909,NA
NCT04589104,ClinicalTrials.gov,2020-10-12,2020-05-26,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience,63,https://clinicaltrials.gov/show/NCT04589104,NA
NCT04589117,ClinicalTrials.gov,2020-10-12,2020-05-27,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience for Parents,11,https://clinicaltrials.gov/show/NCT04589117,NA
NCT04589936,ClinicalTrials.gov,2020-10-06,2020-09-03,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,56,https://clinicaltrials.gov/show/NCT04589936,NA
NCT04589949,ClinicalTrials.gov,2020-10-12,2020-10-12,FALSE,Recruiting,Phase 3,Interventional,Netherlands,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),690,https://clinicaltrials.gov/show/NCT04589949,NA
NCT04590053,ClinicalTrials.gov,2020-10-15,2020-10-20,FALSE,Recruiting,Phase 2,Interventional,Israel,"Allocetra-OTS in COVID-19, Phase II",24,https://clinicaltrials.gov/show/NCT04590053,NA
NCT04590209,ClinicalTrials.gov,2020-10-05,2020-10-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,25,https://clinicaltrials.gov/show/NCT04590209,NA
NCT04590222,ClinicalTrials.gov,2020-10-09,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04590222,NA
NCT04590261,ClinicalTrials.gov,2020-10-15,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Myeloid Cells in Patients With Covid-19 Pneumonia,120,https://clinicaltrials.gov/show/NCT04590261,NA
NCT04590274,ClinicalTrials.gov,2020-10-07,2020-11-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),5000,https://clinicaltrials.gov/show/NCT04590274,NA
NCT04591158,ClinicalTrials.gov,2020-09-15,2020-09-15,FALSE,Recruiting,Not Applicable,Interventional,Canada,COVID-19 and Lung Ultrasound Utility,100,https://clinicaltrials.gov/show/NCT04591158,NA
NCT04591600,ClinicalTrials.gov,2020-10-15,2020-07-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iraq,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,140,https://clinicaltrials.gov/show/NCT04591600,NA
NCT04591873,ClinicalTrials.gov,2020-09-23,2020-10-10,FALSE,Not Recruiting,Not Applicable,Observational,Taiwan,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,100,https://clinicaltrials.gov/show/NCT04591873,NA
NCT04592354,ClinicalTrials.gov,2020-10-15,2020-10-15,FALSE,Recruiting,Not Applicable,Interventional,United States,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,40,https://clinicaltrials.gov/show/NCT04592354,NA
NCT04592705,ClinicalTrials.gov,2020-10-07,2020-09-11,TRUE,Recruiting,Phase 1,Interventional,United States,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,10,https://clinicaltrials.gov/show/NCT04592705,NA
NCT04592835,ClinicalTrials.gov,2020-10-07,2020-10-19,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",24,https://clinicaltrials.gov/show/NCT04592835,NA
NCT04593069,ClinicalTrials.gov,2020-10-12,2020-10-07,TRUE,Recruiting,Not Applicable,Interventional,Belgium,The COGCOV Study in ICU Patients,60,https://clinicaltrials.gov/show/NCT04593069,NA
NCT04593641,ClinicalTrials.gov,2020-10-05,2020-09-04,TRUE,Not Recruiting,Phase 1,Interventional,South Korea,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",18,https://clinicaltrials.gov/show/NCT04593641,NA
NCT04593654,ClinicalTrials.gov,2020-10-16,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,257,https://clinicaltrials.gov/show/NCT04593654,NA
NCT04594291,ClinicalTrials.gov,2020-09-28,2020-10-07,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,MRI Changes of Acute Kidney Injury in COVID-19,60,https://clinicaltrials.gov/show/NCT04594291,NA
NCT04594330,ClinicalTrials.gov,2020-10-05,2020-06-01,TRUE,Recruiting,Phase 2,Interventional,Indonesia,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04594330,NA
NCT04594460,ClinicalTrials.gov,2020-10-19,2020-10-31,FALSE,Not Recruiting,Not Applicable,Interventional,China,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),198,https://clinicaltrials.gov/show/NCT04594460,NA
NCT04594668,ClinicalTrials.gov,2020-10-07,2020-04-24,TRUE,Recruiting,Phase 2,Interventional,Denmark,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,46,https://clinicaltrials.gov/show/NCT04594668,NA
NCT04595110,ClinicalTrials.gov,2020-09-14,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,Italy,Hemostatic Profile in Patients Affected by COVID-19,400,https://clinicaltrials.gov/show/NCT04595110,NA
NCT04595175,ClinicalTrials.gov,2020-06-10,2020-06-10,FALSE,Recruiting,Not Applicable,Observational,United States,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),2000,https://clinicaltrials.gov/show/NCT04595175,NA
NCT04595240,ClinicalTrials.gov,2020-10-14,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Semen Analysis Changes in Covid-19 Positivepatients,100,https://clinicaltrials.gov/show/NCT04595240,NA
NCT04596085,ClinicalTrials.gov,2020-10-19,2020-09-16,TRUE,Recruiting,Not Applicable,Interventional,India,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",124,https://clinicaltrials.gov/show/NCT04596085,NA
NCT04596657,ClinicalTrials.gov,2020-10-15,2020-10-27,FALSE,Recruiting,Not Applicable,Interventional,United States,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,2099,https://clinicaltrials.gov/show/NCT04596657,NA
NCT04597034,ClinicalTrials.gov,2020-10-03,2020-10-02,TRUE,Recruiting,Not Applicable,Interventional,Mexico,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,35,https://clinicaltrials.gov/show/NCT04597034,NA
NCT04597047,ClinicalTrials.gov,2020-10-19,2020-08-20,TRUE,Recruiting,Not Applicable,Interventional,United States,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,200,https://clinicaltrials.gov/show/NCT04597047,NA
NCT04597216,ClinicalTrials.gov,2020-10-13,2020-10-15,FALSE,Recruiting,Not Applicable,Interventional,France,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),200,https://clinicaltrials.gov/show/NCT04597216,NA
NCT04597242,ClinicalTrials.gov,2020-10-20,2020-09-28,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia,Not Available,https://clinicaltrials.gov/show/NCT04597242,NA
NCT04597736,ClinicalTrials.gov,2020-10-02,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),100,https://clinicaltrials.gov/show/NCT04597736,NA
NCT04597775,ClinicalTrials.gov,2020-10-18,2020-10-27,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,93,https://clinicaltrials.gov/show/NCT04597775,NA
NCT04598256,ClinicalTrials.gov,2020-10-21,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,77,https://clinicaltrials.gov/show/NCT04598256,NA
NCT04598347,ClinicalTrials.gov,2020-10-21,2020-08-08,TRUE,Recruiting,Not Applicable,Observational,Spain,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,225,https://clinicaltrials.gov/show/NCT04598347,NA
NCT04598620,ClinicalTrials.gov,2020-10-21,2020-09-19,TRUE,Recruiting,Not Applicable,Observational,Denmark,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,50,https://clinicaltrials.gov/show/NCT04598620,NA
NCT04598763,ClinicalTrials.gov,2020-10-15,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,France,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,80,https://clinicaltrials.gov/show/NCT04598763,NA
NCT04599998,ClinicalTrials.gov,2020-10-19,2020-10-15,TRUE,Recruiting,Not Applicable,Observational,Turkey,Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia,37,https://clinicaltrials.gov/show/NCT04599998,NA
NCT04600440,ClinicalTrials.gov,2020-10-20,2020-04-25,TRUE,Recruiting,Not Applicable,Interventional,Sweden,Convalescent Plasma in the Treatment of Covid-19,100,https://clinicaltrials.gov/show/NCT04600440,NA
NCT04600999,ClinicalTrials.gov,2020-10-08,2020-10-07,TRUE,Recruiting,Phase 3,Interventional,Hungary,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04600999,NA
NCT04601090,ClinicalTrials.gov,2020-10-15,2020-09-16,TRUE,Recruiting,Not Applicable,Observational,Norway,Survival Rates and Longterm Outcomes After COVID-19,250,https://clinicaltrials.gov/show/NCT04601090,NA
NCT04602000,ClinicalTrials.gov,2020-10-18,2020-09-25,TRUE,Recruiting,Phase 2/Phase 3,Interventional,South Korea,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,1020,https://clinicaltrials.gov/show/NCT04602000,NA
NCT04602260,ClinicalTrials.gov,2020-09-03,2020-06-09,TRUE,Recruiting,Not Applicable,Observational,Canada,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,211,https://clinicaltrials.gov/show/NCT04602260,NA
NCT04602442,ClinicalTrials.gov,2020-10-21,2020-10-01,TRUE,Recruiting,Phase 2,Interventional,Russian Federation,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,90,https://clinicaltrials.gov/show/NCT04602442,NA
NCT04602481,ClinicalTrials.gov,2020-10-23,2020-05-31,TRUE,Recruiting,Not Applicable,Observational,Switzerland,COVID-19 in People With Primary Ciliary Dyskinesia,1000,https://clinicaltrials.gov/show/NCT04602481,NA
NCT04602637,ClinicalTrials.gov,2020-10-22,2019-12-15,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,3,https://clinicaltrials.gov/show/NCT04602637,NA
NCT04602832,ClinicalTrials.gov,2020-10-23,2020-10-14,TRUE,Recruiting,Not Applicable,Interventional,Canada,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,350,https://clinicaltrials.gov/show/NCT04602832,NA
NCT04603664,ClinicalTrials.gov,2020-10-17,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,Egypt,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,88,https://clinicaltrials.gov/show/NCT04603664,NA
NCT04603677,ClinicalTrials.gov,2020-10-25,2020-07-08,TRUE,Recruiting,Not Applicable,Observational,United States,Northern Colorado COVID-19 Biobank,200,https://clinicaltrials.gov/show/NCT04603677,NA
NCT04603729,ClinicalTrials.gov,2020-10-21,2020-05-30,TRUE,Not Recruiting,Phase 3,Interventional,Pakistan,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,100,https://clinicaltrials.gov/show/NCT04603729,NA
NCT04603794,ClinicalTrials.gov,2020-10-21,2020-10-01,TRUE,Recruiting,Phase 4,Interventional,United States,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,60,https://clinicaltrials.gov/show/NCT04603794,NA
NCT04603963,ClinicalTrials.gov,2020-10-25,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in Patients With COVID-19,55,https://clinicaltrials.gov/show/NCT04603963,NA
NCT04604080,ClinicalTrials.gov,2020-10-25,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,Pakistan,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,390,https://clinicaltrials.gov/show/NCT04604080,NA
NCT04604119,ClinicalTrials.gov,2020-10-25,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,104,https://clinicaltrials.gov/show/NCT04604119,NA
NCT04604327,ClinicalTrials.gov,2020-10-23,2020-10-26,FALSE,Recruiting,Phase 3,Interventional,Spain,Comparison of Two Different Doses of Bemiparin in COVID-19,164,https://clinicaltrials.gov/show/NCT04604327,NA
NCT04604769,ClinicalTrials.gov,2020-04-27,2019-06-26,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,60,https://clinicaltrials.gov/show/NCT04604769,NA
NCT04604977,ClinicalTrials.gov,2020-10-20,2020-09-15,TRUE,Recruiting,Not Applicable,Interventional,Italy,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,25,https://clinicaltrials.gov/show/NCT04604977,NA
NCT04605692,ClinicalTrials.gov,2020-10-26,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,706,https://clinicaltrials.gov/show/NCT04605692,NA
NCT04605952,ClinicalTrials.gov,2020-10-23,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,India,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,201,https://clinicaltrials.gov/show/NCT04605952,NA
NCT04606069,ClinicalTrials.gov,2020-10-26,2020-11-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Treat COVID-19 Patients With Regadenoson,40,https://clinicaltrials.gov/show/NCT04606069,NA
NCT04606563,ClinicalTrials.gov,2020-10-27,2020-10-09,TRUE,Recruiting,Phase 3,Interventional,"Belgium, Canada, United States, Spain, Japan, France",Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,1372,https://clinicaltrials.gov/show/NCT04606563,NA
NCT04607928,ClinicalTrials.gov,2020-10-28,2020-08-01,TRUE,Recruiting,Phase 2,Interventional,Spain,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,148,https://clinicaltrials.gov/show/NCT04607928,NA
NCT04607941,ClinicalTrials.gov,2020-10-20,2020-10-27,FALSE,Recruiting,Not Applicable,Observational,France,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",57720,https://clinicaltrials.gov/show/NCT04607941,NA
NCT04608214,ClinicalTrials.gov,2020-10-12,2020-11-01,FALSE,Not Recruiting,Phase 2,Interventional,France,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04608214,NA
NCT04609332,ClinicalTrials.gov,2020-10-23,2020-11-10,FALSE,Recruiting,Not Applicable,Observational,Chile,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,40,https://clinicaltrials.gov/show/NCT04609332,NA
NCT04609371,ClinicalTrials.gov,2020-10-19,2020-10-21,FALSE,Recruiting,Not Applicable,Interventional,Canada,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,176,https://clinicaltrials.gov/show/NCT04609371,NA
NCT04609423,ClinicalTrials.gov,2020-10-22,2020-11-10,FALSE,Recruiting,Phase 4,Interventional,Norway,Cod Liver Oil for Covid-19 Prevention Study,80000,https://clinicaltrials.gov/show/NCT04609423,NA
NCT04609488,ClinicalTrials.gov,2020-10-28,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Surfactant Levels in the Lungs of COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04609488,NA
NCT04609839,ClinicalTrials.gov,2020-10-26,2020-10-27,FALSE,Recruiting,Not Applicable,Observational,France,FOLLOW-UP OF PATIENTS WITH COVID-19.,200,https://clinicaltrials.gov/show/NCT04609839,NA
NCT04610489,ClinicalTrials.gov,2020-10-27,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),800,https://clinicaltrials.gov/show/NCT04610489,NA
NCT04610541,ClinicalTrials.gov,2020-10-11,2020-10-12,FALSE,Not Recruiting,Phase 3,Interventional,Hungary,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,2000,https://clinicaltrials.gov/show/NCT04610541,NA
NCT04610554,ClinicalTrials.gov,2020-10-29,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,74,https://clinicaltrials.gov/show/NCT04610554,NA
NCT04610801,ClinicalTrials.gov,2020-10-26,2020-08-08,TRUE,Recruiting,Phase 3,Interventional,United States,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,200,https://clinicaltrials.gov/show/NCT04610801,NA
NCT04611243,ClinicalTrials.gov,2020-06-29,2020-05-22,TRUE,Recruiting,Not Applicable,Observational,Hong Kong,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",80,https://clinicaltrials.gov/show/NCT04611243,NA
NCT04611256,ClinicalTrials.gov,2020-10-29,2020-08-01,TRUE,Recruiting,Phase 1,Interventional,Mexico,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,20,https://clinicaltrials.gov/show/NCT04611256,NA
NCT04611269,ClinicalTrials.gov,2020-10-29,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,950,https://clinicaltrials.gov/show/NCT04611269,NA
NCT04611841,ClinicalTrials.gov,2020-09-26,2020-07-21,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2,250,https://clinicaltrials.gov/show/NCT04611841,NA
NCT04613297,ClinicalTrials.gov,2020-11-02,2020-10-19,TRUE,Recruiting,Not Applicable,Interventional,France,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,120,https://clinicaltrials.gov/show/NCT04613297,NA
NCT04613310,ClinicalTrials.gov,2020-10-26,2020-09-25,TRUE,Recruiting,Not Applicable,Interventional,Switzerland,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),1250,https://clinicaltrials.gov/show/NCT04613310,NA
NCT04614012,ClinicalTrials.gov,2020-11-02,2020-07-02,TRUE,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04614012,NA
NCT04614025,ClinicalTrials.gov,2020-11-02,2020-11-01,TRUE,Recruiting,Phase 2,Interventional,"Germany, Israel",Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04614025,NA
NCT04615000,ClinicalTrials.gov,2020-11-03,2020-10-29,TRUE,Recruiting,Not Applicable,Observational,Belgium,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,1000,https://clinicaltrials.gov/show/NCT04615000,NA
NCT04615026,ClinicalTrials.gov,2020-11-03,2020-11-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Prevalence of Thrombosis in COVID-Patients,400,https://clinicaltrials.gov/show/NCT04615026,NA
NCT04615195,ClinicalTrials.gov,2020-11-03,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,France,Effect of COVID19-related COntainment in ChildreN,1000,https://clinicaltrials.gov/show/NCT04615195,NA
NCT04615390,ClinicalTrials.gov,2020-10-29,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,200,https://clinicaltrials.gov/show/NCT04615390,NA
NCT04615416,ClinicalTrials.gov,2020-10-26,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04615416,NA
NCT04615676,ClinicalTrials.gov,2020-11-03,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,France,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,4734,https://clinicaltrials.gov/show/NCT04615676,NA
NCT04615728,ClinicalTrials.gov,2020-11-02,2019-11-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,207,https://clinicaltrials.gov/show/NCT04615728,NA
NCT04615871,ClinicalTrials.gov,2020-10-29,2020-11-30,FALSE,Not Recruiting,Phase 2,Interventional,"Canada, United Kingdom, Mexico, Brazil",Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,400,https://clinicaltrials.gov/show/NCT04615871,NA
NCT04615936,ClinicalTrials.gov,2020-11-02,2020-07-10,TRUE,Recruiting,Not Applicable,Interventional,Canada,Nasal Photodisinfection COVID Proof of Concept Study,100,https://clinicaltrials.gov/show/NCT04615936,NA
NCT04615975,ClinicalTrials.gov,2020-10-31,2020-11-01,FALSE,Recruiting,Not Applicable,Interventional,Italy,Ketogenic Diet as Protective Factor During COVID-19,28,https://clinicaltrials.gov/show/NCT04615975,NA
NCT04616001,ClinicalTrials.gov,2020-11-02,2020-11-01,TRUE,Not Recruiting,Phase 4,Interventional,United States,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,10,https://clinicaltrials.gov/show/NCT04616001,NA
NCT04616846,ClinicalTrials.gov,2020-11-02,2020-08-04,TRUE,Recruiting,Not Applicable,Interventional,"France, Monaco",Thromboembolic Risk Screening in Patients With Cancer and COVID-19,120,https://clinicaltrials.gov/show/NCT04616846,NA
NCT04616950,ClinicalTrials.gov,2020-11-04,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,800,https://clinicaltrials.gov/show/NCT04616950,NA
NCT04616976,ClinicalTrials.gov,2020-11-01,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,COVID-19 With Convalescent Plasma,78,https://clinicaltrials.gov/show/NCT04616976,NA
NCT04617119,ClinicalTrials.gov,2020-10-28,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Kuwait,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,38,https://clinicaltrials.gov/show/NCT04617119,NA
NCT04617483,ClinicalTrials.gov,2020-11-04,2020-10-31,TRUE,Recruiting,Phase 3,Interventional,China,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",1040,https://clinicaltrials.gov/show/NCT04617483,NA
NCT04617535,ClinicalTrials.gov,2020-11-02,2021-01-01,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04617535,NA
NCT04618341,ClinicalTrials.gov,2020-10-28,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,A Clinical Study of Online Active Play Program With Adolescents,32,https://clinicaltrials.gov/show/NCT04618341,NA
NCT04618796,ClinicalTrials.gov,2020-11-02,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of COVID-19 Pandemic on Vaccination Compliance,100,https://clinicaltrials.gov/show/NCT04618796,NA
NCT04618861,ClinicalTrials.gov,2020-11-03,2020-10-13,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,127,https://clinicaltrials.gov/show/NCT04618861,NA
NCT04619290,ClinicalTrials.gov,2020-11-04,2020-10-12,TRUE,Recruiting,Phase 1,Interventional,Mexico,Outpatient Treatment With CoVid-19 With Prexablu,46,https://clinicaltrials.gov/show/NCT04619290,NA
NCT04619368,ClinicalTrials.gov,2020-11-03,2020-07-27,TRUE,Recruiting,Not Applicable,Observational,France,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,100,https://clinicaltrials.gov/show/NCT04619368,NA
NCT04619576,ClinicalTrials.gov,2020-11-05,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,1000,https://clinicaltrials.gov/show/NCT04619576,NA
NCT04620798,ClinicalTrials.gov,2020-11-04,2020-09-14,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,1700,https://clinicaltrials.gov/show/NCT04620798,NA
NCT04621058,ClinicalTrials.gov,2020-11-06,2020-11-09,FALSE,Recruiting,Phase 3,Interventional,Spain,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,108,https://clinicaltrials.gov/show/NCT04621058,NA
NCT04621084,ClinicalTrials.gov,2020-11-05,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,1000,https://clinicaltrials.gov/show/NCT04621084,NA
NCT04621149,ClinicalTrials.gov,2020-11-05,2020-11-09,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,120,https://clinicaltrials.gov/show/NCT04621149,NA
NCT04621214,ClinicalTrials.gov,2020-11-04,2020-03-21,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,60,https://clinicaltrials.gov/show/NCT04621214,NA
NCT04621903,ClinicalTrials.gov,2020-11-06,2020-10-08,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,26,https://clinicaltrials.gov/show/NCT04621903,NA
NCT04622748,ClinicalTrials.gov,2020-09-06,2020-07-10,TRUE,Recruiting,Not Applicable,Observational,China,Neurocognitive Functions of Recovered COVID-19 Patients,160,https://clinicaltrials.gov/show/NCT04622748,NA
NCT04622826,ClinicalTrials.gov,2020-11-04,2020-05-15,TRUE,Recruiting,Phase 2,Interventional,Italy,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,50,https://clinicaltrials.gov/show/NCT04622826,NA
NCT04622865,ClinicalTrials.gov,2020-11-09,2020-06-01,TRUE,Recruiting,Phase 2,Interventional,France,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,200,https://clinicaltrials.gov/show/NCT04622865,NA
NCT04622891,ClinicalTrials.gov,2020-11-06,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,300,https://clinicaltrials.gov/show/NCT04622891,NA
NCT04623138,ClinicalTrials.gov,2020-10-30,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,950,https://clinicaltrials.gov/show/NCT04623138,NA
NCT04623177,ClinicalTrials.gov,2020-11-02,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Thromboprophylaxis for Patients in ICU With COVID-19,950,https://clinicaltrials.gov/show/NCT04623177,NA
NCT04623255,ClinicalTrials.gov,2020-06-11,2020-10-16,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Randomised Study of Plasma Exchange in Severe COVID-19,20,https://clinicaltrials.gov/show/NCT04623255,NA
NCT04623346,ClinicalTrials.gov,2020-11-07,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,262,https://clinicaltrials.gov/show/NCT04623346,NA
NCT04623385,ClinicalTrials.gov,2020-11-08,2020-11-01,TRUE,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,1000,https://clinicaltrials.gov/show/NCT04623385,NA
NCT04623619,ClinicalTrials.gov,2020-11-09,2020-12-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,100,https://clinicaltrials.gov/show/NCT04623619,NA
NCT04623697,ClinicalTrials.gov,2020-11-09,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,Denmark,Covid-19 Infection and New Onset Type 1 Diabetes,600,https://clinicaltrials.gov/show/NCT04623697,NA
NCT04624048,ClinicalTrials.gov,2020-11-08,2020-12-04,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Exercise Influence on COVID-19,30000,https://clinicaltrials.gov/show/NCT04624048,NA
NCT04624503,ClinicalTrials.gov,2020-10-17,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,500,https://clinicaltrials.gov/show/NCT04624503,NA
NCT04624997,ClinicalTrials.gov,2020-06-17,2020-06-08,TRUE,Recruiting,Not Applicable,Observational,France,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,1000,https://clinicaltrials.gov/show/NCT04624997,NA
NCT04625075,ClinicalTrials.gov,2020-11-09,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),40,https://clinicaltrials.gov/show/NCT04625075,NA
NCT04625114,ClinicalTrials.gov,2020-11-05,2020-11-04,TRUE,Recruiting,Phase 2,Interventional,Belgium,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,150,https://clinicaltrials.gov/show/NCT04625114,NA
NCT04625296,ClinicalTrials.gov,2020-11-10,2020-09-17,TRUE,Recruiting,Not Applicable,Observational,France,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,75,https://clinicaltrials.gov/show/NCT04625296,NA
NCT04625738,ClinicalTrials.gov,2020-11-04,2020-11-06,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,30,https://clinicaltrials.gov/show/NCT04625738,NA
NCT04626076,ClinicalTrials.gov,2020-11-10,2020-08-13,TRUE,Recruiting,Not Applicable,Observational,Pakistan,International Registry of Healthcare Workers Exposed to COVID-19 Patients,10000,https://clinicaltrials.gov/show/NCT04626076,NA
NCT04627194,ClinicalTrials.gov,2020-11-06,2020-02-20,TRUE,Not Recruiting,Not Applicable,Observational,Kazakhstan,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,1000,https://clinicaltrials.gov/show/NCT04627194,NA
NCT04627233,ClinicalTrials.gov,2020-11-06,2020-12-20,FALSE,Not Recruiting,Phase 1,Interventional,Iran,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,20,https://clinicaltrials.gov/show/NCT04627233,NA
NCT04627623,ClinicalTrials.gov,2020-11-12,2020-06-22,TRUE,Recruiting,Not Applicable,Observational,Poland,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,6000,https://clinicaltrials.gov/show/NCT04627623,NA
NCT04628000,ClinicalTrials.gov,2020-11-11,2020-10-27,TRUE,Recruiting,Not Applicable,Observational,United States,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,50,https://clinicaltrials.gov/show/NCT04628000,NA
NCT04628104,ClinicalTrials.gov,2020-11-12,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,60,https://clinicaltrials.gov/show/NCT04628104,NA
NCT04628143,ClinicalTrials.gov,2020-11-10,2020-11-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04628143,NA
NCT04628195,ClinicalTrials.gov,2020-11-10,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Chile,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04628195,NA
NCT04628637,ClinicalTrials.gov,2020-11-10,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,144,https://clinicaltrials.gov/show/NCT04628637,NA
NCT04629001,ClinicalTrials.gov,2020-11-12,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Effect of Covid-19 on Outcomes of Pregnancy,1000,https://clinicaltrials.gov/show/NCT04629001,NA
NCT04629105,ClinicalTrials.gov,2020-09-29,2020-07-24,TRUE,Recruiting,Phase 1,Interventional,United States,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),70,https://clinicaltrials.gov/show/NCT04629105,NA
NCT04629157,ClinicalTrials.gov,2020-11-04,2020-11-05,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,400,https://clinicaltrials.gov/show/NCT04629157,NA
NCT04629222,ClinicalTrials.gov,2020-11-13,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,France,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04629222,NA
NCT04629638,ClinicalTrials.gov,2020-11-12,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,500,https://clinicaltrials.gov/show/NCT04629638,NA
NCT04629755,ClinicalTrials.gov,2020-11-09,2020-04-04,TRUE,Not Recruiting,Not Applicable,Interventional,United States,A Smartphone Intervention for Relational and Mental Well Being,1765,https://clinicaltrials.gov/show/NCT04629755,NA
NCT04630015,ClinicalTrials.gov,2020-11-13,2020-08-31,TRUE,Recruiting,Not Applicable,Observational,United States,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,250,https://clinicaltrials.gov/show/NCT04630015,NA
NCT04631172,ClinicalTrials.gov,2020-11-14,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Covid-19 Anxiety and Phobia Levels of the Parents,150,https://clinicaltrials.gov/show/NCT04631172,NA
NCT04631367,ClinicalTrials.gov,2020-11-13,2021-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,404,https://clinicaltrials.gov/show/NCT04631367,NA
NCT04631380,ClinicalTrials.gov,2020-08-04,2020-08-01,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Prayer in Commbate to Corona Virus - Covid -19,200,https://clinicaltrials.gov/show/NCT04631380,NA
NCT04631861,ClinicalTrials.gov,2020-11-14,2014-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Physical Activity and the Risk of COVID-19 Infection and Mortality,132069,https://clinicaltrials.gov/show/NCT04631861,NA
NCT04632082,ClinicalTrials.gov,2020-11-05,2020-11-05,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,2200,https://clinicaltrials.gov/show/NCT04632082,NA
NCT04632173,ClinicalTrials.gov,2020-11-15,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Head and Neck cancERs International cOviD-19 collabOraTion,750,https://clinicaltrials.gov/show/NCT04632173,NA
NCT04632355,ClinicalTrials.gov,2020-11-13,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,100,https://clinicaltrials.gov/show/NCT04632355,NA
NCT04632602,ClinicalTrials.gov,2020-11-16,2020-04-04,TRUE,Recruiting,Not Applicable,Interventional,France,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04632602,NA
NCT04632719,ClinicalTrials.gov,2020-11-14,2020-11-08,TRUE,Recruiting,Not Applicable,Interventional,Brazil,The MentalPlusÂ® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,200,https://clinicaltrials.gov/show/NCT04632719,NA
NCT04633772,ClinicalTrials.gov,2020-11-06,2020-08-05,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Use of Angiotensin-(1-7) in COVID-19,130,https://clinicaltrials.gov/show/NCT04633772,NA
NCT04633941,ClinicalTrials.gov,2020-11-12,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,272,https://clinicaltrials.gov/show/NCT04633941,NA
NCT04633980,ClinicalTrials.gov,2020-11-16,2020-12-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Hydrogen Therapy in Patients With Moderate Covid-19,10,https://clinicaltrials.gov/show/NCT04633980,NA
NCT04634214,ClinicalTrials.gov,2020-11-15,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,1050,https://clinicaltrials.gov/show/NCT04634214,NA
NCT04634370,ClinicalTrials.gov,2020-11-16,2021-01-02,FALSE,Not Recruiting,Phase 1,Interventional,Brazil,Fase I Clinical Trial on NK Cells for COVID-19,24,https://clinicaltrials.gov/show/NCT04634370,NA
NCT04634422,ClinicalTrials.gov,2020-11-14,2020-11-16,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,220,https://clinicaltrials.gov/show/NCT04634422,NA
NCT04635241,ClinicalTrials.gov,2020-11-14,2020-06-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"Egypt, Argentina",Inhaled Heparin for Hospitalised COVID-19 Patients,656,https://clinicaltrials.gov/show/NCT04635241,NA
NCT04635592,ClinicalTrials.gov,2020-11-17,2020-11-01,TRUE,Not Recruiting,Not Applicable,Observational,Slovenia,Serological Diagnostics of COVID-19 in Health Care Workers,300,https://clinicaltrials.gov/show/NCT04635592,NA
NCT04635618,ClinicalTrials.gov,2020-11-05,2020-11-05,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,999,https://clinicaltrials.gov/show/NCT04635618,NA
NCT04635787,ClinicalTrials.gov,2020-11-13,2020-11-05,TRUE,Recruiting,Not Applicable,Observational,United States,Vital Sensor Monitors for CV19 Detection,300,https://clinicaltrials.gov/show/NCT04635787,NA
NCT04635813,ClinicalTrials.gov,2020-11-17,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,3800,https://clinicaltrials.gov/show/NCT04635813,NA
NCT04636021,ClinicalTrials.gov,2020-11-13,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,United States,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,1000,https://clinicaltrials.gov/show/NCT04636021,NA
NCT04636320,ClinicalTrials.gov,2020-11-18,2020-06-13,TRUE,Recruiting,Not Applicable,Interventional,France,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,240,https://clinicaltrials.gov/show/NCT04636320,NA
NCT04637828,ClinicalTrials.gov,2020-11-17,2020-11-18,FALSE,Recruiting,Phase 2,Interventional,France,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,178,https://clinicaltrials.gov/show/NCT04637828,NA
NCT04637893,ClinicalTrials.gov,2020-11-18,2020-12-16,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,1000,https://clinicaltrials.gov/show/NCT04637893,NA
NCT04639349,ClinicalTrials.gov,2020-11-19,2020-11-19,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,40,https://clinicaltrials.gov/show/NCT04639349,NA
NCT04639427,ClinicalTrials.gov,2020-11-19,2020-11-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,4,https://clinicaltrials.gov/show/NCT04639427,NA
NCT04639440,ClinicalTrials.gov,2020-10-28,2020-11-23,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of Adipose Tissue in COVID-19,60,https://clinicaltrials.gov/show/NCT04639440,NA
NCT04641182,ClinicalTrials.gov,2020-09-12,2020-07-06,TRUE,Not Recruiting,Not Applicable,Observational,Chile,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,66,https://clinicaltrials.gov/show/NCT04641182,NA
NCT04641806,ClinicalTrials.gov,2020-11-20,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,120,https://clinicaltrials.gov/show/NCT04641806,NA
NCT04641988,ClinicalTrials.gov,2020-11-23,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),111,https://clinicaltrials.gov/show/NCT04641988,NA
NCT04642014,ClinicalTrials.gov,2020-11-23,2020-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,Poland,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,500,https://clinicaltrials.gov/show/NCT04642014,NA
NCT04642040,ClinicalTrials.gov,2020-11-21,2020-06-30,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,100,https://clinicaltrials.gov/show/NCT04642040,NA
NCT04642196,ClinicalTrials.gov,2020-11-22,2020-05-02,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 in Home Healthcare,155,https://clinicaltrials.gov/show/NCT04642196,NA
NCT04642326,ClinicalTrials.gov,2020-11-16,2020-06-26,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,50,https://clinicaltrials.gov/show/NCT04642326,NA
NCT04642339,ClinicalTrials.gov,2020-11-16,2020-11-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",2000,https://clinicaltrials.gov/show/NCT04642339,NA
NCT04642703,ClinicalTrials.gov,2020-11-18,2020-03-03,TRUE,Recruiting,Not Applicable,Observational,Chile,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,100,https://clinicaltrials.gov/show/NCT04642703,NA
NCT04643054,ClinicalTrials.gov,2020-11-22,2020-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04643054,NA
NCT04643522,ClinicalTrials.gov,2020-11-24,2020-01-07,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Semen Parameters and COVID-19 in Infertile Men,21,https://clinicaltrials.gov/show/NCT04643522,NA
NCT04643548,ClinicalTrials.gov,2020-11-16,2020-10-13,TRUE,Recruiting,Not Applicable,Observational,France,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,20,https://clinicaltrials.gov/show/NCT04643548,NA
NCT04643561,ClinicalTrials.gov,2020-11-24,2020-11-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Using Travelan to Boost Immune Response in Vitro to COVID-19,5,https://clinicaltrials.gov/show/NCT04643561,NA
NCT04643691,ClinicalTrials.gov,2020-11-24,2020-09-11,TRUE,Recruiting,Phase 2,Interventional,France,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,90,https://clinicaltrials.gov/show/NCT04643691,NA
NCT04643964,ClinicalTrials.gov,2020-11-12,2020-11-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Brief Video Interventions for Depression,501,https://clinicaltrials.gov/show/NCT04643964,NA
NCT04644146,ClinicalTrials.gov,2020-11-19,2020-12-01,FALSE,Recruiting,Not Applicable,Observational,France,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),40,https://clinicaltrials.gov/show/NCT04644146,NA
NCT04644159,ClinicalTrials.gov,2020-11-18,2020-11-13,TRUE,Recruiting,Not Applicable,Observational,France,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",2000,https://clinicaltrials.gov/show/NCT04644159,NA
NCT04644172,ClinicalTrials.gov,2020-11-23,2020-11-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United States,Improving Thinking in Everyday Life After Covid-19,40,https://clinicaltrials.gov/show/NCT04644172,NA
NCT04644302,ClinicalTrials.gov,2020-11-24,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,Czech Republic,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,25,https://clinicaltrials.gov/show/NCT04644302,NA
NCT04644705,ClinicalTrials.gov,2020-11-02,2020-11-02,FALSE,Recruiting,Phase 1,Interventional,Germany,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,28,https://clinicaltrials.gov/show/NCT04644705,NA
NCT04645368,ClinicalTrials.gov,2020-11-20,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19",160,https://clinicaltrials.gov/show/NCT04645368,NA
NCT04645407,ClinicalTrials.gov,2020-02-15,2020-02-01,TRUE,Not Recruiting,Phase 4,Interventional,China,Effects of Fuzheng Huayu Tablets on COVID-19,66,https://clinicaltrials.gov/show/NCT04645407,NA
NCT04645433,ClinicalTrials.gov,2020-11-07,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,100,https://clinicaltrials.gov/show/NCT04645433,NA
NCT04645498,ClinicalTrials.gov,2020-11-25,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Hereditary Metabolic Diseases,77,https://clinicaltrials.gov/show/NCT04645498,NA
NCT04645563,ClinicalTrials.gov,2020-11-20,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Using Whatsapp for the Consultation,144,https://clinicaltrials.gov/show/NCT04645563,NA
NCT04646031,ClinicalTrials.gov,2020-11-24,2020-05-20,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04646031,NA
NCT04646525,ClinicalTrials.gov,2020-11-05,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,300,https://clinicaltrials.gov/show/NCT04646525,NA
NCT04646551,ClinicalTrials.gov,2020-11-26,2020-12-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Covid-19 Risk Factors and Pattern Between Healthcare Workers,165,https://clinicaltrials.gov/show/NCT04646551,NA
NCT04646655,ClinicalTrials.gov,2020-11-22,2020-07-27,TRUE,Recruiting,Phase 3,Interventional,Italy,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,300,https://clinicaltrials.gov/show/NCT04646655,NA
NCT04647604,ClinicalTrials.gov,2020-06-12,2020-06-23,FALSE,Recruiting,Phase 2,Interventional,Sweden,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,40,https://clinicaltrials.gov/show/NCT04647604,NA
NCT04647656,ClinicalTrials.gov,2020-11-29,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,70,https://clinicaltrials.gov/show/NCT04647656,NA
NCT04647734,ClinicalTrials.gov,2020-11-25,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,Denmark,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,40,https://clinicaltrials.gov/show/NCT04647734,NA
ChiCTR2000038672,ChiCTR,2020-09-27,2020-11-05,FALSE,Not Recruiting,Phase 1,Interventional,China,"A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults",12,http://www.chictr.org.cn/showproj.aspx?proj=59313,NA
ChiCTR2000038343,ChiCTR,2020-09-19,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,China,Evaluation of primary preventive measures in populations at high risk for novel coronavirus pneumonia (COVID-19) sequelae osteonecrosis of the femoral head -- a prospective randomized controlled trial,120,http://www.chictr.org.cn/showproj.aspx?proj=61668,NA
ChiCTR2000038333,ChiCTR,2020-09-18,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,China,Study on Screening and prevention of osteonecrosis of the femoral head during novel coronavirus pneumonia (COVID-19) recovery,120,http://www.chictr.org.cn/showproj.aspx?proj=61769,NA
EUCTR2020-002502-75,EudraCT,2020-06-26,2020-11-26,FALSE,Authorised,Phase 2,Interventional,Germany,Covid-19 Vaccination Trial,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002502-75,DE
EUCTR2020-001928-34,EudraCT,2020-04-24,2020-05-28,FALSE,Authorised,Phase 2,Interventional,Sweden,Treatment with inhalation of Ciclesonide for patients with coronavirus disease: A randomised open study.,446,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001928-34,SE
ACTRN12618001845224,ANZCTR,2018-11-13,2019-02-27,FALSE,Recruiting,Not Applicable,Interventional,Australia,"HARMONY - A randomised controlled trial of a GP systems intervention for family violence experienced by South Asian migrant and refugee women and children in Melbourne, Australia..",28,https://anzctr.org.au/ACTRN12618001845224.aspx,NA
ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-04,TRUE,Not Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,680,https://anzctr.org.au/ACTRN12620000417987.aspx,NA
ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",780,https://anzctr.org.au/ACTRN12620000555954.aspx,NA
ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,650,https://anzctr.org.au/ACTRN12620000501943.aspx,NA
ACTRN12620000640909,ANZCTR,2020-06-01,2020-08-14,FALSE,Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",200,https://anzctr.org.au/ACTRN12620000640909.aspx,NA
ACTRN12620000636954,ANZCTR,2020-05-29,2020-07-23,FALSE,Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,35,https://anzctr.org.au/ACTRN12620000636954.aspx,NA
ACTRN12620000620921,ANZCTR,2020-05-28,2020-06-17,FALSE,Recruiting,Not Applicable,Observational,"Australia, United Kingdom, Belgium, Canada, Italy, Germany","Angiotensin II Infusion in COVID-19-Associated Vasodilatory Shock: A multinational, multicentre registry",315,https://anzctr.org.au/ACTRN12620000620921.aspx,NA
ACTRN12620000779976,ANZCTR,2020-07-30,2020-06-08,TRUE,Not Recruiting,Not Applicable,Interventional,"Australia, United Kingdom",The effect of Cognitive behaviour therapy on adult mental health during the COVID-19 pandemic.,100,https://anzctr.org.au/ACTRN12620000779976.aspx,NA
ACTRN12620000975998,ANZCTR,2020-09-30,2021-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Feasibility and acceptability of a volunteer-peer telephone support programme - A COVID-19 response,100,https://anzctr.org.au/ACTRN12620000975998.aspx,NA
ACTRN12620001167954,ANZCTR,2020-11-06,2021-01-18,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Melanoma Patientsâ€™ and Cliniciansâ€™ Satisfaction with Telehealth During COVID-19,100,https://anzctr.org.au/ACTRN12620001167954.aspx,NA
ACTRN12620001308987,ANZCTR,2020-12-04,2020-09-12,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of a novel Receptor Binding Domain (RBD) COVID-19 Vaccine in Healthy Adults",255,https://anzctr.org.au/ACTRN12620001308987.aspx,NA
ACTRN12620001371987,ANZCTR,2020-12-22,2021-05-01,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"A randomized, double-blind, placebo-controlled investigation of the safety, tolerability and pharmacokinetics of 1% SPL7013 nasal spray in healthy volunteers when administered four times a day for 14 days (1% SPL7013 nasal spray is intended to help prevent COVID-19)",40,https://anzctr.org.au/ACTRN12620001371987.aspx,NA
ISRCTN14652655,ISRCTN,2020-12-18,2020-03-12,TRUE,Not Recruiting,Not Applicable,Observational,Romania,The effects of the COVID-19 pandemic on mental health,500,http://isrctn.com/ISRCTN14652655,NA
ISRCTN14159936,ISRCTN,2020-12-14,2020-01-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Change in disability in activities of daily living over time among adults with advanced respiratory disease during the COVID-19 pandemic,120,http://isrctn.com/ISRCTN14159936,NA
ISRCTN11713182,ISRCTN,2020-12-02,2020-12-21,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Testing the effectiveness of almitrine bismesylate in the treatment of COVID-19,116,http://isrctn.com/ISRCTN11713182,NA
ISRCTN12735607,ISRCTN,2020-12-02,2020-01-10,TRUE,Recruiting,Not Applicable,Observational,Ireland,Exploring the role of virtual reality in midwifery education: a prospective study,40,http://isrctn.com/ISRCTN12735607,NA
ISRCTN19845486,ISRCTN,2020-12-02,2020-01-07,TRUE,Recruiting,Not Applicable,Interventional,Ireland,"VR Baby, a virtual reality learning environment - does it help medical students to learn about complex topics in obstetrics and gynaecology?",40,http://isrctn.com/ISRCTN19845486,NA
ISRCTN33037282,ISRCTN,2020-11-27,2020-11-06,TRUE,Not Recruiting,Not Applicable,Observational,Colombia,Comparing two medications (dexamethasone and methylprednisolone high dose) for the treatment of pneumonia in patients with COVID-19,216,http://isrctn.com/ISRCTN33037282,NA
ISRCTN77941736,ISRCTN,2020-11-23,2020-11-14,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Coping during COVID-19: Peer-delivered training to improve adolescent wellbeing,120,http://isrctn.com/ISRCTN77941736,NA
ISRCTN12833010,ISRCTN,2020-11-12,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,A study of parents' views and motivations on presenting to their local paediatric emergency department during the coronavirus pandemic (COVID-19),165,http://isrctn.com/ISRCTN12833010,NA
ISRCTN18172749,ISRCTN,2020-10-30,2020-11-23,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,"Lessons from the frontline: the impact of redeployment during COVID-19 on nurse wellbeing, performance and retention",93,http://isrctn.com/ISRCTN18172749,NA
ISRCTN95933274,ISRCTN,2020-09-09,2020-06-30,TRUE,Recruiting,Not Applicable,Interventional,Singapore,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients,68,http://isrctn.com/ISRCTN95933274,NA
ISRCTN37530113,ISRCTN,2020-01-31,2017-04-09,TRUE,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,70,http://isrctn.com/ISRCTN37530113,NA
IRCT20200204046369N1,IRCT,2020-04-08,2020-08-07,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,82,http://en.irct.ir/trial/46776,NA
IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",70,http://en.irct.ir/trial/47193,NA
IRCT20200421047153N1,IRCT,2020-12-19,2020-07-04,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine prophylaxis in preventing the severe forms of  Covid-19,1000,http://en.irct.ir/trial/47337,NA
IRCT20140312016968N2,IRCT,2020-11-01,2020-04-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Study of the effects of grapefruit extract on COVID-19,20,http://en.irct.ir/trial/47381,NA
IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Nivasha oral spray in controlling the symptoms of patients with COVID-19,80,http://en.irct.ir/trial/47477,NA
IRCT20180610040049N6,IRCT,2020-12-04,2020-05-18,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations of patients with COVID-19,60,http://en.irct.ir/trial/47626,NA
IRCT20200621047859N2,IRCT,2020-12-29,2020-08-22,TRUE,Not Recruiting,Phase 1,Interventional,Iran,Immune cell therapy for patients with COVID-19 related pneumonia using allogenic ex vivo NK cells,15,http://en.irct.ir/trial/49382,NA
IRCT20200516047462N2,IRCT,2020-07-17,2020-07-08,TRUE,Not Recruiting,Phase 2,Interventional,Iran,The effect of Hyoscyamus niger with propolis on covid-19,140,http://en.irct.ir/trial/49628,NA
IRCT20120703010178N22,IRCT,2020-12-07,2020-08-22,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Bromhexine hydrochloride for prophylaxis against COVID-19,1050,http://en.irct.ir/trial/49850,NA
IRCT20160131026298N5,IRCT,2020-08-23,2020-09-22,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of SINA anti-flu natural product on COVID-19,80,http://en.irct.ir/trial/49886,NA
IRCT20200727048217N1,IRCT,2020-09-13,2020-08-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of ethanol and DMSO in prophylaxis and treatment of COVID-19,610,http://en.irct.ir/trial/49924,NA
IRCT20200731048257N1,IRCT,2020-11-08,2020-08-15,TRUE,Recruiting,Phase 3,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,224,http://en.irct.ir/trial/50012,NA
IRCT20161206031255N4,IRCT,2020-12-07,2020-09-22,TRUE,Recruiting,Phase 3,Interventional,Iran,?Efficacy of prebiotic products on admitted patients with Covid-19,60,http://en.irct.ir/trial/50229,NA
IRCT20170611034452N12,IRCT,2020-12-20,2020-04-20,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Tele-counselling on perinatal mental health during pandemics,60,http://en.irct.ir/trial/50289,NA
IRCT20200818048444N1,IRCT,2020-09-15,2020-09-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Verification of the efficacy of Bromhexine-hydrochloride in treatment of patients with COVID19 disease,1300,http://en.irct.ir/trial/50780,NA
IRCT20150830023823N3,IRCT,2020-12-06,2020-11-15,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Barley water (Hordeum vulgare) in clinical outcome of  COVID-19 patients,50,http://en.irct.ir/trial/50854,NA
IRCT20200921048783N1,IRCT,2020-12-06,2021-01-08,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Effect of  GRAPEX in treatment of COVID-19,80,http://en.irct.ir/trial/51199,NA
IRCT20200927048849N1,IRCT,2020-12-05,2020-11-10,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Study of the safety of hyper immune bovine milk and colostrum against covid-19,40,http://en.irct.ir/trial/51259,NA
IRCT20201004048923N1,IRCT,2020-12-13,2020-10-15,TRUE,Recruiting,Phase 3,Interventional,Iran,"Effect of biotin, brewerâ€™s yeast and vitamin C supplements in patients with COVID-19",50,http://en.irct.ir/trial/51442,NA
IRCT20201001048894N1,IRCT,2020-12-15,2020-10-22,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Interferon beta-1-b on COVID-19 patients,90,http://en.irct.ir/trial/51492,NA
IRCT20181208041886N3,IRCT,2020-12-22,2020-12-21,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of Montelukast on COVID 19 disease activity,60,http://en.irct.ir/trial/51633,NA
IRCT20201028049175N1,IRCT,2020-12-12,2020-11-21,TRUE,Recruiting,Phase 3,Interventional,Iran,EVALUATION OF THE EFFECT OF FAVIPIRAVIR ON MANAGEMENT PATIENT WITH COVID-19,114,http://en.irct.ir/trial/51946,NA
IRCT20200408046987N3,IRCT,2020-12-06,2020-11-30,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of prophylaxis induced by ivermectin in populations exposed to COVID-19 patients,800,http://en.irct.ir/trial/51999,NA
IRCT20080901001157N17,IRCT,2020-11-29,2020-11-15,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effects of herbal drug IMFLUNA on patients with COVID-19,60,http://en.irct.ir/trial/52070,NA
IRCT20180625040232N7,IRCT,2020-11-30,2020-11-10,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effect of hemoperfusion on patients with severe symptoms of covid-19 which are resistant to conventional therapies,20,http://en.irct.ir/trial/52081,NA
IRCT20110302005952N2,IRCT,2020-12-17,2020-11-25,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of orange peel and peppermint extract in coronavirus treatment,60,http://en.irct.ir/trial/52356,NA
IRCT20180205038626N7,IRCT,2020-12-27,2020-12-05,TRUE,Recruiting,Phase 2,Interventional,Iran,The investigation of the effectiveness of ASA usage on  corona virus,36,http://en.irct.ir/trial/52374,NA
IRCT20201003048904N2,IRCT,2020-12-10,2020-12-05,TRUE,Recruiting,Not Applicable,Interventional,Iran,combination therapy trial in COVID-19 patients,200,http://en.irct.ir/trial/52607,NA
IRCT20201128049508N1,IRCT,2020-12-28,2020-09-22,TRUE,Recruiting,Phase 3,Interventional,Iran,effect  of  statin in  COVID19,60,http://en.irct.ir/trial/52648,NA
IRCT20171219037964N3,IRCT,2020-12-02,2020-12-21,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Favipiravir on outpatient treatment of Covid-19,70,http://en.irct.ir/trial/52696,NA
IRCT20201202049567N1,IRCT,2020-12-15,2020-12-21,FALSE,Recruiting,Phase 1,Interventional,Iran,Phase 1 clinical trial of an inactivated COVID-19 vaccine (Shifa-Pharmed) in healthy individuals,56,http://en.irct.ir/trial/52701,NA
IRCT20171219037964N2,IRCT,2020-12-02,2020-12-21,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of Steroid on the outpatient treatment of Covid-19,70,http://en.irct.ir/trial/52709,NA
IRCT20100130003227N15,IRCT,2020-12-10,2020-12-21,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of Hyssop and Verbascum herbal tea on clinical symptoms of Covide-19.,50,http://en.irct.ir/trial/52719,NA
IRCT20190415043279N9,IRCT,2020-12-22,2020-12-05,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Propolis COVID 19,72,http://en.irct.ir/trial/52853,NA
IRCT20170218032635N3,IRCT,2020-12-27,2021-01-20,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The efficacy of mindfulness based stress reduction program on mental well-being and quality of life in patients with COVID-19 after discharge,100,http://en.irct.ir/trial/53134,NA
IRCT20200818048444N2,IRCT,2020-12-31,2020-11-14,TRUE,Recruiting,Phase 3,Interventional,Iran,The Effect of Bromhexine Hydrochloride on Clinical Outcomes of Patients with COVID-19 disease,400,http://en.irct.ir/trial/53165,NA
ChiCTR2000038943,ChiCTR,2020-10-10,2020-01-17,TRUE,Recruiting,Not Applicable,Observational,China,Outcomes of and Prognosis Factors for COVID-19 Patients: an Observational Study,233,http://www.chictr.org.cn/showproj.aspx?proj=61717,NA
ChiCTR2000038866,ChiCTR,2020-10-07,2020-10-15,FALSE,Not Recruiting,Not Applicable,Interventional,China,A mHealth-based randomized controlled trial for improving mental health among people living with HIV during the COVID-19 outbreak,120,http://www.chictr.org.cn/showproj.aspx?proj=61662,NA
ChiCTR2000038865,ChiCTR,2020-10-07,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Indonesia,"Does elective orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia",35,http://www.chictr.org.cn/showproj.aspx?proj=61044,NA
ChiCTR2000038864,ChiCTR,2020-10-07,2020-10-19,FALSE,Recruiting,Not Applicable,Observational,China,"Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic",600,http://www.chictr.org.cn/showproj.aspx?proj=62357,NA
ChiCTR2000038827,ChiCTR,2020-10-05,2020-11-02,FALSE,Not Recruiting,Not Applicable,Interventional,China,Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic,1500,http://www.chictr.org.cn/showproj.aspx?proj=61884,NA
ChiCTR2000038471,ChiCTR,2020-09-23,2020-09-25,FALSE,Recruiting,Not Applicable,Observational,China,A study of neurological damage in patients recovering from novel coronavirus pneumonia (COVID-19),160,http://www.chictr.org.cn/showproj.aspx?proj=61958,NA
JPRN-UMIN000042270,UMIN-CTR,2020-12-09,2020-10-28,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,Disinfection and cross infection tests on sports equipment in covid-19 epidemic,41,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048258,NA
JPRN-UMIN000042599,UMIN-CTR,2020-12-01,2020-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation of SARS-CoV-2 Serum Antibody Titer in Pediatric Health Workers,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048622,NA
JPRN-UMIN000042681,UMIN-CTR,2020-12-07,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Effectiveness of ICU diaries on satisfaction of family members of COVID-19 patients in the ICU,4,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048694,NA
JPRN-UMIN000042717,UMIN-CTR,2020-12-10,2020-11-09,TRUE,Recruiting,Not Applicable,Observational,Japan,The mechanism of COVID-19 associated coagulopathy: a prospective cohort study,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048021,NA
JPRN-UMIN000042723,UMIN-CTR,2020-12-11,2020-12-14,FALSE,Recruiting,Not Applicable,Observational,Japan,Impact of nanopore platform on rapid diagnosis of COVID-19 in patients with respiratory tract infections,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048652,NA
JPRN-UMIN000042807,UMIN-CTR,2020-12-23,2020-12-23,FALSE,Not Recruiting,Not Applicable,Interventional,Asia(except Japan),"Developing an Adaptive Intervention for the Mental Health and Psychosocial Support of Health Workers in the Philippines under COVID-19 Pandemic using the Sequential, Multiple Assignment, Randomized Trial (SMART)",373,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048854,NA
EUCTR2020-003654-71,EudraCT,2020-09-30,2020-06-10,TRUE,Authorised,Phase 3,Interventional,"Chile, Moldova, Republic of, Greece, United States, Brazil, Mexico, Romania",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003654-71,RO
EUCTR2020-004994-27,EudraCT,2020-10-21,2020-12-16,FALSE,Authorised,Phase 2,Interventional,United Kingdom,Nitric Oxide Nasal Spray for COVID-19 treatment,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004994-27,GB
EUCTR2020-002504-39,EudraCT,2020-08-14,2020-10-11,FALSE,Authorised,Phase 3,Interventional,Germany,Hamburg Edoxaban foR anticoagulation in COvid-19 study,172,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002504-39,DE
EUCTR2020-001558-23,EudraCT,2020-06-26,2020-09-04,FALSE,Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23,IT
EUCTR2020-004323-16,EudraCT,2020-11-23,2020-11-25,FALSE,Authorised,Phase 2,Interventional,Italy,Evaluation of the efficacy of high doses of methylprednisolone in SARS-CoV2  pneumonia patients.,260,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004323-16,IT
EUCTR2020-001921-30,EudraCT,2020-06-26,2020-05-14,TRUE,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30,IT
EUCTR2020-004285-19,EudraCT,2020-11-23,2020-11-25,FALSE,Authorised,Phase 4,Interventional,"Italy, United States",Evaluation of Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004285-19,IT
EUCTR2020-001645-40,EudraCT,2020-09-22,2020-06-05,TRUE,Authorised,Phase 2/Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,159,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001645-40,IT
EUCTR2020-003936-25,EudraCT,2020-11-23,2020-10-31,TRUE,Authorised,Phase 2/Phase 3,Interventional,Italy,Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25,IT
EUCTR2020-004719-28,EudraCT,2020-10-12,2020-11-20,FALSE,Authorised,Phase 3,Interventional,"United States, United Kingdom","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have been potentially exposed to COVID-19"".",1125,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004719-28,GB
EUCTR2020-003367-26,EudraCT,2020-09-21,2020-05-10,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, South Korea, Ukraine, United States, Israel, Spain, Italy, Mexico, Brazil, Japan, Poland, France, Philippines",MK-4482 Ph 2/3 Study in Hospitalized Participants with COVID-19,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003367-26,GB
EUCTR2020-003368-24,EudraCT,2020-09-21,2020-05-10,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, Canada, Ukraine, United States, Israel, Spain, Italy, Mexico, Brazil, France, Germany, Philippines",MK-4482 Ph 2/3 Study in Non-Hospitalized Participants with COVID-19,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003368-24,GB
KCT0005649,CRiS,2020-12-02,2020-09-18,TRUE,Recruiting,Phase 2,Interventional,South Korea,"A prospective, open-label, randomized, multi-center, phase 2a study to evaluate the dose response, efficacy and safety of Hyper-Ig (Hyper-immunoglobulin) GC5131 in Patients with COVID-19",60,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17659,NA
KCT0005711,CRiS,2020-12-29,2020-12-28,TRUE,Not Recruiting,Not Applicable,Interventional,South Korea,"Effects of time use intervention on occupational balance, mental health and quality of life in COVID-19 patients",50,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18369,NA
NCT03944447,ClinicalTrials.gov,2019-05-03,2018-12-01,TRUE,Recruiting,Phase 2,Interventional,United States,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,200000,https://clinicaltrials.gov/show/NCT03944447,NA
NCT04169542,ClinicalTrials.gov,2019-11-18,2019-05-21,TRUE,Recruiting,Not Applicable,Observational,United States,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",600,https://clinicaltrials.gov/show/NCT04169542,NA
NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,FALSE,Not Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom, United States, Mexico, Spain, Japan, Singapore, Germany, South Korea",Adaptive COVID-19 Treatment Trial (ACTT),1062,https://clinicaltrials.gov/show/NCT04280705,NA
NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",1000,https://clinicaltrials.gov/show/NCT04304690,NA
NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Italy, United States",Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,16,https://clinicaltrials.gov/show/NCT04324021,NA
NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),173,https://clinicaltrials.gov/show/NCT04329923,NA
NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,FALSE,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,219,https://clinicaltrials.gov/show/NCT04333914,NA
NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,FALSE,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,25,https://clinicaltrials.gov/show/NCT04339426,NA
NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,FALSE,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,3000,https://clinicaltrials.gov/show/NCT04341441,NA
NCT04351399,ClinicalTrials.gov,2020-04-14,2020-04-27,FALSE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,318,https://clinicaltrials.gov/show/NCT04351399,NA
NCT04351633,ClinicalTrials.gov,2020-04-15,2020-04-23,FALSE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,52,https://clinicaltrials.gov/show/NCT04351633,NA
NCT04351802,ClinicalTrials.gov,2020-04-16,2020-05-11,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,180,https://clinicaltrials.gov/show/NCT04351802,NA
NCT04351854,ClinicalTrials.gov,2020-04-16,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,Germany,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,500,https://clinicaltrials.gov/show/NCT04351854,NA
NCT04353011,ClinicalTrials.gov,2020-04-15,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,312,https://clinicaltrials.gov/show/NCT04353011,NA
NCT04353336,ClinicalTrials.gov,2020-04-15,2020-03-23,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,200,https://clinicaltrials.gov/show/NCT04353336,NA
NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,0,https://clinicaltrials.gov/show/NCT04355676,NA
NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,500,https://clinicaltrials.gov/show/NCT04359797,NA
NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,2587,https://clinicaltrials.gov/show/NCT04363593,NA
NCT04366154,ClinicalTrials.gov,2020-04-16,2020-04-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,809,https://clinicaltrials.gov/show/NCT04366154,NA
NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,30,https://clinicaltrials.gov/show/NCT04368000,NA
NCT04368338,ClinicalTrials.gov,2020-04-28,2020-04-28,FALSE,Recruiting,Not Applicable,Observational,France,Lung Ultrasound to Diagnose COVID-19,100,https://clinicaltrials.gov/show/NCT04368338,NA
NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,TRUE,Not Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,233,https://clinicaltrials.gov/show/NCT04370262,NA
NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,FALSE,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,18,https://clinicaltrials.gov/show/NCT04370782,NA
NCT04371640,ClinicalTrials.gov,2020-04-28,2020-07-06,FALSE,Not Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,0,https://clinicaltrials.gov/show/NCT04371640,NA
NCT04373759,ClinicalTrials.gov,2020-04-30,2020-05-02,FALSE,Not Recruiting,Not Applicable,Observational,"France, Martinique",Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,186,https://clinicaltrials.gov/show/NCT04373759,NA
NCT04380688,ClinicalTrials.gov,2020-05-07,2020-06-13,FALSE,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,62,https://clinicaltrials.gov/show/NCT04380688,NA
NCT04380779,ClinicalTrials.gov,2020-05-07,2020-04-13,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,2430,https://clinicaltrials.gov/show/NCT04380779,NA
NCT04380792,ClinicalTrials.gov,2020-05-07,2020-04-13,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,2497,https://clinicaltrials.gov/show/NCT04380792,NA
NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,FALSE,Recruiting,Phase 3,Interventional,Egypt,Novel Regimens in COVID-19 Treatment,160,https://clinicaltrials.gov/show/NCT04382846,NA
NCT04382924,ClinicalTrials.gov,2020-05-08,2020-08-05,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Philippines, Australia, United States, Romania",Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,682,https://clinicaltrials.gov/show/NCT04382924,NA
NCT04383457,ClinicalTrials.gov,2020-05-04,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,Sweden,Covid-19 Triage Using Camera-based AI,214,https://clinicaltrials.gov/show/NCT04383457,NA
NCT04385797,ClinicalTrials.gov,2020-05-07,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,200,https://clinicaltrials.gov/show/NCT04385797,NA
NCT04386551,ClinicalTrials.gov,2020-05-11,2020-05-06,TRUE,Not Recruiting,Not Applicable,Observational,France,Detection of COVID-19 in Saliva Collection,501,https://clinicaltrials.gov/show/NCT04386551,NA
NCT04387968,ClinicalTrials.gov,2020-05-12,2020-08-24,FALSE,Recruiting,Not Applicable,Observational,France,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",5000,https://clinicaltrials.gov/show/NCT04387968,NA
NCT04394104,ClinicalTrials.gov,2020-05-15,2020-05-27,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Wellness Survey,593,https://clinicaltrials.gov/show/NCT04394104,NA
NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,TRUE,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,308,https://clinicaltrials.gov/show/NCT04401293,NA
NCT04402853,ClinicalTrials.gov,2020-05-22,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04402853,NA
NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-27,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,34,https://clinicaltrials.gov/show/NCT04402983,NA
NCT04405843,ClinicalTrials.gov,2020-05-23,2020-07-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),476,https://clinicaltrials.gov/show/NCT04405843,NA
NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,FALSE,Not Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,41,https://clinicaltrials.gov/show/NCT04407286,NA
NCT04408248,ClinicalTrials.gov,2020-05-27,2020-08-20,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,AKI Biomarkers in Coronavirus(COVID)-19,30,https://clinicaltrials.gov/show/NCT04408248,NA
NCT04408365,ClinicalTrials.gov,2020-05-27,2020-08-05,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",82,https://clinicaltrials.gov/show/NCT04408365,NA
NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,44,https://clinicaltrials.gov/show/NCT04410354,NA
NCT04412226,ClinicalTrials.gov,2020-05-31,2020-06-10,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,13,https://clinicaltrials.gov/show/NCT04412226,NA
NCT04416100,ClinicalTrials.gov,2020-05-26,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Austria,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),130,https://clinicaltrials.gov/show/NCT04416100,NA
NCT04424355,ClinicalTrials.gov,2020-06-05,2020-05-19,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,115,https://clinicaltrials.gov/show/NCT04424355,NA
NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,TRUE,Not Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,80,https://clinicaltrials.gov/show/NCT04431856,NA
NCT04432870,ClinicalTrials.gov,2020-06-12,2020-06-09,TRUE,Recruiting,Not Applicable,Observational,United States,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,200,https://clinicaltrials.gov/show/NCT04432870,NA
NCT04433546,ClinicalTrials.gov,2020-05-28,2020-07-15,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",54,https://clinicaltrials.gov/show/NCT04433546,NA
NCT04436484,ClinicalTrials.gov,2020-06-12,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Immune Biomarkers of Outcome From COVID-19,200,https://clinicaltrials.gov/show/NCT04436484,NA
NCT04441710,ClinicalTrials.gov,2020-06-18,2020-10-27,FALSE,Recruiting,Not Applicable,Observational,France,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,2500,https://clinicaltrials.gov/show/NCT04441710,NA
NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,FALSE,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,50,https://clinicaltrials.gov/show/NCT04445194,NA
NCT04445233,ClinicalTrials.gov,2020-06-22,2020-04-29,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Household Transmission Study,315,https://clinicaltrials.gov/show/NCT04445233,NA
NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,FALSE,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04447534,NA
NCT04453384,ClinicalTrials.gov,2020-06-22,2020-09-01,FALSE,Recruiting,Phase 2,Interventional,France,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,414,https://clinicaltrials.gov/show/NCT04453384,NA
NCT04460443,ClinicalTrials.gov,2020-07-04,2020-08-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir in Treatment of COVID 19,60,https://clinicaltrials.gov/show/NCT04460443,NA
NCT04466085,ClinicalTrials.gov,2020-07-08,2020-07-12,FALSE,Not Recruiting,Phase 2,Interventional,China,Clinical Study of Recombinant Novel Coronavirus Vaccine,900,https://clinicaltrials.gov/show/NCT04466085,NA
NCT04466982,ClinicalTrials.gov,2020-07-09,2020-07-02,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,90,https://clinicaltrials.gov/show/NCT04466982,NA
NCT04476745,ClinicalTrials.gov,2020-07-16,2020-10-05,FALSE,Recruiting,Not Applicable,Interventional,Jordan,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,100,https://clinicaltrials.gov/show/NCT04476745,NA
NCT04477213,ClinicalTrials.gov,2020-07-17,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,600,https://clinicaltrials.gov/show/NCT04477213,NA
NCT04483271,ClinicalTrials.gov,2020-07-18,2020-10-02,FALSE,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,100,https://clinicaltrials.gov/show/NCT04483271,NA
NCT04492449,ClinicalTrials.gov,2020-07-20,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",260,https://clinicaltrials.gov/show/NCT04492449,NA
NCT04497649,ClinicalTrials.gov,2020-08-01,2020-07-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,100,https://clinicaltrials.gov/show/NCT04497649,NA
NCT04497948,ClinicalTrials.gov,2020-06-16,2020-09-21,FALSE,Not Recruiting,Phase 1,Interventional,"United States, Brazil",Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,8,https://clinicaltrials.gov/show/NCT04497948,NA
NCT04501432,ClinicalTrials.gov,2020-07-29,2020-07-14,TRUE,Not Recruiting,Not Applicable,Observational,Austria,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,27,https://clinicaltrials.gov/show/NCT04501432,NA
NCT04519437,ClinicalTrials.gov,2020-07-24,2020-07-26,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",974,https://clinicaltrials.gov/show/NCT04519437,NA
NCT04521088,ClinicalTrials.gov,2020-07-02,2020-07-02,FALSE,Recruiting,Not Applicable,Observational,Germany,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,1000,https://clinicaltrials.gov/show/NCT04521088,NA
NCT04524715,ClinicalTrials.gov,2020-08-19,2021-03-31,FALSE,Not Recruiting,Not Applicable,Interventional,United States,LLLT Treatment of Lung Inflammation in COVID-19,64,https://clinicaltrials.gov/show/NCT04524715,NA
NCT04527081,ClinicalTrials.gov,2020-08-24,2020-08-31,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0302-COVID19),30,https://clinicaltrials.gov/show/NCT04527081,NA
NCT04530136,ClinicalTrials.gov,2020-08-26,2020-11-30,FALSE,Recruiting,Phase 2,Interventional,United States,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,120,https://clinicaltrials.gov/show/NCT04530136,NA
NCT04530500,ClinicalTrials.gov,2020-08-26,2020-08-13,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression,200,https://clinicaltrials.gov/show/NCT04530500,NA
NCT04537975,ClinicalTrials.gov,2020-08-25,2020-09-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,0,https://clinicaltrials.gov/show/NCT04537975,NA
NCT04542226,ClinicalTrials.gov,2020-09-08,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,"Russian Federation, Belarus",Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,81,https://clinicaltrials.gov/show/NCT04542226,NA
NCT04552366,ClinicalTrials.gov,2020-09-15,2020-09-29,FALSE,Not Recruiting,Phase 1,Interventional,China,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,149,https://clinicaltrials.gov/show/NCT04552366,NA
NCT04552379,ClinicalTrials.gov,2020-08-21,2020-12-01,FALSE,Recruiting,Phase 3,Interventional,Chile,The Containing Coronavirus Disease 19 (COVID-19) Trial,1240,https://clinicaltrials.gov/show/NCT04552379,NA
NCT04553055,ClinicalTrials.gov,2020-09-15,2020-07-20,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Antibiotic Misuse During COVID-19 Pandemic,413,https://clinicaltrials.gov/show/NCT04553055,NA
NCT04556149,ClinicalTrials.gov,2020-05-23,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,United States,"imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope",30,https://clinicaltrials.gov/show/NCT04556149,NA
NCT04558372,ClinicalTrials.gov,2020-09-20,2020-04-01,TRUE,Recruiting,Not Applicable,Interventional,Indonesia,Genosvid Diagnostic Test for Early Detection of COVID-19,1543,https://clinicaltrials.gov/show/NCT04558372,NA
NCT04559113,ClinicalTrials.gov,2020-09-15,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Methylprednisolone in COVID-19 Patients (Methyl19LGH),200,https://clinicaltrials.gov/show/NCT04559113,NA
NCT04560205,ClinicalTrials.gov,2020-07-11,2020-05-01,TRUE,Recruiting,Phase 1,Interventional,Pakistan,Tocilizumab in COVID-19 Lahore General Hospital,50,https://clinicaltrials.gov/show/NCT04560205,NA
NCT04560257,ClinicalTrials.gov,2020-07-13,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,High Flow Nasal Cannula HFNC In Covid-19 Patients,30,https://clinicaltrials.gov/show/NCT04560257,NA
NCT04560608,ClinicalTrials.gov,2020-09-08,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,France,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",255,https://clinicaltrials.gov/show/NCT04560608,NA
NCT04564716,ClinicalTrials.gov,2020-09-24,2020-09-28,FALSE,Not Recruiting,Phase 3,Interventional,Belarus,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",100,https://clinicaltrials.gov/show/NCT04564716,NA
NCT04565197,ClinicalTrials.gov,2020-09-24,2020-05-01,TRUE,Not Recruiting,Phase 1,Interventional,Pakistan,Convalescent Plasma Therapy for COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04565197,NA
NCT04570189,ClinicalTrials.gov,2020-09-17,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,Canada,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",40,https://clinicaltrials.gov/show/NCT04570189,NA
NCT04583189,ClinicalTrials.gov,2020-10-01,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,500,https://clinicaltrials.gov/show/NCT04583189,NA
NCT04583982,ClinicalTrials.gov,2020-10-07,2020-10-09,FALSE,Recruiting,Not Applicable,Observational,United States,ImmuneSenseâ„¢ COVID-19 Study,125,https://clinicaltrials.gov/show/NCT04583982,NA
NCT04584658,ClinicalTrials.gov,2020-10-10,2020-09-15,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),36,https://clinicaltrials.gov/show/NCT04584658,NA
NCT04601077,ClinicalTrials.gov,2020-10-21,2020-11-01,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,100,https://clinicaltrials.gov/show/NCT04601077,NA
NCT04602507,ClinicalTrials.gov,2020-10-22,2020-12-07,FALSE,Recruiting,Phase 2,Interventional,Colombia,Ivermectin in Adults With Severe COVID-19.,100,https://clinicaltrials.gov/show/NCT04602507,NA
NCT04603690,ClinicalTrials.gov,2020-10-24,2020-12-15,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04603690,NA
NCT04605965,ClinicalTrials.gov,2020-08-12,2020-06-09,TRUE,Recruiting,Not Applicable,Observational,United States,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,100,https://clinicaltrials.gov/show/NCT04605965,NA
NCT04606407,ClinicalTrials.gov,2020-10-22,2020-11-25,FALSE,Recruiting,Not Applicable,Interventional,Israel,Inhaled NO for the Treatment of Viral Pneumonia in Adults,90,https://clinicaltrials.gov/show/NCT04606407,NA
NCT04608201,ClinicalTrials.gov,2020-10-23,2020-12-09,FALSE,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,220,https://clinicaltrials.gov/show/NCT04608201,NA
NCT04609969,ClinicalTrials.gov,2020-10-28,2020-10-13,TRUE,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,200,https://clinicaltrials.gov/show/NCT04609969,NA
NCT04613245,ClinicalTrials.gov,2020-10-29,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,400,https://clinicaltrials.gov/show/NCT04613245,NA
NCT04628208,ClinicalTrials.gov,2020-11-12,2020-11-17,FALSE,Recruiting,Not Applicable,Observational,Canada,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),60,https://clinicaltrials.gov/show/NCT04628208,NA
NCT04634318,ClinicalTrials.gov,2020-11-17,2020-12-10,FALSE,Recruiting,Not Applicable,Interventional,France,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),118,https://clinicaltrials.gov/show/NCT04634318,NA
NCT04638673,ClinicalTrials.gov,2020-11-18,2020-11-19,FALSE,Recruiting,Phase 2,Interventional,United States,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,30,https://clinicaltrials.gov/show/NCT04638673,NA
NCT04641858,ClinicalTrials.gov,2020-11-22,2020-12-03,FALSE,Recruiting,Phase 4,Interventional,"Mozambique, Guinea-Bissau, Cape Verde",BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,1050,https://clinicaltrials.gov/show/NCT04641858,NA
NCT04646616,ClinicalTrials.gov,2020-11-25,2021-01-06,FALSE,Not Recruiting,Not Applicable,Interventional,United States,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,800,https://clinicaltrials.gov/show/NCT04646616,NA
NCT04647695,ClinicalTrials.gov,2020-11-27,2020-11-20,TRUE,Recruiting,Phase 2,Interventional,Hong Kong,IFN-beta 1b and Remdesivir for COVID19,100,https://clinicaltrials.gov/show/NCT04647695,NA
NCT04647994,ClinicalTrials.gov,2020-11-23,2020-09-21,TRUE,Recruiting,Not Applicable,Observational,Brazil,Exploratory Study: COVID-19 and Pregnancy,500,https://clinicaltrials.gov/show/NCT04647994,NA
NCT04648800,ClinicalTrials.gov,2020-10-18,2020-07-07,TRUE,Recruiting,Phase 3,Interventional,Poland,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,1000,https://clinicaltrials.gov/show/NCT04648800,NA
NCT04649320,ClinicalTrials.gov,2020-11-30,2020-11-23,TRUE,Recruiting,Not Applicable,Observational,Austria,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,300,https://clinicaltrials.gov/show/NCT04649320,NA
NCT04649333,ClinicalTrials.gov,2020-11-30,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,Austria,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,1336,https://clinicaltrials.gov/show/NCT04649333,NA
NCT04649515,ClinicalTrials.gov,2020-11-26,2020-12-04,FALSE,Recruiting,Phase 3,Interventional,Singapore,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",1305,https://clinicaltrials.gov/show/NCT04649515,NA
NCT04649658,ClinicalTrials.gov,2020-11-30,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,93,https://clinicaltrials.gov/show/NCT04649658,NA
NCT04649827,ClinicalTrials.gov,2020-11-26,2020-04-02,TRUE,Recruiting,Not Applicable,Observational,Brazil,A Clinical Trial for Hospitalized Patients With COVID-19 in CearÃ¡: ResCOVID Study,3000,https://clinicaltrials.gov/show/NCT04649827,NA
NCT04649840,ClinicalTrials.gov,2020-12-01,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Belarus,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04649840,NA
NCT04649879,ClinicalTrials.gov,2020-12-01,2020-12-03,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,920,https://clinicaltrials.gov/show/NCT04649879,NA
NCT04649944,ClinicalTrials.gov,2020-11-26,2020-12-05,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,40,https://clinicaltrials.gov/show/NCT04649944,NA
NCT04649957,ClinicalTrials.gov,2020-12-01,2021-01-04,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Profiling Recovery of Those Discharged Into the Community With COVID-19,100,https://clinicaltrials.gov/show/NCT04649957,NA
NCT04649996,ClinicalTrials.gov,2020-12-01,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,532,https://clinicaltrials.gov/show/NCT04649996,NA
NCT04650035,ClinicalTrials.gov,2020-12-01,2020-11-01,TRUE,Not Recruiting,Not Applicable,Observational,Jordan,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,60,https://clinicaltrials.gov/show/NCT04650035,NA
NCT04650178,ClinicalTrials.gov,2020-08-19,2020-05-26,TRUE,Recruiting,Not Applicable,Observational,United States,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,274,https://clinicaltrials.gov/show/NCT04650178,NA
NCT04650191,ClinicalTrials.gov,2020-11-30,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,United States,Surfactant Protein Genetic Variants in COVID-19 Infection,300,https://clinicaltrials.gov/show/NCT04650191,NA
NCT04651374,ClinicalTrials.gov,2020-11-27,2020-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 And Geko Evaluation: The CAGE Study,40,https://clinicaltrials.gov/show/NCT04651374,NA
NCT04651413,ClinicalTrials.gov,2020-12-02,2020-11-24,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,PCR Cycle Threshold Values and COVID-19 Outcomes,800,https://clinicaltrials.gov/show/NCT04651413,NA
NCT04652115,ClinicalTrials.gov,2020-12-01,2021-01-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,42,https://clinicaltrials.gov/show/NCT04652115,NA
NCT04652505,ClinicalTrials.gov,2020-09-11,2020-07-13,TRUE,Recruiting,Not Applicable,Observational,United States,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",700,https://clinicaltrials.gov/show/NCT04652505,NA
NCT04652648,ClinicalTrials.gov,2020-12-02,2020-05-27,TRUE,Not Recruiting,Phase 4,Interventional,United States,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,54,https://clinicaltrials.gov/show/NCT04652648,NA
NCT04653831,ClinicalTrials.gov,2020-10-27,2020-11-08,FALSE,Recruiting,Not Applicable,Interventional,Israel,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,100,https://clinicaltrials.gov/show/NCT04653831,NA
NCT04653857,ClinicalTrials.gov,2020-12-03,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,250,https://clinicaltrials.gov/show/NCT04653857,NA
NCT04654325,ClinicalTrials.gov,2020-11-30,2020-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,1280,https://clinicaltrials.gov/show/NCT04654325,NA
NCT04654416,ClinicalTrials.gov,2020-12-02,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Colombia,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,301,https://clinicaltrials.gov/show/NCT04654416,NA
NCT04654481,ClinicalTrials.gov,2020-12-03,2020-12-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04654481,NA
NCT04655521,ClinicalTrials.gov,2020-12-02,2020-12-02,FALSE,Recruiting,Not Applicable,Observational,Germany,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,300,https://clinicaltrials.gov/show/NCT04655521,NA
NCT04655612,ClinicalTrials.gov,2020-12-03,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,France,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,5000,https://clinicaltrials.gov/show/NCT04655612,NA
NCT04655716,ClinicalTrials.gov,2020-12-04,2021-02-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Urine Alkalinisation to Prevent AKI in COVID-19,80,https://clinicaltrials.gov/show/NCT04655716,NA
NCT04656613,ClinicalTrials.gov,2020-11-30,2020-12-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,1000,https://clinicaltrials.gov/show/NCT04656613,NA
NCT04656626,ClinicalTrials.gov,2020-12-04,2020-07-07,TRUE,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,146,https://clinicaltrials.gov/show/NCT04656626,NA
NCT04657263,ClinicalTrials.gov,2020-12-07,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on Vaccination,500,https://clinicaltrials.gov/show/NCT04657263,NA
NCT04657406,ClinicalTrials.gov,2020-12-03,2019-06-01,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04657406,NA
NCT04657445,ClinicalTrials.gov,2020-12-06,2020-11-17,TRUE,Recruiting,Not Applicable,Observational,Greece,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",100,https://clinicaltrials.gov/show/NCT04657445,NA
NCT04657458,ClinicalTrials.gov,2020-12-07,2020-11-17,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,Not Available,https://clinicaltrials.gov/show/NCT04657458,NA
NCT04657510,ClinicalTrials.gov,2020-11-14,2020-11-14,FALSE,Recruiting,Not Applicable,Observational,Italy,Femoral frACturEs and COVID-19.,140,https://clinicaltrials.gov/show/NCT04657510,NA
NCT04658433,ClinicalTrials.gov,2020-12-05,2020-12-05,FALSE,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,100,https://clinicaltrials.gov/show/NCT04658433,NA
NCT04658979,ClinicalTrials.gov,2020-12-02,2020-12-01,TRUE,Recruiting,Not Applicable,Interventional,Canada,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,30,https://clinicaltrials.gov/show/NCT04658979,NA
NCT04659122,ClinicalTrials.gov,2020-12-04,2021-01-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,9,https://clinicaltrials.gov/show/NCT04659122,NA
NCT04659135,ClinicalTrials.gov,2020-11-30,2020-04-19,TRUE,Recruiting,Not Applicable,Observational,United States,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,2000,https://clinicaltrials.gov/show/NCT04659135,NA
NCT04659187,ClinicalTrials.gov,2020-12-08,2020-03-26,TRUE,Recruiting,Not Applicable,Observational,Germany,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - A Registry From Germany,4000,https://clinicaltrials.gov/show/NCT04659187,NA
NCT04659460,ClinicalTrials.gov,2020-07-03,2020-12-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,30,https://clinicaltrials.gov/show/NCT04659460,NA
NCT04659473,ClinicalTrials.gov,2020-12-08,2020-12-09,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Spanish Survey on Third Wave of COVID-19,1000,https://clinicaltrials.gov/show/NCT04659473,NA
NCT04659486,ClinicalTrials.gov,2020-12-01,2020-09-24,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Adolescents With COVID-19/MIS-C at HCFMUSP,100,https://clinicaltrials.gov/show/NCT04659486,NA
NCT04659746,ClinicalTrials.gov,2020-12-07,2020-12-09,FALSE,Not Recruiting,Not Applicable,Interventional,Paraguay,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,96,https://clinicaltrials.gov/show/NCT04659746,NA
NCT04659876,ClinicalTrials.gov,2020-12-08,2020-03-22,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,445,https://clinicaltrials.gov/show/NCT04659876,NA
NCT04659889,ClinicalTrials.gov,2020-12-07,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Clinical and Haematological Phenotypes in Long COVID,100,https://clinicaltrials.gov/show/NCT04659889,NA
NCT04659941,ClinicalTrials.gov,2020-12-08,2020-10-01,TRUE,Recruiting,Phase 2,Interventional,Brazil,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,1000,https://clinicaltrials.gov/show/NCT04659941,NA
NCT04661423,ClinicalTrials.gov,2020-12-07,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Use of RDS MultiSenseÂ® in Post-ICU Patients in the COVID-19 Era,60,https://clinicaltrials.gov/show/NCT04661423,NA
NCT04661462,ClinicalTrials.gov,2020-09-29,2020-09-30,FALSE,Recruiting,Not Applicable,Observational,Austria,Health After Covid-19 in Tyrol,1000,https://clinicaltrials.gov/show/NCT04661462,NA
NCT04661527,ClinicalTrials.gov,2020-09-10,2020-04-22,TRUE,Recruiting,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,60,https://clinicaltrials.gov/show/NCT04661527,NA
NCT04661631,ClinicalTrials.gov,2020-12-07,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,Colombia,Surgery and Lung Ultrasound in SARS-CoV-2 Infection,451,https://clinicaltrials.gov/show/NCT04661631,NA
NCT04661930,ClinicalTrials.gov,2020-12-09,2020-12-13,FALSE,Recruiting,Phase 3,Interventional,Israel,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,50,https://clinicaltrials.gov/show/NCT04661930,NA
NCT04662437,ClinicalTrials.gov,2020-12-08,2020-09-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,150,https://clinicaltrials.gov/show/NCT04662437,NA
NCT04662684,ClinicalTrials.gov,2020-12-08,2020-10-16,TRUE,Recruiting,Phase 3,Interventional,Brazil,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,320,https://clinicaltrials.gov/show/NCT04662684,NA
NCT04662697,ClinicalTrials.gov,2020-12-09,2020-12-11,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults (USA),918,https://clinicaltrials.gov/show/NCT04662697,NA
NCT04663659,ClinicalTrials.gov,2020-12-10,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04663659,NA
NCT04663776,ClinicalTrials.gov,2020-12-05,2020-11-04,TRUE,Recruiting,Not Applicable,Observational,United States,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,100000,https://clinicaltrials.gov/show/NCT04663776,NA
NCT04663906,ClinicalTrials.gov,2020-12-10,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Oral Isotretinoin and Covid-19 Infection,300,https://clinicaltrials.gov/show/NCT04663906,NA
NCT04664010,ClinicalTrials.gov,2020-12-07,2020-02-06,TRUE,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),60,https://clinicaltrials.gov/show/NCT04664010,NA
NCT04664023,ClinicalTrials.gov,2020-12-03,2020-12-09,FALSE,Recruiting,Not Applicable,Observational,France,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",120,https://clinicaltrials.gov/show/NCT04664023,NA
NCT04665258,ClinicalTrials.gov,2020-12-10,2020-12-14,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Vaccine and Impact on Fertility Study,60,https://clinicaltrials.gov/show/NCT04665258,NA
NCT04665778,ClinicalTrials.gov,2020-12-07,2020-12-04,TRUE,Recruiting,Not Applicable,Observational,France,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,1516,https://clinicaltrials.gov/show/NCT04665778,NA
NCT04666025,ClinicalTrials.gov,2020-12-10,2020-09-23,TRUE,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 Donor-Recipient Immunity Transfer,36,https://clinicaltrials.gov/show/NCT04666025,NA
NCT04666064,ClinicalTrials.gov,2020-12-11,2020-12-10,TRUE,Recruiting,Not Applicable,Observational,France,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,100,https://clinicaltrials.gov/show/NCT04666064,NA
NCT04666116,ClinicalTrials.gov,2020-04-25,2020-04-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Changes in Viral Load in COVID-19 After Probiotics,96,https://clinicaltrials.gov/show/NCT04666116,NA
NCT04666207,ClinicalTrials.gov,2020-11-08,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,Denmark,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",20,https://clinicaltrials.gov/show/NCT04666207,NA
NCT04666246,ClinicalTrials.gov,2020-12-11,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Inspiratory Effort in COVID-19,40,https://clinicaltrials.gov/show/NCT04666246,NA
NCT04666493,ClinicalTrials.gov,2020-12-11,2020-12-04,TRUE,Recruiting,Not Applicable,Interventional,Canada,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,100,https://clinicaltrials.gov/show/NCT04666493,NA
NCT04666558,ClinicalTrials.gov,2020-11-30,2020-11-30,FALSE,Recruiting,Not Applicable,Interventional,Canada,Heal-Me Personalized Online Nutrition and Exercise Routines,216,https://clinicaltrials.gov/show/NCT04666558,NA
NCT04666753,ClinicalTrials.gov,2020-12-11,2020-07-02,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Retrospective Study of ImmunoFormulation for COVID-19,40,https://clinicaltrials.gov/show/NCT04666753,NA
ISRCTN14037053,ISRCTN,2020-12-31,2020-07-12,TRUE,Recruiting,Phase 1,Interventional,Indonesia,Dendritic cell vaccine to prevent COVID-19,27,http://isrctn.com/ISRCTN14037053,NA
ISRCTN27707558,ISRCTN,2020-12-30,2020-01-02,TRUE,Recruiting,Not Applicable,Observational,Italy,"An investigation of malnutrition, obesity, diabetes, high blood pressure and severe COVID-19 in Italy",2000,http://isrctn.com/ISRCTN27707558,NA
ChiCTR2000040044,ChiCTR,2020-11-19,2020-11-20,FALSE,Not Recruiting,Phase 2,Interventional,China,A Phase II clinical trial of novel coronavirus pneumonia (COVID-19)  mRNA Vaccine (BNT162b2) in China,960,http://www.chictr.org.cn/showproj.aspx?proj=64544,NA
ChiCTR2000039002,ChiCTR,2020-10-13,2021-01-01,FALSE,Recruiting,Not Applicable,Interventional,China,Psychological responses of medical staff during COVID-19 and the adjustment effect of brief mindfulness meditation,400,http://www.chictr.org.cn/showproj.aspx?proj=62120,NA
ChiCTR2000039000,ChiCTR,2020-10-13,2020-09-02,TRUE,Recruiting,Phase 3,Interventional,Morocco,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),600,http://www.chictr.org.cn/showproj.aspx?proj=62581,NA
EUCTR2020-001370-30,EudraCT,2020-04-16,2020-12-05,FALSE,Not Recruiting,Phase 3,Interventional,"Hungary, United Kingdom, United States, Italy, Spain, France, Germany",Study of efficacy and safety of canakinumab treatment for CRS in participants with COVID-19-induced pneumonia.,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001370-30,FR
EUCTR2020-002259-39,EudraCT,2020-08-26,2020-09-28,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Ukraine, United States, Italy, Spain, Brazil, France, Germany, Philippines","This global, multicenter, Phase 1/2, randomized, double-blind, placebo-controlled study will evaluate the efficacy and safety of adding TL-895 treatment to standard available therapy (SAT) in subjects with cancer hospitalized for COVID-19.",146,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002259-39,HU
EUCTR2020-002234-32,EudraCT,2021-01-04,2020-12-28,TRUE,Authorised,Phase 3,Interventional,"Spain, Switzerland, Italy, Belgium",Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19),420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002234-32,IT
EUCTR2020-001857-31,EudraCT,2020-07-21,2020-09-11,FALSE,Authorised,Phase 2,Interventional,"Germany, Bulgaria, Israel",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31,DE
EUCTR2020-001513-20,EudraCT,2020-06-24,2020-06-05,TRUE,Authorised,Phase 2,Interventional,Italy,"Use of Defibrotide to reduce progression of acute respiratory failure rate in
patients with COVID-19 pneumonia",50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001513-20,IT
EUCTR2020-001795-15,EudraCT,2020-06-26,2020-07-05,FALSE,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15,IT
EUCTR2020-001987-28,EudraCT,2020-06-24,2020-06-05,TRUE,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28,IT
EUCTR2020-002458-25,EudraCT,2020-08-10,2020-06-23,TRUE,Authorised,Phase 2,Interventional,Italy,"Clinical study for the treatment with Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 patients: randomized, controlled, open label",126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002458-25,IT
EUCTR2020-001390-76,EudraCT,2020-06-24,2020-04-27,TRUE,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76,IT
EUCTR2020-001528-32,EudraCT,2020-06-24,2020-05-14,TRUE,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32,IT
EUCTR2020-002119-23,EudraCT,2020-09-22,2020-11-16,FALSE,Authorised,Phase 2,Interventional,Italy,prevention of complications from COVID-19 in cancer patients under active treatment,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002119-23,IT
EUCTR2020-001501-24,EudraCT,2020-06-24,2020-04-28,TRUE,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24,IT
EUCTR2020-002283-32,EudraCT,2020-08-10,2020-12-06,FALSE,Authorised,Phase 2,Interventional,"Spain, Italy","Randomized, Double-blind, Multi Centre Phase II, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19",122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002283-32,IT
EUCTR2020-001854-23,EudraCT,2020-06-26,2020-04-27,TRUE,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23,IT
EUCTR2020-001441-39,EudraCT,2020-06-24,2020-08-05,FALSE,Authorised,Phase 3,Interventional,"Malawi, Indonesia, United Kingdom, Vietnam, Thailand, Italy, Uganda, Lao People's Democratic Republic, Kenya","Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)",40000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001441-39,IT
EUCTR2020-003872-42,EudraCT,2020-11-23,2020-06-11,TRUE,Authorised,Phase 2,Interventional,Italy,Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003872-42,IT
NCT03188796,ClinicalTrials.gov,2017-06-13,2017-10-10,FALSE,Recruiting,Phase 3,Interventional,"Belgium, Austria",The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients,2400,https://clinicaltrials.gov/show/NCT03188796,NA
NCT04334252,ClinicalTrials.gov,2020-04-02,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,528,https://clinicaltrials.gov/show/NCT04334252,NA
NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,FALSE,Not Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,102,https://clinicaltrials.gov/show/NCT04339712,NA
NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,FALSE,Not Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",152,https://clinicaltrials.gov/show/NCT04342663,NA
NCT04345159,ClinicalTrials.gov,2020-04-10,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,France,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,572,https://clinicaltrials.gov/show/NCT04345159,NA
NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,FALSE,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,2000,https://clinicaltrials.gov/show/NCT04352348,NA
NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,131,https://clinicaltrials.gov/show/NCT04354831,NA
NCT04366115,ClinicalTrials.gov,2020-04-26,2021-01-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,16,https://clinicaltrials.gov/show/NCT04366115,NA
NCT04373096,ClinicalTrials.gov,2020-04-30,2020-12-07,FALSE,Recruiting,Not Applicable,Interventional,Canada,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,42,https://clinicaltrials.gov/show/NCT04373096,NA
NCT04373486,ClinicalTrials.gov,2020-04-30,2020-03-03,TRUE,Not Recruiting,Not Applicable,Observational,France,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,160,https://clinicaltrials.gov/show/NCT04373486,NA
NCT04379661,ClinicalTrials.gov,2020-05-05,2020-05-07,FALSE,Not Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,32,https://clinicaltrials.gov/show/NCT04379661,NA
NCT04385238,ClinicalTrials.gov,2020-05-10,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,United States,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,6894,https://clinicaltrials.gov/show/NCT04385238,NA
NCT04394429,ClinicalTrials.gov,2020-05-18,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,France,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,184,https://clinicaltrials.gov/show/NCT04394429,NA
NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,TRUE,Not Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,90,https://clinicaltrials.gov/show/NCT04398004,NA
NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,The COVID-19 Pandemic and Exercise Study,334,https://clinicaltrials.gov/show/NCT04400279,NA
NCT04406688,ClinicalTrials.gov,2020-05-18,2020-06-22,FALSE,Recruiting,Not Applicable,Observational,"Spain, Germany, Portugal, United Kingdom",Prediction of Acute Kidney Injury in Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04406688,NA
NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,TRUE,Not Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,60,https://clinicaltrials.gov/show/NCT04407182,NA
NCT04412473,ClinicalTrials.gov,2020-05-27,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,1000,https://clinicaltrials.gov/show/NCT04412473,NA
NCT04426279,ClinicalTrials.gov,2020-06-09,2020-08-18,FALSE,Recruiting,Not Applicable,Observational,France,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,1500,https://clinicaltrials.gov/show/NCT04426279,NA
NCT04435275,ClinicalTrials.gov,2020-06-09,2021-01-02,FALSE,Recruiting,Not Applicable,Interventional,Canada,Virtual Assistant for COVID-19 PPE,50,https://clinicaltrials.gov/show/NCT04435275,NA
NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-13,FALSE,Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04435587,NA
NCT04437342,ClinicalTrials.gov,2020-06-15,2020-06-30,FALSE,Not Recruiting,Not Applicable,Observational,Greece,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,330,https://clinicaltrials.gov/show/NCT04437342,NA
NCT04438967,ClinicalTrials.gov,2020-06-15,2020-06-16,FALSE,Recruiting,Not Applicable,Observational,United States,Brain Health in the Time of COVID-19,10000,https://clinicaltrials.gov/show/NCT04438967,NA
NCT04454398,ClinicalTrials.gov,2020-06-30,2020-09-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,0,https://clinicaltrials.gov/show/NCT04454398,NA
NCT04459364,ClinicalTrials.gov,2020-07-03,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,67,https://clinicaltrials.gov/show/NCT04459364,NA
NCT04469634,ClinicalTrials.gov,2020-07-13,2020-07-31,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,150,https://clinicaltrials.gov/show/NCT04469634,NA
NCT04470544,ClinicalTrials.gov,2020-07-09,2020-07-28,FALSE,Recruiting,Phase 2,Interventional,United States,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,264,https://clinicaltrials.gov/show/NCT04470544,NA
NCT04472013,ClinicalTrials.gov,2020-07-14,2020-08-12,FALSE,Recruiting,Not Applicable,Observational,Switzerland,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",40,https://clinicaltrials.gov/show/NCT04472013,NA
NCT04473261,ClinicalTrials.gov,2020-07-14,2020-07-14,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Iodine Complex Against COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04473261,NA
NCT04527562,ClinicalTrials.gov,2020-08-25,2020-07-14,TRUE,Not Recruiting,Not Applicable,Interventional,Bangladesh,Colchicine in Moderate Symptomatic COVID-19 Patients,299,https://clinicaltrials.gov/show/NCT04527562,NA
NCT04547257,ClinicalTrials.gov,2020-04-29,2021-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,42,https://clinicaltrials.gov/show/NCT04547257,NA
NCT04550325,ClinicalTrials.gov,2020-09-10,2020-08-05,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",12,https://clinicaltrials.gov/show/NCT04550325,NA
NCT04574219,ClinicalTrials.gov,2020-09-24,2020-11-03,FALSE,Recruiting,Not Applicable,Interventional,"Canada, United States",Virtual Parental Presence on Induction,184,https://clinicaltrials.gov/show/NCT04574219,NA
NCT04583761,ClinicalTrials.gov,2020-10-05,2020-10-12,FALSE,Not Recruiting,Not Applicable,Observational,France,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),700,https://clinicaltrials.gov/show/NCT04583761,NA
NCT04590170,ClinicalTrials.gov,2020-10-05,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,France,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,100,https://clinicaltrials.gov/show/NCT04590170,NA
NCT04603105,ClinicalTrials.gov,2020-10-09,2021-02-28,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,CCP Cancer UK Companion Study,9000,https://clinicaltrials.gov/show/NCT04603105,NA
NCT04604678,ClinicalTrials.gov,2020-10-26,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04604678,NA
NCT04639466,ClinicalTrials.gov,2020-11-04,2020-12-11,FALSE,Recruiting,Phase 1,Interventional,United States,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",129,https://clinicaltrials.gov/show/NCT04639466,NA
NCT04662021,ClinicalTrials.gov,2020-12-04,2020-12-10,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,40,https://clinicaltrials.gov/show/NCT04662021,NA
NCT04664075,ClinicalTrials.gov,2020-12-01,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),100,https://clinicaltrials.gov/show/NCT04664075,NA
NCT04672590,ClinicalTrials.gov,2020-12-09,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Neurological Disease: A Prospective Study,681,https://clinicaltrials.gov/show/NCT04672590,NA
NCT04676971,ClinicalTrials.gov,2020-12-16,2020-12-11,TRUE,Recruiting,Phase 2,Interventional,"Russian Federation, Italy",Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,105,https://clinicaltrials.gov/show/NCT04676971,NA
NCT04679415,ClinicalTrials.gov,2020-12-21,2020-12-17,TRUE,Recruiting,Phase 2,Interventional,Indonesia,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,63,https://clinicaltrials.gov/show/NCT04679415,NA
NCT04681001,ClinicalTrials.gov,2020-12-21,2020-12-20,TRUE,Recruiting,Not Applicable,Interventional,Austria,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers",300,https://clinicaltrials.gov/show/NCT04681001,NA
NCT04694482,ClinicalTrials.gov,2020-12-30,2020-11-12,TRUE,Recruiting,Not Applicable,Observational,Italy,The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology,200,https://clinicaltrials.gov/show/NCT04694482,NA
NCT04695457,ClinicalTrials.gov,2020-12-08,2020-07-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,74,https://clinicaltrials.gov/show/NCT04695457,NA
NCT04695678,ClinicalTrials.gov,2020-12-11,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Epidemiological Multicohort Study of Latent COVID-19 Infections,4000,https://clinicaltrials.gov/show/NCT04695678,NA
NCT04695743,ClinicalTrials.gov,2020-12-11,2020-09-01,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Group CST Using Zoom: A Proof of Concept Study,50,https://clinicaltrials.gov/show/NCT04695743,NA
NCT04695756,ClinicalTrials.gov,2021-01-04,2020-12-15,TRUE,Recruiting,Not Applicable,Observational,Argentina,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),1000,https://clinicaltrials.gov/show/NCT04695756,NA
NCT04695821,ClinicalTrials.gov,2021-01-01,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,10,https://clinicaltrials.gov/show/NCT04695821,NA
NCT04696562,ClinicalTrials.gov,2020-12-30,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",44,https://clinicaltrials.gov/show/NCT04696562,NA
NCT04696601,ClinicalTrials.gov,2020-12-23,2021-01-10,FALSE,Not Recruiting,Not Applicable,Interventional,France,Rapid Screening for Olfactory Disorders in Covid-19 Infection,2000,https://clinicaltrials.gov/show/NCT04696601,NA
NCT04696913,ClinicalTrials.gov,2020-11-19,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?,347,https://clinicaltrials.gov/show/NCT04696913,NA
NCT04697030,ClinicalTrials.gov,2020-12-31,2020-09-15,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan,443,https://clinicaltrials.gov/show/NCT04697030,NA
NCT04697927,ClinicalTrials.gov,2021-01-04,2020-12-30,TRUE,Recruiting,Not Applicable,Observational,United States,A Study of Risk Factors for the COVID-19 Virus Infection,10000,https://clinicaltrials.gov/show/NCT04697927,NA
NCT04698044,ClinicalTrials.gov,2021-01-05,2020-05-08,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period,1107,https://clinicaltrials.gov/show/NCT04698044,NA
NCT04698083,ClinicalTrials.gov,2021-01-04,2020-07-22,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Electrocardiographic QRS Axis Shift ,Rotation and COVID-19",160,https://clinicaltrials.gov/show/NCT04698083,NA
NCT04699097,ClinicalTrials.gov,2020-12-31,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children,105,https://clinicaltrials.gov/show/NCT04699097,NA
NCT04699227,ClinicalTrials.gov,2021-01-06,2020-04-23,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Can RIC Prevent Deterioration to Critical Care in Covid19,20,https://clinicaltrials.gov/show/NCT04699227,NA
NCT04699578,ClinicalTrials.gov,2021-01-01,2020-12-28,TRUE,Recruiting,Not Applicable,Observational,Italy,COVID-19 Infection and Fetal-neonatal Outcomes,230,https://clinicaltrials.gov/show/NCT04699578,NA
NCT04699851,ClinicalTrials.gov,2020-11-25,2020-11-18,TRUE,Recruiting,Not Applicable,Interventional,Canada,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,1200,https://clinicaltrials.gov/show/NCT04699851,NA
NCT04701515,ClinicalTrials.gov,2020-09-22,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,500,https://clinicaltrials.gov/show/NCT04701515,NA
NCT04701528,ClinicalTrials.gov,2020-10-27,2020-11-15,FALSE,Recruiting,Phase 2,Interventional,Netherlands,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,20,https://clinicaltrials.gov/show/NCT04701528,NA
NCT04701905,ClinicalTrials.gov,2021-01-07,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,France,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,450,https://clinicaltrials.gov/show/NCT04701905,NA
NCT04701944,ClinicalTrials.gov,2021-01-07,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,France,Clinical Study of Pregnant Women With COVID-19,54,https://clinicaltrials.gov/show/NCT04701944,NA
NCT04702295,ClinicalTrials.gov,2021-01-05,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE),250,https://clinicaltrials.gov/show/NCT04702295,NA
NCT04702945,ClinicalTrials.gov,2021-01-06,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Canada,Canadian COVID-19 Emergency Department Registry,200000,https://clinicaltrials.gov/show/NCT04702945,NA
NCT04703270,ClinicalTrials.gov,2021-01-07,2021-01-04,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Understanding COVID-19 Infection in Pregnant Women and Their Babies,1200,https://clinicaltrials.gov/show/NCT04703270,NA
NCT04703478,ClinicalTrials.gov,2021-01-04,2021-01-20,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,20,https://clinicaltrials.gov/show/NCT04703478,NA
NCT04703777,ClinicalTrials.gov,2021-01-08,2020-04-04,TRUE,Recruiting,Not Applicable,Observational,France,Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic,500,https://clinicaltrials.gov/show/NCT04703777,NA
NCT04703907,ClinicalTrials.gov,2021-01-08,2020-12-03,TRUE,Recruiting,Not Applicable,Interventional,Germany,Auricular Stimulation for Relief of Stress and Anxiety,60,https://clinicaltrials.gov/show/NCT04703907,NA
NCT04705831,ClinicalTrials.gov,2021-01-07,2020-12-30,TRUE,Recruiting,Phase 4,Interventional,United States,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04705831,NA
NCT04706260,ClinicalTrials.gov,2021-01-08,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,France,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals,600,https://clinicaltrials.gov/show/NCT04706260,NA
ACTRN12621000016831,ANZCTR,2021-01-13,2022-12-15,FALSE,Not Recruiting,Phase 2,Interventional,Australia,Effect of Tasquinimod on COVID-19 patients,125,https://anzctr.org.au/ACTRN12621000016831.aspx,NA
ACTRN12621000013864,ANZCTR,2021-01-12,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,Poland,Incidence of COVID-19 disease and the severity of SARS-CoV-2 infection and relationship with angiotensin II type 1 receptor (ATII-1R) concentration in healthcare professionals.,80,https://anzctr.org.au/ACTRN12621000013864.aspx,NA
ChiCTR2000040179,ChiCTR,2020-11-24,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Characteristics of novel coronavirus pneumonia (COVID-19) patients with mild nucleic acid in hospital for over 30 days,170,http://www.chictr.org.cn/showproj.aspx?proj=64541,NA
ChiCTR2000040153,ChiCTR,2020-11-22,2020-11-30,FALSE,Not Recruiting,Phase 3,Interventional,China,"A randomized, double-blind, placebo-controlled phase III clinical trial of the effectiveness and safety of inoculation of recombinant new coronavirus vaccine (CHO cells) in the prevention of COVID-19 in people 18 years and older",29000,http://www.chictr.org.cn/showproj.aspx?proj=64718,NA
ChiCTR2000039079,ChiCTR,2020-10-16,2020-01-13,TRUE,Recruiting,Not Applicable,Observational,China,Stress and neuropsychiatric symptoms/disorders (i.e. functional brain diseases): COVID-19 as a source of stress,200,http://www.chictr.org.cn/showproj.aspx?proj=62482,NA
ChiCTR2000034780,ChiCTR,2020-07-18,2020-07-16,TRUE,Not Recruiting,Phase 3,Interventional,The Arab Republic of Egypt,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),45000,http://www.chictr.org.cn/showproj.aspx?proj=56651,NA
EUCTR2020-001257-51,EudraCT,2020-03-26,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,DK
EUCTR2020-000982-18,EudraCT,2020-04-20,2020-03-06,TRUE,Not Recruiting,Phase 3,Interventional,"Sweden, Norway",A clinical study to evaluate the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19).,1218,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000982-18,SE
EUCTR2020-001498-63,EudraCT,2020-04-03,2020-07-22,FALSE,Authorised,Phase 2,Interventional,"France, United Kingdom, United States, Belgium","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",310,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,FR
EUCTR2020-001172-15,EudraCT,2020-03-23,2020-03-04,TRUE,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,DK
EUCTR2020-004206-59,EudraCT,2020-09-23,2021-11-01,FALSE,Authorised,Phase 2,Interventional,"South Africa, Belgium, Netherlands, Brazil, Spain, India, Germany, Bulgaria","Clinical trial, conducted at multiple trial sites, to test the safety and effectiveness of ATR-002 in hospitalized patients diagnosed with the lung disease COVID-19.",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004206-59,DE
EUCTR2020-003505-58,EudraCT,2020-11-06,2021-07-01,FALSE,Authorised,Phase 2,Interventional,Italy,Use of Inhaled liposomal -Cyclosporin-A in the treatment of moderate COVID-19-related pneumonia: a two-step phase II clinical trial,31,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003505-58,IT
EUCTR2020-002233-15,EudraCT,2020-05-13,2020-06-17,FALSE,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered in combination and compared to placebo in COVID-19 patients",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15,DE
NCT03963622,ClinicalTrials.gov,2019-05-06,2020-11-23,FALSE,Recruiting,Not Applicable,Interventional,"Spain, Canada, France",Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19),740,https://clinicaltrials.gov/show/NCT03963622,NA
NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),440,https://clinicaltrials.gov/show/NCT04321278,NA
NCT04341688,ClinicalTrials.gov,2020-04-06,2021-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04341688,NA
NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,90,https://clinicaltrials.gov/show/NCT04347538,NA
NCT04347954,ClinicalTrials.gov,2020-04-13,2020-08-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),40,https://clinicaltrials.gov/show/NCT04347954,NA
NCT04350099,ClinicalTrials.gov,2020-04-11,2020-04-15,FALSE,Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,200,https://clinicaltrials.gov/show/NCT04350099,NA
NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,102,https://clinicaltrials.gov/show/NCT04350320,NA
NCT04351139,ClinicalTrials.gov,2020-04-15,2020-05-06,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,205,https://clinicaltrials.gov/show/NCT04351139,NA
NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,0,https://clinicaltrials.gov/show/NCT04351516,NA
NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,FALSE,Recruiting,Phase 4,Interventional,"Spain, Argentina",Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,300,https://clinicaltrials.gov/show/NCT04355637,NA
NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,FALSE,Not Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,71,https://clinicaltrials.gov/show/NCT04364009,NA
NCT04364763,ClinicalTrials.gov,2020-04-20,2020-08-05,FALSE,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),252,https://clinicaltrials.gov/show/NCT04364763,NA
NCT04368897,ClinicalTrials.gov,2020-04-27,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,Spain,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,200,https://clinicaltrials.gov/show/NCT04368897,NA
NCT04374045,ClinicalTrials.gov,2020-04-30,2020-04-30,FALSE,Not Recruiting,Not Applicable,Observational,France,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,50,https://clinicaltrials.gov/show/NCT04374045,NA
NCT04376879,ClinicalTrials.gov,2020-05-04,2020-05-16,FALSE,Recruiting,Not Applicable,Observational,France,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),384,https://clinicaltrials.gov/show/NCT04376879,NA
NCT04377685,ClinicalTrials.gov,2020-05-05,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,France,Prediction of Clinical Course in COVID19 Patients,800,https://clinicaltrials.gov/show/NCT04377685,NA
NCT04377815,ClinicalTrials.gov,2020-04-24,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,569,https://clinicaltrials.gov/show/NCT04377815,NA
NCT04379544,ClinicalTrials.gov,2020-05-04,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,United States,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,125,https://clinicaltrials.gov/show/NCT04379544,NA
NCT04386447,ClinicalTrials.gov,2020-05-12,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,"France, Italy",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,0,https://clinicaltrials.gov/show/NCT04386447,NA
NCT04390152,ClinicalTrials.gov,2020-05-12,2020-01-13,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,40,https://clinicaltrials.gov/show/NCT04390152,NA
NCT04403061,ClinicalTrials.gov,2020-05-23,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,106,https://clinicaltrials.gov/show/NCT04403061,NA
NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,FALSE,Not Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,150,https://clinicaltrials.gov/show/NCT04405908,NA
NCT04406064,ClinicalTrials.gov,2020-05-26,2021-01-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,0,https://clinicaltrials.gov/show/NCT04406064,NA
NCT04406558,ClinicalTrials.gov,2020-05-24,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,France,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,400,https://clinicaltrials.gov/show/NCT04406558,NA
NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,FALSE,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,48,https://clinicaltrials.gov/show/NCT04407689,NA
NCT04420676,ClinicalTrials.gov,2020-06-04,2020-09-24,FALSE,Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,120,https://clinicaltrials.gov/show/NCT04420676,NA
NCT04425252,ClinicalTrials.gov,2020-06-09,2020-08-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,23,https://clinicaltrials.gov/show/NCT04425252,NA
NCT04432779,ClinicalTrials.gov,2020-06-15,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,3000,https://clinicaltrials.gov/show/NCT04432779,NA
NCT04435184,ClinicalTrials.gov,2020-06-16,2020-07-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,50,https://clinicaltrials.gov/show/NCT04435184,NA
NCT04437940,ClinicalTrials.gov,2020-06-17,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,38,https://clinicaltrials.gov/show/NCT04437940,NA
NCT04456452,ClinicalTrials.gov,2020-06-30,2020-07-27,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,10,https://clinicaltrials.gov/show/NCT04456452,NA
NCT04457817,ClinicalTrials.gov,2020-06-24,2020-12-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Compensatory Reserve Index (CRI) for Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04457817,NA
NCT04458363,ClinicalTrials.gov,2020-06-25,2020-07-04,FALSE,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in Pediatric COVID-19,3,https://clinicaltrials.gov/show/NCT04458363,NA
NCT04460014,ClinicalTrials.gov,2020-07-06,2020-09-30,FALSE,Recruiting,Not Applicable,Interventional,Sweden,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,164,https://clinicaltrials.gov/show/NCT04460014,NA
NCT04460183,ClinicalTrials.gov,2020-07-03,2020-07-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,300,https://clinicaltrials.gov/show/NCT04460183,NA
NCT04473157,ClinicalTrials.gov,2020-07-15,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 in Patients With Anosmia in Egypt,58,https://clinicaltrials.gov/show/NCT04473157,NA
NCT04477954,ClinicalTrials.gov,2020-07-16,2020-07-06,TRUE,Not Recruiting,Phase 2,Interventional,Argentina,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,40,https://clinicaltrials.gov/show/NCT04477954,NA
NCT04479319,ClinicalTrials.gov,2020-07-16,2020-12-31,FALSE,Recruiting,Not Applicable,Observational,Turkey,Decision Support System Algorithm for COVID-19 Diagnosis,10000,https://clinicaltrials.gov/show/NCT04479319,NA
NCT04481529,ClinicalTrials.gov,2020-07-20,2020-07-29,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,1576,https://clinicaltrials.gov/show/NCT04481529,NA
NCT04482387,ClinicalTrials.gov,2020-07-17,2020-07-24,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,DigiVis: Self-testing Vision App for Telephone Consultations,250,https://clinicaltrials.gov/show/NCT04482387,NA
NCT04515147,ClinicalTrials.gov,2020-08-13,2020-09-28,FALSE,Not Recruiting,Phase 2,Interventional,"Panama, Peru","A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",674,https://clinicaltrials.gov/show/NCT04515147,NA
NCT04522089,ClinicalTrials.gov,2020-08-12,2020-08-24,FALSE,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,70,https://clinicaltrials.gov/show/NCT04522089,NA
NCT04526977,ClinicalTrials.gov,2020-08-22,2021-01-10,FALSE,Recruiting,Not Applicable,Observational,Spain,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,90,https://clinicaltrials.gov/show/NCT04526977,NA
NCT04531319,ClinicalTrials.gov,2020-08-27,2020-08-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Immune Cell Subgroups in Covid 19 Patients,50,https://clinicaltrials.gov/show/NCT04531319,NA
NCT04531345,ClinicalTrials.gov,2020-08-27,2020-10-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Cytokine Status of Covid-19 Patients,60,https://clinicaltrials.gov/show/NCT04531345,NA
NCT04542915,ClinicalTrials.gov,2020-09-08,2020-09-29,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19-Related Health and Practices Among Dental Hygienists,4776,https://clinicaltrials.gov/show/NCT04542915,NA
NCT04542941,ClinicalTrials.gov,2020-08-31,2020-06-16,TRUE,Not Recruiting,Not Applicable,Interventional,Uganda,Assessment of Safety and Efficacy of CCP,136,https://clinicaltrials.gov/show/NCT04542941,NA
NCT04545047,ClinicalTrials.gov,2020-09-09,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,10000,https://clinicaltrials.gov/show/NCT04545047,NA
NCT04545541,ClinicalTrials.gov,2020-09-05,2020-11-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Nebulised Heparin in Patients With Severe COVID-19,300,https://clinicaltrials.gov/show/NCT04545541,NA
NCT04547218,ClinicalTrials.gov,2020-09-11,2020-06-22,TRUE,Not Recruiting,Not Applicable,Observational,Malaysia,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,150,https://clinicaltrials.gov/show/NCT04547218,NA
NCT04550403,ClinicalTrials.gov,2020-09-10,2020-07-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,700,https://clinicaltrials.gov/show/NCT04550403,NA
NCT04565392,ClinicalTrials.gov,2020-09-21,2021-05-01,FALSE,Not Recruiting,Phase 4,Interventional,United States,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),150,https://clinicaltrials.gov/show/NCT04565392,NA
NCT04570397,ClinicalTrials.gov,2020-09-29,2020-12-18,FALSE,Recruiting,Phase 3,Interventional,United States,Ravulizumab and COVID-19,32,https://clinicaltrials.gov/show/NCT04570397,NA
NCT04579588,ClinicalTrials.gov,2020-10-06,2020-10-29,FALSE,Recruiting,Not Applicable,Observational,United States,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04579588,NA
NCT04595695,ClinicalTrials.gov,2020-10-14,2020-09-03,TRUE,Not Recruiting,Not Applicable,Interventional,United States,The Effect of Clear Masks in Improving Patient Relationships,200,https://clinicaltrials.gov/show/NCT04595695,NA
NCT04595903,ClinicalTrials.gov,2020-10-08,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With HemopurifierÂ® Device,40,https://clinicaltrials.gov/show/NCT04595903,NA
NCT04596098,ClinicalTrials.gov,2020-07-30,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,France,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,100,https://clinicaltrials.gov/show/NCT04596098,NA
NCT04601012,ClinicalTrials.gov,2020-10-22,2020-09-20,TRUE,Not Recruiting,Not Applicable,Observational,Italy,OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection,40,https://clinicaltrials.gov/show/NCT04601012,NA
NCT04605757,ClinicalTrials.gov,2020-10-11,2020-07-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,100,https://clinicaltrials.gov/show/NCT04605757,NA
NCT04609722,ClinicalTrials.gov,2020-10-26,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04609722,NA
NCT04610567,ClinicalTrials.gov,2020-10-24,2020-10-27,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),100,https://clinicaltrials.gov/show/NCT04610567,NA
NCT04619693,ClinicalTrials.gov,2020-11-02,2020-11-18,FALSE,Recruiting,Not Applicable,Observational,France,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04619693,NA
NCT04636034,ClinicalTrials.gov,2020-11-18,2021-01-12,FALSE,Recruiting,Phase 3,Interventional,Denmark,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04636034,NA
NCT04638842,ClinicalTrials.gov,2020-11-19,2020-12-24,FALSE,Recruiting,Not Applicable,Interventional,Mexico,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,42,https://clinicaltrials.gov/show/NCT04638842,NA
NCT04663594,ClinicalTrials.gov,2020-11-27,2020-12-04,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Online Culture for Mental Health in People Aged 16-24,400,https://clinicaltrials.gov/show/NCT04663594,NA
NCT04664049,ClinicalTrials.gov,2020-12-04,2020-12-23,FALSE,Recruiting,Not Applicable,Observational,Taiwan,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,51000,https://clinicaltrials.gov/show/NCT04664049,NA
NCT04665245,ClinicalTrials.gov,2020-12-10,2020-12-15,FALSE,Recruiting,Not Applicable,Observational,United States,Symptom-Based Markers for COVID-19 Transmission,500,https://clinicaltrials.gov/show/NCT04665245,NA
NCT04683328,ClinicalTrials.gov,2020-12-20,2021-02-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,560,https://clinicaltrials.gov/show/NCT04683328,NA
NCT04686773,ClinicalTrials.gov,2020-12-25,2021-02-10,FALSE,Not Recruiting,Phase 2,Interventional,Azerbaijan,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",100,https://clinicaltrials.gov/show/NCT04686773,NA
NCT04694573,ClinicalTrials.gov,2020-12-28,2020-12-28,FALSE,Recruiting,Not Applicable,Observational,Germany,Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies,600,https://clinicaltrials.gov/show/NCT04694573,NA
NCT04701996,ClinicalTrials.gov,2021-01-06,2020-09-23,TRUE,Recruiting,Not Applicable,Observational,Democratic Republic of Congo,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,1600,https://clinicaltrials.gov/show/NCT04701996,NA
NCT04705753,ClinicalTrials.gov,2021-01-06,2020-04-01,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Greece,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",20,https://clinicaltrials.gov/show/NCT04705753,NA
NCT04706039,ClinicalTrials.gov,2021-01-08,2021-01-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,3000,https://clinicaltrials.gov/show/NCT04706039,NA
NCT04706143,ClinicalTrials.gov,2021-01-04,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians,100,https://clinicaltrials.gov/show/NCT04706143,NA
NCT04706325,ClinicalTrials.gov,2021-01-11,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,COVID-19 RELATED KIDNEY DAMAGE,100,https://clinicaltrials.gov/show/NCT04706325,NA
NCT04706390,ClinicalTrials.gov,2021-01-11,2021-01-12,FALSE,Recruiting,Not Applicable,Observational,Norway,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,2500,https://clinicaltrials.gov/show/NCT04706390,NA
NCT04706416,ClinicalTrials.gov,2020-12-31,2020-11-14,TRUE,Not Recruiting,Phase 1,Interventional,United States,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),50,https://clinicaltrials.gov/show/NCT04706416,NA
NCT04707339,ClinicalTrials.gov,2021-01-11,2020-01-30,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Management of Acute Appendicitis at District General Hospital,200,https://clinicaltrials.gov/show/NCT04707339,NA
NCT04707742,ClinicalTrials.gov,2021-01-07,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,84,https://clinicaltrials.gov/show/NCT04707742,NA
NCT04707820,ClinicalTrials.gov,2020-12-29,2020-04-16,TRUE,Recruiting,Not Applicable,Interventional,France,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04707820,NA
NCT04707833,ClinicalTrials.gov,2020-12-29,2020-11-26,TRUE,Recruiting,Not Applicable,Interventional,France,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,385,https://clinicaltrials.gov/show/NCT04707833,NA
NCT04708158,ClinicalTrials.gov,2021-01-12,2021-01-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,Novaferon for COVID-19 Treatment Trial (NCTT-005),385,https://clinicaltrials.gov/show/NCT04708158,NA
NCT04708327,ClinicalTrials.gov,2021-01-12,2021-04-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,75,https://clinicaltrials.gov/show/NCT04708327,NA
NCT04708457,ClinicalTrials.gov,2020-12-04,2021-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,"Australia, Germany","The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO",12,https://clinicaltrials.gov/show/NCT04708457,NA
NCT04709003,ClinicalTrials.gov,2021-01-06,2020-12-23,TRUE,Recruiting,Not Applicable,Observational,Israel,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI),4504,https://clinicaltrials.gov/show/NCT04709003,NA
NCT04709146,ClinicalTrials.gov,2021-01-11,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The Influence of Covid-19 on the Audio-vestibular System,70,https://clinicaltrials.gov/show/NCT04709146,NA
NCT04709172,ClinicalTrials.gov,2021-01-12,2021-01-05,TRUE,Recruiting,Phase 4,Interventional,Spain,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,30,https://clinicaltrials.gov/show/NCT04709172,NA
NCT04709302,ClinicalTrials.gov,2021-01-12,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,"South Africa, Nigeria",Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa,342,https://clinicaltrials.gov/show/NCT04709302,NA
NCT04709744,ClinicalTrials.gov,2021-01-09,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,38,https://clinicaltrials.gov/show/NCT04709744,NA
NCT04710316,ClinicalTrials.gov,2021-01-08,2021-01-30,FALSE,Not Recruiting,Not Applicable,Interventional,Mali,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",450,https://clinicaltrials.gov/show/NCT04710316,NA
NCT04711954,ClinicalTrials.gov,2021-01-12,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,"Netherlands, Ukraine",HIV/COV in Ukraine-NL,2000,https://clinicaltrials.gov/show/NCT04711954,NA
NCT04712045,ClinicalTrials.gov,2021-01-11,2020-08-01,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,67,https://clinicaltrials.gov/show/NCT04712045,NA
NCT04712175,ClinicalTrials.gov,2021-01-12,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry,250,https://clinicaltrials.gov/show/NCT04712175,NA
NCT04712279,ClinicalTrials.gov,2021-01-13,2021-01-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),294,https://clinicaltrials.gov/show/NCT04712279,NA
NCT04712292,ClinicalTrials.gov,2021-01-13,2020-09-08,TRUE,Recruiting,Not Applicable,Observational,Italy,Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC),2000,https://clinicaltrials.gov/show/NCT04712292,NA
NCT04712357,ClinicalTrials.gov,2021-01-07,2020-11-09,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,219,https://clinicaltrials.gov/show/NCT04712357,NA
NCT04713150,ClinicalTrials.gov,2020-12-17,2020-10-05,TRUE,Recruiting,Not Applicable,Observational,United States,HEALthy Brain and Child Development Study - COVID-19 Supplement,75,https://clinicaltrials.gov/show/NCT04713150,NA
NCT04713163,ClinicalTrials.gov,2021-01-12,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Vaccine Induced Immunity,200,https://clinicaltrials.gov/show/NCT04713163,NA
NCT04713852,ClinicalTrials.gov,2021-01-15,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients,116,https://clinicaltrials.gov/show/NCT04713852,NA
NCT04713878,ClinicalTrials.gov,2021-01-09,2020-05-08,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,21,https://clinicaltrials.gov/show/NCT04713878,NA
NCT04714008,ClinicalTrials.gov,2021-01-14,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,France,Covid-19 and ONline GAmbling,180000,https://clinicaltrials.gov/show/NCT04714008,NA
NCT04714125,ClinicalTrials.gov,2021-01-14,2020-06-19,TRUE,Recruiting,Not Applicable,Observational,Brazil,Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients,250,https://clinicaltrials.gov/show/NCT04714125,NA
NCT04714515,ClinicalTrials.gov,2020-09-19,2020-02-20,TRUE,Not Recruiting,Not Applicable,Observational,"China, Pakistan",Montelukast - a Treatment Choice for COVID-19,150,https://clinicaltrials.gov/show/NCT04714515,NA
NCT04715360,ClinicalTrials.gov,2021-01-15,2020-12-29,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Indonesia,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,30,https://clinicaltrials.gov/show/NCT04715360,NA
NCT04715477,ClinicalTrials.gov,2021-01-15,2021-01-17,FALSE,Recruiting,Not Applicable,Observational,Turkey,Intensive Care Anxiety in SARS-CoV-2 Patients,100,https://clinicaltrials.gov/show/NCT04715477,NA
ACTRN12621000034831,ANZCTR,2021-01-15,2020-11-20,TRUE,Recruiting,Not Applicable,Interventional,South Africa,Virucidal pilot study of NasodineÂ® (povidone-iodine 0.5%) nasal spray in people in South Africa with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,15,https://anzctr.org.au/ACTRN12621000034831.aspx,NA
ACTRN12621000048886,ANZCTR,2021-01-19,2020-07-12,TRUE,Recruiting,Not Applicable,Interventional,Australia,The feasibility and efficacy of self-collected nasopharyngeal specimens for COVID-19 detection in an Australian oncology population,274,https://anzctr.org.au/ACTRN12621000048886.aspx,NA
ACTRN12621000031864,ANZCTR,2021-01-15,2021-01-25,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Home-based virtual rehabililtation for people with persistent symptoms after COVID-19 disease (Long COVID-19),32,https://anzctr.org.au/ACTRN12621000031864.aspx,NA
ISRCTN18107122,ISRCTN,2021-01-11,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Participatory digital interventions for front-line staff during the coronavirus (COVID-19) pandemic,180,http://isrctn.com/ISRCTN18107122,NA
ISRCTN74727214,ISRCTN,2020-08-10,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,Oman,Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support,75,http://isrctn.com/ISRCTN74727214,NA
ChiCTR2000039212,ChiCTR,2020-10-22,2020-10-28,FALSE,Recruiting,Phase 1,Interventional,China,"A Phase Ib clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years",120,http://www.chictr.org.cn/showproj.aspx?proj=63183,NA
ChiCTR2000038152,ChiCTR,2020-09-11,2020-09-14,FALSE,Not Recruiting,Phase 1,Interventional,China,"A Single-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4800, Administered Intradermally Followed by Electroporation in Healthy Volunteers",45,http://www.chictr.org.cn/showproj.aspx?proj=59326,NA
ChiCTR2000032573,ChiCTR,2020-05-02,2020-05-02,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bufei Huoxue Capsule in the treatment of convalescent COVID-19 patients",120,http://www.chictr.org.cn/showproj.aspx?proj=53225,NA
JPRN-jRCT1030200309,jRCT,2021-01-18,2020-12-21,TRUE,Recruiting,Not Applicable,Interventional,Japan,The effect of telephone instructions on physical activity in community-dwelling older adults.,300,https://jrct.niph.go.jp/latest-detail/jRCT1030200309,NA
JPRN-jRCT1030200310,jRCT,2021-01-18,2020-12-21,TRUE,Recruiting,Not Applicable,Interventional,Japan,The effect of virtual community activity on physical activity in community-dwelling older adults.,300,https://jrct.niph.go.jp/latest-detail/jRCT1030200310,NA
JPRN-UMIN000042939,UMIN-CTR,2021-01-10,2021-01-07,TRUE,Recruiting,Not Applicable,Observational,Japan,Establishment of endobarrier during screening esophagogastroduodenoscopy during COVID-19 pandemic,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049014,NA
CTRI/2020/03/024402,CTRI,2020-03-31,2020-08-04,FALSE,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,NA
CTRI/2020/04/024442,CTRI,2020-04-01,2020-08-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,NA
CTRI/2020/04/024413,CTRI,2020-04-01,2020-09-04,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,NA
CTRI/2020/04/024473,CTRI,2020-04-03,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,"United States, Italy, India, United Kingdom",Viral Infection and Respiratory illness Universal Study,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,NA
CTRI/2020/04/024482,CTRI,2020-04-07,2020-07-04,FALSE,Not Recruiting,Not Applicable,Observational,India,A pan-india non-interventional virtual registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workers,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42777,NA
CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Hydroxychloroquine in addition to standard therapy in COVID-19 patients,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,NA
CTRI/2020/04/024636,CTRI,2020-04-15,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,NA
CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,FALSE,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,NA
CTRI/2020/04/024706,CTRI,2020-04-17,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,India,Effect of convalescent plasma  in COVID-19 patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43039,NA
CTRI/2020/04/024697,CTRI,2020-04-17,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 Data-bank Project,100000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42835,NA
CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,FALSE,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,NA
CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,NA
CTRI/2020/04/024772,CTRI,2020-04-21,2020-04-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Comparison of suspected or negative cases with confirmed cases of COVID-19 at Max Hospital,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43079,NA
CTRI/2020/04/024747,CTRI,2020-04-21,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,NA
CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,NA
CTRI/2020/04/024773,CTRI,2020-04-21,2020-01-05,TRUE,Recruiting,Phase 3,Interventional,"Argentina, Qatar, Iran, Indonesia, Peru, South Africa, Canada, Norway, Brazil, Spain, Thailand, India, Germany, Switzerland",A clinical trial to study the effects of additional treatments for patients hospitalized and receiving treatment due to  COVID -19.,7000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897,NA
CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,FALSE,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,NA
CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,FALSE,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,NA
CTRI/2020/04/024804,CTRI,2020-04-22,2020-11-05,FALSE,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,NA
CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,FALSE,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,NA
CTRI/2020/04/024784,CTRI,2020-04-22,2020-04-24,FALSE,Not Recruiting,Not Applicable,Observational,India,ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42939,NA
CTRI/2020/04/024805,CTRI,2020-04-22,2020-04-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of Covid-19 pandemic on practice pattern of Indian urologists,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42979,NA
CTRI/2020/04/024833,CTRI,2020-04-24,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,NA
CTRI/2020/04/024846,CTRI,2020-04-24,2020-04-30,FALSE,Recruiting,Phase 3,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,NA
CTRI/2020/04/024857,CTRI,2020-04-25,2020-04-05,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,NA
CTRI/2020/04/024859,CTRI,2020-04-25,2020-04-25,FALSE,Not Recruiting,Not Applicable,Observational,India,To Study the Clinical characteristics and treatment Outcome of COVID-19 Patients admitted in hospitals of Max Healthcare (SCOPe Study),1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43232,NA
CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Ã¢??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,NA
CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,FALSE,Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,NA
CTRI/2020/04/024904,CTRI,2020-04-28,2020-11-05,FALSE,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,NA
CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,FALSE,Not Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,NA
CTRI/2020/04/024914,CTRI,2020-04-29,2020-08-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Characteristics of seriously ill COVID-19 patients admitted to a tertiary care centre,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43323,NA
CTRI/2020/04/024915,CTRI,2020-04-29,2020-09-05,FALSE,Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,NA
CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,FALSE,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,NA
CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,FALSE,Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,NA
CTRI/2020/04/024947,CTRI,2020-04-30,2020-08-05,FALSE,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,NA
CTRI/2020/05/024967,CTRI,2020-05-01,2020-11-05,FALSE,Not Recruiting,Phase 4,Interventional,India,Herbal product Clinical trial on COVID-19 patients,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,NA
CTRI/2020/05/024959,CTRI,2020-05-01,2020-01-05,TRUE,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,NA
CTRI/2020/05/024969,CTRI,2020-05-01,2020-10-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,NA
CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,NA
CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,NA
CTRI/2020/05/024982,CTRI,2020-05-02,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Effects of using hydroxychloroquine and azithromycin in the treatment of confirmed COVID-19 positive patients,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43432,NA
CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,NA
CTRI/2020/05/024984,CTRI,2020-05-03,2020-12-05,FALSE,Not Recruiting,Not Applicable,Observational,India,How has the spread of COVID 19 disease affected the teaching and training of postgraduate students who are studying anaesthesiology,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43425,NA
CTRI/2020/05/025010,CTRI,2020-05-04,2020-04-05,TRUE,Not Recruiting,Not Applicable,Observational,India,Hydroxychloroquine prophylaxis in Covid 19 infection,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43269,NA
CTRI/2020/05/024989,CTRI,2020-05-04,2020-11-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Mechanism of Covid 19 infection in Humans,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43377,NA
CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,NA
CTRI/2020/05/024985,CTRI,2020-05-04,2020-05-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Attempting to pass a breathing tube in a model of human body using two different preventive device as a precautionary measure in the times of COVID,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43462,NA
CTRI/2020/05/025013,CTRI,2020-05-05,2020-06-05,FALSE,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,NA
CTRI/2020/05/025022,CTRI,2020-05-05,2020-06-05,FALSE,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,NA
CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,FALSE,Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,6950,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,NA
CTRI/2020/05/025041,CTRI,2020-05-06,2020-06-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43277,NA
CTRI/2020/05/025049,CTRI,2020-05-06,2020-08-05,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,NA
CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,9200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,NA
CTRI/2020/05/025070,CTRI,2020-05-07,2020-09-05,FALSE,Not Recruiting,Not Applicable,Observational,India,An Observational study to identify the issues and challenges in cancer patients on active treatment during the COVID-19 Pandemic and the resulting Lockdown,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43343,NA
CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,FALSE,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,NA
CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,FALSE,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,NA
CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,NA
CTRI/2020/05/025089,CTRI,2020-05-09,2020-05-18,FALSE,Recruiting,Not Applicable,Observational,India,Effect of Hydroxychloroquine on QTc Interval,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43506,NA
CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,NA
CTRI/2020/05/025092,CTRI,2020-05-11,2020-05-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Outcomes of viral infection in hematology patients,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43608,NA
CTRI/2020/05/025091,CTRI,2020-05-11,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Knowledge status of public about COVID 19 disease prevention and control  in Tamil Nadu,549,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43622,NA
CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,FALSE,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,NA
CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,NA
CTRI/2020/05/025163,CTRI,2020-05-13,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,"South Africa, Benin, United Kingdom, United States, Zambia, Pakistan, Italy, Mexico, Spain, Rwanda, France, India, Philippines",Surgery Outcomes in COVID patients,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43610,NA
CTRI/2020/05/025160,CTRI,2020-05-13,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,"Ghana, Australia, South Africa, United Arab Emirates, Benin, United Kingdom, United States, Canada, Pakistan, Zambia, Italy, Mexico, Spain, Rwanda, France, India, Nigeria, Philippines",Outcomes Of Cancer Surgery During COVID-19 Pandemic,7000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43628,NA
CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,FALSE,Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,NA
CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,FALSE,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,NA
CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,NA
CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,FALSE,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,NA
CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,FALSE,Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,NA
CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,FALSE,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,NA
CTRI/2020/05/025184,CTRI,2020-05-15,2020-05-19,FALSE,Not Recruiting,Not Applicable,Observational,"United States, India, United Arab Emirates",Psychological impact of COVID Ã¢?? 19 Pandemic,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43600,NA
CTRI/2020/05/025194,CTRI,2020-05-15,2020-05-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Mental status of public during lockdown COVID-19,280,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43664,NA
CTRI/2020/05/025182,CTRI,2020-05-15,2020-05-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Siddha interventions prevention to front line workers,366,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43680,NA
CTRI/2020/05/025213,CTRI,2020-05-15,2020-05-23,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ayurveda formulation for COVID-19 prevention,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698,NA
CTRI/2020/05/025205,CTRI,2020-05-15,2020-05-24,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Arsenicum album Ã¢?? 30 as prophylactic for Covid-19,33000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721,NA
CTRI/2020/05/025214,CTRI,2020-05-15,2020-05-24,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine for the treatment of COVID-19,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727,NA
CTRI/2020/05/025183,CTRI,2020-05-15,2020-05-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Questionnaire based study of drugs taken by healthcare workers to prevent COVID 19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43241,NA
CTRI/2020/05/025212,CTRI,2020-05-15,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,India,"Assessing Stress levels among the Health Care Workers during and after Outbreak of
COVID-19",350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43757,NA
CTRI/2020/05/025209,CTRI,2020-05-15,2020-05-20,FALSE,Recruiting,Phase 2,Interventional,India,A clinical trial for validating therapeutic efficacy of convalescent plasma in severe COVID-19 disease,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251,NA
CTRI/2020/05/025216,CTRI,2020-05-16,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,India,HCQ POCKET ECG Ambulatory Telemetry  Study,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43755,NA
CTRI/2020/05/025215,CTRI,2020-05-16,2020-05-25,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,"Effectiveness of Siddha medicine, Kabasura kudineer and vitamin c-zinc supplementation in the management of Mild COVID 19 patients.",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,NA
CTRI/2020/05/025217,CTRI,2020-05-17,2020-05-29,FALSE,Recruiting,Not Applicable,Observational,India,COVID-19 and cancer chemotherapy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43015,NA
CTRI/2020/05/025220,CTRI,2020-05-17,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To study the effect of COVID-19 pandemic and Psychological Well-being of Healthcare Professionals and Support Staff in Max Super Speciality Hospital, Saket in New Delhi, India.",1300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43619,NA
CTRI/2020/05/025219,CTRI,2020-05-17,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,India,To find out what has happened to the treatment and care of children suffering with cancer in India during the lockdown from the COVID-19 pandemic,1250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43750,NA
CTRI/2020/05/025221,CTRI,2020-05-17,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Create registry of Childhood Cancer patients in India with COVID 19 to provide guidelines for prevention and treatment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43753,NA
CTRI/2020/05/025218,CTRI,2020-05-17,2020-05-25,FALSE,Not Recruiting,Not Applicable,Observational,India,A survey for challenges faced by the Investigators during COVID-19 pandemic in the conduct of Clinical Trials at Tata Memorial Centre.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43772,NA
CTRI/2020/05/025222,CTRI,2020-05-18,2020-01-06,TRUE,Not Recruiting,Phase 4,Interventional,India,Efficacy of Tablet AOIM - Z in Prevention of  COVID - 19   in High Risk Healthy Police Personnel,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803,NA
CTRI/2020/05/025224,CTRI,2020-05-18,2020-05-24,FALSE,Not Recruiting,Phase 2,Interventional,India,Study to efficacy of Ivermectin in patients of COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728,NA
CTRI/2020/05/025242,CTRI,2020-05-19,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Hydroxychloroquine of pharmacokinetics in healthcare workers,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057,NA
CTRI/2020/05/025243,CTRI,2020-05-19,2020-05-19,FALSE,Not Recruiting,Not Applicable,Observational,India,A study on salivary samples and nasopharyngeal samples in diagnosis of COVID-19 Disease Patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43615,NA
CTRI/2020/05/025238,CTRI,2020-05-19,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Emotional Impact of Isolation during COVID 19 among college students and staff,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43623,NA
CTRI/2020/05/025272,CTRI,2020-05-20,2020-05-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the efficacy of Homoeopathic medicine in the prevention of Covid-19 
",800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790,NA
CTRI/2020/05/025254,CTRI,2020-05-20,2020-05-29,FALSE,Not Recruiting,Phase 3,Interventional,India,To Study effectiveness and outcomes of Unani Medicine prophylactic interventions on population at risk of COVID-19,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630,NA
CTRI/2020/05/025276,CTRI,2020-05-20,2020-05-29,FALSE,Not Recruiting,Phase 3,Interventional,India,effect of Ayurvedic intervention in COVID-19 positive cases,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892,NA
CTRI/2020/05/025273,CTRI,2020-05-20,2020-05-29,FALSE,Not Recruiting,Not Applicable,Interventional,India,Impact of effect of Ayurvedic treatment on novel Corona virus disease,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900,NA
CTRI/2020/05/025275,CTRI,2020-05-20,2020-05-30,FALSE,Not Recruiting,Phase 3,Interventional,India,Role of Chyawanprash in the prevention of COVID-19 in health care workers,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917,NA
CTRI/2020/05/025274,CTRI,2020-05-20,2020-05-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of remote audio-visual surveillance of doffing process during COVID 19 pandemic on the safety of health care workers,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43921,NA
CTRI/2020/05/025271,CTRI,2020-05-20,2020-05-31,FALSE,Recruiting,Phase 3,Interventional,India,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,NA
CTRI/2020/05/025248,CTRI,2020-05-20,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,COVID-19 telephonic counseling model for addressing mental health concerns in different populations during corona outbreak in India,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479,NA
CTRI/2020/05/025247,CTRI,2020-05-20,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,India,"To Study Clinical Characteristics, Treatment Outcome of Coronavirus (COVID-19) Patients",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43762,NA
CTRI/2020/05/025293,CTRI,2020-05-21,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,India,Difficulties faced by pregnant women during the Covid 19 Pandemic and lockdown,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43824,NA
CTRI/2020/05/025289,CTRI,2020-05-21,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,An observational study on QT interval changes with Hydroxychloroquine used as prophylaxis in COVID exposure risk individuals,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43612,NA
CTRI/2020/05/025291,CTRI,2020-05-21,2020-05-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Corona virus in tears,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43654,NA
CTRI/2020/05/025297,CTRI,2020-05-21,2020-05-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Spectrum of injuries during COVID-19 Lock down at a major trauma centre in Central India,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43911,NA
CTRI/2020/05/025290,CTRI,2020-05-21,2020-05-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological distress among health care workers due to COVID-19 outbreak,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43671,NA
CTRI/2020/05/025277,CTRI,2020-05-21,2020-05-31,FALSE,Recruiting,Phase 3,Interventional,India,Clinical Trial of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176,NA
CTRI/2020/05/025299,CTRI,2020-05-21,2020-01-06,TRUE,Not Recruiting,Phase 2,Interventional,India,Convalescent Plasma treatment trial in COVID 19 patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,NA
CTRI/2020/05/025298,CTRI,2020-05-21,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Siddha Intervention Population Study.,21500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761,NA
CTRI/2020/05/025320,CTRI,2020-05-22,2020-05-22,FALSE,Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Yoga & Naturopathy in patients with COVID-19,658,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576,NA
CTRI/2020/05/025317,CTRI,2020-05-22,2020-05-26,FALSE,Not Recruiting,Phase 4,Interventional,India,SURVEY OF MOUTH-DISSOLVING TURMERIC LOZENGES IN HEALTHCARE WORKERS,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754,NA
CTRI/2020/05/025319,CTRI,2020-05-22,2020-01-06,TRUE,Recruiting,Phase 3,Interventional,India,Trial of antihypertensive losartan for additional benefit in treating COVID 19 infection.,186,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751,NA
CTRI/2020/05/025331,CTRI,2020-05-23,2020-05-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Home based prehabilitation via telemedicine in lung cancer patients during COVID 19,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339,NA
CTRI/2020/05/025327,CTRI,2020-05-23,2020-09-06,FALSE,Not Recruiting,Not Applicable,Observational,India,To study some blood tests which would help predict severity and outcome in children with cancers having the novel corona virus infection.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43914,NA
CTRI/2020/05/025326,CTRI,2020-05-23,2020-05-31,FALSE,Not Recruiting,Phase 2,Interventional,India,Tablet PINAK given as treatment  to COVID positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951,NA
CTRI/2020/05/025328,CTRI,2020-05-23,2020-01-06,TRUE,Not Recruiting,Phase 2,Interventional,India,Study to Assess the Safety and Efficacy of Convalescent Plasma on outcome of COVID-19 Associated Complications,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703,NA
CTRI/2020/05/025338,CTRI,2020-05-24,2020-02-06,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033,NA
CTRI/2020/05/025342,CTRI,2020-05-24,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,mask use in covid in medical personnel - a survey,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44039,NA
CTRI/2020/05/025336,CTRI,2020-05-24,2020-01-06,TRUE,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934,NA
CTRI/2020/05/025334,CTRI,2020-05-24,2020-05-30,FALSE,Not Recruiting,Phase 2,Interventional,India,Protect and prevent onset of COVID like infections in Health Care Workers and High risk person.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935,NA
CTRI/2020/05/025337,CTRI,2020-05-24,2020-01-06,TRUE,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940,NA
CTRI/2020/05/025335,CTRI,2020-05-24,2020-06-20,FALSE,Not Recruiting,Phase 3,Interventional,India,"Efficacy of AYUSH-64 (a polyherbal formulation) in COVID - 19 Cases
",40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949,NA
CTRI/2020/05/025339,CTRI,2020-05-24,2020-02-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Treatment and economical problems faced due to non COVID patients admitted in severe acute respiratory illness (SARI) ICU based on SARI criteria,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43959,NA
CTRI/2020/05/025341,CTRI,2020-05-24,2020-02-06,TRUE,Recruiting,Not Applicable,Interventional,India,A study to know the effect of Ayurvedic Kwath(Kiratiktadi Kwath) & Ashwagandha Churna along with yoga exercises in the treatment of COVID-19 Positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013,NA
CTRI/2020/05/025343,CTRI,2020-05-25,2020-05-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study results of Ayurvedic treatment on COVID patients using proprietary herbal formulation SUVED and whole colostrum REIMMUGEN.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919,NA
CTRI/2020/05/025345,CTRI,2020-05-25,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,India,Detailed Organ System Analysis of Asymptomatic COVID19 patients using noninvasive mobile tool,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43948,NA
CTRI/2020/05/025347,CTRI,2020-05-25,2020-01-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Psychological impact of COVID-19 pandemic on health care workers,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43958,NA
CTRI/2020/05/025348,CTRI,2020-05-25,2020-01-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Medical students preference and perspective for online teaching during lockdown period,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43979,NA
CTRI/2020/05/025344,CTRI,2020-05-25,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,India,Effects of the corona virus disease on mental health of Anaesthesiologists working at different parts of India.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44024,NA
CTRI/2020/05/025346,CTRI,2020-05-25,2020-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Assess the Safety and Efficacy of Convalescent Plasma in Severe Covid-19 patients.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005,NA
CTRI/2020/05/025350,CTRI,2020-05-26,2020-05-31,FALSE,Not Recruiting,Phase 2,Interventional,India,Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559,NA
CTRI/2020/05/025370,CTRI,2020-05-27,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,India,Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064,NA
CTRI/2020/05/025385,CTRI,2020-05-27,2020-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,India,Research study to evaluate the impact of Selected Ayurvedic interventions in containment zone,30000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953,NA
CTRI/2020/05/025369,CTRI,2020-05-27,2020-05-30,FALSE,Recruiting,Phase 3,Interventional,India,A study on treatment of COVID-19 patients with study drug along with standard of care,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485,NA
CTRI/2020/05/025371,CTRI,2020-05-27,2020-02-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Retrospective Assessment of Treatments of Hospitalized COVID19 Patients.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44023,NA
CTRI/2020/05/025425,CTRI,2020-05-28,2020-02-06,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic intervention (Chyawanprash) in the prevention of COVID-19 pandemic  among Health Care Personnel,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043,NA
CTRI/2020/05/025424,CTRI,2020-05-28,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Clinical features and outcome of COVID-19 and non-COVID respiratory infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44074,NA
CTRI/2020/05/025398,CTRI,2020-05-28,2020-05-28,FALSE,Recruiting,Not Applicable,Interventional,India,Study to find out the results of Ayurvedic Kwath & Ashwagandha churna with Yoga exercises to prevent our health workers against corona virus infection.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831,NA
CTRI/2020/05/025397,CTRI,2020-05-28,2020-05-06,TRUE,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect and safety of a phytopharmaceutical drug in treatment of Coronavirus infection,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702,NA
CTRI/2020/05/025423,CTRI,2020-05-28,2020-01-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Pregnancy and COVID-19 Registry,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43519,NA
CTRI/2020/05/025429,CTRI,2020-05-29,2020-10-06,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,effect of Ashwagandha (Withania somnifera) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058,NA
CTRI/2020/05/025430,CTRI,2020-05-29,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,India,EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH OF CORONA WARRIORS,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44060,NA
CTRI/2020/05/025431,CTRI,2020-05-29,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,India,"A study to find our proportion of Covid 19 cases, need for hospital beds and utility of lockdown at Aurangabad",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44128,NA
CTRI/2020/05/025428,CTRI,2020-05-29,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,India,"COVID -19 Pandemic and Lockdown : Impact on Parents Stress level, Infant care and follow-up",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43890,NA
CTRI/2020/05/025427,CTRI,2020-05-29,2020-05-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical Characteristics and Outcomes of  Patients Admitted with Severe Acute Respiratory Illness,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43933,NA
CTRI/2020/05/025434,CTRI,2020-05-29,2020-05-31,FALSE,Recruiting,Phase 4,Interventional,India,A clinical trial to evaluate the Medicinal effects of ZingiVir-H as Anti-Viral therapy in COVID-19 patients.,135,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957,NA
CTRI/2020/05/025466,CTRI,2020-05-29,2020-03-07,TRUE,Not Recruiting,Not Applicable,Observational,India,A study to estimate drug levels in health care workers on COVID infection prophylaxis,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43209,NA
CTRI/2020/05/025433,CTRI,2020-05-29,2020-01-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Respiratory emergencies during the COVID-19 Pandemic.,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43743,NA
CTRI/2020/05/025483,CTRI,2020-05-30,2020-02-06,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Use of Clevira in COVID19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041,NA
CTRI/2020/05/025485,CTRI,2020-05-30,2020-06-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,the effect of Guduchi (Tinospora cordifolia) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052,NA
CTRI/2020/05/025484,CTRI,2020-05-30,2020-03-06,TRUE,Recruiting,Phase 2/Phase 3,Interventional,India,study on the effect of Chyavanprash Lehyam as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055,NA
CTRI/2020/05/025486,CTRI,2020-05-30,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,India,Dental studentsÃ¢?? perceptions and concerns regarding the current COVID-19 pandemics,750,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44071,NA
CTRI/2020/05/025487,CTRI,2020-05-30,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Development of Smell based test for identifying COVID-19 infection.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43586,NA
CTRI/2020/05/025490,CTRI,2020-05-31,2020-07-06,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,A Clinical trial to study the efficacy of pH based Integrated  SARS Cov-2 Immunity in Human Subjects.,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042,NA
CTRI/2020/05/025488,CTRI,2020-05-31,2020-03-06,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Guduchi Ghana Vati as a preventive remedy in pandemic of COVID-19,12000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062,NA
CTRI/2020/05/025491,CTRI,2020-05-31,2020-08-06,FALSE,Recruiting,Phase 2,Interventional,India,The efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065,NA
CTRI/2020/05/025489,CTRI,2020-05-31,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,India,To compare two intubation scopes for securing the airway during COVID pandemic in patients undergoing surgery,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376,NA
CTRI/2020/05/025492,CTRI,2020-05-31,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Impact of tele-consultation for following up newborns during COVID-19 pandemic,2978,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382,NA
CTRI/2020/05/025493,CTRI,2020-05-31,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"Effect of Ayurvedic medicine in the Prophylaxis for COVID-19 of Police personnel Dept of AYUSH, TS  & CCRAS- NIIMH, Hyderabad.",1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44177,NA
CTRI/2020/05/025494,CTRI,2020-05-31,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,India,"Mental impact of SARS Covid-19 disease outbreaks among suspects coming to AIIMS Rishikesh, their close contacts, and associated healthcare providers",3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44179,NA
CTRI/2020/05/025496,CTRI,2020-05-31,2020-08-06,FALSE,Recruiting,Phase 1,Interventional,India,Study to observe safety of CNV01 homeopathy preparation in healthy volunteers,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192,NA
CTRI/2020/05/025495,CTRI,2020-05-31,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,India,"Screening of healthcare workers,  Doctors and Nurses  working in Covid-19 wards using a continous wearable watch device",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44209,NA
CTRI/2020/05/025497,CTRI,2020-05-31,2020-06-14,FALSE,Not Recruiting,Not Applicable,Observational,India,"Knowledge, attitudes, and practices towards COVID-19 among Indian residents during the period of the COVID-19 outbreak",480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44257,NA
CTRI/2020/06/025523,CTRI,2020-06-01,2020-08-06,FALSE,Not Recruiting,Not Applicable,Interventional,India,The effect of meditation on well-being of SARS-Cov-2 infected patients.,84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396,NA
CTRI/2020/06/025526,CTRI,2020-06-01,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,India,To observe the impact of Ayurveda Kwath in Healthy and Suspected persons for COVID-19,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44182,NA
CTRI/2020/06/025522,CTRI,2020-06-01,2020-02-06,TRUE,Not Recruiting,Not Applicable,Interventional,India,Comparison of two devices for intubation in COVID simulated scenario in mannequin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438,NA
CTRI/2020/06/025527,CTRI,2020-06-01,2020-01-06,TRUE,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968,NA
CTRI/2020/06/025557,CTRI,2020-06-02,2020-11-06,FALSE,Recruiting,Phase 2,Interventional,India,A clinical study of  Ayurvedic formulations  in the treatment  of Mild to Moderate COVID-19 patients,420,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812,NA
CTRI/2020/06/025530,CTRI,2020-06-02,2020-06-18,FALSE,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for Prevention and Treatment of Viral Fevers including COVID19,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305,NA
CTRI/2020/06/025556,CTRI,2020-06-02,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to know the effect of VirulinaÃ‚Â® along with standard treatment in covid 19 positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144,NA
CTRI/2020/06/025558,CTRI,2020-06-02,2020-06-15,FALSE,Not Recruiting,Phase 4,Interventional,India,Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411,NA
CTRI/2020/06/025560,CTRI,2020-06-02,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Difficulty in doing usual work after wearing personal protective equipment.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43710,NA
CTRI/2020/06/025529,CTRI,2020-06-02,2020-10-06,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, Practice and mental health status of Spinal injured people",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44243,NA
CTRI/2020/06/025575,CTRI,2020-06-03,2020-06-15,FALSE,Recruiting,Phase 3/Phase 4,Interventional,India,Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trial,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076,NA
CTRI/2020/06/025588,CTRI,2020-06-03,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,India,"Data of patients with Corona virus disease admitted to the ICU at P.D. Hinduja Hospital, Mumbai.",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43851,NA
CTRI/2020/06/025590,CTRI,2020-06-03,2020-08-06,FALSE,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate safety and efficacy of polyherbal capsule Astha-15 used as an add on therapy with standard care of therapy as an immunity booster in the suspected and COVID-19 diagnosed patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121,NA
CTRI/2020/06/025589,CTRI,2020-06-03,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,comparison of two different  laryngoscopes using COVID barrier box,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164,NA
CTRI/2020/06/025561,CTRI,2020-06-03,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,India,"Effect of Ayurvedic medicine in the Prophylaxis for COVID-19 of AYUSH healthcare workers , Dept of AYUSH, TS  & CCRAS- NIIMH, Hyderabad.

",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44244,NA
CTRI/2020/06/025613,CTRI,2020-06-04,2020-06-15,FALSE,Not Recruiting,Phase 4,Interventional,India,Melatonin Immune Boost COVID 19 Study,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,NA
CTRI/2020/06/025593,CTRI,2020-06-04,2020-12-06,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to determine relative efficacy of hydroxy-chloroquine prophylaxis to healthcare-professionals for Covid-19 mitigation,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44173,NA
CTRI/2020/06/025637,CTRI,2020-06-05,2020-06-22,FALSE,Not Recruiting,Not Applicable,Interventional,India,"As the present outbreak of novel coronavirus in Indian scenario we want to study about the prophylactic study in Distric Hospital, Vidisha.",10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550,NA
CTRI/2020/06/025625,CTRI,2020-06-05,2020-11-05,FALSE,Recruiting,Phase 2,Interventional,India,Study of the effect of Siddha Treatment in addition to standard therapy in COVID-19 patients,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345,NA
CTRI/2020/06/025664,CTRI,2020-06-05,2020-06-15,FALSE,Recruiting,Phase 2,Interventional,India,Phase II study to evaluate the Safety and Efficacy of 2-Deoxy-D-Glucose in COVID -19 patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369,NA
CTRI/2020/06/025634,CTRI,2020-06-05,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,To assess the  postoperative outcomes after implementation of the protocol in patients undergoing surgery for gynaecological malignancies in the COVID-19 pandemic,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43893,NA
CTRI/2020/06/025650,CTRI,2020-06-05,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,India,To assess the safety and outcome of herbal medicine in prevention of COVID-19 infection among high risk population,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412,NA
CTRI/2020/06/025673,CTRI,2020-06-06,2020-07-30,FALSE,Not Recruiting,Not Applicable,Observational,India,A study on association between tobacco and COVID 19 to help policy makers,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44398,NA
CTRI/2020/06/025672,CTRI,2020-06-06,2020-06-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To evaluate the effect of herbal medicine in prevention and management of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415,NA
CTRI/2020/06/025671,CTRI,2020-06-06,2020-06-15,FALSE,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425,NA
CTRI/2020/06/025675,CTRI,2020-06-06,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,This study has been conducted to collect the Cough and breathing sound of COVID-19 positive and COVID-19 negative patients for analysis of early indication of COVID-19 in humans.,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44427,NA
CTRI/2020/06/025674,CTRI,2020-06-06,2020-06-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Oral Fluid Sars-CoV-2 Ab Rapid test,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44431,NA
CTRI/2020/06/025703,CTRI,2020-06-08,2020-06-17,FALSE,Not Recruiting,Not Applicable,Observational,"Australia, New Zealand, United Arab Emirates, United Kingdom, United States, India, Singapore","Knowledge, Attitude, Feelings and Behavior in Adolescents during COVID-19",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44358,NA
CTRI/2020/06/025702,CTRI,2020-06-08,2020-06-15,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Clinical Trial On Mildly Symptomatic Covid -19 Patients And Health Care Workers Posted To Covid Wards

",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376,NA
CTRI/2020/06/025704,CTRI,2020-06-08,2020-01-07,TRUE,Not Recruiting,Phase 3,Interventional,India,Ulinastatin for COVID-19 in patients with breathlessness,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170,NA
CTRI/2020/06/025714,CTRI,2020-06-08,2020-02-06,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Holistic Health Management through Yoga and Naturopathy for Frontline COVID Health Care Providers Ã¢?? The H2M trial,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020,NA
CTRI/2020/06/025763,CTRI,2020-06-09,2020-07-17,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Randomized controlled Clinical Trial to determine the efficacy of Siddha drugs in COVID 19 patients,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340,NA
CTRI/2020/06/025764,CTRI,2020-06-09,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,India,"Assessment of depression, anxiety and coping strategies among Health care workers working in dedicated COVID-19 hospitals",93,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44405,NA
CTRI/2020/06/025766,CTRI,2020-06-09,2020-11-06,FALSE,Not Recruiting,Not Applicable,Interventional,India,A study of 254nm UVC ray therapy in pharynx for asymptomatic to mild cases of Corona Virus Disease,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171,NA
CTRI/2020/06/025760,CTRI,2020-06-09,2020-06-17,FALSE,Not Recruiting,Phase 3,Interventional,India,A clinical trial to study the effect of drug named Sofosbuvir in hospitalized patients with COVID 19.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441,NA
CTRI/2020/06/025768,CTRI,2020-06-09,2020-07-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445,NA
CTRI/2020/06/025761,CTRI,2020-06-09,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"Population based cross sectional study for COVID 19 prophylaxis with
Polyherbal Siddha formulation Kabasura Kudineer / Nilavembu kudineer in containment zones and non
containment zones during 2020 pandemic in Tamil Nadu, South India",10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44258,NA
CTRI/2020/06/025762,CTRI,2020-06-09,2020-06-15,FALSE,Not Recruiting,Phase 3,Interventional,India,"An Open-Label Randomized Controlled, Proof-of-Concept (PoC) Study to
Evaluate the Safety and Efficacy of selected Siddha formulations in patients
diagnosed with COVID-19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259,NA
CTRI/2020/06/025769,CTRI,2020-06-09,2020-06-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,"A prophylactic interventional study to determine the possible protective effect of Siddha Polyherbal formulation Kabasura Kudineer against the COVID 19 on
intermittent, month-long consumption by public with close contacts to COVID patients and frontline workers in Tamil Nadu, India",40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260,NA
CTRI/2020/06/025801,CTRI,2020-06-10,2020-06-19,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Role of Herbal Immunomodulators   in mild COVID-19 confirmed cases,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293,NA
CTRI/2020/06/025796,CTRI,2020-06-10,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181,NA
CTRI/2020/06/025798,CTRI,2020-06-10,2020-06-18,FALSE,Not Recruiting,Phase 4,Interventional,India,A Clinical trial to establish the appropriate line of management of Non Muscle Invasive Bladder Cancers who have had their intravesical BCG therapy interrupted,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460,NA
CTRI/2020/06/025779,CTRI,2020-06-10,2020-06-17,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study of AYUSH KWATH in quarantine persons,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463,NA
CTRI/2020/06/025802,CTRI,2020-06-10,2020-06-17,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study,314,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44476,NA
CTRI/2020/06/025799,CTRI,2020-06-10,2020-06-17,FALSE,Not Recruiting,Phase 3,Interventional,India,"A study of Favipiravir in patients with mild to moderate coronavirus disease (COVID-19)
",156,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480,NA
CTRI/2020/06/025800,CTRI,2020-06-10,2020-06-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Role of Ayurveda in Covid 19 management.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485,NA
CTRI/2020/06/025797,CTRI,2020-06-10,2020-06-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Quality of Life During COVID-19 Lockdown,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43759,NA
CTRI/2020/06/025804,CTRI,2020-06-11,2020-06-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of lying face down in improving the outcome of COVID-19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572,NA
CTRI/2020/06/025803,CTRI,2020-06-11,2020-06-18,FALSE,Recruiting,Phase 3,Interventional,India,Effect of convalescent plasma in COVID-19 patients,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478,NA
CTRI/2020/06/025848,CTRI,2020-06-12,2020-06-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical Analysis of Patients Hospitalized Due To Covid-19,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44593,NA
CTRI/2020/06/025849,CTRI,2020-06-12,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Study to Evaluate the Safety and Efficacy of a Combination of Nitazoxanide and Hydroxychloroquine Versus Hydroxychloroquine Alone in COVID-19 Patients,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408,NA
CTRI/2020/06/025852,CTRI,2020-06-12,2020-06-14,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,RNB in UPUMS SAIFAI,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,NA
CTRI/2020/06/025853,CTRI,2020-06-12,2020-06-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Mental Health of children during Covid-19 Pandemic,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44466,NA
CTRI/2020/06/025850,CTRI,2020-06-12,2020-06-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Studying tobacco use and quitting behaviour due to the coronavirus lockdown in India.,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44518,NA
CTRI/2020/06/025844,CTRI,2020-06-12,2020-06-22,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Pre-Identified Homoeopathic Medicines In Asymptomatic Covid -19 Individuals Receiving Standard Treatment Protocol,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760,NA
CTRI/2020/06/025854,CTRI,2020-06-13,2020-06-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,BCG vaccination against COVID-19,1450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,NA
CTRI/2020/06/025856,CTRI,2020-06-13,2020-06-25,FALSE,Not Recruiting,Phase 2,Interventional,India,Evaluation of siddha regimen in the management of covid 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606,NA
CTRI/2020/06/025855,CTRI,2020-06-13,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Effect of AYUSH 64 in COVID 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386,NA
CTRI/2020/06/025858,CTRI,2020-06-13,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Observational study on suspected COVID 19 patients admitted to ICU,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44652,NA
CTRI/2020/06/025857,CTRI,2020-06-13,2020-06-23,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,Follow-up of COVID-19 Positive Patients,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44663,NA
CTRI/2020/06/025861,CTRI,2020-06-14,2020-06-20,FALSE,Recruiting,Phase 3,Interventional,India,Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level study,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072,NA
CTRI/2020/06/025862,CTRI,2020-06-14,2020-06-13,TRUE,Recruiting,Phase 1,Interventional,India,Low Dose Radiation Therapy for COVID-19,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,NA
CTRI/2020/06/025874,CTRI,2020-06-15,2020-06-24,FALSE,Not Recruiting,Phase 2,Interventional,India,To observe the effect of Siddha formulation Kabasura kudineer in COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,NA
CTRI/2020/06/025927,CTRI,2020-06-16,2020-06-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of C-MAC and Mc-GRATH laryngoscopes for intubation in COVID scenario.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316,NA
CTRI/2020/06/025928,CTRI,2020-06-16,2020-06-30,FALSE,Recruiting,Not Applicable,Interventional,India,Local application of Povidone Iodine solution in nose and oral gargle for house hold contacts of COVID19 cases,204,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664,NA
CTRI/2020/06/025917,CTRI,2020-06-16,2020-06-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Psychological assessment of the health care-workers amid COVID-19 working at a tertiary care teaching hospital of the central India and impact of tele-counselling on their psychological problems,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505,NA
CTRI/2020/06/025957,CTRI,2020-06-17,2020-06-29,FALSE,Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir and Umifenovir Compared to Favipiravir alone in Hospitalized Patients with Moderate COVID-19.,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709,NA
CTRI/2020/06/025977,CTRI,2020-06-18,2020-06-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical Study to Study Safety and Efficacy of herbal formulation - Aayudh Advance,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449,NA
CTRI/2020/06/025996,CTRI,2020-06-19,2020-06-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622,NA
CTRI/2020/06/025998,CTRI,2020-06-20,2020-06-30,FALSE,Not Recruiting,Phase 3,Interventional,India,Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707,NA
CTRI/2020/06/026000,CTRI,2020-06-21,2020-06-26,FALSE,Recruiting,Not Applicable,Observational,India,COVID-19 in kidney transplant recipient,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44567,NA
CTRI/2020/06/026001,CTRI,2020-06-21,2020-06-25,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,Ivermectin in COVID,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,NA
CTRI/2020/06/025999,CTRI,2020-06-21,2020-06-27,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764,NA
CTRI/2020/06/026005,CTRI,2020-06-21,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Pooled testing for COVID,321,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44520,NA
CTRI/2020/06/026002,CTRI,2020-06-21,2020-01-07,TRUE,Not Recruiting,Phase 2,Interventional,India,Study of use of Ayurveda Intervention (Ayush-64) in COVID 19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799,NA
CTRI/2020/06/026039,CTRI,2020-06-22,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,India,CANCER care in COVID-19 ERAÃ¢?? A survey proposed to study the treatment preference and perspectives of patients with blood cancer in a highly specialized cancer care hospital in India during COVID-19 ERA.,213,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43815,NA
CTRI/2020/06/026044,CTRI,2020-06-22,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,India,Oral Fluid Sars-CoV-2 Ab Rapid test,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44919,NA
CTRI/2020/06/026045,CTRI,2020-06-22,2020-01-07,TRUE,Not Recruiting,Phase 3,Interventional,India,A study to improve the resistance against Covid 19 illness with the help of Homoeopathic remedies.,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677,NA
CTRI/2020/06/026055,CTRI,2020-06-23,2020-06-26,FALSE,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306,NA
CTRI/2020/06/026056,CTRI,2020-06-23,2020-06-26,FALSE,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130,NA
CTRI/2020/06/026047,CTRI,2020-06-23,2020-01-07,TRUE,Not Recruiting,Not Applicable,Observational,India,Dental education and coronavirus,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44913,NA
CTRI/2020/06/026087,CTRI,2020-06-23,2020-08-07,FALSE,Not Recruiting,Phase 2,Interventional,India,"Phase II, randomized, controlled, open-label study of
Pegylated IFN alfa-2b with SARS-CoV-2",40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775,NA
CTRI/2020/06/026118,CTRI,2020-06-24,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,India,"Antiphospholipid Antibody (APLA) level in COVID-19 Cases.
",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44829,NA
CTRI/2020/06/026123,CTRI,2020-06-24,2020-06-25,FALSE,Not Recruiting,Phase 2,Interventional,India,Plasma therapy in corona patients(Severe COVID-19).,472,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,NA
CTRI/2020/06/026120,CTRI,2020-06-24,2020-03-07,TRUE,Not Recruiting,Not Applicable,Observational,India,"Validation of Rapid Test kit for Antibody (IgG, IgM) detection against COVID19.",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44931,NA
CTRI/2020/06/026119,CTRI,2020-06-24,2020-06-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Efficacy of Arsenic Album 30C and 200C potency in mild case of COVID-19 positive . (Isolation ward of Sir T General Hospital, Bhavnagar) patients: A randomized controlled study.",90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218,NA
CTRI/2020/06/026121,CTRI,2020-06-24,2020-04-07,TRUE,Recruiting,Not Applicable,Observational,India,To Understand Knowledge and Compliance of Hydroxychloroquine Prophylaxis among Health Care Workers during COVID-19 pandemic,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45006,NA
CTRI/2020/06/026147,CTRI,2020-06-25,2020-10-06,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among quarantined individuals exposed to COVID 19 patients,604,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778,NA
CTRI/2020/06/026151,CTRI,2020-06-25,2020-10-06,FALSE,Not Recruiting,Phase 2,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among healthcare workers,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770,NA
CTRI/2020/06/026161,CTRI,2020-06-26,2020-09-21,FALSE,Not Recruiting,Not Applicable,Interventional,India,Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation II [Sanshamani Vati Plus] as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832,NA
CTRI/2020/06/026152,CTRI,2020-06-26,2020-06-26,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 in dialysis patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43879,NA
CTRI/2020/06/026181,CTRI,2020-06-26,2020-04-07,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Herbal Steaminhaler clinical trial on  COVID patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976,NA
CTRI/2020/06/026190,CTRI,2020-06-26,2020-07-14,FALSE,Not Recruiting,Phase 2,Interventional,India,A Trial of Shirashadi Kasai in patients with Covid-19,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005,NA
CTRI/2020/06/026188,CTRI,2020-06-26,2020-06-07,TRUE,Not Recruiting,Not Applicable,Observational,India,Psychological Assessment of adult COVID-19 patients,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45024,NA
CTRI/2020/06/026187,CTRI,2020-06-26,2020-05-07,TRUE,Not Recruiting,Phase 2,Interventional,India,Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027,NA
CTRI/2020/06/026189,CTRI,2020-06-26,2020-01-08,TRUE,Not Recruiting,Phase 2,Interventional,India,"To Compare the safety and efficacy of Vitamin D, with Magnesium in mild to moderate Covid 19 patients",210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,NA
CTRI/2020/06/026184,CTRI,2020-06-26,2020-06-07,TRUE,Not Recruiting,Not Applicable,Observational,India,Mental Health of Health Care Workers during COVID-19 pandemics,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45031,NA
CTRI/2020/06/026191,CTRI,2020-06-27,2020-01-08,TRUE,Not Recruiting,Phase 2,Interventional,India,"To study the safety and efficacy   of Vitamin D3, Vitamin K2-7 & magnesium ,  in prevention of COVID 19 infection in health care professional (HCP)",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,NA
CTRI/2020/06/026192,CTRI,2020-06-28,2020-07-13,FALSE,Not Recruiting,Phase 2,Interventional,"India, Russian Federation, Ukraine, United Kingdom",The study of C21 in hospitalised subjects with COVID-19 infection not requiring mechanical ventilation,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815,NA
CTRI/2020/06/026194,CTRI,2020-06-28,2020-06-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,Using N-acetylcysteine as therapeutic drug for COVID-19 patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44341,NA
CTRI/2020/06/026195,CTRI,2020-06-28,2020-08-07,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as an add-on in treatment of COVID-19,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129,NA
CTRI/2020/06/026198,CTRI,2020-06-28,2020-10-07,FALSE,Not Recruiting,Not Applicable,Observational,India,Conscious posture therapy and covid 19 hypoxemia,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43651,NA
CTRI/2020/06/026196,CTRI,2020-06-28,2020-08-15,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,"Ghana, South Africa, Benin, United Kingdom, Italy, Mexico, Rwanda, India, Nigeria",Prevention of Respiratory Complications In At Surgery in COVID-19 Pandemic,6400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482,NA
CTRI/2020/06/026193,CTRI,2020-06-28,2020-07-30,FALSE,Recruiting,Not Applicable,Interventional,India,A study of drug Lithium on patients of Covid 19 disease,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766,NA
CTRI/2020/06/026197,CTRI,2020-06-28,2020-06-07,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Validation of Classical Ayurvedic formulations in treatment of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052,NA
CTRI/2020/06/026228,CTRI,2020-06-29,2020-06-29,FALSE,Not Recruiting,Phase 2,Interventional,"Sweden, Russian Federation, Italy, Brazil, Spain, Turkey, Japan, France, India, Germany",Study in Hospitalized COVID-19 patients with Acalabrutinib along with the Best Supportive Care versus Best Supportive Care,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,NA
CTRI/2020/06/026222,CTRI,2020-06-29,2020-06-29,FALSE,Not Recruiting,Phase 2,Interventional,India,Intravenous Immunoglobulin Therapy in the treatment of Moderate Pneumonia in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299,NA
CTRI/2020/06/026227,CTRI,2020-06-29,2020-07-07,FALSE,Not Recruiting,Phase 3,Interventional,India,"A Study on Unani regimen 
for prevention of high/moderate risk population of COVID 19",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584,NA
CTRI/2020/06/026229,CTRI,2020-06-29,2020-10-07,FALSE,Recruiting,Phase 2,Interventional,India,A clinical trial of Ayurveda formulations in COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105,NA
CTRI/2020/06/026220,CTRI,2020-06-29,2020-07-17,FALSE,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the efficacy and safety of Nafamostat Mesilate in treatment of Coronavirus infection,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350,NA
CTRI/2020/06/026232,CTRI,2020-06-29,2020-10-07,FALSE,Not Recruiting,Phase 3,Interventional,India,Ivermectin in the prevention of covid-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,NA
CTRI/2020/06/026231,CTRI,2020-06-29,2020-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,"To study effect of ayurvedic treatment for prevention and management of asymptomatic, mild and moderate cases of COVID-19.",160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497,NA
CTRI/2020/06/026221,CTRI,2020-06-29,2020-01-07,TRUE,Not Recruiting,Phase 2,Interventional,India,Intervention of Ayurvedic Medicine (Arogya Kashayam) in Covid-19 positive cases (Asymptomatic and Mild Symptomatic),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542,NA
CTRI/2020/06/026250,CTRI,2020-06-30,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Correlation of urinary porphyrin and biochemical markers with the severity of symptoms of COVID-19 cases.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45057,NA
CTRI/2020/06/026256,CTRI,2020-06-30,2020-10-07,FALSE,Not Recruiting,Not Applicable,Observational,India,Resveratrol and copper for the treatment of COVID-19 pnuemonia.,230,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45115,NA
CTRI/2020/06/026262,CTRI,2020-06-30,2020-01-07,TRUE,Not Recruiting,Not Applicable,Interventional,India,"Single Center,Study on Evaluation of use of,Ã¢??AYURCOVÃ¢?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889,NA
CTRI/2020/07/026301,CTRI,2020-07-01,2020-08-07,FALSE,Not Recruiting,Not Applicable,Interventional,India,Role of Yoga in deStressing HCWs in COVID-19 : A RCT,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651,NA
CTRI/2020/07/026299,CTRI,2020-07-01,2020-07-13,FALSE,Recruiting,Not Applicable,Observational,India,Impact of Corona virus pandemic and lockdown on people with mental illness and their caregivers,804,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45163,NA
CTRI/2020/07/026298,CTRI,2020-07-01,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,India,The impact of COVID-19 pandemic in frontline health care professionals,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43722,NA
CTRI/2020/07/026337,CTRI,2020-07-02,2020-11-07,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,The Covid-19 Study with Ayurveda add-on to ICMR Guideline,36,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863,NA
CTRI/2020/07/026338,CTRI,2020-07-02,2020-07-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study to assess the Health care workersÃ¢?? knowledge of the Medical cause of death certification for COVID-19 related deaths in cancer patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181,NA
CTRI/2020/07/026340,CTRI,2020-07-02,2020-11-07,FALSE,Not Recruiting,Not Applicable,Interventional,India,To study the role of Zinc combined with standard treatment for COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929,NA
CTRI/2020/07/026339,CTRI,2020-07-02,2020-07-15,FALSE,Recruiting,Not Applicable,Observational,India,Understanding COVID and cancer,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44951,NA
CTRI/2020/07/026330,CTRI,2020-07-02,2020-11-07,FALSE,Not Recruiting,Not Applicable,Observational,India,"Illness Wellness Scale is a new scale which is being developed to assess the physical performance status of all patients, whether or not suffering from COVID infection, requiring surgical intervention or care.",210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45213,NA
CTRI/2020/07/026331,CTRI,2020-07-02,2020-06-07,TRUE,Not Recruiting,Not Applicable,Observational,India,Survey on Convalescent Plasma (CVP) for COVID-19,2200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45017,NA
CTRI/2020/07/026351,CTRI,2020-07-03,2020-07-14,FALSE,Not Recruiting,Not Applicable,Observational,India,"Software for COVID19 Detection from Chest X-Ray, CT or Ultrasonography",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45151,NA
CTRI/2020/07/026343,CTRI,2020-07-03,2020-11-07,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana treatment as an addon therapy to improve the results in management of coronavirus disease,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204,NA
CTRI/2020/07/026349,CTRI,2020-07-03,2020-04-07,TRUE,Recruiting,Phase 3,Interventional,India,Effect of awake proning in patients with COVID-19 related respiratory failure,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918,NA
CTRI/2020/07/026350,CTRI,2020-07-03,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Stress and coping among healthcare workers during COVID-19 outbreak,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44198,NA
CTRI/2020/07/026355,CTRI,2020-07-04,2020-07-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Evaluation Of The Efficacy of AYUSH KWATH in The Prevention  of COVID-19 

",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327,NA
CTRI/2020/07/026354,CTRI,2020-07-04,2020-07-13,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Clinical trial of ozone therapy  in mild to moderate Covid-19 subjects.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173,NA
CTRI/2020/07/026353,CTRI,2020-07-04,2020-12-07,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266,NA
CTRI/2020/07/026352,CTRI,2020-07-04,2020-07-13,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects.,1048,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306,NA
CTRI/2020/07/026367,CTRI,2020-07-05,2020-07-15,FALSE,Not Recruiting,Not Applicable,Observational,"United States, India, United Kingdom","An international multi-centre appraisal of the management of acute 
CHOLEcystitis during the COVID-19 pandemic: The CHOLECOVID audit.",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45324,NA
CTRI/2020/07/026369,CTRI,2020-07-05,2020-07-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of rapid diagnostic kit (COVIDAG-SP) in the detection of COVID-19 virus antigen,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44880,NA
CTRI/2020/07/026370,CTRI,2020-07-05,2020-07-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of rapid diagnostic kit (COVIDAB-SP) in the detection of COVID-19 virus antibody,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45185,NA
CTRI/2020/07/026368,CTRI,2020-07-05,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Spread of corona virus disease and factors affecting it in Pune city.,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45232,NA
CTRI/2020/07/026371,CTRI,2020-07-05,2020-07-13,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272,NA
CTRI/2020/07/026389,CTRI,2020-07-06,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,India,Effect of Corona virus infection and lockdown on access to health services and on mental health among urban and peri-urban low- to mid-socioeconomic neighborhoods in South Delhi,450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44395,NA
CTRI/2020/07/026424,CTRI,2020-07-08,2020-07-14,FALSE,Not Recruiting,Not Applicable,Observational,India,An Observational Study on Health issues during covid 19 lock down,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45337,NA
CTRI/2020/07/026431,CTRI,2020-07-08,2020-01-09,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,India,A clinical trial to find out the effectiveness of traditional awareness method and anticipatory guidance through motivational interviewing.,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340,NA
CTRI/2020/07/026433,CTRI,2020-07-08,2020-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of Ayurveda medicinein Covid-19 mild symptoms,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,NA
CTRI/2020/07/026463,CTRI,2020-07-09,2020-10-07,FALSE,Recruiting,Not Applicable,Interventional,India,Clinical study to evaluate efficacy and safety of GanjhuVir syrup and tablet in Covid-19 positive patients.,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844,NA
CTRI/2020/07/026462,CTRI,2020-07-09,2020-07-20,FALSE,Not Recruiting,Phase 3,Interventional,India,A study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of asymptomatic mild to moderate symptomatic cases.,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637,NA
CTRI/2020/07/026445,CTRI,2020-07-09,2020-07-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Types of dental emergencies during Covid epidemic,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45445,NA
CTRI/2020/07/026451,CTRI,2020-07-09,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,India,"Observational Study of Sensitivity and Specificity of COVID-19 Screening and
Diagnostics in COVID-19 Infected Individuals.
",150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44483,NA
CTRI/2020/07/026471,CTRI,2020-07-10,2020-07-20,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus disease,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318,NA
CTRI/2020/07/026469,CTRI,2020-07-10,2020-07-14,FALSE,Not Recruiting,Phase 4,Interventional,India,Rapid diagnostic test for the detection of COVID-19 antibodies,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336,NA
CTRI/2020/07/026468,CTRI,2020-07-10,2020-09-18,FALSE,Recruiting,Not Applicable,Interventional,India,"Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients 
",140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844,NA
CTRI/2020/07/026470,CTRI,2020-07-10,2020-07-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Safety and Effectiveness of  Siddha Sastric Medicines for the Management of Covid-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363,NA
CTRI/2020/07/026472,CTRI,2020-07-10,2020-07-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Epidemiology and outcomes of COVID-19 in Udupi,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45392,NA
CTRI/2020/07/026499,CTRI,2020-07-10,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of India Health FoundationÃ¢??s (IHFÃ¢??s) RT PCR kit for detection of COVID-19 virus (SARS-CoV-2) antigens,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45406,NA
CTRI/2020/07/026473,CTRI,2020-07-10,2020-07-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Views of Indian dental students on international dental higher education after Covid-19,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45448,NA
CTRI/2020/07/026474,CTRI,2020-07-10,2020-07-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of insulins (a chemical in our body which decreases blood sugar) sugar lowering effect in COVID-19 patients,125,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45474,NA
CTRI/2020/07/026510,CTRI,2020-07-12,2020-07-17,FALSE,Not Recruiting,Not Applicable,Observational,India,"Clinical presentation, Management, Treatment and Outcome of  COVID patients",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45415,NA
CTRI/2020/07/026509,CTRI,2020-07-12,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Serosurvey for antibodies against SARS-CoV-2 in Pune city,1520,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45476,NA
CTRI/2020/07/026508,CTRI,2020-07-12,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Genome Sequencing of COVID-19 virus,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44266,NA
CTRI/2020/07/026514,CTRI,2020-07-13,2020-07-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19 Cancer Patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580,NA
CTRI/2020/07/026515,CTRI,2020-07-13,2020-07-22,FALSE,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection with Cancer Patients.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584,NA
CTRI/2020/07/026532,CTRI,2020-07-13,2020-07-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison to two different position to relieve difficulty in breathing in COVID- 19 patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354,NA
CTRI/2020/07/026534,CTRI,2020-07-13,2020-07-20,FALSE,Not Recruiting,Phase 3,Interventional,India,Study of antiviral nutraceutical PICOVRID in COVID 19 patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137,NA
CTRI/2020/07/026533,CTRI,2020-07-13,2020-07-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Study to observe cancer directed treatment during COVID-19 pandemic situation.,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45172,NA
CTRI/2020/07/026529,CTRI,2020-07-13,2020-07-20,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Study to evaluate the safety and efficacy of Eflornithine against the standard of care in human adult hospitalized COVID-19 patients,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475,NA
CTRI/2020/07/026516,CTRI,2020-07-13,2020-07-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical manifestations in neonates born to Covid 19 positive mothers.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44982,NA
CTRI/2020/07/026528,CTRI,2020-07-13,2020-08-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,Herbal formulation for immunity boosting during pandemic,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269,NA
CTRI/2020/07/026530,CTRI,2020-07-13,2020-01-08,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurvedic formulations for the prevention of COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532,NA
CTRI/2020/07/026535,CTRI,2020-07-13,2020-07-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical study to observe the effects of 8.4% Sodium Bicarbonate impregnated steam inhalation on Covid-19 infected patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535,NA
CTRI/2020/07/026576,CTRI,2020-07-14,2020-07-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Influence of Lockdown on dental professionals,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45573,NA
CTRI/2020/07/026560,CTRI,2020-07-14,2020-07-21,FALSE,Not Recruiting,Phase 3,Interventional,India,Neem Prophylaxis for Subjects Coming in Contact with COVID-19 Patients,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385,NA
CTRI/2020/07/026574,CTRI,2020-07-14,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To assess the seriousness  in COVID-19 patients with the blood test report.
",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45396,NA
CTRI/2020/07/026571,CTRI,2020-07-14,2020-07-21,FALSE,Not Recruiting,Not Applicable,Observational,India,"Pattern of ocular surface involvement in COVID-19 patients in Hassan,Karnataka.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45426,NA
CTRI/2020/07/026575,CTRI,2020-07-14,2020-07-20,FALSE,Not Recruiting,Phase 2,Interventional,India,Sahadevi Choorna for COVID 19,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500,NA
CTRI/2020/07/026570,CTRI,2020-07-14,2020-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of Ayurvedic Capsule in mild to moderate COVID-19 infection.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007,NA
CTRI/2020/07/026559,CTRI,2020-07-14,2020-07-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Survey about knowledge towards blood donation during COVID 19 pandemic,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45544,NA
CTRI/2020/07/026579,CTRI,2020-07-14,2020-07-24,FALSE,Not Recruiting,Phase 3,Interventional,India,Role of Herbal Immunomodulators in in Boosting the Immunity among healthcare workers assigned to COVID-19 wards,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034,NA
CTRI/2020/07/026568,CTRI,2020-07-14,2020-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ayurveda Rasayan therapy for reducing risk of COVID infection in high risk individuals with comorbidities,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035,NA
CTRI/2020/07/026611,CTRI,2020-07-15,2020-07-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Surgical Outcomes in COVID-19 Patients (SOVID),50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44568,NA
CTRI/2020/07/026612,CTRI,2020-07-15,2020-07-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Psycho-social Problems among COVID Infection Survivors,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45100,NA
CTRI/2020/07/026602,CTRI,2020-07-15,2020-07-24,FALSE,Not Recruiting,Phase 2,Interventional,India,Study of an Ayurveda regimen in COVID Positive patients,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628,NA
CTRI/2020/07/026608,CTRI,2020-07-15,2020-07-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to study the effects of two drugs methylprednisolone and dexamethasone in patients with severe COVID-19,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638,NA
CTRI/2020/07/026610,CTRI,2020-07-15,2020-07-28,FALSE,Not Recruiting,Not Applicable,Observational,India,General anaesthesia with aerosol box during COVID pandemic,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45643,NA
CTRI/2020/07/026609,CTRI,2020-07-15,2020-07-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Yoganidra benefits on COVID health care workers,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139,NA
CTRI/2020/07/026607,CTRI,2020-07-15,2020-07-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Evaluation of Non Invasive Ventilator,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998,NA
CTRI/2020/07/026601,CTRI,2020-07-15,2020-07-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A study to check effect of an Ayurvedic treatment on corona positive patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564,NA
CTRI/2020/07/026630,CTRI,2020-07-16,2020-07-22,FALSE,Recruiting,Phase 2,Interventional,India,Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581,NA
CTRI/2020/07/026632,CTRI,2020-07-16,2020-07-27,FALSE,Not Recruiting,Phase 2,Interventional,India,Siddha Treatment for COVID 19- a Pilot Study,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680,NA
CTRI/2020/07/026631,CTRI,2020-07-16,2020-07-19,FALSE,Not Recruiting,Not Applicable,Interventional,India,Uses of herbal combination by taking it in hot water  in  covid 19 positive patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494,NA
CTRI/2020/07/026658,CTRI,2020-07-17,2020-07-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Teleophthalmology experience during COVIDÃ¢??19 lockdown.,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45350,NA
CTRI/2020/07/026667,CTRI,2020-07-17,2020-07-17,FALSE,Not Recruiting,Not Applicable,Interventional,India,: Efficacy of Pranayama on Positivity rate in People exposed to Covid-19 Patients and mental status,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342,NA
CTRI/2020/07/026633,CTRI,2020-07-17,2020-07-25,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,Mental state of the Bangladeshi physiotherapist amid COVID-19 pandemic.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45666,NA
CTRI/2020/07/026659,CTRI,2020-07-17,2020-07-25,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 related study among dental patients in Udupi District,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45431,NA
CTRI/2020/07/026664,CTRI,2020-07-17,2020-07-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To find the frequency of misting ""fogging""of protective spectacles and comparison of various techniques to reduce misting of spectacles while working in intensive care unit during COVID 19 pandemic",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44690,NA
CTRI/2020/07/026660,CTRI,2020-07-17,2020-07-27,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to measure the mental stress of the upcoming primary caregivers of children cancer patients diagnosed with Covid-19 illness,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45715,NA
CTRI/2020/07/026669,CTRI,2020-07-18,2020-03-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,Unani Herbal tablets for mild cases od Covid 19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623,NA
CTRI/2020/07/026673,CTRI,2020-07-18,2020-05-08,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Siddha formulations for the prevention of COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673,NA
CTRI/2020/07/026668,CTRI,2020-07-18,2020-05-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,To study the effect of BCG vaccine in Reducing the Incidence and severity of COVID-19 in the high-risk population,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677,NA
CTRI/2020/07/026670,CTRI,2020-07-18,2020-07-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Role of immune boosting kit in covid disease,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713,NA
CTRI/2020/07/026671,CTRI,2020-07-18,2020-07-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ozone Therapy for Covid 19 patients,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,NA
CTRI/2020/07/026672,CTRI,2020-07-18,2020-07-28,FALSE,Not Recruiting,Not Applicable,Observational,"Nepal, Saudi Arabia, Syrian Arab Republic, United Kingdom, Yemen, Azerbaijan, Gabon, Guatemala, Cote d'Ivoire, Austria, Armenia, China, Poland, Romania, Denmark, Malawi, Belgium, Burkina Faso, Brunei Darussalam, Ethiopia, Swaziland, United States, Cameroon, Mongolia, Timor-Leste, Botswana, Myanmar, Panama, Turkmenistan, Democratic People's Republic of Korea, Cyprus, New Zealand, Netherlands, Nauru, Madagascar, San Marino, Tajikistan, Slovenia, Singapore, Slovakia, Colombia, Andorra, Burundi, Spain, Togo, Uganda, Guinea-Bissau, Sri Lanka, United Republic of Tanzania, Georgia, Angola, Bhutan, Norway, Turkey, Djibouti, Finland, Paraguay, Chad, Costa Rica, Afghanistan, Mozambique, Luxembourg, Uruguay, Ecuador, Sudan, Central African Republic, Lebanon, Bulgaria, Switzerland, Croatia, Namibia, Nicaragua, Brazil, Mali, Lao People's Democratic Republic, El Salvador, Nigeria, Sierra Leone, Chile, The former Yugoslav Republic of Macedonia, Bahrain, Iran, Suriname, Albania, Mauritius, Kuwait, Kiribati, Barbados, Jamaica, Saint Kitts and Nevis, India, Tonga, Haiti, Guyana, Kyrgyzstan, Zambia, Cambodia, Algeria, Japan, Antigua and Barbuda, Maldives, Rwanda, Belize, France, Saint Vincent and the Grenadines, Lithuania, Dominican Republic, Honduras, Fiji, Greece, United Arab Emirates, Taiwan, Czech Republic, Uzbekistan, Montenegro, Kazakhstan, Seychelles, Argentina, Hungary, Iceland, Democratic Republic of Congo, Solomon Islands, Papua New Guinea, Italy, Mexico, Malta, Other, Vanuatu, Monaco, Liberia, Malaysia, Philippines, Kenya, Palau, Senegal, Australia, Portugal, Eritrea, Samoa, Comoros, Cook Islands, Bahamas, Estonia, Thailand, Niue, Cuba, Micronesia (Federated States of), Sweden, Republic of Korea, Russian Federation, Tanzania, Democratic Republic of the Congo, Benin, Jordan, Venezuela (Bolivarian Republic of), Canada, Pakistan, Morocco, Saint Lucia, Bolivia, Egypt, Vietnam, Lesotho, Sao Tome and Principe, Niger, Bosnia and Herzegovina, Mauritania, Hong Kong, Ireland, Indonesia, Bangladesh, Belarus, Gambia, Iraq, Somalia, Germany, Tuvalu, Equatorial Guinea, South Africa, Trinidad and Tobago, Republic of Moldova, Marshall Islands, Cape Verde, Serbia , Dominica, Grenada, Ukraine, Oman, Latvia, Ghana, Tunisia, Qatar, Peru, Israel, Libyan Arab Jamahiriya, Zimbabwe, Guinea",Mental health affected by COVID-19,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45764,NA
CTRI/2020/07/026676,CTRI,2020-07-19,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on Pregnant women,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44603,NA
CTRI/2020/07/026674,CTRI,2020-07-19,2020-07-27,FALSE,Not Recruiting,Phase 1,Interventional,India,Effect of Ayurveda Spice Mix Tablet for the Prevention of COVID-19 infection in people exposed to Covid 19 and in high risk patients,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712,NA
CTRI/2020/07/026675,CTRI,2020-07-19,2020-07-27,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Efficacy of Ayurveda treatment Protocol with Tulsimmune Tablet in Covid 19,76,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,NA
CTRI/2020/07/026677,CTRI,2020-07-19,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Role of cough and voice analysis using artificial intelligence in the management of COVID 19 patients,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45780,NA
CTRI/2020/07/026678,CTRI,2020-07-19,2020-07-30,FALSE,Recruiting,Not Applicable,Observational,India,what are the clinical effects in newborns born to mothers exposed to COVID-19 viral infection.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45786,NA
CTRI/2020/07/026705,CTRI,2020-07-20,2020-07-28,FALSE,Not Recruiting,Phase 1,Interventional,India,Efficacy and safety of AYUSH 64 tablets in treating mild to moderate Covid 19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088,NA
CTRI/2020/07/026698,CTRI,2020-07-20,2020-05-19,TRUE,Not Recruiting,Not Applicable,Observational,India,COVID 19 and changes in the heart,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43604,NA
CTRI/2020/07/026700,CTRI,2020-07-20,2020-07-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana therapies,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,NA
CTRI/2020/07/026701,CTRI,2020-07-20,2020-07-23,FALSE,Not Recruiting,Not Applicable,Observational,India,"Scanning of Lungs, Heart and blood vessels by two different techniques using ultrasound in COVID-19 patients",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44985,NA
CTRI/2020/07/026714,CTRI,2020-07-21,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on Healthcare Workers,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44848,NA
CTRI/2020/07/026728,CTRI,2020-07-21,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,India,"Knowledge,Attitude,and Practice towards COVID-19 among Kerala Residents during the outbreak period:an online cross sectional survey.",140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45408,NA
CTRI/2020/07/026715,CTRI,2020-07-21,2020-07-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Structured online training program on specific COVID-19 Airway Management,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45798,NA
CTRI/2020/07/026757,CTRI,2020-07-23,2020-07-31,FALSE,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824,NA
CTRI/2020/07/026758,CTRI,2020-07-23,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,India,Knowledge Attitude and Practice of Nurses towards Hand hygiene in COVID-19 care units,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45877,NA
CTRI/2020/07/026759,CTRI,2020-07-23,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Detection of Antibodies to COVID-19,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45882,NA
CTRI/2020/07/026755,CTRI,2020-07-23,2020-07-27,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical severity and outcome among covid-19 infected patients in respect to viral load and immune & inflammatory response.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44619,NA
CTRI/2020/07/026747,CTRI,2020-07-23,2020-07-24,FALSE,Not Recruiting,Not Applicable,Observational,India,In this study selenium levels would be determined in both normal volunteers as well as patients suffering from COVID-19.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45446,NA
CTRI/2020/07/026756,CTRI,2020-07-23,2020-07-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ayurveda strength and immunity enhancing protocol and immunity in health care workers : Clinical trial of an Ayurveda Intervention,425,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755,NA
CTRI/2020/07/026791,CTRI,2020-07-25,2020-01-08,TRUE,Recruiting,Phase 2/Phase 3,Interventional,India,Statin and Aspirin in SARS-CoV-2 infection,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814,NA
CTRI/2020/07/026798,CTRI,2020-07-25,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,"Depression, Anxiety and 
 Stress among healthcare workers during the curved 19 pandemic",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45852,NA
CTRI/2020/07/026796,CTRI,2020-07-25,2020-03-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,A trial to evaluate the effect of cotton face-masks and other behavioral factors on COVID-19 risk in rural Telangana,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868,NA
CTRI/2020/07/026792,CTRI,2020-07-25,2020-07-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Affect in surgical care in children due to COVID 19 in India: a  online survey of surgeons,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45616,NA
CTRI/2020/07/026789,CTRI,2020-07-25,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical study to see effect of  ArtemiC in patients with COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,NA
CTRI/2020/07/026797,CTRI,2020-07-25,2020-02-08,TRUE,Not Recruiting,Not Applicable,Observational,India,An observational study of lying down flat on chest in treatment of corona patient who breath on their own and on oxygen therapy.,111,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45903,NA
CTRI/2020/07/026790,CTRI,2020-07-25,2020-03-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,This is the comparative study between two protective boxes which can be used by the doctors while managing critical COVID 19 patients in addition to personal protective equipment.,21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143,NA
CTRI/2020/07/026800,CTRI,2020-07-25,2020-03-08,TRUE,Recruiting,Not Applicable,Observational,India,A study to campare various blood investigations  in  COVID-19 positive patients.,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45937,NA
CTRI/2020/07/026799,CTRI,2020-07-25,2020-04-08,TRUE,Recruiting,Phase 2/Phase 3,Interventional,India,Yoga for Nurses (COVID-19),60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964,NA
CTRI/2020/07/026793,CTRI,2020-07-25,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,India,Panchgavya Therapy in prophylaxis and as an adjuvant therapy in management of Covid 19.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721,NA
CTRI/2020/07/026788,CTRI,2020-07-25,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,A Qualitative study regarding stress and coping in Front-line Health Care Doctors at a tertiary-care hospital.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44768,NA
CTRI/2020/07/026794,CTRI,2020-07-25,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Vitamin-D levels in COVID-19 Patients and their relationship with other bone metabolism markers,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45802,NA
CTRI/2020/07/026836,CTRI,2020-07-27,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of COVID - 19 pandemic researchers,1850,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45113,NA
CTRI/2020/07/026831,CTRI,2020-07-27,2020-01-08,TRUE,Not Recruiting,Phase 3,Interventional,India,"Controlled evaluation of Angiotensin Receptor Blockers for COVID-19
Respiratory Disease
",605,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605,NA
CTRI/2020/07/026820,CTRI,2020-07-27,2020-09-08,FALSE,Not Recruiting,Phase 4,Interventional,India,Curcumin for COVID-19 Pre Exposure Prophylaxis,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936,NA
CTRI/2020/07/026834,CTRI,2020-07-27,2020-07-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,REaCHing to you with listening ears; A friendly telephonic interaction Program for the DDU-GKY members,1480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953,NA
CTRI/2020/07/026837,CTRI,2020-07-27,2020-04-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Antibody response to COVID-19 in health care workers,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45957,NA
CTRI/2020/07/026840,CTRI,2020-07-27,2020-07-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 cases,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981,NA
CTRI/2020/07/026821,CTRI,2020-07-27,2020-08-24,FALSE,Not Recruiting,Not Applicable,Observational,India,"Study of skin, hair and nail changes after COVID 19 illness.",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45989,NA
CTRI/2020/07/026839,CTRI,2020-07-27,2020-05-08,TRUE,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation in management of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994,NA
CTRI/2020/07/026835,CTRI,2020-07-27,2020-07-27,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparison of two different types of simple non-invasive oxygen therapy devices in coronavirus lung infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539,NA
CTRI/2020/07/026832,CTRI,2020-07-27,2020-07-13,TRUE,Not Recruiting,Not Applicable,Observational,India,Artificial intelligence and machine learning for Covid 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44797,NA
CTRI/2020/07/026841,CTRI,2020-07-28,2020-03-08,TRUE,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 ( Turmeric extract ) drops in patients with Corona virus infection.",260,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659,NA
CTRI/2020/07/026902,CTRI,2020-07-29,2020-05-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Effect of CRP blood test in management of COVID 19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45977,NA
CTRI/2020/07/026925,CTRI,2020-07-30,2020-07-31,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,"to see the effect of twakadi(tea made up of dalcheeni, tulasi pepper, clove, etc)tea on police worker who have a duty in covid 19 pandemic",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587,NA
CTRI/2020/07/026922,CTRI,2020-07-30,2020-04-08,TRUE,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic intervention in COVID-19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909,NA
CTRI/2020/07/026954,CTRI,2020-07-31,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,India,Study of blood tests findings in patients of COVID 19 in a tertiary care centre,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46080,NA
CTRI/2020/07/026955,CTRI,2020-07-31,2020-08-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"What are risk factors associated with disease severity and length of hospital stay in patients admitted with COVID-19 in GCS Medical College, Hospital & Research Centre, Ahmedabad?",910,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46111,NA
CTRI/2020/07/026943,CTRI,2020-07-31,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Effects of revised COVID19 specific infection control protocol on the well being of dental professionals,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44582,NA
CTRI/2020/07/026953,CTRI,2020-07-31,2020-03-08,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,COMPARISON OF THREE HOMOEOPATHIC DRUGS FOR COVID 19 IMMUNE BOOSTERS AGAINST STANDARD TREATMENT,704,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668,NA
CTRI/2020/07/026952,CTRI,2020-07-31,2020-01-08,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Survey and Management 
 of depression, Anxiety and Stress due to COVID-19 fear",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683,NA
CTRI/2020/07/026942,CTRI,2020-07-31,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,India,Study of COVID 19 suspected pregnant women,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45698,NA
CTRI/2020/07/026926,CTRI,2020-07-31,2020-07-31,FALSE,Not Recruiting,Not Applicable,Observational,"Nepal, Indonesia, Sri Lanka, Thailand, Singapore, India, Malaysia, Philippines",Ethics of Behavioral Interventions during the Covid 19,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45456,NA
CTRI/2020/08/026956,CTRI,2020-08-01,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,India,Telemedicine effectiveness during COVID-19,463,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46136,NA
CTRI/2020/08/026957,CTRI,2020-08-02,2020-07-08,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,A Clinical trial to evaluate the effect of a combination of treatment of Reginmune capsule and Immunofree tablets in the treatment of mild to moderate COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825,NA
CTRI/2020/08/026980,CTRI,2020-08-04,2020-10-08,FALSE,Not Recruiting,Phase 3,Interventional,India,"Effect  Ayurveda decoctions, tablet and Panchagavya on COVID 19",180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082,NA
CTRI/2020/08/026964,CTRI,2020-08-04,2020-09-08,FALSE,Not Recruiting,Not Applicable,Observational,India,An observational study of effect of positioning on either side on oxygen level in corona patient.,167,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46100,NA
CTRI/2020/08/026977,CTRI,2020-08-04,2020-10-08,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of two online learning method of resuscitation training.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057,NA
CTRI/2020/08/026962,CTRI,2020-08-04,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,"Incubation period of COVID-19 cases admitted in North Kerala, India",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46133,NA
CTRI/2020/08/026985,CTRI,2020-08-04,2020-08-14,FALSE,Not Recruiting,Phase 2,Interventional,India,"Assessment of safety and efficacy of Kabasura
Kudineer in mild to moderate COVID-19",126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168,NA
CTRI/2020/08/026983,CTRI,2020-08-04,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Point of care ultrasound study in patients with respiratory illness during COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45679,NA
CTRI/2020/08/026978,CTRI,2020-08-04,2020-08-19,FALSE,No Status Given,Not Applicable,Interventional,Nepal,Effectiveness of Ayurvedic Formulation for COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435,NA
CTRI/2020/08/027007,CTRI,2020-08-05,2020-07-31,TRUE,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827,NA
CTRI/2020/08/027008,CTRI,2020-08-05,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Advantage of Artificial Intelligence to detect COVID 19 using Chest X-Ray.,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46099,NA
CTRI/2020/08/026999,CTRI,2020-08-05,2020-10-08,FALSE,Not Recruiting,Phase 2,Interventional,India,Evaluate the Efficacy of Siddha Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134,NA
CTRI/2020/08/027005,CTRI,2020-08-05,2020-12-08,FALSE,Recruiting,Phase 2,Interventional,India,Investigation of effect of homoeopathic remedy as add on therapy to standard of care (regular treatment) in adult patients with moderate to severe COVID-19,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189,NA
CTRI/2020/08/027000,CTRI,2020-08-05,2020-08-14,FALSE,Recruiting,Not Applicable,Observational,India,Retrospective cohort study in COVID 19 recovered patients,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45722,NA
CTRI/2020/08/026998,CTRI,2020-08-05,2020-08-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Youth experiences during COVID-19 pandemic,540,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46243,NA
CTRI/2020/08/027009,CTRI,2020-08-05,2020-08-15,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Use of Herbal Medicine like Tulasi,Amruth(Giloy), Turmeric,Ashwagandha for Improving the Immunity among Health care workers.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269,NA
CTRI/2020/08/027001,CTRI,2020-08-05,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,association of cardiac markers with severity of covid 19,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45531,NA
CTRI/2020/08/027033,CTRI,2020-08-07,2020-07-08,TRUE,Not Recruiting,Phase 2,Interventional,India,SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded),100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096,NA
CTRI/2020/08/027032,CTRI,2020-08-07,2020-11-08,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical study to assess the effects of MEDITATION (MINDFUL HAPPINESS) as an additional therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920,NA
CTRI/2020/08/027034,CTRI,2020-08-07,2020-08-15,FALSE,Not Recruiting,Not Applicable,Observational,India,An observational study of Guduchi Extract Tablet,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46193,NA
CTRI/2020/08/027038,CTRI,2020-08-07,2020-08-20,FALSE,Not Recruiting,Phase 3,Interventional,India,Study  to assess effects of nano ozonised hydrogen peroxide nebulisation on results of RT-PCR for novel corona Virus thus infectivity and clinical course among mild to moderate sick COVID-19 Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197,NA
CTRI/2020/08/027035,CTRI,2020-08-07,2020-08-19,FALSE,Not Recruiting,Not Applicable,Interventional,India,A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult population,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262,NA
CTRI/2020/08/027036,CTRI,2020-08-07,2020-08-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Retrospective Analysis of 245 COVID-19 Cases from a Government Teaching Hospital of North India,245,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46280,NA
CTRI/2020/08/027037,CTRI,2020-08-07,2020-08-17,FALSE,Recruiting,Phase 3,Interventional,India,Effect of Yoga for COVID-19 patients in addition to regular treatment,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324,NA
CTRI/2020/08/027040,CTRI,2020-08-08,2020-12-08,FALSE,Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846,NA
CTRI/2020/08/027047,CTRI,2020-08-09,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Nursing students perception of out of the classroom learning during the period of COVID-19,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46338,NA
CTRI/2020/08/027048,CTRI,2020-08-09,2020-08-17,FALSE,Recruiting,Phase 3,Interventional,India,Yoga for Police personnel,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344,NA
CTRI/2020/08/027049,CTRI,2020-08-09,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Study of families who travelled from another place and had COVID-19,19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46361,NA
CTRI/2020/08/027051,CTRI,2020-08-09,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,India,Survey of challenges faced by pain and palliative physicians working in cancer set up during corona virus disease time,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44061,NA
CTRI/2020/08/027050,CTRI,2020-08-09,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of PPE usage pattern and the associated Surgeon Discomfort and Fatigue Study.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46415,NA
CTRI/2020/08/027045,CTRI,2020-08-09,2020-08-17,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate efficacy and safety of Camphora tablets in Covid positive patients,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226,NA
CTRI/2020/08/027043,CTRI,2020-08-09,2020-10-08,FALSE,Not Recruiting,Phase 1,Interventional,India,Mesenchymal Stem Cell Therapy For Covid 19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175,NA
CTRI/2020/08/027046,CTRI,2020-08-09,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,A survey to analyze the understanding about the use of face mask among the general public during COVID 19,697,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46254,NA
CTRI/2020/08/027041,CTRI,2020-08-09,2020-08-14,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on COVID 19 patients to Improve Immunity,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258,NA
CTRI/2020/08/027042,CTRI,2020-08-09,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,"Secondary attack rate of COVID 19, Kerala",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46277,NA
CTRI/2020/08/027044,CTRI,2020-08-09,2020-08-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the outcome of Classical Ayurvedic medicine for the treatment of COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249,NA
CTRI/2020/08/027082,CTRI,2020-08-10,2020-08-18,FALSE,Not Recruiting,Not Applicable,Observational,India,To assess the fear and readiness of medical workers to work in the health care set up in the state of Karnataka during COVID-19 illness after the lock down is over.,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46351,NA
CTRI/2020/08/027078,CTRI,2020-08-10,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Establishment of surveillance system for individuals diagnosed with COVID-19.,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45924,NA
CTRI/2020/08/027079,CTRI,2020-08-10,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,study of lab investigations among hospitalized COVID-19 patients,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46185,NA
CTRI/2020/08/027084,CTRI,2020-08-10,2020-08-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Evaluate the medicinal effects of both Ayurveda combinations Bio-Immune as Anti-viral and Covalix Vaccoil as alternate to Vaccine of COVID-19 on exposed individuals and Covid19 contact.,61000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420,NA
CTRI/2020/08/027061,CTRI,2020-08-10,2020-08-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated Study to see the safety and efficacy of adding Thymosin Alpha to existing standard of care in severe COVID patients.,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729,NA
CTRI/2020/08/027080,CTRI,2020-08-10,2020-08-15,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Benefit of positioning in COVID-19 patient on Bipap mechnical support,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272,NA
CTRI/2020/08/027081,CTRI,2020-08-10,2020-08-17,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparision of two barrier devices for placement of tube into trachea(windpipe)in COVID19 patients,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289,NA
CTRI/2020/08/027083,CTRI,2020-08-10,2020-08-18,FALSE,Not Recruiting,Not Applicable,Observational,India,"Giloy Gomutra Capsule, Asthi churna aur Kamdhenu Asava ka vaishvik mahamari Covid-19 par logo ka anubhav aur Chikitsakiya prabhava ka Ankalan",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46331,NA
CTRI/2020/08/027085,CTRI,2020-08-11,2020-08-17,FALSE,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of citrobioShield product in improving immunity in COVID 19 patients via inhalation.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278,NA
CTRI/2020/08/027094,CTRI,2020-08-11,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Role of Digital communication in COVID 19 isolation facilities an observation study,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43763,NA
CTRI/2020/08/027102,CTRI,2020-08-13,2020-08-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Colchichine use for preventing COVID infection in haemodialysis patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658,NA
CTRI/2020/08/027106,CTRI,2020-08-13,2020-08-20,FALSE,Recruiting,Not Applicable,Interventional,India,"TO EVALUATE EFFICACY AND SAFETY OF Ã¢??VIRACIDEÃ¢?? 
IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)
",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639,NA
CTRI/2020/08/027109,CTRI,2020-08-13,2020-08-21,FALSE,Recruiting,Phase 2,Interventional,"Russian Federation, Indonesia, Italy, Spain, India",Efficacy and safety assessments of BDB-001 injection in treating patients with progressive severe COVID-19,256,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44387,NA
CTRI/2020/08/027104,CTRI,2020-08-13,2020-08-13,FALSE,Not Recruiting,Not Applicable,Observational,India,"CROSS SECTIONAL RETROSPECTIVE ANALYSIS OF CLINICAL SIGN OF breathlessness in sitting and supine position  IN
COVID-19 PATIENTS",45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45464,NA
CTRI/2020/08/027118,CTRI,2020-08-13,2020-08-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Personal Experience During COVID - 19 Pandemic,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46509,NA
CTRI/2020/08/027112,CTRI,2020-08-13,2020-08-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of N95 mask in our body study in high volume center,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46270,NA
CTRI/2020/08/027110,CTRI,2020-08-13,2020-08-22,FALSE,Not Recruiting,Not Applicable,Observational,India,"The role of  markers(nlr,il-6,d-dimer) in COVID-19 patients and itÃ¢??s co-relationship with oxygenation ,a retrospective  observational study in Tertiary  care covid ICU",250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46271,NA
CTRI/2020/08/027103,CTRI,2020-08-13,2020-08-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Novel Safe Transport Medium and Rapid RNA Extraction Method for COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46285,NA
CTRI/2020/08/027120,CTRI,2020-08-13,2020-08-20,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to know the efficacy and safety of herbal product Virowin in combination with Energy-Z capsule in treating mild to moderate COVID-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319,NA
CTRI/2020/08/027166,CTRI,2020-08-14,2020-08-18,FALSE,Not Recruiting,Not Applicable,Observational,India,"Study of stress, depression and anxiety in healthcare workers doing COVID duty",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46395,NA
CTRI/2020/08/027163,CTRI,2020-08-14,2020-08-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,Ashwagandha in the prevention of COVID-19 in Health Care workers,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406,NA
CTRI/2020/08/027165,CTRI,2020-08-14,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,"Sweden, United Kingdom, Canada, Norway, Algeria, Egypt, Finland, Austria, France, Denmark, Belgium, United States, Czech Republic, Germany, Argentina, New Zealand, Iceland, Italy, Brazil, Mexico, Chile, Australia, Iran, India",COVID-19 Global Rheumatology Alliance,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46228,NA
CTRI/2020/08/027162,CTRI,2020-08-14,2020-08-20,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the standard of Care in Covid patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240,NA
CTRI/2020/08/027168,CTRI,2020-08-14,2020-08-21,FALSE,Recruiting,Not Applicable,Interventional,India,Clinical trial study to investigate safety and efficacy of ImmunoSEB and ProbioSEB,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750,NA
CTRI/2020/08/027164,CTRI,2020-08-14,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,India,National Clinical Registry of COVID 19,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46320,NA
CTRI/2020/08/027170,CTRI,2020-08-15,2020-08-24,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study to check the safety and immune response of a COVID-19 vaccine in healthy Indian adults.,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186,NA
CTRI/2020/08/027169,CTRI,2020-08-15,2020-08-25,FALSE,Not Recruiting,Not Applicable,Observational,India,"Disease Profile of Covid-19 in patients admitted at AIIMS, Rishikesh",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46255,NA
CTRI/2020/08/027171,CTRI,2020-08-15,2020-08-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Measurement of renal biomarker in COVID-19 associated acute renal failure,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527,NA
CTRI/2020/08/027175,CTRI,2020-08-15,2020-08-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical profile of neonates born to mothers with COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44760,NA
CTRI/2020/08/027174,CTRI,2020-08-15,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on frontline health care workers,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45547,NA
CTRI/2020/08/027173,CTRI,2020-08-15,2020-08-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Necessary measures taken for covid positive pregnant women during pandemic.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46063,NA
CTRI/2020/08/027172,CTRI,2020-08-15,2020-08-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical Profile and Outcome of Neonates Born to Mothers with COVID in a Tertiary Care Centre,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46077,NA
CTRI/2020/08/027192,CTRI,2020-08-17,2020-08-22,FALSE,Not Recruiting,Not Applicable,Observational,India,"to assess the impact of COVID-19 pandemic on the delivery of radiation therapy in delhi national
capital region, india",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45344,NA
CTRI/2020/08/027193,CTRI,2020-08-17,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID -19 situation on people staying and discharged from a psychiatric rehabilitation centre,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46646,NA
CTRI/2020/08/027189,CTRI,2020-08-17,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Role of chest CT scan in covid19 patients: A study in a dedicated covid hospital of odisha,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46430,NA
CTRI/2020/08/027224,CTRI,2020-08-18,2020-08-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608,NA
CTRI/2020/08/027225,CTRI,2020-08-18,2020-08-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ivermectin as a possible treatment for COVID-19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660,NA
CTRI/2020/08/027226,CTRI,2020-08-18,2020-08-28,FALSE,Recruiting,Not Applicable,Observational,India,Study of Radiotherapy practice during Corona Pandemic,2500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46685,NA
CTRI/2020/08/027218,CTRI,2020-08-18,2020-01-09,TRUE,Recruiting,Not Applicable,Observational,"Democratic Republic of the Congo, Zambia, Pakistan, Bangladesh, Guatemala, India, Kenya",COVID-19 prevalence during pregnancy and pregnancy outcomes in low resource settings,16000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45967,NA
CTRI/2020/08/027205,CTRI,2020-08-18,2020-08-21,FALSE,Not Recruiting,Phase 2,Interventional,"Chile, Argentina, Russian Federation, South Africa, Peru, United Kingdom, Belgium, Colombia, Canada, Netherlands, United States, Brazil, Mexico, Spain, Japan, Poland, France, India",Clinical trial of otilimab in patients with severe pulmonary COVID-19 related disease.,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45488,NA
CTRI/2020/08/027210,CTRI,2020-08-18,2020-08-19,FALSE,Not Recruiting,Not Applicable,Observational,India,A backdated comparison of patients operated before the COVID-19 pandemic versus those operated during the COVID_19 pandemic.,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46279,NA
CTRI/2020/08/027222,CTRI,2020-08-18,2020-08-24,FALSE,Not Recruiting,Phase 2,Interventional,India,Unani formulations for prevention of COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308,NA
CTRI/2020/08/027244,CTRI,2020-08-19,2020-08-29,FALSE,Not Recruiting,Not Applicable,Observational,India,Behavioural and emotional difficulties of school going children during COVID times,3500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46157,NA
CTRI/2020/08/027247,CTRI,2020-08-19,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Lower morbidity and mortality in COVID-19 patients admitted in a dedicated COVID Hospital of Odisha - A Radiological perspective,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46417,NA
CTRI/2020/08/027243,CTRI,2020-08-19,2020-11-09,FALSE,Not Recruiting,Not Applicable,Observational,India,Identifying the factors that alters the recovery time of the COVID-19 patients.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46500,NA
CTRI/2020/08/027246,CTRI,2020-08-19,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Role of Tocilizumab in COVID-19 Pneumonia patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46546,NA
CTRI/2020/08/027275,CTRI,2020-08-20,2020-08-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"The study of occurrence , distribution and control measures of COVID-19 among police personnel during pandemic in Pune city , Maharashtra",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46386,NA
CTRI/2020/08/027281,CTRI,2020-08-20,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessing the fear and worries associated with covid-19 in out-patient population of a hospital,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46396,NA
CTRI/2020/08/027282,CTRI,2020-08-20,2020-08-31,FALSE,Not Recruiting,Phase 3,Interventional,India,Prophylactic Ivermectin in COVID 19 Contacts,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676,NA
CTRI/2020/08/027284,CTRI,2020-08-20,2020-08-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,A study to evaluate the efficacy and safety of Aceinavir combined with supportive Standard of Care (SoC) in hospitalized patients with moderate coronavirus disease (COVID-19),44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679,NA
CTRI/2020/08/027285,CTRI,2020-08-20,2020-08-21,FALSE,Recruiting,Not Applicable,Observational,India,Safety of convalescent plasma (CVP) drawn from mild symptomatic COVID-19 patients.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45050,NA
CTRI/2020/08/027283,CTRI,2020-08-20,2020-08-24,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy and safety of Ayurvedic kit in COVID-19 positive Patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591,NA
CTRI/2020/08/027301,CTRI,2020-08-21,2020-08-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of anxiety related to excessive internate search regarding covid-19 pandemic in medical students and para-medical staff.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46394,NA
CTRI/2020/08/027316,CTRI,2020-08-21,2020-08-28,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,The effect of Ayurvedic intervention (Ayurveda Raksha Kit) as a preventive measure in the Pandemic of COVID-19 - A community based study,200000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680,NA
CTRI/2020/08/027299,CTRI,2020-08-21,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,"A study to find out possible causes of mortality amongst the Covid-19 patients that are admitted in GCS Medical College, Ahmedabad",600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46175,NA
CTRI/2020/08/027286,CTRI,2020-08-21,2020-08-22,FALSE,Recruiting,Phase 2,Interventional,India,Effectiveness of Siddha Medicines Kabasura Kudineer and Nilavembu Kudineer in the Management of Smptomatic COVID 19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511,NA
CTRI/2020/08/027300,CTRI,2020-08-21,2020-01-09,TRUE,Not Recruiting,Not Applicable,Interventional,India,Efficacy and feasibility of Teleneurorehabilitation in Persons with Parkinsons Disease,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285,NA
CTRI/2020/08/027324,CTRI,2020-08-23,2020-01-09,TRUE,Not Recruiting,Not Applicable,Interventional,India,"Study to assess the usefulness, effectiveness and feasibility for future use of the consultations done using telephone/whatsapp in rheumatic diseases during CoVID-19 pandemic",5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339,NA
CTRI/2020/08/027323,CTRI,2020-08-23,2020-08-26,FALSE,Not Recruiting,Not Applicable,Observational,India,A survey to collect vital parameters and symptoms of participants at risk of COVID19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46086,NA
CTRI/2020/08/027345,CTRI,2020-08-24,2020-08-31,FALSE,Not Recruiting,Phase 3,Interventional,India,Re-purposing of Anti HCV drugs for the treatment of COVID-19 diseasr,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932,NA
CTRI/2020/08/027346,CTRI,2020-08-24,2020-08-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229,NA
CTRI/2020/08/027359,CTRI,2020-08-24,2020-09-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study regarding knowledge, attitude and practice about immunity boosting measures for prevention of COVID-19 infection among healthcare workers at tertiary care hospital",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829,NA
CTRI/2020/08/027396,CTRI,2020-08-26,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Mental health of pregnant women Covid-19 pandemic,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46853,NA
CTRI/2020/08/027394,CTRI,2020-08-26,2020-02-09,TRUE,Not Recruiting,Not Applicable,Interventional,India,Assessment of response of ivermectin on virological clearance in COVID 19 patients,56,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873,NA
CTRI/2020/08/027403,CTRI,2020-08-26,2020-07-09,TRUE,Not Recruiting,Not Applicable,Observational,India,A retrospective assessment of risk factors for COVID- 19 in health care workers,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46923,NA
CTRI/2020/08/027397,CTRI,2020-08-26,2020-03-09,TRUE,Recruiting,Phase 2,Interventional,India,Role of Siddha medicine in the management of Covid-19 positive patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165,NA
CTRI/2020/08/027407,CTRI,2020-08-26,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 with Hypertension is responsible for death of patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46707,NA
CTRI/2020/08/027395,CTRI,2020-08-26,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Study of Radiological Imaging in COVID Patients,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46716,NA
CTRI/2020/08/027393,CTRI,2020-08-26,2020-08-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Physiotherapy Practices for patients with COVID-19- A National Survey,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46249,NA
CTRI/2020/08/027420,CTRI,2020-08-27,2020-06-09,TRUE,Not Recruiting,Not Applicable,Observational,India,A Survey to Assess the Impact of the COVID-19 Pandemic and Resultant Lockdown Measures on Ongoing Clinical Trials in India,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46472,NA
CTRI/2020/08/027418,CTRI,2020-08-27,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Offline versus online presentation:  Benefits & Challenges during Covid pandemic .,225,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46745,NA
CTRI/2020/08/027419,CTRI,2020-08-27,2020-07-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Realtion of Catalytic iron and Hepcidin with Poor Outcomes in COVID-19 patients,49,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46503,NA
CTRI/2020/08/027435,CTRI,2020-08-27,2020-08-30,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 severity in Elderly people aged more than 60years,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46530,NA
CTRI/2020/08/027458,CTRI,2020-08-28,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,laboratory predictors and covid,850,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46665,NA
CTRI/2020/08/027460,CTRI,2020-08-28,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Oxygen requirement in COVID patients.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46545,NA
CTRI/2020/08/027459,CTRI,2020-08-28,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,To study about the outcome of COVID-19 on Diabetes patients,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46552,NA
CTRI/2020/08/027465,CTRI,2020-08-29,2020-04-09,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Nasal Wash and Gargle to Mitigate COVID-19,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634,NA
CTRI/2020/08/027466,CTRI,2020-08-29,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,"Ireland, United States, France, India, Germany",Outcomes of liver and pancreatic caner surgery during the COVID-19 pandemic,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46198,NA
CTRI/2020/08/027501,CTRI,2020-08-31,2020-10-09,FALSE,Not Recruiting,Not Applicable,Interventional,India,A study to assess aspects of safety and efficacy of NuvastaticÃ¢?Â¢ (C5OSEW5050ESA) as an immunomodulator supportive treatment to the standard care of treatment in Covid 19 patients.,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303,NA
CTRI/2020/08/027494,CTRI,2020-08-31,2020-06-09,TRUE,Not Recruiting,Not Applicable,Observational,India,To identify the pathogenesis of COVID-19 at different stages with the help of Ayurveda,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46900,NA
CTRI/2020/08/027475,CTRI,2020-08-31,2020-01-09,TRUE,Recruiting,Phase 3,Interventional,India,A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 Pneumonia,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627,NA
CTRI/2020/08/027502,CTRI,2020-08-31,2020-10-09,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison two types of artificial respiration in severe COVID-19 patients,216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862,NA
CTRI/2020/08/027477,CTRI,2020-08-31,2020-03-09,TRUE,Not Recruiting,Phase 2,Interventional,India,Evaluation of safety and efficacy of T-AYU-HM Premium and Onion steam vaporization/nebulization in Covid-19 patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654,NA
CTRI/2020/08/027499,CTRI,2020-08-31,2020-05-09,TRUE,Recruiting,Phase 2,Interventional,India,Role of siddha medicine in the management of covid -19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927,NA
CTRI/2020/08/027468,CTRI,2020-08-31,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,"HRCT chest imaging in pediartic, adult and geriatric patients with COVID-19 infection",900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46446,NA
CTRI/2020/08/027500,CTRI,2020-08-31,2020-08-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Study for predicting hypoxemia in COVID 19 patients on the basis of HRCT thorax findings with correlating the CT findings with SpO2 levels.,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46721,NA
CTRI/2020/08/027492,CTRI,2020-08-31,2020-06-09,TRUE,Not Recruiting,Not Applicable,Observational,India,"Mental health status, adjustment strategies due  to covid19 pandemic and related factors",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46983,NA
CTRI/2020/08/027490,CTRI,2020-08-31,2020-10-09,FALSE,Not Recruiting,Not Applicable,Observational,India,Neurological manifestations of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47009,NA
CTRI/2020/08/027491,CTRI,2020-08-31,2020-06-09,TRUE,Not Recruiting,Phase 2,Interventional,India,benefits of Siddha medicines in covid-19 positive patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256,NA
CTRI/2020/08/027503,CTRI,2020-08-31,2021-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of blood thinning medicine in COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980,NA
CTRI/2020/08/027467,CTRI,2020-08-31,2020-08-31,FALSE,Not Recruiting,Phase 3,Interventional,India,Effect of Allo-vedic Preparation Raj Nirwan Bati (RNB) on Severe COVID-19 Patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524,NA
CTRI/2020/08/027470,CTRI,2020-08-31,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Anaesthesia practices and safety of caregivers during the covid 19 pandemic.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45806,NA
CTRI/2020/08/027471,CTRI,2020-08-31,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Association of COVID-19 severity with blood group antigens.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45049,NA
CTRI/2020/09/027516,CTRI,2020-09-01,2020-07-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Coronavirus infection among healthcare workers,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46986,NA
CTRI/2020/09/027517,CTRI,2020-09-01,2020-07-09,TRUE,Not Recruiting,Not Applicable,Observational,India,Management of cardiac disease during COVID 19 pandemic and impact among cardiologist in Tamil Nadu,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47025,NA
CTRI/2020/09/027535,CTRI,2020-09-01,2020-08-09,TRUE,Recruiting,Phase 3,Interventional,India,"Efficacy and safety study of antiviral Umifenovir therapy in non-severe COVID-
19 patients.",132,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236,NA
CTRI/2020/09/027518,CTRI,2020-09-01,2020-09-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Compare marker abnormalities in COVID positive and negative cancer patients,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47089,NA
CTRI/2020/09/027548,CTRI,2020-09-02,2020-12-09,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effects of health drink additional to standard of care treatment in COVID 19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125,NA
CTRI/2020/09/027560,CTRI,2020-09-02,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,"Sweden, Australia, Hong Kong, United Arab Emirates, United Kingdom, Belgium, United States, Canada, Italy, Norway, Thailand, China, India, Germany, Singapore, Switzerland","Identifying homeopathy medicines in use for protection against
COVID-19, calculating the number of COVID-19 cases or cases with COVID-19 like symptoms in these homeopathy users and identifying some general features like age, gender and location in them.",6500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47165,NA
CTRI/2020/09/027558,CTRI,2020-09-02,2020-10-09,FALSE,Not Recruiting,Not Applicable,Observational,India,Dental Students Health and Well being During Covid-19 Pandemic.,480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44917,NA
CTRI/2020/09/027544,CTRI,2020-09-02,2020-10-09,FALSE,Not Recruiting,Not Applicable,Observational,India,Covid 19 and Professional course students quality of life,636,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47068,NA
CTRI/2020/09/027562,CTRI,2020-09-03,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Effect of prone positioning with HFNC on oxygenation and overall outcomes in severe COVID-19 patients.,92,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47154,NA
CTRI/2020/09/027572,CTRI,2020-09-03,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,India,"""Effect of comorbidities in the outcome of COVID-19 patients, a study in tertiary care centre ICU in IndiaÃ¢??",350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46643,NA
CTRI/2020/09/027596,CTRI,2020-09-04,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Behavioral changes during COVID 19 among cricket players in India,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47171,NA
CTRI/2020/09/027616,CTRI,2020-09-05,2021-01-13,FALSE,Not Recruiting,Phase 1,Interventional,India,Oral medicine trial for COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155,NA
CTRI/2020/09/027615,CTRI,2020-09-05,2020-11-09,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clinical trial of homeopathic medicine arsenic album as add on therapy in hospitalized patients admitted with Covid 19 disease.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648,NA
CTRI/2020/09/027613,CTRI,2020-09-05,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"Pattern of acute MI admissions in India during COVID-19 era: a  Cardiological Society of India  study
",30000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46158,NA
CTRI/2020/09/027617,CTRI,2020-09-05,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of COVID-19 positivity on pregnancy characteristics and pregnancy on infectivity potential of COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47239,NA
CTRI/2020/09/027618,CTRI,2020-09-05,2020-09-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Identification of SARS-CoV-2 in female genital tract and breast milk in confirmed cases of COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47248,NA
CTRI/2020/09/027614,CTRI,2020-09-05,2020-08-24,TRUE,Not Recruiting,Not Applicable,Observational,India,Effectiveness of training programme on hand hygiene among laundry staff,14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46274,NA
CTRI/2020/09/027622,CTRI,2020-09-07,2020-08-09,TRUE,Recruiting,Not Applicable,Interventional,India,Role of female sex hormone in COVID 19 patients,64,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908,NA
CTRI/2020/09/027661,CTRI,2020-09-08,2020-09-15,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Preventive Study among COVID 19 frontline warriors and their families,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273,NA
CTRI/2020/09/027674,CTRI,2020-09-08,2020-08-09,TRUE,Recruiting,Phase 1/Phase 2,Interventional,India,"A Phase 1, Followed by a Phase 2, vaccine given Randomly in subjects in different sites
to Evaluate the Safety, side effects, and resistance of the Virus Vaccine, BBV152D Administered between the layers of the skin(intradermal) in Healthy Volunteers.",124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312,NA
CTRI/2020/09/027684,CTRI,2020-09-09,2020-09-15,FALSE,Recruiting,Not Applicable,Interventional,India,"Protective effect of re-vaccination with
BCG against COVID-19 in healthcare workers Ã¢?? A Pilot Study
",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179,NA
CTRI/2020/09/027680,CTRI,2020-09-09,2020-09-20,FALSE,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, South Africa, Peru, United Kingdom, Colombia, United States, Canada, Italy, Brazil, Mexico, Spain, Turkey, Panama, France, India, Germany",Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID),402,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46451,NA
CTRI/2020/09/027681,CTRI,2020-09-09,2020-01-10,TRUE,Recruiting,Not Applicable,Observational,"Sweden, Republic of Korea, Nepal, Saudi Arabia, Benin, Georgia, Jordan, Canada, Pakistan, Morocco, United Kingdom, Venezuela (Bolivarian Republic of), Norway, Zambia, Algeria, Egypt, Finland, Guatemala, Japan, Paraguay, Turkey, Austria, Poland, Rwanda, Romania, Denmark, Malawi, Ireland, Indonesia, Greece, Belgium, Mozambique, United Arab Emirates, United States, Bangladesh, Montenegro, Cameroon, Ecuador, Uruguay, Panama, Iraq, Somalia, Germany, Bulgaria, Argentina, Hungary, New Zealand, Namibia, Nicaragua, South Africa, Italy, Brazil, Mexico, Mali, Oman, Nigeria, Philippines, Kenya, Senegal, Ghana, Singapore, Australia, Bahrain, Peru, Portugal, Colombia, Qatar, Kuwait, Samoa, Estonia, Spain, India",Determining The Best Time For Surgery After COVID-19 Infection,45000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46744,NA
CTRI/2020/09/027687,CTRI,2020-09-09,2020-09-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Assessment of effect of steam inhalation, saline gargling and povidone Iodine gargling on reduction of symptoms and prevention of spread of COVID 19",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280,NA
CTRI/2020/09/027683,CTRI,2020-09-09,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Online survey on Dry eye symptoms in health care workers and children during COVID 19 pandemic,330,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47026,NA
CTRI/2020/09/027685,CTRI,2020-09-09,2020-09-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clinical Study to Investigate Safety and Efficacy of ImmunoSEB and ProbioSEB,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321,NA
CTRI/2020/09/027686,CTRI,2020-09-09,2020-09-20,FALSE,Not Recruiting,Not Applicable,Observational,India,To determine whether diabetes in COVID-19 patients is associated with more complications.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47332,NA
CTRI/2020/09/027689,CTRI,2020-09-09,2020-09-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessing the impact of COVID-19 pandemic on Cancer related care in a tertiary cancer hospital of Varanasi district.,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47353,NA
CTRI/2020/09/027741,CTRI,2020-09-10,2020-09-15,FALSE,Recruiting,Not Applicable,Interventional,India,Role of heat killed Mycobacterium w (Sepsivac) in Corona virus disease 2019 (COVID-19),50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197,NA
CTRI/2020/09/027719,CTRI,2020-09-10,2020-09-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Satisfaction of medical students with online learning,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47277,NA
CTRI/2020/09/027691,CTRI,2020-09-10,2020-09-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Improving real-time COVID-19 monitoring through smartphone voice analysis,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46833,NA
CTRI/2020/09/027775,CTRI,2020-09-11,2020-09-19,FALSE,Not Recruiting,Phase 2,Interventional,India,Efficacy and safety clinical study of ES16001 as an adjunct in COVID positive patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367,NA
CTRI/2020/09/027769,CTRI,2020-09-11,2020-09-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Views regarding dental facilities and the manner in which patients wants to use dental facilities during COVID 19 in a hospital setting.,375,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47390,NA
CTRI/2020/09/027786,CTRI,2020-09-14,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Management of Covid 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950,NA
CTRI/2020/09/027785,CTRI,2020-09-14,2020-09-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Case Control study to check the effect of Measles vaccine in prevention of COVID-19,548,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47016,NA
CTRI/2020/09/027787,CTRI,2020-09-14,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Effect of wearing N 95 mask along with surgical mask in health care workers in covid era,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47329,NA
CTRI/2020/09/027782,CTRI,2020-09-14,2020-09-23,FALSE,Not Recruiting,Not Applicable,Observational,India,Dental practices in COVID-19,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47085,NA
CTRI/2020/09/027817,CTRI,2020-09-15,2020-09-18,FALSE,Recruiting,Phase 3,Interventional,India,A Phase III Clinical Study to assess the Safety and Efficacy of Ayurvedic Tablets combined with the current available medicine and its impact on lab parameters in Subjects with Uncomplicated Moderate COVID-19 infection.,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041,NA
CTRI/2020/09/027841,CTRI,2020-09-16,2020-09-22,FALSE,Recruiting,Not Applicable,Interventional,India,"In this study IMMUACTIVE would be compared with an inert substance, as a supplement in treatment of COVID-19 patients.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174,NA
CTRI/2020/09/027829,CTRI,2020-09-16,2020-09-20,FALSE,Recruiting,Phase 3,Interventional,"Argentina, United States, Mexico, Brazil, India",DARE-19 (Dapagliflozin in Respiratory failure in patients with COVID-19),900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521,NA
CTRI/2020/09/027842,CTRI,2020-09-16,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Effect of Teleyoga on health care workers involved in Covid 19 duty,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591,NA
CTRI/2020/09/027833,CTRI,2020-09-16,2020-09-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID 19 Patients having mild to moderate symptoms not requiring oxygen support,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46839,NA
CTRI/2020/09/027882,CTRI,2020-09-17,2020-09-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Evaluate the effect of an Ayurvedic Regimen administered in (COVID Ã¢?? 19) Patients,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632,NA
CTRI/2020/09/027881,CTRI,2020-09-17,2020-09-17,FALSE,Not Recruiting,Not Applicable,Observational,India,An observational multi-center study on COVID 19 disease to study on HERD immunity,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46661,NA
CTRI/2020/09/027862,CTRI,2020-09-17,2020-09-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Study on placenta of women with coronavirus disease 2019 (COVID-19),150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47505,NA
CTRI/2020/09/027908,CTRI,2020-09-18,2020-09-28,FALSE,Not Recruiting,Not Applicable,Observational,India,STRESS AND COPING AMONG HEALTH WORKERS DURING COVID,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47619,NA
CTRI/2020/09/027904,CTRI,2020-09-18,2020-02-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Autologous whole blood injection as treatment for Covid-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392,NA
CTRI/2020/09/027903,CTRI,2020-09-18,2020-09-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Testing the efficacy and safety of a blood product COVID-19 Hyper-Immuneglobulin (Human) Solution in Participants with Active COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147,NA
CTRI/2020/09/027910,CTRI,2020-09-18,2020-10-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Transcendental Meditation (TM) to reduce stress and improve immunity of health care providers during COVID-19 pandemic,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292,NA
CTRI/2020/09/027907,CTRI,2020-09-18,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Stress of Doctors in Covid era,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47598,NA
CTRI/2020/09/027914,CTRI,2020-09-19,2020-09-22,FALSE,Recruiting,Phase 2/Phase 3,Interventional,India,"Evaluation of efficacy of Fixed Ayurvedic Regimen of Giloy Ki Ghan Vati,Tulsi Tablets,Kalmegh Tablets and Dabur Chyawanprash in COVID-19",72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442,NA
CTRI/2020/09/027917,CTRI,2020-09-21,2020-09-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Surveillance of Bala Vriddhikara Bhava (FACTORS RESPONSIBLE FOR HOST IMMUNITY) in COVID-19 subjects,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47662,NA
CTRI/2020/09/027915,CTRI,2020-09-21,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Tele-yoga for prevention and management of COVID-19,136,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754,NA
CTRI/2020/09/027941,CTRI,2020-09-21,2020-09-26,FALSE,Not Recruiting,Phase 4,Interventional,India,Single arm study of Itolizumab in the treatment of COVID 19 complication.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023,NA
CTRI/2020/09/027938,CTRI,2020-09-21,2020-09-25,FALSE,Not Recruiting,Phase 3,Interventional,India,Study of Particle Life Sciences Formulation in management of COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586,NA
CTRI/2020/09/027916,CTRI,2020-09-21,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Covid19 Post Treatment Restorative Healthcare,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333,NA
CTRI/2020/09/027974,CTRI,2020-09-22,2020-10-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical Evaluation of Chyawanprash for the prevention of COVID-19 among Health Care Personnel .,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658,NA
CTRI/2020/09/027944,CTRI,2020-09-22,2020-09-22,FALSE,Not Recruiting,Phase 3,Interventional,India,"An open label, prospective comparative study to evaluate the proposed therapy in adults with mild symptomatic COVID-19 patients receiving the standard treatment of COVID infection.",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392,NA
CTRI/2020/09/027975,CTRI,2020-09-22,2020-02-10,TRUE,Not Recruiting,Phase 3,Interventional,India,Utility of Medihope as an addon therapy for Covid 19 patients,880,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748,NA
CTRI/2020/09/027993,CTRI,2020-09-23,2020-09-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of effect of COVID-19 on fatigue and exercise capacity in patients with Covid-19 treated at a government tertiary care hospital.,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47645,NA
CTRI/2020/09/027992,CTRI,2020-09-23,2020-09-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated  Study to Evaluate the Effectiveness and Safety of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) in Moderate COVID-19 Patients,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389,NA
CTRI/2020/09/028045,CTRI,2020-09-24,2020-09-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Online learning programme for providing cardiopulmonary resuscitation among Nurses,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046,NA
CTRI/2020/09/028044,CTRI,2020-09-24,2020-09-30,FALSE,Recruiting,Phase 4,Interventional,India,Phase IV study to evaluate the safety and efficacy of Artemisinin- a herbal supplement on COVID-19 subjects,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432,NA
CTRI/2020/09/028043,CTRI,2020-09-24,2020-09-21,TRUE,Not Recruiting,Phase 4,Interventional,India,"Clinical study to assess role of Vasa Ghana, Guduchi Ghana and Vasa-Guduchi
Ghana in therapeutic management of symptoms in Covid19",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443,NA
CTRI/2020/09/028040,CTRI,2020-09-24,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Seroprevalence of COVID 19 in children,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47809,NA
CTRI/2020/09/028046,CTRI,2020-09-24,2020-05-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Homoeopathy management for covid 19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038,NA
CTRI/2020/09/028049,CTRI,2020-09-25,2020-10-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of Atypical imaging features on HRCT CHEST.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46447,NA
CTRI/2020/09/028050,CTRI,2020-09-25,2020-02-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Intubation and ventilatory support in COVID patients: observational study from a tertiary care ICU.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47764,NA
CTRI/2020/09/028090,CTRI,2020-09-28,2020-07-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Social factors related to COVID 19,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47924,NA
CTRI/2020/09/028069,CTRI,2020-09-28,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Variation in biochemical parameters in COVID-19 infection,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47703,NA
CTRI/2020/09/028085,CTRI,2020-09-28,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,India,"Coping methods of stress  among frontline Healthcare workers 

",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47774,NA
CTRI/2020/09/028087,CTRI,2020-09-28,2020-10-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of severity of chest CT findings in covid 19 patients with pre-existing illness,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47816,NA
CTRI/2020/09/028086,CTRI,2020-09-28,2020-08-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,Effect of 12-weeks of Online Sudarshan Kriya Yoga practice on Burnout and Health Parameters among COVID-19 Frontline Warriors.,43,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819,NA
CTRI/2020/09/028088,CTRI,2020-09-28,2020-10-31,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Open Label Randomized trial of Colchicine, Aspirin and Montelukast in Covid-19",34,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829,NA
CTRI/2020/09/028089,CTRI,2020-09-28,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Role of self sampling in COVID 19 patients,1350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47832,NA
CTRI/2020/09/028083,CTRI,2020-09-28,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Effect of poor sleep hygiene and screen time usage on sleep,330,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47599,NA
CTRI/2020/09/028131,CTRI,2020-09-29,2020-02-10,TRUE,Recruiting,Not Applicable,Interventional,India,A study of Cordyceps Capsules as an Add-On Therapy in patients with moderate COVID 19 Infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887,NA
CTRI/2020/09/028122,CTRI,2020-09-29,2020-06-10,TRUE,Not Recruiting,Phase 3,Interventional,India,Homoeopathy in the prevention of COVID-19,15992,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851,NA
CTRI/2020/09/028132,CTRI,2020-09-29,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,India,A cross sectional study to assess the impact of COVID-19 on patints with non communicable disease at AYUSH LSD clinics,450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47860,NA
CTRI/2020/09/028133,CTRI,2020-09-29,2020-05-10,TRUE,Recruiting,Not Applicable,Interventional,India,Oral VIRAHALT (Novel Immunomodulatory Herbal combination) Compared to standard of care in Subjects with Moderate to Severe COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866,NA
CTRI/2020/09/028153,CTRI,2020-09-30,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,India,A survey is to study the prophylactic effect of Homoeopathic medicine namely Arsenicum album 30 against COVID 19 infection in Madurai tamilnadu,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47878,NA
CTRI/2020/09/028158,CTRI,2020-09-30,2020-05-10,TRUE,Recruiting,Not Applicable,Interventional,India,Ayurvedic Proprietary Medicine (VIRANORM) clinical trial on  COVID-19 patients,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896,NA
CTRI/2020/09/028162,CTRI,2020-09-30,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,"Argentina, Ghana, Russian Federation, Indonesia, United Kingdom, Macedonia, United States, Pakistan, Italy, Brazil, Egypt, Mexico, Japan, Spain, France, India, Nigeria","A prospective cohort study of the effects of COVID-19
in pregnancy and the neonatal period",1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46374,NA
CTRI/2020/09/028157,CTRI,2020-09-30,2020-10-10,FALSE,Not Recruiting,Not Applicable,Observational,India,Perspective of MBBS Students towards Teaching through Onscreen Classes,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47423,NA
CTRI/2020/09/028156,CTRI,2020-09-30,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Comparative Study of Artificial Intelligence and Radiologists in Assessing Severity of COVID19 Patient Images,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47790,NA
CTRI/2020/09/028165,CTRI,2020-09-30,2020-05-10,TRUE,No Status Given,Not Applicable,Observational,Bangladesh,A cross sectional study to identify the symptoms that are presenting by COVID-19 suffering people in Bangladesh,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47824,NA
CTRI/2020/09/028164,CTRI,2020-09-30,2021-04-10,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843,NA
CTRI/2020/10/028195,CTRI,2020-10-01,2020-08-10,TRUE,Recruiting,Not Applicable,Interventional,India,The role of Yogic breathing techniques in progression and recovery from COVID-19.,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893,NA
CTRI/2020/10/028196,CTRI,2020-10-01,2020-10-10,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,Coping with COVID Pandemic,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47979,NA
CTRI/2020/10/028192,CTRI,2020-10-01,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,India,A survey to assess the effectiveness of Arsenicum Album 30C as a Prophylactic medicine against COVID 19 infection,15000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47846,NA
CTRI/2020/10/028179,CTRI,2020-10-01,2020-07-10,TRUE,No Status Given,Not Applicable,Interventional,Bangladesh,An experimental study to find out the impact of post COVID physiotherapy and rehabilitation in Bangladesh,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847,NA
CTRI/2020/10/028230,CTRI,2020-10-05,2020-12-10,FALSE,Not Recruiting,Phase 2,Interventional,India,clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188,NA
CTRI/2020/10/028233,CTRI,2020-10-05,2020-10-10,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study on use of Homoeopathy Medicines in Treatment of Covid 19 cases,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982,NA
CTRI/2020/10/028231,CTRI,2020-10-05,2020-12-10,FALSE,Not Recruiting,Not Applicable,Interventional,India,Proof of Concept Study of Ketoji (Liquid) for its Effectiveness in Treatment and Management of COVID-19 Patients,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237,NA
CTRI/2020/10/028234,CTRI,2020-10-05,2020-12-10,FALSE,Not Recruiting,Phase 4,Interventional,India,Study to compare the effect of different antiviral medicines in  COVID-19 infected sick children,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844,NA
CTRI/2020/10/028232,CTRI,2020-10-05,2020-10-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological effect of coronavirus disease 2019 on pregnant women,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48105,NA
CTRI/2020/10/028254,CTRI,2020-10-06,2020-08-10,TRUE,Not Recruiting,Not Applicable,Observational,India,Ã¢??Retrospective Study of Pregnancy with COVID-19Ã¢??,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47156,NA
CTRI/2020/10/028253,CTRI,2020-10-06,2020-10-10,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical trial to test the effectiveness of thalidomide in reducing immune dysfunction in covid-19 disease.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986,NA
CTRI/2020/10/028257,CTRI,2020-10-06,2020-10-10,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological Impacts Of The COVID-19 Pandemic On Medical Students In India: A Web-Based Cross-Sectional Study,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48025,NA
CTRI/2020/10/028256,CTRI,2020-10-06,2020-10-13,FALSE,Not Recruiting,Not Applicable,Interventional,India,A study to know whether we can supervise cancer patients infected with COVID-19 from without admission in hospitals. We will test how much helpful is a software called Datos health along with pulse oximeter and thermometer in this supervision by doctors.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118,NA
CTRI/2020/10/028250,CTRI,2020-10-06,2020-10-14,FALSE,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effects of stem cells in patients with Acute Respiratory Distress syndrome caused by Pneumonia due to COVID-19,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119,NA
CTRI/2020/10/028251,CTRI,2020-10-06,2020-10-15,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 and Children with congenital heart disease,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47097,NA
CTRI/2020/10/028280,CTRI,2020-10-07,2020-10-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of COVID-19,18000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199,NA
CTRI/2020/10/028277,CTRI,2020-10-07,2020-12-10,FALSE,Not Recruiting,Phase 3,Interventional,India,"A study to assess the safety and effectiveness of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) used for the treatment of Moderate to severe COVID 19 Patients.

",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691,NA
CTRI/2020/10/028278,CTRI,2020-10-07,2020-12-10,FALSE,Not Recruiting,Not Applicable,Observational,India,"The Knowledge, Attitude And Practices related to COVID-19 in Patients Presenting to Glaucoma Clinic and the Reasons for seeking Glaucoma care",246,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47232,NA
CTRI/2020/10/028279,CTRI,2020-10-07,2020-12-10,FALSE,Not Recruiting,Not Applicable,Interventional,India,Standard of care with homoeopathy as adjuvant in COVID19,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085,NA
CTRI/2020/10/028295,CTRI,2020-10-08,2020-10-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Perception Of Dentists On Infection Control Measures During Novel Corona Virus (COVID-19) Pandemic,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48202,NA
CTRI/2020/10/028296,CTRI,2020-10-08,2020-10-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of the COVID-19 pandemic on graduating dental interns: A studentÃ¢??s perspective,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46970,NA
CTRI/2020/10/028297,CTRI,2020-10-08,2020-10-26,FALSE,Not Recruiting,Phase 2,Interventional,India,Cotrimoxazole in hospitalised patients with moderate to early-severe COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268,NA
CTRI/2020/10/028333,CTRI,2020-10-09,2020-10-13,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Prospective on evaluation of use of , Ã¢??AyurCoro3Ã¢?? as an add on medication  for the treatment purpose in COVID-19 patients",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137,NA
CTRI/2020/10/028335,CTRI,2020-10-09,2020-12-10,FALSE,Not Recruiting,Phase 3,Interventional,India,A clinical study to assess the efficacy and safety of Tinefcon in patients with moderate COVID-19 infection,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359,NA
CTRI/2020/10/028324,CTRI,2020-10-09,2020-09-10,TRUE,Not Recruiting,Not Applicable,Interventional,India,"Evaluation of use of , Ã¢??study medication Ã¢??for prophylaxis in frontline health care workers involved in treating COVID-19 patients",120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697,NA
CTRI/2020/10/028326,CTRI,2020-10-09,2020-10-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Assessment of memory cells response to Mycobacterium Indicus Pranii vaccination,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214,NA
CTRI/2020/10/028325,CTRI,2020-10-09,2020-10-19,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of Tocilizumab Vs Itolizumab in covid 19 patient.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319,NA
CTRI/2020/10/028339,CTRI,2020-10-12,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,India,"To study the relationship between spirituality,hope, distress and ability to bounce back from stress among family members of recovered COVID-19 patients",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47879,NA
CTRI/2020/10/028340,CTRI,2020-10-12,2020-10-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical characteristics and laboratory parameters of COVID-19 patients on oxygen,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46861,NA
CTRI/2020/10/028364,CTRI,2020-10-12,2020-10-19,FALSE,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to evaluate the effectiveness and safety of Vedicinals-9-a Herbal Formulation in Mild to Moderate COVID-19
Patients.",124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152,NA
CTRI/2020/10/028363,CTRI,2020-10-12,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,India,The barriers encountered by health-service providers while giving healthcare to patients admitted to COVID hospitals of Odisha,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48039,NA
CTRI/2020/10/028360,CTRI,2020-10-12,2020-10-19,FALSE,Not Recruiting,Not Applicable,Observational,India,"Psychiatric sequelae in COVID-19 infection recovered resident doctors and
interns of a tertiary health care hospital.
",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48352,NA
CTRI/2020/10/028361,CTRI,2020-10-12,2020-10-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Endothelial Dysfunction in Severe COVID 19 disease,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48356,NA
CTRI/2020/10/028362,CTRI,2020-10-12,2020-10-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study to assess the efficacy of deep breathing Pranayama technique in  addition to conventional allopathic treatment in management of COVID19,278,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109,NA
CTRI/2020/10/028376,CTRI,2020-10-13,2020-10-22,FALSE,Not Recruiting,Not Applicable,Interventional,India,A Clinical Study to evaluate the safety and efficacy of CoviToneÃ¢?Â¢ in Mild to moderate Covid patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426,NA
CTRI/2020/10/028372,CTRI,2020-10-13,2020-10-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of Respiratory profile and radiological changes in patients after recovery from COVID-19,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48321,NA
CTRI/2020/10/028373,CTRI,2020-10-13,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,"""Experiences among nurses caring patients with COVID 19""",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48335,NA
CTRI/2020/10/028384,CTRI,2020-10-13,2020-10-16,FALSE,Not Recruiting,Not Applicable,Observational,India,A population based survey on COVID-19 infection in Goa state among both urban and rural population.,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48092,NA
CTRI/2020/10/028412,CTRI,2020-10-14,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,school teachers experience in online teaching during this COVID-19 situation,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48163,NA
CTRI/2020/10/028422,CTRI,2020-10-15,2020-10-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of COVID 19 on lymphocyte and eosinophil count,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47424,NA
CTRI/2020/10/028414,CTRI,2020-10-15,2020-02-11,TRUE,Not Recruiting,Phase 2,Interventional,India,Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010,NA
CTRI/2020/10/028423,CTRI,2020-10-15,2020-10-28,FALSE,Recruiting,Phase 2,Interventional,India,A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infection,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514,NA
CTRI/2020/10/028424,CTRI,2020-10-15,2020-10-30,FALSE,Not Recruiting,Phase 3,Interventional,India,Clinical study to evaluate the effect of Ayurveda intervention as a prophylaxis for COVID-19 in Healthcare workers,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294,NA
CTRI/2020/10/028439,CTRI,2020-10-16,2020-10-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Secondary attack rate of COVID-19 and risk factors for transmission,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44034,NA
CTRI/2020/10/028437,CTRI,2020-10-16,2020-02-11,TRUE,Not Recruiting,Phase 3,Interventional,India,Effect of Ayurvedic Treatment Regimen in COVID-19 Patients,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956,NA
CTRI/2020/10/028432,CTRI,2020-10-16,2020-10-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Mental health of COVID 19 patients during outbreak,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48231,NA
CTRI/2020/10/028438,CTRI,2020-10-16,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Perspective of cancer patient in COVID-19 pandemic,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48532,NA
CTRI/2020/10/028436,CTRI,2020-10-16,2020-10-25,FALSE,Not Recruiting,Not Applicable,Observational,India,This study is designed to look at certain blood parameters like biomarkers for predicting the outcome of COVID patients,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47604,NA
CTRI/2020/10/028472,CTRI,2020-10-19,2020-10-29,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study of Edaravone as adjunctive treatment in COVID,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524,NA
CTRI/2020/10/028470,CTRI,2020-10-19,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,"Relation of lung disease and smoking with the severity of COVID-19 in a district hospital of Pune city, Maharashtra",489,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47547,NA
CTRI/2020/10/028471,CTRI,2020-10-19,2020-02-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,"Effect of the drug Ã¢??ImmuneÃ¢??- an Ayurveda medication in COVID-19 patients
",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593,NA
CTRI/2020/10/028486,CTRI,2020-10-20,2020-02-11,TRUE,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 Patients with mild symptoms,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223,NA
CTRI/2020/10/028489,CTRI,2020-10-20,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,To study the relationship of COVID-19 severity with blood vessels,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48502,NA
CTRI/2020/10/028488,CTRI,2020-10-20,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Role of blood cellular mechanism in severity of COVID-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48575,NA
CTRI/2020/10/028485,CTRI,2020-10-20,2020-02-11,TRUE,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 healthcare workers,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619,NA
CTRI/2020/10/028487,CTRI,2020-10-20,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,To Study the safety of Remdesivir in COVID-19 Patients.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48636,NA
CTRI/2020/10/028523,CTRI,2020-10-21,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Hematological and biochemical abnormalities parameters in the severity of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48500,NA
CTRI/2020/10/028525,CTRI,2020-10-21,2020-10-31,FALSE,Not Recruiting,Not Applicable,Observational,India,A study of association of chest x ray with clinical severity in hospitalised covid19 patients,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48521,NA
CTRI/2020/10/028524,CTRI,2020-10-21,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,"Impact of Covid-19 on mental health among health care workers.
",632,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48550,NA
CTRI/2020/10/028520,CTRI,2020-10-21,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Challenges faced by PG students in conducting research,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48305,NA
CTRI/2020/10/028571,CTRI,2020-10-22,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Treatment and followup outcomes of gynecological cancer patients treated with radiation therapy during lockdown phase of COVID pandemic,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47944,NA
CTRI/2020/10/028569,CTRI,2020-10-22,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Challenges for healthcare workers with infection control practices during COVID-19 pandemic,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47444,NA
CTRI/2020/10/028568,CTRI,2020-10-22,2020-10-26,FALSE,Not Recruiting,Phase 2,Interventional,India,"Evaluate Safety 
and Efficacy of RV Forte Capsule as an immunomodulator in adult 
Covid 19 positive patients",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761,NA
CTRI/2020/10/028566,CTRI,2020-10-22,2020-02-11,TRUE,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 asymptomatic patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585,NA
CTRI/2020/10/028537,CTRI,2020-10-22,2020-10-22,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical trial of Ayurvedic Medicines in Patients with Asymptomatic and/or Mild Symptoms of COVID-19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342,NA
CTRI/2020/10/028570,CTRI,2020-10-22,2020-05-11,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,To study the effect of Vyaghradi Kashay tablet on COVID-19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600,NA
CTRI/2020/10/028567,CTRI,2020-10-22,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Red cell antibody profile in Covid-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46310,NA
CTRI/2020/10/028539,CTRI,2020-10-22,2020-10-28,FALSE,Not Recruiting,Not Applicable,Observational,India,High-flow nasal cannula oxygen in adult patients of COVID-19 admitted to intensive care units.,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48627,NA
CTRI/2020/10/028597,CTRI,2020-10-23,2020-06-11,TRUE,Not Recruiting,Phase 2,Interventional,India,Low dose lung X-ray therapy for COVID-19,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730,NA
CTRI/2020/10/028598,CTRI,2020-10-23,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Assessment of SARS CoV-2 seroprevalence and clinical profiling of COVID Unsuspected patients attending Otorhinolaryngology Department at AIIMS Jodhpur.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47989,NA
CTRI/2020/10/028602,CTRI,2020-10-23,2020-03-11,TRUE,Not Recruiting,Phase 2,Interventional,"India, South Africa",Phase II Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797,NA
CTRI/2020/10/028600,CTRI,2020-10-23,2020-05-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Knowledge Attitude and Practice of Hand hygiene among Nursing Assistants and Trolley workers in a COVID-19 care units,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46239,NA
CTRI/2020/10/028581,CTRI,2020-10-23,2020-10-23,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID cases,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042,NA
CTRI/2020/10/028580,CTRI,2020-10-23,2020-10-26,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of an online training module with lectures and videos regarding maternal and newborn care during COVID 19 pandemic on the knowledge and acceptability among nursing students,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581,NA
CTRI/2020/10/028637,CTRI,2020-10-26,2020-04-11,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Best Larnyngoscopes for tracheal intubation in covid patient with intubation box,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357,NA
CTRI/2020/10/028635,CTRI,2020-10-26,2020-02-11,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,use of VIRUNIL an Ayurvedic medicie as a supportive treatment in management of COVID-19.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783,NA
CTRI/2020/10/028634,CTRI,2020-10-26,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Impact of high flow oxygen therapy on outcomes of COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48823,NA
CTRI/2020/10/028639,CTRI,2020-10-26,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,India,"Trends of Symptoms in Patients Under Institutional Isolation in COVID-19 Pandemic in India-An Observational studyÃ¢??
",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44503,NA
CTRI/2020/10/028636,CTRI,2020-10-26,2020-01-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Covid 19 infection during pregnancy and its effect on the mother and baby,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48380,NA
CTRI/2020/10/028648,CTRI,2020-10-27,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,India,To assess the overall effect of COVID-19 on intent of treatment and staging of cancer,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46401,NA
CTRI/2020/10/028649,CTRI,2020-10-27,2020-10-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Surgery complications rates in pre and post COVID era,888,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48029,NA
CTRI/2020/10/028657,CTRI,2020-10-27,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Remdesivir effect in the treatment of corona,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47817,NA
CTRI/2020/10/028672,CTRI,2020-10-27,2020-11-30,FALSE,Not Recruiting,Not Applicable,Observational,India,A survey to know effect of Corona pandemic on medical postgraduate studentÃ¢??s mental stress and their attitude to choose anaesthesiology as a career.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48895,NA
CTRI/2020/10/028696,CTRI,2020-10-28,2020-10-29,FALSE,Not Recruiting,Not Applicable,Observational,India,online survey among anaesthesiologists about method of assessing breathing tube before administering anaesthesia duirng Covid 19 pandemic,392,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48669,NA
CTRI/2020/10/028695,CTRI,2020-10-28,2020-05-11,TRUE,Not Recruiting,Phase 4,Interventional,India,Can Vitamin C reduces COVID-19 symptoms,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749,NA
CTRI/2020/10/028774,CTRI,2020-10-29,2020-10-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical evaluation of STANDARD Q COVID-19 Ag Test,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48412,NA
CTRI/2020/10/028731,CTRI,2020-10-29,2020-01-11,TRUE,Not Recruiting,Phase 3,Interventional,"Denmark, India",Higher vs. Lower Doses of Steroids in Patients with COVID-19,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46442,NA
CTRI/2020/10/028744,CTRI,2020-10-29,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"effect of COVID-19on physical activity, screen time and emotional wellbeing on medical students",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48499,NA
CTRI/2020/11/028799,CTRI,2020-11-02,2020-02-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,The study of psychological interventions either individually or in groups and comparing its effect in reduction of  psychological distress  in covid-19 positive patients.,55,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864,NA
CTRI/2020/11/028813,CTRI,2020-11-02,2020-10-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Evaluation of antibody and cytokine detection in tears of COVID-19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48182,NA
CTRI/2020/11/028811,CTRI,2020-11-02,2020-07-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960,NA
CTRI/2020/11/028800,CTRI,2020-11-02,2020-11-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Side effects of drugs used in ICU,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49028,NA
CTRI/2020/11/028779,CTRI,2020-11-02,2020-05-11,TRUE,Not Recruiting,Phase 1,Interventional,India,Effect of SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment) in hospitalised COVID-19 patients with moderate disease.,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578,NA
CTRI/2020/11/028836,CTRI,2020-11-03,2020-11-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Correlating the Clinical and CT Severity of COVID-19 patients with the Inflammatory markers and Co-morbidities,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48390,NA
CTRI/2020/11/028846,CTRI,2020-11-03,2020-11-11,FALSE,Not Recruiting,Not Applicable,Observational,India,"A study on knowledge, attitude and behavior of healthcare workers on practices required to prevent COVID - 19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48947,NA
CTRI/2020/11/028827,CTRI,2020-11-03,2020-04-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,Yoga program on COVID 19 patients,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946,NA
CTRI/2020/11/028843,CTRI,2020-11-03,2020-09-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Outcomes of Nutrition scores on serious COVID patients,78,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49036,NA
CTRI/2020/11/028848,CTRI,2020-11-03,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Lifestyle and psychological changes during COVID 19 lockdown among undergraduate students in Chennai,526,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49115,NA
CTRI/2020/11/028859,CTRI,2020-11-03,2020-11-11,FALSE,Not Recruiting,Not Applicable,Observational,India,Cancer Services during COVID-19 Pandemic Ã¢?? Importance of a symptoms based screening strategy,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49144,NA
CTRI/2020/11/028905,CTRI,2020-11-04,2020-12-11,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,An academic trial to study the prophylactic activity of Vishasura Kudineer(VSK)in healthcare workers exposed/non-exposed to COVID-19 patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668,NA
CTRI/2020/11/028903,CTRI,2020-11-04,2020-09-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,Telephonic intervention for people tested positive for Covid,0,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964,NA
CTRI/2020/11/028897,CTRI,2020-11-04,2020-11-16,FALSE,Not Recruiting,Phase 3,Interventional,India,"To Evaluate the Efficacy and Safety of ANT-V Syrup to show antiviral action of upper respiratory
tract like common cold and act as an immune booster to fight against infection, flu, fever, sore
throat, nasal and chest congestion Breathlessness in COVID-19 patients.",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480,NA
CTRI/2020/11/028885,CTRI,2020-11-04,2020-09-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Frailty assessment for COVID-19 severity,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47990,NA
CTRI/2020/11/028938,CTRI,2020-11-05,2020-11-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Ultrasonography in Covid19 patients with a focus on possible clinical diagnosis and management decisions,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48595,NA
CTRI/2020/11/028967,CTRI,2020-11-06,2020-11-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Seroprevalence of COVID-19 antibodies,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47399,NA
CTRI/2020/11/028954,CTRI,2020-11-06,2020-10-11,TRUE,Not Recruiting,Not Applicable,Observational,India,Psychological burden in COVID19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48686,NA
CTRI/2020/11/028969,CTRI,2020-11-06,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect Of COVID-19 on breast cancer treatment and its outcome,900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49266,NA
CTRI/2020/11/028959,CTRI,2020-11-06,2020-06-11,TRUE,Not Recruiting,Not Applicable,Interventional,India,Effect of recombinant erythropoietin in covid-19 patients.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272,NA
CTRI/2020/11/028976,CTRI,2020-11-09,2020-11-11,FALSE,Not Recruiting,Phase 3,Interventional,India,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity,and Lot-to-Lot consistency of BBV152, a Whole virion Inactivated Vaccine in Adults greater than or equal to 18 Years of Age.",25800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,NA
CTRI/2020/11/029025,CTRI,2020-11-10,2020-11-15,FALSE,Recruiting,Not Applicable,Interventional,India,An open label observational study on post covid complications and radiological pattern changes on those patients treated with ZingiVir H .,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174,NA
CTRI/2020/11/029035,CTRI,2020-11-10,2020-11-15,FALSE,Recruiting,Not Applicable,Observational,India,Compare oxygen saturation from pulse oximetry and ABG in COVID-19 patients in ICU/HDU,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48696,NA
CTRI/2020/11/029004,CTRI,2020-11-10,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,RADIOLOGICAL AND LABORATORY TESTS CORELATION WITH CLINCIAL SEVERITY OF COVID19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48969,NA
CTRI/2020/11/029026,CTRI,2020-11-10,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Long term lung problem of children who were affected by corona virus.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49243,NA
CTRI/2020/11/029006,CTRI,2020-11-10,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"Survey of Knowledge, Attitudes and Practices towards Covid-19 Pandemic",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49299,NA
CTRI/2020/11/029029,CTRI,2020-11-10,2020-12-11,FALSE,Not Recruiting,Not Applicable,Observational,India,"A pilot study to determine health concerns developed during COVID-19 pandemic in childhood cancer survivors and siblings of Tata Memorial Hospital, who are now grown up adults.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48282,NA
CTRI/2020/11/029008,CTRI,2020-11-10,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To study the overall impact of consumption of non-alcoholic beverages on working from home adults, pre and during COVID times",295,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49069,NA
CTRI/2020/11/029007,CTRI,2020-11-10,2020-11-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Signs and symptoms and outcome of babies less than 28 days age admitted during pandemic in a only COVID-19 hospital in north India,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49326,NA
CTRI/2020/11/029009,CTRI,2020-11-10,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"An online survey to compare the diet and physical activity management before and during COVID and how it is affected by education, occupation and income in people with diabetes belonging to middle and upper socioeconomic classes",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49077,NA
CTRI/2020/11/029012,CTRI,2020-11-10,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To assess the impact of COVID-19 on the Diet, lifestyle and physical activity of IT employees (20-30 years)",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49084,NA
CTRI/2020/11/029032,CTRI,2020-11-10,2020-11-16,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Biological EÃ¢??s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.,360,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329,NA
CTRI/2020/11/029030,CTRI,2020-11-10,2020-11-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Multicentric observational study on Pediatric Multisystem Inflammatory Syndrome (PMIS) related to Covid-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48102,NA
CTRI/2020/11/029036,CTRI,2020-11-10,2020-11-16,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to identify the rehabilitation need in post-discharge COVID-19 survivors,384,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46058,NA
CTRI/2020/11/029037,CTRI,2020-11-10,2020-11-18,FALSE,Not Recruiting,Not Applicable,Observational,India,"The performance of a novel ultra-rapid diagnostic test in the detection of COVID 19, an observational and case controlled study.",750,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48368,NA
CTRI/2020/11/029060,CTRI,2020-11-11,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,"High chloride level, anaemia and severity of COVID-19",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49411,NA
CTRI/2020/11/029059,CTRI,2020-11-11,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Blood Glucose Management in Diabetic COVID19 Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48971,NA
CTRI/2020/11/029040,CTRI,2020-11-11,2020-11-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of corona virus disease on  the mental state of  anesthesiologists in India,383,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44640,NA
CTRI/2020/11/029038,CTRI,2020-11-11,2020-10-19,TRUE,Not Recruiting,Phase 3,Interventional,India,"Can combination of Haldi, Pomegranate and Zinger extract tablets help in reducing duration of hospital stay of mild to moderate COVID-19 patients.",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233,NA
CTRI/2020/11/029041,CTRI,2020-11-11,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to assess the overall dietary practices among young and middle-aged adults pre and during COVID times,317,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49076,NA
CTRI/2020/11/029042,CTRI,2020-11-11,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Measurement of nutritional and health status of Beedi workers before and during COVID times.,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49098,NA
CTRI/2020/11/029061,CTRI,2020-11-11,2020-11-29,FALSE,Recruiting,Not Applicable,Observational,India,Multisystemic inflammatory  syndrome  in  children (MIS-C) in COVID pandemic,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49371,NA
CTRI/2020/11/029058,CTRI,2020-11-11,2020-11-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study to assess the impact of COVID 19 infection on pulmonary function tests in children,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392,NA
CTRI/2020/11/029063,CTRI,2020-11-12,2020-12-11,FALSE,Not Recruiting,Phase 3,Interventional,India,To study the effect of povidone iodine gargle and nasal drops on disease transmissibility in SARS-CoV-2 infected patients,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939,NA
CTRI/2020/11/029067,CTRI,2020-11-12,2020-11-15,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to look out outcomes of treated COVID-19 patients admitted to a private hospital in Bangalore,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47660,NA
CTRI/2020/11/029068,CTRI,2020-11-12,2020-11-17,FALSE,Not Recruiting,Not Applicable,Observational,India,study of heart injury by laboratory investigation  in corona positive patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48973,NA
CTRI/2020/11/029070,CTRI,2020-11-12,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To study the Influence of Food habits, Physical activity and knowledge of pregnant mothers on the problems faced in pregnancy, type of delivery and Birth weight of newborn during COVID-19 times.",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49261,NA
CTRI/2020/11/029084,CTRI,2020-11-12,2020-11-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Covid-19 risk factors among health care workers,172,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49352,NA
CTRI/2020/11/029124,CTRI,2020-11-13,2020-11-21,FALSE,Not Recruiting,Not Applicable,Observational,India,"Effect of COVID-19 on exercise pattern, diet pattern and weight change in athletes",336,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49435,NA
CTRI/2020/11/029130,CTRI,2020-11-16,2020-11-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,The lying in prone position effect on oxygen saturation in patients in early stage and not intubated having mild to moderate Lung Disease with COVID-19,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155,NA
CTRI/2020/11/029143,CTRI,2020-11-16,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 on Guillain-BarrÃƒÂ© Syndrome in India,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47626,NA
CTRI/2020/11/029142,CTRI,2020-11-16,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Effect of COVID19 work from home on musculoskeletal disorders.,498,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49439,NA
CTRI/2020/11/029141,CTRI,2020-11-16,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,"Sero-surveillance for Dengue, Chikungunya and COVID",5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49486,NA
CTRI/2020/11/029144,CTRI,2020-11-16,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of work from home on stress level and nutritional status of IT professionals during COVID-19 pandemic,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49306,NA
CTRI/2020/11/029146,CTRI,2020-11-16,2020-11-23,FALSE,Not Recruiting,Not Applicable,Interventional,India,Use of a new breathing device for covid 19 patients,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879,NA
CTRI/2020/11/029170,CTRI,2020-11-17,2020-11-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,Lignocaine nebulisation in covid pneumonia,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412,NA
CTRI/2020/11/029148,CTRI,2020-11-17,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Difficulties encountered with respiration while providing analgesia for surgeries to patients who had recovered from Covid-19 infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49160,NA
CTRI/2020/11/029188,CTRI,2020-11-17,2020-11-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Quality  of life in post covid  affected patients,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47149,NA
CTRI/2020/11/029174,CTRI,2020-11-17,2020-11-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 on domestic responsibilities in physicians,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48433,NA
CTRI/2020/11/029159,CTRI,2020-11-17,2020-11-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"Study to evaluate the knowledge, attitude and mental health  of in-hospital front-line warriors of operation theatre",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44643,NA
CTRI/2020/11/029173,CTRI,2020-11-17,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,What does Covid 19 do to patients with long standing Kidney disease and the impact of treatment on their course in hospital - a tertiary care hospital study,62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49522,NA
CTRI/2020/11/029172,CTRI,2020-11-17,2020-11-23,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of the globally spread Covid-19 on the diet and lifestyle of adults (25-60 years),200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49271,NA
CTRI/2020/11/029166,CTRI,2020-11-17,2020-01-12,TRUE,Not Recruiting,Phase 3,Interventional,India,Curaneum 20 for Covid 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785,NA
CTRI/2020/11/029171,CTRI,2020-11-17,2020-11-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Mothers view on the impact of increased screen time on the overall health of school going children during COVID-19,261,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49097,NA
CTRI/2020/11/029200,CTRI,2020-11-18,2020-11-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological effect of COVID 19 on Positive female patient,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49556,NA
CTRI/2020/11/029233,CTRI,2020-11-19,2020-12-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,An observation and comparison of the efficacy and relative satisfaction of Health Care Workers while being monitored by the  standard BUDDY technique versus the Remote Audio Visual Doffing Surveillance (RADS) of the doffing process during the COVID 19 Pandemic,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177,NA
CTRI/2020/11/029221,CTRI,2020-11-19,2020-11-24,FALSE,Not Recruiting,Not Applicable,Observational,India,"Measurement of Quality of food intake, mental health status, and safety measures followed by the hospital support staff during COVID-19.",354,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49250,NA
CTRI/2020/11/029235,CTRI,2020-11-19,2020-11-23,FALSE,Not Recruiting,Not Applicable,Observational,India,"Impact of COVID-19 on screen time, physical activity, sleep pattern and food intake among students of 18-23 years.",478,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49267,NA
CTRI/2020/11/029232,CTRI,2020-11-19,2020-11-25,FALSE,Not Recruiting,Phase 3,Interventional,India,Role Of Montelukast In Management Of COVID 19,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293,NA
CTRI/2020/11/029230,CTRI,2020-11-19,2020-11-20,FALSE,Not Recruiting,Phase 3,Interventional,India,ROLE OF VITAMIN C IN MANAGEMENT OF COVID 19,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295,NA
CTRI/2020/11/029236,CTRI,2020-11-19,2020-01-12,TRUE,Recruiting,Not Applicable,Observational,India,Patient satisfaction with psychiatry services during the pandemic,347,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48376,NA
CTRI/2020/11/029263,CTRI,2020-11-20,2020-11-30,FALSE,Recruiting,Phase 4,Interventional,India,A clinical study on Favipiravir in mild to moderate COVID-19 patients,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353,NA
CTRI/2020/11/029265,CTRI,2020-11-20,2020-11-30,FALSE,Not Recruiting,Phase 3,Interventional,India,Preventive trial of Homoeopathic medicines in COVID-19,20000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401,NA
CTRI/2020/11/029264,CTRI,2020-11-20,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,To study the long term ill effects of  covid 19 infection in old age people,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47176,NA
CTRI/2020/11/029266,CTRI,2020-11-20,2020-04-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Response of patients and chest x-ray improvement after Remdesivir,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49576,NA
CTRI/2020/11/029289,CTRI,2020-11-23,2020-11-25,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial of Siddha drugs M V kashayam (Internally) for the management   and  treatment of COVID 19,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077,NA
CTRI/2020/11/029297,CTRI,2020-11-23,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Changing Trends in Presentation of Trauma Patients during Nationwide lockdown for COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47331,NA
CTRI/2020/11/029305,CTRI,2020-11-24,2020-11-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clarithromycin in Post Covid 19 parenchymal organizing pneumonia,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195,NA
CTRI/2020/11/029328,CTRI,2020-11-24,2020-11-30,FALSE,Not Recruiting,Phase 2,Interventional,India,A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are hospitalized SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.,118,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552,NA
CTRI/2020/11/029335,CTRI,2020-11-24,2020-02-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Apprehensions and Challenges faced by dentists during Covid 19 pandemic,189,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49555,NA
CTRI/2020/11/029356,CTRI,2020-11-25,2020-11-25,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical study to compare high flow nasal oxygen and non invasive ventilation in patients with covid-19.,82,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432,NA
CTRI/2020/11/029346,CTRI,2020-11-25,2020-11-26,FALSE,Not Recruiting,Not Applicable,Interventional,India,Spectrum of eye infections in COVID-19 affected individuals,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444,NA
CTRI/2020/11/029345,CTRI,2020-11-25,2020-11-25,FALSE,Not Recruiting,Phase 4,Interventional,"United States, India, Mexico, Brazil","To determine efficacy, safety and optimal dosing of anticoagulant strategies to prevent adverse outcomes in hospitalized COVID-19 patients.
",3600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48213,NA
CTRI/2020/11/029350,CTRI,2020-11-25,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,"Assessing the knowledge and precautions taken by dentists and dental auxiliaries(operating, non-operating) in dental office during the pandemic of Corona virus (COVID-19)",108,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49535,NA
CTRI/2020/11/029396,CTRI,2020-11-26,2020-01-12,TRUE,Not Recruiting,Not Applicable,Interventional,India,Safety of an aerosol having as its active ingredient 8.4 % sodium bicarbonate and xylitol 5% when administered to the nasopharynx and oropharynx,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442,NA
CTRI/2020/11/029399,CTRI,2020-11-26,2020-10-12,TRUE,Not Recruiting,Phase 1,Interventional,India,Develop homeopathic Nosodes for Immunity Against COVID 19.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714,NA
CTRI/2020/11/029393,CTRI,2020-11-26,2020-11-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Eye Diseases associated with COVID-19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48183,NA
CTRI/2020/11/029398,CTRI,2020-11-26,2020-07-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Palliative Care in COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49741,NA
CTRI/2020/11/029377,CTRI,2020-11-26,2020-12-15,FALSE,Recruiting,Not Applicable,Observational,India,Formative research for management of serious infections in infants less than 2 months of age during COVID pandemic,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49498,NA
CTRI/2020/11/029414,CTRI,2020-11-26,2020-12-14,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID WITH AKI,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49245,NA
CTRI/2020/11/029388,CTRI,2020-11-26,2020-11-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Pirdal Nasal Spray in preventing symptomatic manifestation of disease in Covid-19 proven cases,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529,NA
CTRI/2020/11/029394,CTRI,2020-11-26,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Precautionary measure during surgical process during COVID-19 pandemic around the globe,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48280,NA
CTRI/2020/11/029390,CTRI,2020-11-26,2020-11-28,FALSE,Not Recruiting,Not Applicable,Observational,India,A study of clinical profile of children with  COVID 19 INFECTION admitted at tertiary care hospital,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49606,NA
CTRI/2020/11/029444,CTRI,2020-11-27,2020-03-12,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to study effect of Madhav Rasayan tablets in COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712,NA
CTRI/2020/11/029437,CTRI,2020-11-27,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"A study to evaluate post COVID-19 lung damage.


",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49744,NA
CTRI/2020/11/029438,CTRI,2020-11-27,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Reinfection with SARS-COV-2 and associated factors,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49809,NA
CTRI/2020/12/029475,CTRI,2020-12-01,2020-07-12,TRUE,Not Recruiting,Not Applicable,Interventional,India,A clinical study to determine the effect of CL20189 and CL20193 in mild to moderate COVID-19 patients,66,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49723,NA
CTRI/2020/12/029476,CTRI,2020-12-01,2020-12-15,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect of herbal medicine on enhancing immune function in COVID recovery patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48455,NA
CTRI/2020/12/029452,CTRI,2020-12-01,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Covid outcomes among patients with comorbidities,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49272,NA
CTRI/2020/12/029478,CTRI,2020-12-01,2020-11-12,TRUE,Not Recruiting,Not Applicable,Observational,India,study of Covid 19 infection in hemodialysis and post renal transplant patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49796,NA
CTRI/2020/12/029454,CTRI,2020-12-01,2020-11-26,TRUE,Not Recruiting,Not Applicable,Observational,India,Severity of COVID among type 2 diabetes patients,1050,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49574,NA
CTRI/2020/12/029463,CTRI,2020-12-01,2020-07-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Types of drugs used and their side effects in Covid-19 patients,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49849,NA
CTRI/2020/12/029456,CTRI,2020-12-01,2020-03-12,TRUE,Not Recruiting,Not Applicable,Observational,India,How COVID 19 affected MAHE students diet and lifestyle practices,294,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49340,NA
CTRI/2020/12/029515,CTRI,2020-12-02,2020-06-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID-19 pandemic on post graduate medical trainees in India,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49857,NA
CTRI/2020/12/029575,CTRI,2020-12-04,2020-04-12,TRUE,Not Recruiting,Phase 3,Interventional,India,Effectiveness of Unani add-on therapy in preventing the disease severity  of  COVID-19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49430,NA
CTRI/2020/12/029581,CTRI,2020-12-04,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,A study of kidney Problems with covid 19 in admitted patients at a teritiary care hospital.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49709,NA
CTRI/2020/12/029586,CTRI,2020-12-04,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"Various Blood Parameters Affecting outcome in ICU Patients 
",150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49982,NA
CTRI/2020/12/029563,CTRI,2020-12-04,2020-10-12,TRUE,Not Recruiting,Not Applicable,Observational,India,Ã¢??AN OBSERVATIONAL STUDY OF HIGH FLOW NASAL OXYGEN THERAPY IN COVID 19 PATIENTS ADMITTED IN INTENSIVE CARE UNITÃ¢??,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49001,NA
CTRI/2020/12/029584,CTRI,2020-12-04,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Effects of PPE among Healthcare Workers,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49269,NA
CTRI/2020/12/029587,CTRI,2020-12-04,2020-12-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,To compare the effect of lying in face down position along with oxygen therapy given through high flow nasal cannula device versus lying face down with oxygen given by non-rebreathing face mask in COVID-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49803,NA
CTRI/2020/12/029585,CTRI,2020-12-04,2020-12-12,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to compare the effect of non-invasive ventilation with high-flow nasal oxygen therapy versus only high flow nasal oxygen therapy in COVID 19 patients with respiratory failure.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49854,NA
CTRI/2020/12/029614,CTRI,2020-12-07,2020-12-16,FALSE,Not Recruiting,Phase 2,Interventional,India,Liberal use of oxygen in early stage of COVID-19 patients.,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49680,NA
CTRI/2020/12/029615,CTRI,2020-12-07,2020-12-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Remdesivir plus Tocilizumab efficacy trial in moderate to severe COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731,NA
CTRI/2020/12/029613,CTRI,2020-12-07,2020-12-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,Drug to prevent lung injury secondary to COVID 19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026,NA
CTRI/2020/12/029671,CTRI,2020-12-09,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Blood changes in COVID 19 and itÃ¢??s influence,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48689,NA
CTRI/2020/12/029668,CTRI,2020-12-09,2021-01-01,FALSE,Not Recruiting,Phase 2,Interventional,India,Add-on homoeopathic treatment of COVID-19 patients,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45821,NA
CTRI/2020/12/029669,CTRI,2020-12-09,2020-12-21,FALSE,Not Recruiting,Not Applicable,Interventional,India,Assessment of pulmonary function test in patients recovered from COVID 19 infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50175,NA
CTRI/2020/12/029712,CTRI,2020-12-10,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of sugars on patients diagnosed with COVID,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49971,NA
CTRI/2020/12/029724,CTRI,2020-12-10,2020-12-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Has COVID 19 pandemic been affecting scientific trials to be done by students of anaesthesia department?,91,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50076,NA
CTRI/2020/12/029713,CTRI,2020-12-10,2020-12-15,FALSE,Recruiting,Phase 2,Interventional,India,A STUDY TO ASSESS THE EFFECTIVENESS OF IMMUNRICH IN COVID 19 POSITIVE PATIENTS,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46813,NA
CTRI/2020/12/029714,CTRI,2020-12-10,2020-12-15,FALSE,Recruiting,Phase 2,Interventional,India,A STUDY TO ASSESS THE EFFECTIVENESS OF CAP ASMO IN COVID 19 POSITIVE CASES,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46814,NA
CTRI/2020/12/029755,CTRI,2020-12-11,2020-12-25,FALSE,Not Recruiting,Not Applicable,Observational,India,To assess symptoms and quality of life in post covid patients,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50254,NA
CTRI/2020/12/029743,CTRI,2020-12-11,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Analysing effect of COVID 19 on mental health of frontline healthcare workers,246,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48997,NA
CTRI/2020/12/029733,CTRI,2020-12-11,2020-12-25,FALSE,Not Recruiting,Not Applicable,Observational,India,"To Assess CT Chest finding of Post-covid Pneumonia Patient 
",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50279,NA
CTRI/2020/12/029735,CTRI,2020-12-11,2020-12-15,FALSE,Recruiting,Phase 3,Interventional,India,A Study to Assess the Safety and Efficacy of CoroQuil-Zn 750 in Comparison to the Standard of Care for the Treatment of Mild to Moderate COVID-19.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48763,NA
CTRI/2020/12/029754,CTRI,2020-12-11,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,India,study of clinical and radiological presentation among covid-19 hospitalised patients based on covid swab tests,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50080,NA
CTRI/2020/12/029744,CTRI,2020-12-11,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Analysing impact of pre-existing comorbidities on serious adverse outcomes in hospitalised COVID19 patients,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49072,NA
CTRI/2020/12/029745,CTRI,2020-12-11,2020-12-12,FALSE,Not Recruiting,Not Applicable,Interventional,India,Efficacy of Homoeopathic prophylaxis Arsenicum Album against COVID-19,15000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49613,NA
CTRI/2020/12/029761,CTRI,2020-12-11,2020-12-12,FALSE,Not Recruiting,Not Applicable,Observational,India,what happens when a patient having connective tissue disease develops covid 19 infection.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49404,NA
CTRI/2020/12/029780,CTRI,2020-12-14,2020-12-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Mental health impact of COVID-19 pandemic on PMNS cohort,370,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49510,NA
CTRI/2020/12/029773,CTRI,2020-12-14,2020-12-23,FALSE,Not Recruiting,Not Applicable,Observational,India,Establishment of a Indo-US Molecular Biomarker Knowledge Network for COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50309,NA
CTRI/2020/12/029772,CTRI,2020-12-14,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of malaria or dengue in COVID-19 patients.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50363,NA
CTRI/2020/12/029783,CTRI,2020-12-14,2020-12-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,nintedanib therapy will improve management in covid 19 fibrosis if given early or not.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49405,NA
CTRI/2020/12/029805,CTRI,2020-12-15,2020-12-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Evaluating efficacy and safety of goggles with or without inbuilt fan in health care workers inside COVID ICU,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50445,NA
CTRI/2020/12/029812,CTRI,2020-12-15,2020-12-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of psychological outcomes in cancer patients during COVID-19 pandemic,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50458,NA
CTRI/2020/12/029803,CTRI,2020-12-15,2020-12-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Oxygen therapy in covid positive patients,122,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49947,NA
CTRI/2020/12/029814,CTRI,2020-12-15,2020-12-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,comparison of two drugs for better treatment of covid-19 related lung problems,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49778,NA
CTRI/2020/12/029793,CTRI,2020-12-15,2020-12-31,FALSE,Not Recruiting,Phase 3,Interventional,India,The use of tocilizumab in patients with severe COVID 19 pneumonia - a trial to know its efficacy in those on steroids,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50303,NA
CTRI/2020/12/029841,CTRI,2020-12-16,2020-12-18,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of a techniques named  goal directed therapy with clinician guided regime for fluid management in COVID -19 critical care unit,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48427,NA
CTRI/2020/12/029847,CTRI,2020-12-16,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to see the result of planned cancer surgery in COVID-19 survivors,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50526,NA
CTRI/2020/12/029855,CTRI,2020-12-16,2020-12-28,FALSE,Recruiting,Phase 3,Interventional,India,"Phase III, Randomized, Controlled, Open-Label Study of
Pegylated Interferon Alfa-2b With SARS-CoV-2",250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49858,NA
CTRI/2020/12/029869,CTRI,2020-12-16,2021-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Effectiveness of Siddha Medicines on COVID-19 patients,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50422,NA
CTRI/2020/12/029873,CTRI,2020-12-17,2020-12-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Professional quality of life in health care workers of ICUs during COVID-19 pandemic,323,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50567,NA
CTRI/2020/12/029887,CTRI,2020-12-17,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Comparison of anaesthesia management and procedures during COVID 19 time and one year before,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50575,NA
CTRI/2020/12/029884,CTRI,2020-12-17,2020-12-26,FALSE,Not Recruiting,Not Applicable,Observational,India,response to an upcoming COVID 19 vaccine about how an individual looks towards it.,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50596,NA
CTRI/2020/12/029885,CTRI,2020-12-17,2020-12-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of transport media s for detecting COVID-19 positivity.,394,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50606,NA
CTRI/2020/12/029882,CTRI,2020-12-17,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Socio demographic profile and clinical outcome in COVID 19 in a tertiary care hospital -A Retrospective study,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50155,NA
CTRI/2020/12/029894,CTRI,2020-12-18,2020-12-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study to compare the effectiveness of two drugs, Dexamethasone versus Methylprednisolone in the treatment of moderate Covid 19 patients",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49273,NA
CTRI/2020/12/029896,CTRI,2020-12-18,2020-12-25,FALSE,Not Recruiting,Not Applicable,Observational,India,To study Covid disease pattern in health care personnel working in a dedicated Covid Hospital,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45178,NA
CTRI/2020/12/029926,CTRI,2020-12-18,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Cost Burden of Covid-19 in a Tertiary care hospital,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50574,NA
CTRI/2020/12/029898,CTRI,2020-12-18,2020-12-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Self-prone positioning to reduce need of ventilatory support in COVID-19 patients,190,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48811,NA
CTRI/2020/12/029902,CTRI,2020-12-18,2021-01-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A clinical trial of a new product to understand the effectiveness and safety to manage the symptoms of covid positive adult patients.
",80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49842,NA
CTRI/2020/12/029900,CTRI,2020-12-18,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,A study on stress during work and tiredness in health care workers working in covid units of the university teaching hospital of south India,147,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50369,NA
CTRI/2020/12/029901,CTRI,2020-12-18,2021-01-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Experiences of the Patients and Pharmacists with respect to medicine supply during COVID-19 Pandemic,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50383,NA
CTRI/2020/12/029897,CTRI,2020-12-18,2020-12-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Hematological and biochemical markers as poor outcome predictors in COVID-19,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50388,NA
CTRI/2020/12/029957,CTRI,2020-12-21,2020-12-22,FALSE,Not Recruiting,Not Applicable,Interventional,India,To study the effectiveness of pulmonary rehabilitation program in people who have recovered from covid 19 pneumonia and Acute Respiratory Distress,217,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48186,NA
CTRI/2020/12/029956,CTRI,2020-12-21,2021-01-14,FALSE,Not Recruiting,Not Applicable,Observational,India,Web Based Survey to assess the mental health status of health sciences students during COVID 19,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50542,NA
CTRI/2020/12/029955,CTRI,2020-12-21,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of the COVID-19 on services offered to pregnant women and their mental health in urban areas of Hyderabad- A study,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48528,NA
CTRI/2020/12/029954,CTRI,2020-12-21,2020-12-28,FALSE,Not Recruiting,Phase 3,Interventional,India,Use of soapy nasal irrigation in covid 19 positive cases to reduce  viral load in nasopharynx and oropharynx,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50385,NA
CTRI/2020/12/029970,CTRI,2020-12-22,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Analysis of COVID 19 features in HRCT Chest of patients who have no evidence of Tuberculosis infection and comparison between COVID and Tuberculosis imaging features in COVID patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46461,NA
CTRI/2020/12/029982,CTRI,2020-12-23,2021-12-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Ã¢??Experiences and readiness of the volunteers during the COVID-19 in BengaluruÃ¢??,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50712,NA
CTRI/2020/12/029985,CTRI,2020-12-23,2020-12-28,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,An Open labeled study in efficacy of add-on Ayurveda intervention in comparison with standard  in Covid-19 patients with moderate severity and with type 2 diabetes followed by 60 day follwo-up,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50354,NA
CTRI/2020/12/029984,CTRI,2020-12-23,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,India,STUDY OF CORRELATION BETWEEN MARKERS OF COAGULATION AND CLINICAL SEVERITY IN COVID 19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49872,NA
CTRI/2020/12/029981,CTRI,2020-12-23,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Study to look for cardiovascular manifestations of COVID,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50659,NA
CTRI/2020/12/030015,CTRI,2020-12-24,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,India,High Flow Nasal Oxygen Therapy in COVID-19 patients,108,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50436,NA
CTRI/2020/12/030014,CTRI,2020-12-24,2020-12-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Study of mental status(anxiety and depression) in pregnant women during COVID-19 pandemic,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50457,NA
CTRI/2020/12/030013,CTRI,2020-12-24,2020-12-25,FALSE,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate the efficacy and safety of Sofosbuvir/Daclatasvir (tablet) with or without Nitazoxanide when given with the standard of care in Moderate COVID-19 Patients.,366,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50222,NA
CTRI/2020/12/030046,CTRI,2020-12-28,2020-12-31,FALSE,Not Recruiting,Not Applicable,Observational,India,safety of remdesivir use in patients with impaired kidney function and covid 19 infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50693,NA
CTRI/2020/12/030049,CTRI,2020-12-28,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,India,A RETROSPECTIVE OBSERVATIONAL STUDY IN COVID-19 PATIENTS ADMITTED TO THE ICU TO SEE WHETHER DERANGEMENT OF VARIOUS BIOMARKERS IN PATIENT BLOOD TESTS CORRELATE WITH THE OUTCOME OF THEIR ILLNESS.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50718,NA
CTRI/2020/12/030050,CTRI,2020-12-28,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,India,An observational study to observe the effect of SARS COVID 19 infection on mother and fetus.,220,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50778,NA
CTRI/2020/12/030044,CTRI,2020-12-28,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Questionnaire survey for analyzing the students concept on online learning during the COVID 19 pandemic,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50524,NA
CTRI/2020/12/030072,CTRI,2020-12-28,2020-12-30,FALSE,Not Recruiting,Not Applicable,Interventional,"India, United Kingdom",Investigator Initiated Study To Evaluate Leflunomide for the Treatment of Corona Virus Disease 2019 (COVID-19),178,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50013,NA
CTRI/2020/12/030048,CTRI,2020-12-28,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Role of imaging in the diagnosis of extrapulmonary manifestations of COVID 19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50284,NA
CTRI/2020/12/030053,CTRI,2020-12-28,2021-01-23,FALSE,Not Recruiting,Not Applicable,Observational,India,Blood Investigations in Covid 19 patients,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50813,NA
CTRI/2020/12/030070,CTRI,2020-12-28,2021-01-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Inflammatory markers and other  biochemical parameters in COVID -19 and their association with mortality outcome in Diabetes verses Non Diabetes patients of coastal karnataka tertiary care hospital.,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50147,NA
CTRI/2020/12/030052,CTRI,2020-12-28,2021-01-20,FALSE,Not Recruiting,Not Applicable,Observational,India,RESEARCH STUDY ON COVID19 ANTIBODIES IN HEALTH CARE WORKERS AT TERTIARY CARE HOSPITAL,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50149,NA
CTRI/2020/12/030051,CTRI,2020-12-28,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,India,ImmunoModulatory Efficacy of Nichi Glucan in Covid19 Patients.,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48880,NA
CTRI/2020/12/030083,CTRI,2020-12-29,2020-12-31,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,To Study the Role of Vitamin D in the Treatment of Confirmed COVID-19 Infection,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46899,NA
CTRI/2020/12/030085,CTRI,2020-12-29,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,India,Efficacy of Mycobacterium w in preventing COVID-19 among peri-urban population of Haryana,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50812,NA
CTRI/2020/12/030094,CTRI,2020-12-29,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,India,To understand and study the experiences of patients and doctors at the COVID-19 isolation wards,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49616,NA
CTRI/2020/12/030082,CTRI,2020-12-29,2020-12-30,FALSE,Not Recruiting,Not Applicable,Observational,India,CYTOKINES(INFLAMMATORY MARKERS) IN SEVERE AND MODERATE COVID 19 PATIENTS AND ITS RELATION WITH THE OUTCOMES,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50171,NA
CTRI/2020/12/030113,CTRI,2020-12-30,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,India,"Analysis of Antibody (IgM & IgG) responses among symptomatic adult COVID-19 Positive patients, getting admitted to Odisha COVID Hospital, KIMS, BBSR


",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50776,NA
CTRI/2020/12/030127,CTRI,2020-12-30,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Trends of maternal mortality during COVID -19 pandemic at our tertiary care institute.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49841,NA
CTRI/2020/12/030165,CTRI,2020-12-31,2021-08-01,FALSE,Recruiting,Not Applicable,Interventional,India,"To assess the body resistance improvement and to evaluate the clinical use and well-being of DailyTabÃ¢?Â¢Gold immuno booster and DailyTabÃ¢?Â¢Gold immuno booster (For cardiac, diabetic and neuro conditions) along with standard of care in novel corona virus (COVID-19) patients.",45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50753,NA
CTRI/2020/12/030164,CTRI,2020-12-31,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,India,National Registry for COVID in Pregnant women,4650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50578,NA
CTRI/2020/12/030143,CTRI,2020-12-31,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,India,comparison of different steroid regimes in critically ill adult patients of COVID-19,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50886,NA
CTRI/2020/12/030156,CTRI,2020-12-31,2021-01-13,FALSE,Not Recruiting,Not Applicable,Observational,India,"Orientation of time, stress, and well-being of Middle-aged Employees during the Covid-19 Pandemic",130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50914,NA
CTRI/2021/01/030169,CTRI,2021-01-01,2021-04-01,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Study to evaluate the effect of two herbal drugs NIFAy.C-19(CONTAZAP)and AYUSH 64 in corona patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50842,NA
CTRI/2021/01/030186,CTRI,2021-01-01,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Periodic Change in Antibody titers against SARS-CoV-2 among COVID-19 positive patients: A Observational Cohort Study,84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49335,NA
CTRI/2021/01/030231,CTRI,2021-01-04,2021-12-01,FALSE,Not Recruiting,Phase 3,Interventional,India,"A randomized, two treatment group clinical study to evaluate the effectiveness and safety of study drug  2-Deoxy-D-Glucose with SOC compared to SOC alone in treatment of moderate to severe COVID-19 patients",220,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50985,NA
CTRI/2021/01/030202,CTRI,2021-01-04,2021-01-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Challenges encountered by person with disability during COVID-19,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51001,NA
CTRI/2021/01/030212,CTRI,2021-01-04,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Managing problems of any food or bone or object impaction in food tract during Covid pandemic,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51005,NA
CTRI/2021/01/030197,CTRI,2021-01-04,2021-10-01,FALSE,Not Recruiting,Not Applicable,Observational,India,"CORRELATION OF HRCT CHEST IMAGING FINDINGS WITH DISEASE STATUS IN
COVID-19 PATIENTS",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49519,NA
CTRI/2021/01/030213,CTRI,2021-01-04,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of Risks of corona virus Infection in Health Care Workers at a Tertiary Cancer Care Centre With COVID Care Facility,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50861,NA
CTRI/2021/01/030241,CTRI,2021-01-05,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Pattern of COVID 19 infection in different age groups,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50515,NA
CTRI/2021/01/030242,CTRI,2021-01-05,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,India,Covid 19 among healthcare professionals,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51037,NA
CTRI/2021/01/030236,CTRI,2021-01-05,2021-01-18,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of Hypertonic saline nasal irrigation and gargling in COVID-19,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50290,NA
CTRI/2021/01/030235,CTRI,2021-01-05,2021-12-01,FALSE,Recruiting,Not Applicable,Observational,India,Lung Function Test in Post Covid patients: An Observational Study.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51076,NA
CTRI/2021/01/030244,CTRI,2021-01-05,2021-01-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinico-Demographic Profile And Morbidity Of Percutaneous Nephrolithotomy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51152,NA
CTRI/2021/01/030297,CTRI,2021-01-06,2021-01-13,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,"Prevalence of depression, anxiety, and stress among physiotherapy students and interns",1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51101,NA
CTRI/2021/01/030316,CTRI,2021-01-07,2021-01-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Symptoms of COVID and its relation with severity,320,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47274,NA
CTRI/2021/01/030319,CTRI,2021-01-07,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,"A study on knowledge,attitude and behavior of undergraduate students of medical field on practices which are useful and required to prevent COVID 19 Pandemic",600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50887,NA
CTRI/2021/01/030333,CTRI,2021-01-08,2021-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,India,An eKnee School  for patients suffering from knee osteoarthritis,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50964,NA
CTRI/2021/01/030341,CTRI,2021-01-08,2021-01-17,FALSE,Not Recruiting,Not Applicable,Observational,India,The outcome of Remdesivir and Tocilizumab in COVID 19.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51287,NA
CTRI/2021/01/030344,CTRI,2021-01-08,2021-01-28,FALSE,Not Recruiting,Not Applicable,Observational,India,"A study of blood group in COVID-19 patients admitted at tertiary care hospital, Ahmedabad",600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50637,NA
CTRI/2021/01/030363,CTRI,2021-01-11,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Serological response to COVID-19 and association with MR containing vaccine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50953,NA
CTRI/2021/01/030364,CTRI,2021-01-11,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,EVALUATING THE CT PATTERNS ASSOCIATED WITH COVID-19 FROM CHEST CT BY USING ARTIFICIAL INTELLIGENCE,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49740,NA
CTRI/2021/01/030373,CTRI,2021-01-11,2021-11-01,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,"Australia, Russian Federation, South Africa, United Kingdom, Belgium, Brazil, Spain, Austria, India",ETHIC trial: Early LMWH in symptomatic COVID-19 positive patients,1370,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50288,NA
CTRI/2021/01/030385,CTRI,2021-01-11,2021-01-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To study whether Remdesivir (an antiviral, used for the treatment of COVID - 19) is effective in COVID 19 patients with respect to complications of the disease or death.",1066,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51172,NA
CTRI/2021/01/030384,CTRI,2021-01-11,2021-01-20,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID -19 death predictors,1071,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50170,NA
CTRI/2021/01/030416,CTRI,2021-01-12,2021-01-20,FALSE,Recruiting,Phase 3,Interventional,India,"Novel Corona Virus-2019-nCov vaccine by intradermal route in
healthy subjects.",28216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51254,NA
CTRI/2021/01/030414,CTRI,2021-01-12,2021-01-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Healthcare workers reflections on COVID 19 pandemic,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51377,NA
CTRI/2021/01/030433,CTRI,2021-01-13,2021-01-18,FALSE,Not Recruiting,Not Applicable,Observational,India,A retrospective analysis to study the Effectiveness and Safety profile of Remdesivir therapy in patients who diagnosed with COVID-19,1050,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49676,NA
CTRI/2021/01/030432,CTRI,2021-01-13,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Importance of blood investigations in assessing severity and recovery in Covid 19 patients,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51518,NA
CTRI/2021/01/030430,CTRI,2021-01-13,2021-01-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Questionnaire based study to assess physical and mental health status of health care workers who have recovered from COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51547,NA
CTRI/2021/01/030431,CTRI,2021-01-13,2021-01-29,FALSE,Not Recruiting,Not Applicable,Observational,India,"Relation of Oxygen saturation, respiratory rate ratios with failure of high flow oxygen therapy in Corona patients",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51381,NA
CTRI/2021/01/030454,CTRI,2021-01-14,2021-01-22,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Zandu Chyavanprash as a preventive remedy in pandemic of Covid-19.,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51491,NA
CTRI/2021/01/030451,CTRI,2021-01-14,2021-01-23,FALSE,Not Recruiting,Not Applicable,Observational,India,A study done to find out anxiety in patients admitted in icu requiring Non invasive ventilation,39,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49457,NA
CTRI/2021/01/030477,CTRI,2021-01-14,2021-01-19,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study to find out whether immunosuppressant Mycophenolate Sodium is effective in the treatment of Covid 19 infection.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48197,NA
CTRI/2021/01/030455,CTRI,2021-01-14,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,Prevalence of COVID19 antibodies among blood donors.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51086,NA
CTRI/2021/01/030456,CTRI,2021-01-14,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,Exploring experiences of ethics committee members during COVID-19 pandemic,383,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51410,NA
CTRI/2021/01/030485,CTRI,2021-01-15,2021-01-30,FALSE,Not Recruiting,Not Applicable,Observational,India,THE EFFECT OF THE COVID-19 PANDEMIC ON HOSPITAL VISITS OF PATIENTS PRESENTING WITH CHEST PAIN TO THE EMERGENCY DEPARTMENT,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51385,NA
CTRI/2021/01/030488,CTRI,2021-01-15,2021-01-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Healthcare access and quality of life of persons with disabilities during COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51403,NA
CTRI/2021/01/030522,CTRI,2021-01-18,2021-02-28,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID and dental treatment,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51566,NA
CTRI/2021/01/030529,CTRI,2021-01-18,2021-01-18,FALSE,Not Recruiting,Not Applicable,Interventional,India,Ã¢?? Ayurvedic intervention in the management of COVID-19 positive childrenÃ¢??,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51315,NA
CTRI/2021/01/030534,CTRI,2021-01-18,2021-01-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Study of ENT Manifestations of COVID-19,273,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51122,NA
CTRI/2021/01/030533,CTRI,2021-01-18,2021-01-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Sildenafil Use in Covid-19 Patients - A Pilot Study,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51393,NA
CTRI/2021/01/030546,CTRI,2021-01-18,2021-01-26,FALSE,No Status Given,Not Applicable,Observational,Bangladesh,Acceptance of COVID-19 vaccine among Bangladeshi general population,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51674,NA
CTRI/2021/01/030573,CTRI,2021-01-19,2021-01-22,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to understand post COVID quality of life,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51269,NA
CTRI/2021/01/030582,CTRI,2021-01-19,2021-01-23,FALSE,Not Recruiting,Not Applicable,Observational,India,"A Real World Evaluation of safety, immunogenicity and efficacy of COVID-19 Vaccines among health care workers",5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51278,NA
CTRI/2021/01/030603,CTRI,2021-01-20,2021-01-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Explore the problems encountered by Physiotherapists during COVID-19 pandemic,372,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51728,NA
CTRI/2021/01/030601,CTRI,2021-01-20,2021-01-20,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Cardamom Extract Clinical trial on Covid patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50754,NA
CTRI/2021/01/030630,CTRI,2021-01-20,2021-02-02,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to identify SARS-CoV-2 in Red Blood Cells in infected patients.,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47720,NA
CTRI/2021/01/030604,CTRI,2021-01-20,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,To understand cardiac and pulmonary function in patients with covid-19 in India,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49046,NA
CTRI/2021/01/030652,CTRI,2021-01-21,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,Influence of COVID-19 on the Occurrence of Cleanliness associated Diseases and Antibiotic Use,691,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51761,NA
CTRI/2021/01/030647,CTRI,2021-01-21,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,"Assesement of the risk perception and readiness of current dental students in treating patients during the COVID-19 pandemic

Aimed at identifying the hesitancies and concerns which can then be addressed by dental colleges throughout the country",384,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51078,NA
CTRI/2021/01/030651,CTRI,2021-01-21,2021-01-31,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Knowledge, Attitude and Practices regarding COVID care in ICU",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49805,NA
CTRI/2021/01/030661,CTRI,2021-01-21,2021-01-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Study to prove the use of Svasth Viral detection scanner using Near Infrared technology for Covid-19 detection and Viral load without taking Nasal or mouth swab or even blood sample.Comparing the results with RT-PCR results which is the current gold standard in Covid-19 detection.,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48292,NA
CTRI/2021/01/030679,CTRI,2021-01-22,2021-03-31,FALSE,Not Recruiting,Not Applicable,Observational,India,Infections of lungs in a COVID patients with symptoms and detection of its antibiotic sensitivity .,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50788,NA
CTRI/2021/01/030680,CTRI,2021-01-22,2021-01-27,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to find out the stress among the dental students before and during the Covid-19 situation,77,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51368,NA
CTRI/2021/01/030722,CTRI,2021-01-22,2021-01-25,FALSE,Not Recruiting,Not Applicable,Observational,India,"Study of clinical, radiological presentation and outcomeof Covid 19 positive patients",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51390,NA
CTRI/2021/01/030733,CTRI,2021-01-25,2021-01-02,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Clinical study on Zandu Chyawanprash, Zandu Pure Honey, Trishun Tablets and Immuzan Tablets as an add to treatment of Covid 19",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51715,NA
CTRI/2021/01/030743,CTRI,2021-01-25,2021-01-25,FALSE,Not Recruiting,Not Applicable,Observational,India,The occurence of kidney disease in patients admitted with COVID-19 in a higher treatment centre,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48798,NA
CTRI/2021/01/030729,CTRI,2021-01-25,2021-01-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Effect of Crocodile breathing versus Prone positioning on heart rate,respiratory rate and oxygen saturation and pulmonary Function test in patients affected by COVID-19: A Pilot Study.",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51654,NA
CTRI/2021/01/030734,CTRI,2021-01-25,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,Lung Problems in Covid Recovered Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50936,NA
NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,FALSE,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, Singapore, United States, Italy, Spain, Japan, China, France, Germany, Iran, South Korea, Switzerland",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,1113,https://clinicaltrials.gov/show/NCT04292730,NA
NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,FALSE,Not Recruiting,Phase 3,Interventional,"South Africa, Canada, United States, Brazil, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),4506,https://clinicaltrials.gov/show/NCT04322682,NA
NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,FALSE,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04335136,NA
NCT04337359,ClinicalTrials.gov,2020-04-03,2021-02-11,FALSE,Not Recruiting,Not Applicable,Expanded Access,"Indonesia, Italy",Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Not Available,https://clinicaltrials.gov/show/NCT04337359,NA
NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,1500,https://clinicaltrials.gov/show/NCT04342689,NA
NCT04344119,ClinicalTrials.gov,2020-04-09,2020-04-09,FALSE,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,30,https://clinicaltrials.gov/show/NCT04344119,NA
NCT04356950,ClinicalTrials.gov,2020-04-16,2020-04-28,FALSE,Not Recruiting,Not Applicable,Observational,France,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,175,https://clinicaltrials.gov/show/NCT04356950,NA
NCT04366050,ClinicalTrials.gov,2020-04-24,2020-05-11,FALSE,Recruiting,Phase 2,Interventional,United States,Ramipril for the Treatment of COVID-19,560,https://clinicaltrials.gov/show/NCT04366050,NA
NCT04366778,ClinicalTrials.gov,2020-04-23,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Thrombosis and Covid-19,341,https://clinicaltrials.gov/show/NCT04366778,NA
NCT04384055,ClinicalTrials.gov,2020-05-08,2020-03-21,TRUE,Recruiting,Not Applicable,Observational,United States,Predicting Outcomes for Covid-19 Using Sonography,200,https://clinicaltrials.gov/show/NCT04384055,NA
NCT04386239,ClinicalTrials.gov,2020-05-07,2021-01-01,FALSE,Recruiting,Phase 1,Interventional,Italy,Study on the Use of Sarilumab in Patients With COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04386239,NA
NCT04390126,ClinicalTrials.gov,2020-05-14,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Related Lockdown Effects On Chronic Diseases,1200,https://clinicaltrials.gov/show/NCT04390126,NA
NCT04406389,ClinicalTrials.gov,2020-05-26,2020-10-13,FALSE,Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),186,https://clinicaltrials.gov/show/NCT04406389,NA
NCT04409509,ClinicalTrials.gov,2020-05-28,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),124,https://clinicaltrials.gov/show/NCT04409509,NA
NCT04409925,ClinicalTrials.gov,2020-05-13,2020-12-25,FALSE,Recruiting,Phase 1,Interventional,Canada,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),25,https://clinicaltrials.gov/show/NCT04409925,NA
NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,TRUE,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,714,https://clinicaltrials.gov/show/NCT04410562,NA
NCT04414124,ClinicalTrials.gov,2020-06-01,2020-08-02,FALSE,Not Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,350,https://clinicaltrials.gov/show/NCT04414124,NA
NCT04424992,ClinicalTrials.gov,2020-06-04,2020-02-28,TRUE,Recruiting,Not Applicable,Observational,Italy,The Natural History of Hospitalized COVID-19 Patients,1433,https://clinicaltrials.gov/show/NCT04424992,NA
NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,55,https://clinicaltrials.gov/show/NCT04425005,NA
NCT04425616,ClinicalTrials.gov,2020-06-03,2020-06-04,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,1100,https://clinicaltrials.gov/show/NCT04425616,NA
NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-14,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 and the Healthy Minds Program for Educators,733,https://clinicaltrials.gov/show/NCT04426318,NA
NCT04438239,ClinicalTrials.gov,2020-06-10,2020-06-22,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Rehabilitation Needs After COVID-19 Hospital Treatment,150,https://clinicaltrials.gov/show/NCT04438239,NA
NCT04444401,ClinicalTrials.gov,2020-06-22,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Registry on NEN Patients and COVID-19,50,https://clinicaltrials.gov/show/NCT04444401,NA
NCT04445441,ClinicalTrials.gov,2020-06-22,2020-04-24,TRUE,Not Recruiting,Not Applicable,Observational,Burkina Faso,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,153,https://clinicaltrials.gov/show/NCT04445441,NA
NCT04455815,ClinicalTrials.gov,2020-06-25,2020-09-25,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,389,https://clinicaltrials.gov/show/NCT04455815,NA
NCT04456088,ClinicalTrials.gov,2020-07-01,2020-07-15,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),0,https://clinicaltrials.gov/show/NCT04456088,NA
NCT04468009,ClinicalTrials.gov,2020-07-09,2020-06-25,TRUE,Recruiting,Phase 2,Interventional,Argentina,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,36,https://clinicaltrials.gov/show/NCT04468009,NA
NCT04476888,ClinicalTrials.gov,2020-07-16,2020-04-26,TRUE,Not Recruiting,Not Applicable,Interventional,Pakistan,Convalescent Plasma Treatment in COVID-19,110,https://clinicaltrials.gov/show/NCT04476888,NA
NCT04482361,ClinicalTrials.gov,2020-07-20,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,Argentina,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,5900,https://clinicaltrials.gov/show/NCT04482361,NA
NCT04482595,ClinicalTrials.gov,2020-07-17,2020-11-11,FALSE,Recruiting,Phase 2,Interventional,United States,BIO 300 Oral Suspension in Discharged COVID-19 Patients,66,https://clinicaltrials.gov/show/NCT04482595,NA
NCT04483960,ClinicalTrials.gov,2020-07-22,2020-07-28,FALSE,Recruiting,Phase 3,Interventional,Australia,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,2400,https://clinicaltrials.gov/show/NCT04483960,NA
NCT04485338,ClinicalTrials.gov,2020-07-23,2020-08-01,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Chest Radiography in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04485338,NA
NCT04487769,ClinicalTrials.gov,2020-07-24,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Lung Ultrasound in COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04487769,NA
NCT04502433,ClinicalTrials.gov,2020-08-03,2021-01-06,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),85,https://clinicaltrials.gov/show/NCT04502433,NA
NCT04522492,ClinicalTrials.gov,2020-08-07,2020-08-11,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of COVID-19 on Mental Health of Patients With Skin Picking,18,https://clinicaltrials.gov/show/NCT04522492,NA
NCT04526990,ClinicalTrials.gov,2020-08-22,2020-09-15,FALSE,Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, Pakistan, Mexico",Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,40000,https://clinicaltrials.gov/show/NCT04526990,NA
NCT04530396,ClinicalTrials.gov,2020-08-25,2020-09-07,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",33758,https://clinicaltrials.gov/show/NCT04530396,NA
NCT04542343,ClinicalTrials.gov,2020-09-03,2020-11-01,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Risk Reduction Among African American Parishioners,265,https://clinicaltrials.gov/show/NCT04542343,NA
NCT04545242,ClinicalTrials.gov,2020-09-05,2021-02-08,FALSE,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,980,https://clinicaltrials.gov/show/NCT04545242,NA
NCT04572412,ClinicalTrials.gov,2020-09-29,2020-11-25,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,13,https://clinicaltrials.gov/show/NCT04572412,NA
NCT04581083,ClinicalTrials.gov,2020-10-07,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,Bolivia,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",30,https://clinicaltrials.gov/show/NCT04581083,NA
NCT04587219,ClinicalTrials.gov,2020-10-13,2020-10-22,FALSE,Not Recruiting,Phase 2,Interventional,Russian Federation,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",110,https://clinicaltrials.gov/show/NCT04587219,NA
NCT04605887,ClinicalTrials.gov,2020-10-27,2021-01-18,FALSE,Recruiting,Phase 2,Interventional,Israel,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,120,https://clinicaltrials.gov/show/NCT04605887,NA
NCT04609865,ClinicalTrials.gov,2020-10-23,2020-11-04,FALSE,Recruiting,Phase 3,Interventional,France,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,100,https://clinicaltrials.gov/show/NCT04609865,NA
NCT04630054,ClinicalTrials.gov,2020-11-13,2020-11-15,FALSE,Recruiting,Not Applicable,Interventional,Bangladesh,Face Masks to Reduce COVID-19 in Bangladesh,450000,https://clinicaltrials.gov/show/NCT04630054,NA
NCT04632732,ClinicalTrials.gov,2020-11-03,2020-10-26,TRUE,Recruiting,Not Applicable,Observational,Canada,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,140,https://clinicaltrials.gov/show/NCT04632732,NA
NCT04634799,ClinicalTrials.gov,2020-11-17,2021-01-08,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,80,https://clinicaltrials.gov/show/NCT04634799,NA
NCT04661410,ClinicalTrials.gov,2020-12-07,2020-12-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04661410,NA
NCT04665115,ClinicalTrials.gov,2020-12-10,2021-06-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),134,https://clinicaltrials.gov/show/NCT04665115,NA
NCT04667442,ClinicalTrials.gov,2020-12-10,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,United States,Investigational Performance Evaluation of the Nanomix eLabÂ® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,60,https://clinicaltrials.gov/show/NCT04667442,NA
NCT04700254,ClinicalTrials.gov,2021-01-06,2020-12-28,TRUE,Not Recruiting,Not Applicable,Observational,Greece,"Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece",150,https://clinicaltrials.gov/show/NCT04700254,NA
NCT04701892,ClinicalTrials.gov,2021-01-07,2021-01-19,FALSE,Recruiting,Not Applicable,Observational,Belgium,poSt Covid-19 Infection centraL Sensitisation 2,200,https://clinicaltrials.gov/show/NCT04701892,NA
NCT04703452,ClinicalTrials.gov,2021-01-07,2021-01-19,FALSE,Recruiting,Not Applicable,Observational,Belgium,poSt Covid-19 Infection centraL sENsitisaTion,100,https://clinicaltrials.gov/show/NCT04703452,NA
NCT04712344,ClinicalTrials.gov,2020-12-30,2021-01-18,FALSE,Recruiting,Phase 2,Interventional,Germany,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),58,https://clinicaltrials.gov/show/NCT04712344,NA
NCT04713540,ClinicalTrials.gov,2021-01-14,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Rehabilitation in Intensive Care Unit,58,https://clinicaltrials.gov/show/NCT04713540,NA
NCT04714138,ClinicalTrials.gov,2021-01-14,2021-01-05,TRUE,Recruiting,Not Applicable,Observational,France,Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection,190,https://clinicaltrials.gov/show/NCT04714138,NA
NCT04714333,ClinicalTrials.gov,2021-01-15,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,Canada,Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath,1000,https://clinicaltrials.gov/show/NCT04714333,NA
NCT04715295,ClinicalTrials.gov,2020-10-02,2020-10-05,FALSE,Recruiting,Phase 4,Interventional,Cameroon,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,200,https://clinicaltrials.gov/show/NCT04715295,NA
NCT04715919,ClinicalTrials.gov,2020-12-28,2021-01-15,FALSE,Recruiting,Not Applicable,Observational,Turkey,Long Term Outcomes of Coronavirus Disease-19 (COVID-19),80,https://clinicaltrials.gov/show/NCT04715919,NA
NCT04715997,ClinicalTrials.gov,2021-01-18,2020-12-30,TRUE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults",170,https://clinicaltrials.gov/show/NCT04715997,NA
NCT04716023,ClinicalTrials.gov,2020-07-02,2019-08-23,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,42,https://clinicaltrials.gov/show/NCT04716023,NA
NCT04716088,ClinicalTrials.gov,2021-01-15,2020-11-18,TRUE,Not Recruiting,Not Applicable,Observational,Slovenia,Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19,36,https://clinicaltrials.gov/show/NCT04716088,NA
NCT04716179,ClinicalTrials.gov,2021-01-17,2021-01-18,FALSE,Recruiting,Not Applicable,Interventional,Russian Federation,Prospective Two-arm Study of Fertility in Men With COVID-19,88,https://clinicaltrials.gov/show/NCT04716179,NA
NCT04716465,ClinicalTrials.gov,2021-01-18,2021-01-19,FALSE,Recruiting,Not Applicable,Observational,Belgium,Dysautonomia in Patients Post COVID-19 Infection,200,https://clinicaltrials.gov/show/NCT04716465,NA
NCT04716543,ClinicalTrials.gov,2020-12-14,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,5400,https://clinicaltrials.gov/show/NCT04716543,NA
NCT04716647,ClinicalTrials.gov,2021-01-18,2020-10-09,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,28,https://clinicaltrials.gov/show/NCT04716647,NA
NCT04716998,ClinicalTrials.gov,2021-01-17,2021-01-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Israel,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,35,https://clinicaltrials.gov/show/NCT04716998,NA
NCT04717024,ClinicalTrials.gov,2021-01-19,2020-09-15,TRUE,Recruiting,Not Applicable,Observational,United States,The Nanowear Wearable Covid-19 Observational and Analysis Trend,100,https://clinicaltrials.gov/show/NCT04717024,NA
NCT04718285,ClinicalTrials.gov,2021-01-15,2021-01-30,FALSE,Not Recruiting,Phase 2,Interventional,Turkey,Investigation the Effect of Montelukast in COVID-19,380,https://clinicaltrials.gov/show/NCT04718285,NA
NCT04718480,ClinicalTrials.gov,2021-01-18,2020-11-27,TRUE,Recruiting,Phase 2,Interventional,Hungary,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,100,https://clinicaltrials.gov/show/NCT04718480,NA
NCT04718506,ClinicalTrials.gov,2021-01-16,2021-01-12,TRUE,Recruiting,Not Applicable,Interventional,Spain,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,56,https://clinicaltrials.gov/show/NCT04718506,NA
NCT04719182,ClinicalTrials.gov,2021-01-18,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04719182,NA
NCT04719208,ClinicalTrials.gov,2020-10-21,2020-10-06,TRUE,Recruiting,Not Applicable,Interventional,United States,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,60,https://clinicaltrials.gov/show/NCT04719208,NA
NCT04719234,ClinicalTrials.gov,2021-01-20,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Lung Ultrasonography in COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04719234,NA
NCT04720404,ClinicalTrials.gov,2021-01-12,2020-06-23,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),220,https://clinicaltrials.gov/show/NCT04720404,NA
NCT04720612,ClinicalTrials.gov,2021-01-13,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,Canada,COVID-19 Immunologic Antiviral Therapy With Omalizumab,200,https://clinicaltrials.gov/show/NCT04720612,NA
NCT04720794,ClinicalTrials.gov,2020-10-13,2020-09-25,TRUE,Not Recruiting,Not Applicable,Interventional,United States,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,101,https://clinicaltrials.gov/show/NCT04720794,NA
NCT04721236,ClinicalTrials.gov,2021-01-20,2020-11-19,TRUE,Recruiting,Not Applicable,Interventional,Italy,Early Use of Hyperimmune Plasma in COVID-19,300,https://clinicaltrials.gov/show/NCT04721236,NA
NCT04721457,ClinicalTrials.gov,2021-01-19,2021-01-03,TRUE,Recruiting,Phase 4,Interventional,Saudi Arabia,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,120,https://clinicaltrials.gov/show/NCT04721457,NA
NCT04723407,ClinicalTrials.gov,2021-01-22,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism,950,https://clinicaltrials.gov/show/NCT04723407,NA
NCT04723550,ClinicalTrials.gov,2021-01-21,2021-01-05,TRUE,Recruiting,Not Applicable,Interventional,China,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,120,https://clinicaltrials.gov/show/NCT04723550,NA
NCT04723576,ClinicalTrials.gov,2021-01-14,2020-12-03,TRUE,Recruiting,Not Applicable,Interventional,United States,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),2132,https://clinicaltrials.gov/show/NCT04723576,NA
NCT04723589,ClinicalTrials.gov,2020-11-26,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),40,https://clinicaltrials.gov/show/NCT04723589,NA
NCT04724538,ClinicalTrials.gov,2020-12-29,2020-10-15,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,15,https://clinicaltrials.gov/show/NCT04724538,NA
NCT04724616,ClinicalTrials.gov,2021-01-10,2021-01-06,TRUE,Recruiting,Not Applicable,Interventional,Austria,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,60,https://clinicaltrials.gov/show/NCT04724616,NA
NCT04724629,ClinicalTrials.gov,2020-10-05,2021-01-05,FALSE,Recruiting,Phase 3,Interventional,Brazil,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),60,https://clinicaltrials.gov/show/NCT04724629,NA
NCT04724681,ClinicalTrials.gov,2020-10-21,2021-02-01,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,800,https://clinicaltrials.gov/show/NCT04724681,NA
NCT04728243,ClinicalTrials.gov,2021-01-20,2021-02-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,WHO QualityRights E-training in Ghana,216,https://clinicaltrials.gov/show/NCT04728243,NA
ACTRN12620000516987,ANZCTR,2020-04-27,2020-11-25,FALSE,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,90,https://anzctr.org.au/ACTRN12620000516987.aspx,NA
ACTRN12620000641998,ANZCTR,2020-06-01,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,"United States, Australia",Ventricular Arrhythmias in Implantable Cardioverter Defibrillator Patients During the COVID-19 Pandemic,6000,https://anzctr.org.au/ACTRN12620000641998.aspx,NA
ACTRN12620000634976,ANZCTR,2020-05-29,2020-06-23,FALSE,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,46,https://anzctr.org.au/ACTRN12620000634976.aspx,NA
ACTRN12621000067875,ANZCTR,2021-01-27,2021-02-17,FALSE,Not Recruiting,Phase 1,Interventional,Australia,Assessment of the safety and tolerability of inhaled aerosolised ethanol in adult volunteers for COVID-19,18,https://anzctr.org.au/ACTRN12621000067875.aspx,NA
ACTRN12620000982910,ANZCTR,2020-09-30,2021-02-15,FALSE,Not Recruiting,Phase 3,Interventional,Australia,A randomized double-blind placebo-controlled trial of oral ivermectin for outpatient treatment of those at high risk for hospitalization due to COVID-19,400,https://anzctr.org.au/ACTRN12620000982910.aspx,NA
ACTRN12621000065897,ANZCTR,2021-01-27,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,Australia,An investigation of fit testing of face masks in a real world intensive care setting during the COVID-19 pandemic,50,https://anzctr.org.au/ACTRN12621000065897.aspx,NA
ISRCTN17941313,ISRCTN,2021-01-20,2020-01-02,TRUE,Recruiting,Not Applicable,Interventional,"Tanzania, Nigeria",Determining trustworthiness and safety of remote consulting during the COVID-19 pandemic in primary healthcare for chronic disease populations in Nigeria and Tanzania,800,http://isrctn.com/ISRCTN17941313,NA
ISRCTN33260034,ISRCTN,2020-08-20,2020-10-20,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Adalimumab for coronavirus in community care,750,http://isrctn.com/ISRCTN33260034,NA
ChiCTR2000040146,ChiCTR,2020-11-22,2020-12-02,FALSE,Not Recruiting,Phase 2,Interventional,China,"A Phase II, Randomized, Double-Blinded, Placebo-Controlled, Dose-Finding Clinical Trial to Evaluate the Safety and Immunogenicity of Different Doses of COVID-19 DNA Vaccine INO-4800 Administered Intradermally Followed by Electroporation in Healthy Adult and Elderly Volunteers",640,http://www.chictr.org.cn/showproj.aspx?proj=64452,NA
ChiCTR2000039462,ChiCTR,2020-10-28,2020-10-27,TRUE,Recruiting,Phase 2,Interventional,China,A phase II clinical trial for inactivated SARS-CoV-2 (COVID-19) Vaccine (Vero Cells),1000,http://www.chictr.org.cn/showproj.aspx?proj=63353,NA
ChiCTR2000039369,ChiCTR,2020-10-24,2020-02-28,TRUE,Not Recruiting,Not Applicable,Interventional,China,The Effects of Narrative Exposure Therapy on COVID-19 Patients with Post-Traumatic Stress Disorder: a Randomized Controlled Trial,111,http://www.chictr.org.cn/showproj.aspx?proj=63048,NA
ChiCTR2000039364,ChiCTR,2020-10-24,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,China,The clinical characteristics and the etiology of COVID-19 infected patients with myocardial damage,200,http://www.chictr.org.cn/showproj.aspx?proj=63240,NA
ChiCTR2000032457,ChiCTR,2020-04-29,2020-05-01,FALSE,Recruiting,Not Applicable,Interventional,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,60,http://www.chictr.org.cn/showproj.aspx?proj=52925,NA
NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,300,https://clinicaltrials.gov/show/NCT04290780,NA
NCT04331106,ClinicalTrials.gov,2020-03-27,2020-03-27,FALSE,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,7500,https://clinicaltrials.gov/show/NCT04331106,NA
NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,FALSE,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,228,https://clinicaltrials.gov/show/NCT04333225,NA
NCT04334434,ClinicalTrials.gov,2020-04-02,2020-07-30,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),30,https://clinicaltrials.gov/show/NCT04334434,NA
NCT04337996,ClinicalTrials.gov,2020-04-01,2020-07-13,FALSE,Not Recruiting,Not Applicable,Interventional,France,Dynamic Evaluation of COVID-19 Diagnostic Tests,8,https://clinicaltrials.gov/show/NCT04337996,NA
NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,FALSE,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,200,https://clinicaltrials.gov/show/NCT04338958,NA
NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-08,FALSE,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,161,https://clinicaltrials.gov/show/NCT04341584,NA
NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,320,https://clinicaltrials.gov/show/NCT04346693,NA
NCT04347031,ClinicalTrials.gov,2020-04-07,2020-04-08,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,320,https://clinicaltrials.gov/show/NCT04347031,NA
NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,40,https://clinicaltrials.gov/show/NCT04347174,NA
NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,FALSE,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04347915,NA
NCT04354155,ClinicalTrials.gov,2020-04-13,2020-06-02,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,38,https://clinicaltrials.gov/show/NCT04354155,NA
NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,FALSE,Not Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,40,https://clinicaltrials.gov/show/NCT04365127,NA
NCT04366934,ClinicalTrials.gov,2020-04-22,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of the Pathogenesis of Olfactory Disorders in COVID-19,26,https://clinicaltrials.gov/show/NCT04366934,NA
NCT04368208,ClinicalTrials.gov,2020-04-28,2020-04-29,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,501,https://clinicaltrials.gov/show/NCT04368208,NA
NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,FALSE,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,100,https://clinicaltrials.gov/show/NCT04368845,NA
NCT04376658,ClinicalTrials.gov,2020-05-04,2020-07-15,FALSE,Recruiting,Not Applicable,Observational,Brazil,Quality of Life and Long-term Outcomes After Hospitalization for COVID-19,1000,https://clinicaltrials.gov/show/NCT04376658,NA
NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,TRUE,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,40,https://clinicaltrials.gov/show/NCT04390477,NA
NCT04391686,ClinicalTrials.gov,2020-05-15,2020-07-03,FALSE,Recruiting,Not Applicable,Observational,France,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,90,https://clinicaltrials.gov/show/NCT04391686,NA
NCT04401371,ClinicalTrials.gov,2020-05-21,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Distance Learning for Dental Student During COVID-19 Pandemic,418,https://clinicaltrials.gov/show/NCT04401371,NA
NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,FALSE,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",1968,https://clinicaltrials.gov/show/NCT04403100,NA
NCT04403932,ClinicalTrials.gov,2020-05-24,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,300,https://clinicaltrials.gov/show/NCT04403932,NA
NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,TRUE,Not Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,1008,https://clinicaltrials.gov/show/NCT04411433,NA
NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,FALSE,Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,32,https://clinicaltrials.gov/show/NCT04412668,NA
NCT04427332,ClinicalTrials.gov,2020-06-10,2020-06-11,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Smell and Taste Disorders in COVID-19 Patients,376,https://clinicaltrials.gov/show/NCT04427332,NA
NCT04430049,ClinicalTrials.gov,2020-06-10,2020-06-22,FALSE,Recruiting,Not Applicable,Observational,France,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",480,https://clinicaltrials.gov/show/NCT04430049,NA
NCT04431284,ClinicalTrials.gov,2020-06-10,2020-06-16,FALSE,Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,37,https://clinicaltrials.gov/show/NCT04431284,NA
NCT04434118,ClinicalTrials.gov,2020-06-13,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Egypt,Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients,600,https://clinicaltrials.gov/show/NCT04434118,NA
NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-18,FALSE,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,2038,https://clinicaltrials.gov/show/NCT04435379,NA
NCT04452669,ClinicalTrials.gov,2020-06-29,2020-09-15,FALSE,Recruiting,Phase 2,Interventional,United States,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,20,https://clinicaltrials.gov/show/NCT04452669,NA
NCT04452695,ClinicalTrials.gov,2020-06-29,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,United States,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,40,https://clinicaltrials.gov/show/NCT04452695,NA
NCT04459403,ClinicalTrials.gov,2020-07-02,2020-06-08,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Psychiatric Disturbances and COVID-19 Infection,400,https://clinicaltrials.gov/show/NCT04459403,NA
NCT04459962,ClinicalTrials.gov,2020-07-03,2020-06-29,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Covid-19 Breath Test,330,https://clinicaltrials.gov/show/NCT04459962,NA
NCT04462627,ClinicalTrials.gov,2020-07-07,2020-04-14,TRUE,Recruiting,Not Applicable,Interventional,Belgium,Reduction of COVID 19 Transmission to Health Care Professionals,500,https://clinicaltrials.gov/show/NCT04462627,NA
NCT04465474,ClinicalTrials.gov,2020-07-03,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,"China, Hong Kong, Spain","Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",3000,https://clinicaltrials.gov/show/NCT04465474,NA
NCT04468386,ClinicalTrials.gov,2020-07-08,2020-07-07,TRUE,Not Recruiting,Not Applicable,Observational,United States,Specimen Collection Study Protocol,40,https://clinicaltrials.gov/show/NCT04468386,NA
NCT04469114,ClinicalTrials.gov,2020-07-10,2020-09-16,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,260,https://clinicaltrials.gov/show/NCT04469114,NA
NCT04474457,ClinicalTrials.gov,2020-07-15,2020-06-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,1000,https://clinicaltrials.gov/show/NCT04474457,NA
NCT04486001,ClinicalTrials.gov,2020-07-22,2020-12-15,FALSE,Recruiting,Phase 1,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,20,https://clinicaltrials.gov/show/NCT04486001,NA
NCT04488575,ClinicalTrials.gov,2020-07-23,2020-08-26,FALSE,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,60,https://clinicaltrials.gov/show/NCT04488575,NA
NCT04497922,ClinicalTrials.gov,2020-07-30,2021-01-25,FALSE,Recruiting,Not Applicable,Interventional,United States,Virtual White Boards for Patient Satisfaction,100,https://clinicaltrials.gov/show/NCT04497922,NA
NCT04498377,ClinicalTrials.gov,2020-07-31,2021-01-26,FALSE,Recruiting,Phase 2,Interventional,United States,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,38,https://clinicaltrials.gov/show/NCT04498377,NA
NCT04498442,ClinicalTrials.gov,2020-08-03,2020-05-22,TRUE,Not Recruiting,Not Applicable,Interventional,United States,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",8519,https://clinicaltrials.gov/show/NCT04498442,NA
NCT04506528,ClinicalTrials.gov,2020-08-07,2020-08-10,FALSE,Recruiting,Not Applicable,Observational,United States,The C3I COVID-19 Project,170000,https://clinicaltrials.gov/show/NCT04506528,NA
NCT04509999,ClinicalTrials.gov,2020-08-07,2020-10-26,FALSE,Recruiting,Phase 3,Interventional,United States,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04509999,NA
NCT04519411,ClinicalTrials.gov,2020-08-18,2020-05-21,TRUE,Recruiting,Not Applicable,Interventional,United States,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,10,https://clinicaltrials.gov/show/NCT04519411,NA
NCT04528368,ClinicalTrials.gov,2020-08-19,2020-12-11,FALSE,Recruiting,Phase 2,Interventional,Brazil,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,60,https://clinicaltrials.gov/show/NCT04528368,NA
NCT04528667,ClinicalTrials.gov,2020-08-20,2021-01-06,FALSE,Recruiting,Phase 2,Interventional,Brazil,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,400,https://clinicaltrials.gov/show/NCT04528667,NA
NCT04528901,ClinicalTrials.gov,2020-08-25,2020-09-04,FALSE,Recruiting,Not Applicable,Observational,France,Study of seroPREvalence Vis-Ã -vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),1080,https://clinicaltrials.gov/show/NCT04528901,NA
NCT04535856,ClinicalTrials.gov,2020-08-28,2020-11-14,FALSE,Not Recruiting,Phase 1,Interventional,Indonesia,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,9,https://clinicaltrials.gov/show/NCT04535856,NA
NCT04537208,ClinicalTrials.gov,2020-09-02,2020-09-03,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,440,https://clinicaltrials.gov/show/NCT04537208,NA
NCT04538456,ClinicalTrials.gov,2020-09-01,2020-10-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Impact of COVID-19 on Lung Cancer Patients,800,https://clinicaltrials.gov/show/NCT04538456,NA
NCT04557046,ClinicalTrials.gov,2020-09-17,2020-06-26,TRUE,Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,400,https://clinicaltrials.gov/show/NCT04557046,NA
NCT04581746,ClinicalTrials.gov,2020-09-22,2020-11-25,FALSE,Recruiting,Not Applicable,Interventional,France,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),1800,https://clinicaltrials.gov/show/NCT04581746,NA
NCT04584450,ClinicalTrials.gov,2020-10-09,2020-09-02,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,100,https://clinicaltrials.gov/show/NCT04584450,NA
NCT04590352,ClinicalTrials.gov,2020-08-27,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,187,https://clinicaltrials.gov/show/NCT04590352,NA
NCT04591613,ClinicalTrials.gov,2020-10-10,2020-12-31,FALSE,Recruiting,Not Applicable,Interventional,"France, French Guiana",Late Clinical Events Associated With COVID-19 Infection,1000,https://clinicaltrials.gov/show/NCT04591613,NA
NCT04595084,ClinicalTrials.gov,2020-10-19,2021-02-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,240,https://clinicaltrials.gov/show/NCT04595084,NA
NCT04599959,ClinicalTrials.gov,2020-10-22,2020-10-26,FALSE,Not Recruiting,Not Applicable,Interventional,Mexico,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With SalivetteÂ® Cortisol for Viral RNA Sampling for RT-qPCR,144,https://clinicaltrials.gov/show/NCT04599959,NA
NCT04605926,ClinicalTrials.gov,2020-10-21,2020-11-01,FALSE,Not Recruiting,Phase 3,Interventional,Colombia,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,0,https://clinicaltrials.gov/show/NCT04605926,NA
NCT04610138,ClinicalTrials.gov,2020-10-28,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,276,https://clinicaltrials.gov/show/NCT04610138,NA
NCT04613050,ClinicalTrials.gov,2020-10-30,2020-07-02,TRUE,Recruiting,Not Applicable,Interventional,Egypt,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,80,https://clinicaltrials.gov/show/NCT04613050,NA
NCT04613271,ClinicalTrials.gov,2020-10-25,2020-10-15,TRUE,Not Recruiting,Phase 3,Interventional,Indonesia,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,210,https://clinicaltrials.gov/show/NCT04613271,NA
NCT04623021,ClinicalTrials.gov,2020-11-05,2020-09-25,TRUE,Not Recruiting,Phase 2,Interventional,Russian Federation,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,104,https://clinicaltrials.gov/show/NCT04623021,NA
NCT04635605,ClinicalTrials.gov,2020-09-28,2020-11-05,FALSE,Recruiting,Phase 2,Interventional,Switzerland,Methylene Blue Treatment of COVID-19,64,https://clinicaltrials.gov/show/NCT04635605,NA
NCT04637295,ClinicalTrials.gov,2020-11-17,2021-01-27,FALSE,Recruiting,Not Applicable,Observational,United States,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",1000,https://clinicaltrials.gov/show/NCT04637295,NA
NCT04640038,ClinicalTrials.gov,2020-11-19,2020-12-18,FALSE,Recruiting,Phase 3,Interventional,United States,Contrast Enhanced Ultrasound in COVID-19,30,https://clinicaltrials.gov/show/NCT04640038,NA
NCT04646109,ClinicalTrials.gov,2020-11-15,2020-05-11,TRUE,Not Recruiting,Phase 3,Interventional,Turkey,Ivermectin for Severe COVID-19 Management,66,https://clinicaltrials.gov/show/NCT04646109,NA
NCT04647682,ClinicalTrials.gov,2020-10-29,2020-11-01,FALSE,Recruiting,Not Applicable,Observational,France,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,30,https://clinicaltrials.gov/show/NCT04647682,NA
NCT04659200,ClinicalTrials.gov,2020-12-07,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04659200,NA
NCT04661657,ClinicalTrials.gov,2020-12-08,2020-12-28,FALSE,Recruiting,Not Applicable,Observational,United States,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,70,https://clinicaltrials.gov/show/NCT04661657,NA
NCT04674644,ClinicalTrials.gov,2020-12-16,2020-10-16,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,850,https://clinicaltrials.gov/show/NCT04674644,NA
NCT04682041,ClinicalTrials.gov,2020-12-18,2020-12-22,FALSE,Recruiting,Not Applicable,Interventional,Spain,Evaluating the Impact of EnteraGam In People With COVID-19,420,https://clinicaltrials.gov/show/NCT04682041,NA
NCT04682912,ClinicalTrials.gov,2020-12-22,2021-01-30,FALSE,Recruiting,Not Applicable,Observational,Turkey,Blood Types in Children With COVID-19,2000,https://clinicaltrials.gov/show/NCT04682912,NA
NCT04689542,ClinicalTrials.gov,2020-12-29,2021-01-01,FALSE,Recruiting,Not Applicable,Interventional,Belgium,Surgical Face Mask Effects in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04689542,NA
NCT04691180,ClinicalTrials.gov,2020-12-17,2021-01-05,FALSE,Recruiting,Phase 1,Interventional,China,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",24,https://clinicaltrials.gov/show/NCT04691180,NA
NCT04692129,ClinicalTrials.gov,2020-12-30,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,"Spain, Mexico, Brazil",Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04692129,NA
NCT04695301,ClinicalTrials.gov,2020-12-29,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,50,https://clinicaltrials.gov/show/NCT04695301,NA
NCT04696679,ClinicalTrials.gov,2020-11-03,2020-06-19,TRUE,Not Recruiting,Not Applicable,Observational,France,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,170,https://clinicaltrials.gov/show/NCT04696679,NA
NCT04704466,ClinicalTrials.gov,2021-01-08,2021-01-07,TRUE,Recruiting,Not Applicable,Observational,France,Impact of Covid-19 Pandemic on Management of Head and Neck Cancers,150,https://clinicaltrials.gov/show/NCT04704466,NA
NCT04707534,ClinicalTrials.gov,2021-01-11,2021-01-21,FALSE,Recruiting,Phase 4,Interventional,United States,Dexamethasone for COVID-19,300,https://clinicaltrials.gov/show/NCT04707534,NA
NCT04715763,ClinicalTrials.gov,2021-01-14,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,INvestigating TELmisartin Study,40,https://clinicaltrials.gov/show/NCT04715763,NA
NCT04715815,ClinicalTrials.gov,2021-01-15,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Its Effects on Chronic Pain Patients,30,https://clinicaltrials.gov/show/NCT04715815,NA
NCT04721535,ClinicalTrials.gov,2021-01-20,2021-01-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,1012,https://clinicaltrials.gov/show/NCT04721535,NA
NCT04723524,ClinicalTrials.gov,2021-01-22,2020-09-22,TRUE,Recruiting,Phase 2,Interventional,Pakistan,Jinhua Qinggan Granules in the Treatment of COVID-19,300,https://clinicaltrials.gov/show/NCT04723524,NA
NCT04724434,ClinicalTrials.gov,2021-01-13,2020-12-04,TRUE,Recruiting,Not Applicable,Observational,Germany,Follow-up Study of COVID-19 Patients in the District Konstanz,400,https://clinicaltrials.gov/show/NCT04724434,NA
NCT04724642,ClinicalTrials.gov,2021-01-24,2020-12-28,TRUE,Recruiting,Not Applicable,Observational,Israel,"COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency",110,https://clinicaltrials.gov/show/NCT04724642,NA
NCT04724707,ClinicalTrials.gov,2021-01-16,2020-09-11,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Russian Cardiovascular Registry of COVID-19,900,https://clinicaltrials.gov/show/NCT04724707,NA
NCT04724850,ClinicalTrials.gov,2021-01-11,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura,5000,https://clinicaltrials.gov/show/NCT04724850,NA
NCT04725084,ClinicalTrials.gov,2021-01-21,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,300,https://clinicaltrials.gov/show/NCT04725084,NA
NCT04725097,ClinicalTrials.gov,2021-01-25,2020-12-10,TRUE,Recruiting,Not Applicable,Observational,"Spain, India, United States, United Kingdom",A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection,10000,https://clinicaltrials.gov/show/NCT04725097,NA
NCT04725110,ClinicalTrials.gov,2021-01-21,2021-03-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,250,https://clinicaltrials.gov/show/NCT04725110,NA
NCT04726098,ClinicalTrials.gov,2021-01-23,2021-01-15,TRUE,Recruiting,Phase 4,Interventional,Spain,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,198,https://clinicaltrials.gov/show/NCT04726098,NA
NCT04726111,ClinicalTrials.gov,2021-01-21,2020-12-30,TRUE,Recruiting,Not Applicable,Interventional,France,COVID-19 and Pregnancy: Placental and Immunological Impacts,200,https://clinicaltrials.gov/show/NCT04726111,NA
NCT04726137,ClinicalTrials.gov,2021-01-18,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19,1150,https://clinicaltrials.gov/show/NCT04726137,NA
NCT04726150,ClinicalTrials.gov,2021-01-13,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias,250,https://clinicaltrials.gov/show/NCT04726150,NA
NCT04726163,ClinicalTrials.gov,2021-01-19,2021-01-29,FALSE,Recruiting,Not Applicable,Interventional,France,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,60,https://clinicaltrials.gov/show/NCT04726163,NA
NCT04726371,ClinicalTrials.gov,2021-01-15,2021-01-08,TRUE,Recruiting,Not Applicable,Interventional,United States,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,5350,https://clinicaltrials.gov/show/NCT04726371,NA
NCT04726865,ClinicalTrials.gov,2021-01-25,2020-10-01,TRUE,Not Recruiting,Not Applicable,Observational,Jordan,COVID-19 Pandemic and Medical Students,415,https://clinicaltrials.gov/show/NCT04726865,NA
NCT04727294,ClinicalTrials.gov,2021-01-26,2021-01-22,TRUE,Recruiting,Not Applicable,Observational,United States,"MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey",1500,https://clinicaltrials.gov/show/NCT04727294,NA
NCT04728594,ClinicalTrials.gov,2021-01-26,2021-01-15,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,9656,https://clinicaltrials.gov/show/NCT04728594,NA
NCT04728698,ClinicalTrials.gov,2021-01-26,2021-03-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04728698,NA
NCT04728880,ClinicalTrials.gov,2021-01-26,2021-01-26,FALSE,Recruiting,Not Applicable,Observational,Egypt,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,300,https://clinicaltrials.gov/show/NCT04728880,NA
NCT04728906,ClinicalTrials.gov,2021-01-26,2021-03-05,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Heart Patch for Myocardial Infarction COVID-19,10,https://clinicaltrials.gov/show/NCT04728906,NA
NCT04728919,ClinicalTrials.gov,2021-01-19,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,Finland,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04728919,NA
NCT04728958,ClinicalTrials.gov,2021-01-11,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Reflective Tasks With Healthcare Workers During COVID-19,219,https://clinicaltrials.gov/show/NCT04728958,NA
NCT04729075,ClinicalTrials.gov,2021-01-19,2021-01-19,FALSE,Not Recruiting,Not Applicable,Observational,United States,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset",1800,https://clinicaltrials.gov/show/NCT04729075,NA
NCT04729153,ClinicalTrials.gov,2021-01-23,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,100,https://clinicaltrials.gov/show/NCT04729153,NA
NCT04729491,ClinicalTrials.gov,2021-01-25,2020-06-30,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,EAT-DUTA AndroCoV Trial,138,https://clinicaltrials.gov/show/NCT04729491,NA
NCT04730284,ClinicalTrials.gov,2020-08-25,2020-08-25,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,Evaluation of a Synbiotic Formula in Patient With COVID-19,20,https://clinicaltrials.gov/show/NCT04730284,NA
NCT04730323,ClinicalTrials.gov,2021-01-26,2020-05-12,TRUE,Not Recruiting,Phase 4,Interventional,Pakistan,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,93,https://clinicaltrials.gov/show/NCT04730323,NA
NCT04730427,ClinicalTrials.gov,2021-01-20,2021-01-01,TRUE,Recruiting,Phase 1,Interventional,South Korea,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04730427,NA
NCT04731051,ClinicalTrials.gov,2021-01-28,2021-03-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Jordan,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,28,https://clinicaltrials.gov/show/NCT04731051,NA
NCT04731116,ClinicalTrials.gov,2021-01-28,2021-01-10,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Israel,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,40,https://clinicaltrials.gov/show/NCT04731116,NA
NCT04731870,ClinicalTrials.gov,2021-01-27,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines,632,https://clinicaltrials.gov/show/NCT04731870,NA
NCT04732767,ClinicalTrials.gov,2021-01-28,2021-01-20,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples,50,https://clinicaltrials.gov/show/NCT04732767,NA
NCT04733625,ClinicalTrials.gov,2021-01-31,2020-09-15,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,56,https://clinicaltrials.gov/show/NCT04733625,NA
NCT04733833,ClinicalTrials.gov,2021-01-27,2021-01-26,TRUE,Recruiting,Phase 2,Interventional,Israel,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04733833,NA
NCT04734886,ClinicalTrials.gov,2020-12-10,2020-11-27,TRUE,Recruiting,Not Applicable,Interventional,Sweden,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,400,https://clinicaltrials.gov/show/NCT04734886,NA
NCT04734912,ClinicalTrials.gov,2021-01-13,2021-01-13,FALSE,Recruiting,Not Applicable,Interventional,Germany,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04734912,NA
ISRCTN15615697,ISRCTN,2021-01-31,2020-10-13,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Hormones after COVID-19,100,http://isrctn.com/ISRCTN15615697,NA
ACTRN12620000445976,ANZCTR,2020-04-06,2020-07-28,FALSE,Recruiting,Phase 3,Interventional,"India, New Zealand, Australia","Australasian COVID-19 Trial: An Adaptive Platform Trial (ASCOT-ADAPT). A multi-centre randomised adaptive platform clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19)",2500,https://anzctr.org.au/ACTRN12620000445976.aspx,NA
ACTRN12621000112864,ANZCTR,2021-02-04,2020-12-18,TRUE,Recruiting,Not Applicable,Interventional,"United States, Australia",The effect of an online diabetes risk communication intervention for people impacted by alcohol and other drugs: A randomized controlled trial,360,https://anzctr.org.au/ACTRN12621000112864.aspx,NA
ChiCTR2000039640,ChiCTR,2020-11-04,2020-11-30,FALSE,Recruiting,Not Applicable,Interventional,China,Application of an intelligent mobile isolation operating cabin preventing COVID-19 infection,10,http://www.chictr.org.cn/showproj.aspx?proj=61895,NA
ChiCTR2000039593,ChiCTR,2020-11-02,2020-03-11,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,A clinical trial of a new pharyngeal exposure device for pharyngeal swab operation and its effect of testing novel coronavirus pneumonia (COVID-19) infection,0,http://www.chictr.org.cn/showproj.aspx?proj=63496,NA
ChiCTR2000039592,ChiCTR,2020-11-02,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Effect of Group Otago Exercise Program on Cognitive Frailty in the Nursing Home: a Randomised Controlled Trial,62,http://www.chictr.org.cn/showproj.aspx?proj=62882,NA
ChiCTR2000039567,ChiCTR,2020-10-31,2020-10-19,TRUE,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for noninvasive ventilation in patients with coronavirus disease 2019 (COVID-19) related acute hypoxemic respiratory failure,40,http://www.chictr.org.cn/showproj.aspx?proj=62786,NA
NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,FALSE,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,19,https://clinicaltrials.gov/show/NCT04325061,NA
NCT04334044,ClinicalTrials.gov,2020-04-01,2020-09-01,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044,NA
NCT04335084,ClinicalTrials.gov,2020-04-02,2020-06-22,FALSE,Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",600,https://clinicaltrials.gov/show/NCT04335084,NA
NCT04336384,ClinicalTrials.gov,2020-03-30,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,5000,https://clinicaltrials.gov/show/NCT04336384,NA
NCT04343664,ClinicalTrials.gov,2020-04-09,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,10000,https://clinicaltrials.gov/show/NCT04343664,NA
NCT04344002,ClinicalTrials.gov,2020-04-09,2020-04-21,FALSE,Recruiting,Not Applicable,Observational,Spain,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),200,https://clinicaltrials.gov/show/NCT04344002,NA
NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,FALSE,Not Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,550,https://clinicaltrials.gov/show/NCT04344730,NA
NCT04346199,ClinicalTrials.gov,2020-04-09,2020-06-12,FALSE,Not Recruiting,Phase 2,Interventional,"Chile, Argentina, Russian Federation, South Africa, Peru, Italy, Brazil, Mexico, Turkey, Japan, Spain, France, India, Germany",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,177,https://clinicaltrials.gov/show/NCT04346199,NA
NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,FALSE,Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,150,https://clinicaltrials.gov/show/NCT04348383,NA
NCT04357769,ClinicalTrials.gov,2020-04-16,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic Burden in Severe Mental Disease Patients,400,https://clinicaltrials.gov/show/NCT04357769,NA
NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),30,https://clinicaltrials.gov/show/NCT04358926,NA
NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,FALSE,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,1407,https://clinicaltrials.gov/show/NCT04359680,NA
NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,FALSE,Not Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,2,https://clinicaltrials.gov/show/NCT04361344,NA
NCT04362956,ClinicalTrials.gov,2020-04-21,2020-07-10,FALSE,Not Recruiting,Not Applicable,Observational,Argentina,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,114,https://clinicaltrials.gov/show/NCT04362956,NA
NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,5,https://clinicaltrials.gov/show/NCT04363346,NA
NCT04367129,ClinicalTrials.gov,2020-04-16,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,Italy,Electrocardiogram Analysis in COVID-19 Patients,1014,https://clinicaltrials.gov/show/NCT04367129,NA
NCT04367883,ClinicalTrials.gov,2020-04-28,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Spain,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",2574,https://clinicaltrials.gov/show/NCT04367883,NA
NCT04370236,ClinicalTrials.gov,2020-04-29,2020-10-21,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,INB03 for the Treatment of Pulmonary Complications From COVID-19,366,https://clinicaltrials.gov/show/NCT04370236,NA
NCT04373889,ClinicalTrials.gov,2020-04-13,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 Among Healthcare Workers in Belgian Hospitals,850,https://clinicaltrials.gov/show/NCT04373889,NA
NCT04374513,ClinicalTrials.gov,2020-05-02,2020-04-02,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Community Pharmacists Behaviour During Covid-19,318,https://clinicaltrials.gov/show/NCT04374513,NA
NCT04382625,ClinicalTrials.gov,2020-04-14,2020-10-01,FALSE,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,0,https://clinicaltrials.gov/show/NCT04382625,NA
NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-29,FALSE,Recruiting,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,20,https://clinicaltrials.gov/show/NCT04384731,NA
NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,26,https://clinicaltrials.gov/show/NCT04385901,NA
NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,TRUE,Not Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,42,https://clinicaltrials.gov/show/NCT04388683,NA
NCT04402905,ClinicalTrials.gov,2020-05-20,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,France,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",450,https://clinicaltrials.gov/show/NCT04402905,NA
NCT04406038,ClinicalTrials.gov,2020-05-26,2020-05-27,FALSE,Not Recruiting,Not Applicable,Observational,Russian Federation,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",1038,https://clinicaltrials.gov/show/NCT04406038,NA
NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,FALSE,Not Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,72,https://clinicaltrials.gov/show/NCT04407130,NA
NCT04407143,ClinicalTrials.gov,2020-05-25,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Spain,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,128,https://clinicaltrials.gov/show/NCT04407143,NA
NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,FALSE,Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,20,https://clinicaltrials.gov/show/NCT04408027,NA
NCT04409327,ClinicalTrials.gov,2020-05-28,2020-07-11,FALSE,Not Recruiting,Phase 2,Interventional,United States,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,36,https://clinicaltrials.gov/show/NCT04409327,NA
NCT04409821,ClinicalTrials.gov,2020-05-22,2020-05-29,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,50,https://clinicaltrials.gov/show/NCT04409821,NA
NCT04409847,ClinicalTrials.gov,2020-05-22,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),70,https://clinicaltrials.gov/show/NCT04409847,NA
NCT04416399,ClinicalTrials.gov,2020-06-03,2020-07-16,FALSE,Not Recruiting,Phase 2,Interventional,United Kingdom,STerOids in COVID-19 Study,146,https://clinicaltrials.gov/show/NCT04416399,NA
NCT04418193,ClinicalTrials.gov,2020-06-02,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,Monaco,Patient Preference Trial for COVID-19 (PPT-COVID),0,https://clinicaltrials.gov/show/NCT04418193,NA
NCT04435457,ClinicalTrials.gov,2020-06-02,2020-09-01,FALSE,Recruiting,Not Applicable,Observational,United States,Cardiovascular Implications of COVID-19,70,https://clinicaltrials.gov/show/NCT04435457,NA
NCT04435522,ClinicalTrials.gov,2020-06-15,2020-10-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Maraviroc in Patients With Moderate and Severe COVID-19,9,https://clinicaltrials.gov/show/NCT04435522,NA
NCT04438863,ClinicalTrials.gov,2020-06-17,2020-08-08,FALSE,Recruiting,Not Applicable,Observational,Israel,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,90,https://clinicaltrials.gov/show/NCT04438863,NA
NCT04441502,ClinicalTrials.gov,2020-06-12,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,240,https://clinicaltrials.gov/show/NCT04441502,NA
NCT04451993,ClinicalTrials.gov,2020-06-26,2020-06-25,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,63,https://clinicaltrials.gov/show/NCT04451993,NA
NCT04453657,ClinicalTrials.gov,2020-06-26,2021-02-04,FALSE,Recruiting,Not Applicable,Interventional,United States,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",270,https://clinicaltrials.gov/show/NCT04453657,NA
NCT04459286,ClinicalTrials.gov,2020-07-03,2020-10-09,FALSE,Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,98,https://clinicaltrials.gov/show/NCT04459286,NA
NCT04465552,ClinicalTrials.gov,2020-07-09,2020-07-10,FALSE,Recruiting,Not Applicable,Observational,United States,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,750,https://clinicaltrials.gov/show/NCT04465552,NA
NCT04466241,ClinicalTrials.gov,2020-07-06,2020-11-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,294,https://clinicaltrials.gov/show/NCT04466241,NA
NCT04476706,ClinicalTrials.gov,2020-07-16,2021-02-01,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Canakinumab MAP in COVID-19 Pneumonia With CRS,Not Available,https://clinicaltrials.gov/show/NCT04476706,NA
NCT04490486,ClinicalTrials.gov,2020-07-27,2021-09-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,21,https://clinicaltrials.gov/show/NCT04490486,NA
NCT04492475,ClinicalTrials.gov,2020-07-28,2020-08-05,FALSE,Not Recruiting,Phase 3,Interventional,"South Korea, United States, Mexico, Japan, Singapore",Adaptive COVID-19 Treatment Trial 3 (ACTT-3),969,https://clinicaltrials.gov/show/NCT04492475,NA
NCT04498416,ClinicalTrials.gov,2020-07-31,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,France,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,70,https://clinicaltrials.gov/show/NCT04498416,NA
NCT04509752,ClinicalTrials.gov,2020-08-11,2020-10-08,FALSE,Recruiting,Not Applicable,Observational,Turkey,Dysphagia Management During COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04509752,NA
NCT04510454,ClinicalTrials.gov,2020-08-11,2020-11-02,FALSE,Recruiting,Not Applicable,Interventional,France,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,200,https://clinicaltrials.gov/show/NCT04510454,NA
NCT04511923,ClinicalTrials.gov,2020-08-10,2020-12-23,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Ireland,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,40,https://clinicaltrials.gov/show/NCT04511923,NA
NCT04511949,ClinicalTrials.gov,2020-08-12,2020-07-12,TRUE,Not Recruiting,Not Applicable,Interventional,France,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,500,https://clinicaltrials.gov/show/NCT04511949,NA
NCT04519255,ClinicalTrials.gov,2020-08-18,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT,60,https://clinicaltrials.gov/show/NCT04519255,NA
NCT04525417,ClinicalTrials.gov,2020-08-21,2020-04-25,TRUE,Not Recruiting,Not Applicable,Interventional,France,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,75,https://clinicaltrials.gov/show/NCT04525417,NA
NCT04529499,ClinicalTrials.gov,2020-08-19,2020-08-20,FALSE,Not Recruiting,Phase 3,Interventional,Kuwait,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,780,https://clinicaltrials.gov/show/NCT04529499,NA
NCT04536376,ClinicalTrials.gov,2020-08-26,2021-01-15,FALSE,Recruiting,Not Applicable,Interventional,United States,First Responder Resiliency Program During COVID-19,10,https://clinicaltrials.gov/show/NCT04536376,NA
NCT04542200,ClinicalTrials.gov,2020-09-08,2021-01-01,FALSE,Recruiting,Not Applicable,Observational,United States,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,70812,https://clinicaltrials.gov/show/NCT04542200,NA
NCT04542395,ClinicalTrials.gov,2020-09-03,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,310,https://clinicaltrials.gov/show/NCT04542395,NA
NCT04548934,ClinicalTrials.gov,2020-09-02,2020-09-13,FALSE,Not Recruiting,Not Applicable,Interventional,Italy,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,34,https://clinicaltrials.gov/show/NCT04548934,NA
NCT04568850,ClinicalTrials.gov,2020-09-21,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Pakistan,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,50,https://clinicaltrials.gov/show/NCT04568850,NA
NCT04579458,ClinicalTrials.gov,2020-10-06,2020-12-28,FALSE,Not Recruiting,Not Applicable,Observational,United States,Assessment of COVID-19 in Tearfilm,0,https://clinicaltrials.gov/show/NCT04579458,NA
NCT04581200,ClinicalTrials.gov,2020-10-04,2021-01-25,FALSE,Recruiting,Not Applicable,Interventional,United States,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,300,https://clinicaltrials.gov/show/NCT04581200,NA
NCT04584567,ClinicalTrials.gov,2020-10-06,2020-11-20,FALSE,Recruiting,Phase 3,Interventional,Tunisia,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 """,1100,https://clinicaltrials.gov/show/NCT04584567,NA
NCT04584710,ClinicalTrials.gov,2020-10-08,2020-10-13,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,60,https://clinicaltrials.gov/show/NCT04584710,NA
NCT04585945,ClinicalTrials.gov,2020-09-17,2020-08-04,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 on Placental Gene Expression and Pathology,100,https://clinicaltrials.gov/show/NCT04585945,NA
NCT04603079,ClinicalTrials.gov,2020-10-19,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Nurse Leadership for Hospital Infection Control,200,https://clinicaltrials.gov/show/NCT04603079,NA
NCT04604249,ClinicalTrials.gov,2020-10-25,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,Peru,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,200,https://clinicaltrials.gov/show/NCT04604249,NA
NCT04607915,ClinicalTrials.gov,2020-07-30,2021-02-05,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,30,https://clinicaltrials.gov/show/NCT04607915,NA
NCT04609774,ClinicalTrials.gov,2020-10-27,2020-10-08,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,8,https://clinicaltrials.gov/show/NCT04609774,NA
NCT04613817,ClinicalTrials.gov,2020-10-30,2020-12-03,FALSE,Recruiting,Not Applicable,Observational,Belgium,Sero-prevalence COVID-19 Among Belgian Children,1640,https://clinicaltrials.gov/show/NCT04613817,NA
NCT04615429,ClinicalTrials.gov,2020-10-25,2020-09-15,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,20,https://clinicaltrials.gov/show/NCT04615429,NA
NCT04639375,ClinicalTrials.gov,2020-11-16,2020-11-15,TRUE,Recruiting,Phase 4,Interventional,United States,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),300,https://clinicaltrials.gov/show/NCT04639375,NA
NCT04643678,ClinicalTrials.gov,2020-11-24,2020-10-30,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Qatar,Anakinra in the Management of COVID-19 Infection,80,https://clinicaltrials.gov/show/NCT04643678,NA
NCT04647747,ClinicalTrials.gov,2020-11-27,2020-11-30,FALSE,Recruiting,Not Applicable,Interventional,Norway,Silent Hypoxia and Awake Proning in COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04647747,NA
NCT04653727,ClinicalTrials.gov,2020-11-23,2021-01-06,FALSE,Recruiting,Not Applicable,Observational,Germany,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,3000,https://clinicaltrials.gov/show/NCT04653727,NA
NCT04656444,ClinicalTrials.gov,2020-12-04,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,250,https://clinicaltrials.gov/show/NCT04656444,NA
NCT04658121,ClinicalTrials.gov,2020-11-19,2021-02-04,FALSE,Recruiting,Not Applicable,Observational,"Puerto Rico, United States",SARS-CoV-2/COVID-19 Prevalence Study,3920,https://clinicaltrials.gov/show/NCT04658121,NA
NCT04663555,ClinicalTrials.gov,2020-12-09,2021-02-02,FALSE,Recruiting,Phase 4,Interventional,Czech Republic,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,300,https://clinicaltrials.gov/show/NCT04663555,NA
NCT04663945,ClinicalTrials.gov,2020-12-08,2020-12-11,FALSE,Recruiting,Not Applicable,Interventional,United States,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,45,https://clinicaltrials.gov/show/NCT04663945,NA
NCT04668625,ClinicalTrials.gov,2020-12-09,2020-11-30,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",1000,https://clinicaltrials.gov/show/NCT04668625,NA
NCT04668911,ClinicalTrials.gov,2020-12-11,2020-12-13,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,"Oral Health, Microbial Burden and COVID-19",150,https://clinicaltrials.gov/show/NCT04668911,NA
NCT04669912,ClinicalTrials.gov,2020-12-07,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management,77,https://clinicaltrials.gov/show/NCT04669912,NA
NCT04672395,ClinicalTrials.gov,2020-12-16,2021-03-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Dominican Republic, Nepal, South Africa, Colombia, Belgium, Brazil, Poland, Panama, Germany, Philippines",A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,22000,https://clinicaltrials.gov/show/NCT04672395,NA
NCT04678687,ClinicalTrials.gov,2020-12-02,2021-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 and Tissue Damage in Vital Organs,10,https://clinicaltrials.gov/show/NCT04678687,NA
NCT04678700,ClinicalTrials.gov,2020-12-12,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,Spain,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,40,https://clinicaltrials.gov/show/NCT04678700,NA
NCT04685629,ClinicalTrials.gov,2020-12-21,2020-05-07,TRUE,Recruiting,Not Applicable,Observational,Belgium,Covid-19 Long-term Revalidation Follow-up,50,https://clinicaltrials.gov/show/NCT04685629,NA
NCT04686565,ClinicalTrials.gov,2020-12-23,2020-02-15,TRUE,Recruiting,Not Applicable,Observational,Turkey,Covid-19 Pandemic and Cerebral Palsy,100,https://clinicaltrials.gov/show/NCT04686565,NA
NCT04686578,ClinicalTrials.gov,2020-12-23,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia,100,https://clinicaltrials.gov/show/NCT04686578,NA
NCT04703036,ClinicalTrials.gov,2021-01-06,2021-01-11,FALSE,Recruiting,Phase 1,Interventional,United States,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",64,https://clinicaltrials.gov/show/NCT04703036,NA
NCT04713488,ClinicalTrials.gov,2021-01-13,2021-01-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",110,https://clinicaltrials.gov/show/NCT04713488,NA
NCT04716972,ClinicalTrials.gov,2021-01-18,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes,200,https://clinicaltrials.gov/show/NCT04716972,NA
NCT04726176,ClinicalTrials.gov,2021-01-25,2021-01-30,FALSE,Recruiting,Not Applicable,Observational,Belgium,COVID-19 and the Brain,40,https://clinicaltrials.gov/show/NCT04726176,NA
NCT04729374,ClinicalTrials.gov,2021-01-25,2021-01-27,FALSE,Recruiting,Not Applicable,Observational,China,COVID-19 Vaccine Induced Adaptive Immune Responses,200,https://clinicaltrials.gov/show/NCT04729374,NA
NCT04730661,ClinicalTrials.gov,2021-01-19,2020-12-21,TRUE,Recruiting,Not Applicable,Interventional,France,Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19,146,https://clinicaltrials.gov/show/NCT04730661,NA
NCT04732702,ClinicalTrials.gov,2021-01-28,2020-10-29,TRUE,Recruiting,Not Applicable,Observational,Germany,Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents,30,https://clinicaltrials.gov/show/NCT04732702,NA
NCT04732858,ClinicalTrials.gov,2021-01-29,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,"Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey",50,https://clinicaltrials.gov/show/NCT04732858,NA
NCT04733651,ClinicalTrials.gov,2021-01-31,2021-02-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,250,https://clinicaltrials.gov/show/NCT04733651,NA
NCT04733729,ClinicalTrials.gov,2021-01-31,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Covid-19 in Hematological Malignancies,3000,https://clinicaltrials.gov/show/NCT04733729,NA
NCT04733846,ClinicalTrials.gov,2021-02-01,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,9,https://clinicaltrials.gov/show/NCT04733846,NA
NCT04734171,ClinicalTrials.gov,2021-01-29,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,United States,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",1200,https://clinicaltrials.gov/show/NCT04734171,NA
NCT04734223,ClinicalTrials.gov,2021-01-29,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Neuroimaging Findings in Patients With COVID-19,436,https://clinicaltrials.gov/show/NCT04734223,NA
NCT04734678,ClinicalTrials.gov,2021-01-31,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,84,https://clinicaltrials.gov/show/NCT04734678,NA
NCT04734717,ClinicalTrials.gov,2021-02-01,2021-01-12,TRUE,Recruiting,Not Applicable,Interventional,Hungary,Coordination and Locomotor Problems in Patients With Covid-19 Virus,2,https://clinicaltrials.gov/show/NCT04734717,NA
NCT04735744,ClinicalTrials.gov,2021-01-28,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,1315,https://clinicaltrials.gov/show/NCT04735744,NA
NCT04736524,ClinicalTrials.gov,2021-02-01,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,United States,Immune Response Following COVID-19 Vaccination,500,https://clinicaltrials.gov/show/NCT04736524,NA
NCT04736680,ClinicalTrials.gov,2021-02-01,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital,667,https://clinicaltrials.gov/show/NCT04736680,NA
NCT04736732,ClinicalTrials.gov,2021-02-01,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Canada,The IRCM POST-COVID-19 (IPCO) Clinic,570,https://clinicaltrials.gov/show/NCT04736732,NA
NCT04736901,ClinicalTrials.gov,2021-02-01,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,90,https://clinicaltrials.gov/show/NCT04736901,NA
NCT04738032,ClinicalTrials.gov,2021-02-02,2020-08-26,TRUE,Not Recruiting,Not Applicable,Observational,United States,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,76,https://clinicaltrials.gov/show/NCT04738032,NA
NCT04738175,ClinicalTrials.gov,2021-02-02,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMGâ„¢) to Treat COVID-19,209,https://clinicaltrials.gov/show/NCT04738175,NA
NCT04738435,ClinicalTrials.gov,2021-01-31,2021-01-05,TRUE,Recruiting,Not Applicable,Observational,Argentina,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",600,https://clinicaltrials.gov/show/NCT04738435,NA
NCT04738760,ClinicalTrials.gov,2021-02-01,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,150,https://clinicaltrials.gov/show/NCT04738760,NA
NCT04739345,ClinicalTrials.gov,2021-02-03,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,50,https://clinicaltrials.gov/show/NCT04739345,NA
NCT04739410,ClinicalTrials.gov,2021-02-02,2020-05-01,TRUE,Not Recruiting,Phase 4,Interventional,Pakistan,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04739410,NA
NCT04740125,ClinicalTrials.gov,2021-02-04,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Tunisia,SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY,368,https://clinicaltrials.gov/show/NCT04740125,NA
NCT04740372,ClinicalTrials.gov,2021-02-04,2020-11-20,TRUE,Recruiting,Not Applicable,Observational,Norway,"Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ",350,https://clinicaltrials.gov/show/NCT04740372,NA
NCT04740489,ClinicalTrials.gov,2021-01-29,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff,30,https://clinicaltrials.gov/show/NCT04740489,NA
NCT04741178,ClinicalTrials.gov,2021-02-03,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Italy,PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis,600,https://clinicaltrials.gov/show/NCT04741178,NA
NCT04742049,ClinicalTrials.gov,2021-01-17,2020-12-28,TRUE,Recruiting,Not Applicable,Interventional,Turkey,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",30,https://clinicaltrials.gov/show/NCT04742049,NA
NCT04742569,ClinicalTrials.gov,2021-01-14,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,United States,Wearable Diagnostic for Detection of COVID-19 Infection,2352,https://clinicaltrials.gov/show/NCT04742569,NA
NCT04742595,ClinicalTrials.gov,2021-02-03,2020-12-18,TRUE,Recruiting,Phase 1,Interventional,United States,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,16,https://clinicaltrials.gov/show/NCT04742595,NA
NCT04742712,ClinicalTrials.gov,2020-10-28,2020-10-27,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19,40,https://clinicaltrials.gov/show/NCT04742712,NA
NCT04742738,ClinicalTrials.gov,2021-02-04,2021-01-20,TRUE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),260,https://clinicaltrials.gov/show/NCT04742738,NA
NCT04742842,ClinicalTrials.gov,2021-01-28,2021-02-15,FALSE,Not Recruiting,Phase 1,Interventional,Australia,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,150,https://clinicaltrials.gov/show/NCT04742842,NA
NCT04742946,ClinicalTrials.gov,2021-02-03,2021-02-15,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Covid-19 After Hospital Discharge,237,https://clinicaltrials.gov/show/NCT04742946,NA
NCT04743232,ClinicalTrials.gov,2021-02-03,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,1000,https://clinicaltrials.gov/show/NCT04743232,NA
NCT04743349,ClinicalTrials.gov,2021-02-05,2021-01-26,TRUE,Recruiting,Not Applicable,Interventional,Italy,Steam Inhalations in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04743349,NA
NCT04743908,ClinicalTrials.gov,2021-02-05,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,2400,https://clinicaltrials.gov/show/NCT04743908,NA
NCT04743947,ClinicalTrials.gov,2021-02-04,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,Germany,Vaccination Against COVID-19 in Chronic Kidney Disease,400,https://clinicaltrials.gov/show/NCT04743947,NA
NCT04744415,ClinicalTrials.gov,2021-02-02,2020-11-09,TRUE,Recruiting,Not Applicable,Observational,Italy,Hospitalizations During Pandemia in the Italian Coronary Care Unit Network,4000,https://clinicaltrials.gov/show/NCT04744415,NA
NCT04745923,ClinicalTrials.gov,2021-02-06,2021-01-20,TRUE,Recruiting,Not Applicable,Observational,Turkey,Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic,28,https://clinicaltrials.gov/show/NCT04745923,NA
NCT04747769,ClinicalTrials.gov,2021-02-01,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19. CT-Scan Modeling in COVID19 Sequelae,50,https://clinicaltrials.gov/show/NCT04747769,NA
NCT04748471,ClinicalTrials.gov,2021-01-24,2021-02-10,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y),180,https://clinicaltrials.gov/show/NCT04748471,NA
NCT04750018,ClinicalTrials.gov,2021-02-06,2020-07-03,TRUE,Recruiting,Not Applicable,Observational,Taiwan,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,600,https://clinicaltrials.gov/show/NCT04750018,NA
ACTRN12620000468921,ANZCTR,2020-04-14,2020-05-20,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,240,https://anzctr.org.au/ACTRN12620000468921.aspx,NA
ACTRN12621000130864,ANZCTR,2021-02-08,2020-11-12,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Droplet and aerosol generation during high intensity exercise,3,https://anzctr.org.au/ACTRN12621000130864.aspx,NA
ACTRN12621000131853,ANZCTR,2021-02-09,2021-04-19,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"An interventional study to evaluate the safety, tolerability (how well a substance is tolerated by participants), and Pharmacokinetics (PK, the measure of how the human body processes a substance), of different dosages of TTI-0102 when given to healthy participants as either a single oral dose, or as an oral dose give twice daily on one day (as a potential treatment for COVID-19), compared with a single oral dose of the marketed product Cystagon (registered trademark).",12,https://anzctr.org.au/ACTRN12621000131853.aspx,NA
ISRCTN13450549,ISRCTN,2021-01-12,2020-08-11,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Investigating the inflammatory process of COVID-19,200,http://isrctn.com/ISRCTN13450549,NA
ISRCTN68026880,ISRCTN,2020-04-30,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,"Russian Federation, United Kingdom, Canada, Egypt, Guatemala, Japan, Austria, Bosnia and Herzegovina, Romania, Ireland, Indonesia, Greece, Belgium, United Arab Emirates, Czech Republic, United States, Ecuador, Germany, Lebanon, Argentina, Hungary, South Africa, Netherlands, Italy, Brazil, Mexico, Latvia, Malta, Nigeria, Chile, Tunisia, Australia, Qatar, Peru, Portugal, Colombia, Thailand, Estonia, Israel, Spain, Uganda, India","A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention",1000,http://isrctn.com/ISRCTN68026880,NA
ChiCTR2000040366,ChiCTR,2020-11-28,2020-12-01,FALSE,Recruiting,Not Applicable,Observational,China,Effect of remote management on comprehensive management of diabetes mellitus during the COVID-19 epidemic,180,http://www.chictr.org.cn/showproj.aspx?proj=63287,NA
ChiCTR2000040324,ChiCTR,2020-11-27,2020-12-01,FALSE,Recruiting,Not Applicable,Interventional,China,Special project to support elderly singleton or doubleton in the new wave of COVID-19 pandemic,11000,http://www.chictr.org.cn/showproj.aspx?proj=65022,NA
ChiCTR2000040265,ChiCTR,2020-11-26,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Impact of COVID-19 pandemic on Hepatobiliary and Pancreatic surgical services,547,http://www.chictr.org.cn/showproj.aspx?proj=64743,NA
ChiCTR2000039715,ChiCTR,2020-11-06,2020-11-17,FALSE,Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),720,http://www.chictr.org.cn/showproj.aspx?proj=63754,NA
ChiCTR2000039711,ChiCTR,2020-11-06,2020-11-08,FALSE,Recruiting,Not Applicable,Observational,China,The impact of COVID-19 on selective orthopaetic surgery in Shanghai Sixth People's Hospital: a retrospective study.,2000,http://www.chictr.org.cn/showproj.aspx?proj=63807,NA
NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,FALSE,Recruiting,Not Applicable,Interventional,"Canada, Israel",Medical Masks vs N95 Respirators for COVID-19,576,https://clinicaltrials.gov/show/NCT04296643,NA
NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,580,https://clinicaltrials.gov/show/NCT04311177,NA
NCT04321811,ClinicalTrials.gov,2020-03-23,2020-03-21,TRUE,Not Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",100000,https://clinicaltrials.gov/show/NCT04321811,NA
NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,FALSE,Not Recruiting,Phase 2,Interventional,Denmark,Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,117,https://clinicaltrials.gov/show/NCT04322396,NA
NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19,100,https://clinicaltrials.gov/show/NCT04328012,NA
NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,FALSE,Not Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,16,https://clinicaltrials.gov/show/NCT04331600,NA
NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-08,FALSE,Not Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,12,https://clinicaltrials.gov/show/NCT04333355,NA
NCT04335201,ClinicalTrials.gov,2020-03-31,2020-05-20,FALSE,Recruiting,Phase 2,Interventional,Italy,Defibrotide in COVID-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04335201,NA
NCT04336215,ClinicalTrials.gov,2020-04-02,2020-04-07,FALSE,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,750,https://clinicaltrials.gov/show/NCT04336215,NA
NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,160,https://clinicaltrials.gov/show/NCT04336332,NA
NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,FALSE,Not Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,143,https://clinicaltrials.gov/show/NCT04337918,NA
NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,FALSE,Not Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,47,https://clinicaltrials.gov/show/NCT04338828,NA
NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,214,https://clinicaltrials.gov/show/NCT04342728,NA
NCT04346147,ClinicalTrials.gov,2020-04-07,2020-05-07,FALSE,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,165,https://clinicaltrials.gov/show/NCT04346147,NA
NCT04348422,ClinicalTrials.gov,2020-04-13,2020-05-01,FALSE,Recruiting,Not Applicable,Observational,Israel,Evaluating the Immune Response for COVID-19,1000,https://clinicaltrials.gov/show/NCT04348422,NA
NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,200,https://clinicaltrials.gov/show/NCT04348864,NA
NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,8,https://clinicaltrials.gov/show/NCT04349371,NA
NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-15,FALSE,Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04349618,NA
NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,France,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,176,https://clinicaltrials.gov/show/NCT04352959,NA
NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,TRUE,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),1000,https://clinicaltrials.gov/show/NCT04357366,NA
NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),30,https://clinicaltrials.gov/show/NCT04357808,NA
NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,30,https://clinicaltrials.gov/show/NCT04361448,NA
NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),2300,https://clinicaltrials.gov/show/NCT04363827,NA
NCT04366908,ClinicalTrials.gov,2020-04-25,2020-05-07,FALSE,Recruiting,Phase 2,Interventional,Spain,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,1008,https://clinicaltrials.gov/show/NCT04366908,NA
NCT04368026,ClinicalTrials.gov,2020-04-27,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Poland,SARS-CoV-2 (COVID-19) and Surgery,70,https://clinicaltrials.gov/show/NCT04368026,NA
NCT04368143,ClinicalTrials.gov,2020-04-27,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Immune Repertoire Sequencing,100,https://clinicaltrials.gov/show/NCT04368143,NA
NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,110,https://clinicaltrials.gov/show/NCT04368156,NA
NCT04371289,ClinicalTrials.gov,2020-04-28,2020-04-08,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,5500,https://clinicaltrials.gov/show/NCT04371289,NA
NCT04375761,ClinicalTrials.gov,2020-04-30,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19: Human Epidemiology and Response to SARS-CoV-2,5599,https://clinicaltrials.gov/show/NCT04375761,NA
NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,TRUE,Recruiting,Phase 1/Phase 2,Interventional,France,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",90,https://clinicaltrials.gov/show/NCT04378920,NA
NCT04379258,ClinicalTrials.gov,2020-04-22,2021-02-08,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Analysis of Mortality of Critically Ill Patients With COVID-19,868,https://clinicaltrials.gov/show/NCT04379258,NA
NCT04383730,ClinicalTrials.gov,2020-05-08,2020-06-26,FALSE,Recruiting,Not Applicable,Observational,"United States, Spain, France, Germany, Switzerland",Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),400,https://clinicaltrials.gov/show/NCT04383730,NA
NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,FALSE,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04384965,NA
NCT04385160,ClinicalTrials.gov,2020-05-11,2020-05-13,FALSE,Recruiting,Not Applicable,Observational,"Denmark, United Kingdom, Italy, United States, Spain, Poland, France, Germany",Myeloproliferative Neoplasms (MPN) and COVID-19,552,https://clinicaltrials.gov/show/NCT04385160,NA
NCT04386564,ClinicalTrials.gov,2020-05-11,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Russian Federation,Kidney Injury Severity and COVID-19,340,https://clinicaltrials.gov/show/NCT04386564,NA
NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,TRUE,Not Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,143,https://clinicaltrials.gov/show/NCT04389294,NA
NCT04392453,ClinicalTrials.gov,2020-05-15,2020-10-26,FALSE,Recruiting,Not Applicable,Interventional,Italy,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,40,https://clinicaltrials.gov/show/NCT04392453,NA
NCT04392531,ClinicalTrials.gov,2020-05-03,2020-04-16,TRUE,Recruiting,Phase 4,Interventional,Spain,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,120,https://clinicaltrials.gov/show/NCT04392531,NA
NCT04393155,ClinicalTrials.gov,2020-05-06,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID Cohort Study,16,https://clinicaltrials.gov/show/NCT04393155,NA
NCT04394026,ClinicalTrials.gov,2020-05-15,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Italy,Imaging Feature of SARS-CoV2 Infection,500,https://clinicaltrials.gov/show/NCT04394026,NA
NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,FALSE,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,120,https://clinicaltrials.gov/show/NCT04394403,NA
NCT04397705,ClinicalTrials.gov,2020-05-20,2020-10-12,FALSE,Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,30,https://clinicaltrials.gov/show/NCT04397705,NA
NCT04398264,ClinicalTrials.gov,2020-05-20,2020-07-22,FALSE,Recruiting,Not Applicable,Observational,United States,Characteristics of COVID-19 Infection Among PREGnant Women,100,https://clinicaltrials.gov/show/NCT04398264,NA
NCT04407260,ClinicalTrials.gov,2020-05-27,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,United States,"Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study.",136,https://clinicaltrials.gov/show/NCT04407260,NA
NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,0,https://clinicaltrials.gov/show/NCT04409483,NA
NCT04414293,ClinicalTrials.gov,2020-06-01,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,41,https://clinicaltrials.gov/show/NCT04414293,NA
NCT04436458,ClinicalTrials.gov,2020-06-16,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,100,https://clinicaltrials.gov/show/NCT04436458,NA
NCT04442165,ClinicalTrials.gov,2020-06-16,2020-12-15,FALSE,Recruiting,Not Applicable,Observational,Mozambique,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,15393,https://clinicaltrials.gov/show/NCT04442165,NA
NCT04449588,ClinicalTrials.gov,2020-06-26,2020-07-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Indonesia, Bangladesh, Spain, China, India",Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,368,https://clinicaltrials.gov/show/NCT04449588,NA
NCT04453891,ClinicalTrials.gov,2020-06-29,2021-07-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Hexoskin Feasibility Study With COVID-19 Patients,16,https://clinicaltrials.gov/show/NCT04453891,NA
NCT04456595,ClinicalTrials.gov,2020-06-30,2020-07-21,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,12688,https://clinicaltrials.gov/show/NCT04456595,NA
NCT04462367,ClinicalTrials.gov,2020-06-23,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,Brazil,Northeast COVID-19 and Pregnancy Study Group,180,https://clinicaltrials.gov/show/NCT04462367,NA
NCT04470648,ClinicalTrials.gov,2020-07-12,2020-07-22,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,183,https://clinicaltrials.gov/show/NCT04470648,NA
NCT04472585,ClinicalTrials.gov,2020-07-14,2020-11-14,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,180,https://clinicaltrials.gov/show/NCT04472585,NA
NCT04485741,ClinicalTrials.gov,2020-07-21,2020-09-23,FALSE,Recruiting,Not Applicable,Observational,United States,Strados System at Center of Excellence,30,https://clinicaltrials.gov/show/NCT04485741,NA
NCT04487197,ClinicalTrials.gov,2020-07-24,2020-07-15,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",282,https://clinicaltrials.gov/show/NCT04487197,NA
NCT04490824,ClinicalTrials.gov,2020-07-27,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,100,https://clinicaltrials.gov/show/NCT04490824,NA
NCT04491214,ClinicalTrials.gov,2020-07-20,2020-07-24,FALSE,Not Recruiting,Not Applicable,Observational,France,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),112,https://clinicaltrials.gov/show/NCT04491214,NA
NCT04494776,ClinicalTrials.gov,2020-07-16,2020-05-21,TRUE,Recruiting,Not Applicable,Observational,Brazil,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,500,https://clinicaltrials.gov/show/NCT04494776,NA
NCT04494984,ClinicalTrials.gov,2020-07-29,2020-07-27,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Argentina,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",242,https://clinicaltrials.gov/show/NCT04494984,NA
NCT04501458,ClinicalTrials.gov,2020-08-05,2020-08-10,FALSE,Not Recruiting,Not Applicable,Interventional,Kenya,Western Kenya Integrated COVID-19 Response,200000,https://clinicaltrials.gov/show/NCT04501458,NA
NCT04512079,ClinicalTrials.gov,2020-08-11,2020-09-08,FALSE,Recruiting,Phase 4,Interventional,"Colombia, United States, Mexico, Brazil, India",FREEDOM COVID-19 Anticoagulation Strategy,3600,https://clinicaltrials.gov/show/NCT04512079,NA
NCT04517162,ClinicalTrials.gov,2020-08-14,2020-08-19,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04517162,NA
NCT04517188,ClinicalTrials.gov,2020-08-15,2021-04-01,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Halodine Nasal Antiseptic in Patients With COVID-19,40,https://clinicaltrials.gov/show/NCT04517188,NA
NCT04517630,ClinicalTrials.gov,2020-08-15,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,Renal Biomarkers in AKI and COVID-19,90,https://clinicaltrials.gov/show/NCT04517630,NA
NCT04524962,ClinicalTrials.gov,2020-08-19,2020-09-15,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Descartes-30 in Acute Respiratory Distress Syndrome,30,https://clinicaltrials.gov/show/NCT04524962,NA
NCT04529525,ClinicalTrials.gov,2020-08-21,2020-08-19,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Ivermectin to Prevent Hospitalizations in COVID-19,500,https://clinicaltrials.gov/show/NCT04529525,NA
NCT04530409,ClinicalTrials.gov,2020-08-24,2020-08-26,FALSE,Recruiting,Phase 4,Interventional,Egypt,Timing of Corticosteroids in COVID-19,450,https://clinicaltrials.gov/show/NCT04530409,NA
NCT04530539,ClinicalTrials.gov,2020-08-26,2020-10-05,FALSE,Recruiting,Not Applicable,Interventional,United States,The Effect of Melatonin and Vitamin C on COVID-19,150,https://clinicaltrials.gov/show/NCT04530539,NA
NCT04530656,ClinicalTrials.gov,2020-08-27,2020-08-28,FALSE,Not Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),168,https://clinicaltrials.gov/show/NCT04530656,NA
NCT04534790,ClinicalTrials.gov,2020-08-05,2020-07-24,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,30,https://clinicaltrials.gov/show/NCT04534790,NA
NCT04542434,ClinicalTrials.gov,2020-09-04,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide in COVID-19,148,https://clinicaltrials.gov/show/NCT04542434,NA
NCT04544176,ClinicalTrials.gov,2020-09-09,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Risk From Attending Outpatient Radiology Appointments,48000,https://clinicaltrials.gov/show/NCT04544176,NA
NCT04547660,ClinicalTrials.gov,2020-09-09,2020-07-16,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Convalescent Plasma for Severe COVID-19 Patients,160,https://clinicaltrials.gov/show/NCT04547660,NA
NCT04557241,ClinicalTrials.gov,2020-09-16,2020-01-14,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,1017,https://clinicaltrials.gov/show/NCT04557241,NA
NCT04558203,ClinicalTrials.gov,2020-09-19,2020-09-22,FALSE,Recruiting,Not Applicable,Observational,Egypt,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",450,https://clinicaltrials.gov/show/NCT04558203,NA
NCT04559100,ClinicalTrials.gov,2020-09-17,2020-11-15,FALSE,Recruiting,Not Applicable,Observational,Colombia,Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus,112,https://clinicaltrials.gov/show/NCT04559100,NA
NCT04561089,ClinicalTrials.gov,2020-09-21,2020-02-13,TRUE,Recruiting,Not Applicable,Observational,United States,Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel,2000,https://clinicaltrials.gov/show/NCT04561089,NA
NCT04561102,ClinicalTrials.gov,2020-09-21,2020-09-11,TRUE,Recruiting,Not Applicable,Observational,United States,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population,2500,https://clinicaltrials.gov/show/NCT04561102,NA
NCT04568811,ClinicalTrials.gov,2020-09-28,2020-09-26,TRUE,Not Recruiting,Phase 1,Interventional,China,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,89,https://clinicaltrials.gov/show/NCT04568811,NA
NCT04568889,ClinicalTrials.gov,2020-09-24,2020-09-28,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Minnesota COVID-19 Testing Project,1000,https://clinicaltrials.gov/show/NCT04568889,NA
NCT04581863,ClinicalTrials.gov,2020-10-07,2020-11-30,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Watch + COVID-19 Pulse,850,https://clinicaltrials.gov/show/NCT04581863,NA
NCT04581928,ClinicalTrials.gov,2020-10-06,2020-10-10,FALSE,Recruiting,Not Applicable,Observational,Egypt,Patients Reactions Towards Their Diagnosis as Having COVID-19,300,https://clinicaltrials.gov/show/NCT04581928,NA
NCT04584697,ClinicalTrials.gov,2020-10-07,2020-12-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMGâ„¢) in Outpatients With COVID-19",0,https://clinicaltrials.gov/show/NCT04584697,NA
NCT04593433,ClinicalTrials.gov,2020-10-13,2021-03-04,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,40,https://clinicaltrials.gov/show/NCT04593433,NA
NCT04595123,ClinicalTrials.gov,2020-10-06,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,"Chile, Cyprus, Portugal, Albania, Greece, United Kingdom, Brazil, Israel, Spain, Turkey, Malta, France, Bulgaria",Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),3900,https://clinicaltrials.gov/show/NCT04595123,NA
NCT04621461,ClinicalTrials.gov,2020-11-06,2020-12-20,FALSE,Not Recruiting,Phase 4,Interventional,United States,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,3,https://clinicaltrials.gov/show/NCT04621461,NA
NCT04629183,ClinicalTrials.gov,2020-11-13,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,400,https://clinicaltrials.gov/show/NCT04629183,NA
NCT04631497,ClinicalTrials.gov,2020-11-09,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Poland,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",100,https://clinicaltrials.gov/show/NCT04631497,NA
NCT04652596,ClinicalTrials.gov,2020-11-30,2021-02-08,FALSE,Recruiting,Not Applicable,Interventional,United States,Reducing Food Insecurity During COVID-19,250,https://clinicaltrials.gov/show/NCT04652596,NA
NCT04652765,ClinicalTrials.gov,2020-12-02,2021-02-03,FALSE,Recruiting,Phase 1,Interventional,United States,Camostat With Bicalutamide for COVID-19,60,https://clinicaltrials.gov/show/NCT04652765,NA
NCT04659239,ClinicalTrials.gov,2020-12-05,2021-01-28,FALSE,Recruiting,Phase 3,Interventional,"Malaysia, Brazil","The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",34020,https://clinicaltrials.gov/show/NCT04659239,NA
NCT04662671,ClinicalTrials.gov,2020-12-09,2020-11-18,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",31,https://clinicaltrials.gov/show/NCT04662671,NA
NCT04691921,ClinicalTrials.gov,2020-12-30,2021-01-04,FALSE,Not Recruiting,Not Applicable,Observational,"India, United Arab Emirates",Current Pharmacological Practices in Severe COVID-19,1055,https://clinicaltrials.gov/show/NCT04691921,NA
NCT04694703,ClinicalTrials.gov,2021-01-03,2021-01-06,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",20,https://clinicaltrials.gov/show/NCT04694703,NA
NCT04694716,ClinicalTrials.gov,2021-01-03,2021-01-06,FALSE,Recruiting,Not Applicable,Observational,Turkey,Determination of Serum Trace Element and Physical Activity Levels in COVID-19,40,https://clinicaltrials.gov/show/NCT04694716,NA
NCT04695158,ClinicalTrials.gov,2021-01-02,2021-01-06,FALSE,Recruiting,Not Applicable,Observational,Turkey,Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19,60,https://clinicaltrials.gov/show/NCT04695158,NA
NCT04703140,ClinicalTrials.gov,2020-11-30,2021-02-11,FALSE,Recruiting,Not Applicable,Interventional,France,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,350,https://clinicaltrials.gov/show/NCT04703140,NA
NCT04709068,ClinicalTrials.gov,2021-01-12,2021-02-08,FALSE,Recruiting,Not Applicable,Observational,United States,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,2050,https://clinicaltrials.gov/show/NCT04709068,NA
NCT04710329,ClinicalTrials.gov,2021-01-13,2021-01-16,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients,78,https://clinicaltrials.gov/show/NCT04710329,NA
NCT04710771,ClinicalTrials.gov,2021-01-09,2020-11-23,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Effect of Prone Positioning in Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04710771,NA
NCT04717011,ClinicalTrials.gov,2021-01-19,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,Spain,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04717011,NA
NCT04735588,ClinicalTrials.gov,2021-02-02,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",140,https://clinicaltrials.gov/show/NCT04735588,NA
NCT04739020,ClinicalTrials.gov,2021-02-01,2021-01-18,TRUE,Recruiting,Not Applicable,Interventional,Germany,Respiratory Aerosols in Patients With COVID-19 and Healthy Controls,525,https://clinicaltrials.gov/show/NCT04739020,NA
NCT04739462,ClinicalTrials.gov,2021-02-01,2021-02-03,FALSE,Recruiting,Not Applicable,Interventional,"Uganda, United States",SMS Maama Project COVID-19,248,https://clinicaltrials.gov/show/NCT04739462,NA
NCT04740320,ClinicalTrials.gov,2021-01-26,2020-12-15,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 SARS-CoV-2 Screening Protocol,250,https://clinicaltrials.gov/show/NCT04740320,NA
NCT04743388,ClinicalTrials.gov,2021-02-03,2021-01-04,TRUE,Recruiting,Not Applicable,Observational,Greece,Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System,600,https://clinicaltrials.gov/show/NCT04743388,NA
NCT04745377,ClinicalTrials.gov,2021-01-15,2021-01-12,TRUE,Recruiting,Not Applicable,Observational,Greece,Responses to COVID-19 Vaccination in Patients With Cancer,300,https://clinicaltrials.gov/show/NCT04745377,NA
NCT04745416,ClinicalTrials.gov,2021-01-29,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Clinical Characteristics of Patients With Leukemia and COVID-19,30,https://clinicaltrials.gov/show/NCT04745416,NA
NCT04745442,ClinicalTrials.gov,2021-02-08,2020-04-27,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19,48,https://clinicaltrials.gov/show/NCT04745442,NA
NCT04745533,ClinicalTrials.gov,2021-02-04,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Contact Study by Antigen Detection Test,3000,https://clinicaltrials.gov/show/NCT04745533,NA
NCT04745611,ClinicalTrials.gov,2021-01-26,2020-12-12,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Neurological and Neuropsychological Sequelae of COVID-19 Infection,400,https://clinicaltrials.gov/show/NCT04745611,NA
NCT04746066,ClinicalTrials.gov,2021-02-02,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19,10000,https://clinicaltrials.gov/show/NCT04746066,NA
NCT04746092,ClinicalTrials.gov,2021-02-02,2021-01-06,TRUE,Recruiting,Not Applicable,Observational,Israel,The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19,550,https://clinicaltrials.gov/show/NCT04746092,NA
NCT04746365,ClinicalTrials.gov,2021-02-06,2020-12-06,TRUE,Not Recruiting,Phase 4,Interventional,Egypt,Ivermectin Role in Covid-19 Clinical Trial,300,https://clinicaltrials.gov/show/NCT04746365,NA
NCT04746443,ClinicalTrials.gov,2021-02-08,2020-12-08,TRUE,Recruiting,Not Applicable,Observational,Saudi Arabia,Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey,40,https://clinicaltrials.gov/show/NCT04746443,NA
NCT04746521,ClinicalTrials.gov,2021-02-08,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Cellular-Mediated Immunity in COVID-19,100,https://clinicaltrials.gov/show/NCT04746521,NA
NCT04747132,ClinicalTrials.gov,2021-02-06,2020-07-20,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency,110,https://clinicaltrials.gov/show/NCT04747132,NA
NCT04747249,ClinicalTrials.gov,2021-02-08,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19,115,https://clinicaltrials.gov/show/NCT04747249,NA
NCT04747366,ClinicalTrials.gov,2021-01-20,2020-11-06,TRUE,Recruiting,Not Applicable,Observational,Germany,"Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity",750,https://clinicaltrials.gov/show/NCT04747366,NA
NCT04747405,ClinicalTrials.gov,2021-02-09,2021-02-22,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study,100,https://clinicaltrials.gov/show/NCT04747405,NA
NCT04747522,ClinicalTrials.gov,2021-02-04,2021-01-22,TRUE,Recruiting,Not Applicable,Observational,Norway,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19),150,https://clinicaltrials.gov/show/NCT04747522,NA
NCT04747678,ClinicalTrials.gov,2021-02-01,2021-02-03,FALSE,Recruiting,Not Applicable,Observational,Egypt,Adverse Effects of Ivermectin Used in Egypt During COVID-19,200,https://clinicaltrials.gov/show/NCT04747678,NA
NCT04747756,ClinicalTrials.gov,2021-02-03,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Creating a Virtual Village for People Aging With HIV During COVID-19,80,https://clinicaltrials.gov/show/NCT04747756,NA
NCT04747782,ClinicalTrials.gov,2021-02-03,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Canada,COVID-19 Longitudinal Biomarkers in Lung Injury,200,https://clinicaltrials.gov/show/NCT04747782,NA
NCT04748120,ClinicalTrials.gov,2021-02-05,2020-12-28,TRUE,Recruiting,Not Applicable,Interventional,United States,Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients,50,https://clinicaltrials.gov/show/NCT04748120,NA
NCT04748185,ClinicalTrials.gov,2021-02-03,2021-01-18,TRUE,Recruiting,Not Applicable,Observational,United States,Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies,650,https://clinicaltrials.gov/show/NCT04748185,NA
NCT04748614,ClinicalTrials.gov,2021-02-08,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Analysis Before and After COVID 19,500,https://clinicaltrials.gov/show/NCT04748614,NA
NCT04749121,ClinicalTrials.gov,2021-02-04,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Thailand,Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators,20,https://clinicaltrials.gov/show/NCT04749121,NA
NCT04750317,ClinicalTrials.gov,2021-02-10,2020-05-11,TRUE,Not Recruiting,Phase 2,Interventional,Russian Federation,Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia,414,https://clinicaltrials.gov/show/NCT04750317,NA
NCT04750343,ClinicalTrials.gov,2021-02-10,2021-02-03,TRUE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19),320,https://clinicaltrials.gov/show/NCT04750343,NA
NCT04750356,ClinicalTrials.gov,2021-01-28,2021-01-27,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)",6000,https://clinicaltrials.gov/show/NCT04750356,NA
NCT04750369,ClinicalTrials.gov,2021-02-08,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Canada,Enhanced Triage for COVID-19,400,https://clinicaltrials.gov/show/NCT04750369,NA
NCT04751227,ClinicalTrials.gov,2021-02-04,2020-11-22,TRUE,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Modafinil for Wakefulness in the Critical Care Units,8,https://clinicaltrials.gov/show/NCT04751227,NA
NCT04751604,ClinicalTrials.gov,2021-02-03,2021-02-01,TRUE,Recruiting,Not Applicable,Interventional,Germany,Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19,840,https://clinicaltrials.gov/show/NCT04751604,NA
NCT04751617,ClinicalTrials.gov,2021-02-05,2021-01-01,TRUE,Recruiting,Not Applicable,Interventional,Poland,Pulmonary Rehabilitation of Patients With a History of COVID-19,60,https://clinicaltrials.gov/show/NCT04751617,NA
NCT04751630,ClinicalTrials.gov,2021-02-09,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effects of COVID-19 Hospitalization on Physical Performance,78,https://clinicaltrials.gov/show/NCT04751630,NA
NCT04751695,ClinicalTrials.gov,2021-02-09,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines",20,https://clinicaltrials.gov/show/NCT04751695,NA
NCT04751721,ClinicalTrials.gov,2021-02-09,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines",20,https://clinicaltrials.gov/show/NCT04751721,NA
NCT04751734,ClinicalTrials.gov,2021-02-08,2021-01-16,TRUE,Recruiting,Not Applicable,Observational,Spain,Impact of Maternal COVID-19 Vaccines on Breast Milk,150,https://clinicaltrials.gov/show/NCT04751734,NA
NCT04752839,ClinicalTrials.gov,2021-02-09,2021-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus Pandemic,300,https://clinicaltrials.gov/show/NCT04752839,NA
NCT04753346,ClinicalTrials.gov,2021-02-12,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19,240,https://clinicaltrials.gov/show/NCT04753346,NA
NCT04753762,ClinicalTrials.gov,2021-01-26,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,France,Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04753762,NA
NCT04754113,ClinicalTrials.gov,2021-02-06,2021-02-07,FALSE,Not Recruiting,Not Applicable,Interventional,China,Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19,10,https://clinicaltrials.gov/show/NCT04754113,NA
NCT04754633,ClinicalTrials.gov,2021-02-10,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines,764,https://clinicaltrials.gov/show/NCT04754633,NA
NCT04756193,ClinicalTrials.gov,2021-02-07,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,United States,Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound,250,https://clinicaltrials.gov/show/NCT04756193,NA
ISRCTN61884303,ISRCTN,2021-02-10,2021-01-25,TRUE,Recruiting,Not Applicable,Observational,Greece,The response after the first and second dose of the BNT162b2 Covid-19 vaccine: real-world evidence from Greece,450,http://isrctn.com/ISRCTN61884303,NA
ChiCTR2000039994,ChiCTR,2020-11-17,2020-11-17,FALSE,Recruiting,Phase 2,Interventional,China,Recombinant COVID-19 Vaccine (Sf9 cells) Phase II Clinical Trial,960,http://www.chictr.org.cn/showproj.aspx?proj=64449,NA
ChiCTR2000039855,ChiCTR,2020-11-12,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,China,The efficacy and safety of systemic anticoagulation in novel coronavirus pneumonia (COVID-19): a medical records based retrospective cohort study,750,http://www.chictr.org.cn/showproj.aspx?proj=63405,NA
IRCT20190409043215N2,IRCT,2021-02-14,2020-12-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of Viola odorata syrup on aleviating the manifestations of COVID-19 (Corona) infection: A double-blind placebo controlled trial,100,http://en.irct.ir/trial/46581,NA
IRCT20150303021315N22,IRCT,2021-01-27,2020-07-04,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Adalimumab effectiveness in COVID-19,40,http://en.irct.ir/trial/46955,NA
IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,200,http://en.irct.ir/trial/47173,NA
IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,100,http://en.irct.ir/trial/47295,NA
IRCT20200424047184N1,IRCT,2021-01-16,2020-04-03,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Hydroxychloroquine in prevention of sever forms of COVID-19 in healthcare workers,400,http://en.irct.ir/trial/47775,NA
IRCT20081027001411N4,IRCT,2020-07-09,2020-04-29,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19,40,http://en.irct.ir/trial/48396,NA
IRCT20200611047727N3,IRCT,2021-01-03,2020-07-22,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Corton's effect in improving patients with covid-19,60,http://en.irct.ir/trial/49116,NA
IRCT20180103038199N3,IRCT,2020-08-30,2020-10-22,FALSE,Recruiting,Phase 2,Interventional,Iran,effects of three products containing Noscapine on COVID-19,160,http://en.irct.ir/trial/49775,NA
IRCT20191211045691N1,IRCT,2020-07-28,2020-07-30,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patients,100,http://en.irct.ir/trial/49879,NA
IRCT20200906048638N1,IRCT,2021-02-01,2020-12-21,TRUE,Recruiting,Phase 4,Interventional,Iran,Efficacy of Atorvastatin on in-hospital outcome of COVID-19 infection,90,http://en.irct.ir/trial/50860,NA
IRCT20200921048794N1,IRCT,2020-11-19,2021-02-19,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the Effects of L-carnitine Supplementation on Patients with COVID-19,64,http://en.irct.ir/trial/51120,NA
IRCT20200928048865N1,IRCT,2021-01-01,2020-11-05,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of environmental health education on self-efficacy and anxiety caused of Covid-19,60,http://en.irct.ir/trial/51258,NA
IRCT20191125045496N3,IRCT,2021-01-25,2020-04-20,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the Effect of Pulmonary Rehabilitation in COVID-19 Patients,40,http://en.irct.ir/trial/51644,NA
IRCT20201024049134N1,IRCT,2020-11-02,2021-01-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Arbidol in treatment of COVID-19,80,http://en.irct.ir/trial/51847,NA
IRCT20111121008146N34,IRCT,2021-01-24,2020-09-22,TRUE,Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of laser acupuncture in controlling COVID-19 compared to common medical treatments,60,http://en.irct.ir/trial/51948,NA
IRCT20201111049348N1,IRCT,2021-01-03,2021-01-29,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The Effect of  Licorice Root Extract on the Treatment of Patients with Covid-19,120,http://en.irct.ir/trial/52276,NA
IRCT20200611047735N2,IRCT,2021-02-13,2020-10-22,TRUE,Not Recruiting,Phase 2,Interventional,Iran,The effect of Plasmapheresis in the treatment of patients with COVID-19,45,http://en.irct.ir/trial/52426,NA
IRCT20201122049463N1,IRCT,2021-01-18,2021-01-20,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of chest wall hyperthermia on the blood oxygen saturation of Covid-19 patients,60,http://en.irct.ir/trial/52495,NA
IRCT20200927048849N2,IRCT,2021-01-06,2020-11-27,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patients,40,http://en.irct.ir/trial/52537,NA
IRCT20201125049486N1,IRCT,2020-12-24,2020-12-21,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The use of oxygen-enrich water in therapy of patients with  Covid 19,44,http://en.irct.ir/trial/52541,NA
IRCT20170123032129N9,IRCT,2021-01-05,2020-12-10,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of information support on patient's resilience, fear and anxiety",84,http://en.irct.ir/trial/52574,NA
IRCT20201128049520N1,IRCT,2021-02-22,2021-03-05,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,effect of olive leaf extract on Covid-19 patients,129,http://en.irct.ir/trial/52677,NA
IRCT20201119049445N1,IRCT,2021-02-13,2021-01-20,TRUE,Recruiting,Not Applicable,Interventional,Iran,Comparing the effect of psychotherapy on the grief experience and quality of life in first-degree relatives of the deceased caused by COVID 19,40,http://en.irct.ir/trial/52747,NA
IRCT20201202049566N1,IRCT,2021-01-22,2020-02-20,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"treatment strategy  Included: hydroxychloroquine, naproxen, and oseltamivir for outpatient patients with Covid 19",150,http://en.irct.ir/trial/52800,NA
IRCT20190717044241N3,IRCT,2020-12-31,2020-12-21,TRUE,Recruiting,Phase 2,Interventional,Iran,Cell therapy in patients with COVID-19,20,http://en.irct.ir/trial/52820,NA
IRCT20160808029255N10,IRCT,2021-01-10,2021-01-20,FALSE,Recruiting,Not Applicable,Interventional,Iran,"The effect of Remote Group intervention on sexual health literacy, sexual function, sexual self-efficacy and quality of sexual life of women in reproductive age",110,http://en.irct.ir/trial/52822,NA
IRCT20200621047859N4,IRCT,2021-01-03,2020-10-28,TRUE,Recruiting,Phase 1,Interventional,Iran,The effects of mesenchymal stem cells in COVID-19,20,http://en.irct.ir/trial/52947,NA
IRCT20201213049693N1,IRCT,2021-02-13,2020-12-29,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of educational intervention based on social support theory on the reduction of Stress related Covid-19 in Diabetic Patients in Bandar Abbas,212,http://en.irct.ir/trial/53006,NA
IRCT20180316039112N3,IRCT,2021-02-01,2020-06-21,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Plasmapheresis in the treatment of patients with COVID-19,100,http://en.irct.ir/trial/53059,NA
IRCT20200318046812N3,IRCT,2021-01-12,2020-12-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,"Efficacy and safety of ""BioBoost"" supplement on the incidence of COVID-19 symptoms of asymptomatic family members of COVID-19 patients",500,http://en.irct.ir/trial/53187,NA
IRCT20201127049505N1,IRCT,2021-02-06,2020-12-28,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Study on the evaluation of the safety and efficacy of Sofosbuvir  in participants with mild coronavirus in outpatients (COVID-19),360,http://en.irct.ir/trial/53212,NA
IRCT20170807035551N2,IRCT,2021-01-16,2021-01-20,FALSE,Recruiting,Phase 3,Interventional,Iran,Efficacy of Tadalafil on improvement of erectile dysfunction,60,http://en.irct.ir/trial/53252,NA
IRCT20160110025929N34,IRCT,2021-01-16,2021-01-19,FALSE,Recruiting,Not Applicable,Interventional,Iran,effect of virtual relaxation technique training (Jacobson and Benson) on anxiety in patients with Covid -19,60,http://en.irct.ir/trial/53265,NA
IRCT20201223049816N1,IRCT,2021-01-11,2020-12-20,TRUE,Recruiting,Phase 1,Interventional,Iran,Evaluation of the effectiveness of PHR-160 spray in hospitalized patients with Covid-19,240,http://en.irct.ir/trial/53342,NA
IRCT20201028049175N3,IRCT,2021-01-15,2021-02-19,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin to decrease intensity of clinical manifestations in patient with COVID19,100,http://en.irct.ir/trial/53410,NA
IRCT20200223046586N3,IRCT,2021-01-11,2021-01-13,FALSE,Recruiting,Not Applicable,Interventional,Iran,multimedia-based peer support groups on anxiety in patients,100,http://en.irct.ir/trial/53538,NA
IRCT20210109049978N1,IRCT,2021-01-13,2021-01-18,FALSE,Recruiting,Not Applicable,Interventional,Iran,Effect of Internet- Based Psychoeducational Support on Perceived Stress and Caring Burden in Caregivers of Patients with COVID-19,70,http://en.irct.ir/trial/53594,NA
IRCT20110425006280N11,IRCT,2021-01-27,2021-01-19,TRUE,Recruiting,Phase 2,Interventional,Iran,The effect of pentoxifylline in the treatment of Covid-19 disease,20,http://en.irct.ir/trial/53644,NA
IRCT20210111050011N1,IRCT,2021-02-16,2021-02-19,FALSE,Recruiting,Not Applicable,Interventional,Iran,The Effect of Tele-Nursing on Caregiver Burden in Family Caregivers and Self-Efficacy in Patients With Covid-19,60,http://en.irct.ir/trial/53741,NA
IRCT20210120050092N1,IRCT,2021-02-19,2020-04-20,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of stress and anxiety due to Covid 19 epidemic in pregnant women,100,http://en.irct.ir/trial/53834,NA
IRCT20190804044429N6,IRCT,2021-02-20,2021-02-18,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Nasal spray of mometasone 0.05% effects on olfactory improvement in  COVID-19,60,http://en.irct.ir/trial/54008,NA
IRCT20210205050247N1,IRCT,2021-02-13,2021-02-18,FALSE,Recruiting,Phase 1,Interventional,Iran,The effect of olfactory training and vitamin A in the olfactory loss of patients with covid-19.,90,http://en.irct.ir/trial/54178,NA
IRCT20200506047323N7,IRCT,2021-02-16,2021-02-28,FALSE,Not Recruiting,Phase 3,Interventional,Iran,melatonin in patients with COVID-19,60,http://en.irct.ir/trial/54268,NA
IRCT20210214050350N1,IRCT,2021-02-22,2021-02-14,TRUE,Recruiting,Phase 3,Interventional,Iran,Comparing the effectiveness of Kaletra/Hydroxychloroquine and Atazanavir/Dolutegravir/Hydroxychloroquine treatment regiments in COVID-19 treatment,60,http://en.irct.ir/trial/54295,NA
IRCT20210214050356N1,IRCT,2021-02-22,2021-02-19,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of Muscle Release Treatment in Patients Infected by Corona- Virus,50,http://en.irct.ir/trial/54351,NA
IRCT20200509047364N3,IRCT,2021-02-20,2021-03-02,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of N-Acetylcysteine on COVID-19,40,http://en.irct.ir/trial/54372,NA
IRCT20190804044429N5,IRCT,2021-02-18,2021-02-22,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Colchicine effects on treatment of COVID-19,110,http://en.irct.ir/trial/54385,NA
KCT0005907,CRiS,2021-02-18,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,South Korea,The relationship between job stress and resilience of nursing hospital nurses in the COVID-19 situation,230,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18774,NA
KCT0005834,CRiS,2021-01-28,2020-08-18,TRUE,Recruiting,Phase 2,Interventional,South Korea,"A Multi-center, Randomized, Double-blind, Parallel, Placebo-Controlled, Phase ? Clinical Trial to Evaluate Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients",76,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18138,NA
KCT0005896,CRiS,2021-02-16,2020-09-04,TRUE,Not Recruiting,Phase1,Interventional,South Korea,"A Phase 1 study to Evaluate the Safety, Tolerability and Virology of CT-P59 in Patient with Mild COVID-19",18,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18143,NA
JPRN-jRCTs052200134,jRCT,2021-02-15,2021-02-15,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Japan,A clinical study of a new virus adsorption therapy in patients with severe COVID-19 infection,25,https://jrct.niph.go.jp/latest-detail/jRCTs052200134,NA
JPRN-UMIN000042919,UMIN-CTR,2021-02-19,2020-08-16,TRUE,Recruiting,Not Applicable,Observational,Asia(except Japan),dr,403,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048996,NA
JPRN-UMIN000043167,UMIN-CTR,2021-01-29,2021-02-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Questionnaire Survey for the Impact of COVID-19 Crisis on Patients with Parkinson&#39;s Disease and their Caregivers,3000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049272,NA
JPRN-UMIN000043256,UMIN-CTR,2021-02-05,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Retrospective observational study to assess the impact of COVID 19 on emergency care in Niigata city,18000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049370,NA
JPRN-UMIN000043377,UMIN-CTR,2021-02-19,2021-02-17,TRUE,Recruiting,Not Applicable,Observational,Japan,Cohort Survey at the Beginning of SARS-CoV-2 Vaccination in Japan,20000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049528,NA
CTRI/2021/01/030789,CTRI,2021-01-27,2021-01-29,FALSE,Not Recruiting,Not Applicable,Observational,India,Evaluation of different complete blood count(CBC) parameters in prognosis of COVID -19  patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50967,NA
CTRI/2021/01/030782,CTRI,2021-01-27,2021-05-02,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 Vaccine effectiveness and hesitancy study in Healthcare Workers of Max Group of Hospitals,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52014,NA
CTRI/2021/01/030752,CTRI,2021-01-27,2021-01-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of Online Yoga for 12-weeks in comparison to no-treatment on change in Burnout and Professional Quality of Life among COVID-19 Frontline Warriors.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51380,NA
CTRI/2021/01/030788,CTRI,2021-01-27,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,Prevalence of arrhythmia in COVID 19 patients,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50911,NA
CTRI/2021/01/030796,CTRI,2021-01-28,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,A simple test for COVID-19 immunity,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51818,NA
CTRI/2021/01/030795,CTRI,2021-01-28,2021-01-02,TRUE,Recruiting,Phase 2,Interventional,India,Clinical study to evaluate the safety and efficacy of ATRICOV 452 for the treatment of COVID-19 along with the standard of care.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51391,NA
CTRI/2021/01/030794,CTRI,2021-01-28,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,"Is there a difference in outcome of patients undergoing surgery after recovery from COVID 19. A multicentre study in India. 
",442,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50368,NA
CTRI/2021/01/030793,CTRI,2021-01-28,2021-01-30,FALSE,Recruiting,Phase 3,Interventional,India,A clinical trial of Intravenous Glutathione along with standard treatment in Moderate COVID-19 Pneumonia Patients.,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48850,NA
CTRI/2021/01/030816,CTRI,2021-01-28,2021-05-02,FALSE,Not Recruiting,Not Applicable,Observational,India,"EAR,NOSE AND THROAT SYMPTOMS PERSISTING AFTER PATIENTS RECOVERED FROM COVID-19 OR LONG TERM CONSEQUENCES OF THE DISEASE",250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51937,NA
CTRI/2021/01/030826,CTRI,2021-01-29,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,India,Clinical virtual simulation is effective in nursing education,52,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47638,NA
CTRI/2021/01/030829,CTRI,2021-01-29,2021-05-02,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of HFNC Vs non rebreathing mask for oxygen therapy in COVID 19 pneumonia,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51297,NA
CTRI/2021/01/030830,CTRI,2021-01-29,2021-08-02,FALSE,Not Recruiting,Phase 3,Interventional,"Sweden, Georgia, United Kingdom, Japan, Poland, France, Denmark, Greece, United States, Germany, Switzerland, Argentina, Brazil, Mexico, Nigeria, Singapore, Chile, Australia, Peru, Portugal, Thailand, Israel, Spain, India",Therapeutics for Inpatients with COVID-19 (TICO),1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52067,NA
CTRI/2021/01/030825,CTRI,2021-01-29,2021-01-02,TRUE,Not Recruiting,Phase 3,Interventional,India,"Role of Unani drugs (Tiryaqe Wabai, Arque-e-Ajeeb, Habb-e- Loban) in the treatment of COVID-19 patients.",46,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51863,NA
CTRI/2021/01/030824,CTRI,2021-01-29,2021-01-29,FALSE,Recruiting,Phase 2,Interventional,India,Efficacy and Safety Study of COVID-19 Hyperimmunoglobulin in patients with COVID-19,66,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50900,NA
CTRI/2021/01/030843,CTRI,2021-01-29,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,India,"Daily life Experiences as such distress, violence and coping of Wives of persons with Alcohol dependence during COVID-19 Pandemic",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46808,NA
CTRI/2021/02/030887,CTRI,2021-02-01,2021-10-02,FALSE,Recruiting,Phase 2,Interventional,India,A safety and efficacy study of Eflornithine (NSRT2020Ã¢?Â¢) against the standard of care in adult hospitalized patients showing signs and symptoms of moderate COVID-19 infection.,208,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48386,NA
CTRI/2021/02/030892,CTRI,2021-02-01,2021-01-02,TRUE,Recruiting,Phase 3,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients,416,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49972,NA
CTRI/2021/02/030878,CTRI,2021-02-01,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,India,A  pilot  study  to  assess  the  various  dermatoses  associated  with  usage  of  facial  mask  in  COVID-19  Pandemic,364,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51853,NA
CTRI/2021/02/030880,CTRI,2021-02-01,2021-05-02,FALSE,Not Recruiting,Not Applicable,Observational,India,A Study to explore the challenges and adaptations in government schools in Tezpur in the context of the  COVID-19 pandemic,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45246,NA
CTRI/2021/02/030897,CTRI,2021-02-01,2021-11-02,FALSE,Not Recruiting,Not Applicable,Interventional,India,Covid yoga practice among health care professionals having stress anxiety and depression,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52184,NA
CTRI/2021/02/030946,CTRI,2021-02-02,2021-02-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Correlation of Vitamin B12 with blood clotting in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52174,NA
CTRI/2021/02/030947,CTRI,2021-02-02,2021-08-02,FALSE,Not Recruiting,Not Applicable,Observational,India,CT chest as a diagnostic tool for COVID 19,365,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52200,NA
CTRI/2021/02/030957,CTRI,2021-02-03,2021-02-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,A clinical study to determine whether an alkaline barrier created in the oropharynx by use of spray containing 8.4% sodium bicarbonate can mitigate  development of Influenza Like Illness (ILI) and Covid-19 infection.,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52251,NA
CTRI/2021/02/030950,CTRI,2021-02-03,2021-08-02,FALSE,Not Recruiting,Not Applicable,Observational,India,A new test to diagnose COVID-19,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52209,NA
CTRI/2021/02/030986,CTRI,2021-02-04,2021-05-02,FALSE,Not Recruiting,Phase 2,Interventional,India,A trial of sodium-copper-chlorophyllin given along with treatment of physicianÃ¢??s choice versus treatment of physicianÃ¢??s choice in asymptomatic or mildly symptomatic patients with Covid-19,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51800,NA
CTRI/2021/02/031011,CTRI,2021-02-04,2021-10-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Post Covid 19 disability scale translation to Kannada language,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52142,NA
CTRI/2021/02/031012,CTRI,2021-02-04,2021-02-15,FALSE,Recruiting,Not Applicable,Interventional,India,Cotrimoxazole in hospitalised patients with severe COVID-19 infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51954,NA
CTRI/2021/02/031036,CTRI,2021-02-05,2021-10-02,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of Gayatri Mantra and Pranayama on covid-19 patients.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51219,NA
CTRI/2021/02/031052,CTRI,2021-02-05,2021-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,India,"comparison of  ease and duration of intubation with Macintosh versus King vision video-laryngoscope using COVID-19 barrier box on manikins, so that we can use one of them (according to study outcome showing ease of intubation) for intubation of COVID patients",32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46372,NA
CTRI/2021/02/031096,CTRI,2021-02-08,2021-08-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Role of CD4 cell counts in predicting disease outcome in covid positive patients,116,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51462,NA
CTRI/2021/02/031079,CTRI,2021-02-08,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,"Chile, Iran, Turkey, Liberia, India, Malaysia, Nigeria",Survey of challenges faced by Ethics Committees while reviewing protocols during COVID-19 pandemic,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52326,NA
CTRI/2021/02/031123,CTRI,2021-02-09,2021-11-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Antibodies to COVID vaccine,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51974,NA
CTRI/2021/02/031115,CTRI,2021-02-09,2021-12-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Clinical profile and outcome in COVID-19 positive cases in rural population.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52268,NA
CTRI/2021/02/031139,CTRI,2021-02-09,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID - 19 pandemic on the outpatient dental visits.,3821,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49499,NA
CTRI/2021/02/031138,CTRI,2021-02-09,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Observational study of severity and outcomes of artificially respiring COVID-19 positive patients with COVID-19 Complication causing respiratory distress.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52439,NA
CTRI/2021/02/031176,CTRI,2021-02-10,2021-02-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of Phase I Cardiac Rehabilitation among Patients Undergoing CABG Surgery - A Randomized Controlled Trial,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52050,NA
CTRI/2021/02/031197,CTRI,2021-02-10,2021-02-18,FALSE,Not Recruiting,Not Applicable,Observational,India,Association of tuberculosis with Covid-19 infection in children,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51049,NA
CTRI/2021/02/031165,CTRI,2021-02-10,2021-11-02,FALSE,Not Recruiting,Not Applicable,Observational,India,Level of IgG Antibodies against Covid19 in people of Ahmedabad as on February 2021,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52169,NA
CTRI/2021/02/031232,CTRI,2021-02-11,2021-02-03,TRUE,Not Recruiting,Phase 2,Interventional,India,Perceived stress and potential correlates among the frontline nurses during the COVID -19  pandemic.,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52011,NA
CTRI/2021/02/031212,CTRI,2021-02-11,2021-02-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Blood sugars and COVID,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48458,NA
CTRI/2021/02/031230,CTRI,2021-02-11,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Estimation of vitamin D levels in covid 19 positive patients.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52097,NA
CTRI/2021/02/031256,CTRI,2021-02-12,2021-02-19,FALSE,Not Recruiting,Phase 2,Interventional,India,Madhav Rasayan Plus in subjects of COVID 19.,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52613,NA
CTRI/2021/02/031295,CTRI,2021-02-15,2021-02-20,FALSE,Not Recruiting,Phase 1,Interventional,India,Intranasal Adenoviral vector COVID-19 vaccine (BBV154) Phase 1 study,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51327,NA
CTRI/2021/02/031286,CTRI,2021-02-15,2021-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Internet based self-guided intervention for COVID-19 related dysfunctional worry,290,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52451,NA
CTRI/2021/02/031322,CTRI,2021-02-16,2021-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Study of Effectiveness of Telemedicine Based Pulmonary Rehabilitation in Recovered patients of Covid 19 Lung Infection,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52024,NA
CTRI/2021/02/031353,CTRI,2021-02-17,2021-02-24,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurveda clinical trial on mildly symptomatic COVID- 19 patientsÃ¢??,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52810,NA
CTRI/2021/02/031357,CTRI,2021-02-17,2021-02-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Breath analysis for Post COVID condition using E-nose,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52837,NA
CTRI/2021/02/031370,CTRI,2021-02-17,2021-02-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 on mental and respiratory functions of ventilated patients at six months post discharge,56,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52587,NA
CTRI/2021/02/031375,CTRI,2021-02-17,2021-08-03,FALSE,Not Recruiting,Not Applicable,Interventional,India,Non Invasive Ventilation by Helmet mask vs. Facemask in Covid pneumonia patients.,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52608,NA
CTRI/2021/02/031394,CTRI,2021-02-18,2021-02-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Demographic and Health parameters of patients with CIVID 19 positive status who required advanced level of respiratory assistance (need of ventilatory support) in Intensive Care Unit.,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51833,NA
CTRI/2021/02/031424,CTRI,2021-02-19,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,India,"A observational study to check the results of patients with COVID-19 infection treated with using high flow nasal cannula(using heat and 
 humified delivered oxygen through nasal cannula)",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51886,NA
CTRI/2021/02/031420,CTRI,2021-02-19,2021-02-27,FALSE,Not Recruiting,Phase 2,Interventional,India,Effectivenes of Siddha Supplement MAM Granules in the Management of Pre Symptomatic COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52957,NA
CTRI/2021/02/031409,CTRI,2021-02-19,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,India,A multicentre observational study to look into the practise of using non invasive ventilation in COVID-19 patients requiring ICU admission for respiratory support and their outcome in terms of their failure rate as well as exploiting the HACOR scale to predict NiV failure.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50943,NA
NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,2,https://clinicaltrials.gov/show/NCT04331366,NA
NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,275,https://clinicaltrials.gov/show/NCT04331834,NA
NCT04334291,ClinicalTrials.gov,2020-04-01,2020-03-23,TRUE,Not Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",8168,https://clinicaltrials.gov/show/NCT04334291,NA
NCT04342104,ClinicalTrials.gov,2020-04-08,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,100,https://clinicaltrials.gov/show/NCT04342104,NA
NCT04349592,ClinicalTrials.gov,2020-04-12,2020-04-14,FALSE,Not Recruiting,Not Applicable,Interventional,Qatar,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,456,https://clinicaltrials.gov/show/NCT04349592,NA
NCT04352517,ClinicalTrials.gov,2020-04-10,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,"Chile, Uruguay, Brazil",Influence Physical Activity Psychological Responses COVID-19 Pandemic,3500,https://clinicaltrials.gov/show/NCT04352517,NA
NCT04354584,ClinicalTrials.gov,2020-04-13,2020-04-06,TRUE,Recruiting,Not Applicable,Observational,Denmark,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04354584,NA
NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),64,https://clinicaltrials.gov/show/NCT04355962,NA
NCT04361838,ClinicalTrials.gov,2020-04-16,2020-05-21,FALSE,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,1000,https://clinicaltrials.gov/show/NCT04361838,NA
NCT04363333,ClinicalTrials.gov,2020-04-19,2020-04-27,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Obstructive Sleep Apnea & Covid-19 Outcomes,320,https://clinicaltrials.gov/show/NCT04363333,NA
NCT04364828,ClinicalTrials.gov,2020-04-22,2020-10-21,FALSE,Recruiting,Not Applicable,Interventional,Germany,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,1000,https://clinicaltrials.gov/show/NCT04364828,NA
NCT04365595,ClinicalTrials.gov,2020-04-24,2020-06-03,FALSE,Not Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),58,https://clinicaltrials.gov/show/NCT04365595,NA
NCT04366830,ClinicalTrials.gov,2020-04-24,2020-07-21,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",Not Available,https://clinicaltrials.gov/show/NCT04366830,NA
NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-30,FALSE,Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,100,https://clinicaltrials.gov/show/NCT04367636,NA
NCT04373811,ClinicalTrials.gov,2020-04-26,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,France,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,60,https://clinicaltrials.gov/show/NCT04373811,NA
NCT04374474,ClinicalTrials.gov,2020-04-29,2021-01-10,FALSE,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),0,https://clinicaltrials.gov/show/NCT04374474,NA
NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,447,https://clinicaltrials.gov/show/NCT04377789,NA
NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Slovakia",Efficacy and Safety of PolyoxidoniumÂ® in Hospitalized Patients With Coronavirus Disease COVID-19,394,https://clinicaltrials.gov/show/NCT04381377,NA
NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,FALSE,Not Recruiting,Phase 2,Interventional,"Spain, Mexico, United States, Brazil",A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,410,https://clinicaltrials.gov/show/NCT04386616,NA
NCT04390217,ClinicalTrials.gov,2020-05-13,2021-10-31,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,120,https://clinicaltrials.gov/show/NCT04390217,NA
NCT04393142,ClinicalTrials.gov,2020-04-26,2020-05-05,FALSE,Not Recruiting,Not Applicable,Observational,Mexico,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,96,https://clinicaltrials.gov/show/NCT04393142,NA
NCT04395430,ClinicalTrials.gov,2020-02-03,2020-09-18,FALSE,Recruiting,Not Applicable,Interventional,Singapore,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,40,https://clinicaltrials.gov/show/NCT04395430,NA
NCT04395456,ClinicalTrials.gov,2020-05-19,2021-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),144,https://clinicaltrials.gov/show/NCT04395456,NA
NCT04408040,ClinicalTrials.gov,2020-05-15,2020-07-14,FALSE,Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,700,https://clinicaltrials.gov/show/NCT04408040,NA
NCT04408287,ClinicalTrials.gov,2020-05-20,2020-09-15,FALSE,Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,50,https://clinicaltrials.gov/show/NCT04408287,NA
NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,FALSE,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",120,https://clinicaltrials.gov/show/NCT04412291,NA
NCT04414631,ClinicalTrials.gov,2020-05-19,2020-08-06,FALSE,Recruiting,Phase 2,Interventional,"Switzerland, Mexico, Brazil",Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,120,https://clinicaltrials.gov/show/NCT04414631,NA
NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,17,https://clinicaltrials.gov/show/NCT04425538,NA
NCT04426071,ClinicalTrials.gov,2020-05-28,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,Canada,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,142,https://clinicaltrials.gov/show/NCT04426071,NA
NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,TRUE,Not Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04428268,NA
NCT04431297,ClinicalTrials.gov,2020-06-12,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04431297,NA
NCT04442178,ClinicalTrials.gov,2020-06-19,2020-09-15,FALSE,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),48,https://clinicaltrials.gov/show/NCT04442178,NA
NCT04448704,ClinicalTrials.gov,2020-06-25,2020-06-22,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,1011,https://clinicaltrials.gov/show/NCT04448704,NA
NCT04456153,ClinicalTrials.gov,2020-06-30,2020-07-22,FALSE,Not Recruiting,Phase 2,Interventional,United States,Atovaquone for Treatment of COVID-19,61,https://clinicaltrials.gov/show/NCT04456153,NA
NCT04456439,ClinicalTrials.gov,2020-06-29,2020-11-06,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",Not Available,https://clinicaltrials.gov/show/NCT04456439,NA
NCT04459819,ClinicalTrials.gov,2020-06-27,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Respiratory Physiotherapy in Severe COVID-19 Patients,84,https://clinicaltrials.gov/show/NCT04459819,NA
NCT04463004,ClinicalTrials.gov,2020-07-07,2020-09-02,FALSE,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,2,https://clinicaltrials.gov/show/NCT04463004,NA
NCT04463849,ClinicalTrials.gov,2020-07-02,2020-06-30,TRUE,Recruiting,Not Applicable,Interventional,Italy,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,90,https://clinicaltrials.gov/show/NCT04463849,NA
NCT04473898,ClinicalTrials.gov,2020-07-14,2020-06-19,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation After Coronavirus,35,https://clinicaltrials.gov/show/NCT04473898,NA
NCT04476667,ClinicalTrials.gov,2020-07-13,2020-06-15,TRUE,Recruiting,Not Applicable,Interventional,Canada,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",80,https://clinicaltrials.gov/show/NCT04476667,NA
NCT04476953,ClinicalTrials.gov,2020-07-15,2020-08-03,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation,70,https://clinicaltrials.gov/show/NCT04476953,NA
NCT04477668,ClinicalTrials.gov,2020-07-09,2021-02-08,FALSE,Recruiting,Not Applicable,Interventional,Saudi Arabia,Helmet Non-Invasive Ventilation for COVID-19 Patients,320,https://clinicaltrials.gov/show/NCT04477668,NA
NCT04479150,ClinicalTrials.gov,2020-07-19,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,5307,https://clinicaltrials.gov/show/NCT04479150,NA
NCT04486482,ClinicalTrials.gov,2020-07-23,2021-01-12,FALSE,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,50,https://clinicaltrials.gov/show/NCT04486482,NA
NCT04498546,ClinicalTrials.gov,2020-07-27,2020-07-20,TRUE,Recruiting,Not Applicable,Observational,Turkey,Mask Usage and Exercise During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04498546,NA
NCT04507893,ClinicalTrials.gov,2020-08-05,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Comparison Between Positive and Negative COVID-19 Pneumonia,80,https://clinicaltrials.gov/show/NCT04507893,NA
NCT04527575,ClinicalTrials.gov,2020-08-11,2020-07-27,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",100,https://clinicaltrials.gov/show/NCT04527575,NA
NCT04533347,ClinicalTrials.gov,2020-08-28,2021-02-19,FALSE,Recruiting,Phase 2,Interventional,United States,Tafenoquine in Patients With Mild to Moderate COVID-19,275,https://clinicaltrials.gov/show/NCT04533347,NA
NCT04533360,ClinicalTrials.gov,2020-08-28,2020-09-28,FALSE,Recruiting,Not Applicable,Observational,United States,Prevalence of COVID-19 Antibodies Kingman AZ,3000,https://clinicaltrials.gov/show/NCT04533360,NA
NCT04534803,ClinicalTrials.gov,2020-08-21,2021-09-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),2100,https://clinicaltrials.gov/show/NCT04534803,NA
NCT04540419,ClinicalTrials.gov,2020-08-17,2020-09-11,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,500,https://clinicaltrials.gov/show/NCT04540419,NA
NCT04561180,ClinicalTrials.gov,2020-09-22,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,96,https://clinicaltrials.gov/show/NCT04561180,NA
NCT04563247,ClinicalTrials.gov,2020-09-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,970,https://clinicaltrials.gov/show/NCT04563247,NA
NCT04582344,ClinicalTrials.gov,2020-10-01,2020-09-14,TRUE,Recruiting,Phase 3,Interventional,Turkey,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),13000,https://clinicaltrials.gov/show/NCT04582344,NA
NCT04583410,ClinicalTrials.gov,2020-09-28,2020-10-22,FALSE,Recruiting,Phase 3,Interventional,France,Efficacy of Nicotine in Preventing COVID-19 Infection,1633,https://clinicaltrials.gov/show/NCT04583410,NA
NCT04594525,ClinicalTrials.gov,2020-10-12,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Maternal Telemental Health Interventions in Response to Covid-19*,58,https://clinicaltrials.gov/show/NCT04594525,NA
NCT04600141,ClinicalTrials.gov,2020-10-22,2020-11-10,FALSE,Recruiting,Phase 3,Interventional,Brazil,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection,308,https://clinicaltrials.gov/show/NCT04600141,NA
NCT04606732,ClinicalTrials.gov,2020-10-27,2020-09-20,TRUE,Recruiting,Not Applicable,Observational,Italy,CardioVascular Disease Progression and Prognosis in COVID-19,2000,https://clinicaltrials.gov/show/NCT04606732,NA
NCT04636294,ClinicalTrials.gov,2020-11-18,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Borderline COVID-19 PCR Test Result,30000,https://clinicaltrials.gov/show/NCT04636294,NA
NCT04636554,ClinicalTrials.gov,2020-11-09,2020-08-01,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia,Not Available,https://clinicaltrials.gov/show/NCT04636554,NA
NCT04643444,ClinicalTrials.gov,2020-11-19,2021-02-09,FALSE,Recruiting,Not Applicable,Observational,Switzerland,Police COVID-19 Serosurvey,1000,https://clinicaltrials.gov/show/NCT04643444,NA
NCT04649918,ClinicalTrials.gov,2020-11-25,2020-11-25,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,50,https://clinicaltrials.gov/show/NCT04649918,NA
NCT04657809,ClinicalTrials.gov,2020-12-02,2020-10-01,TRUE,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,40,https://clinicaltrials.gov/show/NCT04657809,NA
NCT04673292,ClinicalTrials.gov,2020-12-16,2021-02-08,FALSE,Recruiting,Not Applicable,Interventional,United States,Community Collaboration to Combat COVID-19 (C-FORWARD),3000,https://clinicaltrials.gov/show/NCT04673292,NA
NCT04692779,ClinicalTrials.gov,2020-12-29,2021-01-31,FALSE,Recruiting,Not Applicable,Observational,United States,A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients,60,https://clinicaltrials.gov/show/NCT04692779,NA
NCT04704544,ClinicalTrials.gov,2021-01-06,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE),320,https://clinicaltrials.gov/show/NCT04704544,NA
NCT04710836,ClinicalTrials.gov,2020-12-10,2020-12-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,NoRCoRP Assessment Clinic,500,https://clinicaltrials.gov/show/NCT04710836,NA
NCT04715854,ClinicalTrials.gov,2021-01-03,2021-02-19,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,15,https://clinicaltrials.gov/show/NCT04715854,NA
NCT04741061,ClinicalTrials.gov,2021-02-02,2021-02-19,FALSE,Recruiting,Phase 3,Interventional,Russian Federation,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light",6000,https://clinicaltrials.gov/show/NCT04741061,NA
NCT04749173,ClinicalTrials.gov,2021-01-20,2020-11-21,TRUE,Recruiting,Phase 1,Interventional,South Korea,"To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.",24,https://clinicaltrials.gov/show/NCT04749173,NA
NCT04750759,ClinicalTrials.gov,2021-02-08,2021-02-03,TRUE,Recruiting,Phase 2,Interventional,Germany,Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat,40,https://clinicaltrials.gov/show/NCT04750759,NA
NCT04756128,ClinicalTrials.gov,2021-01-28,2021-01-25,TRUE,Recruiting,Phase 2,Interventional,United States,Impact of Colchicine and Low-dose Naltrexone on COVID-19,164,https://clinicaltrials.gov/show/NCT04756128,NA
NCT04756271,ClinicalTrials.gov,2021-02-13,2021-02-11,TRUE,Recruiting,Phase 3,Interventional,Egypt,Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection,140,https://clinicaltrials.gov/show/NCT04756271,NA
NCT04756323,ClinicalTrials.gov,2021-02-09,2020-10-27,TRUE,Not Recruiting,Phase 2,Interventional,China,A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),1000,https://clinicaltrials.gov/show/NCT04756323,NA
NCT04756479,ClinicalTrials.gov,2021-02-08,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Mortality Due to COVID-19 in the COVID-AGEBRU Study,160,https://clinicaltrials.gov/show/NCT04756479,NA
NCT04756518,ClinicalTrials.gov,2021-02-15,2020-07-06,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI),785,https://clinicaltrials.gov/show/NCT04756518,NA
NCT04756609,ClinicalTrials.gov,2021-02-06,2021-02-12,FALSE,Not Recruiting,Not Applicable,Interventional,France,"Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID",104000,https://clinicaltrials.gov/show/NCT04756609,NA
NCT04756674,ClinicalTrials.gov,2020-11-02,2021-02-09,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Covid-19 on Skeletal Muscle,36,https://clinicaltrials.gov/show/NCT04756674,NA
NCT04756817,ClinicalTrials.gov,2021-02-14,2021-02-13,TRUE,Recruiting,Not Applicable,Observational,Greece,Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece,500,https://clinicaltrials.gov/show/NCT04756817,NA
NCT04756830,ClinicalTrials.gov,2021-02-15,2021-02-01,TRUE,Not Recruiting,Phase 4,Interventional,Brazil,A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19,1200,https://clinicaltrials.gov/show/NCT04756830,NA
NCT04756869,ClinicalTrials.gov,2021-02-15,2020-04-28,TRUE,Not Recruiting,Not Applicable,Observational,United States,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology,226,https://clinicaltrials.gov/show/NCT04756869,NA
NCT04757285,ClinicalTrials.gov,2021-02-06,2020-05-10,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Copeptin and Psychological Stress of Medic During COVID-19 Pandemic,90,https://clinicaltrials.gov/show/NCT04757285,NA
NCT04757298,ClinicalTrials.gov,2021-02-15,2021-02-12,TRUE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Treatment Cascade Optimization Study,670,https://clinicaltrials.gov/show/NCT04757298,NA
NCT04757792,ClinicalTrials.gov,2021-02-11,2020-06-06,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU,475,https://clinicaltrials.gov/show/NCT04757792,NA
NCT04757818,ClinicalTrials.gov,2021-02-16,2021-02-04,TRUE,Recruiting,Not Applicable,Interventional,Spain,"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.",140,https://clinicaltrials.gov/show/NCT04757818,NA
NCT04757870,ClinicalTrials.gov,2021-02-16,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Macro-scale Estimators of Covid-19's Worldwide Cases and Deaths,1790,https://clinicaltrials.gov/show/NCT04757870,NA
NCT04757883,ClinicalTrials.gov,2021-02-11,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients,100,https://clinicaltrials.gov/show/NCT04757883,NA
NCT04758039,ClinicalTrials.gov,2021-02-15,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,Chile,Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort,395,https://clinicaltrials.gov/show/NCT04758039,NA
NCT04758273,ClinicalTrials.gov,2021-02-09,2020-10-07,TRUE,Not Recruiting,Phase 1,Interventional,China,A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),180,https://clinicaltrials.gov/show/NCT04758273,NA
NCT04758286,ClinicalTrials.gov,2021-02-11,2020-07-01,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19,209,https://clinicaltrials.gov/show/NCT04758286,NA
NCT04760418,ClinicalTrials.gov,2021-02-10,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic,6,https://clinicaltrials.gov/show/NCT04760418,NA
NCT04760561,ClinicalTrials.gov,2021-02-15,2021-02-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Self-prone Positioning for Awake Non-intubated Patients With COVID-19,82,https://clinicaltrials.gov/show/NCT04760561,NA
NCT04760639,ClinicalTrials.gov,2021-02-10,2020-12-16,TRUE,Recruiting,Not Applicable,Observational,United States,COVID Breath Test - Ancon,100,https://clinicaltrials.gov/show/NCT04760639,NA
NCT04760730,ClinicalTrials.gov,2021-02-17,2021-03-17,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19),100,https://clinicaltrials.gov/show/NCT04760730,NA
NCT04760743,ClinicalTrials.gov,2021-02-17,2020-12-17,TRUE,Not Recruiting,Phase 1,Interventional,South Korea,Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19),50,https://clinicaltrials.gov/show/NCT04760743,NA
NCT04760795,ClinicalTrials.gov,2021-02-17,2020-11-15,TRUE,Recruiting,Not Applicable,Observational,France,"Stress, Personality, Attachment and Coping During the Covid Crisis.",118,https://clinicaltrials.gov/show/NCT04760795,NA
NCT04760821,ClinicalTrials.gov,2021-02-17,2020-12-10,TRUE,Recruiting,Phase 2,Interventional,Brazil,Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19,80,https://clinicaltrials.gov/show/NCT04760821,NA
NCT04761692,ClinicalTrials.gov,2021-02-02,2021-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake",570,https://clinicaltrials.gov/show/NCT04761692,NA
NCT04762186,ClinicalTrials.gov,2021-02-11,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19,51,https://clinicaltrials.gov/show/NCT04762186,NA
NCT04762628,ClinicalTrials.gov,2021-02-11,2020-10-27,TRUE,Not Recruiting,Not Applicable,Interventional,Ukraine,"Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients",600,https://clinicaltrials.gov/show/NCT04762628,NA
NCT04763213,ClinicalTrials.gov,2021-01-29,2018-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,New Predictors in Determining the Need for Invasive Treatment in Non-STEMI,276,https://clinicaltrials.gov/show/NCT04763213,NA
NCT04763395,ClinicalTrials.gov,2021-02-17,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,Egypt,Liver Function Test Abnormalities in COVID-19,100,https://clinicaltrials.gov/show/NCT04763395,NA
NCT04764032,ClinicalTrials.gov,2021-02-12,2020-09-02,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Right Ventricular Dysfunction in Ventilated Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04764032,NA
NCT04764721,ClinicalTrials.gov,2021-02-19,2021-04-12,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID,50,https://clinicaltrials.gov/show/NCT04764721,NA
NCT04764773,ClinicalTrials.gov,2021-02-19,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Persistence of Symptoms After Improvement of Acute COVID-19,250,https://clinicaltrials.gov/show/NCT04764773,NA
NCT04764981,ClinicalTrials.gov,2021-02-14,2021-05-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19),350,https://clinicaltrials.gov/show/NCT04764981,NA
NCT04765254,ClinicalTrials.gov,2021-02-18,2021-02-20,FALSE,Recruiting,Not Applicable,Observational,Egypt,COVID-19 Infection in Diabetic Patients,300,https://clinicaltrials.gov/show/NCT04765254,NA
NCT04765436,ClinicalTrials.gov,2021-02-16,2021-01-14,TRUE,Recruiting,Phase 1,Interventional,Canada,"PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64",60,https://clinicaltrials.gov/show/NCT04765436,NA
NCT04766983,ClinicalTrials.gov,2021-01-27,2021-01-22,TRUE,Recruiting,Not Applicable,Observational,Italy,Incidence of VAP in Patients With Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04766983,NA
NCT04767087,ClinicalTrials.gov,2021-02-20,2021-02-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Pakistan,Honey and Nigella Sativa in COVID-19 Prophylaxis,1000,https://clinicaltrials.gov/show/NCT04767087,NA
ACTRN12621000183886,ANZCTR,2021-02-22,2021-02-22,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a peer and clinician co-facilitated group program for people with borderline personality disorder,120,https://anzctr.org.au/ACTRN12621000183886.aspx,NA
ISRCTN14962466,ISRCTN,2021-02-19,2021-02-23,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,A mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England,1072,http://isrctn.com/ISRCTN14962466,NA
ISRCTN11204126,ISRCTN,2021-02-17,2021-05-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Contact tracing in care homes using digital technology for improving infection control including COVID-19,400,http://isrctn.com/ISRCTN11204126,NA
ISRCTN95881792,ISRCTN,2020-12-21,2021-03-02,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,SARS-CoV-2 vaccination for COVID-19 disease safety study,1000000,http://isrctn.com/ISRCTN95881792,NA
ISRCTN69564614,ISRCTN,2020-12-16,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Moving on trial: COVID-19 and homelessness,1200,http://isrctn.com/ISRCTN69564614,NA
ISRCTN48734830,ISRCTN,2020-07-10,2020-03-08,TRUE,Recruiting,Phase 4,Interventional,Sweden,Using the blood pressure medication losartan to improve outcomes for patients with SARS CoV-2,750,http://isrctn.com/ISRCTN48734830,NA
ISRCTN53431343,ISRCTN,2020-02-11,2019-01-09,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Evaluating mental health decision units in acute care pathways (DECISION): a quasi-experimental and health economic evaluation,1151,http://isrctn.com/ISRCTN53431343,NA
NCT03256773,ClinicalTrials.gov,2017-08-18,2016-04-15,TRUE,Recruiting,Not Applicable,Observational,United States,High Resolution Micro OCT Imaging,60,https://clinicaltrials.gov/show/NCT03256773,NA
NCT03305341,ClinicalTrials.gov,2017-10-04,2020-07-18,FALSE,Not Recruiting,Phase 1,Interventional,United States,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,20,https://clinicaltrials.gov/show/NCT03305341,NA
NCT03348670,ClinicalTrials.gov,2017-11-15,2020-07-20,FALSE,Not Recruiting,Phase 1,Interventional,United States,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),20,https://clinicaltrials.gov/show/NCT03348670,NA
NCT04160975,ClinicalTrials.gov,2019-11-08,2019-12-20,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,2902,https://clinicaltrials.gov/show/NCT04160975,NA
NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"United States, Israel",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,196,https://clinicaltrials.gov/show/NCT04311697,NA
NCT04324736,ClinicalTrials.gov,2020-03-25,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",5309,https://clinicaltrials.gov/show/NCT04324736,NA
NCT04325048,ClinicalTrials.gov,2020-03-25,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,Israel,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,5000,https://clinicaltrials.gov/show/NCT04325048,NA
NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-24,FALSE,Not Recruiting,Phase 3,Interventional,France,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04325633,NA
NCT04329559,ClinicalTrials.gov,2020-03-29,2020-03-30,FALSE,Not Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,21,https://clinicaltrials.gov/show/NCT04329559,NA
NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,FALSE,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,120,https://clinicaltrials.gov/show/NCT04334460,NA
NCT04344925,ClinicalTrials.gov,2020-04-03,2020-04-18,FALSE,Not Recruiting,Not Applicable,Observational,Canada,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,21,https://clinicaltrials.gov/show/NCT04344925,NA
NCT04345536,ClinicalTrials.gov,2020-04-05,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,400,https://clinicaltrials.gov/show/NCT04345536,NA
NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,FALSE,Recruiting,Phase 1,Interventional,Hungary,Anti COVID-19 Convalescent Plasma Therapy,20,https://clinicaltrials.gov/show/NCT04345679,NA
NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),500,https://clinicaltrials.gov/show/NCT04351724,NA
NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-20,FALSE,Not Recruiting,Phase 4,Interventional,"Germany, Austria",Stopping ACE-inhibitors in COVID-19,216,https://clinicaltrials.gov/show/NCT04353596,NA
NCT04354272,ClinicalTrials.gov,2020-04-10,2020-04-21,FALSE,Not Recruiting,Not Applicable,Observational,France,Evaluation of Dental Emergency Treatments During COVID19 Crisis,503,https://clinicaltrials.gov/show/NCT04354272,NA
NCT04355702,ClinicalTrials.gov,2020-04-17,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Covid-19 in Lupus Patients,130,https://clinicaltrials.gov/show/NCT04355702,NA
NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04355728,NA
NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,FALSE,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,2000,https://clinicaltrials.gov/show/NCT04358003,NA
NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,100,https://clinicaltrials.gov/show/NCT04366141,NA
NCT04369274,ClinicalTrials.gov,2020-04-23,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,30,https://clinicaltrials.gov/show/NCT04369274,NA
NCT04370249,ClinicalTrials.gov,2020-04-28,2020-04-09,TRUE,Not Recruiting,Not Applicable,Observational,France,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,313,https://clinicaltrials.gov/show/NCT04370249,NA
NCT04371354,ClinicalTrials.gov,2020-04-28,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Covid-19 Protective Measures in Endoscopy,100,https://clinicaltrials.gov/show/NCT04371354,NA
NCT04377763,ClinicalTrials.gov,2020-05-05,2020-07-15,FALSE,Recruiting,Not Applicable,Observational,France,Developement and Evaluation of Serological Assays for COVID-19,500,https://clinicaltrials.gov/show/NCT04377763,NA
NCT04382495,ClinicalTrials.gov,2020-05-08,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,Egypt,The Impact of COVID-19 Pandemic on Cancer Care,400,https://clinicaltrials.gov/show/NCT04382495,NA
NCT04383899,ClinicalTrials.gov,2020-05-07,2020-09-30,FALSE,Not Recruiting,Not Applicable,Observational,France,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,0,https://clinicaltrials.gov/show/NCT04383899,NA
NCT04384042,ClinicalTrials.gov,2020-05-10,2020-06-06,FALSE,Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,60,https://clinicaltrials.gov/show/NCT04384042,NA
NCT04384445,ClinicalTrials.gov,2020-05-09,2020-09-08,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Zofin (Organicell Flow) for Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04384445,NA
NCT04384471,ClinicalTrials.gov,2020-05-01,2020-04-29,TRUE,Not Recruiting,Not Applicable,Observational,Canada,Covid-19 Pandemic: Patients' Experience in T1D,384,https://clinicaltrials.gov/show/NCT04384471,NA
NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,0,https://clinicaltrials.gov/show/NCT04388709,NA
NCT04390165,ClinicalTrials.gov,2020-05-10,2020-06-06,FALSE,Not Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,498,https://clinicaltrials.gov/show/NCT04390165,NA
NCT04390269,ClinicalTrials.gov,2020-05-12,2020-09-10,FALSE,Recruiting,Not Applicable,Observational,Egypt,Immunogenetics Predictors With COVID-19,200,https://clinicaltrials.gov/show/NCT04390269,NA
NCT04394013,ClinicalTrials.gov,2020-05-18,2020-08-26,FALSE,Not Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,70,https://clinicaltrials.gov/show/NCT04394013,NA
NCT04395976,ClinicalTrials.gov,2020-05-19,2020-05-10,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04395976,NA
NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,FALSE,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,50,https://clinicaltrials.gov/show/NCT04397510,NA
NCT04397575,ClinicalTrials.gov,2020-05-13,2020-04-03,TRUE,Not Recruiting,Not Applicable,Observational,France,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,1509,https://clinicaltrials.gov/show/NCT04397575,NA
NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,FALSE,Not Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",204,https://clinicaltrials.gov/show/NCT04405570,NA
NCT04408170,ClinicalTrials.gov,2020-05-26,2020-06-19,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),1000,https://clinicaltrials.gov/show/NCT04408170,NA
NCT04408196,ClinicalTrials.gov,2020-05-21,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,Italy,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,121,https://clinicaltrials.gov/show/NCT04408196,NA
NCT04410549,ClinicalTrials.gov,2020-05-21,2020-06-01,FALSE,Recruiting,Not Applicable,Interventional,"Italy, Brazil",Pulmonary Optical Coherence Tomography in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04410549,NA
NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,TRUE,Recruiting,Phase 1,Interventional,United States,Intermediate IND Severe Illness COVID-19 CP,90,https://clinicaltrials.gov/show/NCT04411602,NA
NCT04412317,ClinicalTrials.gov,2020-05-30,2020-06-03,FALSE,Recruiting,Not Applicable,Observational,France,Use of PCR-Sars-CoV-2 in Children,600,https://clinicaltrials.gov/show/NCT04412317,NA
NCT04429555,ClinicalTrials.gov,2020-06-09,2021-01-11,FALSE,Recruiting,Phase 2,Interventional,United States,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",40,https://clinicaltrials.gov/show/NCT04429555,NA
NCT04432922,ClinicalTrials.gov,2020-06-15,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,France,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",15,https://clinicaltrials.gov/show/NCT04432922,NA
NCT04441372,ClinicalTrials.gov,2020-06-17,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,"India, Bangladesh",Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,600,https://clinicaltrials.gov/show/NCT04441372,NA
NCT04456413,ClinicalTrials.gov,2020-06-30,2020-11-06,FALSE,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,306,https://clinicaltrials.gov/show/NCT04456413,NA
NCT04472611,ClinicalTrials.gov,2020-07-14,2020-10-30,FALSE,Recruiting,Phase 3,Interventional,United States,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,466,https://clinicaltrials.gov/show/NCT04472611,NA
NCT04472728,ClinicalTrials.gov,2020-07-06,2020-06-16,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"Belgium, Puerto Rico, United States, Brazil, France",Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,310,https://clinicaltrials.gov/show/NCT04472728,NA
NCT04475913,ClinicalTrials.gov,2020-07-14,2018-07-11,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,56,https://clinicaltrials.gov/show/NCT04475913,NA
NCT04495816,ClinicalTrials.gov,2020-07-30,2020-07-15,TRUE,Recruiting,Phase 2,Interventional,United States,COVID-19 Anosmia Study,126,https://clinicaltrials.gov/show/NCT04495816,NA
NCT04505774,ClinicalTrials.gov,2020-08-06,2020-09-04,FALSE,Recruiting,Phase 4,Interventional,"Spain, United States",Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),2000,https://clinicaltrials.gov/show/NCT04505774,NA
NCT04525443,ClinicalTrials.gov,2020-08-21,2020-06-03,TRUE,Not Recruiting,Not Applicable,Observational,"Spain, United States",Endothelial Function and COVID-19,110,https://clinicaltrials.gov/show/NCT04525443,NA
NCT04532411,ClinicalTrials.gov,2020-08-25,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Testing Sample Acquisition Throughput and Efficiency,28948,https://clinicaltrials.gov/show/NCT04532411,NA
NCT04533048,ClinicalTrials.gov,2020-08-22,2020-08-07,TRUE,Not Recruiting,Phase 1,Interventional,China,A Clinical Study to Evaluate MW33 Injection,42,https://clinicaltrials.gov/show/NCT04533048,NA
NCT04535674,ClinicalTrials.gov,2020-08-31,2020-10-09,FALSE,Recruiting,Phase 2,Interventional,"Spain, Russian Federation",Asunercept in Patients With Severe COVID-19,400,https://clinicaltrials.gov/show/NCT04535674,NA
NCT04535869,ClinicalTrials.gov,2020-08-28,2020-12-28,FALSE,Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),50,https://clinicaltrials.gov/show/NCT04535869,NA
NCT04541979,ClinicalTrials.gov,2020-06-05,2020-06-04,TRUE,Recruiting,Phase 2,Interventional,Sweden,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04541979,NA
NCT04542850,ClinicalTrials.gov,2020-08-16,2020-11-15,FALSE,Recruiting,Not Applicable,Interventional,Bahrain,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",40,https://clinicaltrials.gov/show/NCT04542850,NA
NCT04557358,ClinicalTrials.gov,2020-09-16,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,Mexico,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in MÃ©xico During the COVID-19 Pandemic,346,https://clinicaltrials.gov/show/NCT04557358,NA
NCT04568707,ClinicalTrials.gov,2020-08-31,2020-10-23,FALSE,Recruiting,Not Applicable,Interventional,France,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),200,https://clinicaltrials.gov/show/NCT04568707,NA
NCT04588415,ClinicalTrials.gov,2020-10-08,2021-01-03,FALSE,Recruiting,Not Applicable,Interventional,Canada,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04588415,NA
NCT04603781,ClinicalTrials.gov,2020-10-03,2020-12-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,CBD Oil for Reducing Emotional Impact of COVID-19,160,https://clinicaltrials.gov/show/NCT04603781,NA
NCT04608383,ClinicalTrials.gov,2020-10-23,2020-11-19,FALSE,Recruiting,Not Applicable,Observational,France,Laparoscopy and COVID-19 Contamination,20,https://clinicaltrials.gov/show/NCT04608383,NA
NCT04613739,ClinicalTrials.gov,2020-10-29,2020-12-08,FALSE,Recruiting,Not Applicable,Interventional,United States,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,430,https://clinicaltrials.gov/show/NCT04613739,NA
NCT04614844,ClinicalTrials.gov,2020-11-02,2021-01-06,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),84,https://clinicaltrials.gov/show/NCT04614844,NA
NCT04615208,ClinicalTrials.gov,2020-11-02,2020-12-19,FALSE,Recruiting,Not Applicable,Observational,Canada,Screening for COVID-19,200,https://clinicaltrials.gov/show/NCT04615208,NA
NCT04618835,ClinicalTrials.gov,2020-10-31,2021-01-11,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04618835,NA
NCT04625036,ClinicalTrials.gov,2020-10-30,2020-05-30,TRUE,Recruiting,Not Applicable,Observational,Italy,NO-mediated Vascular Function in Covid-19 Patient,30,https://clinicaltrials.gov/show/NCT04625036,NA
NCT04627584,ClinicalTrials.gov,2020-11-12,2020-12-29,FALSE,Recruiting,Phase 2,Interventional,China,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,150,https://clinicaltrials.gov/show/NCT04627584,NA
NCT04632043,ClinicalTrials.gov,2020-11-15,2020-11-18,FALSE,Recruiting,Not Applicable,Interventional,Greece,Early Versus Delayed Intubation of Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04632043,NA
NCT04644341,ClinicalTrials.gov,2020-11-14,2021-01-15,FALSE,Recruiting,Not Applicable,Observational,Canada,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,20,https://clinicaltrials.gov/show/NCT04644341,NA
NCT04651790,ClinicalTrials.gov,2020-11-20,2020-11-27,FALSE,Recruiting,Phase 3,Interventional,Chile,"Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults",2300,https://clinicaltrials.gov/show/NCT04651790,NA
NCT04659707,ClinicalTrials.gov,2020-12-07,2021-02-22,FALSE,Recruiting,Phase 1,Interventional,United States,Hyperpolarized 129Xe MRI of Survivors of COVID-19,20,https://clinicaltrials.gov/show/NCT04659707,NA
NCT04678843,ClinicalTrials.gov,2020-12-17,2021-02-09,FALSE,Recruiting,Phase 1,Interventional,Canada,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,36,https://clinicaltrials.gov/show/NCT04678843,NA
NCT04679272,ClinicalTrials.gov,2020-12-20,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients,2000,https://clinicaltrials.gov/show/NCT04679272,NA
NCT04679909,ClinicalTrials.gov,2020-12-21,2021-02-01,FALSE,Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),180,https://clinicaltrials.gov/show/NCT04679909,NA
NCT04681053,ClinicalTrials.gov,2020-12-16,2021-02-25,FALSE,Recruiting,Phase 3,Interventional,Egypt,Inhaled Ivermectin and COVID-19,80,https://clinicaltrials.gov/show/NCT04681053,NA
NCT04695197,ClinicalTrials.gov,2020-12-14,2021-01-08,FALSE,Recruiting,Phase 3,Interventional,"Kenya, Burkina Faso",Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,142,https://clinicaltrials.gov/show/NCT04695197,NA
NCT04700462,ClinicalTrials.gov,2021-01-06,2021-02-05,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Preventive Behavior in African Americans,250,https://clinicaltrials.gov/show/NCT04700462,NA
NCT04701502,ClinicalTrials.gov,2021-01-04,2020-11-09,TRUE,Not Recruiting,Phase 2,Interventional,Bulgaria,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04701502,NA
NCT04701710,ClinicalTrials.gov,2021-01-07,2020-10-15,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Argentina,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,300,https://clinicaltrials.gov/show/NCT04701710,NA
NCT04706156,ClinicalTrials.gov,2021-01-11,2021-01-27,FALSE,Recruiting,Not Applicable,Observational,"Germany, Czech Republic, Slovakia",Oral Side Effects of COVID-19 Vaccine,1540,https://clinicaltrials.gov/show/NCT04706156,NA
NCT04713176,ClinicalTrials.gov,2021-01-14,2021-02-02,FALSE,Recruiting,Phase 3,Interventional,South Korea,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,1022,https://clinicaltrials.gov/show/NCT04713176,NA
NCT04723563,ClinicalTrials.gov,2021-01-22,2021-02-22,FALSE,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19,50,https://clinicaltrials.gov/show/NCT04723563,NA
NCT04727372,ClinicalTrials.gov,2021-01-22,2021-01-23,FALSE,Not Recruiting,Not Applicable,Observational,Pakistan,Social Acceptability of COVID-19 Vaccines in Pakistan,986,https://clinicaltrials.gov/show/NCT04727372,NA
NCT04728828,ClinicalTrials.gov,2021-01-26,2021-01-25,TRUE,Recruiting,Not Applicable,Observational,France,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,500,https://clinicaltrials.gov/show/NCT04728828,NA
NCT04729595,ClinicalTrials.gov,2021-01-25,2021-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Evaluate Tempol (MBM-02) to Help Prevent Hospitalizations in COVID-19 Patients.,310,https://clinicaltrials.gov/show/NCT04729595,NA
NCT04730934,ClinicalTrials.gov,2021-01-28,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Effects of the COVID-19 Pandemic on Fibromyalgia Patients,1360,https://clinicaltrials.gov/show/NCT04730934,NA
NCT04733170,ClinicalTrials.gov,2021-01-22,2021-02-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,600,https://clinicaltrials.gov/show/NCT04733170,NA
NCT04747158,ClinicalTrials.gov,2021-01-27,2020-08-10,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Paraguay,COVID-19 Convalescent Plasma Therapy,350,https://clinicaltrials.gov/show/NCT04747158,NA
NCT04757857,ClinicalTrials.gov,2021-02-08,2020-09-29,TRUE,Recruiting,Phase 4,Interventional,Brazil,COVID-19 Antithrombotic Rivaroxaban Evaluation,1000,https://clinicaltrials.gov/show/NCT04757857,NA
NCT04760132,ClinicalTrials.gov,2021-02-08,2021-02-08,FALSE,Recruiting,Phase 4,Interventional,Denmark,National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE),10000,https://clinicaltrials.gov/show/NCT04760132,NA
NCT04762693,ClinicalTrials.gov,2021-02-16,2020-11-11,TRUE,Recruiting,Not Applicable,Observational,Spain,Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks,300,https://clinicaltrials.gov/show/NCT04762693,NA
NCT04766788,ClinicalTrials.gov,2021-02-22,2020-09-03,TRUE,Not Recruiting,Not Applicable,Observational,United States,Studying Students at Risk for COVID-19,2494,https://clinicaltrials.gov/show/NCT04766788,NA
NCT04768153,ClinicalTrials.gov,2021-02-09,2020-06-29,TRUE,Recruiting,Not Applicable,Observational,Martinique,Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies,700,https://clinicaltrials.gov/show/NCT04768153,NA
NCT04768179,ClinicalTrials.gov,2021-02-14,2021-02-19,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients,490,https://clinicaltrials.gov/show/NCT04768179,NA
NCT04768244,ClinicalTrials.gov,2021-02-10,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Spain,Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health,100,https://clinicaltrials.gov/show/NCT04768244,NA
NCT04768257,ClinicalTrials.gov,2021-02-21,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Physical Activity Post COVID-19,195,https://clinicaltrials.gov/show/NCT04768257,NA
NCT04768413,ClinicalTrials.gov,2020-11-27,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Colombia,Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis,200,https://clinicaltrials.gov/show/NCT04768413,NA
NCT04769154,ClinicalTrials.gov,2021-02-23,2021-02-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04769154,NA
NCT04769245,ClinicalTrials.gov,2021-02-15,2021-02-18,FALSE,Recruiting,Not Applicable,Observational,Turkey,The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04769245,NA
NCT04769258,ClinicalTrials.gov,2021-02-04,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD),1380,https://clinicaltrials.gov/show/NCT04769258,NA
NCT04769284,ClinicalTrials.gov,2021-02-23,2021-02-12,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Psychological State of Students of Health Sciences During COVID-19,332,https://clinicaltrials.gov/show/NCT04769284,NA
NCT04769297,ClinicalTrials.gov,2021-02-22,2020-04-15,TRUE,Not Recruiting,Phase 4,Interventional,United States,"Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic",30,https://clinicaltrials.gov/show/NCT04769297,NA
NCT04769349,ClinicalTrials.gov,2021-02-09,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,United States,Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness,800,https://clinicaltrials.gov/show/NCT04769349,NA
NCT04769700,ClinicalTrials.gov,2021-02-02,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,"Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19",250,https://clinicaltrials.gov/show/NCT04769700,NA
NCT04769999,ClinicalTrials.gov,2020-07-13,2020-06-04,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Computer Assisted Lessening of Intrusive Memories in the Emergency Department,14,https://clinicaltrials.gov/show/NCT04769999,NA
NCT04770649,ClinicalTrials.gov,2021-02-22,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,United States,Vaccine Observation to Include All Communities for Equitable Science,10000,https://clinicaltrials.gov/show/NCT04770649,NA
NCT04770740,ClinicalTrials.gov,2021-02-24,2021-02-22,TRUE,Recruiting,Phase 2,Interventional,Netherlands,Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19,40,https://clinicaltrials.gov/show/NCT04770740,NA
NCT04771052,ClinicalTrials.gov,2021-02-23,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Canada,Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly,128,https://clinicaltrials.gov/show/NCT04771052,NA
NCT04771117,ClinicalTrials.gov,2021-02-03,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Defiances to Face COVID-19 Pandemic in Mexico,4004,https://clinicaltrials.gov/show/NCT04771117,NA
NCT04771585,ClinicalTrials.gov,2021-01-26,2021-03-15,FALSE,Recruiting,Not Applicable,Interventional,Germany,Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19,30,https://clinicaltrials.gov/show/NCT04771585,NA
NCT04771598,ClinicalTrials.gov,2021-02-21,2021-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Breathing Exercise After COVID-19 Pneumonia,52,https://clinicaltrials.gov/show/NCT04771598,NA
NCT04771624,ClinicalTrials.gov,2021-02-22,2020-10-30,TRUE,Recruiting,Not Applicable,Observational,Turkey,Assessment of Executive Functions After Covid-19,100,https://clinicaltrials.gov/show/NCT04771624,NA
NCT04772586,ClinicalTrials.gov,2021-02-23,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19,120,https://clinicaltrials.gov/show/NCT04772586,NA
NCT04772703,ClinicalTrials.gov,2021-02-25,2020-11-23,TRUE,Recruiting,Not Applicable,Observational,Czech Republic,DNA Damage in Critically Ill COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04772703,NA
NCT04772833,ClinicalTrials.gov,2021-02-24,2020-06-05,TRUE,Recruiting,Not Applicable,Observational,Spain,"Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19",50,https://clinicaltrials.gov/show/NCT04772833,NA
NCT04773756,ClinicalTrials.gov,2021-02-22,2020-11-01,TRUE,Not Recruiting,Phase 4,Interventional,Egypt,Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt,54,https://clinicaltrials.gov/show/NCT04773756,NA
NCT04775017,ClinicalTrials.gov,2021-01-21,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Germany,Delirium in Covid-19: Germany-wide Covid-19 Intensive Register,1000,https://clinicaltrials.gov/show/NCT04775017,NA
NCT04775056,ClinicalTrials.gov,2021-02-26,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,Hong Kong,A Study to Evaluate Vaccines Against COVID-19 in the Real World,30000,https://clinicaltrials.gov/show/NCT04775056,NA
NCT04775563,ClinicalTrials.gov,2021-02-24,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients,740,https://clinicaltrials.gov/show/NCT04775563,NA
NCT04775784,ClinicalTrials.gov,2021-02-25,2020-12-17,TRUE,Recruiting,Not Applicable,Observational,Italy,Determination of COVID-19 Related Virus in Central Nervous System,300,https://clinicaltrials.gov/show/NCT04775784,NA
NCT04776941,ClinicalTrials.gov,2021-02-09,2020-08-07,TRUE,Recruiting,Not Applicable,Interventional,United States,Expressive Writing for the Management of Stress in Cancer Survivors,120,https://clinicaltrials.gov/show/NCT04776941,NA
NCT04778033,ClinicalTrials.gov,2021-02-08,2021-02-09,FALSE,Recruiting,Not Applicable,Observational,Israel,Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine,75,https://clinicaltrials.gov/show/NCT04778033,NA
NCT04779138,ClinicalTrials.gov,2021-02-27,2021-09-11,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Increasing Vaccine Uptake in Underresourced Public Housing Areas,600,https://clinicaltrials.gov/show/NCT04779138,NA
ISRCTN15615992,ISRCTN,2021-02-23,2021-01-05,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Neuropsychological evaluation and rehabilitation in multiple sclerosis â€“ qualitative case study,35,http://isrctn.com/ISRCTN15615992,NA
ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,FALSE,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,10300,http://isrctn.com/ISRCTN89951424,NA
ISRCTN87329095,ISRCTN,2019-02-25,2021-01-03,FALSE,Recruiting,Phase 3,Interventional,United Kingdom,Morphine and BrEathLessness trial (MABEL),158,http://isrctn.com/ISRCTN87329095,NA
ChiCTR2000041375,ChiCTR,2020-12-24,2020-05-07,TRUE,Recruiting,Not Applicable,Interventional,China,Study on the safety and efficacy of donor-specific transfusions in deceased-donor liver transplantation during COVID-19 outbreaks,56,http://www.chictr.org.cn/showproj.aspx?proj=62474,NA
EUCTR2020-001366-11,EudraCT,2020-03-26,2020-03-27,FALSE,Not Recruiting,Phase 4,Interventional,"Ireland, Portugal, Slovakia, Italy, Spain, Latvia, Lithuania, Romania",An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,100000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001366-11,ES
EUCTR2020-001608-40,EudraCT,2020-04-14,2020-07-15,FALSE,Not Recruiting,Phase 3,Interventional,"China, Germany","A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients with COVID-19-Moderate Typ",256,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001608-40,DE
EUCTR2021-000166-15,EudraCT,2021-01-25,2021-03-03,FALSE,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ivermectin in asymptomatic and mild severity COVID-19 patients",70,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000166-15,HU
EUCTR2020-005539-62,EudraCT,2021-01-25,2021-04-03,FALSE,Authorised,Phase 2/Phase 3,Interventional,Hungary,BGP-15 effect on the hospitalization rate of COVID-19 patients,660,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005539-62,HU
EUCTR2021-000516-37,EudraCT,2021-02-04,2021-04-03,FALSE,Authorised,Phase 1/Phase 2,Interventional,Hungary,The efficacy and the safety of TS-020 in acute viral infection,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000516-37,HU
EUCTR2020-005915-39,EudraCT,2021-03-01,2021-02-19,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Chile, Argentina, South Africa, Indonesia, Belgium, Italy, Brazil, Poland, France, Germany, Malaysia, Czech Republic",A Clinical Study with GRAd-COV2 Vaccine for the Prevention of COVID-19 in Adults,10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005915-39,IT
EUCTR2021-001072-41,EudraCT,2021-02-27,2021-02-03,TRUE,Authorised,Phase 4,Interventional,Netherlands,COBRA-KAI study: COVID-19 vaccination in patients with a hematological disease,850,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001072-41,NL
EUCTR2020-005315-44,EudraCT,2021-03-02,2021-01-03,TRUE,Authorised,Phase 3,Interventional,"Hungary, Russian Federation, United Kingdom, United States, Mexico, Spain, Italy, Japan, Germany","Phase 3, Double-blind, Placebo-controlled Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults",1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005315-44,HU
EUCTR2020-001936-86,EudraCT,2020-08-20,2020-10-19,FALSE,Authorised,Phase 2,Interventional,Germany,Clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001936-86,DE
NCT02788903,ClinicalTrials.gov,2016-05-27,2016-03-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,A Patient-Centered PaTH to Addressing Diabetes,2000000,https://clinicaltrials.gov/show/NCT02788903,NA
NCT04279899,ClinicalTrials.gov,2020-02-18,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,100,https://clinicaltrials.gov/show/NCT04279899,NA
NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),402,https://clinicaltrials.gov/show/NCT04317092,NA
NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,FALSE,Not Recruiting,Phase 4,Interventional,"Italy, Belgium",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),80,https://clinicaltrials.gov/show/NCT04326920,NA
NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-03,FALSE,Not Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,342,https://clinicaltrials.gov/show/NCT04330638,NA
NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",32,https://clinicaltrials.gov/show/NCT04331795,NA
NCT04334980,ClinicalTrials.gov,2020-03-31,2020-11-02,FALSE,Not Recruiting,Phase 1,Interventional,"Canada, Australia, United States","Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",24,https://clinicaltrials.gov/show/NCT04334980,NA
NCT04340232,ClinicalTrials.gov,2020-04-03,2021-03-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,0,https://clinicaltrials.gov/show/NCT04340232,NA
NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,416,https://clinicaltrials.gov/show/NCT04343729,NA
NCT04344977,ClinicalTrials.gov,2020-04-13,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,"United States Minor Outlying Islands, United States",Collection of Anti-SARS-CoV-2 Immune Plasma,151,https://clinicaltrials.gov/show/NCT04344977,NA
NCT04345601,ClinicalTrials.gov,2020-04-10,2021-02-12,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),30,https://clinicaltrials.gov/show/NCT04345601,NA
NCT04348071,ClinicalTrials.gov,2020-04-13,2021-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,0,https://clinicaltrials.gov/show/NCT04348071,NA
NCT04351152,ClinicalTrials.gov,2020-04-15,2020-05-05,FALSE,Not Recruiting,Phase 3,Interventional,"United States, Brazil",Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,520,https://clinicaltrials.gov/show/NCT04351152,NA
NCT04355494,ClinicalTrials.gov,2020-04-17,2021-04-01,FALSE,Not Recruiting,Not Applicable,Expanded Access,"France, United States",SOLIRISÂ® (Eculizumab) Treatment of Participants With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04355494,NA
NCT04358211,ClinicalTrials.gov,2020-04-17,2020-04-20,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04358211,NA
NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,TRUE,Not Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,50,https://clinicaltrials.gov/show/NCT04359901,NA
NCT04363463,ClinicalTrials.gov,2020-04-22,2020-08-28,FALSE,Recruiting,Not Applicable,Interventional,"France, Monaco",Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,400,https://clinicaltrials.gov/show/NCT04363463,NA
NCT04371848,ClinicalTrials.gov,2020-04-22,2020-04-16,TRUE,Not Recruiting,Not Applicable,Observational,Canada,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuÃ©bec Sub-study,2465,https://clinicaltrials.gov/show/NCT04371848,NA
NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,TRUE,Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,200,https://clinicaltrials.gov/show/NCT04372680,NA
NCT04374279,ClinicalTrials.gov,2020-05-04,2021-04-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,0,https://clinicaltrials.gov/show/NCT04374279,NA
NCT04377165,ClinicalTrials.gov,2020-05-04,2020-05-06,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities,34,https://clinicaltrials.gov/show/NCT04377165,NA
NCT04379089,ClinicalTrials.gov,2020-04-30,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,United States,Neurologic Manifestations of COVID 19 in Children,1000,https://clinicaltrials.gov/show/NCT04379089,NA
NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,FALSE,Not Recruiting,Phase 2,Interventional,"India, Israel","A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",50,https://clinicaltrials.gov/show/NCT04382040,NA
NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,FALSE,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,60,https://clinicaltrials.gov/show/NCT04382391,NA
NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-22,FALSE,Not Recruiting,Phase 2,Interventional,Belgium,ZilucoplanÂ® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,81,https://clinicaltrials.gov/show/NCT04382755,NA
NCT04387760,ClinicalTrials.gov,2020-05-09,2020-08-11,FALSE,Recruiting,Phase 2,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine vs Control in COVID -19,150,https://clinicaltrials.gov/show/NCT04387760,NA
NCT04389359,ClinicalTrials.gov,2020-05-12,2020-09-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,0,https://clinicaltrials.gov/show/NCT04389359,NA
NCT04390503,ClinicalTrials.gov,2020-05-14,2021-03-01,FALSE,Recruiting,Phase 2,Interventional,"United States, Brazil",Convalescent Plasma for Early Treatment of COVID-19,150,https://clinicaltrials.gov/show/NCT04390503,NA
NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-06,FALSE,Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,198,https://clinicaltrials.gov/show/NCT04397718,NA
NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,TRUE,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,160,https://clinicaltrials.gov/show/NCT04402918,NA
NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin as a Novel Therapy in COVID-19 Treatment,160,https://clinicaltrials.gov/show/NCT04403555,NA
NCT04406545,ClinicalTrials.gov,2020-05-23,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,Brazil,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,25,https://clinicaltrials.gov/show/NCT04406545,NA
NCT04407546,ClinicalTrials.gov,2020-05-27,2020-05-27,FALSE,Recruiting,Not Applicable,Observational,United States,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,300,https://clinicaltrials.gov/show/NCT04407546,NA
NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-02,FALSE,Not Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preventing Smoking Relapse,108,https://clinicaltrials.gov/show/NCT04409496,NA
NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,83,https://clinicaltrials.gov/show/NCT04412057,NA
NCT04416919,ClinicalTrials.gov,2020-05-13,2020-05-20,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,20,https://clinicaltrials.gov/show/NCT04416919,NA
NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-12,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,52,https://clinicaltrials.gov/show/NCT04417270,NA
NCT04420273,ClinicalTrials.gov,2020-06-03,2020-07-02,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,1000,https://clinicaltrials.gov/show/NCT04420273,NA
NCT04424017,ClinicalTrials.gov,2020-06-08,2020-06-07,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,1546,https://clinicaltrials.gov/show/NCT04424017,NA
NCT04427254,ClinicalTrials.gov,2020-05-26,2020-06-26,FALSE,Recruiting,Not Applicable,Interventional,France,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,500,https://clinicaltrials.gov/show/NCT04427254,NA
NCT04434261,ClinicalTrials.gov,2020-06-15,2020-05-11,TRUE,Recruiting,Not Applicable,Observational,Brazil,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,1500,https://clinicaltrials.gov/show/NCT04434261,NA
NCT04443075,ClinicalTrials.gov,2020-06-03,2020-06-24,FALSE,Not Recruiting,Not Applicable,Observational,China,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,180,https://clinicaltrials.gov/show/NCT04443075,NA
NCT04447469,ClinicalTrials.gov,2020-06-23,2020-07-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Chile, South Africa, Peru, United States, Brazil",Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,588,https://clinicaltrials.gov/show/NCT04447469,NA
NCT04447833,ClinicalTrials.gov,2020-06-20,2020-06-17,TRUE,Not Recruiting,Phase 1,Interventional,Sweden,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,7,https://clinicaltrials.gov/show/NCT04447833,NA
NCT04463823,ClinicalTrials.gov,2020-07-03,2020-07-06,FALSE,Recruiting,Not Applicable,Observational,Norway,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",500,https://clinicaltrials.gov/show/NCT04463823,NA
NCT04464408,ClinicalTrials.gov,2020-06-28,2020-07-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Favipiravir Therapy in Adults With Mild COVID-19,576,https://clinicaltrials.gov/show/NCT04464408,NA
NCT04465604,ClinicalTrials.gov,2020-07-02,2021-02-01,FALSE,Recruiting,Not Applicable,Interventional,Saudi Arabia,Hypertonic Saline for COVID-19 Symptoms,50,https://clinicaltrials.gov/show/NCT04465604,NA
NCT04469491,ClinicalTrials.gov,2020-07-13,2020-09-20,FALSE,Recruiting,Phase 2,Interventional,France,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,146,https://clinicaltrials.gov/show/NCT04469491,NA
NCT04470622,ClinicalTrials.gov,2020-07-13,2020-07-20,FALSE,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),100,https://clinicaltrials.gov/show/NCT04470622,NA
NCT04471766,ClinicalTrials.gov,2020-07-14,2020-07-20,FALSE,Not Recruiting,Not Applicable,Interventional,Guinea-Bissau,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,40000,https://clinicaltrials.gov/show/NCT04471766,NA
NCT04473547,ClinicalTrials.gov,2020-07-14,2020-07-10,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,COVID 19 Preventive Measures Among Mansoura Nursing Students,144,https://clinicaltrials.gov/show/NCT04473547,NA
NCT04486521,ClinicalTrials.gov,2020-07-22,2020-07-22,FALSE,Recruiting,Not Applicable,Observational,Saudi Arabia,Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19,860,https://clinicaltrials.gov/show/NCT04486521,NA
NCT04490200,ClinicalTrials.gov,2020-07-19,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,1000,https://clinicaltrials.gov/show/NCT04490200,NA
NCT04517396,ClinicalTrials.gov,2020-08-17,2020-08-18,FALSE,Recruiting,Phase 2,Interventional,United States,FEnofibRate as a Metabolic INtervention for COVID-19,700,https://clinicaltrials.gov/show/NCT04517396,NA
NCT04522310,ClinicalTrials.gov,2020-07-17,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,France,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,183,https://clinicaltrials.gov/show/NCT04522310,NA
NCT04530435,ClinicalTrials.gov,2020-08-25,2020-10-06,FALSE,Not Recruiting,Not Applicable,Interventional,Denmark,PEP Flute-selfcare in COVID-19,400,https://clinicaltrials.gov/show/NCT04530435,NA
NCT04531254,ClinicalTrials.gov,2020-08-24,2020-08-10,TRUE,Not Recruiting,Not Applicable,Observational,Canada,Back to School COVID-19 Simulation Study,190,https://clinicaltrials.gov/show/NCT04531254,NA
NCT04542993,ClinicalTrials.gov,2020-09-08,2020-09-08,FALSE,Not Recruiting,Phase 2,Interventional,United States,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,60,https://clinicaltrials.gov/show/NCT04542993,NA
NCT04547127,ClinicalTrials.gov,2020-09-10,2020-04-29,TRUE,Not Recruiting,Phase 2,Interventional,Spain,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),200,https://clinicaltrials.gov/show/NCT04547127,NA
NCT04551898,ClinicalTrials.gov,2020-09-10,2020-12-02,FALSE,Not Recruiting,Phase 2,Interventional,"Australia, South Africa, United States, Mexico, Brazil",Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),181,https://clinicaltrials.gov/show/NCT04551898,NA
NCT04555096,ClinicalTrials.gov,2020-09-16,2020-09-09,TRUE,Recruiting,Phase 2,Interventional,United States,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,50,https://clinicaltrials.gov/show/NCT04555096,NA
NCT04559542,ClinicalTrials.gov,2020-08-25,2020-09-10,FALSE,Recruiting,Not Applicable,Observational,Norway,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",200,https://clinicaltrials.gov/show/NCT04559542,NA
NCT04569786,ClinicalTrials.gov,2020-09-24,2020-10-29,FALSE,Not Recruiting,Phase 1,Interventional,United States,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),232,https://clinicaltrials.gov/show/NCT04569786,NA
NCT04576351,ClinicalTrials.gov,2020-09-10,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Norway,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,150,https://clinicaltrials.gov/show/NCT04576351,NA
NCT04590430,ClinicalTrials.gov,2020-10-08,2020-10-20,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",24,https://clinicaltrials.gov/show/NCT04590430,NA
NCT04596579,ClinicalTrials.gov,2020-10-16,2020-10-09,TRUE,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida,1200,https://clinicaltrials.gov/show/NCT04596579,NA
NCT04604704,ClinicalTrials.gov,2020-10-26,2021-01-28,FALSE,Recruiting,Phase 2,Interventional,United States,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,60,https://clinicaltrials.gov/show/NCT04604704,NA
NCT04617262,ClinicalTrials.gov,2020-11-02,2021-01-05,FALSE,Recruiting,Not Applicable,Interventional,United States,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,100,https://clinicaltrials.gov/show/NCT04617262,NA
NCT04623047,ClinicalTrials.gov,2020-11-09,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Using Smart Watches to Detect and Monitor COVID-19,100000,https://clinicaltrials.gov/show/NCT04623047,NA
NCT04632615,ClinicalTrials.gov,2020-11-12,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,84,https://clinicaltrials.gov/show/NCT04632615,NA
NCT04649424,ClinicalTrials.gov,2020-11-27,2020-12-22,FALSE,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Nasal Swab Trial,72,https://clinicaltrials.gov/show/NCT04649424,NA
NCT04659759,ClinicalTrials.gov,2020-12-07,2020-11-17,TRUE,Recruiting,Not Applicable,Observational,United States,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",300,https://clinicaltrials.gov/show/NCT04659759,NA
NCT04659772,ClinicalTrials.gov,2020-12-07,2020-12-03,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,1,https://clinicaltrials.gov/show/NCT04659772,NA
NCT04690413,ClinicalTrials.gov,2020-08-31,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,NOWDx Test for the Detection of Antibodies to COVID-19,129,https://clinicaltrials.gov/show/NCT04690413,NA
NCT04695704,ClinicalTrials.gov,2021-01-04,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:,284,https://clinicaltrials.gov/show/NCT04695704,NA
NCT04706403,ClinicalTrials.gov,2021-01-05,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Views on COVID-19 and Vaccination,3000,https://clinicaltrials.gov/show/NCT04706403,NA
NCT04716556,ClinicalTrials.gov,2021-01-14,2020-07-16,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,474,https://clinicaltrials.gov/show/NCT04716556,NA
NCT04717089,ClinicalTrials.gov,2021-01-19,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,Hong Kong,Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis,300,https://clinicaltrials.gov/show/NCT04717089,NA
NCT04730401,ClinicalTrials.gov,2021-01-26,2021-01-27,FALSE,Recruiting,Phase 2,Interventional,Finland,Convalescent Plasma in the Treatment of Covid-19,390,https://clinicaltrials.gov/show/NCT04730401,NA
NCT04747574,ClinicalTrials.gov,2021-01-26,2020-09-25,TRUE,Recruiting,Phase 1,Interventional,Israel,Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection,35,https://clinicaltrials.gov/show/NCT04747574,NA
NCT04752085,ClinicalTrials.gov,2021-02-09,2020-11-01,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Prognosis and Course of COVID-19 Infection in Hospitalised Patients,345,https://clinicaltrials.gov/show/NCT04752085,NA
NCT04756466,ClinicalTrials.gov,2021-01-21,2021-01-01,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly,201,https://clinicaltrials.gov/show/NCT04756466,NA
NCT04760990,ClinicalTrials.gov,2021-02-17,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Switzerland,A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.,1400,https://clinicaltrials.gov/show/NCT04760990,NA
NCT04761913,ClinicalTrials.gov,2020-12-11,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04761913,NA
NCT04771559,ClinicalTrials.gov,2021-02-17,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,1000,https://clinicaltrials.gov/show/NCT04771559,NA
NCT04775407,ClinicalTrials.gov,2021-02-22,2021-01-18,TRUE,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark,1400,https://clinicaltrials.gov/show/NCT04775407,NA
NCT04775966,ClinicalTrials.gov,2021-02-26,2021-01-15,TRUE,Not Recruiting,Not Applicable,Observational,France,CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic,8477,https://clinicaltrials.gov/show/NCT04775966,NA
NCT04776005,ClinicalTrials.gov,2021-02-26,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies,500,https://clinicaltrials.gov/show/NCT04776005,NA
NCT04777981,ClinicalTrials.gov,2021-02-25,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC,60,https://clinicaltrials.gov/show/NCT04777981,NA
NCT04778020,ClinicalTrials.gov,2021-02-20,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,International COVID-19 Clinical Evaluation Registry -2 (HOPE-2),10000,https://clinicaltrials.gov/show/NCT04778020,NA
NCT04778059,ClinicalTrials.gov,2021-02-26,2021-04-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19,184,https://clinicaltrials.gov/show/NCT04778059,NA
NCT04779021,ClinicalTrials.gov,2021-02-23,2020-02-15,TRUE,Recruiting,Not Applicable,Observational,France,Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department,1300,https://clinicaltrials.gov/show/NCT04779021,NA
NCT04779359,ClinicalTrials.gov,2021-03-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease,1,https://clinicaltrials.gov/show/NCT04779359,NA
NCT04779424,ClinicalTrials.gov,2021-02-22,2020-11-15,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19),5000,https://clinicaltrials.gov/show/NCT04779424,NA
NCT04779749,ClinicalTrials.gov,2021-03-01,2020-12-08,TRUE,Recruiting,Not Applicable,Observational,"France, Italy, Belgium",Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19,10000,https://clinicaltrials.gov/show/NCT04779749,NA
NCT04779879,ClinicalTrials.gov,2021-03-01,2021-02-18,TRUE,Recruiting,Phase 2,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19",40,https://clinicaltrials.gov/show/NCT04779879,NA
NCT04779996,ClinicalTrials.gov,2021-03-02,2021-02-16,TRUE,Recruiting,Not Applicable,Observational,Puerto Rico,Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment,250,https://clinicaltrials.gov/show/NCT04779996,NA
NCT04780035,ClinicalTrials.gov,2021-02-25,2020-11-18,TRUE,Not Recruiting,Phase 3,Interventional,Russian Federation,"Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19",3000,https://clinicaltrials.gov/show/NCT04780035,NA
NCT04780126,ClinicalTrials.gov,2021-02-19,2021-02-26,FALSE,Recruiting,Not Applicable,Observational,Spain,Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19,64,https://clinicaltrials.gov/show/NCT04780126,NA
NCT04780295,ClinicalTrials.gov,2021-02-09,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,"Denmark, Ireland, Italy, Brazil, Mexico, Spain, Turkey, Germany",COvid-19 REgistry on THROMBOSIS Complications,5000,https://clinicaltrials.gov/show/NCT04780295,NA
NCT04780334,ClinicalTrials.gov,2021-03-02,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,200,https://clinicaltrials.gov/show/NCT04780334,NA
NCT04780581,ClinicalTrials.gov,2021-02-15,2021-02-01,TRUE,Recruiting,Phase 4,Interventional,Spain,Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients,290,https://clinicaltrials.gov/show/NCT04780581,NA
NCT04780594,ClinicalTrials.gov,2021-03-01,2020-02-13,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital,2530,https://clinicaltrials.gov/show/NCT04780594,NA
NCT04780659,ClinicalTrials.gov,2021-02-19,2021-02-23,FALSE,Recruiting,Phase 4,Interventional,Sweden,COVID-19 Vaccination of Immunodeficient Persons (COVAXID),540,https://clinicaltrials.gov/show/NCT04780659,NA
NCT04780685,ClinicalTrials.gov,2021-03-01,2021-03-20,FALSE,Recruiting,Phase 2,Interventional,United States,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,40,https://clinicaltrials.gov/show/NCT04780685,NA
NCT04781400,ClinicalTrials.gov,2021-02-22,2021-02-08,TRUE,Recruiting,Not Applicable,Interventional,South Africa,"Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young People",600,https://clinicaltrials.gov/show/NCT04781400,NA
NCT04782336,ClinicalTrials.gov,2021-02-17,2020-12-12,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test",3500,https://clinicaltrials.gov/show/NCT04782336,NA
NCT04782427,ClinicalTrials.gov,2021-03-02,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Canada,COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave,1200,https://clinicaltrials.gov/show/NCT04782427,NA
NCT04784403,ClinicalTrials.gov,2020-12-21,2020-12-14,TRUE,Not Recruiting,Not Applicable,Observational,Spain,SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY,3356,https://clinicaltrials.gov/show/NCT04784403,NA
NCT04784468,ClinicalTrials.gov,2021-03-03,2020-11-19,TRUE,Recruiting,Not Applicable,Observational,Austria,DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients,135,https://clinicaltrials.gov/show/NCT04784468,NA
NCT04784546,ClinicalTrials.gov,2021-03-01,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection",60,https://clinicaltrials.gov/show/NCT04784546,NA
NCT04784624,ClinicalTrials.gov,2021-02-08,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),100,https://clinicaltrials.gov/show/NCT04784624,NA
NCT04785781,ClinicalTrials.gov,2021-02-24,2021-02-01,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Effects of Face Masks on Cardiopulmonary Capacity in Healthy Individuals,16,https://clinicaltrials.gov/show/NCT04785781,NA
NCT04785807,ClinicalTrials.gov,2021-02-23,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic,140,https://clinicaltrials.gov/show/NCT04785807,NA
NCT04785898,ClinicalTrials.gov,2021-03-01,2020-11-09,TRUE,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance of the ID Nowâ„¢ COVID-19 Screening Test Versus Simplexaâ„¢ COVID-19 Direct Assay,1000,https://clinicaltrials.gov/show/NCT04785898,NA
NCT04786041,ClinicalTrials.gov,2021-03-05,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Israel,the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis,200,https://clinicaltrials.gov/show/NCT04786041,NA
NCT04786080,ClinicalTrials.gov,2021-02-24,2021-03-15,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Supporting Parents & Kids Through Lockdown Experiences (SPARKLE).,616,https://clinicaltrials.gov/show/NCT04786080,NA
NCT04786353,ClinicalTrials.gov,2021-03-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Long COVID Kids DK - Investigating Long-term Covid-19,300000,https://clinicaltrials.gov/show/NCT04786353,NA
NCT04786483,ClinicalTrials.gov,2021-02-24,2020-11-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Laughter Therapy on Students in the COVID-19 Pandemic,80,https://clinicaltrials.gov/show/NCT04786483,NA
NCT04786808,ClinicalTrials.gov,2021-03-05,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Risk Factors for COVID-19 Mortality,200,https://clinicaltrials.gov/show/NCT04786808,NA
NCT04787510,ClinicalTrials.gov,2021-03-04,2020-12-23,TRUE,Recruiting,Not Applicable,Observational,Greece,COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection,50,https://clinicaltrials.gov/show/NCT04787510,NA
NCT04787536,ClinicalTrials.gov,2021-03-03,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,Canada,Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE),300,https://clinicaltrials.gov/show/NCT04787536,NA
NCT04787588,ClinicalTrials.gov,2021-03-04,2021-02-14,TRUE,Recruiting,Not Applicable,Observational,Canada,COVID-19 Infection and Epithelial Cell Markers,235,https://clinicaltrials.gov/show/NCT04787588,NA
NCT04787614,ClinicalTrials.gov,2021-01-28,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,United States,2019 NSECE COVID-19 Follow-up,15200,https://clinicaltrials.gov/show/NCT04787614,NA
NCT04788355,ClinicalTrials.gov,2020-09-05,2020-07-01,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Prevention of Complications (SARS-CoV-2): Clinical Study,176,https://clinicaltrials.gov/show/NCT04788355,NA
NCT04788433,ClinicalTrials.gov,2021-03-07,2021-03-04,TRUE,Recruiting,Not Applicable,Observational,Italy,Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE,615,https://clinicaltrials.gov/show/NCT04788433,NA
ACTRN12620000447954,ANZCTR,2020-04-06,NA,FALSE,No Status Given,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,150,https://anzctr.org.au/ACTRN12620000447954.aspx,NA
ACTRN12620000473965,ANZCTR,2020-04-15,2020-08-18,FALSE,Not Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx,NA
ISRCTN14376817,ISRCTN,2021-01-06,2021-03-03,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,A pilot study of lung ultrasound as point of care evaluation in post-COVID-19 patients,20,http://isrctn.com/ISRCTN14376817,NA
ISRCTN10175886,ISRCTN,2020-07-14,2020-03-17,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Coronavirus infection in immunosuppressed children,400,http://isrctn.com/ISRCTN10175886,NA
ISRCTN47591507,ISRCTN,2020-02-20,2018-10-22,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Treating auditory impairment and cognition pilot trial,76,http://isrctn.com/ISRCTN47591507,NA
ChiCTR2000041578,ChiCTR,2020-12-30,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,China,Follow up study for recovered patients of novel coronavirus pneumonia (COVID-19),100,http://www.chictr.org.cn/showproj.aspx?proj=119492,NA
ChiCTR2000041481,ChiCTR,2020-12-27,2020-12-28,FALSE,Recruiting,Not Applicable,Observational,China,Study on the Immune Cell function and Intestinal Microecological Changes After novel coronavirus pneumonia (COVID-19) Vaccine Vaccination,60,http://www.chictr.org.cn/showproj.aspx?proj=66226,NA
ChiCTR2000041425,ChiCTR,2020-12-26,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,China,Changes in the pathogen profile of community-acquired pneumonia in children before and after COVID-19,500,http://www.chictr.org.cn/showproj.aspx?proj=65865,NA
ChiCTR2000040571,ChiCTR,2020-12-02,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) treated with different antiviral regimens: a medical records based study for analysis of therapeutic effect and length of stay of hospitalization,180,http://www.chictr.org.cn/showproj.aspx?proj=65024,NA
EUCTR2020-001224-33,EudraCT,2020-03-24,2020-03-25,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Systematic study of the medicine hydroxychloroquine against placebo for the treatment of adult patients with acute coronavirus disease 2019 â€“ COVID-19,220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001224-33,DE
EUCTR2020-001420-34,EudraCT,2020-04-01,2020-04-14,FALSE,Not Recruiting,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,DK
EUCTR2020-003904-15,EudraCT,2020-08-11,2020-08-27,FALSE,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for seniors to prevent infections during the COVID-19 pandemic.,1900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003904-15,DK
EUCTR2021-001054-57,EudraCT,2021-03-08,2021-08-03,FALSE,Authorised,"Human pharmacology (Phase I): yes
Therapeutic exploratory (Phase II): no
Therapeutic confirmatory - (Phase III): no
Therapeutic use (Phase IV): yes
",Interventional,Netherlands,SARS-CoV-2 vaccination study in people living with HIV,1650,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001054-57,NL
EUCTR2020-002130-33,EudraCT,2020-05-06,2020-05-26,FALSE,Authorised,Phase 2,Interventional,Belgium,ZilucoplanÂ® in patients with acute hypoxic respiratory failure due to COVID-19,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33,BE
EUCTR2021-001279-18,EudraCT,2021-03-09,NA,FALSE,Not Available,Phase 4,Interventional,United Kingdom,Embedded RCT Short Title: Smartphone app-based mental health and wellbeing intervention for healthcare workers during Covid-19.,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001279-18,Outside-EU/EEA
EUCTR2020-005979-12,EudraCT,2021-02-08,2021-03-03,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and safety of XAV-19 for the treatment of moderate to severe COVID-19,722,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005979-12,GR
NCT03183570,ClinicalTrials.gov,2017-05-08,2017-11-08,FALSE,Recruiting,Phase 1,Interventional,United States,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",30,https://clinicaltrials.gov/show/NCT03183570,NA
NCT04303299,ClinicalTrials.gov,2020-02-24,2020-08-19,FALSE,Recruiting,Phase 3,Interventional,Thailand,Fight COVID-19 Trial,320,https://clinicaltrials.gov/show/NCT04303299,NA
NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,FALSE,Not Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,24,https://clinicaltrials.gov/show/NCT04312243,NA
NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,34,https://clinicaltrials.gov/show/NCT04324528,NA
NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,FALSE,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,479,https://clinicaltrials.gov/show/NCT04332991,NA
NCT04336254,ClinicalTrials.gov,2020-03-28,2020-05-06,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04336254,NA
NCT04336761,ClinicalTrials.gov,2020-04-03,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,901,https://clinicaltrials.gov/show/NCT04336761,NA
NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Remdesivir Efficacy in Coronavirus Disease,120,https://clinicaltrials.gov/show/NCT04345419,NA
NCT04345510,ClinicalTrials.gov,2020-04-12,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,Germany,Testing for COVID-19 Infection in Asymptomatic Persons,500,https://clinicaltrials.gov/show/NCT04345510,NA
NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,FALSE,Not Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,125,https://clinicaltrials.gov/show/NCT04346667,NA
NCT04347408,ClinicalTrials.gov,2020-04-07,2020-05-06,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Seroprevalence of SARS-Cov-2 Antibodies in Children,1000,https://clinicaltrials.gov/show/NCT04347408,NA
NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,1000,https://clinicaltrials.gov/show/NCT04348305,NA
NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,FALSE,Not Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,137,https://clinicaltrials.gov/show/NCT04351191,NA
NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment,300,https://clinicaltrials.gov/show/NCT04351347,NA
NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,0,https://clinicaltrials.gov/show/NCT04351490,NA
NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,TRUE,Not Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,21,https://clinicaltrials.gov/show/NCT04353037,NA
NCT04358406,ClinicalTrials.gov,2020-04-16,2020-07-30,FALSE,Not Recruiting,Phase 2,Interventional,"Spain, Romania",Rhu-pGSN for Severe Covid-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04358406,NA
NCT04361942,ClinicalTrials.gov,2020-04-17,2020-05-01,FALSE,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),24,https://clinicaltrials.gov/show/NCT04361942,NA
NCT04365166,ClinicalTrials.gov,2020-04-19,2020-04-21,FALSE,Recruiting,Not Applicable,Observational,France,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),100,https://clinicaltrials.gov/show/NCT04365166,NA
NCT04365335,ClinicalTrials.gov,2020-04-24,2020-04-25,FALSE,Not Recruiting,Not Applicable,Observational,France,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04365335,NA
NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,0,https://clinicaltrials.gov/show/NCT04372082,NA
NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,75,https://clinicaltrials.gov/show/NCT04373200,NA
NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,84,https://clinicaltrials.gov/show/NCT04374461,NA
NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,FALSE,Not Recruiting,Phase 3,Interventional,"Russian Federation, United States",Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),211,https://clinicaltrials.gov/show/NCT04377620,NA
NCT04382378,ClinicalTrials.gov,2020-05-04,2021-02-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Effects of NMES in Critically Ill Patients,120,https://clinicaltrials.gov/show/NCT04382378,NA
NCT04382417,ClinicalTrials.gov,2020-05-04,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,57,https://clinicaltrials.gov/show/NCT04382417,NA
NCT04385771,ClinicalTrials.gov,2020-04-19,2020-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,80,https://clinicaltrials.gov/show/NCT04385771,NA
NCT04387240,ClinicalTrials.gov,2020-05-12,2022-01-01,FALSE,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,22,https://clinicaltrials.gov/show/NCT04387240,NA
NCT04387838,ClinicalTrials.gov,2020-05-13,2020-05-14,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,845,https://clinicaltrials.gov/show/NCT04387838,NA
NCT04388618,ClinicalTrials.gov,2020-05-13,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,Saudi Arabia,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,250,https://clinicaltrials.gov/show/NCT04388618,NA
NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,FALSE,Not Recruiting,Phase 3,Interventional,"Russian Federation, Ukraine, United States",Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,208,https://clinicaltrials.gov/show/NCT04400058,NA
NCT04404270,ClinicalTrials.gov,2020-05-25,2020-05-26,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),1146,https://clinicaltrials.gov/show/NCT04404270,NA
NCT04407273,ClinicalTrials.gov,2020-05-27,2020-05-14,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Statin Therapy and COVID-19 Infection,2159,https://clinicaltrials.gov/show/NCT04407273,NA
NCT04408001,ClinicalTrials.gov,2020-05-28,2020-06-04,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,499,https://clinicaltrials.gov/show/NCT04408001,NA
NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,FALSE,Not Recruiting,Phase 3,Interventional,"Russian Federation, United States, Brazil, Spain, France",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,649,https://clinicaltrials.gov/show/NCT04409262,NA
NCT04411511,ClinicalTrials.gov,2020-05-20,2020-05-06,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"COVID-19, Obesity and Lifestyle in Children",4000,https://clinicaltrials.gov/show/NCT04411511,NA
NCT04412395,ClinicalTrials.gov,2020-05-15,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,516,https://clinicaltrials.gov/show/NCT04412395,NA
NCT04414618,ClinicalTrials.gov,2020-05-26,2020-07-02,FALSE,Not Recruiting,Phase 2,Interventional,"United States, Israel",A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,42,https://clinicaltrials.gov/show/NCT04414618,NA
NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,80,https://clinicaltrials.gov/show/NCT04420741,NA
NCT04427566,ClinicalTrials.gov,2020-06-05,2020-07-23,FALSE,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,24,https://clinicaltrials.gov/show/NCT04427566,NA
NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-02,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04432324,NA
NCT04432350,ClinicalTrials.gov,2020-06-12,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,United States,Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications,50000,https://clinicaltrials.gov/show/NCT04432350,NA
NCT04439825,ClinicalTrials.gov,2020-06-18,2020-07-20,FALSE,Not Recruiting,Phase 1,Interventional,United States,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,45,https://clinicaltrials.gov/show/NCT04439825,NA
NCT04453371,ClinicalTrials.gov,2020-06-26,2020-10-15,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),0,https://clinicaltrials.gov/show/NCT04453371,NA
NCT04460638,ClinicalTrials.gov,2020-07-06,2020-07-23,FALSE,Recruiting,Not Applicable,Observational,France,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,600,https://clinicaltrials.gov/show/NCT04460638,NA
NCT04466683,ClinicalTrials.gov,2020-06-20,2020-08-28,FALSE,Recruiting,Phase 2,Interventional,"United States, Colombia",Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,100,https://clinicaltrials.gov/show/NCT04466683,NA
NCT04490174,ClinicalTrials.gov,2020-07-28,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,United States,Serological Surveillance for COVID-19 in Central North Carolina,2500,https://clinicaltrials.gov/show/NCT04490174,NA
NCT04494386,ClinicalTrials.gov,2020-07-24,2020-07-23,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United States,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,60,https://clinicaltrials.gov/show/NCT04494386,NA
NCT04498247,ClinicalTrials.gov,2020-08-03,2020-08-27,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Belgium, United States, Austria","A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",263,https://clinicaltrials.gov/show/NCT04498247,NA
NCT04504240,ClinicalTrials.gov,2020-08-06,2020-08-01,TRUE,Not Recruiting,Phase 3,Interventional,Bangladesh,Role of Famotidine in the Clinical Improvement of COVID-19 Patients.,200,https://clinicaltrials.gov/show/NCT04504240,NA
NCT04506268,ClinicalTrials.gov,2020-08-07,2020-09-09,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 SAFE Enrollment,412,https://clinicaltrials.gov/show/NCT04506268,NA
NCT04507230,ClinicalTrials.gov,2020-08-07,2020-08-07,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Associated Coagulopathy in Egypt,106,https://clinicaltrials.gov/show/NCT04507230,NA
NCT04508075,ClinicalTrials.gov,2020-08-07,2020-08-10,FALSE,Not Recruiting,Phase 3,Interventional,Indonesia,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",1620,https://clinicaltrials.gov/show/NCT04508075,NA
NCT04510038,ClinicalTrials.gov,2020-08-10,2020-01-01,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,75,https://clinicaltrials.gov/show/NCT04510038,NA
NCT04513561,ClinicalTrials.gov,2020-08-11,2020-07-21,TRUE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,921,https://clinicaltrials.gov/show/NCT04513561,NA
NCT04514874,ClinicalTrials.gov,2020-08-14,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,479,https://clinicaltrials.gov/show/NCT04514874,NA
NCT04516928,ClinicalTrials.gov,2020-08-14,2020-09-21,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,392,https://clinicaltrials.gov/show/NCT04516928,NA
NCT04517136,ClinicalTrials.gov,2020-08-15,2020-09-14,FALSE,Recruiting,Not Applicable,Observational,France,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,60,https://clinicaltrials.gov/show/NCT04517136,NA
NCT04525820,ClinicalTrials.gov,2020-08-17,2020-12-15,FALSE,Recruiting,Not Applicable,Interventional,Switzerland,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",80,https://clinicaltrials.gov/show/NCT04525820,NA
NCT04539626,ClinicalTrials.gov,2020-09-03,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,Mexico,Estrogen Therapy in Non-severe COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04539626,NA
NCT04545008,ClinicalTrials.gov,2020-09-01,2020-10-20,FALSE,Recruiting,Phase 1,Interventional,United States,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,42,https://clinicaltrials.gov/show/NCT04545008,NA
NCT04548505,ClinicalTrials.gov,2020-09-11,2020-10-05,FALSE,Recruiting,Not Applicable,Observational,France,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,100,https://clinicaltrials.gov/show/NCT04548505,NA
NCT04550390,ClinicalTrials.gov,2020-09-14,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19,329,https://clinicaltrials.gov/show/NCT04550390,NA
NCT04552392,ClinicalTrials.gov,2020-09-15,2020-09-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of Institutional Quarantine,176,https://clinicaltrials.gov/show/NCT04552392,NA
NCT04575038,ClinicalTrials.gov,2020-10-01,2020-11-19,FALSE,Not Recruiting,Phase 2,Interventional,United States,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,115,https://clinicaltrials.gov/show/NCT04575038,NA
NCT04578132,ClinicalTrials.gov,2020-10-06,2020-11-24,FALSE,Recruiting,Not Applicable,Observational,Spain,Description of the Population With Genitourinary Tumors and COVID-19,250,https://clinicaltrials.gov/show/NCT04578132,NA
NCT04581577,ClinicalTrials.gov,2020-09-29,2020-09-11,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,75,https://clinicaltrials.gov/show/NCT04581577,NA
NCT04629989,ClinicalTrials.gov,2020-11-13,2020-11-13,FALSE,Not Recruiting,Not Applicable,Interventional,Belgium,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,27,https://clinicaltrials.gov/show/NCT04629989,NA
NCT04646239,ClinicalTrials.gov,2020-11-20,2020-12-17,FALSE,Recruiting,Not Applicable,Observational,United States,Biomarkers of Trained Immunity Following MMR Vaccination,140,https://clinicaltrials.gov/show/NCT04646239,NA
NCT04659252,ClinicalTrials.gov,2020-12-08,2021-03-04,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19),70,https://clinicaltrials.gov/show/NCT04659252,NA
NCT04661540,ClinicalTrials.gov,2020-12-04,2021-03-02,FALSE,Recruiting,Phase 2,Interventional,United States,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,36,https://clinicaltrials.gov/show/NCT04661540,NA
NCT04666441,ClinicalTrials.gov,2020-12-10,2020-12-15,FALSE,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,1164,https://clinicaltrials.gov/show/NCT04666441,NA
NCT04666779,ClinicalTrials.gov,2020-12-11,2020-12-18,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Access to Chiropractic Care During the COVID-19 Pandemic,399,https://clinicaltrials.gov/show/NCT04666779,NA
NCT04667962,ClinicalTrials.gov,2020-12-13,2020-12-23,FALSE,Recruiting,Not Applicable,Observational,France,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,302,https://clinicaltrials.gov/show/NCT04667962,NA
NCT04671017,ClinicalTrials.gov,2020-12-15,2020-12-16,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults",153,https://clinicaltrials.gov/show/NCT04671017,NA
NCT04681040,ClinicalTrials.gov,2020-12-19,2020-12-19,FALSE,Recruiting,Not Applicable,Observational,"Denmark, United States, Brazil, Japan, Philippines",Risk Stratification of COVID-19 Using Urine Biomarkers,1000,https://clinicaltrials.gov/show/NCT04681040,NA
NCT04684446,ClinicalTrials.gov,2020-12-23,2021-03-30,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Russian Federation, Belarus",AstraZeneca Vax - Sputnik V Combination Study,100,https://clinicaltrials.gov/show/NCT04684446,NA
NCT04686721,ClinicalTrials.gov,2020-12-21,2020-12-20,TRUE,Recruiting,Not Applicable,Observational,Italy,Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04686721,NA
NCT04710303,ClinicalTrials.gov,2021-01-13,2021-03-02,FALSE,Recruiting,Phase 1,Interventional,South Africa,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,35,https://clinicaltrials.gov/show/NCT04710303,NA
NCT04713111,ClinicalTrials.gov,2021-01-08,2020-05-04,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Stress and Recovery in Frontline COVID-19 Workers,383,https://clinicaltrials.gov/show/NCT04713111,NA
NCT04715607,ClinicalTrials.gov,2021-01-12,2021-01-22,FALSE,Recruiting,Not Applicable,Interventional,Denmark,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens",22000,https://clinicaltrials.gov/show/NCT04715607,NA
NCT04732663,ClinicalTrials.gov,2021-01-28,2021-03-04,FALSE,Recruiting,Not Applicable,Observational,Canada,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,225,https://clinicaltrials.gov/show/NCT04732663,NA
NCT04733105,ClinicalTrials.gov,2021-01-24,2020-11-19,TRUE,Recruiting,Not Applicable,Observational,France,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure,530,https://clinicaltrials.gov/show/NCT04733105,NA
NCT04750720,ClinicalTrials.gov,2021-02-09,2020-08-27,TRUE,Recruiting,Not Applicable,Interventional,France,Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection,300,https://clinicaltrials.gov/show/NCT04750720,NA
NCT04753463,ClinicalTrials.gov,2021-02-04,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,Poland,Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland,130,https://clinicaltrials.gov/show/NCT04753463,NA
NCT04757272,ClinicalTrials.gov,2021-02-12,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?,1150,https://clinicaltrials.gov/show/NCT04757272,NA
NCT04775134,ClinicalTrials.gov,2021-02-26,2021-01-31,TRUE,Recruiting,Not Applicable,Observational,Belgium,Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19),75,https://clinicaltrials.gov/show/NCT04775134,NA
NCT04776044,ClinicalTrials.gov,2021-02-26,2021-03-01,FALSE,Recruiting,Phase 2,Interventional,"South Africa, Netherlands, Spain, India, Germany",Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19,220,https://clinicaltrials.gov/show/NCT04776044,NA
NCT04780425,ClinicalTrials.gov,2021-02-28,2021-01-26,TRUE,Not Recruiting,Not Applicable,Interventional,Ghana,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana",206,https://clinicaltrials.gov/show/NCT04780425,NA
NCT04780672,ClinicalTrials.gov,2021-02-25,2021-03-09,FALSE,Recruiting,Phase 3,Interventional,Russian Federation,Clinical Study in the Treatment of Patients With COVID-19,330,https://clinicaltrials.gov/show/NCT04780672,NA
NCT04786197,ClinicalTrials.gov,2021-03-05,2020-12-17,TRUE,Recruiting,Not Applicable,Observational,France,Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence,603,https://clinicaltrials.gov/show/NCT04786197,NA
NCT04786249,ClinicalTrials.gov,2021-03-05,2021-02-24,TRUE,Recruiting,Not Applicable,Observational,France,Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department,2400,https://clinicaltrials.gov/show/NCT04786249,NA
NCT04786301,ClinicalTrials.gov,2021-03-03,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,United States,Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza),1200,https://clinicaltrials.gov/show/NCT04786301,NA
NCT04787211,ClinicalTrials.gov,2021-03-04,2021-03-01,TRUE,Not Recruiting,Phase 2,Interventional,China,"A Phase 2 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",24,https://clinicaltrials.gov/show/NCT04787211,NA
NCT04788394,ClinicalTrials.gov,2021-03-07,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Qatar,Renal Involvement in Hospitalized Children With COVID-19,500,https://clinicaltrials.gov/show/NCT04788394,NA
NCT04788407,ClinicalTrials.gov,2021-03-07,2020-12-01,TRUE,Recruiting,Phase 4,Interventional,Argentina,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts,456,https://clinicaltrials.gov/show/NCT04788407,NA
NCT04789226,ClinicalTrials.gov,2021-03-04,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Covid-19 Assiut University Hospital Experience,239,https://clinicaltrials.gov/show/NCT04789226,NA
NCT04789395,ClinicalTrials.gov,2021-03-08,2020-09-02,TRUE,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT,25,https://clinicaltrials.gov/show/NCT04789395,NA
NCT04789525,ClinicalTrials.gov,2021-03-05,2020-03-10,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Physical Training and Diet for Childhood Obesity,76,https://clinicaltrials.gov/show/NCT04789525,NA
NCT04790994,ClinicalTrials.gov,2021-02-10,2020-07-24,TRUE,Not Recruiting,Not Applicable,Observational,France,COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests,1145,https://clinicaltrials.gov/show/NCT04790994,NA
NCT04791072,ClinicalTrials.gov,2021-02-27,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-coaching in Patients With COVID-19,36,https://clinicaltrials.gov/show/NCT04791072,NA
NCT04791085,ClinicalTrials.gov,2021-03-08,2021-02-08,TRUE,Recruiting,Not Applicable,Observational,Greece,Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19,200,https://clinicaltrials.gov/show/NCT04791085,NA
NCT04791241,ClinicalTrials.gov,2021-02-22,2021-03-03,FALSE,Recruiting,Not Applicable,Interventional,France,A Check-list Including Lung Ultrasound for ED Patients With ARF,105,https://clinicaltrials.gov/show/NCT04791241,NA
NCT04791436,ClinicalTrials.gov,2021-03-07,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Oral and Olfactory Complications of Recovered COVID-19 Patients,402,https://clinicaltrials.gov/show/NCT04791436,NA
NCT04791462,ClinicalTrials.gov,2021-02-26,2021-03-10,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 in Osteoarthritis Patients,500,https://clinicaltrials.gov/show/NCT04791462,NA
NCT04792021,ClinicalTrials.gov,2021-03-07,2021-03-09,FALSE,Recruiting,Phase 3,Interventional,Egypt,Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04792021,NA
NCT04792086,ClinicalTrials.gov,2021-02-02,2021-02-18,FALSE,Recruiting,Not Applicable,Observational,Norway,Disease Containment Measures Among Older Adults During the Covid-19 Pandemia,12000,https://clinicaltrials.gov/show/NCT04792086,NA
NCT04793243,ClinicalTrials.gov,2021-03-03,2020-08-17,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico,42,https://clinicaltrials.gov/show/NCT04793243,NA
NCT04793269,ClinicalTrials.gov,2021-03-04,2021-02-23,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Characteristics of Long COVID-19 Syndrome,200,https://clinicaltrials.gov/show/NCT04793269,NA
NCT04793984,ClinicalTrials.gov,2021-03-09,2021-03-08,TRUE,Recruiting,Not Applicable,Interventional,Austria,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,228,https://clinicaltrials.gov/show/NCT04793984,NA
NCT04794062,ClinicalTrials.gov,2021-02-15,2020-09-16,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Myocardial Injury and Quality of Life After COVID-19,100,https://clinicaltrials.gov/show/NCT04794062,NA
NCT04794361,ClinicalTrials.gov,2021-03-10,2020-03-05,TRUE,Not Recruiting,Not Applicable,Observational,France,Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner,400,https://clinicaltrials.gov/show/NCT04794361,NA
NCT04794374,ClinicalTrials.gov,2021-03-09,2020-11-16,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Effects of Telerehabilitation After Discharge in COVID-19 Survivors,30,https://clinicaltrials.gov/show/NCT04794374,NA
NCT04794803,ClinicalTrials.gov,2021-03-08,2020-05-05,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,"Italy, Brazil",Reparixin in COVID-19 Pneumonia - Efficacy and Safety,55,https://clinicaltrials.gov/show/NCT04794803,NA
NCT04794920,ClinicalTrials.gov,2021-03-09,2020-07-10,TRUE,Not Recruiting,Not Applicable,Observational,France,Post-Covid-19 Emotional Aspects of Hospital Staff,780,https://clinicaltrials.gov/show/NCT04794920,NA
NCT04794998,ClinicalTrials.gov,2021-03-10,2021-02-08,TRUE,Recruiting,Not Applicable,Observational,Italy,A Simple Approach to Treat COVID-19 Patients at Home.,216,https://clinicaltrials.gov/show/NCT04794998,NA
NCT04795557,ClinicalTrials.gov,2021-03-08,2021-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Adaptogens in Patients With Long COVID-19,100,https://clinicaltrials.gov/show/NCT04795557,NA
NCT04796064,ClinicalTrials.gov,2021-03-10,2020-03-30,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia,76,https://clinicaltrials.gov/show/NCT04796064,NA
NCT04797624,ClinicalTrials.gov,2021-03-12,2021-01-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?,146,https://clinicaltrials.gov/show/NCT04797624,NA
NCT04797871,ClinicalTrials.gov,2021-03-08,2021-03-08,FALSE,Recruiting,Not Applicable,Interventional,Spain,Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19,100,https://clinicaltrials.gov/show/NCT04797871,NA
NCT04797936,ClinicalTrials.gov,2021-03-08,2020-05-01,TRUE,Not Recruiting,Phase 4,Interventional,Ukraine,BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19,133,https://clinicaltrials.gov/show/NCT04797936,NA
NCT04798599,ClinicalTrials.gov,2021-03-08,2020-12-01,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Information and Communication Technologies (ICTS) in Dentistry for SUS,368,https://clinicaltrials.gov/show/NCT04798599,NA
NCT04798625,ClinicalTrials.gov,2021-03-10,2021-02-15,TRUE,Recruiting,Not Applicable,Observational,Norway,Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication,1600,https://clinicaltrials.gov/show/NCT04798625,NA
NCT04799132,ClinicalTrials.gov,2021-03-09,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Colombia,Association Between Body Mass Index and HFNC Therapy Success,303,https://clinicaltrials.gov/show/NCT04799132,NA
NCT04799444,ClinicalTrials.gov,2021-03-14,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Poland,LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults,500,https://clinicaltrials.gov/show/NCT04799444,NA
NCT04799561,ClinicalTrials.gov,2021-03-01,2021-03-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Teleprehabilitation for Surgical Cancer Patients,100,https://clinicaltrials.gov/show/NCT04799561,NA
NCT04799600,ClinicalTrials.gov,2021-03-10,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU,158,https://clinicaltrials.gov/show/NCT04799600,NA
NCT04799704,ClinicalTrials.gov,2021-03-11,2020-09-11,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.,30,https://clinicaltrials.gov/show/NCT04799704,NA
NCT04800146,ClinicalTrials.gov,2021-03-10,2021-02-25,TRUE,Recruiting,Not Applicable,Observational,Switzerland,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,240,https://clinicaltrials.gov/show/NCT04800146,NA
NCT04802187,ClinicalTrials.gov,2021-03-12,2020-12-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Implementation of SARS-CoV Testing Strategies in Community Health Centers,76300,https://clinicaltrials.gov/show/NCT04802187,NA
ACTRN12621000283875,ANZCTR,2021-03-16,2021-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,"A randomised trial comparing a brief wellbeing intervention delivered by coaches with a self-directed intervention to promote recovery in Victorian regional and rural communities impacted by bushfires, drought, and COVID-19.",80,https://anzctr.org.au/ACTRN12621000283875.aspx,NA
ISRCTN32077121,ISRCTN,2021-03-12,2020-06-22,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"Virus Watch: Understanding how COVID-19 spreads in the community, how sick people become, the types of symptoms they experience and what activities put people at risk of catching it",52500,http://isrctn.com/ISRCTN32077121,NA
ISRCTN39426207,ISRCTN,2021-03-04,2018-01-06,TRUE,Recruiting,Not Applicable,Interventional,Canada,High-intensity functional interval training in heart failure,30,http://isrctn.com/ISRCTN39426207,NA
ISRCTN85787008,ISRCTN,2021-01-08,2020-07-21,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Effect of heartfulness meditation on loneliness and sleep in physicians and advance practice providers,200,http://isrctn.com/ISRCTN85787008,NA
ISRCTN17782018,ISRCTN,2020-07-31,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 cancer attitudes and behaviour study,3535,http://isrctn.com/ISRCTN17782018,NA
ISRCTN21598625,ISRCTN,2020-07-30,2020-09-06,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,The impact of coronavirus on mental health and well-being in Wales,5500,http://isrctn.com/ISRCTN21598625,NA
ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,200,http://isrctn.com/ISRCTN59048638,NA
ISRCTN10974028,ISRCTN,2020-01-08,2020-01-02,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Language intervention in the early years - comparing the effectiveness of language intervention approaches for pre-school children with language difficulties,104,http://isrctn.com/ISRCTN10974028,NA
ISRCTN51287266,ISRCTN,2019-12-06,2019-12-13,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Aspergillosis in patients with severe influenza or coronavirus infection,180,http://isrctn.com/ISRCTN51287266,NA
EUCTR2020-002345-42,EudraCT,2020-07-22,2020-08-26,FALSE,Authorised,Phase 2,Interventional,"Sweden, Russian Federation, Brazil, Spain, France","A randomized, placebo controlled, double-blind, multi-center, phase II trial investigating the efficacy and safety of trimodulin (BT588) as add-on therapy to standard of care in adult subjects with severe COVID-19",114,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002345-42,ES
EUCTR2020-005963-29,EudraCT,2020-12-18,2021-02-22,FALSE,Authorised,Phase 3,Interventional,"Denmark, New Zealand, Australia, India",Clinical trial of anti-coagulant drug for COVID-19 inpatients,2400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005963-29,DK
EUCTR2020-005961-16,EudraCT,2020-12-15,2021-05-02,FALSE,Authorised,Phase 2,Interventional,Denmark,Coenzym Q10 til behandling af senfÃ¸lger efter COVID-19 (QVID studiet),120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005961-16,DK
EUCTR2021-000320-35,EudraCT,2021-02-04,2021-05-03,FALSE,Authorised,Phase 2,Interventional,Czech Republic,Study to evaluate safety and efficacy of Bazedoxifene in addition to Standard of Care in hospitalized COVID-19 patients suffering from moderate to severe Pneumonia,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000320-35,CZ
EUCTR2021-000710-42,EudraCT,2021-03-08,2021-03-15,FALSE,Authorised,Phase 4,Interventional,Netherlands,Research into the effect of the COVID-vaccine in patients who are treated with rituximab (RTX-COVAC study),270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000710-42,NL
EUCTR2020-001504-42,EudraCT,2020-05-03,2020-12-06,FALSE,Authorised,Phase 2/Phase 3,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",730,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42,BE
EUCTR2021-000842-16,EudraCT,2021-02-18,2021-03-18,FALSE,Authorised,Phase 4,Interventional,Sweden,The effects of Perfluoroalkyl substances on SARS-CoV-2 vaccination.,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000842-16,SE
EUCTR2020-002982-33,EudraCT,2020-12-21,2021-02-03,FALSE,Authorised,Phase 1/Phase 2,Interventional,Sweden,"A study to to evaluate the efficacy, safety and tolerability of PDNO (nitrosooxypropanol) infusion in COVID-19 patients with high blood pressure in lung arteries.",16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002982-33,SE
EUCTR2018-002571-18,EudraCT,2018-09-26,2019-07-22,FALSE,Authorised,Phase 4,Interventional,Netherlands,"Effect of Iron infusion on endurance and muscle strength after kidney transplantation
",158,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-002571-18,NL
ChiCTR2100041718,ChiCTR,2021-01-02,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,China,Effect evaluation on the application of Entry Card combined with electronic pre-inspection system,7822,http://www.chictr.org.cn/showproj.aspx?proj=66415,NA
ChiCTR2100041709,ChiCTR,2021-01-02,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Acute Appendicitis During Coronavirus Disease in Turkey: Changes in Clinical Approach, Treatment, and Diagnosis Modalities, a Retrospective Cohort Study",8972,http://www.chictr.org.cn/showproj.aspx?proj=65920,NA
ChiCTR2100041706,ChiCTR,2021-01-01,2021-01-05,FALSE,Recruiting,Not Applicable,Interventional,China,Safety and immunogenicity of New Coronavirus vaccine (COVID-19) inactivated by safety personnel: a randomized controlled trial,360,http://www.chictr.org.cn/showproj.aspx?proj=66405,NA
ChiCTR2100041705,ChiCTR,2021-01-01,2021-01-02,FALSE,Recruiting,Not Applicable,Interventional,China,"A randomized, controlled trial for the safety and immunogenicity of novel coronavirus pneumonia (COVID-19) inactivated vaccine in airline ground staff",360,http://www.chictr.org.cn/showproj.aspx?proj=66407,NA
ChiCTR2100041704,ChiCTR,2021-01-01,2020-09-29,TRUE,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized controlled trial for the safety and immunogenicity of novel coronavirus pneumonia (COVID-19) inactivated vaccine in medical and health services personnel",360,http://www.chictr.org.cn/showproj.aspx?proj=66464,NA
ChiCTR2000040633,ChiCTR,2020-12-04,2020-10-01,TRUE,Not Recruiting,Not Applicable,Health services research,Jordan,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak: A Survey.,60,http://www.chictr.org.cn/showproj.aspx?proj=65196,NA
ChiCTR2000040632,ChiCTR,2020-12-04,2020-03-17,TRUE,Not Recruiting,Phase 1,Interventional,Pakistan,COVID-19 Cure Using Integrative Treatment,34,http://www.chictr.org.cn/showproj.aspx?proj=65372,NA
ChiCTR2000040628,ChiCTR,2020-12-04,2020-02-29,TRUE,Recruiting,Not Applicable,Observational,China,A follow-up study of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19),430,http://www.chictr.org.cn/showproj.aspx?proj=65329,NA
NCT03680274,ClinicalTrials.gov,2018-09-19,2018-11-08,FALSE,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C,800,https://clinicaltrials.gov/show/NCT03680274,NA
NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,FALSE,Not Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,2271,https://clinicaltrials.gov/show/NCT04332107,NA
NCT04344834,ClinicalTrials.gov,2020-04-11,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,Egypt,Short and Long-term Psychological Impact of Covid-19 on The Egyptians,300,https://clinicaltrials.gov/show/NCT04344834,NA
NCT04348461,ClinicalTrials.gov,2020-04-10,2020-05-06,FALSE,Not Recruiting,Phase 2,Interventional,Spain,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,100,https://clinicaltrials.gov/show/NCT04348461,NA
NCT04351711,ClinicalTrials.gov,2020-04-10,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,130,https://clinicaltrials.gov/show/NCT04351711,NA
NCT04363489,ClinicalTrials.gov,2020-04-23,2020-08-20,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),60,https://clinicaltrials.gov/show/NCT04363489,NA
NCT04364984,ClinicalTrials.gov,2020-04-23,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,Ukraine,"ARB, ACEi, DRi in COVID-19",10,https://clinicaltrials.gov/show/NCT04364984,NA
NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,TRUE,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),60,https://clinicaltrials.gov/show/NCT04379154,NA
NCT04380402,ClinicalTrials.gov,2020-05-01,2020-06-25,FALSE,Recruiting,Phase 2,Interventional,United States,Atorvastatin as Adjunctive Therapy in COVID-19,300,https://clinicaltrials.gov/show/NCT04380402,NA
NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,TRUE,Not Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,820,https://clinicaltrials.gov/show/NCT04385095,NA
NCT04391166,ClinicalTrials.gov,2020-05-15,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,United States,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,108,https://clinicaltrials.gov/show/NCT04391166,NA
NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,FALSE,Not Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,100,https://clinicaltrials.gov/show/NCT04391179,NA
NCT04393805,ClinicalTrials.gov,2020-05-16,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,744,https://clinicaltrials.gov/show/NCT04393805,NA
NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,13,https://clinicaltrials.gov/show/NCT04395144,NA
NCT04396314,ClinicalTrials.gov,2020-05-15,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,54,https://clinicaltrials.gov/show/NCT04396314,NA
NCT04407533,ClinicalTrials.gov,2020-05-27,2020-05-25,TRUE,Not Recruiting,Not Applicable,Observational,Canada,Dietary Intake and Eating Habits During the COVID-19 Pandemic,2020,https://clinicaltrials.gov/show/NCT04407533,NA
NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,185,https://clinicaltrials.gov/show/NCT04408157,NA
NCT04418284,ClinicalTrials.gov,2020-06-03,2020-06-05,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,1517,https://clinicaltrials.gov/show/NCT04418284,NA
NCT04420637,ClinicalTrials.gov,2020-06-04,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,Austria,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,1000,https://clinicaltrials.gov/show/NCT04420637,NA
NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,TRUE,Not Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,483,https://clinicaltrials.gov/show/NCT04429854,NA
NCT04433910,ClinicalTrials.gov,2020-05-06,2020-08-30,FALSE,Not Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,106,https://clinicaltrials.gov/show/NCT04433910,NA
NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-24,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,122,https://clinicaltrials.gov/show/NCT04439045,NA
NCT04445220,ClinicalTrials.gov,2020-06-22,2020-11-19,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,22,https://clinicaltrials.gov/show/NCT04445220,NA
NCT04452097,ClinicalTrials.gov,2020-06-28,2021-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,39,https://clinicaltrials.gov/show/NCT04452097,NA
NCT04453839,ClinicalTrials.gov,2020-06-27,2020-10-05,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE),Not Available,https://clinicaltrials.gov/show/NCT04453839,NA
NCT04470999,ClinicalTrials.gov,2020-07-09,2020-04-15,TRUE,Recruiting,Not Applicable,Interventional,United States,Changes in Cellular Immune Profile During COVID-19 Infection,25,https://clinicaltrials.gov/show/NCT04470999,NA
NCT04476680,ClinicalTrials.gov,2020-07-16,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion,900,https://clinicaltrials.gov/show/NCT04476680,NA
NCT04483375,ClinicalTrials.gov,2020-07-17,2020-07-24,FALSE,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",33,https://clinicaltrials.gov/show/NCT04483375,NA
NCT04487691,ClinicalTrials.gov,2020-07-23,2020-12-08,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Nebulized PL for Post-COVID-19 Syndrome,1,https://clinicaltrials.gov/show/NCT04487691,NA
NCT04495803,ClinicalTrials.gov,2020-07-30,2020-09-01,FALSE,Recruiting,Not Applicable,Interventional,Canada,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),120,https://clinicaltrials.gov/show/NCT04495803,NA
NCT04497324,ClinicalTrials.gov,2020-07-31,2020-09-21,FALSE,Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,100,https://clinicaltrials.gov/show/NCT04497324,NA
NCT04521309,ClinicalTrials.gov,2020-05-07,2020-06-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Pakistan,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04521309,NA
NCT04522986,ClinicalTrials.gov,2020-08-20,2020-08-21,FALSE,Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,6,https://clinicaltrials.gov/show/NCT04522986,NA
NCT04542213,ClinicalTrials.gov,2020-09-03,2020-08-01,TRUE,Not Recruiting,Phase 3,Interventional,Mexico,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,70,https://clinicaltrials.gov/show/NCT04542213,NA
NCT04551339,ClinicalTrials.gov,2020-09-09,2020-09-28,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,4500,https://clinicaltrials.gov/show/NCT04551339,NA
NCT04565379,ClinicalTrials.gov,2020-09-23,2020-09-25,FALSE,Recruiting,Phase 2,Interventional,Romania,Clinical Trial to Investigate the Efficacy and Safety of NuSepinÂ® in COVID-19 Pneumonia Patients,60,https://clinicaltrials.gov/show/NCT04565379,NA
NCT04568044,ClinicalTrials.gov,2020-09-23,2020-09-16,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,128,https://clinicaltrials.gov/show/NCT04568044,NA
NCT04568863,ClinicalTrials.gov,2020-09-28,2020-06-20,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,18,https://clinicaltrials.gov/show/NCT04568863,NA
NCT04570202,ClinicalTrials.gov,2020-09-28,2020-11-20,FALSE,Recruiting,Not Applicable,Interventional,France,Health cAre woRkers exposeD to COVID-19,900,https://clinicaltrials.gov/show/NCT04570202,NA
NCT04604223,ClinicalTrials.gov,2020-10-26,2021-01-18,FALSE,Recruiting,Phase 4,Interventional,"Kuwait, Qatar",Effect of Pioglitazone on T2DM Patients With COVID-19,1506,https://clinicaltrials.gov/show/NCT04604223,NA
NCT04610502,ClinicalTrials.gov,2020-09-15,2020-09-06,TRUE,Not Recruiting,Phase 2,Interventional,Costa Rica,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,26,https://clinicaltrials.gov/show/NCT04610502,NA
NCT04611399,ClinicalTrials.gov,2020-10-08,2021-03-05,FALSE,Recruiting,Not Applicable,Interventional,Italy,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,90,https://clinicaltrials.gov/show/NCT04611399,NA
NCT04619719,ClinicalTrials.gov,2020-11-05,2021-03-15,FALSE,Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia,360,https://clinicaltrials.gov/show/NCT04619719,NA
NCT04621123,ClinicalTrials.gov,2020-11-04,2020-10-30,TRUE,Recruiting,Phase 2,Interventional,Spain,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,474,https://clinicaltrials.gov/show/NCT04621123,NA
NCT04633915,ClinicalTrials.gov,2020-11-15,2020-11-26,FALSE,Not Recruiting,Not Applicable,Observational,Russian Federation,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,51,https://clinicaltrials.gov/show/NCT04633915,NA
NCT04635943,ClinicalTrials.gov,2020-11-09,2020-08-29,TRUE,Recruiting,Phase 2,Interventional,Peru,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,186,https://clinicaltrials.gov/show/NCT04635943,NA
NCT04637906,ClinicalTrials.gov,2020-11-18,2020-11-18,FALSE,Recruiting,Not Applicable,Interventional,Italy,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),290,https://clinicaltrials.gov/show/NCT04637906,NA
NCT04641481,ClinicalTrials.gov,2020-11-09,2020-11-16,FALSE,Not Recruiting,Phase 3,Interventional,India,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,25800,https://clinicaltrials.gov/show/NCT04641481,NA
NCT04659356,ClinicalTrials.gov,2020-12-08,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,France,NOSOcomial COVID-19 in ICU (NOSOCOVID),600,https://clinicaltrials.gov/show/NCT04659356,NA
NCT04661813,ClinicalTrials.gov,2020-10-29,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,United States,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,75,https://clinicaltrials.gov/show/NCT04661813,NA
NCT04663737,ClinicalTrials.gov,2020-12-01,2020-12-03,FALSE,Recruiting,Phase 2,Interventional,United States,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",20,https://clinicaltrials.gov/show/NCT04663737,NA
NCT04666311,ClinicalTrials.gov,2020-12-07,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,"South Africa, Lesotho",Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,1400,https://clinicaltrials.gov/show/NCT04666311,NA
NCT04684433,ClinicalTrials.gov,2020-12-23,2020-04-14,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Surgery in the Time of COVID-19 Pandemic,707,https://clinicaltrials.gov/show/NCT04684433,NA
NCT04705766,ClinicalTrials.gov,2020-12-16,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,United States,KIDney Injury in Times of COVID-19 (KIDCOV),2000,https://clinicaltrials.gov/show/NCT04705766,NA
NCT04705844,ClinicalTrials.gov,2021-01-10,2021-05-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT),1444,https://clinicaltrials.gov/show/NCT04705844,NA
NCT04716569,ClinicalTrials.gov,2021-01-19,2021-01-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,150,https://clinicaltrials.gov/show/NCT04716569,NA
NCT04723459,ClinicalTrials.gov,2021-01-20,2021-01-23,FALSE,Recruiting,Not Applicable,Interventional,Egypt,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,150,https://clinicaltrials.gov/show/NCT04723459,NA
NCT04723706,ClinicalTrials.gov,2021-01-20,2021-03-19,FALSE,Recruiting,Not Applicable,Observational,United States,Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,150,https://clinicaltrials.gov/show/NCT04723706,NA
NCT04727424,ClinicalTrials.gov,2021-01-25,2021-01-19,TRUE,Recruiting,Phase 3,Interventional,Brazil,Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms,2724,https://clinicaltrials.gov/show/NCT04727424,NA
NCT04735757,ClinicalTrials.gov,2021-01-14,2021-02-03,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI",40,https://clinicaltrials.gov/show/NCT04735757,NA
NCT04738045,ClinicalTrials.gov,2021-01-31,2020-11-01,TRUE,Recruiting,Phase 4,Interventional,Egypt,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04738045,NA
NCT04738695,ClinicalTrials.gov,2021-01-25,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,Belgium,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19),3036,https://clinicaltrials.gov/show/NCT04738695,NA
NCT04741282,ClinicalTrials.gov,2021-01-30,2021-09-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,52,https://clinicaltrials.gov/show/NCT04741282,NA
NCT04743609,ClinicalTrials.gov,2021-01-20,2021-02-08,FALSE,Recruiting,Not Applicable,Observational,France,RSV Burden in Outpatient Settings,1600,https://clinicaltrials.gov/show/NCT04743609,NA
NCT04746339,ClinicalTrials.gov,2021-02-08,2021-03-04,FALSE,Recruiting,Phase 4,Interventional,Brazil,Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19,1000,https://clinicaltrials.gov/show/NCT04746339,NA
NCT04750265,ClinicalTrials.gov,2021-02-09,2021-01-21,TRUE,Recruiting,Not Applicable,Interventional,Germany,Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04750265,NA
NCT04765384,ClinicalTrials.gov,2021-02-19,2021-03-12,FALSE,Not Recruiting,Phase 2,Interventional,"Australia, South Africa, United Kingdom, Canada, United States, Brazil, Spain, Finland",A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19),400,https://clinicaltrials.gov/show/NCT04765384,NA
NCT04779047,ClinicalTrials.gov,2021-02-25,2020-10-01,TRUE,Recruiting,Phase 4,Interventional,Egypt,Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.,150,https://clinicaltrials.gov/show/NCT04779047,NA
NCT04779346,ClinicalTrials.gov,2021-02-27,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,Germany,Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting,500,https://clinicaltrials.gov/show/NCT04779346,NA
NCT04779541,ClinicalTrials.gov,2021-03-01,2021-02-08,TRUE,Recruiting,Not Applicable,Observational,France,National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units,1000,https://clinicaltrials.gov/show/NCT04779541,NA
NCT04780061,ClinicalTrials.gov,2021-03-01,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Dietary Supplements for COVID-19,200,https://clinicaltrials.gov/show/NCT04780061,NA
NCT04788459,ClinicalTrials.gov,2021-03-01,2021-02-25,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Italy,"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers",160,https://clinicaltrials.gov/show/NCT04788459,NA
NCT04789356,ClinicalTrials.gov,2021-03-05,2021-03-18,FALSE,Recruiting,Phase 4,Interventional,Brazil,Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity,10156,https://clinicaltrials.gov/show/NCT04789356,NA
NCT04790851,ClinicalTrials.gov,2021-03-08,2021-02-23,TRUE,Recruiting,Phase 4,Interventional,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1152,https://clinicaltrials.gov/show/NCT04790851,NA
NCT04795414,ClinicalTrials.gov,2021-03-11,2021-01-14,TRUE,Recruiting,Not Applicable,Observational,China,Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers,1370,https://clinicaltrials.gov/show/NCT04795414,NA
NCT04797091,ClinicalTrials.gov,2020-04-16,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,Germany,Kidney in Coronavirus Disease 2019 Registry,500,https://clinicaltrials.gov/show/NCT04797091,NA
NCT04797208,ClinicalTrials.gov,2021-03-11,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Remote Glucose Monitoring in Hospital Settings,30,https://clinicaltrials.gov/show/NCT04797208,NA
NCT04797975,ClinicalTrials.gov,2021-03-12,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19,54,https://clinicaltrials.gov/show/NCT04797975,NA
NCT04798716,ClinicalTrials.gov,2021-03-12,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,55,https://clinicaltrials.gov/show/NCT04798716,NA
NCT04799652,ClinicalTrials.gov,2021-03-15,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,Belgium,Are Surgeons Ready to Get the COVID-19 Vaccine?,700,https://clinicaltrials.gov/show/NCT04799652,NA
NCT04799691,ClinicalTrials.gov,2021-03-15,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,France,Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia,140,https://clinicaltrials.gov/show/NCT04799691,NA
NCT04799743,ClinicalTrials.gov,2021-03-10,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,Hong Kong,The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04799743,NA
NCT04799808,ClinicalTrials.gov,2021-03-08,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,Germany,"Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff",2500,https://clinicaltrials.gov/show/NCT04799808,NA
NCT04799834,ClinicalTrials.gov,2021-03-11,2020-11-30,TRUE,Recruiting,Not Applicable,Observational,Italy,Genotype and Susceptibility to COVID-19,1200,https://clinicaltrials.gov/show/NCT04799834,NA
NCT04799873,ClinicalTrials.gov,2021-03-14,2020-04-08,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Alpha-1-Antitrypsin-Deficiency in COVID-19,10,https://clinicaltrials.gov/show/NCT04799873,NA
NCT04799977,ClinicalTrials.gov,2021-02-15,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,France,COVID-19: Post-covid Olfactory Disorders Assessment,300,https://clinicaltrials.gov/show/NCT04799977,NA
NCT04800120,ClinicalTrials.gov,2020-11-13,2021-02-15,FALSE,Recruiting,Not Applicable,Interventional,United States,Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress,10,https://clinicaltrials.gov/show/NCT04800120,NA
NCT04800770,ClinicalTrials.gov,2021-03-10,2021-03-03,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU,160,https://clinicaltrials.gov/show/NCT04800770,NA
NCT04801017,ClinicalTrials.gov,2021-03-01,2021-04-01,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects,18,https://clinicaltrials.gov/show/NCT04801017,NA
NCT04801030,ClinicalTrials.gov,2021-03-11,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Vaccine Hesitancy Among African Americans,300,https://clinicaltrials.gov/show/NCT04801030,NA
NCT04801134,ClinicalTrials.gov,2021-03-11,2021-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04801134,NA
NCT04801888,ClinicalTrials.gov,2021-03-15,2021-03-01,TRUE,Not Recruiting,Phase 4,Interventional,China,Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine,480,https://clinicaltrials.gov/show/NCT04801888,NA
NCT04801940,ClinicalTrials.gov,2021-03-12,2021-03-01,TRUE,Not Recruiting,Phase 3,Interventional,No Country Given,HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID),2631,https://clinicaltrials.gov/show/NCT04801940,NA
NCT04802044,ClinicalTrials.gov,2021-01-30,2020-12-08,TRUE,Recruiting,Not Applicable,Observational,Indonesia,"COVID-19, Aging, and Cardiometabolic Risk Factors Study",500,https://clinicaltrials.gov/show/NCT04802044,NA
NCT04802083,ClinicalTrials.gov,2021-02-17,2021-01-11,TRUE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,COVID-19 Soliris Expanded Access Protocol,Not Available,https://clinicaltrials.gov/show/NCT04802083,NA
NCT04802278,ClinicalTrials.gov,2021-03-15,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,Singapore,Gestational Immunity for Transfer,120,https://clinicaltrials.gov/show/NCT04802278,NA
NCT04802382,ClinicalTrials.gov,2021-03-10,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19,252,https://clinicaltrials.gov/show/NCT04802382,NA
NCT04802408,ClinicalTrials.gov,2021-03-10,2021-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial,200,https://clinicaltrials.gov/show/NCT04802408,NA
NCT04802642,ClinicalTrials.gov,2021-03-16,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students",80,https://clinicaltrials.gov/show/NCT04802642,NA
NCT04803227,ClinicalTrials.gov,2021-02-12,2021-03-11,FALSE,Recruiting,Phase 1,Interventional,United States,Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19,50,https://clinicaltrials.gov/show/NCT04803227,NA
NCT04803370,ClinicalTrials.gov,2021-03-09,2020-07-08,TRUE,Recruiting,Not Applicable,Interventional,Spain,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,100,https://clinicaltrials.gov/show/NCT04803370,NA
NCT04803812,ClinicalTrials.gov,2021-02-08,2021-01-26,TRUE,Recruiting,Not Applicable,Interventional,Canada,Supporting the Wellness of Ontario Physicians During COVID-19,19000,https://clinicaltrials.gov/show/NCT04803812,NA
NCT04805086,ClinicalTrials.gov,2021-03-03,2021-03-08,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19,5,https://clinicaltrials.gov/show/NCT04805086,NA
NCT04805203,ClinicalTrials.gov,2020-12-15,2020-12-16,FALSE,Recruiting,Not Applicable,Interventional,France,Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma,400,https://clinicaltrials.gov/show/NCT04805203,NA
NCT04805645,ClinicalTrials.gov,2021-03-16,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit,50,https://clinicaltrials.gov/show/NCT04805645,NA
NCT04805684,ClinicalTrials.gov,2021-03-15,2021-01-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia,59,https://clinicaltrials.gov/show/NCT04805684,NA
NCT04805840,ClinicalTrials.gov,2021-03-17,2021-02-19,TRUE,Recruiting,Not Applicable,Observational,United States,Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen,4400,https://clinicaltrials.gov/show/NCT04805840,NA
NCT04806061,ClinicalTrials.gov,2021-03-15,2021-04-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Urine Alkalinisation in COVID-19,80,https://clinicaltrials.gov/show/NCT04806061,NA
NCT04806074,ClinicalTrials.gov,2021-03-17,2020-08-14,TRUE,Not Recruiting,Not Applicable,Interventional,Portugal,FOODLIT-PRO: Improving Food Literacy and Food Sustainability Amidst the COVID-19 Pandemic,215,https://clinicaltrials.gov/show/NCT04806074,NA
NCT04806529,ClinicalTrials.gov,2021-03-17,2020-12-15,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older",0,https://clinicaltrials.gov/show/NCT04806529,NA
NCT04806880,ClinicalTrials.gov,2021-03-17,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,France,Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application,700,https://clinicaltrials.gov/show/NCT04806880,NA
NCT04807075,ClinicalTrials.gov,2021-03-17,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19, Infection",60,https://clinicaltrials.gov/show/NCT04807075,NA
NCT04807699,ClinicalTrials.gov,2021-03-18,2020-07-25,TRUE,Recruiting,Not Applicable,Observational,Brazil,Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL,3500,https://clinicaltrials.gov/show/NCT04807699,NA
NCT04808284,ClinicalTrials.gov,2021-03-16,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Neuromodulation in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04808284,NA
NCT04808882,ClinicalTrials.gov,2021-03-08,2021-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,ANTIcoagulation in Severe COVID-19 Patients,353,https://clinicaltrials.gov/show/NCT04808882,NA
NCT04808895,ClinicalTrials.gov,2021-03-15,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Italy,Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19,204,https://clinicaltrials.gov/show/NCT04808895,NA
NCT04808986,ClinicalTrials.gov,2021-03-17,2021-04-02,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,2000,https://clinicaltrials.gov/show/NCT04808986,NA
NCT04809272,ClinicalTrials.gov,2021-03-15,2021-03-08,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,ePLH Pilot Study: Online Support Parent Groups - ParentChat,900,https://clinicaltrials.gov/show/NCT04809272,NA
NCT04809480,ClinicalTrials.gov,2021-03-19,2017-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Acute Invasive Fungal Rhinosinusitis,56,https://clinicaltrials.gov/show/NCT04809480,NA
NCT04809948,ClinicalTrials.gov,2021-03-14,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Effects of COVID 19 Vaccine on Egyptian Population,800,https://clinicaltrials.gov/show/NCT04809948,NA
NCT04810689,ClinicalTrials.gov,2021-03-17,2021-03-01,TRUE,Recruiting,Phase 2,Interventional,United States,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19",60,https://clinicaltrials.gov/show/NCT04810689,NA
NCT04812327,ClinicalTrials.gov,2021-03-19,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Singapore,Capturing Infectious COVID-19 Asymptomatic Cases in Singapore,150,https://clinicaltrials.gov/show/NCT04812327,NA
NCT04819919,ClinicalTrials.gov,2021-03-24,2021-04-15,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Viral Load Reduction of a Single Dose of Plitidepsin in Adult Patients With COVID-19,122,https://clinicaltrials.gov/show/NCT04819919,NA
ACTRN12619001134112,ANZCTR,2019-08-14,2019-09-23,FALSE,Recruiting,Not Applicable,Interventional,Australia,WalkBack - Effectiveness and cost-effectiveness of a progressive individualised walking and education program for the prevention of a recurrence of low back pain.,698,https://anzctr.org.au/ACTRN12619001134112.aspx,NA
ACTRN12620000486921,ANZCTR,2020-04-17,2020-05-22,FALSE,Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",865,https://anzctr.org.au/ACTRN12620000486921.aspx,NA
ACTRN12620000612910,ANZCTR,2020-05-25,2020-01-06,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,24,https://anzctr.org.au/ACTRN12620000612910.aspx,NA
ACTRN12620001355965,ANZCTR,2020-12-16,2021-01-27,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Optimising COVID-19 testing intentions and behaviour with enhanced messaging,1430,https://anzctr.org.au/ACTRN12620001355965.aspx,NA
ACTRN12621000344897,ANZCTR,2021-03-25,2020-12-15,TRUE,Recruiting,Not Applicable,Interventional,Australia,Addressing the hidden burden of wound care amid the COVID-19 pandemic: A Virtual Wound Care Command Centre.,60,https://anzctr.org.au/ACTRN12621000344897.aspx,NA
ACTRN12621000309886,ANZCTR,2021-03-19,2021-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,"Immediate effects of a respiratory telerehabilitation program in confined
patients affected by COVID-19",60,https://anzctr.org.au/ACTRN12621000309886.aspx,NA
ISRCTN17401860,ISRCTN,2021-03-19,2021-03-22,FALSE,Recruiting,Not Applicable,Observational,Germany,Prevalence and associated risk factors of COVID-19 infection experienced by refugees seeking asylum in Berlin,800,http://isrctn.com/ISRCTN17401860,NA
ISRCTN15499304,ISRCTN,2021-03-19,2021-03-22,FALSE,Recruiting,Not Applicable,Observational,Switzerland,"Zurich Coronavirus Vaccination Cohort: an observational study to assess longer-term immune responses and health status after coronavirus (COVID-19) vaccination in Zurich, Switzerland",800,http://isrctn.com/ISRCTN15499304,NA
ISRCTN16806663,ISRCTN,2021-03-11,2020-09-20,TRUE,Not Recruiting,Phase 2,Interventional,India,A clinical trial to evaluate the effects of inhaled nitric oxide gas among COVID-19 patients with pneumonia,25,http://isrctn.com/ISRCTN16806663,NA
ISRCTN12821688,ISRCTN,2021-02-17,2021-02-22,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Observational cohort trial of immune response in patients with chronic health conditions following coronavirus vaccination,5000,http://isrctn.com/ISRCTN12821688,NA
ISRCTN11265821,ISRCTN,2021-01-21,2020-10-29,TRUE,Recruiting,Not Applicable,Observational,United States,A long-term follow-up study of patients with coronavirus (COVID-19) associated pneumonia,300,http://isrctn.com/ISRCTN11265821,NA
ISRCTN13593711,ISRCTN,2021-01-21,2020-03-04,TRUE,Not Recruiting,Not Applicable,Interventional,"Denmark, United Kingdom, Netherlands, Canada, United States, Italy, Spain, France, Germany",A study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia,450,http://isrctn.com/ISRCTN13593711,NA
ISRCTN11811602,ISRCTN,2020-11-23,2020-01-11,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,UK-REACH: United Kingdom research study into ethnicity and COVID-19 outcomes in healthcare workers,1530180,http://isrctn.com/ISRCTN11811602,NA
ISRCTN11970082,ISRCTN,2020-11-20,2020-08-16,TRUE,Not Recruiting,Not Applicable,Interventional,India,Effect of the drug indomethacin in the treatment of COVID-19 patients,250,http://isrctn.com/ISRCTN11970082,NA
ISRCTN12792822,ISRCTN,2020-11-18,2020-11-21,FALSE,Recruiting,Not Applicable,Interventional,Kenya,Cash transfers to stimulate school re-enrollment among vulnerable adolescent girls in urban informal settlements as Kenya responds to COVID-19,1700,http://isrctn.com/ISRCTN12792822,NA
ISRCTN15019599,ISRCTN,2020-11-10,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,CCP Cancer UK Study. Companion study to educate and inform practice and guidelines regarding COVID-19 infection in cancer patients,9000,http://isrctn.com/ISRCTN15019599,NA
ISRCTN15874265,ISRCTN,2020-11-03,2020-06-03,TRUE,Not Recruiting,Phase 3,Interventional,"Sweden, Hong Kong, United Kingdom, Netherlands, Taiwan, United States, Korea, South, Italy, Spain, Japan, France, Germany, Singapore, Switzerland",Study to assess the safety and effectiveness of remdesivir in people with severe COVID-19,6000,http://isrctn.com/ISRCTN15874265,NA
ISRCTN16865246,ISRCTN,2020-11-02,2020-10-22,TRUE,Recruiting,Not Applicable,Observational,Chile,One year follow-ups of Chilean patients with COVID-19,250,http://isrctn.com/ISRCTN16865246,NA
ISRCTN66141262,ISRCTN,2020-10-22,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"ASTERIX: An observational study to identify sub-groups of COVID-19 patients based on their demographic, clinical and laboratory profile, and to determine if these sub-groups can be used to predict severity of disease and response to therapy",600,http://isrctn.com/ISRCTN66141262,NA
ISRCTN13773960,ISRCTN,2020-10-22,2018-01-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Schools Transmission Study (COVID-19 and scarlet fever),344,http://isrctn.com/ISRCTN13773960,NA
ISRCTN21447815,ISRCTN,2020-10-16,2020-09-19,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Studying aerosol emission of the COVID-19 virus in healthcare settings,600,http://isrctn.com/ISRCTN21447815,NA
ISRCTN18395399,ISRCTN,2020-09-30,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,The psychosocial impact of the COVID-19 pandemic on NHS affiliated staff â€“ monitoring the response to the pandemic and the evaluation of local and national staff support programmes,20000,http://isrctn.com/ISRCTN18395399,NA
ISRCTN31062548,ISRCTN,2020-09-07,2020-09-14,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,"GETAFIX (Glasgow Early Treatment Arm Favipiravir) â€“ a study to compare the effectiveness of adding the antiviral drug favipiravir to standard care in COVID-19 patients, compared with standard care alone",302,http://isrctn.com/ISRCTN31062548,NA
ISRCTN36352994,ISRCTN,2020-08-05,2019-01-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Sickness absence in NHS staff during the time of COVID-19,800000,http://isrctn.com/ISRCTN36352994,NA
ISRCTN60033461,ISRCTN,2020-07-31,2020-01-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Neonatal complications of coronavirus disease (COVID-19) study,10000,http://isrctn.com/ISRCTN60033461,NA
ISRCTN17896927,ISRCTN,2020-07-27,2020-07-17,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Encouraging behavior to reduce the spread of COVID-19,3000,http://isrctn.com/ISRCTN17896927,NA
ISRCTN17301812,ISRCTN,2020-07-23,2020-07-24,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Search for antiviral antibodies in COVID-19 patients' eye secretions,60,http://isrctn.com/ISRCTN17301812,NA
ISRCTN14990068,ISRCTN,2020-07-22,2020-07-27,FALSE,Recruiting,Not Applicable,Observational,Switzerland,"Zurich Coronavirus Cohort: an observational study to determine long-term clinical outcomes and immune responses after coronavirus infection (COVID-19), assess the influence of virus genetics, and examine the spread of the coronavirus in the population of the Canton of Zurich, Switzerland",3200,http://isrctn.com/ISRCTN14990068,NA
ISRCTN14212905,ISRCTN,2020-07-22,2020-03-07,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,Understanding how COVID-19 leads to respiratory failure in COVID-19 positive patients,100,http://isrctn.com/ISRCTN14212905,NA
ISRCTN13990999,ISRCTN,2020-06-24,2020-03-04,TRUE,Not Recruiting,Not Applicable,Observational,Italy,A diagnostic study comparing different tests for the diagnosis of COVID-19,400,http://isrctn.com/ISRCTN13990999,NA
ISRCTN15324611,ISRCTN,2020-06-01,2020-06-04,FALSE,Not Recruiting,Not Applicable,Observational,Singapore,"A study to assess the usefulness of combination of Vitamin D, magnesium and Vitamin B12 in older COVID-19 patients",40,http://isrctn.com/ISRCTN15324611,NA
ISRCTN11060415,ISRCTN,2020-05-28,2020-05-27,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,"Study of the spread of COVID-19 in St Petersburg, Russia",1000,http://isrctn.com/ISRCTN11060415,NA
ISRCTN64783542,ISRCTN,2020-05-22,2020-01-03,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Investigating blood clotting changes in patients with COVID-19,1000,http://isrctn.com/ISRCTN64783542,NA
ISRCTN44324934,ISRCTN,2020-05-18,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"The symptoms, virology and immunity of COVID in healthcare workers",135,http://isrctn.com/ISRCTN44324934,NA
ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,FALSE,Not Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),116,http://isrctn.com/ISRCTN13311119,NA
ISRCTN10077335,ISRCTN,2020-04-07,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,25,http://isrctn.com/ISRCTN10077335,NA
ChiCTR2100041956,ChiCTR,2021-01-10,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,China,Effect evaluation of mental health intervention for junior middle school students based on new media under the background of COVID-19,1540,http://www.chictr.org.cn/showproj.aspx?proj=64751,NA
ChiCTR2100041855,ChiCTR,2021-01-08,2021-01-11,FALSE,Recruiting,Phase 2,Interventional,China,A Phase II clinical trial to evaluate the immunogenicity and safety of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years,420,http://www.chictr.org.cn/showproj.aspx?proj=119719,NA
ChiCTR2000040729,ChiCTR,2020-12-08,2020-12-30,FALSE,Recruiting,Not Applicable,Observational,China,A survey of the impact on mental health and therapies in patients with chronic disease during the pandemic of COVID-19,800,http://www.chictr.org.cn/showproj.aspx?proj=65466,NA
EUCTR2020-005801-14,EudraCT,2020-12-30,2021-08-02,FALSE,Authorised,Phase 3,Interventional,"Germany, United States, Poland",A Phase 3 Study to Evaluate 3 Dose Levels of Ad26.COV2.S Administered As Single-Dose And Two-Dose Schedules in Healthy Adults,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005801-14,PL
EUCTR2021-000182-33,EudraCT,2021-01-21,2021-03-25,FALSE,Authorised,Phase 4,Interventional,Netherlands,"Impact of BCG vaccination, originally made to prevent tuberculosis, on the immune response to the COVID-19 vaccine in health care workers",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000182-33,NL
EUCTR2021-000206-17,EudraCT,2021-02-10,2021-10-03,FALSE,Authorised,Phase 4,Interventional,Sweden,"Studies of ongoing and completed SARS-CoV-2 infection (which causes COVID-19) within the healthcare in Stockholm County, with regard to vaccinations.",10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000206-17,SE
EUCTR2021-000349-42,EudraCT,2021-02-08,2021-03-26,FALSE,Authorised,Phase 4,Interventional,Sweden,Evaluation of How Long Immune Responses to SARS-CoV-2 Persist Following COVID-19 Vaccination,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000349-42,SE
EUCTR2020-005291-35,EudraCT,2021-03-22,2021-03-02,TRUE,Authorised,Phase 3,Interventional,Italy,A multicenter randomized trial to evaluate the efficacy of tocilizumab in patients with severe Coronavirus Disease 2019 (Covid-19) pneumonia failing glucocorticoids.,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005291-35,IT
EUCTR2020-005763-31,EudraCT,2021-03-22,2021-12-03,FALSE,Authorised,Phase 2,Interventional,"Portugal, Italy, United States, Spain, Poland",FREEDOM COVID Anticoagulation Strategy Randomized Trial,3600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005763-31,IT
EUCTR2021-000454-26,EudraCT,2021-03-25,2021-03-25,FALSE,Authorised,Phase 1/Phase 2,Interventional,Netherlands,"Safety and protection after vaccination against SARS-CoV-2, by injecting the vaccine in the skin",150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000454-26,NL
EUCTR2020-005828-11,EudraCT,2020-12-09,2020-12-16,FALSE,Authorised,Phase 3,Interventional,Greece,Anakinra treatment to prevent respiratory failure in COVID-19,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005828-11,GR
JPRN-jRCT2032200381,jRCT,2021-03-15,2021-02-03,TRUE,Recruiting,Phase 2,Interventional,Japan,Pilot Study of NOA-001,35,https://jrct.niph.go.jp/latest-detail/jRCT2032200381,NA
JPRN-jRCT2051200153,jRCT,2021-03-12,2021-10-03,FALSE,Not Recruiting,Phase 1,Interventional,Japan,"A Phase 1, single-dose and multiple-dose study of DS-2319b inhalation powder to assess the safety and pharmacokinetics of DS-2319a in healthy Japanese subjects",76,https://jrct.niph.go.jp/latest-detail/jRCT2051200153,NA
JPRN-UMIN000043367,UMIN-CTR,2021-02-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Rehabilitation in acute COVID-19 patients: Japanese multi-institutional survey,110,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049469,NA
JPRN-UMIN000043400,UMIN-CTR,2021-02-21,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation of operational capacity of mobile &quot;street laboratory&quot;: a pilot study using PCR test and antibody test for COVID-19,2400,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049552,NA
JPRN-UMIN000043403,UMIN-CTR,2021-02-28,2021-03-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Identifying the risk of COVID-19 between different underlying comorbidities through the collaborative effort of Core Hospitals for Clinical Research in Japan,7000000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049453,NA
JPRN-UMIN000043443,UMIN-CTR,2021-02-26,2021-02-09,TRUE,Recruiting,Not Applicable,Observational,Japan,The prevalence and characteristics of chronic cardiac injury associated with COVID-19,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049018,NA
JPRN-UMIN000043459,UMIN-CTR,2021-02-27,2021-02-27,FALSE,Recruiting,Not Applicable,Other,Asia(except Japan),"Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis",1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049628,NA
JPRN-UMIN000043530,UMIN-CTR,2021-03-05,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,The research on infections due to COVID-19,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049709,NA
JPRN-UMIN000043537,UMIN-CTR,2021-03-05,2021-01-01,TRUE,Recruiting,Not Applicable,Interventional,Africa,Post COVID-19 Anosmia,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049715,NA
JPRN-UMIN000043545,UMIN-CTR,2021-03-08,2021-02-25,TRUE,Recruiting,Not Applicable,Observational,Japan,Japan prospective multicenter study for the optimization of the COVID-19 vaccination based on the immune response and safety profile in inflammatory bowel disease patients,600,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049729,NA
JPRN-UMIN000043558,UMIN-CTR,2021-03-10,2021-03-10,FALSE,Recruiting,Not Applicable,Observational,Japan,Background factors affecting the effectiveness of the COVID-19 vaccine and their association with the microbiomes in the oral cavity and intestinal tract,180,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049712,NA
JPRN-UMIN000043566,UMIN-CTR,2021-03-09,2021-03-09,FALSE,Recruiting,Phase 1,Interventional,Japan,A pilot study of frailty prevention program during the COVID-19 pandemic,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049753,NA
JPRN-UMIN000043622,UMIN-CTR,2021-03-16,2021-03-16,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Retrospective cohort study utilizing COVIREGI-JP to evaluate the efficacy of tocilizumab for severe COVID-19 pneumonia,248,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049811,NA
EUCTR2020-001602-34,EudraCT,2020-04-03,2020-10-04,FALSE,Not Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D supplementation: a multicenter randomized controlled Trial of high dose versus standard dose vitamin D3 in high-risk COVID-19 patients,260,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001602-34,FR
EUCTR2020-002091-12,EudraCT,2020-05-05,2020-05-15,FALSE,Not Recruiting,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,BG
EUCTR2020-001498-63,EudraCT,2020-05-03,2020-05-18,FALSE,Authorised,Phase 2,Interventional,"United Kingdom, Belgium, United States, Brazil, France","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,BE
EUCTR2020-004408-32,EudraCT,2020-10-01,2020-10-23,FALSE,Authorised,Phase 2,Interventional,Greece,Clinical trial of the investigational drug AMY-101 for the treatment of patients with severe COVID-19.,62,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004408-32,GR
EUCTR2020-002772-12,EudraCT,2020-06-03,2020-07-17,FALSE,Authorised,Phase 2,Interventional,France,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002772-12,FR
EUCTR2020-001749-38,EudraCT,2020-07-01,2020-02-10,TRUE,Authorised,Phase 1/Phase 2,Interventional,Italy,Visualization of inflammation in COVID-19 patients,4,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001749-38,IT
EUCTR2020-002345-42,EudraCT,2020-09-23,2020-12-16,FALSE,Authorised,Phase 2,Interventional,"Sweden, Russian Federation, Brazil, Spain, France","A randomized, placebo controlled, double-blind, multi-center, phase II trial investigating the efficacy and safety of trimodulin (BT588) as add-on therapy to standard of care in adult subjects with severe COVID-19",114,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002345-42,FR
EUCTR2020-003614-13,EudraCT,2020-11-23,2020-12-18,FALSE,Authorised,Phase 2,Interventional,"Russian Federation, Italy","Study with hzVSF-v13 in patients with COVID-19 pneumonia: a phase II, proof of concept, multicentre, randomized, parallel-group, double-blind, placebo-controlled study",105,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003614-13,IT
EUCTR2020-001325-31,EudraCT,2020-04-07,2020-05-20,FALSE,Not Recruiting,Phase 2,Interventional,Netherlands,RDG-PET/CT imaging in COVID-19 patients.,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001325-31,NL
EUCTR2020-004571-41,EudraCT,2020-12-22,2021-01-22,FALSE,Authorised,Phase 2,Interventional,"Hungary, Slovakia, Ukraine, Poland, Bulgaria, Romania","A Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety and Efficacy of Rabeximod Compared to Standard of Care in Patients With Moderate Coronavirus Disease (COVID-19)",300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004571-41,HU
EUCTR2020-005919-51,EudraCT,2021-01-25,2021-01-19,TRUE,Authorised,Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,303,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005919-51,IT
EUCTR2020-001038-36,EudraCT,2020-04-14,2020-04-20,FALSE,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of vaccines in adults.,618,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001038-36,DE
EUCTR2020-001632-10,EudraCT,2020-04-20,2020-04-05,TRUE,Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,DE
EUCTR2018-003377-97,EudraCT,2018-11-05,2018-12-18,FALSE,Authorised,Phase 3/Phase 4,Interventional,Sweden,Long term effect on immune response after pneumococcal vaccination in patients with chronic lymphocytic leukemia and evaluation of the effect of revaccination.,126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003377-97,SE
EUCTR2020-003349-12,EudraCT,2020-08-14,2020-09-10,FALSE,Authorised,Phase 2,Interventional,Ireland,This is a proof of principle / feasibility study aiming to evaluate the effect of nebulised unfractionated heparin on procoagulant markers related to acute respiratory distress syndrome in patients invasively ventilated for Covid 19 lung disease.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003349-12,IE
EUCTR2020-005447-23,EudraCT,2021-01-28,2021-01-28,FALSE,Authorised,Phase 2,Interventional,Netherlands,Intravenous imatinib for corona virus-related lung injury.,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005447-23,NL
EUCTR2020-003363-25,EudraCT,2020-07-17,2020-08-18,FALSE,Authorised,Phase 3,Interventional,"Denmark, Sweden, India",Higher vs. Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Oxygen Deficiency: the COVID STEROID 2 trial,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003363-25,DK
EUCTR2020-001335-28,EudraCT,2020-04-03,2020-04-30,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, South Africa, Peru, Belgium, Netherlands, United States, Brazil, Mexico, France, Germany",A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,DE
EUCTR2020-002027-10,EudraCT,2020-04-24,2020-07-13,FALSE,Authorised,Phase 2,Interventional,Sweden,"A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19)",600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002027-10,SE
EUCTR2020-002190-10,EudraCT,2021-01-22,2021-05-02,FALSE,Authorised,Phase 3,Interventional,Ireland,A Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002190-10,IE
EUCTR2020-001644-25,EudraCT,2020-04-11,2020-06-05,FALSE,Not Recruiting,Phase 2,Interventional,"Sweden, Italy, United States, Spain, France, Germany",A Phase 2 Randomized Study of the Efficacy and Safety of Acalabrutinib with Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized with COVID-19,428,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001644-25,FR
EUCTR2020-001659-42,EudraCT,2020-04-20,2020-04-18,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,ES
EUCTR2021-000515-24,EudraCT,2021-02-05,2021-02-15,FALSE,Authorised,Phase 4,Interventional,Netherlands,Vaccination Against Covid in Primary Immune Deficiencies,700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000515-24,NL
EUCTR2020-002123-11,EudraCT,2020-05-08,2020-07-05,FALSE,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE CYCLOSPORINE VS. NON TREATMENT ASSOCIATED TO STANDARD OF CARE TO COMPARE THEIR EFFICACY IN THE  COVID-19 PNEUMONIA.,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,ES
EUCTR2020-003734-20,EudraCT,2021-02-15,2021-03-02,FALSE,Authorised,Phase 1/Phase 2,Interventional,Italy,"Study to determine the safety and immunogenicity of COVID-eVax, a vaccine for COVID-19 in healthy adult volunteers.",160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003734-20,IT
EUCTR2020-005410-18,EudraCT,2020-11-16,2020-02-12,TRUE,Authorised,Phase 2/Phase 3,Interventional,Poland,"Multicentre, randomized, double-blind, placebo-controlled, non-commercial clinical trial to evaluate the efficacy and safety of specific anti-SARS-CoV-2 immunoglobulin in the treatment of COVID-19",480,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005410-18,PL
EUCTR2021-000868-30,EudraCT,2021-02-17,2021-02-17,FALSE,Authorised,Phase 4,Interventional,Netherlands,The efficacy and safety of COVID-19 vaccination in patients with a kidney disease,850,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000868-30,NL
EUCTR2021-000412-28,EudraCT,2021-02-04,2021-02-17,FALSE,Authorised,Phase 4,Interventional,Belgium,Sars-Cov2 vaccination in kidney transplant patient: a phase IV study of the immunogenicity and its determinants,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000412-28,BE
EUCTR2021-000461-33,EudraCT,2021-02-04,2021-02-17,FALSE,Authorised,Phase 4,Interventional,Belgium,Covid-19: Sars-Cov2 vaccination in hemodialysis patient: a phase IV study of the immunogenicity and its determinants,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000461-33,BE
EUCTR2020-001760-29,EudraCT,2020-11-19,2020-09-09,TRUE,Authorised,Phase 2,Interventional,Spain,Phase III clinical trial to evaluate the efficacy and safety of inhaled ethanol in the treatment of early-stage COVID-19.,156,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001760-29,ES
EUCTR2020-006042-39,EudraCT,2021-01-12,2021-02-19,FALSE,Authorised,Phase 2,Interventional,Hungary,Safety and efficacy of Favipiravir,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006042-39,HU
EUCTR2020-001236-10,EudraCT,2020-03-31,2020-03-31,FALSE,Not Recruiting,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,NL
EUCTR2020-004715-27,EudraCT,2020-12-16,2021-03-02,FALSE,Authorised,Phase 2,Interventional,Germany,"A study to investigate the effect of NOC-100 in terms of efficacy, safety, tolerability and drug levels in the blood in patients with acute and chronic cough.",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004715-27,DE
EUCTR2021-000413-17,EudraCT,2021-02-15,2021-02-24,FALSE,Authorised,Phase 4,Interventional,Sweden,COVERS (COVID-Vaccination Efficiency Risk and Safety Study),4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000413-17,SE
EUCTR2020-002542-16,EudraCT,2020-09-29,2020-10-16,FALSE,Authorised,Phase 3,Interventional,"Denmark, Argentina, Portugal, Greece, United Kingdom, Belgium, Peru, United States, Thailand, Spain, Israel, Mexico, Japan, Poland, France, Germany, Nigeria",Treatment of patients with coronavirus infection with immunoglobulin,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002542-16,GR
EUCTR2020-001251-41,EudraCT,2020-03-25,2020-04-17,FALSE,Not Recruiting,Phase 2,Interventional,France,STUDY TESTING THE VALUE OF IMATINIB IN PREVENTION OF COVID-19 IN AGED PATIENTS.,382,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001251-41,FR
EUCTR2020-001870-32,EudraCT,2020-05-05,2020-05-14,FALSE,Not Recruiting,Phase 2,Interventional,"Denmark, Hungary, Netherlands, Spain, Germany","Study to assess efficacy and safety of DFV890 in patients with COVID-19 pneumonia and impaired respiratory function
",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001870-32,HU
EUCTR2020-003654-71,EudraCT,2020-11-26,2020-04-12,TRUE,Not Recruiting,Phase 3,Interventional,"Chile, Moldova, Republic of, Greece, United States, Brazil, Mexico, Israel, Romania",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003654-71,GR
EUCTR2020-000936-23,EudraCT,2020-05-14,2020-05-14,FALSE,Not Recruiting,Phase 3,Interventional,"France, Portugal, Austria","This study is an adaptive, randomized, open clinical trial to evaluate the safety and efficacy of possible therapeutic agents in hospitalized adult patients diagnosed with COVID-19.",3100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23,AT
EUCTR2020-001244-26,EudraCT,2020-03-31,2020-11-04,FALSE,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,AT
EUCTR2020-002913-16,EudraCT,2020-11-05,2020-11-26,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Denmark, Sweden, Russian Federation, Portugal, United Kingdom, Belgium, Netherlands, Italy, Brazil, Spain, Austria, China, France, Germany",The TRISTARDS trial - ThRombolysIS Therapy for ARDS A study to test whether different doses of alteplase help people with severe breathing problems because of COVID 19.,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002913-16,BE
EUCTR2020-002299-11,EudraCT,2020-06-02,2020-09-17,FALSE,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled, adaptive-design study to assess the safety and efficacy of daily 200 mg fluvoxamine as add-on therapy to standard of care in moderate severity COVID-19 patients",100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002299-11,HU
NCT03808922,ClinicalTrials.gov,2019-01-16,2019-05-23,FALSE,Recruiting,Phase 3,Interventional,"Denmark, Australia, Hong Kong, Taiwan, United States, China, France, South Korea",Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,274,https://clinicaltrials.gov/show/NCT03808922,NA
NCT04302766,ClinicalTrials.gov,2020-03-02,2021-02-10,FALSE,Not Recruiting,Not Applicable,Expanded Access,"Afghanistan, Kuwait, Guam, United States, Djibouti, Japan, Iraq, Germany",Expanded Access Remdesivir (RDV; GS-5734â„¢),Not Available,https://clinicaltrials.gov/show/NCT04302766,NA
NCT04316884,ClinicalTrials.gov,2020-03-13,2020-03-12,TRUE,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,300,https://clinicaltrials.gov/show/NCT04316884,NA
NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-24,FALSE,Not Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,243,https://clinicaltrials.gov/show/NCT04317040,NA
NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,FALSE,Not Recruiting,Phase 2,Interventional,"Gibraltar, Greece",The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,105,https://clinicaltrials.gov/show/NCT04326790,NA
NCT04333472,ClinicalTrials.gov,2020-04-01,2021-01-06,FALSE,Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,40,https://clinicaltrials.gov/show/NCT04333472,NA
NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,FALSE,Not Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,1363,https://clinicaltrials.gov/show/NCT04334148,NA
NCT04340349,ClinicalTrials.gov,2020-04-02,2021-02-01,FALSE,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,214,https://clinicaltrials.gov/show/NCT04340349,NA
NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,TRUE,Not Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,44,https://clinicaltrials.gov/show/NCT04341493,NA
NCT04342806,ClinicalTrials.gov,2020-04-08,2020-04-10,FALSE,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",100000,https://clinicaltrials.gov/show/NCT04342806,NA
NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,FALSE,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),800,https://clinicaltrials.gov/show/NCT04343248,NA
NCT04346927,ClinicalTrials.gov,2020-04-13,2020-08-10,FALSE,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation for Patients Diagnosed With Coronavirus,30,https://clinicaltrials.gov/show/NCT04346927,NA
NCT04348435,ClinicalTrials.gov,2020-04-14,2020-05-14,FALSE,Not Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",100,https://clinicaltrials.gov/show/NCT04348435,NA
NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),227,https://clinicaltrials.gov/show/NCT04351243,NA
NCT04352634,ClinicalTrials.gov,2020-04-08,2020-04-26,FALSE,Recruiting,Not Applicable,Observational,"Saudi Arabia, Bolivia, Guatemala, Turkey, Armenia, Venezuela, Costa Rica, Puerto Rico, Germany, Lebanon, Argentina, Netherlands, Italy, Mexico, Nigeria, Chile, Tunisia, Australia, United States, Spain, Czech Republic",The Covid-19 HEalth caRe wOrkErS (HEROES) Study,2000,https://clinicaltrials.gov/show/NCT04352634,NA
NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,FALSE,Recruiting,Not Applicable,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,40,https://clinicaltrials.gov/show/NCT04353674,NA
NCT04355234,ClinicalTrials.gov,2020-04-17,2020-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,France,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",2500,https://clinicaltrials.gov/show/NCT04355234,NA
NCT04355533,ClinicalTrials.gov,2020-04-17,2020-07-29,FALSE,Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,1000,https://clinicaltrials.gov/show/NCT04355533,NA
NCT04356144,ClinicalTrials.gov,2020-04-15,2020-04-15,FALSE,Not Recruiting,Not Applicable,Observational,Austria,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,58,https://clinicaltrials.gov/show/NCT04356144,NA
NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,66,https://clinicaltrials.gov/show/NCT04356833,NA
NCT04357886,ClinicalTrials.gov,2020-04-20,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Awareness of COVID-19 in Turkey,2605,https://clinicaltrials.gov/show/NCT04357886,NA
NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,FALSE,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,20,https://clinicaltrials.gov/show/NCT04358081,NA
NCT04360278,ClinicalTrials.gov,2020-04-22,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,United States,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,1500,https://clinicaltrials.gov/show/NCT04360278,NA
NCT04362189,ClinicalTrials.gov,2020-04-21,2020-06-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04362189,NA
NCT04363034,ClinicalTrials.gov,2020-04-23,2020-05-15,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,Not Available,https://clinicaltrials.gov/show/NCT04363034,NA
NCT04365439,ClinicalTrials.gov,2020-04-18,2020-07-20,FALSE,Not Recruiting,Not Applicable,Interventional,Switzerland,Convalescent Plasma for COVID-19,11,https://clinicaltrials.gov/show/NCT04365439,NA
NCT04365764,ClinicalTrials.gov,2020-04-25,2020-03-14,TRUE,Recruiting,Not Applicable,Observational,France,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,400,https://clinicaltrials.gov/show/NCT04365764,NA
NCT04367740,ClinicalTrials.gov,2020-04-27,2020-04-28,FALSE,Recruiting,Not Applicable,Observational,United States,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",10000,https://clinicaltrials.gov/show/NCT04367740,NA
NCT04367870,ClinicalTrials.gov,2020-04-28,2020-05-23,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 Detection Test in Oncology,450,https://clinicaltrials.gov/show/NCT04367870,NA
NCT04368221,ClinicalTrials.gov,2020-04-24,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,France,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,576,https://clinicaltrials.gov/show/NCT04368221,NA
NCT04368676,ClinicalTrials.gov,2020-04-26,2020-06-25,FALSE,Not Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04368676,NA
NCT04370119,ClinicalTrials.gov,2020-04-29,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,Germany,Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,4000,https://clinicaltrials.gov/show/NCT04370119,NA
NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,223,https://clinicaltrials.gov/show/NCT04371393,NA
NCT04371432,ClinicalTrials.gov,2020-04-29,2020-05-05,FALSE,Recruiting,Not Applicable,Observational,United States,Genetics of COVID-19 Susceptibility and Manifestations,2500,https://clinicaltrials.gov/show/NCT04371432,NA
NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,20,https://clinicaltrials.gov/show/NCT04374149,NA
NCT04375410,ClinicalTrials.gov,2020-04-30,2020-04-22,TRUE,Not Recruiting,Not Applicable,Observational,Denmark,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,6273,https://clinicaltrials.gov/show/NCT04375410,NA
NCT04378777,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Immunophenotyping Assessment in a COVID-19 Cohort,1227,https://clinicaltrials.gov/show/NCT04378777,NA
NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,69,https://clinicaltrials.gov/show/NCT04382560,NA
NCT04388813,ClinicalTrials.gov,2020-05-04,2020-05-28,FALSE,Recruiting,Not Applicable,Observational,United States,Predictors of Severe COVID-19 Outcomes,1500,https://clinicaltrials.gov/show/NCT04388813,NA
NCT04391738,ClinicalTrials.gov,2020-05-14,2020-02-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Association Between BMI and COVID-19,1200,https://clinicaltrials.gov/show/NCT04391738,NA
NCT04394195,ClinicalTrials.gov,2020-05-16,2020-04-03,TRUE,Not Recruiting,Not Applicable,Observational,France,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,72,https://clinicaltrials.gov/show/NCT04394195,NA
NCT04394884,ClinicalTrials.gov,2020-05-19,2021-09-09,FALSE,Not Recruiting,Not Applicable,Observational,United States,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),120,https://clinicaltrials.gov/show/NCT04394884,NA
NCT04397614,ClinicalTrials.gov,2020-05-20,2020-07-22,FALSE,Recruiting,Phase 2,Interventional,United States,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,500,https://clinicaltrials.gov/show/NCT04397614,NA
NCT04397939,ClinicalTrials.gov,2020-05-19,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,United States,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,5000,https://clinicaltrials.gov/show/NCT04397939,NA
NCT04399603,ClinicalTrials.gov,2020-05-19,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Mechanisms of Multi-organ Failure in COVID-19,120,https://clinicaltrials.gov/show/NCT04399603,NA
NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",40,https://clinicaltrials.gov/show/NCT04400305,NA
NCT04401150,ClinicalTrials.gov,2020-05-21,2020-08-14,FALSE,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,800,https://clinicaltrials.gov/show/NCT04401150,NA
NCT04401410,ClinicalTrials.gov,2020-05-21,2020-11-04,FALSE,Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,58,https://clinicaltrials.gov/show/NCT04401410,NA
NCT04401423,ClinicalTrials.gov,2020-05-21,2021-02-10,FALSE,Recruiting,Phase 2,Interventional,United States,TXA127 for the Treatment of Severe COVID-19,100,https://clinicaltrials.gov/show/NCT04401423,NA
NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,TRUE,Not Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246,NA
NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,FALSE,Recruiting,Phase 2,Interventional,United States,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,225,https://clinicaltrials.gov/show/NCT04408183,NA
NCT04410718,ClinicalTrials.gov,2020-05-05,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Denmark,Glycaemia and Cardiac Function in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04410718,NA
NCT04411446,ClinicalTrials.gov,2020-05-26,2020-08-11,FALSE,Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,1264,https://clinicaltrials.gov/show/NCT04411446,NA
NCT04415359,ClinicalTrials.gov,2020-05-29,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,700,https://clinicaltrials.gov/show/NCT04415359,NA
NCT04416464,ClinicalTrials.gov,2020-06-03,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,Portugal,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,230,https://clinicaltrials.gov/show/NCT04416464,NA
NCT04418557,ClinicalTrials.gov,2020-06-03,2020-04-28,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 and Obstetric Transmission,200,https://clinicaltrials.gov/show/NCT04418557,NA
NCT04428801,ClinicalTrials.gov,2020-04-08,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,200,https://clinicaltrials.gov/show/NCT04428801,NA
NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease",22,https://clinicaltrials.gov/show/NCT04432298,NA
NCT04441476,ClinicalTrials.gov,2020-06-17,2020-04-21,TRUE,Not Recruiting,Not Applicable,Observational,France,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,3080,https://clinicaltrials.gov/show/NCT04441476,NA
NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-17,FALSE,Not Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,20,https://clinicaltrials.gov/show/NCT04441996,NA
NCT04445870,ClinicalTrials.gov,2020-06-23,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,France,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,100,https://clinicaltrials.gov/show/NCT04445870,NA
NCT04446169,ClinicalTrials.gov,2020-06-20,2020-06-27,FALSE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 (SARS-CoV-2) in Urine and Semen,43,https://clinicaltrials.gov/show/NCT04446169,NA
NCT04458298,ClinicalTrials.gov,2020-06-29,2020-08-11,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,24,https://clinicaltrials.gov/show/NCT04458298,NA
NCT04466098,ClinicalTrials.gov,2020-07-08,2020-07-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),9,https://clinicaltrials.gov/show/NCT04466098,NA
NCT04466371,ClinicalTrials.gov,2020-07-07,2021-07-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,9209,https://clinicaltrials.gov/show/NCT04466371,NA
NCT04466800,ClinicalTrials.gov,2020-07-09,2020-07-30,FALSE,Recruiting,Not Applicable,Interventional,France,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),160,https://clinicaltrials.gov/show/NCT04466800,NA
NCT04466839,ClinicalTrials.gov,2020-06-23,2020-07-02,FALSE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,411,https://clinicaltrials.gov/show/NCT04466839,NA
NCT04467112,ClinicalTrials.gov,2020-06-30,2020-07-30,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,8,https://clinicaltrials.gov/show/NCT04467112,NA
NCT04474496,ClinicalTrials.gov,2020-07-10,2020-07-27,FALSE,Not Recruiting,Not Applicable,Observational,United States,Impact of COVID-19 on Marshallese Communities in the U.S.,120,https://clinicaltrials.gov/show/NCT04474496,NA
NCT04476992,ClinicalTrials.gov,2020-07-16,2020-07-24,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,20,https://clinicaltrials.gov/show/NCT04476992,NA
NCT04481477,ClinicalTrials.gov,2020-07-21,2020-11-27,FALSE,Recruiting,Not Applicable,Observational,Spain,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,450,https://clinicaltrials.gov/show/NCT04481477,NA
NCT04481620,ClinicalTrials.gov,2020-07-20,2020-08-31,FALSE,Recruiting,Not Applicable,Observational,France,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",1315,https://clinicaltrials.gov/show/NCT04481620,NA
NCT04482023,ClinicalTrials.gov,2020-07-21,2021-03-23,FALSE,Recruiting,Not Applicable,Observational,Spain,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,150,https://clinicaltrials.gov/show/NCT04482023,NA
NCT04482647,ClinicalTrials.gov,2020-07-21,2020-06-17,TRUE,Recruiting,Phase 1,Interventional,United States,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,50,https://clinicaltrials.gov/show/NCT04482647,NA
NCT04486313,ClinicalTrials.gov,2020-07-23,2020-08-13,FALSE,Not Recruiting,Phase 3,Interventional,United States,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,1092,https://clinicaltrials.gov/show/NCT04486313,NA
NCT04496245,ClinicalTrials.gov,2020-07-26,2020-08-24,FALSE,Not Recruiting,Phase 3,Interventional,Australia,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,59,https://clinicaltrials.gov/show/NCT04496245,NA
NCT04497636,ClinicalTrials.gov,2020-08-01,2020-07-03,TRUE,Recruiting,Not Applicable,Observational,Chile,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,1092,https://clinicaltrials.gov/show/NCT04497636,NA
NCT04508556,ClinicalTrials.gov,2020-08-07,2020-09-30,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,40,https://clinicaltrials.gov/show/NCT04508556,NA
NCT04510207,ClinicalTrials.gov,2020-08-03,2020-07-16,TRUE,Recruiting,Phase 3,Interventional,"Egypt, Bahrain, United Arab Emirates, Jordan","A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",45000,https://clinicaltrials.gov/show/NCT04510207,NA
NCT04511819,ClinicalTrials.gov,2020-08-08,2020-08-28,FALSE,Not Recruiting,Phase 3,Interventional,"Mexico, Peru, United States, Brazil",Losmapimod Safety and Efficacy in COVID-19,410,https://clinicaltrials.gov/show/NCT04511819,NA
NCT04514016,ClinicalTrials.gov,2020-08-13,2020-08-12,TRUE,Not Recruiting,Not Applicable,Observational,United States,Cross Sectional CFAR HIV/COVID-19 Study,64,https://clinicaltrials.gov/show/NCT04514016,NA
NCT04523246,ClinicalTrials.gov,2020-08-20,2020-09-01,FALSE,Recruiting,Phase 1,Interventional,United States,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,250,https://clinicaltrials.gov/show/NCT04523246,NA
NCT04526145,ClinicalTrials.gov,2020-08-10,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,30,https://clinicaltrials.gov/show/NCT04526145,NA
NCT04527224,ClinicalTrials.gov,2020-08-21,2021-12-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,10,https://clinicaltrials.gov/show/NCT04527224,NA
NCT04527354,ClinicalTrials.gov,2020-08-24,2020-09-01,FALSE,Not Recruiting,Phase 2,Interventional,Russian Federation,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04527354,NA
NCT04528329,ClinicalTrials.gov,2020-08-24,2020-08-30,FALSE,Recruiting,Phase 4,Interventional,Egypt,Anosmia and / or Ageusia and Early Corticosteroid Use,300,https://clinicaltrials.gov/show/NCT04528329,NA
NCT04528641,ClinicalTrials.gov,2020-08-19,2020-08-10,TRUE,Not Recruiting,Phase 1,Interventional,Italy,GRAd-COV2 Vaccine Against COVID-19,90,https://clinicaltrials.gov/show/NCT04528641,NA
NCT04542512,ClinicalTrials.gov,2020-09-06,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,France,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,800,https://clinicaltrials.gov/show/NCT04542512,NA
NCT04544033,ClinicalTrials.gov,2020-09-05,2020-09-15,FALSE,Recruiting,Not Applicable,Observational,Egypt,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,120,https://clinicaltrials.gov/show/NCT04544033,NA
NCT04551378,ClinicalTrials.gov,2020-09-15,2020-07-13,TRUE,Recruiting,Not Applicable,Observational,United States,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,600,https://clinicaltrials.gov/show/NCT04551378,NA
NCT04558385,ClinicalTrials.gov,2020-09-20,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Seroconversion in COVID-19 Recovered Population,275,https://clinicaltrials.gov/show/NCT04558385,NA
NCT04568499,ClinicalTrials.gov,2020-09-24,2020-11-27,FALSE,Recruiting,Not Applicable,Observational,"South Sudan, Democratic Republic of Congo","Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",1000,https://clinicaltrials.gov/show/NCT04568499,NA
NCT04583592,ClinicalTrials.gov,2020-10-07,2020-11-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),295,https://clinicaltrials.gov/show/NCT04583592,NA
NCT04594278,ClinicalTrials.gov,2020-10-18,2021-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Burnout Study,100,https://clinicaltrials.gov/show/NCT04594278,NA
NCT04598334,ClinicalTrials.gov,2020-10-21,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,Bangladesh,Cytokine Storm Among Bangladeshi Patients With COVID-19,75,https://clinicaltrials.gov/show/NCT04598334,NA
NCT04600713,ClinicalTrials.gov,2020-10-09,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,180,https://clinicaltrials.gov/show/NCT04600713,NA
NCT04600895,ClinicalTrials.gov,2020-09-15,2020-11-30,FALSE,Recruiting,Phase 3,Interventional,United States,The Prevent Severe COVID-19 (PRESECO) Study,826,https://clinicaltrials.gov/show/NCT04600895,NA
NCT04603742,ClinicalTrials.gov,2020-10-21,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Anakinra, COVID-19, Cytokine Storm",170,https://clinicaltrials.gov/show/NCT04603742,NA
NCT04606784,ClinicalTrials.gov,2020-10-27,2020-10-28,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,40,https://clinicaltrials.gov/show/NCT04606784,NA
NCT04608266,ClinicalTrials.gov,2020-10-28,2020-12-03,FALSE,Recruiting,Phase 3,Interventional,France,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,596,https://clinicaltrials.gov/show/NCT04608266,NA
NCT04609462,ClinicalTrials.gov,2020-09-24,2020-08-11,TRUE,Not Recruiting,Not Applicable,Interventional,Colombia,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,199,https://clinicaltrials.gov/show/NCT04609462,NA
NCT04619680,ClinicalTrials.gov,2020-11-05,2020-11-18,FALSE,Recruiting,Phase 4,Interventional,United States,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,120,https://clinicaltrials.gov/show/NCT04619680,NA
NCT04626050,ClinicalTrials.gov,2020-11-10,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",120,https://clinicaltrials.gov/show/NCT04626050,NA
NCT04631536,ClinicalTrials.gov,2020-10-28,2021-01-10,FALSE,Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,80,https://clinicaltrials.gov/show/NCT04631536,NA
NCT04632537,ClinicalTrials.gov,2020-11-04,2020-12-07,FALSE,Not Recruiting,Phase 3,Interventional,United States,BCG Vaccination to Prevent COVID-19,0,https://clinicaltrials.gov/show/NCT04632537,NA
NCT04640402,ClinicalTrials.gov,2020-11-19,2020-11-17,TRUE,Recruiting,Phase 2,Interventional,China,A Phase ? Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),960,https://clinicaltrials.gov/show/NCT04640402,NA
NCT04642638,ClinicalTrials.gov,2020-11-23,2020-11-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",401,https://clinicaltrials.gov/show/NCT04642638,NA
NCT04644276,ClinicalTrials.gov,2020-11-18,2021-02-17,FALSE,Recruiting,Not Applicable,Interventional,United States,Mask Adhesive Institutional Study,30,https://clinicaltrials.gov/show/NCT04644276,NA
NCT04646642,ClinicalTrials.gov,2020-11-25,2020-12-14,FALSE,Not Recruiting,Not Applicable,Observational,United States,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",21,https://clinicaltrials.gov/show/NCT04646642,NA
NCT04655586,ClinicalTrials.gov,2020-12-02,2020-12-10,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",100,https://clinicaltrials.gov/show/NCT04655586,NA
NCT04664309,ClinicalTrials.gov,2020-12-09,2021-03-26,FALSE,Recruiting,Not Applicable,Observational,United States,Understanding Immunity to the COVID-19 Vaccines,1000,https://clinicaltrials.gov/show/NCT04664309,NA
NCT04665752,ClinicalTrials.gov,2020-12-11,2021-02-02,FALSE,Recruiting,Not Applicable,Observational,United States,Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors,150,https://clinicaltrials.gov/show/NCT04665752,NA
NCT04666012,ClinicalTrials.gov,2020-12-10,2020-12-29,FALSE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,150,https://clinicaltrials.gov/show/NCT04666012,NA
NCT04668209,ClinicalTrials.gov,2020-12-02,2021-01-01,FALSE,Recruiting,Phase 2,Interventional,United States,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),40,https://clinicaltrials.gov/show/NCT04668209,NA
NCT04668339,ClinicalTrials.gov,2020-11-25,2021-01-07,FALSE,Not Recruiting,Phase 2,Interventional,"Singapore, United States",A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,600,https://clinicaltrials.gov/show/NCT04668339,NA
NCT04678739,ClinicalTrials.gov,2020-12-19,2020-08-15,TRUE,Not Recruiting,Phase 3,Interventional,Bangladesh,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,205,https://clinicaltrials.gov/show/NCT04678739,NA
NCT04679493,ClinicalTrials.gov,2020-12-18,2020-12-24,FALSE,Not Recruiting,Phase 1,Interventional,Russian Federation,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers",16,https://clinicaltrials.gov/show/NCT04679493,NA
NCT04680949,ClinicalTrials.gov,2020-12-18,2020-12-23,FALSE,Not Recruiting,Phase 3,Interventional,"Italy, Greece",suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,606,https://clinicaltrials.gov/show/NCT04680949,NA
NCT04689399,ClinicalTrials.gov,2020-12-26,2020-12-26,FALSE,Not Recruiting,Not Applicable,Interventional,Denmark,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,4697,https://clinicaltrials.gov/show/NCT04689399,NA
NCT04690387,ClinicalTrials.gov,2020-12-28,2020-12-07,TRUE,Not Recruiting,Phase 1,Interventional,Indonesia,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",27,https://clinicaltrials.gov/show/NCT04690387,NA
NCT04695652,ClinicalTrials.gov,2020-12-31,2020-12-30,TRUE,Not Recruiting,Phase 2,Interventional,"Taiwan, Vietnam",A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,3700,https://clinicaltrials.gov/show/NCT04695652,NA
NCT04700163,ClinicalTrials.gov,2021-01-05,2021-01-11,FALSE,Not Recruiting,Phase 1,Interventional,United States,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,23,https://clinicaltrials.gov/show/NCT04700163,NA
NCT04701606,ClinicalTrials.gov,2021-01-06,2021-03-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Philippines,The Safety and Efficacy of Pyronaridine-artesunate (PyramaxÂ® or ArtecomÂ®)in COVID-19 Patients,402,https://clinicaltrials.gov/show/NCT04701606,NA
NCT04704388,ClinicalTrials.gov,2021-01-07,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,478,https://clinicaltrials.gov/show/NCT04704388,NA
NCT04706533,ClinicalTrials.gov,2021-01-08,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,United States,"Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19",2000,https://clinicaltrials.gov/show/NCT04706533,NA
NCT04708912,ClinicalTrials.gov,2021-01-11,2020-12-15,TRUE,Recruiting,Not Applicable,Observational,Turkey,Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04708912,NA
NCT04709328,ClinicalTrials.gov,2021-01-13,2021-03-28,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,690,https://clinicaltrials.gov/show/NCT04709328,NA
NCT04710394,ClinicalTrials.gov,2021-01-13,2021-01-11,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,240,https://clinicaltrials.gov/show/NCT04710394,NA
NCT04712110,ClinicalTrials.gov,2021-01-14,2021-02-24,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),200,https://clinicaltrials.gov/show/NCT04712110,NA
NCT04720118,ClinicalTrials.gov,2021-01-14,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,United States,Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic,150,https://clinicaltrials.gov/show/NCT04720118,NA
NCT04723290,ClinicalTrials.gov,2021-01-21,2020-06-20,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,2817,https://clinicaltrials.gov/show/NCT04723290,NA
NCT04727762,ClinicalTrials.gov,2021-01-22,2021-02-04,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Use of the Mask and Current Pandemic,629,https://clinicaltrials.gov/show/NCT04727762,NA
NCT04729140,ClinicalTrials.gov,2020-12-30,2020-12-28,TRUE,Recruiting,Phase 4,Interventional,United States,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,150,https://clinicaltrials.gov/show/NCT04729140,NA
NCT04732637,ClinicalTrials.gov,2021-01-28,2021-03-31,FALSE,Not Recruiting,Not Applicable,Observational,"India, Singapore",Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA,300,https://clinicaltrials.gov/show/NCT04732637,NA
NCT04733677,ClinicalTrials.gov,2021-01-27,2021-03-19,FALSE,Recruiting,Not Applicable,Observational,United States,User Experience of the OSR M-1,200,https://clinicaltrials.gov/show/NCT04733677,NA
NCT04737486,ClinicalTrials.gov,2020-12-31,2020-12-16,TRUE,Not Recruiting,Phase 1,Interventional,United States,A First-in-Human Study of AV-001 in Healthy Subjects,48,https://clinicaltrials.gov/show/NCT04737486,NA
NCT04741386,ClinicalTrials.gov,2021-02-04,2021-02-17,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study,849,https://clinicaltrials.gov/show/NCT04741386,NA
NCT04748172,ClinicalTrials.gov,2021-02-06,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Israel,COVID-19 Vaccine and Ovarian Reserve,200,https://clinicaltrials.gov/show/NCT04748172,NA
NCT04753632,ClinicalTrials.gov,2021-02-12,2021-03-09,FALSE,Recruiting,Not Applicable,Observational,Spain,Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04753632,NA
NCT04756141,ClinicalTrials.gov,2021-02-12,2021-03-03,FALSE,Recruiting,Not Applicable,Interventional,United States,CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)),20,https://clinicaltrials.gov/show/NCT04756141,NA
NCT04757831,ClinicalTrials.gov,2021-02-11,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children),1000000,https://clinicaltrials.gov/show/NCT04757831,NA
NCT04760704,ClinicalTrials.gov,2021-02-17,2021-02-19,FALSE,Recruiting,Not Applicable,Observational,France,Covid-19 Vaccine Response in Elderly Subjects,250,https://clinicaltrials.gov/show/NCT04760704,NA
NCT04764422,ClinicalTrials.gov,2021-02-08,2021-03-20,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Thailand,Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand,460,https://clinicaltrials.gov/show/NCT04764422,NA
NCT04765475,ClinicalTrials.gov,2021-01-29,2021-03-08,FALSE,Recruiting,Not Applicable,Interventional,United States,Protecting Native Families From COVID-19,600,https://clinicaltrials.gov/show/NCT04765475,NA
NCT04766931,ClinicalTrials.gov,2021-02-04,2021-03-27,FALSE,Recruiting,Phase 1,Interventional,United States,The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection,32,https://clinicaltrials.gov/show/NCT04766931,NA
NCT04767958,ClinicalTrials.gov,2021-02-19,2021-03-19,FALSE,Recruiting,Not Applicable,Interventional,Canada,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,2500,https://clinicaltrials.gov/show/NCT04767958,NA
NCT04772404,ClinicalTrials.gov,2021-02-12,2021-03-07,FALSE,Recruiting,Not Applicable,Observational,Spain,"Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep",100,https://clinicaltrials.gov/show/NCT04772404,NA
NCT04784689,ClinicalTrials.gov,2021-03-03,2021-02-24,TRUE,Recruiting,Not Applicable,Observational,United States,Host Immune Response to Novel RNA COVID-19 Vaccination,400,https://clinicaltrials.gov/show/NCT04784689,NA
NCT04789512,ClinicalTrials.gov,2021-03-06,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19,42,https://clinicaltrials.gov/show/NCT04789512,NA
NCT04793464,ClinicalTrials.gov,2021-02-25,2021-02-04,TRUE,Recruiting,Not Applicable,Interventional,United States,COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos),3600,https://clinicaltrials.gov/show/NCT04793464,NA
NCT04794088,ClinicalTrials.gov,2021-02-26,2021-03-14,FALSE,Recruiting,Phase 2,Interventional,Netherlands,Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04794088,NA
NCT04798066,ClinicalTrials.gov,2021-03-11,2021-04-08,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,Intermediate Size Expanded Access Protocol Evaluating HB-adMSC's for the Treatment of Post-COVID-19 Syndrome,Not Available,https://clinicaltrials.gov/show/NCT04798066,NA
NCT04798677,ClinicalTrials.gov,2021-03-12,2020-10-29,TRUE,Recruiting,Not Applicable,Interventional,Spain,Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine,90,https://clinicaltrials.gov/show/NCT04798677,NA
NCT04800965,ClinicalTrials.gov,2021-02-06,2021-01-31,TRUE,Recruiting,Not Applicable,Interventional,United States,Text-based Interventions to Promote COVID-19 Vaccinations,400000,https://clinicaltrials.gov/show/NCT04800965,NA
NCT04801524,ClinicalTrials.gov,2021-03-15,2021-02-07,TRUE,Recruiting,Not Applicable,Interventional,United States,Text-based Reminders to Promote COVID-19 Vaccinations,250000,https://clinicaltrials.gov/show/NCT04801524,NA
NCT04802018,ClinicalTrials.gov,2021-03-16,2021-03-09,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04802018,NA
NCT04805632,ClinicalTrials.gov,2021-03-16,2021-03-23,FALSE,Recruiting,Not Applicable,Observational,Russian Federation,Immune Response in Dialysis Patients Vaccinated Against SARS-CoV-2,42,https://clinicaltrials.gov/show/NCT04805632,NA
NCT04806620,ClinicalTrials.gov,2021-03-17,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,United States,Comparison of ME/CFS and Long COVID-19 Patients,10000,https://clinicaltrials.gov/show/NCT04806620,NA
NCT04806867,ClinicalTrials.gov,2020-12-09,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia,918,https://clinicaltrials.gov/show/NCT04806867,NA
NCT04810637,ClinicalTrials.gov,2021-03-17,2020-11-01,TRUE,Recruiting,Phase 2,Interventional,Indonesia,A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19,210,https://clinicaltrials.gov/show/NCT04810637,NA
NCT04810949,ClinicalTrials.gov,2021-03-18,2020-08-05,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml,41,https://clinicaltrials.gov/show/NCT04810949,NA
NCT04811339,ClinicalTrials.gov,2021-03-20,2020-09-02,TRUE,Recruiting,Phase 4,Interventional,United States,Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol),35,https://clinicaltrials.gov/show/NCT04811339,NA
NCT04811352,ClinicalTrials.gov,2021-03-22,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,Drug Abuse During the COVID-19 Pandemic.,200,https://clinicaltrials.gov/show/NCT04811352,NA
NCT04811391,ClinicalTrials.gov,2021-03-19,2021-02-19,TRUE,Recruiting,Not Applicable,Observational,Albania,COVID-19 Vaccine Effectiveness in Albanian Health Workers,1500,https://clinicaltrials.gov/show/NCT04811391,NA
NCT04811456,ClinicalTrials.gov,2021-03-22,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,Poland,MultiOrgan Inflammatory Syndromes COVID-19 Related Study,1000,https://clinicaltrials.gov/show/NCT04811456,NA
NCT04811859,ClinicalTrials.gov,2021-02-25,2021-01-10,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Inspiratory Muscle Training in Post COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04811859,NA
NCT04811885,ClinicalTrials.gov,2021-03-02,2019-10-14,TRUE,Not Recruiting,Not Applicable,Observational,Ireland,The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,120,https://clinicaltrials.gov/show/NCT04811885,NA
NCT04812041,ClinicalTrials.gov,2021-03-21,2021-01-21,TRUE,Recruiting,Not Applicable,Observational,Turkey,Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU,150,https://clinicaltrials.gov/show/NCT04812041,NA
NCT04812184,ClinicalTrials.gov,2021-03-17,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Adhesive Tape Placement on Patients' Masks in the ED Increases Compliance of Proper Face Mask Use,123,https://clinicaltrials.gov/show/NCT04812184,NA
NCT04812496,ClinicalTrials.gov,2021-03-19,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Peru,Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV),100,https://clinicaltrials.gov/show/NCT04812496,NA
NCT04813328,ClinicalTrials.gov,2021-03-22,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms,600,https://clinicaltrials.gov/show/NCT04813328,NA
NCT04813471,ClinicalTrials.gov,2021-03-22,2021-01-20,TRUE,Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH,70,https://clinicaltrials.gov/show/NCT04813471,NA
NCT04813497,ClinicalTrials.gov,2021-03-21,2021-02-05,TRUE,Recruiting,Not Applicable,Interventional,Belgium,Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members,4000,https://clinicaltrials.gov/show/NCT04813497,NA
NCT04813575,ClinicalTrials.gov,2021-02-08,2021-04-01,FALSE,Recruiting,Not Applicable,Interventional,Saudi Arabia,COVID-19 Pathophysiology of Long Term Implications,60,https://clinicaltrials.gov/show/NCT04813575,NA
NCT04813692,ClinicalTrials.gov,2021-03-23,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics,150,https://clinicaltrials.gov/show/NCT04813692,NA
NCT04813731,ClinicalTrials.gov,2021-03-07,2020-12-12,TRUE,Recruiting,Not Applicable,Observational,"Denmark, Sweden, Australia, Ireland, Georgia, Belgium, Netherlands, United Kingdom, Ukraine, Italy, Brazil, Poland, France, Germany, Romania",COVID-19 And Lingering Symptoms In Primary Care Patients,300,https://clinicaltrials.gov/show/NCT04813731,NA
NCT04813939,ClinicalTrials.gov,2021-03-22,2021-03-22,FALSE,Recruiting,Not Applicable,Observational,Poland,Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?,65,https://clinicaltrials.gov/show/NCT04813939,NA
NCT04814914,ClinicalTrials.gov,2021-03-23,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,United States,"An Observational Clinical Study to Evaluate COVID-19 Symptoms in ""Long Hauler"" Patients Who Participated in K031-120 or K032-120",300,https://clinicaltrials.gov/show/NCT04814914,NA
NCT04815018,ClinicalTrials.gov,2021-03-11,2020-10-07,TRUE,Recruiting,Not Applicable,Observational,United States,Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2,300,https://clinicaltrials.gov/show/NCT04815018,NA
NCT04815096,ClinicalTrials.gov,2021-03-23,2021-04-15,FALSE,Recruiting,Phase 1,Interventional,United States,Imaging Immune Activation in COVID-19,20,https://clinicaltrials.gov/show/NCT04815096,NA
NCT04815109,ClinicalTrials.gov,2021-03-23,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Prospective Electroencephalography Evaluation of Sedation in COVID-19,50,https://clinicaltrials.gov/show/NCT04815109,NA
NCT04815135,ClinicalTrials.gov,2021-03-22,2019-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Jordan,Effect of Covid-19 Pandemic on Emergency Surgery Practice,344,https://clinicaltrials.gov/show/NCT04815135,NA
NCT04815304,ClinicalTrials.gov,2021-03-19,2020-03-13,TRUE,Recruiting,Not Applicable,Observational,Italy,Clinical Features of COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04815304,NA
NCT04815759,ClinicalTrials.gov,2021-03-20,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Dental Anxiety Among Children Pre and Post COVID 19 Pandemic,82,https://clinicaltrials.gov/show/NCT04815759,NA
NCT04815850,ClinicalTrials.gov,2021-03-23,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study,150,https://clinicaltrials.gov/show/NCT04815850,NA
NCT04816084,ClinicalTrials.gov,2021-03-19,2020-11-05,TRUE,Not Recruiting,Not Applicable,Interventional,France,SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes,389,https://clinicaltrials.gov/show/NCT04816084,NA
NCT04816630,ClinicalTrials.gov,2021-03-15,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,United States,Feasibility Study of Hematology Parameters in COVID-19 Disease,500,https://clinicaltrials.gov/show/NCT04816630,NA
NCT04816656,ClinicalTrials.gov,2021-03-24,2020-08-03,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,43,https://clinicaltrials.gov/show/NCT04816656,NA
NCT04816682,ClinicalTrials.gov,2021-03-19,2021-03-17,TRUE,Recruiting,Phase 4,Interventional,Slovakia,Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes,30,https://clinicaltrials.gov/show/NCT04816682,NA
NCT04816760,ClinicalTrials.gov,2021-02-12,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,France,Immune Cells Phenotypes During COVID-19,100,https://clinicaltrials.gov/show/NCT04816760,NA
NCT04816786,ClinicalTrials.gov,2021-03-24,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Kuwait,COVID-19 Patients Admitted to the ICU,100,https://clinicaltrials.gov/show/NCT04816786,NA
NCT04816942,ClinicalTrials.gov,2021-02-12,2020-04-23,TRUE,Not Recruiting,Phase 3,Interventional,Egypt,Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt,102,https://clinicaltrials.gov/show/NCT04816942,NA
NCT04817332,ClinicalTrials.gov,2021-01-25,2020-06-05,TRUE,Not Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19,400,https://clinicaltrials.gov/show/NCT04817332,NA
NCT04817371,ClinicalTrials.gov,2021-03-15,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.,192,https://clinicaltrials.gov/show/NCT04817371,NA
NCT04817553,ClinicalTrials.gov,2021-03-24,2021-03-24,FALSE,Recruiting,Not Applicable,Observational,Hong Kong,Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients,150,https://clinicaltrials.gov/show/NCT04817553,NA
NCT04817657,ClinicalTrials.gov,2021-03-24,2021-04-07,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use,Not Available,https://clinicaltrials.gov/show/NCT04817657,NA
NCT04818489,ClinicalTrials.gov,2021-02-13,2021-03-25,FALSE,Recruiting,Phase 4,Interventional,Egypt,Colchicine and Post-COVID-19 Pulmonary Fibrosis,250,https://clinicaltrials.gov/show/NCT04818489,NA
NCT04818697,ClinicalTrials.gov,2021-03-24,2020-06-24,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic",105,https://clinicaltrials.gov/show/NCT04818697,NA
NCT04818801,ClinicalTrials.gov,2021-03-19,2021-04-01,FALSE,Not Recruiting,Phase 1,Interventional,New Zealand,"Safety, Reactogenicity and Immunogenicity Study of ReCOV",160,https://clinicaltrials.gov/show/NCT04818801,NA
NCT04818866,ClinicalTrials.gov,2021-03-25,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,United States,International Study of Inflammation in COVID-19,2000,https://clinicaltrials.gov/show/NCT04818866,NA
NCT04819165,ClinicalTrials.gov,2021-03-25,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Healthcare-associated Infections in Severe COVID-19 During 2020,252,https://clinicaltrials.gov/show/NCT04819165,NA
NCT04819282,ClinicalTrials.gov,2021-03-24,2020-09-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics,46,https://clinicaltrials.gov/show/NCT04819282,NA
NCT04819802,ClinicalTrials.gov,2021-03-26,2021-03-28,FALSE,Recruiting,Not Applicable,Observational,France,MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04819802,NA
NCT04820751,ClinicalTrials.gov,2021-03-25,2021-04-10,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial,200,https://clinicaltrials.gov/show/NCT04820751,NA
NCT04820803,ClinicalTrials.gov,2021-03-23,2021-02-03,TRUE,Recruiting,Not Applicable,Interventional,Spain,Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04820803,NA
NCT04821570,ClinicalTrials.gov,2021-03-26,2021-02-23,TRUE,Recruiting,Not Applicable,Observational,United States,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,500,https://clinicaltrials.gov/show/NCT04821570,NA
NCT04821674,ClinicalTrials.gov,2021-03-25,2021-03-15,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects,152,https://clinicaltrials.gov/show/NCT04821674,NA
NCT04821908,ClinicalTrials.gov,2021-03-29,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Consequences of COVID 19 Pandemic on Childhood Asthma,577,https://clinicaltrials.gov/show/NCT04821908,NA
NCT04821934,ClinicalTrials.gov,2021-03-26,2021-03-26,FALSE,Recruiting,Not Applicable,Interventional,Italy,Tele-rehabilitation Program After Hospitalization for COVID-19,74,https://clinicaltrials.gov/show/NCT04821934,NA
NCT04821973,ClinicalTrials.gov,2021-03-25,2020-09-22,TRUE,Recruiting,Not Applicable,Interventional,France,Respiratory Tele Monitoring COVID 19 (TMR COVID-19),80,https://clinicaltrials.gov/show/NCT04821973,NA
NCT04822012,ClinicalTrials.gov,2021-03-26,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Israel,Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid,50,https://clinicaltrials.gov/show/NCT04822012,NA
NCT04822285,ClinicalTrials.gov,2021-03-26,2020-01-22,TRUE,Not Recruiting,Not Applicable,Interventional,Egypt,Effect Psychological Triaging Intervention on Students' Psychological Distress and Resilience Capacity,64,https://clinicaltrials.gov/show/NCT04822285,NA
NCT04822402,ClinicalTrials.gov,2021-03-27,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Among Pregnant Women in Assiut,50,https://clinicaltrials.gov/show/NCT04822402,NA
NCT04822818,ClinicalTrials.gov,2021-03-25,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEVÂ®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19,174,https://clinicaltrials.gov/show/NCT04822818,NA
NCT04823182,ClinicalTrials.gov,2021-03-26,2021-02-16,TRUE,Recruiting,Not Applicable,Observational,Ireland,Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland,100,https://clinicaltrials.gov/show/NCT04823182,NA
NCT04823234,ClinicalTrials.gov,2021-03-26,2021-03-10,TRUE,Recruiting,Not Applicable,Observational,Italy,Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women,40,https://clinicaltrials.gov/show/NCT04823234,NA
NCT04823351,ClinicalTrials.gov,2021-03-25,2021-04-08,FALSE,Not Recruiting,Not Applicable,Interventional,Switzerland,Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks,1200,https://clinicaltrials.gov/show/NCT04823351,NA
NCT04824222,ClinicalTrials.gov,2021-03-26,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters,366,https://clinicaltrials.gov/show/NCT04824222,NA
NCT04824313,ClinicalTrials.gov,2021-02-18,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Vascular Abnormalities Detected With Chest CT in COVID-19,1000,https://clinicaltrials.gov/show/NCT04824313,NA
NCT04824391,ClinicalTrials.gov,2021-03-25,2021-02-10,TRUE,Recruiting,Phase 2,Interventional,Turkey,"Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19",250,https://clinicaltrials.gov/show/NCT04824391,NA
NCT04824495,ClinicalTrials.gov,2021-03-29,2021-01-07,TRUE,Recruiting,Not Applicable,Observational,Austria,Evaluation of Inflammatory Cytokines During COVID-19,100,https://clinicaltrials.gov/show/NCT04824495,NA
NCT04824638,ClinicalTrials.gov,2021-03-07,2021-03-08,FALSE,Recruiting,Phase 2,Interventional,France,BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers,300,https://clinicaltrials.gov/show/NCT04824638,NA
NCT04824651,ClinicalTrials.gov,2021-03-25,2021-03-25,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Covid-19 Vaccine Cohort in Specific Populations,10500,https://clinicaltrials.gov/show/NCT04824651,NA
NCT04824664,ClinicalTrials.gov,2021-03-29,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce,400,https://clinicaltrials.gov/show/NCT04824664,NA
NCT04824677,ClinicalTrials.gov,2021-03-24,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Spain,Risk Factors and Prognoses in Patients Hospitalized for COVID-19,1000,https://clinicaltrials.gov/show/NCT04824677,NA
NCT04825093,ClinicalTrials.gov,2020-12-02,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19,500,https://clinicaltrials.gov/show/NCT04825093,NA
NCT04826367,ClinicalTrials.gov,2021-03-29,2021-01-20,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,64,https://clinicaltrials.gov/show/NCT04826367,NA
NCT04826731,ClinicalTrials.gov,2021-03-27,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Turkey,Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04826731,NA
NCT04826770,ClinicalTrials.gov,2021-03-22,2021-01-06,TRUE,Recruiting,Not Applicable,Observational,Germany,Adaptive Immune Response Against Corona Virus Vaccination,50,https://clinicaltrials.gov/show/NCT04826770,NA
NCT04826822,ClinicalTrials.gov,2021-03-28,2021-02-24,TRUE,Recruiting,Phase 3,Interventional,Russian Federation,Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19,440,https://clinicaltrials.gov/show/NCT04826822,NA
NCT04827160,ClinicalTrials.gov,2021-03-30,2020-03-02,TRUE,Not Recruiting,Not Applicable,Observational,France,Prediction of Thrombosis Using D-dimer Trends in COVID-19,280,https://clinicaltrials.gov/show/NCT04827160,NA
NCT04828148,ClinicalTrials.gov,2021-03-30,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Mexico,Incidence of Infection and Mortality by COVID-19 in Specialists,400,https://clinicaltrials.gov/show/NCT04828148,NA
NCT04828161,ClinicalTrials.gov,2021-03-24,2021-04-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19",2100,https://clinicaltrials.gov/show/NCT04828161,NA
NCT04828460,ClinicalTrials.gov,2021-03-31,2021-02-09,TRUE,Recruiting,Not Applicable,Observational,France,Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients,3500,https://clinicaltrials.gov/show/NCT04828460,NA
NCT04828538,ClinicalTrials.gov,2021-03-12,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,Mexico,"Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19",3600,https://clinicaltrials.gov/show/NCT04828538,NA
NCT04828564,ClinicalTrials.gov,2021-04-01,2021-04-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Turkey,Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19,100,https://clinicaltrials.gov/show/NCT04828564,NA
NCT04828629,ClinicalTrials.gov,2021-03-12,2020-12-23,TRUE,Recruiting,Not Applicable,Observational,Poland,Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity,100,https://clinicaltrials.gov/show/NCT04828629,NA
NCT04828668,ClinicalTrials.gov,2021-03-10,2021-04-02,FALSE,Recruiting,Not Applicable,Interventional,United States,Study to Evaluate Benefits & Safety of Endourage Formula Câ„¢ Oral Drops in People With Post-Acute COVID-19 Syndrome.,60,https://clinicaltrials.gov/show/NCT04828668,NA
NCT04828772,ClinicalTrials.gov,2021-03-25,2020-08-17,TRUE,Not Recruiting,Not Applicable,Observational,Japan,A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan,9282,https://clinicaltrials.gov/show/NCT04828772,NA
NCT04828915,ClinicalTrials.gov,2021-03-24,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Germany,Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning,1000,https://clinicaltrials.gov/show/NCT04828915,NA
NCT04829188,ClinicalTrials.gov,2021-03-26,2021-03-30,FALSE,Recruiting,Not Applicable,Interventional,United States,Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia,1668,https://clinicaltrials.gov/show/NCT04829188,NA
NCT04829552,ClinicalTrials.gov,2021-03-22,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,United States,Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units,704,https://clinicaltrials.gov/show/NCT04829552,NA
NCT04830020,ClinicalTrials.gov,2021-03-31,2021-02-26,TRUE,Recruiting,Phase 2,Interventional,Italy,Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes,200,https://clinicaltrials.gov/show/NCT04830020,NA
NCT04830046,ClinicalTrials.gov,2021-03-31,2021-09-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Covid-19 Vaccine Responsiveness in MM and Waldenstrom,160,https://clinicaltrials.gov/show/NCT04830046,NA
NCT04830800,ClinicalTrials.gov,2021-03-12,2021-03-10,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Vietnam,A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC,420,https://clinicaltrials.gov/show/NCT04830800,NA
NCT04830943,ClinicalTrials.gov,2020-12-24,2020-08-01,TRUE,Not Recruiting,Phase 4,Interventional,Egypt,Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia,100,https://clinicaltrials.gov/show/NCT04830943,NA
NCT04831853,ClinicalTrials.gov,2021-04-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB),400,https://clinicaltrials.gov/show/NCT04831853,NA
NCT04832828,ClinicalTrials.gov,2021-03-31,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive,114,https://clinicaltrials.gov/show/NCT04832828,NA
NCT04832867,ClinicalTrials.gov,2021-03-27,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Pulmonary Rehabilitation in COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04832867,NA
NCT04832880,ClinicalTrials.gov,2020-10-12,2021-04-06,FALSE,Not Recruiting,Phase 3,Interventional,Italy,Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial),4000,https://clinicaltrials.gov/show/NCT04832880,NA
NCT04833010,ClinicalTrials.gov,2021-02-09,2021-01-20,TRUE,Recruiting,Not Applicable,Interventional,United States,Effects of Face Masks During Exercise,100,https://clinicaltrials.gov/show/NCT04833010,NA
NCT04834102,ClinicalTrials.gov,2021-04-04,2021-01-27,TRUE,Recruiting,Not Applicable,Observational,Turkey,COVID-19 Induced Telogen Effluvium,200,https://clinicaltrials.gov/show/NCT04834102,NA
NCT04834115,ClinicalTrials.gov,2021-03-28,2020-11-17,TRUE,Recruiting,Phase 3,Interventional,Paraguay,Efficacy of Ivermectin in Outpatients With Non-severe COVID-19,400,https://clinicaltrials.gov/show/NCT04834115,NA
NCT04834375,ClinicalTrials.gov,2021-03-31,2021-03-19,TRUE,Recruiting,Phase 4,Interventional,United States,Randomized Open Investigation Determining Steroid Dose,142,https://clinicaltrials.gov/show/NCT04834375,NA
NCT04834401,ClinicalTrials.gov,2021-04-02,2021-03-22,TRUE,Recruiting,Not Applicable,Observational,United States,Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis,120,https://clinicaltrials.gov/show/NCT04834401,NA
ACTRN12620001048976,ANZCTR,2020-10-15,2021-05-04,FALSE,Not Recruiting,Phase 1,Interventional,"United States, Puerto Rico, New Zealand, Germany","A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to
Evaluate the Pharmacokinetics of Remdesivir and Metabolites in
Participants with Normal Renal Function and Renal Impairment",80,https://anzctr.org.au/ACTRN12620001048976.aspx,NA
ACTRN12621000387820,ANZCTR,2021-04-08,2021-04-19,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Comparing the effects of a diet and exercise program versus psychological treatment for reducing depression in adults with COVID-19 related distress: The CALM trial,184,https://anzctr.org.au/ACTRN12621000387820.aspx,NA
ACTRN12620001249943,ANZCTR,2020-11-20,2021-03-29,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Australia,"Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 (COVID-19)  as a passive immunity modality in healthy individuals: an open-label, active control Phase 1/2 Study",30,https://anzctr.org.au/ACTRN12620001249943.aspx,NA
ACTRN12621000347864,ANZCTR,2021-03-26,2021-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Efficacy of a telerehabilitation program for therapeutic toning and respiratory exercises in patients affected by Covid-19 sequelae,60,https://anzctr.org.au/ACTRN12621000347864.aspx,NA
ISRCTN14081521,ISRCTN,2021-03-31,2021-01-04,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"Can people with cystic fibrosis safely stop taking some of their nebulised treatments if they are established on the new modulator therapy, Kaftrio?",764,http://isrctn.com/ISRCTN14081521,NA
ISRCTN16393332,ISRCTN,2021-03-24,2020-10-26,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Remote monitoring of blood pressure in patients with high blood pressure during the COVID-19 pandemic,1000,http://isrctn.com/ISRCTN16393332,NA
ISRCTN21085622,ISRCTN,2021-03-23,2020-09-29,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Assessing the safety and effectiveness of sofosbuvir plus daclatasvir or ravidasvir in Egyptian adults with COVID-19,120,http://isrctn.com/ISRCTN21085622,NA
ISRCTN70307341,ISRCTN,2021-03-23,2021-01-04,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,A study to test a package of support to help women who have stopped smoking while pregnant to stay smoke-free after giving birth,880,http://isrctn.com/ISRCTN70307341,NA
ISRCTN17441953,ISRCTN,2021-03-22,2021-01-08,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Ultrasound visual biofeedback versus standard treatment for children with cleft lip and palate,40,http://isrctn.com/ISRCTN17441953,NA
ISRCTN17846723,ISRCTN,2021-03-16,2021-03-16,FALSE,Recruiting,Not Applicable,Interventional,Canada,A web-based referral service to facilitate rapid and direct access to mental health care for youth,180,http://isrctn.com/ISRCTN17846723,NA
ISRCTN78284710,ISRCTN,2021-03-03,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Clinical characteristics and outcomes of patients with COVID-19 on mechanical ventilation in Argentina,1300,http://isrctn.com/ISRCTN78284710,NA
ISRCTN17354061,ISRCTN,2021-03-03,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,A pan-pandemic respiratory infection surveillance study,60000,http://isrctn.com/ISRCTN17354061,NA
ISRCTN55371988,ISRCTN,2021-02-24,2021-01-27,TRUE,Recruiting,Not Applicable,Observational,Italy,Immune response to the BNT162b2 vaccine against the COVID-19 virus in healthcare workers and immunocompromised patients,2000,http://isrctn.com/ISRCTN55371988,NA
ISRCTN85436698,ISRCTN,2021-02-03,2021-12-01,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Portugal, United Kingdom, Colombia, Belgium, Netherlands, United States, Italy, Brazil, Israel, Mexico, Serbia, Spain, France, India, Germany, Romania",Phase III trial of inhaled SNG001 compared to placebo for the treatment of patients hospitalised due to moderate COVID-19,610,http://isrctn.com/ISRCTN85436698,NA
ISRCTN82411169,ISRCTN,2020-12-17,2020-12-16,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A phase I/II study to evaluate the safety of and immunological response to a vaccine candidate (VLA2001) against COVID-19,150,http://isrctn.com/ISRCTN82411169,NA
ISRCTN91064601,ISRCTN,2020-12-16,2020-12-06,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Presence of antibodies in children and young adults living with at least one SARS-CoV-2 positive person,49,http://isrctn.com/ISRCTN91064601,NA
ISRCTN90437126,ISRCTN,2020-11-17,2020-09-15,TRUE,Recruiting,Phase 3,Interventional,Brazil,Study on the effects of using ivermectin to prevent COVID-19 in an adult population in Brazil,800,http://isrctn.com/ISRCTN90437126,NA
ISRCTN40292537,ISRCTN,2020-11-17,2020-01-04,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Early Pandemic Evaluation and Enhanced Surveillance of the coronavirus COVID-19 (EAVE II),5400000,http://isrctn.com/ISRCTN40292537,NA
ISRCTN45562523,ISRCTN,2020-10-19,2020-01-03,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Development of a risk prediction model for people with diabetes and COVID-19 in Scotland,5782649,http://isrctn.com/ISRCTN45562523,NA
ISRCTN56609224,ISRCTN,2020-09-21,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating home antibody test kits for the detection of coronavirus (COVID-19) antibodies,3000,http://isrctn.com/ISRCTN56609224,NA
ISRCTN91495258,ISRCTN,2020-07-14,2018-01-01,TRUE,Recruiting,Not Applicable,Observational,"Sweden, Hungary, Iceland, Ireland, Portugal, United Kingdom, Netherlands, Italy, Spain, Turkey, Latvia, Austria, Malta, France, Slovenia, Germany, Lithuania",Investigating the impact of the coronavirus (COVID-19) pandemic on children presenting to emergency departments across Europe,2400000,http://isrctn.com/ISRCTN91495258,NA
ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,FALSE,Not Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,45,http://isrctn.com/ISRCTN40302986,NA
ISRCTN88057279,ISRCTN,2020-05-14,2020-01-10,TRUE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Preventative treatment for patients at risk of COVID-19 infection (PROTECT),500,http://isrctn.com/ISRCTN88057279,NA
ISRCTN97041334,ISRCTN,2020-05-04,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 social study: the effects of quarantine on mental health,1000000,http://isrctn.com/ISRCTN97041334,NA
ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,FALSE,Not Recruiting,Phase 3,Interventional,"Saudi Arabia, Canada, Norway, Honduras, Ireland, Indonesia, Germany, Lebanon, Switzerland, Argentina, South Africa, Italy, Brazil, Malaysia, Philippines, Kenya, Iran, Qatar, Peru, Thailand, Israel, Spain, India",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,10000,http://isrctn.com/ISRCTN83971151,NA
ISRCTN14966097,ISRCTN,2020-02-27,2020-02-03,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,"Exploring the impact on patients with lupus and related autoimmune diseases of peer support, relationships with clinicians and COVID-19 changes to care",180,http://isrctn.com/ISRCTN14966097,NA
ChiCTR2100043018,ChiCTR,2021-02-04,2021-02-27,FALSE,Recruiting,Not Applicable,Observational,No Country Given,Survey on the willingness and influencing factors of novel coronavirus pneumonia (COVID-19) inactivated vaccine among medical staff in women's and children's Hospital,3800,http://www.chictr.org.cn/showproj.aspx?proj=121435,NA
ChiCTR2100043012,ChiCTR,2021-02-04,2021-02-04,FALSE,Not Recruiting,Phase 4,Interventional,China,Real-world study on the prevention effect of Lian-Hua Qing-Wen Capsules on close contacts of new coronavirus pneumonia,2200,http://www.chictr.org.cn/showproj.aspx?proj=120867,NA
ChiCTR2100042192,ChiCTR,2021-01-15,2021-01-14,TRUE,Recruiting,Not Applicable,Interventional,China,Investigation and intervention study on psychosomatic health status of quarantinable inbound people during the COVID-19 epidemic,106,http://www.chictr.org.cn/showproj.aspx?proj=119629,NA
ChiCTR2100042177,ChiCTR,2021-01-15,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Efficacy and safety of Qingfei Paidu Decoction (Granules) in the treatment of COVID-19,3600,http://www.chictr.org.cn/showproj.aspx?proj=120429,NA
ChiCTR2100042150,ChiCTR,2021-01-14,2021-01-14,FALSE,Not Recruiting,Phase 1,Interventional,China,"Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic profile and immunogenicity of JMB-2002  injection in Chinese healthy subjects after intravenous infusion of single dose",40,http://www.chictr.org.cn/showproj.aspx?proj=66096,NA
ChiCTR2100042069,ChiCTR,2021-01-12,2021-01-01,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of COVID-19 patients with mild and common-type",120,http://www.chictr.org.cn/showproj.aspx?proj=120071,NA
ChiCTR2100042068,ChiCTR,2021-01-12,2021-01-01,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of severe novel coronavirus pneumonia",20,http://www.chictr.org.cn/showproj.aspx?proj=120075,NA
ChiCTR2100042066,ChiCTR,2021-01-13,2021-01-01,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, open-label,  blank-controlled, multi-center clinical study for Lian-Hua Qing-Wen Capsule/Granule in the treatment of asymptomatic patients with novel coronavirus pneumonia",120,http://www.chictr.org.cn/showproj.aspx?proj=120077,NA
ChiCTR2100042004,ChiCTR,2021-01-12,2020-02-19,TRUE,No Status Given,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),20,http://www.chictr.org.cn/showproj.aspx?proj=65719,NA
ChiCTR2100042003,ChiCTR,2021-01-12,2020-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,"Effect of whole process management on nausea and vomiting during oropharyngeal swab collection in cancer patients in the Covid-19 pandemic: a single-blind, randomized controlled trial",2485,http://www.chictr.org.cn/showproj.aspx?proj=64795,NA
ChiCTR2000040847,ChiCTR,2020-12-11,2021-01-01,FALSE,Recruiting,Not Applicable,Interventional,China,A clinical study of new aerosol inhalation in the treatment of severe patients with respiratory virus infection,20,http://www.chictr.org.cn/showproj.aspx?proj=53028,NA
ChiCTR2000040770,ChiCTR,2020-12-09,2020-01-10,TRUE,Recruiting,Not Applicable,Observational,China,A study on efficacy of combined Chinese and Western medicine and follow-up of long-term prognosis in patients with novel coronavirus pneumonia (COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=65377,NA
ChiCTR2000040765,ChiCTR,2020-12-09,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,No Country Given,Optimized TCM diagnosis and treatment plan for novel coronavirus pneumonia (COVID-19),700,http://www.chictr.org.cn/showproj.aspx?proj=65161,NA
EUCTR2020-001411-25,EudraCT,2020-04-01,2020-05-18,FALSE,Not Recruiting,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, Italy, Israel, Spain, United States, Austria, France, India, Germany, Malaysia",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,DE
EUCTR2020-001406-27,EudraCT,2020-04-03,2020-07-04,FALSE,Not Recruiting,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,FR
EUCTR2020-001307-16,EudraCT,2020-04-08,2020-01-04,TRUE,Not Recruiting,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,ES
EUCTR2020-001440-26,EudraCT,2020-04-20,2020-04-19,TRUE,Not Recruiting,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,ES
EUCTR2020-005827-35,EudraCT,2020-12-11,2021-03-25,FALSE,Authorised,Phase 4,Interventional,France,Neurotropism and neuroinflammation in COVID-19 patients with delirium,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005827-35,FR
EUCTR2020-001310-38,EudraCT,2020-03-31,2020-06-04,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Clinical Study to assess positive value of blood plasma from donors having built immunity against the new corona virus (SARS-CoV-2) transfused to patients suffering from SARS-CoV-2 infection,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001310-38,DE
EUCTR2021-000880-63,EudraCT,2021-02-23,2021-11-03,FALSE,Authorised,Phase 4,Interventional,Sweden,COVID-19 vaccine in patients with rheumatic diseases: The impact of treatments on the vaccine response  protection against infection (COVID19-REUMA),868,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000880-63,SE
EUCTR2021-000905-26,EudraCT,2021-03-12,2021-03-31,FALSE,Authorised,Phase 4,Interventional,Sweden,Response to Covid-19 vaccination in patients with cancer,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000905-26,SE
EUCTR2021-000864-32,EudraCT,2021-03-19,2021-03-29,FALSE,Authorised,Phase 1/Phase 2,Interventional,Netherlands,The ConvP COVig PKPD study: an investigation for the use of plasma or antibodies against the novel coronavirus (SARS-CoV-2),104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000864-32,NL
NCT04025580,ClinicalTrials.gov,2019-07-18,2019-10-02,FALSE,Recruiting,Phase 2,Interventional,United States,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,300,https://clinicaltrials.gov/show/NCT04025580,NA
NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,17,https://clinicaltrials.gov/show/NCT04275245,NA
NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,FALSE,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,30,https://clinicaltrials.gov/show/NCT04280224,NA
NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,FALSE,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,200,https://clinicaltrials.gov/show/NCT04312009,NA
NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,FALSE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),500,https://clinicaltrials.gov/show/NCT04323800,NA
NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),1090,https://clinicaltrials.gov/show/NCT04324606,NA
NCT04329195,ClinicalTrials.gov,2020-03-28,2020-04-09,FALSE,Not Recruiting,Phase 3,Interventional,France,ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic,44,https://clinicaltrials.gov/show/NCT04329195,NA
NCT04331171,ClinicalTrials.gov,2020-03-30,2020-03-17,TRUE,Not Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,12000000,https://clinicaltrials.gov/show/NCT04331171,NA
NCT04331886,ClinicalTrials.gov,2020-03-31,2020-04-13,FALSE,Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,5000,https://clinicaltrials.gov/show/NCT04331886,NA
NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,152,https://clinicaltrials.gov/show/NCT04338009,NA
NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,FALSE,Not Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,31,https://clinicaltrials.gov/show/NCT04341415,NA
NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,FALSE,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,20,https://clinicaltrials.gov/show/NCT04343976,NA
NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,FALSE,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Auxora in Patients With Severe COVID-19 Pneumonia,346,https://clinicaltrials.gov/show/NCT04345614,NA
NCT04353180,ClinicalTrials.gov,2020-04-10,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),100000,https://clinicaltrials.gov/show/NCT04353180,NA
NCT04357444,ClinicalTrials.gov,2020-04-10,2020-10-23,FALSE,Not Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,30,https://clinicaltrials.gov/show/NCT04357444,NA
NCT04358029,ClinicalTrials.gov,2020-04-20,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,United States,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),10000,https://clinicaltrials.gov/show/NCT04358029,NA
NCT04359836,ClinicalTrials.gov,2020-04-20,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,United States,A Study to Explore the Role of Gut Flora in COVID-19 Infection,250,https://clinicaltrials.gov/show/NCT04359836,NA
NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,22000,https://clinicaltrials.gov/show/NCT04359875,NA
NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-23,FALSE,Not Recruiting,Phase 3,Interventional,"Switzerland, Brazil",Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,326,https://clinicaltrials.gov/show/NCT04364022,NA
NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),400,https://clinicaltrials.gov/show/NCT04367077,NA
NCT04369599,ClinicalTrials.gov,2020-04-28,2020-08-11,FALSE,Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System,36,https://clinicaltrials.gov/show/NCT04369599,NA
NCT04373148,ClinicalTrials.gov,2020-04-30,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,United States,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",1000,https://clinicaltrials.gov/show/NCT04373148,NA
NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,FALSE,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,1344,https://clinicaltrials.gov/show/NCT04373460,NA
NCT04378452,ClinicalTrials.gov,2020-04-15,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Assessment of the Psycho-social Impact of COVID-19 Outbreak,56656,https://clinicaltrials.gov/show/NCT04378452,NA
NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,30,https://clinicaltrials.gov/show/NCT04390139,NA
NCT04395716,ClinicalTrials.gov,2020-05-19,2020-01-01,TRUE,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCureâ„¢ to Treat COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04395716,NA
NCT04402944,ClinicalTrials.gov,2020-05-12,2020-07-05,FALSE,Recruiting,Phase 2,Interventional,United States,Pulmozyme to Improve COVID-19 ARDS Outcomes,60,https://clinicaltrials.gov/show/NCT04402944,NA
NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,FALSE,Not Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,38,https://clinicaltrials.gov/show/NCT04405986,NA
NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,FALSE,Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,752,https://clinicaltrials.gov/show/NCT04415060,NA
NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,180,https://clinicaltrials.gov/show/NCT04428021,NA
NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,FALSE,Not Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",32,https://clinicaltrials.gov/show/NCT04429529,NA
NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Belgium",A Study of Ad26.COV2.S in Adults (COVID-19),1085,https://clinicaltrials.gov/show/NCT04436276,NA
NCT04440007,ClinicalTrials.gov,2020-06-17,2020-10-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,80,https://clinicaltrials.gov/show/NCT04440007,NA
NCT04448145,ClinicalTrials.gov,2020-06-24,2020-03-26,TRUE,Recruiting,Not Applicable,Observational,United States,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,325,https://clinicaltrials.gov/show/NCT04448145,NA
NCT04449731,ClinicalTrials.gov,2020-06-23,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Spain,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),30000,https://clinicaltrials.gov/show/NCT04449731,NA
NCT04459247,ClinicalTrials.gov,2020-07-03,2020-06-15,TRUE,Not Recruiting,Not Applicable,Interventional,India,"Short Term, High Dose Vitamin D Supplementation for COVID-19",30,https://clinicaltrials.gov/show/NCT04459247,NA
NCT04459702,ClinicalTrials.gov,2020-06-25,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Study of Combination Therapies to Treat COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04459702,NA
NCT04471636,ClinicalTrials.gov,2020-07-09,2020-09-18,FALSE,Recruiting,Not Applicable,Interventional,Germany,Telemedicine in Outpatient Covid-19 Patients,600,https://clinicaltrials.gov/show/NCT04471636,NA
NCT04477993,ClinicalTrials.gov,2020-07-13,2020-08-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,5,https://clinicaltrials.gov/show/NCT04477993,NA
NCT04478019,ClinicalTrials.gov,2020-07-15,2020-07-07,TRUE,Recruiting,Phase 1,Interventional,United States,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,250,https://clinicaltrials.gov/show/NCT04478019,NA
NCT04479488,ClinicalTrials.gov,2020-07-13,2020-07-27,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),1587,https://clinicaltrials.gov/show/NCT04479488,NA
NCT04479631,ClinicalTrials.gov,2020-07-14,2020-07-12,TRUE,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",16,https://clinicaltrials.gov/show/NCT04479631,NA
NCT04479644,ClinicalTrials.gov,2020-07-14,2020-07-13,TRUE,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",17,https://clinicaltrials.gov/show/NCT04479644,NA
NCT04482699,ClinicalTrials.gov,2020-07-20,2020-12-30,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,RAPA-501-Allo Therapy of COVID-19-ARDS,88,https://clinicaltrials.gov/show/NCT04482699,NA
NCT04488796,ClinicalTrials.gov,2020-07-22,2020-09-07,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,148,https://clinicaltrials.gov/show/NCT04488796,NA
NCT04494893,ClinicalTrials.gov,2020-07-29,2020-04-24,TRUE,Not Recruiting,Not Applicable,Observational,United States,ImmuneRACE - Immune Response Action to COVID-19 Events,808,https://clinicaltrials.gov/show/NCT04494893,NA
NCT04497298,ClinicalTrials.gov,2020-07-31,2020-08-10,FALSE,Not Recruiting,Phase 1,Interventional,"France, Belgium",Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,90,https://clinicaltrials.gov/show/NCT04497298,NA
NCT04505761,ClinicalTrials.gov,2020-07-03,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",48,https://clinicaltrials.gov/show/NCT04505761,NA
NCT04508777,ClinicalTrials.gov,2020-08-10,2020-09-09,FALSE,Recruiting,Not Applicable,Observational,United States,COVID SAFE: COVID-19 Screening Assessment for Exposure,600,https://clinicaltrials.gov/show/NCT04508777,NA
NCT04522830,ClinicalTrials.gov,2020-08-18,2020-07-30,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,28,https://clinicaltrials.gov/show/NCT04522830,NA
NCT04539262,ClinicalTrials.gov,2020-08-26,2020-09-14,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",156,https://clinicaltrials.gov/show/NCT04539262,NA
NCT04556513,ClinicalTrials.gov,2020-09-16,2020-09-18,FALSE,Recruiting,Not Applicable,Observational,France,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,500,https://clinicaltrials.gov/show/NCT04556513,NA
NCT04558125,ClinicalTrials.gov,2020-09-19,2020-09-08,TRUE,Recruiting,Phase 4,Interventional,United States,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,45,https://clinicaltrials.gov/show/NCT04558125,NA
NCT04563702,ClinicalTrials.gov,2020-09-21,2020-09-21,FALSE,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,35,https://clinicaltrials.gov/show/NCT04563702,NA
NCT04573764,ClinicalTrials.gov,2020-10-01,2021-02-01,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04573764,NA
NCT04581915,ClinicalTrials.gov,2020-09-16,2020-09-08,TRUE,Recruiting,Phase 2/Phase 3,Interventional,South Africa,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,420,https://clinicaltrials.gov/show/NCT04581915,NA
NCT04583345,ClinicalTrials.gov,2020-10-09,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,32,https://clinicaltrials.gov/show/NCT04583345,NA
NCT04594343,ClinicalTrials.gov,2020-10-18,2020-11-20,FALSE,Recruiting,Phase 2,Interventional,Brazil,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,200,https://clinicaltrials.gov/show/NCT04594343,NA
NCT04602871,ClinicalTrials.gov,2020-10-21,2020-07-03,TRUE,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,108,https://clinicaltrials.gov/show/NCT04602871,NA
NCT04602884,ClinicalTrials.gov,2020-10-21,2020-09-22,TRUE,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis,50,https://clinicaltrials.gov/show/NCT04602884,NA
NCT04602949,ClinicalTrials.gov,2020-10-21,2020-11-12,FALSE,Recruiting,Not Applicable,Interventional,Israel,Detection of COVID-19 Using Breath Analysis - Validation Study,4000,https://clinicaltrials.gov/show/NCT04602949,NA
NCT04606498,ClinicalTrials.gov,2020-10-26,2020-12-18,FALSE,Recruiting,Not Applicable,Observational,United States,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,200,https://clinicaltrials.gov/show/NCT04606498,NA
NCT04621071,ClinicalTrials.gov,2020-11-05,2021-01-12,FALSE,Recruiting,Not Applicable,Interventional,Canada,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,84,https://clinicaltrials.gov/show/NCT04621071,NA
NCT04625985,ClinicalTrials.gov,2020-10-23,2020-07-14,TRUE,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",20,https://clinicaltrials.gov/show/NCT04625985,NA
NCT04626089,ClinicalTrials.gov,2020-10-23,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",0,https://clinicaltrials.gov/show/NCT04626089,NA
NCT04627467,ClinicalTrials.gov,2020-10-30,2020-03-28,TRUE,Not Recruiting,Phase 2,Interventional,Colombia,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),3217,https://clinicaltrials.gov/show/NCT04627467,NA
NCT04644185,ClinicalTrials.gov,2020-11-22,2021-03-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Argentina, Peru, Colombia, United States, Brazil, Mexico",The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,795,https://clinicaltrials.gov/show/NCT04644185,NA
NCT04667923,ClinicalTrials.gov,2020-12-11,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome,50,https://clinicaltrials.gov/show/NCT04667923,NA
NCT04668196,ClinicalTrials.gov,2020-12-11,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR),367,https://clinicaltrials.gov/show/NCT04668196,NA
NCT04669925,ClinicalTrials.gov,2020-08-31,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 Impact on the Lombardy Region's Emergency System,10000,https://clinicaltrials.gov/show/NCT04669925,NA
NCT04670003,ClinicalTrials.gov,2020-12-14,2021-01-02,FALSE,Not Recruiting,Not Applicable,Observational,France,Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application,4975,https://clinicaltrials.gov/show/NCT04670003,NA
NCT04681365,ClinicalTrials.gov,2020-12-18,2021-02-24,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating Bubble-PAPR for Healthcare Workers,66,https://clinicaltrials.gov/show/NCT04681365,NA
NCT04682548,ClinicalTrials.gov,2020-12-22,2021-01-05,FALSE,Recruiting,Not Applicable,Observational,United States,Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients,1000,https://clinicaltrials.gov/show/NCT04682548,NA
NCT04685447,ClinicalTrials.gov,2020-12-22,2020-03-16,TRUE,Recruiting,Not Applicable,Interventional,Italy,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,30,https://clinicaltrials.gov/show/NCT04685447,NA
NCT04686734,ClinicalTrials.gov,2020-12-27,2021-01-06,FALSE,Recruiting,Not Applicable,Observational,Norway,Long-term Effects of COVID-19 in Adolescents,500,https://clinicaltrials.gov/show/NCT04686734,NA
NCT04688372,ClinicalTrials.gov,2020-12-28,2020-10-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Hospital COVID-19 Surge and Associated Mortality Risk,144116,https://clinicaltrials.gov/show/NCT04688372,NA
NCT04710199,ClinicalTrials.gov,2021-01-05,2021-02-08,FALSE,Recruiting,Phase 2,Interventional,Spain,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),40,https://clinicaltrials.gov/show/NCT04710199,NA
NCT04716426,ClinicalTrials.gov,2021-01-18,2021-01-28,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,APTâ„¢ T3X on the COVID-19 Contamination Rate,100,https://clinicaltrials.gov/show/NCT04716426,NA
NCT04718220,ClinicalTrials.gov,2021-01-16,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,United States,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",420,https://clinicaltrials.gov/show/NCT04718220,NA
NCT04720235,ClinicalTrials.gov,2021-01-15,2020-12-09,TRUE,Not Recruiting,Not Applicable,Interventional,United States,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,304,https://clinicaltrials.gov/show/NCT04720235,NA
NCT04732468,ClinicalTrials.gov,2021-01-27,2021-02-24,FALSE,Recruiting,Phase 1,Interventional,United States,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,65,https://clinicaltrials.gov/show/NCT04732468,NA
NCT04734561,ClinicalTrials.gov,2020-12-31,2021-02-08,FALSE,Recruiting,Not Applicable,Interventional,Spain,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,88,https://clinicaltrials.gov/show/NCT04734561,NA
NCT04734860,ClinicalTrials.gov,2021-01-29,2021-04-01,FALSE,Recruiting,Phase 2,Interventional,United States,Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Adults With Mild COVID-19 Symptoms,500,https://clinicaltrials.gov/show/NCT04734860,NA
NCT04736004,ClinicalTrials.gov,2021-01-29,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,United States,Hearts of Athletes,500,https://clinicaltrials.gov/show/NCT04736004,NA
NCT04747821,ClinicalTrials.gov,2021-02-05,2021-02-07,FALSE,Not Recruiting,Phase 4,Interventional,Brazil,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,27711,https://clinicaltrials.gov/show/NCT04747821,NA
NCT04748783,ClinicalTrials.gov,2021-02-09,2021-03-26,FALSE,Not Recruiting,Phase 2,Interventional,United States,Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19,2,https://clinicaltrials.gov/show/NCT04748783,NA
NCT04751669,ClinicalTrials.gov,2021-02-11,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,Spain,Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial,300,https://clinicaltrials.gov/show/NCT04751669,NA
NCT04761107,ClinicalTrials.gov,2021-02-17,2021-02-18,FALSE,Recruiting,Not Applicable,Observational,United States,Impact of COVID-19 on GU Disease,15240,https://clinicaltrials.gov/show/NCT04761107,NA
NCT04762173,ClinicalTrials.gov,2021-02-15,2020-11-06,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Self-Help for Stress Related to COVID-19,585,https://clinicaltrials.gov/show/NCT04762173,NA
NCT04762771,ClinicalTrials.gov,2021-02-18,2020-12-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19),75,https://clinicaltrials.gov/show/NCT04762771,NA
NCT04771351,ClinicalTrials.gov,2021-02-23,2021-04-01,FALSE,Recruiting,Phase 2,Interventional,United States,Study to Evaluate a Single Dose of STI-2020 (COVI-AMGâ„¢) in Hospitalized Adults With COVID-19,280,https://clinicaltrials.gov/show/NCT04771351,NA
NCT04781218,ClinicalTrials.gov,2021-03-01,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,ABC Science Collaborative Registry Study,1000000,https://clinicaltrials.gov/show/NCT04781218,NA
NCT04789499,ClinicalTrials.gov,2021-03-08,2021-03-15,FALSE,Recruiting,Phase 2,Interventional,United States,Smell in Covid-19 and Efficacy of Nasal Theophylline,50,https://clinicaltrials.gov/show/NCT04789499,NA
NCT04791423,ClinicalTrials.gov,2021-02-22,2021-03-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Study of GRAd-COV2 for the Prevention of COVID-19 in Adults,10300,https://clinicaltrials.gov/show/NCT04791423,NA
NCT04794036,ClinicalTrials.gov,2021-03-01,2021-04-05,FALSE,Recruiting,Not Applicable,Interventional,Spain,Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient,32,https://clinicaltrials.gov/show/NCT04794036,NA
NCT04796402,ClinicalTrials.gov,2021-03-10,2021-03-17,FALSE,Recruiting,Phase 4,Interventional,Canada,A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19,576,https://clinicaltrials.gov/show/NCT04796402,NA
NCT04798053,ClinicalTrials.gov,2021-03-10,2021-04-08,FALSE,Recruiting,Not Applicable,Interventional,France,Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients,318,https://clinicaltrials.gov/show/NCT04798053,NA
NCT04800133,ClinicalTrials.gov,2021-03-01,2021-04-01,FALSE,Recruiting,Phase 2,Interventional,China,Covid-19 Vaccination in Adolescents,900,https://clinicaltrials.gov/show/NCT04800133,NA
NCT04800939,ClinicalTrials.gov,2021-03-11,2021-04-05,FALSE,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness,60,https://clinicaltrials.gov/show/NCT04800939,NA
NCT04808921,ClinicalTrials.gov,2021-03-18,2021-01-09,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test,151,https://clinicaltrials.gov/show/NCT04808921,NA
NCT04810065,ClinicalTrials.gov,2021-03-19,2021-03-29,FALSE,Recruiting,Not Applicable,Interventional,Ireland,SingStrong: Strong Lungs Through Song - Long COVID-19 Study,35,https://clinicaltrials.gov/show/NCT04810065,NA
NCT04815057,ClinicalTrials.gov,2021-03-11,2020-11-02,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period,176,https://clinicaltrials.gov/show/NCT04815057,NA
NCT04817280,ClinicalTrials.gov,2021-03-24,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,Poland,COVID-19 in Polish Ice Swimmers.,2534,https://clinicaltrials.gov/show/NCT04817280,NA
NCT04817397,ClinicalTrials.gov,2021-03-23,2021-03-20,TRUE,Recruiting,Not Applicable,Observational,Egypt,The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients,100,https://clinicaltrials.gov/show/NCT04817397,NA
NCT04818281,ClinicalTrials.gov,2021-03-24,2021-03-27,FALSE,Recruiting,Phase 1,Interventional,Turkey,Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults,36,https://clinicaltrials.gov/show/NCT04818281,NA
NCT04818853,ClinicalTrials.gov,2021-03-25,2021-03-09,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI),400,https://clinicaltrials.gov/show/NCT04818853,NA
NCT04830683,ClinicalTrials.gov,2021-03-26,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,Belgium,Endothelial Dysfunction in Covid-19,85,https://clinicaltrials.gov/show/NCT04830683,NA
NCT04830761,ClinicalTrials.gov,2021-03-25,2021-03-26,FALSE,Recruiting,Not Applicable,Interventional,Switzerland,Behavior Change in Context to Contain the Spread of COVID-19,710,https://clinicaltrials.gov/show/NCT04830761,NA
NCT04832945,ClinicalTrials.gov,2021-04-01,2020-06-29,TRUE,Not Recruiting,Not Applicable,Observational,Dominican Republic,SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study,713,https://clinicaltrials.gov/show/NCT04832945,NA
NCT04833088,ClinicalTrials.gov,2021-04-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Exploratory Study About the Implementation of Technology in the Rehabilitation,100,https://clinicaltrials.gov/show/NCT04833088,NA
NCT04834089,ClinicalTrials.gov,2021-04-01,2021-05-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases,618,https://clinicaltrials.gov/show/NCT04834089,NA
NCT04834128,ClinicalTrials.gov,2021-03-29,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,TCB008 in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04834128,NA
NCT04834739,ClinicalTrials.gov,2021-01-10,2021-01-04,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19,60,https://clinicaltrials.gov/show/NCT04834739,NA
NCT04834752,ClinicalTrials.gov,2021-03-31,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,South Korea,Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19,400000,https://clinicaltrials.gov/show/NCT04834752,NA
NCT04834856,ClinicalTrials.gov,2021-04-06,2021-04-01,TRUE,Recruiting,Phase 2,Interventional,Netherlands,"Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients",40,https://clinicaltrials.gov/show/NCT04834856,NA
NCT04834882,ClinicalTrials.gov,2021-03-31,2021-01-20,TRUE,Recruiting,Not Applicable,Observational,France,"Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic",1000,https://clinicaltrials.gov/show/NCT04834882,NA
NCT04834934,ClinicalTrials.gov,2021-04-06,2020-02-16,TRUE,Recruiting,Not Applicable,Observational,Italy,Artificial Intelligence - SARS-CoV-2 Risk Evaluation,2000,https://clinicaltrials.gov/show/NCT04834934,NA
NCT04834947,ClinicalTrials.gov,2021-04-06,2021-04-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19,30,https://clinicaltrials.gov/show/NCT04834947,NA
NCT04836039,ClinicalTrials.gov,2021-04-02,2021-01-27,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak,400,https://clinicaltrials.gov/show/NCT04836039,NA
NCT04836052,ClinicalTrials.gov,2021-03-14,2020-12-24,TRUE,Recruiting,Phase 3,Interventional,Qatar,Omega-3 Oil Use in COVID-19 Patients in Qatar,372,https://clinicaltrials.gov/show/NCT04836052,NA
NCT04836065,ClinicalTrials.gov,2020-06-25,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Belgium,ESICM UNITE COVID-19 Project (UNITE-COVID),4995,https://clinicaltrials.gov/show/NCT04836065,NA
NCT04836260,ClinicalTrials.gov,2021-04-06,2021-04-08,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04836260,NA
NCT04836299,ClinicalTrials.gov,2021-03-02,2021-05-08,FALSE,Not Recruiting,Phase 2,Interventional,Bolivia,"Clinical Trial to ""Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)",90,https://clinicaltrials.gov/show/NCT04836299,NA
NCT04836351,ClinicalTrials.gov,2021-03-29,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,Norway,Rehabilitation for Patients With Persistent Symptoms Post COVID-19,20,https://clinicaltrials.gov/show/NCT04836351,NA
NCT04836754,ClinicalTrials.gov,2021-04-07,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components,30,https://clinicaltrials.gov/show/NCT04836754,NA
NCT04836780,ClinicalTrials.gov,2021-03-18,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Spain,DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia,126,https://clinicaltrials.gov/show/NCT04836780,NA
NCT04837755,ClinicalTrials.gov,2021-04-06,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Germany,CORONA in the Saarland,300,https://clinicaltrials.gov/show/NCT04837755,NA
NCT04838080,ClinicalTrials.gov,2021-04-06,2021-03-19,TRUE,Recruiting,Phase 1,Interventional,Turkey,Safety and Immunogenicity of the Inactivated KoÃ§ak-19 Inaktif Adjuvanli COVID-19 Vaccine Compared to Placebo,38,https://clinicaltrials.gov/show/NCT04838080,NA
NCT04838093,ClinicalTrials.gov,2021-04-05,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Austria,COVID-19 Testing in Patients With Vascular Disorders,2243,https://clinicaltrials.gov/show/NCT04838093,NA
NCT04838106,ClinicalTrials.gov,2021-04-07,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales,319600,https://clinicaltrials.gov/show/NCT04838106,NA
NCT04838834,ClinicalTrials.gov,2021-02-11,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,United States,Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children,472,https://clinicaltrials.gov/show/NCT04838834,NA
NCT04838847,ClinicalTrials.gov,2021-04-08,2021-05-14,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19,180,https://clinicaltrials.gov/show/NCT04838847,NA
NCT04839068,ClinicalTrials.gov,2021-04-08,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,the Impact of Covid-19 Pandemic Stress on Pregnancy Outcomes,7000,https://clinicaltrials.gov/show/NCT04839068,NA
NCT04839094,ClinicalTrials.gov,2021-04-06,2020-12-10,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.,58,https://clinicaltrials.gov/show/NCT04839094,NA
NCT04839315,ClinicalTrials.gov,2021-04-05,2021-02-15,TRUE,Recruiting,Phase 1,Interventional,United States,COVID-19 Vaccination in Rheumatic Disease Patients,100,https://clinicaltrials.gov/show/NCT04839315,NA
NCT04839913,ClinicalTrials.gov,2021-04-07,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study",121,https://clinicaltrials.gov/show/NCT04839913,NA
NCT04840082,ClinicalTrials.gov,2021-04-06,2021-03-07,TRUE,Not Recruiting,Not Applicable,Interventional,Denmark,Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs,109,https://clinicaltrials.gov/show/NCT04840082,NA
NCT04840459,ClinicalTrials.gov,2021-04-05,2020-11-20,TRUE,Recruiting,Phase 2,Interventional,United States,Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting,1000,https://clinicaltrials.gov/show/NCT04840459,NA
NCT04840953,ClinicalTrials.gov,2021-04-08,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,Spain,"Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients",2,https://clinicaltrials.gov/show/NCT04840953,NA
NCT04840992,ClinicalTrials.gov,2021-04-08,2021-04-20,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,China,Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation,840,https://clinicaltrials.gov/show/NCT04840992,NA
NCT04841681,ClinicalTrials.gov,2021-04-06,2020-06-07,TRUE,Not Recruiting,Not Applicable,Interventional,Indonesia,Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta,42,https://clinicaltrials.gov/show/NCT04841681,NA
NCT04842708,ClinicalTrials.gov,2020-12-29,2020-12-24,TRUE,Recruiting,Not Applicable,Interventional,Israel,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,50,https://clinicaltrials.gov/show/NCT04842708,NA
NCT04842734,ClinicalTrials.gov,2021-04-10,2021-03-27,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic,60,https://clinicaltrials.gov/show/NCT04842734,NA
NCT04843878,ClinicalTrials.gov,2021-04-09,2021-01-05,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Testing Pilot Study,326,https://clinicaltrials.gov/show/NCT04843878,NA
ACTRN12621000420842,ANZCTR,2021-04-15,2021-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,The Pomerium Trial: Effect of a Specialised Nutritional Supplementation on Immune Function in Older Adults Living in Residential Aged Care Facilities,160,https://anzctr.org.au/ACTRN12621000420842.aspx,NA
ISRCTN17472338,ISRCTN,2021-04-07,2021-04-15,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,"Advancing understanding of adolescent exposome exposure and methodology, intervention development, and translation for prevention strategies and policy",296,http://isrctn.com/ISRCTN17472338,NA
ISRCTN72605600,ISRCTN,2021-03-24,2021-03-02,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,What messaging is effective in recruiting schools to take up tutoring? A randomised controlled trial of email messages to schools.,2000,http://isrctn.com/ISRCTN72605600,NA
ISRCTN10182320,ISRCTN,2021-03-16,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,Estonia,Monitoring the course of the COVID-19 epidemic in Estonia,2000,http://isrctn.com/ISRCTN10182320,NA
ISRCTN51046126,ISRCTN,2021-03-11,2021-04-30,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Feasibility of providing additional oxygen in patients with resistant high blood pressure and obstructive sleep apnoea,20,http://isrctn.com/ISRCTN51046126,NA
ISRCTN76339681,ISRCTN,2021-03-05,2020-10-13,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,A long-term observational study of people who have had coronavirus disease (COVID-19) in Scotland,300,http://isrctn.com/ISRCTN76339681,NA
ISRCTN57085639,ISRCTN,2020-09-24,2020-08-05,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,A platform to investigate the safety and effectiveness of several new medicines for the treatment of COVID-19 in hospitalised patients,1800,http://isrctn.com/ISRCTN57085639,NA
ISRCTN14226970,ISRCTN,2020-07-20,2020-10-29,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Rapid community testing for COVID-19,2000,http://isrctn.com/ISRCTN14226970,NA
ISRCTN18181860,ISRCTN,2020-07-13,2020-01-04,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss population,25000,http://isrctn.com/ISRCTN18181860,NA
ISRCTN15644757,ISRCTN,2019-12-31,2021-12-04,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Goldilocks Work Principle â€“ Childcare,132,http://isrctn.com/ISRCTN15644757,NA
ChiCTR2100042356,ChiCTR,2021-01-20,2020-04-30,TRUE,Not Recruiting,Not Applicable,Interventional,China,Self-help Cognitive Behavioral Therapy Application for COVID-19-related Mental Health Problems: a Longitudinal Trial,154,http://www.chictr.org.cn/showproj.aspx?proj=120364,NA
ChiCTR2100042315,ChiCTR,2021-01-18,2020-01-22,TRUE,Not Recruiting,Not Applicable,Observational,China,The Impact of COVID-19 on Short-Term Prognosis of ST-Segment Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention in Wuhan China: a Single-Center Retrospective Study,62,http://www.chictr.org.cn/showproj.aspx?proj=120463,NA
ChiCTR2100042314,ChiCTR,2021-01-17,2021-01-17,FALSE,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of TCM Syndrome Differentiation and Treatment based on community/isolated population in preventing novel coronavirus pneumonia (COVID-19),3000,http://www.chictr.org.cn/showproj.aspx?proj=120541,NA
ChiCTR2100042222,ChiCTR,2021-01-16,2021-01-13,TRUE,Recruiting,Not Applicable,Observational,China,Study on Influencing Factors of immune response to New Coronavirus (COVID-19) vaccine by health care workers,60,http://www.chictr.org.cn/showproj.aspx?proj=120313,NA
EUCTR2020-001391-15,EudraCT,2020-03-31,2020-04-24,FALSE,Not Recruiting,Phase 2,Interventional,Ireland,"A randomized double-blind placebo-controlled, pilot trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.",36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,IE
NCT04314817,ClinicalTrials.gov,2020-03-17,2020-03-17,FALSE,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,1000,https://clinicaltrials.gov/show/NCT04314817,NA
NCT04320511,ClinicalTrials.gov,2020-03-23,2020-06-24,FALSE,Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,25,https://clinicaltrials.gov/show/NCT04320511,NA
NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),630,https://clinicaltrials.gov/show/NCT04322123,NA
NCT04341012,ClinicalTrials.gov,2020-04-07,2019-09-10,TRUE,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,120,https://clinicaltrials.gov/show/NCT04341012,NA
NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,24,https://clinicaltrials.gov/show/NCT04344080,NA
NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,FALSE,Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),394,https://clinicaltrials.gov/show/NCT04347239,NA
NCT04348214,ClinicalTrials.gov,2020-04-13,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,4040,https://clinicaltrials.gov/show/NCT04348214,NA
NCT04357041,ClinicalTrials.gov,2020-04-17,2020-04-17,FALSE,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",500,https://clinicaltrials.gov/show/NCT04357041,NA
NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),405,https://clinicaltrials.gov/show/NCT04358939,NA
NCT04360486,ClinicalTrials.gov,2020-04-20,2020-11-20,FALSE,Not Recruiting,Not Applicable,Expanded Access,"Afghanistan, Kuwait, Guam, United States, Djibouti, Japan, Iraq, Germany",Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),Not Available,https://clinicaltrials.gov/show/NCT04360486,NA
NCT04362995,ClinicalTrials.gov,2020-04-22,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,United States,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,1517,https://clinicaltrials.gov/show/NCT04362995,NA
NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,FALSE,Not Recruiting,Phase 2,Interventional,United States,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),45,https://clinicaltrials.gov/show/NCT04365153,NA
NCT04365725,ClinicalTrials.gov,2020-04-25,2020-05-05,FALSE,Not Recruiting,Not Applicable,Observational,France,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",84,https://clinicaltrials.gov/show/NCT04365725,NA
NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,FALSE,Not Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,400,https://clinicaltrials.gov/show/NCT04377711,NA
NCT04383678,ClinicalTrials.gov,2020-05-07,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,"Sweden, United Kingdom, Italy, Finland, France, Germany",Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,132,https://clinicaltrials.gov/show/NCT04383678,NA
NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,120,https://clinicaltrials.gov/show/NCT04392141,NA
NCT04393311,ClinicalTrials.gov,2020-05-15,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,160,https://clinicaltrials.gov/show/NCT04393311,NA
NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,2,https://clinicaltrials.gov/show/NCT04395807,NA
NCT04397900,ClinicalTrials.gov,2020-05-19,2020-04-09,TRUE,Not Recruiting,Not Applicable,Observational,United States,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,80,https://clinicaltrials.gov/show/NCT04397900,NA
NCT04400461,ClinicalTrials.gov,2020-05-20,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,71,https://clinicaltrials.gov/show/NCT04400461,NA
NCT04403880,ClinicalTrials.gov,2020-05-22,2020-05-13,TRUE,Not Recruiting,Not Applicable,Observational,"Malawi, South Africa, Peru, Tanzania, Zambia, Mozambique, United States, Zimbabwe",Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,727,https://clinicaltrials.gov/show/NCT04403880,NA
NCT04404244,ClinicalTrials.gov,2020-05-25,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04404244,NA
NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,FALSE,Not Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),9453,https://clinicaltrials.gov/show/NCT04416308,NA
NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,FALSE,Not Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,0,https://clinicaltrials.gov/show/NCT04433078,NA
NCT04459676,ClinicalTrials.gov,2020-07-03,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04459676,NA
NCT04470258,ClinicalTrials.gov,2020-06-10,2020-06-25,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Elmo Respiratory Support Project - COVID-19,10,https://clinicaltrials.gov/show/NCT04470258,NA
NCT04476979,ClinicalTrials.gov,2020-07-16,2020-07-16,FALSE,Recruiting,Phase 2,Interventional,French Guiana,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,660,https://clinicaltrials.gov/show/NCT04476979,NA
NCT04477655,ClinicalTrials.gov,2020-07-15,2020-05-03,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,430,https://clinicaltrials.gov/show/NCT04477655,NA
NCT04486508,ClinicalTrials.gov,2020-07-22,2020-07-30,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,600,https://clinicaltrials.gov/show/NCT04486508,NA
NCT04492254,ClinicalTrials.gov,2020-07-22,2020-09-15,FALSE,Recruiting,Phase 3,Interventional,"Australia, South Africa, Belgium",Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,1370,https://clinicaltrials.gov/show/NCT04492254,NA
NCT04500626,ClinicalTrials.gov,2020-07-31,2021-04-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Canada,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,234,https://clinicaltrials.gov/show/NCT04500626,NA
NCT04501796,ClinicalTrials.gov,2020-07-27,2020-11-27,FALSE,Recruiting,Phase 1,Interventional,United States,A Trial of NT-I7 in COVID-19 (SPESELPIS),30,https://clinicaltrials.gov/show/NCT04501796,NA
NCT04504032,ClinicalTrials.gov,2020-08-05,2020-09-02,FALSE,Not Recruiting,Phase 2,Interventional,"United States, United Kingdom",A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),497,https://clinicaltrials.gov/show/NCT04504032,NA
NCT04509947,ClinicalTrials.gov,2020-08-11,2020-08-11,FALSE,Not Recruiting,Phase 1,Interventional,Japan,A Study of Ad26.COV2.S in Adults (COVID-19),250,https://clinicaltrials.gov/show/NCT04509947,NA
NCT04523181,ClinicalTrials.gov,2020-08-19,2020-10-08,FALSE,Recruiting,Phase 2,Interventional,"Argentina, Peru, United States",Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,174,https://clinicaltrials.gov/show/NCT04523181,NA
NCT04524598,ClinicalTrials.gov,2020-08-20,2020-07-20,TRUE,Recruiting,Not Applicable,Interventional,United States,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,355,https://clinicaltrials.gov/show/NCT04524598,NA
NCT04530448,ClinicalTrials.gov,2020-08-20,2020-10-05,FALSE,Recruiting,Phase 4,Interventional,United States,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,40,https://clinicaltrials.gov/show/NCT04530448,NA
NCT04530682,ClinicalTrials.gov,2020-07-27,2021-03-05,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,200,https://clinicaltrials.gov/show/NCT04530682,NA
NCT04537650,ClinicalTrials.gov,2020-09-01,2021-01-01,FALSE,Recruiting,Not Applicable,Observational,"Canada, United States",Swallowing Impairment After COVID-19 Infection,75,https://clinicaltrials.gov/show/NCT04537650,NA
NCT04549922,ClinicalTrials.gov,2020-09-09,2020-10-22,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,111,https://clinicaltrials.gov/show/NCT04549922,NA
NCT04565665,ClinicalTrials.gov,2020-09-22,2020-07-29,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United States,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,70,https://clinicaltrials.gov/show/NCT04565665,NA
NCT04570384,ClinicalTrials.gov,2020-09-17,2020-10-15,FALSE,Recruiting,Phase 2,Interventional,United States,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,60,https://clinicaltrials.gov/show/NCT04570384,NA
NCT04570501,ClinicalTrials.gov,2020-09-28,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,160,https://clinicaltrials.gov/show/NCT04570501,NA
NCT04584684,ClinicalTrials.gov,2020-10-09,2020-12-18,FALSE,Recruiting,Phase 2,Interventional,United States,Mouth Rinses for Inactivation of COVID-19,480,https://clinicaltrials.gov/show/NCT04584684,NA
NCT04591015,ClinicalTrials.gov,2020-10-05,2021-02-01,FALSE,Recruiting,Phase 3,Interventional,United States,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,172,https://clinicaltrials.gov/show/NCT04591015,NA
NCT04598581,ClinicalTrials.gov,2020-10-20,2020-11-02,FALSE,Not Recruiting,Not Applicable,Interventional,Switzerland,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",22,https://clinicaltrials.gov/show/NCT04598581,NA
NCT04611425,ClinicalTrials.gov,2020-10-07,2020-11-30,FALSE,Recruiting,Phase 2,Interventional,France,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",30,https://clinicaltrials.gov/show/NCT04611425,NA
NCT04619407,ClinicalTrials.gov,2020-11-04,2020-11-04,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",142,https://clinicaltrials.gov/show/NCT04619407,NA
NCT04622332,ClinicalTrials.gov,2020-11-03,2020-12-18,FALSE,Recruiting,Phase 1,Interventional,United States,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04622332,NA
NCT04651400,ClinicalTrials.gov,2020-11-19,2020-10-19,TRUE,Recruiting,Not Applicable,Observational,"France, Germany, Austria","Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",300,https://clinicaltrials.gov/show/NCT04651400,NA
NCT04659304,ClinicalTrials.gov,2020-12-07,2021-06-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Study Evaluating Safety and Tolerability of Allocetra-OTS in Patients With COVID-19,18,https://clinicaltrials.gov/show/NCT04659304,NA
NCT04667286,ClinicalTrials.gov,2020-12-11,2021-01-16,FALSE,Recruiting,Not Applicable,Interventional,Italy,Awake Pronation for Covid-19 Treatment,100,https://clinicaltrials.gov/show/NCT04667286,NA
NCT04678830,ClinicalTrials.gov,2020-12-14,2021-03-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Long-Haulers Study,56,https://clinicaltrials.gov/show/NCT04678830,NA
NCT04685655,ClinicalTrials.gov,2020-12-23,2020-01-07,TRUE,Recruiting,Not Applicable,Interventional,Germany,RescuE pLAsma eXchange in Severe COVID-19,228,https://clinicaltrials.gov/show/NCT04685655,NA
NCT04711863,ClinicalTrials.gov,2021-01-13,2021-01-16,FALSE,Not Recruiting,Phase 2,Interventional,South Korea,Fluvoxamine for Adults With Mild to Moderate COVID-19,400,https://clinicaltrials.gov/show/NCT04711863,NA
NCT04716907,ClinicalTrials.gov,2021-01-16,2021-03-19,FALSE,Recruiting,Not Applicable,Observational,France,Thymic Function in Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04716907,NA
NCT04737161,ClinicalTrials.gov,2021-02-01,2021-03-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome,0,https://clinicaltrials.gov/show/NCT04737161,NA
NCT04743011,ClinicalTrials.gov,2021-02-03,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Enriched Heparin Anti COVID-19 Trial,50,https://clinicaltrials.gov/show/NCT04743011,NA
NCT04751474,ClinicalTrials.gov,2021-02-08,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,"The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction",93,https://clinicaltrials.gov/show/NCT04751474,NA
NCT04773665,ClinicalTrials.gov,2021-02-24,2021-03-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,"Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)",780,https://clinicaltrials.gov/show/NCT04773665,NA
NCT04780555,ClinicalTrials.gov,2021-02-21,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19,150,https://clinicaltrials.gov/show/NCT04780555,NA
NCT04800224,ClinicalTrials.gov,2021-03-12,2021-04-12,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2),200,https://clinicaltrials.gov/show/NCT04800224,NA
NCT04800731,ClinicalTrials.gov,2021-03-11,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04800731,NA
NCT04810728,ClinicalTrials.gov,2021-03-16,2020-06-20,TRUE,Not Recruiting,Phase 3,Interventional,Indonesia,Efficacy of Psidii Guava's Extract For COVID-19,90,https://clinicaltrials.gov/show/NCT04810728,NA
NCT04817293,ClinicalTrials.gov,2021-03-22,2021-04-06,FALSE,Recruiting,Not Applicable,Observational,France,Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region,1000,https://clinicaltrials.gov/show/NCT04817293,NA
NCT04818463,ClinicalTrials.gov,2021-03-18,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Germany,Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients,300,https://clinicaltrials.gov/show/NCT04818463,NA
NCT04824625,ClinicalTrials.gov,2021-03-27,2021-03-27,FALSE,Not Recruiting,Not Applicable,Observational,Spain,Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert,5000,https://clinicaltrials.gov/show/NCT04824625,NA
NCT04828902,ClinicalTrials.gov,2021-03-21,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Poland,Incidence of Postoperative Delirium After Cardiac Surgery in Adults.,600,https://clinicaltrials.gov/show/NCT04828902,NA
NCT04830774,ClinicalTrials.gov,2021-04-01,2021-04-15,FALSE,Not Recruiting,Not Applicable,Interventional,"Belgium, Italy, United States, Turkey, Switzerland",Natural History of COVID-19-Related Atrial Fibrillation,200,https://clinicaltrials.gov/show/NCT04830774,NA
NCT04832022,ClinicalTrials.gov,2021-03-31,2021-04-07,FALSE,Recruiting,Not Applicable,Observational,France,Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination,1500,https://clinicaltrials.gov/show/NCT04832022,NA
NCT04834908,ClinicalTrials.gov,2021-03-23,2021-05-01,FALSE,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,160,https://clinicaltrials.gov/show/NCT04834908,NA
NCT04837651,ClinicalTrials.gov,2021-03-16,2021-03-08,TRUE,Recruiting,Not Applicable,Observational,United States,Comparing the Antibody Response to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab or Natalizumab,100,https://clinicaltrials.gov/show/NCT04837651,NA
NCT04838795,ClinicalTrials.gov,2021-02-17,2021-02-18,FALSE,Recruiting,Phase 3,Interventional,South Africa,Sisonke (Together): OPEN LABEL TRIAL COVID-19,500000,https://clinicaltrials.gov/show/NCT04838795,NA
NCT04839146,ClinicalTrials.gov,2021-03-11,2021-03-11,FALSE,Recruiting,Phase 1,Interventional,Netherlands,Safety and Tolerability of COVID-19 Vaccine (ABNCoV2),42,https://clinicaltrials.gov/show/NCT04839146,NA
NCT04840940,ClinicalTrials.gov,2021-04-08,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,Italy,Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04840940,NA
NCT04840966,ClinicalTrials.gov,2021-04-08,2020-05-05,TRUE,Not Recruiting,Not Applicable,Observational,Italy,A Simplified Test to Assess Flavor in COVID-19 Patients,111,https://clinicaltrials.gov/show/NCT04840966,NA
NCT04842305,ClinicalTrials.gov,2021-04-05,2021-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination,500,https://clinicaltrials.gov/show/NCT04842305,NA
NCT04843917,ClinicalTrials.gov,2021-04-10,2021-04-09,TRUE,Recruiting,Not Applicable,Observational,Argentina,Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine,100,https://clinicaltrials.gov/show/NCT04843917,NA
NCT04844268,ClinicalTrials.gov,2021-04-08,2021-05-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,"Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19",78,https://clinicaltrials.gov/show/NCT04844268,NA
NCT04844346,ClinicalTrials.gov,2021-04-13,2021-04-19,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Plant Stanol Esters and COVID-19 Vaccination Response,100,https://clinicaltrials.gov/show/NCT04844346,NA
NCT04844541,ClinicalTrials.gov,2021-03-23,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Prophylaxis and Treatment of COVID-19,500,https://clinicaltrials.gov/show/NCT04844541,NA
NCT04844554,ClinicalTrials.gov,2021-03-29,2021-04-19,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS,60,https://clinicaltrials.gov/show/NCT04844554,NA
NCT04844567,ClinicalTrials.gov,2021-03-18,2020-11-26,TRUE,Recruiting,Not Applicable,Interventional,Switzerland,Virtual Reality Intervention to Alleviate Breathlessness (COVID-19),35,https://clinicaltrials.gov/show/NCT04844567,NA
NCT04844632,ClinicalTrials.gov,2021-04-12,2021-02-11,TRUE,Recruiting,Not Applicable,Observational,Italy,"COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring",5000,https://clinicaltrials.gov/show/NCT04844632,NA
NCT04844658,ClinicalTrials.gov,2021-04-12,2021-02-17,TRUE,Recruiting,Not Applicable,Interventional,Belgium,"Covid-19, Hospitalized, PatIents, Nasafytol",50,https://clinicaltrials.gov/show/NCT04844658,NA
NCT04844710,ClinicalTrials.gov,2021-04-12,2020-09-01,TRUE,Not Recruiting,Not Applicable,Interventional,Indonesia,The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms,22,https://clinicaltrials.gov/show/NCT04844710,NA
NCT04845048,ClinicalTrials.gov,2021-04-12,2021-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine,900,https://clinicaltrials.gov/show/NCT04845048,NA
NCT04845880,ClinicalTrials.gov,2021-04-13,2020-10-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,SARS Cov_2 Incidence of Healthy Health Workers,182,https://clinicaltrials.gov/show/NCT04845880,NA
NCT04845971,ClinicalTrials.gov,2020-11-17,2020-11-05,TRUE,Recruiting,Phase 2,Interventional,Italy,Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia,97,https://clinicaltrials.gov/show/NCT04845971,NA
NCT04845984,ClinicalTrials.gov,2021-03-02,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region,3500,https://clinicaltrials.gov/show/NCT04845984,NA
NCT04845997,ClinicalTrials.gov,2021-04-12,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Argentina,COVID-19 Vaccination in Patients With Rheumatic Diseases,3000,https://clinicaltrials.gov/show/NCT04845997,NA
NCT04846790,ClinicalTrials.gov,2021-04-14,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,United States,The Effect of a Combined Nature-based and Virtual Mindfulness Intervention on Perceived Stress in Healthcare Workers,90,https://clinicaltrials.gov/show/NCT04846790,NA
NCT04846907,ClinicalTrials.gov,2021-04-13,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic,1148,https://clinicaltrials.gov/show/NCT04846907,NA
NCT04847349,ClinicalTrials.gov,2021-04-13,2021-04-13,FALSE,Recruiting,Not Applicable,Interventional,United States,Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial,45,https://clinicaltrials.gov/show/NCT04847349,NA
NCT04847362,ClinicalTrials.gov,2021-04-12,2021-04-11,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic,74,https://clinicaltrials.gov/show/NCT04847362,NA
NCT04847375,ClinicalTrials.gov,2021-04-10,2021-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Exogenous Surfactant Through Nebulizer Mask on Clinical Outcomes in Covid-19 Patients,60,https://clinicaltrials.gov/show/NCT04847375,NA
NCT04847518,ClinicalTrials.gov,2021-04-13,2021-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Georgia,Assessment of Efficacy of KAN-JANGÂ® in Mild COVID-19,140,https://clinicaltrials.gov/show/NCT04847518,NA
NCT04847544,ClinicalTrials.gov,2021-04-13,2021-03-31,TRUE,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.",30,https://clinicaltrials.gov/show/NCT04847544,NA
NCT04847622,ClinicalTrials.gov,2021-03-17,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,"United Kingdom, Netherlands, Israel, Spain, France",Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.,450,https://clinicaltrials.gov/show/NCT04847622,NA
NCT04847661,ClinicalTrials.gov,2021-04-14,2021-03-28,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial",1500,https://clinicaltrials.gov/show/NCT04847661,NA
NCT04847687,ClinicalTrials.gov,2021-04-13,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Investigation of Hospitalisation Times and Mortality According to Drug Dose in Patients Given Systemic Methylprednisolone With a Pre-diagnosis of Covid-19 Pneumonia; Retrospective Study,300,https://clinicaltrials.gov/show/NCT04847687,NA
NCT04847791,ClinicalTrials.gov,2021-04-12,2021-01-14,TRUE,Recruiting,Not Applicable,Interventional,Italy,Lactoferrin in Covid-19 Hospitalized Patients,194,https://clinicaltrials.gov/show/NCT04847791,NA
NCT04847804,ClinicalTrials.gov,2021-04-12,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Hong Kong,Large-scale COVID-19 Population Screening,200,https://clinicaltrials.gov/show/NCT04847804,NA
NCT04847817,ClinicalTrials.gov,2020-10-16,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,Gabon,Important Data on COVID-19 Profile in Africa,270,https://clinicaltrials.gov/show/NCT04847817,NA
NCT04848441,ClinicalTrials.gov,2021-04-14,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Risk of COVID-19 Infection After Vaccination,2000000,https://clinicaltrials.gov/show/NCT04848441,NA
NCT04848610,ClinicalTrials.gov,2021-04-12,2020-10-18,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Factors That Affect the Infection of COVID-19,1104,https://clinicaltrials.gov/show/NCT04848610,NA
NCT04848831,ClinicalTrials.gov,2021-02-07,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid",100,https://clinicaltrials.gov/show/NCT04848831,NA
NCT04849546,ClinicalTrials.gov,2021-04-15,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Staff Physical and Mental Health Assessment in the Aftermath of the First Peak of the Covid-19 Outbreak,1491,https://clinicaltrials.gov/show/NCT04849546,NA
NCT04849598,ClinicalTrials.gov,2021-04-13,2021-04-13,FALSE,Recruiting,Not Applicable,Interventional,Germany,Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection,15,https://clinicaltrials.gov/show/NCT04849598,NA
NCT04849611,ClinicalTrials.gov,2021-03-22,2020-11-12,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Covid-19 Fear and Compliance With Protective Measures of Students,188,https://clinicaltrials.gov/show/NCT04849611,NA
NCT04849624,ClinicalTrials.gov,2021-03-18,2021-03-05,TRUE,Recruiting,Not Applicable,Observational,Malaysia,Body Composition Study in Critically Ill Patients-Extended to COVID-19,50,https://clinicaltrials.gov/show/NCT04849624,NA
NCT04849637,ClinicalTrials.gov,2021-03-19,2020-10-22,TRUE,Recruiting,Phase 2,Interventional,Philippines,Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients,74,https://clinicaltrials.gov/show/NCT04849637,NA
NCT04849793,ClinicalTrials.gov,2021-04-08,2021-04-13,FALSE,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Anxiety Level,52,https://clinicaltrials.gov/show/NCT04849793,NA
NCT04851561,ClinicalTrials.gov,2021-04-11,2021-03-02,TRUE,Recruiting,Not Applicable,Observational,Israel,Post-coronavirus Disease-2019 Fatigue,153,https://clinicaltrials.gov/show/NCT04851561,NA
NCT04852055,ClinicalTrials.gov,2021-04-16,2021-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a COVID-specific Advance Care Planning Intervention,3000,https://clinicaltrials.gov/show/NCT04852055,NA
NCT04852809,ClinicalTrials.gov,2021-04-16,2021-04-26,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients,100,https://clinicaltrials.gov/show/NCT04852809,NA
NCT04853316,ClinicalTrials.gov,2021-04-16,2020-11-16,TRUE,Recruiting,Not Applicable,Observational,"Canada, United States",Asymptomatic SARS-CoV-2 Detection in Children,1600,https://clinicaltrials.gov/show/NCT04853316,NA
NCT04853901,ClinicalTrials.gov,2021-03-01,2020-07-27,TRUE,Not Recruiting,Phase 3,Interventional,Egypt,Remdesivir Efficacy In Management Of COVID-19 Patients,77,https://clinicaltrials.gov/show/NCT04853901,NA
NCT04853953,ClinicalTrials.gov,2021-04-16,2021-04-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Cerebral Bleeding in COVID-19 ARDS Patients on Veno-venous ECMO,400,https://clinicaltrials.gov/show/NCT04853953,NA
NCT04853966,ClinicalTrials.gov,2021-04-18,2021-04-17,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Effects of Physical Activity Counseling on Physical Activity and Quality of Life in Covid-19 Patients,30,https://clinicaltrials.gov/show/NCT04853966,NA
ACTRN12621000460808,ANZCTR,2021-04-20,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,New Zealand,COVID-19 VaccinAtion in patients with chronic Kidney disease in New Zealand (C-VAK NZ study),600,https://anzctr.org.au/ACTRN12621000460808.aspx,NA
ACTRN12621000468820,ANZCTR,2021-04-20,2021-05-31,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of of PRTX007 in  Healthy Adults",88,https://anzctr.org.au/ACTRN12621000468820.aspx,NA
ACTRN12621000476831,ANZCTR,2021-04-21,2021-04-23,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Postural orthostatic tachycardia syndrome (POTS) in Long COVID syndrome: A detailed profiling study,218,https://anzctr.org.au/ACTRN12621000476831.aspx,NA
ISRCTN15677965,ISRCTN,2021-04-14,2020-01-12,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Pandemic tracking of healthcare workers cohort and questionnaire study,500,http://isrctn.com/ISRCTN15677965,NA
ISRCTN18304314,ISRCTN,2021-04-13,2020-03-06,TRUE,Not Recruiting,Not Applicable,Interventional,Suriname,Effect of convalescent plasma therapy on intensive care unit (ICU) deaths from COVID-19 in Suriname,180,http://isrctn.com/ISRCTN18304314,NA
ISRCTN14810048,ISRCTN,2020-11-17,2020-03-25,TRUE,Not Recruiting,Not Applicable,Observational,Germany,AspCOVID-19 study: fungal infection of the airways in severe COVID-19 pneumonia,32,http://isrctn.com/ISRCTN14810048,NA
ISRCTN13035264,ISRCTN,2020-07-24,2020-03-31,TRUE,Not Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom",Adaptive COVID-19 treatment trial in the EU & UK,400,http://isrctn.com/ISRCTN13035264,NA
ISRCTN11384058,ISRCTN,2020-05-26,2020-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",300,http://isrctn.com/ISRCTN11384058,NA
ISRCTN10437835,ISRCTN,2020-05-21,2020-01-02,TRUE,Recruiting,Not Applicable,Observational,Spain,Survival of patients suffering an out-of-hospital cardiac arrest treated by emergency services in Spain during the COVID-19 pandemic and 1 year later,4000,http://isrctn.com/ISRCTN10437835,NA
ISRCTN10666798,ISRCTN,2020-04-23,2020-03-18,TRUE,Not Recruiting,Not Applicable,Observational,"Ireland, United Kingdom",The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic,6000,http://isrctn.com/ISRCTN10666798,NA
ISRCTN75313566,ISRCTN,2017-06-27,2017-09-25,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,PRedSS: Prednisolone in early diffuse systemic sclerosis,72,http://isrctn.com/ISRCTN75313566,NA
EUCTR2020-005128-12,EudraCT,2020-11-04,2021-01-02,FALSE,Authorised,Phase 3,Interventional,Lithuania,"An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia
",96,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005128-12,LT
EUCTR2020-005214-18,EudraCT,2020-11-04,2021-01-02,FALSE,Authorised,Phase 3,Interventional,Lithuania,"An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia
",75,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005214-18,LT
EUCTR2021-000566-14,EudraCT,2021-02-17,2021-03-17,FALSE,Authorised,Phase 4,Interventional,Czech Republic,Post-authorization Phase IV effectiveness and safety multicentric study of COVID-19 vaccines â€“ CoVigi,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000566-14,CZ
EUCTR2020-006130-12,EudraCT,2021-02-25,2021-03-25,FALSE,Authorised,Phase 3,Interventional,Italy,Acetylsalicylic acid in the prevention of severe COVID-19 pneumonia in hospitalised patients,204,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006130-12,IT
EUCTR2021-000365-33,EudraCT,2021-03-02,2021-03-17,FALSE,Authorised,Phase 2,Interventional,Netherlands,"Viral clearance, PK and tolerability of ensovibep in COVID-19 patients",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000365-33,NL
EUCTR2020-005759-18,EudraCT,2021-03-11,2021-01-04,TRUE,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18,BE
EUCTR2020-006075-15,EudraCT,2021-03-19,2021-03-25,FALSE,Authorised,Phase 3,Interventional,Netherlands,"An infusion of antibodies to COVID-19 for patients with B cell disorder, a randomized (randomized) study (COVID Compromise study).",86,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006075-15,NL
EUCTR2021-000701-24,EudraCT,2021-03-22,2021-03-31,FALSE,Authorised,Phase 4,Interventional,Netherlands,Switching of COVID-19 Vaccines: a solution for the problems?,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000701-24,NL
EUCTR2021-001655-13,EudraCT,2021-03-24,2021-01-04,TRUE,Authorised,Phase 4,Interventional,Netherlands,SARS-CoV2 vaccination and activation of the clotting system,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001655-13,NL
EUCTR2021-001414-10,EudraCT,2021-03-24,2021-03-30,FALSE,Authorised,Phase 4,Interventional,Netherlands,Response to corona vaccination in patients with primary SjÃ¶gren's syndrome,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001414-10,NL
EUCTR2021-001080-24,EudraCT,2021-03-18,2021-08-04,FALSE,Authorised,Phase 4,Interventional,Netherlands,Plant stanol esters and COVID-19 vaccination response,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001080-24,NL
EUCTR2021-000440-22,EudraCT,2021-02-25,2021-03-25,FALSE,Authorised,Phase 4,Interventional,Belgium,Vaccination against COVID-19 in Pregnant and Lactating Women in Belgium,420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000440-22,BE
EUCTR2021-001665-20,EudraCT,2021-03-26,2021-04-20,FALSE,Authorised,Phase 2,Interventional,Hungary,Efficacy of nebulized 4.2% sodium-bicarbonate in COVID-19 pneumonia,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001665-20,HU
EUCTR2021-000455-39,EudraCT,2021-02-15,2021-09-04,FALSE,Authorised,Phase 2,Interventional,Sweden,"A double-blind, placebo-controlled, interventional parallel group study to evaluate the antiviral effect of a single nasal application of LTX-109 3% gel, in comparison to placebo gel, in subjects with COVID-19 infection",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000455-39,SE
EUCTR2020-004272-17,EudraCT,2020-11-18,2021-03-25,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Dominican Republic, South Africa, Nepal, Belgium, Colombia, Brazil, Guatemala, Poland, Panama, Germany, Philippines",A controlled Phase 2/3 study of adjuvanted recombinant SARS-CoV-2 trimeric S-protein vaccine (SCB-2019) for the prevention of COVID-19,22000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004272-17,BE
EUCTR2020-002584-63,EudraCT,2020-08-12,2020-02-09,TRUE,Authorised,Phase 2,Interventional,"Argentina, United Kingdom, Netherlands, Canada, United States, Brazil, Spain, Germany","A Study to Evaluate Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults Aged 18 to 55 Years Inclusive, Adults Aged 65 Years and Healthy Adolescents Aged 12 to 17 Years",1285,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002584-63,DE
EUCTR2021-000175-37,EudraCT,2021-01-22,2021-09-02,FALSE,Authorised,Phase 4,Interventional,Sweden,"Immunologiskt svar efter vaccinering med mRNA vaccin mot covid-19, Comirnaty, hos immunsupprimerade och immunkompetenta personer. En Ã¶ppen icke randomiserad multicenterstudie i fas IV.",540,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000175-37,SE
EUCTR2021-000872-13,EudraCT,2021-02-27,2021-02-03,TRUE,Authorised,Phase 4,Interventional,Netherlands,Vaccination against cOvid In CancEr,873,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000872-13,NL
EUCTR2020-002282-33,EudraCT,2020-05-29,2020-01-10,TRUE,Authorised,Phase 2,Interventional,Germany,"Effect of anticoagulation therapy on clinical outcomes in COVID-19 (COVID-PREVENT)
",400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002282-33,DE
EUCTR2020-004070-22,EudraCT,2021-03-12,2021-12-04,FALSE,Authorised,Phase 3,Interventional,Belgium,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARSCoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities",1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004070-22,BE
EUCTR2020-001493-29,EudraCT,2020-04-14,2020-11-05,FALSE,Authorised,Phase 2,Interventional,Germany,CharitÃ© trial of Cenicriviroc (CVC) treatment for COVID-19 patients,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001493-29,DE
EUCTR2020-002869-34,EudraCT,2020-08-29,2020-11-08,FALSE,Authorised,Phase 2,Interventional,"Argentina, Moldova, Republic of, South Africa, Belgium, Ukraine, United States, Brazil, Egypt, Spain, Philippines, Romania","Safety and effectiveness of AT-527 compared to placebo, in moderate Covid-19 disease",190,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002869-34,BE
EUCTR2020-001857-31,EudraCT,2020-11-13,2021-04-03,FALSE,Authorised,Phase 2,Interventional,"Germany, Bulgaria, Israel",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31,BG
EUCTR2020-006003-42,EudraCT,2020-12-21,2020-12-30,FALSE,Authorised,Phase 4,Interventional,Denmark,Same as above,10000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006003-42,DK
EUCTR2020-003998-22,EudraCT,2020-11-19,2020-11-12,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Belgium, Netherlands, Colombia, Mexico, Spain, Panama, Germany",Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older,36500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003998-22,DE
EUCTR2020-003779-17,EudraCT,2020-11-13,2020-12-15,FALSE,Authorised,Phase 2/Phase 3,Interventional,Germany,A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory problems,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003779-17,DE
IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,200,http://en.irct.ir/trial/46867,NA
IRCT20200610047722N1,IRCT,2020-07-07,2020-06-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,?Effect of Allicin derivatives capsule in treatment of patients with new Coronavirus,25,http://en.irct.ir/trial/48869,NA
IRCT20150725023332N4,IRCT,2021-03-08,2020-04-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,The effect of morphine and fentanyl use in patients with corona,60,http://en.irct.ir/trial/49124,NA
IRCT20150725023332N5,IRCT,2021-04-06,2020-06-21,TRUE,Not Recruiting,Phase 3,Interventional,Iran,TheÂ effectÂ ofÂ hesperidinÂ useÂ onÂ theÂ clinicalÂ conditionÂ ofÂ patientsÂ withÂ theÂ newÂ coronavirus,60,http://en.irct.ir/trial/49150,NA
IRCT20200629047953N1,IRCT,2021-03-17,2021-04-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of olfactory training on anosmia of COVID-19,40,http://en.irct.ir/trial/49449,NA
IRCT20200707048047N1,IRCT,2021-03-27,2020-07-22,TRUE,Recruiting,Phase 2,Interventional,Iran,colchicine effect on persistent dyspnea  in COVID19,40,http://en.irct.ir/trial/49766,NA
IRCT20200509047373N2,IRCT,2021-04-13,2021-04-08,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of  herbal medicine containing Zataria multiflora and Glycyrrhiza glabra on clinical and paraclinical symptoms in COVID-19,120,http://en.irct.ir/trial/50551,NA
IRCT20150815023620N9,IRCT,2021-03-13,2020-04-01,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of herbal food product in patients with COVID 19,150,http://en.irct.ir/trial/52045,NA
IRCT20130812014333N164,IRCT,2021-04-01,2020-12-05,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effects of the exosomes on patients with COVID-19,8,http://en.irct.ir/trial/52416,NA
IRCT20200927048849N3,IRCT,2021-03-17,2021-03-20,FALSE,Recruiting,Phase 3,Interventional,Iran,Effect of hyperimmune bovine milk & colostrum in the healing process of COVID-19 patients,600,http://en.irct.ir/trial/52429,NA
IRCT20200823048495N1,IRCT,2020-12-12,2020-01-17,TRUE,Not Recruiting,Phase 1,Interventional,Pakistan,COVID-19 Cure Using Integrative Treatment,39,http://en.irct.ir/trial/52742,NA
IRCT20110423006257N3,IRCT,2021-04-03,2021-04-09,FALSE,Recruiting,Phase 3,Interventional,Iran,Thalidomide effects in COVID-19,66,http://en.irct.ir/trial/53279,NA
IRCT20201111049348N2,IRCT,2021-02-25,2021-02-28,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The Effect of Turmeric Extract on the Treatment of Patients with Covid-19,120,http://en.irct.ir/trial/53645,NA
IRCT20160516027929N8,IRCT,2021-03-02,2020-06-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of high flow oxygen delivery through the nasal cannula in comparison with non-invasive ventilation in patients with COVID-19,60,http://en.irct.ir/trial/53646,NA
IRCT20150902023864N2,IRCT,2021-02-08,2021-01-20,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Lemon Balm/ Star anice in treatment of COVID-19 patients as well as their prophylactic effects in close contacts with COVID-19 patients,120,http://en.irct.ir/trial/53653,NA
IRCT20210102049912N1,IRCT,2021-04-07,2021-04-09,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of vitamin A supplementation in outpatients with COVID-19,140,http://en.irct.ir/trial/53693,NA
IRCT20201212049681N1,IRCT,2021-02-28,2021-01-20,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of gargling with Hydrogen Peroxide 1% and Povidine Iodine 0.25% on viral load of SARS-CoV-2 in covid19 patients,60,http://en.irct.ir/trial/53702,NA
IRCT20150711023153N2,IRCT,2021-02-28,2021-02-28,FALSE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the Effects of natural Pomegranate juice (Punica granatum)   in patients with covid-19,48,http://en.irct.ir/trial/53860,NA
IRCT20210123050116N1,IRCT,2021-03-04,2021-04-21,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of acceptance and commitment counseling on body image and breastfeeding self-efficacy,90,http://en.irct.ir/trial/53872,NA
IRCT20111224008507N4,IRCT,2021-01-31,2021-02-19,FALSE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in treatment of outpatients with COVID-19,1000,http://en.irct.ir/trial/53949,NA
IRCT20140810018754N12,IRCT,2021-03-15,2021-02-08,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of pulmonary tele-rehabilitation and progressive muscle relaxation training in COVID-19 patients,52,http://en.irct.ir/trial/54036,NA
IRCT20210203050233N1,IRCT,2021-04-14,2021-02-19,TRUE,Recruiting,Phase 3,Interventional,Iran,Assessment of effect of crocin on Covid-19 patients,60,http://en.irct.ir/trial/54085,NA
IRCT20210202050219N1,IRCT,2021-04-08,2021-03-05,TRUE,Recruiting,Not Applicable,Interventional,Iran,Investigating the effect of education on stress and anxiety of COVID-19 patients' caregivers,25,http://en.irct.ir/trial/54110,NA
IRCT20210204050238N1,IRCT,2021-03-02,2021-03-21,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of zinc supplementation on COVID-19,44,http://en.irct.ir/trial/54136,NA
IRCT20111224008507N5,IRCT,2021-02-22,2021-02-19,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in treatment of patients admitted with COVID-19,1000,http://en.irct.ir/trial/54402,NA
IRCT20210218050404N1,IRCT,2021-03-10,2021-06-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Control of inflammatory process in patients with coronavirus affected by polyflavonoid extract of Mangifera indica leaf,60,http://en.irct.ir/trial/54447,NA
IRCT20180728040617N3,IRCT,2021-03-14,2021-03-10,TRUE,Recruiting,Not Applicable,Interventional,Iran,Effect of Stress Management Program on Psychological Distress of Cancer Patients and Caring Burden and Quality of Life of Their Caregivers during the COVID-19 Epidemic,60,http://en.irct.ir/trial/54613,NA
IRCT20200405046958N2,IRCT,2021-04-14,2021-03-10,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of plasmapheresis in the treatment of Covid 19,42,http://en.irct.ir/trial/54653,NA
IRCT20160808029264N10,IRCT,2021-04-13,2021-04-03,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effects of laser therapy in patients with COVID-19,30,http://en.irct.ir/trial/54655,NA
IRCT20210223050466N1,IRCT,2021-03-27,2021-03-21,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison between dexamethasone and methylprednisolone in treatment of COVID-19,140,http://en.irct.ir/trial/54662,NA
IRCT20201124049480N1,IRCT,2021-03-28,2021-04-21,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Levamisol in Treating COVID-19,250,http://en.irct.ir/trial/54675,NA
IRCT20210301050536N1,IRCT,2021-03-15,2021-03-16,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of using short message information system on the level of anxiety and awareness of patient companions during surgery and wound care after surgery,110,http://en.irct.ir/trial/54698,NA
IRCT20210213050344N1,IRCT,2021-04-06,2021-04-10,FALSE,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 Patients,375,http://en.irct.ir/trial/54710,NA
IRCT20180226038870N1,IRCT,2021-03-05,2021-05-10,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effectiveness of pulmonary rehabilitation and exercise therapy in reducing the length of hospital stay of patients with Covid-19,100,http://en.irct.ir/trial/54725,NA
IRCT20201202049568N3,IRCT,2021-03-05,2021-03-05,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosome therapy in ARDS patients,72,http://en.irct.ir/trial/54758,NA
IRCT20200329046892N2,IRCT,2021-03-09,2021-03-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of tofacitinib in COVID-19,60,http://en.irct.ir/trial/54800,NA
IRCT20200413047063N2,IRCT,2021-04-14,2021-03-21,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosomes Derived from placental Mesenchymal Stem Cells as Treatment for Severe COVID-19: Phase 1 & 2 Clinical Trials,50,http://en.irct.ir/trial/54828,NA
IRCT20201202049567N3,IRCT,2021-03-13,2021-03-14,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluate the safety and efficacy of COVID-19 inactivated vaccine,20000,http://en.irct.ir/trial/54881,NA
IRCT20200527047581N2,IRCT,2021-03-17,2021-04-09,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Chlorhexidine 0/12% and 0/2 % Povidone-iodine mouth rinse on clinical characteristics of patients with COVID-19,180,http://en.irct.ir/trial/54884,NA
IRCT20201202049567N2,IRCT,2021-03-13,2021-03-13,FALSE,Recruiting,Phase 1,Interventional,Iran,Phase 1 clinical trial of an inactivated COVID-19 vaccine (Shifa-Pharmed) in healthy individuals aged 51-75 years,32,http://en.irct.ir/trial/54885,NA
IRCT20210302050555N1,IRCT,2021-03-28,2021-04-21,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of mobile-learning on stress and self-efficacy among diabetes patients with covid-19,70,http://en.irct.ir/trial/54915,NA
IRCT20180721040538N1,IRCT,2021-03-25,2021-04-03,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of combined and online protocol  ergonomic advice-exercise in comparison with ergonomic advice protocol on forward head deformity of students during Covid-19 pandemic,180,http://en.irct.ir/trial/54933,NA
IRCT20180619040147N6,IRCT,2021-04-01,2021-04-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,menstrual blood stem cell therapy for covid-19,30,http://en.irct.ir/trial/54971,NA
IRCT20210311050671N1,IRCT,2021-04-13,2021-04-04,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of laser acupuncture on improving the sense of smell in patients with COVID-19,90,http://en.irct.ir/trial/54973,NA
IRCT20171219037964N4,IRCT,2021-03-20,2021-04-09,FALSE,Recruiting,Not Applicable,Interventional,Iran,study the effect of cognitive therapy on insomnia and heart rate variability of health care workers,70,http://en.irct.ir/trial/55028,NA
IRCT20180302038915N1,IRCT,2021-04-05,2021-04-14,FALSE,Recruiting,Phase 3,Interventional,Iran,Safety and efficacy of sofosbuvir in the moderate COVID19,50,http://en.irct.ir/trial/55052,NA
IRCT20151226025699N5,IRCT,2021-04-07,2021-04-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"The effect of vitamin A, B, C, D, and E supplementations in COVID-19",135,http://en.irct.ir/trial/55074,NA
IRCT20131129015584N4,IRCT,2021-04-04,2021-04-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of Padzahr tablets on the symptoms of COVID-19,68,http://en.irct.ir/trial/55081,NA
IRCT20190303042889N1,IRCT,2021-03-30,2021-05-05,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of complementary therapy with Portulaca oleracea capsule on the clinical symptoms of outpatients with COVID-19,70,http://en.irct.ir/trial/55153,NA
IRCT20210324050760N1,IRCT,2021-04-17,2021-04-21,FALSE,Not Recruiting,Phase 4,Interventional,Iran,Effect of Remdesivir in treatment of COVID-19,100,http://en.irct.ir/trial/55187,NA
IRCT20200329046892N3,IRCT,2021-03-29,2021-04-09,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of ivermectin in COVID-19,60,http://en.irct.ir/trial/55216,NA
IRCT20201214049709N2,IRCT,2021-04-13,2021-04-21,FALSE,Not Recruiting,Phase 2,Interventional,Iran,"Phase II, Safety and Immunogenicity of recombinant vaccine for COVID-19",500,http://en.irct.ir/trial/55238,NA
IRCT20111210008348N51,IRCT,2021-04-10,2021-04-21,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of Jacobsen relaxation application on anxiety and job stress of nurses,70,http://en.irct.ir/trial/55240,NA
IRCT20210325050769N1,IRCT,2021-04-12,2021-04-19,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of herbal therapeutic supplements (Marsh - Mallow, Sweet violet, Malva sylvestris, Damask rose, Liquorice root) against corona disease",200,http://en.irct.ir/trial/55493,NA
ChiCTR2100042401,ChiCTR,2021-01-21,2021-01-13,TRUE,Recruiting,Not Applicable,Interventional,China,The effectiveness of guided narrative technique on improving COVID-19 related positive and negative emotions and cognition: a randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=120319,NA
ChiCTR2100042375,ChiCTR,2021-01-21,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Evaluation of Biomarkers for Prediction of Morbidity and Mortality in COVID-19 at a Tertiary Care Center in Pakistan,157,http://www.chictr.org.cn/showproj.aspx?proj=120493,NA
ChiCTR2100042374,ChiCTR,2021-01-21,2021-01-28,FALSE,Recruiting,Phase 2,Interventional,China,Phase IIb clinical trial of recombinant novel coronavirus pneumonia (COVID-19) vaccine (Sf9 cells),4800,http://www.chictr.org.cn/showproj.aspx?proj=120494,NA
CTRI/2021/02/031451,CTRI,2021-02-22,2021-02-22,FALSE,Recruiting,Not Applicable,Observational,India,"
                Immunogenicity Assessment Extension Study of nCoV-2019
                novel coronavirus vaccine developed by Cadila Healthcare Ltd in
                Phase I part of Protocol NCOV 1002.
",20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52576,NA
CTRI/2021/02/031430,CTRI,2021-02-22,2021-02-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Remdesevir and Hydroxychloroquine in moderate to severe Covid 19 patient.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47292,NA
CTRI/2021/02/031479,CTRI,2021-02-23,2021-02-26,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effects of online Mindfulness program on Stress,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48898,NA
CTRI/2021/02/031484,CTRI,2021-02-23,2021-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Effectiveness of Holistic Traditional Complementary Alternative Medicine (HTCAM) on immuno, metabolic, clinical and psychosocial outcomes in suspected isolated cases of SARS CoV-2 : a Pilot Randomized Control Trial",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52585,NA
CTRI/2021/02/031472,CTRI,2021-02-23,2021-02-23,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to compare HRCT chest and RT PCR in identification of coronavirus disease 2019(COVID 19),180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50600,NA
CTRI/2021/02/031520,CTRI,2021-02-24,2021-02-25,FALSE,Recruiting,Phase 2,Interventional,India,A clinical study  to see the effect of ArtemiC in patients with COVID-19,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52515,NA
CTRI/2021/02/031523,CTRI,2021-02-24,2022-01-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Serum Creatinine and BUN in Covid 19 Hospitalised patients.Ã¢??,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52370,NA
CTRI/2021/02/031521,CTRI,2021-02-24,2021-02-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Effect of COVID-19 pandemic on dental expenses of patients,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50379,NA
CTRI/2021/02/031570,CTRI,2021-02-25,2021-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Mindfulness for children,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53018,NA
CTRI/2021/02/031541,CTRI,2021-02-25,2021-02-27,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to evaluate the usefulness and side effects of injection Remdesivir in moderate to severe covid 19 lung affected patients in a multispeciality hospital in Kolkata.,63,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52099,NA
CTRI/2021/02/031566,CTRI,2021-02-25,2021-03-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of Equine antibody treatment in patient with COVID 19 infection,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51849,NA
CTRI/2021/02/031547,CTRI,2021-02-25,2021-02-25,FALSE,Recruiting,Phase 2,Interventional,India,A clinical trial to induce immunity and herd immunity against viruses including covid 19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43929,NA
CTRI/2021/02/031543,CTRI,2021-02-25,2021-11-03,FALSE,Not Recruiting,Not Applicable,Interventional,India,COVID-19 Pandemic- Impact of online yoga on mental health and quality of life in adolescents,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52892,NA
CTRI/2021/02/031554,CTRI,2021-02-25,2021-02-26,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,The study to check the safety and immune response of (Covid-19 vaccine) COVOVAX in adults,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49327,NA
CTRI/2021/02/031545,CTRI,2021-02-25,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,India,"This is a comparison study between perceived comfort, acceptability and efficiency between low cost loose fitting PAPR and PPE ( full body PPE, along with N95 mask, goggles, and also a face shield in the front)",20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52734,NA
CTRI/2021/03/031616,CTRI,2021-03-01,2021-05-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52784,NA
CTRI/2021/03/031615,CTRI,2021-03-01,2021-02-03,TRUE,Recruiting,Not Applicable,Observational,India,"Knowledge, Attitude and Practice (KAP) in regard to COVID-19 patients",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53060,NA
CTRI/2021/03/031614,CTRI,2021-03-01,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,India,Comparative study of two types of steroids for severe COVID disease,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52090,NA
CTRI/2021/03/031617,CTRI,2021-03-01,2021-05-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Ã¢??Study of sequential antibody estimation   post COVID-19 vaccination amongst health care workersÃ¢??,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53164,NA
CTRI/2021/03/031663,CTRI,2021-03-02,2021-08-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Complete Blood Count as screening tool for COVID-19,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53270,NA
CTRI/2021/03/031665,CTRI,2021-03-02,2021-03-15,FALSE,Not Recruiting,Phase 4,Interventional,India,Ivermectin prophylaxis for  Covid-19 Infection in Health care Personnel,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53325,NA
CTRI/2021/03/031668,CTRI,2021-03-02,2021-02-17,TRUE,Not Recruiting,Not Applicable,Observational,India,Adi five layered designer cotton face mask with filter,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52317,NA
CTRI/2021/03/031664,CTRI,2021-03-02,2021-08-03,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Open Label Study to Evaluate the Safety and Efficacy of SwasVimochan, SwasanRakshak, Swasamrit, Immune Energy Tablets with Mild to Moderate COVID-19 Patients",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52574,NA
CTRI/2021/03/031667,CTRI,2021-03-02,2021-03-25,FALSE,Not Recruiting,Phase 3,Interventional,India,Effect of Chatushashti Prahari Pippali in the management of Post COVID syndrome,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53117,NA
CTRI/2021/03/031666,CTRI,2021-03-02,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Post-operative complications and mortality in patients with COVID 19 undergoing surgery under anaesthesia- A single centre retrospective case control study,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52917,NA
CTRI/2021/03/031662,CTRI,2021-03-02,2021-10-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Measure of Depression and Anxiety level in Home Isolated Covid positive patients,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51935,NA
CTRI/2021/03/031684,CTRI,2021-03-03,2021-10-03,FALSE,Not Recruiting,Phase 3,Interventional,India,clinical study of Vardhamana Pippli Rasayana and WHO rehabilitation guidelines in the management of post Covid syndrome,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52741,NA
CTRI/2021/03/031687,CTRI,2021-03-03,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Audit of Indian Clinical trials on COVID-19,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53075,NA
CTRI/2021/03/031685,CTRI,2021-03-03,2021-05-03,FALSE,Not Recruiting,Not Applicable,Observational,India,Ã¢??COVID-19 vaccination: The dilemma faced by a Health care worker.,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53173,NA
CTRI/2021/03/031686,CTRI,2021-03-03,2021-10-03,FALSE,Not Recruiting,Phase 3,Interventional,India,Clinical Trial on Post Covid 19 through Ayurvedic intervention Agastya Haritaki amd Ashwagandha along with Yoga,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53215,NA
CTRI/2021/03/031721,CTRI,2021-03-04,2021-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Spironolactone on  COVID-19 patients.,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53532,NA
CTRI/2021/03/031720,CTRI,2021-03-04,2021-03-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,The study to explore the effect of  Bacillus calusii and Bacillus Coagulans (the Probiotics) on Covid-19 disease progression in addition to routine Covid-19 treatment.,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53161,NA
CTRI/2021/03/031756,CTRI,2021-03-08,2021-08-03,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to investigate the performance of the rapid antigen test kit for detecting the SARs-CoV2 coronavirus.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53298,NA
CTRI/2021/03/031790,CTRI,2021-03-08,2021-03-15,FALSE,Not Recruiting,Phase 2,Interventional,India,Ketoji a nutritional therapy  in management of symptoms of Covid-19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53090,NA
CTRI/2021/03/031774,CTRI,2021-03-08,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Ã¢??Clinical profile and outcomes of COVID-19 patients admitted to an intensive care unit in a tertiary care hospitalÃ¢??.,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53613,NA
CTRI/2021/03/031757,CTRI,2021-03-08,2021-10-03,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID 19 Infected ST-Elevation Myocardial Infarction in INDIA (COSTA INDIA) - A Cardiological Society of India Study,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53151,NA
CTRI/2021/03/031813,CTRI,2021-03-09,2021-10-03,FALSE,Recruiting,Not Applicable,Observational,India,"Concerns and trust that form the basis for general public living in an Indian city, to accept or not to accept COVID-19 vaccine - a qualitative study",15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51555,NA
CTRI/2021/03/031841,CTRI,2021-03-09,2021-03-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Non-contact kiosk for screening  COVID19,6800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51148,NA
CTRI/2021/03/031815,CTRI,2021-03-09,2021-03-15,FALSE,Not Recruiting,Phase 3,Interventional,India,An Anti-Viral Ayurvedic formulation for the treatment of COVID-19 Patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52987,NA
CTRI/2021/03/031898,CTRI,2021-03-10,2021-03-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Willingness to Accept COVID 19 vaccine In India: A Web Based Survey,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53719,NA
CTRI/2021/03/031933,CTRI,2021-03-11,2021-03-19,FALSE,Not Recruiting,Not Applicable,Observational,India,"SARS CoV 2 antibody status of health care workers in a covid tertiary care hospital in Bangalore, Karnataka.",250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53812,NA
CTRI/2021/03/031907,CTRI,2021-03-11,2021-03-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Assessment of physical activity and perception about health among adults during COVID-19 pandemic in India,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50741,NA
CTRI/2021/03/031945,CTRI,2021-03-12,2021-01-04,TRUE,Recruiting,Not Applicable,Observational,India,"This is a study to describe the various poisonings and injuries that occurred during the COVID-19 pandemic lockdown in Bangalore, India",650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53809,NA
CTRI/2021/03/031939,CTRI,2021-03-12,2021-03-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Immediate effect of  positioning on oxygen level in patients with COVID 19.,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49214,NA
CTRI/2021/03/031940,CTRI,2021-03-12,2021-03-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Clinical trial for TADIOS as supplemental therapy in mild to moderate COVID-19,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53172,NA
CTRI/2021/03/031998,CTRI,2021-03-15,2021-03-21,FALSE,Not Recruiting,Not Applicable,Observational,India,To determine the safety and antibody performance in Indian adults after taking COVID-19 vaccine.,6000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53828,NA
CTRI/2021/03/031969,CTRI,2021-03-15,2021-03-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Reducing systemic inflammation in cancer patients with COVID-19 using Topotecan with Dexamethasone and Remdesivir,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52816,NA
CTRI/2021/03/031970,CTRI,2021-03-15,2021-03-29,FALSE,Not Recruiting,Not Applicable,Observational,India,LDH and Ferritin levels in Diabetes Mellitus.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52372,NA
CTRI/2021/03/032037,CTRI,2021-03-16,2021-03-22,FALSE,Not Recruiting,Not Applicable,Observational,India,"An Online Survey of Knowledge, Attitude and Perception of COVID-19 Vaccine in Non-vaccinated Individuals from the age group of 18-25 years of age.",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53771,NA
CTRI/2021/03/032028,CTRI,2021-03-16,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,"An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, India",40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53836,NA
CTRI/2021/03/032051,CTRI,2021-03-16,2021-03-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Trial to evaluate 3mg dose of Covid Vaccine of Cadila healthcare Limited,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53226,NA
CTRI/2021/03/032072,CTRI,2021-03-17,2021-03-19,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,A study to assess Efficacy and safety of Ayurvedic Kadha in health and immunity related parameters in mild COVID-19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53003,NA
CTRI/2021/03/032066,CTRI,2021-03-17,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Identifying heart damage  in Covid 19 patients - Earlier the better.,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53263,NA
CTRI/2021/03/032067,CTRI,2021-03-17,2021-09-04,FALSE,Not Recruiting,Not Applicable,Observational,India,"
                Clinical and biochemical profile of AKI in patients with COVID 19. A single center experience.

",800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52536,NA
CTRI/2021/03/032063,CTRI,2021-03-17,2021-03-22,FALSE,Not Recruiting,Not Applicable,Observational,India,"Understanding of tiredness, level of function and quality of life amongst Post-Covid patients who were admitted in hospitals and asked to be home quarantined",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53868,NA
CTRI/2021/03/032059,CTRI,2021-03-17,2021-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,India,Investigator initiated study to evaluate the effect of Marketed Colchicine 0.5mg given along marketed Asprin 75mg with SOC and Marketed aspirin 75mg with SOC on COVID 19 patients,62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53115,NA
CTRI/2021/03/032065,CTRI,2021-03-17,2021-03-29,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to assess patient satisfaction and experience at a tertiary care hospital during the Covid-19 pandemic,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53939,NA
CTRI/2021/03/032086,CTRI,2021-03-17,2021-03-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To study the mental health status, job satisfaction  and quality of sleep among nursing staff during COVID 19 pandemic",400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52929,NA
CTRI/2021/03/032060,CTRI,2021-03-17,2021-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,India,"
                Investigator initiated study to evaluate the effect of Marketed Colchicine 0.5mg given along
                marketed Asprin 75mg with SOC and Marketed aspirin 75mg with SOC on COVID 19 patients
",62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53231,NA
CTRI/2021/03/032135,CTRI,2021-03-18,2021-03-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of spirometry and neurophysiological facilitation technique to reduce the level of dyspnea in post covid-19 patient-A randomized controlled trial,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51532,NA
CTRI/2021/03/032159,CTRI,2021-03-19,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Mental health of pregnant women during the covid 19 pandemic,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52882,NA
CTRI/2021/03/032158,CTRI,2021-03-19,2021-03-24,FALSE,Recruiting,Not Applicable,Interventional,India,Effects of Covieshield vaccine on Liver cirrhosis patients,2200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54015,NA
NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,222,https://clinicaltrials.gov/show/NCT04325906,NA
NCT04333953,ClinicalTrials.gov,2020-03-31,2020-04-01,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,500,https://clinicaltrials.gov/show/NCT04333953,NA
NCT04338126,ClinicalTrials.gov,2020-04-06,2021-09-30,FALSE,Not Recruiting,Phase 2,Interventional,United States,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,0,https://clinicaltrials.gov/show/NCT04338126,NA
NCT04346628,ClinicalTrials.gov,2020-04-10,2020-07-12,FALSE,Not Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,149,https://clinicaltrials.gov/show/NCT04346628,NA
NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,FALSE,Not Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,17,https://clinicaltrials.gov/show/NCT04348500,NA
NCT04353531,ClinicalTrials.gov,2020-03-23,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,United States,Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures,15,https://clinicaltrials.gov/show/NCT04353531,NA
NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,FALSE,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),100,https://clinicaltrials.gov/show/NCT04355364,NA
NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-13,FALSE,Not Recruiting,Phase 2,Interventional,"Puerto Rico, United States",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,20,https://clinicaltrials.gov/show/NCT04358068,NA
NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,FALSE,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,1000,https://clinicaltrials.gov/show/NCT04362176,NA
NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,FALSE,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,102,https://clinicaltrials.gov/show/NCT04363606,NA
NCT04365959,ClinicalTrials.gov,2020-04-21,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Italy,The Prone Position in Covid-19 Affected Patients,56,https://clinicaltrials.gov/show/NCT04365959,NA
NCT04367142,ClinicalTrials.gov,2020-04-27,2020-08-24,FALSE,Recruiting,Not Applicable,Observational,France,Rapid Detection of COVID-19 by Portable and Connected Biosensor,300,https://clinicaltrials.gov/show/NCT04367142,NA
NCT04368234,ClinicalTrials.gov,2020-04-27,2020-04-18,TRUE,Recruiting,Not Applicable,Observational,United States,Duke COVID-19 Shared Data and Specimen Repository,100000,https://clinicaltrials.gov/show/NCT04368234,NA
NCT04370808,ClinicalTrials.gov,2020-04-26,2020-08-01,FALSE,Not Recruiting,Not Applicable,Observational,Portugal,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,517,https://clinicaltrials.gov/show/NCT04370808,NA
NCT04371692,ClinicalTrials.gov,2020-04-28,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,900,https://clinicaltrials.gov/show/NCT04371692,NA
NCT04375137,ClinicalTrials.gov,2020-05-03,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Iran,Correlation Between Oxidative Stress Status and COVID-19 Severity,90,https://clinicaltrials.gov/show/NCT04375137,NA
NCT04377568,ClinicalTrials.gov,2020-04-30,2020-10-07,FALSE,Not Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,0,https://clinicaltrials.gov/show/NCT04377568,NA
NCT04380701,ClinicalTrials.gov,2020-05-06,2020-04-23,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,476,https://clinicaltrials.gov/show/NCT04380701,NA
NCT04381923,ClinicalTrials.gov,2020-05-07,2021-06-15,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,200,https://clinicaltrials.gov/show/NCT04381923,NA
NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,4,https://clinicaltrials.gov/show/NCT04381988,NA
NCT04382235,ClinicalTrials.gov,2020-05-05,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Non-invasive Ventilatory Support of Patients Affected by COVID-19,900,https://clinicaltrials.gov/show/NCT04382235,NA
NCT04395599,ClinicalTrials.gov,2020-05-19,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,40,https://clinicaltrials.gov/show/NCT04395599,NA
NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,15,https://clinicaltrials.gov/show/NCT04400032,NA
NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,FALSE,Not Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,200,https://clinicaltrials.gov/show/NCT04404361,NA
NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,180,https://clinicaltrials.gov/show/NCT04412356,NA
NCT04428008,ClinicalTrials.gov,2020-06-07,2021-01-12,FALSE,Recruiting,Phase 2,Interventional,United States,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,240,https://clinicaltrials.gov/show/NCT04428008,NA
NCT04451291,ClinicalTrials.gov,2020-06-26,2020-09-25,FALSE,Recruiting,Not Applicable,Interventional,Canada,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,20,https://clinicaltrials.gov/show/NCT04451291,NA
NCT04455958,ClinicalTrials.gov,2020-07-01,2021-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,0,https://clinicaltrials.gov/show/NCT04455958,NA
NCT04463602,ClinicalTrials.gov,2020-07-07,2020-07-25,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Desidustat in the Management of COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04463602,NA
NCT04465513,ClinicalTrials.gov,2020-07-08,2020-08-31,FALSE,Recruiting,Not Applicable,Interventional,Canada,Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04465513,NA
NCT04473365,ClinicalTrials.gov,2020-07-11,2020-07-20,FALSE,Recruiting,Not Applicable,Observational,Ethiopia,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),1000,https://clinicaltrials.gov/show/NCT04473365,NA
NCT04486144,ClinicalTrials.gov,2020-07-20,2020-05-20,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Impact Nerium Oleander on Immune Function,82,https://clinicaltrials.gov/show/NCT04486144,NA
NCT04491071,ClinicalTrials.gov,2020-07-27,2020-10-22,FALSE,Recruiting,Not Applicable,Observational,"France, United Kingdom",Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,405,https://clinicaltrials.gov/show/NCT04491071,NA
NCT04492384,ClinicalTrials.gov,2020-07-27,2020-06-11,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,5800,https://clinicaltrials.gov/show/NCT04492384,NA
NCT04495933,ClinicalTrials.gov,2020-07-13,2020-07-13,FALSE,Recruiting,Phase 1,Interventional,Australia,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",216,https://clinicaltrials.gov/show/NCT04495933,NA
NCT04525911,ClinicalTrials.gov,2020-08-19,2020-08-26,FALSE,Recruiting,Not Applicable,Observational,France,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,258,https://clinicaltrials.gov/show/NCT04525911,NA
NCT04527471,ClinicalTrials.gov,2020-08-06,2020-09-04,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,45,https://clinicaltrials.gov/show/NCT04527471,NA
NCT04539873,ClinicalTrials.gov,2020-08-29,2021-04-30,FALSE,Not Recruiting,Phase 3,Interventional,Colombia,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,128,https://clinicaltrials.gov/show/NCT04539873,NA
NCT04542031,ClinicalTrials.gov,2020-09-07,2020-12-14,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,7911,https://clinicaltrials.gov/show/NCT04542031,NA
NCT04550338,ClinicalTrials.gov,2020-09-13,2021-08-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,0,https://clinicaltrials.gov/show/NCT04550338,NA
NCT04567836,ClinicalTrials.gov,2020-09-22,2020-07-09,TRUE,Recruiting,Not Applicable,Observational,Italy,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,3000,https://clinicaltrials.gov/show/NCT04567836,NA
NCT04570488,ClinicalTrials.gov,2020-09-25,2020-05-15,TRUE,Recruiting,Not Applicable,Interventional,United States,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,1200,https://clinicaltrials.gov/show/NCT04570488,NA
NCT04578158,ClinicalTrials.gov,2020-10-06,2020-09-29,TRUE,Not Recruiting,Phase 3,Interventional,Pakistan,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,152,https://clinicaltrials.gov/show/NCT04578158,NA
NCT04588792,ClinicalTrials.gov,2020-10-14,2021-04-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Canada,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,640,https://clinicaltrials.gov/show/NCT04588792,NA
NCT04591184,ClinicalTrials.gov,2020-09-23,2021-04-07,FALSE,Recruiting,Phase 1,Interventional,Canada,A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,72,https://clinicaltrials.gov/show/NCT04591184,NA
NCT04608305,ClinicalTrials.gov,2020-10-26,2020-10-28,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Israel,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",1040,https://clinicaltrials.gov/show/NCT04608305,NA
NCT04623671,ClinicalTrials.gov,2020-10-07,2020-11-15,FALSE,Recruiting,Phase 2,Interventional,United States,Intravenous Infusion of CAP-1002 in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04623671,NA
NCT04636203,ClinicalTrials.gov,2020-11-17,2020-01-15,TRUE,Recruiting,Not Applicable,Observational,Italy,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,3500,https://clinicaltrials.gov/show/NCT04636203,NA
NCT04641195,ClinicalTrials.gov,2020-11-19,2021-04-22,FALSE,Recruiting,Phase 3,Interventional,India,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,700,https://clinicaltrials.gov/show/NCT04641195,NA
NCT04643860,ClinicalTrials.gov,2020-11-24,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Differential Leucocyte Count and Covid-19 Diagnosis,1000,https://clinicaltrials.gov/show/NCT04643860,NA
NCT04648709,ClinicalTrials.gov,2020-11-27,2021-03-09,FALSE,Recruiting,Not Applicable,Observational,France,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,100,https://clinicaltrials.gov/show/NCT04648709,NA
NCT04649775,ClinicalTrials.gov,2020-10-14,2021-04-09,FALSE,Recruiting,Not Applicable,Interventional,United States,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,50,https://clinicaltrials.gov/show/NCT04649775,NA
NCT04651387,ClinicalTrials.gov,2020-12-01,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,74,https://clinicaltrials.gov/show/NCT04651387,NA
NCT04659109,ClinicalTrials.gov,2020-11-30,2020-12-16,FALSE,Recruiting,Phase 2,Interventional,France,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,60,https://clinicaltrials.gov/show/NCT04659109,NA
NCT04664296,ClinicalTrials.gov,2020-12-10,2020-12-21,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),72,https://clinicaltrials.gov/show/NCT04664296,NA
NCT04670094,ClinicalTrials.gov,2020-12-14,2020-12-30,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Comorbidities and Risk Score in COVID-19 Patients,2500,https://clinicaltrials.gov/show/NCT04670094,NA
NCT04675281,ClinicalTrials.gov,2020-12-15,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,France,Pathological Findings of Fatal COVID-19,170,https://clinicaltrials.gov/show/NCT04675281,NA
NCT04681092,ClinicalTrials.gov,2020-12-22,2021-04-12,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Anti-COVID19 AKS-452 - ACT Study,130,https://clinicaltrials.gov/show/NCT04681092,NA
NCT04681859,ClinicalTrials.gov,2020-12-22,2021-04-17,FALSE,Recruiting,Not Applicable,Interventional,Bangladesh,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04681859,NA
NCT04682132,ClinicalTrials.gov,2020-12-22,2020-05-26,TRUE,Not Recruiting,Not Applicable,Observational,United States,Polk COVID-19 and Flu Response,686,https://clinicaltrials.gov/show/NCT04682132,NA
NCT04682197,ClinicalTrials.gov,2020-12-16,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cereset Research In Healthcare Workers During COVID-19,100,https://clinicaltrials.gov/show/NCT04682197,NA
NCT04685213,ClinicalTrials.gov,2020-12-23,2020-08-18,TRUE,Recruiting,Phase 1,Interventional,United States,Electrical Stimulation for Critically Ill Covid-19 Patients,20,https://clinicaltrials.gov/show/NCT04685213,NA
NCT04723446,ClinicalTrials.gov,2021-01-05,2021-04-20,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,40,https://clinicaltrials.gov/show/NCT04723446,NA
NCT04741412,ClinicalTrials.gov,2021-02-01,2020-06-03,TRUE,Recruiting,Not Applicable,Observational,Germany,"Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences",230,https://clinicaltrials.gov/show/NCT04741412,NA
NCT04748536,ClinicalTrials.gov,2021-02-01,2021-01-29,TRUE,Not Recruiting,Phase 1,Interventional,United Kingdom,Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers,18,https://clinicaltrials.gov/show/NCT04748536,NA
NCT04748757,ClinicalTrials.gov,2021-02-02,2021-04-20,FALSE,Recruiting,Phase 2,Interventional,Canada,Annexin A5 in Patients With Severe COVID-19 Disease,60,https://clinicaltrials.gov/show/NCT04748757,NA
NCT04751643,ClinicalTrials.gov,2021-02-05,2021-04-19,FALSE,Recruiting,Not Applicable,Interventional,France,Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections,132,https://clinicaltrials.gov/show/NCT04751643,NA
NCT04756856,ClinicalTrials.gov,2021-02-15,2021-04-21,FALSE,Recruiting,Not Applicable,Interventional,Italy,Muscle-targeted Nutritional Therapy for the Recovery From COVID-19,50,https://clinicaltrials.gov/show/NCT04756856,NA
NCT04761874,ClinicalTrials.gov,2021-02-15,2019-12-01,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic,296,https://clinicaltrials.gov/show/NCT04761874,NA
NCT04765371,ClinicalTrials.gov,2021-02-18,2021-03-03,FALSE,Recruiting,Phase 3,Interventional,France,"Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19",220,https://clinicaltrials.gov/show/NCT04765371,NA
NCT04772859,ClinicalTrials.gov,2021-02-13,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic,54,https://clinicaltrials.gov/show/NCT04772859,NA
NCT04780321,ClinicalTrials.gov,2020-09-23,2020-10-30,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects,90,https://clinicaltrials.gov/show/NCT04780321,NA
NCT04783311,ClinicalTrials.gov,2021-03-03,2021-02-23,TRUE,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults",280,https://clinicaltrials.gov/show/NCT04783311,NA
NCT04784481,ClinicalTrials.gov,2021-02-20,2020-09-20,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Argentina,Ivermectin Reproposing for Mild Stage COVID-19 Outpatients,254,https://clinicaltrials.gov/show/NCT04784481,NA
NCT04784767,ClinicalTrials.gov,2021-03-03,2021-04-05,FALSE,Recruiting,Phase 1,Interventional,United States,SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults,72,https://clinicaltrials.gov/show/NCT04784767,NA
NCT04803409,ClinicalTrials.gov,2021-03-16,2021-03-22,FALSE,Recruiting,Not Applicable,Interventional,United States,UNITE Study (UCSD-SW) for COVID-19,40,https://clinicaltrials.gov/show/NCT04803409,NA
NCT04809974,ClinicalTrials.gov,2021-03-19,2021-05-15,FALSE,Not Recruiting,Phase 4,Interventional,United States,Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID),100,https://clinicaltrials.gov/show/NCT04809974,NA
NCT04833101,ClinicalTrials.gov,2021-04-03,2021-04-07,FALSE,Not Recruiting,Phase 4,Interventional,China,Study on Sequential Immunization of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine,120,https://clinicaltrials.gov/show/NCT04833101,NA
NCT04834869,ClinicalTrials.gov,2021-04-06,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,"Ghana, Croatia, Portugal, Canada, Ethiopia, United States, Estonia, Mexico, Spain, Poland, Iran, Slovenia, Germany, Czech Republic, Romania",COVID-19 Vaccines Safety Tracking (CoVaST),30000,https://clinicaltrials.gov/show/NCT04834869,NA
NCT04839042,ClinicalTrials.gov,2021-04-07,2021-06-01,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"A Phase 1, First-In-Human Study of the Investigational COVID-19 Vaccine SC-Ad6-1 in Healthy Volunteers",40,https://clinicaltrials.gov/show/NCT04839042,NA
NCT04847336,ClinicalTrials.gov,2021-04-13,2020-09-02,TRUE,Recruiting,Not Applicable,Observational,Italy,Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic,10000,https://clinicaltrials.gov/show/NCT04847336,NA
NCT04847583,ClinicalTrials.gov,2021-04-14,2021-04-30,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients",66,https://clinicaltrials.gov/show/NCT04847583,NA
NCT04848493,ClinicalTrials.gov,2021-04-08,2021-04-19,FALSE,Recruiting,Not Applicable,Observational,Italy,"National Project on Vaccines, COVID-19 and Frail Patients",1300,https://clinicaltrials.gov/show/NCT04848493,NA
NCT04852705,ClinicalTrials.gov,2021-04-20,2021-05-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,"A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)",28000,https://clinicaltrials.gov/show/NCT04852705,NA
NCT04852718,ClinicalTrials.gov,2021-04-15,2021-04-13,TRUE,Recruiting,Not Applicable,Observational,Spain,Rehabilitation Program for the Sequelae of COVID 19 Infection,120,https://clinicaltrials.gov/show/NCT04852718,NA
NCT04852770,ClinicalTrials.gov,2020-12-22,2021-04-23,FALSE,Recruiting,Not Applicable,Interventional,Brazil,"Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics",135,https://clinicaltrials.gov/show/NCT04852770,NA
NCT04852796,ClinicalTrials.gov,2021-03-30,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,France,Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients,1000,https://clinicaltrials.gov/show/NCT04852796,NA
NCT04852978,ClinicalTrials.gov,2021-04-19,2021-04-20,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers",180,https://clinicaltrials.gov/show/NCT04852978,NA
NCT04853004,ClinicalTrials.gov,2021-04-19,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,Sweden,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare With Regard to Vaccinations,10000,https://clinicaltrials.gov/show/NCT04853004,NA
NCT04853069,ClinicalTrials.gov,2021-04-06,2021-05-17,FALSE,Not Recruiting,Phase 2,Interventional,Qatar,Oestrogen Treatment for COVID-19 Symptoms,2000,https://clinicaltrials.gov/show/NCT04853069,NA
NCT04853108,ClinicalTrials.gov,2021-04-19,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Remote Monitoring of COVID-19 Positive Outpatients,500,https://clinicaltrials.gov/show/NCT04853108,NA
NCT04853134,ClinicalTrials.gov,2021-04-19,2020-11-01,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for COVID-19 Female Outpatients,200,https://clinicaltrials.gov/show/NCT04853134,NA
NCT04853836,ClinicalTrials.gov,2021-04-16,2021-04-25,FALSE,Not Recruiting,Phase 4,Interventional,Italy,Olfactory Disfunction and Co-ultraPEALut,400,https://clinicaltrials.gov/show/NCT04853836,NA
NCT04853927,ClinicalTrials.gov,2021-04-17,2021-02-08,TRUE,Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit,600,https://clinicaltrials.gov/show/NCT04853927,NA
NCT04854759,ClinicalTrials.gov,2021-04-17,2021-03-15,TRUE,Recruiting,Phase 3,Interventional,Poland,The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms,200,https://clinicaltrials.gov/show/NCT04854759,NA
NCT04854785,ClinicalTrials.gov,2021-04-20,2021-05-01,FALSE,Recruiting,Not Applicable,Observational,Canada,Neuroinflammation in COVID-19 and Depression,120,https://clinicaltrials.gov/show/NCT04854785,NA
NCT04854824,ClinicalTrials.gov,2021-04-21,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,A Simple Approach to Prevent Hospitalization for COVID-19 Patients,212,https://clinicaltrials.gov/show/NCT04854824,NA
NCT04854837,ClinicalTrials.gov,2021-04-21,2021-04-12,TRUE,Recruiting,Not Applicable,Observational,Hungary,Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis,60,https://clinicaltrials.gov/show/NCT04854837,NA
NCT04854941,ClinicalTrials.gov,2021-04-07,2020-12-10,TRUE,Not Recruiting,Not Applicable,Interventional,Russian Federation,Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus Infection,200,https://clinicaltrials.gov/show/NCT04854941,NA
NCT04854980,ClinicalTrials.gov,2021-04-20,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Serologic Response to the SARS-CoV-2 mRNA-1273 Vaccine in Select Subsets of Oncology Patients,55,https://clinicaltrials.gov/show/NCT04854980,NA
NCT04855162,ClinicalTrials.gov,2021-04-13,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,"United States, Mexico",Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning,35,https://clinicaltrials.gov/show/NCT04855162,NA
NCT04855539,ClinicalTrials.gov,2021-04-19,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Coronavirus: Ventilator Outcomes Using Artificial Intelligence Chest Radiographs & Other Evidence-based Co-variates,300,https://clinicaltrials.gov/show/NCT04855539,NA
NCT04858412,ClinicalTrials.gov,2021-04-21,2021-04-01,TRUE,Recruiting,Not Applicable,Interventional,United States,Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19,48,https://clinicaltrials.gov/show/NCT04858412,NA
NCT04858542,ClinicalTrials.gov,2021-03-22,2021-02-26,TRUE,Recruiting,Not Applicable,Interventional,United States,Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19,10,https://clinicaltrials.gov/show/NCT04858542,NA
NCT04858581,ClinicalTrials.gov,2021-04-15,2021-04-01,TRUE,Not Recruiting,Not Applicable,Interventional,France,Prospective Clinical and Virological Analysis of Healthcare Workers Diagnosed Positive for Covid-19.,100,https://clinicaltrials.gov/show/NCT04858581,NA
NCT04858620,ClinicalTrials.gov,2021-02-04,2020-08-30,TRUE,Recruiting,Phase 3,Interventional,United States,A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection,200,https://clinicaltrials.gov/show/NCT04858620,NA
NCT04858763,ClinicalTrials.gov,2021-04-22,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,MS Relapses During COVID-19 Pandemic,340,https://clinicaltrials.gov/show/NCT04858763,NA
NCT04859881,ClinicalTrials.gov,2021-04-19,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Mexico,Risk Factors for Barotrauma in COVID-19,262,https://clinicaltrials.gov/show/NCT04859881,NA
NCT04859894,ClinicalTrials.gov,2021-04-13,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"Physiological Studies in Post-COVID-19 Syndrome, and the Association With DNA Methylation",150,https://clinicaltrials.gov/show/NCT04859894,NA
NCT04860193,ClinicalTrials.gov,2021-04-18,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Audio Vestibular Functions in COVID 19 Patients in Sohag Governate,150,https://clinicaltrials.gov/show/NCT04860193,NA
NCT04860206,ClinicalTrials.gov,2021-04-20,2021-01-05,TRUE,Recruiting,Not Applicable,Observational,Slovenia,Post COVID19 Functional and Cognitive Assessments,80,https://clinicaltrials.gov/show/NCT04860206,NA
NCT04860219,ClinicalTrials.gov,2021-04-21,2020-07-08,TRUE,Recruiting,Not Applicable,Interventional,Egypt,Lactoferrin Use in (SARS-CoV-2) Management,54,https://clinicaltrials.gov/show/NCT04860219,NA
NCT04860232,ClinicalTrials.gov,2021-04-22,2021-04-26,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospital.,200,https://clinicaltrials.gov/show/NCT04860232,NA
NCT04860245,ClinicalTrials.gov,2021-04-22,2020-07-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Risks and Outcomes Among COVID-19 Patients Admitted to Assiut University Hospitals.,200,https://clinicaltrials.gov/show/NCT04860245,NA
NCT04860271,ClinicalTrials.gov,2021-04-23,2021-03-09,TRUE,Recruiting,Not Applicable,Interventional,Indonesia,Manual Acupuncture Using Acupuncture Needle vs Press Needle for COVID-19 Healthcare Anxiety,36,https://clinicaltrials.gov/show/NCT04860271,NA
NCT04860284,ClinicalTrials.gov,2021-04-23,2020-09-18,TRUE,Not Recruiting,Phase 2,Interventional,Uganda,Hydroxychloroquine for Treatment of Non-Severe COVID-19,105,https://clinicaltrials.gov/show/NCT04860284,NA
NCT04860518,ClinicalTrials.gov,2021-04-22,2021-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With CoronavirUS,140,https://clinicaltrials.gov/show/NCT04860518,NA
NCT04860687,ClinicalTrials.gov,2021-04-22,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.,309,https://clinicaltrials.gov/show/NCT04860687,NA
NCT04861272,ClinicalTrials.gov,2021-04-25,2021-04-15,TRUE,Recruiting,Not Applicable,Observational,Saudi Arabia,Risk Perception Associated With Covid-19 Among Anesthetists,1000,https://clinicaltrials.gov/show/NCT04861272,NA
NCT04861402,ClinicalTrials.gov,2021-04-25,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Brazil,Non-Invasive Intracranial Pressure in COVID-19 Individuals,60,https://clinicaltrials.gov/show/NCT04861402,NA
ISRCTN48563324,ISRCTN,2021-04-22,2021-01-06,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Bathing adaptations in the homes of older adults 2,360,http://isrctn.com/ISRCTN48563324,NA
ISRCTN15851697,ISRCTN,2021-04-21,2021-04-23,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Helping alleviate the longer-term consequences of COVID-19,1754,http://isrctn.com/ISRCTN15851697,NA
ISRCTN34804192,ISRCTN,2021-04-19,2021-12-04,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Study of children and young people who may be experiencing long COVID,30000,http://isrctn.com/ISRCTN34804192,NA
ISRCTN14396374,ISRCTN,2021-04-12,2021-04-15,FALSE,Recruiting,Not Applicable,Interventional,Colombia,"A research study in Colombia, to build capacity in school mental health and to adapt an intervention called DIALOG+ for use in adolescents in post-conflict Colombia during the COVID-19 pandemic",222,http://isrctn.com/ISRCTN14396374,NA
ISRCTN14722499,ISRCTN,2020-11-04,2020-11-15,FALSE,Recruiting,Phase 3,Interventional,"South Africa, United Kingdom, Colombia, Belgium, United States, Spain, France, Germany, Philippines",A study of the Ad26.COV2.S vaccine candidate for the prevention of SARS-CoV-2-mediated COVID-19 in adults,30000,http://isrctn.com/ISRCTN14722499,NA
ISRCTN14602359,ISRCTN,2020-08-12,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Germ Defence: a website to improve infection control during the COVID-19 pandemic,6822,http://isrctn.com/ISRCTN14602359,NA
ISRCTN67000769,ISRCTN,2020-07-20,2019-05-28,TRUE,Recruiting,Not Applicable,Interventional,"Hungary, Australia, Croatia, Ireland, New Zealand, Belgium, Netherlands, Canada, Portugal, Saudi Arabia, United Kingdom, United States, Spain, Finland, France, Germany",An international platform trial for severely ill patients with community-acquired pneumonia or COVID-19,6000,http://isrctn.com/ISRCTN67000769,NA
ISRCTN16483855,ISRCTN,2019-08-05,2019-01-07,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"Inhale work package 3 â€“ rapid versus standard testing to diagnose lung infections in intensive care, including COVID-19 observational sub-study",552,http://isrctn.com/ISRCTN16483855,NA
EUCTR2020-001306-35,EudraCT,2020-03-27,2020-05-04,FALSE,Not Recruiting,Phase 3,Interventional,France,Protective role of inhaled steroids for COVID-19 infection,Not Available,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001306-35,FR
EUCTR2020-001490-68,EudraCT,2020-04-01,2020-04-15,FALSE,Not Recruiting,Phase 2,Interventional,Sweden,Inhaled Nitric Oxide Gas Therapy in Respiratory Treated Patients with COVID-19 infection,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001490-68,SE
EUCTR2020-001411-25,EudraCT,2020-04-03,2020-04-14,FALSE,Not Recruiting,Phase 2,Interventional,"Australia, United Kingdom, Belgium, Canada, Italy, Israel, Spain, United States, Austria, France, India, Germany, Malaysia",A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients with Severe COVID-19 Infection,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001411-25,AT
EUCTR2020-002038-33,EudraCT,2020-06-26,2020-07-16,FALSE,Not Recruiting,Phase 2,Interventional,Finland,Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002038-33,FI
EUCTR2020-003210-13,EudraCT,2020-10-20,2020-10-27,FALSE,Authorised,Phase 2,Interventional,"Australia, United Kingdom, United States, Brazil, Spain, Romania","A Phase 2 Randomized, Double-blind, Placebo-controlled Safety and Efficacy Trial of Deupirfenidone (LYT-100) in Post-acute COVID-19 Respiratory Disease",168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003210-13,RO
EUCTR2020-001264-28,EudraCT,2020-05-07,2020-05-27,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Moldova, Republic of, Hungary, Russian Federation, Greece, Macedonia, the former Yugoslav Republic of, Ukraine, United States, Bosnia and Herzegovina, Germany, Bulgaria, Romania",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,BG
EUCTR2020-001623-13,EudraCT,2020-04-22,2020-05-20,FALSE,Not Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13,GR
EUCTR2020-001673-75,EudraCT,2020-04-27,2020-10-07,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Belgium, Italy, Brazil, Spain, Mexico, France, Germany","Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to respiratory distress.

",1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,DE
EUCTR2021-000893-27,EudraCT,2021-03-04,2021-04-27,FALSE,Authorised,Phase 4,Interventional,Belgium,COVID-19: study to detect transfer of SARS-Cov-2 antibodies in breastmilk,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000893-27,BE
EUCTR2021-000930-32,EudraCT,2021-03-04,2021-04-27,FALSE,Authorised,Phase 4,Interventional,Belgium,COVID-19: Determination of effect of COVID vaccination on immunity of hemodialysis patients,580,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000930-32,BE
EUCTR2021-001040-10,EudraCT,2021-03-26,2021-04-26,FALSE,Authorised,Phase 4,Interventional,Austria,Humoral (antibodies) and cellular (white blood cells) immune response to COVID-19  vaccines in immunocompromised (people with impaired immune system) and healthy individuals â€“ The CoVVac study,390,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001040-10,AT
EUCTR2020-005580-32,EudraCT,2021-04-15,2021-04-26,FALSE,Authorised,Phase 2,Interventional,Austria,Pilot study on silibinin as a possible therapeutic agent for mildly ill COVID-19 patients,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005580-32,AT
EUCTR2021-000492-36,EudraCT,2021-04-21,NA,FALSE,Not Available,Phase 2,Interventional,Belgium,Home and?Outpatients?Precocious?Eradication of?COVID-19,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000492-36,BE
EUCTR2021-001144-98,EudraCT,2021-04-23,2021-04-20,TRUE,Authorised,Phase 3,Interventional,Poland,The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001144-98,PL
EUCTR2020-005849-16,EudraCT,2020-12-18,2021-09-03,FALSE,Authorised,Phase 2,Interventional,"Germany, Switzerland","An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on  COVID-19 development in hospitalized patients infected with  SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2)",432,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005849-16,DE
EUCTR2020-004066-19,EudraCT,2020-11-20,2020-12-18,FALSE,Authorised,Phase 3,Interventional,Germany,Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany),2520,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004066-19,DE
EUCTR2020-002102-58,EudraCT,2020-05-06,2020-12-06,FALSE,Authorised,Phase 2,Interventional,Belgium,Therapy with stem cells for Patients with severe COVID-19 infection,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002102-58,BE
EUCTR2020-002208-37,EudraCT,2020-06-08,2021-04-29,FALSE,Authorised,Phase 2,Interventional,Denmark,"CIMMCov: A randomized clinical study for prevention of severe disease in mild-to-moderate COVID-19 patients, using the inhaled medication Ciclesonide.",138,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002208-37,DK
EUCTR2020-005015-40,EudraCT,2021-03-25,2021-04-29,FALSE,Authorised,Phase 3,Interventional,"Spain, Czech Republic, Italy, Slovakia",Ivermectin to prevent SARS-CoV-2 (COVID-19) hospitalisation in subjects over 50,832,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005015-40,SK
ChiCTR2100042528,ChiCTR,2021-01-23,2021-01-15,TRUE,Recruiting,Not Applicable,Observational,China,Evaluation of duration of antibody responses to novel coronavirus pneumonia (COVID-19) in convalescent plasma in Chongqing,25,http://www.chictr.org.cn/showproj.aspx?proj=120361,NA
NCT03376854,ClinicalTrials.gov,2017-12-07,2018-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,0,https://clinicaltrials.gov/show/NCT03376854,NA
NCT04107402,ClinicalTrials.gov,2019-04-11,2019-03-15,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,150,https://clinicaltrials.gov/show/NCT04107402,NA
NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,233,https://clinicaltrials.gov/show/NCT04319445,NA
NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,FALSE,Recruiting,Phase 1/Phase 2,Interventional,"Denmark, Sweden",The Impact of Camostat Mesilate on COVID-19 Infection,580,https://clinicaltrials.gov/show/NCT04321096,NA
NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,FALSE,Recruiting,Phase 3,Interventional,"Chile, Russian Federation, Saudi Arabia, United Arab Emirates, Colombia, Canada, Pakistan, Brazil, Egypt, Ecuador, India, Philippines",Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,4000,https://clinicaltrials.gov/show/NCT04324463,NA
NCT04327570,ClinicalTrials.gov,2020-03-26,2020-03-27,FALSE,Recruiting,Not Applicable,Observational,Belgium,In-depth Immunological Investigation of COVID-19.,100,https://clinicaltrials.gov/show/NCT04327570,NA
NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,FALSE,Not Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,1279,https://clinicaltrials.gov/show/NCT04328480,NA
NCT04343898,ClinicalTrials.gov,2020-04-09,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,5154,https://clinicaltrials.gov/show/NCT04343898,NA
NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),260,https://clinicaltrials.gov/show/NCT04344041,NA
NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,82,https://clinicaltrials.gov/show/NCT04344535,NA
NCT04344548,ClinicalTrials.gov,2020-04-10,2020-03-30,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia,0,https://clinicaltrials.gov/show/NCT04344548,NA
NCT04344665,ClinicalTrials.gov,2020-04-09,2020-04-23,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,905,https://clinicaltrials.gov/show/NCT04344665,NA
NCT04346329,ClinicalTrials.gov,2020-04-10,2020-03-30,TRUE,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,0,https://clinicaltrials.gov/show/NCT04346329,NA
NCT04347824,ClinicalTrials.gov,2020-04-09,2020-04-27,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,223,https://clinicaltrials.gov/show/NCT04347824,NA
NCT04347993,ClinicalTrials.gov,2020-04-13,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",5000,https://clinicaltrials.gov/show/NCT04347993,NA
NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,FALSE,Not Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,8,https://clinicaltrials.gov/show/NCT04356690,NA
NCT04357847,ClinicalTrials.gov,2020-04-09,2020-04-09,FALSE,Recruiting,Not Applicable,Observational,France,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,100,https://clinicaltrials.gov/show/NCT04357847,NA
NCT04359914,ClinicalTrials.gov,2020-04-19,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,Germany,Neurocognitive Impairment in Patients With COVID-19,80,https://clinicaltrials.gov/show/NCT04359914,NA
NCT04360538,ClinicalTrials.gov,2020-04-16,2020-04-08,TRUE,Recruiting,Not Applicable,Observational,United States,Long Term Outcomes of Patients With COVID-19,500,https://clinicaltrials.gov/show/NCT04360538,NA
NCT04360733,ClinicalTrials.gov,2020-04-22,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Precision Immunology to Determine the Immune Response in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04360733,NA
NCT04362865,ClinicalTrials.gov,2020-04-24,2020-04-27,FALSE,Recruiting,Not Applicable,Observational,United States,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,360,https://clinicaltrials.gov/show/NCT04362865,NA
NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,FALSE,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,0,https://clinicaltrials.gov/show/NCT04365582,NA
NCT04372056,ClinicalTrials.gov,2020-04-29,2020-05-06,FALSE,Recruiting,Not Applicable,Observational,Norway,The COVID-ICU Healthcare Professional Study,2200,https://clinicaltrials.gov/show/NCT04372056,NA
NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,13,https://clinicaltrials.gov/show/NCT04374942,NA
NCT04376515,ClinicalTrials.gov,2020-03-31,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),300,https://clinicaltrials.gov/show/NCT04376515,NA
NCT04381273,ClinicalTrials.gov,2020-05-06,2020-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,1178,https://clinicaltrials.gov/show/NCT04381273,NA
NCT04386070,ClinicalTrials.gov,2020-04-30,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://clinicaltrials.gov/show/NCT04386070,NA
NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-15,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04400799,NA
NCT04401436,ClinicalTrials.gov,2020-05-22,2020-05-22,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood,350,https://clinicaltrials.gov/show/NCT04401436,NA
NCT04401475,ClinicalTrials.gov,2020-05-21,2020-11-25,FALSE,Recruiting,Phase 2,Interventional,"Canada, United States, Colombia","A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",396,https://clinicaltrials.gov/show/NCT04401475,NA
NCT04404062,ClinicalTrials.gov,2020-05-22,2020-03-16,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Serological and PCR Testing for COVID-19,2500,https://clinicaltrials.gov/show/NCT04404062,NA
NCT04406532,ClinicalTrials.gov,2020-05-22,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,0,https://clinicaltrials.gov/show/NCT04406532,NA
NCT04410107,ClinicalTrials.gov,2020-05-25,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",134,https://clinicaltrials.gov/show/NCT04410107,NA
NCT04414410,ClinicalTrials.gov,2020-05-27,2020-05-12,TRUE,Recruiting,Not Applicable,Observational,France,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,1500,https://clinicaltrials.gov/show/NCT04414410,NA
NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-12,FALSE,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,191,https://clinicaltrials.gov/show/NCT04421508,NA
NCT04422873,ClinicalTrials.gov,2020-06-04,2020-06-10,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,The Impact of COVID-19 on Dialysis Users,20,https://clinicaltrials.gov/show/NCT04422873,NA
NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,TRUE,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,100,https://clinicaltrials.gov/show/NCT04424901,NA
NCT04444661,ClinicalTrials.gov,2020-06-19,2020-06-10,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,21,https://clinicaltrials.gov/show/NCT04444661,NA
NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-15,FALSE,Not Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID-19,3400,https://clinicaltrials.gov/show/NCT04445428,NA
NCT04447209,ClinicalTrials.gov,2020-06-17,2020-06-06,TRUE,Not Recruiting,Not Applicable,Observational,Malaysia,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,400,https://clinicaltrials.gov/show/NCT04447209,NA
NCT04448418,ClinicalTrials.gov,2020-06-01,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,111,https://clinicaltrials.gov/show/NCT04448418,NA
NCT04449380,ClinicalTrials.gov,2020-06-23,2020-11-02,FALSE,Not Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 Patients,56,https://clinicaltrials.gov/show/NCT04449380,NA
NCT04452318,ClinicalTrials.gov,2020-06-26,2020-07-13,FALSE,Not Recruiting,Phase 3,Interventional,"Moldova, Republic of, United States, Romania",COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,3750,https://clinicaltrials.gov/show/NCT04452318,NA
NCT04453566,ClinicalTrials.gov,2020-06-29,2020-05-27,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",208,https://clinicaltrials.gov/show/NCT04453566,NA
NCT04453969,ClinicalTrials.gov,2020-06-29,2020-05-24,TRUE,Recruiting,Not Applicable,Observational,Canada,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,50,https://clinicaltrials.gov/show/NCT04453969,NA
NCT04453982,ClinicalTrials.gov,2020-06-29,2020-06-21,TRUE,Recruiting,Not Applicable,Observational,Canada,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,500,https://clinicaltrials.gov/show/NCT04453982,NA
NCT04456036,ClinicalTrials.gov,2020-06-30,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,100,https://clinicaltrials.gov/show/NCT04456036,NA
NCT04460027,ClinicalTrials.gov,2020-07-01,2020-06-22,TRUE,Not Recruiting,Phase 1,Interventional,United States,W-SUDs for COVID-19,180,https://clinicaltrials.gov/show/NCT04460027,NA
NCT04462757,ClinicalTrials.gov,2020-06-12,2020-05-28,TRUE,Not Recruiting,Phase 2,Interventional,United Kingdom,SCIL-1Ra in COVID-19 Feasibility & PK/PD,5,https://clinicaltrials.gov/show/NCT04462757,NA
NCT04462783,ClinicalTrials.gov,2020-07-07,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Emergency Department (ED) Self-Monitoring Pilot COVID-19,200,https://clinicaltrials.gov/show/NCT04462783,NA
NCT04467931,ClinicalTrials.gov,2020-07-06,2020-01-19,TRUE,Not Recruiting,Not Applicable,Observational,United States,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,22213,https://clinicaltrials.gov/show/NCT04467931,NA
NCT04468893,ClinicalTrials.gov,2020-07-10,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,Mexico,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,128,https://clinicaltrials.gov/show/NCT04468893,NA
NCT04480424,ClinicalTrials.gov,2020-07-20,2020-09-17,FALSE,Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04480424,NA
NCT04489446,ClinicalTrials.gov,2020-07-25,2020-08-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Chile,Sildenafil in COVID-19,40,https://clinicaltrials.gov/show/NCT04489446,NA
NCT04490239,ClinicalTrials.gov,2020-07-20,2020-10-09,FALSE,Not Recruiting,Phase 1,Interventional,United States,Intranasal Heparin Tolerability Study,6,https://clinicaltrials.gov/show/NCT04490239,NA
NCT04495101,ClinicalTrials.gov,2020-07-28,2020-07-29,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,100,https://clinicaltrials.gov/show/NCT04495101,NA
NCT04498286,ClinicalTrials.gov,2020-08-03,2020-07-31,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,546,https://clinicaltrials.gov/show/NCT04498286,NA
NCT04499378,ClinicalTrials.gov,2020-08-03,2020-08-15,FALSE,Recruiting,Not Applicable,Observational,Mexico,Tomographic Findings in COVID-19 and Influenza H1N1,200,https://clinicaltrials.gov/show/NCT04499378,NA
NCT04499677,ClinicalTrials.gov,2020-06-16,2020-09-24,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,240,https://clinicaltrials.gov/show/NCT04499677,NA
NCT04500639,ClinicalTrials.gov,2020-08-04,2020-07-23,TRUE,Recruiting,Not Applicable,Observational,Canada,Over-the-counter Medications & COVID-19,4000,https://clinicaltrials.gov/show/NCT04500639,NA
NCT04513964,ClinicalTrials.gov,2020-08-13,2020-11-01,FALSE,Recruiting,Not Applicable,Observational,France,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,60,https://clinicaltrials.gov/show/NCT04513964,NA
NCT04514900,ClinicalTrials.gov,2020-07-20,2020-09-23,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,73,https://clinicaltrials.gov/show/NCT04514900,NA
NCT04517422,ClinicalTrials.gov,2020-08-16,2020-08-19,FALSE,Not Recruiting,Not Applicable,Interventional,Mexico,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,300,https://clinicaltrials.gov/show/NCT04517422,NA
NCT04529421,ClinicalTrials.gov,2020-08-25,2020-09-04,FALSE,Not Recruiting,Not Applicable,Observational,Norway,Assocation Between In-person Instruction and COVID-19 Risk,26754,https://clinicaltrials.gov/show/NCT04529421,NA
NCT04530357,ClinicalTrials.gov,2020-08-26,2020-09-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCovid-inÂ® COVID-19 Vaccine",244,https://clinicaltrials.gov/show/NCT04530357,NA
NCT04534595,ClinicalTrials.gov,2020-08-31,2019-04-30,TRUE,Recruiting,Not Applicable,Observational,Canada,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,1500,https://clinicaltrials.gov/show/NCT04534595,NA
NCT04539795,ClinicalTrials.gov,2020-09-03,2021-01-25,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Study of Safety and Tolerability of Alvelestat,15,https://clinicaltrials.gov/show/NCT04539795,NA
NCT04540120,ClinicalTrials.gov,2020-08-13,2020-09-25,FALSE,Recruiting,Phase 2,Interventional,"Netherlands, United States, Switzerland",Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,80,https://clinicaltrials.gov/show/NCT04540120,NA
NCT04540406,ClinicalTrials.gov,2020-09-03,2021-05-27,FALSE,Recruiting,Phase 2,Interventional,United States,NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04540406,NA
NCT04555122,ClinicalTrials.gov,2020-04-29,2021-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Ad Intervention,0,https://clinicaltrials.gov/show/NCT04555122,NA
NCT04563065,ClinicalTrials.gov,2020-09-19,2020-08-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Active Pregnancy Against COVID-19,280,https://clinicaltrials.gov/show/NCT04563065,NA
NCT04568551,ClinicalTrials.gov,2020-09-24,2020-10-30,FALSE,Recruiting,Not Applicable,Observational,Germany,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",300,https://clinicaltrials.gov/show/NCT04568551,NA
NCT04581031,ClinicalTrials.gov,2020-05-04,2020-07-11,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,COntinuous Signs Monitoring In Covid-19 Patients,60,https://clinicaltrials.gov/show/NCT04581031,NA
NCT04584541,ClinicalTrials.gov,2020-06-10,2020-06-11,FALSE,Recruiting,Not Applicable,Interventional,France,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,150,https://clinicaltrials.gov/show/NCT04584541,NA
NCT04588441,ClinicalTrials.gov,2020-10-13,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,30,https://clinicaltrials.gov/show/NCT04588441,NA
NCT04588480,ClinicalTrials.gov,2020-10-14,2020-10-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",160,https://clinicaltrials.gov/show/NCT04588480,NA
NCT04590365,ClinicalTrials.gov,2020-05-28,2020-12-17,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Carrageenan Nasal Spray for COVID-19 Prophylaxis,480,https://clinicaltrials.gov/show/NCT04590365,NA
NCT04590378,ClinicalTrials.gov,2020-10-14,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Pulmonary Embolism and COVID-19,600,https://clinicaltrials.gov/show/NCT04590378,NA
NCT04591704,ClinicalTrials.gov,2020-10-16,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,2000,https://clinicaltrials.gov/show/NCT04591704,NA
NCT04592055,ClinicalTrials.gov,2020-10-16,2020-03-20,TRUE,Recruiting,Not Applicable,Observational,Turkey,The Effect of COVID-19 on Diabetes Mellitus,500,https://clinicaltrials.gov/show/NCT04592055,NA
NCT04594356,ClinicalTrials.gov,2020-10-19,2020-11-19,FALSE,Not Recruiting,Not Applicable,Observational,France,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",120,https://clinicaltrials.gov/show/NCT04594356,NA
NCT04596943,ClinicalTrials.gov,2020-10-20,2020-10-15,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,RGD PET/CT Imaging in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04596943,NA
NCT04608097,ClinicalTrials.gov,2020-10-28,2020-10-28,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,Understanding Reactions to Emotional Material in the Media During COVID-19,74,https://clinicaltrials.gov/show/NCT04608097,NA
NCT04612972,ClinicalTrials.gov,2020-08-18,2020-09-09,FALSE,Not Recruiting,Phase 3,Interventional,Peru,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru",12000,https://clinicaltrials.gov/show/NCT04612972,NA
NCT04613986,ClinicalTrials.gov,2020-11-02,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,20,https://clinicaltrials.gov/show/NCT04613986,NA
NCT04615741,ClinicalTrials.gov,2020-10-29,2020-11-09,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Finding Wellness in the Pandemic,187,https://clinicaltrials.gov/show/NCT04615741,NA
NCT04625257,ClinicalTrials.gov,2020-11-10,2020-10-24,TRUE,Recruiting,Not Applicable,Observational,Switzerland,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",3000,https://clinicaltrials.gov/show/NCT04625257,NA
NCT04636086,ClinicalTrials.gov,2020-11-17,2020-11-12,TRUE,Recruiting,Phase 4,Interventional,Belgium,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04636086,NA
NCT04636671,ClinicalTrials.gov,2020-11-18,2021-04-14,FALSE,Recruiting,Phase 3,Interventional,Italy,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),680,https://clinicaltrials.gov/show/NCT04636671,NA
NCT04647305,ClinicalTrials.gov,2020-11-24,2021-01-16,FALSE,Not Recruiting,Not Applicable,Interventional,Colombia,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,233,https://clinicaltrials.gov/show/NCT04647305,NA
NCT04648410,ClinicalTrials.gov,2020-11-26,2021-02-16,FALSE,Recruiting,Not Applicable,Observational,Czech Republic,Corticosteroids in Severe COVID-19(ASAP-C Study),2000,https://clinicaltrials.gov/show/NCT04648410,NA
NCT04649931,ClinicalTrials.gov,2020-11-25,2020-12-14,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),450,https://clinicaltrials.gov/show/NCT04649931,NA
NCT04652518,ClinicalTrials.gov,2020-12-02,2020-12-11,FALSE,Recruiting,Phase 2,Interventional,"Philippines, United Kingdom, United States, Romania",LYT-100 in Post-acute COVID-19 Respiratory Disease,168,https://clinicaltrials.gov/show/NCT04652518,NA
NCT04656691,ClinicalTrials.gov,2020-12-04,2021-01-04,FALSE,Not Recruiting,Phase 4,Interventional,United States,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,4000,https://clinicaltrials.gov/show/NCT04656691,NA
NCT04659928,ClinicalTrials.gov,2020-11-30,2021-06-01,FALSE,Not Recruiting,Phase 4,Interventional,United States,Evaluation of Aerosol in a Dental Clinic,50,https://clinicaltrials.gov/show/NCT04659928,NA
NCT04665193,ClinicalTrials.gov,2020-12-08,2020-11-23,TRUE,Not Recruiting,Not Applicable,Interventional,Canada,An Approach to Screening for COVID-19 at Vancouver Airport,592,https://clinicaltrials.gov/show/NCT04665193,NA
NCT04666285,ClinicalTrials.gov,2020-10-15,2021-02-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Southampton Women's Survey COVID-19 Study,1000,https://clinicaltrials.gov/show/NCT04666285,NA
NCT04668222,ClinicalTrials.gov,2020-11-30,2021-04-30,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Hong Kong,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,480,https://clinicaltrials.gov/show/NCT04668222,NA
NCT04673318,ClinicalTrials.gov,2020-10-23,2021-02-26,FALSE,Recruiting,Not Applicable,Interventional,United States,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,87,https://clinicaltrials.gov/show/NCT04673318,NA
NCT04674410,ClinicalTrials.gov,2020-12-17,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients,100000,https://clinicaltrials.gov/show/NCT04674410,NA
NCT04678778,ClinicalTrials.gov,2020-12-11,2019-03-19,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Virtual Reality Study - COVID-19 Protocol,14,https://clinicaltrials.gov/show/NCT04678778,NA
NCT04685681,ClinicalTrials.gov,2020-12-07,2021-01-07,FALSE,Not Recruiting,Not Applicable,Interventional,United States,The Get Outside Study,53,https://clinicaltrials.gov/show/NCT04685681,NA
NCT04688502,ClinicalTrials.gov,2020-12-24,2021-06-11,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Wearing a Face Mask During CrossFit Exercise,24,https://clinicaltrials.gov/show/NCT04688502,NA
NCT04689724,ClinicalTrials.gov,2020-12-29,2020-08-10,TRUE,Recruiting,Not Applicable,Observational,Canada,Covid-19 Airway Management,250,https://clinicaltrials.gov/show/NCT04689724,NA
NCT04691908,ClinicalTrials.gov,2020-12-21,2020-12-25,FALSE,Not Recruiting,Phase 3,Interventional,Kazakhstan,"Immunogenicity, Efficacy and Safety of QazCovid-inÂ® COVID-19 Vaccine",3000,https://clinicaltrials.gov/show/NCT04691908,NA
NCT04697654,ClinicalTrials.gov,2021-01-04,2020-10-14,TRUE,Recruiting,Phase 1,Interventional,"Taiwan, Australia","The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",30,https://clinicaltrials.gov/show/NCT04697654,NA
NCT04698382,ClinicalTrials.gov,2021-01-05,2020-08-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",5000,https://clinicaltrials.gov/show/NCT04698382,NA
NCT04700137,ClinicalTrials.gov,2021-01-05,2021-01-18,FALSE,Recruiting,Not Applicable,Interventional,United States,"Mental Health Among Patients, Providers, and Staff During the COVID-19 Era",660,https://clinicaltrials.gov/show/NCT04700137,NA
NCT04703114,ClinicalTrials.gov,2020-11-30,2021-02-05,FALSE,Recruiting,Not Applicable,Interventional,France,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),80,https://clinicaltrials.gov/show/NCT04703114,NA
NCT04703790,ClinicalTrials.gov,2021-01-07,2021-04-07,FALSE,Recruiting,Not Applicable,Observational,United States,Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods,1200,https://clinicaltrials.gov/show/NCT04703790,NA
NCT04712448,ClinicalTrials.gov,2021-01-13,2020-12-30,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Serum Prevalence of Sars-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE),3500,https://clinicaltrials.gov/show/NCT04712448,NA
NCT04715438,ClinicalTrials.gov,2021-01-11,2021-01-08,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Vaccination Against COVID-19 in Cancer,873,https://clinicaltrials.gov/show/NCT04715438,NA
NCT04718519,ClinicalTrials.gov,2021-01-20,2020-06-22,TRUE,Not Recruiting,Not Applicable,Observational,Singapore,Migrant Workers' Responses to the COVID-19 Pandemic,1011,https://clinicaltrials.gov/show/NCT04718519,NA
NCT04732819,ClinicalTrials.gov,2021-01-27,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Improving COVID-19 Vaccine Uptake in Nursing Homes,25332,https://clinicaltrials.gov/show/NCT04732819,NA
NCT04747990,ClinicalTrials.gov,2021-02-05,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,"Spain, Italy",coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis,600,https://clinicaltrials.gov/show/NCT04747990,NA
NCT04748588,ClinicalTrials.gov,2021-02-08,2021-02-12,FALSE,Recruiting,Phase 4,Interventional,Canada,Treatment of Nosocomial COVID-19,648,https://clinicaltrials.gov/show/NCT04748588,NA
NCT04750278,ClinicalTrials.gov,2021-02-02,2021-04-06,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)",403,https://clinicaltrials.gov/show/NCT04750278,NA
NCT04767477,ClinicalTrials.gov,2020-12-21,2021-03-28,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors,60,https://clinicaltrials.gov/show/NCT04767477,NA
NCT04779775,ClinicalTrials.gov,2021-02-10,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Best Practices in Perinatal Mental Health During COVID-19,70,https://clinicaltrials.gov/show/NCT04779775,NA
NCT04780373,ClinicalTrials.gov,2021-01-22,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Prognostic Score in Covid-19,200,https://clinicaltrials.gov/show/NCT04780373,NA
NCT04782739,ClinicalTrials.gov,2021-02-23,2021-03-15,FALSE,Recruiting,Not Applicable,Observational,Zimbabwe,Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe,30,https://clinicaltrials.gov/show/NCT04782739,NA
NCT04790786,ClinicalTrials.gov,2021-02-26,2021-03-10,FALSE,Recruiting,Phase 3,Interventional,United States,"UPMC OPTIMISE-C19 Trial, a COVID-19 Study",5000,https://clinicaltrials.gov/show/NCT04790786,NA
NCT04809389,ClinicalTrials.gov,2021-03-19,2021-03-29,FALSE,Recruiting,Phase 1,Interventional,Hong Kong,A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19,115,https://clinicaltrials.gov/show/NCT04809389,NA
NCT04810117,ClinicalTrials.gov,2021-03-19,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Monitoring the IgG/IgM Antibodies in COVID-19 Patients,100,https://clinicaltrials.gov/show/NCT04810117,NA
NCT04816318,ClinicalTrials.gov,2021-03-23,2021-04-28,FALSE,Not Recruiting,Not Applicable,Observational,Chile,Policy Responses Against the COVID-19 Pandemic in Latin America,10000,https://clinicaltrials.gov/show/NCT04816318,NA
NCT04817319,ClinicalTrials.gov,2021-03-23,2021-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,40,https://clinicaltrials.gov/show/NCT04817319,NA
NCT04821921,ClinicalTrials.gov,2021-03-29,2021-04-09,FALSE,Recruiting,Not Applicable,Observational,Germany,The Impact of the COVID-19 Pandemic on Diabetes Management,750,https://clinicaltrials.gov/show/NCT04821921,NA
NCT04824365,ClinicalTrials.gov,2021-03-26,2021-04-12,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections,60,https://clinicaltrials.gov/show/NCT04824365,NA
NCT04836767,ClinicalTrials.gov,2021-04-07,2021-02-16,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term,40,https://clinicaltrials.gov/show/NCT04836767,NA
NCT04839107,ClinicalTrials.gov,2021-01-29,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,Argentina,Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients,20000,https://clinicaltrials.gov/show/NCT04839107,NA
NCT04841746,ClinicalTrials.gov,2021-04-09,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy of FES Cycling After a Severe Form of COVID-19,70,https://clinicaltrials.gov/show/NCT04841746,NA
NCT04841785,ClinicalTrials.gov,2021-03-22,2021-04-22,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients,14300,https://clinicaltrials.gov/show/NCT04841785,NA
NCT04842721,ClinicalTrials.gov,2021-04-11,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Canada,Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.,20,https://clinicaltrials.gov/show/NCT04842721,NA
NCT04843787,ClinicalTrials.gov,2021-04-09,2021-05-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,SLV213 Treatment in COVID-19 Patients,81,https://clinicaltrials.gov/show/NCT04843787,NA
NCT04844580,ClinicalTrials.gov,2021-03-25,2021-03-10,TRUE,Recruiting,Phase 2,Interventional,Turkey,A Clinical Study Evaluating Inhaled Aviptadil on COVID-19,80,https://clinicaltrials.gov/show/NCT04844580,NA
NCT04853940,ClinicalTrials.gov,2021-04-12,2021-01-01,TRUE,Recruiting,Not Applicable,Observational,Spain,"Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients",50,https://clinicaltrials.gov/show/NCT04853940,NA
NCT04854486,ClinicalTrials.gov,2021-04-17,2020-11-16,TRUE,Recruiting,Phase 3,Interventional,United States,Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients,250,https://clinicaltrials.gov/show/NCT04854486,NA
NCT04854863,ClinicalTrials.gov,2021-04-15,2021-08-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Respiratory Muscles After Hospitalisation for COVID-19,50,https://clinicaltrials.gov/show/NCT04854863,NA
NCT04854928,ClinicalTrials.gov,2021-04-21,2021-04-01,TRUE,Recruiting,Phase 2,Interventional,Sweden,Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection.,60,https://clinicaltrials.gov/show/NCT04854928,NA
NCT04856111,ClinicalTrials.gov,2021-04-19,2021-03-17,TRUE,Recruiting,Phase 4,Interventional,India,Pirfenidone vs. Nintedanib for Fibrotic Lung Disease After Coronavirus Disease-19 Pneumonia,48,https://clinicaltrials.gov/show/NCT04856111,NA
NCT04857060,ClinicalTrials.gov,2021-04-20,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Palliative Care Educator,4800,https://clinicaltrials.gov/show/NCT04857060,NA
NCT04858607,ClinicalTrials.gov,2021-04-21,2021-04-19,TRUE,Recruiting,Not Applicable,Observational,Austria,Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals,390,https://clinicaltrials.gov/show/NCT04858607,NA
NCT04859244,ClinicalTrials.gov,2021-04-19,2021-01-01,TRUE,Not Recruiting,Phase 1,Interventional,United States,First-in-Human Study of Orally Administered GS-441524 for COVID-19,1,https://clinicaltrials.gov/show/NCT04859244,NA
NCT04860297,ClinicalTrials.gov,2021-04-21,2021-04-16,TRUE,Recruiting,Phase 3,Interventional,United States,A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants,240,https://clinicaltrials.gov/show/NCT04860297,NA
NCT04860739,ClinicalTrials.gov,2021-04-22,2021-04-24,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose,676,https://clinicaltrials.gov/show/NCT04860739,NA
NCT04860895,ClinicalTrials.gov,2021-04-25,2021-02-11,TRUE,Recruiting,Not Applicable,Interventional,Turkey,Detection of SARS-CoV-2 in Nasopharyngeal Swabs by Using Multi-Spectral Screening System,4400,https://clinicaltrials.gov/show/NCT04860895,NA
NCT04860908,ClinicalTrials.gov,2021-04-26,2021-04-26,FALSE,Recruiting,Not Applicable,Observational,Israel,COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS,100,https://clinicaltrials.gov/show/NCT04860908,NA
NCT04861298,ClinicalTrials.gov,2021-04-25,2021-01-11,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early COVID-19 Symptoms at Home,142,https://clinicaltrials.gov/show/NCT04861298,NA
NCT04862806,ClinicalTrials.gov,2021-03-21,2021-02-01,TRUE,Recruiting,Not Applicable,Interventional,Israel,"Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL",1000,https://clinicaltrials.gov/show/NCT04862806,NA
NCT04863131,ClinicalTrials.gov,2021-04-15,2021-04-28,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Japan,Safety and Immunogenicity of EXG-5003,60,https://clinicaltrials.gov/show/NCT04863131,NA
NCT04863534,ClinicalTrials.gov,2021-04-22,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Ultrasound Grayscale Analysis in ARDS covid19,32,https://clinicaltrials.gov/show/NCT04863534,NA
NCT04863547,ClinicalTrials.gov,2021-04-08,2021-03-11,TRUE,Recruiting,Not Applicable,Observational,"France, Martinique",Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection,2200,https://clinicaltrials.gov/show/NCT04863547,NA
NCT04863573,ClinicalTrials.gov,2021-04-27,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Antibody Responses In Cystic Fibrosis,1000,https://clinicaltrials.gov/show/NCT04863573,NA
NCT04863586,ClinicalTrials.gov,2021-04-27,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Multiple Sclerosis Disease Modifying Therapies,14240,https://clinicaltrials.gov/show/NCT04863586,NA
NCT04864015,ClinicalTrials.gov,2021-04-27,2021-03-17,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 Aerosol in EGD Using a Droplet Reduction Mouthpiece,80,https://clinicaltrials.gov/show/NCT04864015,NA
NCT04864899,ClinicalTrials.gov,2021-03-19,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR),112,https://clinicaltrials.gov/show/NCT04864899,NA
NCT04864925,ClinicalTrials.gov,2021-04-25,2020-12-28,TRUE,Not Recruiting,Phase 3,Interventional,United States,Measurement of Viral Load Reduction in the Oral Cavity After a Regimental Use of OC Toothpaste Products,30,https://clinicaltrials.gov/show/NCT04864925,NA
NCT04864938,ClinicalTrials.gov,2021-02-09,2020-08-01,TRUE,Recruiting,Not Applicable,Observational,Finland,Recovery After Critical Covid-19 Infection,250,https://clinicaltrials.gov/show/NCT04864938,NA
NCT04865029,ClinicalTrials.gov,2021-04-21,2021-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Estradiol and Progesterone in Hospitalized COVID-19 Patients,120,https://clinicaltrials.gov/show/NCT04865029,NA
NCT04865133,ClinicalTrials.gov,2021-04-22,2021-03-31,TRUE,Recruiting,Not Applicable,Observational,United States,Efficacy and Safety of COVID-19 Vaccine in Cancer Patients,1070,https://clinicaltrials.gov/show/NCT04865133,NA
NCT04865237,ClinicalTrials.gov,2021-04-01,2021-03-06,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,SARS-CoV-2 Human Challenge Characterisation Study,90,https://clinicaltrials.gov/show/NCT04865237,NA
NCT04865900,ClinicalTrials.gov,2021-04-28,2021-03-09,TRUE,Recruiting,Not Applicable,Observational,Israel,Prevalence of Perimyocarditis After Covid-19 Vaccine,500,https://clinicaltrials.gov/show/NCT04865900,NA
NCT04865913,ClinicalTrials.gov,2021-04-27,2021-01-13,TRUE,Recruiting,Not Applicable,Observational,Canada,Venous Thrombosis Virtual Surveillance in COVID,500,https://clinicaltrials.gov/show/NCT04865913,NA
NCT04866082,ClinicalTrials.gov,2021-04-26,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Czech Republic,Corticosteroids in Severe COVID-19 (ASAP-ESICM Study),1000,https://clinicaltrials.gov/show/NCT04866082,NA
NCT04866303,ClinicalTrials.gov,2021-04-27,2021-04-26,TRUE,Recruiting,Not Applicable,Interventional,United States,Protecting Our Community: COVID-19 Testing,400,https://clinicaltrials.gov/show/NCT04866303,NA
NCT04867161,ClinicalTrials.gov,2021-04-27,2020-12-21,TRUE,Recruiting,Not Applicable,Observational,Czech Republic,Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients,300,https://clinicaltrials.gov/show/NCT04867161,NA
NCT04867213,ClinicalTrials.gov,2021-04-24,2021-02-15,TRUE,Recruiting,Not Applicable,Observational,Canada,Breath Analysis of Patients Diagnosed With COVID-19 Using Infrared Spectroscopy,200,https://clinicaltrials.gov/show/NCT04867213,NA
NCT04868188,ClinicalTrials.gov,2021-02-18,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Pharmacokinetics of Voriconazole in Adult ECMO Patients,50,https://clinicaltrials.gov/show/NCT04868188,NA
NCT04868435,ClinicalTrials.gov,2021-04-26,2020-11-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Triggers for Post-Viral Parosmia After Covid and Non-Covid Infections,400,https://clinicaltrials.gov/show/NCT04868435,NA
NCT04868448,ClinicalTrials.gov,2021-04-29,2021-03-20,TRUE,Recruiting,Not Applicable,Observational,Georgia,COVID-19 Vaccine Effectiveness Among Health Workers in Georgia,1600,https://clinicaltrials.gov/show/NCT04868448,NA
NCT04868890,ClinicalTrials.gov,2021-04-22,2021-04-01,TRUE,Recruiting,Phase 2,Interventional,United States,A Study of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19,200,https://clinicaltrials.gov/show/NCT04868890,NA
NCT04868903,ClinicalTrials.gov,2021-04-06,2020-11-30,TRUE,Recruiting,Not Applicable,Interventional,United States,Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19,2000,https://clinicaltrials.gov/show/NCT04868903,NA
NCT04869072,ClinicalTrials.gov,2021-04-08,2020-04-29,TRUE,Not Recruiting,Phase 1,Interventional,Switzerland,Convalescent Plasma Therapy - Zurich Protocol,30,https://clinicaltrials.gov/show/NCT04869072,NA
NCT04869202,ClinicalTrials.gov,2021-04-29,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Jordan,Covid-19 Infection in Pregnancy,500,https://clinicaltrials.gov/show/NCT04869202,NA
NCT04869579,ClinicalTrials.gov,2021-04-29,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.",100,https://clinicaltrials.gov/show/NCT04869579,NA
NCT04870307,ClinicalTrials.gov,2021-02-15,2020-09-30,TRUE,Recruiting,Not Applicable,Interventional,United States,Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations,780,https://clinicaltrials.gov/show/NCT04870307,NA
NCT04870333,ClinicalTrials.gov,2021-03-01,2021-02-19,TRUE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V,1500,https://clinicaltrials.gov/show/NCT04870333,NA
NCT04870723,ClinicalTrials.gov,2021-04-23,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,"Canada, India, Thailand",#SafeHandsSafeHearts: An eHealth Intervention for COVID-19 Prevention and Support,900,https://clinicaltrials.gov/show/NCT04870723,NA
NCT04870736,ClinicalTrials.gov,2021-04-29,2021-05-03,FALSE,Not Recruiting,Not Applicable,Observational,Czech Republic,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic (MOVE),0,https://clinicaltrials.gov/show/NCT04870736,NA
NCT04870775,ClinicalTrials.gov,2021-04-29,2020-11-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Effectiveness of a Mindfulness Training Program in Health Care Proffesional,40,https://clinicaltrials.gov/show/NCT04870775,NA
NCT04871165,ClinicalTrials.gov,2021-04-20,2021-03-24,TRUE,Recruiting,Not Applicable,Observational,Lithuania,"Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals",1200,https://clinicaltrials.gov/show/NCT04871165,NA
NCT04871633,ClinicalTrials.gov,2021-01-11,2020-08-01,TRUE,Not Recruiting,Not Applicable,Interventional,Pakistan,Effectiveness of Remedesvir in COVID-19 Patients Presenting at Mayo Hospital Lahore,66,https://clinicaltrials.gov/show/NCT04871633,NA
NCT04871685,ClinicalTrials.gov,2021-04-27,2020-10-18,TRUE,Not Recruiting,Not Applicable,Observational,Italy,"The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19",950,https://clinicaltrials.gov/show/NCT04871685,NA
NCT04871776,ClinicalTrials.gov,2021-04-30,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Use of Construal Level Theory to Inform Messaging to Increase Vaccination Against COVID-19,10000,https://clinicaltrials.gov/show/NCT04871776,NA
NCT04871789,ClinicalTrials.gov,2021-03-21,2021-01-20,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19,200,https://clinicaltrials.gov/show/NCT04871789,NA
NCT04871802,ClinicalTrials.gov,2021-03-21,2021-05-10,FALSE,Not Recruiting,Not Applicable,Interventional,Russian Federation,Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia,100,https://clinicaltrials.gov/show/NCT04871802,NA
NCT04871815,ClinicalTrials.gov,2021-04-27,2021-04-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.,50,https://clinicaltrials.gov/show/NCT04871815,NA
NCT04871841,ClinicalTrials.gov,2021-05-01,2021-04-05,TRUE,Recruiting,Not Applicable,Observational,Kazakhstan,Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan,70,https://clinicaltrials.gov/show/NCT04871841,NA
NCT04871867,ClinicalTrials.gov,2021-05-01,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,France,Cardiac and Lung Assessment of Professional Soccer Players Following COVID-19 Disease,60,https://clinicaltrials.gov/show/NCT04871867,NA
NCT04871893,ClinicalTrials.gov,2021-04-29,2021-06-14,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy,40,https://clinicaltrials.gov/show/NCT04871893,NA
NCT04871945,ClinicalTrials.gov,2021-04-29,2021-04-20,TRUE,Recruiting,Not Applicable,Observational,South Korea,Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis,200,https://clinicaltrials.gov/show/NCT04871945,NA
NCT04871958,ClinicalTrials.gov,2021-04-29,2021-03-19,TRUE,Recruiting,Not Applicable,Interventional,Italy,"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward",66,https://clinicaltrials.gov/show/NCT04871958,NA
NCT04872309,ClinicalTrials.gov,2021-04-29,2019-09-04,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology,160,https://clinicaltrials.gov/show/NCT04872309,NA
NCT04872699,ClinicalTrials.gov,2021-05-02,2021-04-22,TRUE,Recruiting,Not Applicable,Observational,France,Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study,150,https://clinicaltrials.gov/show/NCT04872699,NA
NCT04872712,ClinicalTrials.gov,2021-05-02,2021-05-03,FALSE,Not Recruiting,Not Applicable,Interventional,Indonesia,THE ROLE OF MANUAL ACUPUNCTURE USING PRESS NEEDLES COMPARED WITH FILIFORM NEEDLES IN IMPROVING SYMPTOMS OF INSOMNIA AND MELATONIN HORMONE FOR HEALTHCARE WORKERS TREATING COVID-19 PATIENTS.,34,https://clinicaltrials.gov/show/NCT04872712,NA
NCT04872764,ClinicalTrials.gov,2021-05-02,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Acute Kidney Injury in Patients With CoVID-19,600,https://clinicaltrials.gov/show/NCT04872764,NA
NCT04874363,ClinicalTrials.gov,2021-05-01,2020-03-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Effects of Smoking on Mortality in Patients With Acute Respiratory Syndrome Coronavirus 2 Infection,150,https://clinicaltrials.gov/show/NCT04874363,NA
NCT04874753,ClinicalTrials.gov,2021-05-02,2020-11-03,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease,200,https://clinicaltrials.gov/show/NCT04874753,NA
NCT04874779,ClinicalTrials.gov,2021-05-02,2020-06-08,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Acute Kidney Injury Risk in COVID-19,83,https://clinicaltrials.gov/show/NCT04874779,NA
ACTRN12620000478910,ANZCTR,2020-04-16,2021-01-07,FALSE,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,24,https://anzctr.org.au/ACTRN12620000478910.aspx,NA
ACTRN12621000533897,ANZCTR,2021-05-06,2021-03-05,TRUE,Recruiting,Not Applicable,Observational,Australia,Coronavirus in Victorian Healthcare and Aged care workers (COVIC-HA) Cohort Study,1850,https://anzctr.org.au/ACTRN12621000533897.aspx,NA
ACTRN12621000524897,ANZCTR,2021-05-04,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,New Zealand,Long-term health impacts of COVID-19 on confirmed cases: Long-COVID Study,96,https://anzctr.org.au/ACTRN12621000524897.aspx,NA
ISRCTN10839729,ISRCTN,2021-04-29,2020-01-11,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Anti-viral photodynamic therapy in COVID-19 management: a novel approach in treating patients in early infection stages,140,http://isrctn.com/ISRCTN10839729,NA
ISRCTN23769228,ISRCTN,2021-04-26,2020-01-11,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Can we understand and identify factors contributing to the successful detection of deteriorating patients and rescuing them within the hospital ward?,830,http://isrctn.com/ISRCTN23769228,NA
ISRCTN91172459,ISRCTN,2021-04-26,2021-01-04,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"The impact of COVID-19 pandemic on the assessment, management and outcomes for patients with common upper limb fractures",500,http://isrctn.com/ISRCTN91172459,NA
ISRCTN11041050,ISRCTN,2021-01-12,2020-06-18,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Does the presence of antibodies to SARS-CoV-2 reduce the risk of subsequent COVID-19 in healthcare workers?,10000,http://isrctn.com/ISRCTN11041050,NA
ISRCTN12890382,ISRCTN,2020-10-23,2020-02-11,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Child anxiety treatment in the context of COVID-19,560,http://isrctn.com/ISRCTN12890382,NA
ISRCTN45176516,ISRCTN,2020-09-21,2020-09-23,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Impact of biologic therapy on SARS-CoV-2 infection and immunity in patients with inflammatory bowel disease,6970,http://isrctn.com/ISRCTN45176516,NA
ISRCTN50212645,ISRCTN,2020-05-20,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"
                COG-UK Project Hospital-Onset COVID-19 Infections (HOCI) Study: How effective are infection
                prevention and control measures that are informed by genetic analysis of coronavirus (rapid and
                standard) at preventing COVID-19 in NHS hospitals?
",2380,http://isrctn.com/ISRCTN50212645,NA
ChiCTR2100042804,ChiCTR,2021-01-28,2021-01-31,FALSE,Recruiting,Not Applicable,Observational,China,A survey and study on COVID-19 vaccination,1300,http://www.chictr.org.cn/showproj.aspx?proj=121164,NA
ChiCTR2100042780,ChiCTR,2021-01-28,2021-01-31,FALSE,Recruiting,Not Applicable,Observational,China,Study on the Psychological Stress and Practice of College Students and Influencing Factors in the post epidemic era,1300,http://www.chictr.org.cn/showproj.aspx?proj=121050,NA
ChiCTR2100042726,ChiCTR,2021-01-27,2020-03-27,TRUE,Not Recruiting,Not Applicable,Interventional,China,Mindfulness and Psychological Intervention Programs for College Students in the Context of COVID-19: A Randomized Controlled Trial,114,http://www.chictr.org.cn/showproj.aspx?proj=66123,NA
ChiCTR2100042717,ChiCTR,2021-01-26,2021-01-11,TRUE,Recruiting,Not Applicable,Interventional,China,Study on the impact of metabolic disorders on novel coronavirus pneumonia (COVID-19) vaccination and related mechanisms,200,http://www.chictr.org.cn/showproj.aspx?proj=121027,NA
ChiCTR2100042634,ChiCTR,2021-01-24,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,China,Study on serum free nucleic acid of patients with novel coronavirus pneumonia (COVID-19),196,http://www.chictr.org.cn/showproj.aspx?proj=52617,NA
ChiCTR2000029618,ChiCTR,2020-02-07,2020-08-01,FALSE,Recruiting,Not Applicable,Interventional,China,"Effect of the online-guide direct and indirect pelvic floor muscle training during pregnancy on SUI prevention during the COVID-19 pandemic: protocol for a multicenter, randomized controlled trial",734,http://www.chictr.org.cn/showproj.aspx?proj=48903,NA
EUCTR2021-000235-30,EudraCT,2021-01-28,2021-09-02,FALSE,Not Recruiting,Phase 4,Interventional,Netherlands,The COPPER study: Do people with Corona recover faster through early treatment with dexamethasone?,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000235-30,NL
EUCTR2020-005020-11,EudraCT,2021-02-01,2021-04-05,FALSE,Authorised,Phase 2,Interventional,Spain,Study on ozonated blood in COVID-19 severe pneumonia,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005020-11,ES
EUCTR2020-005280-31,EudraCT,2021-02-01,2021-04-21,FALSE,Authorised,Phase 4,Interventional,Spain,Study to evaluate the impact of early treatment with a budesonide / formoterol versus standard of care on the evolution of the disease in vulnerable patients with COVID-19: INHALAVID Trial,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005280-31,ES
EUCTR2020-003369-20,EudraCT,2020-09-14,2020-11-13,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Hungary, Russian Federation, Ireland, Peru, South Africa, Ukraine, United States, Italy, Spain, Mexico, Brazil, Poland, India, South Korea, Romania",Trial to evaluate the Efficacy and Safety CT-P59 in Combination with Standard of Care in Outpatients with SARS-CoV-2 Infection (COVID-19),1472,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003369-20,IE
EUCTR2021-000988-68,EudraCT,2021-03-08,2021-03-31,FALSE,Authorised,Phase 4,Interventional,Sweden,Immune response after covid-19 vaccination in patients with renal failure stadium 4 or 5 .,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000988-68,SE
EUCTR2021-000981-13,EudraCT,2021-03-17,2021-03-30,FALSE,Authorised,Phase 3,Interventional,Poland,Skutecznosc leczenia amantadyna chorych na COVID-19,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000981-13,PL
EUCTR2021-001304-15,EudraCT,2021-03-16,2021-06-05,FALSE,Authorised,Phase 4,Interventional,Belgium,Immuneresponse after vaccination against SARS-COV-2,85,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001304-15,BE
EUCTR2021-001520-18,EudraCT,2021-03-25,2021-09-04,FALSE,Authorised,Phase 4,Interventional,Netherlands,Long term efficacy and safety of COVID-19 vaccination in patients with a kidney disease,24300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001520-18,NL
EUCTR2021-001357-31,EudraCT,2021-04-20,2021-03-05,TRUE,Authorised,Phase 4,Interventional,Netherlands,Study of the immune response after corona vaccination,1800,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001357-31,NL
EUCTR2020-005952-39,EudraCT,2021-02-03,2021-12-03,FALSE,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to test COR-101 in hospitalized patients with moderate to severe Covid-19,261,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005952-39,DE
EUCTR2020-001635-27,EudraCT,2020-04-06,2020-04-05,TRUE,Authorised,Phase 2,Interventional,France,Evaluation of a combination of Masitinib and Isoquercetin in the Treatment of Hospitalized COVID-19 Patients.,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001635-27,FR
EUCTR2021-001202-30,EudraCT,2021-04-16,2021-04-05,TRUE,Authorised,Phase 4,Interventional,Netherlands,SARS-CoV-2 immune response,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001202-30,NL
EUCTR2021-001978-37,EudraCT,2021-05-06,2021-04-19,TRUE,Authorised,Phase 2,Interventional,Spain,"A Phase 2, Comparative, Randomised, Adaptive Trial to Evaluate the safety and immunogenicity of one dose of COMIRNATY in subjects that had received one dose of VAXZEVRIA.",600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001978-37,ES
NCT03957447,ClinicalTrials.gov,2019-05-17,2019-05-07,TRUE,Not Recruiting,Not Applicable,Observational,Cote d'Ivoire,Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHOrecommended Wound Management in West Africa,5000,https://clinicaltrials.gov/show/NCT03957447,NA
NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,FALSE,Recruiting,Not Applicable,Interventional,"Nepal, Indonesia, Benin, United Kingdom, Zambia, Ethiopia, Bangladesh, Pakistan, Italy, Thailand, Mali, Lao People's Democratic Republic, Niger, Kenya",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,40000,https://clinicaltrials.gov/show/NCT04303507,NA
NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,TRUE,Not Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441,NA
NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,FALSE,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19),276,https://clinicaltrials.gov/show/NCT04332094,NA
NCT04335123,ClinicalTrials.gov,2020-03-31,2020-04-04,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,34,https://clinicaltrials.gov/show/NCT04335123,NA
NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,206,https://clinicaltrials.gov/show/NCT04344015,NA
NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04344236,NA
NCT04353583,ClinicalTrials.gov,2020-04-06,2020-04-21,FALSE,Recruiting,Not Applicable,Observational,Germany,Renal Outcome in Patients With COVID-19,400,https://clinicaltrials.gov/show/NCT04353583,NA
NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,FALSE,Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,240,https://clinicaltrials.gov/show/NCT04354259,NA
NCT04355767,ClinicalTrials.gov,2020-04-17,2020-08-11,FALSE,Not Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,511,https://clinicaltrials.gov/show/NCT04355767,NA
NCT04355793,ClinicalTrials.gov,2020-04-18,2020-08-11,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,Not Available,https://clinicaltrials.gov/show/NCT04355793,NA
NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,FALSE,Not Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,50,https://clinicaltrials.gov/show/NCT04357730,NA
NCT04361877,ClinicalTrials.gov,2020-04-20,2020-03-30,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),1900,https://clinicaltrials.gov/show/NCT04361877,NA
NCT04365530,ClinicalTrials.gov,2020-04-26,2020-04-01,TRUE,Recruiting,Not Applicable,Observational,France,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,2000,https://clinicaltrials.gov/show/NCT04365530,NA
NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-24,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,10,https://clinicaltrials.gov/show/NCT04366791,NA
NCT04368312,ClinicalTrials.gov,2020-04-09,2020-05-06,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Psychological Impairment Due to Covid-19,100,https://clinicaltrials.gov/show/NCT04368312,NA
NCT04369807,ClinicalTrials.gov,2020-04-22,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,507,https://clinicaltrials.gov/show/NCT04369807,NA
NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Canada, Mexico, United States, Brazil",Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),1203,https://clinicaltrials.gov/show/NCT04372589,NA
NCT04372628,ClinicalTrials.gov,2020-04-30,2020-06-01,FALSE,Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,600,https://clinicaltrials.gov/show/NCT04372628,NA
NCT04374370,ClinicalTrials.gov,2020-05-01,2018-07-13,TRUE,Not Recruiting,Not Applicable,Expanded Access,United States,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),Not Available,https://clinicaltrials.gov/show/NCT04374370,NA
NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,FALSE,Not Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),30,https://clinicaltrials.gov/show/NCT04377672,NA
NCT04379518,ClinicalTrials.gov,2020-05-06,2020-09-04,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,64,https://clinicaltrials.gov/show/NCT04379518,NA
NCT04380870,ClinicalTrials.gov,2020-05-05,2020-05-11,FALSE,Recruiting,Not Applicable,Observational,United States,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,500,https://clinicaltrials.gov/show/NCT04380870,NA
NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,TRUE,Not Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,107,https://clinicaltrials.gov/show/NCT04380909,NA
NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-29,FALSE,Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),446,https://clinicaltrials.gov/show/NCT04381364,NA
NCT04381962,ClinicalTrials.gov,2020-05-07,2020-06-03,FALSE,Not Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),298,https://clinicaltrials.gov/show/NCT04381962,NA
NCT04385264,ClinicalTrials.gov,2020-04-21,2022-01-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,800,https://clinicaltrials.gov/show/NCT04385264,NA
NCT04386044,ClinicalTrials.gov,2020-05-10,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,986,https://clinicaltrials.gov/show/NCT04386044,NA
NCT04387955,ClinicalTrials.gov,2020-04-29,2020-04-30,FALSE,Recruiting,Not Applicable,Interventional,France,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),11,https://clinicaltrials.gov/show/NCT04387955,NA
NCT04391816,ClinicalTrials.gov,2020-05-15,2020-06-03,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,700,https://clinicaltrials.gov/show/NCT04391816,NA
NCT04402957,ClinicalTrials.gov,2020-05-12,2020-10-14,FALSE,Not Recruiting,Phase 2,Interventional,"Turkey, Canada, United States",LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),60,https://clinicaltrials.gov/show/NCT04402957,NA
NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",660,https://clinicaltrials.gov/show/NCT04405076,NA
NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-07,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,49,https://clinicaltrials.gov/show/NCT04409743,NA
NCT04409873,ClinicalTrials.gov,2020-05-28,2021-03-31,FALSE,Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),150,https://clinicaltrials.gov/show/NCT04409873,NA
NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-30,FALSE,Not Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,20,https://clinicaltrials.gov/show/NCT04412785,NA
NCT04420364,ClinicalTrials.gov,2020-06-04,2021-05-03,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,0,https://clinicaltrials.gov/show/NCT04420364,NA
NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,34,https://clinicaltrials.gov/show/NCT04421404,NA
NCT04421612,ClinicalTrials.gov,2020-06-04,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,Norway,COVID-19 - No Health Without Mental Health,91,https://clinicaltrials.gov/show/NCT04421612,NA
NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,FALSE,Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,2300,https://clinicaltrials.gov/show/NCT04421625,NA
NCT04422509,ClinicalTrials.gov,2020-06-03,2020-10-30,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,43,https://clinicaltrials.gov/show/NCT04422509,NA
NCT04432272,ClinicalTrials.gov,2020-06-12,2020-07-16,FALSE,Not Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),71,https://clinicaltrials.gov/show/NCT04432272,NA
NCT04445493,ClinicalTrials.gov,2020-06-18,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,United States,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),250,https://clinicaltrials.gov/show/NCT04445493,NA
NCT04453852,ClinicalTrials.gov,2020-06-03,2020-06-30,FALSE,Not Recruiting,Phase 1,Interventional,Australia,Monovalent Recombinant COVID19 Vaccine,40,https://clinicaltrials.gov/show/NCT04453852,NA
NCT04468789,ClinicalTrials.gov,2020-07-08,2020-11-03,FALSE,Not Recruiting,Not Applicable,Observational,South Africa,Evaluation of Six-month HIV Treatment Dispensing in South Africa,0,https://clinicaltrials.gov/show/NCT04468789,NA
NCT04485130,ClinicalTrials.gov,2020-07-22,2021-05-01,FALSE,Recruiting,Phase 2,Interventional,United States,DISulfiram for COvid-19 (DISCO) Trial,60,https://clinicaltrials.gov/show/NCT04485130,NA
NCT04496076,ClinicalTrials.gov,2020-07-13,2020-04-02,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Brain Injury,300,https://clinicaltrials.gov/show/NCT04496076,NA
NCT04496128,ClinicalTrials.gov,2020-07-13,2020-04-13,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID19 Neurological Manifestation,300,https://clinicaltrials.gov/show/NCT04496128,NA
NCT04512300,ClinicalTrials.gov,2020-08-12,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,267,https://clinicaltrials.gov/show/NCT04512300,NA
NCT04520191,ClinicalTrials.gov,2020-08-17,2021-01-04,FALSE,Recruiting,Not Applicable,Observational,United States,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study,529,https://clinicaltrials.gov/show/NCT04520191,NA
NCT04527315,ClinicalTrials.gov,2020-08-24,2020-07-17,TRUE,Recruiting,Not Applicable,Observational,United States,COVID-19 Survivorship Registry,350,https://clinicaltrials.gov/show/NCT04527315,NA
NCT04527432,ClinicalTrials.gov,2020-08-24,2020-12-16,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Health Professional Impact Study,1504,https://clinicaltrials.gov/show/NCT04527432,NA
NCT04528888,ClinicalTrials.gov,2020-08-21,2020-11-25,FALSE,Recruiting,Phase 3,Interventional,Italy,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,210,https://clinicaltrials.gov/show/NCT04528888,NA
NCT04531748,ClinicalTrials.gov,2020-08-27,2021-12-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Selective Estrogen Modulation and Melatonin in Early COVID-19,0,https://clinicaltrials.gov/show/NCT04531748,NA
NCT04532372,ClinicalTrials.gov,2020-08-25,2020-10-23,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,30,https://clinicaltrials.gov/show/NCT04532372,NA
NCT04537962,ClinicalTrials.gov,2020-07-14,2020-06-11,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices,202,https://clinicaltrials.gov/show/NCT04537962,NA
NCT04540393,ClinicalTrials.gov,2020-08-26,2020-09-02,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,AZD1222 Vaccine for the Prevention of COVID-19,100,https://clinicaltrials.gov/show/NCT04540393,NA
NCT04542967,ClinicalTrials.gov,2020-09-04,2020-06-23,TRUE,Not Recruiting,Phase 2,Interventional,Mexico,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,150,https://clinicaltrials.gov/show/NCT04542967,NA
NCT04545060,ClinicalTrials.gov,2020-09-04,2020-08-27,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,"Chile, Peru, United Kingdom, Canada, United States, Brazil, Spain, Austria, France",VIR-7831 for the Early Treatment of COVID-19 in Outpatients,1360,https://clinicaltrials.gov/show/NCT04545060,NA
NCT04551768,ClinicalTrials.gov,2020-09-15,2021-02-10,FALSE,Recruiting,Phase 1,Interventional,"Greece, Mexico",Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,50,https://clinicaltrials.gov/show/NCT04551768,NA
NCT04551911,ClinicalTrials.gov,2020-09-15,2020-10-26,FALSE,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,160,https://clinicaltrials.gov/show/NCT04551911,NA
NCT04558320,ClinicalTrials.gov,2020-09-19,2020-07-02,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 and Lactating Mothers,100,https://clinicaltrials.gov/show/NCT04558320,NA
NCT04592549,ClinicalTrials.gov,2020-10-12,2020-12-04,FALSE,Recruiting,Phase 1,Interventional,United States,Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19,40,https://clinicaltrials.gov/show/NCT04592549,NA
NCT04597853,ClinicalTrials.gov,2020-10-19,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,Switzerland,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,25,https://clinicaltrials.gov/show/NCT04597853,NA
NCT04602286,ClinicalTrials.gov,2020-10-19,2020-10-28,FALSE,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),292,https://clinicaltrials.gov/show/NCT04602286,NA
NCT04602312,ClinicalTrials.gov,2020-10-19,2020-10-28,FALSE,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),624,https://clinicaltrials.gov/show/NCT04602312,NA
NCT04602351,ClinicalTrials.gov,2020-10-21,2021-03-22,FALSE,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Communication in ICU During COVID-19,296,https://clinicaltrials.gov/show/NCT04602351,NA
NCT04603924,ClinicalTrials.gov,2020-10-20,2020-10-07,TRUE,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,436,https://clinicaltrials.gov/show/NCT04603924,NA
NCT04611802,ClinicalTrials.gov,2020-10-30,2020-12-27,FALSE,Recruiting,Phase 3,Interventional,"Puerto Rico, United States, Mexico","A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults = 18 Years With a Pediatric Expansion in Adolescents (12-17 Years) at Risk for SARS-CoV-2",33000,https://clinicaltrials.gov/show/NCT04611802,NA
NCT04615052,ClinicalTrials.gov,2020-10-29,2020-09-26,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise in COVID-19 Survivors,60,https://clinicaltrials.gov/show/NCT04615052,NA
NCT04619628,ClinicalTrials.gov,2020-11-05,2020-12-11,FALSE,Not Recruiting,Phase 1,Interventional,United Kingdom,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",48,https://clinicaltrials.gov/show/NCT04619628,NA
NCT04632381,ClinicalTrials.gov,2020-11-12,2021-05-07,FALSE,Not Recruiting,Phase 1,Interventional,United States,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,36,https://clinicaltrials.gov/show/NCT04632381,NA
NCT04642950,ClinicalTrials.gov,2020-11-19,2020-12-17,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,60,https://clinicaltrials.gov/show/NCT04642950,NA
NCT04644328,ClinicalTrials.gov,2020-11-13,2020-11-14,FALSE,Not Recruiting,Not Applicable,Interventional,United States,The Doctors for Coronavirus Prevention Project Thanksgiving / Christmas Messaging Campaign,20000000,https://clinicaltrials.gov/show/NCT04644328,NA
NCT04646590,ClinicalTrials.gov,2020-11-25,2020-12-16,FALSE,Recruiting,Phase 3,Interventional,"Indonesia, Pakistan, Uzbekistan, Ecuador, China",A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,29000,https://clinicaltrials.gov/show/NCT04646590,NA
NCT04646603,ClinicalTrials.gov,2020-11-24,2021-01-28,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,18,https://clinicaltrials.gov/show/NCT04646603,NA
NCT04652674,ClinicalTrials.gov,2020-12-02,2020-09-28,TRUE,Recruiting,Not Applicable,Interventional,United States,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04652674,NA
NCT04654442,ClinicalTrials.gov,2020-12-03,2021-03-04,FALSE,Recruiting,Not Applicable,Observational,France,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,60,https://clinicaltrials.gov/show/NCT04654442,NA
NCT04665960,ClinicalTrials.gov,2020-12-09,2021-03-29,FALSE,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2,35,https://clinicaltrials.gov/show/NCT04665960,NA
NCT04668235,ClinicalTrials.gov,2020-12-04,2021-04-23,FALSE,Recruiting,Phase 3,Interventional,Brazil,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),342,https://clinicaltrials.gov/show/NCT04668235,NA
NCT04681430,ClinicalTrials.gov,2020-12-17,2021-01-08,FALSE,Recruiting,Phase 2,Interventional,Germany,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,1094,https://clinicaltrials.gov/show/NCT04681430,NA
NCT04715932,ClinicalTrials.gov,2021-01-15,2021-02-18,FALSE,Not Recruiting,Phase 2,Interventional,Canada,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),216,https://clinicaltrials.gov/show/NCT04715932,NA
NCT04733807,ClinicalTrials.gov,2021-01-28,2021-01-28,FALSE,Recruiting,Not Applicable,Observational,Italy,Antibodies Response to mRNA Vaccine Against Covid-19,600,https://clinicaltrials.gov/show/NCT04733807,NA
NCT04738721,ClinicalTrials.gov,2021-02-01,2021-02-05,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Physical Activity and Physical Fitness Parameters in COVID-19 Lockdown,79,https://clinicaltrials.gov/show/NCT04738721,NA
NCT04746430,ClinicalTrials.gov,2021-02-08,2021-02-16,FALSE,Not Recruiting,Phase 4,Interventional,Netherlands,COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study,17,https://clinicaltrials.gov/show/NCT04746430,NA
NCT04753645,ClinicalTrials.gov,2021-02-11,2020-09-19,TRUE,Not Recruiting,Not Applicable,Interventional,Bangladesh,BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition,3840,https://clinicaltrials.gov/show/NCT04753645,NA
NCT04757207,ClinicalTrials.gov,2021-02-13,2021-02-22,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Pandemia And Exercise in Turkey in University Students of Turkey,5474,https://clinicaltrials.gov/show/NCT04757207,NA
NCT04760184,ClinicalTrials.gov,2020-12-11,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Sweden,Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden,30,https://clinicaltrials.gov/show/NCT04760184,NA
NCT04762056,ClinicalTrials.gov,2021-02-18,2021-02-22,FALSE,Recruiting,Not Applicable,Observational,Turkey,CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge,26,https://clinicaltrials.gov/show/NCT04762056,NA
NCT04766333,ClinicalTrials.gov,2021-02-10,2021-05-03,FALSE,Recruiting,Not Applicable,Interventional,United States,New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations,2000,https://clinicaltrials.gov/show/NCT04766333,NA
NCT04779827,ClinicalTrials.gov,2021-02-21,2021-05-04,FALSE,Recruiting,Not Applicable,Interventional,United States,Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks,1920,https://clinicaltrials.gov/show/NCT04779827,NA
NCT04780113,ClinicalTrials.gov,2021-03-01,2021-02-25,TRUE,Recruiting,Not Applicable,Observational,France,Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis,285,https://clinicaltrials.gov/show/NCT04780113,NA
NCT04797858,ClinicalTrials.gov,2021-03-05,2021-05-05,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Self-Testing Through Rapid Network Distribution,1048,https://clinicaltrials.gov/show/NCT04797858,NA
NCT04813770,ClinicalTrials.gov,2021-03-23,2021-04-06,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions,1113,https://clinicaltrials.gov/show/NCT04813770,NA
NCT04813796,ClinicalTrials.gov,2021-03-22,2021-03-11,TRUE,Recruiting,Phase 1,Interventional,United States,"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19",125,https://clinicaltrials.gov/show/NCT04813796,NA
NCT04816019,ClinicalTrials.gov,2021-03-15,2021-04-01,FALSE,Recruiting,Phase 1,Interventional,United Kingdom,A Study of Intranasal ChAdOx1 nCOV-19,54,https://clinicaltrials.gov/show/NCT04816019,NA
NCT04816071,ClinicalTrials.gov,2021-03-23,2021-05-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Essential Amino Acid Supplementation in Older Adult COVID-19 Patients,0,https://clinicaltrials.gov/show/NCT04816071,NA
NCT04825301,ClinicalTrials.gov,2021-03-29,2020-07-21,TRUE,Recruiting,Not Applicable,Observational,Italy,Prognostic Prediction of COVID-19 Clinical Course Through the Development of Machine Learning Based Algorithms,325,https://clinicaltrials.gov/show/NCT04825301,NA
NCT04834583,ClinicalTrials.gov,2021-03-31,2020-11-02,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Corona And Manual Professions,703,https://clinicaltrials.gov/show/NCT04834583,NA
NCT04834726,ClinicalTrials.gov,2021-04-06,2021-04-29,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccine Text Outreach,20500,https://clinicaltrials.gov/show/NCT04834726,NA
NCT04841759,ClinicalTrials.gov,2021-04-07,2021-04-01,TRUE,Recruiting,Not Applicable,Interventional,Austria,The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome,30,https://clinicaltrials.gov/show/NCT04841759,NA
NCT04847479,ClinicalTrials.gov,2021-04-14,2021-05-06,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Close Contact Self-Testing Study,210,https://clinicaltrials.gov/show/NCT04847479,NA
NCT04847596,ClinicalTrials.gov,2021-04-14,2021-05-31,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,22,https://clinicaltrials.gov/show/NCT04847596,NA
NCT04852861,ClinicalTrials.gov,2021-04-14,2021-05-10,FALSE,Recruiting,Phase 4,Interventional,Belgium,COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine,150,https://clinicaltrials.gov/show/NCT04852861,NA
NCT04854408,ClinicalTrials.gov,2021-04-17,2021-03-18,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Effect of Coronavac Vaccine (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2 Vaccine) on Healthcare Workers' Menstrual Patterns,300,https://clinicaltrials.gov/show/NCT04854408,NA
NCT04858425,ClinicalTrials.gov,2021-04-21,2021-04-30,FALSE,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection,148,https://clinicaltrials.gov/show/NCT04858425,NA
NCT04859023,ClinicalTrials.gov,2021-04-22,2021-02-22,TRUE,Not Recruiting,Not Applicable,Interventional,France,Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).,10000,https://clinicaltrials.gov/show/NCT04859023,NA
NCT04860258,ClinicalTrials.gov,2021-04-22,2021-04-22,FALSE,Recruiting,Phase 3,Interventional,Belgium,"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities for COVID-19",1200,https://clinicaltrials.gov/show/NCT04860258,NA
NCT04865107,ClinicalTrials.gov,2021-04-27,2021-04-27,FALSE,Recruiting,Phase 2,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial,54,https://clinicaltrials.gov/show/NCT04865107,NA
NCT04866069,ClinicalTrials.gov,2021-04-26,2021-04-25,TRUE,Recruiting,Phase 1,Interventional,Turkey,Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults,50,https://clinicaltrials.gov/show/NCT04866069,NA
NCT04866589,ClinicalTrials.gov,2021-04-15,2021-05-03,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: The Effectiveness of Free Face Mask Distribution,10,https://clinicaltrials.gov/show/NCT04866589,NA
NCT04869228,ClinicalTrials.gov,2021-04-29,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,"A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients",724,https://clinicaltrials.gov/show/NCT04869228,NA
NCT04869592,ClinicalTrials.gov,2021-04-24,2021-04-25,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19,3580,https://clinicaltrials.gov/show/NCT04869592,NA
NCT04870164,ClinicalTrials.gov,2021-04-28,2020-11-18,TRUE,Recruiting,Phase 1,Interventional,United Kingdom,"Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)",24,https://clinicaltrials.gov/show/NCT04870164,NA
NCT04871672,ClinicalTrials.gov,2021-04-24,2021-05-23,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Effects of Pilates Exercises on Core Stability After Recovery From COVID -19,30,https://clinicaltrials.gov/show/NCT04871672,NA
NCT04871828,ClinicalTrials.gov,2021-05-01,2021-02-28,TRUE,Recruiting,Phase 3,Interventional,Saudi Arabia,The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19),66,https://clinicaltrials.gov/show/NCT04871828,NA
NCT04872725,ClinicalTrials.gov,2021-05-02,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Covid-19 Process,531,https://clinicaltrials.gov/show/NCT04872725,NA
NCT04872738,ClinicalTrials.gov,2021-05-02,2021-05-07,FALSE,Recruiting,Not Applicable,Observational,United States,Patient Experiences With the COVID-19 Vaccination After Breast Cancer Treatment,2000,https://clinicaltrials.gov/show/NCT04872738,NA
NCT04872751,ClinicalTrials.gov,2021-04-29,2021-04-27,TRUE,Recruiting,Not Applicable,Observational,Malaysia,Immune Response of Haemodialysis Patients Post Covid-19 Vaccination,425,https://clinicaltrials.gov/show/NCT04872751,NA
NCT04873141,ClinicalTrials.gov,2021-04-28,2020-04-28,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Tocilizumab and Cytokine Release Syndrome (CRS) In Covid-19 Pneumonia,24,https://clinicaltrials.gov/show/NCT04873141,NA
NCT04873336,ClinicalTrials.gov,2021-05-04,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Closed Loop Ventilation in Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04873336,NA
NCT04873349,ClinicalTrials.gov,2021-05-04,2021-05-10,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04873349,NA
NCT04873388,ClinicalTrials.gov,2021-05-03,2020-03-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Early Predictors of Prognostic Course in Patients With COVID-19 in Critical or Semi-intensive Area.,150,https://clinicaltrials.gov/show/NCT04873388,NA
NCT04873401,ClinicalTrials.gov,2021-03-24,2021-05-20,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Leveraging Social Networks to Increase COVID-19 Testing Uptake,500,https://clinicaltrials.gov/show/NCT04873401,NA
NCT04874740,ClinicalTrials.gov,2021-04-30,2021-04-30,FALSE,Recruiting,Not Applicable,Observational,Czech Republic,Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region,300,https://clinicaltrials.gov/show/NCT04874740,NA
NCT04874792,ClinicalTrials.gov,2021-05-03,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Bangladesh,Clinical Characteristics of Deceased With COVID-19,282,https://clinicaltrials.gov/show/NCT04874792,NA
NCT04874805,ClinicalTrials.gov,2021-04-16,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Oxygen Saturation: Analytical Comparison for COVID,40,https://clinicaltrials.gov/show/NCT04874805,NA
NCT04874818,ClinicalTrials.gov,2021-04-28,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,CD8+ T-cell PET/CT Imaging in COVID-19 Patients,20,https://clinicaltrials.gov/show/NCT04874818,NA
NCT04875520,ClinicalTrials.gov,2021-04-29,2021-05-07,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population,10000,https://clinicaltrials.gov/show/NCT04875520,NA
NCT04876417,ClinicalTrials.gov,2021-03-15,2021-02-01,TRUE,Recruiting,Not Applicable,Interventional,United States,tDCS for Post COVID-19 Fatigue,50,https://clinicaltrials.gov/show/NCT04876417,NA
NCT04876443,ClinicalTrials.gov,2021-05-05,2020-10-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD),200,https://clinicaltrials.gov/show/NCT04876443,NA
NCT04876560,ClinicalTrials.gov,2021-04-27,2020-03-11,TRUE,Not Recruiting,Not Applicable,Interventional,Greece,Implementation of a CDSS in Oncology Patients During COVID-19,44,https://clinicaltrials.gov/show/NCT04876560,NA
NCT04876573,ClinicalTrials.gov,2021-05-03,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19,60,https://clinicaltrials.gov/show/NCT04876573,NA
NCT04876872,ClinicalTrials.gov,2021-05-03,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Modified Pediatric Early Warning Score and Modified PRISA II During COVID-19 Pandemic,894,https://clinicaltrials.gov/show/NCT04876872,NA
NCT04876885,ClinicalTrials.gov,2021-05-03,2021-05-06,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The Future of Viral Communications: Video-Based Health Promotion Strategies for COVID-19 Vaccinations,100,https://clinicaltrials.gov/show/NCT04876885,NA
NCT04876898,ClinicalTrials.gov,2021-05-03,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,High Body Mass Index and Severity of Coronavirus,114,https://clinicaltrials.gov/show/NCT04876898,NA
NCT04877002,ClinicalTrials.gov,2021-05-03,2021-04-29,TRUE,Recruiting,Not Applicable,Interventional,Canada,Performance Study of SONA Saliva C-19 Rapid Test,500,https://clinicaltrials.gov/show/NCT04877002,NA
NCT04877509,ClinicalTrials.gov,2021-03-04,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Micronutrient Status Involved in Immunity in Elderly Patients With COVID-19,229,https://clinicaltrials.gov/show/NCT04877509,NA
NCT04877704,ClinicalTrials.gov,2021-05-05,2021-05-31,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,Symprove (Probiotic) as an add-on to COVID-19 Management,60,https://clinicaltrials.gov/show/NCT04877704,NA
NCT04877769,ClinicalTrials.gov,2021-05-04,2021-04-25,TRUE,Recruiting,Phase 1,Interventional,United Kingdom,Bronchopulmonary PK of AT-527 (R07496998),24,https://clinicaltrials.gov/show/NCT04877769,NA
NCT04877808,ClinicalTrials.gov,2021-05-03,2021-04-30,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Bacterial Surinfections in COVID-19 ICU Patients,116,https://clinicaltrials.gov/show/NCT04877808,NA
NCT04878042,ClinicalTrials.gov,2021-05-04,2021-04-09,TRUE,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray,200,https://clinicaltrials.gov/show/NCT04878042,NA
NCT04878068,ClinicalTrials.gov,2021-04-27,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Study to Evaluate the Performance of the Therma COVID-19 Rapid Antigen Test for Detection of SARS-CoV-2,300,https://clinicaltrials.gov/show/NCT04878068,NA
NCT04878328,ClinicalTrials.gov,2021-04-30,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Leveraging CHWs to Improve COVID-19 Testing and Mitigation Among CJIs Accessing a Corrections-focused CBO,250,https://clinicaltrials.gov/show/NCT04878328,NA
NCT04878900,ClinicalTrials.gov,2021-05-04,2021-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Effects of COVID-19 in Chronic Pain,100,https://clinicaltrials.gov/show/NCT04878900,NA
NCT04879251,ClinicalTrials.gov,2021-05-06,2021-04-26,TRUE,Recruiting,Not Applicable,Observational,Czech Republic,The Impact of the COVID-19 Pandemic on Cardiovascular Risk Factors in Patients With Diabetes,1000,https://clinicaltrials.gov/show/NCT04879251,NA
NCT04880122,ClinicalTrials.gov,2021-05-05,2020-08-01,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).,440,https://clinicaltrials.gov/show/NCT04880122,NA
NCT04880135,ClinicalTrials.gov,2021-05-06,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Supervised Versus Home Based Exercises Neck and Low Back Pain Among Students Due to Quarantine During COVID-19,404,https://clinicaltrials.gov/show/NCT04880135,NA
NCT04880161,ClinicalTrials.gov,2021-05-06,2021-05-01,TRUE,Recruiting,Phase 1,Interventional,United States,A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID),30,https://clinicaltrials.gov/show/NCT04880161,NA
NCT04880174,ClinicalTrials.gov,2021-04-16,2021-03-22,TRUE,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination,800,https://clinicaltrials.gov/show/NCT04880174,NA
NCT04880317,ClinicalTrials.gov,2021-05-02,2021-05-01,TRUE,Recruiting,Not Applicable,Interventional,Italy,Validation of Quantitative Myocardial Tissue Characterization Through Non-gated CT,188,https://clinicaltrials.gov/show/NCT04880317,NA
NCT04880668,ClinicalTrials.gov,2021-04-27,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Aerosol Box Use on Healthcare Provider Contamination,132,https://clinicaltrials.gov/show/NCT04880668,NA
NCT04881266,ClinicalTrials.gov,2021-03-03,2021-05-07,FALSE,Recruiting,Not Applicable,Observational,Switzerland,"Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors",200,https://clinicaltrials.gov/show/NCT04881266,NA
NCT04881305,ClinicalTrials.gov,2021-05-06,2021-05-01,TRUE,Recruiting,Not Applicable,Observational,Israel,Characterizing Long-term Cognitive and Emotional Impairment in Post-COVID-19 Sequelae,70,https://clinicaltrials.gov/show/NCT04881305,NA
NCT04882865,ClinicalTrials.gov,2021-05-04,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Apparatus and Method for Moving Patients,95,https://clinicaltrials.gov/show/NCT04882865,NA
NCT04884321,ClinicalTrials.gov,2021-05-07,2021-02-27,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Complementary And Alternative Medicine During The COVID-19 Pandemic,3242,https://clinicaltrials.gov/show/NCT04884321,NA
NCT04884477,ClinicalTrials.gov,2021-05-05,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Infection in Patients Receiving Anti-CD20 Therapy,1200,https://clinicaltrials.gov/show/NCT04884477,NA
NCT04884490,ClinicalTrials.gov,2021-05-05,2021-05-15,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients,94,https://clinicaltrials.gov/show/NCT04884490,NA
NCT04884776,ClinicalTrials.gov,2021-04-29,2021-05-10,FALSE,Not Recruiting,Not Applicable,Interventional,Hong Kong,Modulation of Gut Microbiota to Enhance Health and Immunity,484,https://clinicaltrials.gov/show/NCT04884776,NA
NCT04885192,ClinicalTrials.gov,2021-05-04,2021-03-11,TRUE,Recruiting,Not Applicable,Observational,Canada,Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain,200,https://clinicaltrials.gov/show/NCT04885192,NA
NCT04885764,ClinicalTrials.gov,2021-05-08,2021-02-23,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University,4000,https://clinicaltrials.gov/show/NCT04885764,NA
ACTRN12620001104943,ANZCTR,2020-10-26,2020-12-11,FALSE,Not Recruiting,Phase 1,Interventional,Australia,A Single Dose Study to Determine the Safety and Tolerability of Intranasal REVTx-99 in Healthy Adult Volunteers,48,https://anzctr.org.au/ACTRN12620001104943.aspx,NA
ACTRN12621000565842,ANZCTR,2021-05-13,2021-05-18,FALSE,Not Recruiting,Not Applicable,Observational,Australia,Rapid Palliative Care In-Reach for COVID-19 (RaPIC),20,https://anzctr.org.au/ACTRN12621000565842.aspx,NA
ISRCTN18100261,ISRCTN,2021-05-04,2021-03-22,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Daily contact testing schools and colleges trial,200000,http://isrctn.com/ISRCTN18100261,NA
ISRCTN18018895,ISRCTN,2021-05-04,2021-01-05,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Towards understanding COVID-19 prevalence and transmission in prisons,10,http://isrctn.com/ISRCTN18018895,NA
ISRCTN12721265,ISRCTN,2021-04-30,2021-10-05,FALSE,Recruiting,Not Applicable,Interventional,Indonesia,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients in Indonesia,68,http://isrctn.com/ISRCTN12721265,NA
ISRCTN47104509,ISRCTN,2021-04-28,2020-06-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Can the outcome prioritisation tool be used to understand what is most important to patients with multiple long-term health conditions?,2000,http://isrctn.com/ISRCTN47104509,NA
ISRCTN22331899,ISRCTN,2021-04-07,2020-01-07,TRUE,Not Recruiting,Not Applicable,Interventional,United States,How effective is framing public service announcements using identity-based messaging in increasing the likelihood of compliance with COVID-19 guidelines?,300,http://isrctn.com/ISRCTN22331899,NA
ISRCTN14391248,ISRCTN,2021-03-30,2021-03-29,TRUE,Recruiting,Phase 4,Interventional,United Kingdom,Combining influenza and COVID-19 vaccination (ComFluCOV) study,756,http://isrctn.com/ISRCTN14391248,NA
ISRCTN27106947,ISRCTN,2020-12-07,2020-08-09,TRUE,Recruiting,Phase 1/Phase 2,Interventional,"South Africa, United Kingdom",A study to assess several different treatments that may be useful for patients with COVID-19,180,http://isrctn.com/ISRCTN27106947,NA
ISRCTN13953727,ISRCTN,2020-11-02,2020-01-10,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Assessing patientsâ€™ risk of COVID-19 severe infection: developing a risk prediction score,2870,http://isrctn.com/ISRCTN13953727,NA
ISRCTN82901740,ISRCTN,2020-10-13,2020-11-16,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 testing and infection control in schools,6000,http://isrctn.com/ISRCTN82901740,NA
ISRCTN10197987,ISRCTN,2020-10-05,2020-08-09,TRUE,Not Recruiting,Not Applicable,Interventional,Qatar,The possible beneficial role of the regular use of potent mouthwash solutions in the treatment of COVID-19,100,http://isrctn.com/ISRCTN10197987,NA
ISRCTN16912075,ISRCTN,2020-04-06,2020-06-04,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 â€“ CPAP, high-flow nasal oxygen, and standard care",4002,http://isrctn.com/ISRCTN16912075,NA
EUCTR2020-001243-15,EudraCT,2020-03-27,2020-03-26,TRUE,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,BE
EUCTR2020-001266-11,EudraCT,2020-04-16,2020-04-16,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,ES
EUCTR2020-001469-35,EudraCT,2020-04-08,2020-08-04,FALSE,Not Recruiting,Phase 4,Interventional,Poland,"A multicenter, open, randomized, non-commercial study to evaluate the efficacy and safety of chloroquine phosphate in the outpatient treatment of COVID-19 in combination with telemedicine care for patients with SARS-CoV-2 infection with the risk of developing complications to reduce the risk of COVID-19-related hospitalization and death.",400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001469-35,PL
EUCTR2020-001546-19,EudraCT,2020-04-09,2020-04-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19,BE
EUCTR2020-001345-38,EudraCT,2020-03-31,2020-02-04,TRUE,Not Recruiting,Phase 2,Interventional,Greece,CHROLOQUINE PHOSPHATE AGAINST INFECTION BY THE NOVEL CORONAVIRUS,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001345-38,GR
EUCTR2020-001264-28,EudraCT,2020-04-27,2020-05-28,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Moldova, Republic of, Hungary, Russian Federation, Greece, Macedonia, the former Yugoslav Republic of, Ukraine, United States, Bosnia and Herzegovina, Germany, Bulgaria, Romania",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,DE
EUCTR2020-001236-10,EudraCT,2020-11-16,2020-11-12,TRUE,Authorised,Phase 2,Interventional,"Netherlands, Belgium",Countering Lung Damage in COVID-19 infection: the CounterCovid Study,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,BE
EUCTR2020-004356-16,EudraCT,2020-10-25,2020-11-25,FALSE,Authorised,Phase 3,Interventional,"Russian Federation, United Kingdom, Belgium, United States, Spain, France","Phase III, double-blinded study using AZD7442 or Placebo for the prevention of COVID-19 disease in adults who have not been exposed to COVID-19 infection",5000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004356-16,BE
EUCTR2020-002472-12,EudraCT,2020-05-14,2020-11-06,FALSE,Not Recruiting,Phase 4,Interventional,Netherlands,Lanadelumab for treatment of COVID-19 disease,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002472-12,NL
EUCTR2021-000683-30,EudraCT,2021-02-23,2021-03-03,FALSE,Authorised,Phase 4,Interventional,Sweden,CoVacc - Immune response to vaccination against Covid-19,3000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000683-30,SE
EUCTR2020-005759-18,EudraCT,2021-03-11,2021-10-05,FALSE,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18,DE
EUCTR2021-001031-72,EudraCT,2021-03-04,2021-08-04,FALSE,Authorised,Phase 2,Interventional,Denmark,Metabolic MRI of patients with long-term symptoms after COVID19-infection,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001031-72,DK
EUCTR2020-005576-35,EudraCT,2021-04-07,2021-06-05,FALSE,Authorised,Phase 3,Interventional,"Argentina, Hungary, Peru, United Kingdom, Colombia, Canada, United States, Mexico, Spain, Brazil, Poland",COVID-19 Vaccine in Adults 18 Years of Age or Older,30000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005576-35,HU
EUCTR2021-001512-28,EudraCT,2021-04-13,2021-11-05,FALSE,Authorised,Phase 4,Interventional,Germany,Immune response and correlates of protection of COVID-19 vaccines in medical staff and special risk populations,2250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001512-28,DE
EUCTR2021-002014-14,EudraCT,2021-04-16,2021-04-20,FALSE,Authorised,Phase 4,Interventional,Czech Republic,Monitoring of antibody response 28 days after the first dose of COVID19 vaccine in clinically stable subjects with functional kidney transplantation.,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002014-14,CZ
EUCTR2020-001302-30,EudraCT,2020-04-09,2020-04-15,FALSE,Authorised,Phase 2,Interventional,Austria,"A multicenter, randomized, active controlled, open label, platform trial on the efficacy and safety of experimental therapeutics for patients with a lung disease caused by coronavirus infection

ACOVACT (Austrian CoronaVirus Adaptive Clinical Trial)",500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001302-30,AT
EUCTR2020-005299-36,EudraCT,2021-03-29,2021-04-21,FALSE,Authorised,Phase 1/Phase 2,Interventional,"Portugal, Belgium, United States, Mexico, Spain, Italy, France, Romania","A Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19",279,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005299-36,BE
EUCTR2020-003403-33,EudraCT,2020-12-16,2021-01-20,FALSE,Authorised,Phase 2,Interventional,"Hungary, Russian Federation, Georgia, Belgium, Poland",Study to assess the ability of E4 to improve the percentage of patients who recover by Day 28 compared to placebo in those with confirmed SARS-CoV-2 infection who are hospitalized with moderate COVID-19 (i.e. not on high flow oxygen or mechanical ventilation).,162,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003403-33,BE
EUCTR2020-005315-44,EudraCT,2021-01-14,2021-08-04,FALSE,Authorised,Phase 3,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Italy, United States, Spain, Mexico, Brazil, Japan, Poland, Germany, Czech Republic","Phase 3, Double-blind, Placebo-controlled Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults",1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005315-44,DE
ChiCTR2100046272,ChiCTR,2021-05-12,2021-06-15,FALSE,Not Recruiting,Phase 3,Prevention,Malaysia,A global phase III clinical trial of recombinant COVID-19 vaccine (Sf9 cells) in adults aged 18 years and older,40000,http://www.chictr.org.cn/showproj.aspx?proj=126252,NA
ChiCTR2100046227,ChiCTR,2021-05-11,2021-05-14,FALSE,Not Recruiting,Phase 4,Prevention,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1404,http://www.chictr.org.cn/showproj.aspx?proj=126385,NA
ChiCTR2100046174,ChiCTR,2021-05-08,2021-05-12,FALSE,Not Recruiting,Phase 4,Prevention,China,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,1152,http://www.chictr.org.cn/showproj.aspx?proj=126277,NA
ChiCTR2100045993,ChiCTR,2021-05-01,2021-03-09,TRUE,Not Recruiting,Not Applicable,Interventional,China,To evaluate the exploratory clinical trial of homoharringtonine in the treatment of adult COVID-19 patients,40,http://www.chictr.org.cn/showproj.aspx?proj=126032,NA
ChiCTR2100045991,ChiCTR,2021-05-01,2021-04-30,TRUE,Not Recruiting,Phase 1,Interventional,China,Evaluation of safety and immunogenicity of COVID-19 vaccine in patients previously infected with SARS-Cov2,90,http://www.chictr.org.cn/showproj.aspx?proj=126041,NA
ChiCTR2100045984,ChiCTR,2021-05-01,2021-03-26,TRUE,Recruiting,Phase 1,Interventional,No Country Given,"Randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of mRNACOVID-19 vaccine in healthy susceptible populations aged 18 years and older people",240,http://www.chictr.org.cn/showproj.aspx?proj=126046,NA
ChiCTR2100045964,ChiCTR,2021-04-30,2021-04-16,TRUE,Not Recruiting,Not Applicable,Observational,China,A medical records based study for one-year follow-up of sequelae in survivors of Covid-19 patients,2433,http://www.chictr.org.cn/showproj.aspx?proj=125970,NA
ChiCTR2100045849,ChiCTR,2021-04-25,2020-12-18,TRUE,Recruiting,Not Applicable,Observational,China,A study on the detoxification regularity and functional prognosis of novel coronavirus pneumonia (COVID-19) patients,200,http://www.chictr.org.cn/showproj.aspx?proj=125745,NA
ChiCTR2100045845,ChiCTR,2021-04-25,2021-04-25,FALSE,Not Recruiting,Not Applicable,Interventional,China,A study on 3D hologram with mixed reality techniques for better understanding the pulmonary lesions of COVID-19,60,http://www.chictr.org.cn/showproj.aspx?proj=125761,NA
ChiCTR2100045810,ChiCTR,2021-04-25,2020-05-01,TRUE,Recruiting,Not Applicable,Observational,China,Study on the dynamics of specific antibodies and the mechanism of related immunity in SARS-CoV-2 infected individuals (COVID-19),32,http://www.chictr.org.cn/showproj.aspx?proj=124457,NA
ChiCTR2100045631,ChiCTR,2021-04-20,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,China,An observational study on the characteristics of immune response to novel coronavirus (COVID-19) inactivated vaccine inoculated in adult HIV infected persons,100,http://www.chictr.org.cn/showproj.aspx?proj=125427,NA
ChiCTR2100045417,ChiCTR,2021-04-14,2021-04-19,FALSE,Recruiting,Not Applicable,Diagnostic test,China,The clinical value of optical-assisted lateral flow assay to monitor the anti-SARS-CoV-2 neutralizing antibody after receiving novel coronavirus pneumonia (COVID-19) vaccine,76,http://www.chictr.org.cn/showproj.aspx?proj=123288,NA
ChiCTR2100045378,ChiCTR,2021-04-13,2021-04-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,A preliminary clinical study of PET in assessing immune response of novel coronavirus pneumonia (COVID-19) vaccines,50,http://www.chictr.org.cn/showproj.aspx?proj=124299,NA
ChiCTR2100045353,ChiCTR,2021-04-13,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,China,"Research on the effectiveness, safety and effective protection time of novel coronavirus pneumonia (COVID-19) vaccines",3000,http://www.chictr.org.cn/showproj.aspx?proj=124953,NA
ChiCTR2100045160,ChiCTR,2021-04-07,2021-02-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Evaluation of Immunization Effect of 2019-nCoV Inactivated Vaccine,100,http://www.chictr.org.cn/showproj.aspx?proj=123525,NA
ChiCTR2100045109,ChiCTR,2021-04-07,2021-04-09,FALSE,Recruiting,Not Applicable,Interventional,China,The Impact of Timing of Vaccination on the Immune Reaction to Vaccine against SARS-CoV-2,472,http://www.chictr.org.cn/showproj.aspx?proj=124650,NA
ChiCTR2100045108,ChiCTR,2021-04-07,2021-02-22,TRUE,Recruiting,Phase 1,Prevention,China,"A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Healthy Subjects",150,http://www.chictr.org.cn/showproj.aspx?proj=124140,NA
ChiCTR2100045107,ChiCTR,2021-04-07,2021-03-28,TRUE,Not Recruiting,Phase 2,Prevention,China,"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) in Healthy Subjects",720,http://www.chictr.org.cn/showproj.aspx?proj=124702,NA
ChiCTR2100044919,ChiCTR,2021-03-31,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,China,"Study of the correlation between blood, urine and fecal proteomics and vaccine response after vaccination with COVID-19 vaccine",120,http://www.chictr.org.cn/showproj.aspx?proj=122521,NA
ChiCTR2100044860,ChiCTR,2021-03-30,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial on the treatment of COVID-19 by Qingfei Paidu Granule,80,http://www.chictr.org.cn/showproj.aspx?proj=124310,NA
ChiCTR2100044539,ChiCTR,2021-03-23,2021-04-01,FALSE,Not Recruiting,Not Applicable,Basic Science,China,Clinical study on the influence of intestinal microecology on antibody titer after COVID-19 vaccination,100,http://www.chictr.org.cn/showproj.aspx?proj=123658,NA
ChiCTR2100044286,ChiCTR,2021-03-14,2021-01-08,TRUE,Not Recruiting,Not Applicable,Observational,China,The effects of mind-body (Baduanjin) exercise on sleep quality and mental health in patients with COVID-19 early hospitalization stages: A prospective Before-and-After Study,121,http://www.chictr.org.cn/showproj.aspx?proj=123279,NA
ChiCTR2100044249,ChiCTR,2021-03-12,2020-09-22,TRUE,Recruiting,Phase 3,Interventional,Russia,Global phase III trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in adults 18 years of age and older,40000,http://www.chictr.org.cn/showproj.aspx?proj=65034,NA
ChiCTR2100044026,ChiCTR,2021-03-06,2020-03-15,TRUE,Not Recruiting,Phase 4,Interventional,Saudi Arabia,Effects of high-intensity aerobic training with high protein diet in childhood obesity following COVID-19 infection.,76,http://www.chictr.org.cn/showproj.aspx?proj=122577,NA
ChiCTR2100043907,ChiCTR,2021-03-05,2020-12-28,TRUE,Recruiting,Phase 4,Prevention,China,Comprehensive evaluations of dynamic changes in the immune system of healthy volunteers after vaccination with inactivated Novel Coronavirus Pneumonia (COVID-19) vaccine (Vero cells),16,http://www.chictr.org.cn/showproj.aspx?proj=122756,NA
ChiCTR2100043832,ChiCTR,2021-03-04,2021-03-05,FALSE,Not Recruiting,Not Applicable,Observational,China,A cross-sectional study on COVID-19 vaccine related complications and mental health among health care workers in the mainland of China,2000,http://www.chictr.org.cn/showproj.aspx?proj=122718,NA
ChiCTR2100042996,ChiCTR,2021-02-03,2021-02-18,FALSE,Not Recruiting,Not Applicable,Observational,China,Research on the classification and mechanism of behavior of COVID-19 and other public health emergencies induced mood disorder,400,http://www.chictr.org.cn/showproj.aspx?proj=121567,NA
ChiCTR2100042931,ChiCTR,2021-01-31,2020-05-21,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,"Virtual Assessment, Training and Evaluation of Clinical Laboratory Technologists Amidst Peak COVID-19 Pandemic â€“ An Observational Study",20,http://www.chictr.org.cn/showproj.aspx?proj=120184,NA
ChiCTR2100042862,ChiCTR,2021-01-30,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,China,The influence of the double superposition of inflammation on the clinical outcome of patients with schizophrenia comorbid with novel coronavirus pneumonia (COVID-19),375,http://www.chictr.org.cn/showproj.aspx?proj=121199,NA
ChiCTR2100042832,ChiCTR,2021-01-30,2021-01-20,TRUE,Recruiting,Not Applicable,Observational,China,Evaluation of specific-IgA level against novel coronavirus pneumonia (COVID-19) among convalescents and vaccinated participants by COVID-19 inactivated vaccine,785,http://www.chictr.org.cn/showproj.aspx?proj=121147,NA
ChiCTR2100042831,ChiCTR,2021-01-30,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,China,Research of the relationship between immune response and function status after vaccination of new coronavirus (COVID-2019) inactivated vaccine,150,http://www.chictr.org.cn/showproj.aspx?proj=121308,NA
ChiCTR2100042822,ChiCTR,2021-01-29,2021-01-29,FALSE,Recruiting,Not Applicable,Interventional,China,Qing-Jin Yi-Qi granule for patients in the rehabilitation phase of COVID-19: a randomized controlled trial,200,http://www.chictr.org.cn/showproj.aspx?proj=121247,NA
ChiCTR2100042821,ChiCTR,2021-01-29,2020-04-01,TRUE,Not Recruiting,Not Applicable,Diagnostic test,China,"Evaluation of CT CAD software for the diagnosis of pneumonia: a retrospective, multi-center trial",1199,http://www.chictr.org.cn/showproj.aspx?proj=66563,NA
ChiCTR2100042820,ChiCTR,2021-01-28,2021-01-29,FALSE,Recruiting,Not Applicable,Observational,China,A study on convalescence stage of COVID-19 patients,800,http://www.chictr.org.cn/showproj.aspx?proj=121258,NA
ChiCTR2100042819,ChiCTR,2021-01-28,2021-01-20,TRUE,Recruiting,Not Applicable,Observational,China,A national wide multicenter epidemiological study on respiratory pathogen infections other than COVID-19 in the winter and spring of 2020-2021,125,http://www.chictr.org.cn/showproj.aspx?proj=120720,NA
ChiCTR2000033186,ChiCTR,2020-05-23,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,China,A follow-up study about clinically diagnosed cases of novel coronavirus pneumonia (COVID-19),116,http://www.chictr.org.cn/showproj.aspx?proj=53927,NA
ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,TRUE,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),60,http://www.chictr.org.cn/showproj.aspx?proj=50306,NA
JPRN-JapicCTI-205270,JapicCTI,2020-04-23,2020-05-25,FALSE,Not Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,NA
JPRN-JapicCTI-205326,JapicCTI,2020-06-15,2020-01-07,TRUE,Recruiting,Phase 1,Interventional,Japan,Phase 1 study of FOY-305(FOY-305-02)(COVID-19),7,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205326,NA
JPRN-JapicCTI-205465,JapicCTI,2020-08-27,2020-12-17,FALSE,Recruiting,Phase 1,Interventional,Japan,Umbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress Syndrome,12,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465,NA
JPRN-jRCT1030200279,jRCT,2020-12-25,2020-12-25,FALSE,Recruiting,Not Applicable,Interventional,Japan,COVID-CP Banking,100,https://jrct.niph.go.jp/latest-detail/jRCT1030200279,NA
JPRN-jRCT1030210037,jRCT,2021-04-14,2021-12-04,FALSE,Recruiting,Not Applicable,Interventional,Japan,Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial,200,https://jrct.niph.go.jp/latest-detail/jRCT1030210037,NA
JPRN-jRCT1051200078,jRCT,2020-11-24,2020-11-30,FALSE,Recruiting,Phase 2,Interventional,Japan,Study on reduction of salivary virus by povidone iodine on COVID-19,440,https://jrct.niph.go.jp/latest-detail/jRCT1051200078,NA
JPRN-jRCT1051200148,jRCT,2021-03-05,2021-08-03,FALSE,Recruiting,Not Applicable,Observational,Japan,Vaccine effectiveness and reactogenicity of COVID-19 vaccine among residents and staffs at Osaka geriatric intermediate care facilities: prospective cohort study,300,https://jrct.niph.go.jp/latest-detail/jRCT1051200148,NA
JPRN-jRCT1052200041,jRCT,2020-07-31,2020-07-30,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Exploratory study of severity index for COVID-19 patients,40,https://jrct.niph.go.jp/latest-detail/jRCT1052200041,NA
JPRN-jRCT1052200163,jRCT,2021-03-31,2021-03-31,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Exploratory study of exacerbation detection using respiratory stability time in COVID-19 patients,65,https://jrct.niph.go.jp/latest-detail/jRCT1052200163,NA
JPRN-jRCT1061200057,jRCT,2021-02-19,2021-02-22,FALSE,Recruiting,Not Applicable,Observational,Japan,Survey on the SARS-CoV-2 serum antibody retention and health condition both before and after the SARS-CoV-2 vaccine introduction,4300,https://jrct.niph.go.jp/latest-detail/jRCT1061200057,NA
JPRN-jRCT2021200018,jRCT,2020-08-18,2020-07-10,TRUE,Not Recruiting,Phase 2,Interventional,Japan,An exploratory Phase II investigator-initiated clinical trial of the efficacy and safety of TM5614 in patients with novel coronavirus  pneumonia,30,https://jrct.niph.go.jp/latest-detail/jRCT2021200018,NA
JPRN-jRCT2031200035,jRCT,2020-05-20,2020-06-22,FALSE,Not Recruiting,Phase 3,Interventional,"Denmark, United Kingdom, United States, Mexico, Spain, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",35,https://jrct.niph.go.jp/latest-detail/jRCT2031200035,NA
JPRN-jRCT2031200092,jRCT,2020-08-21,2020-08-20,TRUE,Not Recruiting,Phase 3,Interventional,"United States, Mexico, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200092,NA
JPRN-jRCT2031200120,jRCT,2020-09-16,2020-08-10,TRUE,Recruiting,Phase 2,Interventional,Japan,double-blind study in COvid-19 patients with iveRmectin,240,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,NA
JPRN-jRCT2031200126,jRCT,2020-09-23,2020-10-09,FALSE,Not Recruiting,Phase 3,Interventional,"United Kingdom, United States, Spain, Japan, France","A Phase 3 Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome",270,https://jrct.niph.go.jp/latest-detail/jRCT2031200126,NA
JPRN-jRCT2031200180,jRCT,2020-11-04,2021-08-02,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,60,https://jrct.niph.go.jp/latest-detail/jRCT2031200180,NA
JPRN-jRCT2031200198,jRCT,2020-11-12,2020-09-11,TRUE,Recruiting,Phase 3,Interventional,Japan,FOY-305-01:FOY-305 Phase 3(COVID-19),110,https://jrct.niph.go.jp/latest-detail/jRCT2031200198,NA
JPRN-jRCT2031200252,jRCT,2020-12-18,2021-01-14,FALSE,Recruiting,Phase 3,Interventional,"United States, Mexico, Korea, Japan, Singapore","A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200252,NA
JPRN-jRCT2031200368,jRCT,2021-02-19,2021-03-31,FALSE,Recruiting,Phase 3,Interventional,"UK, Hungary, Poland Rep, United States, Russia, Italy, Mexico, Spain, Peru Rep, Czech Rep, Japan, Germany","A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Safety and Efficacy of AZD7442 for the Treatment of COVID-19 in Non-hospitalized Adults",20,https://jrct.niph.go.jp/latest-detail/jRCT2031200368,NA
JPRN-jRCT2031210010,jRCT,2021-04-05,2021-12-04,FALSE,Recruiting,Phase 1,Interventional,Japan,Single and Multiple Dose Study of MK-4482 in Healthy Japanese Adults,72,https://jrct.niph.go.jp/latest-detail/jRCT2031210010,NA
JPRN-jRCT2051200085,jRCT,2020-11-12,2020-11-19,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Phase I / II study of intracutaneous inoculation of COVID-19 DNA vaccine (AG0302-COVID19),20,https://jrct.niph.go.jp/latest-detail/jRCT2051200085,NA
JPRN-jRCT2051200088,jRCT,2020-11-19,2020-11-23,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),500,https://jrct.niph.go.jp/latest-detail/jRCT2051200088,NA
JPRN-jRCT2051200159,jRCT,2021-03-19,2021-08-03,FALSE,Not Recruiting,Phase 3,Interventional,Japan,"A Randomized, Double Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Aerosolized JH509  in Hospitalized Adult Patients with Mild to Moderate COVID 19",385,https://jrct.niph.go.jp/latest-detail/jRCT2051200159,NA
JPRN-jRCT2071200023,jRCT,2020-07-21,2020-07-22,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Japan,Evaluation of Nelfinavir for asymptomatic and mild COVID-19,120,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,NA
JPRN-jRCT2071200041,jRCT,2020-10-12,2020-11-25,FALSE,Recruiting,Phase 2,Interventional,Japan,Therapeutic development of adrenomedullin for severe pneumonia caused by COVID-19,40,https://jrct.niph.go.jp/latest-detail/jRCT2071200041,NA
JPRN-jRCT2071200045,jRCT,2020-10-20,2020-10-21,FALSE,Not Recruiting,Phase 1,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",160,https://jrct.niph.go.jp/latest-detail/jRCT2071200045,NA
JPRN-jRCT2071200078,jRCT,2021-01-07,2021-01-13,FALSE,Recruiting,Phase 2,Interventional,Japan,A randomized double-blind placebo controlled phase 2 clinical trial to assess anti-inflammatory effect of colchicine (DRC3633) in mild to moderately severe COVID-19 patients. - DRC-06C,100,https://jrct.niph.go.jp/latest-detail/jRCT2071200078,NA
JPRN-jRCT2071200109,jRCT,2021-03-08,2021-08-03,FALSE,Recruiting,Phase 1,Interventional,Japan,FOY-305-03:FOY-305 TQT study(COVID-19),39,https://jrct.niph.go.jp/latest-detail/jRCT2071200109,NA
JPRN-jRCT2071200110,jRCT,2021-03-10,2021-03-15,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Japan,"A Phase 1/2 study to assess the safety, immunogenicity and recommended dose of DS-5670a in Japanese healthy adults and elderly subjects",152,https://jrct.niph.go.jp/latest-detail/jRCT2071200110,NA
JPRN-jRCT2071200117,jRCT,2021-03-29,2021-03-31,FALSE,Recruiting,Phase 1,Interventional,Japan,A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS,22,https://jrct.niph.go.jp/latest-detail/jRCT2071200117,NA
JPRN-jRCTs021200020,jRCT,2020-08-25,2020-08-25,FALSE,Recruiting,Phase 3,Interventional,Japan,Study of the additional effect of Kampo medicine on common cold symptoms in COVID-19 patients,150,https://jrct.niph.go.jp/latest-detail/jRCTs021200020,NA
JPRN-jRCTs031190269,jRCT,2020-03-27,2020-03-04,TRUE,Not Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,NA
JPRN-jRCTs031200026,jRCT,2020-05-01,2020-11-06,FALSE,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,NA
JPRN-jRCTs031200124,jRCT,2020-09-17,2020-01-10,TRUE,Recruiting,Not Applicable,Interventional,Japan,COVIPLA-R,59,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,NA
JPRN-jRCTs031200150,jRCT,2020-10-14,2020-11-27,FALSE,Recruiting,Phase 3,Interventional,Japan,Prophylactic study for COVID-19 with Kampo medicines,6000,https://jrct.niph.go.jp/latest-detail/jRCTs031200150,NA
JPRN-jRCTs032200131,jRCT,2020-09-28,2020-08-10,TRUE,Recruiting,Phase 2,Interventional,Japan,PMX-DHP for COVID-19,30,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,NA
JPRN-jRCTs051200036,jRCT,2020-07-27,2020-07-29,FALSE,Recruiting,Phase 2,Interventional,Japan,Efficacy  of nintedanib on severe COVID-19 pneumonia.,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,NA
JPRN-jRCTs052200053,jRCT,2020-09-07,2020-11-26,FALSE,Recruiting,Phase 3,Interventional,Japan,Specified clinical trial for ECMO system for COVID-19 resipiratory failure,50,https://jrct.niph.go.jp/latest-detail/jRCTs052200053,NA
JPRN-jRCTs052200157,jRCT,2021-03-17,2021-03-17,FALSE,Recruiting,Not Applicable,Interventional,Japan,Exploratory research on Anti-SARS-CoV-2 testing,20,https://jrct.niph.go.jp/latest-detail/jRCTs052200157,NA
JPRN-jRCTs071200048,jRCT,2020-10-29,2021-04-02,FALSE,Recruiting,Phase 2,Interventional,Japan,Exploratory examination of Efficacy and safety of functional food included 5-aminolevulinic phosphoric acid/sodium ferrous citrate on COVID-19,50,https://jrct.niph.go.jp/latest-detail/jRCTs071200048,NA
JPRN-UMIN000039873,UMIN-CTR,2020-03-19,2020-03-19,FALSE,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,99999,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,NA
JPRN-UMIN000040162,UMIN-CTR,2020-04-15,2020-04-14,TRUE,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,NA
JPRN-UMIN000040211,UMIN-CTR,2020-04-21,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,"A Multicenter, Retrospective Study to Evaluate the Efficacy of Systemic Gluco-corticoid Against COVID-19",500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045861,NA
JPRN-UMIN000040250,UMIN-CTR,2020-04-30,2020-05-08,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Changes of D-dimer in preventive period for COVID-19 for patients with chronic heart failure,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045918,NA
JPRN-UMIN000040278,UMIN-CTR,2020-05-08,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Had COVID-19 Spread in Nagasaki Prefecture before the first confirmed case?,182,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045953,NA
JPRN-UMIN000040289,UMIN-CTR,2020-05-01,2020-05-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Simulation study of tracheal intubation through an aerosol-box assuming COVID-19,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045947,NA
JPRN-UMIN000040349,UMIN-CTR,2020-05-11,2020-05-10,TRUE,Recruiting,Not Applicable,Observational,Japan,Psychological and physical effects of self-isolation on Japanese school-aged children related to COVID19 epidemic,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046043,NA
JPRN-UMIN000040386,UMIN-CTR,2020-07-01,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,Japan,Evaluation of COVID-19 antigen test in COVID-19 suspected cases,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046087,NA
JPRN-UMIN000040405,UMIN-CTR,2020-05-18,2020-05-18,FALSE,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",International survey to investigate the implementation of ICU daily care for COVID-19,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046103,NA
JPRN-UMIN000040539,UMIN-CTR,2020-07-01,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Study for medical support using smart devise for IBD patients under the novel coronavirus prevalence.,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046274,NA
JPRN-UMIN000040587,UMIN-CTR,2020-06-01,2020-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,"The analysis of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy",500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046321,NA
JPRN-UMIN000040672,UMIN-CTR,2021-04-01,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Effects of activity restriction associated with COVID-19 on the physical and mental health of college athletes,160,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046408,NA
JPRN-UMIN000040679,UMIN-CTR,2020-06-09,2020-06-08,TRUE,Not Recruiting,Not Applicable,Observational,Japan,prospective cohort study of COVID-19 antibody for medical stuff in hospital,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046429,NA
JPRN-UMIN000040683,UMIN-CTR,2020-06-08,2020-06-08,FALSE,Recruiting,Not Applicable,Observational,Japan,"Longitudinal study on work style change, health and well-being due to pandemic of novel coronavirus infection (COVID-19)",2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046432,NA
JPRN-UMIN000040744,UMIN-CTR,2020-06-16,2020-06-22,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Clinical study to evaluate the efficiency of specific antibody against SARS-CoV-2 for the purpose of its social implementation,5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508,NA
JPRN-UMIN000040931,UMIN-CTR,2020-06-28,2020-07-10,FALSE,Not Recruiting,Not Applicable,Observational,Japan,The association between the neutralizing activity and the amount of antibody in early stages of SARS-CoV-2 infection: A multicenter observational study,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046736,NA
JPRN-UMIN000041021,UMIN-CTR,2020-07-07,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,Japan,The association between the neutralizing activity and the amount of antibody in the convalescence stage of SARS-CoV-2 infection: A multicenter observational study,140,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046800,NA
JPRN-UMIN000041168,UMIN-CTR,2020-08-01,2020-08-01,FALSE,Recruiting,Not Applicable,Observational,Japan,A study of the COVID-19 sequlae,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046991,NA
JPRN-UMIN000041191,UMIN-CTR,2020-07-27,2020-07-28,FALSE,Recruiting,Not Applicable,Observational,Japan,Questionnaire survey on anxiety and behavioral changes in Japanese patients with inflammatory bowel disease caused by the COVID-19 pandemic,4000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047033,NA
JPRN-UMIN000041226,UMIN-CTR,2020-07-27,2020-07-08,TRUE,Recruiting,Not Applicable,Observational,Japan,Study of clinical characteristics of acute stroke with COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045903,NA
JPRN-UMIN000041227,UMIN-CTR,2020-07-28,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Immune responses in the convalescence stage of COVID-19 patients,700,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047079,NA
JPRN-UMIN000041387,UMIN-CTR,2020-08-11,2020-08-17,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Japan COVID-19 Study of the psychosocial impacts of the postponement/cancellation of reproductive medicine,1100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047141,NA
JPRN-UMIN000041421,UMIN-CTR,2020-08-14,2020-08-14,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290,NA
JPRN-UMIN000041427,UMIN-CTR,2020-08-16,2020-07-16,TRUE,Not Recruiting,Not Applicable,Other,Asia(except Japan),Prognostic role of simple coagulation profiles in predicting in-hospital mortality of COVID-19 patients: a meta-analysis,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047297,NA
JPRN-UMIN000041428,UMIN-CTR,2020-08-16,2020-05-05,TRUE,Not Recruiting,Not Applicable,Other,Asia(except Japan),Elevated fibrinogen and fibrin degradation product were associated with poor outcome in COVID-19 patients,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046671,NA
JPRN-UMIN000041526,UMIN-CTR,2020-08-25,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,How does the COVID-19 quarantine affect physical activity levels?,400,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047400,NA
JPRN-UMIN000041579,UMIN-CTR,2020-08-28,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,"A multicenter, retrospective longitudinal observational study about Quarantine and social Isolation for COVID-19 and its impact on Kawasaki disease",5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047464,NA
JPRN-UMIN000041705,UMIN-CTR,2020-09-07,2020-09-07,FALSE,Not Recruiting,Not Applicable,Observational,Japan,A survey of the impact of COVID-19 on the prescription and other conditions of patients with gastrointestinal diseases,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047583,NA
JPRN-UMIN000041769,UMIN-CTR,2020-10-01,2020-10-23,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Antibody acquisition and maintenance in childlen with COVID-19: Prospective observational study,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047674,NA
JPRN-UMIN000041893,UMIN-CTR,2020-09-24,2020-09-24,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Assessment of the prediction models to alleviate burden of infectious disease in the emergency department-COVID-19(AMABIE-COVID-19),784,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046668,NA
JPRN-UMIN000041990,UMIN-CTR,2020-10-02,2020-09-29,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,Intervention to promote exercise behavior among older adults under the epidemic of COVID-19,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925,NA
JPRN-UMIN000042076,UMIN-CTR,2020-10-11,2020-10-11,FALSE,Not Recruiting,Not Applicable,Other,Asia(except Japan),Association of calcium channel blocker use with COVID-19 clinical outcome: a metaanalysis,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048016,NA
JPRN-UMIN000042214,UMIN-CTR,2020-10-22,2020-11-15,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Relationships between physical activity during hospitalization and physical capacity after discharge from hospital in patients with COVID-19: a prospective observational study,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048185,NA
JPRN-UMIN000042299,UMIN-CTR,2020-11-02,2020-11-02,FALSE,Recruiting,Not Applicable,Observational,Japan,Infrastructure research for understanding the actual situation and pathophysiology of long-term complications of Coronavirus disease 2019 (COVID-19),2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048241,NA
JPRN-UMIN000042384,UMIN-CTR,2020-11-16,2020-11-16,FALSE,Recruiting,Not Applicable,Interventional,Japan,Verification of stress relief by introducing online visits to the restrictions on visits of COVID-19,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379,NA
JPRN-UMIN000042424,UMIN-CTR,2020-11-11,2020-11-11,FALSE,Not Recruiting,Not Applicable,Other,Asia(except Japan),Prevalence of Right Ventricular Dysfunction-Pulmonary Hypertension and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048431,NA
JPRN-UMIN000042477,UMIN-CTR,2020-11-17,2020-11-17,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Prospective research for early detection of COVID-19 pneumonia using mobile CT vehicle at specialized accommodation facilities,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432,NA
JPRN-UMIN000042522,UMIN-CTR,2020-11-24,2020-11-24,FALSE,Recruiting,Not Applicable,Observational,Japan,"Japanese, multi-center, observational study for hospitalized patients with community-acquired, hospital-acquired, and ventilator-associated pneumonia",1500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048542,NA
JPRN-UMIN000043174,UMIN-CTR,2021-02-01,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,Japan,The relation between the state of emergency because of COVID-19 and disability in patients with chronic pain.,400,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049282,NA
JPRN-UMIN000043350,UMIN-CTR,2021-03-08,2021-03-15,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Clinical trial of laboratory testing for immune response induced by COVID-19 vaccine,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049495,NA
JPRN-UMIN000043368,UMIN-CTR,2021-04-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Response rate to SARS-CoV-2 (COVID-19) vaccine in dialysis patients.,110,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049503,NA
JPRN-UMIN000043369,UMIN-CTR,2021-02-18,2021-03-19,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,"Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia. Immune Modulation-2 DOMAIN",136,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049195,NA
JPRN-UMIN000043532,UMIN-CTR,2021-03-05,2021-03-05,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Impact of COVID-19 on working style and daily life of Japanese adult with AD/HD-like symptoms,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049691,NA
JPRN-UMIN000043534,UMIN-CTR,2021-03-05,2021-03-08,FALSE,Recruiting,Not Applicable,Observational,Japan,Preventive effectiveness and safety of vaccination against nosocomial outbreaks of COVID-19,1030,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049704,NA
JPRN-UMIN000043538,UMIN-CTR,2021-03-06,2021-03-08,FALSE,Not Recruiting,Not Applicable,Observational,Japan,"Survey on prevalence of SARS-CoV-2 infection in health care workers,  working at large-scale medical institutions",500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049716,NA
JPRN-UMIN000043546,UMIN-CTR,2021-03-08,2021-03-08,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Efficacy of a wearable biosensor for patients with COVID-19 or cardiopulmonary diseases,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049731,NA
JPRN-UMIN000043589,UMIN-CTR,2021-04-01,2021-04-15,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort study,60,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049773,NA
JPRN-UMIN000043671,UMIN-CTR,2021-04-01,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Observational study on efficacy and safety of vaccines against the novel coronavirus disease (COVID-19) in hematopoietic stem cell transplantation (HSCT) patient.,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049869,NA
JPRN-UMIN000043769,UMIN-CTR,2021-03-30,2021-04-05,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Research on vaccination against SARS-CoV-2 and cross-saliva antibody,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049963,NA
JPRN-UMIN000043788,UMIN-CTR,2021-03-30,2021-02-10,TRUE,Recruiting,Not Applicable,Interventional,Japan,A multicenter seroepidemiological study of SARS-CoV-2 antibody prevalence in oral surgery medical staff.,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049983,NA
JPRN-UMIN000043802,UMIN-CTR,2021-04-01,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Japan,"Exploratory Research on Potential Risk Factors Relevant to Severe Acute Respiratory Syndrome Coronavirus2 Infection (COVID-19) in Japanese Patients.
- A Multicenter Retrospective Observational Study",2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049989,NA
JPRN-UMIN000043820,UMIN-CTR,2021-04-02,2021-04-05,FALSE,Recruiting,Not Applicable,Interventional,Japan,The effectiveness of support to prevent COVID-19 infection and decline in cognitive and physical function for care givers of elderly people with dementia,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049505,NA
JPRN-UMIN000043821,UMIN-CTR,2021-04-03,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,Japan,A study of causative microorganisms and usefulness of various tests in patients with suspected COVID-19,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050013,NA
JPRN-UMIN000043851,UMIN-CTR,2021-04-10,2021-04-06,TRUE,Recruiting,Not Applicable,Observational,Japan,Short-term safety of the BNT162b2 mRNA COVID-19 vaccine,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050049,NA
JPRN-UMIN000043864,UMIN-CTR,2021-04-07,2021-01-08,TRUE,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa","International survey to investigate the implementation of daily ICU care for patients with and without COVID-19 infection.
A Point Prevalence Study -ISIIC 2 Study-",1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049072,NA
JPRN-UMIN000043867,UMIN-CTR,2021-04-08,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,A Study on the Concentration of Inhaled Oxygen when Oxygen is Administered with an Oxygen Mask while Using a Surgical Mask:A study on the appropriate oxygen administration method under Covid 19 epidemic conditions.,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050077,NA
JPRN-UMIN000043873,UMIN-CTR,2021-04-09,2016-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Effects of the COVID-19 Pandemic on the Gastrointestinal Cancer Stage at Diagnosis in Japan,5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050087,NA
NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,FALSE,Not Recruiting,Phase 3,Interventional,"Canada, United States",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,1312,https://clinicaltrials.gov/show/NCT04308668,NA
NCT04318314,ClinicalTrials.gov,2020-03-17,2020-03-18,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,731,https://clinicaltrials.gov/show/NCT04318314,NA
NCT04320862,ClinicalTrials.gov,2020-03-23,2020-04-03,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,9207,https://clinicaltrials.gov/show/NCT04320862,NA
NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,FALSE,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, Canada, Italy, Brazil, Israel, Spain, Japan, France, Germany",Sarilumab COVID-19,420,https://clinicaltrials.gov/show/NCT04327388,NA
NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,FALSE,Not Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,436,https://clinicaltrials.gov/show/NCT04331054,NA
NCT04333732,ClinicalTrials.gov,2020-03-31,2020-09-04,FALSE,Recruiting,Phase 3,Interventional,"Ghana, Australia, South Africa, Ireland, United Kingdom, Zambia, Netherlands, Canada, United States, Uganda, Zimbabwe",CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,30000,https://clinicaltrials.gov/show/NCT04333732,NA
NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,FALSE,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,214,https://clinicaltrials.gov/show/NCT04335097,NA
NCT04335188,ClinicalTrials.gov,2020-03-31,2020-04-06,FALSE,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),4000,https://clinicaltrials.gov/show/NCT04335188,NA
NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,5,https://clinicaltrials.gov/show/NCT04338074,NA
NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,TRUE,Not Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,180,https://clinicaltrials.gov/show/NCT04343989,NA
NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,FALSE,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,70,https://clinicaltrials.gov/show/NCT04344561,NA
NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,FALSE,Not Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,350,https://clinicaltrials.gov/show/NCT04345523,NA
NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,FALSE,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,48,https://clinicaltrials.gov/show/NCT04345653,NA
NCT04348240,ClinicalTrials.gov,2020-04-15,2020-04-16,FALSE,Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,90,https://clinicaltrials.gov/show/NCT04348240,NA
NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,FALSE,Not Recruiting,Phase 3,Interventional,"Argentina, United Kingdom, Canada, United States, Brazil, Mexico, India",Dapagliflozin in Respiratory Failure in Patients With COVID-19,1250,https://clinicaltrials.gov/show/NCT04350593,NA
NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,57,https://clinicaltrials.gov/show/NCT04354610,NA
NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,TRUE,Not Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,130,https://clinicaltrials.gov/show/NCT04354870,NA
NCT04357457,ClinicalTrials.gov,2020-04-20,2020-09-03,FALSE,Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,212,https://clinicaltrials.gov/show/NCT04357457,NA
NCT04359511,ClinicalTrials.gov,2020-04-20,2020-07-03,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,0,https://clinicaltrials.gov/show/NCT04359511,NA
NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,FALSE,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Plasma Therapy of COVID-19 in Severely Ill Patients,223,https://clinicaltrials.gov/show/NCT04359810,NA
NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,FALSE,Not Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,120,https://clinicaltrials.gov/show/NCT04361474,NA
NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,465,https://clinicaltrials.gov/show/NCT04362085,NA
NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,TRUE,Not Recruiting,Phase 2,Interventional,United States,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,384,https://clinicaltrials.gov/show/NCT04364737,NA
NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,TRUE,Not Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,10,https://clinicaltrials.gov/show/NCT04365699,NA
NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-18,FALSE,Not Recruiting,Phase 3,Interventional,Denmark,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,1293,https://clinicaltrials.gov/show/NCT04373291,NA
NCT04374656,ClinicalTrials.gov,2020-05-01,2020-05-18,FALSE,Recruiting,Not Applicable,Observational,United States,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04374656,NA
NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,46,https://clinicaltrials.gov/show/NCT04375397,NA
NCT04383002,ClinicalTrials.gov,2020-05-01,2020-09-02,FALSE,Not Recruiting,Phase 1,Interventional,Canada,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),21,https://clinicaltrials.gov/show/NCT04383002,NA
NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,340,https://clinicaltrials.gov/show/NCT04383613,NA
NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,TRUE,Not Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,200,https://clinicaltrials.gov/show/NCT04397523,NA
NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,TRUE,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,40,https://clinicaltrials.gov/show/NCT04399980,NA
NCT04403386,ClinicalTrials.gov,2020-05-23,2020-06-01,FALSE,Recruiting,Not Applicable,Observational,United States,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",200,https://clinicaltrials.gov/show/NCT04403386,NA
NCT04409834,ClinicalTrials.gov,2020-05-28,2020-08-05,FALSE,Recruiting,Phase 4,Interventional,United States,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,750,https://clinicaltrials.gov/show/NCT04409834,NA
NCT04419623,ClinicalTrials.gov,2020-06-03,2020-07-09,FALSE,Not Recruiting,Phase 1,Interventional,United States,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,7,https://clinicaltrials.gov/show/NCT04419623,NA
NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,142,https://clinicaltrials.gov/show/NCT04420247,NA
NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,60,https://clinicaltrials.gov/show/NCT04422353,NA
NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"Chile, Moldova, Republic of, United States, Mexico, Brazil, Romania","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",6900,https://clinicaltrials.gov/show/NCT04426695,NA
NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,TRUE,Not Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),72,https://clinicaltrials.gov/show/NCT04438980,NA
NCT04442230,ClinicalTrials.gov,2020-06-17,2020-10-10,FALSE,Recruiting,Phase 2,Interventional,United States,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),96,https://clinicaltrials.gov/show/NCT04442230,NA
NCT04444700,ClinicalTrials.gov,2020-06-22,2020-07-04,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,465,https://clinicaltrials.gov/show/NCT04444700,NA
NCT04463628,ClinicalTrials.gov,2020-06-29,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,France,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",746,https://clinicaltrials.gov/show/NCT04463628,NA
NCT04475120,ClinicalTrials.gov,2020-07-16,2020-04-15,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,92,https://clinicaltrials.gov/show/NCT04475120,NA
NCT04482621,ClinicalTrials.gov,2020-07-21,2020-09-14,FALSE,Recruiting,Phase 2,Interventional,United States,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,40,https://clinicaltrials.gov/show/NCT04482621,NA
NCT04482686,ClinicalTrials.gov,2020-07-21,2020-12-09,FALSE,Recruiting,Phase 2,Interventional,United States,Trial of Combination Therapy to Treat COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04482686,NA
NCT04487873,ClinicalTrials.gov,2020-07-23,2020-07-23,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,74,https://clinicaltrials.gov/show/NCT04487873,NA
NCT04487990,ClinicalTrials.gov,2020-07-23,2020-06-29,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,118,https://clinicaltrials.gov/show/NCT04487990,NA
NCT04494646,ClinicalTrials.gov,2020-07-29,2020-09-08,FALSE,Not Recruiting,Phase 2,Interventional,United States,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),40,https://clinicaltrials.gov/show/NCT04494646,NA
NCT04501445,ClinicalTrials.gov,2020-08-04,2020-09-14,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Psychological Symptoms and Families of COVID-19 Patients,90,https://clinicaltrials.gov/show/NCT04501445,NA
NCT04505592,ClinicalTrials.gov,2020-08-06,2020-09-25,FALSE,Recruiting,Phase 2,Interventional,United States,Tenecteplase in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04505592,NA
NCT04516759,ClinicalTrials.gov,2020-08-14,2020-08-12,TRUE,Not Recruiting,Phase 2,Interventional,"Czech Republic, United Kingdom, Romania",AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,156,https://clinicaltrials.gov/show/NCT04516759,NA
NCT04537806,ClinicalTrials.gov,2020-09-01,2020-12-18,FALSE,Recruiting,Phase 3,Interventional,United States,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,100,https://clinicaltrials.gov/show/NCT04537806,NA
NCT04555213,ClinicalTrials.gov,2020-09-16,2020-09-30,FALSE,Not Recruiting,Phase 1,Interventional,"Moldova, Republic of",A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,41,https://clinicaltrials.gov/show/NCT04555213,NA
NCT04564287,ClinicalTrials.gov,2020-09-24,2020-10-28,FALSE,Recruiting,Not Applicable,Observational,United States,An Observational Study of Neurologic Function After COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04564287,NA
NCT04579393,ClinicalTrials.gov,2020-10-06,2020-10-08,FALSE,Not Recruiting,Phase 2,Interventional,United States,Fostamatinib for Hospitalized Adults With COVID-19,62,https://clinicaltrials.gov/show/NCT04579393,NA
NCT04581187,ClinicalTrials.gov,2020-09-30,2020-12-02,FALSE,Recruiting,Not Applicable,Observational,Italy,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,400,https://clinicaltrials.gov/show/NCT04581187,NA
NCT04582331,ClinicalTrials.gov,2020-10-07,2020-09-10,TRUE,Not Recruiting,Not Applicable,Observational,"India, United States",Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,500,https://clinicaltrials.gov/show/NCT04582331,NA
NCT04584437,ClinicalTrials.gov,2020-10-09,2021-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Treatment of Covid-19 Infections Using Vitality Therapy or the Bible Cure,0,https://clinicaltrials.gov/show/NCT04584437,NA
NCT04603755,ClinicalTrials.gov,2020-10-24,2020-10-26,FALSE,Recruiting,Not Applicable,Observational,France,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,15,https://clinicaltrials.gov/show/NCT04603755,NA
NCT04604184,ClinicalTrials.gov,2020-10-26,2020-11-03,FALSE,Not Recruiting,Phase 2,Interventional,"Chile, Puerto Rico, United States, Mexico, Brazil, Spain",ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,129,https://clinicaltrials.gov/show/NCT04604184,NA
NCT04619706,ClinicalTrials.gov,2020-11-05,2020-12-14,FALSE,Recruiting,Phase 2,Interventional,United States,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,350,https://clinicaltrials.gov/show/NCT04619706,NA
NCT04631666,ClinicalTrials.gov,2020-11-05,2020-12-08,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion,57,https://clinicaltrials.gov/show/NCT04631666,NA
NCT04632368,ClinicalTrials.gov,2020-11-11,2020-11-20,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,80,https://clinicaltrials.gov/show/NCT04632368,NA
NCT04644198,ClinicalTrials.gov,2020-11-18,2021-06-01,FALSE,Recruiting,Phase 2,Interventional,Jamaica,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,30,https://clinicaltrials.gov/show/NCT04644198,NA
NCT04647669,ClinicalTrials.gov,2020-10-15,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Jamaica,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,100,https://clinicaltrials.gov/show/NCT04647669,NA
NCT04649736,ClinicalTrials.gov,2020-11-30,2020-10-26,TRUE,Recruiting,Not Applicable,Interventional,Peru,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,108,https://clinicaltrials.gov/show/NCT04649736,NA
NCT04674566,ClinicalTrials.gov,2020-12-17,2021-04-21,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Germany,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,45,https://clinicaltrials.gov/show/NCT04674566,NA
NCT04684836,ClinicalTrials.gov,2020-12-21,2021-03-15,FALSE,Recruiting,Not Applicable,Observational,United States,Comparative Effectiveness of Telemedicine in Primary Care,216000,https://clinicaltrials.gov/show/NCT04684836,NA
NCT04707703,ClinicalTrials.gov,2021-01-08,2021-03-16,FALSE,Recruiting,Phase 3,Interventional,United States,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,162,https://clinicaltrials.gov/show/NCT04707703,NA
NCT04724395,ClinicalTrials.gov,2020-11-30,2021-03-31,FALSE,Recruiting,Not Applicable,Observational,France,Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19,800,https://clinicaltrials.gov/show/NCT04724395,NA
NCT04729452,ClinicalTrials.gov,2021-01-25,2020-06-01,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Characterisation of the Immune Response to SARS-CoV-2,200,https://clinicaltrials.gov/show/NCT04729452,NA
NCT04742725,ClinicalTrials.gov,2021-02-03,2021-05-23,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,A Study to Evaluate the Efficacy and Safety of Prothioneâ„¢ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),200,https://clinicaltrials.gov/show/NCT04742725,NA
NCT04771013,ClinicalTrials.gov,2021-02-24,2021-02-10,TRUE,Not Recruiting,Phase 2,Interventional,Honduras,Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras,22,https://clinicaltrials.gov/show/NCT04771013,NA
NCT04779450,ClinicalTrials.gov,2021-03-01,2021-08-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,"Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors",30,https://clinicaltrials.gov/show/NCT04779450,NA
NCT04783025,ClinicalTrials.gov,2021-02-25,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes,188,https://clinicaltrials.gov/show/NCT04783025,NA
NCT04789603,ClinicalTrials.gov,2021-03-04,2021-05-10,FALSE,Recruiting,Not Applicable,Interventional,Spain,Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19,50,https://clinicaltrials.gov/show/NCT04789603,NA
NCT04799392,ClinicalTrials.gov,2021-03-14,2021-04-01,FALSE,Recruiting,Not Applicable,Interventional,United States,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,339,https://clinicaltrials.gov/show/NCT04799392,NA
NCT04801836,ClinicalTrials.gov,2021-03-12,2020-11-19,TRUE,Not Recruiting,Phase 2,Interventional,"Hungary, Russian Federation, Poland, Belgium",Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection,162,https://clinicaltrials.gov/show/NCT04801836,NA
NCT04805970,ClinicalTrials.gov,2021-03-17,2021-03-24,FALSE,Recruiting,Not Applicable,Observational,United States,REsearching Covid-19 Outcomes in Diabetes (RECODE),66,https://clinicaltrials.gov/show/NCT04805970,NA
NCT04818736,ClinicalTrials.gov,2021-03-24,2021-04-15,FALSE,Not Recruiting,Phase 4,Interventional,Canada,COVID-19 Vaccine For Indirect Protection,0,https://clinicaltrials.gov/show/NCT04818736,NA
NCT04824469,ClinicalTrials.gov,2021-03-25,2021-05-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life",128,https://clinicaltrials.gov/show/NCT04824469,NA
NCT04832061,ClinicalTrials.gov,2021-03-29,2021-04-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Respiratory Supports and COVID-19 Mortality,2300,https://clinicaltrials.gov/show/NCT04832061,NA
NCT04832919,ClinicalTrials.gov,2021-04-02,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures,810,https://clinicaltrials.gov/show/NCT04832919,NA
NCT04839965,ClinicalTrials.gov,2021-04-08,2021-05-01,FALSE,Recruiting,Phase 2,Interventional,United States,Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen,200,https://clinicaltrials.gov/show/NCT04839965,NA
NCT04842435,ClinicalTrials.gov,2021-04-12,2021-04-12,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Clinical Study in the Treatment of Patients With Moderate Course of COVID-19,376,https://clinicaltrials.gov/show/NCT04842435,NA
NCT04844515,ClinicalTrials.gov,2021-04-13,2021-04-09,TRUE,Recruiting,Not Applicable,Observational,France,The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19),15000,https://clinicaltrials.gov/show/NCT04844515,NA
NCT04844697,ClinicalTrials.gov,2021-04-12,2021-05-12,FALSE,Recruiting,Not Applicable,Observational,Italy,Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study,60,https://clinicaltrials.gov/show/NCT04844697,NA
NCT04847102,ClinicalTrials.gov,2021-04-13,2021-05-28,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above,28000,https://clinicaltrials.gov/show/NCT04847102,NA
NCT04863638,ClinicalTrials.gov,2021-04-27,2021-04-29,FALSE,Recruiting,Phase 4,Interventional,China,"A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated",4400,https://clinicaltrials.gov/show/NCT04863638,NA
NCT04864535,ClinicalTrials.gov,2021-04-22,2021-05-12,FALSE,Recruiting,Not Applicable,Observational,United States,"A Pilot Study for the Collection Of Vocalized, Individual Digital Cough Sound Recordings to Screen for COVID-19",1500,https://clinicaltrials.gov/show/NCT04864535,NA
NCT04870606,ClinicalTrials.gov,2021-04-27,2021-04-24,TRUE,Recruiting,Phase 3,Interventional,United States,Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness,668,https://clinicaltrials.gov/show/NCT04870606,NA
NCT04871646,ClinicalTrials.gov,2021-04-29,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,South Korea,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314,586,https://clinicaltrials.gov/show/NCT04871646,NA
NCT04872049,ClinicalTrials.gov,2021-04-29,2021-04-27,TRUE,Not Recruiting,Not Applicable,Observational,France,Assessment of SARS-CoV-2 Effect on Post-traumatic Stress of Patients Hospitalized in Intensive Care Unit,264,https://clinicaltrials.gov/show/NCT04872049,NA
NCT04872686,ClinicalTrials.gov,2021-04-26,2021-04-10,TRUE,Recruiting,Phase 3,Interventional,Bangladesh,Virucidal Effect of PVP-I on COVID-19 and as Well as Safety of Its Application on Nasopharynx & Oropharynx,798,https://clinicaltrials.gov/show/NCT04872686,NA
NCT04878913,ClinicalTrials.gov,2021-05-04,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Retrospective Evaluation of Lung Pathology in Subjects With COVID-19,35,https://clinicaltrials.gov/show/NCT04878913,NA
NCT04880109,ClinicalTrials.gov,2021-04-29,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.,80,https://clinicaltrials.gov/show/NCT04880109,NA
NCT04880642,ClinicalTrials.gov,2021-04-28,2021-07-01,FALSE,Not Recruiting,Phase 3,Interventional,United States,A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects,600,https://clinicaltrials.gov/show/NCT04880642,NA
NCT04880720,ClinicalTrials.gov,2021-05-10,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Deciphering a Specific Signature of the Immunosenescence Induced in COVID-19+ Patients Versus Rheumatoid Arthritis Patients,45,https://clinicaltrials.gov/show/NCT04880720,NA
NCT04881214,ClinicalTrials.gov,2020-07-03,2020-07-01,TRUE,Recruiting,Not Applicable,Interventional,Switzerland,"COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program",60,https://clinicaltrials.gov/show/NCT04881214,NA
NCT04881253,ClinicalTrials.gov,2020-11-02,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA),100,https://clinicaltrials.gov/show/NCT04881253,NA
NCT04881396,ClinicalTrials.gov,2021-05-04,2021-05-10,FALSE,Not Recruiting,Not Applicable,Observational,France,Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine,100,https://clinicaltrials.gov/show/NCT04881396,NA
NCT04882670,ClinicalTrials.gov,2021-02-16,2021-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic on Health Care and Rehabilitation Outcomes,360,https://clinicaltrials.gov/show/NCT04882670,NA
NCT04883164,ClinicalTrials.gov,2021-05-11,2021-04-27,TRUE,Recruiting,Not Applicable,Observational,United States,Immunity After COVID-19 Vaccination,300,https://clinicaltrials.gov/show/NCT04883164,NA
NCT04883177,ClinicalTrials.gov,2021-04-29,2021-05-11,FALSE,Recruiting,Not Applicable,Observational,China,Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101),1000,https://clinicaltrials.gov/show/NCT04883177,NA
NCT04883203,ClinicalTrials.gov,2021-04-20,2020-04-22,TRUE,Not Recruiting,Phase 3,Interventional,Tunisia,The Effect of Vitamin D Supplementation on COVID-19 Recovery,130,https://clinicaltrials.gov/show/NCT04883203,NA
NCT04883216,ClinicalTrials.gov,2021-05-09,2021-03-24,TRUE,Recruiting,Not Applicable,Observational,Turkey,Investigation of the Characteristics of Chronic Pain Developing After COVID-19,1120,https://clinicaltrials.gov/show/NCT04883216,NA
NCT04883528,ClinicalTrials.gov,2021-05-06,2021-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019,50,https://clinicaltrials.gov/show/NCT04883528,NA
NCT04883788,ClinicalTrials.gov,2021-05-11,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Pandemic on Hip and Knee Replacement,600,https://clinicaltrials.gov/show/NCT04883788,NA
NCT04883801,ClinicalTrials.gov,2021-05-09,2020-03-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19,202,https://clinicaltrials.gov/show/NCT04883801,NA
NCT04884061,ClinicalTrials.gov,2021-05-07,2021-05-07,FALSE,Recruiting,Not Applicable,Observational,France,Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection,30,https://clinicaltrials.gov/show/NCT04884061,NA
NCT04884529,ClinicalTrials.gov,2021-05-07,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial,60,https://clinicaltrials.gov/show/NCT04884529,NA
NCT04885452,ClinicalTrials.gov,2021-05-05,2021-05-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation'). A Prospectvie Cohort.,2000,https://clinicaltrials.gov/show/NCT04885452,NA
NCT04885504,ClinicalTrials.gov,2021-05-11,2021-02-08,TRUE,Recruiting,Not Applicable,Observational,United States,Post COVID-19 Biorepository,100,https://clinicaltrials.gov/show/NCT04885504,NA
NCT04885517,ClinicalTrials.gov,2021-05-11,2021-02-01,TRUE,Recruiting,Not Applicable,Interventional,Italy,"Breathing Effort in Covid-19 Pneumonia: Effects of Positive Pressure, Inspired Oxygen Fraction and Decubitus",72,https://clinicaltrials.gov/show/NCT04885517,NA
NCT04885543,ClinicalTrials.gov,2021-05-06,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,"Guinea, Burkina Faso",COVID-19 STAndard of Care in Sub-Saharan Africa,2495,https://clinicaltrials.gov/show/NCT04885543,NA
NCT04886362,ClinicalTrials.gov,2021-05-10,2021-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectina Colombia (IVERCOL),966,https://clinicaltrials.gov/show/NCT04886362,NA
NCT04886414,ClinicalTrials.gov,2021-05-10,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-based Care and Hand Hygiene Interventions in Honduras,1647,https://clinicaltrials.gov/show/NCT04886414,NA
NCT04887116,ClinicalTrials.gov,2021-05-13,2021-07-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers and Patients Consequent to the COVID-19 Pandemic,20,https://clinicaltrials.gov/show/NCT04887116,NA
NCT04887129,ClinicalTrials.gov,2021-05-13,2021-05-03,TRUE,Recruiting,Not Applicable,Interventional,United States,Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD),950,https://clinicaltrials.gov/show/NCT04887129,NA
NCT04887142,ClinicalTrials.gov,2021-05-08,2020-04-04,TRUE,Recruiting,Not Applicable,Observational,"Croatia, Albania, Montenegro, Serbia, Bosnia and Herzegovina",Predictors of Disease Severity in COVID-19 Patients,1019,https://clinicaltrials.gov/show/NCT04887142,NA
NCT04887207,ClinicalTrials.gov,2021-05-06,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Global Phase III Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells),40000,https://clinicaltrials.gov/show/NCT04887207,NA
NCT04887220,ClinicalTrials.gov,2021-01-21,2021-02-15,FALSE,Recruiting,Not Applicable,Observational,Spain,Persistent Pain and Its Impact on Quality of Life COVID-19 Patients That Required Critical Care,30,https://clinicaltrials.gov/show/NCT04887220,NA
NCT04887233,ClinicalTrials.gov,2021-05-13,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19),60,https://clinicaltrials.gov/show/NCT04887233,NA
NCT04887246,ClinicalTrials.gov,2021-05-10,2021-03-15,TRUE,Recruiting,Not Applicable,Observational,Colombia,Monitoring the Effectiveness and Safety of COVID-19 Vaccines at National University of Colombia,5000,https://clinicaltrials.gov/show/NCT04887246,NA
NCT04887272,ClinicalTrials.gov,2021-03-02,2021-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19",40,https://clinicaltrials.gov/show/NCT04887272,NA
NCT04887350,ClinicalTrials.gov,2021-05-05,2021-06-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,SSIPP vs. PST vs. WLC,45,https://clinicaltrials.gov/show/NCT04887350,NA
NCT04887623,ClinicalTrials.gov,2021-03-27,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Czech Republic,Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients,30,https://clinicaltrials.gov/show/NCT04887623,NA
NCT04888832,ClinicalTrials.gov,2021-05-07,2022-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of Work Requirements in SNAP in Virginia,12500,https://clinicaltrials.gov/show/NCT04888832,NA
NCT04889274,ClinicalTrials.gov,2021-05-06,2021-05-10,FALSE,Recruiting,Phase 1,Interventional,United Kingdom,Investigation of the Effects of Dietary Nitrate and Sex on COVID-19 Vaccine Induced Vascular Dysfunction in Healthy Men and Women (DiNOVasc-COVID-19),98,https://clinicaltrials.gov/show/NCT04889274,NA
NCT04889313,ClinicalTrials.gov,2021-05-14,2021-04-22,TRUE,Not Recruiting,Not Applicable,Observational,France,Post-COVID Neurologic Symptoms : a Somatic Spectrum Disorder ?,50,https://clinicaltrials.gov/show/NCT04889313,NA
NCT04889326,ClinicalTrials.gov,2021-04-27,2021-04-02,TRUE,Recruiting,Not Applicable,Observational,France,Collection of the Thrombo-VaxCov Cohort,100,https://clinicaltrials.gov/show/NCT04889326,NA
NCT04889365,ClinicalTrials.gov,2021-05-10,2021-05-11,FALSE,Not Recruiting,Not Applicable,Observational,Poland,COVID-19 Antigen Rapid Test Kit,200,https://clinicaltrials.gov/show/NCT04889365,NA
NCT04893057,ClinicalTrials.gov,2021-05-11,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,SARS-CoV2 Seroprevalence in Pregnant Women and Blood Donors,800,https://clinicaltrials.gov/show/NCT04893057,NA
NCT04893122,ClinicalTrials.gov,2021-05-14,2016-04-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Pandemic of Presentation to Emergency Department and Admissions,166459,https://clinicaltrials.gov/show/NCT04893122,NA
NCT04894682,ClinicalTrials.gov,2021-05-06,2021-05-04,TRUE,Recruiting,Not Applicable,Observational,China,Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor,300,https://clinicaltrials.gov/show/NCT04894682,NA
NCT04894721,ClinicalTrials.gov,2021-05-06,2021-03-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC),750,https://clinicaltrials.gov/show/NCT04894721,NA
NCT04895449,ClinicalTrials.gov,2021-04-24,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19",240,https://clinicaltrials.gov/show/NCT04895449,NA
ACTRN12621000567820,ANZCTR,2021-05-14,2021-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a parallel crossover randomised controlled trial,400,https://anzctr.org.au/ACTRN12621000567820.aspx,NA
ACTRN12621000607875,ANZCTR,2021-05-20,2021-01-06,TRUE,Not Recruiting,Phase 1,Interventional,Australia,INNA-051 intranasal safety and tolerability study,124,https://anzctr.org.au/ACTRN12621000607875.aspx,NA
ISRCTN13857593,ISRCTN,2021-05-12,2021-05-17,FALSE,Recruiting,Not Applicable,Interventional,Italy,Study on the performance and safety of Sentinox in COVID-19 patients,57,http://isrctn.com/ISRCTN13857593,NA
ISRCTN16275601,ISRCTN,2021-03-10,2021-05-24,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,RALPMH: Remote assessment of lung disease and impact on physical and mental health,60,http://isrctn.com/ISRCTN16275601,NA
ISRCTN85874083,ISRCTN,2021-02-09,2021-02-15,FALSE,Recruiting,Not Applicable,Interventional,India,Comparing cotrimoxazole to standard care for the treatment of severe coronavirus (COVID-19) infection in hospitalised patients,200,http://isrctn.com/ISRCTN85874083,NA
ISRCTN51124684,ISRCTN,2021-01-13,2021-01-05,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Can drinking beetroot juice prevent and reduce the severity of winter viral infections in residential and nursing homes?,416,http://isrctn.com/ISRCTN51124684,NA
ISRCTN10989132,ISRCTN,2020-11-06,2021-01-07,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,ASK: Improving access to kidney transplantation,60,http://isrctn.com/ISRCTN10989132,NA
ISRCTN79623250,ISRCTN,2020-11-04,2020-04-30,TRUE,Not Recruiting,Not Applicable,Interventional,United Kingdom,The digital Hope programme for people living with cancer during COVID-19,40,http://isrctn.com/ISRCTN79623250,NA
ISRCTN12154994,ISRCTN,2020-08-14,2020-06-29,TRUE,Not Recruiting,Not Applicable,Observational,Kenya,Investigating the impact of coronavirus infection (COVID-19) on cardiovascular injury using multiple imaging methods,50,http://isrctn.com/ISRCTN12154994,NA
ISRCTN16561225,ISRCTN,2020-07-27,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,"Argentina, Australia, Ireland, Portugal, South Africa, United Kingdom, Netherlands, Canada, Brazil, India, Switzerland",CovPall: Improving palliative care for people affected by the COVID-19 pandemic by sharing learning â€“ the national and international response,200,http://isrctn.com/ISRCTN16561225,NA
ISRCTN55201674,ISRCTN,2018-09-24,2018-06-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,B-cells in stroke-associated infection,130,http://isrctn.com/ISRCTN55201674,NA
ChiCTR2100043210,ChiCTR,2021-02-08,2021-02-20,FALSE,Recruiting,Not Applicable,Interventional,China,"Clinical study on the efficacy evaluation of traditional Chinese medicine auricular point acupressure in alleviating pain, fatigue and gastrointestinal adverse reactions after injection of novel coronavirus-19 vaccines",360,http://www.chictr.org.cn/showproj.aspx?proj=121519,NA
ChiCTR2100043183,ChiCTR,2021-02-08,2021-02-05,TRUE,Recruiting,Not Applicable,Observational,China,"A prospective cohort study on side effects, production of protective antibodies and effects of antiretroviral therapy in HIV infected patients after vaccination with SARS-CoV-2 vaccines",255,http://www.chictr.org.cn/showproj.aspx?proj=121620,NA
ChiCTR2100043178,ChiCTR,2021-02-07,2021-02-05,TRUE,Recruiting,Not Applicable,Observational,China,A cross-sectional study on the cognition and willingness to inoculate novel coronavirus pneumonia (COVID-19) vaccines in HIV infected patients and related clinicians,1500,http://www.chictr.org.cn/showproj.aspx?proj=121619,NA
ChiCTR2100043108,ChiCTR,2021-02-05,2020-07-01,TRUE,Recruiting,Phase 4,Interventional,China,"A randomized, double-blind, placebo-controlled clinical trial of Shugan Jieyu Capsule on improving sleep disturbance in New Coronavirus pneumonia during convalescence",200,http://www.chictr.org.cn/showproj.aspx?proj=66027,NA
ChiCTR2100043045,ChiCTR,2021-02-04,2021-01-29,TRUE,Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qing Jin Yi Qi granule in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia(COVID-19),300,http://www.chictr.org.cn/showproj.aspx?proj=121511,NA
ChiCTR2000038160,ChiCTR,2020-09-11,2020-09-11,FALSE,Recruiting,Not Applicable,Observational,China,The efficacy and safety of ambroxol hydrochloride in the treatment of novel coronavirus pneumonia (COVID-19): a retrospective medical based study,1200,http://www.chictr.org.cn/showproj.aspx?proj=61045,NA
CTRI/2021/03/032202,CTRI,2021-03-22,2021-03-22,FALSE,Not Recruiting,Not Applicable,Observational,India,Quality of life and mental health of people who have recovered after COVID 19 infection: A survey,384,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53825,NA
CTRI/2021/03/032199,CTRI,2021-03-22,2021-03-31,FALSE,Not Recruiting,Phase 3,Interventional,India,Pirfenidone for COVID-19 related lung fibrosis,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49593,NA
CTRI/2021/03/032226,CTRI,2021-03-23,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Body Mass Index relation with  COVID 19 patients,433,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54283,NA
CTRI/2021/03/032225,CTRI,2021-03-23,2021-03-30,FALSE,Not Recruiting,Phase 3,Interventional,India,Homoeopathic treatment of respiratory sequelae of post- covid cases: an open label prospective study,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50734,NA
CTRI/2021/03/032204,CTRI,2021-03-23,2021-03-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Association of chest x ray findings with clinical severity of covid 19 patients admittedto hospital,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53623,NA
CTRI/2021/03/032223,CTRI,2021-03-23,2021-03-31,FALSE,Not Recruiting,Not Applicable,Observational,India,SOCIAL AND PYSCHOLOGICAL CHANGES IN POSTPARTUM WOMEN DURING COVID-19 PANDEMIC,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52880,NA
CTRI/2021/03/032224,CTRI,2021-03-23,2021-03-28,FALSE,Not Recruiting,Not Applicable,Observational,India,Televisits with in- person visits during pregnancy during COVID-19 pandemic and its revival phase - how will that affect your pregnancy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50863,NA
CTRI/2021/03/032227,CTRI,2021-03-23,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,India,KAP study on COVID 19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54263,NA
CTRI/2021/03/032279,CTRI,2021-03-24,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 pandemic on Ayurveda students,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54146,NA
CTRI/2021/03/032276,CTRI,2021-03-24,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Comorbidities in death due to COVID 19 infection,125,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53439,NA
CTRI/2021/03/032293,CTRI,2021-03-25,2021-04-20,FALSE,Not Recruiting,Phase 3,Interventional,India,Associated lung condition in viral infection,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45649,NA
CTRI/2021/03/032292,CTRI,2021-03-25,2021-03-26,FALSE,Not Recruiting,Not Applicable,Observational,India,Spectrum  of CT findings  in chest in COVID 19 infection and their progression.,264,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51793,NA
CTRI/2021/03/032312,CTRI,2021-03-25,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,COVID 19 in the critically ill,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54355,NA
CTRI/2021/03/032357,CTRI,2021-03-26,2021-02-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Surface sampling for SARS-CoV-2 around hospital patients,355,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54371,NA
CTRI/2021/03/032356,CTRI,2021-03-26,2021-04-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Follow up of COVID19 patients after discharge from ICU.,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54399,NA
CTRI/2021/03/032361,CTRI,2021-03-26,2021-05-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Health careÃ¢??associated infection in  intensive care unit in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54426,NA
CTRI/2021/03/032325,CTRI,2021-03-26,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Digestive symptoms in patients with severe COVID-19 -study of frequency and effect on illness.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53663,NA
CTRI/2021/03/032348,CTRI,2021-03-26,2021-03-29,FALSE,Not Recruiting,Not Applicable,Observational,India,"Assessment of Knowledge, Attitude and Practice towards COVID-19",924,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54210,NA
CTRI/2021/03/032322,CTRI,2021-03-26,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Kidney involvement in COVID 19 infection,2600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51948,NA
CTRI/2021/03/032410,CTRI,2021-03-30,2021-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Effect of Ã¢??Kriya YogaÃ¢?? on brain activity and perceived stress in health care providers, during COVID-19 Pandemic",100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54078,NA
CTRI/2021/03/032369,CTRI,2021-03-30,2021-01-04,TRUE,Not Recruiting,Phase 2,Interventional,India,Tele-Yoga programme for work-from-home employees due to Covid-19 pandemic,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52318,NA
CTRI/2021/03/032368,CTRI,2021-03-30,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,India,Comparison of baseline SOFA score and CURB 65 score in predicting patient severity and outcome in COVID-19 patients of ICU.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52589,NA
CTRI/2021/03/032385,CTRI,2021-03-30,2021-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Use of three different drugs for reduction in severity of COVID-19 disease using Arterial Stiffness as a clinical marker
",160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54420,NA
CTRI/2021/03/032367,CTRI,2021-03-30,2021-03-30,FALSE,Not Recruiting,Not Applicable,Observational,India,THE OUTCOME OF HEMODIALYSIS IN COVID PATIENTS WITH CKD-RETROSPECTIVE COHORT STUDY,66,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50375,NA
CTRI/2021/03/032453,CTRI,2021-03-31,2021-04-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Severity of covid-19 disease in diabetes mellitus patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54590,NA
CTRI/2021/03/032444,CTRI,2021-03-31,2021-03-04,TRUE,Not Recruiting,Not Applicable,Interventional,India,A clinical trial of Yoga On Immunity In Doctors During COVID 19 Pandemic- A Pilot Study,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54405,NA
CTRI/2021/03/032471,CTRI,2021-03-31,2021-12-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Data Analysis of THINQURE 20 in COVID 19 Patients,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54671,NA
CTRI/2021/03/032451,CTRI,2021-03-31,2021-12-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Diagnostic performance of respiratory specimens in critically ill intubated COVID19 patients.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44442,NA
CTRI/2021/04/032473,CTRI,2021-04-01,2021-05-04,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to know about the clinical symptoms with which children with SARS CoVID2 infection present to hospital,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53763,NA
CTRI/2021/04/032501,CTRI,2021-04-01,2021-04-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,Comparison of effect of High Flow Nasal Cannula with Continuous Positive Airway Pressure in reducing incidence of invasive mechanical ventilation in severe COVID 19 patients.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54364,NA
CTRI/2021/04/032541,CTRI,2021-04-05,2024-10-04,FALSE,Recruiting,Phase 2,Interventional,India,Clinical trial of Madhav Rasayan in subjects of COVID 19.,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54622,NA
CTRI/2021/04/032531,CTRI,2021-04-05,2021-12-04,FALSE,Recruiting,Phase 2,Interventional,India,Clinical trial to Compare effects and safety of Etanercept in Patients with Moderate COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53930,NA
CTRI/2021/04/032535,CTRI,2021-04-05,2021-07-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Managing Health workforce during a pandemic,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54519,NA
CTRI/2021/04/032572,CTRI,2021-04-06,2021-04-13,FALSE,Not Recruiting,Not Applicable,Observational,India,Can vaccination produce protective antibodies in people who fail to develop protective antibodies after recovery from COVID-19 infection,35,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54034,NA
CTRI/2021/04/032555,CTRI,2021-04-06,2021-07-04,FALSE,Not Recruiting,Phase 2,Interventional,India,"A Clinical Trial to Assess the Efficacy, Safety and tolerability of Colchicine for Covid-19 Disease Treatment in Indian Patients.",84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54560,NA
CTRI/2021/04/032619,CTRI,2021-04-07,2021-12-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Comparison of the serum ferritin level with diabetic and non-diabetic Covid-19 patients.,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50992,NA
CTRI/2021/04/032613,CTRI,2021-04-07,2021-12-04,FALSE,Not Recruiting,Not Applicable,Observational,India,A study on Immunity boosters for COVID-19,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54677,NA
CTRI/2021/04/032627,CTRI,2021-04-07,2021-04-23,FALSE,No Status Given,Not Applicable,Observational,India,what happens to cardiac patients after covid pneumonia,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54680,NA
CTRI/2021/04/032615,CTRI,2021-04-07,2021-12-04,FALSE,Not Recruiting,Not Applicable,Observational,India,Survey to Assess Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating Women,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54741,NA
CTRI/2021/04/032593,CTRI,2021-04-07,2021-04-15,FALSE,Recruiting,Not Applicable,Interventional,India,Vitamin D and Zinc for COVID-19 patients,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54510,NA
CTRI/2021/04/032670,CTRI,2021-04-08,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 Related Lockdown and impact on Persons with Disabilities and their Caregivers.,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54909,NA
CTRI/2021/04/032647,CTRI,2021-04-08,2021-12-04,FALSE,Not Recruiting,Phase 2,Interventional,India,To see the effect of Unani formulation as an add-on therapy along with Allopathic treatment in the Covid-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53666,NA
CTRI/2021/04/032688,CTRI,2021-04-08,2021-04-19,FALSE,Recruiting,Phase 1/Phase 2,Interventional,India,Safety and immunogenicity study of mRNA based vaccine (HGCO19) against COVID-19 in healthy adult participants.,620,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54697,NA
CTRI/2021/04/032648,CTRI,2021-04-08,2021-10-05,FALSE,Recruiting,Phase 3,Interventional,India,"study to access effectiveness of new drug therapy (aspirin,atorvastatin and nicorandil) in covid-19",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51131,NA
CTRI/2021/04/032707,CTRI,2021-04-09,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"Job Insecurity and Coping Strategies during the COVID-19 Pandemic in Mumbai, India",134,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52020,NA
CTRI/2021/04/032705,CTRI,2021-04-09,2021-04-18,FALSE,Not Recruiting,Not Applicable,Observational,India,To understand the teaching faculties perspectives and attitudes towards their listening health and their engagement in behaviours of noise reduction.,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54965,NA
CTRI/2021/04/032729,CTRI,2021-04-12,2021-04-16,FALSE,Not Recruiting,Not Applicable,Observational,India,Immunity after vaccination in people who have suffered from COVID-infection and people who have never been infected with corona,64,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54807,NA
CTRI/2021/04/032747,CTRI,2021-04-12,2021-04-14,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID 19 and Plastic surgery,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54580,NA
CTRI/2021/04/032755,CTRI,2021-04-12,2021-04-18,FALSE,Not Recruiting,Phase 4,Interventional,India,Ayurveda medicines role in Treatment of COVID-19,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54896,NA
CTRI/2021/04/032757,CTRI,2021-04-12,2021-04-18,FALSE,Not Recruiting,Not Applicable,Observational,India,An online survey to study the Perspectives and attitude of college students towards their listening health in Covid-19 pandemic situation,1300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54915,NA
CTRI/2021/04/032743,CTRI,2021-04-12,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Immunity status of staff of AIIA against Covid-19,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55001,NA
CTRI/2021/04/032766,CTRI,2021-04-13,2021-04-15,FALSE,Not Recruiting,Not Applicable,Interventional,India,To Compare and Evaluate the Effect of Corona affected Patients Undergoing Current Treatment Along with Food Supplements,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54786,NA
CTRI/2021/04/032804,CTRI,2021-04-13,2021-04-18,FALSE,Not Recruiting,Phase 3,Interventional,India,Effect of AEV01 (Kutki) for Mild COVID19 Elderly patients,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54539,NA
CTRI/2021/04/032767,CTRI,2021-04-13,2021-04-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Safety measures taken to reduce the risk of COVID 19 infection among healthcare workers in a quality tertiary care hospital,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53787,NA
CTRI/2021/04/032791,CTRI,2021-04-13,2021-04-06,TRUE,Not Recruiting,Phase 3,Interventional,"Argentina, Portugal, United Kingdom, Colombia, Belgium, Netherlands, Serbia , United States, Italy, Brazil, Israel, Mexico, Spain, France, India, Germany, Romania",Study to Assess Efficacy and Safety of Inhaled Interferon-Beta Therapy for COVID-19,610,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53300,NA
CTRI/2021/04/032768,CTRI,2021-04-13,2021-01-05,TRUE,Not Recruiting,Not Applicable,Observational,India,"to find out whether the use of
 untubated oxygen therapy versus intubated mechanical ventilation(MV) post ICU discharge in COVID patients contributed to any changes in respiratory parameters",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54913,NA
CTRI/2021/04/032795,CTRI,2021-04-13,2021-04-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Use of high flow nasal cannula in Covid 19 patients with respiratory failure,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53163,NA
CTRI/2021/04/032793,CTRI,2021-04-13,2021-04-19,FALSE,Not Recruiting,Not Applicable,Observational,India,Exploring the role of blood clotting pathway in patients with severe COVID-19 infection.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54760,NA
CTRI/2021/04/032788,CTRI,2021-04-13,2021-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of Telerehabilitation based Physiotherapeutic exercises on Physical Function and Quality of life. in patients with COVID 19.,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55016,NA
CTRI/2021/04/032845,CTRI,2021-04-15,2021-08-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,Yoga interventions for the management of COVID 19 in asymptomatic patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52521,NA
CTRI/2021/04/032816,CTRI,2021-04-15,2021-04-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Fetomaternal Outcome In COVID-19 Positive Pregnant Women - A Cohort Study,78,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53584,NA
CTRI/2021/04/032823,CTRI,2021-04-15,2021-04-17,FALSE,Not Recruiting,Not Applicable,Observational,India,Adverse events following COVID-19 vaccination,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54865,NA
CTRI/2021/04/032825,CTRI,2021-04-15,2021-01-05,TRUE,Not Recruiting,Not Applicable,Observational,India,"Link between the levels of antioxidants like Glutathione peroxidase, Superoxide Dismutase and Catalase with that of the levels of related micronutrients like Selenium, Zinc, Copper and Iron in the outcome of patients with COVID19",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55151,NA
CTRI/2021/04/032865,CTRI,2021-04-16,2021-04-21,FALSE,Not Recruiting,Not Applicable,Observational,India,COVID-19 and blood cancer registry,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54950,NA
CTRI/2021/04/032876,CTRI,2021-04-16,2021-04-25,FALSE,Not Recruiting,Not Applicable,Observational,India,The influence of self-compassion ability (to be compassionate towards oneself) and resilience ability (the ability to bounce back adverse life events) on perceived stress and coronaphobia (fear of getting affected by corona virus)among nurses during the Covid-19 pandemic in India,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55211,NA
CTRI/2021/04/032864,CTRI,2021-04-16,2021-04-19,FALSE,Recruiting,Not Applicable,Observational,India,Impact of COVID-19 on Heart Failure Hospitalization and Outcome in India Ã¢?? A Cardiological Society of India Study,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54968,NA
CTRI/2021/04/032904,CTRI,2021-04-19,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,India,"To see if Remdesivir, an antiviral drug helped in reducing the hospital stay and helped patients with COVID 19infection recover faster?",150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54297,NA
CTRI/2021/04/032943,CTRI,2021-04-19,2021-02-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Study of physiological parameters in COVID-19 Disease,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54906,NA
CTRI/2021/04/032952,CTRI,2021-04-20,2021-04-25,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Role of Kabasura Kudineer in managing Covid patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55118,NA
CTRI/2021/04/032976,CTRI,2021-04-20,2021-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,India,"HIV Selftesting Implementation Study

",118440,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50046,NA
CTRI/2021/04/032964,CTRI,2021-04-20,2021-03-05,TRUE,Not Recruiting,Not Applicable,Observational,India,"The impact of COVID-19 pandemic on cancer children  
",500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54185,NA
CTRI/2021/04/032965,CTRI,2021-04-20,2021-04-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Prevalence of asymptomatic COVID positivity in the pre-operative patient,2200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55271,NA
CTRI/2021/04/033000,CTRI,2021-04-22,2021-04-30,FALSE,Not Recruiting,Not Applicable,Observational,India,Correlation between RT-PCR Cycle Time(Ct values) and quantitative estimate of antibodies formed after COVID-19 infection in COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55380,NA
CTRI/2021/04/033004,CTRI,2021-04-22,2021-04-26,FALSE,Not Recruiting,Not Applicable,Observational,India,survey on regional anesthesia practice among anaesthesiologists,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55269,NA
CTRI/2021/04/032989,CTRI,2021-04-22,2021-04-27,FALSE,Recruiting,Not Applicable,Interventional,India,"A study to assess the safety and efficacy of ""pHoxvedic"", an ayurvedic nasal spray in prevention COVID-19 infection in healthy high-risk healthcare professionals
",648,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55273,NA
CTRI/2021/04/033047,CTRI,2021-04-23,2021-03-05,TRUE,Not Recruiting,Not Applicable,Observational,India,Impact of markers like D-Dimer and Coagulation parameters in predicting outcome in COVID-19 patients,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53102,NA
CTRI/2021/04/033038,CTRI,2021-04-23,2021-04-26,FALSE,Not Recruiting,Not Applicable,Observational,India,"General publicÃ¢??s perception of CoVid-19:Anxiety levels and
preventive measures",384,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52346,NA
CTRI/2021/04/033068,CTRI,2021-04-23,2021-01-05,TRUE,Recruiting,Not Applicable,Observational,India,Observational study to see how long the SARS CoV-2 virus remains alive in the nose and throat of cancer patients on chemotherapy,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55435,NA
CTRI/2021/04/033058,CTRI,2021-04-23,2021-01-05,TRUE,Recruiting,Not Applicable,Interventional,India,Effect of early mobility in patients with severe COVID-19 admitted in ICU,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46761,NA
CTRI/2021/04/033073,CTRI,2021-04-23,2021-04-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for the Treatment of Fever due to COVID19 and addressing the associated Respiratory distress.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55218,NA
CTRI/2021/04/033078,CTRI,2021-04-24,2021-04-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Does covid-19 infection lead to hearing loss?,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53377,NA
CTRI/2021/04/033108,CTRI,2021-04-26,2021-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Investigation about the problem in seeing area due to wearing of face mask during COVID-19,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54531,NA
CTRI/2021/04/033118,CTRI,2021-04-26,2021-04-30,FALSE,Recruiting,Phase 3,Interventional,India,A clinical trial of Intravenous Aviptadil along with standard treatment in severe COVID-19 Patients with respiratory failure.,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=53211,NA
CTRI/2021/04/033175,CTRI,2021-04-27,2021-04-30,FALSE,Recruiting,Phase 3,Interventional,India,"PROVE Trial - Positive pRessure therapy in COVid-19 infEction 
",1800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44604,NA
CTRI/2021/04/033158,CTRI,2021-04-27,2021-05-17,FALSE,Not Recruiting,Phase 2,Interventional,India,Low dose X-ray therapy for COVID-19,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55418,NA
CTRI/2021/04/033143,CTRI,2021-04-27,2021-03-05,TRUE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on Covid 19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55493,NA
CTRI/2021/04/033142,CTRI,2021-04-27,2021-03-05,TRUE,Not Recruiting,Not Applicable,Interventional,India,"To see how Methylene blue drug which is used to increase O2 saturation levels, is helpful in treating Covid 19 patients.",10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55513,NA
CTRI/2021/04/033188,CTRI,2021-04-28,2021-05-05,FALSE,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on Covid 19 patients,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55568,NA
CTRI/2021/04/033201,CTRI,2021-04-28,2021-05-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,Gayathri mantra chanting for the Stress and Quality Of Life in  COVID 19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=52520,NA
CTRI/2021/04/033191,CTRI,2021-04-28,2021-03-05,TRUE,Not Recruiting,Not Applicable,Observational,India,Study of COVID 19 in adults belonging to vulnerable age group,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51618,NA
CTRI/2021/04/033193,CTRI,2021-04-28,2021-10-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Histopathological  changes in placenta in COVID 19 mothers.,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55279,NA
CTRI/2021/04/033257,CTRI,2021-04-29,2021-05-14,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of yoga on immunity in COVID positive patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55549,NA
CTRI/2021/04/033263,CTRI,2021-04-30,2021-06-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,A comparison of high dose steroid and tocilizumab in COVID ARDS,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55585,NA
CTRI/2021/04/033264,CTRI,2021-04-30,2021-05-28,FALSE,Not Recruiting,Not Applicable,Interventional,India,Effect of OM chanting on             management Of   Stress and Quality Of Life in COVID 19 Patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=51322,NA
CTRI/2021/04/033260,CTRI,2021-04-30,2021-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,India,Pranayama and meditation to decrease COVID-19 related anxiety,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54998,NA
CTRI/2021/05/033327,CTRI,2021-05-03,2021-05-27,FALSE,Not Recruiting,Not Applicable,Observational,India,A study to predict which parameters of patients with COVID19 admitted in ICU determine the prognosis,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47913,NA
CTRI/2021/05/033301,CTRI,2021-05-03,2021-07-05,FALSE,Not Recruiting,Not Applicable,Observational,India,Study to evaluate Ã¢??AyurCoro3 ( Ayurvedic Preparation )Ã¢?? in covid-19 treatment.,184,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55614,NA
CTRI/2021/05/033303,CTRI,2021-05-03,2021-05-05,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the impact of guided meditation on  anxiety, coping strategy and sleep quality among COVID-19 patients admitted in AIIMS, New Delhi.",60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48255,NA
CTRI/2021/05/033339,CTRI,2021-05-04,2021-09-05,FALSE,Not Recruiting,Phase 3,Interventional,India,To evaluate the efficacy of BIOWIN/BIOWN in asymptomatic mild Covid-19 patients.,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55649,NA
CTRI/2021/05/033373,CTRI,2021-05-04,2021-10-05,FALSE,Not Recruiting,Not Applicable,Observational,India,"Study of correlation between the clinical, immunological and radiological features in mild and moderate COVID-19 patients",50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55705,NA
CTRI/2021/05/033338,CTRI,2021-05-04,2021-05-24,FALSE,Not Recruiting,Not Applicable,Observational,India,A new device to detect COVID-19 in 2 minutes,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54722,NA
CTRI/2021/05/033374,CTRI,2021-05-04,2021-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,Yoga based stress reduction program for health care professionals,188,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55771,NA
CTRI/2021/05/033402,CTRI,2021-05-05,2021-05-16,FALSE,Not Recruiting,Not Applicable,Interventional,India,Surviving Covid 19 and Beyond,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55460,NA
CTRI/2021/05/033409,CTRI,2021-05-06,2021-07-05,FALSE,Not Recruiting,Not Applicable,Observational,India,A CLINICAL STUDY ON OUTCOME OFTRACHEOSTOMIES IN COVID 19 PATIENTS,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54271,NA
CTRI/2021/05/033446,CTRI,2021-05-07,2021-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Study to estimate the risk factors associated with deaths due to COVID-19 infection,450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55837,NA
CTRI/2021/05/033472,CTRI,2021-05-07,2021-05-17,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical trial of CIM-Meg19 to combat the severity of disorders in COVID-19 and post COVID-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55846,NA
CTRI/2021/05/033471,CTRI,2021-05-07,2021-05-31,FALSE,Not Recruiting,Not Applicable,Observational,India,lung changes in patient recovered with covid and coming for a surgery,36,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54655,NA
CTRI/2021/05/033518,CTRI,2021-05-10,2021-05-20,FALSE,Not Recruiting,Not Applicable,Observational,India,Lung function in post covid,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54053,NA
CTRI/2021/05/033523,CTRI,2021-05-10,2021-05-17,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,A comparative study of High dose corticosteroids pulse versus standard of care in severe COVID19 pneumonia,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55876,NA
CTRI/2021/05/033499,CTRI,2021-05-10,2021-05-14,FALSE,Recruiting,Not Applicable,Interventional,India,Efficacy of Karpoor and Ajwain inhalation in COVID-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55679,NA
CTRI/2021/05/033526,CTRI,2021-05-10,2021-05-21,FALSE,Not Recruiting,Not Applicable,Observational,India,Fatigue and Quality of life in post COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55487,NA
CTRI/2021/05/033545,CTRI,2021-05-11,2021-05-24,FALSE,Not Recruiting,Not Applicable,Observational,India,Depression in Pregnant women due to COVID-19 pandemic in India,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55823,NA
CTRI/2021/05/033537,CTRI,2021-05-11,2021-05-24,FALSE,Not Recruiting,Not Applicable,Interventional,India,Will treatment with a drug named colchicine be useful in treating Corona virus infection in kidney failure patients who are on regular dialysis?,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55323,NA
CTRI/2021/05/033543,CTRI,2021-05-11,2021-05-17,FALSE,Not Recruiting,Phase 2,Interventional,India,Clinical trial of CIM-Meg19 in COVID-19 patients,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55879,NA
CTRI/2021/05/033544,CTRI,2021-05-11,2021-05-20,FALSE,Not Recruiting,Phase 2,Interventional,India,Comparison of efficacy of Indomethacin vs Paracetamol along with standard care of treatment in mild and moderate Covid-19 patients,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55941,NA
CTRI/2021/05/033546,CTRI,2021-05-11,2021-05-31,FALSE,Not Recruiting,Phase 2,Interventional,"India, United Kingdom, Mexico",COVID-19 viral disease,1407,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48547,NA
CTRI/2021/05/033588,CTRI,2021-05-12,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,India,Study of outcome of newborn babies born to mothers who are COVID-19 positive at a tertiary hospital in Gujarat,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54860,NA
CTRI/2021/05/033576,CTRI,2021-05-12,2021-05-22,FALSE,Not Recruiting,Phase 2,Interventional,India,"Study to investigate the safety and efficacy of the health supplements ImmunoSEB and ProbioSEB CSC3 on patients suffering from COVID-19 Induced Fatigue/Post Viral Fatigue Syndrome.

",200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54949,NA
CTRI/2021/05/033592,CTRI,2021-05-12,2021-05-25,FALSE,Not Recruiting,Not Applicable,Observational,India,Perception of public about COVID-19 Vaccination,1094,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55994,NA
CTRI/2021/05/033599,CTRI,2021-05-13,2021-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,"Effect of Online Classroom in Infection Prevention
and Control Training of Undergraduate Students during COVID-l9 Pandemic",300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55286,NA
CTRI/2021/05/033622,CTRI,2021-05-14,2021-05-21,FALSE,Not Recruiting,Not Applicable,Interventional,India,Plasma therapy (IgG) in moderate to severe COVID-19 patients,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56002,NA
CTRI/2021/05/033623,CTRI,2021-05-16,2021-05-22,FALSE,Not Recruiting,Phase 4,Interventional,India,"Recording of the effects of select AYUSH drugs, Ayush-64 and Kabasura Kudineer in Covid-19 patients in home isolation.",500000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56044,NA
CTRI/2021/05/033626,CTRI,2021-05-17,2021-05-18,FALSE,Recruiting,Not Applicable,Interventional,India,A study of Ayurvedic medicine Ã¢??CoReachÃ¢?? in COVID-19 positive patients.,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=54292,NA
CTRI/2021/05/033651,CTRI,2021-05-17,2021-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,India,"A clinical study on Ayurveda intervention along with Standard Care Treatment in mild to moderate patients of COVID-19 


",30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55951,NA
CTRI/2021/05/033665,CTRI,2021-05-18,2021-05-24,FALSE,Not Recruiting,Phase 3,Interventional,India,A Clinical Study to Test the Side Effects and Antibody Levels after Hetero-COVID Vaccine in Healthy Adults,228,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56122,NA
CTRI/2021/05/033703,CTRI,2021-05-20,2021-05-23,FALSE,Not Recruiting,Phase 3,Interventional,India,A Clinical Study to Test the Effectiveness and Side Effects of Hetero-Tocilizumab in Severe COVID-19 Patients,188,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56095,NA
CTRI/2021/05/033712,CTRI,2021-05-20,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,India,Challenges faced by hemodialysis patients in times of COVID- 19 Pandemic,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55864,NA
CTRI/2021/05/033693,CTRI,2021-05-20,2021-05-24,FALSE,Not Recruiting,Phase 3,Interventional,India,"A multi-center, Phase- III clinical trial of Molnupiravir capsules.",1218,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=55936,NA
CTRI/2021/05/033696,CTRI,2021-05-20,2021-05-25,FALSE,Not Recruiting,Phase 3,Interventional,India,Emergency management of low oxygen level using ayurved formulation with special referemce to SPO2,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56026,NA
CTRI/2021/05/033695,CTRI,2021-05-20,2021-05-25,FALSE,Not Recruiting,Phase 3,Interventional,India,Role of Kankasav in the management of spo2 level of covid 19 patients,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=56031,NA
KCT0006152,CRiS,2021-05-20,2021-05-03,TRUE,Not Recruiting,Not Applicable,Interventional,South Korea,Feasibility of detection of COVID-19 in Self-Obtained Oral Sample.,34,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19307,NA
IRCT20200330046897N1,IRCT,2021-04-22,2021-04-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of spirulina extract on patients with coronavirus,105,http://en.irct.ir/trial/46918,NA
IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",30,http://en.irct.ir/trial/46933,NA
IRCT20201111049347N1,IRCT,2021-04-16,2021-04-21,FALSE,Recruiting,Phase 3,Interventional,Iran,Effectiveness of enriched garlic extract in patients with COVID-19,248,http://en.irct.ir/trial/52245,NA
IRCT20201127049504N1,IRCT,2020-12-25,2020-12-25,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Effect of acupuncture and warm cupping on clinical manifestations of COVID-19,90,http://en.irct.ir/trial/52621,NA
IRCT20201204049600N1,IRCT,2021-04-06,2021-05-31,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Investigating the impact of breathing exercises on general health of patient infected with Covid-19,70,http://en.irct.ir/trial/52772,NA
IRCT20200904048616N1,IRCT,2021-05-06,2021-05-21,FALSE,Recruiting,Phase 3,Interventional,Iran,efficacy and safety of adding fluoxetine to therapeutic regimen of patients with COVID-19 pneumonia,72,http://en.irct.ir/trial/52777,NA
IRCT20201229049872N1,IRCT,2021-04-22,2021-01-20,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Colchicine in Treatment of Covid-19,80,http://en.irct.ir/trial/53333,NA
IRCT20201229049873N1,IRCT,2021-05-23,2021-01-22,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Infliximab effectiveness in COVID-19 patients,40,http://en.irct.ir/trial/53791,NA
IRCT20171203037733N3,IRCT,2021-05-11,2021-05-20,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of body position on vital signs and comfort pattern of patients with coronary disease,90,http://en.irct.ir/trial/54252,NA
IRCT20170903036041N3,IRCT,2021-05-23,2021-05-05,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of Modafinil on improving consciousness with COVID-19,60,http://en.irct.ir/trial/54376,NA
IRCT20210222050457N1,IRCT,2021-04-20,2021-03-04,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Determining the effect of Pinen.Hydronoplacton.Ribonucleic acid (PHR) spray  in reducing the length of hospital stay of patients with Covid-19,188,http://en.irct.ir/trial/54525,NA
IRCT20210111050007N1,IRCT,2021-05-18,2021-04-09,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effects of resistance training associated with blood-flow restriction on the quadriceps muscles in CORONA virus survivors after recovery,18,http://en.irct.ir/trial/54533,NA
IRCT20180612040068N1,IRCT,2021-04-19,2021-03-05,TRUE,Not Recruiting,Phase 3,Interventional,Iran,To study the effect of Metronidazole and Ivermectin in hospitalized patients with COVID-19.,135,http://en.irct.ir/trial/54625,NA
IRCT20210303050558N1,IRCT,2021-04-24,2021-04-25,FALSE,Not Recruiting,Phase 3,Interventional,Iran,"Efficacy, safety and immunogenicity of Soberana 02 vaccine (product of Finlay Institute): a double-blind, randomized, placebo-controlled phase III clinical trial",24000,http://en.irct.ir/trial/54833,NA
IRCT20180103038199N4,IRCT,2021-04-24,2021-04-30,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Basil on outpatients with COVID-19,140,http://en.irct.ir/trial/54965,NA
IRCT20200611047727N4,IRCT,2021-04-28,2021-04-19,TRUE,Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of high flow oxygen delivery under different temperatures in COVID-19 patients,30,http://en.irct.ir/trial/55024,NA
IRCT20200325046854N2,IRCT,2021-05-03,2021-03-16,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19,70,http://en.irct.ir/trial/55085,NA
IRCT20210317050734N1,IRCT,2021-05-03,2021-05-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of neonatal health index and anxiety of active and inactive pregnant women with Covid19,50,http://en.irct.ir/trial/55130,NA
IRCT20180205038626N8,IRCT,2021-05-09,2021-04-21,TRUE,Recruiting,Phase 2,Interventional,Iran,"Effects of green tea consumption on fatigue, depression and anxiety scores in COVID-19 patients",84,http://en.irct.ir/trial/55208,NA
IRCT20200721048159N2,IRCT,2021-04-22,2021-05-04,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup in the treatment of COVID-19,66,http://en.irct.ir/trial/55368,NA
IRCT20190101042197N2,IRCT,2021-04-19,2021-03-25,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Iran,Exosome therapy in COVID-19 patients,72,http://en.irct.ir/trial/55380,NA
IRCT20210327050775N1,IRCT,2021-05-25,2021-05-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D on the prognosis of patients with COVID-19,120,http://en.irct.ir/trial/55405,NA
IRCT20210406050871N1,IRCT,2021-04-25,2021-04-30,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of percutaneous electrical nerve stimulation on the respiratory outcomes of patients with Covid-19 with moderate pulmonary involvement,120,http://en.irct.ir/trial/55531,NA
IRCT20201129049525N1,IRCT,2021-05-16,2021-05-20,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of aerobic training at home and vitamin D supplementation in MS During Covid-19 quarantine,36,http://en.irct.ir/trial/55602,NA
IRCT20200411047029N1,IRCT,2021-04-24,2021-04-21,TRUE,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of PHR-160 spray in recovery of hospitalized patients with Covid-19 in Isfahan province in 1399,198,http://en.irct.ir/trial/55615,NA
IRCT20200914048719N2,IRCT,2021-05-03,2021-04-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,The Efficacy of  Positive Psychological Intervention (PPI) on Improving Well-Being Among Students of Hamadan Universities,252,http://en.irct.ir/trial/55619,NA
IRCT20210413050957N1,IRCT,2021-05-01,2021-05-05,FALSE,Recruiting,Phase 3,Interventional,Iran,Survey the effect of magnesium citrate supplementation on clinical symptoms and TNF-a  and hs-CRP  factors in patients with COVID-19,60,http://en.irct.ir/trial/55660,NA
IRCT20210416050988N1,IRCT,2021-05-24,2021-04-26,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the Effect of Educational Intervention Based on Health Belief Model on COVID-19 Preventive Behaviors among teachers,140,http://en.irct.ir/trial/55671,NA
IRCT20151020024625N12,IRCT,2021-04-30,2021-04-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Assessing of prone and supine position on oxygenation of patients with COVID-19,30,http://en.irct.ir/trial/55690,NA
IRCT20160516027929N10,IRCT,2021-05-03,2021-04-21,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effect of exercise on respiratory function of patients with Covid-19,40,http://en.irct.ir/trial/55715,NA
IRCT20111224008507N6,IRCT,2021-05-07,2021-05-10,FALSE,Recruiting,Phase 3,Interventional,Iran,Phage therapy for prevention of secondary bacterial pneumonia in COVID-19,60,http://en.irct.ir/trial/55727,NA
IRCT20210408050899N1,IRCT,2021-05-25,2021-04-25,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of The effect of tocilizumab on patients with severe Covid 19,15,http://en.irct.ir/trial/55757,NA
IRCT20200723048178N2,IRCT,2021-04-28,2021-05-02,FALSE,Recruiting,Not Applicable,Interventional,Pakistan,Intermittent CPAP in hypoxemic COVID patients,93,http://en.irct.ir/trial/55771,NA
IRCT20210424051067N1,IRCT,2021-05-11,2021-05-22,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of education on the quality of nutrition of patients undergoing hemodialysis,60,http://en.irct.ir/trial/55820,NA
IRCT20160316027081N2,IRCT,2021-05-13,2021-04-21,TRUE,Recruiting,Phase 3,Interventional,Iran,Blood exchange in COVID-19,60,http://en.irct.ir/trial/56035,NA
IRCT20210315050710N1,IRCT,2021-05-10,2020-10-22,TRUE,Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of plasmapheresis on patients with severe COVID-19,30,http://en.irct.ir/trial/56041,NA
IRCT20121216011763N52,IRCT,2021-05-13,2021-05-15,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in coronary hospitalized patients,50,http://en.irct.ir/trial/56149,NA
IRCT20150303021315N23,IRCT,2021-05-24,2021-05-29,FALSE,Not Recruiting,Phase 2,Interventional,Iran,evaluate efficacy and safety of SpikoGenÂ® vaccine on healthy adults to prevent COVID-19 disease,400,http://en.irct.ir/trial/56287,NA
IRCT20210510051243N1,IRCT,2021-05-25,2021-05-31,FALSE,Not Recruiting,Phase 2,Interventional,Iran,Chitosan supplementation and Coronavirus,80,http://en.irct.ir/trial/56289,NA
IRCT20080901001165N64,IRCT,2021-05-21,2021-05-31,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of efficacy and safety of Glurunic acid (G2013) in patients with COVID-19,180,http://en.irct.ir/trial/56367,NA
IRCT20200223046586N4,IRCT,2021-05-24,2021-06-04,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The Video communication between patient and family member on hospital anxiety and depression and perceived stress of  family member,80,http://en.irct.ir/trial/56369,NA
IRCT20200506047323N8,IRCT,2021-05-24,2021-06-05,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,epinephrine in COVID-19,84,http://en.irct.ir/trial/56388,NA
IRCT20160305026917N2,IRCT,2021-05-25,2021-07-21,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of jujube and saffron supplement on Covid-19,60,http://en.irct.ir/trial/56417,NA
NCT01306084,ClinicalTrials.gov,2011-02-26,2011-03-15,FALSE,Recruiting,Not Applicable,Observational,United States,Viral Infections in Healthy and Immunocompromised Hosts,410,https://clinicaltrials.gov/show/NCT01306084,NA
NCT03452774,ClinicalTrials.gov,2018-02-13,2018-01-01,TRUE,Recruiting,Not Applicable,Observational,United States,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,5000,https://clinicaltrials.gov/show/NCT03452774,NA
NCT03891420,ClinicalTrials.gov,2019-03-15,2020-04-09,FALSE,Not Recruiting,Phase 1,Interventional,Brazil,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19",24,https://clinicaltrials.gov/show/NCT03891420,NA
NCT04061382,ClinicalTrials.gov,2019-07-30,2019-10-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Sero-epidemiological Survey of England in 2019/2020 - COVID-19,2800,https://clinicaltrials.gov/show/NCT04061382,NA
NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,FALSE,Not Recruiting,Phase 2,Interventional,"Sweden, United States",Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,200,https://clinicaltrials.gov/show/NCT04306393,NA
NCT04325646,ClinicalTrials.gov,2020-03-26,2020-03-13,TRUE,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,2000,https://clinicaltrials.gov/show/NCT04325646,NA
NCT04327804,ClinicalTrials.gov,2020-03-26,2020-03-25,TRUE,Not Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,134,https://clinicaltrials.gov/show/NCT04327804,NA
NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,FALSE,Not Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,10,https://clinicaltrials.gov/show/NCT04328493,NA
NCT04329546,ClinicalTrials.gov,2020-03-29,2020-03-27,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,250,https://clinicaltrials.gov/show/NCT04329546,NA
NCT04330690,ClinicalTrials.gov,2020-03-23,2020-03-18,TRUE,Recruiting,Phase 2,Interventional,Canada,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,2900,https://clinicaltrials.gov/show/NCT04330690,NA
NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-25,FALSE,Not Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,120,https://clinicaltrials.gov/show/NCT04331899,NA
NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",120,https://clinicaltrials.gov/show/NCT04336410,NA
NCT04340557,ClinicalTrials.gov,2020-04-06,2020-03-27,TRUE,Not Recruiting,Phase 4,Interventional,United States,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,31,https://clinicaltrials.gov/show/NCT04340557,NA
NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),384,https://clinicaltrials.gov/show/NCT04341116,NA
NCT04342884,ClinicalTrials.gov,2020-04-08,2020-04-08,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,150000,https://clinicaltrials.gov/show/NCT04342884,NA
NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,200,https://clinicaltrials.gov/show/NCT04345848,NA
NCT04350073,ClinicalTrials.gov,2020-04-14,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),120,https://clinicaltrials.gov/show/NCT04350073,NA
NCT04352556,ClinicalTrials.gov,2020-04-09,2020-04-07,TRUE,Recruiting,Not Applicable,Observational,Italy,COVID19-hematological Malignancies: the Italian Hematology Alliance,250,https://clinicaltrials.gov/show/NCT04352556,NA
NCT04353154,ClinicalTrials.gov,2020-04-15,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,Canada,The RAPID COVID-19 TRIAGE Algorithm,66,https://clinicaltrials.gov/show/NCT04353154,NA
NCT04354519,ClinicalTrials.gov,2020-04-06,2020-03-14,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,3000,https://clinicaltrials.gov/show/NCT04354519,NA
NCT04357496,ClinicalTrials.gov,2020-04-20,2021-05-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic Response Study,0,https://clinicaltrials.gov/show/NCT04357496,NA
NCT04357574,ClinicalTrials.gov,2020-04-20,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,United States,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,1000,https://clinicaltrials.gov/show/NCT04357574,NA
NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,50,https://clinicaltrials.gov/show/NCT04358549,NA
NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,31,https://clinicaltrials.gov/show/NCT04358783,NA
NCT04358952,ClinicalTrials.gov,2020-04-09,2020-04-04,TRUE,Not Recruiting,Not Applicable,Observational,France,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,122,https://clinicaltrials.gov/show/NCT04358952,NA
NCT04359095,ClinicalTrials.gov,2020-04-15,2020-08-18,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,1200,https://clinicaltrials.gov/show/NCT04359095,NA
NCT04362137,ClinicalTrials.gov,2020-04-22,2020-05-02,FALSE,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, Peru, United Kingdom, Colombia, Canada, United States, Brazil, Mexico, Spain, Turkey, Italy, France, Germany",Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm,432,https://clinicaltrials.gov/show/NCT04362137,NA
NCT04368065,ClinicalTrials.gov,2020-04-28,2020-04-02,TRUE,Recruiting,Not Applicable,Observational,"United States, United Kingdom",COVID-19 Active Research Experience (CARE),100000,https://clinicaltrials.gov/show/NCT04368065,NA
NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Argentina, South Africa, United States, Brazil, Turkey, Germany","Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",43998,https://clinicaltrials.gov/show/NCT04368728,NA
NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,FALSE,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",1971,https://clinicaltrials.gov/show/NCT04369066,NA
NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,FALSE,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,1,https://clinicaltrials.gov/show/NCT04370834,NA
NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,TRUE,Not Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",208,https://clinicaltrials.gov/show/NCT04371367,NA
NCT04371835,ClinicalTrials.gov,2020-04-28,2020-08-12,FALSE,Recruiting,Not Applicable,Observational,"Argentina, South Africa, Thailand, Brazil, Cameroon, Uganda, Zimbabwe, India, Malaysia, Nigeria",COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,1500,https://clinicaltrials.gov/show/NCT04371835,NA
NCT04371978,ClinicalTrials.gov,2020-04-30,2020-10-01,FALSE,Not Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,64,https://clinicaltrials.gov/show/NCT04371978,NA
NCT04372602,ClinicalTrials.gov,2020-04-30,2020-10-12,FALSE,Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,28,https://clinicaltrials.gov/show/NCT04372602,NA
NCT04373005,ClinicalTrials.gov,2020-04-30,2020-05-11,FALSE,Recruiting,Not Applicable,Observational,Canada,Screening of Cancer Patients to Assess Impact of COVID-19,1000,https://clinicaltrials.gov/show/NCT04373005,NA
NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",6,https://clinicaltrials.gov/show/NCT04373044,NA
NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,29,https://clinicaltrials.gov/show/NCT04374526,NA
NCT04383444,ClinicalTrials.gov,2020-05-09,2020-07-07,FALSE,Recruiting,Not Applicable,Observational,United States,Surveillance of Individuals Following SARS-CoV-2 Infection,1050,https://clinicaltrials.gov/show/NCT04383444,NA
NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,FALSE,Not Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,0,https://clinicaltrials.gov/show/NCT04384900,NA
NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,TRUE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,30,https://clinicaltrials.gov/show/NCT04385199,NA
NCT04385849,ClinicalTrials.gov,2020-05-07,2020-07-22,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,1,https://clinicaltrials.gov/show/NCT04385849,NA
NCT04385940,ClinicalTrials.gov,2020-05-08,2021-03-19,FALSE,Recruiting,Phase 3,Interventional,Canada,Vitamin D and COVID-19 Management,64,https://clinicaltrials.gov/show/NCT04385940,NA
NCT04386252,ClinicalTrials.gov,2020-05-11,2021-09-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,175,https://clinicaltrials.gov/show/NCT04386252,NA
NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,360,https://clinicaltrials.gov/show/NCT04386291,NA
NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,3,https://clinicaltrials.gov/show/NCT04389840,NA
NCT04391920,ClinicalTrials.gov,2020-05-12,2020-08-28,FALSE,Recruiting,Not Applicable,Observational,United States,Registry of CytoSorb Therapy in COVID-19 ICU Patients,500,https://clinicaltrials.gov/show/NCT04391920,NA
NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,30,https://clinicaltrials.gov/show/NCT04392778,NA
NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,FALSE,Not Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",100,https://clinicaltrials.gov/show/NCT04395105,NA
NCT04397796,ClinicalTrials.gov,2020-05-18,2020-08-03,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,45,https://clinicaltrials.gov/show/NCT04397796,NA
NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,30,https://clinicaltrials.gov/show/NCT04399889,NA
NCT04400890,ClinicalTrials.gov,2020-05-22,2020-09-12,FALSE,Not Recruiting,Phase 2,Interventional,United States,"Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19",100,https://clinicaltrials.gov/show/NCT04400890,NA
NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,FALSE,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,183,https://clinicaltrials.gov/show/NCT04401202,NA
NCT04401449,ClinicalTrials.gov,2020-05-22,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,United States,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,180,https://clinicaltrials.gov/show/NCT04401449,NA
NCT04404426,ClinicalTrials.gov,2020-05-22,2020-11-04,FALSE,Not Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,33,https://clinicaltrials.gov/show/NCT04404426,NA
NCT04405102,ClinicalTrials.gov,2020-05-26,2020-09-16,FALSE,Recruiting,Phase 2,Interventional,Canada,COVID-19 Ozanimod Intervention Study,48,https://clinicaltrials.gov/show/NCT04405102,NA
NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,FALSE,Recruiting,Phase 2,Interventional,United States,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),96,https://clinicaltrials.gov/show/NCT04405739,NA
NCT04407507,ClinicalTrials.gov,2020-05-27,2020-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",66,https://clinicaltrials.gov/show/NCT04407507,NA
NCT04411147,ClinicalTrials.gov,2020-05-30,2020-06-17,FALSE,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Sequelae and Immunity,900,https://clinicaltrials.gov/show/NCT04411147,NA
NCT04412551,ClinicalTrials.gov,2020-06-01,2020-05-20,TRUE,Not Recruiting,Not Applicable,Observational,Sweden,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,72,https://clinicaltrials.gov/show/NCT04412551,NA
NCT04415151,ClinicalTrials.gov,2020-06-02,2020-10-14,FALSE,Recruiting,Phase 2,Interventional,United States,Tofacitinib for Treatment of Moderate COVID-19,60,https://clinicaltrials.gov/show/NCT04415151,NA
NCT04416893,ClinicalTrials.gov,2020-06-02,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2) (WHO),0,https://clinicaltrials.gov/show/NCT04416893,NA
NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,FALSE,Not Recruiting,Phase 2,Interventional,"Canada, United States",Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,240,https://clinicaltrials.gov/show/NCT04417257,NA
NCT04419025,ClinicalTrials.gov,2020-06-03,2020-09-23,FALSE,Not Recruiting,Phase 2,Interventional,United States,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,165,https://clinicaltrials.gov/show/NCT04419025,NA
NCT04419610,ClinicalTrials.gov,2020-04-16,2020-10-09,FALSE,Not Recruiting,Phase 1,Interventional,United Kingdom,RAS and Coagulopathy in COVID19,30,https://clinicaltrials.gov/show/NCT04419610,NA
NCT04420182,ClinicalTrials.gov,2020-05-29,2020-08-17,FALSE,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,2000,https://clinicaltrials.gov/show/NCT04420182,NA
NCT04420468,ClinicalTrials.gov,2020-06-05,2020-06-10,FALSE,Recruiting,Not Applicable,Observational,France,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,30,https://clinicaltrials.gov/show/NCT04420468,NA
NCT04422769,ClinicalTrials.gov,2020-06-04,2020-05-22,TRUE,Not Recruiting,Not Applicable,Observational,United States,Needs of Persons With Spinal Cord Injury (SCI),53,https://clinicaltrials.gov/show/NCT04422769,NA
NCT04424004,ClinicalTrials.gov,2020-06-08,2020-06-09,FALSE,Not Recruiting,Not Applicable,Observational,United States,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,500,https://clinicaltrials.gov/show/NCT04424004,NA
NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-09,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04424082,NA
NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Romania, United States, Mexico","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",6420,https://clinicaltrials.gov/show/NCT04425629,NA
NCT04429724,ClinicalTrials.gov,2020-06-10,2020-07-06,FALSE,Not Recruiting,Not Applicable,Interventional,France,Health Professional Exposure Assessment to Covid-19,2129,https://clinicaltrials.gov/show/NCT04429724,NA
NCT04431908,ClinicalTrials.gov,2020-06-12,2020-06-15,FALSE,Not Recruiting,Not Applicable,Observational,United States,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,1320,https://clinicaltrials.gov/show/NCT04431908,NA
NCT04441047,ClinicalTrials.gov,2020-06-17,2021-06-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Universal Anti-Viral Vaccine for Healthy Elderly Adults,40,https://clinicaltrials.gov/show/NCT04441047,NA
NCT04442048,ClinicalTrials.gov,2020-06-19,2020-06-25,FALSE,Not Recruiting,Phase 3,Interventional,Canada,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,195,https://clinicaltrials.gov/show/NCT04442048,NA
NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),179,https://clinicaltrials.gov/show/NCT04443881,NA
NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,TRUE,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,44,https://clinicaltrials.gov/show/NCT04445285,NA
NCT04450017,ClinicalTrials.gov,2020-06-23,2020-04-06,TRUE,Not Recruiting,Not Applicable,Observational,Russian Federation,Clinical Features of Severe Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04450017,NA
NCT04451174,ClinicalTrials.gov,2020-06-26,2020-06-23,TRUE,Not Recruiting,Phase 3,Interventional,Chile,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,60,https://clinicaltrials.gov/show/NCT04451174,NA
NCT04453774,ClinicalTrials.gov,2020-05-06,2020-11-01,FALSE,Recruiting,Not Applicable,Interventional,Canada,At Home Monitoring for Patients With Covid19,1000,https://clinicaltrials.gov/show/NCT04453774,NA
NCT04456062,ClinicalTrials.gov,2020-06-30,2020-08-04,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,102,https://clinicaltrials.gov/show/NCT04456062,NA
NCT04458337,ClinicalTrials.gov,2020-06-26,2020-03-13,TRUE,Recruiting,Not Applicable,Observational,Canada,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),226,https://clinicaltrials.gov/show/NCT04458337,NA
NCT04458519,ClinicalTrials.gov,2020-07-01,2020-07-16,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,23,https://clinicaltrials.gov/show/NCT04458519,NA
NCT04460651,ClinicalTrials.gov,2020-07-02,2020-08-14,FALSE,Recruiting,Phase 3,Interventional,Argentina,PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial,4000,https://clinicaltrials.gov/show/NCT04460651,NA
NCT04467086,ClinicalTrials.gov,2020-06-30,2020-12-11,FALSE,Recruiting,Phase 3,Interventional,Canada,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,108,https://clinicaltrials.gov/show/NCT04467086,NA
NCT04468087,ClinicalTrials.gov,2020-07-03,2021-02-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Antiviral Agents Against COVID-19 Infection,1005,https://clinicaltrials.gov/show/NCT04468087,NA
NCT04471519,ClinicalTrials.gov,2020-07-11,2020-07-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,India,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,755,https://clinicaltrials.gov/show/NCT04471519,NA
NCT04474236,ClinicalTrials.gov,2020-07-07,2020-05-27,TRUE,Not Recruiting,Not Applicable,Observational,France,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,25,https://clinicaltrials.gov/show/NCT04474236,NA
NCT04475107,ClinicalTrials.gov,2020-07-14,2020-07-09,TRUE,Not Recruiting,Phase 2,Interventional,South Korea,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,113,https://clinicaltrials.gov/show/NCT04475107,NA
NCT04475991,ClinicalTrials.gov,2020-07-15,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,100,https://clinicaltrials.gov/show/NCT04475991,NA
NCT04480138,ClinicalTrials.gov,2020-07-20,2020-08-11,FALSE,Recruiting,Phase 2,Interventional,Mexico,Pegylated Interferon - a2b With SARSCoV- 2 (COVID-19),40,https://clinicaltrials.gov/show/NCT04480138,NA
NCT04482712,ClinicalTrials.gov,2020-07-21,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,0,https://clinicaltrials.gov/show/NCT04482712,NA
NCT04483635,ClinicalTrials.gov,2020-06-29,2021-02-08,FALSE,Not Recruiting,Phase 3,Interventional,Canada,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,34,https://clinicaltrials.gov/show/NCT04483635,NA
NCT04487210,ClinicalTrials.gov,2020-07-22,2020-10-07,FALSE,Not Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,45,https://clinicaltrials.gov/show/NCT04487210,NA
NCT04492527,ClinicalTrials.gov,2020-07-28,2020-07-28,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,75,https://clinicaltrials.gov/show/NCT04492527,NA
NCT04495764,ClinicalTrials.gov,2020-07-22,2020-07-20,TRUE,Not Recruiting,Not Applicable,Observational,United States,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,2315,https://clinicaltrials.gov/show/NCT04495764,NA
NCT04495907,ClinicalTrials.gov,2020-07-30,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Progression in End-Stage Kidney Disease,412,https://clinicaltrials.gov/show/NCT04495907,NA
NCT04517006,ClinicalTrials.gov,2020-08-14,2021-01-31,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,1328,https://clinicaltrials.gov/show/NCT04517006,NA
NCT04519372,ClinicalTrials.gov,2020-08-17,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,4099,https://clinicaltrials.gov/show/NCT04519372,NA
NCT04530474,ClinicalTrials.gov,2020-08-26,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,United States,Outpatient Use of Ivermectin in COVID-19,0,https://clinicaltrials.gov/show/NCT04530474,NA
NCT04532294,ClinicalTrials.gov,2020-08-27,2020-09-08,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",18,https://clinicaltrials.gov/show/NCT04532294,NA
NCT04536350,ClinicalTrials.gov,2020-08-21,2021-05-18,FALSE,Recruiting,Phase 2,Interventional,Switzerland,Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS,82,https://clinicaltrials.gov/show/NCT04536350,NA
NCT04537351,ClinicalTrials.gov,2020-08-25,2020-08-24,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause,24,https://clinicaltrials.gov/show/NCT04537351,NA
NCT04537663,ClinicalTrials.gov,2020-08-28,2020-08-25,TRUE,Recruiting,Phase 4,Interventional,Netherlands,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,5200,https://clinicaltrials.gov/show/NCT04537663,NA
NCT04543760,ClinicalTrials.gov,2020-09-08,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,France,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,18,https://clinicaltrials.gov/show/NCT04543760,NA
NCT04546776,ClinicalTrials.gov,2020-09-09,2020-09-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Persistence in Stool,200,https://clinicaltrials.gov/show/NCT04546776,NA
NCT04555187,ClinicalTrials.gov,2020-09-16,2020-06-08,TRUE,Not Recruiting,Not Applicable,Observational,United States,Cardiovascular Risk Stratification in Covid-19,60000,https://clinicaltrials.gov/show/NCT04555187,NA
NCT04558476,ClinicalTrials.gov,2020-09-14,2020-09-01,TRUE,Recruiting,Phase 2,Interventional,Belgium,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,500,https://clinicaltrials.gov/show/NCT04558476,NA
NCT04560855,ClinicalTrials.gov,2020-09-17,2020-09-14,TRUE,Not Recruiting,Not Applicable,Observational,France,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,10,https://clinicaltrials.gov/show/NCT04560855,NA
NCT04565249,ClinicalTrials.gov,2020-09-15,2020-10-22,FALSE,Recruiting,Phase 2,Interventional,United States,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",36,https://clinicaltrials.gov/show/NCT04565249,NA
NCT04565522,ClinicalTrials.gov,2020-09-23,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,Italy,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,5000,https://clinicaltrials.gov/show/NCT04565522,NA
NCT04569877,ClinicalTrials.gov,2020-09-25,2020-09-24,TRUE,Recruiting,Phase 2,Interventional,Germany,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,238,https://clinicaltrials.gov/show/NCT04569877,NA
NCT04570254,ClinicalTrials.gov,2020-09-26,2020-08-19,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,110,https://clinicaltrials.gov/show/NCT04570254,NA
NCT04575532,ClinicalTrials.gov,2020-10-01,2020-10-05,FALSE,Recruiting,Not Applicable,Observational,United States,Detection of COVID-19 Decompensation,1600,https://clinicaltrials.gov/show/NCT04575532,NA
NCT04575610,ClinicalTrials.gov,2020-08-05,2020-11-27,FALSE,Recruiting,Phase 2,Interventional,United States,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),68,https://clinicaltrials.gov/show/NCT04575610,NA
NCT04578509,ClinicalTrials.gov,2020-09-21,2020-10-19,FALSE,Recruiting,Not Applicable,Observational,France,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,2750,https://clinicaltrials.gov/show/NCT04578509,NA
NCT04579640,ClinicalTrials.gov,2020-10-06,2020-10-27,FALSE,Not Recruiting,Phase 3,Interventional,United Kingdom,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,6200,https://clinicaltrials.gov/show/NCT04579640,NA
NCT04581811,ClinicalTrials.gov,2020-10-07,2020-11-10,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),52,https://clinicaltrials.gov/show/NCT04581811,NA
NCT04581954,ClinicalTrials.gov,2020-10-05,2020-10-02,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Inflammatory Signal Inhibitors for COVID-19 (MATIS),456,https://clinicaltrials.gov/show/NCT04581954,NA
NCT04590469,ClinicalTrials.gov,2020-10-13,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Improving Wellbeing and Health for Care Home Residents During COVID-19,2880,https://clinicaltrials.gov/show/NCT04590469,NA
NCT04591717,ClinicalTrials.gov,2020-10-13,2020-10-19,FALSE,Recruiting,Phase 1,Interventional,United States,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,60,https://clinicaltrials.gov/show/NCT04591717,NA
NCT04595136,ClinicalTrials.gov,2020-10-15,2020-11-02,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Colombia,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,60,https://clinicaltrials.gov/show/NCT04595136,NA
NCT04595773,ClinicalTrials.gov,2020-10-20,2021-01-22,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",90,https://clinicaltrials.gov/show/NCT04595773,NA
NCT04596839,ClinicalTrials.gov,2020-10-20,2020-09-04,TRUE,Not Recruiting,Phase 2,Interventional,Bangladesh,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),60,https://clinicaltrials.gov/show/NCT04596839,NA
NCT04601415,ClinicalTrials.gov,2020-08-26,2021-02-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,1500,https://clinicaltrials.gov/show/NCT04601415,NA
NCT04604145,ClinicalTrials.gov,2020-10-23,2021-02-03,FALSE,Recruiting,Not Applicable,Interventional,United States,Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR,60,https://clinicaltrials.gov/show/NCT04604145,NA
NCT04604743,ClinicalTrials.gov,2020-10-25,2021-04-20,FALSE,Recruiting,Not Applicable,Interventional,United States,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,4,https://clinicaltrials.gov/show/NCT04604743,NA
NCT04609501,ClinicalTrials.gov,2020-10-22,2020-06-01,TRUE,Not Recruiting,Not Applicable,Observational,Israel,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",440,https://clinicaltrials.gov/show/NCT04609501,NA
NCT04625218,ClinicalTrials.gov,2020-11-10,2022-01-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study,40,https://clinicaltrials.gov/show/NCT04625218,NA
NCT04625725,ClinicalTrials.gov,2020-11-10,2020-11-21,FALSE,Not Recruiting,Phase 3,Interventional,"United Kingdom, Belgium, United States, Spain, France","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",5198,https://clinicaltrials.gov/show/NCT04625725,NA
NCT04625972,ClinicalTrials.gov,2020-11-10,2020-12-02,FALSE,Not Recruiting,Phase 3,Interventional,"United States, United Kingdom","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",1121,https://clinicaltrials.gov/show/NCT04625972,NA
NCT04634903,ClinicalTrials.gov,2020-11-11,2020-11-19,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",2452,https://clinicaltrials.gov/show/NCT04634903,NA
NCT04636333,ClinicalTrials.gov,2020-11-17,2020-10-30,TRUE,Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),216,https://clinicaltrials.gov/show/NCT04636333,NA
NCT04636697,ClinicalTrials.gov,2020-11-12,2020-11-19,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Canada, United Kingdom, United States, Brazil",Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,30918,https://clinicaltrials.gov/show/NCT04636697,NA
NCT04638634,ClinicalTrials.gov,2020-11-19,2021-02-02,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",24,https://clinicaltrials.gov/show/NCT04638634,NA
NCT04640168,ClinicalTrials.gov,2020-11-19,2020-11-24,FALSE,Not Recruiting,Phase 3,Interventional,"South Korea, United States, Mexico, Japan, Singapore",Adaptive COVID-19 Treatment Trial 4 (ACTT-4),1010,https://clinicaltrials.gov/show/NCT04640168,NA
NCT04640428,ClinicalTrials.gov,2020-11-20,2020-07-10,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Stroke Apical Lung Examination Study,2000,https://clinicaltrials.gov/show/NCT04640428,NA
NCT04644120,ClinicalTrials.gov,2020-11-23,2020-12-10,FALSE,Not Recruiting,Phase 1,Interventional,"Hungary, Netherlands, Puerto Rico, United States, Israel",Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19),24,https://clinicaltrials.gov/show/NCT04644120,NA
NCT04646044,ClinicalTrials.gov,2020-11-14,2020-11-13,TRUE,Not Recruiting,Phase 1,Interventional,United States,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,30,https://clinicaltrials.gov/show/NCT04646044,NA
NCT04649086,ClinicalTrials.gov,2020-09-29,2020-06-05,TRUE,Recruiting,Not Applicable,Interventional,France,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,120,https://clinicaltrials.gov/show/NCT04649086,NA
NCT04650087,ClinicalTrials.gov,2020-11-30,2021-02-15,FALSE,Recruiting,Phase 3,Interventional,United States,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,5320,https://clinicaltrials.gov/show/NCT04650087,NA
NCT04652102,ClinicalTrials.gov,2020-12-01,2020-12-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Colombia, Belgium, Netherlands, Mexico, Spain, Panama, Germany",A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,36500,https://clinicaltrials.gov/show/NCT04652102,NA
NCT04653844,ClinicalTrials.gov,2020-12-03,2020-02-01,TRUE,Recruiting,Not Applicable,Observational,France,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,7000000,https://clinicaltrials.gov/show/NCT04653844,NA
NCT04662060,ClinicalTrials.gov,2020-12-08,2021-04-23,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,120,https://clinicaltrials.gov/show/NCT04662060,NA
NCT04662073,ClinicalTrials.gov,2020-12-08,2021-04-23,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,120,https://clinicaltrials.gov/show/NCT04662073,NA
NCT04662086,ClinicalTrials.gov,2020-12-08,2021-04-23,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,240,https://clinicaltrials.gov/show/NCT04662086,NA
NCT04664101,ClinicalTrials.gov,2020-12-10,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"REmotely Monitored, Mobile Health-Supported High Intensity Interval Training After COVID-19 Critical Illness (REMM-HIIT-COVID-19)",20,https://clinicaltrials.gov/show/NCT04664101,NA
NCT04668950,ClinicalTrials.gov,2020-12-11,2020-12-22,FALSE,Not Recruiting,Phase 3,Interventional,"Canada, United States",Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),1100,https://clinicaltrials.gov/show/NCT04668950,NA
NCT04672564,ClinicalTrials.gov,2020-12-16,2021-03-30,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia, Ukraine, United States, Brazil, Mexico, India, Philippines",Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,300,https://clinicaltrials.gov/show/NCT04672564,NA
NCT04677660,ClinicalTrials.gov,2020-12-18,2021-01-21,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),200,https://clinicaltrials.gov/show/NCT04677660,NA
NCT04678193,ClinicalTrials.gov,2020-11-06,2020-12-24,FALSE,Recruiting,Not Applicable,Observational,"Sweden, India, United States",COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy,27000,https://clinicaltrials.gov/show/NCT04678193,NA
NCT04686760,ClinicalTrials.gov,2020-12-24,2020-11-15,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04686760,NA
NCT04690816,ClinicalTrials.gov,2020-12-30,2021-02-11,FALSE,Recruiting,Not Applicable,Observational,United States,Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases,350,https://clinicaltrials.gov/show/NCT04690816,NA
NCT04699916,ClinicalTrials.gov,2021-01-06,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,Chile,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,50,https://clinicaltrials.gov/show/NCT04699916,NA
NCT04706299,ClinicalTrials.gov,2021-01-10,2021-01-12,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",20,https://clinicaltrials.gov/show/NCT04706299,NA
NCT04708340,ClinicalTrials.gov,2021-01-04,2021-03-25,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Tolerability and Efficacy of RJX in Patients With COVID-19,237,https://clinicaltrials.gov/show/NCT04708340,NA
NCT04709120,ClinicalTrials.gov,2021-01-13,2021-01-11,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,Analysis of Health Status of ?omorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,2500,https://clinicaltrials.gov/show/NCT04709120,NA
NCT04715243,ClinicalTrials.gov,2021-01-09,2021-02-02,FALSE,Recruiting,Not Applicable,Interventional,Oman,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",360,https://clinicaltrials.gov/show/NCT04715243,NA
NCT04716985,ClinicalTrials.gov,2021-01-13,2021-01-22,FALSE,Recruiting,Not Applicable,Interventional,"Serbia, France, Morocco",Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,450,https://clinicaltrials.gov/show/NCT04716985,NA
NCT04718467,ClinicalTrials.gov,2021-01-20,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,China,Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells),0,https://clinicaltrials.gov/show/NCT04718467,NA
NCT04730895,ClinicalTrials.gov,2021-01-28,2021-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.,360,https://clinicaltrials.gov/show/NCT04730895,NA
NCT04732949,ClinicalTrials.gov,2021-01-28,2021-01-12,TRUE,Recruiting,Phase 3,Interventional,"Portugal, United Kingdom, Belgium, United States, Israel, Serbia, France, India",Study to Assess Efficacy and Safety of Inhaled Interferon-ÃŸ Therapy for COVID-19,610,https://clinicaltrials.gov/show/NCT04732949,NA
NCT04738331,ClinicalTrials.gov,2021-02-02,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,France,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database,10000000,https://clinicaltrials.gov/show/NCT04738331,NA
NCT04743401,ClinicalTrials.gov,2021-01-12,2021-07-05,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04743401,NA
NCT04746183,ClinicalTrials.gov,2020-10-13,2020-07-03,TRUE,Recruiting,Phase 1/Phase 2,Interventional,"South Africa, United Kingdom",AGILE (Early Phase Platform Trial for COVID-19),600,https://clinicaltrials.gov/show/NCT04746183,NA
NCT04750330,ClinicalTrials.gov,2021-01-26,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,"Italy, Greece, Belgium",Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection,600,https://clinicaltrials.gov/show/NCT04750330,NA
NCT04753476,ClinicalTrials.gov,2021-02-11,2020-06-08,TRUE,Recruiting,Phase 2,Interventional,Indonesia,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,48,https://clinicaltrials.gov/show/NCT04753476,NA
NCT04758299,ClinicalTrials.gov,2021-02-12,2021-03-13,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits,360,https://clinicaltrials.gov/show/NCT04758299,NA
NCT04761718,ClinicalTrials.gov,2021-02-17,2021-05-20,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Covid-19 Epidemic Lockdown Impact on Psychomotor Performance,300,https://clinicaltrials.gov/show/NCT04761718,NA
NCT04762680,ClinicalTrials.gov,2021-02-18,2021-02-24,FALSE,Not Recruiting,Phase 2,Interventional,"Honduras, United States",Study of Recombinant Protein Vaccine With Adjuvant Against COVID-19 in Adults 18 Years of Age and Older,722,https://clinicaltrials.gov/show/NCT04762680,NA
NCT04764747,ClinicalTrials.gov,2021-02-18,2020-11-01,TRUE,Not Recruiting,Not Applicable,Observational,Iraq,Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19,400,https://clinicaltrials.gov/show/NCT04764747,NA
NCT04765839,ClinicalTrials.gov,2021-02-02,2021-02-12,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations,74,https://clinicaltrials.gov/show/NCT04765839,NA
NCT04775069,ClinicalTrials.gov,2021-02-24,2021-05-21,FALSE,Recruiting,Phase 4,Interventional,Hong Kong,Antibody Response to COVID-19 Vaccines in Liver Disease Patients,900,https://clinicaltrials.gov/show/NCT04775069,NA
NCT04776174,ClinicalTrials.gov,2021-02-08,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,France,Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children,40,https://clinicaltrials.gov/show/NCT04776174,NA
NCT04785157,ClinicalTrials.gov,2021-03-02,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.,25,https://clinicaltrials.gov/show/NCT04785157,NA
NCT04789460,ClinicalTrials.gov,2021-03-04,2021-03-05,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Relationship Between Potential Predictors and Mortality in COVID-19 Patients in Turkey,816,https://clinicaltrials.gov/show/NCT04789460,NA
NCT04790240,ClinicalTrials.gov,2021-02-23,2021-02-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United States,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),120,https://clinicaltrials.gov/show/NCT04790240,NA
NCT04794387,ClinicalTrials.gov,2021-03-09,2021-02-23,TRUE,Recruiting,Not Applicable,Observational,United States,The Lymphoma and Leukemia Society COVID-19 Registry,1000,https://clinicaltrials.gov/show/NCT04794387,NA
NCT04796584,ClinicalTrials.gov,2021-03-11,2021-03-18,FALSE,Recruiting,Not Applicable,Observational,United States,Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication,40,https://clinicaltrials.gov/show/NCT04796584,NA
NCT04798001,ClinicalTrials.gov,2021-03-09,2021-04-12,FALSE,Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,130,https://clinicaltrials.gov/show/NCT04798001,NA
NCT04805671,ClinicalTrials.gov,2021-03-17,2021-07-01,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19,1084,https://clinicaltrials.gov/show/NCT04805671,NA
NCT04805931,ClinicalTrials.gov,2021-03-11,2021-03-15,FALSE,Recruiting,Not Applicable,Interventional,United States,VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans,4311,https://clinicaltrials.gov/show/NCT04805931,NA
NCT04806815,ClinicalTrials.gov,2021-03-17,2021-05-18,FALSE,Recruiting,Not Applicable,Observational,Turkey,"Menstrual Cycle-induced Pain, Fatigue and Anxiety in Women Suffered From COVID-19",180,https://clinicaltrials.gov/show/NCT04806815,NA
NCT04813562,ClinicalTrials.gov,2021-03-19,2021-03-23,FALSE,Recruiting,Phase 2,Interventional,China,Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells),480,https://clinicaltrials.gov/show/NCT04813562,NA
NCT04816643,ClinicalTrials.gov,2021-03-19,2021-03-24,FALSE,Recruiting,Phase 1/Phase 2,Interventional,"Spain, Finland, United States, Poland","Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age",4644,https://clinicaltrials.gov/show/NCT04816643,NA
NCT04816669,ClinicalTrials.gov,2021-03-24,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,United States,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults",610,https://clinicaltrials.gov/show/NCT04816669,NA
NCT04818970,ClinicalTrials.gov,2021-03-24,2021-05-21,FALSE,Recruiting,Not Applicable,Interventional,United States,Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04818970,NA
NCT04821037,ClinicalTrials.gov,2021-03-26,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,Switzerland,Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Nurses During COVID-19,10,https://clinicaltrials.gov/show/NCT04821037,NA
NCT04826640,ClinicalTrials.gov,2021-03-30,2021-05-24,FALSE,Recruiting,Not Applicable,Observational,United States,Observational Maternal COVID-19 Vaccination Study,350,https://clinicaltrials.gov/show/NCT04826640,NA
NCT04828135,ClinicalTrials.gov,2021-03-11,2021-05-26,FALSE,Recruiting,Phase 2,Interventional,United States,Dual MRI for Cardiopulmonary COVID-19 Long Haulers,30,https://clinicaltrials.gov/show/NCT04828135,NA
NCT04831866,ClinicalTrials.gov,2021-04-02,2021-04-26,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Surveillance and Exposure Testing in School Communities,1000000,https://clinicaltrials.gov/show/NCT04831866,NA
NCT04838119,ClinicalTrials.gov,2021-04-07,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,United States,Preop COVID Testing Patterns,300000,https://clinicaltrials.gov/show/NCT04838119,NA
NCT04838821,ClinicalTrials.gov,2021-03-23,2021-03-29,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Costa Rica,Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients,156,https://clinicaltrials.gov/show/NCT04838821,NA
NCT04842448,ClinicalTrials.gov,2021-04-09,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,Sweden,Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome,80,https://clinicaltrials.gov/show/NCT04842448,NA
NCT04844138,ClinicalTrials.gov,2021-04-05,2021-04-30,FALSE,Recruiting,Not Applicable,Interventional,Canada,Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program,100,https://clinicaltrials.gov/show/NCT04844138,NA
NCT04846010,ClinicalTrials.gov,2021-03-31,2021-03-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United States,"Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2",2000,https://clinicaltrials.gov/show/NCT04846010,NA
NCT04847141,ClinicalTrials.gov,2021-04-14,2021-04-28,FALSE,Recruiting,Phase 3,Interventional,Spain,A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients,801,https://clinicaltrials.gov/show/NCT04847141,NA
NCT04849585,ClinicalTrials.gov,2021-02-23,2021-05-01,FALSE,Recruiting,Not Applicable,Observational,France,Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection,40,https://clinicaltrials.gov/show/NCT04849585,NA
NCT04852757,ClinicalTrials.gov,2021-04-20,2021-05-25,FALSE,Recruiting,Not Applicable,Observational,France,Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic,2725,https://clinicaltrials.gov/show/NCT04852757,NA
NCT04852835,ClinicalTrials.gov,2021-04-07,2021-04-30,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19 Vaccine Response,800,https://clinicaltrials.gov/show/NCT04852835,NA
NCT04858568,ClinicalTrials.gov,2021-04-22,2021-03-11,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Immune Responses to COVID-19 Vaccination in Lymphoma Patients,680,https://clinicaltrials.gov/show/NCT04858568,NA
NCT04864132,ClinicalTrials.gov,2021-04-20,2021-05-27,FALSE,Recruiting,Not Applicable,Observational,Turkey,The Investigation Of Exercise Capacity And Exercise-Induced Fatigue in Young Adults Who Survived From Coronavirus,150,https://clinicaltrials.gov/show/NCT04864132,NA
NCT04868864,ClinicalTrials.gov,2021-04-24,2021-05-15,FALSE,Recruiting,Not Applicable,Observational,Canada,The Ontario Multi-Regional Hospital COVID-19 Registry (COREG)- Recovery Trajectory Sub-study,200,https://clinicaltrials.gov/show/NCT04868864,NA
NCT04870385,ClinicalTrials.gov,2021-04-07,2021-04-11,FALSE,Not Recruiting,Not Applicable,Interventional,Malaysia,An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-risk Young Adults in the COVID-19 Pandemic,120,https://clinicaltrials.gov/show/NCT04870385,NA
NCT04870411,ClinicalTrials.gov,2021-03-26,2021-05-12,FALSE,Recruiting,Not Applicable,Observational,France,Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics,200,https://clinicaltrials.gov/show/NCT04870411,NA
NCT04871737,ClinicalTrials.gov,2021-04-21,2021-05-20,FALSE,Recruiting,Phase 1,Interventional,Mexico,Study of a Live rNDV Based Vaccine Against COVID-19,90,https://clinicaltrials.gov/show/NCT04871737,NA
NCT04871932,ClinicalTrials.gov,2021-04-30,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,China,COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics,50,https://clinicaltrials.gov/show/NCT04871932,NA
NCT04874766,ClinicalTrials.gov,2021-04-23,2021-05-28,FALSE,Recruiting,Not Applicable,Interventional,Canada,The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19,24,https://clinicaltrials.gov/show/NCT04874766,NA
NCT04877496,ClinicalTrials.gov,2021-05-06,2021-04-26,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.,425,https://clinicaltrials.gov/show/NCT04877496,NA
NCT04878822,ClinicalTrials.gov,2021-05-04,2021-04-13,TRUE,Recruiting,Not Applicable,Observational,Italy,Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies,300,https://clinicaltrials.gov/show/NCT04878822,NA
NCT04883190,ClinicalTrials.gov,2021-04-30,2021-05-15,FALSE,Recruiting,Not Applicable,Observational,Germany,Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial,500,https://clinicaltrials.gov/show/NCT04883190,NA
NCT04884295,ClinicalTrials.gov,2021-05-06,2021-05-01,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Belgium,"Dose-Finding, Safety, and Efficacy Study of XVR011 Added to Standard of Care in Patients Hospitalised for COVID-19",279,https://clinicaltrials.gov/show/NCT04884295,NA
NCT04885478,ClinicalTrials.gov,2021-05-12,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Spain,Professional's Health in Epidemiological Crisis Covid-19,1350,https://clinicaltrials.gov/show/NCT04885478,NA
NCT04885491,ClinicalTrials.gov,2021-02-15,2021-05-07,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Sweden,"A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Covid-19 Patients With aPH",16,https://clinicaltrials.gov/show/NCT04885491,NA
NCT04888793,ClinicalTrials.gov,2021-05-09,2021-05-12,FALSE,Recruiting,Not Applicable,Observational,Chile,Immune Response to Anti COVID-19 Vaccine in Immunocompromised Patients: a Cohort Study,516,https://clinicaltrials.gov/show/NCT04888793,NA
NCT04889261,ClinicalTrials.gov,2021-05-12,2021-05-17,FALSE,Recruiting,Not Applicable,Observational,Spain,External Validation of the CHOD Risk Scale,245,https://clinicaltrials.gov/show/NCT04889261,NA
NCT04890483,ClinicalTrials.gov,2021-05-17,2021-05-17,FALSE,Recruiting,Not Applicable,Interventional,Brazil,tDCS in Post-Acute COVID-19 Patients With SARDs,20,https://clinicaltrials.gov/show/NCT04890483,NA
NCT04890509,ClinicalTrials.gov,2021-05-17,2020-10-20,TRUE,Not Recruiting,Phase 2,Interventional,India,A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,120,https://clinicaltrials.gov/show/NCT04890509,NA
NCT04890600,ClinicalTrials.gov,2021-04-22,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 and Psycological Well-being in Healthcare Workers,350,https://clinicaltrials.gov/show/NCT04890600,NA
NCT04890626,ClinicalTrials.gov,2021-05-17,2020-04-04,TRUE,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19,2193,https://clinicaltrials.gov/show/NCT04890626,NA
NCT04890665,ClinicalTrials.gov,2021-05-17,2021-06-20,FALSE,Not Recruiting,Not Applicable,Interventional,Mexico,"Online Multi-component Psychological Intervention for Anxiety, Depression, and Burnout on Healthcare Workers During the COVID-19 Pandemic",42,https://clinicaltrials.gov/show/NCT04890665,NA
NCT04891172,ClinicalTrials.gov,2021-05-17,2021-06-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Pakistan,Anti COVID 19 Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients,310,https://clinicaltrials.gov/show/NCT04891172,NA
NCT04891250,ClinicalTrials.gov,2021-05-11,2021-06-01,FALSE,Not Recruiting,Phase 4,Interventional,Zambia,The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19,800,https://clinicaltrials.gov/show/NCT04891250,NA
NCT04891276,ClinicalTrials.gov,2021-05-17,2020-10-16,TRUE,Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk,3300000,https://clinicaltrials.gov/show/NCT04891276,NA
NCT04891302,ClinicalTrials.gov,2021-05-13,2021-03-19,TRUE,Recruiting,Phase 2,Interventional,South Korea,The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19,80,https://clinicaltrials.gov/show/NCT04891302,NA
NCT04892797,ClinicalTrials.gov,2021-02-09,2021-02-03,TRUE,Recruiting,Not Applicable,Observational,United States,Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients,60,https://clinicaltrials.gov/show/NCT04892797,NA
NCT04892888,ClinicalTrials.gov,2021-05-18,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms,1000,https://clinicaltrials.gov/show/NCT04892888,NA
NCT04892979,ClinicalTrials.gov,2021-03-01,2020-10-01,TRUE,Recruiting,Not Applicable,Interventional,Hong Kong,3R Rehabilitation Management of COVID-19 Survivors,400,https://clinicaltrials.gov/show/NCT04892979,NA
NCT04893031,ClinicalTrials.gov,2021-05-10,2020-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,"Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study",213,https://clinicaltrials.gov/show/NCT04893031,NA
NCT04893265,ClinicalTrials.gov,2021-05-17,2021-06-30,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination,240,https://clinicaltrials.gov/show/NCT04893265,NA
NCT04894214,ClinicalTrials.gov,2021-05-17,2021-01-11,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19,11,https://clinicaltrials.gov/show/NCT04894214,NA
NCT04894227,ClinicalTrials.gov,2021-05-10,2021-05-11,FALSE,Not Recruiting,Phase 4,Interventional,China,Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults,1080,https://clinicaltrials.gov/show/NCT04894227,NA
NCT04894266,ClinicalTrials.gov,2021-05-05,2021-06-12,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,An Open-Label Study of Apabetalone in Covid Infection,100,https://clinicaltrials.gov/show/NCT04894266,NA
NCT04894279,ClinicalTrials.gov,2021-05-16,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Reliability and Validity of the Turkish Version of SMILE-C,135,https://clinicaltrials.gov/show/NCT04894279,NA
NCT04894331,ClinicalTrials.gov,2021-05-18,2020-10-08,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Telemedicine for SNAS Patients in COVID-19 Pandemic,20,https://clinicaltrials.gov/show/NCT04894331,NA
NCT04894409,ClinicalTrials.gov,2021-05-16,2020-04-24,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,Evaluation of Silver Nanoparticles for the Prevention of COVID-19,231,https://clinicaltrials.gov/show/NCT04894409,NA
NCT04894760,ClinicalTrials.gov,2021-04-12,2020-12-30,TRUE,Recruiting,Not Applicable,Observational,Mexico,Evaluation of a COVID-19 Rapid Diagnostic Test in ER Departments in Mexico: a Multi-center Study,1000,https://clinicaltrials.gov/show/NCT04894760,NA
NCT04895007,ClinicalTrials.gov,2021-05-14,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Comparative Evaluation of Covid-19 Vaccines Response,1500,https://clinicaltrials.gov/show/NCT04895007,NA
NCT04895085,ClinicalTrials.gov,2021-05-14,2021-04-27,TRUE,Recruiting,Not Applicable,Interventional,United States,"ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance",50,https://clinicaltrials.gov/show/NCT04895085,NA
NCT04895189,ClinicalTrials.gov,2021-05-06,2021-05-03,TRUE,Recruiting,Not Applicable,Observational,United States,Yale COVID-19 Recovery Study,100,https://clinicaltrials.gov/show/NCT04895189,NA
NCT04895267,ClinicalTrials.gov,2021-05-15,2020-07-03,TRUE,Recruiting,Not Applicable,Interventional,Mexico,Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients,17,https://clinicaltrials.gov/show/NCT04895267,NA
NCT04895462,ClinicalTrials.gov,2021-05-16,2021-04-30,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19,300,https://clinicaltrials.gov/show/NCT04895462,NA
NCT04895475,ClinicalTrials.gov,2021-05-17,2021-02-19,TRUE,Not Recruiting,Not Applicable,Observational,United States,Antibody Detection of Vaccine-Induced Secretory Effects,61,https://clinicaltrials.gov/show/NCT04895475,NA
NCT04895683,ClinicalTrials.gov,2021-05-17,2021-05-11,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Using Text Messages to Improve COVID-19 Vaccination Uptake,120000,https://clinicaltrials.gov/show/NCT04895683,NA
NCT04895982,ClinicalTrials.gov,2021-05-05,2021-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants =2 Years",360,https://clinicaltrials.gov/show/NCT04895982,NA
NCT04896541,ClinicalTrials.gov,2021-02-26,2021-03-16,FALSE,Recruiting,Phase 1,Interventional,Japan,"Phase I Double-blind, Placebo-controlled Study of AZD7442",40,https://clinicaltrials.gov/show/NCT04896541,NA
NCT04896606,ClinicalTrials.gov,2021-05-19,2021-06-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease,50,https://clinicaltrials.gov/show/NCT04896606,NA
NCT04896762,ClinicalTrials.gov,2021-05-15,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,Egypt,Extrapulmonary Presentations of COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04896762,NA
NCT04896788,ClinicalTrials.gov,2021-05-18,2021-05-19,FALSE,Recruiting,Not Applicable,Interventional,France,Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff,300,https://clinicaltrials.gov/show/NCT04896788,NA
NCT04896840,ClinicalTrials.gov,2021-05-14,2021-05-20,FALSE,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation in Children With Cerebral Palsy in the Covid-19 Pandemic,30,https://clinicaltrials.gov/show/NCT04896840,NA
NCT04896853,ClinicalTrials.gov,2021-05-18,2021-05-18,FALSE,Recruiting,Phase 1,Interventional,Sweden,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTransÂ®,9,https://clinicaltrials.gov/show/NCT04896853,NA
NCT04896866,ClinicalTrials.gov,2021-05-17,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,Canada,Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP),558,https://clinicaltrials.gov/show/NCT04896866,NA
NCT04896905,ClinicalTrials.gov,2021-05-19,2020-10-01,TRUE,Not Recruiting,Not Applicable,Observational,Switzerland,Rehabilitation After Covid19-Clinical Results and Predictive Factors,101,https://clinicaltrials.gov/show/NCT04896905,NA
NCT04896918,ClinicalTrials.gov,2021-05-20,2015-10-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Tobacco Use and the Risk of COVID-19,450000,https://clinicaltrials.gov/show/NCT04896918,NA
NCT04896944,ClinicalTrials.gov,2021-05-20,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,France,Is Precariousness a Risk Factor for COVID-19 Mortality in Intensive Care?,200,https://clinicaltrials.gov/show/NCT04896944,NA
NCT04896957,ClinicalTrials.gov,2021-05-20,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,France,Perceptions and Representations of Vaccination Against COVID-19,15,https://clinicaltrials.gov/show/NCT04896957,NA
NCT04896970,ClinicalTrials.gov,2021-05-11,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall,1390,https://clinicaltrials.gov/show/NCT04896970,NA
NCT04896983,ClinicalTrials.gov,2021-05-12,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,National Survey of Mental Health After COVID-19 Outbreak,1200,https://clinicaltrials.gov/show/NCT04896983,NA
NCT04897152,ClinicalTrials.gov,2021-05-18,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Coronavirus Associated Pneumomediastinum and Pneumothorax,241,https://clinicaltrials.gov/show/NCT04897152,NA
NCT04898062,ClinicalTrials.gov,2021-05-20,2021-05-05,TRUE,Recruiting,Not Applicable,Interventional,Germany,"CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19",50,https://clinicaltrials.gov/show/NCT04898062,NA
NCT04898088,ClinicalTrials.gov,2021-05-21,2020-01-01,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,A Proof of Concept Study for the DNA Repair Driven by the Mesenchymal Stem Cells in Critical COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04898088,NA
NCT04898127,ClinicalTrials.gov,2021-05-21,2021-05-01,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission (COVID-19) at Mass Gathering Events.,30000,https://clinicaltrials.gov/show/NCT04898127,NA
NCT04898140,ClinicalTrials.gov,2021-05-21,2020-10-20,TRUE,Recruiting,Not Applicable,Observational,Russian Federation,The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents,6500,https://clinicaltrials.gov/show/NCT04898140,NA
NCT04898166,ClinicalTrials.gov,2021-05-11,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).,300,https://clinicaltrials.gov/show/NCT04898166,NA
NCT04898192,ClinicalTrials.gov,2021-05-21,2021-04-01,TRUE,Recruiting,Not Applicable,Observational,Slovakia,Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions,1500,https://clinicaltrials.gov/show/NCT04898192,NA
NCT04898205,ClinicalTrials.gov,2021-05-17,2021-01-21,TRUE,Recruiting,Not Applicable,Interventional,United States,Cardiopulmonary Rehabilitation in COVID-19 Longhaulers,24,https://clinicaltrials.gov/show/NCT04898205,NA
NCT04898738,ClinicalTrials.gov,2021-05-19,2021-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"Prospective COVID-19 Cohort Study, Dominican Republic",2000,https://clinicaltrials.gov/show/NCT04898738,NA
NCT04898946,ClinicalTrials.gov,2021-05-20,2021-03-08,TRUE,Recruiting,Not Applicable,Observational,Hong Kong,Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong,400,https://clinicaltrials.gov/show/NCT04898946,NA
NCT04898985,ClinicalTrials.gov,2021-05-20,2021-05-20,FALSE,Recruiting,Not Applicable,Observational,United States,The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19,1000,https://clinicaltrials.gov/show/NCT04898985,NA
NCT04899232,ClinicalTrials.gov,2021-05-20,2021-06-17,FALSE,Not Recruiting,Phase 2,Interventional,United States,Antithrombin III in Infectious Disease Caused by COVID-19,75,https://clinicaltrials.gov/show/NCT04899232,NA
NCT04899245,ClinicalTrials.gov,2021-05-19,2021-05-04,TRUE,Recruiting,Not Applicable,Interventional,United States,ReSET Aim 1b: Restarting Safe Education and Testing for Children With Medical Complexity - COVID-19 Testing in School With Children and Staff,115,https://clinicaltrials.gov/show/NCT04899245,NA
NCT04900129,ClinicalTrials.gov,2021-05-18,2020-12-01,TRUE,Not Recruiting,Phase 1,Interventional,Bangladesh,"Inhalation of Vapor With Medication (Diclofenac Sodium, Menthol, Methyl Salicylate and N-Acetyl Cysteine) Reduces Oxygen Need and Hospital Stay in COVID-19 Patients - A Case Control Study",43,https://clinicaltrials.gov/show/NCT04900129,NA
NCT04900155,ClinicalTrials.gov,2021-05-09,2020-11-20,TRUE,Recruiting,Not Applicable,Interventional,Russian Federation,Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19,200,https://clinicaltrials.gov/show/NCT04900155,NA
NCT04900233,ClinicalTrials.gov,2021-05-15,2021-05-06,TRUE,Not Recruiting,Not Applicable,Observational,Argentina,Effect of Covid-19 Pandemic in Non Covid-19 Patients at the Emergency Surgical Department,651,https://clinicaltrials.gov/show/NCT04900233,NA
NCT04900259,ClinicalTrials.gov,2021-05-23,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations,183,https://clinicaltrials.gov/show/NCT04900259,NA
NCT04900337,ClinicalTrials.gov,2021-05-19,2021-02-09,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.",100,https://clinicaltrials.gov/show/NCT04900337,NA
NCT04900376,ClinicalTrials.gov,2021-05-22,2021-02-15,TRUE,Recruiting,Not Applicable,Observational,France,Evaluation of Covid-19 Vaccination in Elderly Subjects in Retirement Home (EHPAD) and Long-term Care Units (USLD) in Ile-de-France,4100,https://clinicaltrials.gov/show/NCT04900376,NA
NCT04900389,ClinicalTrials.gov,2021-05-14,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Nurses' Having COVID-19 on Their Professional Lives,354,https://clinicaltrials.gov/show/NCT04900389,NA
NCT04900402,ClinicalTrials.gov,2021-05-11,2021-05-18,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Activity Level and Quality of Life of Individuals With Physical Disabilities,36,https://clinicaltrials.gov/show/NCT04900402,NA
NCT04900415,ClinicalTrials.gov,2021-05-17,2020-07-22,TRUE,Recruiting,Phase 2,Interventional,Hong Kong,Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction,25,https://clinicaltrials.gov/show/NCT04900415,NA
NCT04900428,ClinicalTrials.gov,2021-05-20,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (UK),350,https://clinicaltrials.gov/show/NCT04900428,NA
NCT04900441,ClinicalTrials.gov,2021-05-21,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Tele-assessment in Individuals With COVID-19,500,https://clinicaltrials.gov/show/NCT04900441,NA
NCT04900454,ClinicalTrials.gov,2021-05-20,2021-06-15,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19,18,https://clinicaltrials.gov/show/NCT04900454,NA
NCT04900961,ClinicalTrials.gov,2021-05-10,2021-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,CISCO-21 Prevent and Treat Long COVID-19.,220,https://clinicaltrials.gov/show/NCT04900961,NA
NCT04901065,ClinicalTrials.gov,2021-05-14,2021-05-11,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Canada,Xylocaine to Freeze During Unpleasant Nasopharyngeal Swabs,88,https://clinicaltrials.gov/show/NCT04901065,NA
NCT04901624,ClinicalTrials.gov,2021-03-29,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities,2160,https://clinicaltrials.gov/show/NCT04901624,NA
NCT04901676,ClinicalTrials.gov,2021-05-24,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Leronlimab in Moderatelly Ill Patients With COVID-19 Pneumonia,594,https://clinicaltrials.gov/show/NCT04901676,NA
NCT04901689,ClinicalTrials.gov,2021-05-24,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Leronlimab in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation,306,https://clinicaltrials.gov/show/NCT04901689,NA
NCT04902118,ClinicalTrials.gov,2021-05-25,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,France,Burnout Determinants Among Pediatric Psychiatry Workers During COVID-19 Crisis,300,https://clinicaltrials.gov/show/NCT04902118,NA
NCT04902157,ClinicalTrials.gov,2021-05-25,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,Iran,Relationship Between CT- Value With Prognosis in COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04902157,NA
NCT04902976,ClinicalTrials.gov,2021-05-24,2021-04-04,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Evaluation of SARS-COV-2 Viral Load of Covid-19 Patients After Rinsing With Oral Antimicrobial Mouthwashes,105,https://clinicaltrials.gov/show/NCT04902976,NA
NCT04903132,ClinicalTrials.gov,2021-05-24,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Cellular Senescence and COVID-19 Long-Hauler Syndrome,35,https://clinicaltrials.gov/show/NCT04903132,NA
NCT04903184,ClinicalTrials.gov,2021-05-21,2020-12-09,TRUE,Recruiting,Phase 2,Interventional,Argentina,Exploratory Study to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,369,https://clinicaltrials.gov/show/NCT04903184,NA
NCT04903327,ClinicalTrials.gov,2021-05-21,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04903327,NA
NCT04903834,ClinicalTrials.gov,2021-05-25,2020-06-30,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study,2000,https://clinicaltrials.gov/show/NCT04903834,NA
NCT04904445,ClinicalTrials.gov,2021-05-17,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Antibody Responses In Cystic Fibrosis,30,https://clinicaltrials.gov/show/NCT04904445,NA
NCT04904471,ClinicalTrials.gov,2021-05-26,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells),40000,https://clinicaltrials.gov/show/NCT04904471,NA
NCT04904484,ClinicalTrials.gov,2021-04-15,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Safety Assessment of the iZephyr Hood for NIV in COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04904484,NA
NCT04904497,ClinicalTrials.gov,2021-04-30,2021-04-01,TRUE,Recruiting,Not Applicable,Interventional,Chile,Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19,60,https://clinicaltrials.gov/show/NCT04904497,NA
NCT04904510,ClinicalTrials.gov,2021-05-19,2020-11-20,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Evaluation of the INDICAIDâ„¢ COVID-19 Rapid Antigen Test,22994,https://clinicaltrials.gov/show/NCT04904510,NA
NCT04904523,ClinicalTrials.gov,2021-05-26,2020-12-16,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.,300,https://clinicaltrials.gov/show/NCT04904523,NA
NCT04904536,ClinicalTrials.gov,2021-05-21,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Australia,Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy,400,https://clinicaltrials.gov/show/NCT04904536,NA
NCT04904692,ClinicalTrials.gov,2020-05-28,2020-03-23,TRUE,Not Recruiting,Not Applicable,Observational,Belgium,Virological and Immunological Monitoring in Patients (Suspected of/Confirmed With) COVID-19,109,https://clinicaltrials.gov/show/NCT04904692,NA
NCT04904731,ClinicalTrials.gov,2021-05-24,2021-02-19,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related,24,https://clinicaltrials.gov/show/NCT04904731,NA
NCT04904744,ClinicalTrials.gov,2021-05-25,2021-05-24,TRUE,Not Recruiting,Not Applicable,Interventional,United States,"Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination",1068,https://clinicaltrials.gov/show/NCT04904744,NA
NCT04905823,ClinicalTrials.gov,2021-05-24,2021-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D),600,https://clinicaltrials.gov/show/NCT04905823,NA
NCT04905836,ClinicalTrials.gov,2021-05-27,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,100,https://clinicaltrials.gov/show/NCT04905836,NA
NCT04905862,ClinicalTrials.gov,2021-05-27,2021-02-15,TRUE,Recruiting,Not Applicable,Observational,Poland,Assessment of Immune Response After Vaccination Against COVID-19 in Dialyzed Patients,180,https://clinicaltrials.gov/show/NCT04905862,NA
NCT04905875,ClinicalTrials.gov,2021-05-24,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry,1000,https://clinicaltrials.gov/show/NCT04905875,NA
NCT04906694,ClinicalTrials.gov,2021-05-26,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPSâ„¢) in Outpatient Adults With COVID-19 (US),72,https://clinicaltrials.gov/show/NCT04906694,NA
NCT04906850,ClinicalTrials.gov,2021-05-25,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,France,Evaluation of the New Variant 501Y.V2 of COVID-19,250,https://clinicaltrials.gov/show/NCT04906850,NA
NCT04907877,ClinicalTrials.gov,2021-05-28,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Bifido- and Lactobacilli in Symptomatic Adult COVID-19 Outpatients,300,https://clinicaltrials.gov/show/NCT04907877,NA
NCT04907890,ClinicalTrials.gov,2021-05-26,2021-06-14,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Long Term Outcomes in COVID-19 Patients Recruited in the CORIST Project,10000,https://clinicaltrials.gov/show/NCT04907890,NA
NCT04907903,ClinicalTrials.gov,2021-04-07,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"RinasciMENTE, An Internet-Based Self-Help Intervention for People With Psychological Distress Due to COVID-19",128,https://clinicaltrials.gov/show/NCT04907903,NA
NCT04907916,ClinicalTrials.gov,2021-05-28,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Sirtuin1 in COVID19 Patients,130,https://clinicaltrials.gov/show/NCT04907916,NA
NCT04907942,ClinicalTrials.gov,2021-04-02,2020-10-29,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Feasibility and Acceptability of Click's EMA and Text Message Intervention for STRESS Management,82,https://clinicaltrials.gov/show/NCT04907942,NA
NCT04907994,ClinicalTrials.gov,2021-05-14,2021-09-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases,100000,https://clinicaltrials.gov/show/NCT04907994,NA
NCT04908007,ClinicalTrials.gov,2021-05-17,2020-09-01,TRUE,Recruiting,Not Applicable,Observational,France,COvid Pandemic Institutional maNaGement,20000,https://clinicaltrials.gov/show/NCT04908007,NA
NCT04909892,ClinicalTrials.gov,2021-05-29,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",30,https://clinicaltrials.gov/show/NCT04909892,NA
NCT04909918,ClinicalTrials.gov,2021-05-30,2021-05-28,TRUE,Recruiting,Phase 3,Interventional,Egypt,Impact of Steroids on Inflammatory Response in Covid-19,60,https://clinicaltrials.gov/show/NCT04909918,NA
NCT04909996,ClinicalTrials.gov,2021-05-28,2021-05-20,TRUE,Recruiting,Not Applicable,Interventional,Italy,Study on the Performance and Safety of Sentinox in COVID-19 Patients,57,https://clinicaltrials.gov/show/NCT04909996,NA
NCT04910113,ClinicalTrials.gov,2021-05-17,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Bronchiactasis as Atypical Presentation in COVID-19,35,https://clinicaltrials.gov/show/NCT04910113,NA
NCT04910191,ClinicalTrials.gov,2021-02-23,2020-05-27,TRUE,Recruiting,Not Applicable,Interventional,Israel,Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients,200,https://clinicaltrials.gov/show/NCT04910191,NA
NCT04910542,ClinicalTrials.gov,2021-03-30,2021-03-09,TRUE,Recruiting,Not Applicable,Interventional,Puerto Rico,Epidemiologic Intelligence Network (EpI-Net) to Promote COVID-19 Testing,3060,https://clinicaltrials.gov/show/NCT04910542,NA
NCT04913116,ClinicalTrials.gov,2021-05-12,2021-01-30,TRUE,Recruiting,Not Applicable,Observational,Denmark,Generic Testing of Antigen Tests for COVID-19 in Denmark,4400,https://clinicaltrials.gov/show/NCT04913116,NA
ACTRN12621000538842,ANZCTR,2021-05-06,2021-06-04,FALSE,Recruiting,Not Applicable,Observational,Australia,COVID-19 Vaccine Efficacy in patients with Blood Cancer,50,https://anzctr.org.au/ACTRN12621000538842.aspx,NA
ACTRN12621000532808,ANZCTR,2021-05-06,2021-01-04,TRUE,Recruiting,Not Applicable,Interventional,Australia,Vaccination of kidney transplant and dialysis patients and their close household contacts against COVID-19,200,https://anzctr.org.au/ACTRN12621000532808.aspx,NA
ACTRN12621000661875,ANZCTR,2021-06-01,2021-10-05,FALSE,Recruiting,Phase 4,Interventional,Australia,Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease,100,https://anzctr.org.au/ACTRN12621000661875.aspx,NA
ISRCTN14624773,ISRCTN,2021-05-25,2021-05-24,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"Diabetes, high blood pressure and COVID-19 exposure screening in a dental setting",1056,http://isrctn.com/ISRCTN14624773,NA
ISRCTN17395671,ISRCTN,2021-05-24,2021-01-07,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Does an infant feeding helper service increase infant feeding practices in firstborn babies?,2730,http://isrctn.com/ISRCTN17395671,NA
ISRCTN18003630,ISRCTN,2021-05-19,2021-02-18,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,The development of an online advance care planning resource for nursing homes during a COVID-19 outbreak,99,http://isrctn.com/ISRCTN18003630,NA
ISRCTN47802196,ISRCTN,2021-05-19,1996-01-06,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Effect of BCG vaccination for tuberculosis on COVID-19 in Brazil,200805,http://isrctn.com/ISRCTN47802196,NA
ISRCTN66682918,ISRCTN,2021-05-17,2020-01-03,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of antibiotic use in coronavirus (COVID-19) hospitalised patients,7000,http://isrctn.com/ISRCTN66682918,NA
ISRCTN16205138,ISRCTN,2021-02-26,2021-03-15,FALSE,Recruiting,Not Applicable,Interventional,China,Effectiveness of short-term audio mindfulness in the Chinese community: a pilot study,140,http://isrctn.com/ISRCTN16205138,NA
ISRCTN11203922,ISRCTN,2021-02-09,2021-01-09,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Neuropsychological evaluation and rehabilitation in multiple sclerosis â€“ feasibility study,2545,http://isrctn.com/ISRCTN11203922,NA
ISRCTN37254291,ISRCTN,2021-01-13,2021-01-18,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,"In the general population, do specific forms of COVID-19 vaccine information, above simple information that they are safe and effective, increase willingness to be vaccinated?",18500,http://isrctn.com/ISRCTN37254291,NA
ISRCTN53038326,ISRCTN,2020-09-23,2020-06-22,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,IMU838 and oseltamivir in the treatment of COVID-19,120,http://isrctn.com/ISRCTN53038326,NA
ISRCTN13177364,ISRCTN,2020-09-09,2020-01-11,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"The development, testing and evaluation of a COVID-19 fundamental nursing care protocol",840,http://isrctn.com/ISRCTN13177364,NA
ISRCTN13471603,ISRCTN,2020-06-17,2020-08-06,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Management of patients with heart failure with preserved ejection fraction: what do patients and providers need and want?,50,http://isrctn.com/ISRCTN13471603,NA
ISRCTN90906759,ISRCTN,2020-05-07,2020-05-28,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a vaccine against COVID-19,12390,http://isrctn.com/ISRCTN90906759,NA
ISRCTN15281137,ISRCTN,2020-04-06,2020-03-26,TRUE,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,"A phase I/II study to determine efficacy, safety and immunogenicity of the candidate coronavirus disease (COVID-19) vaccine ChAdOx1 nCoV-19 in UK healthy adult volunteers",1112,http://isrctn.com/ISRCTN15281137,NA
EUCTR2020-001324-33,EudraCT,2020-03-29,2020-09-04,FALSE,Not Recruiting,Phase 4,Interventional,France,Use of a respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in patients with severe confirmed COVID-19 pneumonia,194,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001324-33,FR
EUCTR2020-001748-24,EudraCT,2020-04-20,2020-05-15,FALSE,Not Recruiting,Phase 2,Interventional,Sweden,"A multi-center, randomized, open-label study in patients with COVID-19 and respiratory distress not requiring mechanical ventilation, to compare standard-of-care with anakinra and tocilizumab treatment.
The Immunomodulation-CoV Assessment (ImmCoVA) study.",120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001748-24,SE
EUCTR2020-001172-15,EudraCT,2020-03-23,2020-08-04,FALSE,Not Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, United Kingdom, United States, Austria, Germany",Recombinant human angiotensin-converting enzyme 2 (rhACE2) as a treat-ment for patients with COVID-19,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001172-15,DE
EUCTR2020-001782-37,EudraCT,2020-06-15,2020-07-11,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Slovakia, Italy, Brazil, Poland, France, Romania","A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg PolyoxidoniumÂ®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19).",464,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001782-37,SK
EUCTR2021-001769-19,EudraCT,2021-03-29,2021-04-15,FALSE,Authorised,Phase 4,Interventional,Sweden,"Immune response to SARS-CoV-2 in health care workers, previously infected subjects, and immunocompromised subjects, before and after Covid-19 vaccination: a phase IV trial",1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001769-19,SE
EUCTR2020-005979-12,EudraCT,2021-04-12,2021-05-17,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and safety of XAV-19 for the treatment of moderate to severe COVID-19,722,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005979-12,BG
EUCTR2020-005366-34,EudraCT,2021-04-20,2021-02-06,TRUE,Authorised,Phase 2,Interventional,"Ireland, Greece, United Kingdom, Spain, Poland, Bulgaria","A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005366-34,ES
EUCTR2021-002245-15,EudraCT,2021-04-30,2021-05-25,FALSE,Authorised,Phase 4,Interventional,Germany,An observational study to investigate the effectiveness and safety of Corona vaccines in patients with rheumatologic diseases.,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002245-15,DE
EUCTR2020-005759-18,EudraCT,2021-04-28,2021-05-25,FALSE,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18,PT
EUCTR2021-002327-38,EudraCT,2021-05-17,2021-05-26,FALSE,Authorised,Phase 4,Interventional,Netherlands,PREGCOVAC-19: the follow up of pregnant women who received COVID-19 vaccination in the Dutch national vaccination program,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002327-38,NL
EUCTR2021-002098-25,EudraCT,2021-05-19,2021-05-27,FALSE,Authorised,Phase 2,Interventional,Germany,An unblinded clinical trial investigating the active substance infliximab in the treatment of severe COVID-19 at multiple study centers,88,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002098-25,DE
EUCTR2021-000724-35,EudraCT,2021-03-31,2021-11-05,FALSE,Authorised,Phase 2,Interventional,"Canada, Germany, South Korea, United States","A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate  the Safety, Tolerability and Pharmacokinetics of VIR-7831 in Non-Hospitalized Participants with Mild to Moderate Coronavirus Disease 2019 (COVID-19)",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000724-35,DE
EUCTR2021-001177-22,EudraCT,2021-03-29,2021-04-26,FALSE,Authorised,Phase 3,Interventional,Denmark,"Treatment of mild COVID-19: a randomized, double blinded, placebo controlled study",226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001177-22,DK
EUCTR2021-000307-20,EudraCT,2021-02-12,2021-04-28,FALSE,Authorised,Phase 4,Interventional,Germany,Tracking the immune response to SARS-CoV-2 modRNA vaccines in an open-label multicenter study in participants with relapsing multiple sclerosis treated with ofatumumab s.c. (KYRIOS),40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000307-20,DE
ChiCTR2100043500,ChiCTR,2021-02-21,2021-02-21,FALSE,Recruiting,Not Applicable,Observational,China,Study on Risk Factors and Mechanisms of Late-onset Schizophrenia Induced by COVID-19,90,http://www.chictr.org.cn/showproj.aspx?proj=121034,NA
ChiCTR2100043428,ChiCTR,2021-02-16,2020-02-06,TRUE,Not Recruiting,Not Applicable,Observational,China,Therapeutic Option of Herbal Medicine Honeysuckle for Novel Coronavirus Pneumonia (COVID-19) : a medical records based study,120,http://www.chictr.org.cn/showproj.aspx?proj=122002,NA
ChiCTR2100043350,ChiCTR,2021-02-11,2021-02-10,TRUE,Recruiting,Not Applicable,Observational,China,"Impact of COVID-19 Pandemic on Acute Pancreatitis Presentations, Management and In-Hospital Outcomes:  a Single-Center, Retrospective Observational Study from the Northeast of China",736,http://www.chictr.org.cn/showproj.aspx?proj=121852,NA
ChiCTR2100043319,ChiCTR,2021-02-10,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,Clinical service quality improvement and implementation strategy for COVID-19 under acute myocardial infarction,20000,http://www.chictr.org.cn/showproj.aspx?proj=121890,NA
ChiCTR2100043241,ChiCTR,2021-02-09,2021-02-01,TRUE,Recruiting,Not Applicable,Observational,China,Clinical study on treating novel coronavirus pneumonia with pulmonary fibrosis with the help of Zhuyang Bufei Chubi granule,100,http://www.chictr.org.cn/showproj.aspx?proj=121773,NA
NCT04331665,ClinicalTrials.gov,2020-04-01,2020-05-21,FALSE,Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,3,https://clinicaltrials.gov/show/NCT04331665,NA
NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),0,https://clinicaltrials.gov/show/NCT04341285,NA
NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,FALSE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,52,https://clinicaltrials.gov/show/NCT04343755,NA
NCT04344184,ClinicalTrials.gov,2020-04-09,2020-12-18,FALSE,Recruiting,Phase 2,Interventional,United States,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),60,https://clinicaltrials.gov/show/NCT04344184,NA
NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,FALSE,Not Recruiting,Not Applicable,Interventional,"Spain, United States",Awake Prone Position for Early Hypoxemia in COVID-19,305,https://clinicaltrials.gov/show/NCT04344587,NA
NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,FALSE,Not Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,146,https://clinicaltrials.gov/show/NCT04350580,NA
NCT04352400,ClinicalTrials.gov,2020-04-03,2021-06-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),256,https://clinicaltrials.gov/show/NCT04352400,NA
NCT04359225,ClinicalTrials.gov,2020-04-16,2021-09-30,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,80,https://clinicaltrials.gov/show/NCT04359225,NA
NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,300,https://clinicaltrials.gov/show/NCT04364802,NA
NCT04370821,ClinicalTrials.gov,2020-04-27,2020-05-09,FALSE,Recruiting,Not Applicable,Observational,United States,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",2600,https://clinicaltrials.gov/show/NCT04370821,NA
NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,FALSE,Not Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,17,https://clinicaltrials.gov/show/NCT04371029,NA
NCT04375046,ClinicalTrials.gov,2020-05-01,2021-07-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2,24,https://clinicaltrials.gov/show/NCT04375046,NA
NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,TRUE,Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,10,https://clinicaltrials.gov/show/NCT04376593,NA
NCT04376775,ClinicalTrials.gov,2020-05-04,2020-05-11,FALSE,Not Recruiting,Not Applicable,Observational,France,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,3602,https://clinicaltrials.gov/show/NCT04376775,NA
NCT04377334,ClinicalTrials.gov,2020-04-16,2021-09-01,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),40,https://clinicaltrials.gov/show/NCT04377334,NA
NCT04379037,ClinicalTrials.gov,2020-05-05,2020-06-27,FALSE,Not Recruiting,Not Applicable,Interventional,Argentina,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,50,https://clinicaltrials.gov/show/NCT04379037,NA
NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-11,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,140,https://clinicaltrials.gov/show/NCT04382651,NA
NCT04382950,ClinicalTrials.gov,2020-05-08,2021-07-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications,24,https://clinicaltrials.gov/show/NCT04382950,NA
NCT04386720,ClinicalTrials.gov,2020-05-11,2020-05-25,FALSE,Recruiting,Not Applicable,Observational,France,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,20,https://clinicaltrials.gov/show/NCT04386720,NA
NCT04388605,ClinicalTrials.gov,2020-05-07,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,United States,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,11000,https://clinicaltrials.gov/show/NCT04388605,NA
NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,TRUE,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,52,https://clinicaltrials.gov/show/NCT04389710,NA
NCT04391309,ClinicalTrials.gov,2020-05-14,2021-04-12,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-19 and Anti-CD14 Treatment Trial,300,https://clinicaltrials.gov/show/NCT04391309,NA
NCT04417673,ClinicalTrials.gov,2020-06-04,2020-06-15,FALSE,Recruiting,Not Applicable,Observational,United States,Living With Sickle Cell Disease in the COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04417673,NA
NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,TRUE,Not Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,73,https://clinicaltrials.gov/show/NCT04422613,NA
NCT04424446,ClinicalTrials.gov,2020-06-09,2020-07-13,FALSE,Not Recruiting,Not Applicable,Observational,United States,Saliva as Source of Detection for SARS-CoV-2,456,https://clinicaltrials.gov/show/NCT04424446,NA
NCT04426201,ClinicalTrials.gov,2020-06-09,2020-12-20,FALSE,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),48,https://clinicaltrials.gov/show/NCT04426201,NA
NCT04433364,ClinicalTrials.gov,2020-06-15,2020-06-02,TRUE,Recruiting,Not Applicable,Observational,Sweden,COPE - COVID-19 in Pregnancy and Early Childhood,1200,https://clinicaltrials.gov/show/NCT04433364,NA
NCT04439071,ClinicalTrials.gov,2020-06-17,2020-07-09,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Australia, Portugal, Belgium, United States, Brazil, Mexico, Spain",A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19),380,https://clinicaltrials.gov/show/NCT04439071,NA
NCT04444297,ClinicalTrials.gov,2020-06-20,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Non-clinical Validation,40,https://clinicaltrials.gov/show/NCT04444297,NA
NCT04444323,ClinicalTrials.gov,2020-06-20,2021-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Cohort Study,50,https://clinicaltrials.gov/show/NCT04444323,NA
NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,TRUE,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,495,https://clinicaltrials.gov/show/NCT04445272,NA
NCT04466670,ClinicalTrials.gov,2020-07-08,2020-07-11,FALSE,Recruiting,Phase 2,Interventional,Brazil,Hemostasis in COVID-19: an Adaptive Clinical Trial,379,https://clinicaltrials.gov/show/NCT04466670,NA
NCT04498325,ClinicalTrials.gov,2020-07-30,2021-07-31,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",42,https://clinicaltrials.gov/show/NCT04498325,NA
NCT04501952,ClinicalTrials.gov,2020-08-05,2020-09-18,FALSE,Not Recruiting,Phase 3,Interventional,"Denmark, Portugal, United Kingdom, United States, Spain",Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,585,https://clinicaltrials.gov/show/NCT04501952,NA
NCT04505722,ClinicalTrials.gov,2020-07-31,2020-09-07,FALSE,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Ukraine, United States, Brazil, Mexico, Philippines",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,44325,https://clinicaltrials.gov/show/NCT04505722,NA
NCT04510194,ClinicalTrials.gov,2020-08-07,2021-01-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,"Outpatient Treatment of SARS-CoV-2 With Ivermectin, Fluvoxamine, and Metformin (COVID-19)",1160,https://clinicaltrials.gov/show/NCT04510194,NA
NCT04523090,ClinicalTrials.gov,2020-08-20,2020-08-27,FALSE,Recruiting,Phase 2/Phase 3,Interventional,South Africa,Catalysing the Containment of COVID-19,440,https://clinicaltrials.gov/show/NCT04523090,NA
NCT04524507,ClinicalTrials.gov,2020-08-21,2020-08-27,FALSE,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,56,https://clinicaltrials.gov/show/NCT04524507,NA
NCT04535778,ClinicalTrials.gov,2020-08-12,2020-11-16,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,200,https://clinicaltrials.gov/show/NCT04535778,NA
NCT04537299,ClinicalTrials.gov,2020-09-01,2021-06-01,FALSE,Recruiting,Phase 2,Interventional,United States,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,150,https://clinicaltrials.gov/show/NCT04537299,NA
NCT04539821,ClinicalTrials.gov,2020-09-03,2020-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Virtual Pain Care Management (COVID-19),60,https://clinicaltrials.gov/show/NCT04539821,NA
NCT04545749,ClinicalTrials.gov,2020-09-02,2020-09-25,FALSE,Not Recruiting,Phase 1,Interventional,Taiwan,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",60,https://clinicaltrials.gov/show/NCT04545749,NA
NCT04547140,ClinicalTrials.gov,2020-09-10,2021-01-29,FALSE,Recruiting,Phase 2,Interventional,"Chile, United States, Brazil",Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),100,https://clinicaltrials.gov/show/NCT04547140,NA
NCT04558749,ClinicalTrials.gov,2020-09-18,2020-10-01,FALSE,Recruiting,Not Applicable,Observational,Egypt,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,150,https://clinicaltrials.gov/show/NCT04558749,NA
NCT04616989,ClinicalTrials.gov,2020-10-20,2020-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Uganda,Mental Health in Communities Affected by COVID-19 in Uganda,814,https://clinicaltrials.gov/show/NCT04616989,NA
NCT04627675,ClinicalTrials.gov,2020-11-06,2020-12-30,FALSE,Not Recruiting,Phase 1,Interventional,United States,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),36,https://clinicaltrials.gov/show/NCT04627675,NA
NCT04628039,ClinicalTrials.gov,2020-11-09,2021-05-28,FALSE,Recruiting,Not Applicable,Interventional,United States,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",506,https://clinicaltrials.gov/show/NCT04628039,NA
NCT04637867,ClinicalTrials.gov,2020-11-16,2020-11-23,FALSE,Not Recruiting,Not Applicable,Interventional,France,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),189,https://clinicaltrials.gov/show/NCT04637867,NA
NCT04640233,ClinicalTrials.gov,2020-11-17,2020-11-30,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-?ov-2) Infection,1600,https://clinicaltrials.gov/show/NCT04640233,NA
NCT04649151,ClinicalTrials.gov,2020-11-30,2020-12-09,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",3732,https://clinicaltrials.gov/show/NCT04649151,NA
NCT04655638,ClinicalTrials.gov,2020-12-03,2021-02-10,FALSE,Recruiting,Not Applicable,Interventional,"Italy, Greece",HFNT vs. COT in COVID-19,364,https://clinicaltrials.gov/show/NCT04655638,NA
NCT04667247,ClinicalTrials.gov,2020-12-03,2020-12-03,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Mushroom-based Product for COVID-19,66,https://clinicaltrials.gov/show/NCT04667247,NA
NCT04676867,ClinicalTrials.gov,2020-12-17,2021-01-11,FALSE,Not Recruiting,Phase 2,Interventional,Canada,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,227,https://clinicaltrials.gov/show/NCT04676867,NA
NCT04689464,ClinicalTrials.gov,2020-12-26,2020-12-01,TRUE,Not Recruiting,Not Applicable,Observational,Iraq,COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients,450,https://clinicaltrials.gov/show/NCT04689464,NA
NCT04701489,ClinicalTrials.gov,2021-01-05,2021-01-14,FALSE,Not Recruiting,Not Applicable,Interventional,United States,UNITE Study (UMN-GE) for COVID-19,30,https://clinicaltrials.gov/show/NCT04701489,NA
NCT04703608,ClinicalTrials.gov,2021-01-06,2021-01-22,FALSE,Recruiting,Phase 3,Interventional,Gambia,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,1200,https://clinicaltrials.gov/show/NCT04703608,NA
NCT04705116,ClinicalTrials.gov,2021-01-01,2021-06-01,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19 Vaccines International Pregnancy Exposure Registry,10000,https://clinicaltrials.gov/show/NCT04705116,NA
NCT04710381,ClinicalTrials.gov,2021-01-13,2021-02-01,FALSE,Recruiting,Phase 4,Interventional,Czech Republic,IMUNORÂ® Preparation in the Prevention of COVID-19,100,https://clinicaltrials.gov/show/NCT04710381,NA
NCT04720378,ClinicalTrials.gov,2021-01-21,2021-05-30,FALSE,Recruiting,Phase 1,Interventional,United States,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,12,https://clinicaltrials.gov/show/NCT04720378,NA
NCT04727775,ClinicalTrials.gov,2021-01-22,2020-12-01,TRUE,Recruiting,Not Applicable,Observational,Kazakhstan,Antiviral Drugs on the Treatment of SARS-CoV-2,150,https://clinicaltrials.gov/show/NCT04727775,NA
NCT04730206,ClinicalTrials.gov,2021-01-28,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,Belgium,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,1316,https://clinicaltrials.gov/show/NCT04730206,NA
NCT04730856,ClinicalTrials.gov,2021-01-14,2021-02-01,FALSE,Recruiting,Phase 3,Interventional,Spain,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),600,https://clinicaltrials.gov/show/NCT04730856,NA
NCT04763681,ClinicalTrials.gov,2021-02-13,2021-01-01,TRUE,Recruiting,Not Applicable,Interventional,Canada,Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction),140,https://clinicaltrials.gov/show/NCT04763681,NA
NCT04765449,ClinicalTrials.gov,2021-02-19,2021-07-30,FALSE,Not Recruiting,Phase 1,Interventional,United States,Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection,24,https://clinicaltrials.gov/show/NCT04765449,NA
NCT04770467,ClinicalTrials.gov,2021-02-22,2021-02-01,TRUE,Not Recruiting,Phase 2,Interventional,China,"A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19",0,https://clinicaltrials.gov/show/NCT04770467,NA
NCT04771000,ClinicalTrials.gov,2021-02-24,2021-02-08,TRUE,Recruiting,Phase 2,Interventional,Spain,A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19,150,https://clinicaltrials.gov/show/NCT04771000,NA
NCT04771611,ClinicalTrials.gov,2021-02-24,2021-06-01,FALSE,Recruiting,Phase 2,Interventional,United States,COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications,150,https://clinicaltrials.gov/show/NCT04771611,NA
NCT04773067,ClinicalTrials.gov,2021-02-23,2021-01-30,TRUE,Recruiting,Phase 2,Interventional,Taiwan,"A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers",3850,https://clinicaltrials.gov/show/NCT04773067,NA
NCT04773899,ClinicalTrials.gov,2021-02-19,2021-07-09,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Associated Endothelial Dysfunction Study,75,https://clinicaltrials.gov/show/NCT04773899,NA
NCT04780152,ClinicalTrials.gov,2021-03-02,2021-10-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Mexico,TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic,172,https://clinicaltrials.gov/show/NCT04780152,NA
NCT04784897,ClinicalTrials.gov,2021-03-03,2021-02-22,TRUE,Not Recruiting,Phase 2,Interventional,"Russian Federation, United States",A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19,120,https://clinicaltrials.gov/show/NCT04784897,NA
NCT04789447,ClinicalTrials.gov,2021-03-04,2021-03-04,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,Initial CT Findings and CO-RADS Stage in COVID-19,895,https://clinicaltrials.gov/show/NCT04789447,NA
NCT04793997,ClinicalTrials.gov,2021-02-28,2021-02-01,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,Microbiome Therapy in Covid-19 Primary Care Support,150,https://clinicaltrials.gov/show/NCT04793997,NA
NCT04794400,ClinicalTrials.gov,2021-03-10,2021-02-04,TRUE,Not Recruiting,Not Applicable,Interventional,Sweden,The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.,18,https://clinicaltrials.gov/show/NCT04794400,NA
NCT04794985,ClinicalTrials.gov,2021-03-09,2021-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Post-COVID-Health Study: Multidimensional Health Status of COVID-19 Survivors One Year After a SARS-CoV-2 Infection,200,https://clinicaltrials.gov/show/NCT04794985,NA
NCT04813718,ClinicalTrials.gov,2021-03-15,2021-06-02,FALSE,Recruiting,Not Applicable,Interventional,Austria,Post COVID-19 Syndrome and the Gut-lung Axis,20,https://clinicaltrials.gov/show/NCT04813718,NA
NCT04818892,ClinicalTrials.gov,2021-03-25,2021-03-26,FALSE,Recruiting,Not Applicable,Observational,United States,Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease,260,https://clinicaltrials.gov/show/NCT04818892,NA
NCT04828434,ClinicalTrials.gov,2021-03-23,2021-04-01,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study,34,https://clinicaltrials.gov/show/NCT04828434,NA
NCT04836793,ClinicalTrials.gov,2021-04-06,2021-04-15,FALSE,Recruiting,Not Applicable,Observational,France,COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2,300,https://clinicaltrials.gov/show/NCT04836793,NA
NCT04841707,ClinicalTrials.gov,2021-03-31,2021-05-10,FALSE,Recruiting,Not Applicable,Interventional,United States,Total-Body Parametric 18F-FDG PET of COVID-19,15,https://clinicaltrials.gov/show/NCT04841707,NA
NCT04848467,ClinicalTrials.gov,2021-04-16,2021-10-01,FALSE,Not Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia","COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older",1000,https://clinicaltrials.gov/show/NCT04848467,NA
NCT04848584,ClinicalTrials.gov,2021-03-30,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study - Kaiser Permanente Southern California,999,https://clinicaltrials.gov/show/NCT04848584,NA
NCT04851821,ClinicalTrials.gov,2021-02-06,2021-01-04,TRUE,Recruiting,Phase 1,Interventional,Tunisia,The Effectiveness of Phytotherapy in SARS-COV2(COVID-19),80,https://clinicaltrials.gov/show/NCT04851821,NA
NCT04852276,ClinicalTrials.gov,2021-04-20,2021-04-20,FALSE,Recruiting,Not Applicable,Observational,United States,Analysis of the Immune Response to COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations,600,https://clinicaltrials.gov/show/NCT04852276,NA
NCT04854798,ClinicalTrials.gov,2021-04-20,2021-04-29,FALSE,Recruiting,Not Applicable,Interventional,United States,UNITE Study (UMN-SW) for COVID-19,58,https://clinicaltrials.gov/show/NCT04854798,NA
NCT04854876,ClinicalTrials.gov,2021-04-21,2021-06-20,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19",200,https://clinicaltrials.gov/show/NCT04854876,NA
NCT04860869,ClinicalTrials.gov,2021-03-03,2021-05-12,FALSE,Recruiting,Not Applicable,Observational,United States,"Endocrine, Metabolic and Microbiome Influence on the Post COVID-19 Syndrome",32,https://clinicaltrials.gov/show/NCT04860869,NA
NCT04867265,ClinicalTrials.gov,2021-04-26,2021-05-03,FALSE,Not Recruiting,Not Applicable,Interventional,Czech Republic,Mouth-to-mouth Ventilation Efficiency Through Breathable Self-sterilizing Respirator During BLS in COVID-19 Pandemic,104,https://clinicaltrials.gov/show/NCT04867265,NA
NCT04869358,ClinicalTrials.gov,2021-04-29,2021-05-27,FALSE,Recruiting,Phase 4,Interventional,Germany,Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab,40,https://clinicaltrials.gov/show/NCT04869358,NA
NCT04873414,ClinicalTrials.gov,2021-04-26,2020-12-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Convalescent Plasma as Adjunct Therapy for COVID-19,364,https://clinicaltrials.gov/show/NCT04873414,NA
NCT04878211,ClinicalTrials.gov,2021-05-03,2021-05-31,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,A Open-label Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab,66,https://clinicaltrials.gov/show/NCT04878211,NA
NCT04878796,ClinicalTrials.gov,2021-05-04,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Italy,Effectiveness of mRNA Covid-19 Vaccines on Cancer Patients:Observational Study. (ANTICOV),300,https://clinicaltrials.gov/show/NCT04878796,NA
NCT04883138,ClinicalTrials.gov,2021-05-04,2021-05-24,FALSE,Recruiting,Phase 1,Interventional,United States,Recombinant Hyperimmune Polyclonal Antibody (GIGA-2050) in COVID-19 Patients,18,https://clinicaltrials.gov/show/NCT04883138,NA
NCT04884685,ClinicalTrials.gov,2021-05-07,2021-05-03,TRUE,Not Recruiting,Phase 2,Interventional,China,Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents,500,https://clinicaltrials.gov/show/NCT04884685,NA
NCT04885907,ClinicalTrials.gov,2021-05-09,2021-05-25,FALSE,Not Recruiting,Phase 4,Interventional,Canada,Third Dose of Moderna COVID-19 Vaccine in Transplant Recipients,120,https://clinicaltrials.gov/show/NCT04885907,NA
NCT04891133,ClinicalTrials.gov,2021-05-07,2021-05-01,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"Hungary, Ireland, Belgium, Luxembourg, Italy, Norway, Spain, Turkey, France, Germany",EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial,1900,https://clinicaltrials.gov/show/NCT04891133,NA
NCT04892459,ClinicalTrials.gov,2021-05-10,2021-05-25,FALSE,Recruiting,Phase 4,Interventional,China,Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector),300,https://clinicaltrials.gov/show/NCT04892459,NA
NCT04893070,ClinicalTrials.gov,2021-05-11,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,France,"Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population",186,https://clinicaltrials.gov/show/NCT04893070,NA
NCT04893512,ClinicalTrials.gov,2021-05-14,2021-06-07,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects,45,https://clinicaltrials.gov/show/NCT04893512,NA
NCT04893668,ClinicalTrials.gov,2021-05-11,2021-10-01,FALSE,Not Recruiting,Not Applicable,Observational,Indonesia,Depression and Anxiety in Long Term Coronavirus Disease COVID-19,165,https://clinicaltrials.gov/show/NCT04893668,NA
NCT04894305,ClinicalTrials.gov,2021-05-18,2021-05-21,FALSE,Recruiting,Phase 1,Interventional,Netherlands,A Study of Ad26.COV2.S in Healthy Adults (COVID-19),380,https://clinicaltrials.gov/show/NCT04894305,NA
NCT04895371,ClinicalTrials.gov,2021-05-15,2021-06-12,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Tele-Physiotherapy After COVID-19 Hospitalization,72,https://clinicaltrials.gov/show/NCT04895371,NA
NCT04896710,ClinicalTrials.gov,2021-05-05,2021-05-26,FALSE,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample,569,https://clinicaltrials.gov/show/NCT04896710,NA
NCT04909476,ClinicalTrials.gov,2021-05-28,2020-11-17,TRUE,Recruiting,Not Applicable,Observational,Italy,Tracheal Intubation in COVID-19 Patients,143,https://clinicaltrials.gov/show/NCT04909476,NA
NCT04909879,ClinicalTrials.gov,2021-05-29,2021-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,100,https://clinicaltrials.gov/show/NCT04909879,NA
NCT04909905,ClinicalTrials.gov,2021-05-30,2021-05-30,FALSE,Recruiting,Phase 3,Interventional,Egypt,Glutamine Supplementation and Short-term Mortality in Covid-19,60,https://clinicaltrials.gov/show/NCT04909905,NA
NCT04910230,ClinicalTrials.gov,2021-05-24,2020-03-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19,24,https://clinicaltrials.gov/show/NCT04910230,NA
NCT04910243,ClinicalTrials.gov,2021-05-28,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Czech Republic,The Practice of Providing Palliative Care in the Situation of the COVID-19 (Coronavirus Disease 2019) Pandemic in Czech Republic,2000,https://clinicaltrials.gov/show/NCT04910243,NA
NCT04910295,ClinicalTrials.gov,2021-05-31,2021-03-26,TRUE,Recruiting,Not Applicable,Observational,South Korea,Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients,300,https://clinicaltrials.gov/show/NCT04910295,NA
NCT04910334,ClinicalTrials.gov,2021-02-04,2020-10-01,TRUE,Recruiting,Not Applicable,Observational,Denmark,Long-term Cognitive and Functional Status After COVID-19 Treatment at Danish ICUs,203,https://clinicaltrials.gov/show/NCT04910334,NA
NCT04910516,ClinicalTrials.gov,2021-05-27,2021-04-10,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,88,https://clinicaltrials.gov/show/NCT04910516,NA
NCT04910633,ClinicalTrials.gov,2021-05-10,2020-12-02,TRUE,Not Recruiting,Not Applicable,Observational,France,Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach,44,https://clinicaltrials.gov/show/NCT04910633,NA
NCT04910958,ClinicalTrials.gov,2021-06-01,2021-01-06,TRUE,Recruiting,Not Applicable,Observational,Israel,Impact of COVID-19 Pandemic on Early Spontaneous Abortions and Early Termination of Pregnancy,1000,https://clinicaltrials.gov/show/NCT04910958,NA
NCT04910971,ClinicalTrials.gov,2021-06-01,2021-01-31,TRUE,Recruiting,Not Applicable,Observational,United States,Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year,60,https://clinicaltrials.gov/show/NCT04910971,NA
NCT04911790,ClinicalTrials.gov,2021-06-02,2021-06-05,FALSE,Not Recruiting,Phase 4,Interventional,No Country Given,Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults,121000,https://clinicaltrials.gov/show/NCT04911790,NA
NCT04911868,ClinicalTrials.gov,2021-05-31,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,Surgical Management During the Era of COVID-19,6846,https://clinicaltrials.gov/show/NCT04911868,NA
NCT04912011,ClinicalTrials.gov,2021-06-01,2021-01-01,TRUE,Recruiting,Phase 4,Interventional,Poland,Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.,50,https://clinicaltrials.gov/show/NCT04912011,NA
NCT04912700,ClinicalTrials.gov,2021-06-01,2021-06-01,FALSE,Recruiting,Not Applicable,Observational,United States,The Impact of Vaccination on Severity of Illness in COVID-19,11834,https://clinicaltrials.gov/show/NCT04912700,NA
NCT04912778,ClinicalTrials.gov,2021-06-02,2021-06-01,TRUE,Recruiting,Not Applicable,Observational,Belgium,Profiling of Post Covid-19 Infection Patients: an Online Survey,2000,https://clinicaltrials.gov/show/NCT04912778,NA
NCT04912791,ClinicalTrials.gov,2021-06-02,2021-11-01,FALSE,Not Recruiting,Not Applicable,Observational,Czech Republic,Obstetric Anaesthesia And Analgesia Month Attributes - in COVID-19,5000,https://clinicaltrials.gov/show/NCT04912791,NA
NCT04912804,ClinicalTrials.gov,2021-06-02,2020-06-30,TRUE,Not Recruiting,Not Applicable,Observational,France,Perceived Health After Hospitalization for COVID-19,200,https://clinicaltrials.gov/show/NCT04912804,NA
NCT04912817,ClinicalTrials.gov,2021-05-31,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,PR-VR At-home Program During and After COVID-19,60,https://clinicaltrials.gov/show/NCT04912817,NA
NCT04912895,ClinicalTrials.gov,2021-06-02,2021-04-14,TRUE,Recruiting,Not Applicable,Interventional,United States,Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19,90,https://clinicaltrials.gov/show/NCT04912895,NA
NCT04912921,ClinicalTrials.gov,2020-10-15,2020-10-20,FALSE,Recruiting,Not Applicable,Interventional,United States,Effect of Palmitoylethanolamide on Proinflammatory Markers in Adults Recently Diagnosed With COVID-19,60,https://clinicaltrials.gov/show/NCT04912921,NA
NCT04912934,ClinicalTrials.gov,2021-05-30,2020-06-20,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome,214,https://clinicaltrials.gov/show/NCT04912934,NA
NCT04913129,ClinicalTrials.gov,2021-05-31,2021-06-14,FALSE,Not Recruiting,Not Applicable,Interventional,United States,The Burden of COVID-19 Survivorship,50,https://clinicaltrials.gov/show/NCT04913129,NA
NCT04913142,ClinicalTrials.gov,2021-05-31,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,France,About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.,60,https://clinicaltrials.gov/show/NCT04913142,NA
NCT04913701,ClinicalTrials.gov,2021-05-31,2020-03-21,TRUE,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility,500,https://clinicaltrials.gov/show/NCT04913701,NA
NCT04913740,ClinicalTrials.gov,2021-06-02,2021-06-01,TRUE,Not Recruiting,Not Applicable,Interventional,China,Nursing Study of Skin Lesions Related to Health Care Protection in Novel Nursing Study of Skin Lesions Related to Health Care Protection in Novel Coronavirus Epidemic,170,https://clinicaltrials.gov/show/NCT04913740,NA
NCT04913779,ClinicalTrials.gov,2021-06-01,2021-06-01,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Study to Evaluate the Safety and Effectiveness of an Immunobiological Drug (Anti SARS-CoV-2) in the Treatment of CoViD-19,200,https://clinicaltrials.gov/show/NCT04913779,NA
NCT04913948,ClinicalTrials.gov,2021-03-03,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Canada,"Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada",100,https://clinicaltrials.gov/show/NCT04913948,NA
NCT04914013,ClinicalTrials.gov,2021-06-02,2021-06-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Fugal Infection in COVID-19 Patients,50,https://clinicaltrials.gov/show/NCT04914013,NA
NCT04914364,ClinicalTrials.gov,2021-06-02,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,United States,Balance in COVID-19,40,https://clinicaltrials.gov/show/NCT04914364,NA
NCT04914377,ClinicalTrials.gov,2021-06-02,2021-06-01,TRUE,Recruiting,Phase 2,Interventional,United States,To Evaluate the Safety and Efficacy of TQ Formula in Covid-19 Participants,60,https://clinicaltrials.gov/show/NCT04914377,NA
NCT04914754,ClinicalTrials.gov,2021-04-26,2021-05-07,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Mechanisms Underlying Long-term Fatigue and Exercise Intolerance Following CoV-2 Infection,56,https://clinicaltrials.gov/show/NCT04914754,NA
NCT04914767,ClinicalTrials.gov,2021-05-28,2021-03-01,TRUE,Recruiting,Phase 1,Interventional,Tunisia,Nigella 5 in the Treatment of SARS COV2 (COVID-19),500,https://clinicaltrials.gov/show/NCT04914767,NA
NCT04914832,ClinicalTrials.gov,2021-06-01,2021-06-30,FALSE,Not Recruiting,Phase 4,Interventional,Swaziland,Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death,600,https://clinicaltrials.gov/show/NCT04914832,NA
NCT04915001,ClinicalTrials.gov,2021-05-29,2020-03-09,TRUE,Not Recruiting,Not Applicable,Observational,China,An Investigation on the Role of Emergency Departments in Combatting Against COVID-19 in Zhejiang Province,181,https://clinicaltrials.gov/show/NCT04915001,NA
NCT04915781,ClinicalTrials.gov,2021-06-03,2017-10-02,TRUE,Not Recruiting,Not Applicable,Observational,Finland,Tobacco Use and COVID-19 Incidence in the Finnish General Population,60872,https://clinicaltrials.gov/show/NCT04915781,NA
NCT04915989,ClinicalTrials.gov,2021-06-03,2021-02-16,TRUE,Not Recruiting,Phase 1,Interventional,South Korea,"Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals",30,https://clinicaltrials.gov/show/NCT04915989,NA
NCT04916275,ClinicalTrials.gov,2021-06-04,2021-06-01,TRUE,Not Recruiting,Not Applicable,Observational,France,"Post-traumatic Stress, Signs of Depression and Burnout Syndrome Among Nursing Home Staff in Occitanie During the COVID-19 Pandemic",3750,https://clinicaltrials.gov/show/NCT04916275,NA
NCT04916561,ClinicalTrials.gov,2021-06-03,2020-05-15,TRUE,Not Recruiting,Not Applicable,Observational,France,Detection of Covid-19 in Tissue Samples of Orthopedic Origin,15,https://clinicaltrials.gov/show/NCT04916561,NA
NCT04916639,ClinicalTrials.gov,2021-05-31,2021-05-27,TRUE,Not Recruiting,Not Applicable,Interventional,No Country Given,Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load.,370,https://clinicaltrials.gov/show/NCT04916639,NA
NCT04916873,ClinicalTrials.gov,2021-06-03,2020-05-28,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Rehabilitation Status of Children With Cerebral Palsy and Anxiety of Their Caregivers During the Covid19 Pandemic,206,https://clinicaltrials.gov/show/NCT04916873,NA
NCT04916886,ClinicalTrials.gov,2021-05-30,2021-06-03,FALSE,Recruiting,Not Applicable,Interventional,China,A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.,2016,https://clinicaltrials.gov/show/NCT04916886,NA
NCT04917523,ClinicalTrials.gov,2021-06-04,2021-06-06,FALSE,Not Recruiting,Phase 3,Interventional,United Arab Emirates,Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above,1800,https://clinicaltrials.gov/show/NCT04917523,NA
NCT04917549,ClinicalTrials.gov,2021-06-03,2020-09-02,TRUE,Recruiting,Not Applicable,Observational,Egypt,Prevalence of Oral Lesions in COVID-19 Patients,124,https://clinicaltrials.gov/show/NCT04917549,NA
ACTRN12620000579998,ANZCTR,2020-05-19,2020-03-06,TRUE,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",9,https://anzctr.org.au/ACTRN12620000579998.aspx,NA
ACTRN12621000704897,ANZCTR,2021-06-08,2021-06-27,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Australia","Study to evaluate the safety, tolerability, and efficacy of enoxaparin for inhalation alone and in combination with N-acetylcysteine  in healthy volunteers and hospitalised COVID-19 patients",60,https://anzctr.org.au/ACTRN12621000704897.aspx,NA
ACTRN12621000722897,ANZCTR,2021-06-09,2021-05-07,TRUE,Not Recruiting,Not Applicable,Interventional,New Zealand,The efficacy of a brief mindset intervention on side effect reporting and experience of the COVID-19 vaccination,660,https://anzctr.org.au/ACTRN12621000722897.aspx,NA
ISRCTN15317247,ISRCTN,2021-06-03,2021-07-06,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Using text messages to boost COVID-19 vaccine booking rate,4270000,http://isrctn.com/ISRCTN15317247,NA
ISRCTN23016116,ISRCTN,2021-06-02,2021-05-01,TRUE,Recruiting,Not Applicable,Interventional,Italy,Effect of prone positioning in patients with severe SARS-CoV-2 pneumonia treated with noninvasive ventilation,165,http://isrctn.com/ISRCTN23016116,NA
ISRCTN14643181,ISRCTN,2021-05-24,2021-05-28,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Long term effects of COVID-19 in people with diabetes,1000,http://isrctn.com/ISRCTN14643181,NA
ISRCTN26200758,ISRCTN,2021-05-11,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Italy,Exploration of the Italian response to COVID-19 pandemic,10000,http://isrctn.com/ISRCTN26200758,NA
ISRCTN13848929,ISRCTN,2021-05-06,2019-09-30,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,"Does a new leaflet with information about the breast cancer screening program, its benefits and risks, affect participation in the screening program?",9640,http://isrctn.com/ISRCTN13848929,NA
ISRCTN77689525,ISRCTN,2020-12-02,2020-08-25,TRUE,Not Recruiting,Not Applicable,Interventional,"Uganda, Tanzania, Zambia","Sharing Stories: A digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania, and Uganda",720,http://isrctn.com/ISRCTN77689525,NA
ISRCTN14707226,ISRCTN,2020-10-02,2020-09-10,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating a new model of rehabilitation for individuals recovering from COVID-19,500,http://isrctn.com/ISRCTN14707226,NA
ISRCTN10207947,ISRCTN,2020-07-21,2020-04-29,TRUE,Recruiting,Phase 3,Interventional,"Indonesia, Benin, United Kingdom, Zambia, Ethiopia, Pakistan, Thailand, Laos, Mali, Niger, Kenya",Study of chloroquine/hydroxychloroquine and coronavirus disease (COVID-19) in the healthcare setting,40000,http://isrctn.com/ISRCTN10207947,NA
ISRCTN86124626,ISRCTN,2020-07-16,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating new point-of-care diagnostic tests for COVID-19,1000,http://isrctn.com/ISRCTN86124626,NA
EUCTR2020-001793-30,EudraCT,2020-05-24,2020-01-07,TRUE,Authorised,Phase 4,Interventional,Denmark,High dose Vitamin D in Preventing Aggravation of COVID-19,480,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001793-30,DK
EUCTR2021-000408-39,EudraCT,2021-05-06,2021-02-06,TRUE,Authorised,Phase 3,Interventional,"Argentina, Russian Federation, Belgium, Netherlands, Canada, Ukraine, United States, Mexico, Spain, Egypt, Brazil, Poland, France, India, Germany, Lebanon, Philippines",A study to test whether BI 767551 can prevent COVID-19 in people who might have been exposed to SARS-CoV-2,1700,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000408-39,BE
EUCTR2021-002348-57,EudraCT,2021-05-10,2021-05-30,FALSE,Authorised,Phase 2,Interventional,Austria,"A Randomized, Parallel Group, Single-Blind, Phase 2 Study to Evaluate the immune response of two classes of SARS-Cov-2 Vaccines employed as Second Boost in Patients under current Rituximab Therapy and no humoral response after standard mRNA vaccination",60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002348-57,AT
EUCTR2021-000291-11,EudraCT,2021-05-11,2021-05-30,FALSE,Authorised,Phase 3,Interventional,Austria,Immuneresponse and clinical efficacy after SARS-CoV-2 Vaccination in immunodefficient patients or those undergoing immunosuppresive therapy (COVID-19),3000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000291-11,AT
EUCTR2020-006082-11,EudraCT,2021-05-21,2021-02-06,TRUE,Authorised,Phase 2/Phase 3,Interventional,"Chile, Argentina, Hungary, South Africa, Peru, Greece, Ukraine, Mexico, Turkey, Brazil, Poland, Germany, Bulgaria","A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)",1084,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-006082-11,GR
EUCTR2021-001735-10,EudraCT,2021-06-04,2021-05-28,TRUE,Authorised,Phase 3,Interventional,"Spain, Germany, Austria, Belgium","COVID-19: A study to learn about the safety, local and systemic reactions, and the immune responses to the SARS-CoV-2 mRNA Vaccine (CVnCoV) when given to participants 45 years or older who have either a solid tumor or blood cancer and are already taking or about to start systemic anticancer therapy
",620,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001735-10,BE
EUCTR2015-002340-14,EudraCT,2015-07-13,2015-09-16,FALSE,Authorised,Phase 4,Interventional,"United Kingdom, Canada, Finland, Austria, France, Bosnia and Herzegovina, Romania, Ireland, Greece, Belgium, Germany, Hungary, Croatia, New Zealand, Netherlands, Italy, Slovenia, Australia, Portugal, United States, Estonia, Serbia, Spain, Israel, Czech Republic",Adaptive trial in severe pneumonia (REMAP-CAP),4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002340-14,NL
EUCTR2020-005752-38,EudraCT,2021-01-19,2021-03-18,FALSE,Authorised,Phase 4,Interventional,Germany,An open-label multicenter study to assess response to SARS-CoV-2 modRNA vaccines in participants with secondary progressive multiple sclerosis treated with Mayzent (siponimod) (AMA-VACC),60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005752-38,DE
EUCTR2020-002322-85,EudraCT,2020-05-14,2020-02-07,TRUE,Authorised,Phase 2,Interventional,"Denmark, Sweden","KAND567 Versus Placebo in Subjects Hospitalized with COVID-19. A Phase II, Randomized, 2-Arm Parallel-Group, Double-blind Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics.",40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002322-85,SE
EUCTR2020-004695-18,EudraCT,2020-10-15,2020-02-12,TRUE,Authorised,Phase 2,Interventional,Germany,Plasma from Covid 19 recovered patients or camostat as a therapy for early SARS-CoV-2 infection in high risk individuals,497,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004695-18,DE
EUCTR2020-003267-26,EudraCT,2020-07-08,2020-02-09,TRUE,Authorised,Phase 1/Phase 2,Interventional,Germany,Study to investigate the safety and effects of a vaccine in healthy adults.,96,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003267-26,DE
JPRN-jRCT1021210009,jRCT,2021-06-04,2021-04-06,TRUE,Recruiting,Not Applicable,Observational,Japan,The safety and efficacy of COVID-19 vaccines among lung transplant recipients,80,https://jrct.niph.go.jp/latest-detail/jRCT1021210009,NA
JPRN-jRCT1071210024,jRCT,2021-05-18,2021-12-05,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Research for COVID-19 vaccine among lung cancer patients undergoing chemotherapy,100,https://jrct.niph.go.jp/latest-detail/jRCT1071210024,NA
JPRN-jRCT2021210006,jRCT,2021-05-28,2021-10-06,FALSE,Not Recruiting,Phase 2,Interventional,Japan,"A Placebo-Controlled, Double-Blind, Phase II Physician-Initiated Trial of TM5614 in Patients with SARS-CoV-2 Pneumonia",100,https://jrct.niph.go.jp/latest-detail/jRCT2021210006,NA
JPRN-jRCT2031200443,jRCT,2021-03-25,2021-03-19,TRUE,Not Recruiting,Phase 3,Interventional,"United States, Japan","REMAP-CAP:Randomized,Embedded,Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia Immune Modulation-2 Domain",136,https://jrct.niph.go.jp/latest-detail/jRCT2031200443,NA
JPRN-jRCT2031210095,jRCT,2021-05-18,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Survey of  the Moderna COVID-19 Vaccine in People at High-Risk of developing Severe COVID-19 Symptoms,1000,https://jrct.niph.go.jp/latest-detail/jRCT2031210095,NA
JPRN-jRCT2041210004,jRCT,2021-04-14,2021-04-14,FALSE,Recruiting,Phase 3,Interventional,Japan,Phase III clinical trial of favipiravir in early-onset COVID-19 patients with severe risk factors,316,https://jrct.niph.go.jp/latest-detail/jRCT2041210004,NA
JPRN-jRCT2041210013,jRCT,2021-04-23,2021-05-13,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Safety and Immunogenicity of EXG-5003.,60,https://jrct.niph.go.jp/latest-detail/jRCT2041210013,NA
JPRN-jRCT2051200092,jRCT,2020-12-09,2020-12-16,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Japan,A Phase 1/2 study of S-268019 in Japanese adult participants,300,https://jrct.niph.go.jp/latest-detail/jRCT2051200092,NA
JPRN-jRCT2071200106,jRCT,2021-03-03,2021-02-03,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Placebo-controlled, multicenter, double-blind, randomized, parallel-group, comparative study to evaluate the safety and immunogenicity of KD-414, a vaccine against COVID-19, in healthy adults aged >=20 years to <65 years, and healthy elderly subjects aged >=65 years.",210,https://jrct.niph.go.jp/latest-detail/jRCT2071200106,NA
JPRN-jRCT2071200111,jRCT,2021-03-10,2021-03-16,FALSE,Recruiting,Phase 1,Interventional,Japan,"A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD7442 in Healthy Japanese Participants",32,https://jrct.niph.go.jp/latest-detail/jRCT2071200111,NA
JPRN-jRCTs031200196,jRCT,2020-11-11,2020-11-11,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,"Combination therapy of favipiravir, camostat mesilate and inhaled ciclesonide for COVID-19 pneumonia",118,https://jrct.niph.go.jp/latest-detail/jRCTs031200196,NA
JPRN-jRCTs031200374,jRCT,2021-02-24,2021-02-25,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Japan,"An open-label, randomized, controlled trial to evaluate the efficacy of convalescent plasma therapy for COVID-19.",200,https://jrct.niph.go.jp/latest-detail/jRCTs031200374,NA
JPRN-jRCTs031200436,jRCT,2021-03-23,2021-05-13,FALSE,Recruiting,Phase 2,Interventional,Japan,Safety and efficacy of favipiravir and camostat mesilate in patients with COVID-19.,200,https://jrct.niph.go.jp/latest-detail/jRCTs031200436,NA
JPRN-jRCTs031210123,jRCT,2021-05-31,2021-05-31,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Japan,Safety study of health food containing 5-aminolevulinic acid phosphate in patients with COVID-19 sequelae using smart watch and electronic research collaborator diary.,40,https://jrct.niph.go.jp/latest-detail/jRCTs031210123,NA
JPRN-jRCTs041200072,jRCT,2020-12-10,2021-02-15,FALSE,Recruiting,Phase 2,Interventional,Japan,"COVID-19 Prevention of worsening of symptoms in asymptomatic to mild patients by combined use of kakkonto and hochuekkito:
Exploratory open-label randomized controlled trial",100,https://jrct.niph.go.jp/latest-detail/jRCTs041200072,NA
JPRN-jRCTs051200049,jRCT,2020-08-26,2020-02-11,TRUE,Recruiting,Phase 2,Interventional,Japan,Therapeutic drug development program for COVID-19,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200049,NA
JPRN-jRCTs051200060,jRCT,2020-09-25,2020-09-25,FALSE,Not Recruiting,Phase 1,Interventional,Japan,Prohylaxis with hydroxichloroquine aiming at prevention of COVID-19 for medical care workers,500,https://jrct.niph.go.jp/latest-detail/jRCTs051200060,NA
JPRN-jRCTs061200002,jRCT,2020-05-20,2020-07-15,FALSE,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,NA
JPRN-jRCTs071210011,jRCT,2021-04-13,2021-12-05,FALSE,Recruiting,Not Applicable,Interventional,Japan,"CAM (Clarithromycin) Effectivity for COVID-19 pneumonia which does not require oxygen administration; multicenter, randomized-controlled, open-label, 3-armed parallel group comparison, exploratory trial",60,https://jrct.niph.go.jp/latest-detail/jRCTs071210011,NA
JPRN-UMIN000040235,UMIN-CTR,2020-04-25,2020-04-23,TRUE,Not Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,NA
JPRN-UMIN000040333,UMIN-CTR,2020-05-08,2020-05-19,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Fact-finding survey on subclinical infection of SARS-CoV-2 in Kanagawa Prefecture,1500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046025,NA
JPRN-UMIN000040402,UMIN-CTR,2020-07-01,2020-06-16,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Verification of operating characteristic of COVID-19 antibody test,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046105,NA
JPRN-UMIN000040598,UMIN-CTR,2020-06-01,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Clinical Outcomes of COVID-19 Infection in Hospitalized Patients with Cardiovascular Diseases and/or Risk Factors: CLAVIS-COVID,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046132,NA
JPRN-UMIN000040602,UMIN-CTR,2020-06-01,2020-06-15,FALSE,Not Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,NA
JPRN-UMIN000041276,UMIN-CTR,2020-09-01,2020-09-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Post-Intensive Care outcomeS of patients with COronaVIrus Disease 2019; PICS-COVID study,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047140,NA
JPRN-UMIN000042235,UMIN-CTR,2020-10-26,2020-11-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Venous Thromboembolism in Patients with COVID-19 in Japan Study,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048031,NA
JPRN-UMIN000042556,UMIN-CTR,2020-12-01,2020-12-05,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,Effect of Internet-delivered psychoeducation program named &quot;Imacoco-care&quot; on improving psychological distress among workers under COVID-19 infection,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048548,NA
JPRN-UMIN000043340,UMIN-CTR,2021-02-16,2021-02-16,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Research for acquired immunity according to COVID-19 vaccination,600,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049480,NA
JPRN-UMIN000043830,UMIN-CTR,2021-04-05,2021-04-25,FALSE,Recruiting,Not Applicable,Observational,Japan,Pilot Study of IoRE (Internet of Robot-surgery Education) in general thoracic surgery under the COVID-19 epidemic,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049997,NA
JPRN-UMIN000044145,UMIN-CTR,2021-05-31,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,"Japan,Asia(except Japan)",A randomized controlled trial of the effect of an Internet cognitive behavioral therapy e-learning program for nurses in Vietnam and Thailand,1200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050128,NA
JPRN-UMIN000044213,UMIN-CTR,2021-05-14,2021-05-14,FALSE,Recruiting,Not Applicable,Observational,Japan,A prospective observational study to investigate the safety of SARS-Cov-2 vaccine for patients with advanced lung cancer who are treated with immune checkpoint inhibitor.,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050488,NA
JPRN-UMIN000044237,UMIN-CTR,2021-05-17,2021-05-17,FALSE,Recruiting,Not Applicable,Other,Japan,Cardiac Involvement of Coronavirus Disease 2019 Assessed by Cardiac Magnetic Resonance: A Meta-analysis,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050500,NA
JPRN-UMIN000044254,UMIN-CTR,2021-05-19,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Characteristics and prognosis of COVID-19 patients with hematological diseases in Japan,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049979,NA
JPRN-UMIN000044261,UMIN-CTR,2021-06-07,2021-06-04,TRUE,Recruiting,Not Applicable,Observational,Japan,Consideration of antibody production of a COMIRNATY intramuscular injection,551,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050555,NA
JPRN-UMIN000044291,UMIN-CTR,2021-05-22,2021-05-24,FALSE,Not Recruiting,Not Applicable,Observational,Japan,A Clinical Trial on the Physical and Mental Effects of COVID-19 vaccination in Patients with Chronic Respiratory Failure.,120,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050592,NA
JPRN-UMIN000044332,UMIN-CTR,2021-05-26,2021-05-15,TRUE,Recruiting,Not Applicable,Observational,Japan,Effect of COVID-19 mRNA Vaccine on Semen Parameters,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050574,NA
JPRN-UMIN000044355,UMIN-CTR,2021-05-28,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Japan,The Impact of COVID-19 Outbreak on Nursing Students in Japan,1300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050657,NA
JPRN-UMIN000044435,UMIN-CTR,2021-06-07,2021-06-07,FALSE,Not Recruiting,Not Applicable,Observational,Japan,Establishment of COVID-19 diagnostic method by new PCR device using a small amount of saliva as a sample,10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050475,NA
JPRN-UMIN000044456,UMIN-CTR,2021-06-09,2021-06-07,TRUE,Recruiting,Not Applicable,Observational,Japan,"Feasibility of Remote Intermitted-Scanned Glucose Monitoring in Hospitalized, Quarantined Covid-19 Patients",100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049508,NA
JPRN-UMIN000044486,UMIN-CTR,2021-06-09,2021-03-01,TRUE,Not Recruiting,Not Applicable,Observational,Japan,Changes in Alcohol Consumption Among a Population Who Underwent Medical Checkups During the First Wave of the COVID-19 Pandemic in Japan: A Single-Center Retrospective Study,350,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050823,NA
JPRN-UMIN000044519,UMIN-CTR,2021-06-13,2021-06-14,FALSE,Not Recruiting,Not Applicable,Interventional,Japan,COVID-19 Antibody quantification and vaccination history and association with viral genotype (variant),40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050864,NA
NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,FALSE,Not Recruiting,Phase 3,Interventional,"Portugal, Belgium, Luxembourg, Austria, France",Trial of Treatments for COVID-19 in Hospitalized Adults,2416,https://clinicaltrials.gov/show/NCT04315948,NA
NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,FALSE,Not Recruiting,Phase 3,Interventional,"Australia, United Kingdom, Netherlands, Brazil, Spain",BCG Vaccination to Protect Healthcare Workers Against COVID-19,10078,https://clinicaltrials.gov/show/NCT04327206,NA
NCT04334512,ClinicalTrials.gov,2020-04-02,2020-06-22,FALSE,Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,600,https://clinicaltrials.gov/show/NCT04334512,NA
NCT04339790,ClinicalTrials.gov,2020-04-08,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,3655,https://clinicaltrials.gov/show/NCT04339790,NA
NCT04341935,ClinicalTrials.gov,2020-04-06,2021-06-30,FALSE,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,0,https://clinicaltrials.gov/show/NCT04341935,NA
NCT04349631,ClinicalTrials.gov,2020-04-06,2020-04-22,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,56,https://clinicaltrials.gov/show/NCT04349631,NA
NCT04360096,ClinicalTrials.gov,2020-04-21,2021-02-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Inhaled ZYESAMIâ„¢ (Aviptadil Acetate) for the Treatment of Severe COVID-19,144,https://clinicaltrials.gov/show/NCT04360096,NA
NCT04361396,ClinicalTrials.gov,2020-04-22,2020-06-16,FALSE,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04361396,NA
NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,FALSE,Not Recruiting,Phase 3,Interventional,"Hungary, Russian Federation, United Kingdom, Italy, United States, Spain, France, Germany",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,451,https://clinicaltrials.gov/show/NCT04362813,NA
NCT04363372,ClinicalTrials.gov,2020-04-24,2020-08-01,FALSE,Not Recruiting,Phase 2,Interventional,United Kingdom,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,0,https://clinicaltrials.gov/show/NCT04363372,NA
NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,FALSE,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,30,https://clinicaltrials.gov/show/NCT04363502,NA
NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,FALSE,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),220,https://clinicaltrials.gov/show/NCT04365257,NA
NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,FALSE,Not Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,189,https://clinicaltrials.gov/show/NCT04366960,NA
NCT04367857,ClinicalTrials.gov,2020-04-28,2020-04-18,TRUE,Recruiting,Not Applicable,Observational,United States,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,1000,https://clinicaltrials.gov/show/NCT04367857,NA
NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,TRUE,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),131,https://clinicaltrials.gov/show/NCT04369742,NA
NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,FALSE,Not Recruiting,Phase 3,Interventional,"United Kingdom, Mexico, Brazil",Early Intervention in COVID-19: Favipiravir Verses Standard Care,502,https://clinicaltrials.gov/show/NCT04373733,NA
NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,48,https://clinicaltrials.gov/show/NCT04379076,NA
NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,TRUE,Not Recruiting,Phase 2,Interventional,"Argentina, Russian Federation, South Africa, United States, Mexico, Brazil, Spain",A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,212,https://clinicaltrials.gov/show/NCT04380961,NA
NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,TRUE,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,32,https://clinicaltrials.gov/show/NCT04388527,NA
NCT04389671,ClinicalTrials.gov,2020-05-13,2020-11-02,FALSE,Recruiting,Phase 2,Interventional,United States,The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19),20,https://clinicaltrials.gov/show/NCT04389671,NA
NCT04393246,ClinicalTrials.gov,2020-05-16,2020-07-03,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,1407,https://clinicaltrials.gov/show/NCT04393246,NA
NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,FALSE,Not Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,615,https://clinicaltrials.gov/show/NCT04394377,NA
NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,TRUE,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,80,https://clinicaltrials.gov/show/NCT04397757,NA
NCT04399252,ClinicalTrials.gov,2020-05-19,2020-06-24,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,182,https://clinicaltrials.gov/show/NCT04399252,NA
NCT04412265,ClinicalTrials.gov,2020-05-30,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Italy,Frailty in Elderly Patients With COVID-19,1377,https://clinicaltrials.gov/show/NCT04412265,NA
NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,TRUE,Not Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,32,https://clinicaltrials.gov/show/NCT04412330,NA
NCT04416048,ClinicalTrials.gov,2020-06-02,2020-11-30,FALSE,Recruiting,Phase 2,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,400,https://clinicaltrials.gov/show/NCT04416048,NA
NCT04418505,ClinicalTrials.gov,2020-06-03,2020-09-02,FALSE,Not Recruiting,Not Applicable,Interventional,"Canada, United States",Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,295,https://clinicaltrials.gov/show/NCT04418505,NA
NCT04421027,ClinicalTrials.gov,2020-06-05,2020-06-12,FALSE,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, United Kingdom, Puerto Rico, United States, Brazil, Italy, Mexico, Japan, Spain, India, Germany, South Korea",A Study of Baricitinib (LY3009104) in Participants With COVID-19,1400,https://clinicaltrials.gov/show/NCT04421027,NA
NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,TRUE,Not Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,140,https://clinicaltrials.gov/show/NCT04426305,NA
NCT04431414,ClinicalTrials.gov,2020-06-09,2020-07-20,FALSE,Recruiting,Not Applicable,Observational,"Argentina, Malawi, South Africa, Peru, Tanzania, Zambia, Mozambique, United States, Brazil, Mexico, Zimbabwe, Botswana, Kenya",A Study of Immune Responses to the Virus That Causes COVID-19,800,https://clinicaltrials.gov/show/NCT04431414,NA
NCT04443803,ClinicalTrials.gov,2020-06-19,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,United States,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,9,https://clinicaltrials.gov/show/NCT04443803,NA
NCT04464395,ClinicalTrials.gov,2020-07-07,2020-07-01,TRUE,Not Recruiting,Phase 1,Interventional,United States,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,30,https://clinicaltrials.gov/show/NCT04464395,NA
NCT04467840,ClinicalTrials.gov,2020-07-09,2020-08-21,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,"Russian Federation, Peru, United Kingdom, Colombia, Italy, Israel, United States, Brazil, Mexico, Poland","Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",464,https://clinicaltrials.gov/show/NCT04467840,NA
NCT04470427,ClinicalTrials.gov,2020-07-11,2020-07-27,FALSE,Not Recruiting,Phase 3,Interventional,United States,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",30420,https://clinicaltrials.gov/show/NCT04470427,NA
NCT04471051,ClinicalTrials.gov,2020-07-13,2020-04-30,TRUE,Not Recruiting,Not Applicable,Observational,United States,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,255,https://clinicaltrials.gov/show/NCT04471051,NA
NCT04473690,ClinicalTrials.gov,2020-07-14,2020-12-30,FALSE,Recruiting,Phase 1/Phase 2,Interventional,"Canada, United States",KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,180,https://clinicaltrials.gov/show/NCT04473690,NA
NCT04474483,ClinicalTrials.gov,2020-05-15,2020-11-06,FALSE,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,30,https://clinicaltrials.gov/show/NCT04474483,NA
NCT04475302,ClinicalTrials.gov,2020-07-16,2020-07-01,TRUE,Recruiting,Phase 3,Interventional,India,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,2175,https://clinicaltrials.gov/show/NCT04475302,NA
NCT04475588,ClinicalTrials.gov,2020-07-16,2020-05-01,TRUE,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,32,https://clinicaltrials.gov/show/NCT04475588,NA
NCT04492410,ClinicalTrials.gov,2020-07-28,2020-07-21,TRUE,Not Recruiting,Not Applicable,Interventional,France,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),500,https://clinicaltrials.gov/show/NCT04492410,NA
NCT04497987,ClinicalTrials.gov,2020-07-31,2020-08-02,FALSE,Not Recruiting,Phase 3,Interventional,United States,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,1374,https://clinicaltrials.gov/show/NCT04497987,NA
NCT04504734,ClinicalTrials.gov,2020-08-04,2020-11-27,FALSE,Recruiting,Phase 3,Interventional,"Puerto Rico, United States",Bucillamine in Treatment of Patients With COVID-19,1000,https://clinicaltrials.gov/show/NCT04504734,NA
NCT04519502,ClinicalTrials.gov,2020-08-18,2020-06-23,TRUE,Recruiting,Not Applicable,Observational,United States,Maternal Morbidity and Mortality During the COVID-19 Pandemic,26400,https://clinicaltrials.gov/show/NCT04519502,NA
NCT04524663,ClinicalTrials.gov,2020-04-10,2020-12-19,FALSE,Not Recruiting,Phase 2,Interventional,United States,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,48,https://clinicaltrials.gov/show/NCT04524663,NA
NCT04526717,ClinicalTrials.gov,2020-07-30,2021-12-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,0,https://clinicaltrials.gov/show/NCT04526717,NA
NCT04536298,ClinicalTrials.gov,2020-08-27,2020-12-28,FALSE,Recruiting,Phase 3,Interventional,United States,Vitamin D and COVID-19 Trial,2700,https://clinicaltrials.gov/show/NCT04536298,NA
NCT04539275,ClinicalTrials.gov,2020-08-27,2020-11-16,FALSE,Recruiting,Phase 3,Interventional,"Puerto Rico, United States",COVID-19 (VA CURES-1),702,https://clinicaltrials.gov/show/NCT04539275,NA
NCT04548895,ClinicalTrials.gov,2020-09-10,2020-12-30,FALSE,Not Recruiting,Not Applicable,Observational,United States,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,26,https://clinicaltrials.gov/show/NCT04548895,NA
NCT04569227,ClinicalTrials.gov,2020-09-28,2021-04-30,FALSE,Recruiting,Phase 2,Interventional,United States,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,60,https://clinicaltrials.gov/show/NCT04569227,NA
NCT04576312,ClinicalTrials.gov,2020-09-28,2020-06-29,TRUE,Not Recruiting,Phase 1,Interventional,Denmark,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,64,https://clinicaltrials.gov/show/NCT04576312,NA
NCT04582201,ClinicalTrials.gov,2020-10-06,2020-09-21,TRUE,Recruiting,Phase 1,Interventional,United States,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,55,https://clinicaltrials.gov/show/NCT04582201,NA
NCT04583956,ClinicalTrials.gov,2020-10-09,2020-10-14,FALSE,Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04583956,NA
NCT04590794,ClinicalTrials.gov,2020-10-14,2020-10-11,TRUE,Not Recruiting,Not Applicable,Observational,Greece,SuPAR in Adult Patients With Covid-19,767,https://clinicaltrials.gov/show/NCT04590794,NA
NCT04591210,ClinicalTrials.gov,2020-10-06,2021-01-27,FALSE,Recruiting,Phase 3,Interventional,"Canada, Mexico, Brazil",The COVID-RASi Trial (COVID-19),1155,https://clinicaltrials.gov/show/NCT04591210,NA
NCT04592510,ClinicalTrials.gov,2020-10-16,2021-05-25,FALSE,Recruiting,Not Applicable,Observational,Egypt,"Impact of COVID-19 on Pediatric Dental Practice During First, Second And Third Wave.",345,https://clinicaltrials.gov/show/NCT04592510,NA
NCT04593940,ClinicalTrials.gov,2020-09-23,2020-10-15,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Peru, United States, Brazil",Immune Modulators for Treating COVID-19,2160,https://clinicaltrials.gov/show/NCT04593940,NA
NCT04595097,ClinicalTrials.gov,2020-10-19,2021-03-01,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in COVID-19 Patients,138,https://clinicaltrials.gov/show/NCT04595097,NA
NCT04605588,ClinicalTrials.gov,2020-10-26,2020-12-02,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,7,https://clinicaltrials.gov/show/NCT04605588,NA
NCT04614701,ClinicalTrials.gov,2020-10-21,2021-08-21,FALSE,Not Recruiting,Not Applicable,Observational,Canada,Correlation of Carotid Flow Time and Cardiac Output.,20,https://clinicaltrials.gov/show/NCT04614701,NA
NCT04614883,ClinicalTrials.gov,2020-11-02,2020-10-21,TRUE,Not Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,130,https://clinicaltrials.gov/show/NCT04614883,NA
NCT04627519,ClinicalTrials.gov,2020-11-10,2020-12-09,FALSE,Not Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and Safety of Rhea Health ToneÂ® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,85,https://clinicaltrials.gov/show/NCT04627519,NA
NCT04640181,ClinicalTrials.gov,2020-11-19,2020-12-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),150,https://clinicaltrials.gov/show/NCT04640181,NA
NCT04657497,ClinicalTrials.gov,2020-11-09,2020-11-09,FALSE,Not Recruiting,Phase 3,Interventional,Japan,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),155,https://clinicaltrials.gov/show/NCT04657497,NA
NCT04660422,ClinicalTrials.gov,2020-12-03,2020-12-15,FALSE,Recruiting,Not Applicable,Observational,United States,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,13150,https://clinicaltrials.gov/show/NCT04660422,NA
NCT04672291,ClinicalTrials.gov,2020-10-05,2021-06-15,FALSE,Not Recruiting,Phase 1,Interventional,Canada,Nasal Poly-ICLC (HiltonolÂ®) in Healthy COVID-19 Vaccinated Adults,43,https://clinicaltrials.gov/show/NCT04672291,NA
NCT04681079,ClinicalTrials.gov,2020-12-22,2021-05-04,FALSE,Recruiting,Not Applicable,Observational,United States,Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19,10,https://clinicaltrials.gov/show/NCT04681079,NA
NCT04699058,ClinicalTrials.gov,2020-12-04,2020-07-17,TRUE,Not Recruiting,Not Applicable,Observational,Democratic Republic of Congo,COVID-19 Sero-prevalence Health Care Workers Kinshasa,1650,https://clinicaltrials.gov/show/NCT04699058,NA
NCT04708236,ClinicalTrials.gov,2021-01-08,2021-04-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia,0,https://clinicaltrials.gov/show/NCT04708236,NA
NCT04713553,ClinicalTrials.gov,2021-01-15,2021-02-15,FALSE,Recruiting,Phase 3,Interventional,United States,"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants",1530,https://clinicaltrials.gov/show/NCT04713553,NA
NCT04721444,ClinicalTrials.gov,2020-11-06,2021-01-27,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19),1500,https://clinicaltrials.gov/show/NCT04721444,NA
NCT04724720,ClinicalTrials.gov,2021-01-13,2021-01-19,FALSE,Not Recruiting,Phase 2,Interventional,United States,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,56,https://clinicaltrials.gov/show/NCT04724720,NA
NCT04738136,ClinicalTrials.gov,2021-01-27,2021-06-15,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",30,https://clinicaltrials.gov/show/NCT04738136,NA
NCT04739449,ClinicalTrials.gov,2021-02-03,2021-10-04,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,'4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,100,https://clinicaltrials.gov/show/NCT04739449,NA
NCT04740658,ClinicalTrials.gov,2021-01-28,2021-06-28,FALSE,Not Recruiting,Not Applicable,Observational,France,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,9600,https://clinicaltrials.gov/show/NCT04740658,NA
NCT04745351,ClinicalTrials.gov,2021-02-08,2021-03-31,FALSE,Recruiting,Phase 3,Interventional,"Spain, Portugal, United States, United Kingdom",Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19),1116,https://clinicaltrials.gov/show/NCT04745351,NA
NCT04753242,ClinicalTrials.gov,2021-02-11,2020-12-08,TRUE,Recruiting,Not Applicable,Observational,"Ireland, Poland, Greece, Belgium, Portugal, Canada, United Kingdom, Italy, Norway, Spain, Finland, Austria, Iran, France, Germany, Switzerland",Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals,200,https://clinicaltrials.gov/show/NCT04753242,NA
NCT04766645,ClinicalTrials.gov,2021-02-22,2021-06-10,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,ACE2 Gender Differences in Stroke With COVID-19,100,https://clinicaltrials.gov/show/NCT04766645,NA
NCT04784754,ClinicalTrials.gov,2021-02-22,2021-04-01,FALSE,Recruiting,Phase 2,Interventional,United States,Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,50,https://clinicaltrials.gov/show/NCT04784754,NA
NCT04798027,ClinicalTrials.gov,2021-03-11,2021-03-12,FALSE,Recruiting,Phase 1/Phase 2,Interventional,"Honduras, United States",Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older,333,https://clinicaltrials.gov/show/NCT04798027,NA
NCT04801056,ClinicalTrials.gov,2021-03-11,2021-05-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19,0,https://clinicaltrials.gov/show/NCT04801056,NA
NCT04804072,ClinicalTrials.gov,2021-02-18,2021-06-02,FALSE,Recruiting,Not Applicable,Interventional,United States,INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit,860,https://clinicaltrials.gov/show/NCT04804072,NA
NCT04805216,ClinicalTrials.gov,2021-03-12,2021-03-15,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Covid-19 Vaccine Response in Immunocompromised Haematology Patients,80,https://clinicaltrials.gov/show/NCT04805216,NA
NCT04805892,ClinicalTrials.gov,2021-03-17,2021-03-17,FALSE,Recruiting,Not Applicable,Interventional,United States,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.",250,https://clinicaltrials.gov/show/NCT04805892,NA
NCT04806113,ClinicalTrials.gov,2021-03-12,2021-03-11,TRUE,Not Recruiting,Phase 3,Interventional,Canada,COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases,220,https://clinicaltrials.gov/show/NCT04806113,NA
NCT04811664,ClinicalTrials.gov,2021-03-19,2021-03-24,FALSE,Recruiting,Phase 3,Interventional,United States,A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine,37500,https://clinicaltrials.gov/show/NCT04811664,NA
NCT04822025,ClinicalTrials.gov,2021-03-25,2021-05-20,FALSE,Recruiting,Phase 2,Interventional,Taiwan,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults,400,https://clinicaltrials.gov/show/NCT04822025,NA
NCT04826809,ClinicalTrials.gov,2021-03-18,2021-04-09,FALSE,Recruiting,Not Applicable,Interventional,United States,New Reusable Mask Design With Superior Filtration and Fit,40,https://clinicaltrials.gov/show/NCT04826809,NA
NCT04830735,ClinicalTrials.gov,2021-04-01,2021-07-15,FALSE,Not Recruiting,Phase 2,Interventional,United States,Dasatinib for the Treatment of Moderate and Severe COVID-19,144,https://clinicaltrials.gov/show/NCT04830735,NA
NCT04842292,ClinicalTrials.gov,2021-04-08,2021-05-20,FALSE,Recruiting,Phase 2,Interventional,United States,Nebulized Heparin for COVID19-associated Acute Respiratory Failure,40,https://clinicaltrials.gov/show/NCT04842292,NA
NCT04843722,ClinicalTrials.gov,2021-04-09,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,540,https://clinicaltrials.gov/show/NCT04843722,NA
NCT04843761,ClinicalTrials.gov,2021-04-09,2021-04-20,FALSE,Recruiting,Phase 3,Interventional,United States,ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19,640,https://clinicaltrials.gov/show/NCT04843761,NA
NCT04845191,ClinicalTrials.gov,2021-04-09,2021-06-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,540,https://clinicaltrials.gov/show/NCT04845191,NA
NCT04847050,ClinicalTrials.gov,2021-04-14,2021-04-28,FALSE,Recruiting,Phase 2,Interventional,United States,"A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy",120,https://clinicaltrials.gov/show/NCT04847050,NA
NCT04853979,ClinicalTrials.gov,2021-04-12,2021-05-16,FALSE,Recruiting,Not Applicable,Interventional,Qatar,Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure,200,https://clinicaltrials.gov/show/NCT04853979,NA
NCT04858633,ClinicalTrials.gov,2021-03-22,2021-03-22,FALSE,Recruiting,Phase 3,Interventional,India,Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,1000,https://clinicaltrials.gov/show/NCT04858633,NA
NCT04864561,ClinicalTrials.gov,2021-04-23,2021-04-26,FALSE,Not Recruiting,Phase 3,Interventional,United Kingdom,"Study To Compare The Immunogenicity Against COVID-19, Of VLA2001 Vaccine To AZD1222 Vaccine",4019,https://clinicaltrials.gov/show/NCT04864561,NA
NCT04867174,ClinicalTrials.gov,2021-04-27,2021-05-24,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccination Take-Up,10000,https://clinicaltrials.gov/show/NCT04867174,NA
NCT04869397,ClinicalTrials.gov,2021-04-29,2021-06-14,FALSE,Recruiting,Phase 2,Interventional,Canada,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,48,https://clinicaltrials.gov/show/NCT04869397,NA
NCT04871854,ClinicalTrials.gov,2021-04-25,2021-04-26,FALSE,Recruiting,Phase 2,Interventional,Egypt,Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints,60,https://clinicaltrials.gov/show/NCT04871854,NA
NCT04872673,ClinicalTrials.gov,2021-04-29,2020-02-15,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,The Professional Values and Ethical Sensitivities During the COVID-19 Pandemic,302,https://clinicaltrials.gov/show/NCT04872673,NA
NCT04873128,ClinicalTrials.gov,2021-04-30,2021-06-10,FALSE,Recruiting,Not Applicable,Interventional,Germany,Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach,110,https://clinicaltrials.gov/show/NCT04873128,NA
NCT04877743,ClinicalTrials.gov,2021-05-04,2021-05-31,FALSE,Recruiting,Not Applicable,Observational,"Spain, France, Sweden, Germany",Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222,15000,https://clinicaltrials.gov/show/NCT04877743,NA
NCT04880447,ClinicalTrials.gov,2021-05-05,2021-05-26,FALSE,Recruiting,Not Applicable,Observational,Japan,Special Investigation of COMIRNATY in the Population With Underlying Diseases,1000,https://clinicaltrials.gov/show/NCT04880447,NA
NCT04880694,ClinicalTrials.gov,2021-04-25,2021-05-20,FALSE,Recruiting,Phase 2,Interventional,Belgium,A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019(COVID-19)Pneumonia,25,https://clinicaltrials.gov/show/NCT04880694,NA
NCT04885361,ClinicalTrials.gov,2021-05-07,2021-05-26,FALSE,Recruiting,Phase 1,Interventional,Belgium,"To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults",48,https://clinicaltrials.gov/show/NCT04885361,NA
NCT04885530,ClinicalTrials.gov,2021-04-30,2021-06-08,FALSE,Recruiting,Phase 3,Interventional,United States,ACTIV-6: COVID-19 Study of Repurposed Medications,15000,https://clinicaltrials.gov/show/NCT04885530,NA
NCT04887948,ClinicalTrials.gov,2021-05-10,2021-05-20,FALSE,Recruiting,Phase 3,Interventional,United States,Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2,600,https://clinicaltrials.gov/show/NCT04887948,NA
NCT04894435,ClinicalTrials.gov,2021-05-18,2021-05-20,FALSE,Recruiting,Phase 2,Interventional,Canada,Mix and Match of the Second COVID-19 Vaccine Dose for Safety and Immunogenicity,1200,https://clinicaltrials.gov/show/NCT04894435,NA
NCT04894474,ClinicalTrials.gov,2021-05-18,2021-06-17,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2,1700,https://clinicaltrials.gov/show/NCT04894474,NA
NCT04898179,ClinicalTrials.gov,2021-05-21,2020-11-01,TRUE,Recruiting,Not Applicable,Observational,Italy,Support for COVID19 Patients at Home,600,https://clinicaltrials.gov/show/NCT04898179,NA
NCT04900467,ClinicalTrials.gov,2021-05-21,2021-05-28,FALSE,Recruiting,Not Applicable,Interventional,France,Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine,400,https://clinicaltrials.gov/show/NCT04900467,NA
NCT04902183,ClinicalTrials.gov,2021-05-21,2021-06-09,FALSE,Recruiting,Phase 2,Interventional,Greece,Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19,90,https://clinicaltrials.gov/show/NCT04902183,NA
NCT04904549,ClinicalTrials.gov,2021-05-26,2021-05-26,FALSE,Recruiting,Phase 3,Interventional,United States,Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older,37430,https://clinicaltrials.gov/show/NCT04904549,NA
NCT04904783,ClinicalTrials.gov,2021-05-25,2021-06-01,FALSE,Recruiting,Not Applicable,Interventional,India,Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot Study,20,https://clinicaltrials.gov/show/NCT04904783,NA
NCT04907981,ClinicalTrials.gov,2021-05-23,2021-01-22,TRUE,Not Recruiting,Not Applicable,Observational,China,Eye Detection to Identify Novel Coronavirus Infection,232,https://clinicaltrials.gov/show/NCT04907981,NA
NCT04910269,ClinicalTrials.gov,2021-06-01,2021-06-01,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19,820,https://clinicaltrials.gov/show/NCT04910269,NA
NCT04910360,ClinicalTrials.gov,2021-05-31,2021-03-05,TRUE,Recruiting,Not Applicable,Observational,Turkey,Embolism in COVID-19 Positive Patients,50,https://clinicaltrials.gov/show/NCT04910360,NA
NCT04910607,ClinicalTrials.gov,2021-04-16,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.,310,https://clinicaltrials.gov/show/NCT04910607,NA
NCT04910880,ClinicalTrials.gov,2021-05-29,2021-06-08,FALSE,Recruiting,Not Applicable,Observational,Turkey,Personal Protective Equipment Comfort and User Attitude During COVID-19,250,https://clinicaltrials.gov/show/NCT04910880,NA
NCT04910932,ClinicalTrials.gov,2021-06-01,2021-06-10,FALSE,Recruiting,Not Applicable,Interventional,Turkey,"Effects of Breathing Exercises on Fear of COVID-19, Anxiety, Sleep and Quality of Life During the COVID-19 Pandemic",50,https://clinicaltrials.gov/show/NCT04910932,NA
NCT04913675,ClinicalTrials.gov,2021-05-27,2021-06-09,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19,1020,https://clinicaltrials.gov/show/NCT04913675,NA
NCT04916574,ClinicalTrials.gov,2021-06-03,2021-03-20,TRUE,Not Recruiting,Not Applicable,Interventional,Estonia,Clinical Trial of BioBlock COVID-19 Nasal Spray Containing Anti-SARS-CoV-2 Antibodies Derived From Bovine Colostrum,16,https://clinicaltrials.gov/show/NCT04916574,NA
NCT04916821,ClinicalTrials.gov,2021-05-26,2021-05-15,TRUE,Not Recruiting,Not Applicable,Interventional,Turkey,Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19),45,https://clinicaltrials.gov/show/NCT04916821,NA
NCT04916834,ClinicalTrials.gov,2020-11-09,2020-08-30,TRUE,Recruiting,Not Applicable,Observational,Poland,Impact of SARS-CoV-2/COVID-19 Related Pneumonia on Lung Function and Structure.,100,https://clinicaltrials.gov/show/NCT04916834,NA
NCT04916847,ClinicalTrials.gov,2021-05-27,2021-06-01,FALSE,Not Recruiting,Not Applicable,Observational,France,Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:,540,https://clinicaltrials.gov/show/NCT04916847,NA
NCT04918160,ClinicalTrials.gov,2021-06-02,2021-06-08,FALSE,Recruiting,Not Applicable,Observational,France,Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris,1000,https://clinicaltrials.gov/show/NCT04918160,NA
NCT04918849,ClinicalTrials.gov,2021-06-08,2021-05-21,TRUE,Recruiting,Not Applicable,Observational,Singapore,WhatsApp in India During the COVID-19 Pandemic,1000,https://clinicaltrials.gov/show/NCT04918849,NA
NCT04918875,ClinicalTrials.gov,2021-05-31,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Oxygen Requirements and Use in Patients With COVID-19 in LMICs,2400,https://clinicaltrials.gov/show/NCT04918875,NA
NCT04918888,ClinicalTrials.gov,2021-06-04,2021-04-19,TRUE,Recruiting,Not Applicable,Observational,Austria,COVID-19 Vaccination in Oncologic Patients,1000,https://clinicaltrials.gov/show/NCT04918888,NA
NCT04918901,ClinicalTrials.gov,2021-06-01,2020-05-01,TRUE,Not Recruiting,Not Applicable,Observational,China,Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19,80,https://clinicaltrials.gov/show/NCT04918901,NA
NCT04918914,ClinicalTrials.gov,2021-05-27,2020-10-18,TRUE,Recruiting,Phase 1,Interventional,United States,Critical Care Results of SARS-CoV-2 ARDS by Dapsone and Standard COVID-19 Treatment,100,https://clinicaltrials.gov/show/NCT04918914,NA
NCT04918927,ClinicalTrials.gov,2021-06-04,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19,120,https://clinicaltrials.gov/show/NCT04918927,NA
NCT04918940,ClinicalTrials.gov,2021-06-04,2021-05-21,TRUE,Recruiting,Not Applicable,Interventional,France,Efficacy of COVID-19 Vaccination in Patientstreated With Anti-CD20 for Follicular Lymphoma or Mantle Cell Lymphoma,40,https://clinicaltrials.gov/show/NCT04918940,NA
NCT04919031,ClinicalTrials.gov,2021-06-07,2021-04-20,TRUE,Recruiting,Not Applicable,Interventional,Egypt,Inspiratory Muscle Trainer and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 Persistent Symptoms,30,https://clinicaltrials.gov/show/NCT04919031,NA
NCT04920357,ClinicalTrials.gov,2021-05-31,2021-03-31,TRUE,Recruiting,Not Applicable,Observational,Sweden,"Immune Response to Vaccination Against Covid-19, a Follow up Study",3000,https://clinicaltrials.gov/show/NCT04920357,NA
NCT04920760,ClinicalTrials.gov,2021-06-09,2021-06-21,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Vitamin A Supplementation in Children With Moderate to Severe COVID-19,60,https://clinicaltrials.gov/show/NCT04920760,NA
NCT04920773,ClinicalTrials.gov,2021-06-06,2021-05-03,TRUE,Not Recruiting,Not Applicable,Interventional,India,Community-based Post-exposure Prophylaxis for COVID-19,216,https://clinicaltrials.gov/show/NCT04920773,NA
NCT04920838,ClinicalTrials.gov,2021-05-04,2021-04-12,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"Guinea, Burkina Faso",Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection,600,https://clinicaltrials.gov/show/NCT04920838,NA
NCT04920851,ClinicalTrials.gov,2021-06-09,2021-06-10,FALSE,Recruiting,Not Applicable,Observational,Turkey,Cytokine Hemadsorption in Covid 19 Patients With Bacterial Sepsis,23,https://clinicaltrials.gov/show/NCT04920851,NA
NCT04920890,ClinicalTrials.gov,2021-05-26,2021-06-16,FALSE,Recruiting,Not Applicable,Interventional,Spain,Radiofrequency Intervention in Post COVID-19 Patients,24,https://clinicaltrials.gov/show/NCT04920890,NA
NCT04920916,ClinicalTrials.gov,2021-06-08,2021-05-25,TRUE,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients,40,https://clinicaltrials.gov/show/NCT04920916,NA
NCT04921228,ClinicalTrials.gov,2021-05-20,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Biofeedback for CHAMPS,28,https://clinicaltrials.gov/show/NCT04921228,NA
NCT04921241,ClinicalTrials.gov,2021-06-07,2021-06-08,FALSE,Recruiting,Not Applicable,Observational,United States,In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life,240,https://clinicaltrials.gov/show/NCT04921241,NA
NCT04922632,ClinicalTrials.gov,2021-06-08,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Data-driven Approaches to Healthcare Provider Resilience & Burnout During COVID-19,280,https://clinicaltrials.gov/show/NCT04922632,NA
NCT04922788,ClinicalTrials.gov,2021-06-08,2021-06-07,TRUE,Recruiting,Phase 3,Interventional,Vietnam,"Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19",13000,https://clinicaltrials.gov/show/NCT04922788,NA
NCT04922814,ClinicalTrials.gov,2021-06-08,2021-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19,40,https://clinicaltrials.gov/show/NCT04922814,NA
NCT04922827,ClinicalTrials.gov,2021-06-10,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Infliximab in the Treatment of Patients With Severe COVID-19 Disease,88,https://clinicaltrials.gov/show/NCT04922827,NA
NCT04922905,ClinicalTrials.gov,2021-06-09,2020-04-02,TRUE,Not Recruiting,Not Applicable,Interventional,France,Nervous System Symptoms Associated With COVID 19,99,https://clinicaltrials.gov/show/NCT04922905,NA
NCT04922918,ClinicalTrials.gov,2021-06-09,2020-10-01,TRUE,Recruiting,Not Applicable,Interventional,Spain,Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home,25,https://clinicaltrials.gov/show/NCT04922918,NA
NCT04922931,ClinicalTrials.gov,2021-06-09,2020-06-30,TRUE,Not Recruiting,Not Applicable,Observational,Spain,Post-COVID 19 Patients Undergoing Surgery,207,https://clinicaltrials.gov/show/NCT04922931,NA
NCT04922957,ClinicalTrials.gov,2021-06-09,2021-09-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)",152,https://clinicaltrials.gov/show/NCT04922957,NA
NCT04923061,ClinicalTrials.gov,2021-06-05,2021-04-06,TRUE,Recruiting,Not Applicable,Interventional,Turkey,The Effect of Acupressure on the Sleep Quality and Fatigue,68,https://clinicaltrials.gov/show/NCT04923061,NA
NCT04923386,ClinicalTrials.gov,2021-06-06,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels,40,https://clinicaltrials.gov/show/NCT04923386,NA
NCT04924634,ClinicalTrials.gov,2021-06-08,2021-02-01,TRUE,Not Recruiting,Not Applicable,Observational,Poland,Stress Levels and Mental Well-Being Among Slovak Students During e-Learning,3051,https://clinicaltrials.gov/show/NCT04924634,NA
NCT04924660,ClinicalTrials.gov,2021-06-09,2021-06-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Novel Experimental COVID-19 Therapies Affecting Host Response,1600,https://clinicaltrials.gov/show/NCT04924660,NA
NCT04924790,ClinicalTrials.gov,2021-06-10,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions,158,https://clinicaltrials.gov/show/NCT04924790,NA
NCT04924803,ClinicalTrials.gov,2021-06-09,2021-12-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs,500,https://clinicaltrials.gov/show/NCT04924803,NA
NCT04924816,ClinicalTrials.gov,2021-06-10,2020-07-12,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Awake Prone Position in Patients With COVID-19,32,https://clinicaltrials.gov/show/NCT04924816,NA
NCT04924829,ClinicalTrials.gov,2021-06-10,2021-06-01,TRUE,Recruiting,Not Applicable,Observational,Argentina,Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19,300,https://clinicaltrials.gov/show/NCT04924829,NA
NCT04924842,ClinicalTrials.gov,2021-06-10,2021-06-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2),90,https://clinicaltrials.gov/show/NCT04924842,NA
NCT04924855,ClinicalTrials.gov,2021-06-10,2021-07-01,FALSE,Recruiting,Not Applicable,Observational,Tunisia,Immunity After COVID-19 Vaccination,300,https://clinicaltrials.gov/show/NCT04924855,NA
NCT04924881,ClinicalTrials.gov,2021-06-10,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,Hong Kong,Chinese Medicine for Patients With LCOVID-19 Symptoms,68,https://clinicaltrials.gov/show/NCT04924881,NA
NCT04924894,ClinicalTrials.gov,2021-06-10,2021-06-10,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Determinants of Obtaining Covid Vaccination Among Health Care Workers,350,https://clinicaltrials.gov/show/NCT04924894,NA
NCT04925258,ClinicalTrials.gov,2021-05-03,2021-03-01,TRUE,Recruiting,Not Applicable,Interventional,Canada,Supporting Parent and Child Engagement,40,https://clinicaltrials.gov/show/NCT04925258,NA
NCT04926441,ClinicalTrials.gov,2021-06-13,2021-02-15,TRUE,Not Recruiting,Not Applicable,Observational,"Lithuania, Slovakia, Poland",Stress Levels and Mental Well-Being Among Students During e-Learning,4870,https://clinicaltrials.gov/show/NCT04926441,NA
NCT04930016,ClinicalTrials.gov,2021-06-10,2021-04-14,TRUE,Recruiting,Not Applicable,Observational,Germany,Quality of Life and Survival of Patients With Colorectal Cancer 5 Years After Surgery - Follow-up of the RCT DIQOL,208,https://clinicaltrials.gov/show/NCT04930016,NA
NCT04930185,ClinicalTrials.gov,2021-06-03,2021-09-01,FALSE,Not Recruiting,Not Applicable,Interventional,Malaysia,Reducing Vaccine Hesitancy (VH) And Vaccine Refusal (VR): Its' Correlation Factors and an Educational Intervention Programme,600,https://clinicaltrials.gov/show/NCT04930185,NA
ACTRN12621000738820,ANZCTR,2021-06-11,2021-07-06,FALSE,Recruiting,Phase 1,Interventional,Australia,A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine (IVX-411) in Healthy Adults,84,https://anzctr.org.au/ACTRN12621000738820.aspx,NA
ISRCTN31161020,ISRCTN,2021-06-08,2021-11-06,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Reducing stress in the workplace using a digital intervention designed to improve employee wellbeing and help them stay engaged and productive in work,420,http://isrctn.com/ISRCTN31161020,NA
ISRCTN82492510,ISRCTN,2021-06-07,2021-02-08,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Kidney-specific psychosocial assessment and support,36,http://isrctn.com/ISRCTN82492510,NA
ISRCTN79815558,ISRCTN,2021-04-27,2021-04-28,FALSE,Recruiting,Phase 3,Interventional,United Kingdom,COV-COMPARE: A study to compare the VLA2001 and AZD1222 vaccines against COVID-19 in adults,4000,http://isrctn.com/ISRCTN79815558,NA
ISRCTN46897021,ISRCTN,2021-03-15,2021-01-10,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,"An exploratory study in primary care to test the feasibility of an intervention called DIALOG+, designed to improve quality of life for people in primary care with poor mental and physical health",10,http://isrctn.com/ISRCTN46897021,NA
ISRCTN15638344,ISRCTN,2021-02-11,2021-02-15,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,A phase II study of a candidate COVID-19 vaccine in children (COV006),300,http://isrctn.com/ISRCTN15638344,NA
ISRCTN11466448,ISRCTN,2020-11-23,2020-11-30,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,A randomized trial to assess the effects of physical and mental health rehabilitation for people recovering from COVID-19,535,http://isrctn.com/ISRCTN11466448,NA
ISRCTN34160010,ISRCTN,2020-09-14,2020-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,Russian Federation,A low-intervention study of pre-exposure prophylaxis (PrEP) in healthy volunteers at high risk of coronavirus (SARS-CoV-2) infection.,100,http://isrctn.com/ISRCTN34160010,NA
ISRCTN21086382,ISRCTN,2020-09-14,2020-04-26,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 infection survey of the UK general population,500000,http://isrctn.com/ISRCTN21086382,NA
ISRCTN28342533,ISRCTN,2020-05-04,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of COVID-19 assessment in emergency departments and ambulance services,20000,http://isrctn.com/ISRCTN28342533,NA
EUCTR2020-002039-31,EudraCT,2020-04-28,2020-06-17,FALSE,Not Recruiting,Phase 3,Interventional,Finland,Use of Tocilizumab in the inflammatory phase of COVID-19 / new coronavirus disease,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002039-31,FI
EUCTR2020-001431-27,EudraCT,2020-04-07,2020-05-06,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Is there a benefit in treating novel corona virus (Sars-CoV2) infections with the established antihypertensive valsartan?,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001431-27,DE
EUCTR2020-001549-38,EudraCT,2020-04-06,2020-06-29,FALSE,Not Recruiting,Phase 3,Interventional,Germany,An international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care - WHO-SOLIDARITY-GERMANY,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001549-38,DE
EUCTR2020-005763-31,EudraCT,2020-12-29,2021-03-15,FALSE,Authorised,Phase 2,Interventional,"Portugal, Italy, United States, Spain, Poland",FREEDOM COVID Anticoagulation Strategy Randomized Trial,3600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005763-31,PL
EUCTR2021-000627-12,EudraCT,2021-05-05,2021-01-06,TRUE,Authorised,Phase 3,Interventional,"Russian Federation, United Kingdom, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A Six-Month Follow-Up Study of Patients with COVID-19 Previously Enrolled in a RO7496998 (AT-527) Study

",1040,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000627-12,BE
EUCTR2021-002184-22,EudraCT,2021-05-05,2021-05-14,FALSE,Authorised,Phase 2,Interventional,Greece,A study for patients with moderate or severe COVID-19 for the evaluation of the safety and efficacy of a new investigational drug using exosomes,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002184-22,GR
EUCTR2020-005227-37,EudraCT,2020-12-17,2021-03-03,FALSE,Authorised,Phase 2,Interventional,"Netherlands, Italy, United States, Switzerland",The safety and efficacy of dapansutrile for the treatment of moderate COVID-19 symptoms,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005227-37,NL
EUCTR2020-001675-33,EudraCT,2020-04-17,2020-05-29,FALSE,Authorised,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce elderly people's days with severe respiratory infectious diseases at hospital and/or at home,2038,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001675-33,DE
EUCTR2021-001036-25,EudraCT,2021-04-01,2021-01-06,TRUE,Authorised,Phase 2,Interventional,Germany,Study to test UNI91103 in adults with Covid-19 and no or only mild symptoms,330,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001036-25,DE
EUCTR2020-005997-82,EudraCT,2021-02-27,2021-12-03,FALSE,Authorised,Phase 1/Phase 2,Interventional,Netherlands,Vaccination phase I/II study against COVID-19,176,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005997-82,NL
EUCTR2021-000673-83,EudraCT,2021-02-19,2021-11-03,FALSE,Authorised,Phase 4,Interventional,Belgium,Impact of the immune system on response to COVID-19 vaccine in allogeneic stem cell recipients,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000673-83,BE
EUCTR2020-005366-34,EudraCT,2020-12-21,2021-12-02,FALSE,Authorised,Phase 2,Interventional,"Croatia, Ireland, Greece, United Kingdom, Canada, United States, Spain, Latvia, Poland, Lithuania, Bulgaria","A Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients with Mild or Moderate COVID-19",220,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005366-34,IE
EUCTR2020-005911-27,EudraCT,2021-02-15,2021-03-17,FALSE,Authorised,Phase 3,Interventional,Belgium,The DAWN camostat trial: the efficacy of camostat in ambulatory patients with confirmed COVID-19 infection compared to placebo.,1306,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005911-27,BE
DRKS00022729,DRKS,2020-07-30,2020-07-15,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 Surveillance in Day Care Centers (COVID-19),750,http://www.drks.de/DRKS00022729,NA
DRKS00021439,DRKS,2020-04-20,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,Germany,COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?,70,http://www.drks.de/DRKS00021439,NA
DRKS00021443,DRKS,2020-04-28,2020-04-23,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Feasibility and usability of video-based physical therapy for older people in the context of the COVID-19 pandemic,30,http://www.drks.de/DRKS00021443,NA
DRKS00021447,DRKS,2020-04-27,2020-11-26,FALSE,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,100,http://www.drks.de/DRKS00021447,NA
DRKS00021440,DRKS,2021-01-28,2020-04-17,TRUE,Recruiting,Not Applicable,Observational,Germany,Analysis of the C1-Esterase Inhibitor at patients with COVID-19 as a biomarker for the course of the disease,50,http://www.drks.de/DRKS00021440,NA
DRKS00021416,DRKS,2020-04-30,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in tears in patients with COVID-19,50,http://www.drks.de/DRKS00021416,NA
DRKS00021420,DRKS,2020-04-16,2020-01-04,TRUE,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,30,http://www.drks.de/DRKS00021420,NA
DRKS00021424,DRKS,2020-06-12,2020-02-04,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Explorative Study of the Association of Oropharyngeal Microbiota Profiles with SARS-CoV-2 Infection and COVID-19 disease,360,http://www.drks.de/DRKS00021424,NA
DRKS00022761,DRKS,2020-07-30,2020-02-08,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Fear learning during pandemic fear: how COVID-19 perception affects classical fear conditioning,120,http://www.drks.de/DRKS00022761,NA
DRKS00021432,DRKS,2020-05-04,2020-04-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people,100,http://www.drks.de/DRKS00021432,NA
DRKS00021468,DRKS,2020-06-04,2020-05-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Exploring immunological control mechanisms of SARS-CoV-2 (COVID-19),2000,http://www.drks.de/DRKS00021468,NA
DRKS00022790,DRKS,2020-08-04,2020-08-22,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Risk prEdiction of indoor SporTs And cultuRe events for the Transmission of COVID-19,4000,http://www.drks.de/DRKS00022790,NA
DRKS00021399,DRKS,2020-04-20,2020-12-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as  of patients suffering from COVID-19 at the Klinikum Dortmund,450,http://www.drks.de/DRKS00021399,NA
DRKS00021395,DRKS,2020-04-17,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,60,http://www.drks.de/DRKS00021395,NA
DRKS00025089,DRKS,2021-04-19,2020-05-08,TRUE,Recruiting,Not Applicable,Observational,Germany,Long-term follow-up post SARS-CoV-2 / COVID-19 infection (SARS-CoV-2-Follow-Up),500,http://www.drks.de/DRKS00025089,NA
DRKS00025090,DRKS,2021-04-22,2020-10-23,TRUE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19: National strategy for palliative care in times of pandemic - Specialized palliative home care (PallPan - SAPV).,357,http://www.drks.de/DRKS00025090,NA
DRKS00025091,DRKS,2021-04-19,2020-05-25,TRUE,Recruiting,Not Applicable,Observational,Germany,Prospective study analyzing course of disease and outcome in patients with acute COVID-19 with remote Patient monitoring,500,http://www.drks.de/DRKS00025091,NA
DRKS00025094,DRKS,2021-04-22,2021-04-23,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Family-Centered Care on Pediatric Cardiac Intensive Care Units During COVID-19,280,http://www.drks.de/DRKS00025094,NA
DRKS00021516,DRKS,2020-04-22,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,Switzerland,Dysosmia and Dysgeusia in COVID-19 patients,100,http://www.drks.de/DRKS00021516,NA
DRKS00021521,DRKS,2020-04-22,2020-04-22,FALSE,Recruiting,Not Applicable,Observational,Germany,Prevalence of COVID-19 in Children in Baden-WÃ¼rttemberg,2000,http://www.drks.de/DRKS00021521,NA
DRKS00021523,DRKS,2020-04-27,2020-04-28,FALSE,Not Recruiting,Not Applicable,Observational,Germany,The influence of proton pump inhibitor therapy on the clinical course of COVID-19,152,http://www.drks.de/DRKS00021523,NA
DRKS00021522,DRKS,2020-04-22,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,Germany,Local and systemic markers of inflammation and circadian rhythmicity in COVID-19 disease and their role in the prediction of clinical outcome,50,http://www.drks.de/DRKS00021522,NA
DRKS00021527,DRKS,2020-04-24,2020-04-14,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,100,http://www.drks.de/DRKS00021527,NA
DRKS00022857,DRKS,2020-12-28,2021-03-15,FALSE,Recruiting,Phase 2,Interventional,"Spain, Germany",Safety and Performance Evaluation of Seraph 100 Microbind Affinity Blood Filter (Seraph 100) in the treatment of patients with COVID-19,42,http://www.drks.de/DRKS00022857,NA
DRKS00019207,DRKS,2019-12-23,2019-12-17,TRUE,Recruiting,Not Applicable,Interventional,Germany,EPICS-14: Point of Care Influenzascreening and SARS-CoV-2 (COVID-19) testing in the Emergency Department,3000,http://www.drks.de/DRKS00019207,NA
DRKS00021506,DRKS,2020-04-22,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,Germany,Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19),1000,http://www.drks.de/DRKS00021506,NA
DRKS00022841,DRKS,2021-01-26,2020-04-24,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Risk predicition in Covid-19-patients with sepsis/septic shock by means of a combined evaluation of disturbances in microcirculation and hemostasis,50,http://www.drks.de/DRKS00022841,NA
DRKS00021514,DRKS,2020-04-24,2020-04-26,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Database for diagnosis and therapy of COVID-19 infected patients,150,http://www.drks.de/DRKS00021514,NA
DRKS00022845,DRKS,2020-09-01,2020-06-19,TRUE,Recruiting,Not Applicable,Observational,Germany,Neurological rehabilitation outcome of the treatment of patients with COVID-19 disease,500,http://www.drks.de/DRKS00022845,NA
DRKS00021574,DRKS,2020-05-19,2020-08-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Investigation of the predictive value of coagulation parameters for the course of disease in COVID-19 patients,1000,http://www.drks.de/DRKS00021574,NA
DRKS00021573,DRKS,2020-04-27,2020-04-30,FALSE,Not Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",24,http://www.drks.de/DRKS00021573,NA
DRKS00021575,DRKS,2020-04-29,2020-05-16,FALSE,Recruiting,Not Applicable,Observational,Germany,Covid-19 HOspitalized patients RegisTry,500,http://www.drks.de/DRKS00021575,NA
DRKS00021578,DRKS,2020-04-28,2020-04-24,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Validation of new detection methods for SARS CoV-2 in suspected COVID-19,300,http://www.drks.de/DRKS00021578,NA
DRKS00021537,DRKS,2020-04-30,2020-04-17,TRUE,Recruiting,Not Applicable,Observational,Germany,Long term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score,150,http://www.drks.de/DRKS00021537,NA
DRKS00022868,DRKS,2020-08-20,2020-11-08,FALSE,Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 pandemic and the political measures to contain its spread on children with disabilities and chronic illnesses and their families,1619,http://www.drks.de/DRKS00022868,NA
DRKS00022871,DRKS,2020-10-01,2020-10-13,FALSE,Recruiting,Not Applicable,Observational,Germany,"Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)",400,http://www.drks.de/DRKS00022871,NA
DRKS00022874,DRKS,2020-08-20,2020-07-13,TRUE,Recruiting,Not Applicable,Observational,Germany,Retinal Microangiopathy in Patients after Covid-19 Disease,66,http://www.drks.de/DRKS00022874,NA
DRKS00021585,DRKS,2020-04-29,2020-04-24,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,220,http://www.drks.de/DRKS00021585,NA
DRKS00021588,DRKS,2020-05-04,2020-08-05,FALSE,Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,1000,http://www.drks.de/DRKS00021588,NA
DRKS00021581,DRKS,2020-04-27,2020-04-27,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Alterations in  inflammatory and coagulation variables in COVID-19 patients,100,http://www.drks.de/DRKS00021581,NA
DRKS00021582,DRKS,2020-05-12,2020-05-31,FALSE,Not Recruiting,Not Applicable,Interventional,"United Kingdom, United States, Mexico, Spain, France, Germany","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",20000,http://www.drks.de/DRKS00021582,NA
DRKS00021591,DRKS,2020-04-27,2020-04-29,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Identification of predictive biomarkers for severe progression of COVID-19,100,http://www.drks.de/DRKS00021591,NA
DRKS00003600,DRKS,2012-03-19,2011-03-30,TRUE,Recruiting,Not Applicable,Observational,Germany,"Epigenetic effects of exposure to pre-, peri- and postnatal stress assessed in early infancy (subproject 1 of ""PrÃ¤-, peri- und pOstnatal Stress in human and non-human offspring: Epigenetic Impact on DepressiON (POSEIDON)"") / DIAbetes Mellitus - Obstetric and Neonatal Distress: Epigenetic Effects (DiaMOND E2)",400,http://www.drks.de/DRKS00003600,NA
DRKS00025007,DRKS,2021-04-13,2021-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Exploration of clinical and immunological/biomedical  parameters of the post-COVID syndrome in the context of an outpatient rehabilitation concept,180,http://www.drks.de/DRKS00025007,NA
DRKS00025004,DRKS,2021-05-31,2021-02-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,hospital-based case-control study for efficacy and safety of COVID-19 vaccines,3600,http://www.drks.de/DRKS00025004,NA
DRKS00025013,DRKS,2021-05-04,2020-10-26,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19: National Strategy for Palliative Care of severely ill and dying people and their relatives
in Pandemics (PallPan) in Germany - Pandemic plans and pandemic response teams at federal, state, community level and local
health care facilities (PallPan WP6)",42,http://www.drks.de/DRKS00025013,NA
DRKS00023821,DRKS,2020-12-11,2020-08-04,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"A non-interventional, fully anonymized study for the comparative evaluation of a new direct detection methods for infection with  SARS-CoV-2 (COVID-19) in clinical samples",350,http://www.drks.de/DRKS00023821,NA
DRKS00023822,DRKS,2020-12-21,2020-12-16,TRUE,Recruiting,Phase 3,Interventional,Germany,Validation of a SARS-CoV-2 (COVID-19) rapid antigen test in the daily routine of general practitioners for the diagnosis of corona infection,4600,http://www.drks.de/DRKS00023822,NA
DRKS00023831,DRKS,2021-04-06,2021-01-16,TRUE,Recruiting,Not Applicable,Observational,Germany,Cardiac Injury after survived SARS-CoV2-infection (COVID19),60,http://www.drks.de/DRKS00023831,NA
DRKS00022500,DRKS,2020-08-21,2020-08-25,FALSE,Recruiting,Not Applicable,Observational,Germany,"Online survey on clinical care, health problems and psychosocial stress during the corona pandemic in children and adolescents with chronic inflammatory bowel disease (IBD) (COVID19-CED-PÃ„D)",300,http://www.drks.de/DRKS00022500,NA
DRKS00022504,DRKS,2020-08-06,2020-10-08,FALSE,Recruiting,Not Applicable,Observational,Germany,"Prospective Study initiated by University Hospital Rostock concerning COVID-19 in mothers, nursery and school teachers of children in Rostock",600,http://www.drks.de/DRKS00022504,NA
DRKS00023806,DRKS,2021-03-16,2021-08-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Long-term consequences of COVID-19 for pulmonary and neurocognitive disorders,150,http://www.drks.de/DRKS00023806,NA
DRKS00023807,DRKS,2020-12-10,2020-03-14,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,COVID-19 pandemic and breast cancer management: An observational clinical study from Pakistan,112,http://www.drks.de/DRKS00023807,NA
DRKS00023812,DRKS,2021-01-19,2021-02-14,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Online study on internalizing behavior in 2-6 year old children as a result of the COVID-19 pandemic,100,http://www.drks.de/DRKS00023812,NA
DRKS00022533,DRKS,2020-08-19,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Pilot study to investigate the SmartPointer system in the context of domestic life with older people in need of support,117,http://www.drks.de/DRKS00022533,NA
DRKS00022534,DRKS,2020-11-04,2020-09-16,TRUE,Recruiting,Not Applicable,Observational,Germany,Requirements analysis for a robotic assistive system to support and promote the autonomy of people with neuromuscular diseases,15,http://www.drks.de/DRKS00022534,NA
DRKS00021206,DRKS,2020-03-30,2020-03-26,TRUE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,400,http://www.drks.de/DRKS00021206,NA
DRKS00022536,DRKS,2020-10-21,2020-06-24,TRUE,Recruiting,Not Applicable,Observational,Germany,Trends in suicide rates during the Covid-19 pandemic quarantine,500,http://www.drks.de/DRKS00022536,NA
DRKS00021208,DRKS,2020-03-31,2020-03-04,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),100,http://www.drks.de/DRKS00021208,NA
DRKS00021214,DRKS,2020-04-01,2020-04-04,FALSE,Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,840,http://www.drks.de/DRKS00021214,NA
DRKS00022506,DRKS,2020-07-22,2020-04-16,TRUE,Recruiting,Not Applicable,Observational,Germany,Birth in Times of COVID-19,300,http://www.drks.de/DRKS00022506,NA
DRKS00022507,DRKS,2020-07-22,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Germany,Patients with Breast Cancer in Times of COVID-19,200,http://www.drks.de/DRKS00022507,NA
DRKS00022514,DRKS,2020-12-03,2020-03-12,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Eating habits during the Covid-19 pandemic,200,http://www.drks.de/DRKS00022514,NA
DRKS00021247,DRKS,2020-07-08,2020-04-18,TRUE,Recruiting,Not Applicable,Observational,Germany,"Prospective, multicentre evaluation of psychological distress in obstetric patients during pre-, and postnatal isolation in inpatient setting in the context of the SARS-CoV-2-Pandemic (COVID-19)",100,http://www.drks.de/DRKS00021247,NA
DRKS00021255,DRKS,2020-04-28,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Point-of-care coagulation testing in patients suffering from COVID-19,20,http://www.drks.de/DRKS00021255,NA
DRKS00021254,DRKS,2020-04-03,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",50,http://www.drks.de/DRKS00021254,NA
DRKS00022549,DRKS,2020-07-29,2020-09-04,FALSE,Recruiting,Not Applicable,Observational,Germany,"Assessment of disease progression, infection chains and seroprevalence of Covid-19 infections in Saxony",250,http://www.drks.de/DRKS00022549,NA
DRKS00022553,DRKS,2020-09-14,2020-01-10,TRUE,Recruiting,Phase 4,Interventional,Germany,Psychodiagnostic Screening in U-Examinations,5670,http://www.drks.de/DRKS00022553,NA
DRKS00021226,DRKS,2020-05-04,2020-07-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"PROTEGO: PRospective Observational cohort Trial Evaluating correlation of clinical findings, symptoms and disease development of German in- or Outpatients infected with SARS-CoV-2 - a CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group)",500,http://www.drks.de/DRKS00021226,NA
DRKS00021225,DRKS,2020-04-01,2020-02-04,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Munich,1500,http://www.drks.de/DRKS00021225,NA
DRKS00021220,DRKS,2020-04-01,2020-04-17,FALSE,Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,5000,http://www.drks.de/DRKS00021220,NA
DRKS00023880,DRKS,2021-01-07,2020-11-23,TRUE,Recruiting,Not Applicable,Interventional,Germany,Radiological and immunological effects of COVID-19 infection on the central nervous system,170,http://www.drks.de/DRKS00023880,NA
DRKS00021229,DRKS,2020-07-27,2020-03-27,TRUE,Recruiting,Not Applicable,Observational,Germany,CoronaKids - Epidemiological data acquisition SARS-CoV2/Covid-19,900,http://www.drks.de/DRKS00021229,NA
DRKS00022564,DRKS,2020-09-07,2020-01-09,TRUE,Recruiting,Not Applicable,Observational,Germany,Registry of SARS-CoV2-seroprevalence and Transmission of Covid-19 infections in common households,250,http://www.drks.de/DRKS00022564,NA
DRKS00021231,DRKS,2020-04-02,2020-03-04,TRUE,Recruiting,Not Applicable,Observational,"Germany, Austria",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,2000,http://www.drks.de/DRKS00021231,NA
DRKS00022498,DRKS,2020-07-23,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Germany,The state of health of ambulatory patients after COVID-19 disease,1000,http://www.drks.de/DRKS00022498,NA
DRKS00021166,DRKS,2020-03-27,2020-03-30,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,60,http://www.drks.de/DRKS00021166,NA
DRKS00021161,DRKS,2020-04-07,2020-02-15,TRUE,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,1000,http://www.drks.de/DRKS00021161,NA
DRKS00022496,DRKS,2020-07-20,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Study in times of Corona protection measures. An online survey of medical students in the summer semester 2020 (COVID-19),1000,http://www.drks.de/DRKS00022496,NA
DRKS00021164,DRKS,2020-03-27,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,220,http://www.drks.de/DRKS00021164,NA
DRKS00022495,DRKS,2020-08-25,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,"Germany, Austria",Prospective validation of a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infection,1000,http://www.drks.de/DRKS00022495,NA
DRKS00021145,DRKS,2020-04-08,2020-03-16,TRUE,Recruiting,Not Applicable,Observational,"United Kingdom, Belgium, Italy, Spain, Turkey, Bosnia and Herzegovina, Latvia, Austria, Germany, Switzerland","Lean European Open Survey on 
SARS-CoV-2 infected patients (COVID-19)",20000,http://www.drks.de/DRKS00021145,NA
DRKS00022475,DRKS,2020-07-27,2020-03-08,TRUE,Recruiting,Not Applicable,Observational,Germany,"COVID19 Chronic Morbidity: Follow-up of patients with COVID19 and non-COVID19 pneumonia with respect to clinical status, pulmonary function and radiologic findings",500,http://www.drks.de/DRKS00022475,NA
DRKS00022479,DRKS,2020-07-16,2020-07-26,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Covid-19 safe anesthetic gas measurement with the AnaConDaS system,14,http://www.drks.de/DRKS00022479,NA
DRKS00022473,DRKS,2020-08-27,2020-05-29,TRUE,Recruiting,Not Applicable,Observational,Germany,Palliative care expertise as an integral part of pandemic management (COVID-19),30,http://www.drks.de/DRKS00022473,NA
DRKS00021152,DRKS,2020-04-07,2020-05-04,FALSE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,1000,http://www.drks.de/DRKS00021152,NA
DRKS00021153,DRKS,2020-04-06,2020-07-04,FALSE,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on â€“ tackling worries and finding strength for the crisis (COVID-19) in 10 steps,352,http://www.drks.de/DRKS00021153,NA
DRKS00022484,DRKS,2020-07-17,2020-09-04,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (COVID-19),50,http://www.drks.de/DRKS00022484,NA
DRKS00021186,DRKS,2020-03-26,2020-03-26,FALSE,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",45,http://www.drks.de/DRKS00021186,NA
DRKS00023904,DRKS,2021-01-19,2020-01-10,TRUE,Recruiting,Not Applicable,Observational,Germany,Comparison of different source material for the detection of SARS-CoV-2 (COVID-19),100,http://www.drks.de/DRKS00023904,NA
DRKS00023903,DRKS,2021-04-23,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the loads of the Saxon corona protection regulations (Covid-19) in inpatient care facilities,400,http://www.drks.de/DRKS00023903,NA
DRKS00023911,DRKS,2020-12-18,2020-10-18,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"German research network ""Applied Surveillance and Testing"" - Workpackage schools and Nurseries (COVID-19)",7500,http://www.drks.de/DRKS00023911,NA
DRKS00023913,DRKS,2020-12-21,2020-12-22,FALSE,Recruiting,Not Applicable,Observational,Germany,"Multicenter, exploratory, retrospective observational study to identify optimal CT imaging biomarkers in combination with clinical markers and PCR-RT for the diagnosis and assessment of the therapeutic response of COVID-19 using artificial intelligence",1000,http://www.drks.de/DRKS00023913,NA
DRKS00023917,DRKS,2020-12-17,2021-04-01,FALSE,Recruiting,Not Applicable,Observational,Germany,Digital Monitoring of the course of disease in COVID-19 via wearable in-ear sensors,126,http://www.drks.de/DRKS00023917,NA
DRKS00023921,DRKS,2020-12-17,2020-12-17,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Willingness to receive a vaccination against SARS-CoV-2 (COVID-19) among patients 80 years and older,700,http://www.drks.de/DRKS00023921,NA
DRKS00023934,DRKS,2020-12-21,2020-04-17,TRUE,Recruiting,Not Applicable,Observational,"Qatar, Saudi Arabia, Portugal, Colombia, Italy, Mexico, Spain, Brazil, France, India, Germany",Predictive Value of ROTEM Analysis and Standard Coagulation Tests in Hospitalized Patients with COVID-19,500,http://www.drks.de/DRKS00023934,NA
DRKS00023957,DRKS,2021-01-22,2021-11-02,FALSE,Recruiting,Not Applicable,Observational,Germany,COVID-19 in heart transplant recipients â€“ infection rate â€“ clinical course - immunogenity,1050,http://www.drks.de/DRKS00023957,NA
DRKS00021301,DRKS,2020-04-16,2020-04-06,TRUE,Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,240,http://www.drks.de/DRKS00021301,NA
DRKS00021305,DRKS,2020-06-26,2020-04-13,TRUE,Recruiting,Not Applicable,Observational,"Australia, New Zealand, United Kingdom, United States, Spain, Uruguay, Liechtenstein, Austria, France, Germany, Switzerland",COVID-19 Symptom Tracker,100000,http://www.drks.de/DRKS00021305,NA
DRKS00021306,DRKS,2020-04-14,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,1400,http://www.drks.de/DRKS00021306,NA
DRKS00023971,DRKS,2021-02-02,2021-02-21,FALSE,Recruiting,Not Applicable,Interventional,Germany,Breath-assisted stimulation of the anti-inflammatory reflex of the vagus nerve in covid-19 disease: a randomized-controlled trial,60,http://www.drks.de/DRKS00023971,NA
DRKS00023972,DRKS,2020-12-30,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Vaccine Study,1000,http://www.drks.de/DRKS00023972,NA
DRKS00021289,DRKS,2020-04-14,2020-03-31,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,100,http://www.drks.de/DRKS00021289,NA
DRKS00021295,DRKS,2020-05-04,2020-06-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Clinical characteristics of renal patients with COVID-19 infection,100,http://www.drks.de/DRKS00021295,NA
DRKS00021297,DRKS,2020-05-04,2020-06-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Clinical and immunological predictors of SARS-CoV-2 infection and Covid-19 diseases in patients with renal diseases and healthy persons,100,http://www.drks.de/DRKS00021297,NA
DRKS00021268,DRKS,2020-04-09,2020-04-20,FALSE,Recruiting,Not Applicable,Observational,"Turkey, Germany",VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,5000,http://www.drks.de/DRKS00021268,NA
DRKS00021276,DRKS,2020-04-06,2020-04-13,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,24,http://www.drks.de/DRKS00021276,NA
DRKS00021270,DRKS,2020-04-15,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,900,http://www.drks.de/DRKS00021270,NA
DRKS00021273,DRKS,2020-04-20,2020-04-25,FALSE,Recruiting,Not Applicable,Interventional,"Chile, Argentina, South Africa, Ireland, Italy, Brazil, Spain, Austria, Germany",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,544,http://www.drks.de/DRKS00021273,NA
DRKS00024958,DRKS,2021-03-30,2021-03-31,FALSE,Recruiting,Not Applicable,Observational,Germany,"Waveriding â€“ lessons from 12 months of COVID-19 pandemic
Patient records of 1400 COVID-19 inpatients analyzed for patient characteristics, laboratory values and outcome parameters",1400,http://www.drks.de/DRKS00024958,NA
DRKS00022305,DRKS,2020-07-31,2020-03-08,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of the Patient-Doctor-Relationship during the COVID-19 pandemia,500,http://www.drks.de/DRKS00022305,NA
DRKS00022335,DRKS,2020-07-08,2020-01-07,TRUE,Recruiting,Not Applicable,Observational,Germany,Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany,60000,http://www.drks.de/DRKS00022335,NA
DRKS00022337,DRKS,2020-06-29,2020-06-29,FALSE,Recruiting,Not Applicable,Observational,Chile,Analytical study of the profile of pro-inflammatory and pro-resolution factors in non-obese males with pulmonary symptomatology resulting from SARS Covid-19 verified with PCR blood analysis.,20,http://www.drks.de/DRKS00022337,NA
DRKS00023667,DRKS,2020-11-23,2021-03-05,FALSE,Recruiting,Not Applicable,Observational,Germany,Influence of entrapment and emotion regulation on the development of psychopathological distress and Covid-19 related fear in adults,170,http://www.drks.de/DRKS00023667,NA
DRKS00024992,DRKS,2021-04-07,2021-04-26,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Prevalence of cardiac impairments after COVID-19,200,http://www.drks.de/DRKS00024992,NA
DRKS00024990,DRKS,2021-04-13,2020-08-26,TRUE,Not Recruiting,Not Applicable,Observational,Germany,National Strategy for Palliative Care Provision in Pandemics,1,http://www.drks.de/DRKS00024990,NA
DRKS00023642,DRKS,2020-12-01,2021-05-02,FALSE,Recruiting,Not Applicable,Observational,Germany,Medical Rehabilitation after Coronavirus Disease (Covid-19)/ Re_Co,580,http://www.drks.de/DRKS00023642,NA
DRKS00024979,DRKS,2021-04-08,2020-11-23,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19: National Strategy for Palliative Care during Pandemic Crisis"" (PallPan) - sub project specialist inpatient palliative care services (AP 5 PallPan)",589,http://www.drks.de/DRKS00024979,NA
DRKS00023659,DRKS,2021-01-14,2020-12-24,TRUE,Recruiting,Not Applicable,Observational,Germany,Riding the second wave â€“ incorporation of SARS-Cov2 rapid Antigen test in the triage of COVID-19,250,http://www.drks.de/DRKS00023659,NA
DRKS00023650,DRKS,2021-02-09,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,"China, United States","An entertainment-education approach to improve vaccine confidence during the COVID-19 pandemic: an online randomized controlled experiment with 24,000 participants",24000,http://www.drks.de/DRKS00023650,NA
DRKS00022259,DRKS,2020-07-10,2020-06-22,TRUE,Recruiting,Not Applicable,Observational,Germany,"Prevalence of SARS-CoV-2 Infections in the employees of the Pius-Hospital Oldenburg, confirmed through virus antibody testing - COVID-19",1250,http://www.drks.de/DRKS00022259,NA
DRKS00023584,DRKS,2020-11-17,2020-11-20,FALSE,Recruiting,Not Applicable,Observational,Germany,What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19),44,http://www.drks.de/DRKS00023584,NA
DRKS00022251,DRKS,2020-07-07,2020-08-07,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Medical education with virtual patient encounters only in times of Covid-19 â€“ studentsâ€˜ and staff perceptions,20,http://www.drks.de/DRKS00022251,NA
DRKS00023595,DRKS,2020-11-19,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19: National strategy for palliative care during times of a pandemic - generalst palliative care in hospitals (AP 4 PallPan, qualitative part)",30,http://www.drks.de/DRKS00023595,NA
DRKS00023567,DRKS,2021-05-06,2021-04-23,TRUE,Recruiting,Not Applicable,Interventional,Germany,Effects of personalized supplements on the incidence of respiratory diseases,62,http://www.drks.de/DRKS00023567,NA
DRKS00024896,DRKS,2021-06-18,2021-02-23,TRUE,Recruiting,Not Applicable,Observational,Germany,Effects of the Covid-19 lockdown in Germany on the modulation of immunological responses in early infancy,50,http://www.drks.de/DRKS00024896,NA
DRKS00023561,DRKS,2020-11-13,2020-11-20,FALSE,Recruiting,Not Applicable,Observational,Germany,Covid19 Antibody prevalence and sustainability. A retrospective longitudinal monocentered observational study in Covid 19 PCR positive hospitalworkers.,207,http://www.drks.de/DRKS00023561,NA
DRKS00022244,DRKS,2021-02-25,2021-02-18,TRUE,Recruiting,Not Applicable,Observational,Germany,Telemedicine follow-up of hospitalized patients with coronavirus disease-2019 (COVID-19).,100,http://www.drks.de/DRKS00022244,NA
DRKS00022292,DRKS,2020-06-26,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,Germany,Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19),250,http://www.drks.de/DRKS00022292,NA
DRKS00022294,DRKS,2020-09-14,2020-06-22,TRUE,Recruiting,Not Applicable,Observational,Germany,"TASC-3B (Trace element ATORG Study COVID-19 in Berlin, Bavaria, and Baden-WÃ¼rttemberg): Characterization of COVID-19 infections using parameters of the immune system and trace element status",300,http://www.drks.de/DRKS00022294,NA
DRKS00022277,DRKS,2020-07-30,2020-04-15,TRUE,Recruiting,Not Applicable,Observational,"Denmark, Ireland, Italy, Brazil, Spain, Mexico, Turkey, Germany",COvid-19 REgistry on THROMBOSIS complications associated with hospitalization,5000,http://www.drks.de/DRKS00022277,NA
DRKS00022280,DRKS,2020-07-13,2020-07-16,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 Pandemic on Symptoms of Anxiety Disorders,110,http://www.drks.de/DRKS00022280,NA
DRKS00023713,DRKS,2020-12-02,2020-02-12,TRUE,Recruiting,Not Applicable,Observational,Germany,Prolonged grief disorder due to the Covid-19 lockdown? - Impact of contact restrictions on the relatives of patients who died during lockdown,567,http://www.drks.de/DRKS00023713,NA
DRKS00022406,DRKS,2020-10-06,2020-02-10,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnostics,50,http://www.drks.de/DRKS00022406,NA
DRKS00022409,DRKS,2020-12-03,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Single Center Prospective Controlled Follow-up Study of COVID-19 Patients District Konstanz (FSC19-KN),400,http://www.drks.de/DRKS00022409,NA
DRKS00023742,DRKS,2020-12-10,2020-11-16,TRUE,Recruiting,Not Applicable,Observational,Germany,COVIDOM: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease â€“ consequences for health status and quality of life,2000,http://www.drks.de/DRKS00023742,NA
DRKS00022416,DRKS,2020-07-20,2020-05-13,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak-the CoNAN study,800,http://www.drks.de/DRKS00022416,NA
DRKS00022418,DRKS,2020-07-14,2020-05-07,TRUE,Recruiting,Not Applicable,Observational,Austria,Extent and spread of SARS-CoV-2 (COVID-19) infections in the first acute phase in the area of ??Vorarlberg,1000,http://www.drks.de/DRKS00022418,NA
DRKS00022424,DRKS,2020-07-09,2020-09-07,FALSE,Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and lifestyle changes of German university students during the coronavirus (COVID-19) pandemic: An online survey,10000,http://www.drks.de/DRKS00022424,NA
DRKS00023717,DRKS,2021-06-15,2020-06-10,TRUE,Recruiting,Not Applicable,Observational,Germany,Covid-19 in elite sports - a multicentre cohort study,3560,http://www.drks.de/DRKS00023717,NA
DRKS00023721,DRKS,2020-12-15,2020-01-10,TRUE,Recruiting,Not Applicable,Interventional,Germany,WÃ¼rzburg Childcare Study during the COVID-19 pandemic: A study into the acceptance of different screening measures for the detection of infections with the novel coronavirus (SARS-CoV-2) in child daycare centres in WÃ¼rzburg,1000,http://www.drks.de/DRKS00023721,NA
DRKS00023725,DRKS,2021-01-04,2021-01-18,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Clinical investigation of the effectiveness of different mouth rinses in Covid-19-Patients,60,http://www.drks.de/DRKS00023725,NA
DRKS00022403,DRKS,2020-07-15,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic: THE PREP-CO STUDY,300,http://www.drks.de/DRKS00022403,NA
DRKS00022402,DRKS,2020-07-09,2020-05-15,TRUE,Recruiting,Not Applicable,Observational,Germany,Prospective collection of data and biomaterial of COVID-19 at the location WÃ¼rzburg,400,http://www.drks.de/DRKS00022402,NA
DRKS00022455,DRKS,2020-07-23,2020-05-18,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (COVID-19),600,http://www.drks.de/DRKS00022455,NA
DRKS00023789,DRKS,2020-12-18,2021-01-02,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Developing an ars moriendi nova in the face of the COVID-19 pandemic â€“ a prospective mixed-methods survey,850,http://www.drks.de/DRKS00023789,NA
DRKS00021134,DRKS,2020-03-19,2020-03-20,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),60,http://www.drks.de/DRKS00021134,NA
DRKS00022463,DRKS,2020-07-17,2020-08-30,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Mental recilience in relatives of inpatient palliative care patients during the Corona pandemic (COVID-19),100,http://www.drks.de/DRKS00022463,NA
DRKS00022432,DRKS,2020-07-20,2020-05-19,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena (COVID-19),300,http://www.drks.de/DRKS00022432,NA
DRKS00022434,DRKS,2020-08-07,2020-08-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,CorKid (COVID19/ SARS-CoV-2 seroconversion in kids),3000,http://www.drks.de/DRKS00022434,NA
DRKS00022433,DRKS,2020-07-10,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people (part B),2000,http://www.drks.de/DRKS00022433,NA
DRKS00022438,DRKS,2020-07-10,2020-06-26,TRUE,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people (part C),300,http://www.drks.de/DRKS00022438,NA
DRKS00022448,DRKS,2020-07-22,2020-07-16,TRUE,Not Recruiting,Not Applicable,Observational,Austria,COVID-19 in primary care: assessment of risk factors and predictors for severe courses (PrimeRisk C-19),300,http://www.drks.de/DRKS00022448,NA
DRKS00023770,DRKS,2021-03-22,2020-08-26,TRUE,Recruiting,Not Applicable,Observational,Germany,Establishment of a database of clinical data as well as a biobank for the investigation of SARS-CoV-2 (COVID-19) and other viral pneumonia: A clinic-wide study of the University Medical Center Greifswald,500,http://www.drks.de/DRKS00023770,NA
DRKS00022371,DRKS,2020-07-06,2020-05-28,TRUE,Not Recruiting,Not Applicable,Observational,Liberia,"Knowledge, Attitudes and Practices (KAP) Study on COVID-19 in Maryland, Liberia",500,http://www.drks.de/DRKS00022371,NA
DRKS00022387,DRKS,2020-07-09,2020-12-06,FALSE,Recruiting,Not Applicable,Observational,Austria,Effects of the Covid 19 crisis on the experiences of psychiatric patients in the combination setting of group and individual psychotherapy treatment,450,http://www.drks.de/DRKS00022387,NA
DRKS00022380,DRKS,2020-07-07,2020-07-21,FALSE,Recruiting,Not Applicable,Observational,Germany,Clinical translational and epidemiological research project on SARS coronavirus 2 infection in during the COVID 19 pandemic children in Bavaria,14000,http://www.drks.de/DRKS00022380,NA
DRKS00023685,DRKS,2020-12-18,2020-12-18,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Acceptance, benefits and effectiveness of the CoronaWarn-App (COVID-19 warning app)",500,http://www.drks.de/DRKS00023685,NA
DRKS00022359,DRKS,2020-07-17,2020-06-29,TRUE,Recruiting,Not Applicable,Observational,Germany,Study by DB Fernverkehr AG on corona infections and corona immunity of its employees (COVID-19),1050,http://www.drks.de/DRKS00022359,NA
DRKS00022395,DRKS,2020-08-27,2020-04-20,TRUE,Not Recruiting,Not Applicable,Observational,Germany,The influence of the Covid-19-pandemic on pain and pain related disability in chronic pain patients â€“ an explorative study,197,http://www.drks.de/DRKS00022395,NA
DRKS00017593,DRKS,2019-07-26,2019-02-08,TRUE,Recruiting,Not Applicable,Observational,Germany,Feasibility study of a mobile device for the prevention of sepsis in patients with solid tumors after chemotherapy and patients with infectiose diseases (COVID-19),50,http://www.drks.de/DRKS00017593,NA
DRKS00024710,DRKS,2021-03-26,2021-03-29,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Analysis of physical activity of colon- and lungcancer patients during or after therapy, during the second coronalockdown (COVID-19)  in spring 2021, in comparison to the, by the S3 guidelines and the WHO recommended minimum of physical activity",200,http://www.drks.de/DRKS00024710,NA
DRKS00024701,DRKS,2021-03-08,2020-09-05,TRUE,Recruiting,Not Applicable,Observational,Austria,Postpartum analysis of umbilical cord blood for exclusion of intrauterine transmission of SARS-CoV-2 in women with COVID-19,200,http://www.drks.de/DRKS00024701,NA
DRKS00024702,DRKS,2021-03-11,2020-08-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Coronavirus Disease 2019 (COVID-19) and the Kidney â€“ Biosampling as part of the BIOMASOTA-Biobank,2500,http://www.drks.de/DRKS00024702,NA
DRKS00023418,DRKS,2020-10-28,2020-06-05,TRUE,Not Recruiting,Not Applicable,Observational,Germany,ELISA - LÃ¼bEcker longitudinal study on Infections with SARS-CoV-2 (COVID-19),3000,http://www.drks.de/DRKS00023418,NA
DRKS00023435,DRKS,2020-10-27,2020-08-12,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in Air (COVID-19),15,http://www.drks.de/DRKS00023435,NA
DRKS00023430,DRKS,2020-11-10,2021-03-25,FALSE,Recruiting,Not Applicable,Observational,Germany,Evaluation of the use of video consultation in rheumatology in the context of the COVID-19 pandemic,300,http://www.drks.de/DRKS00023430,NA
DRKS00023401,DRKS,2020-11-30,2020-10-14,TRUE,Recruiting,Not Applicable,Observational,Germany,Effects of a low-threshold Substitution Therape of Opioid-dependent Patients during the Corona Crisis (COVID-19),80,http://www.drks.de/DRKS00023401,NA
DRKS00023402,DRKS,2020-11-30,2020-03-12,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"Nursing care in times of corona (Covid-19). Scientific study on challenges and pressures from the perspective of leaders (continued)
Is the threat of system collapse still present or are we normalizing the madness?",1000,http://www.drks.de/DRKS00023402,NA
DRKS00023406,DRKS,2020-11-09,2020-11-15,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Intubation with VieScope vs. Videolaryngoskopy in complete personal protecion gear in asimulated COVID-19-Patient - A randomized controll trail,35,http://www.drks.de/DRKS00023406,NA
DRKS00024739,DRKS,2021-03-04,2021-03-22,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Course of COVID-19 in vaccinated and unvaccinated individuals,600,http://www.drks.de/DRKS00024739,NA
DRKS00024688,DRKS,2021-03-16,2021-03-19,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Out-of-hospital cardiac arrest care in Freiburg during the COVID-19 pandemic (ReaCOVID study),700,http://www.drks.de/DRKS00024688,NA
DRKS00024687,DRKS,2021-03-17,2020-04-12,TRUE,Recruiting,Not Applicable,Observational,Germany,Retrospective evaluation of prospective data from severely ill patients in need of ICU treatments with COVID-19 regarding to superinfections,2000,http://www.drks.de/DRKS00024687,NA
DRKS00023322,DRKS,2020-10-19,2020-09-04,TRUE,Recruiting,Not Applicable,Observational,"France, Germany",Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients,250,http://www.drks.de/DRKS00023322,NA
DRKS00024664,DRKS,2021-02-26,2020-10-14,TRUE,Recruiting,Not Applicable,Interventional,Germany,Transsectoral communication in the regional management of the pandemic (COVID-19),30,http://www.drks.de/DRKS00024664,NA
DRKS00023334,DRKS,2020-10-30,2020-09-14,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoViD-Endotheliitis Study via Retinal Vascular Analysis (COVID-19),30,http://www.drks.de/DRKS00023334,NA
DRKS00024668,DRKS,2021-03-23,2021-03-23,FALSE,Recruiting,Not Applicable,Observational,Germany,Observational study to assess the SARS-CoV-2 specific immune response in kidney transplant recipients (COVID-19 related immune response),150,http://www.drks.de/DRKS00024668,NA
DRKS00022057,DRKS,2020-06-05,2020-05-31,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Traumatological emergency consultations during the COVID-19 pandemic 2020,25000,http://www.drks.de/DRKS00022057,NA
DRKS00022054,DRKS,2020-06-02,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,Germany,CovidCare 1 â€“ Surveillance and care for confirmed and suspected patients with COVID-19 in general practice: an observational study,400,http://www.drks.de/DRKS00022054,NA
DRKS00023385,DRKS,2020-11-06,2020-02-10,TRUE,Recruiting,Not Applicable,Observational,Germany,"Prospective cohort study on the incidence
of SARS-CoV-2-infections (COVID-19) in professional orchestra musicians and choir singers",2500,http://www.drks.de/DRKS00023385,NA
DRKS00023393,DRKS,2020-10-26,2020-05-04,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Handling and coping with the corona pandemic (Covid-19) and its physical and psychological effects,5000,http://www.drks.de/DRKS00023393,NA
DRKS00022067,DRKS,2020-06-12,2020-06-25,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,134,http://www.drks.de/DRKS00022067,NA
DRKS00022035,DRKS,2020-06-25,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in inpatient care facilities (nursing homes) in Thuringia - it hit us hard! A structured retrospective review of primary care, the work of nurses and the course of infections",100,http://www.drks.de/DRKS00022035,NA
DRKS00022032,DRKS,2020-06-30,2020-05-27,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19),4000,http://www.drks.de/DRKS00022032,NA
DRKS00023364,DRKS,2020-10-19,2020-06-20,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig,2000,http://www.drks.de/DRKS00023364,NA
DRKS00024695,DRKS,2021-04-06,2020-12-16,TRUE,Recruiting,Not Applicable,Observational,Germany,Rapid diagnostics of an floride infection by SARS-CoV-19 (COVID-19) using Ion Mobility Spectrometry for exhaled breath,250,http://www.drks.de/DRKS00024695,NA
DRKS00022071,DRKS,2020-05-29,2020-12-06,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and stress factors of psychiatric patients during the COVID-19 pandemic: Telephone survey of patients in the psychiatric outpatient clinic of the Leipzig University Hospital,150,http://www.drks.de/DRKS00022071,NA
DRKS00022083,DRKS,2020-06-09,2020-05-20,TRUE,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact personsâ€™ immune status and termination of quarantine and self-isolation â€“ a prospective pilot study,70,http://www.drks.de/DRKS00022083,NA
DRKS00022082,DRKS,2020-06-15,2020-06-23,FALSE,Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 on lung function and gas exchange,124,http://www.drks.de/DRKS00022082,NA
DRKS00022088,DRKS,2020-06-03,2020-02-06,TRUE,Recruiting,Not Applicable,Observational,Germany,"Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia, Germany",2550,http://www.drks.de/DRKS00022088,NA
DRKS00024800,DRKS,2021-04-26,2021-04-26,FALSE,Recruiting,Not Applicable,Observational,Germany,Safety profile of COVID-19 vaccines and the comparison to COVID-19 symptomatology,7800,http://www.drks.de/DRKS00024800,NA
DRKS00023500,DRKS,2020-11-05,2020-06-18,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"Rapidly applicable surveillance process for COVID-19 
in day care centers with dual swabs",1250,http://www.drks.de/DRKS00023500,NA
DRKS00023501,DRKS,2021-01-28,2020-10-30,TRUE,Recruiting,Not Applicable,Observational,Germany,Corona (COVID-19): outbreak-related examinations in childcare centers - COALA,500,http://www.drks.de/DRKS00023501,NA
DRKS00024835,DRKS,2021-03-16,2021-03-19,FALSE,Recruiting,Not Applicable,Observational,Germany,"""LONG-COVID-19"" also in pediatric patients. A pilot study asking if a comprehensive aftercare is necessary for children and young adults after a SARS-CoV-2 infection",60,http://www.drks.de/DRKS00024835,NA
DRKS00023507,DRKS,2020-11-27,2020-11-29,FALSE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 Surveillance in childcare facilities,120,http://www.drks.de/DRKS00023507,NA
DRKS00024845,DRKS,2021-03-18,2021-03-19,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,The Potential of home-based Screening for SARS-CoV-2 when opening schools in Baden-WÃ¼rttemberg (COVID-19),100,http://www.drks.de/DRKS00024845,NA
DRKS00024879,DRKS,2021-06-02,2021-05-19,TRUE,Recruiting,Not Applicable,Observational,Germany,Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus â€“ an observational pilot study,60,http://www.drks.de/DRKS00024879,NA
DRKS00023553,DRKS,2020-11-30,2020-01-12,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Remote Patient Monitoring (RPM) for patients with COVID-19 and other infection,120,http://www.drks.de/DRKS00023553,NA
DRKS00022224,DRKS,2020-06-17,2020-06-17,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Ambulatory healthcare models and processes  during the ongoing SARS-CoV-2 pandemic (COVID-19),1000,http://www.drks.de/DRKS00022224,NA
DRKS00022226,DRKS,2020-07-06,2020-01-07,TRUE,Not Recruiting,Not Applicable,Observational,Germany,SLKovid: Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19),5000,http://www.drks.de/DRKS00022226,NA
DRKS00023558,DRKS,2020-11-16,2020-11-22,FALSE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Infection Rate in the Construction- and Cleaning Industry,3000,http://www.drks.de/DRKS00023558,NA
DRKS00023525,DRKS,2020-11-10,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"TEMPO - Telemedical psychiatry and psychotherapy for children and adolescents during the Covid-19 pandemic: feasibility, acceptance, satisfaction and pandemic-specific mental stress",300,http://www.drks.de/DRKS00023525,NA
DRKS00022203,DRKS,2020-06-15,2020-06-20,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled study",90,http://www.drks.de/DRKS00022203,NA
DRKS00024860,DRKS,2021-04-27,2020-05-11,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Longitudinal SARS-CoV-2-infection study with medical and dental students at Ulm University,1102,http://www.drks.de/DRKS00024860,NA
DRKS00022147,DRKS,2020-07-13,2020-02-03,TRUE,Recruiting,Not Applicable,Observational,Germany,Consequences of the COVID-19 pandemic for surgical patient treatment in a tertiary care center in Munich,500,http://www.drks.de/DRKS00022147,NA
DRKS00024777,DRKS,2021-04-12,2021-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Role of the Human Microbiome and covid-19 disease in hospital Acquired and Ventilator Associated pneumonia in critically ill patients,1200,http://www.drks.de/DRKS00024777,NA
DRKS00023447,DRKS,2020-11-03,2020-06-11,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Sars-CoV-2 Infection (Covid-19) During Pregnancy: Effects on Mother and Child,30,http://www.drks.de/DRKS00023447,NA
DRKS00022110,DRKS,2020-12-21,2020-06-15,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Patients with chronic pain prefer maintenance of pain treatment despite COVID-19 pandemic restrictions,400,http://www.drks.de/DRKS00022110,NA
DRKS00024787,DRKS,2021-05-05,2021-05-17,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Pilot study to analyze COVID-19 vaccination response,60,http://www.drks.de/DRKS00024787,NA
DRKS00022185,DRKS,2020-06-16,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Germany,Data evaluation of an online symptom and risk detection application for Covid 19 research,10000,http://www.drks.de/DRKS00022185,NA
DRKS00022188,DRKS,2020-06-15,2020-01-07,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Influence of the Covid-19 pandemic on the patient mix in German emergency departments,500000,http://www.drks.de/DRKS00022188,NA
DRKS00022157,DRKS,2020-08-03,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Physical and Psychological Impact of the COVID-19 Pandemic in Germany - a Survey of General Practitioners,500,http://www.drks.de/DRKS00022157,NA
DRKS00023499,DRKS,2020-11-03,2020-03-11,TRUE,Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 on levels of stress and anxiety in dental students,100,http://www.drks.de/DRKS00023499,NA
DRKS00022166,DRKS,2020-06-15,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Austria,Scientific guidance for risk-control and prevention of COVID-19 in professional soccer-players in Austria,250,http://www.drks.de/DRKS00022166,NA
DRKS00024511,DRKS,2021-02-23,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Follow-up of morphologic and functional Lung Damage after severe COVID-19 Pneumonia,100,http://www.drks.de/DRKS00024511,NA
DRKS00024520,DRKS,2021-02-12,2021-09-03,FALSE,Recruiting,Phase 2,Interventional,Germany,Double-blind placebo-controlled proof-of-concept trial to demonstrate the anti-viral efficacy of different doses of azelastine in COVID-19 positive patients,90,http://www.drks.de/DRKS00024520,NA
DRKS00024505,DRKS,2021-02-19,2021-02-20,FALSE,Not Recruiting,Not Applicable,Observational,"China, Germany","Willingness to participate in COVID-19 vaccination research and immunization campaigns: nationally representative online surveys in China, Germany and United States",300120,http://www.drks.de/DRKS00024505,NA
DRKS00024434,DRKS,2021-02-05,2021-07-02,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Immune-mediated pathogenesis and development of autoimmunity in neurological manifestations of COVID-19,150,http://www.drks.de/DRKS00024434,NA
DRKS00023113,DRKS,2020-09-22,2020-07-10,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-19 Study on natural protection against SARS-CoV2 reinfections,1250,http://www.drks.de/DRKS00023113,NA
DRKS00024445,DRKS,2021-02-19,2021-01-26,TRUE,Recruiting,Not Applicable,Observational,Germany,Consequences of the Corona / COVID-19 Crisis for Users of Geriatric Psychiatric Services,1152,http://www.drks.de/DRKS00024445,NA
DRKS00023117,DRKS,2020-09-21,2020-01-03,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-NA: Changes in emergency department utilitzation during the COVID-19 pandemic,1000000,http://www.drks.de/DRKS00023117,NA
DRKS00024440,DRKS,2021-03-04,2021-08-03,FALSE,Not Recruiting,I-II,Interventional,Germany,Piloting the app-based prevention program â€žbounceâ€œ for the promotion of resilience during the COVID-19 pandemic,100,http://www.drks.de/DRKS00024440,NA
DRKS00024412,DRKS,2021-02-15,2021-03-02,FALSE,Recruiting,Not Applicable,Interventional,Germany,Quantification of the reduction on the viral load (SARS-CoV-2) on persons with COVID-19 after gargling with Linola sept mouthwash,80,http://www.drks.de/DRKS00024412,NA
DRKS00024422,DRKS,2021-02-19,2021-01-03,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"Prospective sample collection, data collection and analysis for the clinical applicability of immunome profiles in the discrimination and therapy monitoring of COVID-19 patients in different disease stages as well as for the identification and characterization of long-term consequences of a SARS-CoV-2 infection in comparison to patients with a respiratory non-COVID-19 viral infectious disease and healthy controls.",200,http://www.drks.de/DRKS00024422,NA
DRKS00024455,DRKS,2021-02-09,2021-02-28,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Force controlled coronavirus  (COVID-19) swab study,80,http://www.drks.de/DRKS00024455,NA
DRKS00024454,DRKS,2021-02-08,2020-10-22,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"Randomized, placebo-controlled clinical trial on the efficacy of a mouthrinse containing 0.1% benzalkoniumchloride on the reduction of intraoral viral load and infectivity in SARS-CoV-2 positive subjects (COVID-19)",50,http://www.drks.de/DRKS00024454,NA
DRKS00024462,DRKS,2021-03-08,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Lung clinics employee survey about the current COVID-19 pandemic situation,600,http://www.drks.de/DRKS00024462,NA
DRKS00023180,DRKS,2020-10-01,2020-04-28,TRUE,Recruiting,Not Applicable,Observational,Germany,Effects of pulmonary rehabilitation in patients with COVID-19,100,http://www.drks.de/DRKS00023180,NA
DRKS00023184,DRKS,2020-10-07,2020-09-20,TRUE,Recruiting,Not Applicable,Interventional,Germany,Impact of personal protective equipment (PPE) during a simulated cardiac arrest in times of the COVID-19 pandemic,400,http://www.drks.de/DRKS00023184,NA
DRKS00023171,DRKS,2020-10-26,2020-02-11,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Virtual Assisted Living,207,http://www.drks.de/DRKS00023171,NA
DRKS00024604,DRKS,2021-04-26,2021-01-29,TRUE,Recruiting,Not Applicable,Observational,Germany,App-based home-monitoring for Covid-19 patients,500,http://www.drks.de/DRKS00024604,NA
DRKS00024633,DRKS,2021-04-23,2021-04-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Characterization of dermatologic inpatients during the COVID-19 year: A retrospective comparison of the years 2020 and 2019 in monocentric side.,6200,http://www.drks.de/DRKS00024633,NA
DRKS00024635,DRKS,2021-03-09,2020-10-12,TRUE,Recruiting,Not Applicable,Observational,Germany,Analyzing the incidence of SARS-Cov-2 infected children and teenager in Western Pomerania,4000,http://www.drks.de/DRKS00024635,NA
DRKS00023312,DRKS,2020-10-13,2020-10-25,FALSE,Recruiting,Not Applicable,Observational,Germany,Investigation of COVID-19 associated neurological comorbidities,250,http://www.drks.de/DRKS00023312,NA
DRKS00024616,DRKS,2021-02-22,2021-02-25,FALSE,Recruiting,Not Applicable,Observational,Germany,Longitudinal Prediction of Individual Resilience and Difficulties in Coping with the COVID-19-Pandemic and its Consequences,360,http://www.drks.de/DRKS00024616,NA
DRKS00024613,DRKS,2021-02-23,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,Switzerland,Rehabilitation of COVID-19 Patients-retrospective Analysis COVID-Rehab,300,http://www.drks.de/DRKS00024613,NA
DRKS00024622,DRKS,2021-02-19,2021-02-22,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Serum profile of bile acids in COVID-19,50,http://www.drks.de/DRKS00024622,NA
DRKS00024621,DRKS,2021-02-23,2020-09-30,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Exploratory survey on the situation of caregivers during the COVID-19 pandemic,200,http://www.drks.de/DRKS00024621,NA
DRKS00024551,DRKS,2021-03-08,2021-08-03,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Monitoring the immune response of anti-SARS-CoV2 vaccinated individuals and COVID-19-positive patients â€“ a prospective monocentric non-interventional observational study,700,http://www.drks.de/DRKS00024551,NA
DRKS00024531,DRKS,2021-02-18,2021-01-14,TRUE,Recruiting,Not Applicable,Interventional,Germany,Impact of wearing face masks as part of Covid-19 infection prevention on physical strain - Part I Effects of different face masks on physical performance and physiological parameters during a standardized bicycle ergometer test.,36,http://www.drks.de/DRKS00024531,NA
DRKS00023263,DRKS,2020-12-04,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Serological investigations of blood donors from the city and area around Magdeburg for antibodies against SARS-CoV-2 (COVID-19),4500,http://www.drks.de/DRKS00023263,NA
DRKS00023271,DRKS,2020-11-30,2020-11-18,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population: study protocol for a cluster-randomised, two-factorial controlled trial.",10000,http://www.drks.de/DRKS00023271,NA
DRKS00024578,DRKS,2021-03-09,2021-01-02,TRUE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Superinfection with Aspergillus spp. (COSIA),531,http://www.drks.de/DRKS00024578,NA
DRKS00023241,DRKS,2020-12-21,2020-12-28,FALSE,Recruiting,Not Applicable,Observational,Germany,Population Based Cognitive Testing in Subjects with SARS-CoV-2,2600,http://www.drks.de/DRKS00023241,NA
DRKS00024585,DRKS,2021-02-25,2021-01-19,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Germany,"A clinical trial to assess the efficacy and safety of PB432 in COVID-19 positive inpatients with acute respiratory insufficiency (ARI)
- COVARI study -",150,http://www.drks.de/DRKS00024585,NA
DRKS00025519,DRKS,2021-06-08,2021-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Specific coagulation impairment in patients with and without extracorporeal lung support during COVID-19-ARDS,20,http://www.drks.de/DRKS00025519,NA
DRKS00025525,DRKS,2021-06-10,2020-08-27,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Coping with chronic pain during the COVID-19 pandemic,20,http://www.drks.de/DRKS00025525,NA
DRKS00025567,DRKS,2021-06-16,2021-06-13,TRUE,Recruiting,Not Applicable,Observational,Germany,Humoral immune response after COVID-19 vaccination.,50,http://www.drks.de/DRKS00025567,NA
DRKS00023001,DRKS,2020-09-14,2020-09-15,FALSE,Recruiting,Not Applicable,Observational,Germany,Coronary heart disease management during the Corona Pandemic (COVID-19),400,http://www.drks.de/DRKS00023001,NA
DRKS00023014,DRKS,2020-09-11,2020-06-11,TRUE,Recruiting,Not Applicable,Observational,Germany,Outpatient treatment of COVID-19: Impact of comorbidities on hospital admissions and other treatment decisions,500,http://www.drks.de/DRKS00023014,NA
DRKS00023012,DRKS,2020-10-27,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 (COVID-19) registry for oncological and hematological patients in Germany,170,http://www.drks.de/DRKS00023012,NA
DRKS00023069,DRKS,2020-10-05,2020-10-26,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Lessons-Learned - Developing a strategy for outpatient care during a pandemic in Baden-WÃ¼rttemberg, Germany. Patient characteristics and clinical course of infections with SARS-CoV-2.",2000,http://www.drks.de/DRKS00023069,NA
DRKS00024378,DRKS,2021-02-02,2020-12-28,TRUE,Recruiting,Not Applicable,Observational,Germany,Epigenetic Regulation of Immunecells in patients with SARS-CoV2 (COVID-19),50,http://www.drks.de/DRKS00024378,NA
DRKS00024376,DRKS,2021-05-04,2021-05-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,CRP apheresis registry for COVID-19,1000,http://www.drks.de/DRKS00024376,NA
DRKS00023086,DRKS,2020-10-09,2020-10-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Analysis of the SARS-CoV-2 specific immune response in persons with SARS-CoV-2 infection (COVID-19),190,http://www.drks.de/DRKS00023086,NA
DRKS00023087,DRKS,2020-09-15,2020-09-21,FALSE,Not Recruiting,Not Applicable,Observational,"Switzerland, Germany, Austria",Survey about SARS-CoV2 / Covid-19,1000,http://www.drks.de/DRKS00023087,NA
DRKS00023091,DRKS,2020-09-24,2020-09-16,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,"Early detection of SARS-CoV-2 (COVID-19) in schools in the state of Hesse, Germany",1000,http://www.drks.de/DRKS00023091,NA
DRKS00023092,DRKS,2020-09-17,2020-09-19,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Does dealing with the worldwide COVID-19-pandemic and alcohol stimuli trigger craving for alcohol for people with Alcohol Use Disorder?
A comparative Eye-Tracking study",30,http://www.drks.de/DRKS00023092,NA
DRKS00021813,DRKS,2020-06-29,2020-06-29,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Antibody assesement for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria,2500,http://www.drks.de/DRKS00021813,NA
DRKS00021812,DRKS,2020-06-12,2020-12-10,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Ability to mentalize in old age. Resilience, risk and transgenerational transmission.",88,http://www.drks.de/DRKS00021812,NA
DRKS00021815,DRKS,2020-06-05,2020-07-28,FALSE,Recruiting,Not Applicable,Observational,Germany,Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-19 research project),10000,http://www.drks.de/DRKS00021815,NA
DRKS00021823,DRKS,2020-05-28,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Survival and risk factors in Covid-19 and influenza, a retrospective analysis",18000,http://www.drks.de/DRKS00021823,NA
DRKS00025333,DRKS,2021-05-25,2021-06-14,FALSE,Recruiting,Not Applicable,Observational,Germany,The impact of the Covid-19-Pandemic on patients in DMP diabetes,128,http://www.drks.de/DRKS00025333,NA
DRKS00025316,DRKS,2021-05-12,2021-05-17,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Immunogenicity according to reactogenicity of Covid-19 vaccines,80,http://www.drks.de/DRKS00025316,NA
DRKS00025373,DRKS,2021-05-21,2021-05-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Active recording of adverse events after COVID-19 vaccination,30000,http://www.drks.de/DRKS00025373,NA
DRKS00025374,DRKS,2021-05-20,2021-05-20,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Evaluation of the Sensitivity and Specificity of three Point of Care Tests (POCT) for Determination of SARS-Cov-2 (COVID-19), including a User Performance Evaluation for two devices",400,http://www.drks.de/DRKS00025374,NA
DRKS00024046,DRKS,2021-02-25,2021-03-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Cologne Corona (COVID-19) Surveillance Model,6000,http://www.drks.de/DRKS00024046,NA
DRKS00024028,DRKS,2021-02-11,2021-01-24,TRUE,Recruiting,Not Applicable,Interventional,Germany,Antiseptic gargle in COVID-19,60,http://www.drks.de/DRKS00024028,NA
DRKS00021810,DRKS,2020-05-27,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,Germany,The role of immune-reactions in patients with COVID-19,1000,http://www.drks.de/DRKS00021810,NA
DRKS00025392,DRKS,2021-06-15,2021-05-18,TRUE,Recruiting,Not Applicable,Observational,Germany,Post-COVID outpatient follow-up at University Medical Center Freiburg,1000,http://www.drks.de/DRKS00025392,NA
DRKS00025406,DRKS,2021-05-27,2021-05-26,TRUE,Recruiting,Not Applicable,Observational,Germany,"Students' well-being, mental health and coping during the COVID-19 pandemic",1000,http://www.drks.de/DRKS00025406,NA
DRKS00024117,DRKS,2021-02-09,2021-01-18,TRUE,Recruiting,Not Applicable,Interventional,Germany,Rapidly applicable surveillance process for COVID-19 in day care centers with dual swabs 2,1500,http://www.drks.de/DRKS00024117,NA
DRKS00024128,DRKS,2021-03-04,2021-07-03,FALSE,Not Recruiting,Not Applicable,Observational,Austria,"COVID-19 Induced Alterations of Pre-operative Management in Paediatric Anaesthesia
A retrospective, comparative analysis",1700,http://www.drks.de/DRKS00024128,NA
DRKS00025452,DRKS,2021-05-28,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,Germany,COVID19-ITS-KISS - Surveillance of infections and multidrug-resistant bacteria among COVID-19 patients in ICUs,5000,http://www.drks.de/DRKS00025452,NA
DRKS00024104,DRKS,2021-02-22,2021-02-15,TRUE,Recruiting,Not Applicable,Observational,Germany,Study to investigate the risk of Corona infection (COVID-19) in local public transport,750,http://www.drks.de/DRKS00024104,NA
DRKS00024162,DRKS,2021-02-09,2021-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Identification of cardiovascular and molecular prognostic factors for the morbidity and mortality in COVID-19-sepsis,320,http://www.drks.de/DRKS00024162,NA
DRKS00024165,DRKS,2021-03-01,2021-02-20,TRUE,Recruiting,Not Applicable,Observational,Germany,Covid-19 outbreak after vaccination in German nursing homes,45,http://www.drks.de/DRKS00024165,NA
DRKS00024143,DRKS,2021-02-09,2020-02-11,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19: assessment, surveillance and testing in studentsÂ´accomodations",1000,http://www.drks.de/DRKS00024143,NA
DRKS00024196,DRKS,2021-01-28,2021-01-14,TRUE,Recruiting,Not Applicable,Observational,"Germany, Austria",COVID-19 in primary care: assessment of risk factors and predictors for severe courses (PrimeRisk C-19/II) â€“ a prospective observational study during the second pandemic wave.,150,http://www.drks.de/DRKS00024196,NA
DRKS00024199,DRKS,2021-02-18,2021-12-03,FALSE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19: Serial antibody progression in heart transplanted patients after protective vaccination against SARS-Cov-2 coronavirus,600,http://www.drks.de/DRKS00024199,NA
DRKS00024176,DRKS,2021-03-01,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"The corona pandemic (COVID-19) as a prognostic factor - Is there ""COVID upstaging"" in patients with head and neck tumors?",100,http://www.drks.de/DRKS00024176,NA
DRKS00021909,DRKS,2020-07-02,2020-05-27,TRUE,Recruiting,Not Applicable,Observational,Germany,Prevalence of SARS-CoV2 in scholars: Comparison of boarding and private school (COVID-19),60,http://www.drks.de/DRKS00021909,NA
DRKS00024184,DRKS,2021-03-24,2021-05-03,FALSE,Recruiting,Not Applicable,Observational,Germany,"Hyposmia during childhood - differences between Covid-19 infection, sinunasal obstraction and normosmia regarding olfactory performance; Development of a screening test for hyposmia in children.",200,http://www.drks.de/DRKS00024184,NA
DRKS00022926,DRKS,2020-08-21,2020-03-22,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the course of COVID-19 and perceptions among those tested positive â€“ a survey based study,1000,http://www.drks.de/DRKS00022926,NA
DRKS00022925,DRKS,2020-09-24,2020-10-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Role, challenges and opportunities of catholic pastoral care as part of 'spiritual care' in the end-of-life setting and under COVID-19 pandemic conditions",30,http://www.drks.de/DRKS00022925,NA
DRKS00022928,DRKS,2021-04-13,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"Impacts of SARS-CoV-2 as recognized occupational disease (BK 3101) or work-related accident on physical capacity, mental health, and ability to work - a contribution to rehabilitation management",115,http://www.drks.de/DRKS00022928,NA
DRKS00021604,DRKS,2020-07-01,2020-05-18,TRUE,Recruiting,Not Applicable,Observational,Germany,Pulmonary embolism and/or deep vein thrombosis in COVID-19 patients.,100,http://www.drks.de/DRKS00021604,NA
DRKS00021605,DRKS,2020-04-28,2020-04-27,TRUE,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the ""double rule out - single rule in"" concept (DURO-SIN)",200,http://www.drks.de/DRKS00021605,NA
DRKS00021611,DRKS,2020-05-12,2020-05-15,FALSE,Recruiting,Not Applicable,Observational,Germany,Hypernatremia in critically ill patients with Covid-19,33,http://www.drks.de/DRKS00021611,NA
DRKS00022941,DRKS,2020-08-28,2020-06-15,TRUE,Recruiting,Not Applicable,Observational,Germany,"""COVID-19: Hotspot hospital?- Epidemiological analysis time shifted antibody tests of hospital employees",3000,http://www.drks.de/DRKS00022941,NA
DRKS00021612,DRKS,2020-04-30,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Germany,CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial,500,http://www.drks.de/DRKS00021612,NA
DRKS00022909,DRKS,2020-08-31,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Health realted self-help strategies during the COVID-19 pandemic - an online-based cross-sectional study,2000,http://www.drks.de/DRKS00022909,NA
DRKS00025199,DRKS,2021-04-30,2020-04-11,TRUE,Not Recruiting,Not Applicable,Interventional,Germany,Training Basic Life Support in COVID-19 times,346,http://www.drks.de/DRKS00025199,NA
DRKS00021638,DRKS,2020-05-11,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Retrospective analysis of the relationship between invasive ventilation (considering COVID-19) and a Comprehensive Geriatric Assessment (CGA),1276,http://www.drks.de/DRKS00021638,NA
DRKS00021649,DRKS,2020-06-30,2020-04-24,TRUE,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 exposure and psychological well-being of health care workers in a German Department of Anesthesiology during the COVID-19 pandemic,100,http://www.drks.de/DRKS00021649,NA
DRKS00021653,DRKS,2020-06-05,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,Germany,"Retrospective examination of the course of a Covid-19 infection
in patients with inflammatory bowel disease",500,http://www.drks.de/DRKS00021653,NA
DRKS00022958,DRKS,2020-10-07,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Covid-19-associated research on hand eczema in the health sector â€“ Part 2,35,http://www.drks.de/DRKS00022958,NA
DRKS00021630,DRKS,2020-05-06,2020-08-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19),30,http://www.drks.de/DRKS00021630,NA
DRKS00022964,DRKS,2020-09-07,2020-07-16,TRUE,Recruiting,Not Applicable,Observational,Germany,"Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study 
DIVI ECMO COVID-19 Register",100,http://www.drks.de/DRKS00022964,NA
DRKS00020352,DRKS,2020-01-13,2020-01-27,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Prospective data acquisition of patients presenting in the specialised CRPS outpatient clinic of the Unfallkrankenhaus Berlin for the assessment of the Budapest criteria,200,http://www.drks.de/DRKS00020352,NA
DRKS00021686,DRKS,2020-12-17,2021-04-21,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Screening for the Need of Palliative Care among Inpatients with Advanced, Incurable Cancer",210,http://www.drks.de/DRKS00021686,NA
DRKS00021688,DRKS,2020-05-13,2020-01-03,TRUE,Recruiting,Not Applicable,Observational,Germany,Analysis of the Pathophysiology and Pathology of Corona Virus Disease 2019 (Pa-COVID-19),1500,http://www.drks.de/DRKS00021688,NA
DRKS00021680,DRKS,2020-05-12,2020-06-05,FALSE,Recruiting,Not Applicable,Observational,Germany,Quality assurance of cochlear implant rehabilitation in times of the COVID-19 pandemic (Corona),100,http://www.drks.de/DRKS00021680,NA
DRKS00021699,DRKS,2020-05-11,2020-12-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,lnfluence of the COVID-19-pandemic on the treatment of ENT patients,20000,http://www.drks.de/DRKS00021699,NA
DRKS00021698,DRKS,2020-05-19,2020-07-04,FALSE,Recruiting,Not Applicable,Observational,Germany,Prospective COVID-19 Cohort Munich,6000,http://www.drks.de/DRKS00021698,NA
DRKS00021658,DRKS,2020-05-05,2020-01-03,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Incidence and risk factors for acute kidney injury in COVID-19,100,http://www.drks.de/DRKS00021658,NA
DRKS00021664,DRKS,2020-05-14,2020-05-20,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Influence of COVID-19 Infection on sensory organs in othorynolaryngology,100,http://www.drks.de/DRKS00021664,NA
DRKS00021672,DRKS,2020-12-01,2020-04-30,TRUE,Recruiting,Not Applicable,Observational,Germany,Investigation of factors that may influence the course of a SARS-CoV-2 infection (COVID-19): A study of the University Medical Center Greifswald,400,http://www.drks.de/DRKS00021672,NA
DRKS00021675,DRKS,2020-05-08,2020-07-05,FALSE,Recruiting,Not Applicable,Observational,Germany,Sorting the wheat form the chaff â€“ COVID-19 in the Emergency department,340,http://www.drks.de/DRKS00021675,NA
DRKS00021677,DRKS,2020-05-11,2020-01-07,TRUE,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 associated neuropathy and myopathy in Germany.,200,http://www.drks.de/DRKS00021677,NA
DRKS00021676,DRKS,2020-05-08,2020-02-04,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Communication in times of the corona virus pandemic (COVID-19),200,http://www.drks.de/DRKS00021676,NA
DRKS00021671,DRKS,2020-05-06,2020-03-04,TRUE,Recruiting,Not Applicable,Observational,Germany,Neuroendocrine mechanisms Social isolation and psychobiological stress during the Covid-19 pandemic,200,http://www.drks.de/DRKS00021671,NA
DRKS00025127,DRKS,2021-04-27,2021-02-14,TRUE,Recruiting,Not Applicable,Observational,Germany,Impact of COVID-19 on patients suffering from obsessive-compulsive disorder,80,http://www.drks.de/DRKS00025127,NA
DRKS00025125,DRKS,2021-05-17,2019-03-06,TRUE,Recruiting,Not Applicable,Observational,Germany,A prospective investigation of developmental trajectories of psychosocial adjustment in adolescents facing a chronic condition,450,http://www.drks.de/DRKS00025125,NA
DRKS00025123,DRKS,2021-04-21,2021-05-13,FALSE,Recruiting,Not Applicable,Observational,Germany,COVID-19@Home Aachen,100,http://www.drks.de/DRKS00025123,NA
DRKS00025112,DRKS,2021-04-22,2021-04-25,FALSE,Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and stress factors of psychiatric patients during the COVID-19 pandemic: Second telephone survey of patients in the psychiatric outpatient clinic of the Leipzig University Hospital,110,http://www.drks.de/DRKS00025112,NA
DRKS00025153,DRKS,2021-04-29,2021-10-03,FALSE,Recruiting,Not Applicable,Observational,Germany,COVID-ICD: interdisciplinary study on COVID-19 associated psychological stress in patients with heart failiure and implanted cardioverter defibrillator,250,http://www.drks.de/DRKS00025153,NA
DRKS00021727,DRKS,2020-05-12,2020-12-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Incidence and long-term course of subclinical and clinical myocardial damage as well as pulmonary vascular and structural changes in patients with COVID-19,100,http://www.drks.de/DRKS00021727,NA
DRKS00021729,DRKS,2020-05-25,2020-12-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,A prospective trial on the prevalence and the variation over time of SARS-CoV-2 antibodies in hospital health care workers (COVID-19),300,http://www.drks.de/DRKS00021729,NA
DRKS00021705,DRKS,2020-08-03,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSa,100,http://www.drks.de/DRKS00021705,NA
DRKS00021706,DRKS,2020-05-15,2020-09-06,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),40,http://www.drks.de/DRKS00021706,NA
DRKS00021709,DRKS,2020-05-18,2020-03-07,TRUE,Recruiting,Not Applicable,Observational,Germany,Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and after the COVID-19 epidemic in Heidelberg and the Rhein-Neckar region,1500,http://www.drks.de/DRKS00021709,NA
DRKS00021757,DRKS,2020-05-19,2020-05-22,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 Pandemic on Symptoms of Obessive Compulsive Disorder,70,http://www.drks.de/DRKS00021757,NA
DRKS00021763,DRKS,2020-05-29,2020-02-06,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Influence of the Corona regulation on the physical activity of hospital staff - COVID-19,175,http://www.drks.de/DRKS00021763,NA
DRKS00021772,DRKS,2020-05-18,2020-03-25,TRUE,Recruiting,Not Applicable,Observational,Germany,Covid-19 related Obstetric Anaesthesia Longitudinal Assessment-Registry,Not Available,http://www.drks.de/DRKS00021772,NA
DRKS00021775,DRKS,2020-06-10,2020-05-31,TRUE,Recruiting,Not Applicable,Observational,Germany,COVID-19 treatment outcomes at the University Medical Center Freiburg,400,http://www.drks.de/DRKS00021775,NA
DRKS00021740,DRKS,2020-05-15,2020-05-04,TRUE,Recruiting,Not Applicable,Observational,Germany,CoViD-19 imaging register study Aachen,100,http://www.drks.de/DRKS00021740,NA
DRKS00021752,DRKS,2020-05-28,2020-05-29,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Study platform ArcHIV - Substudy on SARS-CoV-2 (COVID-19) IgG antibody prevalence in an HIV cohort,500,http://www.drks.de/DRKS00021752,NA
DRKS00021756,DRKS,2020-10-28,2020-12-05,FALSE,Recruiting,Not Applicable,Observational,Germany,Psychological coping with the COVID-19-pandemic,9000,http://www.drks.de/DRKS00021756,NA
DRKS00021788,DRKS,2020-07-14,2020-10-06,FALSE,Recruiting,Not Applicable,Observational,Germany,Infection rate of Covid-19 among medical staff in GP practices in North Rhine-Westphalia (Germany),900,http://www.drks.de/DRKS00021788,NA
DRKS00021780,DRKS,2020-06-29,2020-04-19,TRUE,Recruiting,Not Applicable,Observational,Germany,Collection of clinical data in patients with inflammatory rheumatic disease during the pandemic with the SARS-CoV-2 virus - COVID-19,1521,http://www.drks.de/DRKS00021780,NA
DRKS00021791,DRKS,2020-05-28,2020-08-04,FALSE,Not Recruiting,Not Applicable,Observational,Germany,The Impact of quarantine and social distancing on mental health in the context of the Covid-19 pandemic,Not Available,http://www.drks.de/DRKS00021791,NA
DRKS00025217,DRKS,2021-04-29,2021-04-21,TRUE,Recruiting,Not Applicable,Observational,Germany,Mechanisms of platelet activation in recovered COVID-19 patients,70,http://www.drks.de/DRKS00025217,NA
DRKS00025242,DRKS,2021-05-21,2021-05-24,FALSE,Not Recruiting,Not Applicable,Observational,Germany,"Characteristics of prospective participants and participants in a SARS-CoV-2 vaccination trial (phase I-III): demographics, motivation, attitudes to risk and new technologies",220,http://www.drks.de/DRKS00025242,NA
DRKS00025254,DRKS,2021-05-26,2021-05-26,FALSE,Recruiting,Not Applicable,Observational,Germany,Evaluation of the immune response against COVID-19 in pediatric Cancer patients after vaccination,100,http://www.drks.de/DRKS00025254,NA
DRKS00025221,DRKS,2021-05-03,2021-05-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Observational Study on Sars CoV2 Vaccinations in Patients with MS,1000,http://www.drks.de/DRKS00025221,NA
DRKS00025222,DRKS,2021-04-30,2021-09-05,FALSE,Not Recruiting,Not Applicable,Observational,Germany,Cellfree DNA as a prognostic biomarker in ICU patients suffering from COVID-19 or sepsis,120,http://www.drks.de/DRKS00025222,NA
DRKS00014593,DRKS,2018-05-14,2018-05-15,FALSE,Not Recruiting,Phase 3,Interventional,Germany,Relieving Distressed Caregivers: A Pragmatic Trial.,504,http://www.drks.de/DRKS00014593,NA
DRKS00025271,DRKS,2021-05-11,2021-05-19,FALSE,Recruiting,Phase 4,Interventional,Germany,Evaluation of immunogenicity and reactogenicity of heterologous covid-19 vaccine combination ChAdOx-1S followed by BNT162b2,154,http://www.drks.de/DRKS00025271,NA
SLCTR/2021/008,SLCTR,2021-03-15,2021-03-15,FALSE,Not Recruiting,Phase 2,Interventional,Sri Lanka,"Randomized double blind controlled trial to assess the safety and efficacy of three investigational herbal preparations (nut meg based preparation, sudarshana churna, coriandum based preparation) for the treatment of patients with COVID-19",0,https://slctr.lk/trials/slctr-2021-008,NA
SLCTR/2021/005,SLCTR,2021-02-28,2021-03-10,FALSE,Not Recruiting,Phase 2,Interventional,Sri Lanka,Assessment of efficacy of the Indigenous poly herbal drug â€œDesandun Kalkaâ€ against mild symptomatic patients with SARS-CoV- 2 infection - A randomized clinical trial,0,https://slctr.lk/trials/slctr-2021-005,NA
SLCTR/2021/002,SLCTR,2021-01-08,2021-01-08,FALSE,Not Recruiting,Phase 2,Interventional,Sri Lanka,"Efficacy and safety of  Link Natural Sudarshana tablet (an Ayurvedic medicine)  against COVID-19 infection â€“ A single center, randomized double-blind, placebo-controlled clinical trial",0,https://slctr.lk/trials/slctr-2021-002,NA
SLCTR/2021/001,SLCTR,2021-01-05,2021-01-05,FALSE,Recruiting,Phase 1-2,Interventional,Sri Lanka,Randomized double-blind placebo controlled parallel-group phase 1-2 proof-of-concept clinical trial of the herbal preparation Sri Weera Badhra Dhamma Prathishakthi Jeewa PanayaÂ© for patients with asymptomatic or with mild to moderate COVID-19.,0,https://slctr.lk/trials/slctr-2021-001,NA
SLCTR/2020/026,SLCTR,2020-12-21,2020-12-22,FALSE,Recruiting,Not Applicable,Interventional,American Samoa,"Effects on the clinical evolution of patients with respiratory infection secondary to the Sars-CoV-2 virus, when they are maintaining communication with family/friends through mobile devices compared to patients not having an option of communication",0,https://slctr.lk/trials/slctr-2020-026,NA
SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,FALSE,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",0,https://slctr.lk/trials/slctr-2020-011,NA
IRCT20191231045967N1,IRCT,2020-02-11,2020-02-20,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Determining the effect of vitamin D3 and positive group counseling with lifestyle changes in premenstrual women of reproductive age,84,http://en.irct.ir/trial/45331,NA
IRCT20200404046937N3,IRCT,2020-06-25,2020-06-27,FALSE,Not Recruiting,Phase 3,Interventional,Iran,"Evaluating the effect of Phyllanthus Emblica, Rosa Damascene, Marshmallow and Honey on COVID 19",60,http://en.irct.ir/trial/49029,NA
IRCT20200509047364N1,IRCT,2020-08-09,2020-06-21,TRUE,Recruiting,Phase 2,Interventional,Iran,Effect of erythropoietin on COVID-19,20,http://en.irct.ir/trial/49282,NA
IRCT20200404046937N4,IRCT,2020-08-06,2020-07-30,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of Ivermectin on covid 19 patients,60,http://en.irct.ir/trial/49935,NA
IRCT20170315033086N10,IRCT,2021-03-14,2021-03-05,TRUE,Not Recruiting,Phase 2,Interventional,Iran,Investigation of the efficacy of inflawell syrup on covid-19 patients,40,http://en.irct.ir/trial/51631,NA
IRCT20201101049219N1,IRCT,2021-06-10,2020-07-22,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,Effects of spiritual practice on recovery of Covid-19,70,http://en.irct.ir/trial/52099,NA
IRCT20201024049130N1,IRCT,2021-06-21,2021-05-31,TRUE,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy of Silymarin in patients with COVID-19,50,http://en.irct.ir/trial/52381,NA
IRCT20200818048444N3,IRCT,2021-06-20,2020-12-02,TRUE,Not Recruiting,Phase 1,Interventional,Iran,Ivermectine effect in treatment and prophylaxis of patients and exposed idividuals with COVID-19,25,http://en.irct.ir/trial/52565,NA
IRCT20201220049771N1,IRCT,2020-12-31,2020-12-21,TRUE,Not Recruiting,Not Applicable,Interventional,Iran,"study of the effectiveness of ""SALIRAVIRA"" as a natural product on the treatment of COVID-19 patients",120,http://en.irct.ir/trial/53131,NA
IRCT20210216050373N1,IRCT,2021-05-28,2021-03-03,TRUE,Recruiting,Phase 3,Interventional,Iran,The effect of Spirulina platensis supplement in the treatment of coronavirus,60,http://en.irct.ir/trial/54375,NA
IRCT20210310050663N1,IRCT,2021-05-31,2021-04-21,TRUE,Recruiting,Not Applicable,Interventional,Iran,The effect of respiratory-physical exercises on fatigue and quality of life,60,http://en.irct.ir/trial/54929,NA
IRCT20200721048159N3,IRCT,2021-06-03,2021-06-21,FALSE,Recruiting,Phase 3,Interventional,Iran,The Effectiveness of Pentoxifylline and Colchicine in the Treatment of Covid-19,100,http://en.irct.ir/trial/54937,NA
IRCT20210316050722N1,IRCT,2021-05-30,2021-04-21,TRUE,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effects of lung rehabilitation and prone condition on respiratory parameters in patients with Covid-19,105,http://en.irct.ir/trial/55500,NA
IRCT20210422051044N1,IRCT,2021-05-28,2021-07-06,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Effect of Organosulfur Compounds on COVID-19 patients,60,http://en.irct.ir/trial/55824,NA
IRCT20210427051100N1,IRCT,2021-06-19,2021-06-30,FALSE,Not Recruiting,Phase 3,Interventional,Iran,selenium in covid_19,40,http://en.irct.ir/trial/55898,NA
IRCT20210427051101N1,IRCT,2021-06-19,2021-06-21,FALSE,Recruiting,Phase 3,Interventional,Iran,"Assessment the effect of virtual self-care education on COVID-19 anxiety, among the community dwelling elderly",122,http://en.irct.ir/trial/55906,NA
IRCT20150711023153N3,IRCT,2021-06-04,2021-07-11,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation the Effects of green tea supplement in Covid 19 patients,74,http://en.irct.ir/trial/55948,NA
IRCT20210508051225N1,IRCT,2021-06-14,2021-05-22,TRUE,Recruiting,Phase 3,Interventional,Iran,Effects of Shilajit (Momiai) on COVID-19 disease,110,http://en.irct.ir/trial/56223,NA
IRCT20201129049524N1,IRCT,2021-05-26,2021-06-15,FALSE,Recruiting,Not Applicable,Interventional,Iran,The effect of aerobic exercise at home and turmeric supplementation in type 2 diabetes during Covid -19 quarantine,40,http://en.irct.ir/trial/56329,NA
IRCT20140824018915N9,IRCT,2021-06-04,2021-06-05,FALSE,Recruiting,Phase 3,Interventional,Iran,The effect of captopril on definitive patients with coronavirus pneumonia,40,http://en.irct.ir/trial/56384,NA
IRCT20210426051090N1,IRCT,2021-06-12,2021-06-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,The effect of atorvastatin on Covid 19,80,http://en.irct.ir/trial/56387,NA
IRCT20140804018677N9,IRCT,2021-06-19,2021-05-28,TRUE,Recruiting,Phase 3,Interventional,Iran,"Effect of Astaxanthin Phytochemical, Vitamin D3, Omega-3 and Vitamin E supplement on severity of mild to moderate COVID-19 Symptoms",40,http://en.irct.ir/trial/56509,NA
IRCT20141209020258N160,IRCT,2021-06-06,2021-06-15,FALSE,Recruiting,Phase 3,Interventional,Iran,Comparison of the effect of vitamin C and N-acetyl cysteine (NAC) on improving clinical symptoms and reducing the duration of hospitalization in patients with covid-19,232,http://en.irct.ir/trial/56545,NA
IRCT20201024049134N2,IRCT,2021-06-04,2021-06-22,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of tocilizumab in the treatment of hospitalized patients with COVD-19,60,http://en.irct.ir/trial/56613,NA
IRCT20201024049134N3,IRCT,2021-06-21,2021-06-22,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of colchicine in the treatment of COVID-19 patients,500,http://en.irct.ir/trial/56624,NA
IRCT20210522051363N1,IRCT,2021-06-13,2021-08-23,FALSE,Not Recruiting,Not Applicable,Interventional,Iran,The effect of Omega-3 supplementation in Covid-19,40,http://en.irct.ir/trial/56697,NA
IRCT20210423051056N1,IRCT,2021-06-18,2021-05-22,TRUE,Recruiting,Not Applicable,Interventional,Iran,The combined effect of deep breathing and prone position on common respiratory symptoms in patients with COVID-19,96,http://en.irct.ir/trial/56733,NA
IRCT20120215009014N398,IRCT,2021-06-20,2021-07-06,FALSE,Not Recruiting,Phase 3,Interventional,Iran,Effect of 0.1% sodium hypochlorite mouthwash versus normal saline in early reducing intraoral viral load among patients with COVID-19,118,http://en.irct.ir/trial/56922,NA
LBCTR2020043459,LBCTR,2020-04-16,2020-04-14,TRUE,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,500,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/3459,NA
LBCTR2021014651,LBCTR,2021-02-08,2020-11-15,TRUE,Not Recruiting,Phase 3,Interventional,Lebanon,Managing Endothelial Dysfunction in COVID-19: A Randomized Clinical  Trial  at the Lebanese American University Medical Center- Rizk Hospital,66,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4651,NA
LBCTR2020043495,LBCTR,2020-11-04,2020-04-27,TRUE,Not Recruiting,Phase 3,Interventional,Lebanon,An international randomised trial of additional  treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care,1000,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4658,NA
LBCTR2021034768,LBCTR,2021-03-07,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,Lebanon,In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2,90,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4770,NA
LBCTR2021044780,LBCTR,2021-04-18,2021-04-19,FALSE,Not Recruiting,Not Applicable,Interventional,Lebanon,Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19,90,https://lbctr.moph.gov.lb/LBCTR/Trials/Details/4780,NA
PACTR202004801273802,PACTR,2020-04-02,2020-04-20,FALSE,Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,NA
PACTR202004693933092,PACTR,2020-04-12,2020-04-15,FALSE,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,NA
PACTR202004761408382,PACTR,2020-04-13,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,NA
PACTR202005599385499,PACTR,2020-04-16,2020-04-20,FALSE,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,NA
PACTR202004893013257,PACTR,2020-04-21,2020-04-25,FALSE,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,NA
PACTR202005681895696,PACTR,2020-04-26,2020-01-10,TRUE,Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,NA
PACTR202009786901147,PACTR,2020-05-07,2020-01-10,TRUE,Recruiting,Phase 3,Interventional,Kenya,Hydroxychloroquine for prevention of COVID-19,1600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,NA
PACTR202006473370201,PACTR,2020-05-12,2020-04-30,TRUE,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised COVID-19 patients,10000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037,NA
PACTR202007653923168,PACTR,2020-05-13,2020-01-08,TRUE,Not Recruiting,Phase 3,Interventional,Kenya,A clinical trial comparing use of convalescent plasma therapy plus standard treatment to standard treatment alone in patients with severe COVID-19 infection,206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047,NA
PACTR202005622389003,PACTR,2020-05-14,2020-01-06,TRUE,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,NA
PACTR202006717277937,PACTR,2020-05-25,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,NA
PACTR202006899597082,PACTR,2020-05-29,2020-04-29,TRUE,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,NA
PACTR202007589336711,PACTR,2020-06-04,2020-07-13,FALSE,Not Recruiting,Not Applicable,Interventional,Nigeria,"Physiotherapy as a Complimentary treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors with COVID-19: A Clinical-Controlled Study",30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115,NA
PACTR202010519682638,PACTR,2020-06-12,2020-08-27,FALSE,Not Recruiting,Phase 3,Interventional,Nigeria,Efficay of two hydroxychloroquine based drug combination regimens in comparison to standard of care  in The Treatment of Hospitalized COVID-19 Patients,210,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147,NA
PACTR202006537901307,PACTR,2020-06-15,2020-07-20,FALSE,Recruiting,Phase 3,Interventional,"Cote d'Ivoire, Ghana, Equatorial Guinea, Tanzania, Democratic Republic of the Congo, Burkina Faso, Mozambique, Ethiopia, Cameroon, Sudan, Uganda, Guinea, Kenya","An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19",3000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150,NA
PACTR202007606032743,PACTR,2020-06-19,2020-06-15,TRUE,Recruiting,Not Applicable,Interventional,Egypt,Nebulized heparin in patients with mainly moderate coronavirus disease 2019: Randomized controlled trial. COVID-19,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158,NA
PACTR202006922165132,PACTR,2020-06-22,2020-06-24,FALSE,Recruiting,Phase 1,Interventional,South Africa,COVID-19 vaccine (ChAdOx1 nCoV-19) trial in South African Adults with and without HIV-infection,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166,NA
PACTR202006760881890,PACTR,2020-06-23,2020-01-08,TRUE,Recruiting,Phase 2,Interventional,Nigeria,Lagos Covid-19 Convalescent Plasma Trial (LACCPT),100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,NA
PACTR202006883882711,PACTR,2020-06-30,2020-01-07,TRUE,Not Recruiting,Phase 3,Interventional,Egypt,"Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19",200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175,NA
PACTR202007720062393,PACTR,2020-07-02,2020-07-20,FALSE,Not Recruiting,Phase 2,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV),294,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,NA
PACTR202007611764617,PACTR,2020-07-06,2020-01-09,TRUE,Not Recruiting,Phase 3,Interventional,Nigeria,Lagos COVID-19 Black Seed Oil Trial (LACBSOT),80,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192,NA
PACTR202007700757139,PACTR,2020-07-07,2020-07-13,FALSE,Not Recruiting,Phase 2,Interventional,South Africa,TOGETHER 3 Trial. COVID-19,420,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194,NA
PACTR202008485004797,PACTR,2020-07-17,2020-03-08,TRUE,Not Recruiting,Not Applicable,Interventional,South Africa,TRACE - Transmission of Covid-19 in Crowded Environments,720,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214,NA
PACTR202008855701534,PACTR,2020-08-05,2020-09-21,FALSE,Not Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,98,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12266,NA
PACTR202009726132275,PACTR,2020-08-25,2020-07-30,TRUE,Not Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Safety and Effectiveness of a COVID-19 Vaccine Plus Adjuvant in South African Adults,4404,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,NA
PACTR202009769021840,PACTR,2020-08-31,2020-09-15,FALSE,Not Recruiting,Phase 2,Interventional,Kenya,Whole-lung low dose radiation therapy (LDRT) in the treatment of severe COVID-19 pneumonia,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333,NA
PACTR202009642148520,PACTR,2020-09-02,2020-01-11,TRUE,Recruiting,Phase 3,Interventional,"Burkina Faso, Kenya",Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso,142,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343,NA
PACTR202010537777617,PACTR,2020-09-13,2020-01-11,TRUE,Not Recruiting,Phase 2,Interventional,Kenya,FLAVOCOV Distributed Clinical Trial. COVID-19,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365,NA
PACTR202009483194545,PACTR,2020-09-20,2020-10-15,FALSE,Recruiting,Phase 2,Interventional,Togo,Evaluation of phytopharmaceuticals to improve the prognosis of Covid-19 disease in Togo.,250,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381,NA
PACTR202010729372570,PACTR,2020-09-25,2020-05-10,TRUE,Not Recruiting,Phase 3,Interventional,Uganda,The COVID-19 Community Engagement Study,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392,NA
PACTR202010690466874,PACTR,2020-10-01,2020-01-11,TRUE,Not Recruiting,Phase 2,Interventional,Ghana,KNUST COVID-19 CLINICAL TRIAL,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403,NA
PACTR202010781639956,PACTR,2020-10-07,2020-09-21,TRUE,Recruiting,Phase 3,Interventional,"Ghana, Equatorial Guinea, Democratic Republic of the Congo, Mozambique, Ethiopia, Sudan, Kenya","The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan Africa
Ancillary Study of the ANTICOV Study:
An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",1000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420,NA
PACTR202010472402152,PACTR,2020-10-07,2020-12-10,FALSE,Not Recruiting,Not Applicable,Interventional,Gambia,COVADIS study,1100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421,NA
PACTR202010718451278,PACTR,2020-10-14,2020-02-11,TRUE,Not Recruiting,Phase 3,Interventional,"Mozambique, Ghana, Equatorial Guinea, Kenya","Factors affecting transmission of SARS-CoV-2 in Households of SARS-CoV-2 patients in Sub-Saharan Africa Ancillary study of the ANTICOV Study: An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",2800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432,NA
PACTR202101544570971,PACTR,2020-10-27,2020-01-12,TRUE,Not Recruiting,Phase 3,Interventional,Gambia,Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a  randomized clinical trial (PaTS-COVID)   COVID-19,1200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13461,NA
PACTR202011523101903,PACTR,2020-11-02,2020-01-12,TRUE,Not Recruiting,Phase 3,Interventional,Kenya,"Study of Recombinant Protein Vaccine with Adjuvant against COVID-19 in Adults 18 Years of Age and Older.
",34520,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475,NA
PACTR202101794986980,PACTR,2020-11-21,2021-01-29,FALSE,Not Recruiting,Phase 3,Interventional,Ghana,CROWN CORONATION; COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,150,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14507,NA
PACTR202012892855610,PACTR,2020-11-22,2020-07-12,TRUE,Not Recruiting,Not Applicable,Interventional,Nigeria,Safety and Efficacy of Artemisinin 500 mg capsule in Treatment of Adult Subjects with COVID-19,120,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14510,NA
PACTR202012898601759,PACTR,2020-12-03,2020-12-20,FALSE,Not Recruiting,Phase 2,Interventional,Nigeria,PHASE  2 TRIAL: EVALUATION OF SILYMARIN FOR TREATMENT OF PATIENTS WITH COVID-19,314,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14547,NA
PACTR202102846261362,PACTR,2021-01-22,2021-01-02,TRUE,Not Recruiting,Not Applicable,Interventional,Uganda,Using community influencer groups to address COVID-19 misinformation and potential vaccine hesitancy in Uganda,632,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14631,NA
PACTR202101875903773,PACTR,2021-01-22,2021-01-26,FALSE,Not Recruiting,Not Applicable,Interventional,Egypt,A novel drug combination and route for COVID-19 treatment,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14632,NA
PACTR202102867544936,PACTR,2021-02-03,2021-07-02,FALSE,Recruiting,Not Applicable,Interventional,Tunisia,Endothelial Dysfunction during The COVID-19 follow-up: TUN-EndCOV study,600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14657,NA
PACTR202102588777597,PACTR,2021-02-05,2021-02-02,TRUE,Recruiting,Phase 3,Interventional,Nigeria,Ivermectin Treatment Trial (ITT),240,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14661,NA
PACTR202102616421588,PACTR,2021-02-08,2020-01-11,TRUE,Not Recruiting,Not Applicable,Interventional,Democratic Republic of the Congo,"Effect of a Community-Driven Water, Sanitation, and Hygiene Program on Covid-19 knowledge, behavior, and health:
A Randomized Control Trial in the Democratic Republic of Congo 
",1312,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14670,NA
PACTR202102848675636,PACTR,2021-02-10,2021-01-03,TRUE,Not Recruiting,Phase 2,Interventional,Nigeria,"Double Blind, Community-based, Randomized Controlled Trial on the Use of Ivermectin as Post Exposure Chemo-prophylaxis for COVID-19 among High Risk Individuals in Lagos (IVERPEPCOV)  COVID-19",2100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=14678,NA
PACTR202102855526180,PACTR,2021-02-13,2021-01-03,TRUE,Recruiting,Phase 3,Interventional,South Africa,"Sisonke (Together): OPEN LABEL TRIAL
Open-label, single-arm phase 3B implementation study to monitor the effectiveness of the single-dose Ad26.COV2.S COVID-19 vaccine among health care workers in South Africa (VAC31518COV3012
",500000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15686,NA
PACTR202102535686338,PACTR,2021-02-14,2021-02-22,FALSE,Not Recruiting,Phase 3,Interventional,Nigeria,Efficacy of Ivermectin for the Treatment and Prophylaxis of COVID-19 disease,240,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15689,NA
PACTR202103574924457,PACTR,2021-03-03,2021-01-26,TRUE,Not Recruiting,Not Applicable,Interventional,Ghana,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana (SMSCOVID)    COVID-19",206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15726,NA
PACTR202103845381761,PACTR,2021-03-03,2021-01-04,TRUE,Not Recruiting,Phase 3,Interventional,Kenya,A global Phase III clinical trial of recombinant COVID-19 vaccine (Sf9 cells) in adults aged 18 years and older,40000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15727,NA
PACTR202103601407640,PACTR,2021-03-19,2021-01-18,TRUE,Recruiting,Phase 3,Interventional,Madagascar,"Clinical trial, phase 3, to evaluate the efficacy of CVO +  for the treatment of COVID-19.",338,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15764,NA
PACTR202104601572565,PACTR,2021-04-12,2021-01-05,TRUE,Not Recruiting,Phase 3,Interventional,Ghana,SPUTNIK-LIGHT.  COVID-19,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15817,NA
PACTR202106588702901,PACTR,2021-05-13,2021-06-30,FALSE,Not Recruiting,Phase 3,Interventional,"Ghana, Uganda, Nigeria, Kenya","Study of Monovalent and Bivalent Recombinant Protein Vaccines against COVID-19 in Adults
18 Years of Age and Older",37430,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15870,NA
PACTR202105817814362,PACTR,2021-05-20,2021-06-14,FALSE,Not Recruiting,Phase 3,Interventional,"Malawi, South Africa, Swaziland, Zambia, Uganda, Zimbabwe, Botswana, Kenya","Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern",14000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=15890,NA
RPCEC00000306,RPCEC,2020-04-13,2020-03-27,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,NA
RPCEC00000307,RPCEC,2020-04-14,2020-10-04,FALSE,Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,NA
RPCEC00000308,RPCEC,2020-05-03,2020-04-05,TRUE,Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,NA
RPCEC00000309,RPCEC,2020-05-05,2021-04-30,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,200,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,NA
RPCEC00000310,RPCEC,2020-05-05,2020-03-04,TRUE,Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial,0,https://rpcec.sld.cu/en/trials/RPCEC00000310-En,NA
RPCEC00000311,RPCEC,2020-05-12,2020-03-28,TRUE,Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,NA
RPCEC00000312,RPCEC,2020-05-13,2020-04-29,TRUE,Recruiting,Not Applicable,Observational,Cuba,PrevengHo-Vir Homeoprohylaxis COVID-2019,180,https://rpcec.sld.cu/en/trials/RPCEC00000312-En,NA
RPCEC00000313,RPCEC,2020-05-14,2020-03-31,TRUE,Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,NA
RPCEC00000314,RPCEC,2020-05-22,2020-04-24,TRUE,Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,NA
RPCEC00000315,RPCEC,2020-05-22,2020-05-19,TRUE,Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,NA
RPCEC00000316,RPCEC,2020-05-28,2020-03-07,TRUE,Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,NA
RPCEC00000317,RPCEC,2020-05-28,2020-01-06,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,NA
RPCEC00000318,RPCEC,2020-05-29,2020-11-03,FALSE,Recruiting,Not Applicable,Observational,Cuba,Heberon Alfa R in COVID-19,0,https://rpcec.sld.cu/en/trials/RPCEC00000318-En,NA
RPCEC00000319,RPCEC,2020-05-29,2020-04-13,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM - covid-19 - older adult,160,https://rpcec.sld.cu/en/trials/RPCEC00000319-En,NA
RPCEC00000320,RPCEC,2020-06-05,2020-08-06,FALSE,Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,NA
RPCEC00000321,RPCEC,2020-06-22,2020-04-27,TRUE,Recruiting,Not Applicable,Interventional,Cuba,VIDA study,0,https://rpcec.sld.cu/en/trials/RPCEC00000321-En,NA
RPCEC00000322,RPCEC,2020-07-03,2020-05-05,TRUE,Recruiting,Not Applicable,Interventional,Cuba,Stem cells in patients with lung lesions (COVID-19),20,https://rpcec.sld.cu/en/trials/RPCEC00000322-En,NA
RPCEC00000323,RPCEC,2020-07-03,2020-05-05,TRUE,Recruiting,Not Applicable,Observational,Cuba,PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION,0,https://rpcec.sld.cu/en/trials/RPCEC00000323-En,NA
RPCEC00000330,RPCEC,2020-08-11,2020-11-08,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,DALIA Study,60,https://rpcec.sld.cu/en/trials/RPCEC00000330-En,NA
RPCEC00000332,RPCEC,2020-08-13,2020-08-24,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA 01,676,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,NA
RPCEC00000334,RPCEC,2020-09-10,2020-09-14,FALSE,Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T in older adult for protection in events of local transmission of COVID-19,0,https://rpcec.sld.cu/en/trials/RPCEC00000334-En,NA
RPCEC00000335,RPCEC,2020-09-19,2020-09-26,FALSE,Recruiting,Not Applicable,Interventional,Cuba,BIOMODULINA T in a long-lived population at high risk of COVID-19 infection,0,https://rpcec.sld.cu/en/trials/RPCEC00000335-En,NA
RPCEC00000337,RPCEC,2020-10-01,2020-12-10,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,OLIVO Study,80,https://rpcec.sld.cu/en/trials/RPCEC00000337-En,NA
RPCEC00000338,RPCEC,2020-10-17,2020-10-19,FALSE,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01A,60,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,NA
RPCEC00000340,RPCEC,2020-10-27,2020-02-11,TRUE,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 02,40,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,NA
RPCEC00000341,RPCEC,2020-10-27,2020-08-15,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort.,200,https://rpcec.sld.cu/en/trials/RPCEC00000341-En,NA
RPCEC00000342,RPCEC,2020-11-06,2020-08-06,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2,40,https://rpcec.sld.cu/en/trials/RPCEC00000342-En,NA
RPCEC00000344,RPCEC,2020-11-24,2020-03-19,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia,199,https://rpcec.sld.cu/en/trials/RPCEC00000344-En,NA
RPCEC00000345,RPCEC,2020-11-26,2020-07-12,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,MAMBISA Study,88,https://rpcec.sld.cu/en/trials/RPCEC00000345-En,NA
RPCEC00000346,RPCEC,2020-11-26,2020-07-12,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ABDALA Clinical Study,0,https://rpcec.sld.cu/en/trials/RPCEC00000346-En,NA
RPCEC00000347,RPCEC,2020-12-17,2020-12-21,FALSE,Not Recruiting,Phase 2,Interventional,Cuba,SOBERANA 02A,910,https://rpcec.sld.cu/en/trials/RPCEC00000347-En,NA
RPCEC00000348,RPCEC,2020-12-21,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study,60,https://rpcec.sld.cu/en/trials/RPCEC00000348-En,NA
RPCEC00000349,RPCEC,2021-01-05,2021-09-01,FALSE,Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01B,30,https://rpcec.sld.cu/en/trials/RPCEC00000349-En,NA
RPCEC00000350,RPCEC,2021-01-22,2020-09-21,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Curmeric- Safety-Community-Quarantine-COVID-19,186,https://rpcec.sld.cu/en/trials/RPCEC00000350-En,NA
RPCEC00000351,RPCEC,2021-01-22,2020-03-10,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19,340,https://rpcec.sld.cu/en/trials/RPCEC00000351-En,NA
RPCEC00000352,RPCEC,2021-01-22,2020-10-21,TRUE,Not Recruiting,Not Applicable,Observational,Cuba,Curmeric- Nasal-Safety-Efficacy- Community-Quarantine -COVID-19,148,https://rpcec.sld.cu/en/trials/RPCEC00000352-En,NA
RPCEC00000353,RPCEC,2021-03-01,2021-01-04,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Cuba,AVATAR-2020,354,https://rpcec.sld.cu/en/trials/RPCEC00000353-En,NA
RPCEC00000354,RPCEC,2021-03-03,2021-05-03,FALSE,Not Recruiting,Phase 3,Interventional,Cuba,SOBERANA 02-FaseIII,44010,https://rpcec.sld.cu/en/trials/RPCEC00000354-En,NA
RPCEC00000356,RPCEC,2021-03-11,2021-12-03,FALSE,Not Recruiting,Not Applicable,Interventional,Cuba,CIGB2020- ARI elderly contacts,1440,https://rpcec.sld.cu/en/trials/RPCEC00000356-En,NA
RPCEC00000357,RPCEC,2021-03-16,2020-09-24,TRUE,Not Recruiting,Phase 2,Interventional,Mexico,Oropharyngeal sanitization with electrolyzed superoxidation solution with neutral pH to prevent COVID-19,170,https://rpcec.sld.cu/en/trials/RPCEC00000357-En,NA
RPCEC00000359,RPCEC,2021-03-18,2021-03-22,FALSE,Not Recruiting,Phase 3,Interventional,Cuba,ABDALA Clinical Study - Phase III,48000,https://rpcec.sld.cu/en/trials/RPCEC00000359-En,NA
RPCEC00000360,RPCEC,2021-03-19,2021-03-22,FALSE,Not Recruiting,Not Applicable,Interventional,Cuba,SOBERANA - INTERVENTION,0,https://rpcec.sld.cu/en/trials/RPCEC00000360-En,NA
RPCEC00000361,RPCEC,2021-03-26,2021-01-04,TRUE,Not Recruiting,Not Applicable,Interventional,Cuba,Itolizumab Safety and Efficacy Study in Covid 19,20,https://rpcec.sld.cu/en/trials/RPCEC00000361-En,NA
RPCEC00000363,RPCEC,2021-03-27,2021-03-29,FALSE,Not Recruiting,Not Applicable,Interventional,Cuba,ABDALA-Intervention,124000,https://rpcec.sld.cu/en/trials/RPCEC00000363-En,NA
RPCEC00000366,RPCEC,2021-04-09,2021-04-17,FALSE,Not Recruiting,Phase 2,Interventional,Cuba,SOBERANA PLUS,0,https://rpcec.sld.cu/en/trials/RPCEC00000366-En,NA
RPCEC00000369,RPCEC,2021-05-21,2021-05-24,FALSE,Not Recruiting,Phase 1,Interventional,Cuba,Nimotuzumab in COVID-19,40,https://rpcec.sld.cu/en/trials/RPCEC00000369-En,NA
RPCEC00000374,RPCEC,2021-06-10,2021-06-14,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA PEDIATRIA,350,https://rpcec.sld.cu/en/trials/RPCEC00000374-En,NA
RPCEC00000375,RPCEC,2021-06-18,2021-06-25,FALSE,Not Recruiting,Phase 2,Interventional,Cuba,CIMAvax-EGFÂ®-post-COVID19 convalescent with respiratory disorders-adults-Phase II  (CORVAXCIM),100,https://rpcec.sld.cu/en/trials/RPCEC00000375-En,NA
RPCEC00000376,RPCEC,2021-06-18,2021-06-25,FALSE,Not Recruiting,Phase 2,Interventional,Cuba,"iorÂ®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders",120,https://rpcec.sld.cu/en/trials/RPCEC00000376-En,NA
TCTR20210617008,TCTR,2021-06-17,2021-05-20,TRUE,Recruiting,Not Applicable,Observational,Thailand,"Erectile Function and Associating Factors in Patients with COVID-19 at King Chulalongkorn Memorial Hospital, the Thai Red Cross Society",80,www.thaiclinicaltrials.org/show/TCTR20210617008,NA
TCTR20210617006,TCTR,2021-06-17,2021-01-07,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Effect of COVID-19 on hormone and semen parameter in male COVID-19 patients.,116,www.thaiclinicaltrials.org/show/TCTR20210617006,NA
TCTR20210615002,TCTR,2021-06-15,2021-06-16,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,Effect of Combined Fluvoxamine with Favipiravir versus Favipiravir Monotherapy in Prevention of Clinical Deterioration among mild to moderate COVID-19 patients Monitoring by Telemedicine in Virtual Clinic: Open-label Randomized Controlled Trial,296,www.thaiclinicaltrials.org/show/TCTR20210615002,NA
TCTR20210615001,TCTR,2021-06-15,2020-08-19,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,The comparison of intraoperative arterial blood pressure lability during general anesthesia in treated hypertensive patients who have controlled blood pressure based on office measurement (Masked uncontrolled hypertensive VS adequate blood pressure controlled patients),117,www.thaiclinicaltrials.org/show/TCTR20210615001,NA
TCTR20210613001,TCTR,2021-06-13,2020-06-20,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,"COVID-19 antibody testing utilizing the Rapid IgM/IgG antibodies test kit in comparison to the RT-PCR results in patients, admitted to hospital for obstetrics/operative procedure, and personnel at the department of Obstetrics and Gynaecology",290,www.thaiclinicaltrials.org/show/TCTR20210613001,NA
TCTR20210611006,TCTR,2021-06-11,2021-05-21,TRUE,Recruiting,Not Applicable,Observational,Thailand,Study of immunologic response after COVID-19 vaccination in kidney transplant recipients,60,www.thaiclinicaltrials.org/show/TCTR20210611006,NA
TCTR20210610004,TCTR,2021-06-10,2021-10-06,FALSE,Recruiting,Not Applicable,Observational,Thailand,"Neurological complication after injection of inactivated COVID-19 vaccine in Srinagarind hospital, Thailand: the case series",18,www.thaiclinicaltrials.org/show/TCTR20210610004,NA
TCTR20210610003,TCTR,2021-06-10,2021-06-14,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,A prospective cohort study of the cutaneous reactions after COVID-19 vaccination among Thai healthcare workers.,10000,www.thaiclinicaltrials.org/show/TCTR20210610003,NA
TCTR20210609001,TCTR,2021-06-09,2021-11-06,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,"Efficacy of Andrographis paniculata extract Combined with Favipiravir Treatment to Prevent Disease Progression in mild to moderate COVID-19 Patients:  A Double-blind, Randomized, Placebo-Controlled Study",146,www.thaiclinicaltrials.org/show/TCTR20210609001,NA
TCTR20210603002,TCTR,2021-06-03,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Effectiveness of COVID-19 pre-operative protocol to prevent in-hospital transmission among healthcare personnel and patients undergoing elective cataract surgery under local anesthesia,120,www.thaiclinicaltrials.org/show/TCTR20210603002,NA
TCTR20210602002,TCTR,2021-06-02,2020-10-26,TRUE,Not Recruiting,Phase 4,Interventional,Thailand,Comparison of tele-education and conventional CPR training during COVID-19 pandemic,56,www.thaiclinicaltrials.org/show/TCTR20210602002,NA
TCTR20210526004,TCTR,2021-05-26,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Immunogenicity and safety of SARS-CoV-2 (COVID-19 virus) vaccine in liver transplant recipients,60,www.thaiclinicaltrials.org/show/TCTR20210526004,NA
TCTR20210525005,TCTR,2021-05-25,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Immunogenicity and safety of SARS-CoV-2 (COVID-19 virus) vaccine in patients with hepatocellular carcinoma,60,www.thaiclinicaltrials.org/show/TCTR20210525005,NA
TCTR20210524002,TCTR,2021-05-24,2021-06-15,FALSE,Not Recruiting,Phase 4,Interventional,Thailand,SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipients,120,www.thaiclinicaltrials.org/show/TCTR20210524002,NA
TCTR20210523002,TCTR,2021-05-23,2021-01-07,TRUE,Not Recruiting,Phase 4,Interventional,Thailand,SARS-CoV-2-specific immune responses after COVID-19 vaccination in solid organ transplant recipients,250,www.thaiclinicaltrials.org/show/TCTR20210523002,NA
TCTR20210520004,TCTR,2021-05-20,2021-05-24,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,Safety and immunogenicity of inactivated COVID-19 vaccine and virus vector vaccine in Thai adults with previous infection: Clinical trial,120,www.thaiclinicaltrials.org/show/TCTR20210520004,NA
TCTR20210517006,TCTR,2021-05-17,2021-03-31,TRUE,Recruiting,Phase 2,Interventional,Thailand,"Immunogenicity and safety of Sputnik V, ChAdOx1, and Sinovac vaccines in Thai people.",3000,www.thaiclinicaltrials.org/show/TCTR20210517006,NA
TCTR20210517005,TCTR,2021-05-17,2020-01-12,TRUE,Recruiting,Not Applicable,Observational,Thailand,Clinical characteristics of adult Philadelphila-chromo negative myeloproliferative neoplasms and correlated molecular mutations,226,www.thaiclinicaltrials.org/show/TCTR20210517005,NA
TCTR20210514003,TCTR,2021-05-14,2021-01-06,TRUE,Not Recruiting,Phase 3,Interventional,Thailand,Andrographolide as a medical tool for reduction of hospitalization in mild or asymptomatic COVID-19 patients: a randomized double-blind placebo controlled trial,160,www.thaiclinicaltrials.org/show/TCTR20210514003,NA
TCTR20210510009,TCTR,2021-05-10,2021-05-17,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,SARS-CoV-2 Antibody responses in end-stage renal disease patients after COVID-19  Vaccination,70,www.thaiclinicaltrials.org/show/TCTR20210510009,NA
TCTR20210510008,TCTR,2021-05-10,2021-03-24,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Ocular Surface Erosion of a Vaccine for SARS-CoV2 (COVID-19 virus),20,www.thaiclinicaltrials.org/show/TCTR20210510008,NA
TCTR20210503001,TCTR,2021-05-03,2020-07-15,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Basic life support for healthcare provider training with blended classroom during COVID-19 pandemic,35,www.thaiclinicaltrials.org/show/TCTR20210503001,NA
TCTR20210430003,TCTR,2021-04-30,2020-10-15,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Different perspectives between medical students and teachers in theoretical anesthesiology studies through online learning during COVID-19 pandemic,243,www.thaiclinicaltrials.org/show/TCTR20210430003,NA
TCTR20210412005,TCTR,2021-04-12,2021-03-03,TRUE,Recruiting,Phase 4,Interventional,Thailand,The efficacy of insulated microneedle radiofrequency in Keratosis pilaris,20,www.thaiclinicaltrials.org/show/TCTR20210412005,NA
TCTR20210330003,TCTR,2021-03-30,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Asian bystander&#039;s willingness to perform cardiopulmonary resuscitation during COVID-19  pandemic  and associated factors,1000,www.thaiclinicaltrials.org/show/TCTR20210330003,NA
TCTR20210329003,TCTR,2021-03-29,2021-01-04,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease Severity,36,www.thaiclinicaltrials.org/show/TCTR20210329003,NA
TCTR20210325003,TCTR,2021-03-25,2021-03-23,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Immunogenicity of COVID-19 vaccines in KCMH health care workers,400,www.thaiclinicaltrials.org/show/TCTR20210325003,NA
TCTR20210319003,TCTR,2021-03-19,2021-03-19,FALSE,Recruiting,Not Applicable,Observational,Thailand,A prospective cohort study of safety and Immunogenicity of inactivated COVID-19 vaccine and virus vector vaccine in Thai adults,200,www.thaiclinicaltrials.org/show/TCTR20210319003,NA
TCTR20210319001,TCTR,2021-03-19,2021-09-03,FALSE,Not Recruiting,Not Applicable,Observational,France,History of diagnostic and screening tests in COVID-19 patients,1000,www.thaiclinicaltrials.org/show/TCTR20210319001,NA
TCTR20210310004,TCTR,2021-03-10,2021-04-04,FALSE,Not Recruiting,Not Applicable,Observational,Egypt,Audiovestibular manifestations among COVID-19  Virus patients,100,www.thaiclinicaltrials.org/show/TCTR20210310004,NA
TCTR20210310002,TCTR,2021-03-10,2021-03-05,TRUE,Not Recruiting,Phase 3,Interventional,Thailand,Evaluating the Efficacy of Cognitive Behavior Therapy on Depression in Thai University Students: A Comparative Study of Online and Face-to-Face Methods during COVID-19 Pandemic,72,www.thaiclinicaltrials.org/show/TCTR20210310002,NA
TCTR20210308003,TCTR,2021-03-08,2021-06-03,FALSE,Recruiting,Phase 4,Interventional,Thailand,Safety and Immunogenicity of inactivated COVID-19 vaccine and virus vector vaccine in Thai adults,370,www.thaiclinicaltrials.org/show/TCTR20210308003,NA
TCTR20210226002,TCTR,2021-02-26,2021-04-22,FALSE,Recruiting,Not Applicable,Observational,Thailand,SARS-CoV-2-specific immune responses after COVID-19 vaccination in end-stage  renal disease patients and kidney transplant recipients,120,www.thaiclinicaltrials.org/show/TCTR20210226002,NA
TCTR20210202005,TCTR,2021-02-02,2020-06-25,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Positive airway pressure therapy compliance in obstructive sleep apnea patients during COVID-19 pandemic,156,www.thaiclinicaltrials.org/show/TCTR20210202005,NA
TCTR20210125002,TCTR,2021-01-25,2020-10-20,TRUE,Not Recruiting,Phase 3,Interventional,Thailand,Efficacy of povidone iodine spray for SARS-CoV-2 eradication in upper respiratory tract of patients with COVID-19: A pilot study,35,www.thaiclinicaltrials.org/show/TCTR20210125002,NA
TCTR20201215003,TCTR,2020-12-15,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Stress of Thai Dentist During COVID&#45;19 Pandemic in Thailand,Not Available,www.thaiclinicaltrials.org/show/TCTR20201215003,NA
TCTR20201215001,TCTR,2020-12-15,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,Virtual medical system for cancer patient monitoring and caregiver support during the COVID&#45;19 pandemic,1000,www.thaiclinicaltrials.org/show/TCTR20201215001,NA
TCTR20201214005,TCTR,2020-12-14,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,COVID&#45;19 Seroprevalence Survey among Cancer Patients and Caregivers in Cancer Center,400,www.thaiclinicaltrials.org/show/TCTR20201214005,NA
TCTR20201124002,TCTR,2020-11-24,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Effect of medical mask on maternal oxygen saturation and fetal non&#45;stress test during late third trimester of pregnancy in the COVID&#45;19 era,Not Available,www.thaiclinicaltrials.org/show/TCTR20201124002,NA
TCTR20201027002,TCTR,2020-10-27,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Effect of dexamethasone or ibuprofen&#45;acetaminophen combination for pain management in symptomatic apical periodontitis during COVID&#45;19 outbreak: a retrospective cohort study,50,www.thaiclinicaltrials.org/show/TCTR20201027002,NA
TCTR20201015003,TCTR,2020-10-15,2020-01-10,TRUE,Recruiting,Phase 4,Interventional,No Country Given,Clinical outcomes and safety of preoperative non&#45;preserved steroid eye drop in trabeculectomy: A randomised controlled trial,162,www.thaiclinicaltrials.org/show/TCTR20201015003,NA
TCTR20200901001,TCTR,2020-09-01,2020-07-18,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID&#45;19 pandemic era on the outcome&#44; morbidity&#44; and mortality of Acute Care Surgery patients,61,www.thaiclinicaltrials.org/show/TCTR20200901001,NA
TCTR20200828001,TCTR,2020-08-28,2020-09-15,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,Seroprevalence of COVID&#45;19 in Thailand,400,www.thaiclinicaltrials.org/show/TCTR20200828001,NA
TCTR20200822003,TCTR,2020-08-22,2020-07-07,TRUE,Recruiting,Not Applicable,Observational,Thailand,Herd immunity level to COVID&#45;19 as an indicator of the epidemic progression in Thailand,Not Available,www.thaiclinicaltrials.org/show/TCTR20200822003,NA
TCTR20200822002,TCTR,2020-08-22,2020-08-21,TRUE,Recruiting,Not Applicable,Observational,Thailand,Use of emergency medical services: experience 100 days after first case  of COVID&#45;19,545,www.thaiclinicaltrials.org/show/TCTR20200822002,NA
TCTR20200820006,TCTR,2020-08-20,2020-08-20,FALSE,Recruiting,Not Applicable,Observational,Thailand,Response time of motorlance in COVID&#45;19 pandemic,871,www.thaiclinicaltrials.org/show/TCTR20200820006,NA
TCTR20200709002,TCTR,2020-07-09,2020-06-21,TRUE,Recruiting,Not Applicable,Observational,Thailand,Impact of the COVID&#45;19 lockdown on dry eye,144,www.thaiclinicaltrials.org/show/TCTR20200709002,NA
TCTR20200708001,TCTR,2020-07-08,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,Thailand,SARS&#45;CoV&#45;2 RNA shedding in recovered COVID&#45;19 cases and the presence of antibodies against SARS&#45;CoV&#45;2 in recovered COVID&#45;19 cases and contacts,239,www.thaiclinicaltrials.org/show/TCTR20200708001,NA
TCTR20200601002,TCTR,2020-06-01,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,Malaysia,A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression&#44; Anxiety and Stress among Healthcare Workers during COVID&#45;19 Pandemic in Jerantut&#44; Pahang,110,www.thaiclinicaltrials.org/show/TCTR20200601002,NA
TCTR20200527001,TCTR,2020-05-27,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Endotoxin and circulating bacteriome in severe COVID&#45;19 patients,Not Available,www.thaiclinicaltrials.org/show/TCTR20200527001,NA
TCTR20200514001,TCTR,2020-05-14,2020-01-06,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID&#45;19 Patients without Pneumonia Ã¢Ë†â€™ An open&#45;label randomized controlled study Ã¢Ë†â€™,96,www.thaiclinicaltrials.org/show/TCTR20200514001,NA
TCTR20200426002,TCTR,2020-04-26,2020-08-04,FALSE,Recruiting,Not Applicable,Observational,Thailand,Chula Covid&#45;19 Rapid Test for Pandemic Control,200,www.thaiclinicaltrials.org/show/TCTR20200426002,NA
TCTR20200425001,TCTR,2020-04-25,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,Thailand,Mental Health Circumstances Among Healthcare Workers and General Public Under the Pandemic Situation of COVID&#45;19,2500,www.thaiclinicaltrials.org/show/TCTR20200425001,NA
TCTR20200409006,TCTR,2020-04-09,2020-01-05,TRUE,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID&#45;19,206,www.thaiclinicaltrials.org/show/TCTR20200409006,NA
TCTR20200405001,TCTR,2020-04-05,2020-03-19,TRUE,Recruiting,Not Applicable,Observational,Thailand,Use of Covid&#45;19 Rapid Test for Hospital Care: GI Procedure,40,www.thaiclinicaltrials.org/show/TCTR20200405001,NA
TCTR20200404004,TCTR,2020-04-04,2020-04-27,FALSE,Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID&#45;19 patients,400,www.thaiclinicaltrials.org/show/TCTR20200404004,NA
TCTR20200401002,TCTR,2020-04-01,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Thailand,Social&#44; ethical and behavioural aspects of the novel coronavirus pandemic,2640,www.thaiclinicaltrials.org/show/TCTR20200401002,NA
TCTR20200324001,TCTR,2020-03-24,2020-03-24,FALSE,Not Recruiting,Not Applicable,Observational,France,Covid&#45;19 preparedness among Emergency Departments: a cross&#45;sectional study in France.,650,www.thaiclinicaltrials.org/show/TCTR20200324001,NA
TCTR20200321001,TCTR,2020-03-21,2020-03-20,TRUE,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid&#45;19 pandemic,5000,www.thaiclinicaltrials.org/show/TCTR20200321001,NA
KCT0006252,CRiS,2021-06-14,2021-06-14,FALSE,Not Recruiting,Not Applicable,Interventional,South Korea,Herbal medicines for fatigue or brain fog in Coronavirus disease 2019 (COVID-19) survivors: a prospective pilot clinical study,45,https://cris.nih.go.kr/cris/search/detailSearchEn.do?seq=19179,NA
RBR-9pgwfc,ReBec,2020-04-09,2020-07-04,FALSE,Recruiting,Not Applicable,Observational,"Chile, Portugal, United Kingdom, Colombia, Canada, United States, Brazil, Spain, France",Psychological effects of social isolation in the coronavirus pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9pgwfc,NA
RBR-9ktwx6,ReBec,2020-04-09,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Brazil,Effect of the use of Chloroquine and Hydroxychloroquine as a possible protector for Infection with the New Corona Virus 2019 in patients with Rheumatic Diseases,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9ktwx6,NA
RBR-8969zg,ReBec,2020-04-13,2020-04-14,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8969zg,NA
RBR-658khm,ReBec,2020-04-22,2020-01-04,TRUE,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in SÃ£o Paulo, Brazil",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-658khm,NA
RBR-6w5tbk,ReBec,2020-04-29,2020-04-30,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6w5tbk,NA
RBR-5s2mqg,ReBec,2020-05-05,2020-04-27,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,The effect of an inhibitor of pulmonary inflammation in patients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5s2mqg,NA
RBR-3k4wxb,ReBec,2020-05-05,2020-01-05,TRUE,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3k4wxb,NA
RBR-4vm3yy,ReBec,2020-05-15,2020-04-19,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4vm3yy,NA
RBR-62y3h7,ReBec,2020-05-18,2020-01-05,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Acute impairment of renal function in COVID-19: study on incidence, risk factors and mortality",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-62y3h7,NA
RBR-9d8z6m,ReBec,2020-03-27,2020-03-30,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azythromycin in SARS-Cov-2 Virus,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9d8z6m,NA
RBR-2dxyx4,ReBec,2020-06-02,2020-04-06,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2dxyx4,NA
RBR-43hbks,ReBec,2020-06-03,2020-04-21,TRUE,Recruiting,Not Applicable,Observational,Brazil,Evaluation with ultrasound on the bedside in serious patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-43hbks,NA
RBR-949z6v,ReBec,2020-05-06,2020-05-30,FALSE,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-949z6v,NA
RBR-876qb5,ReBec,2020-06-08,2020-05-27,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-876qb5,NA
RBR-4qjzh7,ReBec,2020-06-08,2020-04-17,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Study of vascular complications in critically ill patients with coronavirus,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4qjzh7,NA
RBR-3zdynp,ReBec,2020-06-23,2020-03-16,TRUE,Recruiting,Phase 4,Interventional,Brazil,Using Tocilizumab in critically ill patients with COVID-19.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3zdynp,NA
RBR-33ytqc,ReBec,2020-06-24,2020-05-13,TRUE,Recruiting,Not Applicable,Observational,Brazil,Evaluation of COVID-19 in patients with Chronic Inflammatory Rheumatic Diseases.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-33ytqc,NA
RBR-4wnx2q,ReBec,2020-06-26,2020-06-06,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Pulmonary rehabilitation in individuals affected by Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4wnx2q,NA
RBR-5kkpg6,ReBec,2020-06-28,2020-06-29,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of eating habits and exposure to light on sleep, emotion, memory and headache in college students during the COVID-19 pandemic",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5kkpg6,NA
RBR-7jqpnw,ReBec,2020-06-29,2020-01-07,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,"Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7jqpnw,NA
RBR-3rywwg,ReBec,2020-07-10,2020-01-06,TRUE,Recruiting,Phase 2,Interventional,Brazil,"A clinical, randomized study to evaluate the efficacy and safety of Naproxen compared to placebo in combination with Azithromycin or Levofloxacin in patients with Severe Acute Respiratory Syndrome during the Covid-19 pandemic",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3rywwg,NA
RBR-7jrxqm,ReBec,2020-07-10,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Effect of a special nutritional oral supplement use on inflammation in patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7jrxqm,NA
RBR-6xqcr4,ReBec,2020-07-10,2020-01-07,TRUE,Recruiting,Not Applicable,Observational,Brazil,Assessment cardiorespiratory  in recovered Covid-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6xqcr4,NA
RBR-45kf9p,ReBec,2020-07-13,2020-06-29,TRUE,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep study : Comparative study between different anti-coagulation strategies in continuous hemodialysis in COVID-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-45kf9p,NA
RBR-7drpyr,ReBec,2020-07-13,2020-06-20,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Effect of two covers to prevent injuries caused to professionals working in the health area due to the use of personal protective equipment,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7drpyr,NA
RBR-62zdkk,ReBec,2020-07-17,2020-12-06,FALSE,Recruiting,Not Applicable,Observational,Brazil,Evaluation of immunity in the evolution of the severe or mild form of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-62zdkk,NA
RBR-8hmb2r,ReBec,2020-07-27,2020-03-08,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Studying the progression and the consequences of the new Coronavirus in Brazil,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8hmb2r,NA
RBR-5ysj54,ReBec,2020-07-27,2020-07-15,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,BCG vaccine use to prevent COVID-19 in health care workers,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5ysj54,NA
RBR-7nky44,ReBec,2020-07-28,2020-01-07,TRUE,Recruiting,Not Applicable,Observational,Brazil,Novel Coronavirus infection among health workers,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7nky44,NA
RBR-3g5f9f,ReBec,2020-07-29,2020-08-28,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,"Educational intervention by cell phone to increase informed choices at childbirth, in the context of the Covid-19 pandemic.",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3g5f9f,NA
RBR-8jyhxh,ReBec,2020-07-30,2020-11-04,FALSE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Clinical trial for the treatment of COVID-19 with Chloroquine and Colchicine,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8jyhxh,NA
RBR-7w5zhr,ReBec,2020-07-30,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Brazil,Frailty and negative consequences in adults hospitalized for COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7w5zhr,NA
RBR-7dsxsv,ReBec,2020-08-04,2020-02-03,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Software to evaluate clinical, epidemiological data and chest computed tomography to predict which patients with COVID-19 will develop a severe form of the disease.",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7dsxsv,NA
RBR-35734p,ReBec,2020-08-05,2020-05-08,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe COVID-19 with angiotensin-(1-7),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-35734p,NA
RBR-564y4n,ReBec,2020-08-06,2020-05-20,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Evaluation of muscle weakness, function and quality of life after Intensive Care Unit discharge in survivors of COVID-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-564y4n,NA
RBR-2w7ghc,ReBec,2020-08-07,2020-07-20,TRUE,Recruiting,Not Applicable,Interventional,Brazil,"Online meditation as an aid in reducing symptoms of Depression, Anxiety and Psychological Stress in Resident Physicians
during COVID-19 pandemic in Brazil",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2w7ghc,NA
RBR-2f9k8p,ReBec,2020-08-07,2020-06-18,TRUE,Recruiting,Not Applicable,Observational,Brazil,Profile of hospitalized patients with Covid-19 and repercussions of physiotherapy,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2f9k8p,NA
RBR-7d7ngw,ReBec,2020-08-07,2020-07-15,TRUE,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Early prone position in patients on spontaneous ventilation,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7d7ngw,NA
RBR-2k66ft,ReBec,2020-08-10,2020-08-20,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,"Randomized,  study to evaluate early prone position in patients with COVID-19
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2k66ft,NA
RBR-9y32yy,ReBec,2020-05-24,2020-01-07,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9y32yy,NA
RBR-4vy54v,ReBec,2020-08-11,2020-07-15,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,On-Line Collectives in Mental Health: Transdisciplinary Action for Groups Vulnerable to COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4vy54v,NA
RBR-4pfygr,ReBec,2020-08-13,2020-07-27,TRUE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,"Clinical study to assess the safety and tolerability of administration, directly into a vein, of human umbilical cord and placental blood plasma (PlasmacordÂ®) in patients with Severe acute respiratory syndrome resulting from Sars-Cov-2 infection (fever, cough headache, muscle aches and difficulty breathing)",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4pfygr,NA
RBR-8j9kqy,ReBec,2020-08-13,2020-02-06,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Evaluation of symptoms, respiratory, pulmonary image and inflammation in patients who have been hospitalized for coronavirus infection in the period of a year, multicentric study (fenix)",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8j9kqy,NA
RBR-3rdhgm,ReBec,2020-05-14,2020-01-05,TRUE,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3rdhgm,NA
RBR-9xs978,ReBec,2020-08-24,2020-06-17,TRUE,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Telehealth for patients with dementia at the Hospital UniversitÃ¡rio Walter Cantidio-UFC,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9xs978,NA
RBR-2z3f7k,ReBec,2020-05-04,2020-04-29,TRUE,Recruiting,Not Applicable,Interventional,Brazil,"Artificial ventilation setting in patients infected with COVID-19
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2z3f7k,NA
RBR-2kjm6y,ReBec,2020-08-26,2020-05-22,TRUE,Recruiting,Phase 2,Interventional,"United States, Brazil",A phase 2 randomized double-blind placebo-controlled study to evaluate safety of BLD-2660 and its activity against COVID-19 virus in hospitalized subjects recently diagnosed with COVID-19 in comparison to standard of care treatment,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2kjm6y,NA
RBR-72bg24,ReBec,2020-08-27,2020-08-31,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,SARS-CoV-2 quick analysis in breath device,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-72bg24,NA
RBR-5vpyh4,ReBec,2020-07-06,2020-08-28,FALSE,Recruiting,Phase 2,Interventional,Brazil,Use of Anti-IL-17 in patients with Covid-19 associated pneumonia,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5vpyh4,NA
RBR-2fvjjm,ReBec,2020-08-11,2020-08-18,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Hyperbaric Oxygen Therapy for hospitalized patients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2fvjjm,NA
RBR-35vwq9,ReBec,2020-09-07,2020-08-15,TRUE,Recruiting,Not Applicable,Observational,Brazil,Telephone orientation on the health of elderly during COVID-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-35vwq9,NA
RBR-4scq8h,ReBec,2020-09-09,2020-07-09,TRUE,Recruiting,Not Applicable,Observational,Dominican Republic,Periodontal problems in covid-positive but asymptomatic patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4scq8h,NA
RBR-65qxs2,ReBec,2020-09-17,2020-01-07,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Effects of COVID-19 on pregnancy, childbirth, puerperium, neonatal period and child development: prospective, multicenter cohort study",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-65qxs2,NA
RBR-5d4dj5,ReBec,2020-09-17,2020-03-14,TRUE,Not Recruiting,Not Applicable,Observational,Brazil,Group of patients admitted to the emergency department with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5d4dj5,NA
RBR-9rnkbs,ReBec,2020-09-22,2020-01-09,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of an equipment to reduce the dispersion of particles in emergency dental care during the Covid-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9rnkbs,NA
RBR-8nfx26,ReBec,2020-09-22,2020-10-10,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Effect of Inhaled Nitric Oxide for the treatment of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8nfx26,NA
RBR-97nt6j,ReBec,2020-09-24,2020-09-25,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Multicenter Study of the Integrative and Complementary Practice of the Use of Ozone Gas in Outpatients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-97nt6j,NA
RBR-5v3k5d,ReBec,2020-10-02,2020-05-07,TRUE,Recruiting,Phase 3,Interventional,Brazil,Study of the use of ozone therapy adjunct to the treatment of Covid-19 infections,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5v3k5d,NA
RBR-8h7q82,ReBec,2020-10-02,2020-01-05,TRUE,Not Recruiting,Phase 2,Interventional,Brazil,"The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirus",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8h7q82,NA
RBR-2xxrrq,ReBec,2020-10-02,2020-08-13,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,The effect of cardiac massage training in patients with cardiac arrest with COVID-19 positioned in the ventral position.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2xxrrq,NA
RBR-63hzd3,ReBec,2020-10-06,2020-01-05,TRUE,Recruiting,Not Applicable,Observational,Brazil,Consequences of COVID-19 in dialytic patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-63hzd3,NA
RBR-825p57,ReBec,2020-10-08,2020-09-20,TRUE,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation for elderly people with Alzheimer's disease and their caregivers,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-825p57,NA
RBR-4nr86m,ReBec,2020-08-24,2020-08-06,TRUE,Recruiting,Phase 2,Interventional,Brazil,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4nr86m,NA
RBR-58ftdj,ReBec,2020-10-28,2020-10-08,TRUE,Recruiting,Not Applicable,Interventional,Brazil,"Evaluation of the Effectiveness of an Oral Antiseptic in Improving the Clinical Status, Decreasing Viral Load and Its Prolonged Action in Patients with COVID-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-58ftdj,NA
RBR-9b6kvp,ReBec,2020-10-29,2020-02-11,TRUE,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of a Cloth Mask Physical Exercise session on Cardiovascular health, Feeling and Exercise Effort, Oxygen Quantity and Jumping Performance: Recommendation for Physical Mask Exercise during and after the COVID-19 global outbreak",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9b6kvp,NA
RBR-4kjqtg,ReBec,2020-08-05,2020-05-08,TRUE,Recruiting,Phase 2,Interventional,Brazil,Testing of BCG vaccine against COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4kjqtg,NA
RBR-8x8g36,ReBec,2020-10-29,2020-01-11,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Effectiveness of a mouthwash and toothpaste containing PHTALOX in controlling symptoms of COVID-19 and flu,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8x8g36,NA
RBR-5d7hkv,ReBec,2020-11-03,2020-11-09,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Effect of Moderate Physical Training on a bicycle associated with altitude simulation on the health status of people recovered from COVID-19 (AEROBI-COVID),Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5d7hkv,NA
RBR-2fvw6v,ReBec,2020-11-16,2021-05-04,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,"Analysis of motor response time, electromyography and muscle strength in volunteers from the group at risk for covid-19 submitted to a home exercise protocol: randomized controlled clinical trial, cross over

",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2fvw6v,NA
RBR-2z5t7z,ReBec,2020-11-16,2020-04-10,TRUE,Recruiting,Phase 1,Interventional,Brazil,Light on COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2z5t7z,NA
RBR-5p8nzk6,ReBec,2020-11-25,2020-03-11,TRUE,Recruiting,Not Applicable,Observational,Brazil,Treatment of COVID-19 sequelae with physical exercises,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5p8nzk6,NA
RBR-8tygcz7,ReBec,2020-12-01,2020-11-16,TRUE,Recruiting,Not Applicable,Observational,Brazil,"Determination of the effectiveness of a mouthwash and nasal spray in clinical improvement, decrease in the number of viruses and their prolonged action in patients with Covid-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8tygcz7,NA
RBR-8vyvnmb,ReBec,NA,2020-12-15,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Safety use of Liraglutide in patients with Covid19 pneumonia,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8vyvnmb,NA
RBR-8yqrskp,ReBec,NA,2020-03-11,FALSE,Recruiting,Not Applicable,Observational,Brazil,Quality of life assessment with the SF-36 instrument during the coronavirus pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8yqrskp,NA
RBR-65trt53,ReBec,NA,2021-04-30,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Clinical study to assess safety and efficacy related to the use of donor stem cells in the treatment of COVID-19.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-65trt53,NA
RBR-3499g3j,ReBec,NA,2020-08-13,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,"Impact of an intervention based on mindful eating on body satisfaction, behavior and food consumption of nutrition students during the Covid-19 pandemic",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3499g3j,NA
RBR-62936mf,ReBec,NA,2020-01-07,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Pain assessment in patients with Oral Lichen Planus and Burning Mouth Syndrome during the COVID-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-62936mf,NA
RBR-7nzwkpg,ReBec,NA,2020-09-11,FALSE,Recruiting,Not Applicable,Observational,Brazil,"Effects of treatment with oral anticoagulant associated with antibiotics on clinical, immunological, hospitalization and death parameters in patients with suspected Covid-19 infection and coagulation disorders",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7nzwkpg,NA
RBR-8r9hy8f,ReBec,NA,2021-01-15,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,A Phase 2 clinical trial of Inhaled Unfractionated Heparin (UFH) for the tretatment of Hospitalised Patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8r9hy8f,NA
RBR-7rgqkhf,ReBec,NA,2021-01-17,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Analysis and validation of leven67 emergency respirator,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7rgqkhf,NA
RBR-10hj7jyn,ReBec,NA,2021-01-01,FALSE,Recruiting,Not Applicable,Observational,Brazil,In vivo evaluation of the effectiveness of two antiseptic solutions in reducing the viral load of SARS-CoV-2 in the saliva of patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-10hj7jyn,NA
RBR-6c9xnw3,ReBec,NA,2020-11-23,FALSE,Recruiting,Not Applicable,Observational,Brazil,Epidemiological study with PhtaloxÂ® mouthwash and the clinical relationship of individuals with a diagnosis of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6c9xnw3,NA
RBR-8z7v5wc,ReBec,NA,2020-10-20,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Neuropsychiatric symptoms related to COVID-19: follow-up study,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8z7v5wc,NA
RBR-10x3sdwq,ReBec,NA,2021-01-20,FALSE,Recruiting,Not Applicable,Observational,Brazil,Compassion Focused Therapy for People with Obesity,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-10x3sdwq,NA
RBR-2xd6dkj,ReBec,NA,2020-07-29,FALSE,Recruiting,Not Applicable,Observational,Brazil,Phase IV Efficacy Study of MMR Vaccine in Preventing or Reduction of Severity of COVID-19 in Healthcare Workers Adults,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2xd6dkj,NA
RBR-5x4cvd9,ReBec,NA,2020-03-11,FALSE,Recruiting,Not Applicable,Observational,Brazil,Application of the mini-questionnaire on quality of life in individuals with high blood pressure (minichal) during the covid-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5x4cvd9,NA
RBR-3h5fr2s,ReBec,NA,2020-07-25,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,"Gastrointestinal symptoms (such as nausea, vomiting, constipation, diarrhea) and nutrient supplementation in patients with COVID-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3h5fr2s,NA
RBR-3q6wqdf,ReBec,NA,2020-12-14,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Evaluation of the salivary viral load of patients with Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3q6wqdf,NA
RBR-7rvhpq9,ReBec,NA,2021-08-03,FALSE,Recruiting,Not Applicable,Observational,Portugal,The effect of rehabilitation in hospitalized COVID-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7rvhpq9,NA
RBR-7f4mt9f,ReBec,NA,2020-04-14,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Use of plasma of cured person to treat patient with severe covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7f4mt9f,NA
RBR-38hjyt3,ReBec,NA,2021-01-18,FALSE,Recruiting,Not Applicable,Observational,Brazil,Auriculotherapy in Stress reduction in primary care health professionals,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-38hjyt3,NA
RBR-2tdj6vs,ReBec,NA,2020-01-03,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Clinical characteristics and outcomes of patients with Severe Acute Respiratory Syndrome during the Covid-19 pandemic.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2tdj6vs,NA
RBR-10gb3p94,ReBec,NA,2021-05-04,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Exercise for recovered Covid-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-10gb3p94,NA
RBR-4j9wkbz,ReBec,NA,2021-05-04,FALSE,Not Recruiting,Not Applicable,Observational,Spain,"Short-term effects of a Exercise through Telerehabilitation, 
in confined patients affected by Covid-19",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4j9wkbz,NA
RBR-8ykm72j,ReBec,NA,2021-03-15,FALSE,Recruiting,Not Applicable,Observational,Brazil,Effectiveness of L carnitine suplementation in COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8ykm72j,NA
RBR-108fyykd,ReBec,NA,2021-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,"Evaluation of safety, effectiveness and duration of immunity after vaccination against Covid-19 in patients with autoimmune rheumatic diseases",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-108fyykd,NA
RBR-7xmbgsz,ReBec,NA,2020-01-09,FALSE,Recruiting,Not Applicable,Observational,Brazil,"Facial Mask Ventilation in the Sars-CoV-2 pandemic scenario
",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7xmbgsz,NA
RBR-95wmphn,ReBec,NA,2021-01-04,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Physical activity and physical inactivity in children during the Coronavirus pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-95wmphn,NA
RBR-8qby2wt,ReBec,NA,2021-01-06,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,"Effects of a remotely supervised home exercise program, during the covid-19 pandemic, on the functional capacity and cognitive function of elderly community members: a randomized clinical trial",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8qby2wt,NA
RBR-6m69fc,ReBec,2020-04-02,2020-01-04,TRUE,Not Recruiting,Not Applicable,Observational,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6m69fc,NA
RBR-4jh63b,ReBec,2020-11-19,2021-10-07,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Stem Cells for Severe COVID-19 patients,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-4jh63b,NA
RBR-2ps876h,ReBec,NA,2020-01-10,FALSE,Recruiting,Not Applicable,Interventional,Brazil,Risk factors in university students during and after the COVID-19 pandemic,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-2ps876h,NA
RBR-77jbq56,ReBec,NA,2021-05-15,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Evaluation of the use of REAC protocols in comparison with conventional therapies or placebo as a treatment for reducing symptoms of Post-Covid Syndrome in adults,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-77jbq56,NA
RBR-84nk5q6,ReBec,NA,2020-11-23,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Homeopathy as a Protective Factor to Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-84nk5q6,NA
RBR-6gdmb8c,ReBec,NA,2020-04-20,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,COVID-19 diagnostic and control methodologies based on artificial intelligence,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-6gdmb8c,NA
RBR-9ksh5f4,ReBec,NA,2021-05-31,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Study to evaluate the effects of the COVID-19 (inactivated) vaccine of the Instituto Butantan in immucompromised persons,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-9ksh5f4,NA
RBR-59447vn,ReBec,NA,2020-12-18,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Effects of the treatment with the anti-inflamatory medication AP1189 on the lung involvement in COVID-19 patients with impaired breathing.,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-59447vn,NA
RBR-7y8j2bs,ReBec,NA,2021-01-06,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Enriched heparin for the treatment of COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-7y8j2bs,NA
RBR-399t4g5,ReBec,NA,2021-07-06,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,"Effect of cranial nerve stimulation on inflammation, normalization of the autonomic nervous system and clinical evolution of patients with Covid -19: a pilot study.",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-399t4g5,NA
RBR-8gmm6ph,ReBec,NA,2021-01-20,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Use of ultrasound for pulmonary evaluation in patients with COVID-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-8gmm6ph,NA
RBR-5c8pz5r,ReBec,NA,2020-10-28,FALSE,Recruiting,Not Applicable,Observational,Brazil,GestÃ£o das EmoÃ§Ãµes na Covid-19,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-5c8pz5r,NA
RBR-3fz9yr,ReBec,2020-08-31,2020-10-06,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,Use of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirus,Not Available,http://ensaiosclinicos.gov.br/rg/RBR-3fz9yr,NA
RBR-10zs97gk,ReBec,NA,2021-01-08,FALSE,Not Recruiting,Not Applicable,Observational,Brazil,"Use of  self-management strategies combined with multicomponent training for the purpose of social distance from COVID-19 in capacity, physical capacity, mental health and quality of life in the older adults.",Not Available,http://ensaiosclinicos.gov.br/rg/RBR-10zs97gk,NA
ChiCTR2100043682,ChiCTR,2021-02-26,2021-03-01,FALSE,Not Recruiting,Not Applicable,Interventional,China,A multicenter study on pulmonary rehabilitation in severe COVID-19 patients,100,http://www.chictr.org.cn/showproj.aspx?proj=122412,NA
ChiCTR2000030817,ChiCTR,2020-03-15,2020-02-28,TRUE,Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,800,http://www.chictr.org.cn/showproj.aspx?proj=50631,NA
NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,FALSE,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),120,https://clinicaltrials.gov/show/NCT04283461,NA
NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,FALSE,Not Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,101,https://clinicaltrials.gov/show/NCT04312997,NA
NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,FALSE,Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,200,https://clinicaltrials.gov/show/NCT04313023,NA
NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany, Romania",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,200,https://clinicaltrials.gov/show/NCT04327505,NA
NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,FALSE,Not Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,68,https://clinicaltrials.gov/show/NCT04330586,NA
NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,80,https://clinicaltrials.gov/show/NCT04332081,NA
NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,FALSE,Not Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,1002,https://clinicaltrials.gov/show/NCT04334928,NA
NCT04337983,ClinicalTrials.gov,2020-03-30,2020-03-13,TRUE,Not Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,60,https://clinicaltrials.gov/show/NCT04337983,NA
NCT04341714,ClinicalTrials.gov,2020-04-08,2020-03-16,TRUE,Not Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,450,https://clinicaltrials.gov/show/NCT04341714,NA
NCT04346277,ClinicalTrials.gov,2020-04-13,2020-11-01,FALSE,Not Recruiting,Not Applicable,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Not Available,https://clinicaltrials.gov/show/NCT04346277,NA
NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,120,https://clinicaltrials.gov/show/NCT04346615,NA
NCT04348656,ClinicalTrials.gov,2020-04-13,2020-03-14,TRUE,Not Recruiting,Phase 3,Interventional,"Canada, United States, Brazil",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),940,https://clinicaltrials.gov/show/NCT04348656,NA
NCT04351503,ClinicalTrials.gov,2020-04-15,2020-04-09,TRUE,Recruiting,Not Applicable,Observational,Switzerland,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,10000,https://clinicaltrials.gov/show/NCT04351503,NA
NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,FALSE,Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19,255,https://clinicaltrials.gov/show/NCT04351581,NA
NCT04354766,ClinicalTrials.gov,2020-04-17,2020-04-29,FALSE,Not Recruiting,Not Applicable,Observational,France,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,10,https://clinicaltrials.gov/show/NCT04354766,NA
NCT04354857,ClinicalTrials.gov,2020-04-17,2020-03-27,TRUE,Not Recruiting,Not Applicable,Observational,France,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,454,https://clinicaltrials.gov/show/NCT04354857,NA
NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),91,https://clinicaltrials.gov/show/NCT04355143,NA
NCT04356677,ClinicalTrials.gov,2020-04-20,2021-05-01,FALSE,Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,0,https://clinicaltrials.gov/show/NCT04356677,NA
NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,FALSE,Not Recruiting,Not Applicable,Interventional,France,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,50,https://clinicaltrials.gov/show/NCT04363749,NA
NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,86,https://clinicaltrials.gov/show/NCT04365101,NA
NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,FALSE,Not Recruiting,Phase 3,Interventional,"South Africa, Peru, United States, Mexico, Brazil, Kenya",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,379,https://clinicaltrials.gov/show/NCT04372186,NA
NCT04372472,ClinicalTrials.gov,2020-04-29,2020-04-07,TRUE,Not Recruiting,Not Applicable,Observational,United States,SQuISH-COVID: A Pilot Study,300,https://clinicaltrials.gov/show/NCT04372472,NA
NCT04377100,ClinicalTrials.gov,2020-05-05,2021-06-30,FALSE,Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,6000,https://clinicaltrials.gov/show/NCT04377100,NA
NCT04379297,ClinicalTrials.gov,2020-05-06,2020-04-10,TRUE,Not Recruiting,Not Applicable,Observational,Luxembourg,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),1800,https://clinicaltrials.gov/show/NCT04379297,NA
NCT04380896,ClinicalTrials.gov,2020-05-04,2020-04-27,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),1000,https://clinicaltrials.gov/show/NCT04380896,NA
NCT04380987,ClinicalTrials.gov,2020-04-30,2020-05-04,FALSE,Recruiting,Not Applicable,Observational,Luxembourg,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,200,https://clinicaltrials.gov/show/NCT04380987,NA
NCT04381013,ClinicalTrials.gov,2020-05-07,2021-06-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),0,https://clinicaltrials.gov/show/NCT04381013,NA
NCT04382586,ClinicalTrials.gov,2020-05-07,2020-07-06,FALSE,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,67,https://clinicaltrials.gov/show/NCT04382586,NA
NCT04387656,ClinicalTrials.gov,2020-05-13,2020-05-21,FALSE,Recruiting,Not Applicable,Observational,"Canada, Puerto Rico, United States","NCI COVID-19 in Cancer Patients, NCCAPS Study",2000,https://clinicaltrials.gov/show/NCT04387656,NA
NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,FALSE,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,40,https://clinicaltrials.gov/show/NCT04388826,NA
NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,TRUE,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,200,https://clinicaltrials.gov/show/NCT04390191,NA
NCT04395508,ClinicalTrials.gov,2020-05-15,2020-11-13,FALSE,Not Recruiting,Not Applicable,Expanded Access,United States,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,Not Available,https://clinicaltrials.gov/show/NCT04395508,NA
NCT04395911,ClinicalTrials.gov,2020-05-17,2020-09-10,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,35,https://clinicaltrials.gov/show/NCT04395911,NA
NCT04395924,ClinicalTrials.gov,2020-05-19,2020-05-05,TRUE,Not Recruiting,Not Applicable,Observational,France,Maternal-foetal Transmission of SARS-Cov-2,50,https://clinicaltrials.gov/show/NCT04395924,NA
NCT04399356,ClinicalTrials.gov,2020-05-19,2020-10-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,Niclosamide for Mild to Moderate COVID-19,73,https://clinicaltrials.gov/show/NCT04399356,NA
NCT04404218,ClinicalTrials.gov,2020-05-24,2020-08-04,FALSE,Recruiting,Phase 2,Interventional,"Canada, Brazil",The AÃ§aÃ­ Berry COVID-19 Anti-Inflammation Trial,480,https://clinicaltrials.gov/show/NCT04404218,NA
NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,TRUE,Not Recruiting,Phase 4,Interventional,United States,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,34,https://clinicaltrials.gov/show/NCT04411667,NA
NCT04411680,ClinicalTrials.gov,2020-05-29,2020-08-18,FALSE,Not Recruiting,Phase 2,Interventional,United States,Study of Sargramostim in Patients With COVID-19,122,https://clinicaltrials.gov/show/NCT04411680,NA
NCT04412369,ClinicalTrials.gov,2020-05-27,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,20,https://clinicaltrials.gov/show/NCT04412369,NA
NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,FALSE,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,50,https://clinicaltrials.gov/show/NCT04413864,NA
NCT04419870,ClinicalTrials.gov,2020-06-05,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",200,https://clinicaltrials.gov/show/NCT04419870,NA
NCT04422691,ClinicalTrials.gov,2020-06-05,2020-07-01,FALSE,Not Recruiting,Not Applicable,Observational,Norway,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,5,https://clinicaltrials.gov/show/NCT04422691,NA
NCT04424797,ClinicalTrials.gov,2020-06-05,2020-07-13,FALSE,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,100,https://clinicaltrials.gov/show/NCT04424797,NA
NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-14,FALSE,Not Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,400,https://clinicaltrials.gov/show/NCT04425915,NA
NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-17,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Puerto Rico, United States",A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,3160,https://clinicaltrials.gov/show/NCT04427501,NA
NCT04431453,ClinicalTrials.gov,2020-06-08,2020-07-21,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Spain, Italy, United States, United Kingdom","Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",52,https://clinicaltrials.gov/show/NCT04431453,NA
NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,FALSE,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,52,https://clinicaltrials.gov/show/NCT04433949,NA
NCT04435795,ClinicalTrials.gov,2020-06-16,2020-09-14,FALSE,Not Recruiting,Phase 2/Phase 3,Interventional,Canada,Inhaled Ciclesonide for Outpatients With COVID19,215,https://clinicaltrials.gov/show/NCT04435795,NA
NCT04438850,ClinicalTrials.gov,2020-04-10,2020-07-31,FALSE,Not Recruiting,Phase 2,Interventional,"Spain, Italy",COVidIVERmectin: Ivermectin for Treatment of Covid-19,93,https://clinicaltrials.gov/show/NCT04438850,NA
NCT04439084,ClinicalTrials.gov,2020-06-17,2020-03-06,TRUE,Not Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With Chronic Liver Diseases,1025,https://clinicaltrials.gov/show/NCT04439084,NA
NCT04446429,ClinicalTrials.gov,2020-06-22,2020-09-15,FALSE,Not Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,268,https://clinicaltrials.gov/show/NCT04446429,NA
NCT04448756,ClinicalTrials.gov,2020-06-25,2020-07-29,FALSE,Recruiting,Phase 2,Interventional,"Philippines, United States, Brazil",Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE),150,https://clinicaltrials.gov/show/NCT04448756,NA
NCT04452435,ClinicalTrials.gov,2020-06-29,2020-07-21,FALSE,Not Recruiting,Phase 2,Interventional,"India, United Kingdom",Safety and Efficacy of C21 in Subjects With COVID-19,206,https://clinicaltrials.gov/show/NCT04452435,NA
NCT04463862,ClinicalTrials.gov,2020-07-08,2020-06-04,TRUE,Not Recruiting,Not Applicable,Observational,"France, Belgium",COVID - AirPollution,660,https://clinicaltrials.gov/show/NCT04463862,NA
NCT04468958,ClinicalTrials.gov,2020-07-08,2020-08-05,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",28,https://clinicaltrials.gov/show/NCT04468958,NA
NCT04468971,ClinicalTrials.gov,2020-07-10,2020-09-29,FALSE,Not Recruiting,Phase 1,Interventional,United States,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,45,https://clinicaltrials.gov/show/NCT04468971,NA
NCT04469179,ClinicalTrials.gov,2020-07-08,2020-08-20,FALSE,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",21,https://clinicaltrials.gov/show/NCT04469179,NA
NCT04472559,ClinicalTrials.gov,2020-07-13,2021-06-16,FALSE,Recruiting,Not Applicable,Interventional,United States,Acupressure for COVID-19 Related Quality of Life and Stress,200,https://clinicaltrials.gov/show/NCT04472559,NA
NCT04476914,ClinicalTrials.gov,2020-07-09,2020-06-29,TRUE,Not Recruiting,Not Applicable,Observational,United States,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,330,https://clinicaltrials.gov/show/NCT04476914,NA
NCT04477902,ClinicalTrials.gov,2020-07-16,2020-07-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Long-Term Experience and Health Effects of COVID-19,64,https://clinicaltrials.gov/show/NCT04477902,NA
NCT04480112,ClinicalTrials.gov,2020-07-19,2020-06-02,TRUE,Recruiting,Not Applicable,Interventional,United States,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,150,https://clinicaltrials.gov/show/NCT04480112,NA
NCT04480411,ClinicalTrials.gov,2020-07-17,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,50,https://clinicaltrials.gov/show/NCT04480411,NA
NCT04481516,ClinicalTrials.gov,2020-07-01,2020-07-01,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Yoga in NHS Health Care Workers With COVID-19 Related Stress,30,https://clinicaltrials.gov/show/NCT04481516,NA
NCT04481685,ClinicalTrials.gov,2020-07-15,2020-07-20,FALSE,Not Recruiting,Phase 2,Interventional,United States,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",20,https://clinicaltrials.gov/show/NCT04481685,NA
NCT04483973,ClinicalTrials.gov,2020-07-13,2021-06-14,FALSE,Recruiting,Phase 2,Interventional,United States,SPI-1005 Treatment in Severe COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04483973,NA
NCT04484025,ClinicalTrials.gov,2020-07-13,2021-06-14,FALSE,Recruiting,Phase 2,Interventional,United States,SPI-1005 Treatment in Moderate COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04484025,NA
NCT04488081,ClinicalTrials.gov,2020-07-14,2020-07-31,FALSE,Recruiting,Phase 2,Interventional,United States,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,1500,https://clinicaltrials.gov/show/NCT04488081,NA
NCT04498273,ClinicalTrials.gov,2020-08-03,2020-09-07,FALSE,Not Recruiting,Phase 3,Interventional,United States,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,657,https://clinicaltrials.gov/show/NCT04498273,NA
NCT04499391,ClinicalTrials.gov,2020-07-31,2020-12-04,FALSE,Recruiting,Not Applicable,Interventional,United States,COVID-19 Project ECHO in Nursing Homes,136,https://clinicaltrials.gov/show/NCT04499391,NA
NCT04501978,ClinicalTrials.gov,2020-08-03,2020-08-04,FALSE,Recruiting,Phase 3,Interventional,"Denmark, Greece, United Kingdom, United States, Spain, Uganda, Poland, India, Singapore, Switzerland",ACTIV-3: Therapeutics for Inpatients With COVID-19,10000,https://clinicaltrials.gov/show/NCT04501978,NA
NCT04507256,ClinicalTrials.gov,2020-08-07,2020-08-18,FALSE,Not Recruiting,Phase 1,Interventional,United Kingdom,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,60,https://clinicaltrials.gov/show/NCT04507256,NA
NCT04508023,ClinicalTrials.gov,2020-08-10,2020-08-13,FALSE,Recruiting,Phase 3,Interventional,United States,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",4000,https://clinicaltrials.gov/show/NCT04508023,NA
NCT04511650,ClinicalTrials.gov,2020-08-07,2020-10-21,FALSE,Not Recruiting,Phase 2,Interventional,United States,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",31,https://clinicaltrials.gov/show/NCT04511650,NA
NCT04518410,ClinicalTrials.gov,2020-08-17,2020-08-19,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Argentina, South Africa, Canada, Puerto Rico, United States, Brazil",ACTIV-2: A Study for Outpatients With COVID-19,2000,https://clinicaltrials.gov/show/NCT04518410,NA
NCT04526912,ClinicalTrials.gov,2020-08-21,2020-08-28,FALSE,Not Recruiting,Phase 1,Interventional,United States,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,10,https://clinicaltrials.gov/show/NCT04526912,NA
NCT04530617,ClinicalTrials.gov,2020-08-26,2020-10-05,FALSE,Not Recruiting,Phase 2,Interventional,Mexico,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,246,https://clinicaltrials.gov/show/NCT04530617,NA
NCT04535128,ClinicalTrials.gov,2020-08-29,2020-03-24,TRUE,Recruiting,Not Applicable,Observational,United States,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",10000,https://clinicaltrials.gov/show/NCT04535128,NA
NCT04535167,ClinicalTrials.gov,2020-08-21,2020-09-09,FALSE,Not Recruiting,Phase 1,Interventional,"Spain, Brazil, United States, Belgium","First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.",26,https://clinicaltrials.gov/show/NCT04535167,NA
NCT04535453,ClinicalTrials.gov,2020-08-27,2020-08-28,FALSE,Not Recruiting,Phase 2,Interventional,"United Kingdom, Netherlands, Canada, United States, Brazil, Spain, Germany",A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,1210,https://clinicaltrials.gov/show/NCT04535453,NA
NCT04537949,ClinicalTrials.gov,2020-09-02,2020-09-09,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,96,https://clinicaltrials.gov/show/NCT04537949,NA
NCT04546581,ClinicalTrials.gov,2020-09-08,2020-10-08,FALSE,Not Recruiting,Phase 3,Interventional,"Denmark, Argentina, Greece, United Kingdom, United States, Spain, Japan, Nigeria",Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),593,https://clinicaltrials.gov/show/NCT04546581,NA
NCT04551547,ClinicalTrials.gov,2020-09-15,2020-10-31,FALSE,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,552,https://clinicaltrials.gov/show/NCT04551547,NA
NCT04556318,ClinicalTrials.gov,2020-09-18,2020-09-23,FALSE,Recruiting,Not Applicable,Observational,Germany,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),392,https://clinicaltrials.gov/show/NCT04556318,NA
NCT04564274,ClinicalTrials.gov,2020-09-24,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,COV2Base-A Rare Disease by COVID Study,5000,https://clinicaltrials.gov/show/NCT04564274,NA
NCT04565067,ClinicalTrials.gov,2020-09-24,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,120,https://clinicaltrials.gov/show/NCT04565067,NA
NCT04565080,ClinicalTrials.gov,2020-09-24,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),150,https://clinicaltrials.gov/show/NCT04565080,NA
NCT04568031,ClinicalTrials.gov,2020-08-21,2020-08-23,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of AZD1222 for the Prevention of COVID-19 in Japan,256,https://clinicaltrials.gov/show/NCT04568031,NA
NCT04568122,ClinicalTrials.gov,2020-09-25,2020-11-20,FALSE,Recruiting,Not Applicable,Interventional,United States,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",3015,https://clinicaltrials.gov/show/NCT04568122,NA
NCT04572360,ClinicalTrials.gov,2020-09-27,2020-10-01,FALSE,Recruiting,Not Applicable,Interventional,Hong Kong,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,172,https://clinicaltrials.gov/show/NCT04572360,NA
NCT04575597,ClinicalTrials.gov,2020-09-30,2020-10-19,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Chile, Sweden, Russian Federation, South Africa, United Kingdom, Colombia, Canada, Ukraine, United States, Brazil, Israel, Italy, Japan, Mexico, Spain, France, Germany, Philippines",Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),1850,https://clinicaltrials.gov/show/NCT04575597,NA
NCT04576728,ClinicalTrials.gov,2020-09-24,2020-10-06,FALSE,Not Recruiting,Phase 2,Interventional,"Spain, France, Russian Federation, Brazil",Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,164,https://clinicaltrials.gov/show/NCT04576728,NA
NCT04577534,ClinicalTrials.gov,2020-09-03,2020-08-14,TRUE,Not Recruiting,Phase 3,Interventional,Finland,COVID-19: Salvage TOcilizumab as a Rescue Measure,88,https://clinicaltrials.gov/show/NCT04577534,NA
NCT04582266,ClinicalTrials.gov,2020-10-08,2021-02-12,FALSE,Recruiting,Not Applicable,Observational,"Puerto Rico, United States",PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,40,https://clinicaltrials.gov/show/NCT04582266,NA
NCT04582903,ClinicalTrials.gov,2020-10-09,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,500,https://clinicaltrials.gov/show/NCT04582903,NA
NCT04583969,ClinicalTrials.gov,2020-10-09,2020-10-19,FALSE,Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,200,https://clinicaltrials.gov/show/NCT04583969,NA
NCT04588363,ClinicalTrials.gov,2020-10-12,2020-11-19,FALSE,Recruiting,Not Applicable,Observational,United States,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C,250,https://clinicaltrials.gov/show/NCT04588363,NA
NCT04590547,ClinicalTrials.gov,2020-10-13,2021-05-07,FALSE,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),132,https://clinicaltrials.gov/show/NCT04590547,NA
NCT04590586,ClinicalTrials.gov,2020-10-14,2020-11-24,FALSE,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, Russian Federation, South Africa, Ukraine, United States, Mexico, Brazil",Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,516,https://clinicaltrials.gov/show/NCT04590586,NA
NCT04594395,ClinicalTrials.gov,2020-10-17,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,Cambodia,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,2700,https://clinicaltrials.gov/show/NCT04594395,NA
NCT04598594,ClinicalTrials.gov,2020-10-15,2020-11-06,FALSE,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,220,https://clinicaltrials.gov/show/NCT04598594,NA
NCT04603651,ClinicalTrials.gov,2020-10-23,2021-06-02,FALSE,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19,Not Available,https://clinicaltrials.gov/show/NCT04603651,NA
NCT04610515,ClinicalTrials.gov,2020-10-28,2020-12-15,FALSE,Recruiting,Not Applicable,Observational,United States,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),4800,https://clinicaltrials.gov/show/NCT04610515,NA
NCT04615949,ClinicalTrials.gov,2020-11-02,2021-04-30,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Mexico, United States, Brazil",Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,422,https://clinicaltrials.gov/show/NCT04615949,NA
NCT04618042,ClinicalTrials.gov,2020-10-23,2020-11-13,FALSE,Not Recruiting,Phase 2,Interventional,France,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,50,https://clinicaltrials.gov/show/NCT04618042,NA
NCT04629703,ClinicalTrials.gov,2020-11-13,2021-02-22,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Peru, United States, Mexico, Brazil","Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",308,https://clinicaltrials.gov/show/NCT04629703,NA
NCT04631705,ClinicalTrials.gov,2020-11-10,2020-12-14,FALSE,Recruiting,Phase 1/Phase 2,Interventional,Germany,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation,78,https://clinicaltrials.gov/show/NCT04631705,NA
NCT04632706,ClinicalTrials.gov,2020-10-26,2020-09-22,TRUE,Not Recruiting,Phase 1,Interventional,United Kingdom,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,24,https://clinicaltrials.gov/show/NCT04632706,NA
NCT04634409,ClinicalTrials.gov,2020-11-17,2020-10-29,TRUE,Recruiting,Phase 2,Interventional,"Puerto Rico, United States",A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,1556,https://clinicaltrials.gov/show/NCT04634409,NA
NCT04640194,ClinicalTrials.gov,2020-11-20,2020-12-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Denmark, Russian Federation, Portugal, Belgium, Netherlands, Italy, Brazil, Spain, Austria, France, Germany",A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,270,https://clinicaltrials.gov/show/NCT04640194,NA
NCT04657419,ClinicalTrials.gov,2020-12-07,2021-03-08,FALSE,Not Recruiting,Not Applicable,Observational,France,Fatigue and Sleep in Patients With COVID-19,60,https://clinicaltrials.gov/show/NCT04657419,NA
NCT04657484,ClinicalTrials.gov,2020-12-05,2020-12-08,FALSE,Recruiting,Not Applicable,Interventional,India,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,100,https://clinicaltrials.gov/show/NCT04657484,NA
NCT04661839,ClinicalTrials.gov,2020-12-09,2020-12-24,FALSE,Not Recruiting,Phase 1,Interventional,United States,A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults,28,https://clinicaltrials.gov/show/NCT04661839,NA
NCT04667780,ClinicalTrials.gov,2020-12-11,2020-12-10,TRUE,Not Recruiting,Phase 3,Interventional,Pakistan,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,102,https://clinicaltrials.gov/show/NCT04667780,NA
NCT04669015,ClinicalTrials.gov,2020-12-14,2021-06-18,FALSE,Recruiting,Phase 3,Interventional,"Chile, Colombia, Brazil",Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,914,https://clinicaltrials.gov/show/NCT04669015,NA
NCT04674189,ClinicalTrials.gov,2020-12-14,2020-12-23,FALSE,Not Recruiting,Phase 3,Interventional,Germany,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,2360,https://clinicaltrials.gov/show/NCT04674189,NA
NCT04684615,ClinicalTrials.gov,2020-12-23,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen,1000,https://clinicaltrials.gov/show/NCT04684615,NA
NCT04698993,ClinicalTrials.gov,2021-01-05,2021-02-12,FALSE,Not Recruiting,Not Applicable,Interventional,Germany,DrÃ¤ger COVID-19 Antigen Test Clinical Performance Study,388,https://clinicaltrials.gov/show/NCT04698993,NA
NCT04699903,ClinicalTrials.gov,2020-12-29,2021-01-05,FALSE,Not Recruiting,Not Applicable,Observational,United States,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood",201,https://clinicaltrials.gov/show/NCT04699903,NA
NCT04701658,ClinicalTrials.gov,2021-01-07,2021-02-01,FALSE,Not Recruiting,Phase 2,Interventional,United States,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),3000,https://clinicaltrials.gov/show/NCT04701658,NA
NCT04703205,ClinicalTrials.gov,2020-12-01,2020-09-16,TRUE,Recruiting,Phase 2,Interventional,Japan,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),240,https://clinicaltrials.gov/show/NCT04703205,NA
NCT04705597,ClinicalTrials.gov,2021-01-04,2021-03-18,FALSE,Recruiting,Phase 2,Interventional,"United States, Brazil","Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Participants = 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure",132,https://clinicaltrials.gov/show/NCT04705597,NA
NCT04707664,ClinicalTrials.gov,2021-01-11,2021-04-27,FALSE,Recruiting,Phase 2,Interventional,United States,Sargramostim Use in COVID-19 to Recover Patient Health,400,https://clinicaltrials.gov/show/NCT04707664,NA
NCT04723394,ClinicalTrials.gov,2021-01-14,2010-06-21,TRUE,Recruiting,Phase 3,Interventional,"Argentina, Hungary, Russian Federation, Peru, United Kingdom, Ukraine, United States, Brazil, Italy, Mexico, Japan, Spain, Poland, Germany, Czech Republic, Bulgaria",Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,1700,https://clinicaltrials.gov/show/NCT04723394,NA
NCT04723537,ClinicalTrials.gov,2021-01-18,2021-02-16,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",310,https://clinicaltrials.gov/show/NCT04723537,NA
NCT04728802,ClinicalTrials.gov,2021-01-27,2021-02-01,FALSE,Not Recruiting,Phase 3,Interventional,Brazil,Proxalutamide Treatment for Hospitalized COVID-19 Patients,645,https://clinicaltrials.gov/show/NCT04728802,NA
NCT04734873,ClinicalTrials.gov,2021-01-29,2021-02-25,FALSE,Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Canada, Ukraine, United States, Brazil, Italy, Mexico, Spain, Israel, France, Germany",CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,1000,https://clinicaltrials.gov/show/NCT04734873,NA
NCT04750629,ClinicalTrials.gov,2021-02-10,2021-02-08,TRUE,Not Recruiting,Not Applicable,Observational,United States,"Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDxâ„¢)",140,https://clinicaltrials.gov/show/NCT04750629,NA
NCT04751682,ClinicalTrials.gov,2021-02-08,2021-03-01,FALSE,Not Recruiting,Phase 1,Interventional,India,Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,175,https://clinicaltrials.gov/show/NCT04751682,NA
NCT04753619,ClinicalTrials.gov,2021-02-10,2021-01-03,TRUE,Recruiting,Phase 2,Interventional,Iraq,Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management,150,https://clinicaltrials.gov/show/NCT04753619,NA
NCT04754594,ClinicalTrials.gov,2021-02-09,2021-02-16,FALSE,Recruiting,Phase 3,Interventional,"South Africa, United Kingdom, United States, Brazil, Spain","Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",700,https://clinicaltrials.gov/show/NCT04754594,NA
NCT04754698,ClinicalTrials.gov,2021-02-08,2021-02-09,FALSE,Not Recruiting,Phase 4,Interventional,Brazil,COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS,2067,https://clinicaltrials.gov/show/NCT04754698,NA
NCT04758962,ClinicalTrials.gov,2021-02-08,2021-02-15,FALSE,Not Recruiting,Phase 1,Interventional,United States,A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,10,https://clinicaltrials.gov/show/NCT04758962,NA
NCT04761822,ClinicalTrials.gov,2021-02-17,2021-04-07,FALSE,Recruiting,Phase 2,Interventional,United States,COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations,3400,https://clinicaltrials.gov/show/NCT04761822,NA
NCT04765540,ClinicalTrials.gov,2021-01-06,2021-01-03,TRUE,Not Recruiting,Not Applicable,Interventional,Bangladesh,The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh,855,https://clinicaltrials.gov/show/NCT04765540,NA
NCT04766294,ClinicalTrials.gov,2021-02-17,2020-04-25,TRUE,Not Recruiting,Not Applicable,Observational,Egypt,Macrophage Activation Markers in COVID-19 Patients,70,https://clinicaltrials.gov/show/NCT04766294,NA
NCT04776317,ClinicalTrials.gov,2021-02-25,2021-03-25,FALSE,Recruiting,Phase 1,Interventional,United States,Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,150,https://clinicaltrials.gov/show/NCT04776317,NA
NCT04780698,ClinicalTrials.gov,2021-02-12,2021-02-12,FALSE,Recruiting,Not Applicable,Interventional,United States,DCI COVID-19 Surveillance Project,160,https://clinicaltrials.gov/show/NCT04780698,NA
NCT04782700,ClinicalTrials.gov,2021-02-25,2021-04-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,P-Co-Li (Pulmonary Covid-19 Study),6,https://clinicaltrials.gov/show/NCT04782700,NA
NCT04784559,ClinicalTrials.gov,2021-03-04,2021-06-04,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Peru, Greece, Colombia, Italy, Brazil, Mexico, Spain, Turkey, France, Bulgaria, Romania",Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection,609,https://clinicaltrials.gov/show/NCT04784559,NA
NCT04785144,ClinicalTrials.gov,2021-03-04,2021-03-29,FALSE,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in NaÃ¯ve and Previously Vaccinated Adults,135,https://clinicaltrials.gov/show/NCT04785144,NA
NCT04794829,ClinicalTrials.gov,2021-03-11,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination,150,https://clinicaltrials.gov/show/NCT04794829,NA
NCT04794946,ClinicalTrials.gov,2021-03-08,2021-03-19,FALSE,Recruiting,Not Applicable,Interventional,India,"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis",2200,https://clinicaltrials.gov/show/NCT04794946,NA
NCT04795583,ClinicalTrials.gov,2021-03-10,2021-08-01,FALSE,Not Recruiting,Phase 3,Interventional,"Mexico, Colombia",Corticosteroids for COVID-19,1526,https://clinicaltrials.gov/show/NCT04795583,NA
NCT04796896,ClinicalTrials.gov,2021-03-11,2021-03-15,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age,7050,https://clinicaltrials.gov/show/NCT04796896,NA
NCT04805125,ClinicalTrials.gov,2021-03-15,2021-04-19,FALSE,Not Recruiting,Phase 3,Interventional,Switzerland,Immunocompromised Swiss Cohorts Based Trial Platform,431,https://clinicaltrials.gov/show/NCT04805125,NA
NCT04815031,ClinicalTrials.gov,2021-03-22,2021-04-20,FALSE,Recruiting,Not Applicable,Observational,Japan,Drug Use Investigation of COMIRNATY Intramuscular Injection,20000,https://clinicaltrials.gov/show/NCT04815031,NA
NCT04818164,ClinicalTrials.gov,2021-03-25,2020-09-01,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome,22,https://clinicaltrials.gov/show/NCT04818164,NA
NCT04818216,ClinicalTrials.gov,2021-03-24,2021-06-11,FALSE,Recruiting,Phase 2,Interventional,United States,Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection,100,https://clinicaltrials.gov/show/NCT04818216,NA
NCT04818320,ClinicalTrials.gov,2021-03-24,2021-02-16,TRUE,Not Recruiting,Phase 3,Interventional,Malaysia,Favipiravir in High-risk COVID-19 Patients,500,https://clinicaltrials.gov/show/NCT04818320,NA
NCT04821531,ClinicalTrials.gov,2021-03-11,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients,60,https://clinicaltrials.gov/show/NCT04821531,NA
NCT04822701,ClinicalTrials.gov,2021-03-29,2021-04-21,FALSE,Recruiting,Phase 2/Phase 3,Interventional,"Portugal, Belgium, Netherlands, United States, Spain",A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19,1500,https://clinicaltrials.gov/show/NCT04822701,NA
NCT04823988,ClinicalTrials.gov,2021-03-30,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,United States,"Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic",3000,https://clinicaltrials.gov/show/NCT04823988,NA
NCT04824443,ClinicalTrials.gov,2021-03-29,2021-03-29,FALSE,Recruiting,Phase 1,Interventional,United States,Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19,20,https://clinicaltrials.gov/show/NCT04824443,NA
NCT04826588,ClinicalTrials.gov,2021-03-31,2021-05-21,FALSE,Recruiting,Phase 3,Interventional,Switzerland,Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY),75,https://clinicaltrials.gov/show/NCT04826588,NA
NCT04830033,ClinicalTrials.gov,2021-03-31,2021-04-28,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,ENO Breathe vs Usual Care in COVID-19 Recovery,120,https://clinicaltrials.gov/show/NCT04830033,NA
NCT04832932,ClinicalTrials.gov,2021-04-02,2021-06-15,FALSE,Recruiting,Not Applicable,Observational,"United Kingdom, United States, Kenya",The COVID-19 Back-to-Normal Study,1000,https://clinicaltrials.gov/show/NCT04832932,NA
NCT04836806,ClinicalTrials.gov,2021-04-06,2021-08-01,FALSE,Recruiting,Phase 4,Interventional,United States,Cetirizine and Famotidine for COVID-19,160,https://clinicaltrials.gov/show/NCT04836806,NA
NCT04843930,ClinicalTrials.gov,2021-04-10,2021-06-17,FALSE,Recruiting,Phase 2,Interventional,United States,Improving Cognitive Health in COVID-19 Survivors,125,https://clinicaltrials.gov/show/NCT04843930,NA
NCT04844242,ClinicalTrials.gov,2021-04-13,2020-12-23,TRUE,Recruiting,Not Applicable,Observational,India,MISC COVID-19 Study in Pediatric Population,180,https://clinicaltrials.gov/show/NCT04844242,NA
NCT04844307,ClinicalTrials.gov,2021-03-23,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups,200,https://clinicaltrials.gov/show/NCT04844307,NA
NCT04844489,ClinicalTrials.gov,2021-04-02,2021-04-16,FALSE,Recruiting,Not Applicable,Interventional,France,Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People,485,https://clinicaltrials.gov/show/NCT04844489,NA
NCT04852289,ClinicalTrials.gov,2021-04-20,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans,160,https://clinicaltrials.gov/show/NCT04852289,NA
NCT04852822,ClinicalTrials.gov,2021-04-19,2021-03-18,TRUE,Recruiting,Not Applicable,Observational,United States,Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma,500,https://clinicaltrials.gov/show/NCT04852822,NA
NCT04854772,ClinicalTrials.gov,2021-04-20,2021-05-15,FALSE,Recruiting,Not Applicable,Interventional,United States,Mind Body Intervention for COVID-19 Long Haul Syndrome,22,https://clinicaltrials.gov/show/NCT04854772,NA
NCT04858789,ClinicalTrials.gov,2021-04-22,2021-06-24,FALSE,Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic,100,https://clinicaltrials.gov/show/NCT04858789,NA
NCT04859517,ClinicalTrials.gov,2021-04-21,2021-04-23,FALSE,Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of ADG20 for the Prevention of COVID-19,6412,https://clinicaltrials.gov/show/NCT04859517,NA
NCT04864548,ClinicalTrials.gov,2021-04-20,2021-05-27,FALSE,Recruiting,Phase 1,Interventional,United Kingdom,COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study,64,https://clinicaltrials.gov/show/NCT04864548,NA
NCT04867226,ClinicalTrials.gov,2021-04-25,2021-05-08,FALSE,Not Recruiting,Phase 2,Interventional,Iraq,Effectiveness of Colchicine Among Patients With COVID-19 Infection,100,https://clinicaltrials.gov/show/NCT04867226,NA
NCT04870593,ClinicalTrials.gov,2021-04-28,2021-04-17,TRUE,Not Recruiting,Not Applicable,Interventional,India,What Works to Get the Elderly Vaccinated Against COVID-19? Experimental Evidence From India,3006,https://clinicaltrials.gov/show/NCT04870593,NA
NCT04872075,ClinicalTrials.gov,2021-04-29,2021-05-26,FALSE,Not Recruiting,Not Applicable,Interventional,France,Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event,7500,https://clinicaltrials.gov/show/NCT04872075,NA
NCT04878055,ClinicalTrials.gov,2021-04-30,2021-02-14,TRUE,Recruiting,Phase 3,Interventional,"Italy, United States",Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.,312,https://clinicaltrials.gov/show/NCT04878055,NA
NCT04878809,ClinicalTrials.gov,2021-04-28,2021-04-22,TRUE,Not Recruiting,Not Applicable,Interventional,Spain,"Rapid Screening Circuit of COVID 19 in Schools, Pilot Study",153,https://clinicaltrials.gov/show/NCT04878809,NA
NCT04881227,ClinicalTrials.gov,2021-05-10,2021-05-25,FALSE,Recruiting,Not Applicable,Interventional,France,The Impact of a Chatbot on COVID-19 Vaccine Perceptions and Intentions in ESPERES Cohort (ESPERES-COVID-19-CHATBOT),892,https://clinicaltrials.gov/show/NCT04881227,NA
NCT04888949,ClinicalTrials.gov,2021-05-09,2021-06-15,FALSE,Recruiting,Phase 2,Interventional,Japan,A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19),20,https://clinicaltrials.gov/show/NCT04888949,NA
NCT04889209,ClinicalTrials.gov,2021-05-13,2021-05-28,FALSE,Recruiting,Phase 1/Phase 2,Interventional,United States,Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines,400,https://clinicaltrials.gov/show/NCT04889209,NA
NCT04894448,ClinicalTrials.gov,2021-05-18,2021-06-10,FALSE,Recruiting,Not Applicable,Observational,Canada,Immunogenicity of COVID-19 Vaccination in PLWH,500,https://clinicaltrials.gov/show/NCT04894448,NA
NCT04896060,ClinicalTrials.gov,2021-05-19,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,United States,The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change,5000,https://clinicaltrials.gov/show/NCT04896060,NA
NCT04902911,ClinicalTrials.gov,2021-05-21,2021-04-13,TRUE,Recruiting,Not Applicable,Interventional,United States,Point of Care Evaluation of Novir 2019-nCoV Immunoglobulin G/ Immunoglobulin M (IgG/IgM) Antibody Test (Collodial Gold),120,https://clinicaltrials.gov/show/NCT04902911,NA
NCT04910282,ClinicalTrials.gov,2021-05-31,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID-19 on Quality of Life of Seniors With Eye Disease and Implementations to Improve Wellness,425,https://clinicaltrials.gov/show/NCT04910282,NA
NCT04911777,ClinicalTrials.gov,2021-06-01,2021-06-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,"Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandirâ„¢ UPPTA for Patients With Early COVID-19",90,https://clinicaltrials.gov/show/NCT04911777,NA
NCT04912284,ClinicalTrials.gov,2021-05-31,2021-05-05,TRUE,Not Recruiting,Not Applicable,Observational,"Senegal, Burkina Faso, Mali, Guinea, Sierra Leone",Africa COVID-19 Vaccine Hesitancy,4977,https://clinicaltrials.gov/show/NCT04912284,NA
NCT04915820,ClinicalTrials.gov,2021-05-28,2021-06-04,FALSE,Recruiting,Not Applicable,Interventional,Kenya,Iron and COVID-19 Vaccine Response,112,https://clinicaltrials.gov/show/NCT04915820,NA
NCT04920942,ClinicalTrials.gov,2021-05-31,2021-06-01,FALSE,Recruiting,Phase 4,Interventional,Malaysia,Ivermectin Treatment Efficacy in Covid-19 High Risk Patients,500,https://clinicaltrials.gov/show/NCT04920942,NA
NCT04922944,ClinicalTrials.gov,2021-03-30,2021-03-08,TRUE,Not Recruiting,Not Applicable,Observational,United States,Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients,167,https://clinicaltrials.gov/show/NCT04922944,NA
NCT04924673,ClinicalTrials.gov,2021-06-10,2020-06-17,TRUE,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients,202,https://clinicaltrials.gov/show/NCT04924673,NA
NCT04925908,ClinicalTrials.gov,2021-06-08,2021-06-01,TRUE,Recruiting,Not Applicable,Observational,Turkey,Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus,260,https://clinicaltrials.gov/show/NCT04925908,NA
NCT04925999,ClinicalTrials.gov,2021-06-08,2021-06-15,FALSE,Recruiting,Not Applicable,Observational,Egypt,Distance Learning and Neck Problems During Pandemic Period,300,https://clinicaltrials.gov/show/NCT04925999,NA
NCT04926428,ClinicalTrials.gov,2021-06-13,2020-12-25,TRUE,Not Recruiting,Not Applicable,Interventional,Mexico,In Situ Thrombolysis With tPA and Inflow Perfusion Analysis in Patient With Severe Covid-19 Infection,15,https://clinicaltrials.gov/show/NCT04926428,NA
NCT04926571,ClinicalTrials.gov,2021-06-11,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United States,Dexamethasone and COVID-19 Inpatient Mortality,20000,https://clinicaltrials.gov/show/NCT04926571,NA
NCT04926779,ClinicalTrials.gov,2021-06-11,2021-05-24,TRUE,Recruiting,Not Applicable,Interventional,United States,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test",150,https://clinicaltrials.gov/show/NCT04926779,NA
NCT04927065,ClinicalTrials.gov,2021-06-14,2021-05-28,TRUE,Not Recruiting,Phase 2/Phase 3,Interventional,United States,A Study to Evaluate the Immunogenicity and Safety of mRNA-1273.211 Vaccine for COVID-19 Variants,300,https://clinicaltrials.gov/show/NCT04927065,NA
NCT04927078,ClinicalTrials.gov,2021-04-13,2020-04-01,TRUE,Not Recruiting,Not Applicable,Observational,United Kingdom,Analysis of Vital Signs in Patients With COVID-19,20,https://clinicaltrials.gov/show/NCT04927078,NA
NCT04927169,ClinicalTrials.gov,2021-06-14,2021-03-01,TRUE,Recruiting,Phase 2,Interventional,Brazil,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort),48,https://clinicaltrials.gov/show/NCT04927169,NA
NCT04927182,ClinicalTrials.gov,2021-06-14,2020-10-15,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.,102,https://clinicaltrials.gov/show/NCT04927182,NA
NCT04927442,ClinicalTrials.gov,2021-06-15,2021-06-30,FALSE,Recruiting,Not Applicable,Observational,United States,Natural History Study of COVID-19 Using Digital Wearables,550,https://clinicaltrials.gov/show/NCT04927442,NA
NCT04927845,ClinicalTrials.gov,2021-06-09,2021-05-19,TRUE,Recruiting,Not Applicable,Interventional,United States,StriveWeekly Trial Post-pandemic,1000,https://clinicaltrials.gov/show/NCT04927845,NA
NCT04927936,ClinicalTrials.gov,2021-06-06,2021-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,A Trial Among HealthCare Workers (HCW) Vaccinated With Janssen Vaccine: the SWITCH Trial,432,https://clinicaltrials.gov/show/NCT04927936,NA
NCT04928430,ClinicalTrials.gov,2021-05-27,2021-04-28,TRUE,Recruiting,Phase 2/Phase 3,Interventional,"Greece, Spain, Turkey, Bulgaria, Romania",Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19,722,https://clinicaltrials.gov/show/NCT04928430,NA
NCT04928456,ClinicalTrials.gov,2021-06-11,2021-06-11,FALSE,Recruiting,Not Applicable,Interventional,United States,Augmentation of Immune Response to COVID-19 mRNA Vaccination Through OMT With Lymphatic Pumps,200,https://clinicaltrials.gov/show/NCT04928456,NA
NCT04928469,ClinicalTrials.gov,2021-06-13,2021-06-15,FALSE,Recruiting,Not Applicable,Observational,Brazil,Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage,86,https://clinicaltrials.gov/show/NCT04928469,NA
NCT04928495,ClinicalTrials.gov,2021-06-14,2021-06-09,TRUE,Not Recruiting,Phase 3,Interventional,Brazil,Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19,219,https://clinicaltrials.gov/show/NCT04928495,NA
NCT04928911,ClinicalTrials.gov,2021-06-14,2021-06-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Expectations About the COVID-19 Vaccines,500,https://clinicaltrials.gov/show/NCT04928911,NA
NCT04929691,ClinicalTrials.gov,2021-06-08,2020-11-13,TRUE,Recruiting,Not Applicable,Interventional,Nigeria,The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19,370,https://clinicaltrials.gov/show/NCT04929691,NA
NCT04929964,ClinicalTrials.gov,2021-06-13,2020-01-01,TRUE,Not Recruiting,Not Applicable,Observational,Pakistan,COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer,29,https://clinicaltrials.gov/show/NCT04929964,NA
NCT04930003,ClinicalTrials.gov,2021-02-22,2021-06-15,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine",244,https://clinicaltrials.gov/show/NCT04930003,NA
NCT04930055,ClinicalTrials.gov,2021-06-15,2021-06-04,TRUE,Recruiting,Not Applicable,Observational,United States,Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC),240,https://clinicaltrials.gov/show/NCT04930055,NA
NCT04930120,ClinicalTrials.gov,2021-06-16,2021-03-01,TRUE,Recruiting,Not Applicable,Observational,France,Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units,3060,https://clinicaltrials.gov/show/NCT04930120,NA
NCT04930731,ClinicalTrials.gov,2020-09-28,2021-09-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Risk Factors and Characteristics of COVID 19 Infection in Patients With Haematological Diseases,60,https://clinicaltrials.gov/show/NCT04930731,NA
NCT04930757,ClinicalTrials.gov,2021-05-14,2021-02-04,TRUE,Recruiting,Not Applicable,Observational,France,Involvement of Polymorphonuclear Neutrophils and Platelets in Severe Form of COVID-19,200,https://clinicaltrials.gov/show/NCT04930757,NA
NCT04930770,ClinicalTrials.gov,2021-06-03,2021-08-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Study About the Response to the Administration of a Third Dose of mRNA-1273 Vaccine (COVID-19 Vaccine Moderna) in Renal Transplants With Immunological Failure Initial to Vaccination,80,https://clinicaltrials.gov/show/NCT04930770,NA
NCT04930861,ClinicalTrials.gov,2021-06-16,2021-03-29,TRUE,Not Recruiting,Phase 1,Interventional,Brazil,Study of Codivir in Patients With COVID-19,12,https://clinicaltrials.gov/show/NCT04930861,NA
NCT04930874,ClinicalTrials.gov,2021-06-15,2021-06-22,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cerebral Autoregulation and COVID-19,37,https://clinicaltrials.gov/show/NCT04930874,NA
NCT04930965,ClinicalTrials.gov,2021-06-16,2021-08-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate,100,https://clinicaltrials.gov/show/NCT04930965,NA
NCT04930978,ClinicalTrials.gov,2021-06-12,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,India,"Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis",250,https://clinicaltrials.gov/show/NCT04930978,NA
NCT04931004,ClinicalTrials.gov,2021-06-16,2021-07-01,FALSE,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection,90,https://clinicaltrials.gov/show/NCT04931004,NA
NCT04931238,ClinicalTrials.gov,2021-06-13,2021-01-20,TRUE,Recruiting,Phase 1,Interventional,China,"Tolerability,Safety of JS016 in SARS-CoV-2 (COVID-19)",200,https://clinicaltrials.gov/show/NCT04931238,NA
NCT04931888,ClinicalTrials.gov,2021-06-11,2021-06-21,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Implementing and Evaluating a Social-Emotional Learning Program for Refugee Children During the COVID-19 Pandemic,70,https://clinicaltrials.gov/show/NCT04931888,NA
NCT04932824,ClinicalTrials.gov,2021-04-13,2021-01-19,TRUE,Recruiting,Phase 1,Interventional,Australia,Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19.,150,https://clinicaltrials.gov/show/NCT04932824,NA
NCT04932837,ClinicalTrials.gov,2021-06-01,2021-06-14,FALSE,Not Recruiting,Not Applicable,Observational,France,"Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences",0,https://clinicaltrials.gov/show/NCT04932837,NA
NCT04932850,ClinicalTrials.gov,2021-06-15,2021-03-01,TRUE,Not Recruiting,Phase 1,Interventional,Italy,Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.,30,https://clinicaltrials.gov/show/NCT04932850,NA
NCT04932863,ClinicalTrials.gov,2021-06-14,2021-03-15,TRUE,Recruiting,Not Applicable,Observational,Italy,BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment,300,https://clinicaltrials.gov/show/NCT04932863,NA
NCT04932876,ClinicalTrials.gov,2021-05-19,2021-04-24,TRUE,Recruiting,Not Applicable,Observational,Greece,The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19,100,https://clinicaltrials.gov/show/NCT04932876,NA
NCT04932889,ClinicalTrials.gov,2021-06-14,2021-06-11,TRUE,Not Recruiting,Not Applicable,Observational,Turkey,Musculoskeletal Symptoms in Post Acute Covid-19 Patients,280,https://clinicaltrials.gov/show/NCT04932889,NA
NCT04932915,ClinicalTrials.gov,2021-06-18,2021-06-21,FALSE,Not Recruiting,Phase 2,Interventional,Germany,Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19,330,https://clinicaltrials.gov/show/NCT04932915,NA
NCT04932941,ClinicalTrials.gov,2021-06-18,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,MP1032 Treatment in Patients With Moderate to Severe COVID-19,120,https://clinicaltrials.gov/show/NCT04932941,NA
NCT04932954,ClinicalTrials.gov,2021-06-17,2020-01-01,TRUE,Recruiting,Not Applicable,Observational,China,Immunohematology in COVID-19 Patients: A Hospital-based Retrospective Cohort Study,2000,https://clinicaltrials.gov/show/NCT04932954,NA
NCT04932967,ClinicalTrials.gov,2021-06-17,2021-07-25,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Use of nMoABs for the Treatment of COVID-19 in Patients With HM.,31,https://clinicaltrials.gov/show/NCT04932967,NA
NCT04933474,ClinicalTrials.gov,2021-06-18,2021-10-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,"Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain",300,https://clinicaltrials.gov/show/NCT04933474,NA
NCT04933799,ClinicalTrials.gov,2021-04-23,2021-01-06,TRUE,Recruiting,Phase 2,Interventional,United States,IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.,68,https://clinicaltrials.gov/show/NCT04933799,NA
NCT04933864,ClinicalTrials.gov,2021-06-15,2020-04-24,TRUE,Not Recruiting,Phase 1,Interventional,Russian Federation,COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04933864,NA
NCT04933929,ClinicalTrials.gov,2021-05-24,2021-03-05,TRUE,Recruiting,Not Applicable,Interventional,France,Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization,135,https://clinicaltrials.gov/show/NCT04933929,NA
NCT04933981,ClinicalTrials.gov,2021-05-21,2020-10-15,TRUE,Not Recruiting,Not Applicable,Observational,Germany,Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic,500,https://clinicaltrials.gov/show/NCT04933981,NA
NCT04933994,ClinicalTrials.gov,2021-06-17,2017-01-01,TRUE,Not Recruiting,Not Applicable,Observational,No Country Given,Comparison of COVID-19 and H1N1 Influenza Pneumonia,483,https://clinicaltrials.gov/show/NCT04933994,NA
NCT04934020,ClinicalTrials.gov,2021-06-20,2021-04-25,TRUE,Recruiting,Not Applicable,Observational,United States,"Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage",10000,https://clinicaltrials.gov/show/NCT04934020,NA
NCT04934085,ClinicalTrials.gov,2021-06-18,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,"COVID-19 Versus Neurological Impairment, Physical Activity, Social Contacts and Education",100,https://clinicaltrials.gov/show/NCT04934085,NA
NCT04934111,ClinicalTrials.gov,2021-06-10,2021-09-01,FALSE,Not Recruiting,Phase 1,Interventional,Uganda,"Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19",42,https://clinicaltrials.gov/show/NCT04934111,NA
NCT04934202,ClinicalTrials.gov,2021-06-18,2021-05-05,TRUE,Recruiting,Not Applicable,Observational,France,Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France,500,https://clinicaltrials.gov/show/NCT04934202,NA
NCT04934215,ClinicalTrials.gov,2021-06-17,2021-06-30,FALSE,Not Recruiting,Not Applicable,Observational,France,Evaluation of Post-vaccination Anti-SARS-CoV-2 Serological Response in Health Care Workers With a History of COVID-19.,100,https://clinicaltrials.gov/show/NCT04934215,NA
NCT04935437,ClinicalTrials.gov,2021-06-01,2021-01-21,TRUE,Recruiting,Not Applicable,Interventional,Greece,Implementing a Rehabilitation Program in Patients Recovering From Covid-19 Infection,40,https://clinicaltrials.gov/show/NCT04935437,NA
NCT04935450,ClinicalTrials.gov,2021-06-21,2020-12-12,TRUE,Recruiting,Not Applicable,Observational,Spain,Pulmonary Inflammation in COVID-19 ARDS,25,https://clinicaltrials.gov/show/NCT04935450,NA
NCT04935463,ClinicalTrials.gov,2021-06-21,2021-05-24,TRUE,Recruiting,Not Applicable,Observational,United States,Mucormycosis in COVID-19,1000,https://clinicaltrials.gov/show/NCT04935463,NA
NCT04935476,ClinicalTrials.gov,2021-06-21,2021-07-05,FALSE,Not Recruiting,Phase 3,Interventional,"Canada, United States",Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19,3000,https://clinicaltrials.gov/show/NCT04935476,NA
NCT04935489,ClinicalTrials.gov,2021-06-11,2021-07-15,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Accelerated Intermittent Theta Burst Stimulation for Depressed Patients During the Covid-19 Pandemic,24,https://clinicaltrials.gov/show/NCT04935489,NA
NCT04935502,ClinicalTrials.gov,2021-06-14,2021-03-15,TRUE,Recruiting,Not Applicable,Interventional,Pakistan,Home Based Exercises With and Without Posture and Ergonomics Among Students During COVID-19,100,https://clinicaltrials.gov/show/NCT04935502,NA
NCT04935515,ClinicalTrials.gov,2021-06-20,2021-04-15,TRUE,Not Recruiting,Not Applicable,Interventional,India,C Reactive Protein in Home Quarantined Coronavirus Disease 2019 (COVID -19) Patients.,25,https://clinicaltrials.gov/show/NCT04935515,NA
NCT04935528,ClinicalTrials.gov,2021-06-18,2021-06-02,TRUE,Recruiting,Not Applicable,Interventional,France,Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center,430,https://clinicaltrials.gov/show/NCT04935528,NA
NCT04936503,ClinicalTrials.gov,2021-06-02,2020-06-18,TRUE,Not Recruiting,Not Applicable,Interventional,France,Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19,984,https://clinicaltrials.gov/show/NCT04936503,NA
NCT04936893,ClinicalTrials.gov,2021-06-07,2020-05-19,TRUE,Not Recruiting,Not Applicable,Interventional,Singapore,Effects of Mindfulness Practice on Healthcare Workers,80,https://clinicaltrials.gov/show/NCT04936893,NA
NCT04936997,ClinicalTrials.gov,2021-06-18,2021-06-07,TRUE,Recruiting,Phase 1,Interventional,United States,Immune Response to the COVID-19 Vaccine,1000,https://clinicaltrials.gov/show/NCT04936997,NA
NCT04937088,ClinicalTrials.gov,2021-06-16,2021-07-01,FALSE,Not Recruiting,Phase 2,Interventional,No Country Given,Outpatient Liquid Aspirin (OLA),200,https://clinicaltrials.gov/show/NCT04937088,NA
NCT04937543,ClinicalTrials.gov,2021-06-23,2021-06-28,FALSE,Not Recruiting,Phase 2,Interventional,Brazil,Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19,260,https://clinicaltrials.gov/show/NCT04937543,NA
NCT04937556,ClinicalTrials.gov,2021-06-14,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19.,60,https://clinicaltrials.gov/show/NCT04937556,NA
NCT04937569,ClinicalTrials.gov,2021-06-23,2021-07-01,FALSE,Not Recruiting,Phase 3,Interventional,Egypt,Ivermectin Versus Standard Treatment in Mild COVID-19,1644,https://clinicaltrials.gov/show/NCT04937569,NA
NCT04937582,ClinicalTrials.gov,2021-05-28,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,No Country Given,Cognitive and Psychological Disorders After Severe COVID-19 Infection,250,https://clinicaltrials.gov/show/NCT04937582,NA
NCT04937595,ClinicalTrials.gov,2021-06-21,2021-01-01,TRUE,Recruiting,Not Applicable,Interventional,United States,iCareDx PSS-1 Point-of-Care (POC) Assay for Detection of COVID-19,500,https://clinicaltrials.gov/show/NCT04937595,NA
NCT04937608,ClinicalTrials.gov,2021-06-21,2021-07-15,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters,60,https://clinicaltrials.gov/show/NCT04937608,NA
NCT04937621,ClinicalTrials.gov,2021-06-22,2020-06-02,TRUE,Not Recruiting,Not Applicable,Observational,France,Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19,196,https://clinicaltrials.gov/show/NCT04937621,NA
NCT04937712,ClinicalTrials.gov,2021-06-22,2021-07-01,FALSE,Not Recruiting,Not Applicable,Observational,No Country Given,Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction,34,https://clinicaltrials.gov/show/NCT04937712,NA
NCT04939155,ClinicalTrials.gov,2021-06-14,2021-03-10,TRUE,Not Recruiting,Not Applicable,Observational,United States,Methylation Effects of COV-19 Infection and Vaccinations,60,https://clinicaltrials.gov/show/NCT04939155,NA
NCT04939402,ClinicalTrials.gov,2021-04-22,2021-05-05,FALSE,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector,200,https://clinicaltrials.gov/show/NCT04939402,NA
NCT04939415,ClinicalTrials.gov,2021-06-21,2021-07-01,FALSE,Not Recruiting,Phase 1,Interventional,United States,Chinese Herbal Formula for COVID-19,66,https://clinicaltrials.gov/show/NCT04939415,NA
NCT04939428,ClinicalTrials.gov,2021-06-24,2021-08-16,FALSE,Not Recruiting,Phase 3,Interventional,No Country Given,Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013),1332,https://clinicaltrials.gov/show/NCT04939428,NA
NCT04939506,ClinicalTrials.gov,2021-06-22,2022-01-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana,375,https://clinicaltrials.gov/show/NCT04939506,NA
NCT04939519,ClinicalTrials.gov,2021-04-07,2021-03-29,TRUE,Recruiting,Not Applicable,Interventional,United States,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers,128000,https://clinicaltrials.gov/show/NCT04939519,NA
NCT04939532,ClinicalTrials.gov,2021-04-07,2021-03-29,TRUE,Recruiting,Not Applicable,Interventional,United States,SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers,128000,https://clinicaltrials.gov/show/NCT04939532,NA
NCT04939558,ClinicalTrials.gov,2021-06-03,2021-06-02,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Cardiorespiratory Diagnostic Study,740,https://clinicaltrials.gov/show/NCT04939558,NA
NCT04939714,ClinicalTrials.gov,2021-06-17,2021-06-07,TRUE,Recruiting,Not Applicable,Interventional,United States,Caregiving During Crisis,100,https://clinicaltrials.gov/show/NCT04939714,NA
NCT04940182,ClinicalTrials.gov,2021-06-23,2021-07-01,FALSE,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19,274,https://clinicaltrials.gov/show/NCT04940182,NA
NCT04940195,ClinicalTrials.gov,2021-06-21,2021-07-01,FALSE,Not Recruiting,Not Applicable,Interventional,United States,Clinical Investigation for 2019-nCoV Antigen Saliva Rapid Test Kit and V-CHEK SARS-CoV-2 Antigen Detection Kit to Detect COVID-19,500,https://clinicaltrials.gov/show/NCT04940195,NA
NCT04940208,ClinicalTrials.gov,2021-06-21,2021-01-11,TRUE,Recruiting,Not Applicable,Observational,France,Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit,250,https://clinicaltrials.gov/show/NCT04940208,NA
ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-20,FALSE,Recruiting,Not Applicable,Interventional,"New Zealand, Australia, South Africa, United Kingdom, United States, Canada, Singapore",Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,154,https://anzctr.org.au/ACTRN12620000448943.aspx,NA
ACTRN12621000637842,ANZCTR,2021-05-27,2021-02-08,TRUE,Not Recruiting,Phase 3,Interventional,"India, Australia",Impact of Colchicine To Improve long-COVID-19 or ARDS Outcomes,1000,https://anzctr.org.au/ACTRN12621000637842.aspx,NA
ACTRN12620000816954,ANZCTR,2020-08-14,2020-08-17,FALSE,Not Recruiting,Phase 1,Interventional,Australia,"A Double-blinded, Randomised, and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults",32,https://anzctr.org.au/ACTRN12620000816954.aspx,NA
ACTRN12621000388819,ANZCTR,2021-04-08,2021-01-06,TRUE,Not Recruiting,Not Applicable,Observational,Australia,Comparison of different N95 styles on fit testing in an Australian healthcare setting during the COVID-19 pandemic,150,https://anzctr.org.au/ACTRN12621000388819.aspx,NA
ISRCTN16993428,ISRCTN,2021-06-25,2019-04-07,TRUE,Recruiting,Not Applicable,Interventional,"Canada, Ireland, United Kingdom",GenOMICC study - Looking at DNA of patients with severe illness and injury to find the genes that cause some people to become very unwell and be admitted to intensive care,40000,http://isrctn.com/ISRCTN16993428,NA
ISRCTN16269648,ISRCTN,2021-06-24,2021-06-28,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Assessing the effectiveness of mouthwashes against SARS-CoV-2 before dental procedures,92,http://isrctn.com/ISRCTN16269648,NA
ISRCTN79488368,ISRCTN,2021-06-24,2021-05-30,TRUE,Recruiting,Not Applicable,Observational,"United Kingdom, Canada, Pakistan, India, Nigeria","The EPIC Project: the mental and physical health impact of the COVID-19 pandemic on healthcare professionals, patients and the general public",100000,http://isrctn.com/ISRCTN79488368,NA
ISRCTN98833037,ISRCTN,2021-06-23,2021-01-07,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,"Identifying subgroups within a population of chronic non-specific low back pain sufferers, and investigating the role of the immune system in certain subgroups by considering their relationship to chronic primary pain syndromes",100,http://isrctn.com/ISRCTN98833037,NA
ISRCTN15689873,ISRCTN,2021-06-17,2021-03-25,TRUE,Recruiting,Not Applicable,Observational,Sweden,"The COVID-19 pandemic and changes in physical activity patterns, mental health and academic performance in Swedish adolescents",1139,http://isrctn.com/ISRCTN15689873,NA
ISRCTN30075312,ISRCTN,2021-06-16,2021-12-03,FALSE,Not Recruiting,Not Applicable,Observational,United Kingdom,Assessment of an artificial intelligence method for determining the result of a COVID-19 lateral flow test,100000,http://isrctn.com/ISRCTN30075312,NA
ISRCTN23403781,ISRCTN,2021-06-16,2020-01-11,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluating a school-based programme to prevent offending behaviour among young people,4000,http://isrctn.com/ISRCTN23403781,NA
ISRCTN15162325,ISRCTN,2021-06-15,2021-01-06,TRUE,Not Recruiting,Not Applicable,Interventional,Norway,Social media campaign to increase COVID-19 testing in migrant groups,234112,http://isrctn.com/ISRCTN15162325,NA
ISRCTN38734433,ISRCTN,2021-06-15,2022-07-01,FALSE,Recruiting,Not Applicable,Interventional,Italy,"Better Outcomes for Everybody: a study to evaluate whether a new service delivered by community pharmacists in collaboration with physicians to asthma and COPD patients, improves disease control and is value for money, compared with usual care, during and after COVID-19",1000,http://isrctn.com/ISRCTN38734433,NA
ISRCTN29153109,ISRCTN,2021-06-14,2021-02-17,TRUE,Recruiting,Not Applicable,Interventional,Saudi Arabia,Acceptability of teledentistry during the COVID-19 pandemic in Saudi Arabia,102,http://isrctn.com/ISRCTN29153109,NA
ISRCTN48554326,ISRCTN,2021-06-14,2021-12-05,FALSE,Recruiting,Phase 2,Interventional,Estonia,BioBlock nasal spray against COVID-19,372,http://isrctn.com/ISRCTN48554326,NA
ISRCTN73765130,ISRCTN,2021-05-13,2021-01-06,TRUE,Recruiting,Phase 2,Interventional,United Kingdom,Evaluating COVID-19 Vaccination Boosters,2886,http://isrctn.com/ISRCTN73765130,NA
ISRCTN12272130,ISRCTN,2021-04-22,2021-06-13,FALSE,Not Recruiting,Not Applicable,Interventional,"Netherlands, Nepal","The comprehensive anaemia programme and personalized therapies (CAPPT) trial testing the effect of home visits, tailored iron therapy and womenâ€™s groups to reduce anaemia in pregnant women in southern Nepal",842,http://isrctn.com/ISRCTN12272130,NA
ISRCTN27841311,ISRCTN,2021-03-26,2021-04-19,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Comparing COVID-19 vaccine schedule combinations  â€“ stage 2,1050,http://isrctn.com/ISRCTN27841311,NA
ISRCTN68832164,ISRCTN,2021-03-18,2021-03-22,FALSE,Recruiting,Not Applicable,Observational,Czech Republic,Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatments,230,http://isrctn.com/ISRCTN68832164,NA
ISRCTN15328700,ISRCTN,2021-03-12,2021-01-07,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,Developing and evaluating a diabetes self-management intervention for people with severe mental illness,30,http://isrctn.com/ISRCTN15328700,NA
ISRCTN69254139,ISRCTN,2021-02-03,2021-08-02,FALSE,Recruiting,Phase 2,Interventional,United Kingdom,Comparing coronavirus (COVID-19) vaccine schedule combinations,820,http://isrctn.com/ISRCTN69254139,NA
ISRCTN13235264,ISRCTN,2020-10-20,2020-10-20,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Identifying acceptable support strategies for parents of children with obsessive-compulsive disorder,95,http://isrctn.com/ISRCTN13235264,NA
ISRCTN58667920,ISRCTN,2020-08-04,2020-01-08,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 effects on the heart,370,http://isrctn.com/ISRCTN58667920,NA
ISRCTN10980107,ISRCTN,2020-07-22,2020-07-25,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Long-term follow up of adults hospitalised with COVID-19,10000,http://isrctn.com/ISRCTN10980107,NA
ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,FALSE,Not Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,240,http://isrctn.com/ISRCTN54917435,NA
ISRCTN14447421,ISRCTN,2020-06-05,2020-03-06,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 in care homes (VIVALDI),11000,http://isrctn.com/ISRCTN14447421,NA
ISRCTN69546370,ISRCTN,2020-06-02,2020-08-06,FALSE,Recruiting,Not Applicable,Observational,United Kingdom,Best available treatment study for inflammatory conditions associated with COVID-19,1800,http://isrctn.com/ISRCTN69546370,NA
ISRCTN12107048,ISRCTN,2020-05-28,2020-08-06,FALSE,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,360,http://isrctn.com/ISRCTN12107048,NA
ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,FALSE,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A clinical trial evaluating treatments for suspected and confirmed COVID-19 for recovery at home,6000,http://isrctn.com/ISRCTN86534580,NA
ISRCTN18274006,ISRCTN,2019-07-29,2018-09-25,TRUE,Recruiting,Not Applicable,Observational,United Kingdom,Understanding cognitive decline after stroke and the impact of COVID-19,2000,http://isrctn.com/ISRCTN18274006,NA
ISRCTN12455871,ISRCTN,2019-06-27,2019-01-08,TRUE,Recruiting,Not Applicable,Interventional,United Kingdom,The quit smoking lung health intervention trial,110,http://isrctn.com/ISRCTN12455871,NA
EUCTR2020-001250-21,EudraCT,2020-03-24,2020-03-04,TRUE,Not Recruiting,Phase 2,Interventional,France,COVID-19 - Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease upon Hydroxychloroquine and Azithromycin Therapy in French Cancer patients,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001250-21,FR
EUCTR2020-001320-34,EudraCT,2020-03-30,2020-10-04,FALSE,Not Recruiting,Phase 4,Interventional,Netherlands,A clinicial trial to investigate te effect of valsartan compared to placebo on acute respiratory failure in hospitalized SARS-CoV-2-infected patients,651,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001320-34,NL
EUCTR2020-001375-32,EudraCT,2020-04-03,2020-03-04,TRUE,Not Recruiting,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,NL
EUCTR2020-001206-35,EudraCT,2020-04-09,2020-04-14,FALSE,Not Recruiting,Phase 4,Interventional,"Germany, Austria",Discontinuation of ACE inhibitors in patients with COVID-19 infection,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35,DE
EUCTR2020-005524-11,EudraCT,2020-12-01,2020-12-21,FALSE,Not Recruiting,Phase 4,Interventional,Czech Republic,IMUNORÂ® preparation in the prevention of COVID-19,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005524-11,CZ
EUCTR2020-003936-25,EudraCT,2021-01-28,2021-06-04,FALSE,Authorised,Phase 2/Phase 3,Interventional,"France, Italy",Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25,FR
EUCTR2021-001070-38,EudraCT,2021-03-24,2021-06-21,FALSE,Authorised,Phase 2,Interventional,Germany,B-pVAC-SARS-CoV-2: Phase I/II multi-center safety and immungenicity trial of multi-peptide vaccination to prevent COVID-19 infection in adults with B-cell/antibody deficiency,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-001070-38,DE
EUCTR2020-005759-18,EudraCT,2021-03-24,2021-08-06,FALSE,Authorised,Phase 3,Interventional,"Russian Federation, Turkey, Japan, Poland, France, Romania, Denmark, Belgium, Germany, Switzerland, Argentina, Hungary, Ukraine, Italy, Mexico, Brazil, Portugal, Peru, Colombia, United States, Serbia, Spain","A study to evaluate the Efficacy, Safety, and Antiviral Activity of RO7496998 (AT-527) in Patients with Mild or Moderate COVID-19",1386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005759-18,FR
EUCTR2021-000045-41,EudraCT,2021-04-12,2021-08-06,FALSE,Authorised,Phase 2/Phase 3,Interventional,France,"Adaptive, Ambulatory, Randomised, Placebo-Controlled, Double-Blind, Phase 2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of TEE001DP in Patients at the Early Stage of Symptomatic COVID-19",686,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-000045-41,FR
EUCTR2021-002174-52,EudraCT,2021-05-06,2021-05-19,FALSE,Authorised,Phase 3,Interventional,France,Essai multicentrique randomisé en ouvert comparant l’efficacité immunologique d’un schéma vaccinal combinant deux vaccins ARNm Covid19 (Pfizer-BioNTech et Moderna) à celle d’une vaccination homologue de chaque vaccin ARNm Covid19 : essai de non infériorité,400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-002174-52,FR
EUCTR2020-005523-37,EudraCT,2021-04-26,2021-06-21,FALSE,Authorised,Phase 2,Interventional,Germany,A prospective controlled proof-of-concept trial to demonstrate anti-viral effects of oral bromelaine in COVID-19 positive patients,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005523-37,DE
EUCTR2021-003388-90,EudraCT,2021-06-21,NA,FALSE,Not Available,Phase 4,Interventional,Netherlands,Monitoring response on COVID-19 vaccination in children with cancer,130,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-003388-90,NL
EUCTR2020-000936-23,EudraCT,2020-03-27,2020-05-20,FALSE,Authorised,Phase 3,Interventional,"Portugal, Belgium, Czech Republic, Norway, Turkey, Austria, France",Safety and efficacy of treatments of COVID-19 in hospitalized adults (Discovery),1240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23,BE
EUCTR2020-001335-28,EudraCT,2020-03-27,2020-03-29,FALSE,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, South Africa, Peru, Belgium, Netherlands, United States, Brazil, Mexico, France, Germany",A phase II/III study of IFX-1 in patients with severe COVID-19 Pneumonia,430,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001335-28,NL
ChiCTR2100043802,ChiCTR,2021-03-03,2021-03-23,FALSE,Recruiting,Not Applicable,Observational,China,Follow up study on health status of rehabilitation patients with novel coronavirus pneumonia (COVID-19),50,http://www.chictr.org.cn/showproj.aspx?proj=122767,NA
ChiCTR2100043801,ChiCTR,2021-03-02,2021-03-23,FALSE,Recruiting,Not Applicable,Observational,China,Study on the effect of novel coronavirus pneumonia (COVID-19) vaccination in Tangdu Hospital,400,http://www.chictr.org.cn/showproj.aspx?proj=122765,NA
ChiCTR2100043788,ChiCTR,2021-02-28,2021-03-01,FALSE,Recruiting,Not Applicable,Observational,China,A medical records based study for the analysis of nutritional status of COVID-19 inpatients,60,http://www.chictr.org.cn/showproj.aspx?proj=65821,NA
NL8536,NTR,2020-04-15,2020-04-28,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure,285,https://trialregister.nl/trial/8536,NA
NL8512,NTR,2020-04-02,2020-03-18,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 patiÃ«nts 
",400,https://trialregister.nl/trial/8512,NA
NL9053,NTR,2020-11-17,2020-09-11,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Evolution of diaphragm and abdominal muscle thickness in ventilated COVID-19 patients,40,https://trialregister.nl/trial/9053,NA
NL8520,NTR,2020-04-12,2020-04-14,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,SARS-CoV-2 Observational Study,600,https://trialregister.nl/trial/8520,NA
NL8551,NTR,2020-04-23,2020-04-23,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Covid High-intensity Immunosuppression in Cytokine release syndrome,160,https://trialregister.nl/trial/8551,NA
NL8501,NTR,2020-04-01,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",2000,https://trialregister.nl/trial/8501,NA
NL8522,NTR,2020-04-12,2020-08-04,FALSE,Recruiting,Not Applicable,Observational,Netherlands,The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic?,50,https://trialregister.nl/trial/8522,NA
NL8523,NTR,2020-04-13,2020-04-26,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 â€“ a pilot study,20,https://trialregister.nl/trial/8523,NA
NL8563,NTR,2020-04-22,2020-04-22,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Patientâ€™s knowledge And behavior oN the COVID-19 disease and as DEterMInants of Contamination,170,https://trialregister.nl/trial/8563,NA
NL8570,NTR,2020-04-29,2020-10-05,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 infections in health care workers,300,https://trialregister.nl/trial/8570,NA
NL8529,NTR,2020-04-14,2020-01-05,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,General practice cooperative COVID-19 centre Urmond,2000,https://trialregister.nl/trial/8529,NA
NL8572,NTR,2020-04-30,2020-04-19,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients,100,https://trialregister.nl/trial/8572,NA
NL8575,NTR,2020-05-02,2020-01-05,TRUE,Recruiting,Not Applicable,Observational,Netherlands,COVID MILK,60,https://trialregister.nl/trial/8575,NA
NL8576,NTR,2020-04-20,2020-04-20,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Effect van COVID-19 op kwaliteit van leven bij astma,80,https://trialregister.nl/trial/8576,NA
NL8521,NTR,2020-04-13,2020-08-05,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,13,https://trialregister.nl/trial/8521,NA
NL8580,NTR,2020-04-28,2020-04-28,FALSE,Recruiting,Not Applicable,Unknown,Netherlands,Metabolic syndrome And Severity of Covid-19,100,https://trialregister.nl/trial/8580,NA
NL8531,NTR,2020-04-08,2020-12-04,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Humoral responses to SARS-CoV-2 infection in children,420,https://trialregister.nl/trial/8531,NA
NL8578,NTR,2020-05-02,2020-07-13,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),124,https://trialregister.nl/trial/8578,NA
NL8577,NTR,2020-05-06,2020-05-15,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,394,https://trialregister.nl/trial/8577,NA
NL8587,NTR,2020-05-06,2020-07-05,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in COVID-19 survivors,500,https://trialregister.nl/trial/8587,NA
NL8589,NTR,2020-05-07,2020-04-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19,250,https://trialregister.nl/trial/8589,NA
NL8528,NTR,2020-04-15,2020-04-22,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Control of COVID-19 in hospitals,2000,https://trialregister.nl/trial/8528,NA
NL8535,NTR,2020-04-15,2020-03-30,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Functional status and health status in COVID-19 patients pre and post rehabilitation,30,https://trialregister.nl/trial/8535,NA
NL9275,NTR,2021-02-16,2021-01-03,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,"Establishing the tolerability, safety and immunogenicity of intradermal delivery of mRNA SARS-CoV-2 vaccine in healthy adults",150,https://trialregister.nl/trial/9275,NA
NL9279,NTR,2021-02-17,2021-01-03,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,VASCO study (Vaccine Study COvid-19),50000,https://trialregister.nl/trial/9279,NA
NL9281,NTR,2021-02-21,2021-02-21,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Confocal laser endomicroscopy in patients with non-resolving acute respiratory failure,15,https://trialregister.nl/trial/9281,NA
NL8513,NTR,2020-04-07,2020-04-13,FALSE,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,8000,https://trialregister.nl/trial/8513,NA
NL8609,NTR,2020-05-11,2020-05-25,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),100,https://trialregister.nl/trial/8609,NA
NL8613,NTR,2020-05-12,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht.,250,https://trialregister.nl/trial/8613,NA
NL8543,NTR,2020-04-18,2020-04-14,TRUE,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound triage,50,https://trialregister.nl/trial/8543,NA
NL8544,NTR,2020-04-18,2020-04-18,FALSE,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound diagnosis,50,https://trialregister.nl/trial/8544,NA
NL8625,NTR,2020-05-15,2020-05-15,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Hocus POCUS: a tool for increasing the efficiency of diagnosing venous thromboembolic disease in critically ill COVID-19 patients?,50,https://trialregister.nl/trial/8625,NA
NL8547,NTR,2020-04-22,2020-04-16,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,"REDUCING HOSPITAL ADMISSION OF ELDERLY IN SARS-CoV-2 PANDEMIC VIA THE INDUCTION OF TRAINED IMMUNITY BY BACILLUS CALMETTE-GUÃ‰RIN VACCINATION, A RANDOMIZED CONTROLLED TRIAL",1600,https://trialregister.nl/trial/8547,NA
NL8627,NTR,2020-05-18,2020-01-03,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Association of BMI with COVID-19 incidence and severity,200,https://trialregister.nl/trial/8627,NA
NL8633,NTR,2020-05-13,2020-05-13,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",430,https://trialregister.nl/trial/8633,NA
NL8645,NTR,2020-05-19,2020-03-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Sero-surveillance SARS-CoV-2,800,https://trialregister.nl/trial/8645,NA
NL9307,NTR,2021-03-10,2020-10-23,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"Helicopter transport of Critical Care patients with COVID-19 in the Netherlands, hemodynamic changes during actual transport",50,https://trialregister.nl/trial/9307,NA
NL8668,NTR,2020-05-28,2020-05-28,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Lifestyle of pregnant women during COVID-19 pandemic,20,https://trialregister.nl/trial/8668,NA
NL8710,NTR,2020-06-12,2020-01-07,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective",500,https://trialregister.nl/trial/8710,NA
NL8473,NTR,2020-03-23,2020-03-23,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,7000,https://trialregister.nl/trial/8473,NA
NL9045,NTR,2020-11-12,2020-03-11,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Healthy volunteers blood sampling,20,https://trialregister.nl/trial/9045,NA
NL8526,NTR,2020-04-14,2020-04-26,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Neuroinvasion in COVID-19,10,https://trialregister.nl/trial/8526,NA
NL9320,NTR,2021-02-18,2021-02-25,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Remote Early Detection of SARS-CoV-2 infections,20000,https://trialregister.nl/trial/9320,NA
NL8685,NTR,2020-05-10,2020-05-18,FALSE,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in professional soccer players (COPROS study),140,https://trialregister.nl/trial/8685,NA
NL8694,NTR,2020-06-10,2020-04-17,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Prospective diagnosis of Covid-19 Ã¯nfectionusing exhaled breath analysis by electronic nose,200,https://trialregister.nl/trial/8694,NA
NL8714,NTR,2020-06-12,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,"The impact of COVID-19 among illiterate people and people with a mild intellectual disabilities: preventative measures, (mental) health and support needs",1000,https://trialregister.nl/trial/8714,NA
NL8726,NTR,2020-06-23,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Effect of hydroxychloroquine treatment on the general immunocompetence,40,https://trialregister.nl/trial/8726,NA
NL8729,NTR,2020-06-26,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Primary care Research on Outcomes of COVID-19,274,https://trialregister.nl/trial/8729,NA
NL9334,NTR,2021-03-10,2021-11-03,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Safety and tolerability of ABNCoV2,42,https://trialregister.nl/trial/9334,NA
NL8735,NTR,2020-06-16,2020-06-16,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Risk of infection with SARS-CoV-2 amongst physicians,3000,https://trialregister.nl/trial/8735,NA
NL8490,NTR,2020-03-31,2020-12-04,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",950,https://trialregister.nl/trial/8490,NA
NL8538,NTR,2020-04-17,2020-04-17,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,342,https://trialregister.nl/trial/8538,NA
NL8765,NTR,2020-07-07,2020-07-07,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"PULmonary DAMage after hospitalization for acute COvid-19 (PULDAMCO), an exploratory prospective cohort study",150,https://trialregister.nl/trial/8765,NA
NL8787,NTR,2020-07-21,2020-01-06,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,COVID-VTE follow-up study,400,https://trialregister.nl/trial/8787,NA
NL9081,NTR,2020-11-30,2021-11-01,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Early@home,62,https://trialregister.nl/trial/9081,NA
NL9354,NTR,2021-03-23,2021-02-17,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Intranasal Ampligen in healthy volunteers.,40,https://trialregister.nl/trial/9354,NA
NL8775,NTR,2020-07-13,2020-07-13,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Postcorona care,90,https://trialregister.nl/trial/8775,NA
NL8818,NTR,2020-08-03,2020-07-29,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Preparations of Dutch Emergency Departments for the SARS-COV-2 outbreak,84,https://trialregister.nl/trial/8818,NA
NL8821,NTR,2020-08-07,2020-10-08,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,In vitro characterization of the immune response of recovered COVID-19 patients and healthy controls to SARS-CoV-2,14,https://trialregister.nl/trial/8821,NA
NL9365,NTR,2021-03-25,2021-08-02,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Behavioural interventions to increase test uptake and self-isolation compliance during Covid-19 community test pilots in the Netherlands: four population-level randomised control trials.,25644,https://trialregister.nl/trial/9365,NA
NL8477,NTR,2020-03-20,2020-03-20,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,BCG vaccination for healthcare workers in SARS-CoV-2 pandemic,1500,https://trialregister.nl/trial/8477,NA
NL8836,NTR,2020-08-14,2020-08-14,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"Registry of COvid 19 survivors for FItness, exercise impairment and exercise Training (COFIT)",200,https://trialregister.nl/trial/8836,NA
NL8837,NTR,2020-08-14,2020-08-31,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"TRACE ll Retrospective: Outcome in patients undergoing (postponed) surgery during the COVID-19 pandemic
",14000,https://trialregister.nl/trial/8837,NA
NL8842,NTR,2020-08-18,2020-09-04,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Online Communities,50,https://trialregister.nl/trial/8842,NA
NL8841,NTR,2020-08-17,2020-01-09,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,TRACE ll Prospective study: Outcome in patients undergoing postponed elective surgery during the COVID-19 pandemic,2500,https://trialregister.nl/trial/8841,NA
NL8705,NTR,2020-06-04,2020-04-06,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in patients with suspected COVID-19,10000,https://trialregister.nl/trial/8705,NA
NL9378,NTR,2021-03-29,2021-03-24,TRUE,Recruiting,Not Applicable,Observational,Netherlands,"Identification of stressors and de-stressors in employees working from home
during COVID-19",200,https://trialregister.nl/trial/9378,NA
NL9379,NTR,2021-03-29,2021-01-04,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV2 immunoglobulines,104,https://trialregister.nl/trial/9379,NA
NL8882,NTR,2020-09-07,2020-05-28,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,The psychological well-being and health-related quality of life of patients admitted to the hospital with COVID-19.,250,https://trialregister.nl/trial/8882,NA
NL9342,NTR,2021-03-16,2021-03-28,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"Research into the effect of the COVID-19 vaccines on patients with rheumatoid arthritis, treated with rituximab",270,https://trialregister.nl/trial/9342,NA
NL8903,NTR,2020-09-15,2020-09-15,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,A diet for the treatment of gout,30,https://trialregister.nl/trial/8903,NA
NL8706,NTR,2020-06-09,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Extracorporeal membrane oxygenation in patients with coronavirus disease 2019,200,https://trialregister.nl/trial/8706,NA
NL8922,NTR,2020-09-23,2020-01-10,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,"COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial",2200,https://trialregister.nl/trial/8922,NA
NL8926,NTR,2020-09-11,2020-01-10,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,"Clinical features of COVID-19 in Pediatric Patients, long term effects
",120,https://trialregister.nl/trial/8926,NA
NL8835,NTR,2020-08-14,2020-06-29,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,"Intensive Care Unit specific Virtual Reality (ICU-VR) to improve psychological impairments in survivors of COVID-19; a multicentre, randomised controlled trial.",80,https://trialregister.nl/trial/8835,NA
NL8562,NTR,2020-04-21,2020-01-04,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study,50,https://trialregister.nl/trial/8562,NA
NL9419,NTR,2021-04-19,2021-04-19,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Precision Medicine for more Oxygen - COVID-19 extension,100,https://trialregister.nl/trial/9419,NA
NL8993,NTR,2020-10-21,2020-01-07,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Online cognitive behavioral therapy for distress in people who lost a loved one during the corona pandemic: A randomized waitlist-controlled trial,52,https://trialregister.nl/trial/8993,NA
NL9007,NTR,2020-10-29,2020-09-06,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,"Exercise via videoconferencing for people with severe mental illness during covid-19 times, a feasibility study",70,https://trialregister.nl/trial/9007,NA
NL9019,NTR,2020-10-23,2020-10-23,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,200,https://trialregister.nl/trial/9019,NA
NL9018,NTR,2020-10-19,2020-09-26,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Performance evaluation of a sars-cov-2 rapid antigentest: test performance in the community in the netherlands,1000,https://trialregister.nl/trial/9018,NA
NL8947,NTR,2020-10-04,2020-05-10,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,ReCOVer: Cognitive Behavioural Therapy for post-COVID-19 fatigue,114,https://trialregister.nl/trial/8947,NA
NL9430,NTR,2021-02-04,2021-01-20,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Intranasal LMWH against COVID-19,24,https://trialregister.nl/trial/9430,NA
NL9436,NTR,2021-04-22,2021-04-15,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,COVID-Compromise,86,https://trialregister.nl/trial/9436,NA
NL8954,NTR,2020-10-06,2020-01-11,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home,50,https://trialregister.nl/trial/8954,NA
NL9063,NTR,2020-11-18,2020-11-22,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 pandemic impact on severe asthma patients care in Europe,900,https://trialregister.nl/trial/9063,NA
NL9067,NTR,2020-11-27,2020-01-12,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,"High-Flow Nasal Cannula for severe COVID-19, a multicentre prospective cohort study",200,https://trialregister.nl/trial/9067,NA
NL9093,NTR,2020-12-04,2020-01-06,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Pulmonary and fitness characteristics of COVID-19 patients with persistent dyspnea and / or reduced exercise capacity,100,https://trialregister.nl/trial/9093,NA
NL8309,NTR,2020-01-13,2018-09-25,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Impact of COVID-19 on physical activity and lifestyle of school going adolescents of Punjab (ICPASA): Designing an evidence-based physical activity intervention in COVID era,834,https://trialregister.nl/trial/8309,NA
NL9082,NTR,2020-11-30,2021-01-01,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19,350,https://trialregister.nl/trial/9082,NA
NL9141,NTR,2020-12-23,2020-12-23,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,Obesity and COVID-19: AdipoSe TissuE Responses to SARS-CoV-2 infection,36,https://trialregister.nl/trial/9141,NA
NL9161,NTR,2021-01-08,2020-10-23,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,200,https://trialregister.nl/trial/9161,NA
NL9177,NTR,2021-01-06,2020-01-08,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Lessons and needs arising from experienced moral stress and moral dilemmas at the ICU during the COVID-19 pandemic,200,https://trialregister.nl/trial/9177,NA
NL9459,NTR,2021-05-03,2021-03-05,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,"CovidTherapy@Home. Action research on development of a regionally supported, safe, feasible, and scalable intervention to monitor and optimally treat COVID-19 patients with hypoxemia and/or respiratory distress in their home setting.",30,https://trialregister.nl/trial/9459,NA
NL8460,NTR,2020-03-16,2020-03-16,FALSE,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,100,https://trialregister.nl/trial/8460,NA
NL9214,NTR,2021-01-20,2021-01-20,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,SARS-CoV-2 vaccination response in people living with HIV,1000,https://trialregister.nl/trial/9214,NA
NL8483,NTR,2020-03-26,2020-03-16,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,17000,https://trialregister.nl/trial/8483,NA
NL8485,NTR,2020-03-27,2020-03-27,FALSE,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,20,https://trialregister.nl/trial/8485,NA
NL9220,NTR,2021-01-25,2021-01-25,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Virtual reality for relatives of ICU patients (ICU-VR-F) to improve psychological sequelae.,160,https://trialregister.nl/trial/9220,NA
NL8491,NTR,2020-03-31,2020-03-31,FALSE,Recruiting,Not Applicable,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection (CounterCovid) study,386,https://trialregister.nl/trial/8491,NA
NL9211,NTR,2021-01-11,2021-01-17,FALSE,Recruiting,Not Applicable,Observational,Netherlands,"Studying coagulation specific for COVID-19 using ""Blood-vessel-on-chip"" technology.",24,https://trialregister.nl/trial/9211,NA
NL9238,NTR,2021-01-25,2020-10-30,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Long term smell and taste alterations in COVID-19 patients.,150,https://trialregister.nl/trial/9238,NA
NL9485,NTR,2021-05-18,2021-01-03,TRUE,Recruiting,Not Applicable,Interventional,Netherlands,Online guided vs. unguided cognitive behavioral therapy for distress in people who lost a loved one during the COVID-19 pandemic: A controlled trial,102,https://trialregister.nl/trial/9485,NA
NL9247,NTR,2021-02-04,2021-01-02,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Clinical validation of lung ultrasound for the diagnosis of COVID-19,150,https://trialregister.nl/trial/9247,NA
NL9250,NTR,2020-12-21,2020-11-26,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Detection COVID-19 from exhaled air analysed with Aeonoseâ„¢,3000,https://trialregister.nl/trial/9250,NA
NL8497,NTR,2020-03-31,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,200,https://trialregister.nl/trial/8497,NA
NL8498,NTR,2020-03-31,2020-03-15,TRUE,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,20,https://trialregister.nl/trial/8498,NA
NL8504,NTR,2020-04-03,2020-06-04,FALSE,Not Recruiting,Not Applicable,Interventional,Netherlands,"Pre-emptive tocilizumab in hypoxic COVID-19 patients, a prospective randomized trial",354,https://trialregister.nl/trial/8504,NA
NL9538,NTR,2021-06-15,2021-02-22,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Investigating the immune response to COVID-19 vaccination in lung transplantation patients (COVALENT study),180,https://trialregister.nl/trial/9538,NA
NL9547,NTR,2021-06-15,2021-05-07,TRUE,Not Recruiting,Not Applicable,Observational,Netherlands,Prospective monitoring of immune response following COVID-19 vaccination in children with cancer,130,https://trialregister.nl/trial/9547,NA
NL9553,NTR,2021-06-07,2021-01-03,TRUE,Not Recruiting,Not Applicable,Interventional,Netherlands,"COVID-19 vaccination in patients with reduced B-cell and T-cell immunity: response after vaccination of a kaleidoscopic group hematological patients, whatâ€™s the impact?",850,https://trialregister.nl/trial/9553,NA
NL9554,NTR,2021-06-08,2021-01-07,TRUE,Recruiting,Not Applicable,Observational,Netherlands,REturn-to-work And DisAbility Pension afTer COVID-19 virus pandemic. A prospective study,2000,https://trialregister.nl/trial/9554,NA
PER-010-20,REPEC,2020-04-16,2020-03-04,TRUE,Recruiting,Phase 3,Interventional,"Argentina, Iran, South Africa, Peru, Bahrain, Norway, Thailand, Spain, India, Switzerland",SOLIDARITY: AN INTERNATIONAL RANDOMIZED CONTROLLED TRIAL TO EVALUATE NON-LICENSED COVID-19 TREATMENTS IN ADDITION TO STANDARD OF CARE AMONG HOSPITALIZED PATIENTS,1000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=010-20,NA
PER-013-20,REPEC,2020-06-25,2020-01-06,TRUE,Not Recruiting,Phase 2,Interventional,Peru,CONVALESCENT PLASMA AS TREATMENT FOR COVID-19,192,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,NA
PER-016-20,REPEC,2020-06-27,2020-01-06,TRUE,Not Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: EVALUATING THE USE OF CONVALESCENT PLASMA AS MANAGEMENT OF COVID-19,98,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=016-20,NA
PER-018-20,REPEC,2020-06-30,2020-05-07,TRUE,Recruiting,Phase 2,Interventional,"Chile, Sweden, Argentina, Russian Federation, South Africa, Peru, Italy, Brazil, Turkey, Spain, Japan, Mexico, India, Germany","
					A PHASE 2, OPEN LABEL, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF
					ACALABRUTINIB WITH BEST SUPPORTIVE CARE VERSUS BEST SUPPORTIVE CARE IN
					SUBJECTS HOSPITALIZED WITH COVID-19
",30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=018-20,NA
PER-030-20,REPEC,2020-07-22,2020-03-08,TRUE,Not Recruiting,Phase 3,Interventional,"Argentina, Russian Federation, Peru, Colombia, Canada, United Kindgdom, Italy, Brazil, Spain, Mexico, United States, France, Germany","PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID)",60,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=030-20,NA
PER-031-20,REPEC,2020-07-27,2020-06-07,TRUE,Not Recruiting,Phase 2,Interventional,Peru,PHASE 2 STUDY OF EFFICACY AND SAFETY OF PLASMA FROM CONVALESCENT PATIENTS WITH COVID-19 IN PATIENTS WITH MODERATE DISEASE (AUNA 20-01),50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20,NA
PER-032-20,REPEC,2020-07-23,2020-07-22,TRUE,Recruiting,Phase 2,Interventional,"Chile, Ireland, South Africa, Peru, United Kindgdom, Italy, United States","A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAVRILIMUMAB (KPL-301) TREATMENT IN ADULT SUBJECTS HOSPITALIZED WITH SEVERE COVID-19 PNEUMONIA AND HYPER-INFLAMMATION",115,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20,NA
PER-034-20,REPEC,2020-07-17,2020-09-07,FALSE,Recruiting,Phase 2,Interventional,Peru,RANDOMIZED PHASE IIA CLINICAL TRIAL TO COMPARE THE EFFICACY OF IVERMECTIN VERSUS PLACEBO TO OBTAIN NEGATIVE PCR RESULTS IN PATIENTS WITH EARLY PHASE COVID-19,68,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20,NA
PER-042-20,REPEC,2020-08-21,2020-01-08,TRUE,Not Recruiting,Phase 2,Interventional,"Chile, Sweden, Argentina, South Africa, Peru, Belgium, Colombia, Canada, United Kindgdom, United States, Brazil, Spain, Mexico, Japan, Poland, France, India, Nederland",Investigating otilimab in patients with severe pulmonary COVID-19 related disease,35,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=042-20,NA
PER-048-20,REPEC,2020-09-28,2020-04-09,TRUE,Not Recruiting,Phase 3,Interventional,"Chile, Argentina, South Africa, Peru, Colombia, Canada, United States, Brazil, Mexico, Philippines","
					A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY TO ASSESS THE EFFICACY AND
					SAFETY OF AD26.COV2.S FOR THE PREVENTION OF SARS-COV-2-MEDIATED COVID-19 IN ADULTS
					AGED 18 YEARS AND OLDER
",2000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=048-20,NA
PER-050-20,REPEC,2020-09-17,2020-09-28,FALSE,Not Recruiting,Phase 2,Interventional,"Denmark, Argentina, Hungary, Russian Federation, Peru, Ukraine, Italy, Brazil, Spain, United States, France, Germany, Philippines, Romania","â€œA PHASE 1/2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF TL-895 WITH STANDARD AVAILABLE TREATMENT VERSUS STANDARD AVAILABLE TREATMENT FOR THE TREATMENT OF COVID-19 IN PATIENTS WITH CANCERâ€",30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20,NA
PER-054-20,REPEC,2020-08-20,2020-10-09,FALSE,Not Recruiting,Phase 2,Interventional,"Panama, Peru, Brazil","COVID-19: A PHASE 2A, PARTIALLY OBSERVER-BLIND, MULTICENTER, CONTROLLED, DOSE-CONFIRMATION CLINICAL TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF THE INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS >60 YEARS OF AGE AND 18 TO 60 YEARS OF AGE",270,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20,NA
PER-055-20,REPEC,2020-08-31,2020-01-10,TRUE,Recruiting,Phase 2,Interventional,"Denmark, Argentina, South Africa, Peru, Brazil, Spain, Mexico, Hungaria, India, Germany",STUDY OF EFFICACY AND SAFETY OF DFV890 IN PATIENTS WITH COVID-19 PNEUMONIA,20,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=055-20,NA
PER-059-20,REPEC,2020-09-17,2020-03-11,TRUE,Recruiting,Phase 3,Interventional,"Chile, Peru, United States","
					A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY IN ADULTS TO DETERMINE THE SAFETY, EFFICACY, AND
					IMMUNOGENICITY OF AZD1222, A NON-REPLICATING CHADOX1 VECTOR VACCINE, FOR THE PREVENTION OF COVID-19
",5000,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=059-20,NA
PER-060-20,REPEC,2020-09-21,2020-07-09,TRUE,Recruiting,Phase 2,Interventional,Peru,"
					RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF THE USE OF PLASMA FROM CONVALESCENT PATIENTS WITH THE NEW CORONAVIRUS DISEASE (COVID-19) FOR THE EXPERIMENTAL TREATMENT  OF PATIENTS HOSPITALIZED IN THE CENTRO MÃ‰DICO NAVAL ""CIRUJANO MAYOR SANTIAGO TÃVARA""
					""
",100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,NA
PER-064-20,REPEC,2020-09-29,2020-01-10,TRUE,Recruiting,Phase 2,Interventional,Peru,LACTOFERRIN FOR PREVENTION OF COVID-19 IN HEALTH CARE PERSONNEL.,336,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20,NA
PER-067-20,REPEC,2020-10-29,2020-09-18,TRUE,Not Recruiting,Phase 2,Interventional,Argentina,"A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTI CENTER STUDY OF OT 101 IN HOSPITALIZED COVID 19 SUBJECTS",48,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20,NA
PER-069-20,REPEC,2020-10-05,2020-10-15,FALSE,Not Recruiting,Phase 2,Interventional,"Hungary, Poland, Slovakia, Belgium, Czech Republic, United Kindgdom, Italy, Spain, Austria, France, Slovenia, Germany","â€œA PHASE 2/3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND THE SAFETY OF ABX464 IN TREATING INFLAMMATION AND PREVENTING COVID-19 ASSOCIATED ACUTE RESPIRATORY FAILURE IN PATIENTS AGED &#8805; 65 AND PATIENTS AGED &#8805;18 WITH AT LEAST ONE ADDITIONAL RISK FACTOR WHO ARE INFECTED WITH SARS-COV-2. (THE MIR-AGE STUDY).â€",100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=069-20,NA
PER-090-20,REPEC,2020-12-16,2020-12-19,FALSE,Recruiting,Phase 2,Interventional,"Argentina, Peru, United States","A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ANTROQUINONOL IN HOSPITALIZED PATIENTS WITH MILD TO MODERATE PNEUMONIA DUE TO COVID-19",50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=090-20,NA
PER-093-20,REPEC,2020-12-30,2020-11-23,TRUE,Not Recruiting,Phase 3,Interventional,"Argentina, Peru, Colombia, United States, Mexico, Brazil",LOSVID STUDY,60,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=093-20,NA
PER-095-20,REPEC,2020-12-15,2020-01-12,TRUE,Not Recruiting,Phase 2,Interventional,"Chile, Peru, Canada, United Kindgdom, Italy, Brazil, Spain, United States","A RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF MONOCLONAL ANTIBODY VIR-7831 FOR THE EARLY TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) IN NON-HOSPITALIZED PATIENTS",50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=095-20,NA
PER-099-20,REPEC,2020-12-30,2020-11-30,TRUE,Recruiting,Phase 2,Interventional,"Argentina, Peru, Colombia, United States, Mexico",Fenofibrate research for the treatment of COVID-19.,150,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=099-20,NA
PER-101-20,REPEC,2020-12-30,2021-04-01,FALSE,Not Recruiting,Phase 3,Interventional,United States,"
					RANDOMIZED MASTER PROTOCOL FOR IMMUNE MODULATORS FOR TREATING COVID-19
",200,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=101-20,NA
PER-106-20,REPEC,2020-12-29,2020-12-30,FALSE,Recruiting,Phase 3,Interventional,"Argentina, Dominican Republic, Peru, Belgium, Colombia, Mexico, Spain, Germany, Nederland",HERALD,10720,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=106-20,NA
PER-108-20,REPEC,2021-03-23,2021-01-01,TRUE,Not Recruiting,Phase 2,Interventional,"Russian Federation, Peru, Brazil, Mexico, Israel","OPAGANIB, A SPHINGOSINE KINASE-2 (SK-2) INHIBITOR IN COVID-19 PNEUMONIA: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN HOSPITALIZED ADULT SUBJECTS WITH SEVERE SARS-COV-PNEUMONIA- 2 POSITIVE",55,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=108-20,NA
PER-002-21,REPEC,NA,2021-03-26,FALSE,No Status Given,Phase 2,Interventional,"Chile, Argentina, Colombia, United States, Mexico, Brazil","A Multicenter, Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial to Evaluate the Efficacy and Safety of Monoclonal Antibody SCTA01 against SARS-CoV-2 in Hospitalized Patients with Severe COVID-19",795,https://repec.ins.gob.pe/maestro/ajax/exportar-ficha-datos-publico/5/en/,NA
